Citrus Sinensis ID: 002021
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 979 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.954 | 0.924 | 0.394 | 1e-173 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.951 | 0.903 | 0.377 | 1e-165 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.979 | 0.935 | 0.382 | 1e-157 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.879 | 0.734 | 0.349 | 1e-127 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.858 | 0.857 | 0.335 | 1e-125 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.888 | 0.696 | 0.328 | 1e-123 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.914 | 0.893 | 0.335 | 1e-122 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.927 | 0.939 | 0.338 | 1e-120 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.930 | 0.908 | 0.331 | 1e-116 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.915 | 0.926 | 0.329 | 1e-115 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 610 bits (1573), Expect = e-173, Method: Compositional matrix adjust.
Identities = 388/984 (39%), Positives = 548/984 (55%), Gaps = 50/984 (5%)
Query: 29 TDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTI 88
TD+ ALL K+ ++ D L+ +WN S P+CNW GV C ++RVT L + L L G I
Sbjct: 24 TDRQALLQFKSQVSEDKRVVLS-SWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVI 82
Query: 89 PSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQH 148
+GNLS L SL+L N G+IP + L+Y+ + N L G P + N S L +
Sbjct: 83 SPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN 142
Query: 149 LDLSSNALSGEIRA----------------NICREIPREFGNLPELELMSLAANNLQGKI 192
L L SN L G + + N+ ++P GNL LE ++L+ NNL+G+I
Sbjct: 143 LRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEI 202
Query: 193 PLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLE 252
P + L + L + N G+ P A++N+S+LK+LG+ N SG L LPNL
Sbjct: 203 PSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLL 262
Query: 253 ILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS- 311
++ GN F+G+IP + N S L L + N+ +G IP TFGN+ NL L L N L S
Sbjct: 263 SFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSD 321
Query: 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
S+++L FL+SL+NC L+ + N L LP ++ NLS L + ISG IP +
Sbjct: 322 SSRDLEFLTSLTNCTQLETLGIGRNRLGGDLP-ISIANLSAKLVTLDLGGTLISGSIPYD 380
Query: 372 ISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDL 431
I NL NL+ + L N L+G + +L KL L+ L L N+L G IP I N+ L LDL
Sbjct: 381 IGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDL 440
Query: 432 DGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLE 490
N G +P N + L + +G N+L +IPL ++ +L L+ S N L GSLP +
Sbjct: 441 SNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQD 500
Query: 491 IGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNL 550
IG+L+ L + L N SG +P +G +E LFL N G IP+ G L+ +K ++L
Sbjct: 501 IGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDL 559
Query: 551 SNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGS-PNL 609
SNN+LSG IP S LE LNLSFN LEGK+P G F N + S GN LCG
Sbjct: 560 SNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGF 619
Query: 610 QIPPCKTSI-----HHKSWKKSILLGIVLPLS---TTFMIVVILLILRYRQRGKRPSNDA 661
Q+ PC + H S K +++G+ + ++ FM V L+ LR R++ K +N
Sbjct: 620 QLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPT 679
Query: 662 NGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGR 720
L SY +L AT+GFS +N++G G FG+VYKA L + VAVKV Q
Sbjct: 680 PSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRG 739
Query: 721 AFKSFDVECEIMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSNC- 774
A KSF ECE +K IRHRNL+K++++CS+ EF+AL+ E+MP+GSL+ +L+
Sbjct: 740 AMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVE 799
Query: 775 -------ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFS 827
L + +RLNI IDVAS L+YLH P+ HCDLKPSNVLLDD++ AH+SDF
Sbjct: 800 EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFG 859
Query: 828 IAKMLTGEDQSMIQTQ-----TLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKK 882
+A++L D+ Q TIGY APEYG G+ S NGDVYSFGI+L+E FTGK+
Sbjct: 860 LARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKR 919
Query: 883 PTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTME 942
PT+E+F G TL + LP +++VD ++L +C++ VF + + C E
Sbjct: 920 PTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVECLTMVFEVGLRCCEE 979
Query: 943 FPKQRINAKEIVTKLLKIRDSLLR 966
P R+ +V +L+ IR+ +
Sbjct: 980 SPMNRLATSIVVKELISIRERFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 582 bits (1500), Expect = e-165, Method: Compositional matrix adjust.
Identities = 383/1015 (37%), Positives = 550/1015 (54%), Gaps = 83/1015 (8%)
Query: 4 FLLLHCLILISLFIAAATANTSSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWT 63
F L L+ + +F A +N TD ALL K+ ++ + + +WN S+P CNW
Sbjct: 9 FNALTLLLQVCIFAQARFSNE----TDMQALLEFKSQVSENNKREVLASWNHSSPFCNWI 64
Query: 64 GVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLK 123
GV C +RV LN+ LTG I +GNLS L+ LNL+ N +IP + + L+
Sbjct: 65 GVTCGRRRERVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQ 124
Query: 124 YVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSL 183
Y+ + N L G PS +SN S L +DLSSN L +P E G+L +L ++ L
Sbjct: 125 YLNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHLG--------HGVPSELGSLSKLAILDL 176
Query: 184 AANNLQGKIPLKIGNLRNLEKLDIGDNKLVG----------------IA--------PIA 219
+ NNL G P +GNL +L+KLD N++ G IA P A
Sbjct: 177 SKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPA 236
Query: 220 IFNVSTLKILGLQDNSLSGCL-SSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSIL 278
++N+S+L+ L L DNS SG L + GY NL L L N F+G IP+ + N S L
Sbjct: 237 LYNISSLESLSLADNSFSGNLRADFGYLLP-NLRRLLLGTNQFTGAIPKTLANISSLERF 295
Query: 279 DLEGNSFSGFIPNTFGNLRNLSWL-VLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNP 337
D+ N SG IP +FG LRNL WL + +++ +S+ L F+ +++NC L+Y D+ YN
Sbjct: 296 DISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNR 355
Query: 338 LYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLS 397
L LP ++ NLS +L + ISG IP +I NL +L+ + L N L+G + ++
Sbjct: 356 LGGELP-ASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFG 414
Query: 398 KLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGS 457
KL LQ + L N + G IP N+ L +L L+ N G IP L + + +
Sbjct: 415 KLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDT 474
Query: 458 NELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIG 516
N L +IP + + ++ S+NFLTG P E+G L++LVG+ S N SG +P IG
Sbjct: 475 NRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIG 534
Query: 517 GLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSF 576
G ++E+LF+ N G+IP+ L+SLK ++ SNNNLSG IP L L L +LNLS
Sbjct: 535 GCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSM 593
Query: 577 NQLEGKIPRGGSFGNFSAQSFEGNELLCGS-PNLQIPPCKTSIHHK-----SWKKSILLG 630
N+ EG++P G F N +A S GN +CG +Q+ PC + S +K ++ G
Sbjct: 594 NKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSG 653
Query: 631 IVLPLSTTFMIVVILLILRYRQRGKR-PSNDANGPLVASRRMF----SYLELCRATDGFS 685
I + +++ +I+++ + + +R K+ ++D N + MF SY EL AT FS
Sbjct: 654 ICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFS 713
Query: 686 ENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
NLIG G FG+V+K LG + VAVKV A KSF ECE K IRHRNL+K+I
Sbjct: 714 STNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLI 773
Query: 745 SSCSN-----EEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASA 791
+ CS+ +F+ALV E+MP GSL+ +L + L ++LNI IDVASA
Sbjct: 774 TVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASA 833
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ-----TLA 846
LEYLH PV HCD+KPSN+LLDD++ AH+SDF +A++L D+ Q
Sbjct: 834 LEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRG 893
Query: 847 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 906
TIGY APEYG G+ S GDVYSFGI+L+E F+GKKPTDE F G+ L + L T
Sbjct: 894 TIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCT 953
Query: 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961
A ++ + V + ++C+ E+P+ R+ E V +L+ IR
Sbjct: 954 SSGGSN-----------AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 557 bits (1435), Expect = e-157, Method: Compositional matrix adjust.
Identities = 389/1017 (38%), Positives = 571/1017 (56%), Gaps = 58/1017 (5%)
Query: 5 LLLHCLILISLFIAAATANTSSTI-----TDQDALLALKAHITHDPTNFLAKNWNTSTPV 59
L+L +L+S+ + + + TI TD+ ALL K+ ++ + + + +WN S P+
Sbjct: 10 LILVSALLVSVSLEHSDMVCAQTIRLTEETDKQALLEFKSQVS-ETSRVVLGSWNDSLPL 68
Query: 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTT 119
C+WTGV C + +RVT +++ L LTG + +GNLS L+SLNL+ N G+IPS +
Sbjct: 69 CSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNL 128
Query: 120 YTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEI----------------RAN 163
+ L+Y+ + N G P +SN SSL LDLSSN L + R N
Sbjct: 129 FRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNN 188
Query: 164 ICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNV 223
+ + P GNL L+++ N ++G+IP I L+ + I NK G+ P I+N+
Sbjct: 189 LTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNL 248
Query: 224 STLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGN 283
S+L L + NS SG L + LPNL+IL + N+F+GTIP + N S L LD+ N
Sbjct: 249 SSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSN 308
Query: 284 SFSGFIPNTFGNLRNLSWLVLSDNYLTS-STQELSFLSSLSNCKFLKYFDLSYNPLYRIL 342
+G IP +FG L+NL L L++N L + S+ +L FL +L+NC L+Y ++ +N L L
Sbjct: 309 HLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQL 368
Query: 343 PRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKL 402
P + NLS L E + ISG IP I NL +L+T+ LG N L G + +L +L +L
Sbjct: 369 P-VFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSEL 427
Query: 403 QDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT- 461
+ + L N L G IP + N++ L L L N GSIP+ + + L ++LG+N+L
Sbjct: 428 RKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNG 487
Query: 462 SIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNL 521
SIP L ++ LN S N L G L +IG LK L+ +D+S N SG IP + +L
Sbjct: 488 SIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSL 547
Query: 522 EYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEG 581
E+L L N G IP+ G L L+FL+LS NNLSG IP + S L++LNLS N +G
Sbjct: 548 EFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDG 606
Query: 582 KIPRGGSFGNFSAQSFEGNELLCGS-PNLQIPPCKTSI--HHKSWKKSILLGIVLPLSTT 638
+P G F N SA S GN LCG P+LQ+ PC + H S +K I + + ++
Sbjct: 607 AVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAAL 666
Query: 639 FMIVVILLILRY---RQRGKRPSNDAN----GPLVASRRMFSYLELCRATDGFSENNLIG 691
++ + ++ L + R + R +N+ N P+ + SY EL + T GFS +NLIG
Sbjct: 667 LLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIG 726
Query: 692 RGGFGSVYKASLGD-GMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSN 749
G FG+V+K LG VA+KV + C R A KSF ECE + IRHRNL+K+++ CS+
Sbjct: 727 SGNFGAVFKGFLGSKNKAVAIKVL-NLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSS 785
Query: 750 E-----EFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLH 796
+F+ALV E+MP+G+L+ +L+ L +F RLNI IDVASAL YLH
Sbjct: 786 SDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLH 845
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ-----TLATIGYM 851
P+ HCD+KPSN+LLD ++ AH+SDF +A++L D+ Q TIGY
Sbjct: 846 TYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYA 905
Query: 852 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-PISTMEVV 910
APEYG G S GDVYSFGI+L+E FTGK+PT+++F +TL + L +++
Sbjct: 906 APEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDIT 965
Query: 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRN 967
D +L +C++ VF + + C+ E P RI+ E ++KL+ IR+S R+
Sbjct: 966 DETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1177), Expect = e-127, Method: Compositional matrix adjust.
Identities = 348/997 (34%), Positives = 508/997 (50%), Gaps = 136/997 (13%)
Query: 83 NLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISN 142
NLTG IP LG+L LQ + N L GSIP +I T L + L GNQL+G P N
Sbjct: 179 NLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGN 238
Query: 143 KSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNL 202
+LQ L L+ N L G+I P E GN L + L N L GKIP ++GNL L
Sbjct: 239 LLNLQSLVLTENLLEGDI--------PAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQL 290
Query: 203 EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSS-IGYARLPNLEILSLWGNNF 261
+ L I NKL P ++F ++ L LGL +N L G +S IG+ L +LE+L+L NNF
Sbjct: 291 QALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGF--LESLEVLTLHSNNF 348
Query: 262 SGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSS 321
+G P+ I N L++L + N+ SG +P G L NL L DN LT SS
Sbjct: 349 TGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIP-----SS 403
Query: 322 LSNCKFLKYFDLSYNPLYRILPR---------TTVG------------------------ 348
+SNC LK DLS+N + +PR ++G
Sbjct: 404 ISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVA 463
Query: 349 --NLSHSLEEF----------KMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITL 396
NL+ +L+ ++S +++G IP EI NL +L +YL N G I +
Sbjct: 464 DNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREM 523
Query: 397 SKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLG 456
S L LQ L + N LEG IP ++ ++ L LDL NK SG IPA FS L SL +SL
Sbjct: 524 SNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQ 583
Query: 457 SNELT-SIP-----LTFWNLKDI---------------------LNLNFSSNFLTGSLPL 489
N+ SIP L+ N DI L LNFS+N LTG++P
Sbjct: 584 GNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPK 643
Query: 490 EIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNL---------------EYLFLGY------ 528
E+G L+++ IDLS N FSG IP + KN+ + +F G
Sbjct: 644 ELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISL 703
Query: 529 ----NRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584
N G IP SFG++ L L+LS+NNL+G IP SL LS L+ L L+ N L+G +P
Sbjct: 704 NLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVP 763
Query: 585 RGGSFGNFSAQSFEGNELLCGSPNLQIPPCKTSIHHKSWKKS-----ILLGIVLPLSTTF 639
G F N +A GN LCGS + PC + K I+LG L
Sbjct: 764 ESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVL 822
Query: 640 MIVVILLILRYRQRGKRPSNDANGPLVASR---RMFSYLELCRATDGFSENNLIGRGGFG 696
++V+IL + +++ S++++ P + S + F EL +ATD F+ N+IG
Sbjct: 823 LLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLS 882
Query: 697 SVYKASLGDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVIS-SCSNEEFK 753
+VYK L DG +AVKV + + K F E + + ++HRNL+K++ + + + K
Sbjct: 883 TVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTK 942
Query: 754 ALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 812
ALVL +M +G+LE ++ S I + +++++ + +AS ++YLH GY P++HCDLKP+N
Sbjct: 943 ALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPAN 1002
Query: 813 VLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA---TIGYMAPEYGREGRVSANGDVYS 869
+LLD + VAH+SDF A++L + T A TIGY+APE+ +V+ DV+S
Sbjct: 1003 ILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFS 1062
Query: 870 FGIMLMETFTGKKPT--DEIFNGEMTLKHWVNDWL---PISTMEVVDANLLSQEDIHFVA 924
FGI++ME T ++PT ++ + +MTL+ V + + V+D L + I +
Sbjct: 1063 FGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLK 1120
Query: 925 KEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961
+E+ + L + CT P+ R + EI+T L+K+R
Sbjct: 1121 QEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 450 bits (1157), Expect = e-125, Method: Compositional matrix adjust.
Identities = 327/976 (33%), Positives = 491/976 (50%), Gaps = 136/976 (13%)
Query: 59 VCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFT 118
VCNW+GV C S +V L+IS
Sbjct: 53 VCNWSGVKCNKESTQVIELDIS-------------------------------------- 74
Query: 119 TYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPE- 177
G L G I+N + L LDLS N G+I P E G+L E
Sbjct: 75 ----------GRDLGGEISPSIANLTGLTVLDLSRNFFVGKI--------PPEIGSLHET 116
Query: 178 LELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIF---NVSTLKILGLQDN 234
L+ +SL+ N L G IP ++G L L LD+G N+L G P+ +F + S+L+ + L +N
Sbjct: 117 LKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNN 176
Query: 235 SLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPN-TF 293
SL+G + + L L L LW N +GT+P + N++ L +DLE N SG +P+
Sbjct: 177 SLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVI 236
Query: 294 GNLRNLSWLVLSDNYLTS---STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNL 350
+ L +L LS N+ S +T F +SL+N L+ +L+ N L + ++V +L
Sbjct: 237 SKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEI-TSSVRHL 295
Query: 351 SHSLEEFKMSNCNISGGIPEEIS------------------------NLTNLRTIYLGGN 386
S +L + + I G IP EIS L+ L +YL N
Sbjct: 296 SVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNN 355
Query: 387 KLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSN 446
L G I + L + +L L + N L GSIP NL++L RL L GN LSG++P
Sbjct: 356 HLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGK 415
Query: 447 LTSLRIVSLGSNELT-SIPL-TFWNLKDI-LNLNFSSNFLTGSLPLEIGSLKVLVGIDLS 503
+L I+ L N LT +IP+ NL+++ L LN SSN L+G +PLE+ + +++ +DLS
Sbjct: 416 CINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLS 475
Query: 504 RNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASL 563
N SG IP ++G LE+L L N ++P+S G L LK L++S N L+G IP S
Sbjct: 476 SNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSF 535
Query: 564 EKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQIPPCKTSIHHKSW 623
++ S L+ LN SFN L G + GSF + +SF G+ LLCGS + CK HK
Sbjct: 536 QQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKKK--HKYP 592
Query: 624 KKSILLGIVLPLSTTFMIVVILLILRYR--------------QRGKRPSNDANGPLVASR 669
+ + + L + + L+ R R K+ ND P +
Sbjct: 593 SVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRI--- 649
Query: 670 RMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFK-SFDVE 728
SY +L AT GF+ ++LIG G FG VYK L + +VAVKV + F SF E
Sbjct: 650 ---SYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRE 706
Query: 729 CEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIM 785
C+I+K RHRNLI++I++CS F ALVL MP+GSLE++LY S+ LD+ Q +NI
Sbjct: 707 CQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNIC 766
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
DVA + YLH V+HCDLKPSN+LLDD M A ++DF I++++ G ++++ ++
Sbjct: 767 SDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSV 826
Query: 846 A----------TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 895
+ ++GY+APEYG R S +GDVYSFG++L+E +G++PTD + N +L
Sbjct: 827 SFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLH 886
Query: 896 HWVNDWLPISTMEVVDANLL------SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN 949
++ P S +++ L E + +E + + L + CT P R +
Sbjct: 887 EFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMI-ELGLVCTQYNPSTRPD 945
Query: 950 AKEIVTKLLKIRDSLL 965
++ ++ ++++ L
Sbjct: 946 MLDVAHEMGRLKEYLF 961
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1137), Expect = e-123, Method: Compositional matrix adjust.
Identities = 341/1039 (32%), Positives = 503/1039 (48%), Gaps = 169/1039 (16%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
+TV + L GTIP++LG L +L+ LNL+ N L G IPS + L+Y+ L NQL
Sbjct: 217 LTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQ 276
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREF-----------------GNLP 176
G P +++ +LQ LDLS+N L+GEI P EF G+LP
Sbjct: 277 GLIPKSLADLGNLQTLDLSANNLTGEI--------PEEFWNMSQLLDLVLANNHLSGSLP 328
Query: 177 E--------LELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKI 228
+ LE + L+ L G+IP+++ ++L++LD+ +N L G P A+F + L
Sbjct: 329 KSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTD 388
Query: 229 LGLQDNSLSGCLS-SIG---------------YARLPN-------LEILSLWGNNFSGTI 265
L L +N+L G LS SI +LP LE+L L+ N FSG I
Sbjct: 389 LYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEI 448
Query: 266 PRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNC 325
P+ I N + L ++D+ GN F G IP + G L+ L+ L L N L +SL NC
Sbjct: 449 PQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGG-----LPASLGNC 503
Query: 326 KFLKYFDLSYNPLYRILPRT-------------------------------TVGNLSH-- 352
L DL+ N L +P + T NLSH
Sbjct: 504 HQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNR 563
Query: 353 ------------SLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQ 400
S F ++N IP E+ N NL + LG N+L G I TL K++
Sbjct: 564 LNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIR 623
Query: 401 KLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNE- 459
+L L + N L G+IP + +L +DL+ N LSG IP L+ L + L SN+
Sbjct: 624 ELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQF 683
Query: 460 LTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLK 519
+ S+P +N +L L+ N L GS+P EIG+L L ++L +N FSG +P +G L
Sbjct: 684 VESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLS 743
Query: 520 NLEYLFLGYNRLQGSIPNSFGDLISLK-FLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578
L L L N L G IP G L L+ L+LS NN +G IP+++ LS LE L+LS NQ
Sbjct: 744 KLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQ 803
Query: 579 LEGKIPR------------------GG----SFGNFSAQSFEGNELLCGSPNLQIPPCKT 616
L G++P GG F + A SF GN LCGSP + ++
Sbjct: 804 LTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRS 863
Query: 617 SIHHKSWK-KSILLGIVLPLSTTFMIVVILLILRYRQRGKRPSNDANG------------ 663
+ + +S+++ + T ++++++ L ++QR +G
Sbjct: 864 NNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQ 923
Query: 664 ----PLV---ASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVK-VFT 715
PL AS+ + ++ AT SE +IG GG G VYKA L +G VAVK +
Sbjct: 924 ATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILW 983
Query: 716 SQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSN 773
+ KSF E + + IRHR+L+K++ CS+ E L+ EYM +GS+ +L+
Sbjct: 984 KDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDK 1043
Query: 774 CIL-------DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 826
+L D RL I + +A +EYLH P++H D+K SNVLLD NM AHL DF
Sbjct: 1044 PVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDF 1103
Query: 827 SIAKMLTGEDQSMIQTQTL--ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT 884
+AK+LT + + T + GY+APEY + + DVYS GI+LME TGK PT
Sbjct: 1104 GLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPT 1163
Query: 885 DEIFNGEMTLKHWVNDWLPISTM---EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTM 941
D +F EM + WV L ++ +++D L + + F C V +A++CT
Sbjct: 1164 DSVFGAEMDMVRWVETHLEVAGSARDKLIDPKL--KPLLPFEEDAACQ--VLEIALQCTK 1219
Query: 942 EFPKQRINAKEIVTKLLKI 960
P++R ++++ LL +
Sbjct: 1220 TSPQERPSSRQACDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-122, Method: Compositional matrix adjust.
Identities = 328/978 (33%), Positives = 502/978 (51%), Gaps = 83/978 (8%)
Query: 28 ITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGT 87
IT+ ALL+LK+ T D + L +WN ST C+WTGV C+V + VT L++S LNL+GT
Sbjct: 25 ITELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGT 84
Query: 88 IPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNK-SSL 146
+ S + +L LQ+L+L+ N++ G IP I Y L+++ L N +G+FP +S+ +L
Sbjct: 85 LSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNL 144
Query: 147 QHLDLSSNALSGEIRANICR----------------EIPREFGNLPELELMSLAANNLQG 190
+ LDL +N L+G++ ++ +IP +G P LE ++++ N L G
Sbjct: 145 RVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTG 204
Query: 191 KIPLKIGNLRNLEKLDIGD-NKLVGIAPIAIFNVSTLKILGLQDNSLSGCLS-SIGYARL 248
KIP +IGNL L +L IG N P I N+S L + L+G + IG +L
Sbjct: 205 KIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIG--KL 262
Query: 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNY 308
L+ L L N F+GTI + + S L +DL N F+G IP +F L+NL+ L L N
Sbjct: 263 QKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNK 322
Query: 309 LTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEE------FKMSNC 362
L + E F+ + + L+ ++ ++ G++ L E +S+
Sbjct: 323 LYGAIPE--FIGEMPELEVLQLWENNF-----------TGSIPQKLGENGRLVILDLSSN 369
Query: 363 NISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICN 422
++G +P + + L T+ GN L GSI +L K + L + + +N L GSIP ++
Sbjct: 370 KLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFG 429
Query: 423 LAELYRLDLDGNKLSGSIPACFSNLT-SLRIVSLGSNELT-SIPLTFWNLKDILNLNFSS 480
L +L +++L N L+G +P ++ L +SL +N+L+ S+P NL + L
Sbjct: 430 LPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDG 489
Query: 481 NFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFG 540
N +GS+P EIG L+ L +D S N FSG I EI K L ++ L N L G IPN
Sbjct: 490 NKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELT 549
Query: 541 DLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGN 600
+ L +LNLS N+L G IP ++ + L ++ S+N L G +P G F F+ SF GN
Sbjct: 550 GMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGN 609
Query: 601 ELLCGSPNLQIPPCKTSIHHKSWKKSILLGIVLPLSTT----------FMIVVILLILRY 650
LCG + PC H K PLS T F +V ++
Sbjct: 610 SHLCGP---YLGPCGKGTHQSHVK---------PLSATTKLLLVLGLLFCSMVFAIVAII 657
Query: 651 RQRGKRPSNDANG-PLVASRRM-FSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGME 708
+ R R +++A L A +R+ F+ ++ D E+N+IG+GG G VYK ++ G
Sbjct: 658 KARSLRNASEAKAWRLTAFQRLDFTCDDVL---DSLKEDNIIGKGGAGIVYKGTMPKGDL 714
Query: 709 VAVKVFT--SQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 766
VAVK S F+ E + + IRHR++++++ CSN E LV EYMP+GSL
Sbjct: 715 VAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLG 774
Query: 767 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 825
+ L+ L R I ++ A L YLH S ++H D+K +N+LLD N AH++D
Sbjct: 775 EVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVAD 834
Query: 826 FSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTD 885
F +AK L S + + GY+APEY +V DVYSFG++L+E TGKKP
Sbjct: 835 FGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVG 894
Query: 886 EIFNGEMTLKHWV---NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTME 942
E +G + + WV D ++V+D LS +H V+ VF +A+ C E
Sbjct: 895 EFGDG-VDIVQWVRSMTDSNKDCVLKVIDLR-LSSVPVHE------VTHVFYVALLCVEE 946
Query: 943 FPKQRINAKEIVTKLLKI 960
+R +E+V L +I
Sbjct: 947 QAVERPTMREVVQILTEI 964
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 433 bits (1113), Expect = e-120, Method: Compositional matrix adjust.
Identities = 329/973 (33%), Positives = 497/973 (51%), Gaps = 65/973 (6%)
Query: 1 MSRFLLLHCLILISLFIAAATANTSSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVC 60
M R +L ++ +F A+ N + AL+A+K ++ L + ++ +C
Sbjct: 5 MQRMVLSLAMVGFMVFGVASAMNN-----EGKALMAIKGSFSNLVNMLLDWDDVHNSDLC 59
Query: 61 NWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTY 120
+W GV C+ S V LN+SSLNL G I +G+L +LQS++L
Sbjct: 60 SWRGVFCDNVSYSVVSLNLSSLNLGGEISPAIGDLRNLQSIDL----------------- 102
Query: 121 TLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELEL 180
+GN+L+G P I N +SL +LDLS N L G+I P L +LE
Sbjct: 103 -------QGNKLAGQIPDEIGNCASLVYLDLSENLLYGDI--------PFSISKLKQLET 147
Query: 181 MSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL 240
++L N L G +P + + NL++LD+ N L G ++ L+ LGL+ N L+G L
Sbjct: 148 LNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYLGLRGNMLTGTL 207
Query: 241 SSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLS 300
SS +L L + GNN +GTIP I N + ILD+ N +G IP G L+ ++
Sbjct: 208 SS-DMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFLQ-VA 265
Query: 301 WLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMS 360
L L N LT E+ L + L DLS N L +P +GNLS + + +
Sbjct: 266 TLSLQGNRLTGRIPEVIGL-----MQALAVLDLSDNELVGPIP-PILGNLSFTGKLYLHG 319
Query: 361 NCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI 420
N ++G IP E+ N++ L + L NKL G+I L KL++L +L L +N+L G IP +I
Sbjct: 320 NM-LTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNI 378
Query: 421 CNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFS 479
+ A L + ++ GN LSGSIP F NL SL ++L SN IP+ ++ ++ L+ S
Sbjct: 379 SSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLS 438
Query: 480 SNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSF 539
N +GS+PL +G L+ L+ ++LSRN+ SG +P E G L++++ + + +N L G IP
Sbjct: 439 GNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTEL 498
Query: 540 GDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEG 599
G L +L L L+NN L G IP L L +LN+SFN L G +P +F F+ SF G
Sbjct: 499 GQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVG 558
Query: 600 NELLCGSPNLQI--PPCKTSIHHKSWKKSILLGIVLPLSTTFMIVVILLILRYRQRGKRP 657
N LCG+ I P K+ + + I+LG++ L F+ V + + +G
Sbjct: 559 NPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLCMIFLAVYKSMQQKKILQGSSK 618
Query: 658 SNDANGPLV---ASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVF 714
+ LV + ++ ++ R T+ +E +IG G +VYK +L +A+K
Sbjct: 619 QAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRL 678
Query: 715 TSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-- 772
+Q + F+ E E + SIRHRN++ + + L +YM +GSL L+ S
Sbjct: 679 YNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLK 738
Query: 773 NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832
LD RL I + A L YLH + +IH D+K SN+LLD+N AHLSDF IAK +
Sbjct: 739 KVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSI 798
Query: 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 892
++ T L TIGY+ PEY R R++ D+YSFGI+L+E TGKK D N
Sbjct: 799 PAS-KTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEANLHQ 857
Query: 893 TLKHWVNDWLPISTMEVVDANL-LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAK 951
+ +D + ME VD + ++ D+ + K F LA+ CT P +R
Sbjct: 858 LILSKADDN---TVMEAVDPEVTVTCMDLGHIRK------TFQLALLCTKRNPLERPTML 908
Query: 952 EIVTKLLKIRDSL 964
E+ LL + SL
Sbjct: 909 EVSRVLLSLVPSL 921
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1077), Expect = e-116, Method: Compositional matrix adjust.
Identities = 327/986 (33%), Positives = 494/986 (50%), Gaps = 75/986 (7%)
Query: 19 AATANTSSTITDQDALLALKAHITH--DPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTV 76
+ T S I++ ALL+LK +T D N +W ST C W GV C+V + VT
Sbjct: 14 SHTFTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHVTS 73
Query: 77 LNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTF 136
L++S LNL+GT+ + +L LQ+L+L+ N + G IP I + L+++ L N +G+F
Sbjct: 74 LDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSF 133
Query: 137 PSFISNK-SSLQHLDLSSNALSGEIRANICR----------------EIPREFGNLPELE 179
P IS+ +L+ LD+ +N L+G++ ++ +IP +G+ P +E
Sbjct: 134 PDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIE 193
Query: 180 LMSLAANNLQGKIPLKIGNLRNLEKLDIGD-NKLVGIAPIAIFNVSTLKILGLQDNSLSG 238
++++ N L GKIP +IGNL L +L IG N P I N+S L + L+G
Sbjct: 194 YLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTG 253
Query: 239 CLS-SIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLR 297
+ IG +L L+ L L N FSG + + S L +DL N F+G IP +F L+
Sbjct: 254 EIPPEIG--KLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELK 311
Query: 298 NLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEF 357
NL+ L L N L E F+ L + L+ ++ N +P+ N L
Sbjct: 312 NLTLLNLFRNKLHGEIPE--FIGDLPELEVLQLWE---NNFTGSIPQKLGEN--GKLNLV 364
Query: 358 KMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIP 417
+S+ ++G +P + + L T+ GN L GSI +L K + L + + +N L GSIP
Sbjct: 365 DLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIP 424
Query: 418 YDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTS-IPLTFWNLKDILNL 476
+ L +L +++L N LSG +P +L +SL +N+L+ +P N + L
Sbjct: 425 KGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKL 484
Query: 477 NFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 536
N G +P E+G L+ L ID S N FSG I EI K L ++ L N L G IP
Sbjct: 485 LLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIP 544
Query: 537 NSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQS 596
N + L +LNLS N+L G IP S+ + L L+ S+N L G +P G F F+ S
Sbjct: 545 NEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTS 604
Query: 597 FEGNELLCGSPNLQIPPCKTSIH---HKSWKKSILLGIVLPLSTTF------------MI 641
F GN LCG + PCK + H+S K PLS + +
Sbjct: 605 FLGNPDLCGP---YLGPCKDGVAKGGHQSHSKG-------PLSASMKLLLVLGLLVCSIA 654
Query: 642 VVILLILRYRQRGKRPSNDANGPLVASRRM-FSYLELCRATDGFSENNLIGRGGFGSVYK 700
++ I++ R K+ S L A +R+ F+ ++ D E+N+IG+GG G VYK
Sbjct: 655 FAVVAIIKARSL-KKASESRAWRLTAFQRLDFTCDDVL---DSLKEDNIIGKGGAGIVYK 710
Query: 701 ASLGDGMEVAVKVFT--SQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758
+ +G VAVK S+ F+ E + + IRHR++++++ CSN E LV E
Sbjct: 711 GVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYE 770
Query: 759 YMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 817
YMP+GSL + L+ L R I ++ A L YLH S ++H D+K +N+LLD
Sbjct: 771 YMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDS 830
Query: 818 NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMET 877
N AH++DF +AK L S + + GY+APEY +V DVYSFG++L+E
Sbjct: 831 NFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLEL 890
Query: 878 FTGKKPTDEIFNGEMTLKHWV---NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 934
TG+KP E +G + + WV D S ++V+D LS IH V+ VF
Sbjct: 891 VTGRKPVGEFGDG-VDIVQWVRKMTDSNKDSVLKVLDPR-LSSIPIHE------VTHVFY 942
Query: 935 LAMECTMEFPKQRINAKEIVTKLLKI 960
+AM C E +R +E+V L +I
Sbjct: 943 VAMLCVEEQAVERPTMREVVQILTEI 968
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 416 bits (1070), Expect = e-115, Method: Compositional matrix adjust.
Identities = 320/970 (32%), Positives = 489/970 (50%), Gaps = 74/970 (7%)
Query: 6 LLHCLILISLFIAAATANTSSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGV 65
L CL ++ + + + ++ + AL+A+KA ++ L + + C+W GV
Sbjct: 10 LFFCLGMVVFMLLGSVSPMNN---EGKALMAIKASFSNVANMLLDWDDVHNHDFCSWRGV 66
Query: 66 ACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYV 125
C+ S V LN+S+LNL G I S LG+L +LQS++L
Sbjct: 67 FCDNVSLNVVSLNLSNLNLGGEISSALGDLMNLQSIDL---------------------- 104
Query: 126 CLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAA 185
+GN+L G P I N SL ++D S+N L G+I P L +LE ++L
Sbjct: 105 --QGNKLGGQIPDEIGNCVSLAYVDFSTNLLFGDI--------PFSISKLKQLEFLNLKN 154
Query: 186 NNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGY 245
N L G IP + + NL+ LD+ N+L G P ++ L+ LGL+ N L+G LS
Sbjct: 155 NQLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSP-DM 213
Query: 246 ARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLS 305
+L L + GNN +GTIP I N + ILD+ N +G IP G L+ ++ L L
Sbjct: 214 CQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVSYNQITGVIPYNIGFLQ-VATLSLQ 272
Query: 306 DNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNIS 365
N LT E+ L + L DLS N L +P +GNLS + + + N ++
Sbjct: 273 GNKLTGRIPEVIGL-----MQALAVLDLSDNELTGPIP-PILGNLSFTGKLYLHGN-KLT 325
Query: 366 GGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAE 425
G IP E+ N++ L + L N+L G I L KL++L +L L +N L G IP +I + A
Sbjct: 326 GQIPPELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCAA 385
Query: 426 LYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLT 484
L + ++ GN LSG++P F NL SL ++L SN IP ++ ++ L+ S N +
Sbjct: 386 LNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFS 445
Query: 485 GSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLIS 544
GS+PL +G L+ L+ ++LSRN+ +G +P E G L++++ + + +N L G IP G L +
Sbjct: 446 GSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQN 505
Query: 545 LKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLC 604
+ L L+NN + G IP L L +LN+SFN L G IP +F FS SF GN LC
Sbjct: 506 INSLILNNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLC 565
Query: 605 GSPNLQIPPCKTSI-HHKSWKKSILLGIVLPLSTTFMIVVILLILRYRQRGKRP-----S 658
G N C S+ + + + ++ +VL T ++ ++ I Y+ + ++P S
Sbjct: 566 G--NWVGSICGPSLPKSQVFTRVAVICMVLGFIT---LICMIFIAVYKSKQQKPVLKGSS 620
Query: 659 NDANGP-----LVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKV 713
G L + ++ ++ R T+ E +IG G +VYK + +A+K
Sbjct: 621 KQPEGSTKLVILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKR 680
Query: 714 FTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY--S 771
+Q F+ F+ E E + SIRHRN++ + + L +YM +GSL L+
Sbjct: 681 IYNQYPSNFREFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPG 740
Query: 772 SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831
LD RL I + A L YLH + +IH D+K SN+LLD N A LSDF IAK
Sbjct: 741 KKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKS 800
Query: 832 LTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
+ ++ T L TIGY+ PEY R R++ D+YSFGI+L+E TGKK D N
Sbjct: 801 IPAT-KTYASTYVLGTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLTGKKAVDNEANLH 859
Query: 892 MTLKHWVNDWLPISTMEVVDANL-LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA 950
+ +D + ME VDA + ++ D + K F LA+ CT P +R
Sbjct: 860 QMILSKADD---NTVMEAVDAEVSVTCMDSGHIKK------TFQLALLCTKRNPLERPTM 910
Query: 951 KEIVTKLLKI 960
+E+ LL +
Sbjct: 911 QEVSRVLLSL 920
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 979 | ||||||
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.979 | 0.941 | 0.488 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.913 | 0.820 | 0.505 | 0.0 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.977 | 0.917 | 0.470 | 0.0 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.902 | 0.833 | 0.51 | 0.0 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.895 | 0.806 | 0.516 | 0.0 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.899 | 0.605 | 0.507 | 0.0 | |
| 255583725 | 973 | serine-threonine protein kinase, plant-t | 0.973 | 0.979 | 0.483 | 0.0 | |
| 359483683 | 1228 | PREDICTED: LRR receptor-like serine/thre | 0.910 | 0.725 | 0.490 | 0.0 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.909 | 0.740 | 0.495 | 0.0 | |
| 147776333 | 1205 | hypothetical protein VITISV_000078 [Viti | 0.910 | 0.739 | 0.489 | 0.0 |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 864 bits (2233), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/1012 (48%), Positives = 640/1012 (63%), Gaps = 53/1012 (5%)
Query: 11 ILISLFIAAATANT----SSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVA 66
IL+S+ + + +S TDQ ALLA K HIT DP N L +W++ T CNW GV+
Sbjct: 8 ILVSMLLMSLPKKCISIPTSNFTDQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMGVS 67
Query: 67 CEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTT------- 119
C + QRVT L++SS+ L GTIP QLGNLS LQ L L N G +PS I
Sbjct: 68 CSLRRQRVTALDLSSMGLLGTIPPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMD 127
Query: 120 ------------------YTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIR 161
+ L+ + GN L+GT PS I N SSL+ LDL N L G +
Sbjct: 128 IGSNKLSLVIVPESFGNLHRLEELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLP 187
Query: 162 ANICREIPR-EF---------GNLP-------ELELMSLAANNLQGKIPLKIGNLRNLEK 204
N+C +PR E G +P EL+L+ L NN G IP ++G L LE
Sbjct: 188 KNMCDHLPRLEMLLLSSNQLSGQIPSDLFKCRELQLLWLPYNNFTGVIPEELGFLPMLEV 247
Query: 205 LDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGT 264
L++G N L G P +IFN+++L+ + + N+LSG + LPNLE L L N +G+
Sbjct: 248 LNLGVNMLSGDLPRSIFNMTSLRTMQICCNNLSGSIPQENSIDLPNLEELQLNLNGITGS 307
Query: 265 IPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS--STQELSFLSSL 322
+PRF+ N S+L ILDL N +G + FGNLR L L L N T+ S+Q L+F++SL
Sbjct: 308 MPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFITSL 367
Query: 323 SNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIY 382
+N + LK + NPL +LP +VGNLS L +F + + G IP EI NL+NL +
Sbjct: 368 TNSRQLKELHIGDNPLDGMLP-NSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVLS 426
Query: 383 LGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA 442
L N L G I T+ L+K+Q L L N L GSIP DIC L + L+ N LSG IP+
Sbjct: 427 LEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPS 486
Query: 443 CFSNLTSLRIVSLGSNELTS-IPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGID 501
C NLTSLR + L N L+S IP+ W+LKD+L LN SNFL GSLP ++G ++ +GI
Sbjct: 487 CIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIR 546
Query: 502 LSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA 561
LS N SG IP+ IG L+NL L N QGSIP +FG L+SL+ L+LS NNLSG IP
Sbjct: 547 LSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPK 606
Query: 562 SLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQIPPCKTSIHHK 621
SLE L YLE ++SFN L+G+IPRGG F NF+A+SF N+ LCG LQ+PPC
Sbjct: 607 SLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKD 666
Query: 622 SWKKSILLGIVLPLSTTFMIVV--ILLILRYRQRGKRPSNDANGPLVASRRMFSYLELCR 679
S KS LL LP + ++VV I L++ R+R ++ P+ A +R SYLEL
Sbjct: 667 SKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLH 726
Query: 680 ATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN 739
AT+ F E+NL+G G FGSVY+ L DG+ VAVK+F Q RAF+SFD ECEIM++IRHRN
Sbjct: 727 ATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRN 786
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
L+K+I SCSN +FKALVLEYMP GSLEK+LYS N LDI QR+NIMIDVASALEYLH GY
Sbjct: 787 LVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGY 846
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG 859
+PV+HCDLKPSNVLLD++MVAH+ DF IAK+L GE++S QT+TLATIGYMAPEYG +G
Sbjct: 847 PSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLL-GENESFAQTRTLATIGYMAPEYGLDG 905
Query: 860 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
VS DVYSFGIMLME T K+PTDE+F GEM+LK V + LP S +++VD+N+L++ D
Sbjct: 906 LVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGD 965
Query: 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGR 971
+ V KE CV+ + LA++C E P +R+ EI+ +L I+ LR+ R
Sbjct: 966 GYSVKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRDSERR 1017
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2195), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/929 (50%), Positives = 629/929 (67%), Gaps = 35/929 (3%)
Query: 73 RVTVLNISSLN--------LTGTIPSQLG-NLSSLQSLNLSFNRLFGSIPSAIFTTYTLK 123
R ++ NI++LN L G I +G NLS+LQ LN+ N+L GS P I +LK
Sbjct: 159 RSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGSFPPKILDLPSLK 218
Query: 124 YVCLRGNQLSGTFPSFISNKSS-LQHLDLSSNALSGEIRANI--CRE------------- 167
++ L+ N LSG + N++S LQ L+L+ N L G+I +++ C+E
Sbjct: 219 FIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKELRSLALHANKFTG 278
Query: 168 -IPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTL 226
IPR GNL +L+ +SL NNL G+IPL+IGNL+NL+ + + N L G P A+FN+ST+
Sbjct: 279 SIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGSIPHALFNISTM 338
Query: 227 KILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFS 286
K + + N+L G L + LPNL L L N SG IP +I NASKL+IL+L NSF+
Sbjct: 339 KWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASKLTILELPSNSFT 398
Query: 287 GFIPNTFGNLRNLSWLVLSDNYLTS--STQELSFLSSLSNCKFLKYFDLSYNPLYRILPR 344
GFIP++ G+LRNL L L N L+S ++QEL+ SSL NC+ LKY LSYNPL LP
Sbjct: 399 GFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLWLSYNPLDGYLPH 458
Query: 345 TTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQD 404
+ VGNLS+SLE F S+ I G + E I NL++L + LG N L G I T+ L+ LQ
Sbjct: 459 S-VGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQG 517
Query: 405 LGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTS-I 463
L L N L+GSIP ++C+L LY L+L GNKLSGSIP CFSNLTSLR + L SN S I
Sbjct: 518 LYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTI 577
Query: 464 PLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEY 523
T W LKDIL +N +SN+LTGSLP EI +L+ + I++S+N SG IP IGGL++L
Sbjct: 578 SSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQ 637
Query: 524 LFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKI 583
L+L N+LQG IP S GD+ SL+FL+LS+NNLSG+IP SL+ L YL+ N+SFN L+G+I
Sbjct: 638 LYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEI 697
Query: 584 PRGGSFGNFSAQSFEGNELLCGSPNLQIPPCK--TSIHHKSWKKSILLGIVLP--LSTTF 639
P GGSF NFSAQSF GNE LCGS LQ+ PCK S ++ I+L VLP + F
Sbjct: 698 PEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLRYVLPAIVFAVF 757
Query: 640 MIVVILLILRYRQRGKRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVY 699
++ ++++ RY +R + S + + + + R SY EL AT+GF E+N +G G FGSVY
Sbjct: 758 VLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVY 817
Query: 700 KASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759
K +L DG +A KVF Q RAFKSFD ECE+++++RHRNL+K+I+SCS FKALVLE+
Sbjct: 818 KGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEF 877
Query: 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 819
MP+ SLEK+LYS + L+ QRLNIM+DVAS LEYLH GY+ P+ HCD+KPSNVLL+++M
Sbjct: 878 MPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDM 937
Query: 820 VAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 879
VA L+DF I+K+L GE+ S++QT TLATIGYMAPEYG EG VS GDVYS+G++LMETFT
Sbjct: 938 VAFLADFGISKLL-GEEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFT 996
Query: 880 GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMEC 939
KKPTD++F +++LK WV L +V+DANLL E+ H AK+ C+ + LA++C
Sbjct: 997 QKKPTDKMFTEQLSLKSWVEQSLSCEVTQVIDANLLGIEEDHLAAKKDCIVSILKLALQC 1056
Query: 940 TMEFPKQRINAKEIVTKLLKIRDSLLRNV 968
+ + P RI+ K +VT L KI+ LR++
Sbjct: 1057 SADLPHDRIDMKHVVTTLQKIKTKFLRDI 1085
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2138), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/1040 (47%), Positives = 654/1040 (62%), Gaps = 83/1040 (7%)
Query: 5 LLLHCLILISLFIAAATANTSSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTG 64
L + ++L S F++ A T+ +DQDALLALK I DP N LA NW+ +T VC W G
Sbjct: 10 LCMKIILLYSFFVSIADGVTN-IASDQDALLALKVRIIRDPNNLLAANWSITTSVCTWVG 68
Query: 65 VACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKY 124
V C RVT L++S + LTGTIP LGNLS L ++ NR GS+P + +K
Sbjct: 69 VTCGARHGRVTALDLSDMGLTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKA 128
Query: 125 VCLRGNQLSGTFPSFISNKSSLQHLDLSS--------------------------NALSG 158
+ N SG PS+I + + LQ L LSS N L+G
Sbjct: 129 FGMSTNYFSGEIPSWIGSFTQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNNLTG 188
Query: 159 EIRANI---------------------------CRE--------------IPREFGNLPE 177
+ NI C++ I ++ GNL
Sbjct: 189 RLPPNIFTHLANLRALYLNSNLFNGPIPSTLMACQQLKLLALSFNHFEGSIHKDIGNLTM 248
Query: 178 LELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLS 237
L+ + L NN G IP +IG+L +LE++ + N L G+ P I+N S + +GL N LS
Sbjct: 249 LQELYLGGNNFSGTIPDEIGDLAHLEEIILNVNGLSGLVPSGIYNASKMTAIGLALNQLS 308
Query: 238 GCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLR 297
G L S + LPNLE + NNF+G IP +FNASKL +DL NSF G IP+ GNL+
Sbjct: 309 GYLPS--SSNLPNLEFFIIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLK 366
Query: 298 NLSWLVLSDNYLT--SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLE 355
+L N+LT SS+ LS SSL+ CK L+ FDLS NPL LP +VGNLS SLE
Sbjct: 367 SLEVFSFWVNHLTVKSSSSGLSLFSSLTKCKHLRRFDLSNNPLNGNLP-ISVGNLSSSLE 425
Query: 356 EFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGS 415
++ +C I+G IP+EI NL++L + LG N L G+I T+ KL KLQ+L L N+LEGS
Sbjct: 426 VVEIFDCGITGTIPKEIGNLSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGS 485
Query: 416 IPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTS-IPLTFWNLKDIL 474
PY++C+L L L L+ N LSG IP+C N+ SLR +S+G N+ +S IP T W L DIL
Sbjct: 486 FPYELCDLQSLAYLYLEVNALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADIL 545
Query: 475 NLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 534
LN SSN L+GSL ++IG+LK + IDLS N SG IP+ IGGLK L L L NRL+GS
Sbjct: 546 ELNLSSNSLSGSLAVDIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGS 605
Query: 535 IPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSA 594
IP FGD ISL+ L+LSNNNLSG IP SLE+L YL N+SFN+L+G+IP G +F N SA
Sbjct: 606 IPQLFGDAISLQLLDLSNNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSA 665
Query: 595 QSFEGNELLCGSPNLQIPPCKTSIHHKSWKKSIL---LGIVLPLSTTFMIVVILLI-LRY 650
+SF GN+ LCG+ LQ+ PC+TS H S S L G++ T + + +I +R
Sbjct: 666 KSFMGNKGLCGAAKLQVQPCETSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRS 725
Query: 651 RQRGKRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVA 710
R+R R + + PL +R+ SY EL +ATD F+E NL+GRG FGSVYK + DG VA
Sbjct: 726 RKRNMRIT-EGLLPLATLKRI-SYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVA 783
Query: 711 VKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS--NEEFKALVLEYMPHGSLEKY 768
VKVF Q AFKSFDVECE+++ IRHRNL+K+I+SCS N +FKALVLE+MP+ SLEK+
Sbjct: 784 VKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKW 843
Query: 769 LYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSI 828
L S L++ +RLNIM+DVASA+EYLH GY+ P++HCDLKPSN+LLD+NMVAH++DF I
Sbjct: 844 LCSPKHFLELLERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGI 903
Query: 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF 888
AK+L G++ S IQT TLAT+GYMAPEYG EG VS GD+YSFGI+LMETFT KKPTD++F
Sbjct: 904 AKLL-GDEHSFIQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKKPTDDMF 962
Query: 889 NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI 948
N E+++K WV + +P ++ D +LL E+ HF AK+ C+ V +A++C+ + P++R
Sbjct: 963 NEEISMKQWVQESVPGGVTQITDPDLLRIEEQHFSAKKDCILSVMQVALQCSADLPEERP 1022
Query: 949 NAKEIVTKLLKIRDSLLRNV 968
N ++++ L + L+++
Sbjct: 1023 NIRDVLNTLNHTKVKFLKDI 1042
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2135), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/900 (51%), Positives = 595/900 (66%), Gaps = 16/900 (1%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
+ VLN+ L G IPS L + L+ L+L NR GSIP I T LK + L N L+
Sbjct: 165 LEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEICTLTKLKELYLGKNNLT 224
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
G P I+ SL+ L L N L+G I PRE GN L + + NNL G IP
Sbjct: 225 GQIPGEIARLVSLEKLGLEVNGLNGNI--------PREIGNCTYLMEIHVENNNLTGVIP 276
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
++GNL L++LD+G N + G P FN S L+ + + N LSG L S LPNLE
Sbjct: 277 NEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNLEE 336
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313
L L N SG IP I NASKL +LDL NSFSG IP+ GNLRNL L L++N LTS +
Sbjct: 337 LYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKS 396
Query: 314 QELSFLSSLS--NCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
S NC+ L Y + NPL LP ++GNLS SLEE +C I G IP
Sbjct: 397 LRSELSFLSSLSNCRSLAYLRFNGNPLRGRLP-VSIGNLSASLEELYAFDCRIIGNIPRG 455
Query: 372 ISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDL 431
I NL+NL + L N+L G+I + +L+ LQD L NKL+G IP +IC+L L L L
Sbjct: 456 IGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYL 515
Query: 432 DGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEI 491
N SGS+PAC SN+TSLR + LGSN TSIP TFW+LKD+L +N S N LTG+LPLEI
Sbjct: 516 LENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPLEI 575
Query: 492 GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLS 551
G+LKV+ ID S N SG IPT I L+NL + L NR+QG IP+SFGDL+SL+FL+LS
Sbjct: 576 GNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLS 635
Query: 552 NNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQI 611
N+LSG IP SLEKL +L+ N+SFN+L+G+I GG F NFS +SF NE LCG +Q+
Sbjct: 636 RNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQV 695
Query: 612 PPCKTSIHHKSWK--KSILLGIVLPLSTTFMIVVILLILRYRQRGKRPSNDANGPL-VAS 668
PPCK+ H+ K + ++ ++P ++V+ L ++ +R+ KR + PL A+
Sbjct: 696 PPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPPAT 755
Query: 669 RRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVE 728
R SY EL RAT+GF+E NL+G G GSVYK +L DG+ +AVKVF Q FD E
Sbjct: 756 WRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSE 815
Query: 729 CEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 788
CE+++ +RHRNL+K+ISSC N +FKAL+LE++PHGSLEK+LYS N LDI QRLNIMIDV
Sbjct: 816 CEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDV 875
Query: 789 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI 848
ASALEYLH G + PV+HCDLKPSNVL++++MVAH+SDF I+++L GE ++ QT TLATI
Sbjct: 876 ASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL-GEGDAVTQTLTLATI 934
Query: 849 GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908
GYMAPEYG EG VS GDVYS+GI LMETFT KKPTD++F GEM+LK+WV LP + E
Sbjct: 935 GYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITE 994
Query: 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968
V+DANLL +E+ HFVAK+ C++ + NLA+EC+ + P +RI ++++ L KI+ ++V
Sbjct: 995 VIDANLLIEEE-HFVAKKDCITSILNLALECSADLPGERICMRDVLPALEKIKLKYKKDV 1053
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2106), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/904 (51%), Positives = 609/904 (67%), Gaps = 27/904 (2%)
Query: 83 NLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISN 142
+L G IP ++G LS+++ L++ N+L G+IPSAIF +L+ + L N LSG PS + N
Sbjct: 181 HLQGNIPEEIGKLSTMKILDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCN 240
Query: 143 K--SSLQHLDLSSNALSGEIRANI--CRE--------------IPREFGNLPELELMSLA 184
S+L+ + LS+N +G I +N+ C E IPR +L +L ++SLA
Sbjct: 241 HELSALRGIRLSANRFTGPIPSNLSKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLA 300
Query: 185 ANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIG 244
AN+L G++P +IG+L L L+I DN L G P IFN+S++ L N+LSG L
Sbjct: 301 ANSLSGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNF 360
Query: 245 YARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVL 304
+ LPNLE L L N SG IP I NASKL LD N +G IP+ G+LR L L L
Sbjct: 361 GSYLPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNL 420
Query: 305 SDNYLT--SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNC 362
N L S QELSFL+SL+NCK L+ LS+NPL ILP ++GNLS SL+ F+ + C
Sbjct: 421 GVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGILP-ISIGNLSTSLQRFEANTC 479
Query: 363 NISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICN 422
+ G IP EI NL+NL + L N L G+I ++ +LQKLQ L L NKL+GSIP DIC
Sbjct: 480 KLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQ 539
Query: 423 LAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTS-IPLTFWNLKDILNLNFSSN 481
L L L L N+LSGSIPAC LT LR + LGSN+L S IP T W+L IL+L+ SSN
Sbjct: 540 LRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSN 599
Query: 482 FLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD 541
FL G LP ++G+LKVLV IDLSRN SG IP+ IGGL++L L L +NR +G I +SF +
Sbjct: 600 FLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSN 659
Query: 542 LISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNE 601
L SL+F++LS+N L G IP SLE L YL+ L++SFN L G+IP G F NFSA+SF N+
Sbjct: 660 LKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNK 719
Query: 602 LLCGSPNLQIPPCKTSIHHKSWKKSILLGIVLP--LSTTFMIVVILLILRYRQRGKRPSN 659
LCGSP L++PPC+T + +LL +LP LST + +I + R R+R
Sbjct: 720 ALCGSPRLKLPPCRTGTRWSTTISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPT 779
Query: 660 DANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCG 719
+ L A+ R SY E+ +AT+GFS NL+GRG GSVY+ +L DG A+KVF Q
Sbjct: 780 QSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEE 839
Query: 720 RAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILD 777
AFKSFD ECE+M IRHRNLIK++SSCSN +FKALVLEY+P+GSLE++LYS N LD
Sbjct: 840 AAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLD 899
Query: 778 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837
I QRLNIMIDVA A+EYLH G S PV+HCDLKPSN+LLD++ H+ DF IAK+L E++
Sbjct: 900 ILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLR-EEE 958
Query: 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 897
S+ +TQTLATIGYMAP+Y G V+ +GDVYS+GI+LMETFT ++PTDEIF+ EM++K+W
Sbjct: 959 SIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNW 1018
Query: 898 VNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
V DWL S EVVDANLL ED F+AK+QC+S + LAM+C + P++RI K++VT L
Sbjct: 1019 VWDWLCGSITEVVDANLLRGEDEQFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTL 1078
Query: 958 LKIR 961
KI+
Sbjct: 1079 KKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2099), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/898 (50%), Positives = 596/898 (66%), Gaps = 17/898 (1%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTY-TLKYVCLRGNQL 132
+ +L+ S ++G IP ++ N+SSLQ +L+ N L GS+P I+ L+ + L N+L
Sbjct: 567 LNILDFGSSGISGPIPPEIFNISSLQIFDLTDNSLLGSLPMDIYKHLPNLQELYLSWNKL 626
Query: 133 SGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKI 192
SG PS +S LQ L L N +G I P FGNL L+ + L NN+QG I
Sbjct: 627 SGQLPSTLSLCGQLQSLSLWGNRFTGNI--------PPSFGNLTALQDLELGDNNIQGNI 678
Query: 193 PLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLE 252
P ++GNL NL+ L + +N L GI P AIFN+S L+ L L N SG L S +LP+LE
Sbjct: 679 PNELGNLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQNHFSGSLPSSLGTQLPDLE 738
Query: 253 ILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS- 311
L++ N FSG IP I N S+L+ LD+ N F+G +P GNLR L +L L N LT
Sbjct: 739 GLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTDE 798
Query: 312 -STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPE 370
S E+ FL+SL+NC FL+ + NPL ILP + +GNLS SLE F S C G IP
Sbjct: 799 HSASEVGFLTSLTNCNFLRTLWIEDNPLKGILPNS-LGNLSISLESFDASACQFRGTIPT 857
Query: 371 EISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLD 430
I NLT+L ++ LG N L G I TL +L+KLQ+LG+ N+L GSIP D+C L L L
Sbjct: 858 GIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYLF 917
Query: 431 LDGNKLSGSIPACFSNLTSLRIVSLGSNELTS-IPLTFWNLKDILNLNFSSNFLTGSLPL 489
L N+L+GSIP+C L LR + L SN L S IP + W L+ +L LN SSNFLTG LP
Sbjct: 918 LSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLPP 977
Query: 490 EIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLN 549
E+G++K + +DLS+N SG IP +G L+NLE L L NRLQG IP FGDL+SLKFL+
Sbjct: 978 EVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLD 1037
Query: 550 LSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNL 609
LS NNLSGVIP SL+ L+YL+ LN+SFN+L+G+IP GG F NF+A+SF NE LCG+P+
Sbjct: 1038 LSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHF 1097
Query: 610 QIPPCKTSIHHKSWK-KSILLGIVLPLSTTFMIVVILLILRYRQRGK-RPSNDANGPLVA 667
Q+ C S +SW+ K +L +LP + + +V+ L+L R+R + L
Sbjct: 1098 QVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRKNLEVPTPIDSWLPG 1157
Query: 668 SRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDV 727
S S+ +L AT+ F E+NLIG+G VYK L +G+ VAVKVF + AF+SFD
Sbjct: 1158 SHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDS 1217
Query: 728 ECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 787
ECE+M+SIRHRNL+K+I+ CSN +FKALVLEYMP GSL+K+LYS N LD+ QRLNIMID
Sbjct: 1218 ECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMID 1277
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
VASALEYLH + V+HCDLKP+N+LLDD+MVAH+ DF IA++LT E +SM QT+TL T
Sbjct: 1278 VASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLLT-ETESMQQTKTLGT 1336
Query: 848 IGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM 907
IGYMAPEYG +G VS GDV+S+GIMLME F KKP DE+FNG++TLK WV + L S +
Sbjct: 1337 IGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWV-ESLADSMI 1395
Query: 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965
EVVDANLL +ED F K C+S + LA+ CT + P++RI+ K++V L KI+ LL
Sbjct: 1396 EVVDANLLRREDEDFATKLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583725|ref|XP_002532616.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223527672|gb|EEF29782.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 809 bits (2089), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/976 (48%), Positives = 621/976 (63%), Gaps = 23/976 (2%)
Query: 4 FLLLHCLILISLFIAAATANTSSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWT 63
+L L ++L F + ++ TDQDALLALK I DP + L NW+T+T VC W
Sbjct: 9 YLTLSMMMLFYSFFTSLVDGVTNISTDQDALLALKVRIVGDPNSLLTTNWSTATSVCTWI 68
Query: 64 GVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSL--QSLNLSFNRLFGSIPSAIFTTYT 121
GV C RVT LN+S + L GTIP LGNLS L LN+ G IP+++F
Sbjct: 69 GVTCGARHNRVTALNLSHMGLAGTIPPHLGNLSFLVFGCLNMFAVLYIGVIPTSLFNLSK 128
Query: 122 LKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELM 181
L L N L G P I N SL+ L L N S IP N+ LE +
Sbjct: 129 LSIFYLSSNNLQGYIPEAIGNLYSLRLLSLEKNEFS--------DSIPSSIFNISSLEQI 180
Query: 182 SLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLS 241
+ N G IP +IGNL NLE +++G N+L G+ P I+N S + ++ L N LSG L
Sbjct: 181 DFSNNRFSGIIPDEIGNLANLELINLGVNRLAGVVPSGIYNASKMMVISLSSNQLSGHLP 240
Query: 242 SIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSW 301
S LPNL L L GNNF+G IP + NAS+L+++ L NSF G IP+ GNLR+L +
Sbjct: 241 SSLGLLLPNLRRLFLGGNNFTGPIPISLSNASELTLIALPSNSFFGHIPDELGNLRSLQY 300
Query: 302 LVLSDNYLT--SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKM 359
L L N+LT S + LS +SL+ CK L+ L NPL LP +VGNLS SLE
Sbjct: 301 LYLWGNHLTIKSLSSGLSLFNSLTKCKDLRILYLHDNPLNGTLP-ISVGNLSSSLEVLSA 359
Query: 360 SNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD 419
C I+G IP EI NL+NL + L N L G+I T+ KL+KLQ L L NKLEG P +
Sbjct: 360 YRCGITGTIPIEIGNLSNLTLLSLYENDLRGTIPATIGKLRKLQALLLDHNKLEGVFPPE 419
Query: 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTS-IPLTFWNLKDILNLNF 478
+C+L L L L N LSGSIP+C N+ SLR +S+ N+ S IP T W L++IL +N
Sbjct: 420 LCDLQSLAILSLGVNTLSGSIPSCLGNVDSLRNLSMQMNKFNSTIPSTLWRLENILIVNL 479
Query: 479 SSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNS 538
S N L+G+L ++IG+LKV IDLS N SG IP +G LK+L L L NR +GSIP S
Sbjct: 480 SFNSLSGALAVDIGNLKVATIIDLSGNQLSGQIPPGLGSLKDLSSLSLADNRFEGSIPQS 539
Query: 539 FGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFE 598
FGD ISL+FL+LSNN LSG IP LE L YL N+SFN+L+G+IP GG+F N SAQSF
Sbjct: 540 FGDAISLQFLDLSNNTLSGEIPKYLEILRYLTYFNVSFNELQGEIPNGGAFTNLSAQSFM 599
Query: 599 GNELLCGSPNLQIPPCKTSIHH--KSWKKSILLGIVLPLSTTFMIV--VILLILRYRQRG 654
GN+ CG+ Q+ PCKT K+ K L ++ T + V V+++ +R R+R
Sbjct: 600 GNKGFCGAAKFQVQPCKTRTDQGSKAGSKLALRYGLMATGLTILAVAAVVIIFIRSRKRN 659
Query: 655 KRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVF 714
+R + + PL R+ SY EL +ATD F+E NL+G+G FGSVYK DG VAVKVF
Sbjct: 660 RR-TTEGLLPLATLERI-SYRELEQATDKFNEINLLGKGSFGSVYKGIFSDGRSVAVKVF 717
Query: 715 TSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS--NEEFKALVLEYMPHGSLEKYLYSS 772
Q AFKSFDVE E+++ IRHRNL+K+I+SCS N EFKALVLE+MP+ SLEK+LYS
Sbjct: 718 NLQAEGAFKSFDVESEVLRMIRHRNLVKIITSCSSVNIEFKALVLEFMPNHSLEKWLYSP 777
Query: 773 NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832
N L+ QRLNIM+DVASA+EYLH GY+ P++HCDLKP+N+LLD+NM AH++DF IAK+L
Sbjct: 778 NHFLEFLQRLNIMLDVASAVEYLHHGYTTPIVHCDLKPNNILLDENMAAHVTDFGIAKLL 837
Query: 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 892
G+++S I+T TLAT+GYMAPEYG EG VS GDVYSFGI+++ETFT +KPTD++FN EM
Sbjct: 838 -GDERSFIRTITLATVGYMAPEYGSEGVVSTGGDVYSFGILMIETFTSRKPTDDMFNEEM 896
Query: 893 TLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKE 952
+K WV + L ++ D NLL ED H AK+ C+ + LA++C+ + P++R N ++
Sbjct: 897 NMKQWVQESLAGGVTQIADPNLLRIEDEHLSAKKDCIISMMQLALQCSADLPEERPNIRD 956
Query: 953 IVTKLLKIRDSLLRNV 968
+++ L I+ L+ +
Sbjct: 957 VLSTLNHIKVKFLKGI 972
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2088), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/944 (49%), Positives = 609/944 (64%), Gaps = 53/944 (5%)
Query: 70 HSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRG 129
H + + VL +S TG IP LG+LS L+ L L +N+L G IP I L + L
Sbjct: 289 HCRELRVLKLSINQFTGGIPKALGSLSDLEELYLGYNKLTGGIPREIGNLSNLNILHLAS 348
Query: 130 NQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICRE---------------------- 167
+ ++G P+ I N SSL +D ++N+LSG + +IC+
Sbjct: 349 SGINGPIPAEIFNISSLHRIDFTNNSLSGGLPMDICKHLPNLQGLYLSQNHLSGQLPTTL 408
Query: 168 -------------------IPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIG 208
IPR+ GNL +LE + L+ N+L G IP GNL+ L+ L +G
Sbjct: 409 FLCGELLLLSLSINKFTGSIPRDIGNLSKLEKIYLSTNSLIGSIPTSFGNLKALKFLQLG 468
Query: 209 DNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL-SSIGYARLPNLEILSLWGNNFSGTIPR 267
N L G P IFN+S L+ L L N LSG L SSIG LP+LE L + GN FSGTIP
Sbjct: 469 SNNLTGTIPEDIFNISKLQTLALAQNHLSGGLPSSIG-TWLPDLEGLFIGGNEFSGTIPV 527
Query: 268 FIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS--TQELSFLSSLSNC 325
I N SKL L + N F+G +P NLR L L L+ N LT T E+ FL+SL+NC
Sbjct: 528 SISNMSKLIRLHISDNYFTGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNC 587
Query: 326 KFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGG 385
KFL+ + YNPL LP + +GNLS +LE F S C+ G IP I NLTNL + LG
Sbjct: 588 KFLRTLWIDYNPLKGTLPNS-LGNLSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGA 646
Query: 386 NKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFS 445
N L GSI TL LQKLQ L + N+++GSIP D+C+L L L L NKLSGSIP+CF
Sbjct: 647 NDLTGSIPTTLGHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFG 706
Query: 446 NLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSR 504
+L +LR +SL SN L +IP++FW+L+D++ L+ SSNFLTG+LP E+G++K + +DLS+
Sbjct: 707 DLPALRELSLDSNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLPPEVGNMKSITTLDLSK 766
Query: 505 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLE 564
N SG IP +G L+NL L L N+LQGSIP FGDL+SL+ ++LS NNL G IP SLE
Sbjct: 767 NLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLFGTIPKSLE 826
Query: 565 KLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQIPPCKTSIHHKSWK 624
L YL+ LN+SFN+L+G+IP GG F NF+A+SF NE LCG+P+ Q+ C + +SWK
Sbjct: 827 ALIYLKHLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNRTQSWK 886
Query: 625 KS--ILLGIVLPL-STTFMIVVILLILRYRQRGKRPSNDANGPLVASRRMFSYLELCRAT 681
IL I+LP+ S ++ I+L +R R + P+ + L + S +L AT
Sbjct: 887 TKSFILKYILLPVGSAVTLVAFIVLWIRRRDNTEIPA-PIDSWLPGAHEKISQQQLLYAT 945
Query: 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI 741
+GF E+NLIG+G G VYK L +G+ VA+KVF + A +SFD ECE+M+ I HRNLI
Sbjct: 946 NGFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLI 1005
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
++I+ CSN +FKALVLEYMP GSL+K+LYS N LD+FQRLNIMIDVASALEYLH S+
Sbjct: 1006 RIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASALEYLHHDCSS 1065
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
V+HCDLKPSNVLLD+NMVAH++DF IA++LT E +SM QT+TL TIGYMAPEYG +G V
Sbjct: 1066 LVVHCDLKPSNVLLDNNMVAHVADFGIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIV 1124
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921
S GDVYS+GI+LME F KKP DE+F G++TLK WV + L S +EVVDANLL ++D
Sbjct: 1125 STKGDVYSYGILLMEVFARKKPMDEMFTGDVTLKTWV-ESLSSSVIEVVDANLLRRDDED 1183
Query: 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965
K +S + LA+ CT + P++RIN K++V +L KI+ LL
Sbjct: 1184 LATKLSYLSSLMALALACTADSPEERINMKDVVVELKKIKIKLL 1227
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2084), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/944 (49%), Positives = 611/944 (64%), Gaps = 54/944 (5%)
Query: 69 VHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLR 128
+H + + +L++S TG IP +G+LS+L++L L FN+L G IP I L +
Sbjct: 259 LHCRELRLLDLSINQFTGFIPQAIGSLSNLETLYLGFNQLAGGIPGEIGNLSNLNLLNSA 318
Query: 129 GNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICRE--------------------- 167
+ LSG P+ I N SSLQ + ++N+LSG + +IC+
Sbjct: 319 SSGLSGPIPAEIFNISSLQEIGFANNSLSGSLPMDICKHLPNLQWLLLSLNQLSGQLPTT 378
Query: 168 --------------------IPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDI 207
IPRE GNL +LE + ++ G IP ++GNL NL+ L +
Sbjct: 379 LSLCGELLTLTLAYNNFTGSIPREIGNLSKLEQIYFRRSSFTGNIPKELGNLVNLQFLSL 438
Query: 208 GDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL-SSIGYARLPNLEILSLWGNNFSGTIP 266
N L GI P AIFN+S L++L L N LSG L SSIG + LPNLE L + GN FSG IP
Sbjct: 439 NVNNLTGIVPEAIFNISKLQVLSLAGNHLSGSLPSSIG-SWLPNLEQLLIGGNEFSGIIP 497
Query: 267 RFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS--STQELSFLSSLSN 324
I N S L LD+ N F G +P GNLR L L LS N LT+ S EL+FL+SL+N
Sbjct: 498 MSISNMSNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEHSASELAFLTSLTN 557
Query: 325 CKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLG 384
C FL+ +S NPL ++P + +GNLS SLE S+C + G IP ISNLTNL + L
Sbjct: 558 CIFLRTLSISDNPLKGMIPNS-LGNLSISLEIIYASDCQLRGTIPTGISNLTNLIGLRLD 616
Query: 385 GNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACF 444
N L G I +LQKLQ L + N++ GSIP +C+L L LDL NKLSG+IP+C
Sbjct: 617 DNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKLSGTIPSCS 676
Query: 445 SNLTSLRIVSLGSNELTS-IPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLS 503
NLT LR V L SN L S IP + NL+ +L LN SSNFL LPL++G++K LV +DLS
Sbjct: 677 GNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLS 736
Query: 504 RNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASL 563
+N FSG IP+ I L+NL L+L +N+LQG IP +FGDL+SL+ L+LS NNLSG IP SL
Sbjct: 737 KNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSL 796
Query: 564 EKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQIPPCKTSIHHKSW 623
E L YLE LN+SFN+L+G+IP GG F NF+A+SF N LCG+P Q+ C+ +
Sbjct: 797 EHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACEKDSRKNT- 855
Query: 624 KKSILLGIVLPLSTTF-MIVVILLILRYRQRGKRPSNDANGPLVASR--RMFSYLELCRA 680
KS+LL ++PLS + I++++L +++++R + L R RM + EL A
Sbjct: 856 -KSLLLKCIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLSLPRMHRMIPHQELLYA 914
Query: 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNL 740
T+ F E+NLIG+G G VYK L DG+ VAVKVF + AFKSF+VECE+M++IRHRNL
Sbjct: 915 TNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNL 974
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
K+ISSCSN +FKALVLEYMP+GSLEK+LYS N LD QRL IMIDVAS LEYLH YS
Sbjct: 975 AKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYS 1034
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
PV+HCDLKPSNVLLDD+MVAH+SDF IAK+L G + M +T+TL T+GYMAPEYG EG
Sbjct: 1035 NPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMG-SEFMKRTKTLGTVGYMAPEYGSEGI 1093
Query: 861 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920
VS GD+YS+GI+LMETF KKPTDE+F E+TLK WV + MEV+DANLL++ED
Sbjct: 1094 VSTKGDIYSYGILLMETFVRKKPTDEMFVEELTLKSWVESSTN-NIMEVIDANLLTEEDE 1152
Query: 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964
F K C S + LA++CT+E P++RIN K++V +L K+ + +
Sbjct: 1153 SFALKRACFSSIMTLALDCTVEPPEKRINTKDVVVRLKKLLNQI 1196
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/944 (48%), Positives = 605/944 (64%), Gaps = 53/944 (5%)
Query: 70 HSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRG 129
H + + VL+ S TG IP +G+L +L+ L L+FN+L G IP I L + L
Sbjct: 266 HCRELRVLSSSFNQFTGGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSNLNILQLGS 325
Query: 130 NQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICRE---------------------- 167
N +SG P+ I N SSLQ +D ++N+LSG + IC+
Sbjct: 326 NGISGPIPAEIFNISSLQVIDFTNNSLSGSLPMGICKHLPNLQGLYLAQNHLSGQLPTTL 385
Query: 168 -------------------IPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIG 208
IPRE GNL +LE + L +N+L G IP GNL+ L+ L++G
Sbjct: 386 SLCGELLFLSLSFNKFRGSIPREIGNLSKLEHIDLRSNSLVGSIPTSFGNLKALKFLNLG 445
Query: 209 DNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL-SSIGYARLPNLEILSLWGNNFSGTIPR 267
N L G P AIFN+S L+ L L N LSG L SSIG LP+LE L + N FSGTIP
Sbjct: 446 INFLTGTVPEAIFNISELQNLALVQNHLSGSLPSSIG-TWLPDLEGLYIGANEFSGTIPM 504
Query: 268 FIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS--TQELSFLSSLSNC 325
I N SKL++L L NSF+G +P NL L +L L+ N LT + FL+SL+NC
Sbjct: 505 SISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNC 564
Query: 326 KFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGG 385
KFL+Y + YNPL LP + +GNL +LE F C G IP I NLTNL + LG
Sbjct: 565 KFLRYLWIGYNPLKGTLPNS-LGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGA 623
Query: 386 NKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFS 445
N L GSI TL +LQKLQ L + N++ GSIP D+C+L L L L NKLSGS P+CF
Sbjct: 624 NDLTGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFG 683
Query: 446 NLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSR 504
+L +LR + L SN L +IP + W+L+D+L LN SSNFLTG+LP E+G++K + +DLS+
Sbjct: 684 DLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSK 743
Query: 505 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLE 564
N SG IP+ +G L+ L L L NRLQG I FGDL+SL+ L+LS+NNLSG IP SLE
Sbjct: 744 NLVSGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLE 803
Query: 565 KLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQIPPCKTSIHHKSWK 624
L YL+ LN+SFN+L+G+IP GG F F+A+SF NE LCG+P+ Q+ C + +SWK
Sbjct: 804 ALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWK 863
Query: 625 KS--ILLGIVLPL-STTFMIVVILLILRYRQRGKRPSNDANGPLVASRRMFSYLELCRAT 681
IL I+LP+ ST ++V I+L +R R + P+ + L+ + S+ +L AT
Sbjct: 864 TKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPT-PIDSWLLGTHEKISHQQLLYAT 922
Query: 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI 741
+ F E+NLIG+G G VYK L +G+ VA+KVF + A +SFD ECE+M+ IRHRNL+
Sbjct: 923 NDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLV 982
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
++I+ CSN +FKALVLEYMP+GSLEK+LYS N LD+ QRLNIMIDVASALEYLH S+
Sbjct: 983 RIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSS 1042
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
V+HCDLKPSNVLLDD+MVAH++DF IAK+LT E +SM QT+TL TIGYMAPE+G G V
Sbjct: 1043 LVVHCDLKPSNVLLDDDMVAHVADFGIAKLLT-ETESMQQTKTLGTIGYMAPEHGSAGIV 1101
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921
S DVYS+GI+LME F KKP DE+F G++TLK WV + L S ++VVD NLL +ED
Sbjct: 1102 STKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDED 1160
Query: 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965
K C+S + LA+ CT + PK+RI+ K+ V +L K R LL
Sbjct: 1161 LATKLSCLSSIMALALACTTDSPKERIDMKDAVVELKKSRIKLL 1204
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 979 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.751 | 0.728 | 0.362 | 1.3e-156 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.753 | 0.729 | 0.328 | 2.5e-147 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.840 | 0.802 | 0.376 | 6.7e-136 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.664 | 0.519 | 0.304 | 2e-112 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.924 | 0.903 | 0.324 | 3.3e-111 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.883 | 0.737 | 0.316 | 1.4e-110 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.752 | 0.719 | 0.356 | 2.9e-110 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.742 | 0.894 | 0.353 | 1.3e-107 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.846 | 0.858 | 0.334 | 1.2e-106 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.854 | 0.842 | 0.314 | 5.1e-106 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1076 (383.8 bits), Expect = 1.3e-156, Sum P(2) = 1.3e-156
Identities = 281/775 (36%), Positives = 399/775 (51%)
Query: 30 DQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIP 89
D+ ALL K+ ++ D L+ +WN S P+CNW GV C ++RVT L + L L G I
Sbjct: 25 DRQALLQFKSQVSEDKRVVLS-SWNHSFPLCNWKGVTCGRKNKRVTHLELGRLQLGGVIS 83
Query: 90 XXXXXXXXXXXXXXXFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHL 149
N G+IP + L+Y+ + N L G P + N S L +L
Sbjct: 84 PSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNL 143
Query: 150 DLSSNALSGEIRA----------------NICREIPREFGNLPELELMSLAANNLQGKIP 193
L SN L G + + N+ ++P GNL LE ++L+ NNL+G+IP
Sbjct: 144 RLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIP 203
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLS-SIGYARLPNLE 252
+ L + L + N G+ P A++N+S+LK+LG+ N SG L +G LPNL
Sbjct: 204 SDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGIL-LPNLL 262
Query: 253 ILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS- 311
++ GN F+G+IP + N S L L + N+ +G IP TFGN+ NL L L N L S
Sbjct: 263 SFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSD 321
Query: 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
S+++L FL+SL+NC L+ + N L LP ++ NLS L + ISG IP +
Sbjct: 322 SSRDLEFLTSLTNCTQLETLGIGRNRLGGDLP-ISIANLSAKLVTLDLGGTLISGSIPYD 380
Query: 372 ISNLTNLRTIYLGGNKLNGSILITXXXXXXXXXXXXXXXXXEGSIPYDICNLAELYRLDL 431
I NL NL+ + L N L+G + + G IP I N+ L LDL
Sbjct: 381 IGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDL 440
Query: 432 DGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLE 490
N G +P N + L + +G N+L +IPL ++ +L L+ S N L GSLP +
Sbjct: 441 SNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQD 500
Query: 491 IGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLIXXXXXXX 550
IG+L+ L + L N SG +P +G +E LFL N G IP+ G L+
Sbjct: 501 IGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDL 559
Query: 551 XXXXXXGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGS-PNL 609
G IP S LE LNLSFN LEGK+P G F N + S GN LCG
Sbjct: 560 SNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGF 619
Query: 610 QIPPCKT---SI--HHKSWKKSILLGI---VLPLSTTFMIVVILLILRYRQRGKRPSNDA 661
Q+ PC + S+ H S K +++G+ + L FM V L+ LR R++ K +N
Sbjct: 620 QLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPT 679
Query: 662 NGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR 720
L SY +L AT+GFS +N++G G FG+VYKA L + VAVKV Q
Sbjct: 680 PSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRG 739
Query: 721 AFKSFDVECEIMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLY 770
A KSF ECE +K IRHRNL+K++++CS+ EF+AL+ E+MP+GSL+ +L+
Sbjct: 740 AMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 995 (355.3 bits), Expect = 2.5e-147, Sum P(2) = 2.5e-147
Identities = 254/774 (32%), Positives = 387/774 (50%)
Query: 30 DQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIP 89
D+ ALL K+ ++ + L+ +WN S P+CNW V C +RVT LN+ L L G +
Sbjct: 25 DRQALLEFKSQVSEGKRDVLS-SWNNSFPLCNWKWVTCGRKHKRVTHLNLGGLQLGGIVS 83
Query: 90 XXXXXXXXXXXXXXXFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHL 149
N G IP + + L+++ + N L G P+ +SN S L +L
Sbjct: 84 PSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLLNL 143
Query: 150 DLSSNALS-------GEI---------RANICREIPREFGNLPELELMSLAANNLQGKIP 193
DL SN L G + R N+ ++PR GNL L+ + NN++G++P
Sbjct: 144 DLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVP 203
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
++ L + L + NK G+ P AI+N+S L+ L L + SG L LPN+
Sbjct: 204 DELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRE 263
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313
L+L N+ G IP + N S L + N +G I FG + +L +L LS+N L S T
Sbjct: 264 LNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYT 323
Query: 314 -QELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI 372
+L F+ SL+NC L+ + Y L LP T++ N+S L + + G IP++I
Sbjct: 324 FGDLEFIDSLTNCTHLQLLSVGYTRLGGALP-TSIANMSTELISLNLIGNHFFGSIPQDI 382
Query: 373 SNLTNLRTIYLGGNKLNGSILITXXXXXXXXXXXXXXXXXEGSIPYDICNLAELYRLDLD 432
NL L+ + LG N L G + + G IP I NL +L L L
Sbjct: 383 GNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLS 442
Query: 433 GNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLEI 491
N G +P + + + +G N+L +IP + ++NL+ N L+GSLP +I
Sbjct: 443 NNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDI 502
Query: 492 GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLIXXXXXXXX 551
GSL+ LV + L N FSG +P +G +E LFL N G+IPN G L+
Sbjct: 503 GSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVRRVDLS 561
Query: 552 XXXXXGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGS-PNLQ 610
G IP S LE LNLS N GK+P G+F N + GN+ LCG +L+
Sbjct: 562 NNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLK 621
Query: 611 IPPC-----KTSIHHKSWKKSILLGIVLPLSTTFMIVVILLIL---RYRQRGKRPSNDAN 662
+ PC H S K + + + + ++ ++V+ ++L R R++ ++ +N
Sbjct: 622 LKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVP 681
Query: 663 GPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCGRA 721
L SY +L AT+GFS +N++G G FG+V+KA L + VAVKV Q A
Sbjct: 682 SKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGA 741
Query: 722 FKSFDVECEIMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLY 770
KSF ECE +K RHRNL+K++++C++ EF+AL+ EY+P+GS++ +L+
Sbjct: 742 MKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLH 795
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1331 (473.6 bits), Expect = 6.7e-136, P = 6.7e-136
Identities = 325/863 (37%), Positives = 471/863 (54%)
Query: 77 LNISSLNLTGTIPXXXXXXXXXXXXXXXFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTF 136
L++ L+G IP N + GSIP+AI L + L NQL G
Sbjct: 108 LDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMI 167
Query: 137 PSFISNKSSLQHLD---LSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
P I +SL+HL L N LSGEI P GNL L+ L+ N L G IP
Sbjct: 168 PREIG--ASLKHLSNLYLYKNGLSGEI--------PSALGNLTSLQEFDLSFNRLSGAIP 217
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
+G L +L +++G N L G+ P +I+N+S+L+ +++N L G + + + L LE+
Sbjct: 218 SSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEV 277
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN-YLTSS 312
+ + N F G IP + NAS L+++ + GN FSG I + FG LRNL+ L L N + T
Sbjct: 278 IDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTRE 337
Query: 313 TQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI 372
+ F+S L+NC L+ +L N L +LP + NLS SL + I+G IP++I
Sbjct: 338 QDDWGFISDLTNCSKLQTLNLGENNLGGVLPNS-FSNLSTSLSFLALELNKITGSIPKDI 396
Query: 373 SNLTNLRTIYLGGNKLNGSILITXXXXXXXXXXXXXXXXXEGSIPYDICNLAELYRLDLD 432
NL L+ +YL N GS+ + GSIP I NL EL L L
Sbjct: 397 GNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLG 456
Query: 433 GNKLSGSIPACFSNLTSLRIVSLGSNELTS-IPLTFWNLKDI-LNLNFSSNFLTGSLPLE 490
NK SG IP SNLT+L + L +N L+ IP +N++ + + +N S N L GS+P E
Sbjct: 457 TNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQE 516
Query: 491 IGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLIXXXXXXX 550
IG LK LV N SG IP +G + L YL+L N L GSIP++ G L
Sbjct: 517 IGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDL 576
Query: 551 XXXXXXGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGS-PNL 609
G IP SL ++ L LNLSFN G++P G+F S S +GN LCG P+L
Sbjct: 577 SSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDL 636
Query: 610 QIPPCKTSIHHKSWKKSILLGIVLPLSTTFMIVVIL-LILRYRQRGKRPSNDANGPLVAS 668
+P C + ++ K +L I + L+ I+ L L++ + +R K+ + +
Sbjct: 637 HLPRCCPLLENR--KHFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTS--MKG 692
Query: 669 RRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVE 728
+ SY +L +ATDGF+ NL+G G FGSVYK L VAVKV + +A KSF E
Sbjct: 693 HPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAE 752
Query: 729 CEIMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLY------SSNCILD 777
CE ++++RHRNL+K+++ CS+ +FKA+V ++MP+GSLE +++ + L+
Sbjct: 753 CEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLN 812
Query: 778 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837
+ +R+ I++DVA AL+YLH PV+HCD+K SNVLLD +MVAH+ DF +A++L +
Sbjct: 813 LHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILV-DGT 871
Query: 838 SMIQTQT-----LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 892
S+IQ T + TIGY APEYG S +GD+YS+GI+++E TGK+PTD F ++
Sbjct: 872 SLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDL 931
Query: 893 TLKHWVNDWLPISTMEVVDANLL 915
L+ +V L +VVD L+
Sbjct: 932 GLRQYVELGLHGRVTDVVDTKLI 954
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 2.0e-112, Sum P(2) = 2.0e-112
Identities = 212/697 (30%), Positives = 328/697 (47%)
Query: 77 LNISSLNLTGTIPXXXXXXXXXXXXXXXFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTF 136
L +S L+G IP N L G IP ++F L + L N L GT
Sbjct: 342 LFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTL 401
Query: 137 PSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI 196
S ISN ++LQ L N L G++ P+E G L +LE+M L N G++P++I
Sbjct: 402 SSSISNLTNLQEFTLYHNNLEGKV--------PKEIGFLGKLEIMYLYENRFSGEMPVEI 453
Query: 197 GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL-SSIGYARLPNLEILS 255
GN L+++D N+L G P +I + L L L++N L G + +S+G + ++
Sbjct: 454 GNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCH--QMTVID 511
Query: 256 LWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQE 315
L N SG+IP + L + + NS G +P++ NL+NL+ + S N S
Sbjct: 512 LADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISP 571
Query: 316 LSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNL 375
L SS +L FD++ N +P +G S +L+ ++ +G IP +
Sbjct: 572 LCGSSS-----YLS-FDVTENGFEGDIP-LELGK-STNLDRLRLGKNQFTGRIPRTFGKI 623
Query: 376 TNLRTIYLGGNKLNGSILITXXXXXXXXXXXXXXXXXEGSIPYDICNLAELYRLDLDGNK 435
+ L + + N L+G I + G IP + L L L L NK
Sbjct: 624 SELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNK 683
Query: 436 LSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSL 494
GS+P +LT++ + L N L SIP NL+ + LN N L+G LP IG L
Sbjct: 684 FVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKL 743
Query: 495 KVLVGIDLSRNNFSGVIPTEIGGLKNLEY-LFLGYNRLQGSIPNSFGDLIXXXXXXXXXX 553
L + LSRN +G IP EIG L++L+ L L YN G IP++ L
Sbjct: 744 SKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHN 803
Query: 554 XXXGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQIPP 613
G +P + + L LNLS+N LEGK+ + F + A +F GN LCGSP +
Sbjct: 804 QLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSP---LSH 858
Query: 614 CKT--SIHHKSW--KKSILLGIVLPLST-TFMIVVILLILRYRQ------RGKRP----- 657
C S + +S K +++ + L+ M++VI+L + RG
Sbjct: 859 CNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSN 918
Query: 658 SNDANGPLVAS---RRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVK-V 713
S+ + PL ++ + + ++ AT +E +IG GG G VYKA L +G +AVK +
Sbjct: 919 SSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI 978
Query: 714 FTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNE 750
+ KSF+ E + + +IRHR+L+K++ CS++
Sbjct: 979 LWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSK 1015
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 3.3e-111, P = 3.3e-111
Identities = 311/958 (32%), Positives = 477/958 (49%)
Query: 33 ALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPXXX 92
ALL+LK+ T D + L +WN ST C+WTGV C+V + VT L++S LNL+GT+
Sbjct: 30 ALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDV 89
Query: 93 XXXXXXXXXXXXFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKS-SLQHLDL 151
N++ G IP I Y L+++ L N +G+FP +S+ +L+ LDL
Sbjct: 90 AHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDL 149
Query: 152 SSNALSGEIRANICR----------------EIPREFGNLPELELMSLAANNLQGKIPLK 195
+N L+G++ ++ +IP +G P LE ++++ N L GKIP +
Sbjct: 150 YNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPE 209
Query: 196 IGNLRNLEKLDIGD-NKLVGIAPIAIFNVSTLKILGLQDNSLSGCLS-SIGYARLPNLEI 253
IGNL L +L IG N P I N+S L + L+G + IG +L L+
Sbjct: 210 IGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIG--KLQKLDT 267
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313
L L N F+GTI + + S L +DL N F+G IP +F L+NL+ L L N L +
Sbjct: 268 LFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAI 327
Query: 314 QELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEIS 373
E F+ + + L+ ++ N +P+ +G + L +S+ ++G +P +
Sbjct: 328 PE--FIGEMPELEVLQLWE---NNFTGSIPQK-LGE-NGRLVILDLSSNKLTGTLPPNMC 380
Query: 374 NLTNLRTIYLGGNKLNGSILITXXXXXXXXXXXXXXXXXEGSIPYDICNLAELYRLDLDG 433
+ L T+ GN L GSI + GSIP ++ L +L +++L
Sbjct: 381 SGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQD 440
Query: 434 NKLSGSIPACFSNLTS-LRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLEI 491
N L+G +P ++ L +SL +N+L+ S+P NL + L N +GS+P EI
Sbjct: 441 NYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEI 500
Query: 492 GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLIXXXXXXXX 551
G L+ L +D S N FSG I EI K L ++ L N L G IPN +
Sbjct: 501 GRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLS 560
Query: 552 XXXXXGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQI 611
G IP ++ + L ++ S+N L G +P G F F+ SF GN LCG P L
Sbjct: 561 RNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCG-PYLG- 618
Query: 612 PPCKTSIHHKSWKK-SILLGIVLPLSTTFMIVVILLILRYRQRGKRPSNDANG-PLVASR 669
PC H K S ++L L F +V ++ + R R +++A L A +
Sbjct: 619 -PCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQ 677
Query: 670 RM-FSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVK-VFTSQCGRAFK-SFD 726
R+ F+ ++ D E+N+IG+GG G VYK ++ G VAVK + T G + F+
Sbjct: 678 RLDFTCDDVL---DSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFN 734
Query: 727 VECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIM 785
E + + IRHR++++++ CSN E LV EYMP+GSL + L+ L R I
Sbjct: 735 AEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIA 794
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
++ A L YLH S ++H D+K +N+LLD N AH++DF +AK L S +
Sbjct: 795 LEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIA 854
Query: 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905
+ GY+APEY +V DVYSFG++L+E TGKKP E +G + + WV +
Sbjct: 855 GSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDG-VDIVQWVRSMTDSN 913
Query: 906 ---TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
++V+D L S +H E V+ VF +A+ C E +R +E+V L +I
Sbjct: 914 KDCVLKVIDLRL-SSVPVH----E--VTHVFYVALLCVEEQAVERPTMREVVQILTEI 964
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1092 (389.5 bits), Expect = 1.4e-110, P = 1.4e-110
Identities = 288/909 (31%), Positives = 462/909 (50%)
Query: 77 LNISSLNLTGTIPXXXXXXXXXXXXXXXFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTF 136
L + LTG IP N+L SIPS++F L ++ L N L G
Sbjct: 269 LELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPI 328
Query: 137 PSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI 196
I SL+ L L SN +GE P+ NL L ++++ NN+ G++P +
Sbjct: 329 SEEIGFLESLEVLTLHSNNFTGEF--------PQSITNLRNLTVLTVGFNNISGELPADL 380
Query: 197 GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSL 256
G L NL L DN L G P +I N + LK+L L N ++G + G+ R+ NL +S+
Sbjct: 381 GLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPR-GFGRM-NLTFISI 438
Query: 257 WGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQEL 316
N+F+G IP IFN S L L + N+ +G + G L+ L L +S N LT
Sbjct: 439 GRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPR- 497
Query: 317 SFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLT 376
+ N K L L N +PR + NL+ L+ +M + ++ G IPEE+ ++
Sbjct: 498 ----EIGNLKDLNILYLHSNGFTGRIPRE-MSNLT-LLQGLRMYSNDLEGPIPEEMFDMK 551
Query: 377 NLRTIYLGGNKLNGSILITXXXXXXXXXXXXXXXXXEGSIPYDICNLAELYRLDLDGNKL 436
L + L NK +G I GSIP + +L+ L D+ N L
Sbjct: 552 LLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLL 611
Query: 437 SGSIPA-CFSNLTSLRI-VSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLEIGS 493
+G+IP ++L ++++ ++ +N LT +IP L+ + ++ S+N +GS+P + +
Sbjct: 612 TGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQA 671
Query: 494 LKVLVGIDLSRNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPNSFGDLIXXXXXXXXX 552
K + +D S+NN SG IP E+ G+ + L L N G IP SFG++
Sbjct: 672 CKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSS 731
Query: 553 XXXXGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQIP 612
G IP SL LS L+ L L+ N L+G +P G F N +A GN LCGS +
Sbjct: 732 NNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLK 790
Query: 613 PC--KTSIHHKSWKKSILLGIVLPLSTTFMIVVILLILRY-RQRGKRPSNDANGPL---- 665
PC K H S + ++L I+ + ++++++LIL +++ K+ N + L
Sbjct: 791 PCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLD 850
Query: 666 -VASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQ--CGRAF 722
+ F EL +ATD F+ N+IG +VYK L DG +AVKV + +
Sbjct: 851 SALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESD 910
Query: 723 KSFDVECEIMKSIRHRNLIKVIS-SCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQ 780
K F E + + ++HRNL+K++ + + + KALVL +M +G+LE ++ S I + +
Sbjct: 911 KWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLE 970
Query: 781 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840
++++ + +AS ++YLH GY P++HCDLKP+N+LLD + VAH+SDF A++L +
Sbjct: 971 KIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGST 1030
Query: 841 QTQTLA---TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT--DEIFNGEMTLK 895
T A TIGY+APE+ +V+ DV+SFGI++ME T ++PT ++ + +MTL+
Sbjct: 1031 TASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLR 1090
Query: 896 HWVNDWLPIST---MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKE 952
V + + V+D L + I + +E+ + L + CT P+ R + E
Sbjct: 1091 QLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNE 1148
Query: 953 IVTKLLKIR 961
I+T L+K+R
Sbjct: 1149 ILTHLMKLR 1157
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1089 (388.4 bits), Expect = 2.9e-110, P = 2.9e-110
Identities = 277/776 (35%), Positives = 405/776 (52%)
Query: 30 DQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIP 89
D+ ALL K+ ++ + + + +WN S P+C+WTGV C + +RVT +++ L LTG +
Sbjct: 40 DKQALLEFKSQVS-ETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVS 98
Query: 90 XXXXXXXXXXXXXXXFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHL 149
N G+IPS + + L+Y+ + N G P +SN SSL L
Sbjct: 99 PFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTL 158
Query: 150 DLSSNALS-------GEI---------RANICREIPREFGNLPELELMSLAANNLQGKIP 193
DLSSN L G + R N+ + P GNL L+++ N ++G+IP
Sbjct: 159 DLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIP 218
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
I L+ + I NK G+ P I+N+S+L L + NS SG L + LPNL+I
Sbjct: 219 GDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQI 278
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS-S 312
L + N+F+GTIP + N S L LD+ N +G IP +FG L+NL L L++N L + S
Sbjct: 279 LYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYS 338
Query: 313 TQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI 372
+ +L FL +L+NC L+Y ++ +N L LP + NLS L E + ISG IP I
Sbjct: 339 SGDLDFLGALTNCSQLQYLNVGFNKLGGQLP-VFIANLSTQLTELSLGGNLISGSIPHGI 397
Query: 373 SNLTNLRTIYLGGNKLNGSILITXXXXXXXXXXXXXXXXXEGSIPYDICNLAELYRLDLD 432
NL +L+T+ LG N L G + + G IP + N++ L L L
Sbjct: 398 GNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLL 457
Query: 433 GNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLEI 491
N GSIP+ + + L ++LG+N+L SIP L ++ LN S N L G L +I
Sbjct: 458 NNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDI 517
Query: 492 GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLIXXXXXXXX 551
G LK L+ +D+S N SG IP + +LE+L L N G IP+ G L
Sbjct: 518 GKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLS 576
Query: 552 XXXXXGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGS-PNLQ 610
G IP + S L++LNLS N +G +P G F N SA S GN LCG P+LQ
Sbjct: 577 KNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQ 636
Query: 611 IPPCKTSI--HHKSWKKSILLGIVLPLSTTFMI---VVILLILRYRQRGKRPSNDAN--- 662
+ PC + H S +K I + + ++ ++ VV L + R + R +N+ N
Sbjct: 637 LQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRS 696
Query: 663 -GPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGD-GMEVAVKVFTSQCGR 720
P+ + SY EL + T GFS +NLIG G FG+V+K LG VA+KV + C R
Sbjct: 697 FSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVL-NLCKR 755
Query: 721 -AFKSFDVECEIMKSIRHRNLIKVISSCSNEEF-----KALVLEYMPHGSLEKYLY 770
A KSF ECE + IRHRNL+K+++ CS+ +F +ALV E+MP+G+L+ +L+
Sbjct: 756 GAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 269/761 (35%), Positives = 390/761 (51%)
Query: 30 DQDALLALKAHITHDPTNFLAKNWNTST--PVCNWTGVAC-EVHSQRVTVLNISSLNLTG 86
D+ ALL+ K+ + + LA +WNTS C W GV C H RV L + S NL G
Sbjct: 34 DELALLSFKSSLLYQGGQSLA-SWNTSGHGQHCTWVGVVCGRRHPHRVVKLRLRSSNLAG 92
Query: 87 TIPXXXXXXXXXXXXXXXFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSL 146
I N L G IP + L+ + L N LSG P+ + N +SL
Sbjct: 93 IISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEIPAALGNLTSL 152
Query: 147 QHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLD 206
L+L++N LSG I P G L L ++LA N L G IP G LR L L
Sbjct: 153 SVLELTNNTLSGAI--------PSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSFLS 204
Query: 207 IGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIP 266
+ N L G P I+N+S+L I + N LSG L + ++ LP+L+ + ++ N F G IP
Sbjct: 205 LAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGRIP 264
Query: 267 RFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS-TQELSFLSSLSNC 325
I NAS +SI + NSFSG +P G +RNL L L + + T + F+++L+NC
Sbjct: 265 ASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALTNC 324
Query: 326 KFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGG 385
L+ +L +LP +V NLS SL + + ISG +P +I NL NL+ + L
Sbjct: 325 SNLQEVELGGCKFGGVLP-DSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLAN 383
Query: 386 NKLNGSILITXXXXXXXXXXXXXXXXXEGSIPYDICNLAELYRLDLDGNKLSGSIPACFS 445
N L GS+ + GS+P I NL +L +++ N G+IP+
Sbjct: 384 NSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLG 443
Query: 446 NLTSLRIVSLGSNE-LTSIPLTFWNLKDILN-LNFSSNFLTGSLPLEIGSLKVLVGIDLS 503
NLT L ++LG N + IP+ +++ + L+ S N L GS+P EIG LK +V
Sbjct: 444 NLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHAD 503
Query: 504 RNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLIXXXXXXXXXXXXXGVIPASL 563
N SG P+ IG + L++LFL N L GSIP + L G IP SL
Sbjct: 504 SNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSL 563
Query: 564 EKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGS-PNLQIPPCKTSIHHKS 622
+ L LNLSFN G++P G F N S +GN +CG P L +P C K
Sbjct: 564 GDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKK 623
Query: 623 WKKSILLGIVLPLSTT---FMIVVILLILRYRQRGKRPSNDANGPLVASRRMFSYLELCR 679
+ +LL +V+ L +T F ++ +LL R++ + P+ + + M +Y +L +
Sbjct: 624 KHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTS----MQGHPMITYKQLVK 679
Query: 680 ATDGFSENNLIGRGGFGSVYKASLG--DG---MEVAVKVFTSQCGRAFKSFDVECEIMKS 734
ATDGFS ++L+G G FGSVYK DG VAV+V + +A KSF ECE +++
Sbjct: 680 ATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRN 739
Query: 735 IRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLY 770
RHRNL+K+++ CS+ +FKA+V ++MP+GSLE +L+
Sbjct: 740 TRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLH 780
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
Identities = 290/867 (33%), Positives = 433/867 (49%)
Query: 108 LFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICRE 167
L G I AI L+ + L+GN+L+G P I N +SL +LDLS N L G+I
Sbjct: 83 LGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLSENLLYGDI------- 135
Query: 168 IPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVG-IAPIAIFNVSTL 226
P L +LE ++L N L G +P + + NL++LD+ N L G I+ + +N L
Sbjct: 136 -PFSISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWN-EVL 193
Query: 227 KILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFS 286
+ LGL+ N L+G LSS +L L + GNN +GTIP I N + ILD+ N +
Sbjct: 194 QYLGLRGNMLTGTLSS-DMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDISYNQIT 252
Query: 287 GFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTT 346
G IP G L+ ++ L L N LT E+ L L DLS N L +P
Sbjct: 253 GEIPYNIGFLQ-VATLSLQGNRLTGRIPEVIGLMQA-----LAVLDLSDNELVGPIP-PI 305
Query: 347 VGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITXXXXXXXXXXX 406
+GNLS + + + N ++G IP E+ N++ L + L NKL G+I
Sbjct: 306 LGNLSFTGKLYLHGNM-LTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELN 364
Query: 407 XXXXXXEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTS-IPL 465
G IP +I + A L + ++ GN LSGSIP F NL SL ++L SN IP+
Sbjct: 365 LANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPV 424
Query: 466 TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLF 525
++ ++ L+ S N +GS+PL +G L+ L+ ++LSRN+ SG +P E G L++++ +
Sbjct: 425 ELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMID 484
Query: 526 LGYNRLQGSIPNSFGDLIXXXXXXXXXXXXXGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585
+ +N L G IP G L G IP L L +LN+SFN L G +P
Sbjct: 485 VSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPP 544
Query: 586 GGSFGNFSAQSFEGNELLCGS--PNLQIPPCKTSIHHKSWKKSILLGIVLPLSTTFMIVV 643
+F F+ SF GN LCG+ ++ P K+ + + I+LG++ L F+ V
Sbjct: 545 MKNFSRFAPASFVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLCMIFLAVY 604
Query: 644 ILLILRYRQRGKRPSNDANGPLVA---SRRMFSYLELCRATDGFSENNLIGRGGFGSVYK 700
+ + +G + LV + ++ ++ R T+ +E +IG G +VYK
Sbjct: 605 KSMQQKKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYK 664
Query: 701 ASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760
+L +A+K +Q + F+ E E + SIRHRN++ + + L +YM
Sbjct: 665 CALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYM 724
Query: 761 PHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN 818
+GSL L+ S LD RL I + A L YLH + +IH D+K SN+LLD+N
Sbjct: 725 ENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDEN 784
Query: 819 MVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETF 878
AHLSDF IAK + ++ T L TIGY+ PEY R R++ D+YSFGI+L+E
Sbjct: 785 FEAHLSDFGIAKSIPAS-KTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELL 843
Query: 879 TGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL-LSQEDIHFVAKEQCVSFVFNLAM 937
TGKK D N + +D + ME VD + ++ D+ + K F LA+
Sbjct: 844 TGKKAVDNEANLHQLILSKADD---NTVMEAVDPEVTVTCMDLGHIRK------TFQLAL 894
Query: 938 ECTMEFPKQRINAKEIVTKLLKIRDSL 964
CT P +R E+ LL + SL
Sbjct: 895 LCTKRNPLERPTMLEVSRVLLSLVPSL 921
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 5.1e-106, Sum P(2) = 5.1e-106
Identities = 284/903 (31%), Positives = 431/903 (47%)
Query: 30 DQDALLALKAHITHDPTNFLAKNW----NTSTPVCNWTGVACEVH---SQRVTVLNISSL 82
D + L +K DP L ++W + +P CNWTG+ C + S VT +++S
Sbjct: 27 DAEILSRVKKTRLFDPDGNL-QDWVITGDNRSP-CNWTGITCHIRKGSSLAVTTIDLSGY 84
Query: 83 NLTGTIPXXXXXXXXXXXXXXXFNRLFGSIPSAIFTTYT-LKYVCLRGNQLSGTFPSFIS 141
N++G P N L G+I SA + + L+ + L N SG P F
Sbjct: 85 NISGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPEFSP 144
Query: 142 NKSSLQHLDLSSNALSGEIRANICRE----------------IPREFGNLPELELMSLAA 185
L+ L+L SN +GEI + R +P G L EL + LA
Sbjct: 145 EFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAY 204
Query: 186 NNLQ-GKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL-SSI 243
+ IP +GNL NL L + + LVG P +I N+ L+ L L NSL+G + SI
Sbjct: 205 ISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESI 264
Query: 244 GYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLV 303
G RL ++ + L+ N SG +P I N ++L D+ N+ +G +P L+ +S+
Sbjct: 265 G--RLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISFN- 321
Query: 304 LSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCN 363
L+DN+ T ++ L+ N K F+ S+ LPR +G S + EF +S
Sbjct: 322 LNDNFFTGGLPDVVALNP--NLVEFKIFNNSFTGT---LPRN-LGKFSE-ISEFDVSTNR 374
Query: 364 ISGGIPEEISNLTNLRTIYLGGNKLNGSILITXXXXXXXXXXXXXXXXXEGSIPYDICNL 423
SG +P + L+ I N+L+G I + G +P L
Sbjct: 375 FSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWEL 434
Query: 424 AELYRLDL-DGNKLSGSIPACFSNLTSLRIVSLGSNELTS-IPLTFWNLKDILNLNFSSN 481
L RL+L + N+L GSIP S L + + +N + IP+ +L+D+ ++ S N
Sbjct: 435 P-LTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRN 493
Query: 482 FLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD 541
GS+P I LK L +++ N G IP+ + L L L NRL+G IP GD
Sbjct: 494 SFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGD 553
Query: 542 LIXXXXXXXXXXXXXGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNE 601
L G IPA L +L L N+S N+L GKIP G F SF GN
Sbjct: 554 LPVLNYLDLSNNQLTGEIPAELLRLK-LNQFNVSDNKLYGKIPSGFQQDIFRP-SFLGNP 611
Query: 602 LLCGSPNLQ-IPPCKTSIHHKSWKKSILLGIVLPLSTTFMIVVILLILRYRQRGKRPSND 660
LC +PNL I PC++ + + + + I+ ++ T +V L ++ + KR
Sbjct: 612 NLC-APNLDPIRPCRSK---RETRYILPISILCIVALTGALV--WLFIKTKPLFKRKPKR 665
Query: 661 ANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR 720
N + R F+ ++ +E+N+IG GG G VY+ L G +AVK + G+
Sbjct: 666 TNKITIFQRVGFTEEDIYPQ---LTEDNIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQ 722
Query: 721 AFKS---FDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---C 774
+S F E E + +RH N++K++ C+ EEF+ LV E+M +GSL L+S
Sbjct: 723 KTESESVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRA 782
Query: 775 I--LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832
+ LD R +I + A L YLH P++H D+K +N+LLD M ++DF +AK L
Sbjct: 783 VSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPL 842
Query: 833 TGEDQSMIQTQTLATI----GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF 888
ED + +++ + GY+APEYG +V+ DVYSFG++L+E TGK+P D F
Sbjct: 843 KREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSF 902
Query: 889 NGE 891
GE
Sbjct: 903 -GE 904
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3943 | 0.9540 | 0.9247 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 979 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-112 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-37 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-35 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-27 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-25 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 6e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-09 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 7e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 369 bits (948), Expect = e-112
Identities = 307/1030 (29%), Positives = 462/1030 (44%), Gaps = 169/1030 (16%)
Query: 8 HCLILISLFIAAATANTSSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVAC 67
HC LI + + + + LL+ K+ I +DP +L+ NWN+S VC W G+ C
Sbjct: 8 HCPYLIFMLFFLFLNFSMLHAEELELLLSFKSSI-NDPLKYLS-NWNSSADVCLWQGITC 65
Query: 68 EVHSQRVTV-------------------------------------------------LN 78
+S RV LN
Sbjct: 66 N-NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN 124
Query: 79 ISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPS 138
+S+ N TG+IP G++ +L++L+LS N L G IP+ I + +LK + L GN L G P+
Sbjct: 125 LSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 139 FISNKSSLQHLDLSSNALSGEIRA----------------NICREIPREFGNLPELELMS 182
++N +SL+ L L+SN L G+I N+ EIP E G L L +
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242
Query: 183 LAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSS 242
L NNL G IP +GNL+NL+ L + NKL G P +IF++ L L L DNSLSG +
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
Query: 243 IGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWL 302
+ +L NLEIL L+ NNF+G IP + + +L +L L N FSG IP G NL+ L
Sbjct: 303 L-VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361
Query: 303 VLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNC 362
DLS N
Sbjct: 362 -----------------------------DLSTN-------------------------- 366
Query: 363 NISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICN 422
N++G IPE + + NL + L N L G I +L + L+ + L+DN G +P +
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426
Query: 423 LAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNF 482
L +Y LD+ N L G I + ++ SL+++SL N+ + K + NL+ S N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQ 486
Query: 483 LTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDL 542
+G++P ++GSL L+ + LS N SG IP E+ K L L L +N+L G IP SF ++
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546
Query: 543 ISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNEL 602
L L+LS N LSG IP +L + L +N+S N L G +P G+F +A + GN
Sbjct: 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNID 606
Query: 603 LCGSPNLQ-IPPCKTSIHHKSWKKSI--LLGIVLPLSTTFMIVVILLILRYRQRGKRPSN 659
LCG +PPCK SW I LG L L+ V + + + +
Sbjct: 607 LCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENE 666
Query: 660 DANGPL--VASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTS 716
D L S+ S + + E N+I RG G+ YK S+ +GM+ VK +
Sbjct: 667 DGTWELQFFDSKVSKS-ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE-IN 724
Query: 717 QCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 776
S + M ++H N++K+I C +E+ L+ EY+ +L + L + L
Sbjct: 725 DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----L 777
Query: 777 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836
+R I I +A AL +LH S V+ +L P +++D HL S+ +L +
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836
Query: 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 896
+ I + Y+APE ++ D+Y FG++L+E TGK P D F ++
Sbjct: 837 KCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVE 890
Query: 897 W---------VNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQR 947
W ++ W I D ++ E + V NLA+ CT P R
Sbjct: 891 WARYCYSDCHLDMW--IDPSIRGDVSVNQNEIVE----------VMNLALHCTATDPTAR 938
Query: 948 INAKEIVTKL 957
A +++ L
Sbjct: 939 PCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 5e-46
Identities = 68/191 (35%), Positives = 101/191 (52%), Gaps = 9/191 (4%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFT-SQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G GGFG+VY A G +VA+K+ + E EI+K + H N++K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
+E LV+EY GSL+ L + L + L I++ + LEYLH S +IH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 808 LKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR-EGRVSANG 865
LKP N+LLD DN L+DF ++K+LT + + + T YMAPE +G S
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 866 DVYSFGIMLME 876
D++S G++L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 26/268 (9%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKVF-TSQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
+G G FG VY A G VA+KV + + + E +I+K ++H N++++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
+E+ LV+EY G L L L + + + SALEYLH S ++H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
DLKP N+LLD++ L+DF +A+ L ++ T + T YMAPE
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 866 DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925
D++S G++L E TGK P F G+ L +S E +
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI-- 231
Query: 926 EQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ V + P++R+ A+E
Sbjct: 232 RKL--LVKD---------PEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 84/278 (30%), Positives = 126/278 (45%), Gaps = 42/278 (15%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDV----ECEIMKSIRHRNLIKVI 744
+G G FG+VYKA G G VAVK+ + D E I++ + H N++++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+ +++ LV+EY G L YL S L + I + + LEYLH S +I
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-------YGR 857
H DLKP N+LLD+N V ++DF +AK L S+ T + T YMAPE YG
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYGP 178
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKP-TDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916
+ DV+S G++L E TGK P + E ++ L ++ L
Sbjct: 179 K------VDVWSLGVILYELLTGKPPFSGENILDQLQL-----------IRRILGPPLEF 221
Query: 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIV 954
E E+ + + P +R A+EI+
Sbjct: 222 DEPKWSSGSEEAKDLIKKC---LNKD-PSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 31/278 (11%)
Query: 687 NNLIGRGGFGSVYKASLGD-----GMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNL 740
+G G FG VYK L +EVAVK + F E IM+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
+K++ C+ EE +V+EYM G L YL + L + L+ + +A +EYL S
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
IH DL N L+ +N+V +SDF +++ L +D + I +MAPE +EG+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
++ DV+SFG++L E FT G++P M+ + + + + L Q
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--------LKNGYRLPQP- 225
Query: 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
C +++L ++C E P+ R E+V L
Sbjct: 226 ------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 77/282 (27%), Positives = 127/282 (45%), Gaps = 44/282 (15%)
Query: 690 IGRGGFGSVYKASL-----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG VYK +L G +VAVK + F E IMK + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
+ C+ E +V EYMP G L +L L + L + + +A +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSA 863
+H DL N L+ +N+V +SDF +++ + +D + I +MAPE ++G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 864 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922
DV+SFG++L E FT G++P + +S EV +
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQP-----------------YPGMSNEEV----------LEL 216
Query: 923 VAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
+ E C ++ L ++C P+ R E+V L
Sbjct: 217 LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 3e-41
Identities = 81/279 (29%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 687 NNLIGRGGFGSVYKASLGDG-----MEVAVKVF-TSQCGRAFKSFDVECEIMKSIRHRNL 740
+G G FG VYK +L +EVAVK + + F E IM+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+K++ C+ EE +V+EYMP G L YL + L + L+ + +A +EYL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG 859
S IH DL N L+ +N+V +SDF +++ L +D I +MAPE +EG
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 860 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918
+ ++ DV+SFG++L E FT G++P M+ + + L +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEY--------LKKGYRLPKP 226
Query: 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
C ++ L ++C E P+ R E+V L
Sbjct: 227 -------PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 43/287 (14%)
Query: 688 NLIGRGGFGSVYKASL----GDGMEVAVKV----FTSQCGRAFKSFDVECEIMKSIRHRN 739
+G G FG VYK L G EVAVK + + + F E +MK + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLGHPN 57
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC--------ILDIFQRLNIMIDVASA 791
+++++ C+ EE LVLEYM G L YL S L + L+ I +A
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYM 851
+EYL S +H DL N L+ +++V +SDF +++ + +D +T I +M
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 852 APEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910
APE ++G ++ DV+SFG++L E FT G P + N E+ L++ +
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEY------------LR 221
Query: 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
L + E C ++ L + C P+ R E+V +L
Sbjct: 222 KGYRLPK-------PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 80/285 (28%), Positives = 118/285 (41%), Gaps = 47/285 (16%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKV--FTSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
L+GRG FGSVY A G +AVK + ++ + E I+ S++H N+++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 745 SSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNI------MIDVASALEYLH 796
S +EE L LEY+ GSL L F +L + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH 118
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYG 856
S ++H D+K +N+L+D + V L+DF AK L + T +MAPE
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA--NL 914
R D++S G ++E TGK P E+ N L I +
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK-------IGSSGEPPEIPEH 228
Query: 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959
LS+E F+ +C + PK+R A E LL+
Sbjct: 229 LSEEAKDFL--RKC--LRRD---------PKKRPTADE----LLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 84/294 (28%), Positives = 130/294 (44%), Gaps = 50/294 (17%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIK 742
+G G FG V+ D VAVK A K F+ E E++ + +H N++K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYS------------SNCI-LDIFQRLNIMIDVA 789
C+ + +V EYM HG L K+L S S L + Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 790 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846
S + YL HF +H DL N L+ ++V + DF +++ + D + T+
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 847 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 905
I +M PE + + DV+SFG++L E FT GK+P + N E+
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV------------- 233
Query: 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959
+E + L Q C S V+++ + C P+QRIN K+I +L K
Sbjct: 234 -IECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 83/274 (30%), Positives = 128/274 (46%), Gaps = 31/274 (11%)
Query: 689 LIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFK-SFDVECEIMKSIRHRNLIKVISSC 747
IG+G FG VYK L EVAVK S K F E EI+K H N++K+I C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
++ +V+E +P GSL +L L + + L + +D A+ +EYL S IH D
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118
Query: 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT----IGYMAPEYGREGRVSA 863
L N L+ +N V +SDF +++ E++ I T + I + APE GR ++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 864 NGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 923
DV+S+GI+L ETF+ G+ N T E +++
Sbjct: 175 ESDVWSYGILLWETFSL---------GDTPYPGMSNQ----QTRERIESGY------RMP 215
Query: 924 AKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
A + C ++ L ++C P+ R + EI +L
Sbjct: 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 83/273 (30%), Positives = 128/273 (46%), Gaps = 36/273 (13%)
Query: 689 LIGRGGFGSVYKASLGD--GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
IG+G FG V LGD G +VAVK A ++F E +M ++RH NL++++
Sbjct: 13 TIGKGEFGDVM---LGDYRGQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
+V EYM GSL YL S ++ + Q+L +DV +EYL +H
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVH 125
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
DL NVL+ +++VA +SDF +AK + S Q + + APE RE + S
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 866 DVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVA 924
DV+SFGI+L E ++ G+ P I P+ +VV ++ A
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRI---------------PLK--DVVPH---VEKGYRMEA 220
Query: 925 KEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
E C V+ + +C P +R K++ +L
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IG+GGFG VYKA G EVA+KV + + E +I+K +H N++K S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
++ +V+E+ GSL+ L S+N L Q + ++ LEYLH S +IH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124
Query: 809 KPSNVLLDDNMVAHLSDFSIAKML--TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGD 866
K +N+LL + L DF ++ L T +M+ T +MAPE D
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-----GTPYWMAPEVINGKPYDYKAD 179
Query: 867 VYSFGIMLMETFTGKKP 883
++S GI +E GK P
Sbjct: 180 IWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 37/293 (12%)
Query: 688 NLIGRGGFGSVYKASL-----GDGMEVAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNLI 741
+G G FG V G +VAVK +S F+ E EI++++ H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 742 KVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
K C ++ L++EY+P GSL YL +++ + L + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT-GEDQSMIQTQTLATIGYMAPEYGRE 858
S IH DL N+L++ + +SDF +AK+L +D ++ + I + APE R
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 859 GRVSANGDVYSFGIMLMETFTGKKPTDE----------IFNGEMTLKHWVNDWLPISTME 908
+ S+ DV+SFG+ L E FT P+ I G+M + +
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE--------- 237
Query: 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961
L +E C V++L C P+ R + +++ + ++R
Sbjct: 238 ------LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
+G G FG V+ + +VAVK + ++F E +IMK +RH L+++ + CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID----VASALEYLHFGYSAPVIH 805
EE +V EYM GSL +L S RL ++D +A + YL S IH
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
DL N+L+ +N+V ++DF +A+++ +D+ + I + APE GR +
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIE-DDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 866 DVYSFGIMLMETFT-GKKP 883
DV+SFGI+L E T G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVK-VFTSQCGRAFKSFDV-ECEIMKSIRHRNLIKVI 744
IG+G FG VY DG +K + S + + E +I+K + H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGYSA 801
S + +V+EY G L + + F Q L+ + + AL+YLH S
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SR 122
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
++H D+KP N+ L N + L DF I+K+L+ + +T + T Y++PE +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV-VGTPYYLSPELCQNKPY 180
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
+ D++S G +L E T K P F GE
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-27
Identities = 86/296 (29%), Positives = 125/296 (42%), Gaps = 33/296 (11%)
Query: 689 LIGRGGFGSVYKASLGDGMEVAVKVF---TSQCGRAFKSFDVECEIMKSIRH-RNLIKVI 744
+G G FG VY A D VA+KV + + F E +I+ S+ H N++K+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+E LV+EY+ GSLE L L + L I+ + SALEYLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 803 VIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLA----TIGYMAPEY-- 855
+IH D+KP N+LLD D V L DF +AK+L + + T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 856 -GREGRVSANGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVNDWLPISTMEVVD 911
S++ D++S GI L E TG P TLK + P +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRN 967
+N E +L + + PK R+++ ++ L L +
Sbjct: 242 SN-----------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286
|
Length = 384 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 51/289 (17%)
Query: 690 IGRGGFGSVYKAS------LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG V+ A D M VAVK A K F E E++ +++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYS---------------SNCILDIFQRLNIMIDV 788
C + + +V EYM HG L K+L + + L + Q L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 789 ASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
AS + YL HF +H DL N L+ N++ + DF +++ + D + T+
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPI 904
I +M PE + + DV+SFG++L E FT GK+P W +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------------WFQL 229
Query: 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
S EV++ ++Q + C V+++ + C P+QR+N KEI
Sbjct: 230 SNTEVIEC--ITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 69/276 (25%), Positives = 125/276 (45%), Gaps = 27/276 (9%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
F+ +G G FG V++ + + VA+K+ S + F E + +K +RH++LI +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ CS E ++ E M GSL +L S +L + +++ VA + YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS 862
IH DL N+L+ +++V ++DF +A+++ ++ + + + APE G S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 863 ANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921
DV+SFGI+L E FT G+ P + N E + + A
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------------VYDQITAGY------R 222
Query: 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
+C ++ + +EC P+ R + K + +L
Sbjct: 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 67/214 (31%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVF-------TSQCGRAFKSFDVECEIMKSIRHRNLI 741
+G+G FG V G A+KV + E I+ I H ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT----ERNILSRINHPFIV 56
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
K+ + EE LVLEY P G L +L + R ++ ALEYLH S
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SL 112
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEYGREGR 860
+I+ DLKP N+LLD + L+DF +AK L+ E +T T T Y+APE
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKG 169
Query: 861 VSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
D +S G++L E TGK P EI+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 79/300 (26%), Positives = 121/300 (40%), Gaps = 76/300 (25%)
Query: 689 LIGRGGFGSVYKASL-GDGMEVAVKVF-TSQCGRAFKSFDV--ECEIM-KSIRHRNLIKV 743
+IG G F +V A E A+K+ Q + K V E E++ + H +IK+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ +EE VLEY P+G L +Y+ Y S LD ++ ALEYLH S
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG------------ 849
+IH DLKP N+LLD +M ++DF AK+L + S + AT
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 850 -------YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902
Y++PE E + D+++ G ++ + TGK P F G N++L
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRG-------SNEYL 229
Query: 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN--AKEIVTKLLKI 960
F ++ FP AK+++ KLL +
Sbjct: 230 -----------------------------TFQKILKLEYSFP-PNFPPDAKDLIEKLLVL 259
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVK--VFTSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
+LIGRG FG VYK +L G VA+K A KS E +++K+++H N++K I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFG 798
S + ++LEY +GSL + + + ++Q V L YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------VLQGLAYLH-- 116
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
VIH D+K +N+L + V L+DF +A L + + T +MAPE
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEM 173
Query: 859 GRVSANGDVYSFGIMLMETFTGKKP 883
S D++S G ++E TG P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 50/294 (17%)
Query: 690 IGRGGFGSVYKASLG------DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG V+ A D M VAVK A + F E E++ ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNC---ILD-----------IFQRLNIMIDVA 789
C+ +V EYM HG L ++L S IL + Q L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 790 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846
S + YL HF +H DL N L+ +V + DF +++ + D + +T+
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 847 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 905
I +M PE + + D++SFG++L E FT GK+P W +S
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-----------------WYQLS 229
Query: 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959
E ++ +E C V+ + C P+QR+ K+I ++L
Sbjct: 230 NTEAIECITQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 65/194 (33%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 689 LIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFK-SFDVECEIMKSIRHRNLIKVISSC 747
L+G+G FG V+K +L D VAVK + K F E I+K H N++K+I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
+ + +V+E +P G +L L Q + +D A+ + YL S IH D
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IGYMAPEYGREGRVSANG 865
L N L+ +N V +SDF +++ ED + + L I + APE GR S+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQ---EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 866 DVYSFGIMLMETFT 879
DV+S+GI+L ETF+
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 76/272 (27%), Positives = 113/272 (41%), Gaps = 35/272 (12%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKV--FTSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
IG G G VYKA G EVA+K Q E IMK +H N++ S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYDS 83
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
+ +V+EYM GSL + + ++ Q + +V LEYLH S VIH
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHR 140
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ---SMIQTQTLATIGYMAPEYGREGRVSA 863
D+K N+LL + L+DF A LT E S++ T +MAPE +
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY-----WMAPEVIKRKDYGP 195
Query: 864 NGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 923
D++S GIM +E G+ P L +P + + S E F+
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP----PLKNPEKWSPEFKDFL 250
Query: 924 AKEQCVSFVFNLAMECTMEFPKQRINAKEIVT 955
K C ++ P++R +A+E++
Sbjct: 251 NK-------------CLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 75/291 (25%), Positives = 135/291 (46%), Gaps = 46/291 (15%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKVFT---SQCGRAFKSFDVECEIMKSIRHRNLIK 742
+G G FG VYK L +V + T + + + F E E+M ++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMID 787
++ C+ E+ ++ EY+ HG L ++L ++ LD L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
+A+ +EYL S +H DL N L+ + + +SDF +++ + D +Q+++L
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 848 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 906
+ +M PE G+ + D++SFG++L E F+ G +P + G S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP----YYG-------------FSN 232
Query: 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
EV++ + + E C + V+ L +EC E P +R K+I T+L
Sbjct: 233 QEVIE---MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
+G G FG V++ + VAVK K F E +IMK +RH LI++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 750 EEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
EE +V E M +GSL +YL L + Q +++ VAS + YL + IH DL
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
NVL+ +N + ++DF +A+++ ED + I + APE R S DV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 869 SFGIMLMETFT-GKKPTDEIFNGE 891
SFGI+L E T G+ P + N E
Sbjct: 189 SFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 68/244 (27%), Positives = 106/244 (43%), Gaps = 22/244 (9%)
Query: 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAF-KSFDVECEIMKSIRHRNLIKVISSC 747
+G+G G VYK G A+K F K E + ++S ++K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 748 SNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
+K ++VLEYM GSL L I + I + L+YLH +
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH--TKRHI 121
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-LATIGYMAPEYGREGRVS 862
IH D+KPSN+L++ ++DF I+K+L + ++ Q T + T+ YM+PE + S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQGESYS 178
Query: 863 ANGDVYSFGIMLMETFTGKKP-TDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921
D++S G+ L+E GK P L + D P S + A S E
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS----LPAEEFSPEFRD 234
Query: 922 FVAK 925
F++
Sbjct: 235 FISA 238
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 690 IGRGGFGSVYKA---SLGDG--MEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKV 743
+G G FG+VYK G+ + VA+KV + A K E +M S+ H +++++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
+ C + + L+ + MP G L Y+ + + LN + +A + YL +
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSA 863
+H DL NVL+ ++DF +AK+L +++ I +MA E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 864 NGDVYSFGIMLMETFT-GKKPTDEI 887
DV+S+G+ + E T G KP + I
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 6/204 (2%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
IG G FG V+ + +VA+K + + + F E ++M + H L+++ C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 809
LV E+M HG L YL + L + +DV + YL S+ VIH DL
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLA 127
Query: 810 PSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYS 869
N L+ +N V +SDF + + + +DQ T T + + +PE + S+ DV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 870 FGIMLMETFT-GKKPTDEIFNGEM 892
FG+++ E F+ GK P + N E+
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 683 GFSENNLIGRGGFGSVYKASLGDGMEV-AVKVFTSQ-C--GRAFKSFDVECEIMKSIRHR 738
F +IG+G FG V D ++ A+K Q C + ++ E I++ + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 739 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 798
L+ + S +EE LV++ + G L +Y S Q + ++ ALEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLH-- 117
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
S +IH D+KP N+LLD+ H++DF+IA +T + + T T T GYMAPE
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCR 173
Query: 859 GRVSANGDVYSFGIMLMETFTGKKP 883
S D +S G+ E GK+P
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 71/203 (34%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 690 IGRGGFGSVYKASLGD--GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
IG+G FG V LGD G +VAVK + ++F E +M +RH NL++++
Sbjct: 14 IGKGEFGDVM---LGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 748 SNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
E+ +V EYM GSL YL S +L L +DV A+EYL + +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
DL NVL+ ++ VA +SDF + K + S Q + + APE RE + S
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 866 DVYSFGIMLMETFT-GKKPTDEI 887
DV+SFGI+L E ++ G+ P I
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRI 203
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 6/203 (2%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
+G G FG V+ ++VA+K+ + + F E ++M + H NL+++ C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 809
+ +V EYM +G L YL L L++ DV A+EYL S IH DL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127
Query: 810 PSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYS 869
N L+ ++ V +SDF +A+ + +DQ T + + PE R S+ DV+S
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 870 FGIMLMETFT-GKKPTDEIFNGE 891
FG+++ E F+ GK P + N E
Sbjct: 187 FGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 9e-23
Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 690 IGRGGFGSV--YK---ASLGDGMEVAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNLIKV 743
+G G FG V Y A+ G G VAVK +CG+ S + E I+K++ H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 744 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
CS + K L++EY+P GSL YL L++ Q L + + YLH S
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKML-TGEDQSMIQTQTLATIGYMAPEYGREGR 860
IH DL NVLLD++ + + DF +AK + G + ++ + + + A E +E +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 861 VSANGDVYSFGIMLMETFT 879
S DV+SFG+ L E T
Sbjct: 187 FSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 9e-23
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 9/206 (4%)
Query: 676 ELCRATDGFSENNLIGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRAFKSFDVECEIMKS 734
E+ R TD + + +G G +G VY+ + VAVK + F E +MK
Sbjct: 2 EMER-TD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKE 58
Query: 735 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALE 793
I+H NL++++ C+ E ++ E+M +G+L YL N ++ L + ++SA+E
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
YL IH DL N L+ +N + ++DF +++++TG D I + AP
Sbjct: 119 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 174
Query: 854 EYGREGRVSANGDVYSFGIMLMETFT 879
E + S DV++FG++L E T
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 70/206 (33%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVI 744
N IG G FG VY A +L G +AVK Q K E ++++ ++H NL+K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD--IFQRLNIMIDVASALEYLHFGYSAP 802
+ E + +EY G+LE+ L ILD + + + + L YLH S
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQL--LEGLAYLH---SHG 119
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI-QTQTLA-TIGYMAPEYGREGR 860
++H D+KP+N+ LD N V L DF A L +M + Q+LA T YMAPE G+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 861 VSANG---DVYSFGIMLMETFTGKKP 883
+G D++S G +++E TGK+P
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 75/272 (27%), Positives = 132/272 (48%), Gaps = 34/272 (12%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
IG G FG+V + G +VAVK +C ++F E +M + H+NL++++ +
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 750 EEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
+V+E M G+L +L + ++ + Q L +DVA +EYL S ++H DL
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
N+L+ ++ VA +SDF +A++ SM + + + APE + + S+ DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181
Query: 869 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 927
S+G++L E F+ G+ P +M+LK EV + ++ E
Sbjct: 182 SYGVLLWEVFSYGRAPYP-----KMSLK------------EVKEC---VEKGYRMEPPEG 221
Query: 928 CVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959
C + V+ L C PK+R + ++ KL K
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 42/287 (14%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG V+ A D + VAVK A K F E E++ +++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCIL----------DIFQRLNIMIDVASA 791
C + +V EYM HG L K+L + + +L Q L+I +A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYM 851
+ YL S +H DL N L+ +N++ + DF +++ + D + T+ I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 852 APEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910
PE + + DV+S G++L E FT GK+P W +S EV+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------------WYQLSNNEVI 232
Query: 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
+ ++Q + C V++L + C P R+N KEI + L
Sbjct: 233 EC--ITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 74/265 (27%), Positives = 117/265 (44%), Gaps = 30/265 (11%)
Query: 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNLIKVISSC 747
IGRG FG V+ L D VAVK K+ F E I+K H N++++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
+ ++ +V+E + G +L + L + + + ++ + A+ +EYL S IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI--GYMAPEYGREGRVSANG 865
L N L+ + V +SDF +++ ED T + I + APE GR S+
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 866 DVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVA 924
DV+SFGI+L E F+ G P + N + T E + ++ +
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQ--------------TREAI------EQGVRLPC 217
Query: 925 KEQCVSFVFNLAMECTMEFPKQRIN 949
E C V+ L C P QR +
Sbjct: 218 PELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
+G+G FG V+ + VA+K + ++F E ++MK +RH L+++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS- 71
Query: 750 EEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
EE +V EYM GSL +L L + Q +++ +AS + Y+ +H DL
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
+ +N+L+ +N+V ++DF +A+++ + + Q I + APE GR + DV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 869 SFGIMLMETFT-GKKPTDEIFNGEM 892
SFGI+L E T G+ P + N E+
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 50/293 (17%)
Query: 690 IGRGGFGSVYKASLG-DGME----VAVKVFTS-QCGRAFKSFDVECEIMKSIRHRNLIKV 743
+G FG +YK L GM+ VA+K + + F E +M + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLY----------SSN------CILDIFQRLNIMID 787
+ + E+ ++ EY+ G L ++L SS+ LD L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 788 VASALEYL--HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
+A+ +EYL HF +H DL N+L+ + + +SD +++ + D +Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPI 904
I +M PE G+ S++ D++SFG++L E F+ G +P N E+
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV------------ 235
Query: 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
+E+V L E C +++L EC E P +R K+I T+L
Sbjct: 236 --IEMVRKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 41/221 (18%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVK---VFTSQCGRAFKSFDV----ECEIMKSIRHRNLI 741
IG G +G VYKA + G VA+K + + G F + E ++++ +RH N++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEG-----FPITAIREIKLLQKLRHPNIV 61
Query: 742 K----VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
+ V S + +V EYM H L L S Q M + L+YLH
Sbjct: 62 RLKEIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH- 117
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--- 854
S ++H D+K SN+L++++ V L+DF +A+ T S T + T+ Y PE
Sbjct: 118 --SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLL 174
Query: 855 ----YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
YG E V D++S G +L E F GK IF G
Sbjct: 175 GATRYGPE--V----DMWSVGCILAELFLGKP----IFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 71/283 (25%), Positives = 133/283 (46%), Gaps = 30/283 (10%)
Query: 685 SENNLIGRGGFGSVYKASLG--DGMEVAVKVFTSQCGRAFKS---FDVECEIMKSIRHRN 739
++ +IG G FG V++ L EVAV + T + G K F E IM H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+I++ + + ++ EYM +G+L+KYL + +Q + ++ +A+ ++YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--- 124
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ-TLATIGYMAPEYGRE 858
+H DL N+L++ N+ +SDF ++++L + + T I + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 859 GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917
+ ++ DV+SFGI++ E + G++P ++ N E+ M+ ++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV--------------MKAIN------ 224
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ A C S V+ L ++C + +R +IV L K+
Sbjct: 225 DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 57/196 (29%), Positives = 87/196 (44%), Gaps = 8/196 (4%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRA-FKSFDVECEIMKSIRHRNLIKVISSC 747
+G G G V K G +AVK + A K E +I+ ++ +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
N ++ +EYM GSL+K L + I + V L YLH + +IH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDV 867
+KPSN+L++ L DF ++ L S+ +T T YMAPE + S D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182
Query: 868 YSFGIMLMETFTGKKP 883
+S G+ L+E TG+ P
Sbjct: 183 WSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 9e-21
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 688 NLIGRGGFGSVYKAS----LGDGME---VAVKVF-TSQCGRAFKSFDVECEIMKSIRHRN 739
N +G G FG VY+ + LG G VAVK + K F E +M + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC------ILDIFQRLNIMIDVASALE 793
++K++ C E + +++E M G L YL + +L + + L+I +DVA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 794 YL---HFGYSAPVIHCDLKPSNVLL-----DDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
YL HF IH DL N L+ D + V + DF +A+ + D + + L
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 883
+ +MAPE +G+ + DV+SFG+++ E T G++P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFT-SQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
IG G VY A L + +VA+K +C + E + M H N++K +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 748 SNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+ LV+ Y+ GSL K Y LD ++ +V LEYLH S I
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLH---SNGQI 124
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKML--TGEDQSMIQTQTLATIGYMAPEYGREGR-V 861
H D+K N+LL ++ ++DF ++ L G+ ++ + T +MAPE +
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 862 SANGDVYSFGIMLMETFTGKKP 883
D++SFGI +E TG P
Sbjct: 185 DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 47/293 (16%)
Query: 689 LIGRGGFGSVYKASL----GDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIK 742
++G G FGSV + L G ++VAVK + F E MK H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 743 VISSC----SNEEFKA--LVLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASA 791
+I C S ++ ++L +M HG L +L S L + L M+D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED---QSMIQTQTLATI 848
+EYL + IH DL N +L ++M ++DF ++K + D Q I +
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---PV 179
Query: 849 GYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTM 907
++A E + ++ DV++FG+ + E T G+ P + N E+ D+L
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY------DYL----- 228
Query: 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
N L Q E C+ +++L C PK R ++ L I
Sbjct: 229 --RHGNRLKQ-------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-20
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 684 FSENNLI-----GRGGFGSVYKAS---LGD--GMEVAVKVFTSQCGRAFKSFDVECEIMK 733
F E +L G+G FGSV L D G VAVK + F+ E EI+K
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60
Query: 734 SIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 790
S++H N++K V S + LV+EY+P+GSL YL LD + L +
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML-TGEDQSMIQTQTLATIG 849
+EYL S +H DL N+L++ + DF + K+L ++ ++ + I
Sbjct: 120 GMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 850 YMAPEYGREGRVSANGDVYSFGIMLMETFT 879
+ APE E + S DV+SFG++L E FT
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 70/218 (32%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 690 IGRGGFGSV----YKASLGDGMEVAVKVF---TSQCGRAFKSFDVECEIMKSIRHRNLIK 742
+G G FGSV Y G +EVAVK G+ K F E +M + H +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYL---HF 797
+I C E LV+E P G L KYL + D+ + VA + YL HF
Sbjct: 61 LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF 116
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML-TGEDQSMIQTQTLATIGYMAPEYG 856
+H DL NVLL + A +SDF +++ L G D T + + APE
Sbjct: 117 ------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 857 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 893
G+ S+ DV+S+G+ L E F+ G KP E+ E+
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 6/207 (2%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
+G G FG V +VA+K+ + + F E ++M + H L+++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 809
+ +V EYM +G L YL Q L + DV + YL S IH DL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127
Query: 810 PSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYS 869
N L+DD +SDF +++ + +D+ + + + PE + S+ DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 870 FGIMLMETFT-GKKPTDEIFNGEMTLK 895
FG+++ E ++ GK P + N E K
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 79/297 (26%), Positives = 126/297 (42%), Gaps = 49/297 (16%)
Query: 689 LIGRGGFGSVYKASLGD------GMEVAVKVF-TSQCGRAFKSFDVECEIMKSI-RHRNL 740
+G G FG V KA VAVK+ + E E+MK I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRL------NIM 785
I ++ C+ E +V+EY HG+L +L S + + L +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
VA +E+L S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPI 904
+ +MAPE + + DV+SFG++L E FT G P + I
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP-----------------YPGI 238
Query: 905 STMEVVDANLLSQEDIHFVAKEQ-CVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
E+ LL + + + K Q C +++L +C E P QR K++V L ++
Sbjct: 239 PVEELFK--LLKEG--YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 10/206 (4%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAF-KSFDVECEIMKSIRHRNLIKVISSCS 748
+G+G FG V+ + +VA+K T + G ++F E +IMK +RH L+ + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
EE +V E+M GSL +L + L + Q +++ +A + Y+ IH D
Sbjct: 72 -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDV 867
L+ +N+L+ DN+V ++DF +A+++ + + Q I + APE GR + DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 186
Query: 868 YSFGIMLMETFT-GKKPTDEIFNGEM 892
+SFGI+L E T G+ P + N E+
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 8/205 (3%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
+G G FG V+ + +VAVK + +SF E +IMK +RH L+++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 750 EEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
E +V EYM GSL +L L + +++ VA+ + Y+ IH DL
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
+ +N+L+ D +V ++DF +A+++ + + Q I + APE GR + DV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDVW 187
Query: 869 SFGIMLMETFT-GKKPTDEIFNGEM 892
SFGI+L E T G+ P + N E+
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREV 212
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFT-SQCGRAFKSFDV-ECEIMKSIRHRNLIKVISS 746
IG+G FG+V K DG + K K V E I++ ++H N+++
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 747 CSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRL------NIMIDVASALEYLHFG 798
+ + L V+EY G L + + C + + + I+ + AL H
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKE-RKYIEEEFIWRILTQLLLALYECHNR 124
Query: 799 YSAP--VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYG 856
V+H DLKP+N+ LD N L DF +AK+L G D S +T + T YM+PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT-YVGTPYYMSPEQL 182
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKP 883
D++S G ++ E P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFT----SQCGRAFKSFDVECEIMKSIRH 737
F +G+G +GSVYK L D A+K SQ R + + E I+ S+ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE-DAVN-EIRILASVNH 58
Query: 738 RNLIKVISSCSNEEF-----KALVLEYMPHGSLEKYLYSSNCILDIFQR---LNIMIDVA 789
N+I E F +V+EY P G L K + + I I +
Sbjct: 59 PNII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 790 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG 849
L+ LH ++H DLK +N+LL N + + D I+K+L ++M +TQ T
Sbjct: 114 RGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPH 166
Query: 850 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
YMAPE + S D++S G +L E T P F
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 689 LIGRGGFGSVY---KASLGDGMEVAVK------VFTSQCGRAFKSFDV---ECEIMKSIR 736
LIG G FGSVY AS G+ M AVK V S R D E ++K ++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELM--AVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
H N+++ + S + + + LEY+P GS+ L + + R N + + L YLH
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH 123
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA------TIGY 850
+ +IH D+K +N+L+D+ +SDF I+K L E S+ A ++ +
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSVFW 178
Query: 851 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
MAPE ++ + D++S G +++E TGK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 33/283 (11%)
Query: 687 NNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNLI 741
IG G FG VY+ + + VAVK + + + F E IM+ H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
K+I + E +V+E P G L YL + LD+ + +++AL YL S
Sbjct: 71 KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ-TQTLATIGYMAPEYGREGR 860
+H D+ NVL+ L DF +++ L ED+S + ++ I +MAPE R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFRR 184
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
++ DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP-------------- 230
Query: 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962
C +++L +C P +R E+ +L I
Sbjct: 231 ------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 65/218 (29%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
F +G G +GSVYKA G VA+KV + E I+K ++K
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN----------IMIDVASAL 792
S +V+EY GS + DI + N I+ L
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGL 112
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG--- 849
EYLH S IH D+K N+LL++ A L+DF ++ LT +M + T+ IG
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTV--IGTPF 164
Query: 850 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEI 887
+MAPE +E + D++S GI +E GK P +I
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 9e-19
Identities = 74/268 (27%), Positives = 123/268 (45%), Gaps = 47/268 (17%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKS-FDV-----ECEIMKSIRHRNL 740
IG G +G V A G +VA+K + F D E ++++ +RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIK----KISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 741 IK---VISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 795
I ++ S E+F + V E M L K + S + D + + + L+YL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK-MLTGEDQSMIQTQTLATIGYMAPE 854
H SA VIH DLKPSN+L++ N + DF +A+ + ED+ T+ + T Y APE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 855 -------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM 907
Y + D++S G + E T KP +F G + +++ I +
Sbjct: 177 LLLSSSRY------TKAIDIWSVGCIFAELLTR-KP---LFPG----RDYIDQLNLI--V 220
Query: 908 EVVDANLLSQEDIHFVAKEQCVSFVFNL 935
EV+ S+ED+ F+ E+ +++ +L
Sbjct: 221 EVLGT--PSEEDLKFITSEKARNYLKSL 246
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 40/286 (13%)
Query: 690 IGRGGFGSVYK---ASLGDG---MEVAVK-VFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
+G+G FG VY+ + G VA+K V + R F E +MK ++++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCILDIFQRLNIM---IDVASALE 793
++ S + +V+E M G L+ YL S +N L + ++A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
YL + +H DL N ++ +++ + DF + + + D + L + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 854 EYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912
E ++G + DV+SFG++L E T ++P + N E LK V+D
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKF------------VIDG 237
Query: 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958
L E C + L C PK R EIV+ L
Sbjct: 238 GHLDL-------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 71/282 (25%), Positives = 109/282 (38%), Gaps = 37/282 (13%)
Query: 689 LIGRGGFGSV----YKASLGDGMEVAVKVFTS-QCGRAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG V + S G + VAVK S + F E IM S+ H NLI++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAP 802
+V E P GSL L I + + +A+ + YL S
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKML-TGEDQSMIQTQTLATIGYMAPEYGREGRV 861
IH DL N+LL + + DF + + L ED +++ + APE R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 862 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEV---VDANLLSQ 917
S DV+ FG+ L E FT G++P W +S ++ +D
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEP-----------------WAGLSGSQILKKIDKEG--- 217
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959
E + E C ++N+ ++C P R + L +
Sbjct: 218 ERLE--RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 66/291 (22%), Positives = 131/291 (45%), Gaps = 46/291 (15%)
Query: 690 IGRGGFGSVYKASL-----GDGME-VAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNLIK 742
+G FG VYK L G+ + VA+K + + F E + ++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLY---------------SSNCILDIFQRLNIMID 787
++ + E+ +++ Y H L ++L + L+ ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
+A+ +E+L S V+H DL NVL+ D + +SD + + + D + +L
Sbjct: 133 IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 848 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 906
I +M+PE G+ S + D++S+G++L E F+ G +P + S
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----------------YCGYSN 232
Query: 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
+V++ ++ + + C ++V+ L +EC EFP +R K+I ++L
Sbjct: 233 QDVIE--MIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-18
Identities = 58/178 (32%), Positives = 84/178 (47%), Gaps = 29/178 (16%)
Query: 476 LNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI 535
L + L G +P +I L+ L I+LS N+ G IP +G + +LE L L YN GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 536 PNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQ 595
P S G L SL+ LNL+ N+LSG +PA+ L G++ SF
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA----------------LGGRLLHRASF------ 520
Query: 596 SFEGNELLCGSPNLQIPPCKTSIHHKSWKKSILLGIVLPLSTTFMIVVILLILRYRQR 653
+F N LCG P L C + +GI +S F+ +VI + +++R
Sbjct: 521 NFTDNAGLCGIPGL--RACGPHL-----SVGAKIGIAFGVSVAFLFLVICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 68/278 (24%), Positives = 127/278 (45%), Gaps = 31/278 (11%)
Query: 687 NNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLI 741
+IG G FG V + L ++VA+K + + F E IM H N+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYS 800
++ + ++ EYM +GSL+K+L ++ + Q + ++ +AS ++YL Y
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
+H DL N+L++ N+V +SDF +++ L + + I + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
++ DV+SFGI++ E + G++P +W D S +V+ A ++
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP------------YW--DM---SNQDVIKA---VEDG 224
Query: 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
C S ++ L ++C + +R +IV+ L
Sbjct: 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 690 IGRGGFGSVY---KASLGDGMEVAVKVFTS---QCGRAFKSFDVECEIMKSIRHRNLIKV 743
I +G +G V+ K S GD A+KV E +I+ + ++K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
S ++ LV+EY+P G L L + LD + ++ ALEYLH S +
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGI 114
Query: 804 IHCDLKPSNVLLDDNMVAHLSDF------SIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
IH DLKP N+L+D N L+DF + + + D + + T Y+APE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
S D +S G +L E G P F+GE
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPP----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 41/296 (13%)
Query: 684 FSENNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRH 737
F+ ++G+G FGSV +A L G +VAVK+ + + F E MK H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 738 RNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMI 786
N+IK+I K ++L +M HG L +L S L + + MI
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 787 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846
D+AS +EYL S IH DL N +L++NM ++DF ++K + D +
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 847 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 905
+ ++A E + + + DV++FG+ + E T G+ P + N E + ++L
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNYL--- 228
Query: 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961
+ N L Q C+ V+ L +C PK R + + + +L I
Sbjct: 229 ----IKGNRLKQ-------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 71/296 (23%), Positives = 123/296 (41%), Gaps = 58/296 (19%)
Query: 690 IGRGGFGSVYKA-SLG-----DGMEVAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNLIK 742
IG+G FG V++A + G VAVK+ + ++ F E +M H N++K
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN---------------------CILDIFQR 781
++ C+ + L+ EYM +G L ++L + L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 782 LNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838
L I VA+ + YL F +H DL N L+ +NMV ++DF +++ + D
Sbjct: 133 LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHW 897
I +M PE R + DV+++G++L E F+ G +P + + E + +
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-EEVIYY- 244
Query: 898 VNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
V D N+LS + C ++NL C + P R + I
Sbjct: 245 -----------VRDGNVLS-------CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 30/211 (14%)
Query: 688 NLIGRGGFGSVYKASL---GDGMEVAVKV---FTSQCGRAFKSFDVECEIM-KSIRHRNL 740
++IG G FG V +A + G M A+K+ F S+ + F E E++ K H N+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--NDHRDFAGELEVLCKLGHHPNI 65
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIM 785
I ++ +C N + + +EY P+G+L +L S + L Q L
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
DVA+ ++YL IH DL NVL+ +N+ + ++DF +++ GE+ + +T
Sbjct: 126 SDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179
Query: 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLME 876
+ +MA E + DV+SFG++L E
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 689 LIGRGGFGSVYKASLGD-GMEVAVKVF-----TSQCGRAFKSFDVECEIMKSIRHRNLIK 742
L+G+G FG VY D G E+AVK + + + + + E +++K+++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
++E ++ +EYMP GS++ L + + + R + +EYLH S
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-----LATIGYMAPE--- 854
++H D+K +N+L D L DF +K L Q++ + T T +M+PE
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 855 ---YGREGRVSANGDVYSFGIMLMETFTGKKP 883
YGR+ DV+S G ++E T K P
Sbjct: 181 GEGYGRK------ADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 688 NLIGRGGFGSVYKASL----GDG--MEVAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNL 740
+G G FG VY+ GD ++VAVK C +S F +E IM H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLY---------SSNCILDIFQRLNIMIDVASA 791
+++I + ++LE M G L+ +L SS + D+ L DVA
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL---LFCARDVAKG 128
Query: 792 LEYL---HFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
+YL HF IH D+ N LL VA ++DF +A+ + + +
Sbjct: 129 CKYLEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182
Query: 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 879
I +M PE +G ++ DV+SFG++L E F+
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (211), Expect = 6e-18
Identities = 79/303 (26%), Positives = 120/303 (39%), Gaps = 74/303 (24%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKV---------FTSQCGRAFKSFDVECEIMKSIRHRN 739
+G G +G VYKA G VA+K S R E ++K ++H N
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKHPN 59
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
++K++ E LV EY L+KYL L +IM + L Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--- 115
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE----- 854
S ++H DLKP N+L++ + V L+DF +A+ ++ T + T+ Y APE
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEILLGS 173
Query: 855 --YGREGRVSANGDVYSFGIMLMETFTGK--------------------KPTDEIFNGEM 892
Y V D++S G + E TGK PT+E + G
Sbjct: 174 KHYSTA--V----DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227
Query: 893 TLKHWVND---WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN 949
L + + P +V+ L E I ++K +N P +RI+
Sbjct: 228 KLPDYKPTFPKFPPKDLEKVL--PRLDPEGIDLLSK----MLQYN---------PAKRIS 272
Query: 950 AKE 952
AKE
Sbjct: 273 AKE 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVF----TSQCGR-AFKSFDVECEIMKSIRHRNLIK 742
L+G G FGSVY+ +L DG AVK Q G+ A K + E ++ ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ + E+ + LE +P GSL K L + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG---YMAPEY-GRE 858
+H D+K +N+L+D N V L+DF +AK Q + + + G +MAPE ++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 859 GRVSANGDVYSFGIMLMETFTGKKP 883
G D++S G ++E TGK P
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 689 LIGRGGFGSVYKASL---GDGME--VAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIK 742
L+G G FG+V+K GD ++ VA+K + GR F+ M S+ H +++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
++ C + LV + P GSL ++ LD + LN + +A + YL
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS 862
++H +L N+LL + + ++DF +A +L +D+ ++ I +MA E GR +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 863 ANGDVYSFGIMLMETFT-GKKP 883
DV+S+G+ + E + G +P
Sbjct: 190 HQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 56/205 (27%), Positives = 105/205 (51%), Gaps = 7/205 (3%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
+G G FG V+ + +VAVK + ++F E +MK+++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL-NIMIDVASALEYLHFGYSAPVIHCDL 808
EE ++ EYM GSL +L S + +L + +A + Y+ IH DL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
+ +NVL+ ++++ ++DF +A+++ +++ + I + APE G + DV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 869 SFGIMLMETFT-GKKPTDEIFNGEM 892
SFGI+L E T GK P + N ++
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 63/260 (24%), Positives = 119/260 (45%), Gaps = 28/260 (10%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
+G G FG V+ +VA+K Q + ++F E +MK ++H L+++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 750 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
E ++ EYM +GSL +L + I L I + +++ +A + ++ IH DL
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
+ +N+L+ + + ++DF +A+++ +++ + I + APE G + DV+
Sbjct: 129 RAANILVSETLCCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 869 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 927
SFGI+L E T G+ P + N E V NL + +
Sbjct: 188 SFGILLTEIVTYGRIPYPGMTNPE------------------VIQNL--ERGYRMPRPDN 227
Query: 928 CVSFVFNLAMECTMEFPKQR 947
C ++ L C E P++R
Sbjct: 228 CPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 18/215 (8%)
Query: 684 FSENN---LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN 739
+ EN ++G+G +G VY A L + +A+K + R + E + ++HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI----DVASALEYL 795
+++ + S S F + +E +P GSL L S L + +I + L+YL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLKYL 124
Query: 796 HFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
H ++H D+K NVL++ + V +SDF +K L G + +T T T+ YMAPE
Sbjct: 125 H---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPE 179
Query: 855 YGREGR--VSANGDVYSFGIMLMETFTGKKPTDEI 887
+G A D++S G ++E TGK P E+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV-----ECEIMKSIRH---RN 739
LIGRG +G+VY+ + G VA+K+ DV E ++ +R N
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+ K S +++EY GS+ + L + I + + + I+ +V AL+Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY-MAPEYGRE 858
VIH D+K +N+L+ + L DF +A +L Q+ + T Y MAPE E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVITE 175
Query: 859 GRV-SANGDVYSFGIMLMETFTGKKP 883
G+ D++S GI + E TG P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 59/209 (28%), Positives = 108/209 (51%), Gaps = 12/209 (5%)
Query: 689 LIGRGGFGSVY--KASLGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKV 743
+IG G FG V + L E+ V + T + G + + F E IM H N+I +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGYSAP 802
+ + +V EYM +GSL+ +L + + Q + ++ +AS ++YL GY
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ-TLATIGYMAPEYGREGRV 861
+H DL N+L++ N+V +SDF ++++L + ++ T+ I + APE +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 862 SANGDVYSFGIMLMETFT-GKKPTDEIFN 889
++ DV+S+GI++ E + G++P E+ N
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-17
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 688 NLIGRGGFGSVYKASL-GDG--MEVAVKVFTSQCGRA-FKSFDVECEIMKSI-RHRNLIK 742
++IG G FG V KA + DG M+ A+K + + F E E++ + H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 787
++ +C + + L +EY PHG+L +L S + L Q L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
VA ++YL IH DL N+L+ +N VA ++DF +++ G++ + +T
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186
Query: 848 IGYMAPEYGREGRVSANGDVYSFGIMLME 876
+ +MA E + N DV+S+G++L E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 11/211 (5%)
Query: 689 LIGRGGFGSVYKAS-LGDG----MEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIK 742
++G G FG+VYK + +G + VA+K+ G +A F E IM S+ H +L++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
++ C + + LV + MPHG L Y++ + LN + +A + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS 862
++H DL NVL+ ++DF +A++L G+++ I +MA E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 863 ANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 892
DV+S+G+ + E T G KP D I E+
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR------HRNLI 741
+G G F S Y+A + G +AVK T + + +V + K IR H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 742 KVISSCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
+++ + + L +E+M GS L KY ++ +N + L YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLH- 120
Query: 798 GYSAPVIHCDLKPSNVLLDDN-MVAHLSDF-SIAKM---LTGEDQSMIQTQTLATIGYMA 852
+IH D+K +N+L+D ++DF + A++ TG + Q Q L TI +MA
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMA 176
Query: 853 PEYGREGRVSANGDVYSFGIMLMETFTGKKP--TDEIFN 889
PE R + + DV+S G +++E T K P ++ N
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEVAVK--------VFTSQCGRAFKSFDVECEIMKSI 735
+++ ++G+G +G+VY G +AVK V ++ + ++ E +++KS+
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAE--KEYEKLQEEVDLLKSL 59
Query: 736 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI-FQRLNIMIDVASALEY 794
+H N+++ + +C ++ ++ +E++P GS+ L + + F + I + Y
Sbjct: 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAY 117
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG----Y 850
LH + V+H D+K +NV+L N + L DF A+ L + L ++ +
Sbjct: 118 LH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 851 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
MAPE E D++S G + E TGK P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IG+G G+VY A + G EVA+K Q + E +M+ +H N++ + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
+ +V+EY+ GSL + + +D Q + + ALE+LH S VIH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
K N+LL + L+DF +T E ++ + T +MAPE D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 869 SFGIMLMETFTGKKP 883
S GIM +E G+ P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVA---VKVFTSQCGRAFKSFDVECEIMKSIR 736
F IG+G F VYKA L DG VA V++F +A + E +++K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALE 793
H N+IK ++S +VLE G L K+ ++ + + SALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
++H S ++H D+KP+NV + V L D + + + ++ + T YM+P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSP 175
Query: 854 EYGREGRVSANGDVYSFGIMLME 876
E E + D++S G +L E
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 6/195 (3%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
+G G FG V+ ++VA+K ++ + + F E ++M + H L+++ C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 809
++ +V E+M +G L YL L L++ DV +EYL IH DL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127
Query: 810 PSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYS 869
N L+ V +SDF + + + +D+ + + + PE + S+ DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186
Query: 870 FGIMLMETFT-GKKP 883
FG+++ E FT GK P
Sbjct: 187 FGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IG G +G VYKA + G VA+KV + G F+ E ++K RH N++ S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN----------IMIDVASALEYLHFG 798
+ +V+EY GSL+ DI+Q + + L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG---YMAPEY 855
IH D+K +N+LL ++ L+DF ++ LT ++ + ++ IG +MAPE
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSF--IGTPYWMAPEV 172
Query: 856 G---REGRVSANGDVYSFGIMLMETFTGKKP 883
R+G D+++ GI +E + P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 21/234 (8%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVK-VFTSQCGRAFKSFDV-ECEIMKSIRHRNL 740
F N IG+G FG V+K D A+K + S+ R + + E ++ + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYS-------SNCILDIFQRLNIMIDVASALE 793
I+ S ++ +V+EY +G L K L + + F I + L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
+LH S ++H D+K N+ LD + D +AK+L+ D + + T Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSP 170
Query: 854 EYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM 907
E + + DV++ G++L E TGK P D G + LK + P+S M
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM 224
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 67/283 (23%), Positives = 131/283 (46%), Gaps = 36/283 (12%)
Query: 689 LIGRGGFGSVYKASLG--DGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKV 743
+IG G FG V + L E+ V + T + G + + F E IM H N+I +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
+ ++ E+M +G+L+ +L ++ + Q + ++ +A+ ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-----TIGYMAPEYGRE 858
+H DL N+L++ N+V +SDF +++ L ED + T T + I + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 859 GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917
+ ++ DV+S+GI++ E + G++P +W +S +V++A +
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP------------YW-----DMSNQDVINA---IE 225
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+D C + + L ++C + R +IV+ L K+
Sbjct: 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 68/293 (23%), Positives = 120/293 (40%), Gaps = 43/293 (14%)
Query: 683 GFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTS----QCGRAFKSFDVECEIM 732
E +GRG FG V+ A G V VK F+ E ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMF 62
Query: 733 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--------LDIFQRLNI 784
+ + H+N+++++ C E ++LEY G L+++L ++ L Q++ +
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
+A +++L +A +H DL N L+ +S S++K +
Sbjct: 123 CTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNA 178
Query: 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 904
L + ++APE +E S DV+SFG+++ E FT GE+ ++
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------QGELPFYGLSDE---- 225
Query: 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
EV+ N L + E C S ++ L C PK R + E+V+ L
Sbjct: 226 ---EVL--NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
+G G FG VYKA G+ A K+ + + F VE +I+ +H N++ + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
E +++E+ G+L+ + L Q + + AL +LH S VIH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY-----GREGRVSA 863
K N+LL + L+DF ++ Q + + T +MAPE ++
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 864 NGDVYSFGIMLMETFTGKKPTDEI 887
D++S GI L+E + P E+
Sbjct: 188 KADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVEC----EI--MKSIRHRNLIK 742
IG G +G VYKA G VA+K F+S + EI +K + H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK----LRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
++ ++ LV E+M L K + L + + + L + H S
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--YGREGR 860
++H DLKP N+L++ V L+DF +A+ + T + T Y APE G +G
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRWYRAPELLLGDKG- 175
Query: 861 VSANGDVYSFGIMLMET------FTGKKPTDEIF 888
S D++S G + E F GK D++F
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 7e-16
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVK------VFTSQCGRAFKSFDVECEIMKSIRHRNL 740
+G G + VYKA G VA+K ++ G F + E ++++ ++H N+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNI 64
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
I ++ ++ LV E+M LEK + + +L + M+ LEYLH +
Sbjct: 65 IGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW- 122
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--YG-R 857
++H DLKP+N+L+ + V L+DF +A+ ++ M T + T Y APE +G R
Sbjct: 123 --ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM--THQVVTRWYRAPELLFGAR 178
Query: 858 EGRVSANGDVYSFGIMLME 876
V D++S G + E
Sbjct: 179 HYGVGV--DMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 690 IGRGGFGSVYKASL---GDGMEVAVKVFTSQCGRAFK-SFDVECEIMKSIRHRNLIKVIS 745
+G G FG V K ++VA+KV ++ ++ + E EIM + + ++++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
C E LV+E G L K+L + + + +M V+ ++YL +H
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IGYMAPEYGREGRVSA 863
DL NVLL + A +SDF ++K L G D S + ++ + + APE + S+
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 864 NGDVYSFGIMLMETFT-GKKP 883
DV+S+GI + E F+ G+KP
Sbjct: 178 RSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 65/244 (26%), Positives = 100/244 (40%), Gaps = 40/244 (16%)
Query: 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQ---CGRAFKSFDVECEIMKSIRHRNLIKVIS 745
+G GGFG V + A+K + + E EI++ H ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
+ ++++ +++EY G L L + D + + V A EYLH + +I+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIY 116
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE------YGRE 858
DLKP N+LLD N L DF AK L +S +T T T Y+APE Y
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPEIILNKGYDF- 171
Query: 859 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918
S D +S GI+L E TG+ P F + D P+ + L
Sbjct: 172 ---SV--DYWSLGILLYELLTGRPP----FGED--------DEDPMEIYNDI---LKGNG 211
Query: 919 DIHF 922
+ F
Sbjct: 212 KLEF 215
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 68/313 (21%), Positives = 124/313 (39%), Gaps = 57/313 (18%)
Query: 670 RMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCG---RAFKSFD 726
F + LC A DG + + + L VAVKV + A + F
Sbjct: 16 GQFGEVHLCEA-DGLQDFSEKAFAENDNADAPVL-----VAVKVL--RPDASDNAREDFL 67
Query: 727 VECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------------- 770
E +I+ + N+ +++ C+ + +++EYM +G L ++L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 771 SSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830
S + + L + +AS + YL S +H DL N L+ N ++DF +++
Sbjct: 128 SFSTL------LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKPTDEIF 888
L D +Q + I +MA E G+ + DV++FG+ L E T ++P + +
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238
Query: 889 NGEMTLKHWVNDWLPISTMEVVDANLLSQED---IHFVAKEQCVSFVFNLAMECTMEFPK 945
+ V +E +A ++D I+ C ++ L +EC +
Sbjct: 239 D------QQV--------IE--NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEE 282
Query: 946 QRINAKEIVTKLL 958
R +EI L
Sbjct: 283 DRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-16
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 688 NLIGRGGFGSVYKASL---GDGMEVAVKVFTSQCGRA-FKSFDVECEIM-KSIRHRNLIK 742
++IG G FG V KA + G M+ A+K + + F E E++ K H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 787
++ +C + + L +EY PHG+L +L S + L Q L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
VA ++YL IH DL N+L+ +N VA ++DF +++ G++ + +T
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 848 IGYMAPEYGREGRVSANGDVYSFGIMLME 876
+ +MA E + N DV+S+G++L E
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 14/209 (6%)
Query: 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAF-KSFDVECEIMKSIRHRN 739
+ E + +G G GSV K L GM A+K T+ K E EI KS +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 740 LIKVISSCSNEEFK--ALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEY 794
++K + +E + +EY GSL+ K + + I V L Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
LH S +IH D+KPSN+LL L DF ++ L S+ T T T YMAPE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFT-GTSFYMAPE 173
Query: 855 YGREGRVSANGDVYSFGIMLMETFTGKKP 883
+ S DV+S G+ L+E + P
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 37/224 (16%)
Query: 689 LIGRGGFGSVY---KASLGDGMEVA-VKVFTSQCGR-------AFKSFDVECEIMKSIRH 737
LIG+G +G VY + G+ M V V++ + GR K+ E E +K + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDIFQRLNIMIDVASALE 793
N+++ + + EE+ ++ LEY+P GS L Y ++ F V L
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGLA 122
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM---LTGEDQSMIQTQTLATIGY 850
YLH S ++H DLK N+L+D + + +SDF I+K + DQ+M ++ +
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM---SMQGSVFW 176
Query: 851 MAPE----YGREGRVSANGDVYSFGIMLMETFTGKKP--TDEIF 888
MAPE Y + SA D++S G +++E F G++P +E
Sbjct: 177 MAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 690 IGRGGFGSVYKASLGDG---MEVAVKVFT-SQCGRA-FKSFDVECEIMKSIRHRNLIKVI 744
+G G FGSV + L ++VAVK + C R+ + F E MK H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 745 SSC----SNEEFKA--LVLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASALE 793
C +E + + ++L +M HG L +L S L + M D+AS +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
YL S IH DL N +L++NM ++DF ++K + D + ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 854 EYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912
E + + DV+SFG+ + E T G+ P + N E + D+L
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IYDYLR-------QG 230
Query: 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
N L Q C+ +++L C + PK R + + + +L K
Sbjct: 231 NRLKQ-------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 59/302 (19%)
Query: 690 IGRGGFGSVYKA-SLGDGME-------VAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRN 739
+G G FG V A ++G E VAVK+ S + E E+MK I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI----LDIFQRLNI 784
+I ++ +C+ + +++EY G+L +YL Y+ + L ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKK----PTDEIFNGEMTLKHWV 898
+ +MAPE + + DV+SFG++L E FT G P +E+F
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 253
Query: 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958
L +E C + ++ + +C P QR K++V L
Sbjct: 254 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297
Query: 959 KI 960
+I
Sbjct: 298 RI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 59/302 (19%)
Query: 690 IGRGGFGSVYKA-SLG-------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRN 739
+G G FG V A +LG + + VAVK+ + E E+MK I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD---IFQRL-NI 784
+I ++ +C+ + +++EY G+L +YL Y + D F+ L +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
VA +EYL S IH DL NVL+ +N V ++DF +A+ + D T
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKK----PTDEIFNGEMTLKHWV 898
+ +MAPE + + DV+SFG+++ E FT G P +E+F
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK--------- 250
Query: 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958
L +E C + ++ + +C P R K++V L
Sbjct: 251 ----------------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
Query: 959 KI 960
+I
Sbjct: 295 RI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 684 FSENNL-----IGRGGFGSVYKASLGD-GMEVAVKVFTSQC-GRAFKSFDVECE-IMKSI 735
F+ +L IGRG FG+V K G +AVK S + K ++ + +M+S
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 736 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA----SA 791
++K + E + +E M SL+K+ +L I+ +A A
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYM 851
L YL +IH D+KPSN+LLD N L DF I+ L S+ +T+ YM
Sbjct: 120 LNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYM 174
Query: 852 APEYGREGRVSANG--------DVYSFGIMLMETFTGKKPTDE 886
APE R+ + DV+S GI L E TGK P +
Sbjct: 175 APE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 12/207 (5%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCS 748
+G G FG V+ A+ +VAVK T + G + ++F E +MK+++H L+K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVK--TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGYSAPVIHCD 807
E ++ E+M GSL +L S Q L +ID ++ + E + F IH D
Sbjct: 72 KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEYGREGRVSANGD 866
L+ +N+L+ ++V ++DF +A+++ ED + I + APE G + D
Sbjct: 128 LRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 867 VYSFGIMLMETFT-GKKPTDEIFNGEM 892
V+SFGI+LME T G+ P + N E+
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 46/269 (17%)
Query: 633 LPLSTTFMIVVILLILRYRQRGKRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGR 692
LPL + + L L S+ ++ A S EL R N IG
Sbjct: 32 LPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGS 84
Query: 693 GGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFK-SFDVECEIMKSIRHRNLIKVISSC--- 747
G G+VYK G A+KV + E EI++ + H N++K C
Sbjct: 85 GAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDM 140
Query: 748 --SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
N E + L LE+M GSLE I D ++ + S + YLH ++H
Sbjct: 141 FDHNGEIQVL-LEFMDGGSLE-----GTHIADEQFLADVARQILSGIAYLH---RRHIVH 191
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ-TQTLATIGYMAPEYGREGRVSAN 864
D+KPSN+L++ ++DF ++++L Q+M ++ TI YM+PE R++ +
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILA---QTMDPCNSSVGTIAYMSPE-----RINTD 243
Query: 865 ----------GDVYSFGIMLMETFTGKKP 883
GD++S G+ ++E + G+ P
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 28/205 (13%)
Query: 689 LIGRGGFGSVYKASLGD-GMEVAVKVF-TSQCGRAFKSFDV-ECEIMKSIRHRNLIKVIS 745
L+G G +G V K + G VA+K F S+ + K + E ++K +RH NL+ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 746 SCSNEEFKALVLEYMPH---GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
++ LV E++ H LEKY LD + + + +E+ H S
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCH---SHN 120
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-------Y 855
+IH D+KP N+L+ + V L DF A+ L + + T +AT Y APE Y
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKY 178
Query: 856 GREGRVSANGDVYSFGIMLMETFTG 880
GR D+++ G ++ E TG
Sbjct: 179 GRA------VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 39/285 (13%)
Query: 690 IGRGGFGSV----YKASLGD--GMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIK 742
+G G FG V Y GD G +VAVK + G E EI++++ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 743 VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
C+ + L++E++P GSL++YL + +++ Q+L + + ++YL S
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---S 127
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKML-TGEDQSMIQTQTLATIGYMAPEYGREG 859
+H DL NVL++ + DF + K + T ++ ++ + + + APE +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 860 RVSANGDVYSFGIMLMETFT----GKKPTDEIF------NGEMTLKHWVNDWLPISTMEV 909
+ DV+SFG+ L E T P +G+MT+ V
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR---------- 237
Query: 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIV 954
+ +E C V+ L +C P +R + ++
Sbjct: 238 -----VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 76/236 (32%), Positives = 107/236 (45%), Gaps = 35/236 (14%)
Query: 679 RATDGFSENNLIGRGGFGSVYKASLGD-GMEVAVK-VFTSQCGRAFKSFDV-ECEIMKSI 735
R D F IG G +G VYKA D G VA+K V F + E +I++ +
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 736 RHRNLIK----VISSCSNEEFKA------LVLEYMPH---GSLEKYL--YSSNCILDIFQ 780
HRN++ V +FK LV EYM H G LE L +S + I +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 781 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840
+L LE L++ + +H D+K SN+LL++ L+DF +A++ E+
Sbjct: 124 QL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 841 QTQTLATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 894
T + T+ Y PE G E R DV+S G +L E FT KKP IF L
Sbjct: 175 -TNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFT-KKP---IFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 68/253 (26%), Positives = 109/253 (43%), Gaps = 37/253 (14%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF----TSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
+G G G+VYKA L +AVKV T + + S E EI+ +I
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS---ELEILYKCDSPYIIGFY 65
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+ E ++ E+M GSL+ Y +L I + V L YL +S ++
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKIL 117
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSAN 864
H D+KPSN+L++ L DF ++ L I + T YMAPE + +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIH 173
Query: 865 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME--------VVDANLLS 916
DV+S GI ME G+ P +I + +L +P+ ++ V+ S
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQCIVDEDPPVLPVGQFS 226
Query: 917 QEDIHFVAKEQCV 929
++ +HF+ QC+
Sbjct: 227 EKFVHFIT--QCM 237
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 78/303 (25%), Positives = 126/303 (41%), Gaps = 61/303 (20%)
Query: 690 IGRGGFGSVYKASLGDGME---------VAVKVFTSQCG-RAFKSFDVECEIMKSI-RHR 738
+G G FG V +A G++ VAVK+ + E E+MK I +H+
Sbjct: 20 LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78
Query: 739 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-----NCILDI---------FQRL-N 783
N+I ++ C+ E +++EY G+L ++L + + DI F+ L +
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 784 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ 843
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D +
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 844 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKK----PTDEIFNGEMTLKHW 897
+ +MAPE + + DV+SFGI++ E FT G P +E+F
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK-------- 247
Query: 898 VNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
L +E C ++ L EC P QR K++V L
Sbjct: 248 -----------------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290
Query: 958 LKI 960
K+
Sbjct: 291 DKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR-----AFKSFDVECEIMKSIRHRNLIK 742
+IG+G FG VY +L D + R + F E IMK H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 743 VISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
++ C E LV L YM HG L ++ S + + + VA +EYL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IGYMAPEYGREG 859
+H DL N +LD++ ++DF +A+ + ++ + T A + +MA E +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 860 RVSANGDVYSFGIMLMETFTGKKP 883
+ + DV+SFG++L E T P
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 684 FSENNL-----IGRGGFGSVYKASL------GDGMEVAVKVFTSQCGRAFK-SFDVECEI 731
F NNL +G G FG V +A+ M+VAVK+ + + + E +I
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 732 MKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVA 789
M + H N++ ++ +C+ ++ EY +G L +L L + L+ VA
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 790 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG 849
+ +L S IH DL NVLL + + DF +A+ + + +++ +
Sbjct: 152 KGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 850 YMAPEYGREGRVSANGDVYSFGIMLMETFT 879
+MAPE + DV+S+GI+L E F+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 690 IGRGGFGSVYKASLGDGME-VAVKVFTSQCGRAFKSFDV-----ECEIMKSIRHRNLIKV 743
+G+GG+G V+ A D E VA+K FK +V E +I+ + + L+K+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSL--LFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGYSAP 802
+ + ++E+ L +EY+P G L + + + R M ++ A++ LH GY
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGY--- 122
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS 862
IH DLKP N L+D + L+DF ++K + S++ + YMAPE R
Sbjct: 123 -IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPD-----YMAPEVLRGKGYD 176
Query: 863 ANGDVYSFGIMLMETFTGKKP-----TDEIFNGEMTLKHW 897
D +S G ML E G P +E + LK+W
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 53/193 (27%), Positives = 101/193 (52%), Gaps = 11/193 (5%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVK-VFTSQCGRAFK-SFDVECEIMKSIRHRNLIKVIS 745
++GRG FG V+ D V +K + Q + + + EC+++K + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+ ++ +V+EY P G+L +Y+ N +LD L+ + + AL ++H + ++
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123
Query: 805 HCDLKPSNVLLDDN-MVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSA 863
H DLK N+LLD + MV + DF I+K+L+ + ++ + T Y++PE +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQ 180
Query: 864 NGDVYSFGIMLME 876
D+++ G +L E
Sbjct: 181 KSDIWALGCVLYE 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 40/234 (17%)
Query: 687 NNLIGRGGFGSVYKA-SLGDGMEVAVK---------------VFTSQCGRAFKSFDVECE 730
+G G +G V KA G VA+K CG F + E +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR-ELK 72
Query: 731 IMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 790
IM I+H N++ ++ +F LV++ M L+K + L Q I++ + +
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILN 130
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK-----MLTGEDQSMIQTQT- 844
L LH Y +H DL P+N+ ++ + ++DF +A+ + Q
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 845 ------LATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKK---PTDEI 887
+ T+ Y APE G E A D++S G + E TGK +EI
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAV-DMWSVGCIFAELLTGKPLFPGENEI 240
|
Length = 335 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 70/287 (24%), Positives = 123/287 (42%), Gaps = 32/287 (11%)
Query: 684 FSENNLIGRGGFGSVYKA---SLGDGME--VAVKVFTSQCG-RAFKSFDVECEIMKSIRH 737
F + ++G G FG+VYK G+ ++ VA+K +A K E +M S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
++H DL NVL+ ++DF +AK+L +++ I +MA E
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 858 EGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916
+ DV+S+G+ + E T G KP D I E++ S +E L
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SILE--KGERLP 231
Query: 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI-RD 962
Q I C V+ + ++C M R +E++ + K+ RD
Sbjct: 232 QPPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 33/214 (15%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
F+ IG+G FG VYKA VA+KV + ++E +I + I +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIE-DIQQEI------Q 51
Query: 743 VISSCSN-----------EEFK-ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 790
+S C + + K +++EY GS L LD I+ +V
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLL 109
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIG 849
LEYLH IH D+K +N+LL + L+DF ++ LT +M + T T
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT---STMSKRNTFVGTPF 163
Query: 850 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
+MAPE ++ D++S GI +E G+ P
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 52/183 (28%), Positives = 95/183 (51%), Gaps = 15/183 (8%)
Query: 709 VAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 767
VAVK+ + + A F E +IM +++ N+I+++ C +++ ++ EYM +G L +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 768 YL-----YS----SNCI--LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 816
+L S +N I + I L + + +AS ++YL S +H DL N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVG 163
Query: 817 DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLME 876
++ ++DF +++ L D IQ + + I +MA E G+ + DV++FG+ L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 877 TFT 879
FT
Sbjct: 224 MFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 41/221 (18%)
Query: 689 LIGRGGFGSVYKASLGD-GMEVAVKV--FTSQCGRAFKSFD-VECEI--MKSIRHRNLIK 742
L+GRG FG VY D G E+AVK F K + +ECEI +K++RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 743 VISSCSNEEFKALVL--EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
+ E K L + EYMP GS++ L + + + R + + YLH S
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG---------YM 851
++H D+K +N+L D L DF +K IQT ++ G +M
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASK--------RIQTICMSGTGIKSVTGTPYWM 176
Query: 852 APE------YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 886
+PE YGR+ DV+S ++E T K P E
Sbjct: 177 SPEVISGEGYGRK------ADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 689 LIGRGGFGSVYKASLGD-GMEVAVKVF-TSQCGRAFKSFDV-ECEIMKSIRHRNLIKVIS 745
++G G +G V K G VA+K F S+ K + E ++++ +RH N++ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
+ + LV EY+ LE L +S L + + + A+ Y H S +IH
Sbjct: 68 AFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-------YGRE 858
D+KP N+L+ ++ V L DF A+ L S + T +AT Y APE YG+
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLVGDTNYGKP 182
Query: 859 GRVSANGDVYSFGIMLMETFTG 880
DV++ G ++ E G
Sbjct: 183 ------VDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-14
Identities = 79/302 (26%), Positives = 127/302 (42%), Gaps = 59/302 (19%)
Query: 690 IGRGGFGSVYKA-SLG-------DGMEVAVKVFTSQ-CGRAFKSFDVECEIMKSI-RHRN 739
+G G FG V A ++G + VAVK+ + E E+MK I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YS-SNCILD----IFQRL-NI 784
+I ++ +C+ + +++EY G+L +YL YS C L F+ L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKK-----PTDEIFNGEMTLKHWV 898
+ +MAPE + + DV+SFG++L E FT G P +E+F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK--------- 247
Query: 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958
L +E C ++ + EC P QR K++V L
Sbjct: 248 ----------------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291
Query: 959 KI 960
++
Sbjct: 292 RV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVK---VFTSQCGRAFKSFDVECEIMKSIRHRN 739
F IGRG F VY+A+ L DG+ VA+K +F +A E +++K + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLH 796
+IK +S + +VLE G L K+ ++ + + SALE++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYG 856
S V+H D+KP+NV + V L D + + + ++ + T YM+PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERI 178
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKP 883
E + D++S G +L E + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 67/302 (22%), Positives = 124/302 (41%), Gaps = 54/302 (17%)
Query: 690 IGRGGFGSVYKAS------LGDGMEVAVKVFTSQCGRA-FKSFDVECEIMKSIRHRNLIK 742
+G G FG V KA+ VAVK+ + + E ++K + H ++IK
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----------------------LDIF 779
+ +CS + L++EY +GSL +L S + L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 780 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839
++ ++ ++YL ++H DL NVL+ + +SDF +++ + ED +
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWV 898
+++ + +MA E + + DV+SFG++L E T G P + G + +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP----YPGIAPERLF- 239
Query: 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958
NLL + E C ++NL + C + P +R +I +L
Sbjct: 240 --------------NLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
Query: 959 KI 960
K+
Sbjct: 285 KM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-14
Identities = 51/188 (27%), Positives = 88/188 (46%), Gaps = 16/188 (8%)
Query: 706 GMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-FKALVLEYMP 761
G EVA+K+ + F E + + H N++ ++ S V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDN 818
+L + L +++ L + +M+ V AL H + ++H DLKP N+++
Sbjct: 63 GRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118
Query: 819 MVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IG---YMAPEYGREGRVSANGDVYSFGIM 873
A + DF I +L G + + T T T +G Y APE R V+ N D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 874 LMETFTGK 881
+E TG+
Sbjct: 179 FLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 39/211 (18%)
Query: 690 IGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFD---VECEIMKSIRHRNLIKVIS 745
+G G FG V + A+K+ + K + E I++SIRH L+ +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYLHFGY 799
S ++ LV+EY+P G L +L S R + V ALEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLALEYLH--- 118
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE---- 854
S +++ DLKP N+LLD + ++DF AK + G +T TL T Y+APE
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLAPEIILS 172
Query: 855 --YGREGRVSANGDVYSFGIMLMETFTGKKP 883
YG+ + D ++ GI++ E G P
Sbjct: 173 KGYGK----AV--DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 678 CRATDGFSENNLIGRGGFGSVYKASLGDGMEVA----VKVFTSQCGRAFKSFDVECEIMK 733
CR+ F + N IG G +G VY+A E+ V++ + G S E ++
Sbjct: 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61
Query: 734 SIRHRNLIK----VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 789
++RH N+++ V+ + F LV+EY L L + Q +M+ +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 790 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG 849
L+YLH + +IH DLK SN+LL D ++DF +A+ + M T + T+
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLW 173
Query: 850 YMAPE--YGREGRVSANGDVYSFGIMLMETFTGK 881
Y APE G +A D+++ G +L E K
Sbjct: 174 YRAPELLLGCTTYTTAI-DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 72/284 (25%), Positives = 120/284 (42%), Gaps = 38/284 (13%)
Query: 690 IGRGGFGSVYKASLGDGME------VAVK-VFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
+G+G FG VY+ + D ++ VAVK V S R F E +MK ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYS-----SNCILDIFQRLNIMI----DVASALE 793
++ S + +V+E M HG L+ YL S N L MI ++A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
YL+ + +H DL N ++ + + DF + + + D + L + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 854 EYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913
E ++G + + D++SFG++L E + + + + E LK V+D
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 238
Query: 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
L Q + C V +L C PK R EIV L
Sbjct: 239 YLDQ-------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IG+G G+VY A + G EVA++ Q + E +M+ ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
+ +V+EY+ GSL + + C +D Q + + ALE+LH S VIH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
K N+LL + L+DF +T E ++ + T +MAPE D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 869 SFGIMLMETFTGKKP 883
S GIM +E G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISS-- 746
IG+G G+V+ A + G EVA+K Q + E +MK +++ N++ + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
+E F +V+EY+ GSL + + C +D Q + + ALE+LH + VIH
Sbjct: 87 VGDELF--VVMEYLAGGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLH---ANQVIHR 139
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGD 866
D+K NVLL + L+DF +T E ++ + T +MAPE D
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 867 VYSFGIMLMETFTGKKP 883
++S GIM +E G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 11/199 (5%)
Query: 690 IGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRAFKSFD---VECEIMKSIRHRNLIKVIS 745
+G+GGFG V + G A K + + K E +I++ + R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+ ++ LV+ M G L+ ++Y+ + + + LE+LH ++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSAN 864
+ DLKP NVLLDD+ +SD +A L G + T GYMAPE + +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---KGRAGTPGYMAPEVLQGEVYDFS 174
Query: 865 GDVYSFGIMLMETFTGKKP 883
D ++ G L E G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 42/111 (37%), Positives = 56/111 (50%), Gaps = 19/111 (17%)
Query: 784 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ 843
I + + ALEYLH S VIH D+KPSNVL++ N L DF I+ L S+ +T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162
Query: 844 TLATIGYMAPEYGREGRVSANG---------DVYSFGIMLMETFTGKKPTD 885
YMAPE R++ DV+S GI ++E TG+ P D
Sbjct: 163 DAGCKPYMAPE-----RINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK---VFTSQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
IGRG F VY+A+ L D VA+K +F +A + E +++K + H N+IK +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 746 SCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
S + +VLE G L KY ++ + + SA+E++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS 862
V+H D+KP+NV + V L D + + + + + + T YM+PE E +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN 184
Query: 863 ANGDVYSFGIMLMETFTGKKP 883
D++S G +L E + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 45/218 (20%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKV---FTSQ--CGRAFKSFDVECEIMKSIRHRNLI 741
+ IG G +G V A G++VA+K F Q C R + E +I++ +H N+I
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENII 66
Query: 742 K---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD-----IFQRLNIMIDVASA 791
+I S E F +V E M L K + + + D ++Q L
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILR-------G 118
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT-GEDQSMIQTQTLATIGY 850
L+Y+H SA V+H DLKPSN+LL+ N + DF +A++ D + T+ +AT Y
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 851 MAPE-------YGREGRVSANGDVYSFGIMLMETFTGK 881
APE Y + D++S G +L E + +
Sbjct: 176 RAPEIMLNSKGY------TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 27/200 (13%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDV----ECEIMKSIRHRNLIKVI 744
IG G G V+KA G VA+K R E + +++ +H ++K++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVAL--RRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 745 ------SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 798
S LV+EYMP L + L L Q + M + + Y+H
Sbjct: 66 DVFPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH-- 116
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--YG 856
+ ++H DLKP+N+L+ + V ++DF +A++ + E+ + + +AT Y APE YG
Sbjct: 117 -ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLYSHQVATRWYRAPELLYG 174
Query: 857 REGRVSANGDVYSFGIMLME 876
+ D+++ G + E
Sbjct: 175 AR-KYDPGVDLWAVGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 690 IGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
+G G FG VYKA + G A KV ++ + + VE EI+ + H ++K++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDI-FQRLNIMIDVASALEYLHFGYSAPVIHCD 807
+ +++E+ P G+++ + LD I + LE L + +S +IH D
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRD 135
Query: 808 LKPSNVLLDDNMVAHLSDFSIA----KMLTGEDQSMIQTQTLATIGYMAPEY-----GRE 858
LK NVLL + L+DF ++ K L D S I T +MAPE ++
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD-SFIGTPY-----WMAPEVVMCETMKD 189
Query: 859 GRVSANGDVYSFGIMLMETFTGKKPTDEI 887
D++S GI L+E + P E+
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 19/109 (17%)
Query: 784 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ 843
+ + + AL YL + VIH D+KPSN+LLD + L DF I+ L S +T+
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173
Query: 844 TLATIGYMAPEYGREGRVSAN---------GDVYSFGIMLMETFTGKKP 883
+ YMAPE R+ DV+S GI L+E TG+ P
Sbjct: 174 SAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 690 IGRGGFGSVY----KASLGDGMEVAVKVFT---SQCGRAFKSFDVECEIMKSIRHRNLIK 742
+G+G FG VY K + D E V + T + R F E +MK ++++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYS---------SNCILDIFQRLNIMIDVASALE 793
++ S + +++E M G L+ YL S + + + + ++A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
YL+ + +H DL N ++ ++ + DF + + + D + L + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 854 EYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913
E ++G + DV+SFG++L E T + + + E L+ V++
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------------VMEGG 238
Query: 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
LL + D C +F L C PK R + EI++ +
Sbjct: 239 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 690 IGRGGFGSVYKASLGDGME------------------VAVKVFTSQCGR-AFKSFDVECE 730
+G G FG V+ +GME VAVK+ + A F E +
Sbjct: 13 LGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 731 IMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQR 781
IM ++ N+I++++ C + ++ EYM +G L ++L ++ + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 782 LNIM-IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840
L M +AS ++YL S +H DL N L+ N ++DF +++ L D I
Sbjct: 132 LIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 879
Q + + I +M+ E G+ + DV++FG+ L E T
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH-RNLIK 742
F++ IG+G FG V+K +V A K D+E E I + I
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVV----------AIKIIDLE-EAEDEIEDIQQEIT 54
Query: 743 VISSCSNEEFKA------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 790
V+S C + +++EY+ GS L + D FQ ++ ++
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILK 112
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
L+YLH S IH D+K +NVLL + L+DF +A LT D + + + T +
Sbjct: 113 GLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFW 167
Query: 851 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEI 887
MAPE ++ + D++S GI +E G+ P ++
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IG+G G+VY A + G EVA+K Q + E +M+ ++ N++ + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
+ +V+EY+ GSL + + C +D Q + + AL++LH S VIH D+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
K N+LL + L+DF +T E ++ + T +MAPE D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 869 SFGIMLMETFTGKKP 883
S GIM +E G+ P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 689 LIGRGGFGSVYKASLGDGME-VAVKVFT-SQCGRAFKSFDV--ECEIMKSIRHRNLIKVI 744
+G G FG V+ A+KV + R + V E ++K + H +I++
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+ ++ F +++EY+P G L YL +S + ++ ALEYLH S ++
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SKEIV 123
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE-YGREGRVS 862
+ DLKP N+LLD L+DF AK L +T TL T Y+APE +G
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAPEVIQSKGHNK 177
Query: 863 ANGDVYSFGIMLMETFTGKKP 883
A D ++ GI++ E G P
Sbjct: 178 AV-DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEV-AVKVFT-SQCGRAFKSFDVECEIMKSIRHRNLI 741
F++ IG+G FG V+K +V A+K+ + + E ++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
K S + +++EY+ GS L LD Q I+ ++ L+YLH S
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
IH D+K +NVLL ++ L+DF +A LT D + + + T +MAPE ++
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEI 887
+ D++S GI +E G+ P E+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 57/194 (29%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IG G +G VYKA ++ G A+KV + G F E +MK +H N++ S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
+ + +E+ GSL+ +Y L Q + + L YLH S +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLT---GEDQSMIQTQTLATIGYMAPEYG---REGRVS 862
K +N+LL DN L+DF ++ +T + +S I T +MAPE R+G +
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPY-----WMAPEVAAVERKGGYN 187
Query: 863 ANGDVYSFGIMLME 876
D+++ GI +E
Sbjct: 188 QLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 684 FSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDV---ECEIMKSIRHRN 739
F + ++G+GGFG V + G A K + + K + E +I++ + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFG 798
++ + + ++ LVL M G L+ ++Y + + + ++ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
+++ DLKP N+LLDD+ +SD +A + E Q++ + T+GYMAPE +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTI--KGRVGTVGYMAPEVVKN 175
Query: 859 GRVSANGDVYSFGIMLMETFTGKKP 883
R + + D ++ G +L E G+ P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-12
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVF-----TSQCGRAFKSFDVECEIMKSIRHRNLIK 742
L+G+G FG VY + G E+A K + + + + + E +++K+++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 743 VISSCSNEEFKALV--LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
+ K L +EYMP GS++ L + + + R + + YLH S
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY-MAPE----- 854
++H D+K +N+L D L DF +K L S +++ Y M+PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 855 -YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 886
YGR+ DV+S G ++E T K P E
Sbjct: 185 GYGRK------ADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 689 LIGRGGFGSVYKASLG----DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743
++G G FG + + L + VA+ + C + + F E + H N++++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAP 802
+ +V EYM +G+L+ +L L Q + ++ +AS ++YL GY
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL---ATIGYMAPEYGREG 859
+H L VL++ ++V +S F + ED+S T+ + + + APE +
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 860 RVSANGDVYSFGIMLMETFT-GKKP 883
S+ DV+SFGI++ E + G++P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 690 IGRGGFGSVYKASLGDGM---EVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVIS 745
IG G FG V + G +V VK + F E + +S++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGY 799
C+ LV+E+ P G L+ YL S QR+ ++A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLH--- 117
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE- 858
IH DL N LL ++ + D+ ++ ED + Q + ++APE E
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 859 -GRV-----SANGDVYSFGIMLMETFT-GKKP 883
G + + +V+S G+ + E F G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 109/405 (26%), Positives = 166/405 (40%), Gaps = 35/405 (8%)
Query: 77 LNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTF 136
+ S N + S ++ QS+NL+F S + + + +
Sbjct: 9 KSALSSNTLREVLSSNTYHTTPQSINLNF------PDSNLESVAVNRLALNLSSNTLLLL 62
Query: 137 PSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI 196
PS +S SL L S + + LP L+L N ++
Sbjct: 63 PSSLSRLLSLDLLSPSGISSLDGSENLLNLL------PLPSLDLN----LNRLRSNISEL 112
Query: 197 GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSL 256
L NL LD+ +N + I P+ S LK L L DN + S + LPNL+ L L
Sbjct: 113 LELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRN--LPNLKNLDL 170
Query: 257 WGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQEL 316
N+ S +P+ + N S L+ LDL GN S +P L L L LS+N +
Sbjct: 171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNN------SII 222
Query: 317 SFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLT 376
LSSLSN K L +LS N L ++GNLS +LE +SN IS + +LT
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKL--EDLPESIGNLS-NLETLDLSNNQIS--SISSLGSLT 277
Query: 377 NLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKL 436
NLR + L GN L+ + L ++ L L +L L ++ + ++ + +G
Sbjct: 278 NLRELDLSGNSLS-NALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE-- 334
Query: 437 SGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSN 481
S P S L SL + N L L + +K+ + +
Sbjct: 335 -TSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGSLLD 378
|
Length = 394 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 690 IGRGGFGSVYKA---SLGDGMEVAVKVFTSQCGRAFKSFDV--ECEIMKSIRHRNLIKVI 744
+G G FG+V K VAVK+ + ++ E +M+ + + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
C E + LV+E G L K+L + + + ++ V+ ++YL +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNFV 117
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IGYMAPEYGREGRVS 862
H DL NVLL A +SDF ++K L G D++ + +T + + APE + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 863 ANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 893
+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 28/181 (15%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV---------ECEIMKSIRHRN 739
IG G +G V A G +VA+K + +FDV E +I++ +H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 740 L--IKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 795
+ I+ I +FK +V++ M L ++S + + R + + L+Y+
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYI 123
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG--EDQSMIQTQTLATIGYMAP 853
H SA VIH DLKPSN+L++++ + DF +A+ L+ + T+ +AT Y AP
Sbjct: 124 H---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 854 E 854
E
Sbjct: 181 E 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 26/204 (12%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKV--FTSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
IG G G V A+ G +VAVK Q R F+ E IM+ +H N++++ SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL-LFN-EVVIMRDYQHPNIVEMYSS 84
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
+ +V+E++ G+L + + ++ Q + + V AL +LH + VIH
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHR 139
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY-MAPE------YGREG 859
D+K ++LL + LSDF ++ E + + ++L Y MAPE YG E
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPYGTE- 195
Query: 860 RVSANGDVYSFGIMLMETFTGKKP 883
D++S GIM++E G+ P
Sbjct: 196 -----VDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
+G G +G VYKA +L G AVK+ + G F E ++K +H N++ S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
+ E + +EY GSL+ +Y L Q + + L YLH S +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-LATIGYMAPEYGREGRVSANG-- 865
K +N+LL DN L+DF +A +T ++ + ++ + T +MAPE V NG
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIGTPYWMAPEV---AAVEKNGGY 186
Query: 866 ----DVYSFGIMLME 876
D+++ GI +E
Sbjct: 187 NQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 80/298 (26%), Positives = 132/298 (44%), Gaps = 64/298 (21%)
Query: 690 IGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRAFKS-FDV-----ECEIMKSIRHRNLIK 742
IGRG +G V A + +VA+K + AF + D E ++++ + H N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK----KIANAFDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 743 ---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD------IFQRLNIMIDVASA 791
++ E F +V E M L + + SS + D ++Q L
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR-------G 120
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYM 851
L+Y+H SA V+H DLKPSN+LL+ N + DF +A+ + + M T+ + T Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYR 175
Query: 852 APE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 904
APE Y DV+S G + E G+KP +F G K +V+ I
Sbjct: 176 APELLLNCSEYT------TAIDVWSVGCIFAELL-GRKP---LFPG----KDYVHQLKLI 221
Query: 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLA----MECTMEFPKQRINAKEIVTKLL 958
E++ + S+ED+ F+ E+ ++ +L FP A +++ K+L
Sbjct: 222 --TELLGSP--SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKML 275
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 53/220 (24%)
Query: 688 NLIGRGGFGSVYKASL-GDGMEVAVKV----FTS--QCGRAFKSFDVECEIMKSIRHRNL 740
+ +G G +G V A G +VA+K F S R ++ E ++K + H N+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHENV 76
Query: 741 IKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDV 788
I ++ + S E+F+ LV M L + Q+L+ ++ +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQI 127
Query: 789 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI 848
L+Y+H SA +IH DLKPSN+ ++++ + DF +A+ D M T +AT
Sbjct: 128 LRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEM--TGYVATR 179
Query: 849 GYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGK 881
Y APE Y + D++S G ++ E TGK
Sbjct: 180 WYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-12
Identities = 31/74 (41%), Positives = 43/74 (58%)
Query: 388 LNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNL 447
L G I +SKL+ LQ + L N + G+IP + ++ L LDL N +GSIP L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 448 TSLRIVSLGSNELT 461
TSLRI++L N L+
Sbjct: 490 TSLRILNLNGNSLS 503
|
Length = 623 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 7e-12
Identities = 74/234 (31%), Positives = 112/234 (47%), Gaps = 58/234 (24%)
Query: 690 IGRGGFGSVYKASLGD---GMEVAVK-VF-------TSQCGRAFKSFDVECEIM--KSIR 736
+G+G +G V+KA D VA+K +F +Q R F+ EIM + +
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQ--RTFR------EIMFLQELG 64
Query: 737 -HRNLIKVISSCSNEEFKA-------LVLEYMP---HGSLEKYLYSSNCILDIFQRLNIM 785
H N++K+++ KA LV EYM H + N + D+ +R IM
Sbjct: 65 DHPNIVKLLNV-----IKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY-IM 113
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT---GEDQSMIQT 842
+ AL+Y+H S VIH DLKPSN+LL+ + L+DF +A+ L+ ++ + T
Sbjct: 114 YQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 843 QTLATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 894
+AT Y APE G R + D++S G +L E GK +F G TL
Sbjct: 171 DYVATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGKP----LFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 69/236 (29%), Positives = 104/236 (44%), Gaps = 49/236 (20%)
Query: 689 LIGRGGFGSVYKASLGDG--------MEVAVK--VFTSQCGRAFKSFDVECEIMKSIRHR 738
++G+GG+G V++ G M+V K + +Q A E I+++++H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVKHP 60
Query: 739 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI-MIDVAS------- 790
++ +I + L+LEY+ G L +L +R I M D A
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYLSEIS 110
Query: 791 -ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATI 848
ALE+LH +I+ DLKP N+LLD L+DF + K E T T TI
Sbjct: 111 LALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT---VTHTFCGTI 164
Query: 849 GYMAPE-YGREGRVSANGDVYSFGIMLMETFTG---------KKPTDEIFNGEMTL 894
YMAPE R G A D +S G ++ + TG KK D+I G++ L
Sbjct: 165 EYMAPEILMRSGHGKAV-DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 22/229 (9%)
Query: 682 DGFSENNLIGRGGFGSVYKASLGDGM-----EVAVKVFT---SQCGRAFKSFDVECEIMK 733
D + ++L+ G FG ++ L D EV VK S+ E ++
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL--LLQESCLLY 63
Query: 734 SIRHRNLIKVISSCSNEEFKALVLE-YMPHGSLEKYLYSSNCI-------LDIFQRLNIM 785
+ H+N++ ++ C + VL YM G+L+ +L L Q +++
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
I +A + YLH VIH D+ N ++D+ + ++D ++++ L D +
Sbjct: 124 IQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 893
+ +MA E S+ DV+SFG++L E T G+ P EI EM
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 31/291 (10%)
Query: 684 FSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDV---ECEIMKSIRHRN 739
F + ++G+GGFG V + G A K + + K + E +I++ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFG 798
++ + + ++ LVL M G L+ ++Y+ N + + L ++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA-KMLTGEDQSMIQTQTLATIGYMAPEYGR 857
++ DLKP N+LLDD +SD +A K+ GE I+ + + T+GYMAPE
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGR-VGTVGYMAPEVLN 174
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917
R + + D + G ++ E G+ P F G K V E VD +L
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP----FRGR---KEKVK-------REEVDRRVLET 220
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968
E+++ + + + + + PKQR+ +E +K R RN+
Sbjct: 221 EEVYSAKFSEEAKSICKMLL---TKDPKQRLGCQEEGAGEVK-RHPFFRNM 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 61/209 (29%), Positives = 87/209 (41%), Gaps = 38/209 (18%)
Query: 690 IGRGGFGSVYKASLGD-GMEVAVKVFT-SQCGRAFKSFDV-ECEIMKSIRHRNLIKVISS 746
IG G +G V+K + G VA+K F S+ K + E ++K ++H NL+ +I
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI-- 66
Query: 747 CSNEEFKA-----LVLEYMPH---GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 798
E F+ LV EY H LEK + I+ A+ + H
Sbjct: 67 ---EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNFCH-- 117
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE---- 854
IH D+KP N+L+ L DF A++LTG T +AT Y APE
Sbjct: 118 -KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVG 174
Query: 855 ---YGREGRVSANGDVYSFGIMLMETFTG 880
YG DV++ G + E TG
Sbjct: 175 DTQYG------PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 690 IGRGGFGS--VYKASLGDGMEVAVKVFTSQCGRAFKSFDV--ECEIMKSIRHRNLIKVIS 745
+G+G FG +Y+ + D + V +V ++ + D E I+ ++H N+I +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-ERRDALNEIVILSLLQHPNIIAYYN 66
Query: 746 SCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
++ + +EY G+L +K + + + L + + SA+ Y+H A ++
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSAN 864
H D+K N+ L + L DF I+K+L G + SM +T + T YM+PE + + +
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181
Query: 865 GDVYSFGIMLMETFTGKK 882
D+++ G +L E T K+
Sbjct: 182 SDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 67/224 (29%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIM-------KSIRHRNLI 741
IG+G FG V A DG AVKV + K + IM K+++H L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE---QKHIMAERNVLLKNVKHPFLV 59
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ S + VL+Y+ G L +L + R ++ASAL YLH S
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SL 115
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
+I+ DLKP N+LLD L+DF + K G + S + T Y+APE R+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 862 SANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKH 896
D + G +L E G P D I N + LK
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 28/231 (12%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKS------FDVECEIMKSIRHRNLIKV 743
IG G FG V GM A +V + RA + F E + + + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKA-RVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL------DIFQRLNIMIDVASALEYLHF 797
+ C LVLE+ P G L+ YL S+ ++ D+ QR+ +VAS L +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH- 117
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
A IH DL N L ++ + D+ +A ED + + + ++APE
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 858 E-------GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900
+ +++S G+ + E FT +P ++ + E LK V +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 689 LIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFD-VECE---IMKSIRHRNLIKV 743
+IG+G FG V A DG AVKV + K + + E ++K+++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
S E VL+Y+ G L +L C L+ R +VASA+ YLH S +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SLNI 117
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSA 863
I+ DLKP N+LLD L+DF + K G + + T Y+APE R+
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 864 NGDVYSFGIMLMETFTGKKP 883
D + G +L E G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 689 LIGRGGFGSVYKAS-LGDG----MEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIK 742
++G G FG+VYK + DG + VA+KV +A K E +M + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
++ C + LV + MP+G L Y+ + + LN + +A + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS 862
++H DL NVL+ ++DF +A++L ++ I +MA E R +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 863 ANGDVYSFGIMLMETFT-GKKPTDEI 887
DV+S+G+ + E T G KP D I
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 34/84 (40%), Positives = 49/84 (58%)
Query: 359 MSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPY 418
+ N + G IP +IS L +L++I L GN + G+I +L + L+ L L N GSIP
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 419 DICNLAELYRLDLDGNKLSGSIPA 442
+ L L L+L+GN LSG +PA
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 79/244 (32%), Positives = 115/244 (47%), Gaps = 7/244 (2%)
Query: 360 SNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD 419
+ N +P +S L +L + G + L L L L L N+L +I +
Sbjct: 54 LSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNIS-E 111
Query: 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFS 479
+ L L LDLD N ++ P ++L+ + L N++ S+P NL ++ NL+ S
Sbjct: 112 LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLS 171
Query: 480 SNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSF 539
N L+ LP + +L L +DLS N S +P EI L LE L L N + + +S
Sbjct: 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL 228
Query: 540 GDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEG 599
+L +L L LSNN L +P S+ LS LE L+LS NQ+ I GS N G
Sbjct: 229 SNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSG 286
Query: 600 NELL 603
N L
Sbjct: 287 NSLS 290
|
Length = 394 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 9/160 (5%)
Query: 728 ECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMI 786
E +IM R ++ + NE + +E+M GSL++ I ++I + I +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAV 110
Query: 787 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846
V L YL+ ++H D+KPSN+L++ L DF + +GE + I +
Sbjct: 111 AVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSIADTFVG 164
Query: 847 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 886
T YM+PE + G+ + DV+S GI ++E GK P
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 53/217 (24%), Positives = 90/217 (41%), Gaps = 23/217 (10%)
Query: 690 IGRGGFGSVY---KASLGDGMEVAVKVFTSQ---CGRAFKSFDVECEIMKSIRHR-NLIK 742
I +G FGSVY K S GD A+KV + E IM + K
Sbjct: 4 ISKGAFGSVYLAKKRSTGD--YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ S ++++ LV+EY+ G + + + + + + + +V +E LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRG 117
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS 862
+IH D+KP N+L+D L+DF +++ + + + T Y+APE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVGDD 171
Query: 863 ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 899
D +S G ++ E G P F+ E + N
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPP----FHAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 34/105 (32%), Positives = 60/105 (57%), Gaps = 4/105 (3%)
Query: 62 WTGVACEVHSQR----VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIF 117
W+G C+ S + + L + + L G IP+ + L LQS+NLS N + G+IP ++
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 118 TTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRA 162
+ +L+ + L N +G+ P + +SL+ L+L+ N+LSG + A
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 43/222 (19%)
Query: 689 LIGRGGFGSVYKASLGD-GMEVAVKVF-----TSQCGRAFKSFDVECEIMKSIRHRNLIK 742
L+G+G FG VY D G E+AVK + + + + + E +++K++ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 743 VISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFGY 799
+ E ++ +E+MP GS++ L S + + + ++ I LE + + +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG---------Y 850
S ++H D+K +N+L D L DF +K L QT L+ G +
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL--------QTICLSGTGMKSVTGTPYW 175
Query: 851 MAPE------YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 886
M+PE YGR+ D++S G ++E T K P E
Sbjct: 176 MSPEVISGEGYGRK------ADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 690 IGRGGFGSVYKASLGDGME-VAVKVFT---SQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
IG G FG+VY A E VA+K + Q ++ E ++ +RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81
Query: 746 SCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDI----FQRLNIMIDVASALEYLHFGYS 800
C E A LV+EY L S++ IL++ Q + I AL+ L + +S
Sbjct: 82 GCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY---GR 857
IH D+K N+LL + L+DF A +++ S + T +MAPE
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSASLVS-PANSFVGTPY-----WMAPEVILAMD 187
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 889
EG+ DV+S GI +E K P +FN
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP---LFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 31/209 (14%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFD--------------VECEIMKSI 735
+G+GGFG V AV+V + A K D +E EI++ +
Sbjct: 1 LGKGGFGEV----------CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV 50
Query: 736 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEY 794
++ + + ++ LV+ M G L+ ++Y+ L++ + ++ + + +
Sbjct: 51 NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
LH S +++ D+KP NVLLDD LSD +A L TQ T GYMAPE
Sbjct: 111 LH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPE 164
Query: 855 YGREGRVSANGDVYSFGIMLMETFTGKKP 883
+E S D ++ G + E G+ P
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 51/192 (26%), Positives = 95/192 (49%), Gaps = 22/192 (11%)
Query: 704 GDGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762
G + VAVK+ + A F E +I+ ++ N+I+++ C +E+ ++ EYM +
Sbjct: 44 GRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 763 GSLEKYLYS----------------SNCILDIFQR--LNIMIDVASALEYLHFGYSAPVI 804
G L ++L S ++C+ I L++ + +AS ++YL S +
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSAN 864
H DL N L+ +N+ ++DF +++ L D IQ + + I +MA E G+ +
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 865 GDVYSFGIMLME 876
DV++FG+ L E
Sbjct: 221 SDVWAFGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 54/228 (23%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVEC----EIMKSIR----HRNL 740
+G G FGSVY A + G VA+K + F S++ EC E+ KS+R H N+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREV-KSLRKLNEHPNI 60
Query: 741 IK---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL-------NIMIDVAS 790
+K V N+E V EYM E LY + D + +I+ +
Sbjct: 61 VKLKEVFRE--NDELY-FVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 791 ALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ-TQTLATI 848
L ++H G+ H DLKP N+L+ V ++DF +A+ E +S T ++T
Sbjct: 111 GLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTR 162
Query: 849 GYMAPE-YGREGRVSANGDVYSFGIMLMETFTGKKP-------TDEIF 888
Y APE R S+ D+++ G ++ E +T +P D+++
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTL-RPLFPGSSEIDQLY 209
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 52/288 (18%)
Query: 690 IGRGGFGSVYKASL---GDGMEVAVKVFTS-------QCGRAFKSFDVECEIMKSIRHRN 739
+G+G F ++YK L D V S R +F +M + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
L+K+ C +E +V EY+ G L+ +L+ + + +L++ +ASAL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118
Query: 800 SAPVIHCDLKPSNVLL---DDNM----VAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
++H ++ N+L+ N LSD I + ++ + I ++A
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIPWIA 172
Query: 853 PEYGREGRVS--ANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909
PE R G+ S D +SFG L+E + G++P + + E + LP+
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM----- 227
Query: 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
++ NL +C P +R + + I+ L
Sbjct: 228 -----PDCAEL------------ANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
F++ IG+G FG VYK EV A+K+ + + E EI + I+ I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--------EAEDEI-EDIQQE--IT 54
Query: 743 VISSCSNEEFKA------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 790
V+S C + +++EY+ GS L L+ I+ ++
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILK 112
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
L+YLH S IH D+K +NVLL + L+DF +A LT D + + + T +
Sbjct: 113 GLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFW 167
Query: 851 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEI 887
MAPE ++ D++S GI +E G+ P ++
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 37/192 (19%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVK---VFTSQCG------RAFKSFDVECEIMK 733
+ E IG G +G+VYKA L G VA+K V S+ G R E ++K
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-------EIALLK 53
Query: 734 SIR---HRNLIKVISSC----SNEEFK-ALVLEYMPHGSLEKYLYSSNCI---LDIFQRL 782
+ H N+++++ C ++ E K LV E++ L YL S C L
Sbjct: 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLPPETIK 110
Query: 783 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842
++M + +++LH S ++H DLKP N+L+ + ++DF +A++ + E M T
Sbjct: 111 DLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALT 164
Query: 843 QTLATIGYMAPE 854
+ T+ Y APE
Sbjct: 165 SVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 11/204 (5%)
Query: 690 IGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
+G G FG VYKA + G+ A KV ++ + + VE +I+ S H N++K++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
E +++E+ G+++ + L Q + AL YLH +IH DL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY-----GREGRVSA 863
K N+L + L+DF ++ T Q + + T +MAPE ++
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 187
Query: 864 NGDVYSFGIMLMETFTGKKPTDEI 887
DV+S GI L+E + P E+
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 71/303 (23%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFT--SQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
+G G + +VYK S +G VA+KV + ++ G F + E ++K ++H N++ +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 747 CSNEEFKALVLEYMPHGSLEKY-------LYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+E V EYM H L +Y L+ N L +FQ L L Y+H +
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQH 123
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP------ 853
++H DLKP N+L+ L+DF +A+ + Q+ + + T+ Y P
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY--SSEVVTLWYRPPDVLLGA 178
Query: 854 -EYGREGRVSANGDVYSFGIMLMETFTGKK---------------------PTDEIFNGE 891
+Y S+ D++ G + +E G+ PT++ + G
Sbjct: 179 TDY------SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232
Query: 892 MTLKHWVNDWLPISTMEV--VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN 949
L ++ +W + V LS+ +LA + M FPK RI+
Sbjct: 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSR-----------PPKAEDLASQMLMMFPKDRIS 281
Query: 950 AKE 952
A++
Sbjct: 282 AQD 284
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 8e-11
Identities = 71/256 (27%), Positives = 109/256 (42%), Gaps = 36/256 (14%)
Query: 689 LIGRGGFGSV-YKASLGDGMEVAVKVF----TSQCGRAFKSFDVEC-------EIMKSIR 736
++G G G+V + DG AVKV S+ + +V C I+K
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC-- 96
Query: 737 HRNLIKVISSCSNEE---FKALVLEYMPHGSLEKYLYSSNCILDIFQRLN---IMIDVAS 790
H + K N E ALVL+Y G L + + S F+ + I V
Sbjct: 97 HEDFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL 154
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
A+ ++H S +IH D+K +N+LL N + L DF +KM + T Y
Sbjct: 155 AVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 851 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTD-----EIFNGEMTLKHWVNDWLPIS 905
+APE R S D++S G++L E T K+P D E+ + + ++ D LP S
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY---DPLPPS 268
Query: 906 T---MEVVDANLLSQE 918
M+ + LLS +
Sbjct: 269 ISPEMQEIVTALLSSD 284
|
Length = 496 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVA---VKVFTSQCGRAFKSFDVECEIMKSIR---HRNLIK 742
IG G +G+VYKA G VA V+V T++ G + E ++K + H N+++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIVR 66
Query: 743 VISSC----SNEEFK-ALVLEYMPHGSLEKYL-------YSSNCILDIFQRLNIMIDVAS 790
++ C ++ E K LV E++ L YL + I D+ ++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF------LR 119
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
L++LH ++H DLKP N+L+ L+DF +A++ + + M T + T+ Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWY 173
Query: 851 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
APE + + D++S G + E F +KP
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-10
Identities = 92/333 (27%), Positives = 149/333 (44%), Gaps = 16/333 (4%)
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
L ++ + L N S T+ + S+L LDL S ++ NL L+ +
Sbjct: 42 LESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPS----GISSLDGSENLLNLLPLPS 97
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
+ + S +S L L DL N + I +G L +L+E +S+ N
Sbjct: 98 LDLNLNRLRSNISELLELTNLTSLDLDNNNITDI--PPLIGLLKSNLKELDLSD-NKIES 154
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427
+P + NL NL+ + L N L+ + LS L L +L L NK+ +P +I L+ L
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212
Query: 428 RLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSL 487
LDL N + + + SNL +L + L +N+L +P + NL ++ L+ S+N ++ S+
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SI 270
Query: 488 PLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKF 547
+GSL L +DLS N+ S +P L LE L L ++ L S+
Sbjct: 271 S-SLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL----LNLLLTLKALELKLNSILL 325
Query: 548 LNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
N +N P +L L L +L N L+
Sbjct: 326 NNNILSNGETSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEV-AVKVFT---SQCGRAFKSFDVECEIMKSIRHRN 739
F++ IG G FG+VY A EV A+K + Q ++ E + ++ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS----ALEYL 795
I+ E LV+EY L S++ +L++ ++ +++A+ AL+ L
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGL 138
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY 855
+ +S +IH D+K N+LL + L+DF A + + + + T +MAPE
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTPYWMAPEV 192
Query: 856 ---GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912
EG+ DV+S GI +E +KP N L H
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYH---------------- 235
Query: 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962
++Q + + + + N C + P+ R ++E++ + +R+
Sbjct: 236 --IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 41/229 (17%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTS-----QCGRAFKSFDVECEIMKSIRHRNLIK 742
+IGRG FG V+ D +V A+KV + A E +I+ ++K
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADSPWIVK 65
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGYSA 801
+ S +EE LV+EYMP G L L + + R I ++ AL+ +H G+
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF-- 122
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAK----------MLTGEDQSMIQTQTLA----- 846
IH D+KP N+L+D + L+DF + K L + + L
Sbjct: 123 --IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 847 ---------TIG---YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
T+G Y+APE R D +S G++L E G P
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKV--FTSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
IG G FG +Y A + D +K T + ++ E ++ ++H N++ +S
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 747 CSNEEFKALVLEYMPHGSLEK-------YLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+V+EY G L K L+S + IL F + ++ L+++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGLKHIH--- 118
Query: 800 SAPVIHCDLKPSNVLLDDN-MVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEYGR 857
++H D+K N+ L N MVA L DF IA+ L + SM T T Y++PE +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQ 175
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKP 883
+ D++S G +L E T K P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 21/192 (10%)
Query: 678 CRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV----ECEIM 732
C + + IG+G FG V+KA VA+K + F + E +I+
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKIL 65
Query: 733 KSIRHRNLIKVISSCSNE-----EFKA---LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 784
+ ++H N++ +I C + +K LV E+ H L L + N + + +
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV 124
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK--MLTGEDQSMIQT 842
M + + L Y+H ++H D+K +N+L+ + + L+DF +A+ L+ + T
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 843 QTLATIGYMAPE 854
+ T+ Y PE
Sbjct: 182 NRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-10
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 1/91 (1%)
Query: 405 LGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SI 463
LGL + L G IP DI L L ++L GN + G+IP ++TSL ++ L N SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 464 PLTFWNLKDILNLNFSSNFLTGSLPLEIGSL 494
P + L + LN + N L+G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 62/200 (31%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 689 LIGRGGFGSVYKASLG-DGMEVAVKVFTSQC---GRAFKSFDVECEIM-KSIRHRNLIKV 743
+IG+G FG V A DG AVKV + + K E ++ K+++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
S E VL+++ G L +L + R ++ASAL YLH S +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSA 863
++ DLKP N+LLD L+DF + K G QS T T Y+APE R+
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 864 NGDVYSFGIMLMETFTGKKP 883
D + G +L E G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 32/234 (13%)
Query: 684 FSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFD---VECEIMKSIRHRN 739
F +G G FG V A G G A+K + K E I+ + H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS----NCILDIFQRLNIMIDVASALEYL 795
++ ++ S +E +LE++ G L +L + N + + ++ A EYL
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE 854
H S +I+ DLKP N+LLD+ ++DF AK + +T TL T Y+APE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPE 185
Query: 855 YGREGRVSANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKHWVN 899
+ D ++ G++L E G P ++I G + +W +
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239
|
Length = 329 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 68/236 (28%), Positives = 93/236 (39%), Gaps = 54/236 (22%)
Query: 680 ATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-- 736
T F +IG G +G VYKA G VA+K+ D E EI +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-------EDEEEEIKEEYNIL 56
Query: 737 -----HRNL-------IKVISSCSNEEFKALVLEYMPHGS---LEKYLYSSNCILDIFQR 781
H N+ IK ++++ LV+E GS L K L +R
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSVTDLVKGLRKKG------KR 109
Query: 782 LN------IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835
L I+ + L YLH VIH D+K N+LL N L DF ++ L
Sbjct: 110 LKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--- 163
Query: 836 DQSMIQTQTLATIG---YMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKP 883
D ++ + T IG +MAPE + A DV+S GI +E GK P
Sbjct: 164 DSTLGRRNT--FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 44/217 (20%)
Query: 689 LIGRGGFGSVY---KASLGD-GMEVAVKVFTSQCGRAFKSFD-----VECEIMKSIRHRN 739
++G+G FG V+ K + D G A+KV K D +E +I+ + H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA---TLKVRDRVRTKMERDILAEVNHPF 59
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN--IMI----------D 787
++K+ + E L+L+++ G D+F RL+ +M +
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAE 106
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
+A AL++LH S +I+ DLKP N+LLD+ L+DF ++K D T
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 161
Query: 848 IGYMAPE-YGREGRVSANGDVYSFGIMLMETFTGKKP 883
+ YMAPE R G + + D +SFG+++ E TG P
Sbjct: 162 VEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 689 LIGRGGFGSVY---KASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
+IGRGGFG VY KA G K++ +C + + E + ++ R ++ ++S
Sbjct: 1 IIGRGGFGEVYGCRKADTG-------KMYAMKCLDKKRIKMKQGETL-ALNERIMLSLVS 52
Query: 746 S-------CSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 793
+ C F +L+ M G L +L + R ++ LE
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLE 111
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
++H + V++ DLKP+N+LLD++ +SD +A + + ++ T GYMAP
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAP 164
Query: 854 EYGREGRV-SANGDVYSFGIMLMETFTGKKP 883
E ++G ++ D +S G ML + G P
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFD---VECEIMKSIRHRNLIKVIS 745
+G+GGFG V + G A K + + K ++ VE I+ + R ++ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ + LV+ M G L ++Y+ N + + S LE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEYGREGRV 861
+I+ DLKP NVLLD++ +SD +A L + QS +T+ A T G+MAPE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELK-DGQS--KTKGYAGTPGFMAPELLQGEEY 174
Query: 862 SANGDVYSFGIMLMETFTGKKP 883
+ D ++ G+ L E + P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 38/221 (17%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVA----VKVFTSQCGRAFKSFDVECEIMK---SIRHRNLI 741
IG G +G V+KA L +G V+V T + G + E +++ + H N++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 742 KVISSCS----NEEFK-ALVLEYMPHGSLEKYL-------YSSNCILDIFQRLNIMIDVA 789
++ C+ + E K LV E++ L YL + I D+ M +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM------MFQLL 120
Query: 790 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG 849
L++LH S V+H DLKP N+L+ + L+DF +A++ + + M T + T+
Sbjct: 121 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLW 174
Query: 850 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 890
Y APE + + D++S G + E F +KP +F G
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRG 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 9e-10
Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 678 CRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVA---VKVFTSQCGRAFKSFDVECEIMK 733
CR+ D + + N I G +G VY+A G VA +K+ + G S E I+
Sbjct: 1 CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59
Query: 734 SIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 791
++H N++ V + SN + +V+EY+ H L+ + + + +M+ + S
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYM 851
+ +LH + ++H DLK SN+LL++ + + DF +A+ + TQ + T+ Y
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYR 173
Query: 852 APE--YGREGRVSANGDVYS----FGIMLMET--FTGKKPTDEI 887
APE G S D++S F +L + F GK D++
Sbjct: 174 APELLLG-AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 8/195 (4%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IG G G V A G +VAVK+ + + + E IM+ +H+N++++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
E +++E++ G+L + S L+ Q + V AL YLH S VIH D+
Sbjct: 89 VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
K ++LL + LSDF ++ + + + T +MAPE D++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 869 SFGIMLMETFTGKKP 883
S GIM++E G+ P
Sbjct: 202 SLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 689 LIGRGGFGSVY---KASLGD-----GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNL 740
++G G +G V+ K + D M+V K Q + + E +++ +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 741 IKVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEYLH 796
+ + E K L+L+Y+ G + +LY D F + ++ ALE+LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH 122
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPEY 855
+++ D+K N+LLD L+DF ++K E++ +T + TI YMAPE
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE--RTYSFCGTIEYMAPEI 177
Query: 856 --GREGRVSANGDVYSFGIMLMETFTGKKP 883
G+ G A D +S GI++ E TG P
Sbjct: 178 IRGKGGHGKAV-DWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 42/216 (19%)
Query: 689 LIGRGGFGSVY---KASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMK-----SIRHRNL 740
+IGRGGFG VY KA G K++ A K D + MK ++ R +
Sbjct: 1 IIGRGGFGEVYGCRKADTG-------KMY------AMKCLDKKRIKMKQGETLALNERIM 47
Query: 741 IKVISS-------CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 788
+ ++S+ C + F + +L+ M G L +L S + + + ++
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEI 106
Query: 789 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI 848
LE++H + V++ DLKP+N+LLD++ +SD +A + + ++ T
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTH 159
Query: 849 GYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKP 883
GYMAPE ++G ++ D +S G ML + G P
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVECEIMK------SIRHRNLI 741
++G+G FG V A L EV A+KV + DV+C + + + +H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDV--ILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ ++ V+EY+ G L + S + R +V AL +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
VI+ DLK N+LLD L+DF + K G + T T Y+APE +E
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 862 SANGDVYSFGIMLMETFTGKKP-----TDEIF 888
+ D ++ G+++ E G+ P D++F
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECE-----------IMKSIRH 737
IG G +G VYKA + G VA+K D E E ++K + H
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI---------RLDTETEGVPSTAIREISLLKELNH 58
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
N++K++ E LV E++ H L+K++ +S + I L I + L+ L F
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASP-LSGIPLPL-IKSYLFQLLQGLAF 115
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
+S V+H DLKP N+L++ L+DF +A+ ++ T + T+ Y APE
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILL 173
Query: 858 EGRV-SANGDVYSFGIMLMET------FTGKKPTDEIF 888
+ S D++S G + E F G D++F
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL 814
L+L+Y+ G L +LY + R+ I ++ AL++LH +I+ D+K N+L
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137
Query: 815 LDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG--DVYSFGI 872
LD L+DF ++K E++ + TI YMAPE R G + D +S G+
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196
Query: 873 MLMETFTGKKP 883
+ E TG P
Sbjct: 197 LTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 678 CRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVK---VFTSQCGRAFKSFDVECEIMK 733
C + +G G FG VYKA + G VA+K + + G + E +I+K
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62
Query: 734 SIRHRNLIK----VISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 785
++H N++ + + K +V YM H L L + + L Q M
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYM 121
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ---- 841
+ + + YLH ++H D+K +N+L+D+ + ++DF +A+ G +
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 842 -----TQTLATIGYMAPEY--GREGRVSANGDVYSFGIMLMETFTGK 881
T + T Y PE G E R + D++ G + E FT +
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 9/92 (9%)
Query: 130 NQ-LSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNL 188
NQ L G P+ IS LQ ++LS N++ G I P G++ LE++ L+ N+
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNI--------PPSLGSITSLEVLDLSYNSF 478
Query: 189 QGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAI 220
G IP +G L +L L++ N L G P A+
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 26/232 (11%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFT---SQCGRAFKSFDVECEIMKSIRHRN 739
FS+ IG G FG+VY A + + VA+K + Q ++ E ++ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI----FQRLNIMIDVASALEYL 795
I+ E LV+EY L S++ +L++ Q + I AL+ L
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY 855
+ +S +IH D+K N+LL + + L DF A ++ + + T +MAPE
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 182
Query: 856 ---GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 904
EG+ DV+S GI +E +KP N L H + P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALYHIAQNESPA 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 689 LIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMK------SIRHRNLI 741
++G+G FG V+ A L G A+K DVEC +++ + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDV--VLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ + +E V+EY+ G L ++ S + D+ + ++ L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SK 115
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI---QTQTL-ATIGYMAPEYGR 857
+++ DLK N+LLD + ++DF + K ++M+ +T T T Y+APE
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK------ENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKP 883
+ + + D +SFG++L E G+ P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 689 LIGRGGFGSVY---KASLGD-----GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNL 740
++G G +G V+ K S D M+V K Q + + E ++++ IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 741 IKVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI-DVASALEYLHFG 798
+ + + K L+L+Y+ G L +L + Q + I ++ ALE+LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH-- 122
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
+I+ D+K N+LLD N L+DF ++K ED+ TI YMAP+ R
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRG 180
Query: 859 GRVSANG--DVYSFGIMLMETFTGKKP 883
G + D +S G+++ E TG P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK----VFTS--QCGRAFKSFDVECEIMKSIRHRNLIK 742
IG G FG V+ + DG VA+K VF + C R F+ + C +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLC----FFKHDNVLS 63
Query: 743 VIS-------SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 795
+ E + V+ + L K + S + ++ + + L+YL
Sbjct: 64 ALDILQPPHIDPFEEIY---VVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYL 119
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE- 854
H SA ++H D+KP N+L++ N V + DF +A+ + D+S TQ + T Y APE
Sbjct: 120 H---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEI 175
Query: 855 -YGREGRVSANGDVYSFGIMLMETFTGK 881
G SA D++S G + E +
Sbjct: 176 LMGSRHYTSAV-DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVF------TSQCGRAFKSFDVECEIMK 733
T+ + + +G G FG V A G VA+K R ++ E +++K
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR----ELKLLK 64
Query: 734 SIRHRNLIKVISS-CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 792
+RH N+I + S E V E + G+ L +S + F + + + L
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQY-FLYQILRGL 121
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
+Y+H SA V+H DLKPSN+L+++N + DF +A++ +D M T ++T Y A
Sbjct: 122 KYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM--TGYVSTRYYRA 173
Query: 853 PE-------YGREGRVSANGDVYSFGIMLMETFTGK 881
PE Y E D++S G + E GK
Sbjct: 174 PEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 684 FSENNLIGRGGFGSV----YKASLGDGMEVAVKVFTSQCGRAFKSFDV---ECEIMKSIR 736
F ++G+GGFG V +A+ G A K + + K + E +I++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 58
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYL 795
R ++ + + ++ LVL M G L+ ++Y+ N D + + ++ LE L
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY 855
H +++ DLKP N+LLDD +SD +A + + I+ + + T+GYMAPE
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI--PEGETIRGR-VGTVGYMAPEV 172
Query: 856 GREGRVSANGDVYSFGIMLMETFTGKKP 883
+ R + + D + G ++ E GK P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 689 LIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMK----SIRHRN--LI 741
++G+G FG V A L G G AVK DVEC +++ ++ N L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDV--VLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ + +E V+E++ G L ++ D+++ ++ L++LH S
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SK 115
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKM-LTGEDQSMIQTQTLATIGYMAPEYGREGR 860
+I+ DLK NV+LD + ++DF + K + G++++ + T Y+APE + +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPDYIAPEILQGLK 172
Query: 861 VSANGDVYSFGIMLMETFTGKKP-----TDEIF 888
+ + D +SFG++L E G+ P DE+F
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 64/224 (28%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIM-------KSIRHRNL 740
+IG+G FG V A + AVKV +A E IM K+++H L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQK---KAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
+ + S + VL+Y+ G L +L C L+ R ++ASAL YLH S
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 114
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
+++ DLKP N+LLD L+DF + K + + + T Y+APE +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 861 VSANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLK 895
D + G +L E G P D I N + LK
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 682 DGFSENNLIGRGGFGSVYKASLGDGMEV-AVKVFTS-----QCGRAFKSFDVECEIMKSI 735
+ F +IGRG FG V +V A+K+ + + AF F E +IM
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHA 100
Query: 736 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 795
++++ + ++++ +V+EYMP G L L S+ I + + R +V AL+ +
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVLALDAI 158
Query: 796 H-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDF-SIAKMLTGEDQSMIQTQT-LATIGYMA 852
H G+ IH D+KP N+LLD + L+DF + KM + M++ T + T Y++
Sbjct: 159 HSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKM---DANGMVRCDTAVGTPDYIS 211
Query: 853 PE----------YGREGRVSANGDVYSFGIMLMETFTGKKP 883
PE YGRE D +S G+ L E G P
Sbjct: 212 PEVLKSQGGDGYYGRE------CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVECEIM-KSI-----RHRNLI 741
++G+G FG V A L E+ AVKV + DVEC + K + +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKK--DVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
++ S ++ V+EY+ G L ++ S D + ++ L++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPEYGREGR 860
+I+ DLK NVLLD ++DF + K + T T T Y+APE
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILSYQP 172
Query: 861 VSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
D ++ G++L E G+ P DE+F
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 7/144 (4%)
Query: 690 IGRGGFGSVYKASLGDGME-VAVK-VFTSQCGRAFKSFDV-ECEIMKSIRHRNLIKVISS 746
IG G +G+V+KA + E VA+K V S + E ++K ++H+N++++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
+++ LV EY L+KY S N +D + M + L + H S V+H
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAK 830
DLKP N+L++ N L+DF +A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVECEIMK------SIRHRNLI 741
++G+G FG V A L E A+K + DVEC +++ + H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDV--VLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ + +E V+EY+ G L ++ SS D + ++ L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KK 115
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKM-LTGEDQSMIQTQTLATIGYMAPEYGREGR 860
+I+ DLK NVLLD + ++DF + K + GE ++ + T Y+APE + +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKGQK 172
Query: 861 VSANGDVYSFGIMLMETFTGKKP-----TDEIF 888
+ + D +SFG++L E G+ P DE+F
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-09
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTS-----QCGRAFKSFDVECEIMKSIRHRNLIK 742
+IGRG FG V +V A+K+ + + AF F E +IM +++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 107
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ + ++++ +V+EYMP G L L S+ + + + + +V AL+ +H S
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH---SMG 162
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-LATIGYMAPEY----GR 857
+IH D+KP N+LLD + L+DF + ++ M++ T + T Y++PE G
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKP 883
+G D +S G+ L E G P
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 8/195 (4%)
Query: 690 IGRGGFGSVYKASLG-DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IG G G V A+ G +VAVK + + + E IM+ H N++ + +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
+ +V+E++ G+L + + ++ Q + + V AL YLH + VIH D+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
K ++LL + LSDF ++ E + + T +MAPE D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 869 SFGIMLMETFTGKKP 883
S GIM++E G+ P
Sbjct: 203 SLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 24/183 (13%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHR 738
D + + +G G + +VYK S +G VA+KV Q G F + E ++K ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 739 NLIKVISSCSNEEFKALVLEYMPHGSLEKY-------LYSSNCILDIFQRLNIMIDVASA 791
N++ + +E LV EY+ H L +Y L+ N L +FQ L
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------G 115
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYM 851
L Y+H Y ++H DLKP N+L+ D L+DF +A+ + + + + T+ Y
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY--SNEVVTLWYR 170
Query: 852 APE 854
P+
Sbjct: 171 PPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQC-GRAFKSFDV-ECEIMKSIRHRNLIKVISS 746
IG G +G VYK + G VA+K + S + E ++K ++H N++ +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-------FGY 799
E L+ E++ L+KYL S +D YL+ F +
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--YGR 857
S V+H DLKP N+L+D+ V L+DF +A+ + + T + T+ Y APE G
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGS 176
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
R S D++S G + E T KKP +F+G+
Sbjct: 177 P-RYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 690 IGRGGFGSVYKASLGDGME-VAVKVFT---SQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
IG G FG+VY A+ E VAVK + Q ++ E + ++ ++H N I+
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI----FQRLNIMIDVASALEYLHFGYSA 801
E LV+EY L S++ +L++ Q + I AL+ L + +S
Sbjct: 89 CYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY---GRE 858
+IH D+K N+LL + L+DF A + + + T +MAPE E
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFVGTPYWMAPEVILAMDE 194
Query: 859 GRVSANGDVYSFGIMLMETFTGKKPTDEIFN 889
G+ DV+S GI +E K P +FN
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPP---LFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 8/195 (4%)
Query: 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IG G G V A++ G VAVK + + + E IM+ +H N++++ +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
+ +V+E++ G+L + + ++ Q + + V AL LH + VIH D+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVY 868
K ++LL + LSDF ++ E + + T +MAPE D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 869 SFGIMLMETFTGKKP 883
S GIM++E G+ P
Sbjct: 201 SLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 6e-09
Identities = 19/40 (47%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 29 TDQDALLALKAHITHDPTNFLAKNWNTSTPV-CNWTGVAC 67
D+DALLA K+ + DP+ L+ +WN S+ C+WTGV C
Sbjct: 3 DDRDALLAFKSSLNGDPSGALS-SWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 684 FSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDV---ECEIMKSIRHRN 739
F ++G+GGFG V + G A K + + K + E I++ + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFG 798
++ + + ++ LVL M G L+ ++Y+ N D + + ++ LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
+++ DLKP N+LLDD +SD +A + E +++ + T+GYMAPE
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGETV--RGRVGTVGYMAPEVINN 175
Query: 859 GRVSANGDVYSFGIMLMETFTGKKP 883
+ + + D + G ++ E G+ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 57/246 (23%), Positives = 91/246 (36%), Gaps = 36/246 (14%)
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNA----SKLSILDLEGNSFSGFIPNT------FGNLR 297
L L++L L GN + + +A L L L N
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 298 NLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPL-YRILPR--TTVGNLSHSL 354
L L LSDN L L SL L+ L+ N L R L + +L +L
Sbjct: 82 GLQELDLSDNALGPDGCG--VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL 139
Query: 355 EEFKMSNCNISGGIPEEISNL----TNLRTIYLGGNKLNGSILITLSK----LQKLQDLG 406
E+ + + G E ++ +L+ + L N + + + L++ L+ L
Sbjct: 140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD 199
Query: 407 LKDNKL--EGSIPYDIC----NLAELYRLDLDGNKLSGSI-----PACFSNLTSLRIVSL 455
L +N L EG+ + +L L L+L N L+ + A S SL +SL
Sbjct: 200 LNNNGLTDEGAS--ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257
Query: 456 GSNELT 461
N++T
Sbjct: 258 SCNDIT 263
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 7/127 (5%)
Query: 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 816
+E+M GSL++ L + I + I I V L YL + ++H D+KPSN+L++
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRDVKPSNILVN 134
Query: 817 DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLME 876
L DF ++ L SM + + T YM+PE + + D++S G+ L+E
Sbjct: 135 SRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
Query: 877 TFTGKKP 883
G+ P
Sbjct: 191 MAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV-ECEIMKSIRHRNLIKVISSC 747
+G G + +VYK + G VA+K S + E +MK ++H N++++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 748 SNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
E LV EYM L+KY+ + LD + + + + H V+H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA----TIGYMAPEYGREGRV 861
DLKP N+L++ L+DF +A+ I T + T+ Y AP+ R
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFG------IPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 862 -SANGDVYSFGIMLMETFTGK 881
S + D++S G ++ E TG+
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTS-----QCGRAFKSFDVECEIMKSIRHRNLIK 742
+IGRG FG V +V A+K+ + + AF F E +IM +++
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 107
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ + ++ + +V+EYMP G L L S+ + + + R +V AL+ +H S
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMG 162
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-LATIGYMAPEY----GR 857
IH D+KP N+LLD + L+DF + E M++ T + T Y++PE G
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKP 883
+G D +S G+ L E G P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 46/228 (20%)
Query: 690 IGRGGFGSVYKASLGD-GMEVAVK-VFTSQCGRAFKSFDVECEIMKSIRHRNLIKVI--- 744
+G G G V+ A D VAVK + + ++ K E +I++ + H N++KV
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 745 ---SSCSNEEFKAL--------VLEYMP---HGSLEKYLYSSNCI-LDIFQRLNIMIDVA 789
S E+ +L V EYM LE+ S L ++Q L
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------ 125
Query: 790 SALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGE-DQSMIQTQTLAT 847
L+Y+H SA V+H DLKP+NV ++ +++V + DF +A+++ ++ L T
Sbjct: 126 -GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 848 IGYMAPEYGREGRVSANG-----DVYSFGIMLMETFTGKKPTDEIFNG 890
Y +P +S N D+++ G + E TGK +F G
Sbjct: 182 KWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKP----LFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 682 DGFSENNLIGRGGFGSVY----KASLGD--GMEVAVK-VFTSQCGRAFKSFDVECEIMKS 734
F +L+GRG FG V KA+ GD M+V K V +Q +F F+ E +I+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSF--FEEERDILSI 57
Query: 735 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 794
+ ++ + +++ LV+EY P G L L N D F +A +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLA 114
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
+H + +H D+KP NVL+D L+DF A LT ++ + + T Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAPE 173
Query: 855 Y------GREGRVSANGDVYSFGIMLMETFTGKKPTDE 886
+G D +S G++ E G+ P E
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 689 LIGRGGFGSVYKASLGDGME--VAVK---VFTSQCGRAFKSFD-------VECEIMK-SI 735
+G G FG VYK + + +A+K V G+ + D E I+K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 736 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRL-NIMIDVASAL 792
RH N+++ + + +V++ + L ++ S F +R+ NI + + AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
YLH ++H DL P+N++L ++ ++DF +AK + + T + TI Y
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKL--TSVVGTILYSC 181
Query: 853 PEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
PE + DV++FG +L + T + P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSF------DVECEIMKSIRHRNLIK 742
+G G +GSV A G+ VAVK + R F+S E ++K ++H N+I
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80
Query: 743 VIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
++ + S EEF + L ++ L + D Q L + + L+Y+H
Sbjct: 81 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH- 137
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
SA +IH DLKPSN+ ++++ + DF +A+ E T +AT Y APE
Sbjct: 138 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIML 190
Query: 858 EG-RVSANGDVYSFGIMLMETFTGK 881
+ D++S G ++ E TG+
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-08
Identities = 64/230 (27%), Positives = 95/230 (41%), Gaps = 43/230 (18%)
Query: 689 LIGRGGFGSVYKASLGD---GMEVAVKVFT---SQCGRAFKSFDVECEIMKSIRHRNLIK 742
LIG+GG G VY A D VA+K S+ K F E +I + H ++
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 743 VISSCSNEEFKALVLEYMPH--GSLEKYLYSSNCILDIFQR-----------LNIMIDVA 789
V S CS+ + V MP+ G K L S + + L+I +
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 790 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ------------ 837
+ +EY+H S V+H DLKP N+LL + D+ A E++
Sbjct: 124 ATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 838 ---SM-IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
SM I + + T YMAPE S + D+Y+ G++L + T P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFT------SQCGRAFKSFDVECEIMKSIRHRNLIK 742
IG G G V A G+ VAVK + + RA++ E ++K + H+N+I
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR----ELVLLKCVNHKNIIS 84
Query: 743 VIS----SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
+++ S EEF+ LV+E M +L + ++ LD + ++ + +++LH
Sbjct: 85 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH 140
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYG 856
SA +IH DLKPSN+++ + + DF +A+ + + T + T Y APE
Sbjct: 141 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVI 194
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 897
N D++S G ++ E G IF G + W
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 2e-08
Identities = 25/60 (41%), Positives = 33/60 (55%)
Query: 520 NLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
NL+ L L NRL +F L +LK L+LS NNL+ + P + L L L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 57/238 (23%)
Query: 689 LIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-------GRAFKSFDVECEIMKSIRHRNL 740
L+G+G G V+ L G G A+KV + R E EI+ ++ H L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL----TEQEILATLDHPFL 63
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLH-F 797
+ +S E + LV++Y P G L + L C+ + R +V ALEYLH
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLL 122
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT---------------GEDQSMIQT 842
G ++ DLKP N+LL ++ LSDF ++K + I +
Sbjct: 123 GI----VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 843 QTLATIG------------YMAPEYGREGRVSANG-----DVYSFGIMLMETFTGKKP 883
+T + Y+APE +S +G D ++ GI+L E G P
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEV-----ISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 689 LIGRGGFGSVY----KASLGDGMEVAVKVFTSQCGRAFKSFD---VECEIMKSIRHRNLI 741
L+G+G FG V KAS G A+K+ + A E ++K+ RH L
Sbjct: 2 LLGKGTFGKVILVREKAS---GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ S ++ V+EY+ G L +L + R ++ SAL+YLH S
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SG 114
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
+++ DLK N++LD + ++DF + K G + T Y+APE +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 862 SANGDVYSFGIMLMETFTGKKP 883
D + G+++ E G+ P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-08
Identities = 26/71 (36%), Positives = 45/71 (63%)
Query: 168 IPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLK 227
IP + L L+ ++L+ N+++G IP +G++ +LE LD+ N G P ++ +++L+
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 228 ILGLQDNSLSG 238
IL L NSLSG
Sbjct: 494 ILNLNGNSLSG 504
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 30/82 (36%), Positives = 49/82 (59%), Gaps = 1/82 (1%)
Query: 229 LGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGF 288
LGL + L G + + ++L +L+ ++L GN+ G IP + + + L +LDL NSF+G
Sbjct: 423 LGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 289 IPNTFGNLRNLSWLVLSDNYLT 310
IP + G L +L L L+ N L+
Sbjct: 482 IPESLGQLTSLRILNLNGNSLS 503
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 3e-08
Identities = 23/56 (41%), Positives = 30/56 (53%)
Query: 500 IDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNL 555
+DLS N + + GL NL+ L L N L P +F L SL+ L+LS NNL
Sbjct: 5 LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 48/228 (21%)
Query: 690 IGRGGFG---SVYKASLGDGMEVAVK----VFTSQ--CGRAFKSFDVECEIMKSIR-HRN 739
+G+G +G S A + VA+K VF+ + RA + E ++++ R H+N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63
Query: 740 LIK------VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD------IFQRLNIMID 787
+ V NE + L E M L + + S + D I+Q L
Sbjct: 64 ITCLYDMDIVFPGNFNELY--LYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL----- 115
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT---GEDQSMIQTQT 844
L+Y+H SA V+H DLKP N+L++ + + DF +A+ + GE+ + T+
Sbjct: 116 --CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEY 169
Query: 845 LATIGYMAPEYGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGE 891
+AT Y APE + DV+S G +L E G+KP +F G+
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 60/222 (27%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKV----FTSQ--CGRAFKSFDVECEIMKSIRHRNLI 741
+G G +GSV A G +VA+K F S+ RA++ E ++K ++H N+I
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVI 77
Query: 742 KVI----SSCSNEEFKA--LVLEYM---------PHGSLEKYLYSSNCILDIFQRLNIMI 786
++ S+ S +EF+ LV+ YM S +K Y ++Q L
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL------VYQML---- 127
Query: 787 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846
L+Y+H SA +IH DLKP N+ ++++ + DF +A+ E T +
Sbjct: 128 ---CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVV 176
Query: 847 TIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGK 881
T Y APE Y + D++S G ++ E TGK
Sbjct: 177 TRWYRAPEVILNWMHYNQ------TVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-08
Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 29/225 (12%)
Query: 688 NLIGRGGFGSVYKASLGDGME-VAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
N+IG G FG VY+A D E VA+K +K + E IMK++ H N+I +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYK--NRELLIMKNLNHINIIFLKDY 127
Query: 747 CSNEEFKA--------LVLEYMPHGSLEKYL--YS-SNCILDIFQRLNIMIDVASALEYL 795
E FK +V+E++P ++ KY+ Y+ +N L +F + AL Y+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
H S + H DLKP N+L+D N L DF AK L +S+ + + Y APE
Sbjct: 187 H---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV---SYICSRFYRAPE 240
Query: 855 YGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 898
+ + D++S G ++ E G IF+G+ ++ V
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYP----IFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 7e-08
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 690 IGRGGFGSVYKA---SLGDG-----MEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI 741
+G+G F ++K +GD EV +KV +SF +M + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
C + +V EY+ GSL+ YL + +++I +L + +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119
Query: 802 PVIHCDLKPSNVLL---DDNMVAH-----LSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
+ H ++ NVLL +D + LSD I+ +T + ++ + I ++ P
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLER----IPWVPP 173
Query: 854 EYGREGR-VSANGDVYSFGIMLMETFTG 880
E + +S D +SFG L E F+G
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 58/217 (26%), Positives = 88/217 (40%), Gaps = 51/217 (23%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVK------VFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
IG G G V A G VA+K + RA++ +MK + H+N+I
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL----VLMKLVNHKNIIG 79
Query: 743 VIS----SCSNEEFKA--LVLEYMP------------HGSLEKYLYSSNCILDIFQRLNI 784
+++ S EEF+ LV+E M H + LY C
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC---------- 129
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
+++LH SA +IH DLKPSN+++ + + DF +A+ G M T
Sbjct: 130 ------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMM--TPY 177
Query: 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK 881
+ T Y APE N D++S G ++ E G
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVK-VFTSQCGRAFKSFDV-ECEIMKSIRHRNLIKVISS 746
IG G +G VYKA G VA+K + S + E ++K + H N+++++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
+E LV E++ L+KY+ S LD + + + + Y H S V+H
Sbjct: 67 VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAK-----MLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
DLKP N+L+D L+DF +A+ + T T + T+ Y APE R
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRT-------YTHEVVTLWYRAPEILLGSR 175
Query: 861 VSANG-DVYSFGIMLMET------FTGKKPTDEIF 888
+ D++S G + E F G D++F
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRA-FKSFDVECEIMKSIRHRNLIKVISSC 747
+G+G +GSVYK G+ +A+K + + F +E +I+ ++ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 748 SNEEFKALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
E + +EYM GSL+K LY + + I V L++L ++ +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSAN 864
H D+KP+NVL++ N L DF + +G + + + YMAPE + G + N
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 865 G------DVYSFGIMLMETFTGKKP 883
DV+S G+ ++E G+ P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 35/209 (16%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSF------DVECEIMKSIRHRNLIKV 743
+G G +GSV A + KV + R F+S E ++K ++H N+I +
Sbjct: 23 VGSGAYGSVCSAY---DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 744 IS----SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALE 793
+ + S E F + L G+ N I+ Q+L+ ++ + L+
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLSDEHVQFLIYQLLRGLK 132
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
Y+H SA +IH DLKPSNV ++++ + DF +A+ D M T +AT Y AP
Sbjct: 133 YIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ---ADDEM--TGYVATRWYRAP 184
Query: 854 EYGREG-RVSANGDVYSFGIMLMETFTGK 881
E + D++S G ++ E GK
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKV 743
+G+G +G V SL DG + +K + R K+ + E +++ ++H N++
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 744 ISSCSNEE-FKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSA 801
S E+ +V+ + G L L +L Q + + +A AL+YLH
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EK 121
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
++H DLK NV L + + D IA++L E+Q + + + T YM+PE
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 862 SANGDVYSFGIMLMETFTGK 881
+ DV++ G + E T K
Sbjct: 180 NYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 9/131 (6%)
Query: 754 ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 812
++ +E+M GSL++ L + I +I +++I V L YL + ++H D+KPSN
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSN 134
Query: 813 VLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 872
+L++ L DF ++ L SM + + T YM+PE + S D++S G+
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
Query: 873 MLMETFTGKKP 883
L+E G+ P
Sbjct: 191 SLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 4/109 (3%)
Query: 776 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835
LD+ L VA +++L S IH D+ NVLL D VA + DF +A+ + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 883
+++ + +MAPE + + DV+S+GI+L E F+ GK P
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 690 IGRGGFGSVYKASLGDGMEVAV--KVFTSQCGRAFKSFDV-ECEIMKSIRHRNLIKVISS 746
IG G +G VYKA E K+ Q S + E ++K ++H N++++
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI----MIDVASALEYLHFGYSAP 802
+E+ LV EY+ L+K++ SS D + + + + + Y H S
Sbjct: 70 VHSEKRLYLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH---SHR 122
Query: 803 VIHCDLKPSNVLLDDNMVA-HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR- 860
V+H DLKP N+L+D A L+DF +A+ ++ T + T+ Y APE R
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVTLWYRAPEILLGSRH 180
Query: 861 VSANGDVYSFGIMLMET------FTGKKPTDEIF 888
S D++S G + E F G DE+F
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214
|
Length = 294 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 24/227 (10%)
Query: 689 LIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMK------SIRHRNLI 741
++G+G FG V A L G AVKV + DVEC + + + H L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDV--ILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
++ + V+E++ G L ++ S + R ++ SAL +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
+I+ DLK NVLLD L+DF + K G + T Y+APE +E
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 862 SANGDVYSFGIMLMETFTGKKP-----TDEIF----NGEMTLKHWVN 899
+ D ++ G++L E G P D++F N E+ W++
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 51/204 (25%)
Query: 683 GFSENNLIGRGGFGSVYKA---SLGDGMEVAVKVF-----------TSQCGRAFKSFDVE 728
+ IGRG +G VYKA + DG E A+K F S C R
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC-R-------- 51
Query: 729 CEIM--KSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL-- 782
EI + ++H N++ ++ K+ L+ +Y H + +
Sbjct: 52 -EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 783 -NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIA-------K 830
+++ + + + YLH S V+H DLKP+N+L+ + V + D +A K
Sbjct: 111 KSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 831 MLTGEDQSMIQTQTLATIGYMAPE 854
L D ++ TI Y APE
Sbjct: 168 PLADLDPVVV------TIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 35/148 (23%), Positives = 66/148 (44%), Gaps = 19/148 (12%)
Query: 689 LIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECE--IMKSIRHRNLI--KVI 744
L+ G VY D + +K+ S+ K D E E I++ + + L KV+
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSRE----KGADREREVAILQLLARKGLPVPKVL 59
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV- 803
+S ++ + L++E++ +L++ + ++ +I +A L LH V
Sbjct: 60 ASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH-QLPLLVL 110
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKM 831
H DL P N+L+DD + + D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 16/202 (7%)
Query: 689 LIGRGGFGSVY----KASLGDGMEVAVKVFTSQCGRAFKSFD---VECEIMKSIRHRNLI 741
L+G+G FG V KA+ G A+K+ + A E ++++ RH L
Sbjct: 2 LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ + + V+EY G L +L + R ++ SALEYLH S
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SR 114
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
V++ D+K N++LD + ++DF + K + +M T Y+APE +
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDY 172
Query: 862 SANGDVYSFGIMLMETFTGKKP 883
D + G+++ E G+ P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 48/224 (21%), Positives = 92/224 (41%), Gaps = 25/224 (11%)
Query: 697 SVYKASLGDGMEVAVKVFT---SQCGRAFKSFDVECEIMKSIRHRNLIKV----ISSCSN 749
S+YK + EV ++ F + E + ++ I N++K+ I +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 809
+L+LEY G L + L L +L++ ID L L+ + P + +L
Sbjct: 94 LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 810 PSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE--GRVSANGDV 867
+ L+ +N + + K+L S + + + Y + + + + D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205
Query: 868 YSFGIMLMETFTGKKP-----TDEIFNGEMTLKHWVNDWLPIST 906
YS G++L E FTGK P T EI++ + + + LP+
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTTKEIYD--LIINKNNSLKLPLDC 247
|
Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 23/66 (34%), Positives = 35/66 (53%)
Query: 352 HSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNK 411
L+ +S +I G IP + ++T+L + L N NGSI +L +L L+ L L N
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 412 LEGSIP 417
L G +P
Sbjct: 502 LSGRVP 507
|
Length = 623 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 713 VFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFKALV---LEYMPHGS 764
+ ++ R + +I + ++ R L + SS S+ E K+L E
Sbjct: 112 PYKTKDARFRQGKSGYGDISEDLKRR-LDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170
Query: 765 L-EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 823
L +K L + I FQ VA +E+L S IH DL N+LL +N V +
Sbjct: 171 LYKKVLTLEDLICYSFQ-------VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKI 220
Query: 824 SDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKK 882
DF +A+ + + + + + +MAPE + + DV+SFG++L E F+ G
Sbjct: 221 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 280
Query: 883 P 883
P
Sbjct: 281 P 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDV-ECEIMKSIRHRN 739
D F + + +G G G V+K S G+ +A K+ + A ++ + E +++
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 798
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 122
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
+ ++H D+KPSN+L++ L DF ++ L SM + + T YM+PE +
Sbjct: 123 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 176
Query: 859 GRVSANGDVYSFGIMLMETFTGKKP 883
S D++S G+ L+E G+ P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 66/310 (21%), Positives = 110/310 (35%), Gaps = 56/310 (18%)
Query: 72 QRVTVLNISSLNLTGT----IPSQLGNLSSLQSLNLSFNRL------FGSIPSAIFTTYT 121
+ VL + L + S L SL+ L LS N S+ +
Sbjct: 23 LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82
Query: 122 LKYVCLRGNQLS----GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPE 177
L+ + L N L G S + + SSLQ L L++N L + + + P
Sbjct: 83 LQELDLSDNALGPDGCGVLESLLRS-SSLQELKLNNNGLGDRGLRLLAKGLKD---LPPA 138
Query: 178 LELMSLAANNLQGKIPLKIGNL----RNLEKLDIGDNKLV--GIAPIA-IFNVST-LKIL 229
LE + L N L+G + R+L++L++ +N + GI +A + L++L
Sbjct: 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVL 198
Query: 230 GLQDNS--------LSGCLSSIGYARLPNLEILSLWGNNFSGTI-----PRFIFNASKLS 276
L +N L+ L+S L +LE+L+L NN + + L
Sbjct: 199 DLNNNGLTDEGASALAETLAS-----LKSLEVLNLGDNNLTDAGAAALASALLSPNISLL 253
Query: 277 ILDLEGN--------SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFL 328
L L N + + +L L L N +L S L L
Sbjct: 254 TLSLSCNDITDDGAKDLAEVLAE-KESLLELD---LRGNKFGEEGAQLLAESLLEPGNEL 309
Query: 329 KYFDLSYNPL 338
+ + +
Sbjct: 310 ESLWVKDDSF 319
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 11/153 (7%)
Query: 727 VECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNI 784
+E +++++ H ++I++ + + +VL PH S + Y Y + L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
+ L YLH + +IH D+K N+ ++D + D A+ + T
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219
Query: 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMET 877
+ T APE + ++ D++S GI+L E
Sbjct: 220 VET---NAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 689 LIGRGGFGSVYKASLGDGME-VAVKVFT-SQCGRAFKSFDV-ECEIMKSIRHRNLIKVIS 745
++G G +G V K + E VA+K F S+ K + E +++++++ N++++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
+ LV EY+ LE N + R I ++ +H+ + ++H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKNDIVH 123
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
D+KP N+L+ N V L DF A+ L+ E + T+ +AT Y +PE
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAV 182
Query: 866 DVYSFGIMLME------TFTGKKPTDEIFNGEMTL 894
D++S G +L E F G+ D++F + L
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 63/247 (25%), Positives = 112/247 (45%), Gaps = 42/247 (17%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVK----VF--TSQCGRAFKSFDVECEIMKSIRHRNLI 741
+IG+G +G V A G +VA+K VF S R + E ++++ +RH +++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLLRHPDIV 62
Query: 742 KVIS---SCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILD------IFQRLNIMIDVAS 790
++ S EFK + V E M L + + +++ + ++Q L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLR------- 114
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI-QTQTLATIG 849
AL+Y+H +A V H DLKP N+L + + + DF +A++ + + I T +AT
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 850 YMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW--VNDWLPIS 905
Y APE + + D++S G + E TGK +F G+ + + D L
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP----LFPGKNVVHQLDLITDLLGTP 227
Query: 906 TMEVVDA 912
+ E +
Sbjct: 228 SPETISR 234
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 31/109 (28%), Positives = 51/109 (46%), Gaps = 4/109 (3%)
Query: 776 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835
LD L+ VA + +L S IH DL N+LL + + DF +A+ + +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 883
+++ + +MAPE + DV+S+GI+L E F+ G P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 689 LIGRGGFGSVYKASLG-DGMEVAVKVF---TSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
L+GR + + A+ G D E V F + A+ ++ C + + H ++K
Sbjct: 74 LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHC--LAACDHFGIVKHF 131
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------------IMIDVASAL 792
+++ L++EY G L K I QRL + + AL
Sbjct: 132 DDFKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
+ +H S ++H DLK +N+ L + L DF +K + + + T Y+A
Sbjct: 183 DEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 853 PEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
PE R S D++S G++L E T +P
Sbjct: 240 PELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 690 IGRGGFGSVYKASL--GDGMEVAVKVFTSQCGRAFKSFD---VECEIMKSIRHRNLIKVI 744
+G G FG V A+ D VA+K F K D E +I+ I H + +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHFGYSA 801
S +E + LVLE++ G +L + + F I++ EYL S
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEYLQ---SL 150
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG---YMAPEYGRE 858
+++ DLKP N+LLD + ++DF AK ++ T+T G Y+APE
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAK--------VVDTRTYTLCGTPEYIAPEILLN 202
Query: 859 GRVSANGDVYSFGIMLMETFTGKKP 883
D ++ GI + E G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 47/173 (27%), Positives = 71/173 (41%), Gaps = 25/173 (14%)
Query: 723 KSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-------SSNCI 775
K+ E +I+K+I HR +I +I + K+ V MP + + Y
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQA 187
Query: 776 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835
+ I +RL AL YLH +IH D+K N+ LD+ A L DF A L
Sbjct: 188 ITIQRRL------LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLME------TFTGKK 882
+ T+ +PE A D++S G++L E T GK+
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291
|
Length = 392 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 690 IGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IG+G FG VY+ D + A+KV + + A K E+ +I RN++ V +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNIL-VRTLLD 53
Query: 749 NEEFKA-------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI-DVASALEY 794
F LV +YM G L +L + R I ++ ALE+
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEH 111
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAP 853
LH +++ DLKP N+LLD L DF ++K ++++ T T T Y+AP
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAP 165
Query: 854 EYGREGR-VSANGDVYSFGIMLMETFTGKKP 883
E + + + + D +S G+++ E G P
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 29/236 (12%)
Query: 671 MFSYLELCRATDGFSENNLIGRGGFGSVYK-ASLGDGMEVAVKVFTSQCGRAFKSFDVEC 729
M L TD + IG+G +G VYK + DG AVK+ + + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEY 69
Query: 730 EIMKSI-RHRNLIKVI------SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 782
I++S+ H N++K + LVLE GS+ + + +L QRL
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKG---LLICGQRL 125
Query: 783 N------IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836
+ I+ L++LH + +IH D+K +N+LL L DF ++ LT
Sbjct: 126 DEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--S 180
Query: 837 QSMIQTQTLATIGYMAPEY-----GREGRVSANGDVYSFGIMLMETFTGKKPTDEI 887
+ + ++ T +MAPE + A DV+S GI +E G P ++
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 68/251 (27%), Positives = 107/251 (42%), Gaps = 45/251 (17%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
+T L++ + N+T P S+L+ L+LS N++
Sbjct: 118 LTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI------------------------- 152
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
+ PS + N +L++LDLS N LS ++P+ NL L + L+ N + +P
Sbjct: 153 ESLPSPLRNLPNLKNLDLSFNDLS---------DLPKLLSNLSNLNNLDLSGNKIS-DLP 202
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
+I L LE+LD+ +N ++ ++ N+ L L L +N L SIG L NLE
Sbjct: 203 PEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIG--NLSNLET 259
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313
L L N + + + + L LDL GNS S +P L L L+L T
Sbjct: 260 LDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALP-----LIALLLLLLELLLNLLLT 312
Query: 314 QELSFLSSLSN 324
+ L S
Sbjct: 313 LKALELKLNSI 323
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-06
Identities = 20/60 (33%), Positives = 26/60 (43%)
Query: 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
NL+ L L N + L +LDL GN+ + P F L +L L LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
VA +E+L S IH DL N+LL +N V + DF +A+ + + + +
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 848 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 883
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 24/184 (13%)
Query: 720 RAFKSFDVECEIMKSIRHRNLIKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLYSSN 773
RA++ E +MK + H+N+I +++ S EEF+ + V+E M +L + +
Sbjct: 69 RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME- 122
Query: 774 CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833
LD + ++ + +++LH SA +IH DLKPSN+++ + + DF +A+
Sbjct: 123 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-- 175
Query: 834 GEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 893
S + T + T Y APE N D++S G ++ E G +F G
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDH 230
Query: 894 LKHW 897
+ W
Sbjct: 231 IDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 776 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835
L L+ VA +E+L S +H DL NVLL + + DF +A+ + +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 879
+ + T + +MAPE + + DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVECEIMK------SIRHRNLI 741
++G+G FG V A E+ A+K+ + DVEC +++ S + L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
++ S + V+EY+ G L + + F+ + + A L F +S
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAK--MLTGEDQSMIQTQTL-ATIGYMAPEYGRE 858
+I+ DLK NV+LD ++DF + K M G + T+T T Y+APE
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-----VTTKTFCGTPDYIAPEIIAY 175
Query: 859 GRVSANGDVYSFGIMLMETFTGKKP-----TDEIFNGEM 892
+ D ++FG++L E G+ P DE+F M
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-06
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 25/114 (21%)
Query: 181 MSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL 240
+ L L+G IP I LR+L+ +++ N + G P ++ ++++L++L L NS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS----- 477
Query: 241 SSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFG 294
F+G+IP + + L IL+L GNS SG +P G
Sbjct: 478 --------------------FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
VA +E+L S IH DL N+LL +N V + DF +A+ + + + +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 848 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 883
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 690 IGRGGFGSVYKASLG-DGMEVAVKV----FTSQ--CGRAFKSFDVECEIMKSIRHRNLIK 742
+G G +G+V A G +VA+K F S+ RA++ E ++K ++H N+I
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78
Query: 743 VI----SSCSNEEFKA--LVLEYMPH--GSLEKYLYSSNCILDIFQRLNIMI-DVASALE 793
++ S + F LV+ +M G L K+ S R+ ++ + L+
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE------DRIQFLVYQMLKGLK 132
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
Y+H +A +IH DLKP N+ ++++ + DF +A+ E T + T Y AP
Sbjct: 133 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAP 184
Query: 854 EYGREG-RVSANGDVYSFGIMLMETFTGK 881
E + D++S G ++ E TGK
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 13/205 (6%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFD---VECEIMKSIRHRNLIKVI 744
+IGRG + V L ++ A+KV + + D E + + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 745 SSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
SC + LV+EY+ G L ++ + + R ++ AL +LH +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPEYGREGRVS 862
I+ DLK NVLLD + L+D+ + K G + T T T Y+APE R
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEILRGEEYG 174
Query: 863 ANGDVYSFGIMLMETFTGKKPTDEI 887
+ D ++ G+++ E G+ P D I
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 690 IGRGGFGSV---YKASLGDGMEVAVKVFT------SQCGRAFKSFDVECEIMKSIRHRNL 740
IG G G V Y A L VA+K + + RA++ E +MK + H+N+
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNI 78
Query: 741 IKVISSCSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 794
I +++ + EEF+ LV+E M +L + + LD + ++ + +++
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKH 134
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
LH SA +IH DLKPSN+++ + + DF +A+ S + T + T Y APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPE 188
Query: 855 YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 897
N D++S G ++ E K +F G + W
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 69/318 (21%), Positives = 118/318 (37%), Gaps = 72/318 (22%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNL 740
D + + IG G +G VYKA G VA+K + D E ++R +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISL 53
Query: 741 IKVISSC------------SNEEFKA---LVLEYMPHGSLEKYLYS----SNCILDIFQR 781
++++S + K LV EY+ L+K++ S L
Sbjct: 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 782 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFSIAKMLTGEDQSMI 840
+ M + + + H V+H DLKP N+L+D + ++D + + + +S
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY- 168
Query: 841 QTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGK------------------ 881
T + T+ Y APE S D++S G + E +
Sbjct: 169 -THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227
Query: 882 --KPTDEIFNGEMTLKHW--VNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 937
PT++++ G L+ W W P V LS E + + K ++
Sbjct: 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD--LSPEGLDLLQK----MLRYD--- 278
Query: 938 ECTMEFPKQRINAKEIVT 955
P +RI+AK +T
Sbjct: 279 ------PAKRISAKAALT 290
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 15/148 (10%)
Query: 689 LIGR----GGFGSVYKASLGDGMEVAVKVFT--SQCGRAFKSFDVECEIMKSIRHRNLIK 742
LIG+ + K + + VAVK S K E + ++H N++
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---NIMIDVASALEYLHFGY 799
++S + +V M +GS E L + + L I+ DV +AL+Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH--- 118
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFS 827
S IH +K S++LL + LS
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLR 146
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 4/128 (3%)
Query: 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 820
P + L + + L + VA+ +E+L S +H DL NVL+ + +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKL 277
Query: 821 AHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT- 879
+ DF +A+ + + + + T + +MAPE + DV+SFGI+L E FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337
Query: 880 GKKPTDEI 887
G P E+
Sbjct: 338 GGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 31/218 (14%)
Query: 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVE---CE-----IMKSIRHRNL 740
+GRG FG V A G A+K G +VE CE S RH L
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKK--GDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS---ALEYLHF 797
+ + + E+ V+EY G L ++++ D+F + A L+YLH
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH- 118
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPEYG 856
+++ DLK N+LLD ++DF + K G +T T T ++APE
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFLAPEVL 173
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
E + D + G+++ E G+ P +E+F+
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 15/204 (7%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFD---VECEIMKSIRHRNLIKVI 744
+IGRG + V L + A+KV + + D E + + + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 745 SSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
SC E + V+EY+ G L ++ + + R +++ AL YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAK--MLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
I+ DLK NVLLD L+D+ + K + G+ S T Y+APE R
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----CGTPNYIAPEILRGEDY 173
Query: 862 SANGDVYSFGIMLMETFTGKKPTD 885
+ D ++ G+++ E G+ P D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFT--SQCGRAFKS-FDVECEIMKSIRHRNLIKVI 744
+IGRG FG V L + +V A+K+ RA + F E +++ + ++ + +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQ-RLNIMIDVASALEYLHFGYSA 801
+ +E LV++Y G L L + D+ + L M+ ++ LH+
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDF-SIAKMLTGEDQSMIQTQTLATIGYMAPEYGR--- 857
+H D+KP N+L+D N L+DF S K++ ED ++ + + T Y++PE +
Sbjct: 124 --VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISPEILQAME 179
Query: 858 --EGRVSANGDVYSFGIMLMETFTGKKP 883
+G+ D +S G+ + E G+ P
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 36/217 (16%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-------RHRNL 740
++G G +G VYK + G A+KV + D E EI I HRN+
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDV-------TEDEEEEIKLEINMLKKYSHHRNI 75
Query: 741 IKVI------SSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASAL 792
S +++ LV+E+ GS+ + ++ N + + + I ++ L
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGL 134
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-LATIGYM 851
+LH + VIH D+K NVLL +N L DF ++ L D+++ + T + T +M
Sbjct: 135 AHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWM 188
Query: 852 APEY-----GREGRVSANGDVYSFGIMLMETFTGKKP 883
APE + D++S GI +E G P
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 690 IGRGGFGSVYK--ASLGDGMEVAVKVFTSQCGRAFKSFDV-ECEIMKSIRHRNLIKVISS 746
+G G + +VYK + L D + VA+K + + E ++K ++H N++ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
E+ LV EY+ L++YL +++ N+ + + L L++ + V+H
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT----LATIGYMAPE-YGREGRV 861
DLKP N+L+++ L+DF +A+ + I T+T + T+ Y P+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKS------IPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 862 SANGDVYSFGIMLMETFTGK 881
S D++ G + E TG+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 1e-05
Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 29/174 (16%)
Query: 731 IMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIFQRLNI 784
+MK + N IK+ S + + L+++Y+ G L E L + I Q
Sbjct: 64 LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ---- 117
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-AHLSDFSIAKMLTGEDQSMIQTQ 843
+ AL LH +IH D+K NVL D +L D+ + K +I T
Sbjct: 118 ---LVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------IIGTP 163
Query: 844 TL--ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 895
+ T+ Y +PE + + D ++ G++ E TGK P E + E+ L+
Sbjct: 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217
|
Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 26/206 (12%)
Query: 690 IGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDV-ECEIMKSIRHRNLIKVIS-- 745
IG+G FG V + D + A+K K+ V E+ ++ R ++ ++
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-------KAHIVSRSEVTHTLAERTVLAQVNCP 53
Query: 746 -------SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 798
S + E LVL ++ G L +L D+ + ++ ALE LH
Sbjct: 54 FIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH-- 110
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPEYGR 857
VI+ DLKP N+LLD L DF + K+ +D +T T T Y+APE
Sbjct: 111 -KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLL 166
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKP 883
+ D ++ G++L E TG P
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 689 LIGRGGFGSVY----KASLGDGMEVAVKVFTSQCGRAFKSFD---VECEIMKSIRHRNLI 741
L+G+G FG V KA+ G A+K+ + A E ++++ RH L
Sbjct: 2 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ S + V+EY G L +L + R ++ SAL+YLH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH--SEK 115
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
V++ DLK N++LD + ++DF + K + +M T Y+APE +
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAPEVLEDNDY 173
Query: 862 SANGDVYSFGIMLMETFTGKKP 883
D + G+++ E G+ P
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 46/199 (23%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 690 IGRGGFG-SVYKASLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
IG G FG ++ S DG + +K + + + E ++ +++H N+++ S
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM---IDVASALEYLHFGYSAPV 803
+V++Y G L K + + +L F I+ + + AL+++H +
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKHVH---DRKI 122
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-LATIGYMAPEYGREGRVS 862
+H D+K N+ L + L DF IA++L + ++ +T + T Y++PE +
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICENRPYN 179
Query: 863 ANGDVYSFGIMLMETFTGK 881
D+++ G +L E T K
Sbjct: 180 NKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNL------ 740
L+G G +G VYK + G A+KV G + E ++K HRN+
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 741 -IKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHF 797
IK +++ LV+E+ GS+ + ++ N + + + I ++ L +LH
Sbjct: 72 FIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH- 128
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-LATIGYMAPEY- 855
VIH D+K NVLL +N L DF ++ L D+++ + T + T +MAPE
Sbjct: 129 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVI 183
Query: 856 ----GREGRVSANGDVYSFGIMLMETFTGKKP 883
+ D++S GI +E G P
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 728 ECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 787
E ++K+++H N++ + E LV EY+ L++YL + ++ + M
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
+ L Y H ++H DLKP N+L+++ L+DF +A+ + ++ + + T
Sbjct: 112 LLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY--SNEVVT 166
Query: 848 IGYMAP-------EYGREGRVSANGDVYSFGIMLMETFTGK 881
+ Y P EY S D++ G +L E TG+
Sbjct: 167 LWYRPPDVLLGSTEY------STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 51/228 (22%), Positives = 92/228 (40%), Gaps = 23/228 (10%)
Query: 690 IGRGGFGSVYKASLGDGMEVA---VKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVIS 745
IG G FG V + + VA VK + + F + + + ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYS 800
C LV EY G L+ YL N L + QR+ ++A+ + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMH---K 117
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY--GRE 858
+H DL N L ++ + D+ I ED + + ++APE
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 859 GRVSAN-----GDVYSFGIMLMETF-TGKKPTDEIFNGEMTLKHWVND 900
G + +V++ G+ L E F +P + + E+ L H + D
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-LNHVIKD 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 40/233 (17%)
Query: 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMK----SI 735
F ++G+G FG V A G A+K+ + DVEC +++ ++
Sbjct: 1 DFNFL--MVLGKGSFGKVMLAERKGTDELYAIKILKKDV--VIQDDDVECTMVEKRVLAL 56
Query: 736 RHRN--LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 793
+ + L ++ S + V+EY+ G L ++ + Q + +++ L
Sbjct: 57 QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGLF 115
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK--MLTGEDQSMIQTQTL-ATIGY 850
+LH +I+ DLK NV+LD ++DF + K M+ G + T+T T Y
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-----VTTRTFCGTPDY 167
Query: 851 MAPE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFNGEM 892
+APE YG+ + D +++G++L E G+ P DE+F M
Sbjct: 168 IAPEIIAYQPYGK------SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 682 DGFSENNLIGRGGFGSVYKASLGDGMEV-AVKVFT---------SQCGRAFKSFDV--EC 729
D F +IGRG FG V + + A+K+ + C R ++ V +C
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 730 EIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNI--MI 786
+ + ++ + + +E + LV++Y G L L + + + R I M+
Sbjct: 61 QWITTLHY--------AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV 112
Query: 787 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF-SIAKMLTGEDQSMIQTQTL 845
++ LH+ +H D+KP NVLLD N L+DF S KM +D ++ + +
Sbjct: 113 LAIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMN--QDGTVQSSVAV 164
Query: 846 ATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKP 883
T Y++PE + G+ D +S G+ + E G+ P
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 5e-05
Identities = 20/57 (35%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 426 LYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSN 481
L LDL N+L+ F L +L+++ L N LTSI F L + +L+ S N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 27/216 (12%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSC 747
IG+G +G V+K + +G + AVK+ + + E I+K++ H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 748 SNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLH 796
++ K LVLE GS+ + L +R+ I+ + L++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY- 855
IH D+K +N+LL L DF ++ LT + + ++ T +MAPE
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEVI 196
Query: 856 ----GREGRVSANGDVYSFGIMLMETFTGKKPTDEI 887
+ A DV+S GI +E G P ++
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 44/196 (22%), Positives = 88/196 (44%), Gaps = 15/196 (7%)
Query: 690 IGRGGFGSVY-----KASLGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743
+G+G FG+VY KA + ++V ++ + + E +++ + H ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 744 ISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
+S + ++ EY L+ + L + L Q I + + Y+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---Q 124
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
++H DLK N+ L +N++ + DF ++++L G + T T YM+PE +
Sbjct: 125 RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQG 181
Query: 861 VSANGDVYSFGIMLME 876
+ D++S G +L E
Sbjct: 182 YDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 43/171 (25%), Positives = 75/171 (43%), Gaps = 32/171 (18%)
Query: 670 RMFSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFD 726
++ +Y +L + +G G + +VYK S G VA+K + G F +
Sbjct: 3 KLETYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR 52
Query: 727 VECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-------IF 779
E ++K ++H N++ + ++ LV EY+ L++Y+ L +F
Sbjct: 53 -EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLF 110
Query: 780 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830
Q L L Y H V+H DLKP N+L+ + L+DF +A+
Sbjct: 111 QLLR-------GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 62/233 (26%), Positives = 94/233 (40%), Gaps = 57/233 (24%)
Query: 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI 741
D F +IGRG FG EVAV V G+ + MK + ++
Sbjct: 1 DDFEILKVIGRGAFG-----------EVAV-VKMKNTGQVYA--------MKILNKWEML 40
Query: 742 K-VISSCSNEEFKALV---------LEYMPHGSLEKYL----YSSNCILDIFQRLNIMI- 786
K ++C EE LV L Y YL Y +L + + +
Sbjct: 41 KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP 100
Query: 787 -DVAS--------ALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDF-SIAKMLTGE 835
D+A A++ +H GY +H D+KP NVLLD N L+DF S ++L
Sbjct: 101 EDMARFYLAEMVLAIDSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-- 154
Query: 836 DQSMIQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKP 883
D ++ + T Y++PE + +GR D +S G+ + E G+ P
Sbjct: 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 43/196 (21%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 690 IGRGGFGSVYK--ASLGDGMEVAVKVFTSQCGRAFKSFDV-ECEIMKSIRHRNLIKVISS 746
+G G + +V+K + L + + VA+K + + E ++K ++H N++ +
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
++ LV EY+ L++Y+ I+ + N+ I + L L + + V+H
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHR 128
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR-EGRVSANG 865
DLKP N+L+++ L+DF +A+ + ++ + + T+ Y P+ S
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 866 DVYSFGIMLMETFTGK 881
D++ G + E +G+
Sbjct: 187 DMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 24/118 (20%)
Query: 787 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL- 845
++A L +LH S +I+ DLK NV+LD ++DF + K ++ T+T
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFC 162
Query: 846 ATIGYMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFNGEM 892
T Y+APE YG+ + D ++FG++L E G+ P DE+F M
Sbjct: 163 GTPDYIAPEIIAYQPYGK------SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 690 IGRGGFGSVYKASLGDGM---EVAVK------VFTSQCGRAFKSFDVECEIMKSIRHRNL 740
+GRG +G VYKA DG E A+K + S C E +++ ++H N+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR--------EIALLRELKHPNV 60
Query: 741 I---KVISSCSNEEFKALVLEYMPHG--SLEKYLYSSNCILDIFQRLNIMID--VASALE 793
I KV S S+ + L+ +Y H + K+ +S Q M+ + L+
Sbjct: 61 IALQKVFLSHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 794 YLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIAKMLTGEDQSMIQTQ-TLATI 848
+H+ ++ V+H DLKP+N+L+ + ++D A++ + + + T
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 849 GYMAPEYGREGRVSANG-DVYSFGIMLMETFTGK 881
Y APE R D+++ G + E T +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 57/247 (23%)
Query: 682 DGFSENNLIGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN- 739
D F +IGRG FG V D G A+K+ K+ +E E + IR
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53
Query: 740 ---------LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 790
++K+ S ++ L++E++P G + L + + + + I +
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVL 112
Query: 791 ALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT---------------- 833
A++ +H G+ IH D+KP N+LLD LSDF + L
Sbjct: 113 AIDAIHQLGF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 834 -----------------GEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLME 876
+++ + T+ T Y+APE + + D +S G+++ E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 877 TFTGKKP 883
G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 24/165 (14%)
Query: 728 ECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM-I 786
E ++++ RH L + S + V+EY G L + + S + R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102
Query: 787 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL- 845
++ SAL YLH S V++ DLK N++LD + ++DF + K E S T
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTF 155
Query: 846 -ATIGYMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKP 883
T Y+APE YGR D + G+++ E G+ P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 23/61 (37%), Positives = 35/61 (57%), Gaps = 1/61 (1%)
Query: 201 NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNN 260
NL+ LD+ +N+L I A + LK+L L N+L+ +S ++ LP+L L L GNN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNN 59
Query: 261 F 261
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 55/246 (22%), Positives = 95/246 (38%), Gaps = 55/246 (22%)
Query: 682 DGFSENNLIGRGGFGSVYKASLGD-GMEVAVKVF-------TSQCG--RAFKSFDVECEI 731
+ F +IGRG FG V D G A+K+ Q G RA + VE +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 732 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 791
+ ++K+ S ++ L++E++P G + L + + + + I + A
Sbjct: 61 LW------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLA 113
Query: 792 LEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT----------------- 833
++ +H G+ IH D+KP N+LLD LSDF + L
Sbjct: 114 IDSIHQLGF----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 834 ----------------GEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMET 877
++ + T+ T Y+APE + + D +S G+++ E
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 878 FTGKKP 883
G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 34/122 (27%), Positives = 54/122 (44%), Gaps = 33/122 (27%)
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM-------------LTGEDQ 837
ALEYLH + ++H DLKP N+L+ L+DF ++K+ + + +
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 838 SMIQTQTLATIGYMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDE 886
+ Q T Y+APE YG+ D ++ GI+L E G P +E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEFLVGCVPFFGDTPEE 223
Query: 887 IF 888
+F
Sbjct: 224 LF 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 20/204 (9%)
Query: 689 LIGRGGFGS--VYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
++G G FG + + D ++ + A + E ++ ++H N++ S
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 747 CSNEEFKALVLEYMPHGSLEK-------YLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+ +V+EY G L + L+ + IL F + + ++++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF------VQMCLGVQHIH--- 117
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG 859
V+H D+K N+ L N L DF A++LT + T Y+ PE
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYACTYVGTPYYVPPEIWENM 175
Query: 860 RVSANGDVYSFGIMLMETFTGKKP 883
+ D++S G +L E T K P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-04
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 46/231 (19%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISS 746
IG G FG V+ E S G R +E +M+ ++H+N+++ I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 747 CSNEEFKAL--VLEYMPHGSLEKYL---------YSSNCILDIFQRLNIMIDVASALEYL 795
N+ + L ++E+ G L + + + I+DI ++L AL Y
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL------LHALAYC 134
Query: 796 HFGYSAP----VIHCDLKPSNVLLDDNM-----------------VAHLSDFSIAKMLTG 834
H P V+H DLKP N+ L + +A + DF ++K +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 835 EDQSMIQTQTLATIGYMAPEYGREGRVSAN--GDVYSFGIMLMETFTGKKP 883
E SM + + T Y +PE S + D+++ G ++ E +GK P
Sbjct: 195 E--SMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-04
Identities = 19/43 (44%), Positives = 30/43 (69%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAI 116
+ VL++S + G+IP LG L+SL+ LNL+ N L G +P+A+
Sbjct: 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 24/65 (36%), Positives = 28/65 (43%), Gaps = 5/65 (7%)
Query: 274 KLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDL 333
L LDL N + F L NL L LS N LTS + E + S L+ DL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE-----AFSGLPSLRSLDL 55
Query: 334 SYNPL 338
S N L
Sbjct: 56 SGNNL 60
|
Length = 60 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 40/220 (18%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV-----ECEIMKSIR-HRNLIK 742
IG G F V KA S G A+K FKS + E + ++ + H N+++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKH----FKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 743 VISSCSNEEFK--ALVLEYMPHGSLE-----KYLYSSNCILDIFQRLNIMIDVASALEYL 795
+I + + ALV E M E K + + M + +L+++
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVK------SYMYQLLKSLDHM 116
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE- 854
H + H D+KP N+L+ D+++ L+DF + G T+ ++T Y APE
Sbjct: 117 H---RNGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYRAPEC 169
Query: 855 ------YGREGRVSANGDVYSFGIM-LMETFTGKKPTDEI 887
YG + + A G V+ F I+ L F G D+I
Sbjct: 170 LLTDGYYGPKMDIWAVGCVF-FEILSLFPLFPGTNELDQI 208
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 36/166 (21%)
Query: 689 LIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
LIG GGFG VY+ + +Q ++ + E +M+++ + N+ +
Sbjct: 19 LIGCGGFGCVYETQCASDHCI-----NNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73
Query: 749 NEEFKAL----VLEYMPHGS------------LEKYLYSSNCILDIFQRL---------N 783
+ + + +Y GS LEK + ++ +IF+R+ N
Sbjct: 74 WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTK---EIFKRIKCKNKKLIKN 130
Query: 784 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829
IM D+ + LEY+H + H D+KP N+++D N ++ D+ IA
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAP 853
L+F + +I+ DLK NVLLD L+D+ + K + T T T Y+AP
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFCGTPNYIAP 165
Query: 854 EYGREGRVSANGDVYSFGIMLMETFTGKKPTD 885
E R + D ++ G+++ E G+ P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 48/206 (23%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFK-SFDVECEIMKSIRHRNLI---KVIS 745
+GRG +G VYKA DG + G S E +++ ++H N+I KV
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 746 SCSNEEFKALVLEYMPHG--SLEKYLYSSNCILDIFQRLNIMID--VASALEYLHFGYSA 801
S ++ + L+ +Y H + K+ +S Q M+ + L+ +H+ ++
Sbjct: 69 SHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 802 PVIHCDLKPSNVLL----DDNMVAHLSDFSIAKMLTGEDQSMIQTQ-TLATIGYMAPEYG 856
V+H DLKP+N+L+ + ++D A++ + + + T Y APE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 857 REGRVSANG-DVYSFGIMLMETFTGK 881
R D+++ G + E T +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 48/227 (21%), Positives = 93/227 (40%), Gaps = 39/227 (17%)
Query: 690 IGRGGFGSVYKASL---------GDGMEVAVKVFTSQCGRAFK----SFDVECEIMKSIR 736
+GRG +Y L G E +KV + + +F +M+ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
H++++ + C + +V E++ G L+ +++ + +L + + +ASAL YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 797 FGYSAPVIHCDLKPSNVLL-------DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG 849
++H ++ N+LL + LSD I + + + + + I
Sbjct: 123 ---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQECVERIP 173
Query: 850 YMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 895
++APE + + S D +SFG L E +NGE+ LK
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 22/61 (36%), Positives = 30/61 (49%), Gaps = 2/61 (3%)
Query: 328 LKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNK 387
LK DLS N L I G +L+ +S N++ PE S L +LR++ L GN
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGL--PNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 388 L 388
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 8/155 (5%)
Query: 728 ECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMI 786
E I+++I H ++I++ + + +F L+L P + Y Y ++ + I L I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 787 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846
V A++YLH +IH D+K N+ ++ L DF A + +
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-G 245
Query: 847 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK 881
TI APE D++S GI+L E T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.003
Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 10/106 (9%)
Query: 755 LVLEYMPHGSLEKYLYSSNCILDIFQR---LNIMIDVASALEYLHFGYSAPVIHCDLKPS 811
LV+EY+ G ++ L+ I F + + +VA AL+YLH +IH DLKP
Sbjct: 81 LVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPD 133
Query: 812 NVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
N+L+ + L+DF ++K+ + +M+ T ++ +Y R
Sbjct: 134 NMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSR 179
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 48/169 (28%), Positives = 69/169 (40%), Gaps = 50/169 (29%)
Query: 689 LIGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNL------ 740
+IGRG FG V D G A+K KS +E E + +R R++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERDILAEADN 60
Query: 741 ---IKVISSCSNEEFKALVLEYMPHGS----LEKY---------LYSSNCILDIFQRLNI 784
+K+ S +E + L++EY+P G L K Y + IL
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL-------- 112
Query: 785 MIDVASALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832
A++ +H GY IH D+KP N+LLD LSDF + L
Sbjct: 113 ------AIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 19/61 (31%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 353 SLEEFKMSNCNISGGIPEEI-SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNK 411
+L+ +SN ++ IP+ L NL+ + L GN L S L L+ L L N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 412 L 412
L
Sbjct: 60 L 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 979 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.24 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.23 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.2 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.18 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.96 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.94 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.91 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.79 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.64 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.62 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-113 Score=1092.76 Aligned_cols=899 Identities=31% Similarity=0.497 Sum_probs=666.3
Q ss_pred CChhHHHHHHHHHHhcccCCCCccccccCCCCCCCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccC
Q 002021 26 STITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSF 105 (979)
Q Consensus 26 ~~~~~~~all~~k~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~ 105 (979)
..+.|++||++||+++. ||.+.+ .+|+.+.+||.|.||+|+. .++|+.|||++|+++|.+++.+..+++|++|||++
T Consensus 26 ~~~~~~~~l~~~~~~~~-~~~~~~-~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~ 102 (968)
T PLN00113 26 LHAEELELLLSFKSSIN-DPLKYL-SNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSN 102 (968)
T ss_pred CCHHHHHHHHHHHHhCC-CCcccC-CCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCC
Confidence 35689999999999994 787766 5898888999999999984 56899999999999999999999999999999999
Q ss_pred CcccccCCcccc-ccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecc
Q 002021 106 NRLFGSIPSAIF-TTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLA 184 (979)
Q Consensus 106 n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~ 184 (979)
|+++|.+|..++ .+.+|++|+|++|+++|.+|. +.+++|++|||++|.+++. +|..++++++|++|+|+
T Consensus 103 n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~--------~p~~~~~l~~L~~L~L~ 172 (968)
T PLN00113 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGE--------IPNDIGSFSSLKVLDLG 172 (968)
T ss_pred CccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCccccc--------CChHHhcCCCCCEEECc
Confidence 999999998877 888999999999998887775 4577888888888887754 66777777777777777
Q ss_pred cccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccc
Q 002021 185 ANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGT 264 (979)
Q Consensus 185 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 264 (979)
+|.+.+.+|..++++++|++|+|++|++.+..|..+.++++|+.|+|++|++++..+. .+..+++|++|++++|++++.
T Consensus 173 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~ 251 (968)
T PLN00113 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY-EIGGLTSLNHLDLVYNNLTGP 251 (968)
T ss_pred cCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCCh-hHhcCCCCCEEECcCceeccc
Confidence 7777777777777777777777777777777777777777777777777777654443 356677777777777777777
Q ss_pred cCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCc
Q 002021 265 IPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPR 344 (979)
Q Consensus 265 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~ 344 (979)
+|..+.++++|++|+|++|.+++.+|..+.++++|++|+|++|.++...+. .+.++++|++|++++|.+.+..+.
T Consensus 252 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~-----~~~~l~~L~~L~l~~n~~~~~~~~ 326 (968)
T PLN00113 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE-----LVIQLQNLEILHLFSNNFTGKIPV 326 (968)
T ss_pred cChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCCh-----hHcCCCCCcEEECCCCccCCcCCh
Confidence 777777777777777777777766677777777777777777766543322 234555555555555555443332
Q ss_pred cccccc-----------------------cccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCC
Q 002021 345 TTVGNL-----------------------SHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQK 401 (979)
Q Consensus 345 ~~~~~l-----------------------~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 401 (979)
.+. .+ .++|+.|++++|++++.+|..+..+++|+.|++++|++.+..|..+..+++
T Consensus 327 ~~~-~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~ 405 (968)
T PLN00113 327 ALT-SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405 (968)
T ss_pred hHh-cCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCC
Confidence 211 11 124445555555554444555555555555555555555555555666666
Q ss_pred CcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccc-cccccccCcCCCcEEEecc
Q 002021 402 LQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSS 480 (979)
Q Consensus 402 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~ls~ 480 (979)
|+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|++|++++|++. .+|. ....++|+.|++++
T Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~-~~~~~~L~~L~ls~ 484 (968)
T PLN00113 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD-SFGSKRLENLDLSR 484 (968)
T ss_pred CCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCc-ccccccceEEECcC
Confidence 666666666666666666666666666677777666666666666777777777777766 3443 33457888899999
Q ss_pred ccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCC
Q 002021 481 NFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP 560 (979)
Q Consensus 481 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 560 (979)
|++++..|..+..+++|+.|+|++|++++.+|..+.++++|++|+|++|++++.+|..|.++++|+.|||++|++++.+|
T Consensus 485 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 564 (968)
T PLN00113 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564 (968)
T ss_pred CccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCccccCeEeccCCcccccCCCCCCCCCcccccccCCccccCCC-CCCCCCCCCccccCccccceeehhhhhhHHHH
Q 002021 561 ASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP-NLQIPPCKTSIHHKSWKKSILLGIVLPLSTTF 639 (979)
Q Consensus 561 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~p-~~~~~~~~~~~~~~~~~~~~~~~iv~~~~~~~ 639 (979)
..+..+++|+.|++++|+++|.+|..+.+.++...++.||+.+||.+ ....|||....... ...+++++++++++++
T Consensus 565 ~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~--~~~~~~~~~~~~~~~~ 642 (968)
T PLN00113 565 KNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTP--SWWFYITCTLGAFLVL 642 (968)
T ss_pred hhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccc--eeeeehhHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999864 34567886432211 1122222222222222
Q ss_pred HHHHHHHHHHhHhcCCCCCC-CCCCCccc----ccccccHHHHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEE
Q 002021 640 MIVVILLILRYRQRGKRPSN-DANGPLVA----SRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKV 713 (979)
Q Consensus 640 ~~~~i~~~~~~r~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~ 713 (979)
++++++++++++++..+.+. ........ ................++..+.||+|+||.||+|.. .+++.||||+
T Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~ 722 (968)
T PLN00113 643 ALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE 722 (968)
T ss_pred HHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEE
Confidence 22222233222222111111 10000000 000011122233345677888999999999999964 6889999999
Q ss_pred eccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHH
Q 002021 714 FTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 793 (979)
Q Consensus 714 ~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~ 793 (979)
+.... .....|++++++++|||||+++++|.+++..++||||+++|+|.++++. ++|.++.+|+.|+|+|++
T Consensus 723 ~~~~~----~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~ 794 (968)
T PLN00113 723 INDVN----SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALR 794 (968)
T ss_pred ccCCc----cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHH
Confidence 86432 1224578999999999999999999999999999999999999999853 789999999999999999
Q ss_pred HHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHH
Q 002021 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 873 (979)
Q Consensus 794 ~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 873 (979)
|||+.++++|+||||||+||+++.++.+++. ||....... .....+|+.|+|||++.+..+++++|||||||+
T Consensus 795 yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvv 867 (968)
T PLN00113 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLI 867 (968)
T ss_pred HhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHH
Confidence 9997777899999999999999999888875 665543211 122367899999999999999999999999999
Q ss_pred HHHHHcCCCCCcccccCcchHhHhhhhhcCCc-cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHH
Q 002021 874 LMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKE 952 (979)
Q Consensus 874 l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 952 (979)
+|||+||+.||+...........|++...... .....|+...... ........++.+++.+||+.||++||||.|
T Consensus 868 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e 943 (968)
T PLN00113 868 LIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV----SVNQNEIVEVMNLALHCTATDPTARPCAND 943 (968)
T ss_pred HHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC----CccHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence 99999999999765555556666765443322 2233333332111 112234567899999999999999999999
Q ss_pred HHHHHHHhHHhhcc
Q 002021 953 IVTKLLKIRDSLLR 966 (979)
Q Consensus 953 il~~L~~~~~~~~~ 966 (979)
++++|+++......
T Consensus 944 vl~~L~~~~~~~~~ 957 (968)
T PLN00113 944 VLKTLESASRSSSS 957 (968)
T ss_pred HHHHHHHhhccccc
Confidence 99999999774443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-58 Score=584.20 Aligned_cols=494 Identities=37% Similarity=0.562 Sum_probs=421.2
Q ss_pred CCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCcccc-CCCCCcEEEccCCccCchhhhhhhccCCcccC
Q 002021 95 LSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFIS-NKSSLQHLDLSSNALSGEIRANICREIPREFG 173 (979)
Q Consensus 95 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~ 173 (979)
..+++.|||++|+++|.+|..+..+++|++|+|++|+++|.+|..+. ++++|++|||++|.++|. +|. +
T Consensus 68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~--------~p~--~ 137 (968)
T PLN00113 68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS--------IPR--G 137 (968)
T ss_pred CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccc--------cCc--c
Confidence 35799999999999999999999999999999999999999998765 999999999999999875 554 5
Q ss_pred CCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCE
Q 002021 174 NLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253 (979)
Q Consensus 174 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~ 253 (979)
.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+..|..+.++++|+.|+|++|.+++..+. .+..+++|++
T Consensus 138 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~ 216 (968)
T PLN00113 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR-ELGQMKSLKW 216 (968)
T ss_pred ccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCCh-HHcCcCCccE
Confidence 689999999999999999999999999999999999999999999999999999999999999876654 5789999999
Q ss_pred EEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEc
Q 002021 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDL 333 (979)
Q Consensus 254 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~L 333 (979)
|+|++|++++.+|..++++++|++|++++|.+++.+|..|+++++|++|+|++|+++...+ .++.++++|++|++
T Consensus 217 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p-----~~l~~l~~L~~L~L 291 (968)
T PLN00113 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP-----PSIFSLQKLISLDL 291 (968)
T ss_pred EECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCc-----hhHhhccCcCEEEC
Confidence 9999999999999999999999999999999999999999999999999999999976432 24778899999999
Q ss_pred cCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccC
Q 002021 334 SYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLE 413 (979)
Q Consensus 334 s~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 413 (979)
++|.+.+..|..+. . .++|+.|++++|.+++.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|++.
T Consensus 292 s~n~l~~~~p~~~~-~-l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~ 369 (968)
T PLN00113 292 SDNSLSGEIPELVI-Q-LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369 (968)
T ss_pred cCCeeccCCChhHc-C-CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeE
Confidence 99999877665432 2 367999999999999999999999999999999999999888888999999999999888888
Q ss_pred CCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccc-ccccccc------------------------
Q 002021 414 GSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFW------------------------ 468 (979)
Q Consensus 414 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~------------------------ 468 (979)
+.+|..++.+++|+.|++++|++.+..|..+..+++|+.|++++|+++ .+|..+.
T Consensus 370 ~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 449 (968)
T PLN00113 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKW 449 (968)
T ss_pred eeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhc
Confidence 777777766666666666666666555655555555555555555555 3444444
Q ss_pred CcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCccccccccccc
Q 002021 469 NLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFL 548 (979)
Q Consensus 469 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 548 (979)
.+++|+.|++++|++.+.+|..+ ...+|+.||+++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|++|
T Consensus 450 ~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 528 (968)
T PLN00113 450 DMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSL 528 (968)
T ss_pred cCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEE
Confidence 44555555555555555555444 23677888888888888999999999999999999999999999999999999999
Q ss_pred ccccccccccCCccccCccccCeEeccCCcccccCCCC-CCCCCcccccccCCccccCCC
Q 002021 549 NLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG-GSFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 549 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~p 607 (979)
+|++|++++.+|..+..+++|+.|+|++|+++|.+|.. ..+..+..+.+.+|+..+.-|
T Consensus 529 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 529 DLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred ECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 99999999999999999999999999999999999973 346678888999998877555
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=427.16 Aligned_cols=290 Identities=43% Similarity=0.673 Sum_probs=246.9
Q ss_pred ccccccHHHHHHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEee
Q 002021 668 SRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747 (979)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 747 (979)
..+.|++.++..+|++|...+.||+|+||.||+|...+|+.||||++........++|..|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988765432145699999999999999999999999
Q ss_pred ccCC-eeEEEEEecCCCccceeeccCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEe
Q 002021 748 SNEE-FKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 825 (979)
Q Consensus 748 ~~~~-~~~lv~E~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D 825 (979)
.+.+ +++||||||++|+|+++++.... .++|.+|++|+.++|+||+|||+.+..+|+||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999998766 899999999999999999999988888999999999999999999999999
Q ss_pred eccccccCCCCCcceeccc-ccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccc-cCcchHhHhhhhhcC
Q 002021 826 FSIAKMLTGEDQSMIQTQT-LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF-NGEMTLKHWVNDWLP 903 (979)
Q Consensus 826 fg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~-~~~~~~~~~~~~~~~ 903 (979)
||+|+..+...... ... .||.+|+|||+...+..+.++|||||||++.|++||+.|.+... .++..+..|......
T Consensus 221 FGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99996653211111 112 79999999999999999999999999999999999999987654 345557888755554
Q ss_pred C-ccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 904 I-STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 904 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
. ...+++|+++...... . ......+..++.+|++.+|.+||+|.||++.|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~-~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYP-D---EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCC-h---HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 4 5778899887631111 0 13455689999999999999999999999999666543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=401.77 Aligned_cols=261 Identities=30% Similarity=0.458 Sum_probs=216.7
Q ss_pred CCCCceeeeecceEEEEEEcCCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEeeccCC-eeEEEEEec
Q 002021 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEE-FKALVLEYM 760 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~ 760 (979)
+...+.||+|+||+||+|.|.....||||++...... ..+.|.+|+.+|++++|||||+++|+|.++. ..++||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3445669999999999999965444999999765422 2468999999999999999999999999887 799999999
Q ss_pred CCCccceeecc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCCEEeCCCC-cEEEEeeccccccCCCCC
Q 002021 761 PHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAP-VIHCDLKPSNVLLDDNM-VAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 761 ~~g~L~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-i~H~Dik~~NIll~~~~-~~kl~Dfg~~~~~~~~~~ 837 (979)
++|+|.++++. .+..+++..+++++.|||+|+.||| +++ |||||+||+|||++.++ .+||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999999988 4778999999999999999999999 788 99999999999999997 99999999998764322
Q ss_pred cceecccccCCCCCCccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 838 SMIQTQTLATIGYMAPEYGR--EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||......+. ...+.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--~~~v~---------------- 259 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--ASAVV---------------- 259 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH----------------
Confidence 2234468999999999999 56899999999999999999999999987544211 11110
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
....+...+..|++.+..+|.+||..||++||++.|++..|+.+........
T Consensus 260 -~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~ 311 (362)
T KOG0192|consen 260 -VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAG 311 (362)
T ss_pred -hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence 0111222233477889999999999999999999999999999988665443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=379.87 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=211.0
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCC-eeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-FKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E 758 (979)
++++..+.||+|..|+|||+. ..+++.+|+|++....+ ...+++.+|++++++.+||+||.+||+|..++ ..+++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 345566899999999999994 45799999999965433 34678899999999999999999999999888 5999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
||++|+|++++... .++++...-+|+.+|++||.|||+ .++|+||||||+|||+++.|+|||||||.+..+...
T Consensus 159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999998765 469999999999999999999994 499999999999999999999999999999887533
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+..... .+.++.-.....
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~------------~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI------------FELLCAIVDEPP 299 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH------------HHHHHHHhcCCC
Confidence 3366789999999999999999999999999999999999999987642222221 122222222111
Q ss_pred hhhhHHHH-HHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 919 DIHFVAKE-QCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~-~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+..+. .+++++.+++..|+++||.+||+++|+++|
T Consensus 300 ---P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 ---PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11122 478899999999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=400.78 Aligned_cols=255 Identities=31% Similarity=0.513 Sum_probs=221.0
Q ss_pred CCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCC
Q 002021 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 763 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 763 (979)
+...+.||+|.||+||.|.|.....||+|.++.. ....++|.+|+++|++++|++||+++++|..++..|||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456789999999999999987779999999754 234578999999999999999999999999999999999999999
Q ss_pred ccceeecc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 764 SLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 764 ~L~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
+|.+|++. .+..+...+.+.++.|||+|++||+ ++++||||+.++|||++++..+||+|||+|+... .+......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTASE 362 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccC-CCceeecC
Confidence 99999997 5678999999999999999999999 9999999999999999999999999999999543 34444445
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (979)
...-++.|.|||.+..+.++.|+|||||||+|||++| |+.||..+...+. +. .-+.+.+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-----~~---------------~le~GyR 422 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-----LE---------------LLERGYR 422 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-----HH---------------HHhccCc
Confidence 5556889999999999999999999999999999999 9998876332211 11 1134556
Q ss_pred hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
.+.|+.||++++++|..||..+|++|||++.+...++++...
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 778889999999999999999999999999988888887754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=375.61 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=209.0
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccccc-------chhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGR-------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
+.|.+.+.||+|+||.|-+| +..+|+.||||++.+.... ......+|+++|++++||+||++.++|..++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 56778899999999999999 6778999999999654211 123356899999999999999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEEeecccc
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFSIAK 830 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~---~~~kl~Dfg~~~ 830 (979)
|+||||++||+|.+++-..+ .+.+.....+++|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999987765 5777888899999999999999 9999999999999999755 789999999999
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccc
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGR---VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM 907 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 907 (979)
..+ ....+.+.+||+.|.|||++.+.. +..++|+||+||++|-+++|..||.+.....-...+
T Consensus 328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ----------- 393 (475)
T KOG0615|consen 328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ----------- 393 (475)
T ss_pred ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH-----------
Confidence 864 334457789999999999997654 334789999999999999999999874333211111
Q ss_pred hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
-........++.+..++.+..++|.+++..||++|||++|+++|
T Consensus 394 -----I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 394 -----ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -----HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11122223345667788899999999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=368.75 Aligned_cols=201 Identities=31% Similarity=0.512 Sum_probs=180.8
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccc--cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.++|...+.||+|+||+||+|++ .++..||||.+.+. ..+..+....|+++++.++|||||.+++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46788888999999999999954 57899999999765 3445677788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC------CcEEEEeeccccc
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN------MVAHLSDFSIAKM 831 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~------~~~kl~Dfg~~~~ 831 (979)
|||+||+|.+|++..+ .+++..++.++.|+|.|+++|| +++|+||||||+|||++.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999998875 6999999999999999999999 9999999999999999864 5689999999998
Q ss_pred cCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccc
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF 888 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~ 888 (979)
+.+. ....+.+|++-|||||++...+|+.|+|+||+|+|+||+++|+.||+...
T Consensus 165 L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 165 LQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred CCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 8532 23356789999999999999999999999999999999999999998643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=404.50 Aligned_cols=260 Identities=31% Similarity=0.525 Sum_probs=225.5
Q ss_pred CCCCCCceeeeecceEEEEEEcC------CCcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
.+.+..+.||+|+||+||+|+.. +...||||.++...+. ...+|++|++++..++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44566788999999999999643 3467999999887665 7789999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 002021 755 LVLEYMPHGSLEKYLYSS-------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~ 821 (979)
+|+|||..|||.+|++.. +..++..+.+.|+.|||.|++||- ++.+||||+..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 999999999999999643 123788999999999999999999 9999999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhh
Q 002021 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~ 900 (979)
||+|||+++..-..+++.......-+++|||||.+..++|+.++|||||||+|||+++ |+.||+...+.+.- ..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI-e~---- 717 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI-EC---- 717 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-HH----
Confidence 9999999998877777766666778899999999999999999999999999999999 99999875444321 10
Q ss_pred hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
.+.... ...++.||.++++||..||+..|++||+++||-..|+....+.
T Consensus 718 --------------i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 718 --------------IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --------------HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 111111 3567899999999999999999999999999999999887644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=385.06 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=211.9
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccc---cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQ---CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
..|...+.||+|||+.||.++. .+|+.||+|++.+. .....+...+|++|.+.++|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688999999999999999955 89999999999753 2345677889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
|.|+.++|.++++ .+..+++.+++.+++||+.|+.||| +++|+|||+|..|++++++.+|||+|||+|..+..++.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999887 4558999999999999999999999 99999999999999999999999999999998864432
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
+..+.+|||-|.|||++.....+..+||||+||++|-|+.|++||+.. .-+..+...+.
T Consensus 174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-~vkety~~Ik~------------------ 232 (592)
T KOG0575|consen 174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-TVKETYNKIKL------------------ 232 (592)
T ss_pred --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-hHHHHHHHHHh------------------
Confidence 345679999999999999889999999999999999999999999752 11111111100
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. ....|...+.++.+||.++++.+|.+|||+++|+.|
T Consensus 233 ~--~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 233 N--EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred c--CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 111222455678999999999999999999999987
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=389.74 Aligned_cols=470 Identities=29% Similarity=0.400 Sum_probs=345.6
Q ss_pred EEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccC
Q 002021 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSS 153 (979)
Q Consensus 74 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 153 (979)
...+++++|+++ .+.+.+.+|..|.+|++++|++. ++|++++.+..++.|+.++|+++ .+|++++.+.+|+.|+.++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 567889999988 56677889999999999999998 89999999999999999999999 8899999999999999999
Q ss_pred CccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccC
Q 002021 154 NALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQD 233 (979)
Q Consensus 154 N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 233 (979)
|.+. ++|++++.+..|+.|+..+|+++ ..|+.++++.+|..|++.+|++....|..+. ++.|++||+..
T Consensus 124 n~~~---------el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~ 192 (565)
T KOG0472|consen 124 NELK---------ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNS 192 (565)
T ss_pred ccee---------ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccch
Confidence 9886 58899999999999999999998 6788888999999999999999988666554 77777777777
Q ss_pred CCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecccccccccc
Q 002021 234 NSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313 (979)
Q Consensus 234 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 313 (979)
|.+... |..++.+.+|..|+|.+|+|. ..| .|.++..|.+|+++.|+|..++
T Consensus 193 N~L~tl--------------------------P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lp 244 (565)
T KOG0472|consen 193 NLLETL--------------------------PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLP 244 (565)
T ss_pred hhhhcC--------------------------ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhH
Confidence 666544 444444444555555555544 233 4455555555555555554444
Q ss_pred chhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhH
Q 002021 314 QELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSIL 393 (979)
Q Consensus 314 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 393 (979)
.+. ++++..|..|||..|+++..+.... +..+|+.||+++|.|+ ..|.+++++ .|+.|-+.||.+..+--
T Consensus 245 ae~-----~~~L~~l~vLDLRdNklke~Pde~c---lLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr 314 (565)
T KOG0472|consen 245 AEH-----LKHLNSLLVLDLRDNKLKEVPDEIC---LLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRR 314 (565)
T ss_pred HHH-----hcccccceeeeccccccccCchHHH---HhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHH
Confidence 432 3444555555555555544433211 2345666666666666 356667777 77777777777642211
Q ss_pred H-----------------------------------------hhhcCCCCcEEEecCcccCCCccccccCCCC---CceE
Q 002021 394 I-----------------------------------------TLSKLQKLQDLGLKDNKLEGSIPYDICNLAE---LYRL 429 (979)
Q Consensus 394 ~-----------------------------------------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L 429 (979)
. ....+.+.+.|++++-+++ .+|+......+ ....
T Consensus 315 ~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~V 393 (565)
T KOG0472|consen 315 EIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSV 393 (565)
T ss_pred HHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEE
Confidence 1 1123445677888888887 45655444444 7788
Q ss_pred ecCCCcccccCCccccCCCcCc-eEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccC
Q 002021 430 DLDGNKLSGSIPACFSNLTSLR-IVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFS 508 (979)
Q Consensus 430 ~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 508 (979)
+++.|++. ++|..+..+..+. .+.+++|.+.-+|..+..+++|..|+|++|.+. .+|..++.+..|+.||+|.|+|.
T Consensus 394 nfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr 471 (565)
T KOG0472|consen 394 NFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR 471 (565)
T ss_pred ecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc
Confidence 88888887 6777777776654 466777788888888888999999999988887 68888888888999999999887
Q ss_pred cccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCC-CC
Q 002021 509 GVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR-GG 587 (979)
Q Consensus 509 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~ 587 (979)
.+|..+-.+..|+.+-.++|++....|..+.+|.+|..|||.+|.+. .+|+.+++|++|++|+++||+|. .++. ..
T Consensus 472 -~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iL 548 (565)
T KOG0472|consen 472 -MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRHQIL 548 (565)
T ss_pred -cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHHHHh
Confidence 78888888888888888889998666666899999999999999998 78889999999999999999998 3232 22
Q ss_pred CCCCcccccccCCc
Q 002021 588 SFGNFSAQSFEGNE 601 (979)
Q Consensus 588 ~~~~~~~~~~~~N~ 601 (979)
..++...++|.+++
T Consensus 549 mkgT~aiL~ylrdr 562 (565)
T KOG0472|consen 549 MKGTAAILSYLRDR 562 (565)
T ss_pred ccChHHHHHHhccc
Confidence 33444455666654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=347.30 Aligned_cols=268 Identities=22% Similarity=0.289 Sum_probs=207.7
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
+.|+...++|+|+||+|||++ .++|+.||||+|....+ ...+...+|++++++++|||+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457778899999999999995 45799999999964432 234567899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
||+. ++.+-+......++.+.+.+++.|++.|+.|+| +++++||||||+|||++.++.+|+||||+|+.+..++.
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence 9988 555556666667899999999999999999999 99999999999999999999999999999998864333
Q ss_pred ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHh--HhhhhhcCCcc---------
Q 002021 839 MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK--HWVNDWLPIST--------- 906 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~--~~~~~~~~~~~--------- 906 (979)
..+..+.|.+|.|||.+.+ .+|++.+||||+||++.||++|..-|....+-+..+. ..+....+...
T Consensus 157 -~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 157 -NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred -hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 3467789999999999887 6899999999999999999999998876443332221 11121111110
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+--+.....+.. ..........+.+++.+|+..||.+|++.+|++.|
T Consensus 236 ~Gv~lP~~~~~epL-e~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPL-ERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccch-hhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00000111000000 01112344568999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.32 Aligned_cols=250 Identities=29% Similarity=0.347 Sum_probs=206.6
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||+||.+ +.++++.+|+|++++.. ..+.+...+|..++.+++||+||+++..|++++..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 367999999999999999999 55679999999997653 23467788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
+||+.||.|.-++++.+ .+++..+..++.+|+.||.||| +++|+|||+||+|||+|++|.++|+|||+++.....
T Consensus 104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~- 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD- 178 (357)
T ss_pred EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence 99999999999998754 6999999999999999999999 999999999999999999999999999999864322
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.....+.+||+.|||||++.+..|+.++|.||+|+++|||++|..||...... .+.+...... .
T Consensus 179 -~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~~I~~~k--------~-- 242 (357)
T KOG0598|consen 179 -GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYDKILKGK--------L-- 242 (357)
T ss_pred -CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHHHHhcCc--------C--
Confidence 22335579999999999999999999999999999999999999999763211 1111111111 0
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCC----CHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI----NAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~eil~~ 956 (979)
...+...+.+..+++.+.++.||++|. ++.+|.+|
T Consensus 243 -----~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 243 -----PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred -----CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 001112345689999999999999996 55555443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.58 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=206.3
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEE-eeccCCe-eEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVIS-SCSNEEF-KALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 756 (979)
.+|++.+.||+|.||+|||+ ...+|..||.|.+.-.. ....+....|+.+|++++|||||+.++ .|.++.. .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 45677789999999999999 67799999999886332 334566778999999999999999999 5555444 8999
Q ss_pred EEecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 757 LEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
|||+++|+|.+.++. .+..+++..+++++.|++.||.++|..+.+ -|+||||||.||+++.+|.||++|||++++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999988753 466899999999999999999999943333 3889999999999999999999999999987
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.... ......+|||.||+||.+.+..|+.++||||+||++|||+.-+.||.+. .+....+ -
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~---------K--- 239 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK---------K--- 239 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH---------H---
Confidence 5332 2335678999999999999999999999999999999999999999763 1111100 0
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
+...+......+.++.++..|+..|+.+||+.||+...++..+.+
T Consensus 240 --I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 240 --IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111111112225677889999999999999999997666655544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=373.39 Aligned_cols=267 Identities=25% Similarity=0.401 Sum_probs=216.4
Q ss_pred HHHHHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe
Q 002021 675 LELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF 752 (979)
Q Consensus 675 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (979)
.++....+++.....||+|.||+||+|.|. | .||||++.... ....+.|+.|+.++++-+|.||+-+.|||..++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444445566778899999999999999994 3 59999986543 3457889999999999999999999999999888
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.+|+.||+|.+|+.+++..+.+++..+.+.|++|||+|+.||| .++|+|||+|..||+++++++|||+|||++..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 8999999999999999999889999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCCcceecccccCCCCCCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREG---RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
..-..........|...|||||+++.. .|++++||||||+|+|||+||..||... ...++.-.+
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~--~~dqIifmV----------- 605 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ--NRDQIIFMV----------- 605 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC--ChhheEEEe-----------
Confidence 222112222344577899999998754 5899999999999999999999999742 111111000
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
-.+...+. .-.....|+.++.+|+..||.+++++||.+.+|+..|+++..+
T Consensus 606 -GrG~l~pd--~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 606 -GRGYLMPD--LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -cccccCcc--chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 00000000 1123357888899999999999999999999999999998875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=362.69 Aligned_cols=268 Identities=27% Similarity=0.326 Sum_probs=212.9
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC--CeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 755 (979)
.+.|+.+++||+|.||.||+| +..+|+.||+|+++... +.......+||.||+++.||||+++.+...+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 355777789999999999999 66789999999997664 33445667899999999999999999988765 78999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|+|||++ +|..++....-.+++.++..+++|+++||+||| .+||+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999988 999999888888999999999999999999999 999999999999999999999999999999988644
Q ss_pred CCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcc-----------hHhHhhhhhcC
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM-----------TLKHWVNDWLP 903 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~-----------~~~~~~~~~~~ 903 (979)
. ....+..+.|.+|.|||++.+. .|+.++|+||.|||+.||++|+..|....+.+. .-.+|... +
T Consensus 272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~--k 348 (560)
T KOG0600|consen 272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS--K 348 (560)
T ss_pred C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc--c
Confidence 3 3336778899999999988764 699999999999999999999998875322111 11112211 1
Q ss_pred CccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+.+..--+...+ ......+....+|+..++..||.+|.||.+++++
T Consensus 349 LP~~~~~kp~~~y~r~l~-E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLR-ETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHH-HHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111122222111111111 1234566778999999999999999999998864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.96 Aligned_cols=267 Identities=23% Similarity=0.339 Sum_probs=210.5
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
+.|...+++|+|.||.||+| ...+|+.||||+++... +.......+|++.++.++||||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35777889999999999999 56789999999997543 2234567889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
||+. +|+..+++....++..++..++.++++|++||| .+.|+|||+||.|+|++++|.+||+|||+|+.+..++..
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9975 999999999889999999999999999999999 999999999999999999999999999999998766544
Q ss_pred ceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhh--------hhcCCc-cch
Q 002021 839 MIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN--------DWLPIS-TME 908 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~--------~~~~~~-~~~ 908 (979)
. +..+.|.+|.|||.+.+. .|+..+||||.|||+.||+-|.+-|....+-+ ++....+ .|.... ..+
T Consensus 158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-QL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-QLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-HHHHHHHHcCCCCcccCcccccccc
Confidence 3 444889999999988775 69999999999999999998876554322111 1111111 111111 111
Q ss_pred hhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+-.......... ....++.++.+++.+++.+||.+|++++|+++|
T Consensus 235 Y~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111111111111 223456678999999999999999999999987
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=383.83 Aligned_cols=272 Identities=24% Similarity=0.441 Sum_probs=232.5
Q ss_pred CCCCceeeeecceEEEEEEcC----CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 684 FSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
..+.++||.|.||+||+|+++ ....||||.++... ++...+|..|+.||.++.||||+++-|+.......++|+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 356689999999999999653 24569999998664 4567889999999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC-C
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED-Q 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 837 (979)
||++|+|+.|++.+...+++.+...++++||.|+.||. +.++||||+.++|||++.+..+|++|||+++.+.... .
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 99999999999999889999999999999999999999 9999999999999999999999999999999774332 2
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.+...+..-+.+|.|||.+...+++.++||||||+++||.++ |.+||-++.+.+. ++ .-
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV-----------------Ik---aI 847 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-----------------IK---AI 847 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-----------------HH---HH
Confidence 222233334689999999999999999999999999999998 9999866433221 11 11
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH--hhccCCCCcceeccCC
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD--SLLRNVGGRCVRQSNL 978 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~--~~~~~~~~~~~~~~~~ 978 (979)
+++++.+.+..||..+++||..||++|..+||++.||+.+|.++.. +..+.+.+...|++++
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~ 911 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQP 911 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCccc
Confidence 3456677888999999999999999999999999999999999987 5566677777776654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=353.43 Aligned_cols=292 Identities=26% Similarity=0.312 Sum_probs=229.9
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHh--cCCCCeeeEEEeeccCC----eeE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKS--IRHRNLIKVISSCSNEE----FKA 754 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~ 754 (979)
....+..+.||+|+||.||||.+ +++.||||+|... ..+.|..|.+|++. ++|+||++++++-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 35566778999999999999998 5699999999743 45778889888775 58999999999875554 789
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEecCCCCCCEEeCCCCcEEEEeecc
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG------YSAPVIHCDLKPSNVLLDDNMVAHLSDFSI 828 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~ 828 (979)
||+||.+.|+|.+|+..+ .++|.+..+|+..+++||+|||++ .+++|+|||||++|||+..|+++.|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999999876 699999999999999999999954 477999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCCCCCCccccCCCC------CCCchhHHHHHHHHHHHHcCCCCCc--ccccCcchHhHhhhh
Q 002021 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGREGR------VSANGDVYSFGIMLMETFTGKKPTD--EIFNGEMTLKHWVND 900 (979)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg~~P~~--~~~~~~~~~~~~~~~ 900 (979)
|..+.+..........+||.+|||||++.+.. .-.+.||||+|.|+||+++++.-++ ...+.+..+..-++.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99887554444445578999999999986542 2246899999999999999887653 333334445444444
Q ss_pred hcCCccc-hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceeccCC
Q 002021 901 WLPISTM-EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQSNL 978 (979)
Q Consensus 901 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~~~~ 978 (979)
.+....+ +++.....+..-...+.....+..+.+.++.||..||+.|.|+.=+-+.+.++........+..+.+..++
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~~~~~s~~~~~~~ 521 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWEDSSGESSSSLVTP 521 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCccCCccccccCCC
Confidence 4433323 33333333333344455556677899999999999999999999999999999876666566666555443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=360.04 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=212.1
Q ss_pred HhhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCee
Q 002021 679 RATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (979)
+...+|..++.||+|+|++||+| +..+++.+|||++.+.- +...+-+..|-++|.++ .||.|++++..|+++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34578999999999999999999 56689999999986432 23345567799999999 799999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
|+|+||+++|+|.++|.+.+ .+++.-++.++.||+.|++||| ++|||||||||+|||+|+++++||+|||.|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999998874 7999999999999999999999 9999999999999999999999999999999875
Q ss_pred CCCCc---------c--eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc
Q 002021 834 GEDQS---------M--IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 834 ~~~~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
+.... . .....+||..|.+||++..+..++.+|+|+||||+|+|+.|+.||.+.-+. ..+..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqk------ 298 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQK------ 298 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHH------
Confidence 43221 1 114578999999999999999999999999999999999999999762111 11111
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
+++ .....++.+++.+.+|+.+.+..||.+|+|++||.+|-
T Consensus 299 ------I~~--------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 299 ------IQA--------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ------HHH--------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 111 11123345667899999999999999999999998874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=374.92 Aligned_cols=475 Identities=26% Similarity=0.355 Sum_probs=395.3
Q ss_pred cEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEcc
Q 002021 73 RVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLS 152 (979)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 152 (979)
-.++|++++|+++ ++|++++.+..+..|+.++|+++ ++|.+++.+.+|+.|+.++|.+. .+|+.++.+..|+.||..
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 4789999999999 78999999999999999999998 89999999999999999999999 788899999999999999
Q ss_pred CCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeecc
Q 002021 153 SNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQ 232 (979)
Q Consensus 153 ~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 232 (979)
+|+++ .+|+.++++.+|..|++.+|++....|..+. ++.|++||...|-++.+ |..++.+.+|..|+|.
T Consensus 146 ~N~i~---------slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tl-P~~lg~l~~L~~LyL~ 214 (565)
T KOG0472|consen 146 NNQIS---------SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETL-PPELGGLESLELLYLR 214 (565)
T ss_pred ccccc---------cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcC-ChhhcchhhhHHHHhh
Confidence 99997 4799999999999999999999966666555 99999999999999877 6689999999999999
Q ss_pred CCCCcCCCcccccCCCCCcCEEEccCCccccccCcccc-cCCCCcEEeccccccccccCccccccccccceecccccccc
Q 002021 233 DNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311 (979)
Q Consensus 233 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 311 (979)
+|+|...+ .|.++..|++|+++.|+|+ .+|.... ++++|.+|||..|+++ ..|+.++-+.+|++||+|+|.|++
T Consensus 215 ~Nki~~lP---ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 215 RNKIRFLP---EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS 289 (565)
T ss_pred hcccccCC---CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc
Confidence 99999766 4789999999999999999 6666655 8999999999999999 679999999999999999999999
Q ss_pred ccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEE--ccCcccc---C------C-CC---ccccCCC
Q 002021 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFK--MSNCNIS---G------G-IP---EEISNLT 376 (979)
Q Consensus 312 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~--L~~n~i~---~------~-~p---~~l~~l~ 376 (979)
+|. +++++ .|+.|-+.+|++..+-....-+.-..-|++|. +..-.++ | . .+ .....+.
T Consensus 290 Lp~------sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i 362 (565)
T KOG0472|consen 290 LPY------SLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAII 362 (565)
T ss_pred CCc------ccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhh
Confidence 886 47888 99999999999876522211111000111111 0000110 0 1 11 1233466
Q ss_pred cccEEEecCCCCCchhHHhhhcCC--CCcEEEecCcccCCCccccccCCCCCceE-ecCCCcccccCCccccCCCcCceE
Q 002021 377 NLRTIYLGGNKLNGSILITLSKLQ--KLQDLGLKDNKLEGSIPYDICNLAELYRL-DLDGNKLSGSIPACFSNLTSLRIV 453 (979)
Q Consensus 377 ~L~~L~L~~N~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L 453 (979)
+.+.|++++-+++..+...|.... -.+..+++.|++. .+|..+..+..+.+. .+++|.+ +.+|..++.+++|..|
T Consensus 363 ~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L 440 (565)
T KOG0472|consen 363 TTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFL 440 (565)
T ss_pred hhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceee
Confidence 889999999999977777775443 4889999999998 789888888776554 5555555 5899999999999999
Q ss_pred ecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccC
Q 002021 454 SLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 533 (979)
Q Consensus 454 ~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 533 (979)
+|++|-+.++|..++.+..|+.|++|.|+|. .+|..+-.+..|+.+-.++|++..+.|+.+.+|.+|..|||.+|.|.
T Consensus 441 ~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq- 518 (565)
T KOG0472|consen 441 DLSNNLLNDLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ- 518 (565)
T ss_pred ecccchhhhcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-
Confidence 9999999999999999999999999999998 68998888889998888999999888888999999999999999999
Q ss_pred CCCCcccccccccccccccccccccCCccccCccccCeEeccCCc
Q 002021 534 SIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578 (979)
Q Consensus 534 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 578 (979)
.+|..+++|++|++|+|++|.|+ ..+..+-.......|..-+++
T Consensus 519 ~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrdr 562 (565)
T KOG0472|consen 519 QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILSYLRDR 562 (565)
T ss_pred hCChhhccccceeEEEecCCccC-CCHHHHhccChHHHHHHhccc
Confidence 89999999999999999999998 555444333444444433333
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=396.40 Aligned_cols=267 Identities=28% Similarity=0.474 Sum_probs=226.6
Q ss_pred CCCCCCceeeeecceEEEEEEcC--CCc----EEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG--DGM----EVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
+..+..+.||+|+||+||.|... +|. .||||.+++..+ ....+|.+|+.+|+.++|||||+++|+|.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34556789999999999999653 343 389999876653 45678999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecc
Q 002021 755 LVLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSI 828 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~ 828 (979)
+++|||++|+|..|+++. ...++....+.++.|||+|+.||+ ++++|||||..+|+|+++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999987 677999999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccc
Q 002021 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTM 907 (979)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 907 (979)
|+.+...+.........-+..|||||.+..+.++.|+|||||||++||++| |..||.+..+.+. +..++
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~~~--------- 918 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLDVL--------- 918 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHHHH---------
Confidence 996655555444444456789999999999999999999999999999999 9999876432221 11111
Q ss_pred hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCc
Q 002021 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGR 971 (979)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~ 971 (979)
.+.+...+..|+..++++|.+||+.+|++||++.+|++.+.++......+....
T Consensus 919 ----------~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~ 972 (1025)
T KOG1095|consen 919 ----------EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGP 972 (1025)
T ss_pred ----------hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccc
Confidence 112455678899999999999999999999999999999999998877766443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=359.94 Aligned_cols=269 Identities=22% Similarity=0.250 Sum_probs=210.0
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccch-hcHHHHHHHHHhcC-CCCeeeEEEeeccCC-eeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAF-KSFDVECEIMKSIR-HRNLIKVISSCSNEE-FKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv 756 (979)
.+.|...+.||.|.||.||+| ...+|..||||+++..-.... -.-.+|++.++++. |||||++.+++.+.+ ..|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 456778899999999999999 567899999999865432222 22357999999998 999999999998877 99999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
||||+. +|++.+++++..++++.++.|+.||++||+|+| ++|+.|||+||+|||+..+..+||+|||+|+.+...+
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCC
Confidence 999976 999999999999999999999999999999999 9999999999999999999999999999999875443
Q ss_pred CcceecccccCCCCCCcccc-CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchH--hHhhhhhcCCccchh----
Q 002021 837 QSMIQTQTLATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL--KHWVNDWLPISTMEV---- 909 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~--~~~~~~~~~~~~~~~---- 909 (979)
. .+..+.|.+|+|||++ +.+.|+.+.||||+|||++|+.+-+.-|.+..+-++-+ .+.++.-..+.+.+-
T Consensus 165 P---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 165 P---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred C---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 3 3667889999999975 56789999999999999999999998776533222211 111111111111110
Q ss_pred --hcccc--cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 910 --VDANL--LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 910 --~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
+.-+. ..........+ +++.++.+++.+|+..||.+||||+|+++|-
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 00000 00011111222 3778899999999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=354.60 Aligned_cols=259 Identities=30% Similarity=0.428 Sum_probs=207.9
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC--eeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE--FKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E 758 (979)
.+|...+.||+|+||.||++.. ++|+..|||..........+...+|+++|++++|||||+.+|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 4577889999999999999954 458999999886553223566889999999999999999999754444 6899999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEEeeccccccCC-CC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFSIAKMLTG-ED 836 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfg~~~~~~~-~~ 836 (979)
|+++|+|.+++.+.+..+++..++..+.||++||+||| ++||+||||||+|||++. ++.+||+|||.++.... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999987667999999999999999999999 999999999999999999 79999999999987653 11
Q ss_pred CcceecccccCCCCCCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCcccccCcc-hHhHhhhhhcCCccchhhcccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEM-TLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.........||+.|||||++..+. ..+++||||+||++.||+||+.||........ .+......
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-------------- 239 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-------------- 239 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--------------
Confidence 122234578999999999998643 44699999999999999999999986411100 01100000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
..+..+...+.++.+++.+|+..+|++||||+|+++|--...+
T Consensus 240 -----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 240 -----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 0112334466779999999999999999999999999765443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=365.15 Aligned_cols=371 Identities=26% Similarity=0.288 Sum_probs=261.8
Q ss_pred eeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecccc
Q 002021 228 ILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307 (979)
Q Consensus 228 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 307 (979)
.|++++|+|+.+... .|..+++|++++|.+|.++ .+|.+.....+|+.|+|.+|.|+.+..+.+..++.|+.||||.|
T Consensus 82 ~LdlsnNkl~~id~~-~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 82 TLDLSNNKLSHIDFE-FFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeccccccccCcHH-HHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 344444444443322 3455666666666666665 55665555556777777777776666666677777777777777
Q ss_pred ccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCC
Q 002021 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNK 387 (979)
Q Consensus 308 ~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~ 387 (979)
.|+.++.. ++..-.++++|+|++|+|+.+....|. .+. +|..|.|++|+|+...+..|.++++|+.|+|..|+
T Consensus 160 ~is~i~~~-----sfp~~~ni~~L~La~N~It~l~~~~F~-~ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ 232 (873)
T KOG4194|consen 160 LISEIPKP-----SFPAKVNIKKLNLASNRITTLETGHFD-SLN-SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNR 232 (873)
T ss_pred hhhcccCC-----CCCCCCCceEEeecccccccccccccc-ccc-hheeeecccCcccccCHHHhhhcchhhhhhccccc
Confidence 77766543 455556677777777777766555443 232 67777777777777777777778888888888888
Q ss_pred CCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCcccccc-cc
Q 002021 388 LNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP-LT 466 (979)
Q Consensus 388 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp-~~ 466 (979)
|.-....+|.++++|+.|.|..|.|.....+.|..+.++++|+|+.|+++..-..++.+|++|+.|+|++|.|..|. ++
T Consensus 233 irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~ 312 (873)
T KOG4194|consen 233 IRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS 312 (873)
T ss_pred eeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch
Confidence 87666677888888888888888887777777888888888888888887777777788888888888888888664 34
Q ss_pred ccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCC---Ccccccc
Q 002021 467 FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP---NSFGDLI 543 (979)
Q Consensus 467 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~ 543 (979)
+...++|++|+|++|+|+...+..|..|..|++|+|++|.++..-...|..+++|+.|||++|.|++.+. ..|.+|+
T Consensus 313 WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~ 392 (873)
T KOG4194|consen 313 WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLP 392 (873)
T ss_pred hhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccch
Confidence 5556778888888888887777778888888888888888887777778888888888888888776554 3567788
Q ss_pred cccccccccccccccCCccccCccccCeEeccCCcccccCCCCCCCCCcccccccCCccccCCC
Q 002021 544 SLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 544 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~p 607 (979)
+|+.|+|.+|+|..+...+|..++.|+.|||.+|.+-..=|....-..+..+-+....++|++.
T Consensus 393 ~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 393 SLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ 456 (873)
T ss_pred hhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence 8888888888887666667888888888888888876554432211234455566666777665
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=343.28 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=215.8
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccc-cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQ-CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.+.|+....||.|..++||+| ....++.||||++.-. +....+.+++|+..|+.++||||++.+..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 467899999999999999999 6678899999999643 34456889999999999999999999999999999999999
Q ss_pred ecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 759 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||.+|++.+.+... ...+++..+..|.+++++||.||| .+|.+|||||+.||||+++|.|||+|||.+..+...+.
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999998765 456899999999999999999999 99999999999999999999999999999877654443
Q ss_pred cce-e-cccccCCCCCCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 838 SMI-Q-TQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 838 ~~~-~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
... . ...+||+.|||||++.. ..|+.|+||||||++..|+.+|..||....+-++.........+.. .....
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~-~t~~~--- 257 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL-LTSGL--- 257 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc-ccccC---
Confidence 221 1 45689999999999543 4699999999999999999999999988766555444332222111 11111
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+......+...+.+++..|++.||.+|||++++++|
T Consensus 258 -------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 258 -------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 112223344579999999999999999999999886
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.21 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=213.6
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
..|.....||+|+.|.||.| +..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|..++..++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45677789999999999999 56788999999997766566677889999999999999999999998889999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
+||+|.|.+... .+++.++..|++++++||+||| .++|+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K 425 (550)
T ss_pred CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence 999999998765 4899999999999999999999 99999999999999999999999999999987754332 4
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....+||+.|||||+.....|++++||||||++++||+-|..||-. +..+..... +......
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyL--------------Ia~ng~P 487 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYL--------------IATNGTP 487 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHH--------------HhhcCCC
Confidence 4678999999999999999999999999999999999999999864 111111000 0111222
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+...++..++.+.+++.+|++.||++|++|.|+++|
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 333456677889999999999999999999999987
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=362.75 Aligned_cols=380 Identities=27% Similarity=0.332 Sum_probs=198.8
Q ss_pred EEEEEecCCCccccCCCCCcCC--CCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEc
Q 002021 74 VTVLNISSLNLTGTIPSQLGNL--SSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDL 151 (979)
Q Consensus 74 v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 151 (979)
...||++++.|...=-+.+..+ +.-+.||+++|+++..-+..|.++++|+.++|.+|.++ .+|...+...+|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 3456777666542111112111 23455777777777666666677777777777777776 56666666666777777
Q ss_pred cCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeec
Q 002021 152 SSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGL 231 (979)
Q Consensus 152 s~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 231 (979)
.+|.|+.. -.+++..++.|+.|||+.|.|+...-.+|..-.++++|+|++|+|+.+....|..+.+|..|.|
T Consensus 133 ~~N~I~sv--------~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkL 204 (873)
T KOG4194|consen 133 RHNLISSV--------TSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKL 204 (873)
T ss_pred eccccccc--------cHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeec
Confidence 77666532 1234555666666666666666444445555556666666666666665555555555555555
Q ss_pred cCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecccccccc
Q 002021 232 QDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311 (979)
Q Consensus 232 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 311 (979)
++|+|+..+.. .|.++++|+.|+|..|+|.-.---.|..+++|+.|.|..|.|...-...|-++.++++|+|+.|+++.
T Consensus 205 srNrittLp~r-~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~ 283 (873)
T KOG4194|consen 205 SRNRITTLPQR-SFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA 283 (873)
T ss_pred ccCcccccCHH-HhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh
Confidence 55555543332 34555555555555555542222334444455555555555544444444445555555555554444
Q ss_pred ccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCch
Q 002021 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGS 391 (979)
Q Consensus 312 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~ 391 (979)
...++ +-+++.|+.|+||+|.|.++ -++.....++|++|+|++|+|+..
T Consensus 284 vn~g~-----lfgLt~L~~L~lS~NaI~ri--------------------------h~d~WsftqkL~~LdLs~N~i~~l 332 (873)
T KOG4194|consen 284 VNEGW-----LFGLTSLEQLDLSYNAIQRI--------------------------HIDSWSFTQKLKELDLSSNRITRL 332 (873)
T ss_pred hhccc-----ccccchhhhhccchhhhhee--------------------------ecchhhhcccceeEeccccccccC
Confidence 44332 33444444444444444333 334444445555555555555555
Q ss_pred hHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCC---ccccCCCcCceEecCCCccccccc-cc
Q 002021 392 ILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIP---ACFSNLTSLRIVSLGSNELTSIPL-TF 467 (979)
Q Consensus 392 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~lp~-~~ 467 (979)
.+.+|..+..|++|+|++|++...-...|..+++|+.|||++|.|+..+. ..|.+|++|+.|.|.+|+|..||. .|
T Consensus 333 ~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAf 412 (873)
T KOG4194|consen 333 DEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAF 412 (873)
T ss_pred ChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhh
Confidence 55555555555555555555554444445555555555555555544332 234455555555555555555554 33
Q ss_pred cCcCCCcEEEeccccccCCCccccccc
Q 002021 468 WNLKDILNLNFSSNFLTGSLPLEIGSL 494 (979)
Q Consensus 468 ~~l~~L~~L~ls~N~l~~~~p~~~~~l 494 (979)
..+.+|++|+|.+|.|..+-|..|..+
T Consensus 413 sgl~~LE~LdL~~NaiaSIq~nAFe~m 439 (873)
T KOG4194|consen 413 SGLEALEHLDLGDNAIASIQPNAFEPM 439 (873)
T ss_pred ccCcccceecCCCCcceeecccccccc
Confidence 444444444444444443333333333
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=352.66 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=208.0
Q ss_pred hhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
..++|+..+.||+|+||+||.| +..+|..+|+|++++.. ....+.++.|..+|....+|.||+++..|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999 56689999999997653 3456788899999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC-
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG- 834 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~- 834 (979)
||||++||++..+|.+.+ .+++..+..++.+++.|++.+| +.|++||||||+|+|||..|.+||+|||++..+..
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999987765 7999999999999999999999 99999999999999999999999999999853321
Q ss_pred ---------------------CCCcc----e-------------------ecccccCCCCCCccccCCCCCCCchhHHHH
Q 002021 835 ---------------------EDQSM----I-------------------QTQTLATIGYMAPEYGREGRVSANGDVYSF 870 (979)
Q Consensus 835 ---------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 870 (979)
.+... . .-..+|||.|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 00000 0 012479999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-
Q 002021 871 GIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN- 949 (979)
Q Consensus 871 G~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps- 949 (979)
|||+|||+.|.+||...... ..+...+... ....++....+.+++.+||.+|+. ||++|.-
T Consensus 375 G~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr----------------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQ-ETYRKIVNWR----------------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh----------------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999999863222 2222211111 111222333445779999999999 9999985
Q ss_pred --HHHHHHH
Q 002021 950 --AKEIVTK 956 (979)
Q Consensus 950 --~~eil~~ 956 (979)
++||.+|
T Consensus 437 ~G~~EIK~H 445 (550)
T KOG0605|consen 437 KGAEEIKKH 445 (550)
T ss_pred ccHHHHhcC
Confidence 7777765
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=349.62 Aligned_cols=262 Identities=23% Similarity=0.407 Sum_probs=219.8
Q ss_pred CCCCceeeeecceEEEEEEcCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
..+.++||+|-||+|.......+..||||.++..+. ....+|.+|+++|.+++|||||+++|+|..++..++|+|||++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 456689999999999999987889999999987654 3458899999999999999999999999999999999999999
Q ss_pred CccceeeccCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 763 GSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 763 g~L~~~l~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
|+|.+|+..+..+ .+.+...+|+.|||.|++||. +..+||||+.++|+|+|.++++||+|||+++-+...+....+
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 9999999887433 366677889999999999999 999999999999999999999999999999977777777778
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
...+-+.+|||||.+..++++.++|||+||+++||+++ ...||.+..+.+. .+-.....+.+...
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ven~~~~~~~~~~~----------- 763 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VENAGEFFRDQGRQ----------- 763 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HHhhhhhcCCCCcc-----------
Confidence 88888999999999999999999999999999999887 7778876443321 11111111111111
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
.-...+.-|+..++++|.+||..|.++||+++++..+|++..
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 011234567888999999999999999999999999998753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=358.37 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=208.9
Q ss_pred hhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc----c-cchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCe
Q 002021 680 ATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC----G-RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEF 752 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~----~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 752 (979)
..+.|...+.||+|+||.|+.| ...+++.||+|++.... . ...+.+.+|+.++++++ ||||+++++++..+..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4578999999999999999999 55678999999765531 1 23456778999999999 9999999999999999
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEEeeccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFSIAKM 831 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfg~~~~ 831 (979)
.++||||+.||+|.+++.. ..++.+.++.++++|++.|++||| .+||+||||||+||+++.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999998 668999999999999999999999 9999999999999999999 9999999999987
Q ss_pred cCCCCCcceecccccCCCCCCccccCCCC-CC-CchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREGR-VS-ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
.. .........+||+.|+|||++.+.. |. .++||||+||++|.|++|+.||++..... .+..
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-l~~k------------- 234 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-LYRK------------- 234 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-HHHH-------------
Confidence 64 1222346678999999999998866 75 78999999999999999999998721110 1111
Q ss_pred hcccccCchhhhhHHHHHH-HHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 910 VDANLLSQEDIHFVAKEQC-VSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
.....+..+..+ ++++.+++.+|+..+|.+|+++.||+ .-.-+.
T Consensus 235 -------i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 235 -------IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred -------HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 001111222333 67789999999999999999999999 434333
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=328.37 Aligned_cols=272 Identities=25% Similarity=0.282 Sum_probs=209.2
Q ss_pred HHhhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEee--ccCCe
Q 002021 678 CRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSC--SNEEF 752 (979)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~ 752 (979)
++..++|+..+.|++|.||.||+| +..+++.||+|+++...+. -.-...+|+.++.+.+|||||.+-.+. .+-+.
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 345567888899999999999999 5678999999999765422 233467899999999999999998876 34567
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.|+|||||++ +|...+...+..+...++..++.|+++|++||| ++.|+|||+|++|+|+.+.|.+||+|||+|+.+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999999987 999999888888999999999999999999999 999999999999999999999999999999998
Q ss_pred CCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhh-------hhhcCC
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV-------NDWLPI 904 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~-------~~~~~~ 904 (979)
..+.. ..+..+.|.+|.|||.+.+. .|+.+.||||+|||+.|+++++.-|.....-+.-...+. ..|...
T Consensus 228 gsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 75533 34667889999999988765 599999999999999999999987765332211111110 011111
Q ss_pred ccchhhcccccCchh-----hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 905 STMEVVDANLLSQED-----IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 905 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..........+.+.. .+|... ......++++...+.+||++|.||.|.++|
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111111100111111 111111 133668899999999999999999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=356.91 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=212.1
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
+.|+.++.||.|+-|.|..|++ .+|+.+|||++.+.. ......+.+|+-||+.+.|||++++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5689999999999999999954 589999999987552 233567889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|-|.+++..++ .+.+.++.+++.||..|++|+| ..+|+|||+||+|+|+|..+++||+|||+|....+
T Consensus 92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--- 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP--- 164 (786)
T ss_pred EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence 9999999999998765 6888999999999999999999 99999999999999999999999999999986432
Q ss_pred cceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.....+.+|+++|.|||++.+..| +.++||||.|||+|-|+||+.||++ ..++..+ ..
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LL----------------lK 223 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLL----------------LK 223 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHH----------------HH
Confidence 222345689999999999999877 5789999999999999999999985 2222211 11
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.....+..+.++++++.+|+.+|+.+||++|.|++||.+|-
T Consensus 224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 12233445567888999999999999999999999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.36 Aligned_cols=278 Identities=26% Similarity=0.370 Sum_probs=216.4
Q ss_pred HhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHh--cCCCCeeeEEEeeccC----Ce
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKS--IRHRNLIKVISSCSNE----EF 752 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~ 752 (979)
.........+.||+|.||+||+|.| .|+.||||+|.. ++.+.+.+|.+|++. ++|+||..+++.-..+ ..
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3445677889999999999999999 588999999964 455778899999886 4999999999975432 35
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEecCCCCCCEEeCCCCcEEEEeec
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF-----GYSAPVIHCDLKPSNVLLDDNMVAHLSDFS 827 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg 827 (979)
.+||++|.+.|+|.||+.+. .++.+..++++..+|.||+|||. +.+..|+|||||+.|||+..++.+.|+|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 78999999999999999874 79999999999999999999993 347789999999999999999999999999
Q ss_pred cccccCCCCC--cceecccccCCCCCCccccCCCC------CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhh
Q 002021 828 IAKMLTGEDQ--SMIQTQTLATIGYMAPEYGREGR------VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 899 (979)
Q Consensus 828 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~ 899 (979)
+|........ .......+||-+|||||++.+.- .-..+||||||.|+||+..+..-.+.....+..+..|+.
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9987654321 23446789999999999986532 124689999999999998755422222222223333333
Q ss_pred hhcCCc-cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 900 DWLPIS-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 900 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
..+... ..+++..+..+..-...+....+...+.++|+.||..+|..|.|+-.|.+.|.++.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 333222 224444444444444455556778889999999999999999999999999999885
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=349.79 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=210.5
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++|-+.+.||+|.||.|||| +..+.+.||+|.+.+.. +++.+...+|++|++.++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45677788999999999999 56678999999986553 3345678999999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+.| +|..++...+ .++++.+..|+.|++.||.||| +.+|.|||+||+||+++..+.+|+||||+|+.+.. ..
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT 154 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence 9977 9999987754 6999999999999999999999 99999999999999999999999999999998743 34
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
...+...|||-|||||+..++.|+..+|+||+||++||+++|++||... .+.+.++....++..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~----------- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVK----------- 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCC-----------
Confidence 4556678999999999999999999999999999999999999999752 222333322221111
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.+...+..+..++...+..||.+|.+-.+++.|=
T Consensus 219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred -----CcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 1124567789999999999999999999998763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=359.52 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=205.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc------CCCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeeeEEEeeccC-C
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIKVISSCSNE-E 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 751 (979)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++.+ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788899999999999999953 2457899999864432 2345688899999999 899999999988764 4
Q ss_pred eeEEEEEecCCCccceeeccCC----------------------------------------------------------
Q 002021 752 FKALVLEYMPHGSLEKYLYSSN---------------------------------------------------------- 773 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~---------------------------------------------------------- 773 (979)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999998886421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCC
Q 002021 774 ---CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850 (979)
Q Consensus 774 ---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 850 (979)
..+++.++..++.||++||+||| +++|+||||||+||++++++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 24778889999999999999999 999999999999999999999999999999865433222223344567889
Q ss_pred CCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHH
Q 002021 851 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 929 (979)
Q Consensus 851 ~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (979)
+|||++.+..++.++|||||||++|||++ |..||......+ .+...+.. .. ....+..++
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~-----------~~-------~~~~~~~~~ 303 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKD-----------GT-------RMRAPENAT 303 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhc-----------CC-------CCCCCCCCC
Confidence 99999988899999999999999999997 999987532211 11111000 00 000122345
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 930 SFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 930 ~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
+.+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=360.97 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=216.0
Q ss_pred hhCCCCCCceeeeecceEEEEEEcC--CC---cEEEEEEeccc---cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLG--DG---MEVAVKVFTSQ---CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE 751 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~---~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (979)
..++....+.||+|+||+||+|++. ++ ..||||..+.. ......+|.+|+++|+.++|||||+++|++..+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 3456666799999999999999653 22 23899988742 2445678999999999999999999999999999
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..++|||+|.||+|.+|++..+..++..++..++.++|+||+||| +++++||||.++|+|++.++.+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999999998778999999999999999999999 99999999999999999999999999999875
Q ss_pred cCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
-. ..........-+..|+|||.+..+.|++++|||||||++||+++ |..||...... ....++
T Consensus 312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI------------ 375 (474)
T KOG0194|consen 312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKI------------ 375 (474)
T ss_pred Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHH------------
Confidence 32 11222223346789999999999999999999999999999999 88898763222 111111
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
.....+.+.+...+.++..++.+||..+|++||+|.++.+.++.+......
T Consensus 376 -----~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 376 -----VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -----HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 011122223335677889999999999999999999999999999986654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=321.01 Aligned_cols=236 Identities=26% Similarity=0.331 Sum_probs=201.1
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||.|+||.|..++ ..+|..+|+|++.++.- +..+....|..+++.+.||+++++++.|.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 568888999999999999994 55789999999976532 23456678999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||++||-|..++++.+ ++++..++.++.||+.|++||| +++|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 9999999999998865 6999999999999999999999 999999999999999999999999999999987432
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.-+.+|||.|+|||.+....|+.++|.|||||++|||+.|..||.+... +.+.+ .-+ .
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~---------------KI~--~ 255 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYE---------------KIL--E 255 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHH---------------HHH--h
Confidence 2457899999999999999999999999999999999999999987332 11111 101 1
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCC
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQR 947 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 947 (979)
. +...|....+++.+|+.+.++.|-.+|
T Consensus 256 ~--~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 G--KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred C--cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 111234556778999999999999999
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=348.69 Aligned_cols=246 Identities=25% Similarity=0.421 Sum_probs=207.2
Q ss_pred CCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 686 ENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
..+-||.|+.|.||+|++ .++.||||+++.. -..+|+.|++++||||+.|.|+|.....++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 346799999999999998 5788999987532 13478889999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccc
Q 002021 766 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845 (979)
Q Consensus 766 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 845 (979)
+..++..+ .++......|..+||.|+.||| .+.|||||+|+-||||..+..|||+|||-++..... ..+-..+
T Consensus 200 ~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa 272 (904)
T KOG4721|consen 200 YEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA 272 (904)
T ss_pred HHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence 99997654 6888899999999999999999 999999999999999999999999999999876432 2234568
Q ss_pred cCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHH
Q 002021 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925 (979)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (979)
||..|||||++++...++|+||||||||||||+||..||.+...... +.- +.......+.+
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----------------IwG---VGsNsL~LpvP 333 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----------------IWG---VGSNSLHLPVP 333 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----------------EEe---ccCCcccccCc
Confidence 99999999999999999999999999999999999999876321110 000 11122344567
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 926 EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 926 ~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
..|+..+.-|+.+||+..|..||++.+|+.||.=....+.
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 7899999999999999999999999999999985444333
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.37 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=208.9
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..|...+.||+|.||.|||| ....++.||+|++.-.. ....+++++|+.++.+++++||.+.|+.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666789999999999999 56689999999997553 44578899999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+.||++.+.++... .+++.++.-|++++..|+.||| .++.+|||||+.||++..+|.||++|||.+..+... ..
T Consensus 93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VK 166 (467)
T ss_pred hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech--hh
Confidence 99999999987754 3488888889999999999999 999999999999999999999999999999876433 23
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
...+.+||+.|||||++....|+.++||||||++.+||.+|..|+....+...-+ .+++...
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------lIpk~~P------------ 228 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------LIPKSAP------------ 228 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------eccCCCC------------
Confidence 3367899999999999998899999999999999999999999987643321110 1111110
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ....+++.+.+++..|++.+|+.||+|.++++|
T Consensus 229 -P~-L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 -PR-LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -Cc-cccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 00 111566779999999999999999999999886
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=318.83 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=208.7
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccc--cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++.|++.+.||+|.|+.||+. ...+|+.+|+|.+... .....+..++|++|-+.++|||||++.+.+.+++..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 466778889999999999998 6678999999977422 3446788899999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfg~~~~~~~ 834 (979)
|+|+|++|..-+-.. ...++..+-..++||+++++|+| .++|+|||+||+|+++.+ ..-+|++|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999996544333 35788889999999999999999 999999999999999963 3468999999999875
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
......+.+|||+|||||+++..+|+..+|||+.|||+|-++.|+.||.+.. +.. ++..-.
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~r---------------lye~I~ 225 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHR---------------LYEQIK 225 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHH---------------HHHHHh
Confidence 2334567889999999999999999999999999999999999999986521 111 111112
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+...+.+..++++..+|+++|+..||.+|.|+.|+++|
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 222333344566778889999999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=342.61 Aligned_cols=246 Identities=22% Similarity=0.295 Sum_probs=200.2
Q ss_pred CceeeeecceEEEEEEcCCCcEEEEEEeccccccc---hhcHHHHHHHHHhcCCCCeeeEEEeecc----CCeeEEEEEe
Q 002021 687 NNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRA---FKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKALVLEY 759 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~ 759 (979)
...||+|++|.||+|.. +|+.||||++....... .+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999988 78999999987543222 4678899999999999999999998866 3467899999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++|+|.+++...+ .+++..+.+++.|++.|++||| + .+++||||||+||++++++.+|++|||+++......
T Consensus 104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999997654 6889999999999999999999 6 488999999999999999999999999998653222
Q ss_pred ceecccccCCCCCCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 839 MIQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.......
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-~~~~i~~~~--------------- 238 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-IYDLIINKN--------------- 238 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcC---------------
Confidence 23467899999999876 678999999999999999999999997532111 111100000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
.+...+..++.++.+++.+||+.||++|||++|+++.|+.+.
T Consensus 239 ---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 ---NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 001111235677999999999999999999999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=311.54 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=212.1
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+.++.||+|.||.||.|+ ..++-.||+|++.+.. .....++.+|++|-+.++||||.+++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4679999999999999999994 4578899999986542 33457788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 757 LEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
+||..+|.+...++.. ...+++.....+..|+|.|+.|+| .++++||||||+|+|++.++..|++|||.+....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 9999999999999854 346899999999999999999999 9999999999999999999999999999998643
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.....+.+||..|.|||...+...+..+|+|++|++.||++.|..||+... .+..+....+.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~--------------- 237 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKV--------------- 237 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHc---------------
Confidence 333466789999999999999999999999999999999999999998755 22233322111
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+...+..++.++.++|.+|+..+|.+|.+..|+++|
T Consensus 238 -----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 -----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111224556779999999999999999999999887
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=354.84 Aligned_cols=258 Identities=23% Similarity=0.384 Sum_probs=204.5
Q ss_pred hCCCCCCceeeeecceEEEEEEc------CCCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (979)
.++|+..+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35688889999999999999953 346689999986442 23345688899999999 89999999999999999
Q ss_pred eEEEEEecCCCccceeeccCC-----------------------------------------------------------
Q 002021 753 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 773 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------- 773 (979)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999998885421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 774 ---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 774 ---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
..++++.+.+++.||++|++||| +++|+||||||+||++++++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 24788899999999999999999 999999999999999999999999999999866433222
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....++....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~--------------- 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGY--------------- 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCc---------------
Confidence 22223345678999999999999999999999999999998 888886532221 1111111000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
+...+...+.++.+++.+||+.||++||++.|+++.|++.
T Consensus 335 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 ---RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0001122345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=323.70 Aligned_cols=272 Identities=24% Similarity=0.312 Sum_probs=207.0
Q ss_pred CCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCC-eeeEEEeeccCC------e
Q 002021 683 GFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRN-LIKVISSCSNEE------F 752 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~ 752 (979)
.|+..++||+|+||+||+| ...+|+.||+|+++-..+ .......+|+.+++.++|+| ||.+++++.... .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4555678999999999999 566899999999976543 35567789999999999999 999999997766 7
Q ss_pred eEEEEEecCCCccceeeccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
.++||||++. +|.+++.... ..++...+..++.|+++|++||| +++|+||||||+||+++++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999965 9999987765 35777899999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHh--hh-----hh
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW--VN-----DW 901 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~--~~-----~~ 901 (979)
+...-+... .+..++|.+|.|||++.+. .|+...||||+|||++||++++.-|....+.+....-+ ++ .|
T Consensus 168 ra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 976533322 4677899999999998876 69999999999999999999998776643322111111 11 11
Q ss_pred cCCccchhhcccccCchhhhhHHH--HHHHHHHHHHHHhccccCcCCCCCHHHHHHH--HHHh
Q 002021 902 LPISTMEVVDANLLSQEDIHFVAK--EQCVSFVFNLAMECTMEFPKQRINAKEIVTK--LLKI 960 (979)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~--L~~~ 960 (979)
.......-.+.........+.... ....+...+++.+|++++|.+|.|++++++| +.++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111111111111111110111111 1112468899999999999999999999998 5544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=344.14 Aligned_cols=242 Identities=24% Similarity=0.313 Sum_probs=204.4
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 755 (979)
.++|...++||+|+||.|++|. ..+++.+|||++++.. +++.+....|.+|+... +||+++.+++.|+.+++.|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 4789999999999999999995 4578899999998764 45677788899998877 59999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+.||++..+.+. ..+++..+..++..|+.||.||| +++|++||+|.+|||+|.+|.+||+|||+++.--..
T Consensus 447 vmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999995555443 36999999999999999999999 999999999999999999999999999999975322
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
....++.+||+.|||||++.+..|+.++|.|||||++|||+.|..||.+..+. +++|.-..
T Consensus 522 --g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----------------e~FdsI~~ 582 (694)
T KOG0694|consen 522 --GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----------------EVFDSIVN 582 (694)
T ss_pred --CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHhc
Confidence 33457889999999999999999999999999999999999999999752211 22332222
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA 950 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 950 (979)
+... .|..++.+..++|.+.+..+|++|.-+
T Consensus 583 d~~~----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DEVR----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCC----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 2222 223456778999999999999999965
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=329.68 Aligned_cols=258 Identities=26% Similarity=0.348 Sum_probs=201.6
Q ss_pred HHhhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccc---------c-----chhcHHHHHHHHHhcCCCCeee
Q 002021 678 CRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCG---------R-----AFKSFDVECEIMKSIRHRNLIK 742 (979)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~---------~-----~~~~~~~E~~~l~~l~h~niv~ 742 (979)
....+.|++.+.||+|.||.|-+| ...+++.||||++.+... . ..+..++|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578999999999999999999 456899999999864310 1 1246889999999999999999
Q ss_pred EEEeecc--CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc
Q 002021 743 VISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 820 (979)
Q Consensus 743 l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~ 820 (979)
++.+..+ .+..|||+|||..|.+.+.= ..+..+++.++++++.++..||+||| .+||+||||||+|+|++++|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence 9999876 46789999999998886532 22334899999999999999999999 999999999999999999999
Q ss_pred EEEEeeccccccCCC---CCcceecccccCCCCCCccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCcccccCcch
Q 002021 821 AHLSDFSIAKMLTGE---DQSMIQTQTLATIGYMAPEYGREGR----VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 893 (979)
Q Consensus 821 ~kl~Dfg~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~ 893 (979)
|||+|||.+...... +........+|||.|+|||...++. .+.+.||||+||+||-++.|+.||-+.+.-+ .
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-l 327 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-L 327 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-H
Confidence 999999999865211 1111223478999999999987643 3578999999999999999999986522111 1
Q ss_pred HhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 894 LKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
+.+.+. ....++...+..+++.+++.+++.+||++|.+..||..|.-
T Consensus 328 ~~KIvn------------------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 328 FDKIVN------------------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHhc------------------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 111110 11122222345567999999999999999999999988864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=353.02 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=204.7
Q ss_pred hCCCCCCceeeeecceEEEEEEc------CCCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (979)
.++|+..+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+++++.+ +||||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35788899999999999999853 234579999987543 22345678899999999 89999999999999999
Q ss_pred eEEEEEecCCCccceeeccCC-----------------------------------------------------------
Q 002021 753 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 773 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------- 773 (979)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998875321
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecc
Q 002021 774 ----------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ 843 (979)
Q Consensus 774 ----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 843 (979)
..+++.++++++.||++||+||| +++|+||||||+||++++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 24788899999999999999999 99999999999999999999999999999976543322222223
Q ss_pred cccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 844 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........ +........ ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~~------------------~~ 334 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRGY------------------QM 334 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHccc------------------Cc
Confidence 345678999999988899999999999999999997 9999876432221 111110000 00
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
..+...++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011123567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.92 Aligned_cols=262 Identities=23% Similarity=0.412 Sum_probs=202.4
Q ss_pred CCCCCCceeeeecceEEEEEEcC-----------------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-----------------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 743 (979)
+.|...+.||+|+||.||+|.+. ++..||+|.+..... .....+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46788899999999999999643 234799999875432 234578899999999999999999
Q ss_pred EEeeccCCeeEEEEEecCCCccceeeccCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 002021 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805 (979)
Q Consensus 744 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H 805 (979)
++++.+.+..++||||+++|+|.+++.... ..+++..+++++.|++.|++||| +++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999998875421 24678889999999999999999 999999
Q ss_pred cCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc--CCCC
Q 002021 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKP 883 (979)
Q Consensus 806 ~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~P 883 (979)
|||||+||++++++.+||+|||++......+.........++..|+|||++..+.+++++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986643333222334456789999999988889999999999999999987 5567
Q ss_pred CcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 884 TDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
|...... .....+.......... .....+..++..+.+++.+||+.||++|||+.||.+.|++
T Consensus 242 ~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE--QVIENAGEFFRDQGRQ-----------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH--HHHHHHHHHhhhcccc-----------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6643211 1111111110000000 0001122456679999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=322.81 Aligned_cols=271 Identities=25% Similarity=0.269 Sum_probs=206.2
Q ss_pred hhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccc--cccchhcHHHHHHHHHhcCCCCeeeEEEeecc-----CC
Q 002021 680 ATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVISSCSN-----EE 751 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 751 (979)
....|...+.||+|+||.|+.| ...+|+.||||++... .....++..+|+++++.++|+||+.+.+++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4455666789999999999999 5668999999998733 33455778899999999999999999998854 45
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..|+|+|+| +.+|.+.++..+ .++..++..+++|+++||+|+| +.+|+|||+||+|++++.+..+||+|||+|+.
T Consensus 100 DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence 689999999 458988887654 4899999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCCCcceecccccCCCCCCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccch--
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME-- 908 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 908 (979)
..........+..+.|.+|.|||++. ...|+.+.||||.|||+.||++|+.-|.+...- ..-..+-...+.+..+
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELLGTPSEEDL 252 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhcCCCCHHHH
Confidence 75432333446778899999999865 467999999999999999999999977642111 1111111111111110
Q ss_pred -hhc---------ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 909 -VVD---------ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 909 -~~~---------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.+. ..-.............+.+.+.+|+.+|+..||.+|+|++|+++|-
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 000 0000000011112235668899999999999999999999999873
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.36 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=200.7
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
|+..+.||+|+||.||+|. ..+|+.||||++.... ......+.+|+++++.++|++++++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 6678899999999999995 4679999999986432 12234577899999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++|+|.+++... ...+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 9999998887643 336899999999999999999999 9999999999999999999999999999998653221
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......||..|+|||++.+..++.++||||+||++|||++|+.||........ ...... ....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~-------------~~~~-- 219 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDR-------------RVKE-- 219 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHH-------------Hhhc--
Confidence 12345789999999999999999999999999999999999999975322111 000000 0000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
.....+..++.++.+++.+||+.||.+||+ ++|+++|
T Consensus 220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 000111234567899999999999999997 8899886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=336.24 Aligned_cols=268 Identities=20% Similarity=0.260 Sum_probs=202.7
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||.||+|. ..+++.||+|+++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 568889999999999999995 4578999999986443 22345677899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++ +|.+++......+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++........
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 975 999988776667899999999999999999999 99999999999999999999999999999976432221
Q ss_pred eecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc---CCccchhhc----
Q 002021 840 IQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL---PISTMEVVD---- 911 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---- 911 (979)
......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||......+ .......... ......+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhccccchhh
Confidence 1234567899999998865 568999999999999999999999996532211 1111111000 000000000
Q ss_pred -ccccCch--hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 -ANLLSQE--DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 -~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....... ..........+.++.+++.+|++.||.+|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00001112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.79 Aligned_cols=255 Identities=22% Similarity=0.384 Sum_probs=205.9
Q ss_pred CCCCCCceeeeecceEEEEEEc----CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.+|+..+.||+|+||.||+|.+ ..+..||+|.++.... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 4678889999999999999954 2467899999876532 2345788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++......+++.+++.++.|++.|++||| +++++||||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999876667899999999999999999999 9999999999999999999999999999876542211
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
........++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .....+...
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~-------------- 224 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDG-------------- 224 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCC--------------
Confidence 111122345678999999988999999999999999999876 99998653221 111111000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
...+.+..++..+.+++.+||+.+|++||+++||.+.|.++
T Consensus 225 ----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112234667799999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=306.25 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=210.4
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccC-----Cee
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFK 753 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 753 (979)
..+.|.+.+.+|+|||+.||.++ ..+++.+|+|++.....+..+...+|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34678899999999999999994 678899999999877667778899999999999999999999987443 348
Q ss_pred EEEEEecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEeCCCCcEEEEeecc
Q 002021 754 ALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFSI 828 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dik~~NIll~~~~~~kl~Dfg~ 828 (979)
|++++|...|+|.+.+... +..+++.++++|+.+|++||++|| +.. ++||||||.||++.+.+.+++.|||.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 9999999999999998654 557999999999999999999999 555 99999999999999999999999999
Q ss_pred ccccCCCCCc-------ceecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhh
Q 002021 829 AKMLTGEDQS-------MIQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 898 (979)
Q Consensus 829 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~ 898 (979)
+....-.-.. ........|..|.|||.+. +...++++|||||||++|.|+.|..||+..........-
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL-- 253 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL-- 253 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE--
Confidence 9754321111 1123345799999999874 445789999999999999999999999864432221110
Q ss_pred hhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
.+. ...+.++....++..+.+++..|+++||.+||++.|++.++..+
T Consensus 254 ---------Av~------n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 ---------AVQ------NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---------eee------ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 011 11222333334678899999999999999999999999998765
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=339.13 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=219.1
Q ss_pred CCCCCceeeeecceEEEEEEcC---CC--cEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASLG---DG--MEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~---~~--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.....+.||+|-||.||+|... .| -.||||.-+.+++ ...+.|.+|+.+|+.++|||||+++|+|.+. ..++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 3455678999999999999543 23 3488898776543 3467899999999999999999999999765 46899
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
||.++-|.|..|++..+..++......++.||+.||+||| ++.+|||||..+|||+.+...||++|||+++.+....
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999999989999999999999999999999 9999999999999999999999999999999886544
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
. +..+...-++.|||||-+.-.+++.++|||-|||++||++. |..||....+.+.- ..
T Consensus 546 y-YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------------------~~ 604 (974)
T KOG4257|consen 546 Y-YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------------------GH 604 (974)
T ss_pred h-hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------------------EE
Confidence 3 33345566889999999988999999999999999999998 99999765443321 12
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
-+.+.+.+.+++||+.++.+|.+||.++|.+||.+.|+...|..++.
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 23445677889999999999999999999999999999999998887
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=337.76 Aligned_cols=270 Identities=21% Similarity=0.282 Sum_probs=203.3
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46799999999999999999954 4789999999865432 223457789999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|++ +++.+++......++++.+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 995 5888888776667899999999999999999999 9999999999999999999999999999987543221
Q ss_pred ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc---c-----chh
Q 002021 839 MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS---T-----MEV 909 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---~-----~~~ 909 (979)
.......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....+................ . ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12234568899999998765 45788999999999999999999999764332222211111000000 0 000
Q ss_pred hcccccC---chh-hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLS---QED-IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~---~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.++.... ... .........+..+.+++.+|++.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000 000 0001111234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=323.80 Aligned_cols=261 Identities=24% Similarity=0.346 Sum_probs=195.0
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccC--C---eeEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--E---FKALV 756 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~---~~~lv 756 (979)
.|...+++|.|+||.||+|.. .+++.||||+.-... +--.+|.++|+.+.|||||++..+|... . ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 356678999999999999954 457899999875332 1224699999999999999999988432 2 34589
Q ss_pred EEecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEEeecccccc
Q 002021 757 LEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFSIAKML 832 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfg~~~~~ 832 (979)
||||+. +|.++++. .+..++...+.-+..|+++|++||| .++|+||||||+|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 99998874 2446777888899999999999999 9999999999999999955 99999999999987
Q ss_pred CCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc--cchh
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS--TMEV 909 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~ 909 (979)
...... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|+.-|.+. .+..++...++..--.. ....
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCCCHHHHhh
Confidence 544332 344578899999998775 6999999999999999999999988762 22223333222111111 1111
Q ss_pred hc--------ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VD--------ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~--------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+. +.+......+ ......+++..+++.++++++|.+|.++.|++.|
T Consensus 253 mn~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11 1111111001 1223466789999999999999999999999876
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=334.78 Aligned_cols=269 Identities=18% Similarity=0.207 Sum_probs=202.8
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3688889999999999999965 468899999986542 2234567889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|++++.+..+. .....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 155 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N 155 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence 99987665443 33446899999999999999999999 9999999999999999999999999999998753222 1
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhh-----------hcCCc-c
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND-----------WLPIS-T 906 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~-----------~~~~~-~ 906 (979)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||......+. ....... ..... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchh
Confidence 122345689999999999888899999999999999999999999975322111 1000000 00000 0
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+...............++.++.+++.+|++.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000001111112356779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.47 Aligned_cols=249 Identities=34% Similarity=0.558 Sum_probs=196.4
Q ss_pred CCceeeeecceEEEEEEcC-----CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 686 ENNLIGRGGFGSVYKASLG-----DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..+.||+|+||.||+|++. .+..||||.+..... ...+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999765 367899999965432 2467899999999999999999999999988889999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++|+|.+++... ...+++.++..|+.||++||+||| +++++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999887 667999999999999999999999 899999999999999999999999999999876333333
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
...........|+|||.+....++.++||||||+++||+++ |+.||.+... ..+...+. +
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~-----------~------ 220 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLK-----------Q------ 220 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHH-----------T------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc-----------c------
Confidence 33344557789999999988889999999999999999999 7788765311 11111110 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
..+...+..++..+.+++.+||..+|++||++.|+++.|
T Consensus 221 -~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 -GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 001112234567799999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.98 Aligned_cols=242 Identities=24% Similarity=0.291 Sum_probs=197.1
Q ss_pred ceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCC
Q 002021 688 NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 763 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 763 (979)
+.||+|+||.||+|. ..+|+.||||++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999995 4678999999987542 223456778999999999999999999999999999999999999
Q ss_pred ccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecc
Q 002021 764 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ 843 (979)
Q Consensus 764 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 843 (979)
+|.+++...+ .+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence 9998887643 6899999999999999999999 9999999999999999999999999999987542221 12234
Q ss_pred cccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhH
Q 002021 844 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 923 (979)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (979)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+. .. . ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~---~~------------~----~~ 213 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELIL---ME------------E----IR 213 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHH---cC------------C----CC
Confidence 56899999999999889999999999999999999999999652111 1111000 00 0 00
Q ss_pred HHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 924 AKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
.+...+.++.+++.+|++.||++|| ++.|+++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1123456789999999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=347.39 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=206.5
Q ss_pred hCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 752 (979)
.++|.+.+.||+|+||.||+|+.. .+..||||++..... ...+.+.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999642 234699999965432 23467889999999996 9999999999999999
Q ss_pred eEEEEEecCCCccceeeccCC-----------------------------------------------------------
Q 002021 753 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 773 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------- 773 (979)
.++||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999998875421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC
Q 002021 774 ------------------------------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 817 (979)
Q Consensus 774 ------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~ 817 (979)
..+++.++..++.|+++|++||| +.+|+||||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 23678888999999999999999 999999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhH
Q 002021 818 NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKH 896 (979)
Q Consensus 818 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~ 896 (979)
++.+|++|||+++...............++..|+|||.+.+..+++++|||||||++|||++ |..||...........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~- 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN- 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH-
Confidence 99999999999986543322222233456788999999988889999999999999999997 9999865322111111
Q ss_pred hhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 897 WVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
.+.. . .+...+..++.++.+++.+||+.+|++||++.++.+.|+++.+
T Consensus 352 ~~~~------------~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 KIKS------------G------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHhc------------C------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0000 0 0011123456779999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=336.59 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=216.9
Q ss_pred hCCCCCCceeeeecceEEEEEEcCC-CcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..++.+..+||-|.||+||.|.|.. .-.||||.++.+ .-..++|..|+.+|+.++|||+|+++|+|..+..+|||+||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3456777899999999999998864 346999999754 34578999999999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|..|+|.+|++++ +..++.-..+.++.||+.|++||. ++.+||||+.++|.|+.++..||++|||+++.+....+
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY- 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY- 420 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-
Confidence 9999999999876 345666677899999999999999 99999999999999999999999999999999865433
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
....+..-++.|.|||-+....++.++|||+|||+|||+.| |-.||....-. .+++ +-+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----------------qVY~---LLE 480 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYG---LLE 480 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----------------HHHH---HHh
Confidence 23334455789999999999999999999999999999999 88887652111 1111 123
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
.+++...++.|++.+++||+.||+..|.+||++.|+-+.++.+.
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 34566678899999999999999999999999999999998654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.77 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=206.8
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccccc---chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGR---AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
..|++.+.||+|.||.|-+| ....|+.||||.+++..-+ +.-.+++|++||+.++||||+.++.+|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 45777889999999999999 4578999999998766432 3446789999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||..+|.|+||+.+.+ .+++.++++++.||..|+.|+| +++++|||+|.+|||+|.++++||+|||++-.+....
T Consensus 133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence 9999999999998865 6999999999999999999999 9999999999999999999999999999998875332
Q ss_pred cceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
...+.+|++-|.+||++.+..| ++.+|-||+||++|-++.|..||+... ....+++..
T Consensus 208 --fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs-------------- 266 (668)
T KOG0611|consen 208 --FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQIS-------------- 266 (668)
T ss_pred --HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhh--------------
Confidence 2356789999999999988776 589999999999999999999998632 122222111
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
...++.+ .-+..+.-||+.|+.++|++|.|+.||..|-
T Consensus 267 ~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 267 RGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111111 1234577899999999999999999998874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.13 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=201.0
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|.. .+++.||+|++.... .+..+.+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3688889999999999999954 478999999986432 123456788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++...+ .+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 9999999999987654 6889999999999999999999 9999999999999999999999999999998653221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..... .... .
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~---i~~~--------~---- 214 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEK---ILAG--------K---- 214 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---HHhC--------C----
Confidence 2346899999999998888999999999999999999999998653211 11110 0000 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
...+..++..+.+++.+|++.||.+||+ ++|+++|
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0011123456889999999999999995 9999887
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=334.93 Aligned_cols=256 Identities=29% Similarity=0.536 Sum_probs=207.3
Q ss_pred CCCCCCceeeeecceEEEEEEcCC------CcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGD------GMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
.+|+..+.||+|+||.||+|.... ...||+|.+..... .....+.+|+++++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999996432 25799999864432 23456889999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC
Q 002021 755 LVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 819 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~ 819 (979)
++|||+++++|.+++.... ..+++.+++.++.|++.|++||| +++++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999986531 45788999999999999999999 99999999999999999999
Q ss_pred cEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhh
Q 002021 820 VAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWV 898 (979)
Q Consensus 820 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~ 898 (979)
.+||+|||++......+.........+++.|+|||.+.++.+++++|||||||++|||++ |..||...... .....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEMI 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 999999999986543333333344566889999999988899999999999999999998 99998753221 111111
Q ss_pred hhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
.. .. ....+..++.++.+++.+||+.||.+||++.||+++|+++
T Consensus 240 ~~------------~~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 RS------------RQ------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred Hc------------CC------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 10 00 0112345677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=340.07 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=207.4
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCc----EEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGM----EVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
.+|+..+.||+|+||.||+|.+. +++ .||||++.... ....+.+.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999653 343 48999986443 23456788899999999999999999998765 5679
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|+||+++|+|.+++......+++..++.++.||+.||+||| +++|+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999887667899999999999999999999 999999999999999999999999999999876533
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
..........++..|+|||++.+..++.++|||||||++||+++ |+.||...... .+..+....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~------------- 227 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKG------------- 227 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCC-------------
Confidence 33222233345678999999998899999999999999999998 99998653211 111111100
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
...+.+..++..+.+++.+||..+|.+||++.|++.++.++.+..
T Consensus 228 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 001112234566899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.18 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=208.4
Q ss_pred CCCCCCceeeeecceEEEEEEcC----CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
++|+..+.||+|+||.||+|.+. +...||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888999999999999999763 245799999865432 2345788899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++......+++.++..++.|++.|++||| +++|+||||||+||++++++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999876667899999999999999999999 9999999999999999999999999999998775333
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.........++..|+|||.+.+..+++++||||||+++||+++ |..||......+ .........
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~------------- 225 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVEDGY------------- 225 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCC-------------
Confidence 2222223345678999999988889999999999999999998 999986532111 111111000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
..+.+..++..+.+++.+||+.+|++||++.|++++|+++
T Consensus 226 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=327.89 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=203.1
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|+..+.||+|+||.||+|.+.++..+|+|.+... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999998888889999987643 2334678899999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+|+|.+++......+++..+..++.|++.|++||| +++|+||||||+||++++++.+|++|||.+........ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence 99999998766556899999999999999999999 99999999999999999999999999999876532221 111
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~~----------------- 219 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGFR----------------- 219 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCC-----------------
Confidence 22345668999999988889999999999999999999 89998653211 11111110000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
...+...+..+.+++.+||+.+|.+||+++|+++.|
T Consensus 220 -~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 -LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 000111235689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=338.34 Aligned_cols=265 Identities=21% Similarity=0.289 Sum_probs=204.7
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 36789999999999999999954 5788999999875432 234678899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
|+++|+|.+++.... .+++..+..++.|++.|++||| +. +|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999987654 5889999999999999999999 64 69999999999999999999999999987653221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC-------------
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI------------- 904 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~------------- 904 (979)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||......+ +..........
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCccc
Confidence 233468999999999998889999999999999999999999996432111 11111000000
Q ss_pred -c--------------cc---hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 905 -S--------------TM---EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 905 -~--------------~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
. .. +..+. +..... .......++.++.+++.+||+.||++|||+.|+++|-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDY-IVNEPP-PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHH-HHhCCC-cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 00 00000 000000 0000113456799999999999999999999999884
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=344.68 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=201.1
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5688889999999999999955 468999999986532 123456888999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999999987653 6788999999999999999999 9999999999999999999999999999998653221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+ .... ..
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~-~~i~--------~~----- 230 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIY-EKIL--------AG----- 230 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHHH-HHHh--------cC-----
Confidence 234689999999999988899999999999999999999999865211 1100 0000 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
....+..++..+.+++.+||+.||.+||+ ++|+++|
T Consensus 231 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 ---RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00011123456889999999999999997 7888877
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=333.45 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=209.0
Q ss_pred CCCCCCceeeeecceEEEEEEc------CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|.+.+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4678889999999999999953 2356699999876555556678999999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 002021 756 VLEYMPHGSLEKYLYSSN------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 823 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl 823 (979)
||||+++++|.+++...+ ..+++.+++.++.|++.|++||| +++++||||||+||++++++.+|+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999886432 24899999999999999999999 999999999999999999999999
Q ss_pred EeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhc
Q 002021 824 SDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 824 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~~--- 237 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQ--- 237 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc---
Confidence 99999986543332222334445778999999988889999999999999999998 898886532211 1111000
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
... . ..+..++.++.+++.+||+.+|.+|||+.|+.+.|+++.+.
T Consensus 238 -~~~--------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 -GRV--------L-------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -CCc--------C-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000 0 01112445689999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=366.53 Aligned_cols=482 Identities=29% Similarity=0.367 Sum_probs=371.9
Q ss_pred EEecCCCccccCCCCCcCCCCCCeeeccCCcccccCC-ccccccCcccEEecccccccccCCccccCCCCCcEEEccCCc
Q 002021 77 LNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIP-SAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNA 155 (979)
Q Consensus 77 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 155 (979)
+|.++.+++ .||..+..-..++.|+++.|.+- ..| ..+....+|+.|||++|+++ .+|..+..+..|+.|+++.|.
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 566666676 67777777677899999999765 333 23334455999999999988 788999999999999999998
Q ss_pred cCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCC
Q 002021 156 LSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNS 235 (979)
Q Consensus 156 l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 235 (979)
|. .+|.+.+++.+|++|.|.+|.+. ..|.++..+.+|++||+|.|++... |..+..++.++.+..++|.
T Consensus 80 i~---------~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~-Pl~i~~lt~~~~~~~s~N~ 148 (1081)
T KOG0618|consen 80 IR---------SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGPI-PLVIEVLTAEEELAASNNE 148 (1081)
T ss_pred Hh---------hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCCC-chhHHhhhHHHHHhhhcch
Confidence 86 47888999999999999999987 7899999999999999999998765 7788889999999999992
Q ss_pred CcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccch
Q 002021 236 LSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQE 315 (979)
Q Consensus 236 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 315 (979)
.... ++.. .++.++|..|.+.+.++..+..+.. .|||.+|.+. . ..+..+.+|+.|....|++..+.-
T Consensus 149 ~~~~-----lg~~-~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~~- 216 (1081)
T KOG0618|consen 149 KIQR-----LGQT-SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELEI- 216 (1081)
T ss_pred hhhh-----hccc-cchhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEEe-
Confidence 2211 1122 2888999999999888888877766 7999999988 2 347778899999999999887542
Q ss_pred hhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHh
Q 002021 316 LSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILIT 395 (979)
Q Consensus 316 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 395 (979)
..++|+.|+.++|.+.... ....+.+|+.++++.|++++ +|++++.+.+|+.|...+|++. ..|..
T Consensus 217 --------~g~~l~~L~a~~n~l~~~~----~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~r 282 (1081)
T KOG0618|consen 217 --------SGPSLTALYADHNPLTTLD----VHPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLR 282 (1081)
T ss_pred --------cCcchheeeeccCcceeec----cccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHH
Confidence 3578999999999998442 22346789999999999995 5599999999999999999994 67788
Q ss_pred hhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCc-CceEecCCCcccccccc-ccCcCCC
Q 002021 396 LSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTS-LRIVSLGSNELTSIPLT-FWNLKDI 473 (979)
Q Consensus 396 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~lp~~-~~~l~~L 473 (979)
+....+|+.|.+.+|.++ -+|....+++.|++|+|..|+|....+..|.-+.. |+.|+.+.|++...|.. -..++.|
T Consensus 283 i~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~L 361 (1081)
T KOG0618|consen 283 ISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAAL 361 (1081)
T ss_pred HhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHH
Confidence 888999999999999998 57888888999999999999998544444444333 67777777777776642 2245667
Q ss_pred cEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccc
Q 002021 474 LNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNN 553 (979)
Q Consensus 474 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 553 (979)
+.|++.+|.++...-+.+.+...|+.|+|++|++...+...+.++..|++|+||+|+|+ .+|..+..++.|++|...+|
T Consensus 362 q~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN 440 (1081)
T KOG0618|consen 362 QELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSN 440 (1081)
T ss_pred HHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCC
Confidence 77777777777666666777777777777777777555556677777777777777777 67777777777777777777
Q ss_pred cccccCCccccCccccCeEeccCCcccc-cCCCCCCCCCcccccccCCcc
Q 002021 554 NLSGVIPASLEKLSYLEDLNLSFNQLEG-KIPRGGSFGNFSAQSFEGNEL 602 (979)
Q Consensus 554 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~~~~~~~~~~N~~ 602 (979)
+|. ..| .+.++++|+.+|+|.|+|+- .+|.....+++.-+.++||++
T Consensus 441 ~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 441 QLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 776 555 67777777777777777753 334433335666677777764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=341.64 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=203.6
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3688899999999999999965 468999999987542 123456788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999987543 6889999999999999999999 99999999999999999999999999999976532
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .... +..+... . ..+... .
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~-i~~~~~~--~--~~~~~~-~ 224 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWEN-LKYWKET--L--QRPVYD-D 224 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHH-HHhcccc--c--cCCCCC-c
Confidence 1234568999999999998899999999999999999999999997532111 1111 0000000 0 000000 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....++.++.+++.+|+..+|.+||++.|+++|
T Consensus 225 ------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 ------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 002345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=340.26 Aligned_cols=242 Identities=22% Similarity=0.300 Sum_probs=196.5
Q ss_pred ceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCC
Q 002021 688 NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 763 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 763 (979)
+.||+|+||.||+|. ..+|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999995 4578999999987542 223456678999999999999999999999999999999999999
Q ss_pred ccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecc
Q 002021 764 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ 843 (979)
Q Consensus 764 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 843 (979)
+|.+++.... .+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence 9988876543 6899999999999999999999 99999999999999999999999999999875322211 1234
Q ss_pred cccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhH
Q 002021 844 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 923 (979)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (979)
..||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........ . ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~~~~----------------~----~~ 213 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILME----------------E----IR 213 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHhcC----------------C----CC
Confidence 568999999999998899999999999999999999999986532111 11110000 0 00
Q ss_pred HHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 924 AKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
.+..+++++.+++.+|++.||++|| ++.|+++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1123456789999999999999998 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=350.34 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=209.9
Q ss_pred CCCCCCceeeeecceEEEEEEcCCC-cEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEe-ecc------CCe
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDG-MEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISS-CSN------EEF 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~ 752 (979)
..+++.+.|.+|||+.||.|....+ ..||+|++-...+...+...+|+++|+.++ |+|||.+++. ... ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4566788999999999999965554 999999987776667788999999999997 9999999993 211 246
Q ss_pred eEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
++|.||||.||.|.|++... ...+++.++++|+.|+|+|+++|| .++.+|+|||||-+||||+.++..||||||.|..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 78999999999999999754 445999999999999999999999 5677899999999999999999999999999975
Q ss_pred cCCCCCcc-------eecccccCCCCCCcccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh
Q 002021 832 LTGEDQSM-------IQTQTLATIGYMAPEYG---REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 901 (979)
Q Consensus 832 ~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~ 901 (979)
........ ..-....|+.|+|||.+ .+..+++|+|||||||+||-|+....||+.. +...+
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s--g~laI------- 266 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES--GKLAI------- 266 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC--cceeE-------
Confidence 43222110 01123579999999975 4667899999999999999999999999862 11111
Q ss_pred cCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 902 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+.++....++..+.+||+.|+++||.+||++-+++.++.++...
T Consensus 267 --------------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 267 --------------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --------------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 112233344456778899999999999999999999999999998863
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.13 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=204.0
Q ss_pred CCCCCCceeeeecceEEEEEEc------CCCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeeeEEEeecc-CCe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIKVISSCSN-EEF 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~ 752 (979)
++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+..|+++++++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4688899999999999999943 2357899999864432 2345677899999999 79999999998754 456
Q ss_pred eEEEEEecCCCccceeeccCC-----------------------------------------------------------
Q 002021 753 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 773 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------- 773 (979)
.+++|||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999998875321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCC
Q 002021 774 -CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852 (979)
Q Consensus 774 -~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 852 (979)
..+++..+.+++.||+.|++||| +++|+||||||+||++++++.+||+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 25789999999999999999999 99999999999999999999999999999987643332222334456778999
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHH
Q 002021 853 PEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 931 (979)
Q Consensus 853 PE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (979)
||++.+..+++++||||+||++|||++ |..||......+ .+........ ....+..++++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~------------------~~~~~~~~~~~ 304 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT------------------RMRAPEYATPE 304 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC------------------CCCCCccCCHH
Confidence 999999999999999999999999998 999986532211 1111110000 00111234567
Q ss_pred HHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 932 VFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 932 l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
+.+++.+||+.+|++||++.|++++|+++..
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.11 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=212.7
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccc--cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe-eEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF-KALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 756 (979)
.++|...+++|+|+||.++.++ ..+++.+|+|.+.-. .+...+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 3678889999999999999984 457789999988643 34455677889999999999999999999998888 9999
Q ss_pred EEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 757 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|+|++||++.+.+.+.+ ..++++++.+++.|++.|+.||| +..|+|||||+.||+++.++.|||+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998765 78999999999999999999999 999999999999999999999999999999998655
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
+. .....+||+.||.||.+.+..|+.|+||||+||++|||++-+.+|.+......-... ..
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki-------------~~---- 220 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI-------------NR---- 220 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH-------------hh----
Confidence 42 235678999999999999999999999999999999999999999763222111110 00
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+.+..++.++..++..|+..+|+.||++.+++.+
T Consensus 221 ---~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 ---GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 00122334556779999999999999999999999987
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=354.67 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=202.0
Q ss_pred CCCCCceeeeecceEEEEEEc-CC-CcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GD-GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.|...+.||+|+||.||+|.. .+ ++.||+|.+..........+.+|+++++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 478889999999999999943 34 6788999775544444556788999999999999999999999999999999999
Q ss_pred CCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 761 PHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 761 ~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
++|+|.+++... ...+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 346889999999999999999999 99999999999999999999999999999987643322
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .... ... . ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~~~---~~~--------~----~~ 287 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EIMQ---QVL--------Y----GK 287 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HHH--------h----CC
Confidence 22234456899999999999889999999999999999999999998642111 1110 000 0 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. .+.+..++.++.+++.+||..||++||++.|++.+
T Consensus 288 ~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 288 Y---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred C---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 0 00112345678999999999999999999999764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.20 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=204.0
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCc----EEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGM----EVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|+..+.||+|+||+||+|.+ .+++ .||+|.+..... .....+..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 4678889999999999999965 3454 477787754322 234567778888999999999999998864 45779
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|+||+++|+|.+++......+++..+..++.|++.|++||| +++++||||||+||++++++.+|++|||.++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999877667999999999999999999999 999999999999999999999999999999866433
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
..........++..|+|||.+.++.++.++||||||+++||+++ |+.||....... ..+++....
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~------------ 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGE------------ 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCC------------
Confidence 32222334557788999999988899999999999999999998 999986532211 111111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+..++..+.+++.+||..+|++|||+.|+++.|..+.+.
T Consensus 229 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 229 ------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0001122445678899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=338.90 Aligned_cols=242 Identities=23% Similarity=0.299 Sum_probs=196.8
Q ss_pred ceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCC
Q 002021 688 NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 763 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 763 (979)
+.||+|+||.||+|. ..+|+.||||++.... ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999995 4578999999987542 233456788999999999999999999999999999999999999
Q ss_pred ccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecc
Q 002021 764 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ 843 (979)
Q Consensus 764 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 843 (979)
+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence 9988886543 6899999999999999999999 9999999999999999999999999999987542221 12234
Q ss_pred cccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhH
Q 002021 844 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 923 (979)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (979)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... ...... . ..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~---~~~~~~------------~----~~ 213 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF---ELILME------------D----IK 213 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHH---HHhccC------------C----cc
Confidence 56899999999999889999999999999999999999999652111 110 000000 0 00
Q ss_pred HHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 924 AKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
.+...+.++.+++.+|++.||++|| ++.|+++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1123456688999999999999997 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.28 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=207.1
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
+.|+..+.||.|.-|+||+++.. ++..+|+|++.+.. .....+.+.|.+||+.+.||.++.+|+.|+.+...|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 34666789999999999999764 45899999997653 233456778999999999999999999999999999999
Q ss_pred EecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 758 EYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+||+|....+++ ...+++..++.++.+|+.||+||| ..|||.||+||+|||+.++|.+.|+||.++.......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999988765 567999999999999999999999 9999999999999999999999999999975331100
Q ss_pred ---------------------------------C---------------------cceecccccCCCCCCccccCCCCCC
Q 002021 837 ---------------------------------Q---------------------SMIQTQTLATIGYMAPEYGREGRVS 862 (979)
Q Consensus 837 ---------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 862 (979)
. ..+....+||-.|.|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0111234689999999999999999
Q ss_pred CchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhcccc
Q 002021 863 ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTME 942 (979)
Q Consensus 863 ~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 942 (979)
.++|.|+|||++|||+.|+.||.... .++.+...+.. ..+++.....+..+.|||++.+.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~-~~~Tl~NIv~~------------------~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSN-NKETLRNIVGQ------------------PLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCC-chhhHHHHhcC------------------CCcCCCCCcchhHHHHHHHHHhcc
Confidence 99999999999999999999997632 23333332211 112333335667899999999999
Q ss_pred CcCCCCC----HHHHHHH
Q 002021 943 FPKQRIN----AKEIVTK 956 (979)
Q Consensus 943 dP~~Rps----~~eil~~ 956 (979)
||.+|.. |.||.+|
T Consensus 375 dP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ChhhhhccccchHHhhcC
Confidence 9999998 9999876
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.12 Aligned_cols=255 Identities=31% Similarity=0.511 Sum_probs=205.3
Q ss_pred CCCCCCceeeeecceEEEEEEcC------CCcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
++|.+.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777899999999999999653 3578999998765433 4568899999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 002021 755 LVLEYMPHGSLEKYLYSS-------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~ 821 (979)
+||||+++++|.+++... ...+++.++..++.|++.|++||| +++++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 999999999999998653 235788899999999999999999 9999999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhh
Q 002021 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~ 900 (979)
|++|||.+................+++.|+|||++.++.+++++||||+||++|||++ |..||...... .......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~~- 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECIT- 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH-
Confidence 9999999976533322222233456788999999999999999999999999999998 99998643211 1111100
Q ss_pred hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
.... ...+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus 239 -----------~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 -----------QGRL------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -----------cCCc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0000 00112345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=328.85 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=210.3
Q ss_pred hhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
...+|+..+.||+|+||.||+|...+++.||+|++..........+..|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999998777999999998766554567788999999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++... ...+++.++..++.|++.|++||| +++++||||||+||++++++.+|++|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999764 346899999999999999999999 999999999999999999999999999999876432211
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....++..|+|||...+..++.++||||||+++|+|++ |+.||...... ..+. .....
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~-~~~~~---------------- 220 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYD-QITAG---------------- 220 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHH-HHHhC----------------
Confidence 223346778999999988889999999999999999998 89998653211 1111 11100
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
.+.+.+..++..+.+++.+||+.+|.+|||++|+.+.|+.+
T Consensus 221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 --YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00111234456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=337.99 Aligned_cols=240 Identities=24% Similarity=0.260 Sum_probs=194.4
Q ss_pred eeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 690 lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999954 568899999986432 23345677899999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccc
Q 002021 766 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845 (979)
Q Consensus 766 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 845 (979)
.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence 99987643 6899999999999999999999 9999999999999999999999999999997543221 1223456
Q ss_pred cCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHH
Q 002021 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925 (979)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (979)
||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......... ....+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~~----------------~~~~~ 213 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQE----------------PLRFP 213 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcC----------------CCCCC
Confidence 899999999999889999999999999999999999999652111 111111000 00111
Q ss_pred HHHHHHHHHHHHhccccCcCCCC---CHHHHHHH
Q 002021 926 EQCVSFVFNLAMECTMEFPKQRI---NAKEIVTK 956 (979)
Q Consensus 926 ~~~~~~l~~l~~~cl~~dP~~Rp---s~~eil~~ 956 (979)
..+++.+.+++.+||+.||++|| ++.|++.|
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 23456789999999999999997 46777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.37 Aligned_cols=254 Identities=24% Similarity=0.418 Sum_probs=206.5
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5688899999999999999987788899999876432 335678899999999999999999999999999999999999
Q ss_pred CCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 762 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 762 ~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
+++|.+++... ...+++.++..++.|++.|++||| +++++||||||+||++++++.++++|||.+........ ..
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TA 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-ec
Confidence 99999998654 456889999999999999999999 99999999999999999999999999999987543221 11
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
.....++..|+|||+...+.+++++|||||||++|||+| |+.||...... .....+....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~----------------- 221 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGY----------------- 221 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC-----------------
Confidence 122345678999999988889999999999999999998 99998653211 1111111000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
..+....++.++.+++.+|+..+|++||+++++.+.|+++
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 -RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011123456689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.47 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=198.2
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999955 578999999876432 23346788999999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccc
Q 002021 766 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845 (979)
Q Consensus 766 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 845 (979)
.+++......+++.+++.++.|++.||+||| +++++||||||+||+++.++.+|++|||.+................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999776667899999999999999999999 9999999999999999999999999999987643221111111222
Q ss_pred cCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHH
Q 002021 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVA 924 (979)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (979)
.+..|+|||.+.++.++.++||||+|+++||+++ |..||...... .......... +...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~------------------~~~~ 217 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGV------------------RLPC 217 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCC------------------CCCC
Confidence 3467999999988889999999999999999998 88888643211 1111100000 0011
Q ss_pred HHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 925 KEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 925 ~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
+..++..+.+++.+|++.+|++|||+.|+.+.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2234567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.64 Aligned_cols=259 Identities=30% Similarity=0.482 Sum_probs=209.0
Q ss_pred CCCCCCceeeeecceEEEEEEc------CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
.+|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3577788999999999999963 2355699999876554455678899999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc
Q 002021 756 VLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 820 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~ 820 (979)
||||+++++|.+++.... ..+++..++.++.|++.|++||| +++|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999986432 34789999999999999999999 999999999999999999999
Q ss_pred EEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhh
Q 002021 821 AHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVN 899 (979)
Q Consensus 821 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~ 899 (979)
++++|||++................++..|+|||++.+..++.++||||||+++|||+| |+.||......+ ....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~-- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIEC-- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH--
Confidence 99999999976543332222334556788999999988889999999999999999999 999986532211 1110
Q ss_pred hhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 900 DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....... ..+..++..+.+++.+||+.+|.+||++.|+++.|+++...
T Consensus 238 -~~~~~~~---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 -ITQGRVL---------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HhCCCCC---------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0000000 01122456689999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=302.40 Aligned_cols=251 Identities=27% Similarity=0.378 Sum_probs=206.7
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccc--------cchhcHHHHHHHHHhc-CCCCeeeEEEeeccCC
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCG--------RAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE 751 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (979)
..|+..+.+|.|..++|.+. ...+|..+|+|++..... +..+...+|+.|++++ .||+|+.+.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45777889999999999998 556788999998853321 1234566799999998 5999999999999999
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..++|+|.|+.|.|.|++... ..+++++.++|+.|+.+|++||| .+.|||||+||+|||+|++.++||+|||+++.
T Consensus 97 F~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeec
Confidence 999999999999999999765 46899999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCCCcceecccccCCCCCCccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGR------EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
+.+.. .....+|||+|.|||.+. ...|+..+|+||.|||+|-++.|+.||-- ..++.+.
T Consensus 173 l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--RkQmlML---------- 237 (411)
T KOG0599|consen 173 LEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RKQMLML---------- 237 (411)
T ss_pred cCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HHHHHHH----------
Confidence 75332 346679999999999874 24588899999999999999999999842 1111111
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..-+..+...+.+++.+++.+..+|+.+|++.||.+|.|++|+++|
T Consensus 238 -----R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 238 -----RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -----HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1111122223345667788899999999999999999999999987
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.77 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=203.4
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|+..+.||+|+||.||+|++.++..||||.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577788999999999999988777779999886432 334678899999999999999999999999889999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+|+|.+++......+++.+++.++.|++.|++||| +++++|+||||+||++++++.+|++|||.++....... ...
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence 99999999776557899999999999999999999 99999999999999999999999999999886543221 112
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....++..|+|||...+..++.++||||||+++|||++ |+.||......+ ..........
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~----------------- 219 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLR----------------- 219 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCC-----------------
Confidence 22345678999999988889999999999999999999 999986432111 1111000000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
...+...+..+.+++.+||+.+|.+||++.++++.++
T Consensus 220 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 -LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0001123456899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=323.74 Aligned_cols=255 Identities=29% Similarity=0.447 Sum_probs=206.0
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.++|+..+.||+|+||.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999987777889999986442 33467889999999999999999999999999999999999
Q ss_pred CCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++|.+++.... ..+++.++..++.|++.|++||| +++++||||||+||++++++.+||+|||++........ .
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence 9999999987643 56899999999999999999999 99999999999999999999999999999987642211 1
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
.......+..|+|||+..+..++.++||||||+++|||++ |+.||....... ..... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~-~~~~---------------- 221 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQV-DQGY---------------- 221 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH-HcCC----------------
Confidence 1122223467999999988889999999999999999999 999986532111 11110 0000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
....+..++..+.+++.+|++.+|.+||+++++++.|+++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0001123456689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=340.83 Aligned_cols=245 Identities=22% Similarity=0.264 Sum_probs=200.3
Q ss_pred CCCCCCceeeeecceEEEEEEcC-C-CcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-D-GMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
++|+..+.||+|+||.||+|... + +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 56888999999999999999643 2 3689999986432 23345678899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 99999999999987654 5899999999999999999999 999999999999999999999999999999865321
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+..... ...
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~------------~~~-- 245 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILE------------GII-- 245 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhc------------CCC--
Confidence 13356899999999998888999999999999999999999999753211 00111000 000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
..+...+..+.+++.+|++.||++|+ +++|+++|
T Consensus 246 ------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01122345678999999999999995 89999887
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=338.02 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=197.0
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC-----CeeE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFKA 754 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 754 (979)
.|+..+.||+|+||.||+|. ..+|+.||||++.... ......+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 36778999999999999995 5578999999986432 22345678899999999999999999987432 3479
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||++ ++|.+++.... .+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 68988886543 5899999999999999999999 99999999999999999999999999999976432
Q ss_pred CCC-cceecccccCCCCCCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 835 EDQ-SMIQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 835 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+.........+...
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHHH
Confidence 221 112234578999999998765 67899999999999999999999999653211 0001111111000000000
Q ss_pred -----------ccccCchhhh-hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 -----------ANLLSQEDIH-FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 -----------~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.......... ......+++.+.+++.+||+.||++|||++|+++|
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 01112345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.98 Aligned_cols=369 Identities=28% Similarity=0.384 Sum_probs=219.1
Q ss_pred cCCCCCCeeeccCCcccc-cCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcc
Q 002021 93 GNLSSLQSLNLSFNRLFG-SIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE 171 (979)
Q Consensus 93 ~~l~~L~~L~L~~n~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~ 171 (979)
+-|+..+-.|+++|.|+| .+|.....+++++.|.|...++. .+| ++
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vP--------------------------------eE 50 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVP--------------------------------EE 50 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hCh--------------------------------HH
Confidence 345666667777777763 45665555555555555555555 444 44
Q ss_pred cCCCCccceeecccccccccccccccCCCCCCceecCCCeeee-cCCccccccCccceeeccCCCCcCCCcccccCCCCC
Q 002021 172 FGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVG-IAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPN 250 (979)
Q Consensus 172 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~ 250 (979)
++.|.+|++|.+++|++. .+...++.|+.|+.+++.+|++.. -+|..+..+..|..||||+|+++.++.. +....+
T Consensus 51 L~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~--LE~AKn 127 (1255)
T KOG0444|consen 51 LSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTN--LEYAKN 127 (1255)
T ss_pred HHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchh--hhhhcC
Confidence 444444555555555444 334445555555555555555541 2344555555555555555555543322 334445
Q ss_pred cCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccE
Q 002021 251 LEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKY 330 (979)
Q Consensus 251 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~ 330 (979)
+-+|+||+|+|..+....+.+++.|-.||||+|++.. .|..+..+..|+.|+|++|.+.... +..+..++.|+.
T Consensus 128 ~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~-LPPQ~RRL~~LqtL~Ls~NPL~hfQ-----LrQLPsmtsL~v 201 (1255)
T KOG0444|consen 128 SIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM-LPPQIRRLSMLQTLKLSNNPLNHFQ-----LRQLPSMTSLSV 201 (1255)
T ss_pred cEEEEcccCccccCCchHHHhhHhHhhhccccchhhh-cCHHHHHHhhhhhhhcCCChhhHHH-----HhcCccchhhhh
Confidence 5555555555553322333445555555555555552 3334555555555555555443221 112222233333
Q ss_pred EEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCc
Q 002021 331 FDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDN 410 (979)
Q Consensus 331 L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 410 (979)
|.+|+.+-+ ...+|.++..+.+|+. ++++.|
T Consensus 202 Lhms~TqRT-------------------------l~N~Ptsld~l~NL~d------------------------vDlS~N 232 (1255)
T KOG0444|consen 202 LHMSNTQRT-------------------------LDNIPTSLDDLHNLRD------------------------VDLSEN 232 (1255)
T ss_pred hhcccccch-------------------------hhcCCCchhhhhhhhh------------------------cccccc
Confidence 333322111 0123444444444444 444444
Q ss_pred ccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccC-CCcc
Q 002021 411 KLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTG-SLPL 489 (979)
Q Consensus 411 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~-~~p~ 489 (979)
.+. ..|+.+.++.+|+.|+||+|+|+ .+....+...+|++|+|+.|+++.+|..+.++++|+.|++.+|+++- -+|.
T Consensus 233 ~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPS 310 (1255)
T KOG0444|consen 233 NLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPS 310 (1255)
T ss_pred CCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCcc
Confidence 444 56777777777777777777777 45556667778888888888888888888888888888888888762 3677
Q ss_pred ccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCccccccccccccccccccc
Q 002021 490 EIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLS 556 (979)
Q Consensus 490 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 556 (979)
.++.|.+|+.+..++|++. ..|+.++.+.+|+.|.|+.|+|- .+|+.+.-|+.|+.|||.+|.=-
T Consensus 311 GIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 311 GIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred chhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 8888888888888888886 77888888888888888888877 67888888888888888887544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=337.19 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=194.4
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 345667899999999999995 45789999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++|+|.+.. ..++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||++........
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9999997643 3467788899999999999999 99999999999999999999999999999986532211
Q ss_pred eecccccCCCCCCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 840 IQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+ ..........
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~----------- 290 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICM----------- 290 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhc-----------
Confidence 1234578999999998743 234568999999999999999999997322111 1110000000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. .....+..++.++.+++.+||+.||++||++.|+++|
T Consensus 291 -~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 -S---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -c---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0001112345678999999999999999999999987
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=340.69 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=219.3
Q ss_pred CCCCceeeeecceEEEEEEc-CCC----cEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 684 FSENNLIGRGGFGSVYKASL-GDG----MEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
....++||+|+||+||+|.| .+| -+||+|++.... .+...++.+|+.+|.+++|||+++++++|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34568999999999999965 344 368999886543 345678899999999999999999999998776 78999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
+||+.|+|.||++.++..+..+..+.|..|||+|+.||| +++++||||.++|||+.+-..+||.|||+++...+.+.
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999999989999999999999999999999 99999999999999999999999999999999877766
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.+......-.+.|||-|.+....|+.++|||||||++||++| |..|++...-.+ +. | .+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--I~---------------d--ll- 913 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--IP---------------D--LL- 913 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--hh---------------H--HH-
Confidence 665566666789999999999999999999999999999999 999987632221 11 1 11
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
+.+.+..+++.|+.+++.+|.+||..|+..||+++++...+.++.+..
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 112235567789999999999999999999999999999999887643
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=328.62 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=204.1
Q ss_pred CCCCCCceeeeecceEEEEEEc-----CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-----GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999963 356789999986432 2234678889999999999999999999999999999
Q ss_pred EEEecCCCccceeeccC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC
Q 002021 756 VLEYMPHGSLEKYLYSS----------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 819 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~ 819 (979)
||||+++++|.+++... ...+++.++..++.|++.|++||| +++++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 99999999999988532 234788899999999999999999 99999999999999999999
Q ss_pred cEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhh
Q 002021 820 VAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWV 898 (979)
Q Consensus 820 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~ 898 (979)
.+|++|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..||..... ....+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 999999999987643333222334456778999999988889999999999999999999 8888864221 1111111
Q ss_pred hhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
.... . ...+..++..+.+++.+||+.||++||++.+|.++|..
T Consensus 240 ~~~~---~---------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQ---L---------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCC---c---------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1100 0 01122355678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=332.42 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=202.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|.. .++..+|+|.+..... ...+.+.+|+++++.++||||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 36789999999999999999955 4788999998865422 234668899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
|+++|+|.+++...+ .+++..+..++.|++.|++||| + ++|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999987654 5888999999999999999999 5 479999999999999999999999999987653221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCcc-----------
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST----------- 906 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----------- 906 (979)
.....++..|+|||++.+..++.++||||+||++|||++|+.||......+. ............
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL--ELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH--HHHhcCcccCCccccccCcccCC
Confidence 1234688999999999888899999999999999999999999875322111 111000000000
Q ss_pred ---------------c---hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 ---------------M---EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ---------------~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+ ...+... .... ........+.++.+++.+||+.||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIV-NEPP-PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHh-cCCC-ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0 0000000 0000 000001234678999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=340.64 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=196.5
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||+||+|. ..+++.||||++.... ......+.+|++++..++||+|+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468889999999999999994 4578999999986532 223456788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++...+ .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999987653 6899999999999999999999 99999999999999999999999999999875432110
Q ss_pred c---------------------------------ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 002021 838 S---------------------------------MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT 884 (979)
Q Consensus 838 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~ 884 (979)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012347999999999999889999999999999999999999999
Q ss_pred cccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccc--cCcCCCCCHHHHHHH
Q 002021 885 DEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTM--EFPKQRINAKEIVTK 956 (979)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~Rps~~eil~~ 956 (979)
...... ..+..... +. . ...++....+++++.+++.+++. .++..||+++|+++|
T Consensus 237 ~~~~~~-~~~~~i~~-~~--~-------------~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQ-ETYKKVMN-WK--E-------------TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHH-HHHHHHHc-Cc--C-------------cccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 653211 11111100 00 0 00001111234457777777443 233457999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.70 Aligned_cols=251 Identities=27% Similarity=0.429 Sum_probs=202.7
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
.+|+..+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999987777789999986432 234568889999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+++|.+++......+++..++.++.|++.|++||| +.+++||||||+||++++++.+|++|||.+........ ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence 99999999776567899999999999999999999 99999999999999999999999999999876532211 111
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ ....+... .
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~------------------~ 218 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAG------------------Y 218 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcC------------------C
Confidence 22234567999999988889999999999999999999 889986532211 11100000 0
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
+...+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0011123566799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.56 Aligned_cols=257 Identities=23% Similarity=0.410 Sum_probs=202.6
Q ss_pred hhCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF 752 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (979)
..++|+..+.||+|+||.||+|... ++..||||++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999998542 35679999886432 1234568889999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeccCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 002021 753 KALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 823 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl 823 (979)
.++||||+++|+|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 23577889999999999999999 899999999999999999999999
Q ss_pred EeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhc
Q 002021 824 SDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 824 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
+|||++................+++.|+|||++.++.+++++|||||||++|||++ |..||...... ..... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~---~~ 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRF---VM 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH---HH
Confidence 99999876543332222223345788999999988889999999999999999999 78888643211 11111 00
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
... .. ..+..++..+.+++.+|++.+|++|||+.|++++|++
T Consensus 236 ~~~--------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGG--------LL-------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCC--------cC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000 00 0112345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=343.72 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=198.1
Q ss_pred CCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.|+..+.||+|+||+||+| ...+++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999 45678999999986532 2234568889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC-
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ- 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~- 837 (979)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999987654 5888999999999999999999 99999999999999999999999999999754311000
Q ss_pred --------------------------------------------cceecccccCCCCCCccccCCCCCCCchhHHHHHHH
Q 002021 838 --------------------------------------------SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 873 (979)
Q Consensus 838 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 873 (979)
.......+||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000123469999999999988889999999999999
Q ss_pred HHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHh--ccccCcCCCCCHH
Q 002021 874 LMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAME--CTMEFPKQRINAK 951 (979)
Q Consensus 874 l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~Rps~~ 951 (979)
+|||++|+.||......+.. ..... +. .....+....+++++.+++.+ |+..+|.+||++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~-~~i~~-~~---------------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQ-LKVIN-WE---------------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHH-HHHHc-cc---------------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999753221111 11000 00 000011111345668889988 5566666799999
Q ss_pred HHHHH
Q 002021 952 EIVTK 956 (979)
Q Consensus 952 eil~~ 956 (979)
|+++|
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=323.78 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=204.8
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.+|+..+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4577788999999999999954 46889999998643 233567889999999999999999999999999999999999
Q ss_pred CCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++|.+++... ...+++..++.++.|+++|++||| +++++||||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 999999998654 346899999999999999999999 999999999999999999999999999999876432211
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... ... .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-~~~~~----~~~---------~----- 221 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYEL----LEK---------G----- 221 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH----HHC---------C-----
Confidence 1122234668999999988889999999999999999998 88998642111 11110 000 0
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
.....+..++.++.+++.+||+.+|++||++.|+++.|+++
T Consensus 222 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 -YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00111234567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=341.65 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=203.2
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|. ..+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 368888999999999999994 4578999999987542 223456788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999877667999999999999999999999 99999999999999999999999999999987643322
Q ss_pred cceecccccCCCCCCccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 838 SMIQTQTLATIGYMAPEYGR------EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
. ......||+.|+|||++. ...++.++||||+||++|||++|+.||....... .+...... ..
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~---~~------ 226 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNF---QR------ 226 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcC---CC------
Confidence 1 223346899999999876 4567889999999999999999999996532111 11110000 00
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...++....++..+.+++.+|++ +|.+||++.++++|
T Consensus 227 -------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 -------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00011112345668899999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=344.06 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=200.4
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999954 578999999986532 223456788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999987654 5899999999999999999999 99999999999999999999999999999875432110
Q ss_pred cc------------------------------------eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCC
Q 002021 838 SM------------------------------------IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK 881 (979)
Q Consensus 838 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~ 881 (979)
.. .....+||+.|+|||++....++.++||||+||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011246899999999998889999999999999999999999
Q ss_pred CCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC---HHHHHHH
Q 002021 882 KPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN---AKEIVTK 956 (979)
Q Consensus 882 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~eil~~ 956 (979)
.||......+ .... +..+.. ....+....+++++.+++.+|+. +|.+|++ +.|+++|
T Consensus 237 ~Pf~~~~~~~-~~~~-i~~~~~---------------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQE-TYRK-IINWKE---------------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHH-HHHH-HHcCCC---------------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9997532111 1111 000000 00001111234568899999996 8999998 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=336.09 Aligned_cols=242 Identities=25% Similarity=0.354 Sum_probs=195.3
Q ss_pred ceeeeecceEEEEEEc----CCCcEEEEEEecccc----ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 688 NLIGRGGFGSVYKASL----GDGMEVAVKVFTSQC----GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+.||+|+||.||++.. .+++.||||++.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999964 367899999986432 12334567899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|.+++...+ .+.+..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-- 155 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence 99999999886653 5788899999999999999999 99999999999999999999999999999875432221
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .... .. ...
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-~~~~----~~--------~~~------ 216 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-TIDK----IL--------KGK------ 216 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-HHHH----HH--------cCC------
Confidence 1233568999999999988889999999999999999999999996522110 0010 00 000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
...+..+++.+.+++.+|++.+|++|| ++.++++|
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 011123456688999999999999999 89998876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.09 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=206.6
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|. ..+++.||||.+.... ......+.+|+++++.++|||++++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 578889999999999999995 4578999999875422 223456788999999999999999999999999999999
Q ss_pred EecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
||+++|+|.+++.. ....+++..+..++.|++.|++||| +++++|+||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999888753 2345788999999999999999999 99999999999999999999999999999887643
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
... ......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||.............+....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------------ 224 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------------ 224 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC------------
Confidence 221 123346888999999998888999999999999999999999998643221111111111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
........++..+.+++.+||+.+|++||++.|+++.++++.
T Consensus 225 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 -----YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000011234566899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.88 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=205.9
Q ss_pred hCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (979)
.++|+..+.||+|+||.||+|... ....||+|.+.... .+....+.+|+++++++ +||||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456888899999999999999653 33679999887542 23345688899999999 79999999999999999
Q ss_pred eEEEEEecCCCccceeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC
Q 002021 753 KALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 817 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~ 817 (979)
.++||||+++|+|.+++... ...+++..++.++.|++.|++||| +++|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence 99999999999999988532 346889999999999999999999 999999999999999999
Q ss_pred CCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhH
Q 002021 818 NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKH 896 (979)
Q Consensus 818 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~ 896 (979)
++.+|++|||.+..+.............++..|+|||++.+..++.++|||||||++||+++ |..||......+ ...
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~ 245 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFK 245 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HHH
Confidence 99999999999987654332222223345678999999988889999999999999999998 989886432111 111
Q ss_pred hhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 897 WVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
... .. .....+..++..+.+++.+||..+|.+|||+.|++++|+++.
T Consensus 246 ~~~------------~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLK------------EG------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH------------cC------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 000 00 000112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=322.98 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=202.2
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
++|+..+.||+|+||.||+|. ..+++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 578899999999999999996 4678999999987554445567888999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++... ..+++.++..++.|++.|++||| +++|+|||+||+||++++++.++++|||++........ .
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06646 89 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K 162 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence 999999988654 36899999999999999999999 99999999999999999999999999999986532211 1
Q ss_pred ecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 841 QTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....++..|+|||.+. ...++.++||||+||++|||++|+.||......+... .+... . ...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~~~~------------~-~~~ 228 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSKS------------N-FQP 228 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-eeecC------------C-CCC
Confidence 23346788999999874 3457889999999999999999999986432111100 00000 0 000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
. ........+..+.+++.+||+.+|++||+++++++++
T Consensus 229 ~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 P--KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C--CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 0001122346789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=326.13 Aligned_cols=270 Identities=27% Similarity=0.404 Sum_probs=205.7
Q ss_pred CCCCCCceeeeecceEEEEEEc-----CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc--CCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-----GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 754 (979)
..|+..+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999963 3578999999876555556778899999999999999999998643 45688
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+++++|.+++......+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999776667899999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCcce-ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC-cc-chhhc
Q 002021 835 EDQSMI-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI-ST-MEVVD 911 (979)
Q Consensus 835 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~ 911 (979)
...... .....++..|+|||...+..++.++||||+||++|||++|..|+...... ..+........ .. ....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence 322111 11122345699999998888999999999999999999998876432111 10000000000 00 00000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
.. ......+.+..++.++.+++.+||..+|++|||+.|+++.|+++
T Consensus 238 --~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 --LL-KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred --HH-hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 00011122234567799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=338.12 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=204.7
Q ss_pred hCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 752 (979)
.++|...+.||+|+||.||+|.+. .++.||||++..... ...+.+.+|++++.++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 356778899999999999999753 346899999975432 23456888999999997 9999999999999999
Q ss_pred eEEEEEecCCCccceeeccCC-----------------------------------------------------------
Q 002021 753 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 773 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------- 773 (979)
.++||||+++|+|.++++..+
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999886431
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 774 --------------------------------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 774 --------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
..+++..++.++.|++.|++||| +++++||||||+||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEE
Confidence 23677788999999999999999 9999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchH
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTL 894 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~ 894 (979)
++++.+|++|||+++...............++..|+|||.+.+..+++++||||||+++|||++ |+.||......+. .
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-F 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-H
Confidence 9999999999999986533222222233456788999999988889999999999999999998 8889865322111 1
Q ss_pred hHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 895 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
...+ ... .+...+..++.++.+++.+||..+|++||+++|+++.|+++.
T Consensus 352 ~~~~------------~~~------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 YNAI------------KRG------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHH------------HcC------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1100 000 001112234567999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=326.53 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=204.3
Q ss_pred CCCCCCceeeeecceEEEEEEc------CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
.+|+..+.||+|+||.||+|.. .++..+|+|.+..........+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4567788999999999999953 2466899998876555556789999999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 002021 756 VLEYMPHGSLEKYLYSSN--------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~ 821 (979)
||||+++++|.+++.... ..+++..++.++.|++.|++||| +++++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 999999999999986542 35789999999999999999999 9999999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhh
Q 002021 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~ 900 (979)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ .......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~ 239 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECITQ 239 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHHc
Confidence 9999999976543322222233345788999999988889999999999999999998 899986532211 1110000
Q ss_pred hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
.. ....+..+++.+.+++.+||+.||++||++.|+.+.|+
T Consensus 240 ~~------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 GR------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred Cc------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 00111235567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.73 Aligned_cols=242 Identities=24% Similarity=0.291 Sum_probs=195.6
Q ss_pred ceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCC
Q 002021 688 NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 763 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 763 (979)
+.||+|+||.||+|. ..+|+.||+|++.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999995 4578999999987542 223456678999999999999999999999999999999999999
Q ss_pred ccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 764 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 764 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
+|.+++.... .+++.++..++.|++.||+||| + ++|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence 9998876543 6899999999999999999999 7 7999999999999999999999999999875432221 123
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+ ... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i---~~~---------~-------~ 213 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELI---LME---------E-------I 213 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHH---hcC---------C-------C
Confidence 456899999999998889999999999999999999999999652211 111100 000 0 0
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
..+...++++.+++.+|++.||++|+ ++.|+++|
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01123456689999999999999997 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.58 Aligned_cols=264 Identities=21% Similarity=0.202 Sum_probs=199.3
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..+|+..+.||+|+||.||+| ...+++.||+|+.. ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999 45678999999753 23467899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+. ++|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....... ..
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 95 68888876543 5889999999999999999999 9999999999999999999999999999997543221 11
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccC------cchHhHhhhhhc------CCccc
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG------EMTLKHWVNDWL------PISTM 907 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~------~~~~~~~~~~~~------~~~~~ 907 (979)
......||+.|+|||++.+..+++++||||+||++|||++|+.||...... ...+...+.... +....
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 223457999999999998889999999999999999999999886532211 111111111000 00000
Q ss_pred ----hhh-c--ccccCch--hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 908 ----EVV-D--ANLLSQE--DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 908 ----~~~-~--~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+ . ....... ..........+.++.+++.+|++.||++|||++|+++|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 0 0000000 00111122356679999999999999999999999975
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.45 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=204.3
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3688889999999999999954 478999999986542 234466888999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC-
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED- 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~- 836 (979)
||+++++|.+++... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999998765 46899999999999999999999 9999999999999999999999999999998654332
Q ss_pred --------------------------CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccC
Q 002021 837 --------------------------QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 890 (979)
Q Consensus 837 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~ 890 (979)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 011223456899999999999999999999999999999999999999753211
Q ss_pred cchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-HHHHHHH
Q 002021 891 EMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-AKEIVTK 956 (979)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~eil~~ 956 (979)
. ....... +. . ....+....+++++.+++.+|+. ||.+||+ ++|+++|
T Consensus 237 ~-~~~~i~~-~~--~-------------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E-TYNKIIN-WK--E-------------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H-HHHHHhc-cC--C-------------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 1111000 00 0 00001111145678999999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=334.02 Aligned_cols=242 Identities=24% Similarity=0.286 Sum_probs=193.8
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.. .+++.||||++.... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999954 578999999986532 23345667788888876 699999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++....... ....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence 99998887653 6899999999999999999999 9999999999999999999999999999987542221 1223
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..... ..... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~---i~~~~----------------~ 213 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEA---ILNDE----------------V 213 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHH---HhcCC----------------C
Confidence 456899999999998888999999999999999999999999753211 11111 10000 0
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCH------HHHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINA------KEIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~eil~~ 956 (979)
..+...+.++.+++.+|++.||++||++ +++++|
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0111234568899999999999999998 666655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=333.99 Aligned_cols=245 Identities=23% Similarity=0.311 Sum_probs=194.9
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHH---HhcCCCCeeeEEEeeccCCeeEEE
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIM---KSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
|++.+.||+|+||.||+|. ..+++.||||++.... ....+.+..|++++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5667899999999999995 4578999999987542 22334566676665 456799999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|..++... .+++.++..++.|++.|++||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 9999999998887653 5899999999999999999999 9999999999999999999999999999987543221
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.......|++.|+|||.+.+..++.++||||+||++|||++|+.||......+ ....... ..
T Consensus 156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~~i~~------------~~--- 217 (324)
T cd05589 156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFDSIVN------------DE--- 217 (324)
T ss_pred --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh------------CC---
Confidence 12234568999999999998899999999999999999999999986532111 0110000 00
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
...+..++..+.+++.+|++.||.+|| ++.|+++|
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 001123456688999999999999999 67787775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=311.23 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=212.1
Q ss_pred CCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
|++..+||+|+||.||+| ....|+.||||.+... .+.+++..|+.+|++++.|++|+.||.|......++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556678999999999999 5568999999998644 4567888999999999999999999988888889999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|++.|.++.....+++.++..|+++.+.||+||| ...-+|||||+.|||++.+|.+|++|||.|..+. ++-....
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKRN 187 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKRN 187 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhh--hhHHhhC
Confidence 9999999988889999999999999999999999 8889999999999999999999999999997653 3333446
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
+..||+.|||||++.+-.|..++||||+|++..||.-|+.||.+..+-..-+ + +-..+...+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------M------IPT~PPPTF 249 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------M------IPTKPPPTF 249 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------e------ccCCCCCCC
Confidence 6789999999999998899999999999999999999999987632211000 0 011122334
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
..++.-+.++-+++++|+...|++|-|+.++++|-
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 45667788899999999999999999999999874
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=350.25 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=203.1
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC-----
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----- 751 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 751 (979)
..++|.+.+.||+|+||.||+|. ..+|+.||||++.... ......+.+|+.++..++|+|++++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 34689999999999999999994 5679999999986442 233456788999999999999999988764322
Q ss_pred ---eeEEEEEecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEe
Q 002021 752 ---FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 825 (979)
Q Consensus 752 ---~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D 825 (979)
..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999988643 346889999999999999999999 99999999999999999999999999
Q ss_pred eccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 826 FSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 826 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+......
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~~~~- 260 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKTLAG- 260 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcC-
Confidence 9999876433222223445789999999999998999999999999999999999999864211 1111111000
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. ..+.+..+++++.+++.+||+.||.+||++.|++++
T Consensus 261 -----------~---~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 -----------R---YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----------C---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 001123456679999999999999999999999876
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.04 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=204.9
Q ss_pred CCCCCCceeeeecceEEEEEEc------CCCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCee
Q 002021 682 DGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (979)
++|...+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688889999999999999953 235579999886542 23346788999999999 799999999999999999
Q ss_pred EEEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 754 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
++||||+.+|+|.++++... ..+++.++..++.|++.|++||| +++|+|+||||+||+++.++.++++|||++...
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999987643 34899999999999999999999 999999999999999999999999999999865
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
.............++..|+|||.+.++.++.++||||+||++||+++ |..||......+ .+........
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~~--------- 261 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEGY--------- 261 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcCC---------
Confidence 43322222223345778999999988889999999999999999998 999986532211 1111111000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
....+...+.++.+++.+|+..+|++||++.|+++.|+++
T Consensus 262 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0001112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.04 Aligned_cols=266 Identities=24% Similarity=0.309 Sum_probs=196.4
Q ss_pred CCCCCceeeeecceEEEEEEc--CCCcEEEEEEeccccc--cchhcHHHHHHHHHhc---CCCCeeeEEEeec-----cC
Q 002021 683 GFSENNLIGRGGFGSVYKASL--GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSI---RHRNLIKVISSCS-----NE 750 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~--~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~ 750 (979)
+|+..+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+++++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 688889999999999999964 3578899998865432 2234566788887766 6999999999874 34
Q ss_pred CeeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 751 EFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
...++||||++ ++|.+++... ...+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999996 5898888654 345899999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh---cCCcc
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW---LPIST 906 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~---~~~~~ 906 (979)
...... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+ .+....... .+...
T Consensus 158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDW 233 (290)
T ss_pred EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhc
Confidence 765322 12244568999999999988889999999999999999999999997532211 111111100 00000
Q ss_pred ch-h-hcccccCchhh--hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 ME-V-VDANLLSQEDI--HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ~~-~-~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. . ........... .......++..+.+++.+|++.||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0 00000000000 001112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=342.51 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=197.8
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+++++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 368888999999999999994 5678999999986432 223456788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+|++|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999987643 6889999999999999999999 99999999999999999999999999999864321100
Q ss_pred c-----------c----------------------------------eecccccCCCCCCccccCCCCCCCchhHHHHHH
Q 002021 838 S-----------M----------------------------------IQTQTLATIGYMAPEYGREGRVSANGDVYSFGI 872 (979)
Q Consensus 838 ~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 872 (979)
. . .....+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001246899999999998888999999999999
Q ss_pred HHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCC---CC
Q 002021 873 MLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQR---IN 949 (979)
Q Consensus 873 il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps 949 (979)
++|||++|+.||...... ..+..... +. .. ...+....++.++.+++.+|+. +|.+| ++
T Consensus 237 il~elltG~~Pf~~~~~~-~~~~~i~~-~~--~~-------------~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 237 IMFECLIGWPPFCSENSH-ETYRKIIN-WR--ET-------------LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhcCCCCCCCCCHH-HHHHHHHc-cC--Cc-------------cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 999999999999653211 11111110 00 00 0001111234568899999997 66665 59
Q ss_pred HHHHHHH
Q 002021 950 AKEIVTK 956 (979)
Q Consensus 950 ~~eil~~ 956 (979)
+.|++.|
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.89 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=205.2
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCc----EEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGM----EVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|+..+.||+|+||.||+|++ .+++ .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 5688889999999999999964 3444 48999886443 23356788899999999999999999998754 4679
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
+|||+++|+|.+++......+++..++.++.|++.|++||| +++|+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999876667999999999999999999999 999999999999999999999999999999876433
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
..........++..|+|||...+..++.++|||||||++||+++ |..||..... .....++.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~----------- 229 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGER----------- 229 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCc-----------
Confidence 22222223345678999999988889999999999999999998 8899865321 112221111100
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
...+..++..+.+++.+||..||++||++.|+++.|+++...
T Consensus 230 -------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 -------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred -------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 011123456789999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.68 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=204.3
Q ss_pred CCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 683 GFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
+|+..+.||+|+||.||+|... ....||+|.+..... ...+.+.+|+++++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999542 235789998865432 234678889999999999999999999999999999
Q ss_pred EEEecCCCccceeeccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 002021 756 VLEYMPHGSLEKYLYSS-----------------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 812 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~-----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~N 812 (979)
||||+.+++|.+++... ...+++.+++.++.|++.|++||| +++++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 99999999999887532 134788999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCc
Q 002021 813 VLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 891 (979)
Q Consensus 813 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~ 891 (979)
|++++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543332222233445678999999888889999999999999999999 99998653211
Q ss_pred chHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 892 MTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
....+... .. ....+..++.++.+++.+|++.+|++||++.|+++.|+++..
T Consensus 237 -~~~~~~~~------------~~------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 -RLFNLLKT------------GY------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHHHHhC------------CC------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111110 00 011122345678999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.37 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=197.4
Q ss_pred eeeeecceEEEEEEcC---CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCc
Q 002021 689 LIGRGGFGSVYKASLG---DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 764 (979)
Q Consensus 689 ~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 764 (979)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|++++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999543 456799999865532 234568899999999999999999998854 56789999999999
Q ss_pred cceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc-eecc
Q 002021 765 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM-IQTQ 843 (979)
Q Consensus 765 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~ 843 (979)
|.+++......+++..+++++.|++.|++||| +++++||||||+||+++.++.+|++|||.+.......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999776667999999999999999999999 9999999999999999999999999999997654332211 1122
Q ss_pred cccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 844 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
..++..|+|||.+....++.++||||||+++||+++ |+.||......+ ....+.... +.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~------------------~~ 217 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGK------------------RL 217 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCC------------------CC
Confidence 234578999999888889999999999999999996 999987532211 111111000 01
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
..+..+++++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11234567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=333.47 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=201.9
Q ss_pred CCCCCCceeeeecceEEEEEEc------CCCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeeeEEEeecc-CCe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIKVISSCSN-EEF 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~ 752 (979)
++|+..+.||+|+||.||+|.. .+++.||||+++.... .....+.+|++++.++ +||||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788999999999999999952 3578999999875432 2345678899999999 68999999998765 456
Q ss_pred eEEEEEecCCCccceeeccCC-----------------------------------------------------------
Q 002021 753 KALVLEYMPHGSLEKYLYSSN----------------------------------------------------------- 773 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------------- 773 (979)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999998875421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceeccccc
Q 002021 774 -------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846 (979)
Q Consensus 774 -------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 846 (979)
..+++.++..++.|+++|++||| +++|+||||||+||++++++.+|++|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 23678888999999999999999 99999999999999999999999999999986533322222233345
Q ss_pred CCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHH
Q 002021 847 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925 (979)
Q Consensus 847 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (979)
+..|+|||.+.+..++.++||||||+++||+++ |..||....... .....+.... +...+
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~------------------~~~~~ 304 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGT------------------RMRAP 304 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccC------------------CCCCC
Confidence 678999999988889999999999999999997 888986532211 1111000000 00011
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 926 EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 926 ~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
..+++++.+++.+||+.+|++|||+.|++++|+.+.+
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1234568999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=333.02 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=196.5
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCC-CeeeEEEeeccCCeeEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHR-NLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 757 (979)
+|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999954 467899999987542 23445677899999999765 6888999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 9999999998886643 5889999999999999999999 99999999999999999999999999999875322221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
......||+.|+|||++.+..++.++||||+||++|||+||+.||......+ ....... .
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-~~~~i~~----~------------- 216 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQSIME----H------------- 216 (324)
T ss_pred --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHc----C-------------
Confidence 1234568999999999998889999999999999999999999996532111 1111000 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH-----HHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA-----KEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~eil~~ 956 (979)
....+...+.++.+++.+|+..||.+|++. .|+.+|
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 000111234568899999999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=339.47 Aligned_cols=253 Identities=22% Similarity=0.275 Sum_probs=201.0
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 4678889999999999999995 4578999999986431 12334577899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999988654 4788899999999999999999 9999999999999999999999999999998654222
Q ss_pred CcceecccccCCCCCCccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREG----RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
. .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..... ..
T Consensus 197 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~---~~-------- 263 (370)
T cd05596 197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMD---HK-------- 263 (370)
T ss_pred c-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHc---CC--------
Confidence 1 122345799999999987643 4788999999999999999999999753211 11111100 00
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCC--CCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQ--RINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~eil~~ 956 (979)
....++....++.++.+++.+|++.+|.+ |+++.|+++|
T Consensus 264 -----~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 -----NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00011111234567899999999999988 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.76 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=207.0
Q ss_pred hCCCCCCceeeeecceEEEEEEc--------CCCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccC
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL--------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE 750 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (979)
.++|...+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 35678889999999999999953 134579999886442 23456788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCccceeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 751 EFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
...++||||+++|+|.+++... ...+++.++..++.|+++|++||| +++++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 9999999999999999998653 135788899999999999999999 9999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchH
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTL 894 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~ 894 (979)
++++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++||+++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999987643332222233445678999999988889999999999999999998 7788754211
Q ss_pred hHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 895 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
..+........ ....+..++..+.+++.+||..+|.+||++.|+++.|+++...
T Consensus 246 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLKEGH---------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHcCC---------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11111000000 0011224567799999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=324.33 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=202.0
Q ss_pred hCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
.++|+..+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456888899999999999999653 356799998764432 2345688899999999999999999999998999
Q ss_pred EEEEEecCCCccceeeccCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEE
Q 002021 754 ALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLS 824 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~ 824 (979)
++||||+++++|.+++...+ ..+++..+++++.||+.|++||| +++++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999986543 25899999999999999999999 99999999999999998654 69999
Q ss_pred eeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcC
Q 002021 825 DFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLP 903 (979)
Q Consensus 825 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 903 (979)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+ ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~---~~ 236 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFV---TG 236 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH---Hc
Confidence 9999987633222111122234568999999988899999999999999999997 999986532211 11110 00
Q ss_pred CccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
.. +...+..++..+.+++.+|++.+|++||++.|++++|.+
T Consensus 237 ~~---------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 237 GG---------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CC---------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 00 001112345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=328.40 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=205.8
Q ss_pred CCCCCCceeeeecceEEEEEEcC--------CCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG--------DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE 751 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (979)
++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+..|+++++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888999999999999999542 23579999987542 23445688899999999 7999999999999999
Q ss_pred eeEEEEEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC
Q 002021 752 FKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 816 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~ 816 (979)
..++||||+++|+|.+++.... ..+++.++++++.|++.|++||| +++++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999987532 24788999999999999999999 99999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHh
Q 002021 817 DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 895 (979)
Q Consensus 817 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~ 895 (979)
+++.+||+|||.+................++..|+|||.+.+..++.++||||+||++|||++ |..||..... ....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~~~ 252 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EELF 252 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHHH
Confidence 999999999999876542222111122234568999999988889999999999999999998 8888754211 1111
Q ss_pred HhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
..+. . . .....+..++.++.+++.+||..+|.+||++.|+++.|.++...-
T Consensus 253 ~~~~---~---------~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 253 KLLK---E---------G------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHH---c---------C------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1000 0 0 001112244567899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.86 Aligned_cols=260 Identities=25% Similarity=0.437 Sum_probs=204.6
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCc--EEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGM--EVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (979)
++|++.+.||+|+||.||+|... ++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888899999999999999653 343 47888876432 23346788899999999 799999999999999999999
Q ss_pred EEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 002021 757 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~ 821 (979)
|||+++++|.+++.... ..+++..++.++.|++.|++||| +++|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999986532 35788999999999999999999 9999999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhh
Q 002021 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~ 900 (979)
||+|||++..... .........+..|+|||+.....++.++|||||||++|||++ |..||......+ ....
T Consensus 159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-----~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-----LYEK 230 (297)
T ss_pred EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence 9999999864321 111112233567999999988889999999999999999998 999986532111 1110
Q ss_pred hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccC
Q 002021 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRN 967 (979)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~ 967 (979)
.. .. .....+..++..+.+++.+||+.+|.+||++.++++.|+++.+.....
T Consensus 231 ~~---------~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 231 LP---------QG------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred Hh---------cC------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 00 00 000111235567899999999999999999999999999999866443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.92 Aligned_cols=268 Identities=19% Similarity=0.255 Sum_probs=201.6
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|...+.||+|+||.||+|.. .+++.||+|++..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688889999999999999954 4788999999864432 2334677899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++ ++.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 975 888888776667899999999999999999999 99999999999999999999999999999876432221
Q ss_pred eecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC--C-ccchh------
Q 002021 840 IQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP--I-STMEV------ 909 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~-~~~~~------ 909 (979)
......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||......+ ........... . .+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1233467899999998765 468899999999999999999999997532211 11111110000 0 00000
Q ss_pred hcccccC-chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLS-QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+..... ...........++.++.+++.+|++.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000 0000001112356678999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.13 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=196.6
Q ss_pred CCCceeeeecceEEEEEEcCC-Cc--EEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC------Cee
Q 002021 685 SENNLIGRGGFGSVYKASLGD-GM--EVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------EFK 753 (979)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~-~~--~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 753 (979)
.+.+.||+|+||.||+|...+ +. .||+|.++... ....+.+..|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999996543 33 68999886432 23456788899999999999999999987432 246
Q ss_pred EEEEEecCCCccceeecc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecc
Q 002021 754 ALVLEYMPHGSLEKYLYS-----SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSI 828 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~ 828 (979)
++||||+++|+|.+++.. ....+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999888642 2345889999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccc
Q 002021 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTM 907 (979)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 907 (979)
++.+.............+++.|+|||...+..+++++||||||+++|||++ |+.||...... .....+.. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~---~~~- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQ---GNR- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc---CCC-
Confidence 987643322222223346778999999998899999999999999999999 78888652211 11111110 000
Q ss_pred hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
...+..++..+.+++.+||+.+|++|||+.|++++|+++
T Consensus 233 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 --------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001123456689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.66 Aligned_cols=245 Identities=23% Similarity=0.285 Sum_probs=194.8
Q ss_pred eeeecceEEEEEE-cCCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 690 lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
||+|+||+||++. ..+++.||+|++..... ...+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999995 45789999999864321 2235567899999999999999999999999999999999999999
Q ss_pred ceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 766 EKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 766 ~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
.+++.. ....+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||.+........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 887643 2346899999999999999999999 99999999999999999999999999999976543222 123
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||........ ........... ..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~----------------~~ 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILND----------------SV 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhccc----------------CC
Confidence 35689999999999999999999999999999999999999965321110 01100000000 00
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
..+..++..+.+++.+|++.||++|| +++|+++|
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11223556789999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.25 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=200.7
Q ss_pred CCCCceeeeecceEEEEEEcC-C---CcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe-----
Q 002021 684 FSENNLIGRGGFGSVYKASLG-D---GMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF----- 752 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~---~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 752 (979)
|+..+.||+|+||.||+|... + +..||||+++... ....+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999653 2 3679999987542 2234578899999999999999999998866554
Q ss_pred -eEEEEEecCCCccceeeccC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEee
Q 002021 753 -KALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 826 (979)
Q Consensus 753 -~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df 826 (979)
.++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999998887432 246899999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCc
Q 002021 827 SIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 827 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
|.++.+.............++..|+|||.+.+..+++++|||||||++|||++ |..||...... ....++....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~--- 232 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGN--- 232 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---
Confidence 99987654333222222345678999999988889999999999999999999 88888653221 1111111000
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
....+..++..+.+++.+||+.||.+||++.|++++|+++
T Consensus 233 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 ---------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011224566799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.40 Aligned_cols=245 Identities=27% Similarity=0.440 Sum_probs=205.2
Q ss_pred ceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCccc
Q 002021 688 NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 766 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 766 (979)
-+||+|.||+||-|+ .++...+|||.+.....+..+-..+|+..-+.++|.|||+.+|.+.+.+.+-+.||.++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999995 4556679999987666666777888999999999999999999999999999999999999999
Q ss_pred eeeccCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEEeeccccccCCCCCcceecc
Q 002021 767 KYLYSSNCIL--DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQ 843 (979)
Q Consensus 767 ~~l~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 843 (979)
+.++..=.++ .+.+.-.+.+||++||.||| +..|||||||.+|||++ -.|.+||+|||-+++..+-.. -..+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc--cccc
Confidence 9998763444 67788889999999999999 99999999999999997 589999999999998754322 2345
Q ss_pred cccCCCCCCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhh
Q 002021 844 TLATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921 (979)
Q Consensus 844 ~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (979)
..||..|||||++..| .|++++|||||||++.||.||++||.+....+..+ +..++. ...
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------------FkVGmy---KvH 797 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------------FKVGMY---KVH 797 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------------hhhcce---ecC
Confidence 6799999999999765 58899999999999999999999998754332211 111121 223
Q ss_pred hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 002021 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVT 955 (979)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~ 955 (979)
++.++..+.++..+|.+|+.+||.+||+|++++.
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 4566788889999999999999999999999875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=333.34 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=198.6
Q ss_pred CCCCCceeeeecceEEEEEEc----CCCcEEEEEEecccc----ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCee
Q 002021 683 GFSENNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQC----GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (979)
+|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+..|+++++.+ +||+|+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999854 368899999986432 12345677899999999 499999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||+++|+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999987643 5899999999999999999999 9999999999999999999999999999997653
Q ss_pred CCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
..... ......||+.|+|||++.+. .++.++||||+||++|||+||+.||........ ..........
T Consensus 157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~--------- 225 (332)
T cd05614 157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK--------- 225 (332)
T ss_pred ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc---------
Confidence 32221 12345689999999998764 478899999999999999999999964321111 1111000000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
.....+...+..+.+++.+|++.||++|| +++|+++|
T Consensus 226 -------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 -------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00011123456688999999999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=333.60 Aligned_cols=242 Identities=23% Similarity=0.288 Sum_probs=194.7
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|+. .+++.||||++.... ....+.+..|.+++..+ +||+|+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999954 568899999987542 23345567788888866 799999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence 99998886553 6889999999999999999999 99999999999999999999999999999875432221 223
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+..... .. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~i~~----~~----------------~ 213 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFESILH----DD----------------V 213 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HHHHHHc----CC----------------C
Confidence 4568999999999988889999999999999999999999997532111 1111000 00 0
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCC-------CHHHHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRI-------NAKEIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-------s~~eil~~ 956 (979)
..+..++.++.+++.+|++.||++|| ++.++++|
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01112345688999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=333.33 Aligned_cols=248 Identities=20% Similarity=0.261 Sum_probs=195.7
Q ss_pred ceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|. ..+++.||||+++... ....+.+..|..+++.+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999995 4578999999997532 22345577899999988 699999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++... ..+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTS 154 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--ccc
Confidence 9998887654 36899999999999999999999 99999999999999999999999999999875322211 123
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCc---chHhHhhhhhcCCccchhhcccccCchh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE---MTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+.....+ .....+..... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~------ 220 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LEK------ 220 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------HcC------
Confidence 4578999999999998899999999999999999999999996422111 11111111000 000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCC------HHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRIN------AKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~eil~~ 956 (979)
....+..++..+.+++.+|++.||.+||+ +.|+++|
T Consensus 221 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 221 -QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 00112234566899999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=326.94 Aligned_cols=254 Identities=25% Similarity=0.440 Sum_probs=201.9
Q ss_pred CCCCCceeeeecceEEEEEEcC------CCcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 683 GFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
+|+..+.||+|+||.||+|... ++..||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566788999999999999642 3578999998754322 24568889999999999999999999999999999
Q ss_pred EEEecCCCccceeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc
Q 002021 756 VLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 820 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~ 820 (979)
++||+++++|.+++... +..+++..+..++.|++.|++|+| +++|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 99999999999887421 235788889999999999999999 999999999999999999999
Q ss_pred EEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhh
Q 002021 821 AHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVN 899 (979)
Q Consensus 821 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~ 899 (979)
+|++|||+++...............+++.|+|||.+.++.++.++||||+||++|||++ |..||...... .....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~-- 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEM-- 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH--
Confidence 99999999886543332222233456789999999988889999999999999999998 88887642211 11111
Q ss_pred hhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 900 DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
...... ...+..++..+.+++.+||+.+|.+||+++||++.|+.
T Consensus 239 -i~~~~~---------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 -IRNRQV---------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHcCCc---------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 110000 01123466779999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=324.84 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=200.6
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.|+..+.||+|+||+||+|.. .+++.||||++..... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 367789999999999999954 5789999999864321 123456789999999999999999999999999999999
Q ss_pred ecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 759 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
|+++|+|.+++... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999887654 346899999999999999999999 9999999999999999999999999999997653221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
......|+..|+|||++.+..++.++||||+||++||+++|+.||..... ......+......
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-~~~~~~~~~~~~~-------------- 219 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEVERRVKE-------------- 219 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-hhHHHHHHHHhhh--------------
Confidence 12345689999999999888899999999999999999999999975221 1111111000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
.....+..++..+.+++.+||..||++|| +++|+++|
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 --DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00011123456689999999999999999 89999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=331.26 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=191.2
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.. .+++.||||+++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999954 568899999987542 22334455677777654 899999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99998887643 6899999999999999999999 9999999999999999999999999999997643222 2223
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .... ..... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~---~i~~~----------------~~ 213 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFD---SILND----------------RP 213 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHH---HHHcC----------------CC
Confidence 456899999999998888999999999999999999999999753211 1110 00000 00
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHH-HHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAK-EIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-eil~~ 956 (979)
..+..++.++.+++.+||+.||.+||++. ++++|
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 01123455688999999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.02 Aligned_cols=266 Identities=27% Similarity=0.426 Sum_probs=209.7
Q ss_pred CCCCCCceeeeecceEEEEEEc--------CCCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCC
Q 002021 682 DGFSENNLIGRGGFGSVYKASL--------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE 751 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (979)
++|...+.||+|+||.||+|+. .....||+|.+.... ......+..|+++++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 5677889999999999999953 134579999886442 23345688899999999 6999999999999999
Q ss_pred eeEEEEEecCCCccceeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC
Q 002021 752 FKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 816 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~ 816 (979)
..++||||+++|+|.+++... ...+++.++.+++.|++.|++||| +++++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 999999999999999998653 135788999999999999999999 99999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHh
Q 002021 817 DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 895 (979)
Q Consensus 817 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~ 895 (979)
+++.+|++|||.++.....+.........++..|+|||.+.++.++.++||||||+++||+++ |..||...... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~ 246 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--ELF 246 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999986643222211122234567999999988889999999999999999999 88888642211 111
Q ss_pred HhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCC
Q 002021 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGG 970 (979)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~ 970 (979)
..... .. ....+..++.++.+++.+||..+|++||++.|+++.|.++......++.+
T Consensus 247 ~~~~~---~~---------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 303 (314)
T cd05099 247 KLLRE---GH---------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLD 303 (314)
T ss_pred HHHHc---CC---------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCcee
Confidence 11000 00 00112244567889999999999999999999999999999877776653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.05 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=211.9
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccccc---chhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGR---AFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 754 (979)
....|+..+.||+|.||.||++. ..+|+.+|+|++.+.... ..+.+.+|+++|++++ |||||.+.++|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34568888999999999999995 456999999999765432 3468899999999998 999999999999999999
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC----CcEEEEeecccc
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFSIAK 830 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~----~~~kl~Dfg~~~ 830 (979)
+|||+++||.|.+.+... .+++..+..++.|++.+++||| +.||+|||+||+|+|+... +.+|++|||++.
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 999999999999998776 3999999999999999999999 9999999999999999733 579999999999
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
.... .......+||+.|+|||++....|+.++||||+||++|.|++|..||.......... . +.
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~------------i~ 251 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-A------------IL 251 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-H------------HH
Confidence 8754 334577899999999999999999999999999999999999999997643222111 1 11
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ........+..++..+.+++.+++..||.+|+|+.++++|
T Consensus 252 ~~----~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 252 RG----DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cC----CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 10 0011223445667789999999999999999999999997
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=341.73 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=196.8
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.|+..+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 47788999999999999994 4678899999986542 2234568889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC-
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ- 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~- 837 (979)
|+++|+|.+++.+.+ .+++..+..++.||+.|++||| +++|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999987653 5788999999999999999999 99999999999999999999999999999753210000
Q ss_pred --------------------------------------------cceecccccCCCCCCccccCCCCCCCchhHHHHHHH
Q 002021 838 --------------------------------------------SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 873 (979)
Q Consensus 838 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 873 (979)
.......+||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000122468999999999988899999999999999
Q ss_pred HHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC---H
Q 002021 874 LMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN---A 950 (979)
Q Consensus 874 l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~ 950 (979)
+|||++|+.||......+. ...... +. .....+.....++++.+++.+++ .+|++|++ +
T Consensus 238 l~elltG~~Pf~~~~~~~~-~~~i~~-~~---------------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLET-QMKVIN-WQ---------------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHhCCCCCCCCCHHHH-HHHHHc-cC---------------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 9999999999975322111 111000 00 00001111233456788888876 48999997 8
Q ss_pred HHHHHH
Q 002021 951 KEIVTK 956 (979)
Q Consensus 951 ~eil~~ 956 (979)
.|+++|
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 988876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=333.02 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=194.5
Q ss_pred ceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999995 4578899999987542 22344577888888876 799999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 99988876543 6899999999999999999999 99999999999999999999999999999875432221 123
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc---hHhHhhhhhcCCccchhhcccccCchh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM---TLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....+..... .. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-------~~------~- 220 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------LE------K- 220 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-------hc------C-
Confidence 45689999999999999999999999999999999999999964221111 1111110000 00 0
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCC------HHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRIN------AKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~eil~~ 956 (979)
....+..++..+.+++.+|++.||++||+ +.|+++|
T Consensus 221 -~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 00112234566889999999999999998 4677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=330.92 Aligned_cols=242 Identities=22% Similarity=0.286 Sum_probs=191.9
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.. .+|+.||+|+++... ....+.+..|..++... +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999954 578999999987542 22345566788888754 899999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++... ..+++.++..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RAS 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--cee
Confidence 9999888664 36889999999999999999999 99999999999999999999999999999875321111 223
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~---------------~----~ 213 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVD---------------T----P 213 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---------------C----C
Confidence 456899999999999889999999999999999999999999653211 111100000 0 0
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHH-HHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAK-EIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-eil~~ 956 (979)
..+..++.++.+++.+|++.||++||++. ++.+|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 01112445688999999999999999985 56543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=341.99 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=198.1
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
+|+..+.||+|+||.||+|+ ..+++.||||++.... ....+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68889999999999999995 4578999999986432 2234567889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC--
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED-- 836 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~-- 836 (979)
|+++|+|.+++...+ .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999987654 5788899999999999999999 9999999999999999999999999999975321000
Q ss_pred ---------------------------------------CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHH
Q 002021 837 ---------------------------------------QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMET 877 (979)
Q Consensus 837 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 877 (979)
.........||+.|+|||++.+..++.++||||+||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00001134689999999999988999999999999999999
Q ss_pred HcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC---CHHHHH
Q 002021 878 FTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI---NAKEIV 954 (979)
Q Consensus 878 ~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---s~~eil 954 (979)
++|+.||......+.. .. +..+.. ....+....++.++.+++.+|+ .+|.+|+ ++.|++
T Consensus 238 l~G~~Pf~~~~~~~~~-~~-i~~~~~---------------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 238 LVGQPPFLADTPAETQ-LK-VINWET---------------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred hhCCCCCCCCCHHHHH-HH-HhccCc---------------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 9999999753221110 00 000000 0000111234456788888876 4999999 999999
Q ss_pred HH
Q 002021 955 TK 956 (979)
Q Consensus 955 ~~ 956 (979)
+|
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 88
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.08 Aligned_cols=267 Identities=26% Similarity=0.408 Sum_probs=203.5
Q ss_pred CCCCceeeeecceEEEEEE-----cCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeecc--CCeeEE
Q 002021 684 FSENNLIGRGGFGSVYKAS-----LGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKAL 755 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-----~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 755 (979)
|+..+.||+|+||+||++. ..+++.||+|++..... ...+.+.+|+++++.++||||+++++++.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 3778999999999998763 24678899999875432 235678889999999999999999998765 346789
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++++|.+++... .+++.+++.++.|++.|++||| +++|+||||||+||++++++.+|++|||++......
T Consensus 86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999998764 4899999999999999999999 999999999999999999999999999999876432
Q ss_pred CCcce-ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh-cCCccchhhccc
Q 002021 836 DQSMI-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW-LPISTMEVVDAN 913 (979)
Q Consensus 836 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 913 (979)
..... .....++..|+|||...+..++.++||||||+++|||+||+.||............+.... ......+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 22111 1223456679999999888899999999999999999999999865322111111100000 000011111111
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
. ..+.+..++.++.+++.+||+.+|++|||++++++.|+++-
T Consensus 241 ~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 M------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred C------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0 11123346678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.65 Aligned_cols=260 Identities=23% Similarity=0.382 Sum_probs=208.5
Q ss_pred hCCCCCCceeeeecceEEEEEEcCC-----CcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeecc-CCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGD-----GMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 753 (979)
.++|+..+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+.+++.++|||++++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999997654 6889999886442 2335668889999999999999999998765 5778
Q ss_pred EEEEEecCCCccceeeccCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEee
Q 002021 754 ALVLEYMPHGSLEKYLYSSN-------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 826 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df 826 (979)
++++||+++++|.+++.... ..+++.++..++.|++.|++||| +++++||||||+||++++++.+|++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999986532 45889999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCc
Q 002021 827 SIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 827 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
|+++.+...+.........++..|+|||++.+..++.++||||+|+++||+++ |+.||.... ......+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~--- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLKDGY--- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHHcCC---
Confidence 99987654333222233445678999999988889999999999999999999 999986531 112222211110
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+..+++++.+++.+||..||++|||+.|+++.|+++.++
T Consensus 237 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 ---------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ---------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0001123456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.75 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=202.7
Q ss_pred HHhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 678 CRATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
..+++++.....||+|+||.||+|. ..+++.||+|.+........+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3455667777899999999999996 456888999998765555567889999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEEeeccccccC
Q 002021 757 LEYMPHGSLEKYLYSSNCIL--DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFSIAKMLT 833 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfg~~~~~~ 833 (979)
|||+++++|.+++......+ ++..+..++.|++.|++||| +++|+||||||+||+++. ++.++|+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999997654445 78889999999999999999 999999999999999986 6799999999987654
Q ss_pred CCCCcceecccccCCCCCCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
.... ......++..|+|||++.+.. ++.++||||+|+++|++++|+.||......... .+....
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~---------- 226 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGM---------- 226 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhh----------
Confidence 2221 112345788999999986543 788999999999999999999998653211111 000000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. .....+..+..++.+++.+||+.+|.+|||+.|++.|
T Consensus 227 ---~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 227 ---FK---IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---hc---cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 0001122345668999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=329.04 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=192.2
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||+||+|.. .+++.||||+++... ....+.+..|..+++.. +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999964 468899999987542 23345566788888764 899999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++... ..+++.++..++.|++.|++||| +++|+||||||+||++++++.+||+|||++........ ...
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC 154 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence 9999988754 35889999999999999999999 99999999999999999999999999999875322211 123
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~-------------------~ 213 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMDN-------------------P 213 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC-------------------C
Confidence 456899999999998888999999999999999999999999753211 1111110000 0
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHH-HHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAK-EIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-eil~~ 956 (979)
..+..++.++.+++.+|++.||++||++. ++.+|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 00112345688999999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.44 Aligned_cols=264 Identities=23% Similarity=0.389 Sum_probs=206.1
Q ss_pred hhCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF 752 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (979)
..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567899999999999999998532 245799998764321 233457789999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeccCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 002021 753 KALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 823 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl 823 (979)
.++||||+++|+|.+++...+ ...++..+..++.|++.|++||| +++|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999986431 33567788999999999999999 999999999999999999999999
Q ss_pred EeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhc
Q 002021 824 SDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 824 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...... ..... ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~---~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKF---VM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH---HH
Confidence 99999886543332222233345678999999988889999999999999999999 78888642211 11111 00
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
+.... ..++.++..+.+++.+|++.+|++|||+.|+++.+++......+
T Consensus 236 --------~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 236 --------DGGYL-------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred --------cCCCC-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 00000 01123456799999999999999999999999999887654443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=340.59 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=194.0
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccC--------C
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--------E 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 751 (979)
..+|+..+.||+|+||.||+|.. .+++.||||++... .....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45789999999999999999954 57899999988532 23345799999999999999998876321 2
Q ss_pred eeEEEEEecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEEeec
Q 002021 752 FKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFS 827 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg 827 (979)
..++||||+++ ++.+++.. ....+++..++.++.|++.||+||| +++|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999975 77666642 3456899999999999999999999 99999999999999999664 79999999
Q ss_pred cccccCCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc-
Q 002021 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS- 905 (979)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~- 905 (979)
+++.+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+...+.......
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence 9987643222 1335689999999987654 68999999999999999999999997532211 1111111100000
Q ss_pred -cchhhcccc-------cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 -TMEVVDANL-------LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 -~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+.. ..........+...+.++.+++.+||+.||.+|||+.|+++|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000000 001111122233456789999999999999999999999977
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.36 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=192.0
Q ss_pred eeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 690 lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
||+|+||.||++. ..+|+.||+|++.... ....+.+..|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999995 4579999999986432 11234456799999999999999999999999999999999999999
Q ss_pred ceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceeccc
Q 002021 766 EKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844 (979)
Q Consensus 766 ~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 844 (979)
.+++... ...+++..+..++.|++.|++||| +++|+||||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 8887553 335889999999999999999999 9999999999999999999999999999987654221 12345
Q ss_pred ccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHH
Q 002021 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVA 924 (979)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (979)
.++..|+|||++.+..++.++||||+||++|||++|+.||....... ........... ... .. .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~--------~~~------~~-~ 218 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLE--------DEV------KF-E 218 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhc--------ccc------cc-c
Confidence 68899999999988889999999999999999999999986532111 11111000000 000 00 0
Q ss_pred HHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 002021 925 KEQCVSFVFNLAMECTMEFPKQRINAKEIVT 955 (979)
Q Consensus 925 ~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~ 955 (979)
...++.++.+++.+|++.||++||++.|+++
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 1134566899999999999999999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.08 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=202.6
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++|++++++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 5688889999999999999987788889999986542 234678899999999999999999998854 56789999999
Q ss_pred CCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 762 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 762 ~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
+++|.+++... ...+++.++..++.|++.|++||| +++++||||||+||++++++.++++|||.+......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence 99999998764 345899999999999999999999 999999999999999999999999999999865432221 1
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
.....++..|+|||+..+..++.++||||||+++||+++ |..||...... ..........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~----------------- 220 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGY----------------- 220 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC-----------------
Confidence 122335678999999988889999999999999999999 88888653211 1111110000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
..+.+..++..+.+++.+|+..+|.+|||+.++.+.|++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 -RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001122345679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.10 Aligned_cols=253 Identities=23% Similarity=0.422 Sum_probs=204.3
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.+.|+..+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++|||++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35688899999999999999988888999999986543 33467889999999999999999999874 45689999999
Q ss_pred CCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++|.+++... ...+++.++..++.|++.|++||| +.+++||||||+||++++++.++++|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence 999999988654 346899999999999999999999 99999999999999999999999999999976542221 1
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......++..|+|||++....++.++||||||+++||+++ |+.||......+ ........
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~----------------- 219 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERG----------------- 219 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcC-----------------
Confidence 1223345678999999988889999999999999999999 999987532211 11111000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
.+...+..++.++.+++.+|+..+|++||+++++.+.|+.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 -YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001112345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.94 Aligned_cols=247 Identities=23% Similarity=0.384 Sum_probs=197.1
Q ss_pred eeeeecceEEEEEEc---CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCC
Q 002021 689 LIGRGGFGSVYKASL---GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 763 (979)
Q Consensus 689 ~lG~G~~g~Vy~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 763 (979)
.||+|+||.||+|.+ .++..||+|+++.... ...+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999954 3678899999864432 23467888999999999999999999885 45678999999999
Q ss_pred ccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc-eec
Q 002021 764 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM-IQT 842 (979)
Q Consensus 764 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~~~ 842 (979)
+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||++++++.+|++|||.+.......... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999986543 6899999999999999999999 9999999999999999999999999999998764333221 112
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (979)
...++..|+|||.+....++.++|||||||++|||++ |+.||...... .....+.... .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~------------------~ 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGE------------------R 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCC------------------C
Confidence 2334678999999988889999999999999999998 99998753221 1111111000 0
Q ss_pred hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
...+..+++++.+++.+||+.||++||++++|.+.|+++
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111224567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=317.33 Aligned_cols=254 Identities=26% Similarity=0.447 Sum_probs=203.2
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
+.|.+.+.||+|+||.||+|...+...||+|++.... ...+.+.+|+++++.++||||+++++++.+ +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 4588889999999999999977666789999986432 234578899999999999999999998754 55789999999
Q ss_pred CCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 762 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 762 ~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
+|+|.+++... ...+++..+..++.|+++|++||| +.+++||||||+||++++++.++|+|||.+......... .
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence 99999999764 345789999999999999999999 999999999999999999999999999999766433221 1
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
.....++..|+|||+..++.++.++||||+|+++||++| |..||......+. ... ... .
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~----~~~---------~------ 219 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQ----VER---------G------ 219 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHH----Hhc---------C------
Confidence 223446678999999988889999999999999999999 8888865322111 100 000 0
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
........++..+.+++.+|++.+|++||++.++++.|++..
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 000111234567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.19 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=201.9
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc-----cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG-----RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|+..+.||+|++|.||+|. ..++++||+|++..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 568899999999999999995 45789999998864321 123567889999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++++|.+++...+ .+++..+..++.|++.|++||| +.+|+||||+|+||++++++.++|+|||.+......
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999887653 5788999999999999999999 999999999999999999999999999999765322
Q ss_pred CCcc-eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSM-IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.... ......++..|+|||.+.+..++.++||||+|+++||+++|+.||....... .... .. ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~-~~--~~~---------- 223 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-AIFK-IA--TQP---------- 223 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-HHHH-Hh--ccC----------
Confidence 1111 1123457789999999998889999999999999999999999986531111 0000 00 000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+..++..+.+++.+||..+|.+|||+.|++++
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0001122345668999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.04 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=205.3
Q ss_pred CCCCCCceeeeecceEEEEEEcC----CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.+|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+..|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999642 23479999886543 23346788899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999876667899999999999999999999 9999999999999999999999999999998764332
Q ss_pred Ccce-ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 837 QSMI-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 837 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||...... ..........
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~------------ 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGY------------ 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCC------------
Confidence 2211 112233568999999988889999999999999999887 99998653221 1111111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
+.+.+..++..+.+++.+|++.+|.+||++.++++.|.++
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=336.59 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=199.5
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
..++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 346789999999999999999954 568899999986421 2234557789999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++... .+++..+..++.||+.||+||| +++|+||||||+||++++++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999998654 4788999999999999999999 999999999999999999999999999999876422
Q ss_pred CCcceecccccCCCCCCccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREG----RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
. ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..... ...
T Consensus 196 ~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~---~~~------ 264 (370)
T cd05621 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMD---HKN------ 264 (370)
T ss_pred C-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHh---CCc------
Confidence 2 1122355799999999988653 3788999999999999999999999653211 11111100 000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCC--CCCHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQ--RINAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~eil~~ 956 (979)
....+.....+..+.+++.+|+..+|.+ |+++.|+++|
T Consensus 265 -------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0011111234566888999999865544 8999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.39 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=209.2
Q ss_pred CCCceeeeecceEEEEEEcC--CC--cEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 685 SENNLIGRGGFGSVYKASLG--DG--MEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~--~~--~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
...++||+|.||+|++|.|. .| ..||||.++..... ...+|.+|+.+|.+++|||++++||+..+ ....+|||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34578999999999999874 34 35899999866543 67889999999999999999999999987 667899999
Q ss_pred cCCCccceeecc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
++.|+|.+.+++ .+..+-......++.|||.|+.||. .+++||||+..+|+++.....|||+|||+++.+...+..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999988 4567888889999999999999999 999999999999999999999999999999988766554
Q ss_pred cee-cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 839 MIQ-TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 839 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
+.+ ......+.|.|||.+....++.++|||+|||++|||+| |..||-..... +..+.+|
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------------qIL~~iD----- 329 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------------QILKNID----- 329 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------------HHHHhcc-----
Confidence 443 34456789999999999999999999999999999999 88887542111 1112222
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
.+.+.+.++.|+..++++|.+||...|++|||+..|.+.+-
T Consensus 330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 22334456789999999999999999999999999985443
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=329.89 Aligned_cols=242 Identities=22% Similarity=0.272 Sum_probs=194.8
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.. .+++.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999954 468899999987542 23345667888999887 699999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 99998886653 6899999999999999999999 99999999999999999999999999999875322221 123
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...|++.|+|||++.+..++.++||||+||++|||++|+.||...... .... ...... .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~---~i~~~~----------------~ 213 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQ---SILEDE----------------V 213 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHH---HHHcCC----------------C
Confidence 346899999999999999999999999999999999999999653211 1111 000000 0
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCH-----HHHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINA-----KEIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~eil~~ 956 (979)
..+..++..+.+++.+||+.||.+||++ .+++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0112345668999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.07 Aligned_cols=256 Identities=24% Similarity=0.435 Sum_probs=204.2
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CC---cEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DG---MEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.+|+..+.||+|+||.||+|... ++ ..||||++.... ....+.|..|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34677899999999999999653 33 369999986542 33456788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++......+++.+++.++.|++.|++||| +++++||||||+||+++.++.+|++|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999876667899999999999999999999 9999999999999999999999999999987654322
Q ss_pred Ccceeccc---ccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 837 QSMIQTQT---LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 837 ~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
........ ..+..|+|||++.+..++.++||||+||++||+++ |..||...... ....++....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~---------- 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDY---------- 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCC----------
Confidence 21111111 12457999999988899999999999999999887 99998653211 1111111000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
+.+.+..++..+.+++.+||..+|.+||++.+++..|+++
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111234566789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.39 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=203.3
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccc--cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467778999999999999954 57899999998643 233456788899999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++... ...+++.+++.++.|++.|++||| +++++|+||||+||++++++.++++|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999998765 457899999999999999999999 99999999999999999999999999999887643322
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......+++.|+|||+..+..++.++|+||||+++|||++|+.||...... ..... .... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~---~~~~---------~~--- 218 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILK---IIRG---------VF--- 218 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---HHcC---------CC---
Confidence 123346788999999999888999999999999999999999998653211 11110 0000 00
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+..++..+.+++.+||+.+|++||++.|++++
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 ---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00111345668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=348.57 Aligned_cols=260 Identities=25% Similarity=0.319 Sum_probs=203.8
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|. ..+|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578889999999999999995 45689999999865422 23456889999999999999999999999999999999
Q ss_pred EecCCCccceeeccC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeec
Q 002021 758 EYMPHGSLEKYLYSS----------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFS 827 (979)
Q Consensus 758 E~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg 827 (979)
||++||+|.+++... ....++..+++++.||++||+||| +++|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999987532 123566788999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCC----------------cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCc
Q 002021 828 IAKMLTGEDQ----------------SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891 (979)
Q Consensus 828 ~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~ 891 (979)
+++....... .......+||+.|+|||.+.+..++.++||||+||++|||+||+.||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 001123468999999999998899999999999999999999999986522111
Q ss_pred chHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC-CHHHHHHHHHHhHH
Q 002021 892 MTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-NAKEIVTKLLKIRD 962 (979)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~eil~~L~~~~~ 962 (979)
..... .. .++ . .......+++.+.+++.+|+..||++|| +++++.+.|+....
T Consensus 239 i~~~~----~i-------~~P-----~--~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYRD----VI-------LSP-----I--EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh----hc-------cCh-----h--hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11100 00 000 0 0011124556788999999999999996 56777777877765
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.35 Aligned_cols=256 Identities=25% Similarity=0.452 Sum_probs=204.6
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CC---cEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DG---MEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
++|+..+.||+|+||.||+|... ++ ..||+|.+.... ....+.+..|+++++.++|||++++++++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999653 33 379999886542 23356788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||++++++.+|++|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999776667899999999999999999999 9999999999999999999999999999997654322
Q ss_pred Ccce-ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 837 QSMI-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 837 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.... ......+..|+|||++....++.++|||||||++||+++ |+.||...... ..... ....
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~---i~~~---------- 226 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKA---INDG---------- 226 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHH---HhcC----------
Confidence 2111 111223457999999988889999999999999999998 99998653221 11111 1000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
...+....++.++.+++.+||+.+|.+||++.|+++.|+++
T Consensus 227 -----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=321.95 Aligned_cols=251 Identities=26% Similarity=0.339 Sum_probs=203.8
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
...|+..+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++|||++++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 3578888999999999999995 457899999998765544557788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|.+++.+. .+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 9999999998653 4789999999999999999999 99999999999999999999999999999876532221
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ....+... ....
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-~~~~~~~~----~~~~----------- 235 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATN----GTPE----------- 235 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-hHHHHhcC----CCCC-----------
Confidence 1233468899999999988888999999999999999999999996532211 11110000 0000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+...+..+.+++.+||..+|++||++.|++++
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00112344568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.46 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=196.2
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 757 (979)
+|+..+.||+|+||.||+|. ..+++.||||++.... ....+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999995 4467899999987542 22334566788888777 5899999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 9999999998886643 5889999999999999999999 9999999999999999999999999999987543221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||...... .....+.. . .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~---~--------~---- 217 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIME---H--------N---- 217 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHh---C--------C----
Confidence 1223456899999999999999999999999999999999999999753211 11111000 0 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH-----HHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA-----KEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~eil~~ 956 (979)
...+...+.++.+++.+|++.||++|++. .++.+|
T Consensus 218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 00112345668899999999999999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=317.13 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=206.9
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|. ..+++.||||.+.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467788999999999999996 4588999999875432 223457888999999999999999999999999999999
Q ss_pred EecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
||+++++|.+++.. ....+++..++.++.|++.|++||| +++++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998763 2346899999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
... ......++..|+|||.+.+..++.++|+||+|+++|||++|..||...........+.+...
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 223 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC------------- 223 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-------------
Confidence 221 12334688899999999888899999999999999999999999864221111111100000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
......+..++.++.+++.+||..+|.+|||+.+|++.++++.
T Consensus 224 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 ----DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000011235667999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.43 Aligned_cols=247 Identities=29% Similarity=0.449 Sum_probs=198.8
Q ss_pred ceeeeecceEEEEEEcCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCccc
Q 002021 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 766 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 766 (979)
+.||+|+||.||+|...+++.||+|++..... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999877889999999865432 23346888999999999999999999999999999999999999999
Q ss_pred eeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceeccccc
Q 002021 767 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846 (979)
Q Consensus 767 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 846 (979)
+++......+++.++..++.|++.|+.|+| +++++||||||+||++++++.+|++|||++........ .......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 998776667899999999999999999999 99999999999999999999999999999875432211 11112234
Q ss_pred CCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHH
Q 002021 847 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925 (979)
Q Consensus 847 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (979)
+..|+|||++.++.++.++||||||+++||+++ |..||....... ....+.... +...+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~~~------------------~~~~~ 216 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEKGY------------------RMSCP 216 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHcCC------------------CCCCC
Confidence 577999999988889999999999999999999 999986532111 111100000 00011
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 926 EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 926 ~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
..++..+.+++.+|+..+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 234567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.65 Aligned_cols=239 Identities=21% Similarity=0.347 Sum_probs=189.7
Q ss_pred ceeeeecceEEEEEEcCC-------------CcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 688 NLIGRGGFGSVYKASLGD-------------GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
+.||+|+||.||+|.+.+ ...||+|++..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997532 2358999886654445567888999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc-------EEEEeec
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-------AHLSDFS 827 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~-------~kl~Dfg 827 (979)
+||||+++|+|..++......+++..+++++.||++|++||| +++|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988776667899999999999999999999 999999999999999986654 8999999
Q ss_pred cccccCCCCCcceecccccCCCCCCccccC-CCCCCCchhHHHHHHHHHHHH-cCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETF-TGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~-tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||......+. ..... .
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~---~-- 224 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFYE---G-- 224 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHHh---c--
Confidence 98754322 2345778899999886 456889999999999999998 58888754211110 00000 0
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.. . .....+.++.+++.+||+.||.+||++.||++++
T Consensus 225 -------~~-~-------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 -------QC-M-------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -------Cc-c-------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 0 0001234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=314.72 Aligned_cols=250 Identities=31% Similarity=0.493 Sum_probs=205.0
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.++|+..+.||.|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.++|+|++++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 35788889999999999999976 478999999875533 4567889999999999999999999999899999999999
Q ss_pred CCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++|.+++.... ..+++..+..++.|++.|++||| +++++||||||+||+++.++.+||+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999987653 36899999999999999999999 9999999999999999999999999999998753211
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
.....+..|+|||++..+.++.++||||+|+++||+++ |+.||...... .....+.. .
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~---~-------------- 215 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEK---G-------------- 215 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhc---C--------------
Confidence 12334668999999988889999999999999999997 99998653211 11111000 0
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
.+...+..+++.+.+++.+|+..+|++||++.|++++|+++
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00011123456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.10 Aligned_cols=263 Identities=23% Similarity=0.380 Sum_probs=204.7
Q ss_pred hCCCCCCceeeeecceEEEEEEcC-----------------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG-----------------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIK 742 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 742 (979)
..+|+..+.||+|+||.||+|... .+..||+|++..... ...+.+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357888999999999999998543 235689999875432 34567889999999999999999
Q ss_pred EEEeeccCCeeEEEEEecCCCccceeeccCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 002021 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 812 (979)
Q Consensus 743 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~N 812 (979)
+++++..++..++||||+++++|.+++.... ..+++..++.++.|++.|++||| +++++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999986543 26899999999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCcccccC
Q 002021 813 VLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKPTDEIFNG 890 (979)
Q Consensus 813 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~P~~~~~~~ 890 (979)
|+++.++.++++|||.+......+.........++..|+|||++.++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976543333222334456788999999988889999999999999999998 66777543211
Q ss_pred cchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 891 EMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
............... .. ....+..++.++.+++.+|++.||++|||+.|+++.|++
T Consensus 241 --~~~~~~~~~~~~~~~-----~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 --QVIENAGHFFRDDGR-----QI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHhccccccc-----cc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111100000000 00 000112345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.39 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=200.5
Q ss_pred CCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 684 FSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
|+..+.||+|+||.||+|.. .++..+|+|.+........+.+.+|+++++.++|||++++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 45678899999999999954 46788999998655445566788899999999999999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
++|.+++......+++..+..++.|+++||+||| +.+++||||||+||+++.++.+|++|||++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccc
Confidence 9999888765567899999999999999999999 9999999999999999999999999999987653221 1223
Q ss_pred ccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 843 QTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
...++..|+|||++. +..++.++||||+||++|||++|+.||......+. ......... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~---------~----- 226 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSEP---------P----- 226 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhcCC---------C-----
Confidence 456889999999873 34577899999999999999999999875322111 111100000 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
....+..++..+.+++.+||+.+|.+||++.+++++-
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 227 ---TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 0011123456689999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.03 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=205.6
Q ss_pred CCCCCCceeeeecceEEEEEEcCC----CcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGD----GMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
++|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|+++++.++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999996532 3468999886554 3345678899999999999999999998875 457899
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++......+++.++..++.|++.|++||| +++++||||||+||+++.++.+|++|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999876667899999999999999999999 9999999999999999999999999999998664332
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
. .......++..|+|||.+....++.++||||||+++||+++ |..||......+. . ......
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~-~~~~~~-------------- 224 (270)
T cd05056 162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-I-GRIENG-------------- 224 (270)
T ss_pred c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-H-HHHHcC--------------
Confidence 1 11223334568999999888889999999999999999986 9999865332211 1 110000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
.+...+..++..+.+++.+|+..+|.+|||+.|+++.|+++.+.
T Consensus 225 ----~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 225 ----ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00011234566799999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.28 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=200.2
Q ss_pred CCCCCCceeeeecceEEEEEEcCC---------------CcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGD---------------GMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVIS 745 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~ 745 (979)
.+|++.+.||+|+||.||++...+ ...||+|+++.... .....+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999985422 23589999875432 23456889999999999999999999
Q ss_pred eeccCCeeEEEEEecCCCccceeeccCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 002021 746 SCSNEEFKALVLEYMPHGSLEKYLYSSN-----------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL 814 (979)
Q Consensus 746 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIl 814 (979)
++......++||||+++++|.+++.... ..+++..+..++.|++.|++||| +++++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999885431 23688899999999999999999 999999999999999
Q ss_pred eCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCcccccCcc
Q 002021 815 LDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKPTDEIFNGEM 892 (979)
Q Consensus 815 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~P~~~~~~~~~ 892 (979)
+++++.+|++|||++................++..|+|||...++.++.++|||||||++|||++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999976543322222233345778999999988889999999999999999998 556765422111
Q ss_pred hHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 893 TLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
............... . ....+..++..+.+++.+||+.+|++||++++|++.|++
T Consensus 241 ~~~~~~~~~~~~~~~------~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEFFRNQGRQ------I------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHhhhhcccc------c------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111110000000000 0 000112245679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.21 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=210.1
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.+-|+..+.||+|.|.+|-.| ..-+|..||||++.+.. +.....+.+|++.|+.++|||||++|.+.......|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 356888899999999999999 45689999999997653 223456788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe-CCCCcEEEEeeccccccCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL-DDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll-~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|.-++|+|.||+.++...+.++-+.+++.||+.|+.|+| +.++||||+||+||.+ ..-|-||++|||++-.+.+..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999999888999999999999999999999 9999999999999876 567899999999997764332
Q ss_pred CcceecccccCCCCCCccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVS-ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.....+|+..|-|||++.+..|. +++||||+|||+|-+++|+.||...-+.+. + .-++|-
T Consensus 174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-L------------TmImDC--- 234 (864)
T KOG4717|consen 174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-L------------TMIMDC--- 234 (864)
T ss_pred ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-h------------hhhhcc---
Confidence 23667899999999999998876 689999999999999999999976322211 1 112221
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+...+...+.+..+||..|+..||.+|.+.+||+.+
T Consensus 235 -----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 -----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -----cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 122345567889999999999999999999998764
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.95 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=207.4
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|++++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999654 89999999886322 223567889999999999999999999999999999999
Q ss_pred EecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
||+++++|.+++.. ....+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999988754 2345889999999999999999999 99999999999999999999999999999876532
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||..... ....+...... ..
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~---------~~ 224 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEK---------CD 224 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhhc---------CC
Confidence 2211 1234578899999999888899999999999999999999999854221 11111111000 00
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
.. ....+.++..+.+++.+||..+|++||++.+|++.|+++.
T Consensus 225 ~~-----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YP-----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CC-----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 0011244567899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.35 Aligned_cols=248 Identities=32% Similarity=0.546 Sum_probs=204.0
Q ss_pred ceeeeecceEEEEEEcCC----CcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASLGD----GMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|+++++.++|+|++++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999996543 788999998765433 257788999999999999999999999999999999999999
Q ss_pred CccceeeccC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 763 GSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 763 g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
++|.+++... ...+++.+++.++.|++.|++||| +++++||||||+||++++++.+|++|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 467899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
...........++..|+|||.+....++.++||||+|+++|||++ |..||...... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~------------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRK------------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc-------------
Confidence 332222344567889999999988889999999999999999999 69998764211 11111110
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
......+..++.++.+++.+||+.+|++|||+.|++++|+
T Consensus 223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011122344677999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.62 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=202.4
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCc--EEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGM--EVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (979)
++|+..+.||+|+||.||+|.. .++. .+|+|.+.... ....+.+.+|++++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5678889999999999999965 3454 46777765432 22345788899999999 899999999999999999999
Q ss_pred EEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 002021 757 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~ 821 (979)
|||+++++|.+++.... ..+++.+++.++.|++.|++||| +++++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 99999999999986432 25789999999999999999999 9999999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhh
Q 002021 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~ 900 (979)
||+|||++..... ........++..|+|||++.+..+++++|||||||++|||+| |..||...... ......
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~-- 236 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL-- 236 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHH--
Confidence 9999999864311 111122234668999999888888999999999999999998 99998643211 111100
Q ss_pred hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
... .....+..++..+.+++.+||+.+|++||++.+++.++.++.....
T Consensus 237 -~~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 237 -PQG---------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred -hcC---------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 000 0000112245568999999999999999999999999998877554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.51 Aligned_cols=269 Identities=23% Similarity=0.380 Sum_probs=204.8
Q ss_pred CCCCCceeeeecceEEEEEEc-----CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC--CeeE
Q 002021 683 GFSENNLIGRGGFGSVYKASL-----GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKA 754 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 754 (979)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+++++.++|||++++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999963 357889999986543 23346788999999999999999999988764 5688
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+++++|.+++......+++.++..++.|++.|++||| +++++||||||+||+++.++.++++|||++.....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999998766556899999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc-cchhhcc
Q 002021 835 EDQS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS-TMEVVDA 912 (979)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 912 (979)
.... .......++..|+|||++.+..+++++||||||+++||++|++.|+....... ........... .....+
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~- 237 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF---LKMIGPTHGQMTVTRLVR- 237 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh---hhhcccccccccHHHHHH-
Confidence 3221 11223456778999999988889999999999999999999887754321110 00000000000 000000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
... .....+.+..++..+.+++.+|++.+|.+||+++|+++.++++
T Consensus 238 ~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLE--EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHH--cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 0001112234567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.43 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=203.1
Q ss_pred CCCCCCceeeeecceEEEEEEcC------CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
++|...+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 56888899999999999999643 34689999986443 233456888999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEe
Q 002021 755 LVLEYMPHGSLEKYLYSS---------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 825 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D 825 (979)
+||||+++|+|.+++... ...+++..+..++.|++.|++||| +++++||||||+||++++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence 999999999999998643 124688899999999999999999 99999999999999999999999999
Q ss_pred eccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCC
Q 002021 826 FSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPI 904 (979)
Q Consensus 826 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 904 (979)
||+++.....+.........++..|+|||.+.++.++.++|||||||++||+++ |..||...... ....+... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~---~ 237 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVID---G 237 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHhc---C
Confidence 999986643332222233456789999999988889999999999999999998 88888642211 11111110 0
Q ss_pred ccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
. ....+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 238 ~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 G---------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred C---------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 00111234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=335.64 Aligned_cols=266 Identities=20% Similarity=0.202 Sum_probs=199.5
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
...|.+.+.||+|+||.||+|.. ..++.||||... ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35688899999999999999954 468899999632 23467899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+. ++|.+++......+++.+++.|+.|+++||+||| +++|+||||||+||+++.++.+||+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 6898888766567999999999999999999999 9999999999999999999999999999998654332222
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccC------cchHhHhhhhhc------C-Ccc
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG------EMTLKHWVNDWL------P-IST 906 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~------~~~~~~~~~~~~------~-~~~ 906 (979)
......||..|+|||++.+..++.++|||||||++|||++|..|+...... ...+...+.... + ...
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 223456899999999999889999999999999999999988765332111 011111111100 0 000
Q ss_pred chhhc---cccc---Cc--hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 MEVVD---ANLL---SQ--EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ~~~~~---~~~~---~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..... .... .. ....+.........+.+++.+|++.||.+|||+.|+++|
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0000 00 000011111234568899999999999999999999986
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=318.57 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=206.8
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCc----EEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGM----EVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|+..+.||+|+||.||+|... +|+ .||+|+...... .....+.+|++++++++|||++++++++.. +..++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999643 333 589998865532 234678889999999999999999999877 78899
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++......+++..+..++.|++.|++||| +++++||||||+||++++++.+||+|||.++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999887667999999999999999999999 899999999999999999999999999999876533
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
..........++..|+|||.+....++.++|+||||+++||+++ |+.||...... .....+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~------------ 228 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGE------------ 228 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCC------------
Confidence 32222222334678999999988889999999999999999999 99998653211 1111111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
..+.+..++..+.+++.+||..+|.+||++.++++.|.++.+.
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0111123445688999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=315.50 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=206.0
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.++|.+.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++++++|||++++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788899999999999999987778889999986432 33467889999999999999999999999889999999999
Q ss_pred CCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++|.+++.... ..+++.++..++.|++.|++||| +.+++|+||||+||++++++.+|++|||.+....... ..
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence 9999999997653 56899999999999999999999 9999999999999999999999999999987654221 11
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
.......+..|+|||.+.+..+++++||||+|+++||+++ |+.||...... ..........
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~~----------------- 221 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVERGY----------------- 221 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCC-----------------
Confidence 1122334578999999988889999999999999999999 99998643211 1111110000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
....+..++.++.+++.+|++.+|++||+++|+.+.|+.
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001112235668999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=313.00 Aligned_cols=248 Identities=32% Similarity=0.496 Sum_probs=200.0
Q ss_pred ceeeeecceEEEEEEcCCCcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCccc
Q 002021 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 766 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 766 (979)
+.||+|+||.||+|...+++.||+|.+...... ..+.+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999997766999999988754333 4567889999999999999999999999999999999999999999
Q ss_pred eeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceeccccc
Q 002021 767 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846 (979)
Q Consensus 767 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 846 (979)
+++......+++..+..++.+++.|++||| +++++||||||+||+++.++.+||+|||.+.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999776557889999999999999999999 99999999999999999999999999999976532211111122234
Q ss_pred CCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHH
Q 002021 847 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925 (979)
Q Consensus 847 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (979)
+..|+|||.+.++.++.++|+||+|+++|||+| |..||...... .......... ....+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~~~------------------~~~~~ 217 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIESGY------------------RMPAP 217 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhcCC------------------CCCCC
Confidence 567999999988889999999999999999999 88888653221 1111111000 00112
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 926 EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 926 ~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
..++.++.+++.+|++.+|.+|||+.|+++.|.
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 234567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=314.34 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=201.5
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+++++.++|||++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4577888999999999999987777789999876432 334678899999999999999999998754 56789999999
Q ss_pred CCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 762 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 762 ~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
+++|.+++... ...+++..+..++.|++.|++||| +.+++|+||||+||++++++.++|+|||.+........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 99999998754 345789999999999999999999 99999999999999999999999999999976533221 11
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
.....++..|+|||...++.++.++||||+|+++|||+| |+.||......+ ...+......
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~---------------- 221 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYR---------------- 221 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC----------------
Confidence 122345678999999988889999999999999999999 899987532211 1111110000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
...+...+..+.+++.+||..+|++||+++++++.|++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=314.81 Aligned_cols=248 Identities=30% Similarity=0.450 Sum_probs=200.2
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEee-ccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC-SNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E~~ 760 (979)
++|+..+.||+|+||.||+|.. .|+.||+|.+... ...+.+.+|+.++++++|++++++++++ .++...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5688889999999999999976 4788999988643 2346788999999999999999999975 4566789999999
Q ss_pred CCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++|.+++.... ..+++..+..++.|++.|++||| +++++||||||+||++++++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999987653 35889999999999999999999 9999999999999999999999999999987643221
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
....++..|+|||+..+..++.++||||+||++|||++ |+.||.... ............
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~~~~------------- 216 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEKGY------------- 216 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhcCC-------------
Confidence 22334568999999988889999999999999999998 999986421 111111110000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
....+..+++.+.+++.+||+.+|++|||+.|++++|+++
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 --KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0011124567789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=313.50 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=205.6
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
++|+..+.||+|+||.||+|.. .+++.+|+|++........+.+.+|+++++.++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788889999999999999954 467899999987654445678889999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++......+++.++..++.|++.|++||| +++++|+||||+||++++++.+|++|||.+....... ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 999999998776567899999999999999999999 9999999999999999999999999999987654221 11
Q ss_pred ecccccCCCCCCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 841 QTQTLATIGYMAPEYGREG---RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....++..|+|||.+... .++.++||||+|+++|||++|+.||......+.... ...... ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-~~~~~~-------------~~ 223 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-ISKSNF-------------PP 223 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhccC-------------CC
Confidence 2334678899999998766 788999999999999999999999865322111110 000000 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. ........+.++.+++.+||..+|.+|||+.|++.+
T Consensus 224 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 P--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 001122345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.32 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=205.7
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
++|+..+.||+|+||.||+|... +++.||+|.+..... .+.+.+|++++++++|||++++++++.+++..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888899999999999999665 478999999865432 678899999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++......+++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||.+........ .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 999999999776677899999999999999999999 99999999999999999999999999999987643321 1
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||......+.... ..... ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~-------------~~ 217 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKP-------------PP 217 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-----hccCC-------------CC
Confidence 2334578899999999888899999999999999999999999875322111000 00000 00
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..++..+.+++.+||+.+|.+|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 011122345678999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=322.73 Aligned_cols=262 Identities=23% Similarity=0.420 Sum_probs=201.6
Q ss_pred CCCCCCceeeeecceEEEEEEcC-----------------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-----------------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 743 (979)
++|+..+.||+|+||.||+|... ++..||+|++..... .....+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998432 234689999875432 234678899999999999999999
Q ss_pred EEeeccCCeeEEEEEecCCCccceeeccCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCE
Q 002021 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNV 813 (979)
Q Consensus 744 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NI 813 (979)
++++...+..++||||+++++|.+++.... ..+++.++..++.|++.|++||| +++++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999986532 24677899999999999999999 99999999999999
Q ss_pred EeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCcccccCc
Q 002021 814 LLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT--GKKPTDEIFNGE 891 (979)
Q Consensus 814 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~P~~~~~~~~ 891 (979)
++++++.++++|||++..+.............++..|+|||....+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322222223345678999998888889999999999999999998 677876432211
Q ss_pred chHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 892 MTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
. ... .......... ....+.+..++..+.+++.+||+.||.+||++.||.+.|++
T Consensus 242 ~-~~~-~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V-IEN-TGEFFRDQGR-----------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H-HHH-HHHHHhhccc-----------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 110 0000000000 00011122355679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=320.30 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=201.9
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
+.|+..+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++|||++++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5688889999999999999955 468999999987655555677889999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|..++.+....+++..+..++.|++.|++||| +++++||||||+||+++.++.+||+|||.+...... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence 999998888766567899999999999999999999 999999999999999999999999999998754322 111
Q ss_pred ecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 841 QTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.....++..|+|||++. ...++.++|||||||++|||++|+.||....... ....+..... +
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~---------~--- 233 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEP---------P--- 233 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhcCCC---------c---
Confidence 23345788999999874 3456789999999999999999999986532111 1111100000 0
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..++.++.+++.+||+.+|++||++.|++++
T Consensus 234 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 -----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 001112334568899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=328.38 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=194.9
Q ss_pred ceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999995 4568899999997542 22345677899999888 699999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++...+ .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence 99988876543 6899999999999999999999 99999999999999999999999999999875322211 223
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCc-chHhHhhhhhcCCccchhhcccccCchhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE-MTLKHWVNDWLPISTMEVVDANLLSQEDIH 921 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+....... . .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------------~---~ 219 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE------------K---P 219 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh------------C---C
Confidence 4578999999999999999999999999999999999999996432211 1111111100000 0 0
Q ss_pred hHHHHHHHHHHHHHHHhccccCcCCCCCH------HHHHHH
Q 002021 922 FVAKEQCVSFVFNLAMECTMEFPKQRINA------KEIVTK 956 (979)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~eil~~ 956 (979)
...+...+..+.+++.+|++.||++|+++ .++++|
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 01112344568899999999999999984 577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=332.39 Aligned_cols=238 Identities=24% Similarity=0.319 Sum_probs=191.5
Q ss_pred ceeeeecceEEEEEEc----CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 688 NLIGRGGFGSVYKASL----GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999853 4689999999875431 233456789999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++........ ..
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~ 155 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KA 155 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ce
Confidence 99999988654 36899999999999999999999 99999999999999999999999999999876532211 12
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (979)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... ..... .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~---~i~~~--------~-------- 214 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMT---MILKA--------K-------- 214 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHH---HHHcC--------C--------
Confidence 3456899999999998888899999999999999999999998653211 1110 00000 0
Q ss_pred hHHHHHHHHHHHHHHHhccccCcCCCCCHHH
Q 002021 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKE 952 (979)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 952 (979)
...+...++.+.+++.+||+.||++||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0011234566889999999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=335.07 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=197.9
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|. ..+++.||||++.... ......+.+|++++..++||+|+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468888999999999999995 4578999999986432 233456788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999987643 5899999999999999999999 99999999999999999999999999999875432110
Q ss_pred c---------------------------------ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 002021 838 S---------------------------------MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT 884 (979)
Q Consensus 838 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~ 884 (979)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011346899999999999999999999999999999999999999
Q ss_pred cccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC---HHHHHHH
Q 002021 885 DEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN---AKEIVTK 956 (979)
Q Consensus 885 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~eil~~ 956 (979)
....... .+.... .+. ....++.....+.++.+++.+++. ||.+|++ +.|+++|
T Consensus 237 ~~~~~~~-~~~~i~-~~~---------------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQE-TYRKVM-NWK---------------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHH-HHHHHH-cCC---------------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 7532211 111100 000 000001111234567888888764 9999984 7788777
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=329.32 Aligned_cols=242 Identities=28% Similarity=0.315 Sum_probs=189.7
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHH-HHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECE-IMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||+||+|.. .+|+.||||++.... ......+..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999954 578999999986432 122233444544 56789999999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence 99998887643 6889999999999999999999 9999999999999999999999999999987532221 1223
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~--------~-------- 213 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNKP--------L-------- 213 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcCC--------C--------
Confidence 456899999999999889999999999999999999999998653111 1111110000 0
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHH----HHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAK----EIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~----eil~~ 956 (979)
..+...+..+.+++.+|++.||.+||++. |+++|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 01112356688999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.14 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=203.3
Q ss_pred hCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
.++|+..+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.+++.++|||++++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357888999999999999999642 467899999875432 2346688999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeccCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 002021 754 ALVLEYMPHGSLEKYLYSSN---------------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 812 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~N 812 (979)
++||||+++|+|.+++.... ..+++.+++.++.|++.|++||| .++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999986421 24678889999999999999999 9999999999999
Q ss_pred EEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCc
Q 002021 813 VLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 891 (979)
Q Consensus 813 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~ 891 (979)
|++++++.++++|||.+..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999876543322222233345678999999988889999999999999999998 88887542211
Q ss_pred chHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 892 MTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
..... .... ... ..+..++.++.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 -~~~~~---~~~~--------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -EVIYY---VRDG--------NVL-------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHHH---HhcC--------CCC-------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 1000 000 0112345679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=332.42 Aligned_cols=266 Identities=23% Similarity=0.296 Sum_probs=198.0
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC-----eeE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-----FKA 754 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 754 (979)
+|+..+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+++++.++||||+++++++..++ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47888999999999999995 4679999999986432 123456788999999999999999999998766 789
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+. ++|.+++... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 5787777544 36899999999999999999999 99999999999999999999999999999986532
Q ss_pred CCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh---
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV--- 910 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 910 (979)
.. ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+ ..... .........+..
T Consensus 156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i-~~~~g~~~~~~~~~~ 232 (372)
T cd07853 156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLI-TDLLGTPSLEAMRSA 232 (372)
T ss_pred Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHH-HHHcCCCCHHHHHHh
Confidence 22 1222344678999999988764 57899999999999999999999997532211 11111 000000000000
Q ss_pred --------cccccCchh--hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 --------DANLLSQED--IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 --------~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......... .........+.++.+++.+|++.||++|||+.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 0000112235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=333.03 Aligned_cols=259 Identities=23% Similarity=0.276 Sum_probs=201.8
Q ss_pred HHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC
Q 002021 676 ELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE 751 (979)
Q Consensus 676 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (979)
+.....++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3344557899999999999999999954 578899999986421 123345778999999999999999999999999
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..++||||+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999999998654 4788899999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCcceecccccCCCCCCccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccc
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREG----RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM 907 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 907 (979)
..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..... ..
T Consensus 192 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~---~~--- 263 (371)
T cd05622 192 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMN---HK--- 263 (371)
T ss_pred cCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHc---CC---
Confidence 64322 1122345799999999988653 3788999999999999999999999752111 11111100 00
Q ss_pred hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCC--CCCHHHHHHHH
Q 002021 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQ--RINAKEIVTKL 957 (979)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~eil~~L 957 (979)
....++....++..+.+++.+|+..++.+ |+++.|+++|.
T Consensus 264 ----------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 ----------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ----------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00111122245567889999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=328.72 Aligned_cols=266 Identities=22% Similarity=0.250 Sum_probs=196.7
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC-----
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----- 751 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 751 (979)
..++|+..+.||+|+||.||+|. ..+|+.||||++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 34789999999999999999995 4578999999986432 223456778999999999999999999885443
Q ss_pred -eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 752 -FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 752 -~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
..++||||+++ ++.+.+.. .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 47999999975 56665543 4788899999999999999999 9999999999999999999999999999997
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
..... .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...... ..+....... .....+..
T Consensus 172 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~-~~~~~~~~ 246 (359)
T cd07876 172 TACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQL-GTPSAEFM 246 (359)
T ss_pred ccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc-CCCcHHHH
Confidence 54321 1123456899999999999889999999999999999999999999753211 0111000000 00000000
Q ss_pred ccc-------ccCchh---h-------------hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 911 DAN-------LLSQED---I-------------HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 911 ~~~-------~~~~~~---~-------------~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
+.. ...... . ........+..+.+++.+|++.||++|||+.|+++|-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000 000000 0 0000112345689999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=350.95 Aligned_cols=461 Identities=30% Similarity=0.380 Sum_probs=347.9
Q ss_pred EEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccC
Q 002021 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSS 153 (979)
Q Consensus 74 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 153 (979)
+.+|||+.|.+. ..|..+..+.+|+.|+++.|-+. ..|.++..+.+|++|+|..|.+. ..|..+..+++|++||+|+
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 678888887766 67888888999999999999887 77888889999999999998888 7888889999999999999
Q ss_pred CccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccC
Q 002021 154 NALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQD 233 (979)
Q Consensus 154 N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 233 (979)
|.+. .+|..+..++.++.+..++|..... ++... ++.++|..|.+.+.++..+.+++. .|+|.+
T Consensus 124 N~f~---------~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~ 187 (1081)
T KOG0618|consen 124 NHFG---------PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRY 187 (1081)
T ss_pred hccC---------CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeeccc
Confidence 9886 4788888888888888888832222 22222 777777777777777777777666 688888
Q ss_pred CCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecccccccccc
Q 002021 234 NSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313 (979)
Q Consensus 234 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 313 (979)
|.+. .. ....+++|+.|....|++... .-..++|+.|+.++|.++...+. + .-.+|+++++++|+++.+|
T Consensus 188 N~~~-~~---dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~-p-~p~nl~~~dis~n~l~~lp 257 (1081)
T KOG0618|consen 188 NEME-VL---DLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVH-P-VPLNLQYLDISHNNLSNLP 257 (1081)
T ss_pred chhh-hh---hhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeeccc-c-ccccceeeecchhhhhcch
Confidence 8776 22 244677788888888877632 12346788888888887733221 1 1246788888888888777
Q ss_pred chhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhH
Q 002021 314 QELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSIL 393 (979)
Q Consensus 314 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 393 (979)
++ ...|.+|+.++..+|++..++...+. ..+|+.|.+..|.++ -+|+....++.|++|+|..|+|...+.
T Consensus 258 -~w-----i~~~~nle~l~~n~N~l~~lp~ri~~---~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~ 327 (1081)
T KOG0618|consen 258 -EW-----IGACANLEALNANHNRLVALPLRISR---ITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPD 327 (1081)
T ss_pred -HH-----HHhcccceEecccchhHHhhHHHHhh---hhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccch
Confidence 33 56677888888888887655443322 246888888888887 567777888899999999999987777
Q ss_pred HhhhcCCC-CcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCcccccccc-ccCcC
Q 002021 394 ITLSKLQK-LQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLT-FWNLK 471 (979)
Q Consensus 394 ~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~ 471 (979)
..|..+.. |..|+.+.|.+.......=..++.|+.|.+.+|.++...-..+.+.++|+.|+|++|+|.++|+. +.++.
T Consensus 328 ~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle 407 (1081)
T KOG0618|consen 328 NFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLE 407 (1081)
T ss_pred HHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchH
Confidence 77766666 88888888888754433334566788999999999888777888889999999999999999874 66888
Q ss_pred CCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCC-CCccccccccccccc
Q 002021 472 DILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI-PNSFGDLISLKFLNL 550 (979)
Q Consensus 472 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L 550 (979)
.|++|+||+|+++ .+|..+..+..|++|...+|++. ..| .+..++.|+.+|+|.|+|+... |.... -++|++|||
T Consensus 408 ~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdl 483 (1081)
T KOG0618|consen 408 ELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDL 483 (1081)
T ss_pred HhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC-Ccccceeec
Confidence 8889999999988 57888888888888888888887 566 8888888999999999888543 33322 278899999
Q ss_pred ccccccccCCccccCccccCeEeccCC
Q 002021 551 SNNNLSGVIPASLEKLSYLEDLNLSFN 577 (979)
Q Consensus 551 s~N~l~~~~p~~~~~l~~L~~L~L~~N 577 (979)
++|.=....-..|..+.++...++.-|
T Consensus 484 SGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 484 SGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cCCcccccchhhhHHhhhhhheecccC
Confidence 998743355566666667776666665
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=320.90 Aligned_cols=268 Identities=19% Similarity=0.239 Sum_probs=201.9
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5688889999999999999954 468899999986443 22344677899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++ ++|.+++......+++..+..++.|+++|++||| +++|+||||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence 97 5899888776667899999999999999999999 99999999999999999999999999999976432221
Q ss_pred eecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh---cCCccchhhccccc
Q 002021 840 IQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW---LPISTMEVVDANLL 915 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 915 (979)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .......... ....+....+....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhccccc
Confidence 1233456889999998765 45788999999999999999999999753211 1111111000 00001011110000
Q ss_pred Cchh-------hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQED-------IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~-------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.... ........++..+.+++.+|++.||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 0001122456678999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.76 Aligned_cols=372 Identities=28% Similarity=0.440 Sum_probs=293.6
Q ss_pred CCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCcccccc
Q 002021 144 SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNV 223 (979)
Q Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 223 (979)
+-.+-.|+|+|.|+|. ..|.....++.++-|.|...++. .+|+.++.+.+|++|.+++|++..+. ..+..+
T Consensus 7 pFVrGvDfsgNDFsg~-------~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vh-GELs~L 77 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGD-------RFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVH-GELSDL 77 (1255)
T ss_pred ceeecccccCCcCCCC-------cCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhh-hhhccc
Confidence 3445677888888765 57888888888888888888887 78999999999999999999987652 334445
Q ss_pred CccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCcccccccccccee
Q 002021 224 STLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLV 303 (979)
Q Consensus 224 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 303 (979)
+.|+.+.+.+|++... -+|..++.+..|.+||||+|++. ..|..+...+++-.|+
T Consensus 78 p~LRsv~~R~N~LKns------------------------GiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLN 132 (1255)
T KOG0444|consen 78 PRLRSVIVRDNNLKNS------------------------GIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLN 132 (1255)
T ss_pred hhhHHHhhhccccccC------------------------CCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEE
Confidence 5555555555554421 25556666666666666666666 4566666666666677
Q ss_pred ccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEe
Q 002021 304 LSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYL 383 (979)
Q Consensus 304 Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L 383 (979)
||+|+|.++|..+ +.++..|-+||||+|++.. +|+.+..+.+|++|.|
T Consensus 133 LS~N~IetIPn~l-----finLtDLLfLDLS~NrLe~---------------------------LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 133 LSYNNIETIPNSL-----FINLTDLLFLDLSNNRLEM---------------------------LPPQIRRLSMLQTLKL 180 (1255)
T ss_pred cccCccccCCchH-----HHhhHhHhhhccccchhhh---------------------------cCHHHHHHhhhhhhhc
Confidence 7777666666543 4556666666666665532 4445566677777777
Q ss_pred cCCCCCchhHHhhhcCCCCcEEEecCcccC-CCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCcccc
Q 002021 384 GGNKLNGSILITLSKLQKLQDLGLKDNKLE-GSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTS 462 (979)
Q Consensus 384 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 462 (979)
++|.+.-.....+..+++|+.|.+++.+-+ .-+|.++..+.+|..+|+|.|.+. ..|+++.++++|+.|+|++|+|++
T Consensus 181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee
Confidence 777776655666667777777777776543 357889999999999999999998 889999999999999999999999
Q ss_pred ccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCc-ccchhhcCCcccceeecCCccccCCCCCcccc
Q 002021 463 IPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSG-VIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD 541 (979)
Q Consensus 463 lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 541 (979)
+......-.+|++|+||+|+++ .+|+.+..|+.|+.|.+.+|+++- -+|..++.|.+|+.+..++|.|. ..|+.+..
T Consensus 260 L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcR 337 (1255)
T KOG0444|consen 260 LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCR 337 (1255)
T ss_pred eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhh
Confidence 9888777889999999999999 799999999999999999999863 47999999999999999999999 89999999
Q ss_pred cccccccccccccccccCCccccCccccCeEeccCCcccccCCC
Q 002021 542 LISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 542 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
+..|+.|.|+.|++- ..|+.+.-++.|+.|||..|+=--.+|.
T Consensus 338 C~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 338 CVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred hHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 999999999999998 7899999999999999999986655565
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.99 Aligned_cols=264 Identities=21% Similarity=0.284 Sum_probs=203.0
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999954 4688899998864422 2345678899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++... ..+++..+..++.|+++|++||| + .+++||||||+||+++.++.+|++|||++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999998765 36889999999999999999999 6 689999999999999999999999999987553221
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccc-----------
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM----------- 907 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~----------- 907 (979)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||..... .....+..........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCCC
Confidence 1345688999999998888899999999999999999999999864321 1111111111000000
Q ss_pred ----------hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 908 ----------EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 908 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
+..+. ......... ....++.++.+++.+|+..+|++||++.|++++-
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 231 PDSPRPMAIFELLDY-IVNEPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCccchhhHHHHHHH-HhcCCCccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000 000000000 0112456799999999999999999999999884
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=319.51 Aligned_cols=250 Identities=26% Similarity=0.332 Sum_probs=204.0
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
..|+..+.||.|+||.||+|. ..+++.||+|.+........+.+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 468888999999999999994 5679999999987554445567888999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++... .+++.++..++.|++.|++||| +++++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 171 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K 171 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence 999999988654 5899999999999999999999 99999999999999999999999999999876543221 1
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
.....++..|+|||.+.+..++.++|||||||++|++++|+.||........ ... ...... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~-~~~~~~----------------~ 233 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL-IATNGT----------------P 233 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHhcCC----------------c
Confidence 2334688899999999888899999999999999999999999865322111 100 000000 0
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..++..+.+++.+||..||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 001122345668899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=313.17 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=202.7
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+.... .....+.+|++++++++||+++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677789999999999999987778899999886432 234578899999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+++|.+++......++++.++.++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+....... ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence 99999998876667899999999999999999999 9999999999999999999999999999987653221 1112
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....++.+|+|||.+.++.++.++||||+|+++||+++ |+.||...... .... ..... ...
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~---~~~~~--~~~----------- 220 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVE---TINAG--FRL----------- 220 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHH---HHhCC--CCC-----------
Confidence 23345678999999988889999999999999999998 99998652211 1111 10000 000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
..+...+.++.+++.+||+.+|++||++.|++++|
T Consensus 221 --~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 221 --YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00111345689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.97 Aligned_cols=253 Identities=30% Similarity=0.443 Sum_probs=198.9
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccch--hcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAF--KSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
|+..+.||+|+||.||+|. ..+++.||+|++........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999995 45677999999976543222 23345999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++.. ...+++.++..++.|+++||+||| +++|+|+||||+||++++++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN 154 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred ccccccccccc-cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccccc
Confidence 99999999983 336899999999999999999999 8999999999999999999999999999997641 22223
Q ss_pred ecccccCCCCCCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 841 QTQTLATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
.....++..|+|||+.. +..++.++||||+|+++|+|++|+.||...... ..... ..........
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~------------~~~~~~~~~~ 220 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEI------------IEKILKRPLP 220 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHH------------HHHHHHTHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhh------------hhhccccccc
Confidence 34567899999999988 788999999999999999999999998764100 00000 0000000000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...........++.+++.+|++.||++||++.|++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001111113679999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=316.42 Aligned_cols=249 Identities=25% Similarity=0.331 Sum_probs=198.1
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 357788999999999999994 4678999999986542 22345688899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|..+. .+++..+..++.|++.|++||| +++|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9999986542 4678889999999999999999 9999999999999999999999999999997653221
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchH--hHhhhhhcCCccchhhcccccCc
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL--KHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....++..|+|||++.+..++.++||||+|+++|+|++|+.||.......... ..+........ .
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~------ 217 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----P------ 217 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----C------
Confidence 234568899999999998889999999999999999999999997533221110 01000000000 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........++++.+++.+|++.+|++||+++|++++
T Consensus 218 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 ---PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000011234568899999999999999999999887
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=315.14 Aligned_cols=239 Identities=23% Similarity=0.343 Sum_probs=188.5
Q ss_pred eeeeecceEEEEEEcC-------------------------CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeE
Q 002021 689 LIGRGGFGSVYKASLG-------------------------DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV 743 (979)
Q Consensus 689 ~lG~G~~g~Vy~~~~~-------------------------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 743 (979)
.||+|+||.||+|.+. ....||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998531 123589998865544445678889999999999999999
Q ss_pred EEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----
Q 002021 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---- 819 (979)
Q Consensus 744 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---- 819 (979)
++++.+....++||||+++|+|.+++......+++..+..++.|+++|++||| +++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999998776667899999999999999999999 99999999999999997543
Q ss_pred ---cEEEEeeccccccCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHH-cCCCCCcccccCcchH
Q 002021 820 ---VAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETF-TGKKPTDEIFNGEMTL 894 (979)
Q Consensus 820 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~-tg~~P~~~~~~~~~~~ 894 (979)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......+.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 4899999988643221 22356788999998865 56889999999999999995 68999865322111
Q ss_pred hHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 895 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
..+... .. . .++...+.+.+++.+||+.+|++|||+.|++++|.
T Consensus 231 ~~~~~~------------~~------~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERFYEK------------KH------R--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHh------------cc------C--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111000 00 0 00111245889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=320.18 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=204.2
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
++|++.+.||+|+||.||+|.. .++..||+|++........+.+.+|++++++++|||++++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 5688889999999999999965 468999999987654455667889999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++...+..+++..+..++.|++.|+.||| +.+|+|+||||+||+++.++.++|+|||.+....... ..
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~ 159 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QK 159 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--cc
Confidence 999999998876667999999999999999999999 9999999999999999999999999999987643221 12
Q ss_pred ecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 841 QTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.....+++.|+|||.+. ...++.++||||+|+++|||++|+.||......+ ....+.....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~------------- 225 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKSEP------------- 225 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcCCC-------------
Confidence 23456889999999874 3446779999999999999999999987532111 1111100000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ----PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011122345678899999999999999999999887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=326.19 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=195.4
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 757 (979)
+|+..+.||+|+||.||+|. ..+|+.||+|++.... ....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36778899999999999995 4578999999987532 223456777888988885 577888999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++.... .+++.++..++.|++.|++||| +++|+||||||+||++++++.+||+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 9999999999886643 5899999999999999999999 99999999999999999999999999999875432211
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..... .... .
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~---i~~~--------~---- 217 (323)
T cd05615 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQS---IMEH--------N---- 217 (323)
T ss_pred --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHH---HHhC--------C----
Confidence 123456899999999998888999999999999999999999999753211 11110 0000 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH-----HHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA-----KEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~eil~~ 956 (979)
...+..++.++.+++.+|++.+|.+|++. +|+.+|
T Consensus 218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 00112234568899999999999999974 556554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=319.60 Aligned_cols=271 Identities=25% Similarity=0.380 Sum_probs=208.7
Q ss_pred CCCCCCceeeeecceEEEEEEcC-----CCcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeecc--CCee
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-----DGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 753 (979)
+.|+..+.||+|+||.||+|.+. ++..||||++...... ..+.+.+|+++++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999753 4688999998765433 45778999999999999999999999877 5678
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||+++++|.+++......+++..+..++.|++.||+||| +++++||||||+||+++.++.++++|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999877667999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCcce-ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 834 GEDQSMI-QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 834 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
....... .....++..|+|||...+..++.++||||||+++|||++|+.|+......... +...............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLE 237 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHH
Confidence 3222111 11233456799999998888999999999999999999999998653222111 0000000000000000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
... .......+..++.++.+++.+||+.+|++|||+.|++++|+++
T Consensus 238 ~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLK--EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHH--cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000 0011122234567799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.41 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=190.7
Q ss_pred ceeeeecceEEEEEEcC---CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCC
Q 002021 688 NLIGRGGFGSVYKASLG---DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 763 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 763 (979)
+.||+|+||.||+|.+. .+..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999653 345799998865432 23356888999999999999999999999999999999999999
Q ss_pred ccceeeccCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 764 SLEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 764 ~L~~~l~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+|.+++.... ...++..+..++.|++.|++||| +++++||||||+||+++.++.+|++|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986532 24567788899999999999999 9999999999999999999999999999997643332222
Q ss_pred eecccccCCCCCCccccCCC-------CCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 840 IQTQTLATIGYMAPEYGREG-------RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+. ....+.. ......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~----~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVRE----QQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhc----ccCCCCC
Confidence 22334567889999987542 35789999999999999996 9999965332221 1110000 0000011
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
+.. ....+..+.+++.+|| .+|++|||++||++.|.
T Consensus 233 ~~~----------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRL----------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred Ccc----------CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 100 1123345788999999 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=319.29 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=204.2
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
...|+..+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 3678889999999999999995 467999999998765444556788899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|.+++... .+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||.+........
T Consensus 98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 9999999998653 4788999999999999999999 99999999999999999999999999999876533221
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
......+++.|+|||...+..++.++|+||+||++|++++|+.||............+.. . .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-----~-------------~ 232 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-----G-------------T 232 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-----C-------------C
Confidence 123346888999999998888999999999999999999999999642211110000000 0 0
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+...+..+.+++.+||..+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000112344568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.13 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=194.8
Q ss_pred ceeeeecceEEEEEEcC----CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeec-cCCeeEEEEEecC
Q 002021 688 NLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCS-NEEFKALVLEYMP 761 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~~ 761 (979)
+.||+|+||.||+|... +...||+|++.... ....+.+.+|+.+++.++|||++++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999642 34579999875432 234567888999999999999999999765 4566899999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc--c
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS--M 839 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~ 839 (979)
+|+|.+++.......++..+..++.|++.|++||| +.+++||||||+||++++++.+|++|||++......... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999876556788888999999999999999 999999999999999999999999999999755322111 1
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCC-CCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK-KPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......++..|+|||+..+..++.++||||||+++|||++|+ .||.... .......+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~---------------- 219 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQGR---------------- 219 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCC----------------
Confidence 112334567899999998888999999999999999999955 4554321 111111110000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
....+..++..+.+++.+||..+|++||++.|+++.|+++..
T Consensus 220 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 001112345568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=316.40 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=200.2
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
++|+..+.||+|+||.||+|. ..+++.||+|+++.........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 457777899999999999995 4578999999987654444566788999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++...+ .+++.++..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 9999999886544 6899999999999999999999 9999999999999999999999999999987653221 11
Q ss_pred ecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 841 QTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....|+..|+|||++. .+.++.++|+||+||++|||++|+.||..................+. ..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--------~~--- 231 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--------KL--- 231 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC--------cc---
Confidence 23456889999999874 45688899999999999999999999865322111111000000000 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....++..+.+++.+|+..+|++||+++|+++|
T Consensus 232 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 -----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0001234458899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=317.03 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=199.5
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
|+..+.||+|+||.||+|. ..+++.||||.+..... ...+.+.+|+.+++.++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6677899999999999994 45789999999864321 1234567899999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++... ...+++..+..++.|++.|++||| +++|+||||||+||++++++.++++|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999988543 345899999999999999999999 9999999999999999999999999999987653221
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||....... ....... .. +.
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~~~~-~~--------~~------ 219 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVER-LV--------KE------ 219 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHHHHh-hh--------hh------
Confidence 1133468999999999988889999999999999999999999997532211 0000000 00 00
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
.....+..+++.+.+++.+||+.||++||| +.|+++|
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 000011234566899999999999999999 8899885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=312.02 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=197.9
Q ss_pred ceeeeecceEEEEEEcC-C---CcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASLG-D---GMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~---~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.+. . +..||+|.+..... ...+.+.+|+++++.+.|||++++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999542 2 26899999875433 24567889999999999999999999876 4467999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce-e
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI-Q 841 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~ 841 (979)
|+|.+++.... .+++..+..++.|++.|++||| ..+++||||||+||+++.++.+|++|||.+........... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997665 6899999999999999999999 99999999999999999999999999999986643322211 1
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||..... .....++....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~----------------- 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER----------------- 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc-----------------
Confidence 12223567999999988889999999999999999998 9999865321 122222111100
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
...+..++..+.+++.+||..+|.+||++.|+++.|+++.
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0112234567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=325.96 Aligned_cols=255 Identities=22% Similarity=0.242 Sum_probs=198.2
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|++.+.||+|+||+||+|. ..+++.||||++.+.. ....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999995 4568999999986421 223456788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++.+....+++..+..++.||+.|++||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999776667899999999999999999999 99999999999999999999999999999876543221
Q ss_pred cceecccccCCCCCCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 838 SMIQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.......||+.|+|||++.. +.++.++||||+||++|||++|+.||......+ .+... ........
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-~~~~i---~~~~~~~~---- 228 (331)
T cd05597 158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKI---MNHKEHFQ---- 228 (331)
T ss_pred -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-HHHHH---HcCCCccc----
Confidence 11223468999999998863 457889999999999999999999986521111 11110 00000000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcC--CCCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPK--QRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~Rps~~eil~~ 956 (979)
. ......++..+.+++.+|+..++. .||++.++++|
T Consensus 229 ----~----~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ----F----PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----C----CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 001112456688899987765443 38899999998
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=317.74 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=198.1
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeecc------CC
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSN------EE 751 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~ 751 (979)
+++.|+..+.||+|+||.||+|. ..+++.||+|++.... .....+.+|+.+++++ +|||++++++++.. +.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 45668888999999999999995 4568899999986543 3345788899999998 69999999998864 24
Q ss_pred eeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
..++||||+++++|.+++... ...+++..+..++.|++.|++||| +++|+|||+||+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 678999999999999998764 346899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcceecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
...... .......|+..|+|||++. ...++.++||||+||++|||++|+.||............ .. ..
T Consensus 160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----~~-~~ 232 (272)
T cd06637 160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----PR-NP 232 (272)
T ss_pred eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----hc-CC
Confidence 653221 1223456889999999875 345788999999999999999999998653221111100 00 00
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ......++.++.+++.+||..+|.+|||+.|+++|
T Consensus 233 -----~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 233 -----AP---------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -----CC---------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 00111234568999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=329.26 Aligned_cols=266 Identities=22% Similarity=0.231 Sum_probs=196.6
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC------
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------ 750 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 750 (979)
..++|+..+.||+|+||.||+|. ...++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999995 4568899999986542 22345677899999999999999999987543
Q ss_pred CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
...++||||+++ ++.+++.. .+++..+..++.|+++||+||| +++|+||||||+||++++++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999975 66666543 4788999999999999999999 9999999999999999999999999999997
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC------
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI------ 904 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~------ 904 (979)
..... .......+|..|+|||++.+..++.++||||+||++|||++|+.||......+ .....+......
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 65322 12234568999999999988889999999999999999999999996532111 010000000000
Q ss_pred ----ccchhhc----------ccccCch--hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 905 ----STMEVVD----------ANLLSQE--DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 905 ----~~~~~~~----------~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+ +...... .............+.+++.+|++.||++|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 0000000 00000111234568899999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=320.74 Aligned_cols=259 Identities=26% Similarity=0.430 Sum_probs=204.3
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCc----EEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGM----EVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
.+|+..+.||+|+||.||+|.+ .+|. .||+|.+..... .....+.+|+.+++.++||||+++++++..+ ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 5677889999999999999964 3444 578888765432 2234678899999999999999999998654 4679
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
++||+++|+|.+++......++++.+..++.|++.|++||| +++|+||||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999998877667899999999999999999999 999999999999999999999999999999876433
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
..........++..|+|||.+.+..++.++||||||+++||+++ |+.||..... .....++.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~----------- 229 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKGER----------- 229 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCCC-----------
Confidence 22222233445778999999988889999999999999999998 8999865321 111221111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
.+.+..++..+.+++.+||..+|++||++.|+++.|+++.+..
T Consensus 230 -------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 -------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0011223456889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=317.22 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=198.8
Q ss_pred CCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 684 FSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
|+..+.||+|+||+||+|.. .+++.||+|.+.... ....+.+.+|+++++.++|++++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999999954 578999999986432 12234567899999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++... ...+++..+..++.|++.|+.||| +++|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999888654 346899999999999999999999 99999999999999999999999999999876532211
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
.....|+..|+|||++.+..++.++|+||+|+++||+++|+.||....... ....+.......
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~~-------------- 220 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLET-------------- 220 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhcc--------------
Confidence 133468999999999988889999999999999999999999997532111 111110000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
.......++.++.+++.+|++.||++||+ +.|+++|
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 --EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00011234556889999999999999999 7788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=333.73 Aligned_cols=266 Identities=21% Similarity=0.186 Sum_probs=200.8
Q ss_pred hCCCCCCceeeeecceEEEEEEc---CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL---GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~---~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
...|+..+.||+|+||.||++.. ..+..||||.+... +...+|+++++.++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 35689999999999999999954 24678999987543 34568999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+. ++|.+++.. ...+++.+++.++.|++.||+||| +++|+||||||+||+++.++.++|+|||++........
T Consensus 166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9996 588888843 446899999999999999999999 99999999999999999999999999999976644333
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCc--chHhHhhhhhcCCc------cc-h
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE--MTLKHWVNDWLPIS------TM-E 908 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~--~~~~~~~~~~~~~~------~~-~ 908 (979)
........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+...++...... .. .
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 322334578999999999998899999999999999999999999986532211 11111111110000 00 0
Q ss_pred h---hcccc-cCchh---hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 909 V---VDANL-LSQED---IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 909 ~---~~~~~-~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. +.... ..... .........+.++.+++.+|+..||++|||+.|++.|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000 00000 0000112234568899999999999999999999987
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=312.55 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=200.5
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
+|+..+.||+|+||.||++. ..++..||+|.++... ....+.+.+|+.+++.++|||++++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 46778999999999999995 4578899999986432 334567888999999999999999999999999999999999
Q ss_pred CCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++|.+++... ...+++..+..++.|++.|++||| +++|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-- 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence 999999988653 345789999999999999999999 99999999999999999999999999999976543221
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
......++..|+|||++.+..+++++|+||+|+++|+|++|+.||....... .. ........
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~---~~~~~~~~------------- 217 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--LI---LKVCQGSY------------- 217 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--HH---HHHhcCCC-------------
Confidence 1233568889999999988889999999999999999999999986521110 00 00000000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+.+..++..+.+++.+||+.||++||++.|++..
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 --KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00112234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.14 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=204.6
Q ss_pred CCCCCCceeeeecceEEEEEEcC--------CCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG--------DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE 751 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (979)
..|++.+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+++++++ +||||+++++++.+++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 45788899999999999999531 12368999886442 23456788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCccceeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC
Q 002021 752 FKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 816 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~ 816 (979)
..++||||+++|+|.+++... ...+++.++..++.|++.|++||| +++++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 999999999999999998643 234788899999999999999999 99999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHh
Q 002021 817 DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 895 (979)
Q Consensus 817 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~ 895 (979)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----E 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----H
Confidence 999999999999986543222221222334567999999988889999999999999999998 8888754211 1
Q ss_pred HhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
.+........ ....+..++.++.+++.+||+.+|++||++.|++++|+++....
T Consensus 244 ~~~~~~~~~~---------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 ELFKLLKEGH---------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHcCC---------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111110000 00111234567899999999999999999999999999998533
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=317.58 Aligned_cols=262 Identities=22% Similarity=0.279 Sum_probs=203.2
Q ss_pred ccHHHHHHhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeec-
Q 002021 672 FSYLELCRATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCS- 748 (979)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 748 (979)
..++.+....++|+..+.||+|+||.||+|. ..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4445566778899999999999999999994 4568899999876432 2345678899999999 6999999999873
Q ss_pred ----cCCeeEEEEEecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 002021 749 ----NEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821 (979)
Q Consensus 749 ----~~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~ 821 (979)
.++..++||||+++++|.+++.. ....+++..+..++.|+++|++||| +++|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence 45678999999999999988753 2346888999999999999999999 9999999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccCCCCCCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhH
Q 002021 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 896 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~ 896 (979)
|++|||.+........ ......|++.|+|||++.. ..++.++||||+||++|||++|+.||........ ...
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFK 240 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhh
Confidence 9999999876543221 1234468899999998753 4478899999999999999999999865321110 000
Q ss_pred hhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 897 WVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
. ....... ...+..++..+.+++.+||+.||++|||+.|++++.
T Consensus 241 ~----~~~~~~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 I----PRNPPPT-------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred c----cccCCCc-------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 0000000 001112345688999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.64 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=199.8
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccccc---------chhcHHHHHHHHHhcCCCCeeeEEEeeccCCe
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGR---------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEF 752 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (979)
.|...+.||+|+||.||+|. ..+++.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 36778899999999999995 456889999988644221 12567889999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.++||||+++++|.+++... ..+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999998765 35788999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCcc----eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccch
Q 002021 833 TGEDQSM----IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908 (979)
Q Consensus 833 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (979)
....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~------- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKI-GEN------- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHH-hcc-------
Confidence 4221111 1122357889999999988889999999999999999999999997532111 11000 000
Q ss_pred hhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+..++..+.+++.+||+.||.+||++.|++++
T Consensus 228 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 -----------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -----------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0001112345678999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=315.25 Aligned_cols=249 Identities=29% Similarity=0.489 Sum_probs=197.8
Q ss_pred ceeeeecceEEEEEEcCC-------CcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 688 NLIGRGGFGSVYKASLGD-------GMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+.||+|+||.||+|+..+ +..||||.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999996532 2579999876443 23456788999999999999999999999999999999999
Q ss_pred cCCCccceeeccC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-----cEEEEeecc
Q 002021 760 MPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-----VAHLSDFSI 828 (979)
Q Consensus 760 ~~~g~L~~~l~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-----~~kl~Dfg~ 828 (979)
+++++|.+++... ...+++.++..++.|++.|++||| +.+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998653 234788999999999999999999 99999999999999999877 899999999
Q ss_pred ccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccc
Q 002021 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTM 907 (979)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 907 (979)
+................++..|+|||++.++.++.++|||||||++|||++ |+.||...... .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~------- 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTA------- 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhc-------
Confidence 976543332222233345788999999999999999999999999999998 99998643211 11111100
Q ss_pred hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
......+..++..+.+++.+||..+|.+||+++++++.|++
T Consensus 229 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 -----------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -----------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00111123456678999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=327.44 Aligned_cols=239 Identities=26% Similarity=0.280 Sum_probs=187.4
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHH-HHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVEC-EIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.. .+++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999954 567889999986432 11223333443 456788999999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++.... .+.+..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~ 154 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS 154 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence 99999887643 5788889999999999999999 9999999999999999999999999999987543221 1223
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .... ..... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~---i~~~~----------------~ 213 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYDN---ILNKP----------------L 213 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHHH---HHhCC----------------c
Confidence 4568999999999998899999999999999999999999996522111 1110 00000 0
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ei 953 (979)
......+..+.+++.+|++.||.+||++.+.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 0112345668899999999999999988743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.45 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=201.1
Q ss_pred CCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc------ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC------GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
+|...+.||+|+||+||+|...+++.+|||.+.... .+..+.+.+|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999987789999999876432 12235678899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++.+.. .+++..+..++.|++.|++||| +.+|+|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999987643 5789999999999999999999 9999999999999999999999999999987643211
Q ss_pred C----cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 837 Q----SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 837 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
. ........++..|+|||++.+..++.++||||+|+++||+++|+.||........ ...... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~---~~~~------ 226 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGA---HRGL------ 226 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhh---ccCC------
Confidence 1 1111234578899999999888899999999999999999999999965321111 100000 0000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..++.++.+++.+||+.+|.+||++.|++++
T Consensus 227 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 227 --------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred --------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000112345668999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.60 Aligned_cols=267 Identities=19% Similarity=0.269 Sum_probs=196.4
Q ss_pred CCceeeee--cceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 686 ENNLIGRG--GFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 686 ~~~~lG~G--~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
..+.||+| +||+||++. ..+|+.||||++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 789999994 4689999999986542 223456778999999999999999999999999999999999
Q ss_pred CCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++|+|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998654 335899999999999999999999 9999999999999999999999999998765432211111
Q ss_pred -----eecccccCCCCCCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCcc------
Q 002021 840 -----IQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST------ 906 (979)
Q Consensus 840 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~------ 906 (979)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||............ .....+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccchh
Confidence 0122346778999999875 45889999999999999999999999754322111111 100000000
Q ss_pred -ch--------hhcccc-----------cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 -ME--------VVDANL-----------LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 -~~--------~~~~~~-----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+ ..+... ........+....+++.+.+++.+||+.||++|||++|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 000000 000000011122345679999999999999999999999885
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.49 Aligned_cols=248 Identities=28% Similarity=0.468 Sum_probs=194.5
Q ss_pred ceeeeecceEEEEEEcC-CCc--EEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASLG-DGM--EVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|... ++. .+|+|.+.... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999653 443 46888876432 23446788899999999 799999999999999999999999999
Q ss_pred CccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeec
Q 002021 763 GSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFS 827 (979)
Q Consensus 763 g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg 827 (979)
|+|.+++.... ..+++.++..++.|++.|++||| +++++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 24789999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCcc
Q 002021 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 906 (979)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 906 (979)
++.... ..........+..|+|||++....++.++||||||+++|||++ |..||...... ..........
T Consensus 158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~~~~~- 228 (270)
T cd05047 158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKLPQGY- 228 (270)
T ss_pred Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHHhCCC-
Confidence 986321 1111122234567999999988889999999999999999997 99998642211 1111110000
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
....+..++.++.+++.+||..+|.+|||+.|+++.|.++.
T Consensus 229 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 --------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00011224456889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=312.02 Aligned_cols=248 Identities=26% Similarity=0.401 Sum_probs=199.2
Q ss_pred ceeeeecceEEEEEEcCC--C--cEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASLGD--G--MEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~--~--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.+.+ + ..||||.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999996532 3 3699999876544 456788899999999999999999999888 889999999999
Q ss_pred CccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc-e
Q 002021 763 GSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM-I 840 (979)
Q Consensus 763 g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~ 840 (979)
++|.+++.+.. ..+++..++.++.|++.||+||| +++++||||||+||+++.++.+||+|||++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999987754 56899999999999999999999 9999999999999999999999999999998765432221 1
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
.....++..|+|||++.+..++.++||||+||++|||++ |+.||......+ ..+.... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~---~~-------------- 217 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDK---EG-------------- 217 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh---cC--------------
Confidence 123456788999999988889999999999999999999 999986432111 1111000 00
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
.....+..++..+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000011234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=322.38 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=202.1
Q ss_pred CCCCceeeeecceEEEEE-EcCCCcEEEEEEeccc---cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQ---CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
|...+-||.|+||.||-| ...+.+.||||++.-. +...+.++..|+.++++++|||++.+-|+|..+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 445678999999999999 5668899999998533 334567888999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
|-| +-.|.+.-.+.++.+-++..|+.+.+.||+||| +++.||||||+.|||+++.|.||++|||.|..+.+.
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 954 777887777778999999999999999999999 999999999999999999999999999999887543
Q ss_pred eecccccCCCCCCcccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 840 IQTQTLATIGYMAPEYG---REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
...+|||.|||||++ ..|.|+-++||||+|+++.|+.-.++|.-.+ +.+.-.+-+....+
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM--NAMSALYHIAQNes------------- 242 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--NAMSALYHIAQNES------------- 242 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc--hHHHHHHHHHhcCC-------------
Confidence 457899999999976 4688999999999999999999999996442 22221111111110
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
+.. .....+..+..++..|++.-|++|||..++++|--
T Consensus 243 -PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 243 -PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred -CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 000 11234566899999999999999999999998743
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=327.09 Aligned_cols=263 Identities=20% Similarity=0.232 Sum_probs=196.2
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..+|+..+.||+|+||.||+|.. .+++.||+|+.... ....|+.++++++||||+++++++.++...++||||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 45799999999999999999955 46788999975322 335699999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+. ++|.+++......+++.++..|+.||+.||+||| +++|+||||||+||+++.++.+||+|||.+.......
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 211 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--- 211 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---
Confidence 95 5898888776667999999999999999999999 9999999999999999999999999999997532211
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCC-cccccCcch--------HhHhhhhhc--CC----
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT-DEIFNGEMT--------LKHWVNDWL--PI---- 904 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~-~~~~~~~~~--------~~~~~~~~~--~~---- 904 (979)
......||+.|+|||++.+..++.++|||||||++|||+++..|+ ......... +...+.... +.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 123456899999999999889999999999999999999965554 322111000 111110000 00
Q ss_pred -ccch----hhc-ccccCch--hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 905 -STME----VVD-ANLLSQE--DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 905 -~~~~----~~~-~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.... ..+ ....... .........++..+.+++.+|++.||.+|||+.|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000 000 0000000 00011112345567789999999999999999999986
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=327.86 Aligned_cols=238 Identities=28% Similarity=0.322 Sum_probs=187.5
Q ss_pred ceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHH-HHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECE-IMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||+||+|. ..+|+.||+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999995 4578999999986432 122334455554 46778999999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT 154 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence 9998887654 36899999999999999999999 99999999999999999999999999999875322211 223
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+.. .... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-~~~~----~~~~--------~~-------- 213 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-MYDN----ILHK--------PL-------- 213 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-HHHH----HHcC--------Cc--------
Confidence 4568999999999999899999999999999999999999986532111 1111 0000 00
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKE 952 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 952 (979)
......+..+.+++.+|++.+|.+||++.+
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 001123456889999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=314.60 Aligned_cols=266 Identities=24% Similarity=0.270 Sum_probs=195.0
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhc---CCCCeeeEEEeecc-----CC
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSI---RHRNLIKVISSCSN-----EE 751 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 751 (979)
+|+..+.||+|+||.||+|. ..+++.||+|.++.... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 37778999999999999994 45789999999865422 2233566788877766 69999999998754 34
Q ss_pred eeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
..++||||+++ +|.+++... ...+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999975 888887654 345899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc---CCccc
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL---PISTM 907 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~---~~~~~ 907 (979)
...... ......+|..|+|||++.+..++.++||||+||++|||++|+.||...... ........... .....
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence 654222 123346789999999998888999999999999999999999998653221 11111111100 00000
Q ss_pred hhhc--ccccCchhhh--hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 908 EVVD--ANLLSQEDIH--FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 908 ~~~~--~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.... .......... ......++..+.+++.+|++.||++|||+.|++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0000000000 01112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=318.66 Aligned_cols=195 Identities=22% Similarity=0.316 Sum_probs=159.3
Q ss_pred CceeeeecceEEEEEEcC---CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc--CCeeEEEEEecC
Q 002021 687 NNLIGRGGFGSVYKASLG---DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKALVLEYMP 761 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~ 761 (979)
.++||+|+||+||+|... +++.||+|++... .....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999643 5678999998643 223457789999999999999999998843 556889999996
Q ss_pred CCccceeeccC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----CCCCcEEEEeeccc
Q 002021 762 HGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIA 829 (979)
Q Consensus 762 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll----~~~~~~kl~Dfg~~ 829 (979)
+ +|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 777765422 235888999999999999999999 9999999999999999 46678999999999
Q ss_pred cccCCCCCc-ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCccc
Q 002021 830 KMLTGEDQS-MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEI 887 (979)
Q Consensus 830 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~ 887 (979)
......... .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876432211 12234578999999998876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.73 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=203.9
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.++|+..+.||+|+||.||+|...++..+|+|.+... ....+.+.+|+++++.++|+|++++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678889999999999999998777888999988643 2334678899999999999999999999887 7789999999
Q ss_pred CCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++|.+++... ....++.++..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 999999998764 446788999999999999999999 89999999999999999999999999999976532221 1
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......++..|+|||++..+.++.++|+|||||++|+++| |+.||...... ....+......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~--------------- 221 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYR--------------- 221 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCC---------------
Confidence 1223345678999999988889999999999999999999 89998653211 11111111000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
.......+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00112345668999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=325.99 Aligned_cols=237 Identities=27% Similarity=0.298 Sum_probs=186.0
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHH-HHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVEC-EIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.. .+++.||+|++.... ......+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999954 578999999986432 12233444454 467889999999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS 154 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence 9998887654 35888899999999999999999 9999999999999999999999999999987532221 1223
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ........... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~----------------~ 213 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHKP----------------L 213 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcCC----------------C
Confidence 45689999999999888899999999999999999999999965311 11111110000 0
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAK 951 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 951 (979)
..+......+.+++.+|++.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 01112345688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.86 Aligned_cols=267 Identities=23% Similarity=0.275 Sum_probs=198.6
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++|||++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 467788999999999999954 578999999986442 22345678899999999999999999999999999999999
Q ss_pred cCCCccceeeccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
++ ++|.+++... ...+++..+..++.|++.||+||| +++++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 5888887643 256899999999999999999999 9999999999999999999999999999987653221
Q ss_pred cceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC--------Cccch
Q 002021 838 SMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP--------ISTME 908 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~--------~~~~~ 908 (979)
.......+++.|+|||.+.+. .++.++||||+|+++|||+||+.||........... ....... .....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR-IFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHhCCCChhhhhcchhhH
Confidence 112334578899999987654 478899999999999999999999875322111110 0000000 00000
Q ss_pred hhcccccCch-hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 909 VVDANLLSQE-DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 909 ~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.......... .........++.++.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 00001112356778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.81 Aligned_cols=268 Identities=23% Similarity=0.247 Sum_probs=199.4
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|++++++++|||++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 367788999999999999954 578999999986432 22335677899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++ ++|.+++......+++..++.++.||++|++||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence 97 4888887765567899999999999999999999 99999999999999999999999999999976532221
Q ss_pred eecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc---c---chhhcc
Q 002021 840 IQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS---T---MEVVDA 912 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~ 912 (979)
......++..|+|||.+.+. .++.++||||+||++|||+||+.|+.........+....+...... . ....+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12334578899999987664 4789999999999999999999986432222211111110000000 0 000000
Q ss_pred cccCc---hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLLSQ---EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..... ...........+.++.+++.+|++.||.+|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 000001112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=323.99 Aligned_cols=255 Identities=20% Similarity=0.250 Sum_probs=198.8
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||+||++.. .+++.||+|++.+.. ......+.+|+.++..++|++|+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3688889999999999999954 467889999985421 223345788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++.+....+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence 999999999999876567899999999999999999999 9999999999999999999999999999987653222
Q ss_pred cceecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 838 SMIQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
........||+.|+|||++. .+.++.++|||||||++|||++|+.||......+ .+..... ......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~---~~~~~~---- 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMN---HKERFQ---- 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-HHHHHhC---CCcccc----
Confidence 22223457899999999875 3467899999999999999999999996531111 1111000 000000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCC--CCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQ--RINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~eil~~ 956 (979)
.......++.++.+++.+|+..++.+ |+++.|+++|
T Consensus 229 --------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 --------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00111234667889999988665444 7899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=324.45 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=199.0
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999954 468899999986421 223455788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999876567899999999999999999999 99999999999999999999999999999976643222
Q ss_pred cceecccccCCCCCCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 838 SMIQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.......||+.|+|||++.+ +.++.++||||+||++|||++|+.||...... ..+..... .......
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~---~~~~~~~--- 229 (331)
T cd05624 158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMN---HEERFQF--- 229 (331)
T ss_pred -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HHHHHHHc---CCCcccC---
Confidence 22234568999999998765 46788999999999999999999999642211 11111000 0000000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCC--CCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQ--RINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~eil~~ 956 (979)
......++.++.+++.+|+..++.+ |++++++++|
T Consensus 230 ---------p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 230 ---------PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---------CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0001124566889999999876544 5689999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.96 Aligned_cols=248 Identities=26% Similarity=0.323 Sum_probs=202.0
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
+|+..+.||.|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++|||++++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 577788999999999999954 478999999986543 334567888999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++... .+++..+..++.|++.|++||| +++++||||+|+||++++++.++++|||.+....... ..
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 154 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SK 154 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cc
Confidence 999999998765 6899999999999999999999 9999999999999999999999999999998764332 12
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
.....++..|+|||++.+..++.++||||||+++|||+||+.||......+. .. ..... . .+..
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~---~~~~~-~----~~~~------ 218 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LF---LIPKN-N----PPSL------ 218 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HH---Hhhhc-C----CCCC------
Confidence 2345678899999999888899999999999999999999999865321111 00 00000 0 0000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....++..+.+++.+||..+|++|||++|++++
T Consensus 219 ---~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 ---EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000145568899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=310.77 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=202.5
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3466778999999999999965 468899999986442 33456788899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|.+++... .+++.++..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence 9999999988653 5888999999999999999999 99999999999999999999999999999976543221
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
......++..|+|||++.+..++.++|+|||||++|||++|..||........... . ...
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-----~---------~~~------ 216 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-----I---------PKN------ 216 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-----h---------hcC------
Confidence 12334578899999999888899999999999999999999999875322111000 0 000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........++..+.+++.+||+.+|++||++.|++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0011123456778999999999999999999999888
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=312.95 Aligned_cols=270 Identities=22% Similarity=0.289 Sum_probs=200.2
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++++|...+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 35788999999999999999994 45789999999865432 22345778999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+. +++.+++......+.+.++..++.|++.||+||| +++|+|+||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 6787777655556788899999999999999999 99999999999999999999999999999876432221
Q ss_pred cceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc-CC-----------
Q 002021 838 SMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-PI----------- 904 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~----------- 904 (979)
......++..|+|||.+.+. .++.++||||+||++|||++|+.||.........+.+.+.... +.
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12334578899999988654 5788999999999999999999999754332222211111000 00
Q ss_pred -ccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 905 -STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 905 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+.. .................+..+.+++.+|+..||++|||++|++.|
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWF-LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhc-cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000 000000000000001124568899999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=325.74 Aligned_cols=265 Identities=22% Similarity=0.230 Sum_probs=197.0
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC------
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------ 750 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 750 (979)
..++|+..+.||+|+||.||+|. ...++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 34789999999999999999995 4578899999986542 22345677899999999999999999987543
Q ss_pred CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
...|+||||+++ ++.+++.. .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999965 67766643 4788999999999999999999 9999999999999999999999999999997
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh-
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV- 909 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 909 (979)
..... .......+|..|+|||++.+..++.++||||+||++|||++|+.||......+ .+...+.... ....+.
T Consensus 175 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~-~~~~~~~ 249 (364)
T cd07875 175 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLG-TPCPEFM 249 (364)
T ss_pred ccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC-CCCHHHH
Confidence 65322 12234568999999999999899999999999999999999999997532111 1111111000 000000
Q ss_pred ----------hcc----------cccCch--hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 ----------VDA----------NLLSQE--DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ----------~~~----------~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... ...... .............+.+++.+|++.||.+|||+.|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000000 00000011123568899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=335.72 Aligned_cols=269 Identities=21% Similarity=0.251 Sum_probs=193.6
Q ss_pred HHHhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCC------CCeeeEEEeecc
Q 002021 677 LCRATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH------RNLIKVISSCSN 749 (979)
Q Consensus 677 ~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 749 (979)
+...+++|++.+.||+|+||.||+|. ..+++.||||+++... ...+.+..|+++++.++| ++++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 33456789999999999999999995 4568899999986432 223456678888887764 458889998865
Q ss_pred C-CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCC--------
Q 002021 750 E-EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNM-------- 819 (979)
Q Consensus 750 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~-------- 819 (979)
+ ++.++|||++ +++|.+++.+. ..+++..+..|+.||+.||+||| + .+|+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5788999988 67888888664 36899999999999999999999 7 5999999999999998765
Q ss_pred --------cEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCc
Q 002021 820 --------VAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891 (979)
Q Consensus 820 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~ 891 (979)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998764321 1234678999999999999999999999999999999999999997532211
Q ss_pred ch--Hh--------HhhhhhcCCccchhhccccc-----Cch------hhhhHHHHHHHHHHHHHHHhccccCcCCCCCH
Q 002021 892 MT--LK--------HWVNDWLPISTMEVVDANLL-----SQE------DIHFVAKEQCVSFVFNLAMECTMEFPKQRINA 950 (979)
Q Consensus 892 ~~--~~--------~~~~~~~~~~~~~~~~~~~~-----~~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 950 (979)
.. +. .|..........++++.... ... ...........+.+.+|+.+|++.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 00 00 01000000000000000000 000 00000011123568899999999999999999
Q ss_pred HHHHHH
Q 002021 951 KEIVTK 956 (979)
Q Consensus 951 ~eil~~ 956 (979)
+|+++|
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999986
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=313.97 Aligned_cols=239 Identities=25% Similarity=0.353 Sum_probs=189.0
Q ss_pred ceeeeecceEEEEEEcC-C-------CcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 688 NLIGRGGFGSVYKASLG-D-------GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~-~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+.||+|+||.||+|... . ..+||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36899999999999542 2 334888887654444456788899999999999999999999998999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc--------EEEEeeccccc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--------AHLSDFSIAKM 831 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~--------~kl~Dfg~~~~ 831 (979)
+++|+|.+++...+..+++..+..++.|++.|++||| +++|+||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999877667899999999999999999999 999999999999999987665 69999999875
Q ss_pred cCCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCC-CCCcccccCcchHhHhhhhhcCCccchh
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK-KPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
.... ....++..|+|||++.+. .++.++||||+|+++||+++|. .||...... .. ......
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~-~~~~~~--------- 220 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KK-LQFYED--------- 220 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HH-HHHHHc---------
Confidence 5322 234577889999998764 5789999999999999999985 454331111 00 000000
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
. ...+.....++.+++.+||+.+|++|||++|+++.|
T Consensus 221 ---~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 ---R--------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ---c--------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 001112234588999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.46 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=195.5
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-----ccchhcHHHHHHHHHhcCCCCeeeEEEeecc--CCee
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-----GRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 753 (979)
.+|+..+.||+|+||.||+|. ..+++.||+|++.... .+..+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368889999999999999995 4578999999886432 1233567889999999999999999998765 4677
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
+++|||+++++|.+++.... .+++..++.++.|++.|++||| +.+|+||||||+||++++++.+||+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999987654 5789999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCC-cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 834 GEDQ-SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 834 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.... ........++..|+|||.+.+..++.++||||+||++||+++|+.||......+ ...+ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-~~~~----~~~~~------- 225 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-AIFK----IATQP------- 225 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-HHHH----HhcCC-------
Confidence 2111 111123457889999999988889999999999999999999999987532111 0000 00000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+..+.+.+.+++ +||..+|++||+++|+++|
T Consensus 226 -------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 -------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00011123345567777 7888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=309.64 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=188.0
Q ss_pred eeeeecceEEEEEEcCC---CcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCc
Q 002021 689 LIGRGGFGSVYKASLGD---GMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 764 (979)
Q Consensus 689 ~lG~G~~g~Vy~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 764 (979)
.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996433 3568888775432 2234567889999999999999999999999999999999999999
Q ss_pred cceeeccCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 765 LEKYLYSSN----CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 765 L~~~l~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
|.+++.... ...++..+..++.|++.|++||| +++|+||||||+||++++++.+|++|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999987643 23467788899999999999999 99999999999999999999999999999875433222222
Q ss_pred ecccccCCCCCCccccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 841 QTQTLATIGYMAPEYGRE-------GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.....++..|+|||+... ..++.++||||+||++|||++ |..||......+ ......... ..+..++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~----~~~~~~~ 233 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQ----DIKLPKP 233 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhcc----CccCCCC
Confidence 233446778999998642 356789999999999999999 778876532211 111111100 0000000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.....++..+.+++..|| .||++|||++||++.|
T Consensus 234 ----------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 234 ----------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ----------cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 011234456778899999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.51 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=203.1
Q ss_pred CCCCCCceeeeecceEEEEEEcC------CCcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
++|+..+.||+|+||.||+|+.. +.+.||+|.+...... ..+.+.+|++++++++|||++++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999643 3467999988654333 3567899999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEee
Q 002021 755 LVLEYMPHGSLEKYLYSSN--------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 826 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df 826 (979)
+||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987543 15899999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCc
Q 002021 827 SIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 827 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
|++....... ........++..|+|||.+.++.+++++||||+|+++|++++ |..||....... ...... ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~---~~~ 235 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQ---AGK 235 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHH---cCC
Confidence 9987543222 122233456778999999888888999999999999999999 788885432211 111110 000
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
. ....+..++..+.+++.+||+.+|++||++.|++++|.+
T Consensus 236 ~--------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 236 L--------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred c--------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0 001112345679999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=307.26 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=203.2
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.|+..+.||+|+||.||.++ ..+++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 37788999999999999984 4578899999876432 33456788999999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++... ...+++.++..++.|++.|++||| +.+++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999998765 456899999999999999999999 89999999999999999999999999999986643321
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......+++.|+|||...+..++.++||||+|+++|||++|+.||......+ ...........
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~~~~~~~~~----------- 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----LVVKIVQGNYT----------- 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHcCCCC-----------
Confidence 2234568899999999988888999999999999999999999986522111 11000000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.....++.++.+++.+||..+|.+||++.|++++.
T Consensus 220 ----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 01123456688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.42 Aligned_cols=262 Identities=24% Similarity=0.302 Sum_probs=204.2
Q ss_pred cccHHHHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeec
Q 002021 671 MFSYLELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCS 748 (979)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 748 (979)
.+...++..++++|+..+.||+|+||.||+|.. .+++.+|+|++.... ...+.+.+|+.+++++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 355566667789999999999999999999954 578999999986432 2345677899999998 7999999999886
Q ss_pred cC-----CeeEEEEEecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc
Q 002021 749 NE-----EFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 820 (979)
Q Consensus 749 ~~-----~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~ 820 (979)
.. +..++||||+++++|.++++. ....+++..++.++.|++.|++||| +++++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence 43 358999999999999988753 3456899999999999999999999 999999999999999999999
Q ss_pred EEEEeeccccccCCCCCcceecccccCCCCCCccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHh
Q 002021 821 AHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG-----RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 895 (979)
Q Consensus 821 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~ 895 (979)
+|++|||.+........ ......++..|+|||.+... .++.++||||+||++|||++|+.||......+. ..
T Consensus 167 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~ 243 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LF 243 (291)
T ss_pred EEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HH
Confidence 99999999886542221 12334678899999987543 367899999999999999999999865322111 11
Q ss_pred HhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+.... .... ..++.....+.+++.+||+.+|++||++.|+++|
T Consensus 244 ~~~~~~----~~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIPRNP----PPTL-------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHhcCC----CCCC-------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111000 0000 0112234568999999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=310.73 Aligned_cols=268 Identities=23% Similarity=0.309 Sum_probs=200.9
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++|+..+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+++++.++|||++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999654 689999998864321 233567889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|++++.+..++... ..+++..++.++.|++.|++||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 99998887776543 35899999999999999999999 99999999999999999999999999999987643321
Q ss_pred ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchH--hHhhhhhcCCccchhhcc---
Q 002021 839 MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL--KHWVNDWLPISTMEVVDA--- 912 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~--- 912 (979)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||......+... .......... .....+.
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-HQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH-Hhhhcccccc
Confidence 1223457789999998765 457889999999999999999999997543221111 1111111000 0000000
Q ss_pred ---cccCchh---hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 ---NLLSQED---IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ---~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....... .........+..+.+++.+||+.+|++||++.|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000 0001112345678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=292.78 Aligned_cols=272 Identities=22% Similarity=0.316 Sum_probs=212.4
Q ss_pred ccHHHHHHhhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeecc
Q 002021 672 FSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSN 749 (979)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 749 (979)
-.+.++...++ +.||+|+|+.|--+ ...+|..+|||++.++.......+.+|++++...+ |+||++++++|++
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 34666766664 58999999999988 67789999999999888888888999999999985 9999999999999
Q ss_pred CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEEee
Q 002021 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDF 826 (979)
Q Consensus 750 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~Df 826 (979)
+..+|||||.|.||+|..++++.+ .+++.++.++.++||.||+||| ++||+|||+||+|||-.+.. -+|||||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecc
Confidence 999999999999999999998765 5899999999999999999999 99999999999999987543 4799999
Q ss_pred ccccccCCCC-----CcceecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhH
Q 002021 827 SIAKMLTGED-----QSMIQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 896 (979)
Q Consensus 827 g~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~ 896 (979)
.++.-+.-.. ......+.+|+..|||||+.. ...|..+.|.||+|||+|-|++|..||...-..+- -
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---G 300 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---G 300 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---C
Confidence 9876443211 112234567889999999642 23588899999999999999999999987544322 1
Q ss_pred hhhhhcCCccchhhcccccCchhhhh--HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 897 WVNDWLPISTMEVVDANLLSQEDIHF--VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
|-+...-....+.+-.. +.+..+.| ..+..++.+..+++...+..|+.+|.++.+++.|
T Consensus 301 WdrGe~Cr~CQ~~LFes-IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFES-IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred ccCCCccHHHHHHHHHH-HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 22211111111111111 11112222 3455678889999999999999999999999873
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=306.66 Aligned_cols=249 Identities=21% Similarity=0.322 Sum_probs=199.4
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeecc-CCeeEEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEFKALVLE 758 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E 758 (979)
+|+..+.||+|++|.||+|. ..+++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47788999999999999995 4568899999986432 2345568889999999999999999998764 446789999
Q ss_pred ecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 759 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
|+++++|.+++... ...+++.+++.++.|++.|++||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999998764 345899999999999999999999 99999999999999999999999999999987643221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
......+++.|+|||+..+..++.++||||+|+++||+++|+.||........ .........
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~--------------- 219 (257)
T cd08223 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEGKL--------------- 219 (257)
T ss_pred --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhcCC---------------
Confidence 22344678999999999988899999999999999999999999864221110 000000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+..++..+.+++.+|++.+|++||++.|++++
T Consensus 220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=321.81 Aligned_cols=264 Identities=23% Similarity=0.256 Sum_probs=196.4
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccC------
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNE------ 750 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 750 (979)
..+.|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 45789999999999999999995 56788999999864321 2335577899999999999999999987533
Q ss_pred CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
...++++|++ +++|.+++... .+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccce
Confidence 3568999988 67898877543 5899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+..... ....+.
T Consensus 167 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~-~~~~~~ 239 (343)
T cd07878 167 QADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVG-TPSPEV 239 (343)
T ss_pred ecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhC-CCCHHH
Confidence 65322 133468999999999876 56889999999999999999999998652211 11111111000 000000
Q ss_pred hc-----------ccccCchhhh-hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VD-----------ANLLSQEDIH-FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~-----------~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. .......... ........+.+.+++.+|++.||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000000000 00011234567899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.05 Aligned_cols=246 Identities=28% Similarity=0.499 Sum_probs=198.3
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|+..+.||+|+||.||+|.. +++.||+|.+... ...+.+.+|+.+++.++|||++++++++...+ .++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence 4578889999999999999975 6788999998643 23467889999999999999999999987654 689999999
Q ss_pred CCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 762 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 762 ~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
+++|.+++... ...+++..+..++.|++.|++||| +++++||||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999998764 335889999999999999999999 9999999999999999999999999999987543211
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
.....+..|+|||++.++.++.++|+||+|+++|||++ |+.||......+ ...... . ..
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~---~---------~~----- 214 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVE---K---------GY----- 214 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHh---C---------CC-----
Confidence 22234568999999988899999999999999999998 999986532211 111110 0 00
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
+......++..+.+++.+||+.+|++||+++|+++.|++
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 001112345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=306.02 Aligned_cols=237 Identities=24% Similarity=0.415 Sum_probs=189.0
Q ss_pred ceeeeecceEEEEEEcCC-C----------cEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 688 NLIGRGGFGSVYKASLGD-G----------MEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~-~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
+.||+|+||.||+|...+ + ..||+|++...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999996643 3 25788877544332 5788899999999999999999999887 778999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-------cEEEEeeccc
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-------VAHLSDFSIA 829 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-------~~kl~Dfg~~ 829 (979)
|||+++|+|.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++ .+|++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999876657899999999999999999999 99999999999999999887 7999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCC--CCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCcc
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 906 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 906 (979)
..... .....++..|+|||++... .++.++||||+|+++||+++ |..||...... ....+.. ....
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~---~~~~ 224 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQ---DQHR 224 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHh---cCCC
Confidence 86532 1234567789999998776 78999999999999999999 57777553211 1111111 0000
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.... ....+.+++.+||..+|.+|||+.|+++.|
T Consensus 225 --------~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 225 --------LPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --------CCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 014688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=347.23 Aligned_cols=255 Identities=28% Similarity=0.374 Sum_probs=207.9
Q ss_pred HhhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 679 RATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
..+-+|+...+||.|.||.||-| ..++|+..|||-++.+. .+..+.+.+|..++..++|||+|+.+|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34566888899999999999999 67789999999876543 3456778899999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
.||||++|+|.+.+...+ ..++.-...+..|++.|++||| ++|||||||||.||+++.+|.+|++|||.|..+.++
T Consensus 1312 FMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999886543 3555566778999999999999 999999999999999999999999999999988655
Q ss_pred CCc--ceecccccCCCCCCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 836 DQS--MIQTQTLATIGYMAPEYGREG---RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 836 ~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
... ..-....||+.|||||++.+. .-..++||||+|||+.||+||++||...... ..+-+-|..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~~---------- 1456 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVAA---------- 1456 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHhc----------
Confidence 322 122356899999999998754 3567899999999999999999999864322 222211111
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+..++.|+..+.+-.+++..|++.||++|+++.|+++|
T Consensus 1457 --------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 --------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11223445577889999999999999999999988876
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=306.60 Aligned_cols=250 Identities=32% Similarity=0.560 Sum_probs=200.8
Q ss_pred CCCCceeeeecceEEEEEEcCC-----CcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 684 FSENNLIGRGGFGSVYKASLGD-----GMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
+++.+.||+|+||.||+|...+ +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999996543 488999998755433 4678889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
||+++++|.+++...... +++.++..++.|++.|++||| +.+++||||||+||++++++.++++|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999998765444 899999999999999999999 9999999999999999999999999999998765332
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.... ....+++.|+|||...+..++.++||||+|+++|||++ |+.||..... ....+......
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~------------- 221 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGY------------- 221 (258)
T ss_pred cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC-------------
Confidence 2211 12336789999999988889999999999999999999 7888764211 11111111000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
....+..++.++.+++.+|+..+|++|||+.|+++.|
T Consensus 222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011122566799999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=306.99 Aligned_cols=257 Identities=26% Similarity=0.337 Sum_probs=205.5
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||.|+||.||+|. ..++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+..+...++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468889999999999999996 4578899999986432 23456788999999999999999999999999999999999
Q ss_pred cCCCccceeeccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
+++++|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||++++++.++++|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999998764 246899999999999999999999 99999999999999999999999999999987654332
Q ss_pred cc--eecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 838 SM--IQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 838 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. ......++..|+|||++... .++.++|+||+||++|||++|+.||......+ .+........+ ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~---------~~ 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPP---------SL 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCC---------Cc
Confidence 21 22334688999999998776 78899999999999999999999997542221 11111110000 00
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ......++..+.+++.+||..||++||++.|+++|
T Consensus 228 -~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 -ET----GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -CC----ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00112445678999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.22 Aligned_cols=254 Identities=24% Similarity=0.297 Sum_probs=204.3
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 3577788999999999999955 468999999987553 23446788899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++......+++..+..++.|++.|++||| + .+++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999999876567899999999999999999999 8 9999999999999999999999999999876532211
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
....++..|+|||.+.+..++.++||||+|+++|++++|+.||.............+........
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 221 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP------------ 221 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC------------
Confidence 11567889999999988899999999999999999999999987543221211111111110000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... ....++.++.+++.+||..+|++|||+.|++++
T Consensus 222 -~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 -PRL-PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -CCC-ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 000 011155678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.03 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=199.3
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788899999999999999654 78999999886542 23346788899999999999999999999999999999999
Q ss_pred cCCCccceeeccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
+++++|.+++... ...+++..+..++.|++.|+.|||+ +++|+||||||+||+++.++.+|++|||.+..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999888664 2368999999999999999999993 3699999999999999999999999999987653221
Q ss_pred cceecccccCCCCCCccccCCC------CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 838 SMIQTQTLATIGYMAPEYGREG------RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
.....++..|+|||.+.+. .++.++|+||+||++|||++|+.||....... .... ..... +
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~-~~~~~--------~ 224 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQ-LSAIV--------D 224 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHH-HHHHh--------h
Confidence 1234578899999987544 35789999999999999999999986532111 0100 00000 0
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. .....+..++.++.+++.+||+.+|++||++.|++.+
T Consensus 225 ~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 225 G-------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred c-------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0 0001122356778999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=312.64 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=202.6
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccc--cccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 757 (979)
...|++.++||.||.+.||++...+.+.+|+|++... .......|..|+..|.+++ |.+||++++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3568888999999999999998888889999876432 2345678999999999995 999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||-+. +|..++.+.........+..+..|++.++.++| .+||||.|+||.|+++-. |.+||+|||+|..+.....
T Consensus 440 E~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 98754 999999887655554588899999999999999 999999999999999864 6899999999999877666
Q ss_pred cceecccccCCCCCCccccCCC-----------CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCcc
Q 002021 838 SMIQTQTLATIGYMAPEYGREG-----------RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 906 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 906 (979)
.......+||+-||+||.+... ..++++||||+|||+|+|+.|+.||+..... |.+..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~aKl~----- 583 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IAKLH----- 583 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HHHHH-----
Confidence 6666778999999999987532 2568899999999999999999999763211 11111
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+.++...- .++.... ..++.++|..|+..||.+||++.|+++|
T Consensus 584 -aI~~P~~~I----efp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 584 -AITDPNHEI----EFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -hhcCCCccc----cccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 111221100 0110000 1228999999999999999999999976
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=344.07 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=196.5
Q ss_pred HhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeecc--CCee
Q 002021 679 RATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFK 753 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 753 (979)
...++|.+.+.||+|+||.||+|. ..++..||+|++.... ......+..|+.+++.++|||||+++++|.+ ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345789999999999999999995 4567889999886432 2345678889999999999999999998744 4578
Q ss_pred EEEEEecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEecCCCCCCEEeCC---------
Q 002021 754 ALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGY----SAPVIHCDLKPSNVLLDD--------- 817 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~i~H~Dik~~NIll~~--------- 817 (979)
|+||||+++|+|.+++... ...+++..++.|+.||+.||+|||... .++|+||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999998653 346899999999999999999999311 146999999999999964
Q ss_pred --------CCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCccc
Q 002021 818 --------NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEI 887 (979)
Q Consensus 818 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~P~~~~ 887 (979)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..+++++|||||||++|||+||+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999998653221 1234568999999998854 45889999999999999999999999642
Q ss_pred ccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 888 FNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ....+....... . ......+..+.++|.+||..+|.+||++.|++.+
T Consensus 247 ~~----~~qli~~lk~~p-------------~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NN----FSQLISELKRGP-------------D---LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred Cc----HHHHHHHHhcCC-------------C---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 21 111111111000 0 0001234568999999999999999999999864
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.94 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=199.1
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
|+..+.||+|+||.||+|. ..+++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 4556789999999999995 4568899999886432 3345678899999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+++|.+++... .+++..+..++.|+++|++||| +++++|+||+|+||++++++.++++|||++....... ...
T Consensus 86 ~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06642 86 GGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred CCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhh
Confidence 99999988653 5889999999999999999999 9999999999999999999999999999997654222 112
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (979)
....++..|+|||++.+..++.++||||||+++|||++|+.||........ ..+. .... .+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~----~~~~----~~--------- 219 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLI----PKNS----PP--------- 219 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhhh----hcCC----CC---------
Confidence 234578899999999888899999999999999999999999865322111 1100 0000 00
Q ss_pred hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....++..+.+++.+||+.+|.+||++.|+++|
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 -TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0112345568899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=308.46 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=198.6
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc---c-------chhcHHHHHHHHHhcCCCCeeeEEEeeccCC
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---R-------AFKSFDVECEIMKSIRHRNLIKVISSCSNEE 751 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (979)
+|...+.||+|+||.||+|. ..+|+.||+|.++.... . ..+.+..|+++++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 36677899999999999994 45789999998753211 1 1245778999999999999999999999999
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..++||||+++++|.+++... ..+++..+..++.|++.|+.||| +++++||||+|+||++++++.++++|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999998775 36899999999999999999999 89999999999999999999999999999976
Q ss_pred cCCCCCcceecccccCCCCCCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
..............++..|+|||.+.... ++.++|+||+|+++||+++|..||...... ..+...........+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~ 233 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAMFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHHHHhhccccCCcC
Confidence 53222111123345788999999887654 789999999999999999999998542111 111110000000000
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. .....++..+.+++.+||..+|.+||+++|+++|
T Consensus 234 -~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 -PP----------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -Cc----------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00 0112345678999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.15 Aligned_cols=195 Identities=23% Similarity=0.318 Sum_probs=158.8
Q ss_pred CceeeeecceEEEEEEcC---CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeec--cCCeeEEEEEecC
Q 002021 687 NNLIGRGGFGSVYKASLG---DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS--NEEFKALVLEYMP 761 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~E~~~ 761 (979)
...||+|+||.||+|+.. ++..||+|.+... .....+.+|+++++.++||||+++++++. .+...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999753 4578999988643 22345778999999999999999999884 4567899999996
Q ss_pred CCccceeeccC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----CCCCcEEEEeeccc
Q 002021 762 HGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIA 829 (979)
Q Consensus 762 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll----~~~~~~kl~Dfg~~ 829 (979)
+ +|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 776665321 235788999999999999999999 9999999999999999 56779999999999
Q ss_pred cccCCCCCc-ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCccc
Q 002021 830 KMLTGEDQS-MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEI 887 (979)
Q Consensus 830 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~ 887 (979)
+........ .......+|+.|+|||.+.+ ..++.++||||+||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876433221 12234568999999998876 45889999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=306.74 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=201.6
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||++. ..+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 47778999999999999994 4578999999986432 23446788999999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++... ...+++.+++.++.|++.|++||| +++++|+||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999988654 335789999999999999999999 99999999999999999999999999999976543221
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......+++.|+|||+..+..++.++|+|||||++|++++|+.||..... ...+.......
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~------------- 217 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGS------------- 217 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCC-------------
Confidence 12234578899999999888899999999999999999999999864211 11111110000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..++..+.+++.+||+.+|.+||++.|+++|
T Consensus 218 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 --YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 001122345668999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=312.91 Aligned_cols=250 Identities=26% Similarity=0.328 Sum_probs=203.6
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
++|+..+.||+|+||.||+|. ..+++.||+|++........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 678888999999999999995 4578899999986544445567888999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++.+. .+++.++..++.|++.|++||| +++++|||+||+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~ 171 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 171 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence 999999998754 4789999999999999999999 99999999999999999999999999999876543322 1
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
.....+++.|+|||.+....++.++|+||||+++|++++|+.||........ ...... . ...
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~~-~----------------~~~ 233 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIAT-N----------------GTP 233 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehhc-C----------------CCC
Confidence 2334688899999999888899999999999999999999999965322111 000000 0 000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+...+..+.+++.+||..+|++||++.|++.|
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122344568899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=310.44 Aligned_cols=268 Identities=21% Similarity=0.283 Sum_probs=199.0
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 6788899999999999999954 4789999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++ +|.+++......+++..+..++.|+++||+||| +++|+||||||+||++++++.+|++|||.+........
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 975 999988776667899999999999999999999 99999999999999999999999999999875422111
Q ss_pred eecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc---CCccchhhcc---
Q 002021 840 IQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL---PISTMEVVDA--- 912 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--- 912 (979)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||..............+... ..........
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 1123346788999998765 45789999999999999999999999654321111111111000 0000000000
Q ss_pred -----cccCchhhhhHHHHHH--HHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 -----NLLSQEDIHFVAKEQC--VSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 -----~~~~~~~~~~~~~~~~--~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......... ...... ...+.+++.+|++.+|++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 239 KPYSFPFYPPRPLI-NHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccCChhHH-HhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000 000011 2567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=310.69 Aligned_cols=258 Identities=21% Similarity=0.288 Sum_probs=200.4
Q ss_pred HHHHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeecc--
Q 002021 674 YLELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSN-- 749 (979)
Q Consensus 674 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 749 (979)
..++....+.|+..+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.+++++ +|||++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 344444567888999999999999999954 578899999886442 2345678899999998 69999999998843
Q ss_pred ----CCeeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEE
Q 002021 750 ----EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 824 (979)
Q Consensus 750 ----~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~ 824 (979)
....++||||+++|+|.+++... ...+++..+..++.|++.|++||| +++|+|+|+||+||++++++.++|+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEe
Confidence 45789999999999999988654 345788889999999999999999 9999999999999999999999999
Q ss_pred eeccccccCCCCCcceecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhh
Q 002021 825 DFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 899 (979)
Q Consensus 825 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~ 899 (979)
|||++........ ......++..|+|||.+. ...++.++||||+||++|||++|+.||........... .
T Consensus 164 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~-- 238 (282)
T cd06636 164 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-I-- 238 (282)
T ss_pred eCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-H--
Confidence 9999875432211 123356889999999875 34578899999999999999999999865321111000 0
Q ss_pred hhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 900 DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... .........++..+.+++.+||+.||.+||++.|++++
T Consensus 239 ----------~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 ----------PRN------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----------hhC------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000 00000112345679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=310.25 Aligned_cols=268 Identities=21% Similarity=0.250 Sum_probs=203.0
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 467788999999999999964 578999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+ +++|.+++......+++.+++.++.|+++|++||| +++++|+||||+||++++++.++++|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999998776667999999999999999999999 99999999999999999999999999999987643321 1
Q ss_pred eecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc---cch---hhc-
Q 002021 840 IQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS---TME---VVD- 911 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~- 911 (979)
......++..|+|||.+.+. .+++++||||+|+++|||++|+.||...... ..+........... ..+ ..+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchh
Confidence 22345688999999987654 4689999999999999999998777543211 11111111000000 000 000
Q ss_pred -ccccCchhh-h-hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 -ANLLSQEDI-H-FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 -~~~~~~~~~-~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......... . .......+..+.+++.+|++.+|++||+++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0 01112345779999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=307.09 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=198.2
Q ss_pred CCCCCceeeeecceEEEEEEcCC--CcEEEEEEecccc----------ccchhcHHHHHHHHHh-cCCCCeeeEEEeecc
Q 002021 683 GFSENNLIGRGGFGSVYKASLGD--GMEVAVKVFTSQC----------GRAFKSFDVECEIMKS-IRHRNLIKVISSCSN 749 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 749 (979)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... ......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999996543 7889999875321 1123446678888765 799999999999999
Q ss_pred CCeeEEEEEecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEee
Q 002021 750 EEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 826 (979)
Q Consensus 750 ~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df 826 (979)
++..++||||+++++|.+++.. ....+++..++.++.|++.|++|||+ ..+++|+||+|+||++++++.+|++||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 34568999999999999999999992 268999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCcc
Q 002021 827 SIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 906 (979)
Q Consensus 827 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 906 (979)
|.+....... ......++..|+|||.+.++.++.++||||||+++|||++|+.||...... .... ...
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~~---~~~---- 226 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLAT---KIV---- 226 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHHH---HHh----
Confidence 9998754332 224456889999999998888999999999999999999999998642111 1110 000
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
..... ......++..+.+++.+||+.||.+||++.|+..+++
T Consensus 227 ----~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 ----EAVYE------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----hccCC------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000 0001123466899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=313.28 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=204.6
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4677788999999999999954 568999999876543 23456788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|.+++...+ .+++..+..++.+++.|+.|||+ .++++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 99999998886643 58999999999999999999993 3689999999999999999999999999986542211
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc------hHhHhhhhhcCCccchhhccc
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM------TLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 913 (979)
.....++..|+|||++.++.++.++|+||+||++|++++|+.||......+. ....+.......
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 228 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE--------- 228 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc---------
Confidence 1234688999999999888899999999999999999999999975432211 001111111000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
..... ....++.++.+++.+|++.||++|||+.|++++.--+.
T Consensus 229 ----~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 229 ----PPPRL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ----cCCCC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 00000 01125567899999999999999999999998854433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=305.89 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=196.4
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-----ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC--Cee
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-----GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 753 (979)
.+|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999954 568999999875322 12245678899999999999999999988663 467
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||+++++|.+++.... .+++..+.+++.|++.|++||| +.+++|+||||+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999987653 5788899999999999999999 9999999999999999999999999999987653
Q ss_pred CCCCc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 834 GEDQS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 834 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||....... ..... ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~---~~~-~------- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIFKI---ATQ-P------- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHHHH---hcC-C-------
Confidence 22111 11223457889999999988889999999999999999999999986531111 11100 000 0
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+......+.+++.+|+. +|++||+++|++++
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 -------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0011122344568889999995 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.62 Aligned_cols=250 Identities=28% Similarity=0.352 Sum_probs=192.7
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHH-HHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEI-MKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++|+..+.||+|+||.||+|.. .+|+.||+|++..... .....+..|..+ ++..+|||++++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 3688889999999999999954 5799999999865422 223345556655 666789999999999999999999999
Q ss_pred ecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 759 YMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 759 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
|++ |+|.+++.. ....+++..++.++.|++.|++||| ++ +++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 588777643 2356899999999999999999999 76 999999999999999999999999999876532
Q ss_pred CCCcceecccccCCCCCCccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGRE----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
. .......++..|+|||.+.+ ..++.++|+||+||++|||++|+.||..................
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 225 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-------- 225 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--------
Confidence 1 11233467889999998764 34688999999999999999999998643222111111110000
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+. . ....++.++.+++.+||..+|.+||++.|++++
T Consensus 226 -~~--------~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 -PQ--------L-PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -CC--------C-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 011245678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=317.16 Aligned_cols=194 Identities=26% Similarity=0.384 Sum_probs=167.9
Q ss_pred CCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-C-----CCeeeEEEeeccCCeeEE
Q 002021 683 GFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-H-----RNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 755 (979)
.|++.+.||+|+||.|.+| +..+++.||||+++.. .....+...|+.+|..++ | -|+|+++++|....+.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6788999999999999999 6678999999999754 234456677999999996 3 499999999999999999
Q ss_pred EEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC--CCcEEEEeecccccc
Q 002021 756 VLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFSIAKML 832 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~--~~~~kl~Dfg~~~~~ 832 (979)
|+|.++. +|+++++.. ...++...++.|+.||+.||.+|| +.+|||+||||+|||+.+ ...+||+|||.+...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999854 999999876 356899999999999999999999 999999999999999974 347999999999875
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcc
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 886 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~ 886 (979)
...-. ..+.+..|+|||++.+.+|+.+.||||||||++||++|..-|.+
T Consensus 342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 32222 34567789999999999999999999999999999999765543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=305.40 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=200.2
Q ss_pred CCCCCceeeeecceEEEEEEcC-CCcEEEEEEecccc-----ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQC-----GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.|+..+.||+|+||.||+|... +++.||+|.+.... .+..+.+.+|+++++.++|+|++++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999654 78999999886432 12346788899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999987653 5889999999999999999999 9999999999999999999999999999987653222
Q ss_pred CcceecccccCCCCCCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
......++..|+|||.+.... ++.++|+||+|+++|++++|+.||......+... .+.. .. .
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~-~~--~---------- 219 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF-KIGR-SK--E---------- 219 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH-HHHh-cc--c----------
Confidence 123456888999999887766 8999999999999999999999987643111100 0000 00 0
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..++..+.+++.+||+.+|.+||++.|++++
T Consensus 220 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 -----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 001112345668899999999999999999999865
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.31 Aligned_cols=267 Identities=22% Similarity=0.250 Sum_probs=199.6
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc-----chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR-----AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
+|+..+.||+|+||.||+|.. .+++.||||++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 367788999999999999964 57899999998654322 234566799999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+ +++|.+++......+++..+..++.|+++||+||| +++|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999998776557899999999999999999999 9999999999999999999999999999998764332
Q ss_pred CcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc---CCccc---hh
Q 002021 837 QSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL---PISTM---EV 909 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~---~~~~~---~~ 909 (979)
.. .....+++.|+|||.+.+ ..++.++||||+||++|||++|..||...... ..+........ ..... ..
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 RK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred cc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccc
Confidence 21 233356788999998754 45788999999999999999997777542211 11111111000 00000 00
Q ss_pred hcccccCc--hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLSQ--EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+...... ...........+..+.+++.+||+.+|.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 000001112345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=323.64 Aligned_cols=241 Identities=22% Similarity=0.251 Sum_probs=186.7
Q ss_pred eeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc---CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI---RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 690 lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
||+|+||.||+|. ..+++.||||++.... ......+..|..++... +||+|+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999995 4578999999986432 12223445577777665 699999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++... ..+++..+..++.||++|++||| +++|+||||||+||++++++.+||+|||++........ ...
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 154 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN 154 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence 9999888654 36899999999999999999999 99999999999999999999999999999875432221 123
Q ss_pred ccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhh
Q 002021 843 QTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (979)
...||+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+.. ..... . +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-~~~~----i~~~~-~-------------~ 215 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-MYRN----IAFGK-V-------------R 215 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-HHHH----HHcCC-C-------------C
Confidence 45689999999988654 47899999999999999999999986522111 0010 00000 0 0
Q ss_pred hHHHHHHHHHHHHHHHhccccCcCCCC----CHHHHHHH
Q 002021 922 FVAKEQCVSFVFNLAMECTMEFPKQRI----NAKEIVTK 956 (979)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~eil~~ 956 (979)
.+ ....+.++.+++.+|++.||.+|| ++.|+++|
T Consensus 216 ~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 216 FP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 00 012345688999999999999998 57777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.39 Aligned_cols=248 Identities=25% Similarity=0.305 Sum_probs=198.2
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
|.....||+|+||.||+|. ..++..||||++........+.+.+|+.+++.++|||++++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 3334679999999999995 457889999998655444556788999999999999999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
++|.+++... .+++.++..++.|++.|++||| +++|+||||||+||++++++.++|+|||++........ ...
T Consensus 104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 9999987543 5889999999999999999999 99999999999999999999999999999876532221 123
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...++..|+|||.+.+..++.++||||+|+++||+++|+.||......+ ..... .... ... .
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~-~~~~--------~~~--------~ 238 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRI-RDNL--------PPR--------V 238 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-HhcC--------CCc--------c
Confidence 3468899999999988889999999999999999999999986421110 01100 0000 000 0
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+..+.+++.+||..||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111234568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.86 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=199.7
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||+|. ..+++.+|||++.... ....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 47778899999999999994 4578899999986442 23456788899999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfg~~~~~~~~~~ 837 (979)
+++++|.+++... ...+++..+..++.|++.|++||| +++++|+||||+||+++++ +.+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999764 345899999999999999999999 9999999999999999854 5689999999987643221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... . .........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~-~~~~~~~~~--------------- 217 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-A-LVLKIMSGT--------------- 217 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-H-HHHHHHhcC---------------
Confidence 12346788999999998888899999999999999999999998653211 1 111000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+.+..++..+.+++.+||..+|.+|||+.|++++
T Consensus 218 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 ---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000112345668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=310.84 Aligned_cols=268 Identities=23% Similarity=0.334 Sum_probs=200.5
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35788899999999999999654 689999998764322 234567889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|++++++.++.... ..+++.++..++.|+++|++||| +.+++|+|++|+||++++++.++++|||++........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 99998888776543 35899999999999999999999 89999999999999999999999999999886543321
Q ss_pred ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc--hHhHhhhhhcCCccchhhcc---
Q 002021 839 MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM--TLKHWVNDWLPISTMEVVDA--- 912 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~--- 912 (979)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ....+..... .......+.
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI-PRHQEIFQKNPL 233 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCc-hhhHHHhccchH
Confidence 1233457889999998765 4578899999999999999999998864321110 0000000000 000000000
Q ss_pred ---ccc---CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 ---NLL---SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ---~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... ............++..+.+++.+||+.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000 00000111123456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=313.21 Aligned_cols=248 Identities=25% Similarity=0.306 Sum_probs=198.5
Q ss_pred CCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 684 FSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
|+....||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++|||++++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33445799999999999954 57899999998654444456788899999999999999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
++|.+++... .+++..++.++.|++.|++||| +.+++||||||+||+++.++.+||+|||++....... ....
T Consensus 103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 175 (297)
T cd06659 103 GALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK 175 (297)
T ss_pred CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence 9999877553 5889999999999999999999 9999999999999999999999999999987543221 1123
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...++..|+|||++.+..++.++||||+||++|||++|+.||...... ..... +...... ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~-~~~~~~~----------------~~ 237 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKR-LRDSPPP----------------KL 237 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HhccCCC----------------Cc
Confidence 456889999999998888999999999999999999999998642211 11111 1100000 00
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+..+.+++.+|++.+|++||++.|++++
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0111234568899999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.72 Aligned_cols=250 Identities=20% Similarity=0.350 Sum_probs=185.8
Q ss_pred eeeeecceEEEEEEcCCC---cEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCc
Q 002021 689 LIGRGGFGSVYKASLGDG---MEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 764 (979)
Q Consensus 689 ~lG~G~~g~Vy~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 764 (979)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999964333 346677665432 2345678899999999999999999999999999999999999999
Q ss_pred cceeeccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 765 LEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 765 L~~~l~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
|.+++.+.. ...++..+..++.|+++|++||| +++++||||||+||+++.++.+|++|||++......+.....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999987542 34566778899999999999999 999999999999999999999999999998643222211222
Q ss_pred cccccCCCCCCccccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 842 TQTLATIGYMAPEYGRE-------GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
....++..|+|||+... ..++.++||||||+++|||++ |..||..... ...+..... .......++.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~----~~~~~~~~~~ 233 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIK----DQQVKLFKPQ 233 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHh----hcccccCCCc
Confidence 34567889999998743 245789999999999999997 5667754221 111111111 1111111111
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.. ....+.+.+++.+|| .+|.+||+++||++.|
T Consensus 234 ~~----------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 234 LE----------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cC----------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 11 113455788999999 6799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=304.72 Aligned_cols=257 Identities=25% Similarity=0.283 Sum_probs=199.8
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeecc--CCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 757 (979)
++|+..+.||.|++|.||+|.. .+++.||+|.+..... .....+.+|++++++++||||++++++|.+ .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3577889999999999999954 5689999999864432 345678899999999999999999998854 44689999
Q ss_pred EecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
||+++++|.+++.. ....+++..+..++.|++.|++||| +.+++|+||+|+||++++++.++++|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999887643 3446788999999999999999999 99999999999999999999999999999875432
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccC---cchHhHhhhhhcCCccchhhc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG---EMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 911 (979)
... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...... ......+...... ....+
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 230 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN---PELKD 230 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc---hhhcc
Confidence 211 2345678999999998888999999999999999999999999764221 1112222111110 00000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
. .......++.+.+++.+||..+|++|||+.|++++-
T Consensus 231 -----~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 231 -----E----PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred -----C----CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 0 000012345689999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.14 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=201.0
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc------cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG------RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
+|+..+.||+|+||.||+|. ..+++.||+|++..... ...+.+.+|++++++++|||++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47788999999999999995 46789999999864321 134678889999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEEeeccccccCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFSIAKMLTG 834 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg~~~~~~~ 834 (979)
||||+++++|.+++.+.+ .+++..+..++.|++.|++||| +++++|+||||+||+++.++ .+||+|||.+..+..
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999987643 6889999999999999999999 99999999999999998775 699999999987643
Q ss_pred CCCc--ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 835 EDQS--MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 835 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.... .......++..|+|||.+.+..++.++||||+|+++|++++|..||....... ....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--------- 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALIFKIASA--------- 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHHHHHhcc---------
Confidence 3111 11223467889999999988889999999999999999999999986422111 11110000000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+...+..+.+++.+|+..+|.+||++.|++++
T Consensus 227 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 ------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00011222345678999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=287.89 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=207.1
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..++||+|.||.|-.+ ...+|+.+|+|++++..- ........|-++++..+||.+..+-..|+..++.++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999 566899999999987642 3344556799999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||..||.|.-++.+.+ .+++...+.+..+|+.||.||| +++||.||+|.+|.|+|.+|.+||+|||+++.-- .
T Consensus 247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--K 320 (516)
T ss_pred EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc--c
Confidence 99999999999987754 6899999999999999999999 9999999999999999999999999999998632 2
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
........+|||.|.|||++....|+.++|.|.+||++|||++|+.||.....+.. .+++-
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL--------------FeLIl----- 381 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL--------------FELIL----- 381 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH--------------HHHHH-----
Confidence 34445778999999999999999999999999999999999999999987433221 11110
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
..+.++ +...++++..|+...+..||.+|. .+.||.+|
T Consensus 382 ~ed~kF--Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 382 MEDLKF--PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hhhccC--CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 111122 223456788999999999999998 45666554
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.25 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=199.1
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcC---CCCeeeEEEeeccCCeeEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIR---HRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 757 (979)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+++++.++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 366778999999999999964 578999999986542 334567888999999997 999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++++|.+++... .+++..+..++.|++.|++||| +.+|+|+||+|+||++++++.++++|||.+........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999988654 6899999999999999999999 99999999999999999999999999999987653332
Q ss_pred cceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 838 SMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
......|+..|+|||.+.++ .++.++|+||||+++|+|++|+.||....... +........ .+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~~~~-----~~~~-- 222 (277)
T cd06917 157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLIPKSK-----PPRL-- 222 (277)
T ss_pred --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhccccCC-----CCCC--
Confidence 12334688899999988654 46889999999999999999999986532111 100000000 0000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....++.++.+++.+||+.||++||++.|++++
T Consensus 223 -------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 223 -------EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 001145678999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=315.49 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=205.3
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
-|+++.-||.|+||.||+|.. ..+-..|-|++....+...++|.-|++||..+.||+||++++.|..+...++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 356667899999999999954 3455567898887777888999999999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
||-++..+-.-+..+++.++.-+++|++.||.||| +..|+|||+|+.|||++-+|.++++|||.+.... ......
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKR 187 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhhh
Confidence 99999888877888999999999999999999999 9999999999999999999999999999986532 222334
Q ss_pred cccccCCCCCCcccc-----CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 842 TQTLATIGYMAPEYG-----REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
....|||.|||||+. ...+|.+++||||||+++.||..+.+|-++...-.. .++.... .
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV----llKiaKS------------e 251 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV----LLKIAKS------------E 251 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH----HHHHhhc------------C
Confidence 567899999999975 456799999999999999999999998654211111 1110000 0
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. .....+...+..+.+++.+|+..+|..||++.++++|
T Consensus 252 P--PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 P--PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred C--CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 0 1112233445668999999999999999999999876
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.91 Aligned_cols=253 Identities=30% Similarity=0.402 Sum_probs=202.3
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.|+..+.||+|+||.||+|.. .+++.||+|+++..... ..+.+..|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 367789999999999999954 57899999998755432 567788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999987653 5788999999999999999999 9999999999999999999999999999998764333221
Q ss_pred e--ecccccCCCCCCccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 840 I--QTQTLATIGYMAPEYGREGR---VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 840 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
. .....++..|+|||++.+.. ++.++||||||+++||+++|+.||...... ...........
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~------------ 223 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGAGH------------ 223 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhcCC------------
Confidence 1 12345788999999987765 889999999999999999999999653211 11111111100
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+....++..+.+++.+||+.+|++||++.|++.+
T Consensus 224 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 ----KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ----CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00011112235668899999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=309.39 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=196.7
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688889999999999999954 568899999986543 123456778999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++++|.+++.... .+++..+..++.|++.|++||| +++++||||||+||+++.++.+|++|||.++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999987654 6889999999999999999999 99999999999999999999999999999864211100
Q ss_pred -------------cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC
Q 002021 838 -------------SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 904 (979)
Q Consensus 838 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 904 (979)
........++..|+|||.+.+..++.++|+||||+++||+++|+.||......+ ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~~~~~~ 235 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIEW 235 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCC
Confidence 001112356889999999988889999999999999999999999986422111 111110000000
Q ss_pred ccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
......++..+.+++.+||+.+|++||++.++.+.+
T Consensus 236 -----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 236 -----------------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred -----------------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 000113456689999999999999999854443333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=299.02 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=205.4
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
+.|..-++||+|+||+||-.. ..+|+-+|.|++.+.. .........|..|+++++.++||.+-.+|..++..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 557788999999999999884 4579999999875442 223345677999999999999999999999999999999
Q ss_pred EecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 758 EYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
..|.||+|.=+|.+.+ ..++++.++.++.+|+.||++|| ..+||.||+||+|||+|+.|.++|+|.|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999998763 57999999999999999999999 9999999999999999999999999999999875332
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
. ...++||.+|||||++.++.|+...|.||+||++|||+.|+.||....... -.+-+|.+...
T Consensus 342 ~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------------k~eEvdrr~~~ 404 (591)
T KOG0986|consen 342 P---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------------KREEVDRRTLE 404 (591)
T ss_pred c---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------------hHHHHHHHHhc
Confidence 2 245689999999999999999999999999999999999999996522110 00111222211
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
... .-++.+++++.++-+..++.||++|. .++|+.+|
T Consensus 405 ~~~---ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 405 DPE---EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred chh---hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 111 12256778899999999999999997 45555554
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=304.03 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=200.0
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
-|+..+.||+|+||.||+|. ..+++.||||.+.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 36677899999999999995 4578999999875432 233467888999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++... .+++..+..++.|++.|++||| +++++|+||+|+||+++.++.++++|||++........ .
T Consensus 85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06641 85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K 157 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence 999999988654 5889999999999999999999 99999999999999999999999999999876543221 1
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
.....++..|+|||.+.+..++.++|+||+||++|++++|..||...... ..... ......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~---~~~~~~-------------- 218 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFL---IPKNNP-------------- 218 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHH---HhcCCC--------------
Confidence 22345788999999998888899999999999999999999998652211 11110 000000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......++.++.+++.+||+.+|.+||++.|+++|
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00112345668899999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.08 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=196.6
Q ss_pred CCCCceeeeecceEEEEEEcC----CCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC------
Q 002021 684 FSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------ 751 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 751 (979)
|...+.||+|+||.||+|.+. ++..||||++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999642 46889999986542 223556888999999999999999999875432
Q ss_pred eeEEEEEecCCCccceeeccC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEee
Q 002021 752 FKALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 826 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df 826 (979)
..++++||+++|+|.+++... ...+++..+..++.|++.|++||| +++|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999998876432 234788999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCc
Q 002021 827 SIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 827 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
|.+................+++.|++||......++.++||||+|+++|||++ |+.||..... .....+..... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~--~ 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYLIKGN--R 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHHHcCC--c
Confidence 99986543222222223345678999999988889999999999999999999 8888764322 11111111000 0
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
. ..+..++..+.+++.+||+.+|.+||++.|++++|+++
T Consensus 234 ---------~-------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 ---------L-------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00112345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.16 Aligned_cols=253 Identities=25% Similarity=0.301 Sum_probs=199.4
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCC------
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE------ 751 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 751 (979)
.+++|+..+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+++++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 457899999999999999999965 467899999986543 2346788999999999 6999999999986543
Q ss_pred eeEEEEEecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecc
Q 002021 752 FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSI 828 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~ 828 (979)
..++||||+++++|.+++... ...+++..+..++.|++.|++||| +.+++|+||+|+||++++++.+|++|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999987653 357899999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCCCCCCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC
Q 002021 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 903 (979)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 903 (979)
+....... .......++..|+|||++.. ..++.++||||+|+++|++++|+.||....... .........
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-- 234 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNP-- 234 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhccC--
Confidence 87653221 12234568889999998753 346788999999999999999999986432111 111110000
Q ss_pred CccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. + .......++.++.+++.+|+..||++|||+.|++++
T Consensus 235 --~-----~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 235 --P-----P--------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred --C-----C--------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0 011112345678899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.95 Aligned_cols=248 Identities=25% Similarity=0.311 Sum_probs=198.8
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
|+..+.||+|++|.||+|. ..+++.||+|++........+.+.+|+.+++.++|||++++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 4556799999999999995 457899999988654434455678899999999999999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
++|.+++.. ..+++.++..++.|++.|++||| +++|+||||+|+||+++.++.++++|||.+........ ...
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~ 173 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK 173 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence 999999876 35899999999999999999999 99999999999999999999999999998875432211 112
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...++..|+|||...+..++.++||||+|+++|||++|+.||...... ..... .....+. ..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~-~~~~~~~----------------~~ 235 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKR-IRDNLPP----------------KL 235 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHH-HHhcCCC----------------CC
Confidence 345889999999998888999999999999999999999998642111 00110 0000000 00
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....++..+.+++.+||+.+|++||++.|++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0111244668999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=292.43 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=221.8
Q ss_pred HHhhCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeecc-
Q 002021 678 CRATDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSN- 749 (979)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 749 (979)
......++...++-+|.||+||+|.|. +.+.|-||.++..+. .....+..|.-.+..+.|||+.++.+++.+
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 334455677778899999999999654 334567777754432 345667889888999999999999998754
Q ss_pred CCeeEEEEEecCCCccceeeccC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEE
Q 002021 750 EEFKALVLEYMPHGSLEKYLYSS-------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 822 (979)
Q Consensus 750 ~~~~~lv~E~~~~g~L~~~l~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~k 822 (979)
.+.+++++.++.-|+|..|+..+ ...++..+...++.|++.|++||| +++++|.||.++|.+||+..+||
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEE
Confidence 56778999999999999999822 345677788999999999999999 99999999999999999999999
Q ss_pred EEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhh
Q 002021 823 LSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDW 901 (979)
Q Consensus 823 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~ 901 (979)
++|=.+++...+.+..........+..||+||.+.+..|+.++|||||||++|||+| |+.|+.+..+.++ ..+
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~y---- 510 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHY---- 510 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHH----
Confidence 999999999999988877777778899999999999999999999999999999999 9999876433322 111
Q ss_pred cCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 902 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
-+.+++..++-+||++++.+|.-||..+|++||+++|++.-|.++..++-+
T Consensus 511 --------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~ 561 (563)
T KOG1024|consen 511 --------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR 561 (563)
T ss_pred --------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence 123345566779999999999999999999999999999999999877654
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=299.19 Aligned_cols=250 Identities=28% Similarity=0.392 Sum_probs=204.6
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
+|+..+.||+|++|.||+|.. .+++.||+|++........+.+.+|+++++.++||+++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 367788999999999999965 4789999999976654456788899999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+++|.+++......+++..+..++.|+++|++||| .++++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999998776567899999999999999999999 89999999999999999999999999999987643321 2
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (979)
....++..|+|||.+.+..++.++||||+|+++|+|++|+.||........... ........
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~------------- 216 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-----IATNGPPG------------- 216 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-----HHhcCCCC-------------
Confidence 345678899999999888899999999999999999999999865321110000 00000000
Q ss_pred hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......++..+.+++.+||+.||++|||+.|+++|
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111124568999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.83 Aligned_cols=245 Identities=26% Similarity=0.301 Sum_probs=200.3
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3678889999999999999954 468999999986432 223466888999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++++|.+++... ..+++..+..++.|++.|++||| +++++||||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998765 46899999999999999999999 999999999999999999999999999999875432
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||...... .........
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~----------------- 213 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEG----------------- 213 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcC-----------------
Confidence 23446889999999998888899999999999999999999998653211 001110000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
....+...+..+.+++.+||..+|.+|+ +++|+++|
T Consensus 214 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 ---KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0001122345688999999999999999 88888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.89 Aligned_cols=266 Identities=23% Similarity=0.282 Sum_probs=197.6
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477889999999999999954 578999999886443 22335688899999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+. ++|.+++... ...+++..+..++.|++.|++||| +++++||||+|+||++++++.+|++|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 5888887653 346899999999999999999999 99999999999999999999999999999876532221
Q ss_pred ceecccccCCCCCCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc-CCc-cc----hhh-
Q 002021 839 MIQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-PIS-TM----EVV- 910 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~-~~----~~~- 910 (979)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||....... .......... +.. .. ...
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHH
Confidence 123345678999999876544 5889999999999999999999986532111 1111111000 000 00 000
Q ss_pred -cccc--cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 -DANL--LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 -~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.... ...... .......+.++.+++.+|++.||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 000000 00112345668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.77 Aligned_cols=253 Identities=28% Similarity=0.331 Sum_probs=205.4
Q ss_pred hhCCCCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
..+.|+..+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++|+|++++++++..++..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566888899999999999999654 688999999875533 45678889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++++|.+++......+++..+..++.|++.|++||| +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 99999999999876557999999999999999999999 99999999999999999999999999999876543221
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .....+.. ...
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-~~~~~~~~----~~~------------ 233 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-RALFLITT----KGI------------ 233 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh----cCC------------
Confidence 112335778999999998888999999999999999999999998642111 11111000 000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........++..+.+++.+|++.+|.+||++.|++++
T Consensus 234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 234 -PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0011122345678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=309.18 Aligned_cols=269 Identities=25% Similarity=0.264 Sum_probs=199.3
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEeeccC--CeeE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKA 754 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 754 (979)
..++|+..+.||+|+||.||+|.. .+|+.||+|+++..... ....+.+|++++++++|+|++++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 357899999999999999999954 57899999998644222 233466799999999999999999998654 5689
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+++ +|.+++......+++.++..++.|++.|++||| +.+++||||||+||++++++.+||+|||.+.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 99999965 888887765567899999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccch----h
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME----V 909 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~----~ 909 (979)
.... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ....... .....+... .
T Consensus 161 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~-~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLII-QLLGTPNESIWPGF 236 (309)
T ss_pred ccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-HhcCCCChhhchhh
Confidence 3211 223345788999998765 45789999999999999999999999753221 1111111 111000000 0
Q ss_pred hcc---cc--cCchhhhh--HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDA---NL--LSQEDIHF--VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~---~~--~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... .. ........ ......++.+.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 00 00000000 0111235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=300.45 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=200.9
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeec--cCCeeEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCS--NEEFKALVL 757 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~ 757 (979)
+|+..+.||.|+||.||+|. ..+++.||+|++.... ....+.+..|+++++.++|||++++++++. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47778899999999999994 4578899999886432 233456788999999999999999999775 345679999
Q ss_pred EecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 758 EYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGY--SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 758 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
||+++++|.+++... ...+++..++.++.|++.|++|||..+ +.+++|+||||+||++++++.+|++|||.+...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 457899999999999999999999443 678999999999999999999999999999876
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... .......+.. .
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~---~-------- 225 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKE---G-------- 225 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhc---C--------
Confidence 43321 1233468899999999988889999999999999999999999987532 1111111110 0
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ...+...+..+.+++.+|++.+|++||++.||+++
T Consensus 226 -~~------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 -KF------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CC------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 01112345678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.87 Aligned_cols=269 Identities=22% Similarity=0.277 Sum_probs=201.1
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++++.++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 578889999999999999965 468899999886432 23346788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++.+..+... ...+++.++..++.|++.|++||| +.+++|+|++|+||++++++.+||+|||.+........ .
T Consensus 82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~ 156 (288)
T cd07833 82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-S 156 (288)
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-c
Confidence 998766655443 345899999999999999999999 99999999999999999999999999999987643322 1
Q ss_pred eecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHh--HhhhhhcC--------Cccch
Q 002021 840 IQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK--HWVNDWLP--------ISTME 908 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~--~~~~~~~~--------~~~~~ 908 (979)
......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+.... .......+ .....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 22335678899999998887 789999999999999999999999875322111000 00000000 00000
Q ss_pred h-hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 909 V-VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 909 ~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. .-+............+..++.++.+++.+||..+|++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00000000000111122346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=311.58 Aligned_cols=253 Identities=28% Similarity=0.367 Sum_probs=201.5
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+..|+++++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3678889999999999999955 4589999999875432 23456888999999999999999999999999999999
Q ss_pred EecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 758 EYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
||+.+++|.+++... ...+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998754 356899999999999999999999 9999999999999999999999999999987543221
Q ss_pred Cc---------------------------ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCccccc
Q 002021 837 QS---------------------------MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 889 (979)
Q Consensus 837 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~ 889 (979)
.. .......|+..|+|||++.+..++.++||||+|+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 011123578899999999888899999999999999999999999865322
Q ss_pred CcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC----HHHHHHH
Q 002021 890 GEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN----AKEIVTK 956 (979)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps----~~eil~~ 956 (979)
.. .+... ... . ...+.....+..+.+++.+|+..+|++||+ +.|+++|
T Consensus 238 ~~-~~~~~---~~~---------~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DE-TFSNI---LKK---------E------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HH-HHHHH---hcC---------C------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11 11110 000 0 000111114567999999999999999999 8888775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=299.13 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=205.3
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|++|.||+|... +++.||||++..... ...+.+.+|++++++++|||++++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999554 599999999875543 3457788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++... ..+++..++.++.|+++|++||| + .+++||||+|+||+++.++.++++|||.+.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999998765 46899999999999999999999 8 99999999999999999999999999999876433222
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
. ....++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ..............
T Consensus 157 ~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~------------ 220 (264)
T cd06623 157 C--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICDGPP------------ 220 (264)
T ss_pred c--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhcCCC------------
Confidence 1 2345788999999998888999999999999999999999998764321 11111111100000
Q ss_pred hhhhHHHHH-HHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 919 DIHFVAKEQ-CVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...... ++..+.+++.+|+..+|++||++.|++++
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 001112 45679999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.78 Aligned_cols=268 Identities=22% Similarity=0.230 Sum_probs=199.2
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccC--CeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 756 (979)
++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999654 688999999864432 2233567899999999999999999998776 889999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++ +|.+++......+++.+++.++.|++.||+||| +++++|+||||+||++++++.+|++|||.+.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999974 998888776557899999999999999999999 9999999999999999999999999999998764332
Q ss_pred CcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC---cc-----c
Q 002021 837 QSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI---ST-----M 907 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~---~~-----~ 907 (979)
. ......++..|+|||.+.+. .++.++|+||+|+++|||++|+.||......+ ............ .. .
T Consensus 161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhcc
Confidence 1 12334578899999988654 46889999999999999999999987532211 111111000000 00 0
Q ss_pred hhhcccccCch---hhhhHHHHH-HHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 908 EVVDANLLSQE---DIHFVAKEQ-CVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 908 ~~~~~~~~~~~---~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........... ......+.. .+..+.+++.+|++.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000 000001111 35668899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.66 Aligned_cols=247 Identities=26% Similarity=0.338 Sum_probs=196.3
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
..|+..+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+++++.++|||++++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4577889999999999999954 4689999998864322 23356788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||++ |++.+++......+++..+..++.|++.|+.||| +.+|+||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9997 5777776655557899999999999999999999 999999999999999999999999999998765322
Q ss_pred cceecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 838 SMIQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
....++..|+|||.+. .+.++.++||||||+++|||++|+.||........ ..... ....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~~~~---~~~~-------- 231 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA---QNDS-------- 231 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HHHHh---cCCC--------
Confidence 2345788999999874 45688999999999999999999999864221110 00000 0000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
. ......++..+.+++.+||..+|++||++.+++.+.
T Consensus 232 ---~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 ---P---TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---C---CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 000122456689999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=280.82 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=197.3
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+.+....||.|..|.||+++. .+|..+|||.+.... .+..+++.....++..- .+|.||+.+|||.......+.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 344556799999999999955 568999999987653 33445566666665555 489999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
|. ..++..+.+.+..+++..+=++...+..||.||.+ +++|+|||+||+|||+|+.|++|+||||++-++....
T Consensus 173 Ms-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--- 246 (391)
T KOG0983|consen 173 MS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--- 246 (391)
T ss_pred HH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence 84 36677777777788888888999999999999997 8999999999999999999999999999998775332
Q ss_pred eecccccCCCCCCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 840 IQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
..+...|-+.|||||.+.. ..|.-++||||||+.++|+.||+.||..-...-..+........
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-------------- 312 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-------------- 312 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--------------
Confidence 2355678899999998864 46888999999999999999999999763222222222222111
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+....+++.+.+++..|++.|+.+||...++++|
T Consensus 313 ---P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 ---PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1111222367789999999999999999999999876
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.92 Aligned_cols=266 Identities=24% Similarity=0.273 Sum_probs=197.7
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
|+..+.||.|++|.||+|. ..+|+.||+|++.... ....+.+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 5667899999999999995 4579999999986543 223356788999999999999999999999999999999999
Q ss_pred CCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+ ++|.+++.... ..+++..+..++.|+++||+||| +++++||||+|+||++++++.++++|||.+........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 68998886643 46899999999999999999999 89999999999999999999999999999976532211
Q ss_pred eecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc-CCc--c---chhhc-
Q 002021 840 IQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-PIS--T---MEVVD- 911 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~--~---~~~~~- 911 (979)
......++..|+|||++.+. .++.++||||+|+++|||++|+.||........ .....+... +.. . ....+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchhh
Confidence 12334568899999987654 568899999999999999999999865322111 111111000 000 0 00000
Q ss_pred -ccccC-chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 -ANLLS-QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 -~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..... ............+..+.+++.+|++.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 0000001122344678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=302.44 Aligned_cols=263 Identities=21% Similarity=0.231 Sum_probs=194.9
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcC-CCCeeeEEEeeccC--CeeEEEEE
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIR-HRNLIKVISSCSNE--EFKALVLE 758 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E 758 (979)
|+..+.||+|+||.||+|. ..+++.||+|+++.... .......+|+.+++++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 4567889999999999995 45789999999865422 22233456888898885 99999999999877 88999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|++ +++.+++......+++.++..++.|++.||+||| +++++||||||+||+++. +.+||+|||.+.........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 997 5888888765567899999999999999999999 999999999999999999 99999999999866432221
Q ss_pred ceecccccCCCCCCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh---hccc-
Q 002021 839 MIQTQTLATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV---VDAN- 913 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 913 (979)
....++..|+|||.+. ++.++.++||||+||++|||++|..||...... ....+...........+ ....
T Consensus 156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2345788999999764 456788999999999999999999999653211 11111111111100000 0000
Q ss_pred -----ccCchh-hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 914 -----LLSQED-IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 914 -----~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...... .-......++.++.+++.+||+++|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 0001123457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=333.11 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=213.8
Q ss_pred hCCCCCCceeeeecceEEEEEEcC--------CCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeeeEEEeeccC
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG--------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIKVISSCSNE 750 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (979)
.++....+.+|+|+||.|++|... ....||||.++.... .+.+.+..|+++|+.+ +||||+.++|+|..+
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344456679999999999999532 145799999875543 4567899999999998 699999999999999
Q ss_pred CeeEEEEEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
+..++|+||+..|+|.+|++..+ ..++....+.++.|||.|++||+ +.+++|||+.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEe
Confidence 99999999999999999998776 44889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCccee-cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcch
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQ-TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 893 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~ 893 (979)
.++..+||+|||+|+.....+..... +...-+..|||||.+....|+.++|||||||++||++| |..||.+..... .
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-~ 530 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-E 530 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH-H
Confidence 99999999999999976554443322 21124667999999999999999999999999999999 888986521111 1
Q ss_pred HhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 894 LKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
+.++ -+.+.+...+..|+.+++++|..||+.+|++||++.|+++.+.....
T Consensus 531 l~~~------------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 531 LLEF------------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHH------------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1111 12333445667889999999999999999999999999999998543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=285.34 Aligned_cols=276 Identities=20% Similarity=0.254 Sum_probs=200.1
Q ss_pred CCCCCCceeeeecceEEEEEE-cC--C--CcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeecc-CCee
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LG--D--GMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEFK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~--~--~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 753 (979)
..|+....||+|.||.||+|. .. + ...+|+|+++...+ .......+|+..++.++|||++.++.+|.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 568888999999999999993 22 2 23789999975532 234567789999999999999999999877 8889
Q ss_pred EEEEEecCCCccceeeccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC----CcEEEEe
Q 002021 754 ALVLEYMPHGSLEKYLYSS----NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN----MVAHLSD 825 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~----~~~kl~D 825 (979)
++++||.+. +|.+.++-+ ...++...+..|+.||+.|+.||| +.-|+|||+||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 888777532 346888899999999999999999 9999999999999999866 9999999
Q ss_pred eccccccCCCCCcc-eecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccC-----cchHhHhh
Q 002021 826 FSIAKMLTGEDQSM-IQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNG-----EMTLKHWV 898 (979)
Q Consensus 826 fg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~-----~~~~~~~~ 898 (979)
+|+++.+..+-... .....+.|.+|.|||.+.+. .|+++.||||.|||+.||+|-.+-|...+.. .....+..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999886553332 33456789999999988775 6999999999999999999988776543211 11111111
Q ss_pred hhh--c----CCccchhhc------------ccccCchhh-h-hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 899 NDW--L----PISTMEVVD------------ANLLSQEDI-H-FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 899 ~~~--~----~~~~~~~~~------------~~~~~~~~~-~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
+.. . .+.+.++.. ......-.. + ......-++..++|+.+++++||-+|.|+.+++++--
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 100 0 000100000 000000000 0 0011112234789999999999999999999998754
Q ss_pred HhH
Q 002021 959 KIR 961 (979)
Q Consensus 959 ~~~ 961 (979)
--.
T Consensus 340 F~~ 342 (438)
T KOG0666|consen 340 FTE 342 (438)
T ss_pred ccc
Confidence 333
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.79 Aligned_cols=280 Identities=24% Similarity=0.304 Sum_probs=209.0
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC------ee
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------FK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 753 (979)
..|...+.||+|+||.||+|+ ..+|+.||||.++... .+..+...+|+++|++++|||||+++++-.+.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 346667899999999999996 6689999999997643 345677889999999999999999999865443 56
Q ss_pred EEEEEecCCCccceeeccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--CCC--cEEEEeec
Q 002021 754 ALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNM--VAHLSDFS 827 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~--~~~--~~kl~Dfg 827 (979)
.+|||||.+|+|...+.+. ...+++.+.+.++.+++.|+.||| +++|+||||||.||++- ++| .-||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 8999999999999999865 457999999999999999999999 99999999999999984 334 46999999
Q ss_pred cccccCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc-
Q 002021 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS- 905 (979)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~- 905 (979)
.|+...... .....+||..|.+||.... +.|+..+|.|||||++|+++||..||.............+....+..
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999874332 4577899999999999884 78999999999999999999999999865544332221111111111
Q ss_pred -cchhhcccccCchh--hhhHHHH----HHHHHHHHHHHhccccCcCCCC--CHHHHHHHHHHhHHhhccC
Q 002021 906 -TMEVVDANLLSQED--IHFVAKE----QCVSFVFNLAMECTMEFPKQRI--NAKEIVTKLLKIRDSLLRN 967 (979)
Q Consensus 906 -~~~~~~~~~~~~~~--~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rp--s~~eil~~L~~~~~~~~~~ 967 (979)
..-........... ...+.+. .....+-.++..++..+|++|. .+.+....+..|.+..+..
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvh 317 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVH 317 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeE
Confidence 11111111110100 0011111 1112244667778888999999 8888888888877755443
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=304.23 Aligned_cols=267 Identities=22% Similarity=0.242 Sum_probs=196.1
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCe-----
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEF----- 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 752 (979)
++|+..+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688889999999999999954 5789999998764432 23456788999999995 6999999998876655
Q ss_pred eEEEEEecCCCccceeeccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEEeec
Q 002021 753 KALVLEYMPHGSLEKYLYSS----NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFS 827 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfg 827 (979)
.++||||+++ ++.+++... ...+++..++.++.||+.||+||| +++|+||||||+||+++. ++.+|++|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 888887543 235799999999999999999999 999999999999999998 8999999999
Q ss_pred cccccCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc-C--
Q 002021 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-P-- 903 (979)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~-~-- 903 (979)
.+..+..... ......+++.|+|||++.+ ..++.++||||+|+++|||++|..||......+... ....... +
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHhCCCCh
Confidence 9876532211 1123356889999998765 457899999999999999999999986532211111 1100000 0
Q ss_pred Cccchhhcccc---c---CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 904 ISTMEVVDANL---L---SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 904 ~~~~~~~~~~~---~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.......+... . ..... ....+..+..+.+++.+|+.++|++||++.|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDL-SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhH-HHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000 0 00000 01112356778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=307.22 Aligned_cols=270 Identities=21% Similarity=0.260 Sum_probs=197.2
Q ss_pred CCCCCceeeeecceEEEEEEcC---CCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC--CeeE
Q 002021 683 GFSENNLIGRGGFGSVYKASLG---DGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKA 754 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 754 (979)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999653 57899999987632 33346678899999999999999999999887 8899
Q ss_pred EEEEecCCCccceeeccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC----CCcEEEEee
Q 002021 755 LVLEYMPHGSLEKYLYSS----NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDF 826 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~----~~~~kl~Df 826 (979)
+||||+++ ++.+++... ...+++..++.++.|++.|++||| +++|+||||||+||+++. ++.+|++||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666655322 236889999999999999999999 999999999999999999 999999999
Q ss_pred ccccccCCCCC-cceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCc--------chHhH
Q 002021 827 SIAKMLTGEDQ-SMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGE--------MTLKH 896 (979)
Q Consensus 827 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~--------~~~~~ 896 (979)
|++........ ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 1222344678899999987654 57899999999999999999999997543221 00111
Q ss_pred hhhhhcCC------------ccch---hhcccccCchhhhhHHH--HHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 897 WVNDWLPI------------STME---VVDANLLSQEDIHFVAK--EQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 897 ~~~~~~~~------------~~~~---~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+...... .... ................. ......+.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11100000 0000 00000000000001111 1345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=305.31 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=197.4
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
|+..+.||+|+||.||+|. ..++..||+|++.... .+..+.+..|+++++.++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 6677899999999999995 4578999999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+.+ ++.+.+......+++.++..++.|++.|+.||| +++|+||||+|+||+++.++.++++|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 975 787777665667899999999999999999999 999999999999999999999999999998754321
Q ss_pred eecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 840 IQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
....+++.|+|||++. .+.++.++|||||||++|||++|+.||....... ....+.....+
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~------------- 242 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP------------- 242 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhccCC-------------
Confidence 2345788999999873 4568899999999999999999999986531111 11111110000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
......++..+.+++.+||+.+|++||++.|+++++..
T Consensus 243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 00112344568999999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=297.18 Aligned_cols=252 Identities=28% Similarity=0.355 Sum_probs=204.8
Q ss_pred CCCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccC--CeeEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKALVL 757 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 757 (979)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+.+. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677789999999999999654 789999999865532 3467788999999999999999999999888 8899999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999987665 7899999999999999999999 89999999999999999999999999999987654332
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
........++..|+|||......++.++||||+|+++|++++|+.||...... .........
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~--------------- 218 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAALYKIGS--------------- 218 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHhccc---------------
Confidence 11123456888999999998888999999999999999999999998764311 110000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.......+...+..+.+++.+|++.+|.+||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 000011122335679999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=298.00 Aligned_cols=248 Identities=21% Similarity=0.245 Sum_probs=193.5
Q ss_pred HHHhhCCCCCCcee--eeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCe
Q 002021 677 LCRATDGFSENNLI--GRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF 752 (979)
Q Consensus 677 ~~~~~~~~~~~~~l--G~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (979)
.....++|++.+.+ |+|+||.||++. ..+++.+|+|.+....... .|+.....+ +|||++++++++..++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33344667776666 999999999994 4578899999986432111 133333323 69999999999999999
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEEeeccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFSIAKM 831 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg~~~~ 831 (979)
.++||||+++++|.+++.... .+++.++..++.|+++|++||| +.+++||||||+||+++.++ .++++|||.+..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999999987664 7899999999999999999999 99999999999999999988 999999999876
Q ss_pred cCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
.... ....++..|+|||++.+..++.++||||+|+++|||++|+.||............+......
T Consensus 160 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 225 (267)
T PHA03390 160 IGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-------- 225 (267)
T ss_pred cCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------
Confidence 5322 22357889999999988889999999999999999999999997543333222222211100
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-HHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-AKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~eil~~ 956 (979)
.......+++.+.+++.+|++.+|.+||+ ++|+++|
T Consensus 226 ---------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 ---------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00111235567899999999999999996 6998864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=282.09 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=201.7
Q ss_pred hhCCCCCC-ceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeecc----CCe
Q 002021 680 ATDGFSEN-NLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSN----EEF 752 (979)
Q Consensus 680 ~~~~~~~~-~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 752 (979)
.+++|.+. ++||-|-.|.|-.. ...+++.+|+|++... ...++|++.--.. .|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566543 67999999999988 5668999999998532 4456788775444 69999999998754 456
Q ss_pred eEEEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC---CCCcEEEEeecc
Q 002021 753 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFSI 828 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~Dfg~ 828 (979)
..+|||.|+||.|.+.+++++ ..+++.++..|++||+.|+.||| +..|+|||+||+|+|.. .+..+|++|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence 779999999999999998763 46999999999999999999999 99999999999999997 456799999999
Q ss_pred ccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccch
Q 002021 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908 (979)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (979)
|+.-.. .....+.+-|+.|.|||++...+|+...|+||+||++|-|++|..||+....... ..
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--------------sp 273 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------------SP 273 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--------------Ch
Confidence 997532 2334556789999999999999999999999999999999999999987433111 01
Q ss_pred hhcccc-cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 909 VVDANL-LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 909 ~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
-++.++ ........+++.+++.+..++|+..+..+|.+|.|+.|+++|
T Consensus 274 gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 274 GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 111111 111222335677888999999999999999999999999876
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=300.45 Aligned_cols=242 Identities=21% Similarity=0.273 Sum_probs=187.2
Q ss_pred eeeeecceEEEEEEc-CCCcEEEEEEeccccc---cchhcHHHHHHHHHh---cCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 689 LIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG---RAFKSFDVECEIMKS---IRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 689 ~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
.||+|+||.||+|.. .+++.||+|.+..... .....+.+|..+++. ..||+++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999954 5789999998864321 112233445444443 479999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+|+|.+++...+ .+++..+..++.|++.|++||| +++|+||||||+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 999998887654 5899999999999999999999 9999999999999999999999999999987543221 1
Q ss_pred cccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....|+..|+|||...+ ..++.++||||+||++|||++|+.||............ ..... .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~----------------~ 214 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTLT----------------V 214 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH--HHhhc----------------C
Confidence 23468999999998864 45789999999999999999999999754322111100 00000 0
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
....+..++.++.+++.+|+..||++|| +++|+++|
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011223456789999999999999999 69999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.35 Aligned_cols=267 Identities=21% Similarity=0.273 Sum_probs=199.9
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
+|+..+.||+|++|.||+|+. .+|+.||||++..... ...+.+.+|+++++.++|||++++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 477889999999999999965 4789999999875432 23456778999999999999999999999999999999999
Q ss_pred CCCccceeeccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 761 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 761 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
++ +|.+++.... ..+++..+..++.|++.|++||| +++++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8888876543 46899999999999999999999 99999999999999999999999999999975532211
Q ss_pred ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC---ccchhhc---
Q 002021 839 MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI---STMEVVD--- 911 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 911 (979)
......++..|+|||.+.+ ..++.++||||+|+++||+++|+.||......+ ............ ....+..
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChhhHHHHhcCch
Confidence 1233457889999998765 357889999999999999999999987543211 111111110000 0000000
Q ss_pred --ccccC-chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 --ANLLS-QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 --~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..... ...........++..+.+++.+|++.||.+||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 0000011112346778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=331.25 Aligned_cols=258 Identities=24% Similarity=0.305 Sum_probs=211.5
Q ss_pred HHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe
Q 002021 677 LCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF 752 (979)
Q Consensus 677 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (979)
+.-..++|++.+.||+|+||+|..++. .+++.+|+|++.+.. .....-|..|..+|..-..+=|+.++.+|+++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 334457899999999999999999954 578999999987631 2344678899999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.|+|||||+||+|...+.+.. .+++..++.++..|+.||+.+| +.|+|||||||+|||+|..|.+|++|||.+-.+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 999999999999999998877 8999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCCcceecccccCCCCCCccccC----C-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccc
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGR----E-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM 907 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 907 (979)
.. +........+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||+...-. ..+...+. .
T Consensus 226 ~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-eTY~KIm~---h---- 296 (1317)
T KOG0612|consen 226 DA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-ETYGKIMN---H---- 296 (1317)
T ss_pred CC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-HHHHHHhc---h----
Confidence 53 3455667789999999999874 3 67999999999999999999999999862111 11111111 1
Q ss_pred hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC---HHHHHHHH
Q 002021 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN---AKEIVTKL 957 (979)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~eil~~L 957 (979)
+....|+....++.++.+||.+.+.. |+.|.. +.|+..|-
T Consensus 297 ---------k~~l~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 297 ---------KESLSFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHP 339 (1317)
T ss_pred ---------hhhcCCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCc
Confidence 11122222234667789999998875 778887 99998874
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=302.45 Aligned_cols=248 Identities=26% Similarity=0.331 Sum_probs=201.4
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
+|+..+.||.|+||.||+|.. .+++.||+|++.... .+..+.+.+|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 477889999999999999965 468999999986432 1345678889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++++|.+++... ..+++.++..++.|+++|++||| +.+++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998765 46899999999999999999999 9999999999999999999999999999988654322
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .......... .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~-~-------------- 216 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQE-T-------------- 216 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhc-c--------------
Confidence 123455788999999998888999999999999999999999998753321 1111110000 0
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCH--HHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINA--KEIVT 955 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~--~eil~ 955 (979)
.....+...+..+.+++.+||+.||.+||++ +|+++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0011122345678999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=302.02 Aligned_cols=267 Identities=25% Similarity=0.289 Sum_probs=199.8
Q ss_pred CCCCceeeeecceEEEEEEcC-CCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC--CeeEEEEE
Q 002021 684 FSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKALVLE 758 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E 758 (979)
|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999654 58999999997653 23345678899999999999999999999887 88999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++ +|.+++......+++.+++.++.|+++|++||| +.+++|+||||+||++++++.+|++|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9975 888888766567899999999999999999999 89999999999999999999999999999987643321
Q ss_pred ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc---CCccchh-----
Q 002021 839 MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL---PISTMEV----- 909 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~----- 909 (979)
.......++..|+|||.+.+ ..+++++||||||+++|||++|+.||...... ........... .......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchh
Confidence 11233456788999997664 45789999999999999999999998753321 11111111000 0000000
Q ss_pred ---hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 ---VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..................++..+.+++.+||+.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000011111136779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=307.78 Aligned_cols=266 Identities=22% Similarity=0.319 Sum_probs=194.5
Q ss_pred ceeeee--cceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRG--GFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G--~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
..||+| +||+||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999954 579999999986432 22346788899999999999999999999999999999999999
Q ss_pred CccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc--
Q 002021 763 GSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM-- 839 (979)
Q Consensus 763 g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-- 839 (979)
+++.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999988764 235889999999999999999999 9999999999999999999999999998654332111110
Q ss_pred ---eecccccCCCCCCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc-CC-------cc
Q 002021 840 ---IQTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-PI-------ST 906 (979)
Q Consensus 840 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~-------~~ 906 (979)
......++..|+|||++.+. .+++++||||+||++|||++|+.||.................. +. ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 01112345679999998763 4789999999999999999999999764322111110000000 00 00
Q ss_pred chh-----------hccc-------ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 MEV-----------VDAN-------LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ~~~-----------~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... .+.. .......+......++..+.+++.+||+.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0000 0000111223344567889999999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=309.71 Aligned_cols=245 Identities=26% Similarity=0.408 Sum_probs=195.0
Q ss_pred CCceeeeecceEEEEE-EcCCCcEEEEEEec--c--ccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe--eEEEEE
Q 002021 686 ENNLIGRGGFGSVYKA-SLGDGMEVAVKVFT--S--QCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF--KALVLE 758 (979)
Q Consensus 686 ~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~E 758 (979)
....||+|+|-+|||| ...+|..||-=.++ . ...+..+.|..|+++|+.++||||+++++++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3467999999999999 44567777653221 1 123345789999999999999999999999876544 778999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEEeeccccccCCCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
.+..|+|..|..+.+ .++.+.+..|++||++||.|||. ...+|+|||||-+||+|+ ..|.|||+|.|+|........
T Consensus 124 L~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred cccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 999999999998775 68899999999999999999994 378999999999999998 678999999999998743322
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
...+|||.|||||+.. ..|.+.+||||||+++.||+|+.+||.+=.....-+++......|..+..+.
T Consensus 202 ----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~------- 269 (632)
T KOG0584|consen 202 ----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK------- 269 (632)
T ss_pred ----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC-------
Confidence 3478999999999875 7799999999999999999999999876333322233322222222233222
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+++.++|.+|+.. .++|||+.|++++
T Consensus 270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 -----------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 24588999999999 8999999999875
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=306.00 Aligned_cols=272 Identities=21% Similarity=0.283 Sum_probs=196.0
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEeeccCC------
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEE------ 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 751 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++...... ....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45788999999999999999954 57899999988644222 2334567999999999999999999886543
Q ss_pred --eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 752 --FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 752 --~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
..++||||+.+ ++.+++......+++.+++.++.|++.|++||| +++++|+||||+||+++.++.+||+|||.+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999964 888887766567899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCCc--ceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcc-hHhHhhhhhcCCc
Q 002021 830 KMLTGEDQS--MIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM-TLKHWVNDWLPIS 905 (979)
Q Consensus 830 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~ 905 (979)
......... .......++..|+|||.+.+. .+++++||||+|+++|||++|+.||........ .....+....+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 765432211 112234578899999987654 478899999999999999999999865321100 0000000000000
Q ss_pred ------cchhhcccccCchhh-hh---HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 ------TMEVVDANLLSQEDI-HF---VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 ------~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+..+......... .. .........+.+++.+|+..||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000000000 00 0001123557899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=304.78 Aligned_cols=253 Identities=26% Similarity=0.312 Sum_probs=193.3
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||++. ..+++.||+|++.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45566789999999999995 4568999999986543 233456788999999996 99999999999999999999999
Q ss_pred cCCCccceee---cc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 760 MPHGSLEKYL---YS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 760 ~~~g~L~~~l---~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
++. ++.++. .. ....+++..+..++.|++.|++|||+ +.+++||||||+||++++++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 554432 22 23468999999999999999999993 359999999999999999999999999999765432
Q ss_pred CCcceecccccCCCCCCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREG---RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.. .....++..|+|||.+.+. .++.++||||+||++|||++|+.||............ ...... +
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~-----~ 229 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ----VVKGDP-----P 229 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhh----hcCCCC-----C
Confidence 21 1334578899999998766 6889999999999999999999998653211001110 000000 0
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ....+..++.++.+++.+||+.+|++|||++|++++
T Consensus 230 ~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 IL------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cC------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 001112356679999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=309.68 Aligned_cols=274 Identities=23% Similarity=0.266 Sum_probs=200.6
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC-----Cee
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 753 (979)
.++|+..+.||+|+||.||+|. ..+|+.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4679999999999999999995 5578999999986432 22345677899999999999999999876543 357
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++|+||+++ ++.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999965 787776543 5899999999999999999999 9999999999999999999999999999997654
Q ss_pred CCCCc-ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh--
Q 002021 834 GEDQS-MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV-- 909 (979)
Q Consensus 834 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 909 (979)
..... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ......+ .........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~-~~~~~~~~~~~~~ 235 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLI-LGVLGTPSQEDLN 235 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH-HHHcCCCCHHHHH
Confidence 32211 11233467899999998654 5688999999999999999999999864211 1111111 11111110010
Q ss_pred --hcccc-------cCchhhh-hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH--HHHhHH
Q 002021 910 --VDANL-------LSQEDIH-FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK--LLKIRD 962 (979)
Q Consensus 910 --~~~~~-------~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~--L~~~~~ 962 (979)
.+... ....... .......+.++.+++.+||+.+|++|||+.|+++| +++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000 0000000 00112345678999999999999999999999998 665544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=298.96 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=199.2
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||+|.. .+|..||+|.+.... ....+.+.+|+++++.++|+|++++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 367788999999999999954 468899999986432 23445778899999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg~~~~~~~~~~ 837 (979)
+++++|.+++... ...+++..+..++.|+++|++||| +.+++|+||||+||++++++ .+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999998654 335799999999999999999999 99999999999999999875 569999999976543221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
......|++.|+|||+..+..++.++|+||+|+++||+++|+.||..... ..++..........
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~--------- 221 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQGYFAP--------- 221 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhcccCCC---------
Confidence 11234588899999999888899999999999999999999999864221 11111111100000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+..+.+++.+||..+|++|||+.|++++
T Consensus 222 ------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=299.85 Aligned_cols=244 Identities=23% Similarity=0.296 Sum_probs=192.9
Q ss_pred eeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 690 lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
||+|+||+||+|. ..+|+.||+|++.... ....+.+..|+++++.++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999994 5578999999986432 12234567899999999999999999999999999999999999999
Q ss_pred ceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceeccc
Q 002021 766 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844 (979)
Q Consensus 766 ~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 844 (979)
.+++.... ..+++..+..++.|++.|+.||| +++++||||+|+||++++++.++++|||.+...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence 99987653 36899999999999999999999 999999999999999999999999999998765321 112334
Q ss_pred ccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHH
Q 002021 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVA 924 (979)
Q Consensus 845 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (979)
.++..|+|||.+.++.++.++||||+|+++|+|++|+.||........ ......... . .....
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-------------~---~~~~~ 217 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTL-------------E---MAVEY 217 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhccc-------------c---ccccC
Confidence 578899999999888899999999999999999999999865322110 000000000 0 00011
Q ss_pred HHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 925 KEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 925 ~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
+..+++.+.+++.+||+.+|++|| ++.+++.|
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 123456789999999999999999 66667654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.35 Aligned_cols=272 Identities=25% Similarity=0.267 Sum_probs=200.6
Q ss_pred HhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCC----
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEE---- 751 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 751 (979)
...++|+..+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+++++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999999965 4689999999865432 23346778999999999999999999886654
Q ss_pred ------eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEe
Q 002021 752 ------FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 825 (979)
Q Consensus 752 ------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D 825 (979)
..++||||+++ ++.+++......+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 777777665557899999999999999999999 99999999999999999999999999
Q ss_pred eccccccCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhh---h
Q 002021 826 FSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND---W 901 (979)
Q Consensus 826 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~---~ 901 (979)
||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ......... .
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence 999986643221 11223346788999998754 45788999999999999999999998753211 111111110 0
Q ss_pred cCCccchhhcccccCc----h---hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 902 LPISTMEVVDANLLSQ----E---DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 902 ~~~~~~~~~~~~~~~~----~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+....++........ . .........++..+.+++.+||+.+|.+||++.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000000000 0 00001122356779999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.79 Aligned_cols=249 Identities=26% Similarity=0.351 Sum_probs=205.7
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
....|.+.+.||+|.|+.|..|+ ..++..||||.+.+..-. ....+.+|+++|+.++|||||+++.+...+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 45778999999999999999994 457999999999766432 234588999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+.+|.+.+|+...+. ..+..+..++.|+.+|++||| ++.|+|||+|++||+++.+..+||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc--
Confidence 999999999999988764 445889999999999999999 99999999999999999999999999999998752
Q ss_pred CcceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.......+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+...-.+.. +..+.
T Consensus 208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------~rvl~ 269 (596)
T KOG0586|consen 208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------PRVLR 269 (596)
T ss_pred -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------chhee
Confidence 223356789999999999987664 68999999999999999999999863211110 01111
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+ .-.+.....+..+++.+++..+|.+|++.+++.++
T Consensus 270 gk----~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GK----YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ee----ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11 11222334567899999999999999999999876
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=309.08 Aligned_cols=269 Identities=23% Similarity=0.283 Sum_probs=199.2
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeecc----CCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 753 (979)
.++|+..+.||+|+||.||+|. ..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3678889999999999999994 45799999999865422 234567789999999999999999998753 3568
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||+. ++|.+++.... .+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999996 58988886554 5899999999999999999999 9999999999999999999999999999997654
Q ss_pred CCCCc--ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 834 GEDQS--MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 834 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
..... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+ ............+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~-~~~~~~~g~~~~~~~ 236 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QL-KLILSVLGSPSEEVL 236 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HH-HHHHHHhCCChhHhh
Confidence 32211 11123468889999998765 468899999999999999999999996532111 01 000000000000000
Q ss_pred c----c-------cccCchhhh-hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 D----A-------NLLSQEDIH-FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~----~-------~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+ . ......... .......+.++.+++.+|++.+|++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 0 000000000 01112346779999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.46 Aligned_cols=266 Identities=20% Similarity=0.247 Sum_probs=195.4
Q ss_pred CceeeeecceEEEEEEcCCCcEEEEEEeccc--cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCc
Q 002021 687 NNLIGRGGFGSVYKASLGDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 764 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 764 (979)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455566666666655 7899999998654 23445678999999999999999999999999999999999999999
Q ss_pred cceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc-----
Q 002021 765 LEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS----- 838 (979)
Q Consensus 765 L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~----- 838 (979)
+.+++... ...+++..+..++.|++.|++||| +++|+||||||+||+++.++.+|++|||.+......+..
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99998754 345889999999999999999999 999999999999999999999999999998755322211
Q ss_pred ceecccccCCCCCCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC----Cccchhhcc
Q 002021 839 MIQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP----ISTMEVVDA 912 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 912 (979)
.......++..|+|||++.. ..++.++||||+||++|||++|+.||............. ....+ .........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-RGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hccCccccccCchhhhcC
Confidence 11123356778999998865 358899999999999999999999997543222111111 10000 000000000
Q ss_pred cc----------cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 913 NL----------LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 913 ~~----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.. ................++.+++.+||+.||++|||++|+++|-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00 0000111122234556789999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=297.57 Aligned_cols=266 Identities=22% Similarity=0.225 Sum_probs=202.2
Q ss_pred CCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 684 FSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
|+..+.||+|++|.||+|.. .+++.+|+|++...... ....+.+|++++++++||+++++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45678999999999999955 47899999998654322 3456788999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++ ++.+++......+++.++..++.|++.|++||| +++|+|+||||+||++++++.++++|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 888888776567899999999999999999999 9999999999999999999999999999998764332 11
Q ss_pred ecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC---Cccchhhc-----
Q 002021 841 QTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP---ISTMEVVD----- 911 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----- 911 (979)
.....++..|+|||.+.+. .++.++|+||+|+++|+++||+.||......+ .+......... .......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhhh
Confidence 2334577889999998776 78999999999999999999999986532211 11111100000 00000000
Q ss_pred -ccccCc-hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 -ANLLSQ-EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 -~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...... ..........++.++.+++.+||+.||.+||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 000011233567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.75 Aligned_cols=248 Identities=28% Similarity=0.390 Sum_probs=202.3
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|++++++++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 367789999999999999954 4688999999876543 3456788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|.+++... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998765 46899999999999999999999 999999999999999999999999999999876433221
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
.....++..|+|||...+..++.++||||+|+++|++++|+.||..... ......... ..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~-~~-------------- 215 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ-DD-------------- 215 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc-cC--------------
Confidence 2334678899999998877789999999999999999999999865321 111101000 00
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..++..+.+++.+|+..+|++||++.|++.+
T Consensus 216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 001112345668899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=295.73 Aligned_cols=243 Identities=26% Similarity=0.350 Sum_probs=195.0
Q ss_pred eeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 690 lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
||.|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999965 458999999986432 12346788999999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccc
Q 002021 766 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845 (979)
Q Consensus 766 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 845 (979)
.+++.+.. .+++..+..++.|++.|++||| +++++|+||+|+||+++.++.++++|||.+....... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99997653 5889999999999999999999 9999999999999999999999999999998764322 122346
Q ss_pred cCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHH
Q 002021 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925 (979)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (979)
++..|+|||.+.+..++.++|+||+|+++|++++|..||............ ... + ... ....+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~--------~----~~~--~~~~~ 216 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN---DIL--------K----GNG--KLEFP 216 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH---HHh--------c----cCC--CCCCC
Confidence 788999999988888999999999999999999999999764321111111 000 0 000 00111
Q ss_pred HHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 926 EQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 926 ~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
..++..+.+++.+||..+|++||+ ++|+++|
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 223567899999999999999999 7777663
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.91 Aligned_cols=249 Identities=26% Similarity=0.330 Sum_probs=203.2
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+++++.++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 467788999999999999955 4689999999875432 4456788899999999999999999999999999999999
Q ss_pred cCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 760 MPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 760 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
+++++|.+++... ...+++.++..++.+++.|++||| +.+++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998765 367999999999999999999999 8999999999999999999999999999998654332
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.......+++.|+|||...+..++.++|+||+|+++|+|++|+.||...... ............
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~--------- 221 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKILKGQYP--------- 221 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHHhcCCCC---------
Confidence 1223346788999999988888999999999999999999999998653211 111111000000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+..++..+.+++.+||..+|++||++.|++++
T Consensus 222 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 ------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0111345668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.02 Aligned_cols=276 Identities=22% Similarity=0.242 Sum_probs=203.6
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC-----Ce
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 752 (979)
...|...+.||+|+||.||+|. ..+++.||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3568889999999999999995 4578999999986432 22345667899999999999999999987543 35
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.++||||+. ++|.+++... ..+++..+..++.|++.|+.||| +++++||||||+||+++.++.+||+|||++...
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 6888887654 36899999999999999999999 999999999999999999999999999999865
Q ss_pred CCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC---Ccc--
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP---IST-- 906 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~---~~~-- 906 (979)
.... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ............. ...
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhh
Confidence 4322 11233457889999998765 4688999999999999999999999965321 1111111110000 000
Q ss_pred ------chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH--HHHhHHhh
Q 002021 907 ------MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK--LLKIRDSL 964 (979)
Q Consensus 907 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~--L~~~~~~~ 964 (979)
....+................++..+.+++.+|++.+|++|||++|+++| ++.+.+.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 00000000000000011123466789999999999999999999999999 76665443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=308.22 Aligned_cols=264 Identities=22% Similarity=0.243 Sum_probs=197.0
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC------
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------ 750 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 750 (979)
..+.|+..+.||+|+||.||+|. ..+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 34779999999999999999994 4578999999986432 22335567899999999999999999987543
Q ss_pred CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
...++||||+++ +|.+++... +++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+.
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 357999999964 888777543 889999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC--Cccc-
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP--ISTM- 907 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~--~~~~- 907 (979)
...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||...... ..+......... ....
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 167 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence 653221 123345788999999998889999999999999999999999998643211 111111000000 0000
Q ss_pred ----------------------hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 908 ----------------------EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 908 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+........... .......+..+.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDS--ESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCccc--ccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 00011345668999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=299.87 Aligned_cols=245 Identities=24% Similarity=0.288 Sum_probs=196.2
Q ss_pred CceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 687 NNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
...||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999954 57899999998654444456788899999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccc
Q 002021 766 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845 (979)
Q Consensus 766 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 845 (979)
.+++... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||.+........ ......
T Consensus 105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 177 (292)
T cd06657 105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 177 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence 9887543 5789999999999999999999 89999999999999999999999999999876532221 123346
Q ss_pred cCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHH
Q 002021 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925 (979)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (979)
++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... ..........+.. ....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~----------------~~~~ 239 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPK----------------LKNL 239 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcc----------------cCCc
Confidence 789999999998888899999999999999999999998642111 1111111000000 0011
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 926 EQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 926 ~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..++..+.+++.+||+.+|.+||++.|+++|
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1234568899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=298.39 Aligned_cols=268 Identities=22% Similarity=0.242 Sum_probs=195.9
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++|+..+.||+|++|.||+|.. .+|+.||+|++..... ...+.+.+|++++++++|||++++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688889999999999999964 4789999998864322 234567889999999999999999999999999999999
Q ss_pred ecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEEeeccccccCCCC
Q 002021 759 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 759 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfg~~~~~~~~~ 836 (979)
|++ +++.+++... ....++..+..++.||+.||+||| +++++||||+|+||++++ ++.+|++|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 4787776543 334678888999999999999999 999999999999999985 5679999999997653221
Q ss_pred CcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh-cC--Cccch---h
Q 002021 837 QSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW-LP--ISTME---V 909 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~-~~--~~~~~---~ 909 (979)
. ......+++.|+|||++.+. .++.++||||+|+++|+|+||+.||......+. ..+..... .+ ..+.. .
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhccccccc
Confidence 1 11334568899999987653 578899999999999999999999975322111 11110000 00 00000 0
Q ss_pred hcccc-cC--chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANL-LS--QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~-~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+... .. ............+.++.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00 0000001112345668999999999999999999999875
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=306.94 Aligned_cols=269 Identities=25% Similarity=0.313 Sum_probs=198.4
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccC--Cee
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE--EFK 753 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 753 (979)
..++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 346788889999999999999954 468899999885421 22345577899999999 999999999988643 468
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||++ ++|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5998888664 6789999999999999999999 9999999999999999999999999999998664
Q ss_pred CCCCc---ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCcc---
Q 002021 834 GEDQS---MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST--- 906 (979)
Q Consensus 834 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--- 906 (979)
..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~-~~~~~~~~~ 236 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIE-VIGPPSAED 236 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH-HhCCCCHHH
Confidence 33221 12233467899999998754 4578899999999999999999999865322111 111100 000000
Q ss_pred ---------chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 ---------MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+................++.++.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00010000000000001111256779999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=300.26 Aligned_cols=253 Identities=24% Similarity=0.296 Sum_probs=194.8
Q ss_pred hCCCCCCceeeeecceEEEEEEcC-CCcEEEEEEecccc-ccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 757 (979)
.++|+..+.||+|+||.||+|... +++.||||++.... ......+..|+.++.+.. ||||+++++++.++...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 366888899999999999999765 48999999986542 223345566777776664 999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
||++ +++.+++......+++..+..++.|++.|++||| + ++|+||||+|+||++++++.+||+|||.+..+....
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9985 4777766554557899999999999999999999 6 599999999999999999999999999987653222
Q ss_pred CcceecccccCCCCCCccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGR----VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..................+.
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 238 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-------- 238 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC--------
Confidence 1 12335778999999986543 78899999999999999999999865322111111111110000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
......++.++.+++.+||..||.+||++.+++++-
T Consensus 239 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 ---------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 000012456689999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=321.62 Aligned_cols=272 Identities=17% Similarity=0.180 Sum_probs=189.7
Q ss_pred hhCCCCCCceeeeecceEEEEEEcC--CCcEEEEEEe--------------cc---ccccchhcHHHHHHHHHhcCCCCe
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLG--DGMEVAVKVF--------------TS---QCGRAFKSFDVECEIMKSIRHRNL 740 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~ni 740 (979)
..++|++.+.||+|+||+||++... ++..+++|.+ .+ ........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999998542 2222222211 00 111233567889999999999999
Q ss_pred eeEEEeeccCCeeEEEEEecCCCccceeeccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC
Q 002021 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSS----NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 816 (979)
Q Consensus 741 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~ 816 (979)
+++++++.+++..|+|+|++. +++.+++... .......++..++.|++.||+||| +++|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 999999999999999999985 4777766443 122346678889999999999999 99999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCC-CcccccC-cchH
Q 002021 817 DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP-TDEIFNG-EMTL 894 (979)
Q Consensus 817 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P-~~~~~~~-~~~~ 894 (979)
.++.+||+|||++..+..... .......||..|+|||++.+..++.++|||||||++|||++|..| +...... ...+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987643222 122345789999999999988999999999999999999998764 4322111 1111
Q ss_pred hHhhhhh------cCCcc---chhhcccccC-ch--hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 895 KHWVNDW------LPIST---MEVVDANLLS-QE--DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 895 ~~~~~~~------~~~~~---~~~~~~~~~~-~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+.+... .+... .+.++..... .. ..........+..+.+++.+|++.||.+|||+.|+++|
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111111 00000 0000000000 00 00011111234567889999999999999999999976
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=254.31 Aligned_cols=266 Identities=24% Similarity=0.263 Sum_probs=201.6
Q ss_pred CCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..++||+|.||+||+| .+.+++.||+|+++-.. +.......+|+-+++.++|.|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566689999999999999 46678999999987543 33456788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
|+. +|..|.......++.+.++.++.|+++|+.++| ++.+.|||+||+|.+|+.+|+.|++|||+++..+-+-..
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc- 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC- 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-
Confidence 965 888888777778999999999999999999999 999999999999999999999999999999876544322
Q ss_pred eecccccCCCCCCccccCCCC-CCCchhHHHHHHHHHHHHcCCCC-CcccccCcchHhHh--hhhhc-CCcc---chhhc
Q 002021 840 IQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKP-TDEIFNGEMTLKHW--VNDWL-PIST---MEVVD 911 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~P-~~~~~~~~~~~~~~--~~~~~-~~~~---~~~~~ 911 (979)
.+..+.|.+|.+|.++.+.. |+...|+||-||++.|+.....| |... +...+.... +-... .+++ ....|
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 35567899999999988865 88999999999999999984444 4331 112222211 11111 1111 11222
Q ss_pred ccccCchhhhhHHHHHHH----HHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCV----SFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~----~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....... .....+.+.. ..-.+++++.+.-+|.+|.++++.++|
T Consensus 236 yk~yp~y-pattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIY-PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCc-cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111110 0111222222 235789999999999999999998875
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=294.24 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=197.2
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-----ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC--Cee
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-----GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 753 (979)
.+|+..+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468889999999999999995 4568999999875321 22345788899999999999999999988653 567
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||+++++|.+++.... .+++..+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999987644 4789999999999999999999 9999999999999999999999999999997653
Q ss_pred CCCC-cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 834 GEDQ-SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 834 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.... ........++..|+|||.+.+..++.++|+|||||++||+++|+.||....... ...+. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~----~~~-------- 224 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKI----ATQ-------- 224 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHH----HcC--------
Confidence 2111 111123457889999999988888999999999999999999999986531111 11110 000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+...+.....++.+++.+||+ +|.+||++.+++.|
T Consensus 225 ------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 225 ------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00011123455678999999999 47999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-33 Score=298.54 Aligned_cols=245 Identities=23% Similarity=0.327 Sum_probs=204.5
Q ss_pred CceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCC
Q 002021 687 NNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 763 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 763 (979)
.+.||.|.||+||-|. ..+|+.||||++.+.. .+.....++|+.|++.+.||.||.+-..|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 3689999999999994 4589999999986543 344577899999999999999999999999999999999999776
Q ss_pred ccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEEeeccccccCCCCCcce
Q 002021 764 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 764 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
-|+-.+...+.++++.....++.||+.||.||| .++|+|+|+||+|||+.+. -++||||||+|+.++... .
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence 666666667788999999999999999999999 9999999999999999754 479999999999985332 2
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....+||+.|.|||++.+..|...-||||.|||+|--++|..||.+.++-..++... ..-+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA-------------------aFMy 783 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA-------------------AFMY 783 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc-------------------cccc
Confidence 356789999999999999999999999999999999999999997644333332221 1122
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+.++.++++++|...++..-++|-|.+..+.|
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 233455677889999999999999999998877654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=294.53 Aligned_cols=247 Identities=26% Similarity=0.338 Sum_probs=201.5
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+|+..+.||+|+||.||+|. ..+++.+|+|++.... ......+.+|+++++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 46778899999999999994 5578899999986542 23345677899999999999999999999999999999999
Q ss_pred cCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 760 MPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 760 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
+++++|.+++.+. ...+++..++.++.|++.|++||| +.+++|+||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 346899999999999999999999 999999999999999999999999999999876433
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
......++..|+|||.+.+..++.++|+||+|+++||+++|+.||...... .+...+.. ...
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~------------~~~- 218 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR------------GKY- 218 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc------------CCC-
Confidence 123345788999999998888999999999999999999999998653211 11111000 000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+..++.++.+++.+|++.+|.+||++.|++++
T Consensus 219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 -----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01112445678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=297.96 Aligned_cols=259 Identities=18% Similarity=0.239 Sum_probs=183.1
Q ss_pred hCCCCCCceeeeecceEEEEEEcCC----CcEEEEEEeccccccch-----------hcHHHHHHHHHhcCCCCeeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGD----GMEVAVKVFTSQCGRAF-----------KSFDVECEIMKSIRHRNLIKVIS 745 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 745 (979)
.+.|++.+.||+|+||.||+|...+ +..+|+|+......... .....+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3678999999999999999996543 45667775432221110 01112333455668999999999
Q ss_pred eeccCC----eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 002021 746 SCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821 (979)
Q Consensus 746 ~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~ 821 (979)
++.... ..++++|++.. ++.+.+... ...++..+..++.|++.|++||| +++|+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence 765433 34677887643 555544432 23577888999999999999999 9999999999999999999999
Q ss_pred EEEeeccccccCCCCCc-----ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhH
Q 002021 822 HLSDFSIAKMLTGEDQS-----MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 896 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~ 896 (979)
+|+|||+++.+...... .......||+.|+|||+..+..++.++||||+||++|||++|+.||............
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999866422211 1112346899999999999999999999999999999999999999764322211111
Q ss_pred hhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 897 WVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
...+.. .. . .. .......++..+.+++..|++.+|++||+++++++.+
T Consensus 246 ~~~~~~--------~~-~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDFI--------KR-L-HE---GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHH--------HH-h-hh---hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 100000 00 0 00 0001224567799999999999999999999998865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-33 Score=322.98 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=186.6
Q ss_pred HhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC------
Q 002021 679 RATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------ 750 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 750 (979)
+...+|+..+.||+||||.||+++ .-||+.+|||++.... ......+.+|+..+++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 445678888999999999999995 3499999999987543 34456688899999999999999998432110
Q ss_pred --------------------------------------------------------------------------------
Q 002021 751 -------------------------------------------------------------------------------- 750 (979)
Q Consensus 751 -------------------------------------------------------------------------------- 750 (979)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 002021 751 ---------------------------------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797 (979)
Q Consensus 751 ---------------------------------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 797 (979)
-..||-||||+..++.+++++....-.....++++.+|++||+|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH- 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH- 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence 1245678888876666666655322246778999999999999999
Q ss_pred CCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC----------------CCCCcceecccccCCCCCCccccCCC--
Q 002021 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT----------------GEDQSMIQTQTLATIGYMAPEYGREG-- 859 (979)
Q Consensus 798 ~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~-- 859 (979)
+.|||||||||.||++|++..|||+|||+|+... ........+..+||.-|+|||++.+.
T Consensus 715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9999999999999999999999999999998721 00111244667899999999998764
Q ss_pred -CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHh
Q 002021 860 -RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAME 938 (979)
Q Consensus 860 -~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 938 (979)
.|+.|+||||+|||++||+. ||....+--..+........+.. ....+ ...+.-..+|+.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~---------------~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFD---------------PEHPEEASLIRW 853 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccc---------------ccchHHHHHHHH
Confidence 49999999999999999984 45431111111111111111111 11111 112335678999
Q ss_pred ccccCcCCCCCHHHHHH
Q 002021 939 CTMEFPKQRINAKEIVT 955 (979)
Q Consensus 939 cl~~dP~~Rps~~eil~ 955 (979)
+++.||.+||||.|+++
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999986
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=294.04 Aligned_cols=242 Identities=22% Similarity=0.287 Sum_probs=186.9
Q ss_pred eeeeecceEEEEEEc-CCCcEEEEEEecccccc---chhcHHHHHHH---HHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 689 LIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR---AFKSFDVECEI---MKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 689 ~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
.||+|+||.||+|.. .+++.||+|.+...... ....+..|..+ ++...||+|+++++++.+++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999954 56899999988653211 11223344443 444579999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+|+|.+++... ..+++.++..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 99999888654 36899999999999999999999 9999999999999999999999999999987653221 1
Q ss_pred cccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||.............. ... .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~----------------~ 214 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLT----------------M 214 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH--hhc----------------c
Confidence 234689999999998754 588999999999999999999999976322111110000 000 0
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
....+..++..+.+++.+|+..+|.+|| ++.|++++
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0011122356789999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=293.80 Aligned_cols=265 Identities=23% Similarity=0.268 Sum_probs=196.3
Q ss_pred CCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccc--cchhcHHHHHHHHHhc---CCCCeeeEEEeeccCCe-----
Q 002021 684 FSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCG--RAFKSFDVECEIMKSI---RHRNLIKVISSCSNEEF----- 752 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 752 (979)
|+..+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999765 589999999874422 2234566788877766 59999999999987766
Q ss_pred eEEEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
.+++|||+.+ +|.+++.... ..+++..++.++.|++.|++||| +++++|+||+|+||+++.++.+|++|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8888876543 36899999999999999999999 99999999999999999999999999999977
Q ss_pred cCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh-
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV- 910 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~- 910 (979)
+..... .....++..|+|||++.+..++.++|+||+||++|||++|+.||...... .....+.............
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence 643221 12335788999999998888999999999999999999999998753221 1222222111100000000
Q ss_pred ----cccccCch-h-hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 ----DANLLSQE-D-IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ----~~~~~~~~-~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........ . .........+..+.+++.+||+.||.+||++.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 0 0011112345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=304.06 Aligned_cols=273 Identities=25% Similarity=0.275 Sum_probs=205.2
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC-----eeE
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-----FKA 754 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 754 (979)
+|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 477889999999999999965 458999999987543 334567888999999999999999999987765 789
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||++ ++|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.++++|||.+.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 48888886654 7899999999999999999999 99999999999999999999999999999987643
Q ss_pred CCC-cceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc-------
Q 002021 835 EDQ-SMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS------- 905 (979)
Q Consensus 835 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~------- 905 (979)
... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+ .+.. +.......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~-i~~~~~~~~~~~~~~ 233 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNL-IVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHH-HHHhcCCCChhHhhh
Confidence 321 0112344678899999998877 78999999999999999999999997543211 0111 11100000
Q ss_pred -----cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH--HHHhHH
Q 002021 906 -----TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK--LLKIRD 962 (979)
Q Consensus 906 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~--L~~~~~ 962 (979)
..+....................+..+.+++.+||+.+|.+||++.+++.+ ++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000000000001112346778999999999999999999999987 555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=297.52 Aligned_cols=243 Identities=28% Similarity=0.349 Sum_probs=193.0
Q ss_pred eeeecceEEEEEEcC-CCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 690 IGRGGFGSVYKASLG-DGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 690 lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999665 599999999865432 3456788899999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC------cc
Q 002021 766 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ------SM 839 (979)
Q Consensus 766 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~------~~ 839 (979)
.+++...+ .+++..+..++.|+++||+||| +.+++||||+|+||++++++.++++|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99987654 6899999999999999999999 99999999999999999999999999999876432211 11
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
......++..|+|||......++.++||||||+++||+++|+.||......+ .... ... ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~---~~~--------------~~ 217 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--IFQN---ILN--------------GK 217 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH---Hhc--------------CC
Confidence 2234467889999999988888999999999999999999999986532111 1100 000 00
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVT 955 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~ 955 (979)
...+.....+..+.+++.+||+.+|.+|||+.++.+
T Consensus 218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 000111113567899999999999999999944443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-34 Score=277.75 Aligned_cols=273 Identities=20% Similarity=0.269 Sum_probs=203.1
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeecc--------C
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSN--------E 750 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 750 (979)
+.|+...+||+|.||+||+| ...+|+.||+|++-...+ .......+|++++..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666789999999999999 455788899987644322 234556789999999999999999998843 3
Q ss_pred CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
..+|+||++|+. +|...+.+...+++..++.+++.++..||.|+| ...|+|||+|+.|+||+.++.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 458999999987 999999888788999999999999999999999 9999999999999999999999999999997
Q ss_pred ccCCCCC--cceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc--hHhHhhhhhcCCc
Q 002021 831 MLTGEDQ--SMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM--TLKHWVNDWLPIS 905 (979)
Q Consensus 831 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~--~~~~~~~~~~~~~ 905 (979)
.+..++. ....+.++.|.+|.+||.+.+ ..|+++.|||+-|||+.||+||.+-+....+.+. .+........++-
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 6543332 223456778999999998765 5799999999999999999999987765332211 1112222222222
Q ss_pred cchhhcccccCch------hhhhHHHHHH------HHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 906 TMEVVDANLLSQE------DIHFVAKEQC------VSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 906 ~~~~~~~~~~~~~------~~~~~~~~~~------~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
+.++....+.... ....-.-++. .++..+++.+++..||.+|+++++++.|--
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 2222211111000 0000000111 246889999999999999999999987643
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=304.01 Aligned_cols=267 Identities=22% Similarity=0.293 Sum_probs=196.2
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC------C
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------E 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 751 (979)
.++|...+.||+|+||.||+|. ..+|+.||||++.... ......+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 3678889999999999999996 4578999999986532 22235678899999999999999999988654 3
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..++|+||+.. ++.++.. ..+++..+..++.|++.|++||| +++++||||||+||+++.++.+|++|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46899999964 6665542 25889999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc---cc
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS---TM 907 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---~~ 907 (979)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+...... .+.. ..
T Consensus 167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~ 239 (342)
T cd07879 167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV-TGVPGPEFV 239 (342)
T ss_pred CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCCCHHHH
Confidence 4321 123456888999998876 458899999999999999999999997532111 11111100 0000 00
Q ss_pred hhhcc----------cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH--HHHhHH
Q 002021 908 EVVDA----------NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK--LLKIRD 962 (979)
Q Consensus 908 ~~~~~----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~--L~~~~~ 962 (979)
+.... ........ .......+..+.+++.+||+.||++||++.|++.| ++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhcccchHHHHhhcCCcccchH-HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 00000000 00111345668899999999999999999999987 666654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=300.88 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=195.5
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+++++.++|+|++++++++..+...++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 356668899999999999954 568899999886421 2234567789999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+. |++.+++......+++.++..++.|++.|++||| +++++||||||+||+++.++.++++|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 5887777655556899999999999999999999 999999999999999999999999999998765322
Q ss_pred ceecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 839 MIQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
....++..|+|||.+. .+.++.++||||+||++|||++|+.||....... ....+.....+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~------------ 232 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP------------ 232 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCCC------------
Confidence 2345788999999874 3567889999999999999999999986521111 11111110000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
......++..+.+++.+||..+|++||++.+++++..
T Consensus 233 ------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 ------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0011234566889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=292.99 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=187.0
Q ss_pred ceeeeecceEEEEEEc-CCCcEEEEEEeccccc---cchhcHHHHHHHHH-hcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG---RAFKSFDVECEIMK-SIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.. .+|+.||||++..... .....+..|..++. ..+|||++++++++.+++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999954 5689999999864321 12233445555443 45899999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.++++|||.+..... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999987643 5889999999999999999999 99999999999999999999999999999875422 12
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...++..|+|||.+.+..++.++||||+|+++||+++|..||......+ ......... . ....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-------------~---~~~~ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRR-------------I---NWPE 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcc-------------c---CCCC
Confidence 3457889999999988888999999999999999999999986532111 011000000 0 0000
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHH---HHHHH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAK---EIVTK 956 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~---eil~~ 956 (979)
.....++..+.+++.+||+.+|++||++. |+++|
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11124567799999999999999999664 55544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=298.65 Aligned_cols=244 Identities=25% Similarity=0.319 Sum_probs=193.3
Q ss_pred CCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 684 FSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
|...+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999954 5789999999864322 2335677899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+. |++.+++......+++.++..++.|++.|++||| +++++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 5787877666667899999999999999999999 99999999999999999999999999999864321
Q ss_pred eecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 840 IQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.....++..|+|||++. .+.++.++|||||||++|||++|..||........ ...... ... +
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~---~~~-----~---- 238 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ---NDS-----P---- 238 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHh---cCC-----C----
Confidence 12346788999999874 45688899999999999999999999865321111 110000 000 0
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......++..+.+++.+||+.+|.+||++.|++++
T Consensus 239 -----~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 -----TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011233458899999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=300.03 Aligned_cols=265 Identities=25% Similarity=0.319 Sum_probs=198.1
Q ss_pred HhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeecc-CCeeE
Q 002021 679 RATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEFKA 754 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 754 (979)
..+++|+..+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+++++.++|||++++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 456889999999999999999994 5689999999885432 2234667889999999999999999998865 56789
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||+|+||++++++.++++|||.+.....
T Consensus 87 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 999999 56888877643 4788889999999999999999 99999999999999999999999999999875422
Q ss_pred CCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHh-----------Hhhhhhc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK-----------HWVNDWL 902 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~-----------~~~~~~~ 902 (979)
. .....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||....... ... ++.....
T Consensus 161 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 161 Q-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred C-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhcc
Confidence 1 123356788999998765 568899999999999999999999986532210 010 1111110
Q ss_pred CCccchhhcccccCchhhhh-HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 903 PISTMEVVDANLLSQEDIHF-VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....++... ......... .....++..+.+++.+|++.+|++||++.|++.+
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000011000 000000000 0112345679999999999999999999999887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=301.79 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=197.1
Q ss_pred HhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC----
Q 002021 679 RATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE---- 751 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 751 (979)
...++|+..+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+++++.++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 345789999999999999999994 5679999999985432 223356778999999999999999999886543
Q ss_pred --eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 752 --FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 752 --~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
..++||||+ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||||+||+++.++.++++|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 67888887643 5899999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC-----
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP----- 903 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~----- 903 (979)
...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||....... ...........
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 765321 123456889999998865 457889999999999999999999987532111 11111110000
Q ss_pred ------Cccchhhccc-ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 904 ------ISTMEVVDAN-LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 904 ------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.......... ...... .......++..+.+++.+|+..||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKD-FRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHhhcchhHHHHHHhccccCcch-HHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 000000 001123456678999999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=300.52 Aligned_cols=269 Identities=21% Similarity=0.225 Sum_probs=195.8
Q ss_pred CCCC-CCceeeeecceEEEEEE-cCCCcEEEEEEeccccccc--------------hhcHHHHHHHHHhcCCCCeeeEEE
Q 002021 682 DGFS-ENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRA--------------FKSFDVECEIMKSIRHRNLIKVIS 745 (979)
Q Consensus 682 ~~~~-~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 745 (979)
+.|. ..+.||+|+||.||+|. ..+++.||||++....... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 35679999999999995 4578999999986432211 124678999999999999999999
Q ss_pred eeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEe
Q 002021 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 825 (979)
Q Consensus 746 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D 825 (979)
++..++..++||||++ |+|.+++... ..+++..+..++.|++.|++||| +++++||||+|+||+++.++.++++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999997 5898888653 35899999999999999999999 99999999999999999999999999
Q ss_pred eccccccCCCC------------CcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcc
Q 002021 826 FSIAKMLTGED------------QSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 892 (979)
Q Consensus 826 fg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~ 892 (979)
||.+....... .........++..|+|||.+.+. .++.++||||+||++|||++|+.||......+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~- 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID- 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 99997654111 01111233467889999988764 46889999999999999999999987532211
Q ss_pred hHhHhhhhh---cCCccchhhc-----ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 893 TLKHWVNDW---LPISTMEVVD-----ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 893 ~~~~~~~~~---~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+....... ....+....+ +...............++.++.+++.+|++.+|++||+++|++.+
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 111111100 0000000000 000000000001112345678999999999999999999999874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=293.25 Aligned_cols=265 Identities=20% Similarity=0.219 Sum_probs=195.5
Q ss_pred CCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccc-cchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEEEec
Q 002021 684 FSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
|+..+.||+|+||.||+|... +++.||||++..... .......+|+..+++++ |||++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999664 578999999865432 12233456899999999 999999999999999999999999
Q ss_pred CCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+|+|.+++.... ..+++.++..++.|++.+++||| +++++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 779988887653 56899999999999999999999 99999999999999999999999999999986543221
Q ss_pred eecccccCCCCCCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchH--hHhhhhhcCCccc------hhh
Q 002021 840 IQTQTLATIGYMAPEYGR-EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL--KHWVNDWLPISTM------EVV 910 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~--~~~~~~~~~~~~~------~~~ 910 (979)
.....++..|+|||.+. ...++.++|+||||+++|||++|+.||......+... ..+.......... ...
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 13345788999999874 4457899999999999999999999986532211100 0000000000000 000
Q ss_pred cccccC--chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DANLLS--QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+..... .... .......+..+.+++.+||+.+|++|||++|++.+
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 0000 00111224678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=298.34 Aligned_cols=271 Identities=21% Similarity=0.242 Sum_probs=196.0
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccC-------
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNE------- 750 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 750 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999954 5689999998864422 2234677899999999999999999977443
Q ss_pred -CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 751 -EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 751 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
...++||||+++ ++.+.+......+++.++..++.|+++||+||| +++|+||||||+||++++++.++++|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999965 677777665567999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCcc---------eecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhh
Q 002021 830 KMLTGEDQSM---------IQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 899 (979)
Q Consensus 830 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~ 899 (979)
.......... ......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||....... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 7654222111 11233567889999987654 57899999999999999999999986432211 1111100
Q ss_pred hh---cCCcc------chhhcccccC-chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 900 DW---LPIST------MEVVDANLLS-QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 900 ~~---~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. .+... ....+..... ...............+.+++.+|++.+|++|||+.|++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00 00000 0000000000 0000001112233668899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=303.42 Aligned_cols=268 Identities=21% Similarity=0.248 Sum_probs=194.7
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccC----------
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNE---------- 750 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 750 (979)
.+|...+.||+|+||.||+|. ..+|+.||+|++........+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 678889999999999999994 457899999998655445556788899999999999999999876543
Q ss_pred ----CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEEe
Q 002021 751 ----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSD 825 (979)
Q Consensus 751 ----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~D 825 (979)
...++||||++ ++|.+++... .+++..+..++.|++.|++||| +++|+||||||+||+++ +++.+|++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 5888877543 5889999999999999999999 99999999999999998 556789999
Q ss_pred eccccccCCCCCc-ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC
Q 002021 826 FSIAKMLTGEDQS-MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 903 (979)
Q Consensus 826 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 903 (979)
||.+......... .......++..|+|||.+.. ..++.++||||+||++|||++|+.||......+. ..........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCC
Confidence 9999765322111 11123357889999997654 5678899999999999999999999965322111 1111110000
Q ss_pred Ccc---chh---hccc----ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 904 IST---MEV---VDAN----LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 904 ~~~---~~~---~~~~----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... ... .... .................++.+++.+|++.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 000 0000 0000000001112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=294.84 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=201.7
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 756 (979)
++|...+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3678889999999999999954 479999999986532 223466788999999998 99999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++.... .+++..+..++.|++.|++||| +++++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999987654 6999999999999999999999 9999999999999999999999999999998654332
Q ss_pred Cc------------------ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhh
Q 002021 837 QS------------------MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 898 (979)
Q Consensus 837 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~ 898 (979)
.. .......++..|+|||......++.++||||+|++++++++|+.||...... ..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~ 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQKIL 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHH
Confidence 11 1223345788999999988888999999999999999999999998753211 0111100
Q ss_pred hhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH----HHHHHH
Q 002021 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA----KEIVTK 956 (979)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~----~eil~~ 956 (979)
. .....+...+..+.+++.+||+.+|.+||++ .|+++|
T Consensus 236 ------------~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 236 ------------K--------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ------------h--------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0 0000112235568999999999999999999 887764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=292.24 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=196.2
Q ss_pred CCCCCceeeeecceEEEEEEc----CCCcEEEEEEecccc----ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCee
Q 002021 683 GFSENNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQC----GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (979)
+|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++++.+ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999964 478999999986532 12335678899999999 599999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999987653 5788999999999999999999 9999999999999999999999999999997653
Q ss_pred CCCCcceecccccCCCCCCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
.... .......++..|+|||.+... .++.++||||+|+++|+|++|+.||...... .....+.......
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~------- 227 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKS------- 227 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhcc-------
Confidence 2221 112234578899999998653 4678999999999999999999998632111 1111111100000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
..+.+..++..+.+++.+|++.+|++|| ++.+++.+
T Consensus 228 ---------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ---------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0001123456688999999999999997 77888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-34 Score=278.59 Aligned_cols=253 Identities=27% Similarity=0.284 Sum_probs=195.1
Q ss_pred CCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccc-cchhcHHHHHHH-HHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCG-RAFKSFDVECEI-MKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.+....||.|+||+|+|- ....|+.+|||+++.... .+.+++..|.+. ++.-++|+||+++|++..++..++.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 334468999999999998 556899999999987654 455677778776 55557999999999999999999999999
Q ss_pred CCCccceeecc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 761 PHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 761 ~~g~L~~~l~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
+- +++.+... .+..+++...-+|....+.||+||.+ +..|+|||+||+|||+|..|.+|+||||.+-.+.
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv--- 219 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV--- 219 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH---
Confidence 54 66554322 24568888888899999999999997 7899999999999999999999999999997653
Q ss_pred CcceecccccCCCCCCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.+...+..+|-..|||||.+... .|.-++||||+|+++||+.||..||......-+++.+.+....+.-.. +.
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~---~~-- 294 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF---DK-- 294 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC---cc--
Confidence 23445667888999999988643 488899999999999999999999876433222222222222211100 00
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....++..+..++.-|+.+|-.+||+..+++++
T Consensus 295 ---------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ---------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 011344568899999999999999999998764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=299.84 Aligned_cols=271 Identities=22% Similarity=0.268 Sum_probs=199.1
Q ss_pred HHHHHHhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC
Q 002021 674 YLELCRATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE 750 (979)
Q Consensus 674 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 750 (979)
..++....++|+..+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34555677899999999999999999994 4678999999986532 12245677899999999999999999987532
Q ss_pred ------CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEE
Q 002021 751 ------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 824 (979)
Q Consensus 751 ------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~ 824 (979)
...++++|++ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||||+||++++++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEe
Confidence 3467888887 77898877543 5899999999999999999999 9999999999999999999999999
Q ss_pred eeccccccCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc-
Q 002021 825 DFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL- 902 (979)
Q Consensus 825 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~- 902 (979)
|||++...... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ...........
T Consensus 163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~ 236 (345)
T cd07877 163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGT 236 (345)
T ss_pred ccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence 99998764221 123467889999998765 46788999999999999999999998643211 11111111000
Q ss_pred -CCccc-hhhcc-------cccCchhhhh-HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 903 -PISTM-EVVDA-------NLLSQEDIHF-VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 903 -~~~~~-~~~~~-------~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+.... .+.+. .........+ ......++++.+++.+|++.||.+||++.|++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 00000 0000000000 0011245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=291.75 Aligned_cols=266 Identities=26% Similarity=0.262 Sum_probs=199.1
Q ss_pred CCCCceeeeecceEEEEEEcC-CCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 684 FSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
|+..+.||+|+||.||+|... +++.||+|++.... ....+.+..|+++++.++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999654 58999999987653 233456778999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
+ ++|.+++......+++..+..++.|++.|++||| +.+|+||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 7 5899999876457999999999999999999999 89999999999999999999999999999986543322 1
Q ss_pred ecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhh---hcCCccchhh-----c
Q 002021 841 QTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND---WLPISTMEVV-----D 911 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~---~~~~~~~~~~-----~ 911 (979)
.....++..|+|||.+.+. .++.++||||+|+++||+++|+.||......+. ....... .......... +
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHHHHhhccccccc
Confidence 2334457789999998766 789999999999999999999999865321110 0000000 0000000000 0
Q ss_pred ccccCchh-hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 ANLLSQED-IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........ .........+..+.+++.+||..+|++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 0000111235679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-33 Score=288.13 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=202.6
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccc--ccc-----chhcHHHHHHHHHhcCCCCeeeEEEeec-cCCe
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQ--CGR-----AFKSFDVECEIMKSIRHRNLIKVISSCS-NEEF 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~--~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~ 752 (979)
+.|-...+||+|+|++||+| .....+.||||+-.-. ..+ ..+...+|.+|-+.+.||.||++|+||. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 34556788999999999999 6677889999975322 211 1234667999999999999999999985 5677
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC---CCCcEEEEeeccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFSIA 829 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~Dfg~~ 829 (979)
+|-|.|||+|.+|+=|+...+ .+++++++.|+.||+.||.||.+ .+.+|+|-|+||.|||+. ..|.+||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 899999999999988887765 68999999999999999999994 478999999999999995 5688999999999
Q ss_pred cccCCCCCc-----ceecccccCCCCCCccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhh
Q 002021 830 KMLTGEDQS-----MIQTQTLATIGYMAPEYGREG----RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 900 (979)
Q Consensus 830 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~ 900 (979)
+.+.+.... ...+...||.+|++||.+.-+ .++.++||||+|||+|+++.|+.||+.....+ ++.+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILq---- 695 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQ---- 695 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHh----
Confidence 998654332 123556899999999977543 46789999999999999999999997532211 1111
Q ss_pred hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...++......|+.++.++.++.++|++|+.+.-++|....++..+
T Consensus 696 ----------eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 696 ----------ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ----------hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 0112223334455566677889999999999999999988877543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=292.00 Aligned_cols=254 Identities=22% Similarity=0.275 Sum_probs=196.9
Q ss_pred CCCCCceeeeecceEEEEEEc----CCCcEEEEEEecccc----ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCee
Q 002021 683 GFSENNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQC----GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (979)
+|+..+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++++++ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999853 357889999986432 12345678899999999 599999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||+++|+|.+++... ..+++..+..++.|+++|++||| +.+++||||||+||+++.++.++++|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999988654 35889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCcceecccccCCCCCCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
..... ......++..|+|||...+.. .+.++||||+|+++|||++|..||...... ........... .
T Consensus 157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~--------~ 226 (288)
T cd05583 157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRIL--------K 226 (288)
T ss_pred ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHH--------c
Confidence 33211 122345788999999886654 788999999999999999999998642111 01111100000 0
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
.....+..++..+.+++.+||+.+|++|||+.++.+.|.
T Consensus 227 --------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 227 --------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred --------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 001112234566899999999999999999887766544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=301.95 Aligned_cols=265 Identities=23% Similarity=0.265 Sum_probs=197.1
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe----
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF---- 752 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 752 (979)
..++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 356788999999999999999955 468899999986432 2233556789999999999999999998766554
Q ss_pred --eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 753 --KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 753 --~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
.++|+||+ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||||+||++++++.++|+|||.+.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 56998888653 5899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhh---------
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND--------- 900 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~--------- 900 (979)
..... .....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||...... .........
T Consensus 167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHH
Confidence 65322 133457889999998765 36788999999999999999999999653211 111111100
Q ss_pred --hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 901 --WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 901 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...........................++..+.+++.+|++.+|++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000000000001112346779999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=288.68 Aligned_cols=248 Identities=20% Similarity=0.261 Sum_probs=192.7
Q ss_pred CCCCCceeeeecceEEEEEEcC-CCcEEEEEEecccc-----ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQC-----GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.|.+.+.||+|+||.||+|... .+..+++|+++... ......+.+|+.+++.++|||++++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3677889999999999999553 34556666654321 12233566799999999999999999999999999999
Q ss_pred EEecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 757 LEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
|||+++++|.+++.. ....+++.+++.++.|+++|++||| +++++|+|+||+||++++ +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988764 3456899999999999999999999 999999999999999975 569999999987764
Q ss_pred CCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
.... ......++..|+|||...+..++.++|+||+|+++|+|++|..||...... ..........
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~~-------- 221 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVLRIVEGP-------- 221 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHcCC--------
Confidence 3222 123345788999999988888889999999999999999999998642111 1100000000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..++.++.+++.+||+.+|++||++.|++++
T Consensus 222 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 -------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 000112445678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=295.32 Aligned_cols=268 Identities=21% Similarity=0.201 Sum_probs=191.6
Q ss_pred CCCCCceeeeecceEEEEEEcC-C--CcEEEEEEeccccc--cchhcHHHHHHHHHhc-CCCCeeeEEEeecc----CCe
Q 002021 683 GFSENNLIGRGGFGSVYKASLG-D--GMEVAVKVFTSQCG--RAFKSFDVECEIMKSI-RHRNLIKVISSCSN----EEF 752 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 752 (979)
+|+..+.||+|+||.||+|... + +..||+|++..... ...+.+.+|+++++++ .||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3677889999999999999643 4 77899999864322 2245677899999999 59999999986532 245
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.++++||++ ++|.+++... ..+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|||.+...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788999986 5898888654 36899999999999999999999 999999999999999999999999999999865
Q ss_pred CCCCCc--ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhh----------
Q 002021 833 TGEDQS--MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN---------- 899 (979)
Q Consensus 833 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~---------- 899 (979)
...... .......|+..|+|||+..+ ..++.++||||+||++|++++|+.||....... .....+.
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 432211 11223468899999998765 468899999999999999999999986522110 0000000
Q ss_pred -hhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 900 -DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 900 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
............................++..+.+++.+|++.+|++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000000000001112235678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=294.59 Aligned_cols=243 Identities=24% Similarity=0.273 Sum_probs=197.8
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++.|+....+|.|+|+.|-++ ...+++..|||++.+. ..+-.+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 456777778999999999998 5567889999999755 23345577776666 69999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe-CCCCcEEEEeeccccccCCCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL-DDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll-~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
.+.|+-+.+.+...+. +. .++..|+.+++.|+.||| .+|++|||+||+|||+ ++.+.++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999988887766532 22 677889999999999999 9999999999999999 58999999999999876433
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
..+.+-|..|.|||+....+|++++|+||+|++||+|++|+.||.....+ ..+...+.
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~------------------ 527 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQ------------------ 527 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhc------------------
Confidence 23446788999999999999999999999999999999999999875544 11111000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
.....+.++.++.+|+.+|++.||.+||++.|+..|--.
T Consensus 528 ---~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 ---MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 001115667789999999999999999999999877543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=283.18 Aligned_cols=239 Identities=28% Similarity=0.315 Sum_probs=193.2
Q ss_pred eeeecceEEEEEEc-CCCcEEEEEEecccccc---chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR---AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 690 lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
||+|+||.||++.. .+++.||+|++...... ..+.+..|+++++.++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999965 46899999998654322 345788899999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccc
Q 002021 766 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845 (979)
Q Consensus 766 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 845 (979)
.+++.... .+++..+..++.|++.|+.|+| +.+++|+||+|+||+++.++.++++|||.+....... .......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 99987654 5899999999999999999999 9999999999999999999999999999998754321 1123456
Q ss_pred cCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHH
Q 002021 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925 (979)
Q Consensus 846 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (979)
++..|+|||...+...+.++|+||||+++||+++|+.||..... ......+.. .....+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~-------------------~~~~~~ 213 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK-------------------DPLRFP 213 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc-------------------CCCCCC
Confidence 78899999999888889999999999999999999999865322 111111000 000111
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCH---HHHHH
Q 002021 926 EQCVSFVFNLAMECTMEFPKQRINA---KEIVT 955 (979)
Q Consensus 926 ~~~~~~l~~l~~~cl~~dP~~Rps~---~eil~ 955 (979)
...+..+.+++.+||..||++||++ .++++
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 2224568899999999999999999 55554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=296.94 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=209.5
Q ss_pred cHHHHHHhhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeec--
Q 002021 673 SYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCS-- 748 (979)
Q Consensus 673 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 748 (979)
.++.+...++.|++.+.||.|.+|.||++ ..++++.+|||+.....+ ..++++.|++|++.. .|||++.++|+|.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34444556788999999999999999999 456899999998876543 346778899999988 5999999999874
Q ss_pred ---cCCeeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEE
Q 002021 749 ---NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 824 (979)
Q Consensus 749 ---~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~ 824 (979)
.++..+||||||.+|+.-|.++.. +..+.|+.+..|++.++.|+.||| ...++|||||..|||++.++.||++
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEe
Confidence 367899999999999999988754 557899999999999999999999 9999999999999999999999999
Q ss_pred eeccccccCCCCCcceecccccCCCCCCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhh
Q 002021 825 DFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 899 (979)
Q Consensus 825 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~ 899 (979)
|||.+.... .+..+..+.+||+.|||||++.- ..|+..+|+||+|++..||.-|..|+.++.+...-+.
T Consensus 166 DFGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~---- 239 (953)
T KOG0587|consen 166 DFGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---- 239 (953)
T ss_pred eeeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc----
Confidence 999987653 23344567789999999998753 3477889999999999999999999876533321111
Q ss_pred hhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 900 DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. .+.+..+...++.-..++.++|..|+..|-++||++.++++|
T Consensus 240 -I-------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 -I-------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -C-------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 0 011111222234456679999999999999999999998875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=315.02 Aligned_cols=145 Identities=28% Similarity=0.401 Sum_probs=129.8
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|.+.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 6788899999999999999955 478999999986532 122356788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
||+++++|.+++...+ .+++..++.++.||+.||+||| .++|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999987643 5788999999999999999999 8999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=278.32 Aligned_cols=219 Identities=21% Similarity=0.164 Sum_probs=176.5
Q ss_pred ecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCccceeecc
Q 002021 693 GGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 771 (979)
Q Consensus 693 G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 771 (979)
|.||.||++ ...+++.||+|++.... .+.+|...+....|||++++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999 45678999999986542 234455556666799999999999999999999999999999998866
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCC
Q 002021 772 SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYM 851 (979)
Q Consensus 772 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 851 (979)
.. .+++..+..++.|+++|++||| +++|+||||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~ 149 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC 149 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence 43 5899999999999999999999 9999999999999999999999999999876553221 2234567899
Q ss_pred CccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHH
Q 002021 852 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 931 (979)
Q Consensus 852 aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (979)
|||...+..+++++||||+|+++|||++|+.|+........ . .. ....+..+++.
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------~--~~-------------~~~~~~~~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------T--HT-------------TLNIPEWVSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------c--cc-------------ccCCcccCCHH
Confidence 99999888899999999999999999999988653211000 0 00 00011234566
Q ss_pred HHHHHHhccccCcCCCCCH
Q 002021 932 VFNLAMECTMEFPKQRINA 950 (979)
Q Consensus 932 l~~l~~~cl~~dP~~Rps~ 950 (979)
+.+++.+|++.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 8999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=274.30 Aligned_cols=242 Identities=21% Similarity=0.264 Sum_probs=194.9
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 755 (979)
..+|....+||+|+||.|-+|+ ..+.+.+|||++++.. +.+.+-...|-++|... +-|.++++..+|+.-+..|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3578899999999999999994 4567789999998763 33444455677777766 57899999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+.||+|--++++-+ ++.+..+..++.+||-||-+|| ++||+.||+|.+|||+|.+|.+||+|||+++.---.
T Consensus 428 VMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 999999999987777654 6888899999999999999999 999999999999999999999999999999863222
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.....+.+||+.|+|||++....|+.++|.||+||++|||+.|+.||+...+ ++.+.......
T Consensus 504 --~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-~elF~aI~ehn-------------- 566 (683)
T KOG0696|consen 504 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQAIMEHN-------------- 566 (683)
T ss_pred --CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHcc--------------
Confidence 2334567899999999999999999999999999999999999999986322 22222111110
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN 949 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps 949 (979)
...+...+.++.++....+...|.+|..
T Consensus 567 ------vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 ------VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 0112234556778888888999999873
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=303.54 Aligned_cols=260 Identities=22% Similarity=0.237 Sum_probs=170.4
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CC----CcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEe------ec
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GD----GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISS------CS 748 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 748 (979)
..++|+..+.||+|+||.||+|.. .+ +..||||++..... .+.+..| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999965 44 78999998754321 1111111 1112222223222221 24
Q ss_pred cCCeeEEEEEecCCCccceeeccCCCC-------------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 002021 749 NEEFKALVLEYMPHGSLEKYLYSSNCI-------------------LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 809 (979)
Q Consensus 749 ~~~~~~lv~E~~~~g~L~~~l~~~~~~-------------------l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik 809 (979)
.+...++||||+++++|.+++...... .....+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 567789999999999999988654211 123346689999999999999 9999999999
Q ss_pred CCCEEeCC-CCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCC----------------------CCCCchh
Q 002021 810 PSNVLLDD-NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG----------------------RVSANGD 866 (979)
Q Consensus 810 ~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 866 (979)
|+|||+++ ++.+||+|||+++...... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 6899999999998653222 2223445789999999965322 2344669
Q ss_pred HHHHHHHHHHHHcCCCCCcccc--------cCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHh
Q 002021 867 VYSFGIMLMETFTGKKPTDEIF--------NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAME 938 (979)
Q Consensus 867 vwslG~il~el~tg~~P~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 938 (979)
|||+||++|||+++..|++... ....+...|.....+.... .....+...........+|+.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASP---------DLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccch---------hhhhhhhhccccchHHHHHHHH
Confidence 9999999999999877654311 0011112221111111000 0000001111112345689999
Q ss_pred ccccCcCCCCCHHHHHHH
Q 002021 939 CTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 939 cl~~dP~~Rps~~eil~~ 956 (979)
|++.||++|||++|+++|
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999987
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=273.14 Aligned_cols=266 Identities=21% Similarity=0.258 Sum_probs=199.3
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-C-C----CeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-H-R----NLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 753 (979)
+..|.+...+|+|.||.|-.. ....+..||||+++.. ++..+...-|+++++++. + | -+|.+.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999998 4455889999998644 344566677999999993 2 2 477888889999999
Q ss_pred EEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---------------
Q 002021 754 ALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--------------- 817 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~--------------- 817 (979)
++|+|.+ |-++.+++... ...++..+++.|+.|++++++||| +.+++|.|+||+||++.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999988 66999999874 457889999999999999999999 999999999999999931
Q ss_pred -----CCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc
Q 002021 818 -----NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 892 (979)
Q Consensus 818 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~ 892 (979)
+..++++|||.|....... +..+.|..|.|||++.+-.++..+||||+||||+|+.||..-|....+.+.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 3458999999998753222 556789999999999999999999999999999999999998875442221
Q ss_pred -hHhHhhhhhcCCccc-----------------hhhccc---ccC----chhhhhHHHHHHHHHHHHHHHhccccCcCCC
Q 002021 893 -TLKHWVNDWLPISTM-----------------EVVDAN---LLS----QEDIHFVAKEQCVSFVFNLAMECTMEFPKQR 947 (979)
Q Consensus 893 -~~~~~~~~~~~~~~~-----------------~~~~~~---~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 947 (979)
.+.+.+-...|...+ +....+ ... ...............+++|+++++.+||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 011111111111100 000000 000 0000111122334569999999999999999
Q ss_pred CCHHHHHHH
Q 002021 948 INAKEIVTK 956 (979)
Q Consensus 948 ps~~eil~~ 956 (979)
+|+.|++.|
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=299.39 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=191.0
Q ss_pred CCCCceeeeecce-EEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 684 FSENNLIGRGGFG-SVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 684 ~~~~~~lG~G~~g-~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
|...+.+|.|+.| .||+|.. +|+.||||++... ...-..+|+..++.- +|||||++++.-.++...|++.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3344678999987 6899988 6889999998643 234567899999988 69999999999999999999999996
Q ss_pred CCccceeeccCCCCCC---HHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----CCcEEEEeeccccccC
Q 002021 762 HGSLEKYLYSSNCILD---IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFSIAKMLT 833 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~---~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-----~~~~kl~Dfg~~~~~~ 833 (979)
. +|.+++........ ....+.+..|++.|++||| +.+|||||+||+||||+. ..+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 99999987411111 1345789999999999999 999999999999999975 3579999999999987
Q ss_pred CCCCc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 834 GEDQS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 834 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
..... .+..+..||.+|+|||++....-+.++||||+||++|+.++ |.+||++...-+..+.. . ..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~---~--------~~~ 731 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT---G--------NYT 731 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---C--------ccc
Confidence 55443 23456789999999999998888889999999999999999 59999874333222211 0 000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...... ...+ ++.+||.+|+.++|..||+|.+|+.|
T Consensus 732 L~~L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 LVHLEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eeeecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 000000 0112 68899999999999999999999876
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=253.68 Aligned_cols=263 Identities=19% Similarity=0.289 Sum_probs=197.9
Q ss_pred hhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeeccC--CeeEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNE--EFKAL 755 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l 755 (979)
..++|++.+++|+|.|++||.| ...+.+.++||++++. ..+.+.+|+.|++.++ ||||++++++..++ ..+.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 3477888999999999999999 5567889999999754 3466889999999997 99999999998664 56789
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEEeeccccccCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfg~~~~~~~ 834 (979)
|+||+++.+..... ..++...++..+.+++.||+|+| ++||+|||+||+||+||. .-.++++|||+|.++.+
T Consensus 113 iFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999886665443 24777889999999999999999 999999999999999995 55799999999999864
Q ss_pred CCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh------------
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW------------ 901 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~------------ 901 (979)
... ...++.+..|..||.+.. ..|...-|+|||||++..|+..+.||--..++..++....+..
T Consensus 186 ~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 433 245567788999998765 4588899999999999999999999854333333322221110
Q ss_pred -c--CCccchhhcccccCchhhhhH---HHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 902 -L--PISTMEVVDANLLSQEDIHFV---AKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 902 -~--~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. +....+++.. ..++.-.++. ......+++.+++.+.+.+|.++|+||+|++.|
T Consensus 263 ~i~Ldp~~~~i~~~-~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGR-HSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhc-cccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 0001111110 0011111111 112345789999999999999999999999886
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=282.19 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=203.3
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCc-EEEEEEeccc---cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGM-EVAVKVFTSQ---CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.+++.+..||-|+||.|=.+...... .+|+|++++. ..+..+.+..|.+||...+.|.||++|-.|.+.+..|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667788999999999999664332 4788877643 2345567788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
|-|-||.+...+++.+ .++...+..++..+.+|++||| .++|+.||+||+|.++|.+|.+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-- 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-- 573 (732)
T ss_pred HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence 9999999999987765 6899999999999999999999 999999999999999999999999999999987533
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
....+.+||+.|.|||++.+.....++|.||+|+++||+++|++||.... ++..| ..-+...
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d----pmktY-------------n~ILkGi 635 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD----PMKTY-------------NLILKGI 635 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc----hHHHH-------------HHHHhhh
Confidence 33466899999999999999999999999999999999999999997632 11111 0000011
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
. ....|..++....++|.+.+..+|.+|.- +.||.+|
T Consensus 636 d--~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 636 D--KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred h--hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1 11122445667889999999999999985 6777766
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=291.97 Aligned_cols=257 Identities=18% Similarity=0.212 Sum_probs=183.0
Q ss_pred hCCCCCCceeeeecceEEEEEEc-----------------CCCcEEEEEEeccccccc--------------hhcHHHHH
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-----------------GDGMEVAVKVFTSQCGRA--------------FKSFDVEC 729 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vAvK~~~~~~~~~--------------~~~~~~E~ 729 (979)
.++|+..++||+|+||.||+|.. .+++.||||++....... .+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999953 245689999986432221 22344577
Q ss_pred HHHHhcCCCCe-----eeEEEeecc--------CCeeEEEEEecCCCccceeeccCC-----------------------
Q 002021 730 EIMKSIRHRNL-----IKVISSCSN--------EEFKALVLEYMPHGSLEKYLYSSN----------------------- 773 (979)
Q Consensus 730 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~----------------------- 773 (979)
.++.+++|.++ ++++++|.. ++..++||||+++++|.++++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 78888876554 677777643 456899999999999999886421
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCc
Q 002021 774 CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853 (979)
Q Consensus 774 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 853 (979)
..+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++....... ........+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence 13467788999999999999999 9999999999999999999999999999997653221 1111223457899999
Q ss_pred cccCCCC--------------------C--CCchhHHHHHHHHHHHHcCCC-CCcccccCc-------chHhHhhhhhcC
Q 002021 854 EYGREGR--------------------V--SANGDVYSFGIMLMETFTGKK-PTDEIFNGE-------MTLKHWVNDWLP 903 (979)
Q Consensus 854 E~~~~~~--------------------~--~~~~DvwslG~il~el~tg~~-P~~~~~~~~-------~~~~~~~~~~~~ 903 (979)
|.+.... + ..+.||||+||++|||++|.. ||....... .....|....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~-- 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK-- 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc--
Confidence 9875322 1 124699999999999999875 664321111 1111121110
Q ss_pred CccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCc---CCCCCHHHHHHH
Q 002021 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFP---KQRINAKEIVTK 956 (979)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~Rps~~eil~~ 956 (979)
.....+.....+.....+++.+++..+| .+|+|++|+++|
T Consensus 458 -------------~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 -------------GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -------------ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0111122233445678999999999766 689999999987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=280.51 Aligned_cols=207 Identities=22% Similarity=0.344 Sum_probs=176.8
Q ss_pred CCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
|..++.||-|+||+|.++ +.++...+|.|.+++.. ......+++|..||.....+=||++|..|++++..|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 667889999999999999 55667789999987653 23456678899999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC----
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE---- 835 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~---- 835 (979)
++||++-.++.+.+ .+.++-++.++.++..|+++.| +.|+|||||||+|||||.+|.+||+|||++.-+...
T Consensus 711 IPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred cCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 99999998887765 6888889999999999999999 999999999999999999999999999998633211
Q ss_pred ----CCcc--------------------------------eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc
Q 002021 836 ----DQSM--------------------------------IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 879 (979)
Q Consensus 836 ----~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t 879 (979)
+.+. .....+||+.|+|||++....|+..+|.||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 1000 0112368999999999999999999999999999999999
Q ss_pred CCCCCcccccCcchH
Q 002021 880 GKKPTDEIFNGEMTL 894 (979)
Q Consensus 880 g~~P~~~~~~~~~~~ 894 (979)
|+.||.+...++.++
T Consensus 867 g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQY 881 (1034)
T ss_pred CCCCccCCCCCccee
Confidence 999998876665443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=245.30 Aligned_cols=217 Identities=27% Similarity=0.341 Sum_probs=173.6
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHH-hcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMK-SIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.+....+..||+|+||.|-+-+ ..+|+..|||+++... .+..+....|..+.. ...+|.+|.++|.+.+++..++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3455566789999999998884 4689999999987543 233455666777644 457999999999999999999999
Q ss_pred EecCCCccceeec---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
|.|+- +|+.+-. ..+..+++.-+=+|+..+.+|+.|||+ +..++|||+||+|||++.+|+||+||||.+-.+..
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99954 7776643 345678888899999999999999996 67999999999999999999999999999987642
Q ss_pred CCCcceecccccCCCCCCccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGRE----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 903 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 903 (979)
+...+...|--.|||||.+.. ..|+-++||||+|+++.||.+++.||+.....-.++.+.+....+
T Consensus 202 ---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 202 ---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred ---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 333344567788999998753 368899999999999999999999998766655555555544433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=254.36 Aligned_cols=247 Identities=22% Similarity=0.276 Sum_probs=197.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 755 (979)
..+|+..++||+|+|..|..+++ .+.+.+|+|++++.. +++..=.+.|-.++.+. +||.+|-+..+|+.+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46789999999999999999954 567899999987653 23334456687777766 69999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|.||++||+|-=++++.+ +++++.++.+..+|+-||.||| ++||+.||+|.+||++|..|.+|++|+|+++.--.+
T Consensus 329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 999999999987776654 6899999999999999999999 999999999999999999999999999999864333
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccc--cCcchHhHhhhhhcCCccchhhccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF--NGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
+ -..++.+||+.|.|||++++.+|+..+|.|++||+++||+.|+.||+... +.++....++...+-. .
T Consensus 405 g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile--------k 474 (593)
T KOG0695|consen 405 G--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--------K 474 (593)
T ss_pred C--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------h
Confidence 2 23467899999999999999999999999999999999999999998532 2333333332222211 1
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI 948 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 948 (979)
.++ .+...+..+..++..-+++||.+|.
T Consensus 475 qir-------iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 QIR-------IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccc-------ccceeehhhHHHHHHhhcCCcHHhc
Confidence 111 1112233355678888899999886
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=268.46 Aligned_cols=239 Identities=30% Similarity=0.350 Sum_probs=193.2
Q ss_pred cceEEEEEEcC-CCcEEEEEEeccccccc-hhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCccceeecc
Q 002021 694 GFGSVYKASLG-DGMEVAVKVFTSQCGRA-FKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 771 (979)
Q Consensus 694 ~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 771 (979)
+||.||+|... +|+.||+|++....... .+.+.+|++.+++++|++++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999665 58999999997664444 67889999999999999999999999998999999999999999999876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCC
Q 002021 772 SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYM 851 (979)
Q Consensus 772 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 851 (979)
... +++..+..++.+++.+++||| +.+++|+||+|+||++++++.++++|||.+....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 543 889999999999999999999 8999999999999999999999999999998764332 223456788999
Q ss_pred CccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHH
Q 002021 852 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 931 (979)
Q Consensus 852 aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (979)
|||...+..+++++||||+|+++|++++|..||....... ....+....... . ......++.+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~------------~----~~~~~~~~~~ 216 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKPKPP------------F----PPPEWKISPE 216 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCCC------------C----ccccccCCHH
Confidence 9999988888999999999999999999999986531111 111111100000 0 0000014567
Q ss_pred HHHHHHhccccCcCCCCCHHHHHHH
Q 002021 932 VFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 932 l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+.+++.+|+..+|.+||++.|++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhhC
Confidence 8999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-31 Score=255.96 Aligned_cols=268 Identities=21% Similarity=0.288 Sum_probs=199.3
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC-----CeeEE
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFKAL 755 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 755 (979)
.+..+.||.|+||.||.++ -++|+.||+|++.... -...+.+.+|.+++..++|.|+...++..+-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3455789999999999984 5689999999985432 22356788899999999999999998876543 34678
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|+|.|. .+|...+-... .++...+.-+++||++||+||| +.+|.||||||.|.+++++...||||||+++... .
T Consensus 135 ~TELmQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-~ 208 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD-Q 208 (449)
T ss_pred HHHHHH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc-h
Confidence 899885 48877775543 6888899999999999999999 9999999999999999999999999999998754 3
Q ss_pred CCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
+....++..+.|..|.|||++.+. .|+.+.||||.|||+.|++.++.-|....+- +..+.+.+......++.+...+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHHHh
Confidence 445556777889999999998875 6999999999999999999988877653221 1122222222222222222111
Q ss_pred cCchh---------------hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 915 LSQED---------------IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 915 ~~~~~---------------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
..... +....+.....+..++..+++.+||.+|.+..+.+.+...
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 11100 0001111223456788999999999999999999887653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=262.98 Aligned_cols=198 Identities=22% Similarity=0.344 Sum_probs=169.0
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--------ccchhcHHHHHHHHHhcC---CCCeeeEEEeec
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--------GRAFKSFDVECEIMKSIR---HRNLIKVISSCS 748 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 748 (979)
..+|...+.+|+|+||.|+.|. ..+...|+||.+.+.. ++..-.+--|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3568888999999999999994 4456789999886542 112223456999999997 999999999999
Q ss_pred cCCeeEEEEEec-CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeec
Q 002021 749 NEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFS 827 (979)
Q Consensus 749 ~~~~~~lv~E~~-~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg 827 (979)
+++.+||+||-. ++.+|.+++..+. .+++.++..|++||+.|+++|| +.+|+|||||-+||.++.+|.+|++|||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence 999999999975 5568899987654 6899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcc
Q 002021 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDE 886 (979)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~ 886 (979)
.+......+ ....+||.+|.|||++.+..| +..-|||++|+++|-++....||+.
T Consensus 716 saa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 998764332 356789999999999998876 4567999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=240.74 Aligned_cols=211 Identities=35% Similarity=0.545 Sum_probs=183.7
Q ss_pred eeeecceEEEEEEcC-CCcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCccce
Q 002021 690 IGRGGFGSVYKASLG-DGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 767 (979)
Q Consensus 690 lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~ 767 (979)
||+|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999764 4899999998755332 34678999999999999999999999999999999999999999999
Q ss_pred eeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEEeeccccccCCCCCcceeccccc
Q 002021 768 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846 (979)
Q Consensus 768 ~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 846 (979)
++......+++..+..++.+++++++||| +.+++|+||+|.||+++. ++.++++|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 98765446899999999999999999999 899999999999999999 89999999999987643321 1233457
Q ss_pred CCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHH
Q 002021 847 TIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925 (979)
Q Consensus 847 t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 925 (979)
...|++||..... .++.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7899999998777 788999999999999998
Q ss_pred HHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 926 EQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 926 ~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
..+.+++.+|++.+|.+||++.++++++
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3478899999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-28 Score=268.10 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=204.5
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.++|+...++|.|.||.|||| ...+++..|||+++-....+....++|+-+++..+|||||.+++.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 367888999999999999999 5678999999999988888888899999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+.+|+|++.-+..+ .+++.++..+++...+|++||| +.+-+|||||..||++++.|.+|+.|||.+..+.. .-.
T Consensus 94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIA 167 (829)
T ss_pred cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hhh
Confidence 99999999776654 6899999999999999999999 99999999999999999999999999999876532 222
Q ss_pred eecccccCCCCCCcccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 840 IQTQTLATIGYMAPEYG---REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
......||+.|||||+. +.+.|...+|||+.|+...|+---+.|..+..+-...+ +.-.....
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~--------------LmTkS~~q 233 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF--------------LMTKSGFQ 233 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH--------------HhhccCCC
Confidence 33457899999999975 45678999999999999999987777743211111100 00000111
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+..+ .+..-.+.+.+++..|+..+|.+||+++.++.|
T Consensus 234 pp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 234 PPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCccc--CCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 11110 111224558899999999999999999887764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=249.99 Aligned_cols=130 Identities=27% Similarity=0.377 Sum_probs=111.5
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC--------CCCeeeEEEeec----
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR--------HRNLIKVISSCS---- 748 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---- 748 (979)
..|-+.++||.|.|++||+| ...+.+.||+|+.++. ....+....||++|++++ ..+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 56778899999999999999 6677899999998754 344566778999999984 248999999985
Q ss_pred cCCeeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 749 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 749 ~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
.+.+.++|+|++ |.+|..+|... ...++...+..|++||+.||+|||. +.||+|.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 467899999999 66898888765 3468999999999999999999997 6699999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=239.72 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=193.3
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeecc------CCe
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSN------EEF 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 752 (979)
..|...+.+|.|+- .|..| ..-.+++||+|+...+. ....+...+|...+..++|+||++++.+|.- ...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666678888888 55555 33468899999875442 2234667889999999999999999999853 345
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.|+|||+|.. +|.+.+.. .++-+.+..|+.|++.|+.||| +.||+|||+||+||++..+..+||.|||+|...
T Consensus 96 ~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence 7999999954 89888873 4788899999999999999999 999999999999999999999999999999864
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc-------
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS------- 905 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~------- 905 (979)
. .....+..+.|..|.|||++-+-.+.+.+||||.||++.||++|+.-|. ++..+.+|-+......
T Consensus 169 ~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 169 D---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred C---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHHHH
Confidence 2 2245566788999999999988889999999999999999999998664 4444444433221100
Q ss_pred ---------------------cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 ---------------------TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+.+....+.... .....-...+.+++.+|+..+|++|.+++++++|
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~---e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVL---EGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccc---cCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000000000000 0001123457899999999999999999999987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-27 Score=251.52 Aligned_cols=275 Identities=22% Similarity=0.265 Sum_probs=203.8
Q ss_pred ccHHHHHHhhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC------CCCeeeEE
Q 002021 672 FSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR------HRNLIKVI 744 (979)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~ 744 (979)
|.+...+.....|.+....|+|-|+.|.+| ....|..||||++... +...+.-..|++||++++ -.|+++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 333334445577888899999999999999 4446789999999755 233455678999999995 35899999
Q ss_pred EeeccCCeeEEEEEecCCCccceeeccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcE
Q 002021 745 SSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVA 821 (979)
Q Consensus 745 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~ 821 (979)
..|....+.|||||-+. -+|.+.+... ...+....+..++.|+.-||..|. ..+|+|.||||.|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCccee
Confidence 99999999999999874 4888888765 345777899999999999999999 9999999999999999965 467
Q ss_pred EEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHh------
Q 002021 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK------ 895 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~------ 895 (979)
||||||.|........ +....+..|.|||++.+-.|....|+||.||+|||+.||+.-|....+.++.-.
T Consensus 577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 9999999987643322 223345689999999999999999999999999999999998876443322110
Q ss_pred ----------HhhhhhcCCc------------------cchhhcc------cccCchhhhhHHHHHHHHHHHHHHHhccc
Q 002021 896 ----------HWVNDWLPIS------------------TMEVVDA------NLLSQEDIHFVAKEQCVSFVFNLAMECTM 941 (979)
Q Consensus 896 ----------~~~~~~~~~~------------------~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 941 (979)
++..+.+... .+..+.+ .+...+.... .......++.+|+.+|+.
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d-eq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD-EQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc-hhHHHHHHHHHHHHHHhc
Confidence 0111111100 1111111 1111111111 122345678999999999
Q ss_pred cCcCCCCCHHHHHHH
Q 002021 942 EFPKQRINAKEIVTK 956 (979)
Q Consensus 942 ~dP~~Rps~~eil~~ 956 (979)
.||++|.|..++++|
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=235.84 Aligned_cols=199 Identities=31% Similarity=0.444 Sum_probs=172.3
Q ss_pred CCCCceeeeecceEEEEEEcCC-CcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 684 FSENNLIGRGGFGSVYKASLGD-GMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999996654 889999999765444 56788899999999999999999999998899999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+++|.+++......+++..+..++.+++.++.+|| +++++|+|++|.||+++.++.++++|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 99999998765433789999999999999999999 89999999999999999999999999999987653321 112
Q ss_pred cccccCCCCCCcccc-CCCCCCCchhHHHHHHHHHHHHcCCCCCcc
Q 002021 842 TQTLATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGKKPTDE 886 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~P~~~ 886 (979)
....++..|++||.. ....++.++|+|++|++++|+++|+.||+.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334577889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=227.12 Aligned_cols=254 Identities=19% Similarity=0.259 Sum_probs=192.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEE-eeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVIS-SCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lv~ 757 (979)
.+.|.+.+.+|+|.||.+-++++ .+.+.+|+|.++.+. ...++|.+|...--.+ .|.||+.-|+ .|+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 36788899999999999999965 467889999887553 3457788888764445 5899999888 567788889999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--CCCcEEEEeeccccccCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~--~~~~~kl~Dfg~~~~~~~~ 835 (979)
||++.|+|.+-+... .+.+....+++.|+++|++|+| ++.+||||||.+||||- +..++|+||||..+..+.
T Consensus 102 E~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred ccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 999999999988765 4788888999999999999999 99999999999999993 445899999999875421
Q ss_pred CCcceecccccCCCCCCccccCC---C--CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 836 DQSMIQTQTLATIGYMAPEYGRE---G--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
.. ...--+..|-|||.... + ...+.+|+|.||+++|.++||+.||....-.+..+..|......... .+.
T Consensus 176 --tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-~~P 250 (378)
T KOG1345|consen 176 --TV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-ALP 250 (378)
T ss_pred --ee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-cCc
Confidence 11 11223456889996532 2 35678999999999999999999998655555566665544333222 111
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
+ . ....++.+..++.+-+..+|++|=.+.++.+...
T Consensus 251 ~--~----------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 251 K--K----------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred h--h----------hcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 1 1 1123455788999999999999965555555544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=240.46 Aligned_cols=269 Identities=23% Similarity=0.343 Sum_probs=196.8
Q ss_pred HhhCCCCCCceeeeecceEEEEEEcC----CCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCee
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFK 753 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 753 (979)
.....|..+++||+|.|++||+|... ..+.||+|.+... .....+..|.++|..+. +.||+++.+++...+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34467888999999999999999432 4678999998654 33456889999999995 89999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEEeecccccc
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKML 832 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfg~~~~~ 832 (979)
.+|+||+++..-.++... ++..++...++.+..||+++| ..|||||||||+|++.+ ..+.-.|+|||+|..+
T Consensus 111 ~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHH
Confidence 999999999887777654 678899999999999999999 99999999999999998 5678899999998722
Q ss_pred CCCC-------------Cc-----------------------------ceecccccCCCCCCccccCC-CCCCCchhHHH
Q 002021 833 TGED-------------QS-----------------------------MIQTQTLATIGYMAPEYGRE-GRVSANGDVYS 869 (979)
Q Consensus 833 ~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws 869 (979)
.... .. .......||+||.|||++.. +.-++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1000 00 00113468999999998765 45688999999
Q ss_pred HHHHHHHHHcCCCCCcccccCcchHhHhhhh------------------hc----CCccc-----hhhc-ccccCchh--
Q 002021 870 FGIMLMETFTGKKPTDEIFNGEMTLKHWVND------------------WL----PISTM-----EVVD-ANLLSQED-- 919 (979)
Q Consensus 870 lG~il~el~tg~~P~~~~~~~~~~~~~~~~~------------------~~----~~~~~-----~~~~-~~~~~~~~-- 919 (979)
.|||+.-+++++.||....+.-..+.+.+.. +. +.... +-++ ..+.....
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 9999999999999986443322222111100 00 00000 0000 00000000
Q ss_pred hhh-HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 920 IHF-VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 920 ~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... ...+..+..++++..+|+..||.+|.|++|+++|
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 011 1122344579999999999999999999999986
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-27 Score=246.06 Aligned_cols=398 Identities=26% Similarity=0.273 Sum_probs=254.2
Q ss_pred CCcEEEccCCccCchhhhhhhccCC-cccCCCCccceeecccccccccccccccCCCCCCceecCC-CeeeecCCccccc
Q 002021 145 SLQHLDLSSNALSGEIRANICREIP-REFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGD-NKLVGIAPIAIFN 222 (979)
Q Consensus 145 ~L~~L~Ls~N~l~~~~~~~~~~~ip-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~ 222 (979)
.-..++|..|+|+. || .+|+.+++|+.|||++|+|+.+-|..|..+.+|.+|-+.+ |+|+.+...+|.+
T Consensus 68 ~tveirLdqN~I~~---------iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~g 138 (498)
T KOG4237|consen 68 ETVEIRLDQNQISS---------IPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGG 138 (498)
T ss_pred cceEEEeccCCccc---------CChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhh
Confidence 45678888888874 44 4678888888888888888877788888888777766655 7888887778888
Q ss_pred cCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccce
Q 002021 223 VSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWL 302 (979)
Q Consensus 223 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 302 (979)
+..|+.|.+.-|++..+.. ..|..+++|..|.+.+|.+...-...|..+..++++.+..|.+-. .++++-+..
T Consensus 139 L~slqrLllNan~i~Cir~-~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla~- 211 (498)
T KOG4237|consen 139 LSSLQRLLLNANHINCIRQ-DALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLAD- 211 (498)
T ss_pred HHHHHHHhcChhhhcchhH-HHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccchhhh-
Confidence 8888888887777764433 356777777777777777774333366667777777777776321 111111110
Q ss_pred eccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCC-ccccCCCcccEE
Q 002021 303 VLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP-EEISNLTNLRTI 381 (979)
Q Consensus 303 ~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p-~~l~~l~~L~~L 381 (979)
++..|.+ .++..+-..-..+.++++..+.+..|... ..++..=..+.+...+.-| ..|..+++|++|
T Consensus 212 ~~a~~~i-----------etsgarc~~p~rl~~~Ri~q~~a~kf~c~-~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~l 279 (498)
T KOG4237|consen 212 DLAMNPI-----------ETSGARCVSPYRLYYKRINQEDARKFLCS-LESLPSRLSSEDFPDSICPAKCFKKLPNLRKL 279 (498)
T ss_pred HHhhchh-----------hcccceecchHHHHHHHhcccchhhhhhh-HHhHHHhhccccCcCCcChHHHHhhcccceEe
Confidence 1111111 12222223333344444444443333221 1111111223333333333 458888888888
Q ss_pred EecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccc
Q 002021 382 YLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT 461 (979)
Q Consensus 382 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 461 (979)
+|++|+|+++...+|.++..+++|.|..|+|.......|.++..|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|.+.
T Consensus 280 nlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 280 NLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred ccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 88888888888888888888888888888888777778888888888888888888888888888888888888877554
Q ss_pred ------ccccccc-----------CcCCCcEEEeccccccC---CCcccccc---------ccccce-EeccCCccCccc
Q 002021 462 ------SIPLTFW-----------NLKDILNLNFSSNFLTG---SLPLEIGS---------LKVLVG-IDLSRNNFSGVI 511 (979)
Q Consensus 462 ------~lp~~~~-----------~l~~L~~L~ls~N~l~~---~~p~~~~~---------l~~L~~-L~Ls~N~l~~~~ 511 (979)
-+-.++. +-..++.+.++.+.+.. ..|++.+. ++-+.+ ..-|++.++ .+
T Consensus 360 CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~l 438 (498)
T KOG4237|consen 360 CNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LL 438 (498)
T ss_pred CccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hc
Confidence 1111211 11234455555554431 12222221 222222 223333333 44
Q ss_pred chhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCC
Q 002021 512 PTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577 (979)
Q Consensus 512 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 577 (979)
|..+. ..-.+|++.+|.++ .+|.. .+.+| .+|+|+|+++..-...|.++++|.+|-|++|
T Consensus 439 p~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 439 PRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred CCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 44332 24567899999999 67766 67788 8999999999777788999999999999887
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-26 Score=224.27 Aligned_cols=248 Identities=21% Similarity=0.337 Sum_probs=195.2
Q ss_pred CCCCceeeeecceEEEEEEcCCCcEEEEEEeccc--cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
.....+|.+...|+.|+|+|+ |..+++|++... ..+..++|..|.-.++.+.||||.++++.|..+....++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344567899999999999995 455666766432 23445789999999999999999999999999999999999999
Q ss_pred CCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEE--eeccccccCCCCCc
Q 002021 762 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS--DFSIAKMLTGEDQS 838 (979)
Q Consensus 762 ~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~--Dfg~~~~~~~~~~~ 838 (979)
.|+|+..++.. ...++..++.+++.++|+|++|||. .++-|.---+.+..|++|++.+++|. |--++.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheecccceeee--------
Confidence 99999999876 4457788999999999999999993 34445555688999999999988875 322221
Q ss_pred ceecccccCCCCCCccccCCCCC---CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRV---SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
...+..-.+.||+||.+...+. -+++|+|||++++||+.|...||.+..+-+..+..
T Consensus 342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------------------- 401 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------------------- 401 (448)
T ss_pred -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------------------
Confidence 1233345688999998876542 35799999999999999999999875544433321
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
..++.+...++..+..+.++|.-|+++||.+||.++.|+-.|+++.
T Consensus 402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1233444556677788999999999999999999999999999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-27 Score=240.96 Aligned_cols=279 Identities=20% Similarity=0.221 Sum_probs=180.6
Q ss_pred CcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEeccc-ccccccCCccccCCCCCcEEE
Q 002021 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRG-NQLSGTFPSFISNKSSLQHLD 150 (979)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~ 150 (979)
...+.|+|..|+|+-..|.+|+.+.+|++||||+|.|+-+-|++|..+.+|..|-+.+ |+|+......|++|.+|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 3577788888888855556788888888888888888877788888888776665544 788866666788888888888
Q ss_pred ccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCee------------eecCCc
Q 002021 151 LSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKL------------VGIAPI 218 (979)
Q Consensus 151 Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l------------~~~~p~ 218 (979)
+.-|++.-. ..+.|..|++|..|.+..|.+.......|..+.+++++.+..|.+ ....|.
T Consensus 147 lNan~i~Ci--------r~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~i 218 (498)
T KOG4237|consen 147 LNANHINCI--------RQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPI 218 (498)
T ss_pred cChhhhcch--------hHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchh
Confidence 877777643 345677777888888888887743334777778888888777762 223344
Q ss_pred cccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccC-cccccCCCCcEEeccccccccccCccccccc
Q 002021 219 AIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIP-RFIFNASKLSILDLEGNSFSGFIPNTFGNLR 297 (979)
Q Consensus 219 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 297 (979)
.++...-..-..+.++++....+......+..+..--.+.+...++-| ..|..+++|+.|+|++|+|+++.+.+|.++.
T Consensus 219 etsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a 298 (498)
T KOG4237|consen 219 ETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA 298 (498)
T ss_pred hcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchh
Confidence 444444444455555555443332221111122111122222222323 3466777888888888888877777888888
Q ss_pred cccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCc
Q 002021 298 NLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTN 377 (979)
Q Consensus 298 ~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~ 377 (979)
.+++|.|..|+|..+...+ |.++.. |+.|+|.+|+|+...|.+|..+..
T Consensus 299 ~l~eL~L~~N~l~~v~~~~-----f~~ls~--------------------------L~tL~L~~N~it~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 299 ELQELYLTRNKLEFVSSGM-----FQGLSG--------------------------LKTLSLYDNQITTVAPGAFQTLFS 347 (498)
T ss_pred hhhhhhcCcchHHHHHHHh-----hhcccc--------------------------ceeeeecCCeeEEEecccccccce
Confidence 8888888888777655442 344444 444455555555556777777888
Q ss_pred ccEEEecCCCCC
Q 002021 378 LRTIYLGGNKLN 389 (979)
Q Consensus 378 L~~L~L~~N~l~ 389 (979)
|.+|+|-.|.+.
T Consensus 348 l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 348 LSTLNLLSNPFN 359 (498)
T ss_pred eeeeehccCccc
Confidence 888888887764
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=267.88 Aligned_cols=361 Identities=19% Similarity=0.234 Sum_probs=207.4
Q ss_pred CcEEEEEecCCCccc-cC-CCCCcCCCCCCeeeccCCc------ccccCCccccccC-cccEEecccccccccCCccccC
Q 002021 72 QRVTVLNISSLNLTG-TI-PSQLGNLSSLQSLNLSFNR------LFGSIPSAIFTTY-TLKYVCLRGNQLSGTFPSFISN 142 (979)
Q Consensus 72 ~~v~~l~l~~~~l~g-~~-~~~l~~l~~L~~L~L~~n~------~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~ 142 (979)
.+|..+.+.-..+.. .+ +.++.++.+|+.|.+..+. +...+|..+..++ +|+.|++.+|.+. .+|..+ .
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~ 609 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-R 609 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-C
Confidence 345554444333321 12 2468889999999997653 3445777777765 5889999888876 667666 4
Q ss_pred CCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccc
Q 002021 143 KSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFN 222 (979)
Q Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 222 (979)
+.+|+.|+|++|.+. .+|..+..+++|+.|+|+++...+.+| .++.+++|++|+|++|......|..+.+
T Consensus 610 ~~~L~~L~L~~s~l~---------~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~ 679 (1153)
T PLN03210 610 PENLVKLQMQGSKLE---------KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQY 679 (1153)
T ss_pred ccCCcEEECcCcccc---------ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhc
Confidence 688889999888875 467778888888888888776555666 4778888888888887665666777777
Q ss_pred cCccceeeccCCC-CcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccc
Q 002021 223 VSTLKILGLQDNS-LSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSW 301 (979)
Q Consensus 223 l~~L~~L~L~~N~-l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 301 (979)
+++|+.|++++|. +..++... .+++|++|++++|.....+|.. ..+|++|+|++|.+.
T Consensus 680 L~~L~~L~L~~c~~L~~Lp~~i---~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~--------------- 738 (1153)
T PLN03210 680 LNKLEDLDMSRCENLEILPTGI---NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE--------------- 738 (1153)
T ss_pred cCCCCEEeCCCCCCcCccCCcC---CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc---------------
Confidence 7777777777653 33322211 4555566666555433333321 234445555555444
Q ss_pred eeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEE
Q 002021 302 LVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTI 381 (979)
Q Consensus 302 L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L 381 (979)
.+|.. ..+++|++|+++.+....+.. .+....+..+...++|+.|
T Consensus 739 ---------~lP~~-------~~l~~L~~L~l~~~~~~~l~~-------------------~~~~l~~~~~~~~~sL~~L 783 (1153)
T PLN03210 739 ---------EFPSN-------LRLENLDELILCEMKSEKLWE-------------------RVQPLTPLMTMLSPSLTRL 783 (1153)
T ss_pred ---------ccccc-------ccccccccccccccchhhccc-------------------cccccchhhhhccccchhe
Confidence 33321 123344444444322111100 0000111112223455555
Q ss_pred EecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccc
Q 002021 382 YLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT 461 (979)
Q Consensus 382 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 461 (979)
+|++|.....+|..++++++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|.. .++|+.|+|++|.++
T Consensus 784 ~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~ 859 (1153)
T PLN03210 784 FLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE 859 (1153)
T ss_pred eCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc
Confidence 555555444455555555555555555554333455444 5666677777665544344432 245666777777777
Q ss_pred cccccccCcCCCcEEEecc-ccccCCCccccccccccceEeccCC
Q 002021 462 SIPLTFWNLKDILNLNFSS-NFLTGSLPLEIGSLKVLVGIDLSRN 505 (979)
Q Consensus 462 ~lp~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N 505 (979)
++|.++..+++|+.|++++ |+++ .+|..+..++.|+.+++++|
T Consensus 860 ~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 860 EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 6666666666666666665 3333 34445555555555555544
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=216.49 Aligned_cols=171 Identities=21% Similarity=0.194 Sum_probs=131.5
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|+|.+++...+..+++.+++.|+.|+++||+||| +++ ||+||+++.++.+|+ ||.+......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence 6888888876667999999999999999999999 666 999999999999999 9998865322
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
...||+.|+|||++.+..+++++|||||||++|||+||+.||............+.......... ..
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------~~ 129 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR-------------DR 129 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc-------------cc
Confidence 12578999999999999999999999999999999999999865433222222222111111000 00
Q ss_pred HHHHHHHH--HHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 923 VAKEQCVS--FVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 923 ~~~~~~~~--~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
........ ++.+++.+||..+|.+||++.|+++++..+....
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 01112222 6899999999999999999999999998886543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-25 Score=270.95 Aligned_cols=199 Identities=16% Similarity=0.199 Sum_probs=142.1
Q ss_pred HhcCC-CCeeeEEEee-------ccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 002021 733 KSIRH-RNLIKVISSC-------SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804 (979)
Q Consensus 733 ~~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~ 804 (979)
+.++| +||++++++| .+.+.++.++||+ +++|.+++......+++.+++.++.||++||+||| +++|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 34556 6888888887 2334567888988 55999999876667999999999999999999999 99999
Q ss_pred ecCCCCCCEEeCCC-------------------CcEEEEeeccccccCCCC--------------CcceecccccCCCCC
Q 002021 805 HCDLKPSNVLLDDN-------------------MVAHLSDFSIAKMLTGED--------------QSMIQTQTLATIGYM 851 (979)
Q Consensus 805 H~Dik~~NIll~~~-------------------~~~kl~Dfg~~~~~~~~~--------------~~~~~~~~~gt~~y~ 851 (979)
||||||+|||++.. +.+|++|||+++...... .........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 445566666654321100 000111245788999
Q ss_pred CccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHH
Q 002021 852 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 931 (979)
Q Consensus 852 aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 931 (979)
|||++.+..++.++|||||||++|||++|..|+..... .+....... .. +......+.
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~--------~~-----------~~~~~~~~~ 240 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRV--------LP-----------PQILLNWPK 240 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhh--------cC-----------hhhhhcCHH
Confidence 99999999999999999999999999998888653110 111100000 00 000011233
Q ss_pred HHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 932 VFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 932 l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
..+++.+||+++|.+||++.|+++|-
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhch
Confidence 56788999999999999999998763
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=246.75 Aligned_cols=262 Identities=27% Similarity=0.326 Sum_probs=164.9
Q ss_pred CcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCcc
Q 002021 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLK 329 (979)
Q Consensus 250 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~ 329 (979)
.-..|+|++|+|+ .+|..+. ++|+.|++++|+|+. +|.. .++|++|+|++|+|+.+|.. .++|+
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~LtsLP~l---------p~sL~ 265 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTSLPVL---------PPGLL 265 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCcccCc---------ccccc
Confidence 3456778888777 5666654 367777777777774 3432 35677777777776665421 23555
Q ss_pred EEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecC
Q 002021 330 YFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKD 409 (979)
Q Consensus 330 ~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 409 (979)
.|++++|.+..++. ++.+ |+.|++++|+++..+. ..++|+.|++++
T Consensus 266 ~L~Ls~N~L~~Lp~------lp~~------------------------L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~ 311 (788)
T PRK15387 266 ELSIFSNPLTHLPA------LPSG------------------------LCKLWIFGNQLTSLPV----LPPGLQELSVSD 311 (788)
T ss_pred eeeccCCchhhhhh------chhh------------------------cCEEECcCCccccccc----cccccceeECCC
Confidence 56666655544321 1233 4445555555443221 124455555555
Q ss_pred cccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCcc
Q 002021 410 NKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPL 489 (979)
Q Consensus 410 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~ 489 (979)
|++++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+.+|.. ..+|+.|++++|+|++ +|.
T Consensus 312 N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~-LP~ 379 (788)
T PRK15387 312 NQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPA 379 (788)
T ss_pred Ccccc-CCCC---cccccccccccCcccc-cccc---ccccceEecCCCccCCCCCC---Ccccceehhhcccccc-Ccc
Confidence 55553 3321 2345666677777663 3321 14677777777777777653 2456667777777774 454
Q ss_pred ccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCcccc
Q 002021 490 EIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYL 569 (979)
Q Consensus 490 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 569 (979)
.. .+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .+|..+.++++|
T Consensus 380 l~---~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L 447 (788)
T PRK15387 380 LP---SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSE 447 (788)
T ss_pred cc---cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCC
Confidence 32 467788888888874 4433 2568888888888884 66543 46788899999988 678888888999
Q ss_pred CeEeccCCcccccCCC
Q 002021 570 EDLNLSFNQLEGKIPR 585 (979)
Q Consensus 570 ~~L~L~~N~l~~~~p~ 585 (979)
+.|+|++|+|+|.+|.
T Consensus 448 ~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 448 TTVNLEGNPLSERTLQ 463 (788)
T ss_pred CeEECCCCCCCchHHH
Confidence 9999999999887765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.1e-23 Score=260.04 Aligned_cols=348 Identities=22% Similarity=0.278 Sum_probs=193.0
Q ss_pred cccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCC-ccceeecccccccccccccccCCCCCCceecCCCeeeecCC
Q 002021 139 FISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLP-ELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAP 217 (979)
Q Consensus 139 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 217 (979)
.|.++++|+.|.+..+..... .+....+|..|..++ +|+.|++.++.+. .+|..+ ...+|++|+|++|++..+ +
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~--~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L-~ 627 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQK--KEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKL-W 627 (1153)
T ss_pred HHhcCccccEEEEeccccccc--ccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccccc-c
Confidence 455556666666554432110 001112444444442 3555555555554 344444 234555555555555433 3
Q ss_pred ccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccc
Q 002021 218 IAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLR 297 (979)
Q Consensus 218 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 297 (979)
..+..+ ++|+.|+|++|.....+|. +..+++|++|+|++|.....+|..++.++
T Consensus 628 ~~~~~l-------------------------~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~ 681 (1153)
T PLN03210 628 DGVHSL-------------------------TGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLN 681 (1153)
T ss_pred cccccC-------------------------CCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccC
Confidence 333444 4444555544432223332 44445555555555544444455555555
Q ss_pred cccceecccc-ccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCC
Q 002021 298 NLSWLVLSDN-YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLT 376 (979)
Q Consensus 298 ~L~~L~Ls~N-~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~ 376 (979)
+|+.|++++| .++.+|.. .++++|++|++++|......| ..+.+|++|++++|.++ .+|..+ .++
T Consensus 682 ~L~~L~L~~c~~L~~Lp~~-------i~l~sL~~L~Lsgc~~L~~~p-----~~~~nL~~L~L~~n~i~-~lP~~~-~l~ 747 (1153)
T PLN03210 682 KLEDLDMSRCENLEILPTG-------INLKSLYRLNLSGCSRLKSFP-----DISTNISWLDLDETAIE-EFPSNL-RLE 747 (1153)
T ss_pred CCCEEeCCCCCCcCccCCc-------CCCCCCCEEeCCCCCCccccc-----cccCCcCeeecCCCccc-cccccc-ccc
Confidence 5555555543 23333321 134555556665554322211 12345667777777665 344443 466
Q ss_pred cccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecC
Q 002021 377 NLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLG 456 (979)
Q Consensus 377 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 456 (979)
+|+.|++.++...... +.+....+..+...++|+.|+|++|...+.+|..++++++|+.|+++
T Consensus 748 ~L~~L~l~~~~~~~l~-----------------~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls 810 (1153)
T PLN03210 748 NLDELILCEMKSEKLW-----------------ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIE 810 (1153)
T ss_pred ccccccccccchhhcc-----------------ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECC
Confidence 7777776654322100 01111112222334567777777776666677777777777777777
Q ss_pred CC-ccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCC-ccccCC
Q 002021 457 SN-ELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGY-NRLQGS 534 (979)
Q Consensus 457 ~N-~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~ 534 (979)
+| .++.+|..+ ++++|+.|++++|.....+|.. ..+|+.|+|++|.++ .+|.++..+++|+.|+|++ |+|. .
T Consensus 811 ~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~ 884 (1153)
T PLN03210 811 NCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-R 884 (1153)
T ss_pred CCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-c
Confidence 65 466777655 5777777777776554445543 357888889998887 6788888899999999988 5566 5
Q ss_pred CCCccccccccccccccccc
Q 002021 535 IPNSFGDLISLKFLNLSNNN 554 (979)
Q Consensus 535 ~p~~~~~l~~L~~L~Ls~N~ 554 (979)
+|..+..+++|+.|++++|.
T Consensus 885 l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 885 VSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cCcccccccCCCeeecCCCc
Confidence 77778888899999988874
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=248.04 Aligned_cols=268 Identities=24% Similarity=0.286 Sum_probs=185.6
Q ss_pred CccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCcccccccccccee
Q 002021 224 STLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLV 303 (979)
Q Consensus 224 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 303 (979)
..-..|+|++|.|+.++... .++|+.|++++|+|+ .+|.. +++|++|+|++|+|+.+ |.. .++|+.|+
T Consensus 201 ~~~~~LdLs~~~LtsLP~~l----~~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLTTLPDCL----PAHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTSL-PVL---PPGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCCcCCcch----hcCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCcc-cCc---ccccceee
Confidence 34668999999999766532 258999999999999 46653 58999999999999954 543 46899999
Q ss_pred ccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEe
Q 002021 304 LSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYL 383 (979)
Q Consensus 304 Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L 383 (979)
+++|.++.++.. .++|+.|++++|++..++. .+++|+.|++++|+|++ +|.. ..+|+.|++
T Consensus 269 Ls~N~L~~Lp~l---------p~~L~~L~Ls~N~Lt~LP~------~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~L 329 (788)
T PRK15387 269 IFSNPLTHLPAL---------PSGLCKLWIFGNQLTSLPV------LPPGLQELSVSDNQLAS-LPAL---PSELCKLWA 329 (788)
T ss_pred ccCCchhhhhhc---------hhhcCEEECcCCccccccc------cccccceeECCCCcccc-CCCC---ccccccccc
Confidence 999999876642 2568899999999987633 23568888888888775 3332 234556666
Q ss_pred cCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccc
Q 002021 384 GGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSI 463 (979)
Q Consensus 384 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 463 (979)
++|++++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+.+
T Consensus 330 s~N~L~~-------------------------LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~L 377 (788)
T PRK15387 330 YNNQLTS-------------------------LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL 377 (788)
T ss_pred ccCcccc-------------------------cccc---ccccceEecCCCccCC-CCCC---CcccceehhhccccccC
Confidence 6666653 2211 1245555666665553 3322 23455566666666666
Q ss_pred cccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccc
Q 002021 464 PLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLI 543 (979)
Q Consensus 464 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 543 (979)
|.. ..+|+.|++++|+|++ +|.. ..+|+.|++++|+|++ +|..+ .+|+.|+|++|+|+ .+|..+.+++
T Consensus 378 P~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~ 445 (788)
T PRK15387 378 PAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLS 445 (788)
T ss_pred ccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhcc
Confidence 643 2456677777777764 4432 2467788888888874 45433 46788889999988 6888888888
Q ss_pred cccccccccccccccCCccccCc
Q 002021 544 SLKFLNLSNNNLSGVIPASLEKL 566 (979)
Q Consensus 544 ~L~~L~Ls~N~l~~~~p~~~~~l 566 (979)
+|+.|+|++|+|++..|..+..+
T Consensus 446 ~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 446 SETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred CCCeEECCCCCCCchHHHHHHHH
Confidence 99999999999988877766443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-22 Score=201.54 Aligned_cols=275 Identities=17% Similarity=0.148 Sum_probs=214.6
Q ss_pred CCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
-.|.++++||+|.||+++.| ..-++++||||-=.. .....+...|.+.++.+. .++|...+.+-.++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 46899999999999999999 456899999996322 234567788999999985 79999999998999999999998
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----CCcEEEEeeccccccCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-----~~~~kl~Dfg~~~~~~~ 834 (979)
+ |.+|+|...-++..++.+++.-||.|+..-++|+| ++.+|.|||||+|+||.. ...+.++|||+|+.+..
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8 77999988878889999999999999999999999 999999999999999973 34689999999999876
Q ss_pred CCCcce-----ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 835 EDQSMI-----QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 835 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
+.+... .....||.+||+-....+.+-+.+.|+=|+|-+++..+-|..||....-...-. .+-+.-..+....+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~-kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE-KYEKIGETKRSTPI 260 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH-HHHHhccccccCCH
Confidence 654321 223469999999999999999999999999999999999999998753321111 11111111111111
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceec
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQ 975 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~ 975 (979)
.+ --+.+|.++..-+.-.-..+=.+-|..+=+..-+.++.+..-....++.+|-
T Consensus 261 ~~------------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~ 314 (449)
T KOG1165|consen 261 EV------------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM 314 (449)
T ss_pred HH------------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 11 1123455566666666666777889999888888888888888888888874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=218.48 Aligned_cols=275 Identities=21% Similarity=0.219 Sum_probs=209.3
Q ss_pred CCCCCceeeeecceEEEEEEcCC--CcEEEEEEeccccccchhcHHHHHHHHHhcCC----CCeeeEEEee-ccCCeeEE
Q 002021 683 GFSENNLIGRGGFGSVYKASLGD--GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH----RNLIKVISSC-SNEEFKAL 755 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 755 (979)
.|.+.+.||+|+||.||.|...+ ...+|+|.-..........+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999996533 35788888765433333378889999999873 6899999988 57888999
Q ss_pred EEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-----CcEEEEeeccc
Q 002021 756 VLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-----MVAHLSDFSIA 829 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~-----~~~kl~Dfg~~ 829 (979)
||+.+ |.+|.+...... ..++..++.+|+.|++.+|+++| +.|++||||||+|+++... ..+++.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 779999875543 68999999999999999999999 9999999999999999854 46999999999
Q ss_pred c--ccCCCCCc----ce--ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh
Q 002021 830 K--MLTGEDQS----MI--QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 901 (979)
Q Consensus 830 ~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~ 901 (979)
+ .+...... .+ .....||..|.++....+.+.+++.|+||++.++.|+..|..||........ ........
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence 8 43222211 11 1345699999999999999999999999999999999999999965433211 11100000
Q ss_pred cCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceeccC
Q 002021 902 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQSN 977 (979)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~~~ 977 (979)
...... . .....+.++.++...+-..+..++|....+...+++..........++.+|..+
T Consensus 254 ~~~~~~----~-----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~ 314 (322)
T KOG1164|consen 254 RKLLTD----R-----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVK 314 (322)
T ss_pred hhhccc----c-----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccc
Confidence 000000 0 011233456667777777889999999999999999988877777788888765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=222.18 Aligned_cols=167 Identities=21% Similarity=0.200 Sum_probs=130.1
Q ss_pred HhhCCCCCCceeeeecceEEEEEEcC--CCcEEEEEEecccc-----ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASLG--DGMEVAVKVFTSQC-----GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE 751 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (979)
...++|+..+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++|+|+++.+..+ +
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 34578999999999999999999553 57888999875331 12345689999999999999999644332 4
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCEEeCCCCcEEEEeecccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL-KPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Di-k~~NIll~~~~~~kl~Dfg~~~ 830 (979)
..++||||++|++|... ... . ...++.|+++||+||| ++||+|||| ||+||+++.++.+||+|||+|+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred CcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 57999999999999632 111 1 1468899999999999 999999999 9999999999999999999998
Q ss_pred ccCCCCCccee------cccccCCCCCCccccCCC
Q 002021 831 MLTGEDQSMIQ------TQTLATIGYMAPEYGREG 859 (979)
Q Consensus 831 ~~~~~~~~~~~------~~~~gt~~y~aPE~~~~~ 859 (979)
.+......... ....+++.|+|||++...
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 76544322211 345678889999988654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=238.56 Aligned_cols=321 Identities=19% Similarity=0.287 Sum_probs=227.7
Q ss_pred hhhcCCCChhHHHHHHHHHHhcccCCCC-ccccccCCCCCCCccce----------------eEeeCCCCcEEEEEecCC
Q 002021 20 ATANTSSTITDQDALLALKAHITHDPTN-FLAKNWNTSTPVCNWTG----------------VACEVHSQRVTVLNISSL 82 (979)
Q Consensus 20 ~~~~~~~~~~~~~all~~k~~~~~~~~~-~~~~~w~~~~~~c~w~g----------------v~c~~~~~~v~~l~l~~~ 82 (979)
+.....+++++.+.++...+.+..-++. .....|++.+++|.=.. |.|. ...|+.+..-|.
T Consensus 54 ~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~ 131 (754)
T PRK15370 54 CHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTES 131 (754)
T ss_pred hCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCcccccccccc
Confidence 3455567788889999999998543221 01124999999996544 5553 445666654442
Q ss_pred Cccc--------------------cCC--------CCC-----cCCCCCCeeeccCCcccccCCccccccCcccEEeccc
Q 002021 83 NLTG--------------------TIP--------SQL-----GNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRG 129 (979)
Q Consensus 83 ~l~g--------------------~~~--------~~l-----~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~ 129 (979)
.... .-+ ..+ +-..+...|++++++++ .+|..+. .+|+.|+|++
T Consensus 132 ~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~ 208 (754)
T PRK15370 132 EQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDN 208 (754)
T ss_pred cccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecC
Confidence 1100 000 001 12256789999999998 6787764 5799999999
Q ss_pred ccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCC
Q 002021 130 NQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGD 209 (979)
Q Consensus 130 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 209 (979)
|+|+ .+|..+. ++|++|+|++|+|++ +|..+. ++|+.|+|++|++. .+|..+. ++|++|+|++
T Consensus 209 N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts---------LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~ 271 (754)
T PRK15370 209 NELK-SLPENLQ--GNIKTLYANSNQLTS---------IPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFH 271 (754)
T ss_pred CCCC-cCChhhc--cCCCEEECCCCcccc---------CChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcC
Confidence 9999 5676554 589999999999973 666543 47999999999998 6777664 5899999999
Q ss_pred CeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEecccccccccc
Q 002021 210 NKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFI 289 (979)
Q Consensus 210 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 289 (979)
|+|+.+ |..+. ++|+.|++++|+|++.+... .++|+.|++++|+++. +|..+. ++|++|++++|.+++ +
T Consensus 272 N~L~~L-P~~l~--~sL~~L~Ls~N~Lt~LP~~l----p~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-L 340 (754)
T PRK15370 272 NKISCL-PENLP--EELRYLSVYDNSIRTLPAHL----PSGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-L 340 (754)
T ss_pred CccCcc-ccccC--CCCcEEECCCCccccCcccc----hhhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-C
Confidence 999975 55443 58999999999999765321 2579999999999984 565443 689999999999996 5
Q ss_pred CccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCC
Q 002021 290 PNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369 (979)
Q Consensus 290 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p 369 (979)
|..+. ++|+.|+|++|+|+.+|..+ .+.|++|++++|++..+++. ++.+|+.|++++|++++ +|
T Consensus 341 P~~l~--~sL~~L~Ls~N~L~~LP~~l--------p~~L~~LdLs~N~Lt~LP~~-----l~~sL~~LdLs~N~L~~-LP 404 (754)
T PRK15370 341 PASLP--PELQVLDVSKNQITVLPETL--------PPTITTLDVSRNALTNLPEN-----LPAALQIMQASRNNLVR-LP 404 (754)
T ss_pred Chhhc--CcccEEECCCCCCCcCChhh--------cCCcCEEECCCCcCCCCCHh-----HHHHHHHHhhccCCccc-Cc
Confidence 66554 68999999999999876432 25789999999988866432 23467777777777763 34
Q ss_pred ccc----cCCCcccEEEecCCCCC
Q 002021 370 EEI----SNLTNLRTIYLGGNKLN 389 (979)
Q Consensus 370 ~~l----~~l~~L~~L~L~~N~l~ 389 (979)
..+ +.++++..|++.+|.++
T Consensus 405 ~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 405 ESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred hhHHHHhhcCCCccEEEeeCCCcc
Confidence 332 33455666666666655
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=193.79 Aligned_cols=274 Identities=19% Similarity=0.175 Sum_probs=209.9
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCC-CCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH-RNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 758 (979)
.+.|..+++||.|+||.+|.| ...+|..||||+=...+ ...+...|.++++.+++ ..|..+..+..++.+-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 467999999999999999999 66789999999865432 23567789999999975 677777778888899999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC---CCCcEEEEeeccccccCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~Dfg~~~~~~~~ 835 (979)
.. |.+|++...-+...++.++++-.+-|++.-++|+| .++++||||||+|+|+. ....+.++|||+|+.+.+.
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 88 77999988877778999999999999999999999 99999999999999996 4567999999999987544
Q ss_pred CCcc-----eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc-cchh
Q 002021 836 DQSM-----IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS-TMEV 909 (979)
Q Consensus 836 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~ 909 (979)
.+.. ......||.+|.+-....+.+-+.+.|+-|+|.++...--|..||.+.........+-.-...+.. ..++
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEV 247 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHH
Confidence 3221 223456899999888777777788999999999999999999999875433221111000000000 0011
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCccee
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVR 974 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~ 974 (979)
.. ..+|.++.-.+.-|-..--++-|...-+-+.++-+.......++=-.+|
T Consensus 248 LC--------------~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW 298 (341)
T KOG1163|consen 248 LC--------------KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDW 298 (341)
T ss_pred Hh--------------CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeH
Confidence 11 2345667777888888878888998888888888877777776555555
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-22 Score=231.92 Aligned_cols=253 Identities=20% Similarity=0.204 Sum_probs=190.1
Q ss_pred CCceeeeecceEEEEE-EcCCCcEEEEEEeccc--cccc----hhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 686 ENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQ--CGRA----FKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 686 ~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
..+.+|.|++|.|+.+ +.......+.|.++.. .... ...+..|+-+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988877 3444555566654311 1111 1224557777778899999999888877766666699
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++ +|..++... ..++..++-.++.|+..|++|+| +.||.|||+|++|++++.++.+||+|||.+....-+...
T Consensus 402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 999988765 35788899999999999999999 999999999999999999999999999999765433332
Q ss_pred --ceecccccCCCCCCccccCCCCCCC-chhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 839 --MIQTQTLATIGYMAPEYGREGRVSA-NGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 839 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
......+|+..|+|||++.+.+|.+ ..||||.|+++..|.+|+.||......+..+.+ .......
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------------~~~~~~~ 544 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------------NNYSDQR 544 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------------hcccccc
Confidence 4556778999999999999998876 579999999999999999999765444333210 0000011
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVT 955 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~ 955 (979)
.............+.+...+|.++++.+|.+|.|+++|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1111222233455667889999999999999999999975
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6e-22 Score=228.23 Aligned_cols=249 Identities=22% Similarity=0.251 Sum_probs=184.0
Q ss_pred CCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc-ccchhcHHHHHHH--HHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC-GRAFKSFDVECEI--MKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++...+.+|.+.|=.|.+|+.+.|. |+||+|-++. ....+.|.++++- ...++|||++++.-+...+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777889999999999999998887 9999997654 2234455544333 5566899999999888788888999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC-CCCCc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT-GEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~-~~~~~ 838 (979)
+.+ +|+|.+..+. .+..-+...|+.|++.|+..+| +.||+|||||.+|||+++-..+.|+||..-+... +.++.
T Consensus 103 vkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 966 9999987654 5777788889999999999999 9999999999999999999999999998765322 23332
Q ss_pred c----eecccccCCCCCCccccCCC-----------CCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhc
Q 002021 839 M----IQTQTLATIGYMAPEYGREG-----------RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 839 ~----~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
. ...+...-.+|.|||.+... ..+++.||||+||+++|+++ |++||.-. ++-.|....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~- 251 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN- 251 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC-
Confidence 2 22333344689999976431 15688999999999999999 78887531 111111100
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
-.+++. .-..-....+..++..|++.||++|.+|++.++.-
T Consensus 252 ------~~~~e~--------~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 252 ------ADDPEQ--------LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ------ccCHHH--------HHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 000000 00000112478899999999999999999999883
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-21 Score=227.64 Aligned_cols=139 Identities=23% Similarity=0.398 Sum_probs=68.9
Q ss_pred CCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccC
Q 002021 425 ELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSR 504 (979)
Q Consensus 425 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 504 (979)
+|+.|++++|+++. +|..+. ++|+.|++++|.++.+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++
T Consensus 305 sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~ 376 (754)
T PRK15370 305 GITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSR 376 (754)
T ss_pred hHHHHHhcCCcccc-CCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCC
Confidence 34444444544442 222221 345555555555555554332 45555555555555 2343332 3566666666
Q ss_pred CccCcccchhhcCCcccceeecCCccccCCCCCccc----ccccccccccccccccccCCccccCccccCeEeccCCccc
Q 002021 505 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFG----DLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580 (979)
Q Consensus 505 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 580 (979)
|+|+. +|..+. .+|+.|++++|+|+ .+|..+. .++++..|+|.+|.++. ..+.+|+.| ++.|.+.
T Consensus 377 N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~ 445 (754)
T PRK15370 377 NALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQ 445 (754)
T ss_pred CcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhccccc
Confidence 66663 343333 24666666666666 3444332 23556666777776652 233444444 3445554
Q ss_pred cc
Q 002021 581 GK 582 (979)
Q Consensus 581 ~~ 582 (979)
|+
T Consensus 446 gp 447 (754)
T PRK15370 446 GP 447 (754)
T ss_pred CC
Confidence 44
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=203.35 Aligned_cols=258 Identities=31% Similarity=0.409 Sum_probs=197.6
Q ss_pred CCCCceeeeecceEEEEEEcCCCcEEEEEEecccccc---chhcHHHHHHHHHhcCCC-CeeeEEEeeccCCeeEEEEEe
Q 002021 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR---AFKSFDVECEIMKSIRHR-NLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~ 759 (979)
|...+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999775 78999998755432 367789999999999988 799999999777778999999
Q ss_pred cCCCccceeeccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEEeeccccccCCCC
Q 002021 760 MPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFSIAKMLTGED 836 (979)
Q Consensus 760 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg~~~~~~~~~ 836 (979)
+.++++.+++.... ..+.......++.|++.+++|+| ..+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999996665543 26889999999999999999999 99999999999999999988 79999999998654333
Q ss_pred Ccc----eecccccCCCCCCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCcccccC--cchHhHhhhhhcCCccc
Q 002021 837 QSM----IQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNG--EMTLKHWVNDWLPISTM 907 (979)
Q Consensus 837 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~P~~~~~~~--~~~~~~~~~~~~~~~~~ 907 (979)
... ......++..|+|||...+ ..+....|+|++|++++++++|..||...... .......+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 221 2356789999999999887 57889999999999999999999997654321 11111111111100
Q ss_pred hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........... ......+.+++.+|+..+|..|.+..+...+
T Consensus 234 -----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000000 2223457889999999999999999988776
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=185.25 Aligned_cols=139 Identities=19% Similarity=0.218 Sum_probs=108.4
Q ss_pred CceeeeecceEEEEEEcCCCcEEEEEEecccccc--c-------hhcH-----------------HHHHHHHHhcCCCCe
Q 002021 687 NNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR--A-------FKSF-----------------DVECEIMKSIRHRNL 740 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~-------~~~~-----------------~~E~~~l~~l~h~ni 740 (979)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998778999999998754211 0 1122 349999999988776
Q ss_pred eeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCEEeCCCC
Q 002021 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAPVIHCDLKPSNVLLDDNM 819 (979)
Q Consensus 741 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~i~H~Dik~~NIll~~~~ 819 (979)
.....+.. ...++||||++++++...... ...++++++..++.|++.+++|+ | +.+|+||||||+||+++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 43333222 223899999998877654332 23688999999999999999999 7 88999999999999998 47
Q ss_pred cEEEEeecccccc
Q 002021 820 VAHLSDFSIAKML 832 (979)
Q Consensus 820 ~~kl~Dfg~~~~~ 832 (979)
.++++|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-20 Score=188.95 Aligned_cols=171 Identities=13% Similarity=0.142 Sum_probs=133.0
Q ss_pred hhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchh---c------HHHHHHHHHhcCCCCeeeEEEeeccC
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFK---S------FDVECEIMKSIRHRNLIKVISSCSNE 750 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~~ 750 (979)
..++|...+.+|.|+||.||.+.. ++..+|||++++......+ . +.+|++.+.+++||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999866 5778999999755332222 2 67899999999999999999886532
Q ss_pred --------CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEE
Q 002021 751 --------EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 822 (979)
Q Consensus 751 --------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~k 822 (979)
+..++||||++|.+|.++.. +++ ....+++.++..+| ..|++|||+||+||++++++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence 35789999999999987631 232 34669999999999 99999999999999999988 99
Q ss_pred EEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHH
Q 002021 823 LSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETF 878 (979)
Q Consensus 823 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 878 (979)
++|||........ ... ..+.....+..++|+|+||+++....
T Consensus 175 liDfg~~~~~~e~-~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQR-KAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccch-hhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988654211 110 01333445667899999999877543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-19 Score=177.94 Aligned_cols=140 Identities=23% Similarity=0.254 Sum_probs=110.3
Q ss_pred CceeeeecceEEEEEEcCCCcEEEEEEeccccccc--------------------------hhcHHHHHHHHHhcCCCCe
Q 002021 687 NNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRA--------------------------FKSFDVECEIMKSIRHRNL 740 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 740 (979)
.+.||+|+||.||+|...+|+.||||+++...... ...+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999977689999999987542110 1123578999999999987
Q ss_pred eeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCC
Q 002021 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNM 819 (979)
Q Consensus 741 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~ 819 (979)
.....+.... .++||||++++++...... ...++..++..++.|++.++.++| . .||+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CC
Confidence 5444433322 4899999998765433222 235778899999999999999999 7 9999999999999999 88
Q ss_pred cEEEEeeccccccC
Q 002021 820 VAHLSDFSIAKMLT 833 (979)
Q Consensus 820 ~~kl~Dfg~~~~~~ 833 (979)
.++++|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-20 Score=207.32 Aligned_cols=217 Identities=23% Similarity=0.231 Sum_probs=115.3
Q ss_pred eeeccCCccc-ccCCccccccCcccEEecccccccc----cCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCC
Q 002021 100 SLNLSFNRLF-GSIPSAIFTTYTLKYVCLRGNQLSG----TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGN 174 (979)
Q Consensus 100 ~L~L~~n~~~-~~~p~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~ 174 (979)
.|+|.++.++ +..+..+..+.+|++|++++|.+++ .++..+...++|++|+++++.+.+. ......++..+..
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~--~~~~~~~~~~l~~ 79 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRI--PRGLQSLLQGLTK 79 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCc--chHHHHHHHHHHh
Confidence 4677777776 3345555566667777777777643 2445555666677777777666420 0111223444555
Q ss_pred CCccceeecccccccccccccccCCCC---CCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCC-CC
Q 002021 175 LPELELMSLAANNLQGKIPLKIGNLRN---LEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARL-PN 250 (979)
Q Consensus 175 l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l-~~ 250 (979)
+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++.....+ ...+..+ ++
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l---------------------~~~l~~~~~~ 138 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL---------------------AKGLKDLPPA 138 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH---------------------HHHHHhCCCC
Confidence 666666666666665444444444433 5555555555542111000 0112233 55
Q ss_pred cCEEEccCCcccc----ccCcccccCCCCcEEeccccccccc----cCccccccccccceeccccccccccchhhhhhcc
Q 002021 251 LEILSLWGNNFSG----TIPRFIFNASKLSILDLEGNSFSGF----IPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSL 322 (979)
Q Consensus 251 L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l 322 (979)
|+.|++++|.+++ .++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.++..... .+...+
T Consensus 139 L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~-~l~~~~ 217 (319)
T cd00116 139 LEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS-ALAETL 217 (319)
T ss_pred ceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH-HHHHHh
Confidence 5555555555552 2233444555666666666666632 222334445677777777766543321 122345
Q ss_pred cCCCCccEEEccCCCCcc
Q 002021 323 SNCKFLKYFDLSYNPLYR 340 (979)
Q Consensus 323 ~~l~~L~~L~Ls~N~l~~ 340 (979)
..+++|++|++++|++.+
T Consensus 218 ~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 218 ASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred cccCCCCEEecCCCcCch
Confidence 566777777777776654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=171.50 Aligned_cols=187 Identities=15% Similarity=0.107 Sum_probs=139.1
Q ss_pred CCCCceeeeecceEEEEEEcCCCcEEEEEEecccccc----chhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEEE
Q 002021 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR----AFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 758 (979)
+.....|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|+++. |+++.+++++ ...+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999998876 6788888877544221 1225789999999995 5789999886 34689999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL-KPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Di-k~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
|++|.+|.+.... ....++.|++++++++| .+||+|||| ||+||++++++.++|+|||++........
T Consensus 79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999888654311 12357889999999999 999999999 79999999999999999999985432221
Q ss_pred c---ce--------ecccccCCCCCCccccCCC-CCC-CchhHHHHHHHHHHHHcCCCCCcc
Q 002021 838 S---MI--------QTQTLATIGYMAPEYGREG-RVS-ANGDVYSFGIMLMETFTGKKPTDE 886 (979)
Q Consensus 838 ~---~~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~el~tg~~P~~~ 886 (979)
. .. ......++.|++|+...-- ..+ .+.+.++-|.-+|+++|++.|.-.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 00 1112356777777743221 223 567899999999999999998644
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.6e-21 Score=174.88 Aligned_cols=180 Identities=28% Similarity=0.472 Sum_probs=144.4
Q ss_pred ccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccce
Q 002021 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVG 499 (979)
Q Consensus 420 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 499 (979)
+.++..++.|.||+|+++ .+|..++.+.+|+.|++++|+|+++|..++.+++|+.|+++-|++. ..|..|+.++.|+.
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 345666777888888887 5666778888888888888888888888888888888888888887 67888888888888
Q ss_pred EeccCCccCc-ccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCc
Q 002021 500 IDLSRNNFSG-VIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578 (979)
Q Consensus 500 L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 578 (979)
|||++|++.. ..|..|..++.|+.|+|++|.++ .+|..++++++|+.|.+.+|.+- ..|..++.+++|++|++.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 8888888864 57888888888888999999888 78888888999999999888887 778888888889999999999
Q ss_pred ccccCCCCCCCC---CcccccccCCccc
Q 002021 579 LEGKIPRGGSFG---NFSAQSFEGNELL 603 (979)
Q Consensus 579 l~~~~p~~~~~~---~~~~~~~~~N~~~ 603 (979)
++-..|+.+.+. .-.....+.|||.
T Consensus 185 l~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 185 LTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred eeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 888777755433 2334556677663
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.3e-19 Score=195.85 Aligned_cols=216 Identities=27% Similarity=0.413 Sum_probs=165.7
Q ss_pred HHhcCCCCeeeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EecCCCC
Q 002021 732 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV-IHCDLKP 810 (979)
Q Consensus 732 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-~H~Dik~ 810 (979)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+......+++.-...+.++|+.|++|+| ..+| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 35688999999999999999999999999999999999988778999999999999999999999 5555 8999999
Q ss_pred CCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCC-------CCCchhHHHHHHHHHHHHcCCCC
Q 002021 811 SNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR-------VSANGDVYSFGIMLMETFTGKKP 883 (979)
Q Consensus 811 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~tg~~P 883 (979)
.|.++|..+.+|++|||+....................-|.|||.+.... .+.++||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987764211111112223446799999887631 46679999999999999999999
Q ss_pred CcccccCcc--hHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 884 TDEIFNGEM--TLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 884 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
|+....... ....+++. .....+.+.+ .......+++..++.+||..+|++||++++|-..++.+.
T Consensus 158 ~~~~~~~~~~~eii~~~~~----~~~~~~rP~i--------~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK----GGSNPFRPSI--------ELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cccccccCChHHHHHHHHh----cCCCCcCcch--------hhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 987443333 22222222 0111111111 111134456899999999999999999999998888776
Q ss_pred H
Q 002021 962 D 962 (979)
Q Consensus 962 ~ 962 (979)
.
T Consensus 226 ~ 226 (484)
T KOG1023|consen 226 K 226 (484)
T ss_pred c
Confidence 5
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=204.19 Aligned_cols=254 Identities=22% Similarity=0.234 Sum_probs=187.1
Q ss_pred hhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC---CCCeeeEEEeeccCCeeEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR---HRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 756 (979)
....|.+.+.||+|+||.||+|...+|+.||+|+=++....+. .-=.+++.+++ -+.|.++..++.-.+.-++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3456778889999999999999888899999998766543322 12234455555 34455555555556777899
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-------CCCcEEEEeeccc
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-------DNMVAHLSDFSIA 829 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~-------~~~~~kl~Dfg~~ 829 (979)
+||.+.|+|.+++... ...++.-+..+..|++..+++|| ..+|||+||||+|.++. +...++|+|||.+
T Consensus 773 ~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 9999999999999844 47899999999999999999999 99999999999999994 3456899999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
..+..-.........++|-.+..+|...+..+++++|.|+++.+++-|+.|++-= ..++ ..+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g-------------~~~~-- 911 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNG-------------SSWM-- 911 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCC-------------ccee--
Confidence 8876555556677888999999999999999999999999999999999998631 0000 0000
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
++..+ .+.+. ... ..+++..+++.|=..=|...++...|+++.+....
T Consensus 912 ~~~~~-----~Ry~~-~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 912 VKTNF-----PRYWK-RDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred ccccc-----hhhhh-HHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 00000 01111 111 33455555556656677888888888887765544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.4e-20 Score=204.33 Aligned_cols=208 Identities=23% Similarity=0.276 Sum_probs=105.1
Q ss_pred ccCCCcccEEEecCCCCCchhHHhhhcCCC---CcEEEecCcccCC----CccccccCC-CCCceEecCCCccccc----
Q 002021 372 ISNLTNLRTIYLGGNKLNGSILITLSKLQK---LQDLGLKDNKLEG----SIPYDICNL-AELYRLDLDGNKLSGS---- 439 (979)
Q Consensus 372 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~---- 439 (979)
+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|.+.+ .+...+..+ ++|+.|++++|.+++.
T Consensus 77 l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 156 (319)
T cd00116 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA 156 (319)
T ss_pred HHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence 333444444444444444333333333332 4444444444431 111222333 4455555555554421
Q ss_pred CCccccCCCcCceEecCCCcccc-----ccccccCcCCCcEEEeccccccCC----CccccccccccceEeccCCccCcc
Q 002021 440 IPACFSNLTSLRIVSLGSNELTS-----IPLTFWNLKDILNLNFSSNFLTGS----LPLEIGSLKVLVGIDLSRNNFSGV 510 (979)
Q Consensus 440 ~~~~~~~l~~L~~L~L~~N~l~~-----lp~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ 510 (979)
++..+..+++|++|++++|.++. ++..+...++|+.|++++|.+++. ++..+..+++|+.|++++|.+++.
T Consensus 157 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~ 236 (319)
T cd00116 157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA 236 (319)
T ss_pred HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence 12233344455555555555541 222333444555666665555422 223344566677777777777653
Q ss_pred cchhhcC-----CcccceeecCCccccC----CCCCccccccccccccccccccccc----CCccccCc-cccCeEeccC
Q 002021 511 IPTEIGG-----LKNLEYLFLGYNRLQG----SIPNSFGDLISLKFLNLSNNNLSGV----IPASLEKL-SYLEDLNLSF 576 (979)
Q Consensus 511 ~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~L~~ 576 (979)
....+.. .+.|+.|++++|.++. .+...+..+++|+++|+++|.++.. ....+... +.|+.|++.+
T Consensus 237 ~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (319)
T cd00116 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKD 316 (319)
T ss_pred HHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCC
Confidence 3333322 3677777887777752 2234455557778888888887743 33344444 6777788777
Q ss_pred Ccc
Q 002021 577 NQL 579 (979)
Q Consensus 577 N~l 579 (979)
|+|
T Consensus 317 ~~~ 319 (319)
T cd00116 317 DSF 319 (319)
T ss_pred CCC
Confidence 764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.9e-20 Score=201.61 Aligned_cols=224 Identities=24% Similarity=0.282 Sum_probs=181.0
Q ss_pred eeeecceEEEEEE----cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 690 IGRGGFGSVYKAS----LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 690 lG~G~~g~Vy~~~----~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+|+|+||.|+.+. .+.|..+|.|+.++... +.......|..++...+ ||.+|++...++.+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999873 24577799998865532 22235667899999997 99999999999999999999999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceec
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 842 (979)
|++...+.... .+++.........++-+++++| +.+|+|||+|++||+++.+|.+++.|||.++..-...
T Consensus 82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------ 151 (612)
T KOG0603|consen 82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------ 151 (612)
T ss_pred chhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh------
Confidence 99988887654 4677777788999999999999 9999999999999999999999999999998753222
Q ss_pred ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 843 QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
..+||..|||||++. ....++|.||||++++||+||..||.. +.... ......
T Consensus 152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~--------------------Il~~~~ 204 (612)
T KOG0603|consen 152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKR--------------------ILKAEL 204 (612)
T ss_pred hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHH--------------------Hhhhcc
Confidence 228999999999987 456789999999999999999999865 11111 111123
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCH
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINA 950 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 950 (979)
..+......+.+++.++...+|..|.-.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 3445666778889999999999998855
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-20 Score=171.16 Aligned_cols=182 Identities=31% Similarity=0.519 Sum_probs=140.4
Q ss_pred CCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEe
Q 002021 399 LQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNF 478 (979)
Q Consensus 399 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l 478 (979)
+.+++.|.|++|+++ .+|..+..+.+|+.|++++|+|. ..|..++.++.|+.|+++-|++..+|..|+.++.|+.|||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhc
Confidence 344555555566655 45666677777777777777776 5666777777777777777777777777777777777777
Q ss_pred cccccc-CCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccc
Q 002021 479 SSNFLT-GSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSG 557 (979)
Q Consensus 479 s~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 557 (979)
+.|++. ..+|..|-.++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|..++.++.|+.|.+.+|+++
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~- 186 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT- 186 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-
Confidence 777765 357788888889999999999997 88999999999999999999998 79999999999999999999998
Q ss_pred cCCccccCcc---ccCeEeccCCcccccCCC
Q 002021 558 VIPASLEKLS---YLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 558 ~~p~~~~~l~---~L~~L~L~~N~l~~~~p~ 585 (979)
++|+.++++. +-+.+.+.+|+|-.+|.+
T Consensus 187 vlppel~~l~l~~~k~v~r~E~NPwv~pIae 217 (264)
T KOG0617|consen 187 VLPPELANLDLVGNKQVMRMEENPWVNPIAE 217 (264)
T ss_pred ecChhhhhhhhhhhHHHHhhhhCCCCChHHH
Confidence 7887777653 345577888888765543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=178.57 Aligned_cols=230 Identities=22% Similarity=0.326 Sum_probs=143.8
Q ss_pred CCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcC----------CCCeeeEEEee--
Q 002021 684 FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIR----------HRNLIKVISSC-- 747 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~-- 747 (979)
+...+.||.|+++.||.++ ..+|+.+|||++.... ....+.+++|.-....+. |-.++-.++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3456789999999999995 5579999999986543 223455666654444322 21222222211
Q ss_pred ----------ccCC-----eeEEEEEecCCCccceeecc---CC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 002021 748 ----------SNEE-----FKALVLEYMPHGSLEKYLYS---SN---CILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806 (979)
Q Consensus 748 ----------~~~~-----~~~lv~E~~~~g~L~~~l~~---~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~ 806 (979)
.... ..+++|+-+ .++|.+++.. .. .......+..+..|+.+.+++|| ..|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 1111 225678877 4588777532 11 12334455677899999999999 9999999
Q ss_pred CCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCC--------CCCCCchhHHHHHHHHHHHH
Q 002021 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE--------GRVSANGDVYSFGIMLMETF 878 (979)
Q Consensus 807 Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~ 878 (979)
||||+|++++++|.++|+||+.....+. ... . ...+..|.|||.... -.++.+.|.|++|+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---RYR-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE---EEE-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc---eee-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999998876431 111 1 345578999996533 24788999999999999999
Q ss_pred cCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCC
Q 002021 879 TGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQR 947 (979)
Q Consensus 879 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 947 (979)
+|+.||+......... | .+. ... +.+..+.+||..+++.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~--~----------------~f~------~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPE--W----------------DFS------RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSG--G----------------GGT------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCcccccc--c----------------cch------hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999997542221110 0 000 011 455678999999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.7e-18 Score=173.70 Aligned_cols=198 Identities=18% Similarity=0.215 Sum_probs=143.1
Q ss_pred CCCCeeeEEEeecc---------------------------CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHH
Q 002021 736 RHRNLIKVISSCSN---------------------------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 788 (979)
Q Consensus 736 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i 788 (979)
+|||||++.++|.+ +...|+||...+. +|.+|+... ..+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 59999999987632 2356888988865 888888665 35666777899999
Q ss_pred HHHHHHHhcCCCCCeEecCCCCCCEEeC--CCC--cEEEEeeccccccCCC----CCcceecccccCCCCCCccccCCCC
Q 002021 789 ASALEYLHFGYSAPVIHCDLKPSNVLLD--DNM--VAHLSDFSIAKMLTGE----DQSMIQTQTLATIGYMAPEYGREGR 860 (979)
Q Consensus 789 a~~L~~LH~~~~~~i~H~Dik~~NIll~--~~~--~~kl~Dfg~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~ 860 (979)
++|+.||| ++||.|||+|++|||+. +++ ...++|||.+-.-... +.........|....||||+.....
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 99999999999999994 333 5789999998543221 1112223345777899999875321
Q ss_pred ------CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHH
Q 002021 861 ------VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 934 (979)
Q Consensus 861 ------~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 934 (979)
.-.++|.|+.|.+.||+++...||+...+-..+...|... .-+..++.|++.+.+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~-------------------qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES-------------------QLPALPSRVPPVARQ 488 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh-------------------hCCCCcccCChHHHH
Confidence 1358999999999999999999998622222222221111 112234578888999
Q ss_pred HHHhccccCcCCCCCHHHHHHHHH
Q 002021 935 LAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 935 l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
++...++.||.+|+++.-....+.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999876655543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=167.91 Aligned_cols=136 Identities=15% Similarity=0.258 Sum_probs=107.1
Q ss_pred CCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhc-----CCCCeeeEEEeeccCC---e-eEE
Q 002021 685 SENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-----RHRNLIKVISSCSNEE---F-KAL 755 (979)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 755 (979)
...+.||+|+||.||. ...++.. +||++........+.+.+|+++++.+ .||||+++++++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 4344544 79988765444557789999999999 5799999999997763 3 337
Q ss_pred EEEe--cCCCccceeeccCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCCEEeCC----CCcEEEEeecc
Q 002021 756 VLEY--MPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDFSI 828 (979)
Q Consensus 756 v~E~--~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~i~H~Dik~~NIll~~----~~~~kl~Dfg~ 828 (979)
|+|| +.+|+|.+++.+. .+++. ..++.|++.++ +||| +++|+||||||+||+++. ++.++|+||+.
T Consensus 83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 8999 5579999999664 35554 35678888777 9999 999999999999999974 34899999544
Q ss_pred c
Q 002021 829 A 829 (979)
Q Consensus 829 ~ 829 (979)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=169.14 Aligned_cols=141 Identities=20% Similarity=0.189 Sum_probs=111.1
Q ss_pred CCCCCceeeeecceEEEEEE--cCCCcEEEEEEecccccc------------------------chhcHHHHHHHHHhcC
Q 002021 683 GFSENNLIGRGGFGSVYKAS--LGDGMEVAVKVFTSQCGR------------------------AFKSFDVECEIMKSIR 736 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 736 (979)
.|++.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999997 568999999998643210 0123567999999997
Q ss_pred CC--CeeeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCCE
Q 002021 737 HR--NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP-VIHCDLKPSNV 813 (979)
Q Consensus 737 h~--niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-i~H~Dik~~NI 813 (979)
+. .+.+++++ ...++||||++++++..+.... ......++..++.|++.++++|| +++ |+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence 53 33444443 2358999999998887765332 24566677899999999999999 999 99999999999
Q ss_pred EeCCCCcEEEEeecccccc
Q 002021 814 LLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 814 ll~~~~~~kl~Dfg~~~~~ 832 (979)
+++ ++.++++|||.+...
T Consensus 181 li~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEE-CCCEEEEEChhhhcc
Confidence 999 889999999998764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-16 Score=164.23 Aligned_cols=134 Identities=25% Similarity=0.346 Sum_probs=113.2
Q ss_pred ceeeeecceEEEEEEcCCCcEEEEEEecccccc--------chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR--------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+.||+|++|.||+|.+ +|..|+||+....... ....+.+|++++..++|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6788999986543211 123567899999999999988777777677788999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
++|++|.+++.... . ++..++.+++.+++++| ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999998876532 2 78899999999999999 99999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=159.61 Aligned_cols=142 Identities=23% Similarity=0.180 Sum_probs=110.8
Q ss_pred HHHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccccc----------------------chhcHHHHHHHHHh
Q 002021 677 LCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR----------------------AFKSFDVECEIMKS 734 (979)
Q Consensus 677 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~----------------------~~~~~~~E~~~l~~ 734 (979)
+......|...+.||+|+||.||+|...+|+.||||++...... ....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333347778899999999999998888999999987543210 01235678889999
Q ss_pred cCCC--CeeeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 002021 735 IRHR--NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 812 (979)
Q Consensus 735 l~h~--niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~N 812 (979)
+.|+ .+.+.++. ...++||||+++++|.+.... .....++.+++.++.++| .++|+||||||+|
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~N 155 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFN 155 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCccc
Confidence 8877 44444442 345899999999998765431 345678999999999999 8999999999999
Q ss_pred EEeCCCCcEEEEeecccccc
Q 002021 813 VLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 813 Ill~~~~~~kl~Dfg~~~~~ 832 (979)
|++++++.++++|||.+...
T Consensus 156 ill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EEEcCCCcEEEEECCccccC
Confidence 99999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.3e-16 Score=187.82 Aligned_cols=152 Identities=28% Similarity=0.496 Sum_probs=121.6
Q ss_pred CCCChhHHHHHHHHHHhcccCCCCccccccCCCCCCC----ccceeEeeCC--C--CcEEEEEecCCCccccCCCCCcCC
Q 002021 24 TSSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVC----NWTGVACEVH--S--QRVTVLNISSLNLTGTIPSQLGNL 95 (979)
Q Consensus 24 ~~~~~~~~~all~~k~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~~--~--~~v~~l~l~~~~l~g~~~~~l~~l 95 (979)
..+.+.|.+||+++|+++. +|.. .+|++ .+|| .|.||+|... . .+|+.|+|++|+++|.+|+.++.|
T Consensus 367 ~~t~~~~~~aL~~~k~~~~-~~~~---~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLG-LPLR---FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred cccCchHHHHHHHHHHhcC-Cccc---CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 3456689999999999984 4432 37965 3453 7999999632 2 258999999999999999999999
Q ss_pred CCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCC
Q 002021 96 SSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNL 175 (979)
Q Consensus 96 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l 175 (979)
++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+++|. +|..++.+
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~--------iP~~l~~~ 513 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR--------VPAALGGR 513 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCccccc--------CChHHhhc
Confidence 9999999999999999999999999999999999999999998888999999999999888875 66666543
Q ss_pred -Cccceeecccccc
Q 002021 176 -PELELMSLAANNL 188 (979)
Q Consensus 176 -~~L~~L~L~~N~l 188 (979)
.++..+++.+|..
T Consensus 514 ~~~~~~l~~~~N~~ 527 (623)
T PLN03150 514 LLHRASFNFTDNAG 527 (623)
T ss_pred cccCceEEecCCcc
Confidence 3455566666543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.6e-16 Score=183.69 Aligned_cols=138 Identities=20% Similarity=0.265 Sum_probs=111.9
Q ss_pred hhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEec-cccc-------cchhcHHHHHHHHHhcCCCCeeeEEEeeccCC
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFT-SQCG-------RAFKSFDVECEIMKSIRHRNLIKVISSCSNEE 751 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~-~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (979)
....|...+.||+|+||.||+|.+.+. .+++|+.. +... ...+.+.+|+++++.++|++++....++.++.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 344456788999999999999987544 44444332 1111 11245788999999999999998888777777
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..++||||+++++|.+++. ....++.+++++++||| +.+++|||+||+||++ +++.++++|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7899999999999988764 45679999999999999 9999999999999999 678999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.5e-16 Score=159.84 Aligned_cols=130 Identities=21% Similarity=0.342 Sum_probs=105.9
Q ss_pred eeeeecceEEEEEEcCCCcEEEEEEecccccc--------chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 689 LIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR--------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 689 ~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.||+|+||.||+|.+ +|..|++|+....... ..+.+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 6788999986532211 1245678999999999887655555555666678999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
+|++|.+++..... .++.+++.+++++| ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887654321 78999999999999 99999999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.4e-16 Score=179.24 Aligned_cols=212 Identities=24% Similarity=0.267 Sum_probs=145.7
Q ss_pred hCCCCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..+|+.++.|..|+||.||.+++. ..+.+|+|. .++... .+. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-lRn------ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-LRN------ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh-hhc------cccccCCccee------------------
Confidence 367999999999999999999654 467788853 322110 000 33333444444
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC--
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ-- 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 837 (979)
|+-...+...+ .+.... +.+++|+| ..+|+|||+||+|.+|+.-|.+|++|||+++...-.-.
T Consensus 136 ---gDc~tllk~~g-~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG-PLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhcccCC-CCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444443322 222222 78999999 99999999999999999999999999999875321100
Q ss_pred ----------c-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCcc
Q 002021 838 ----------S-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 906 (979)
Q Consensus 838 ----------~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 906 (979)
. ......+||+.|.|||++....|+..+|.|++|+|+||.+.|+.||..... ++.+.+.+.+.+...
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~wp- 278 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEWP- 278 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhcccc-
Confidence 0 112345899999999999999999999999999999999999999876322 222333222222110
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAK 951 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 951 (979)
...+..++++.+++.+.++.+|..|.-..
T Consensus 279 ----------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 279 ----------------EEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ----------------ccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 01123456789999999999999997443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.8e-16 Score=170.89 Aligned_cols=174 Identities=24% Similarity=0.366 Sum_probs=131.1
Q ss_pred CeeEEEEEecCCCccceeeccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecc
Q 002021 751 EFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSI 828 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~ 828 (979)
.+.|+.|++++..+|.+|+... ....++.....++.|++.|++| ++.+|||+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 4578999999999999999643 5567888899999999999999 6899999999999999999999999999
Q ss_pred ccccCCCC----CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcC
Q 002021 829 AKMLTGED----QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLP 903 (979)
Q Consensus 829 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 903 (979)
........ .....+..+||..||+||.+.+..|+.++||||+|++++|+++ -..+++.. .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~--------~------- 467 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI--------A------- 467 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH--------H-------
Confidence 98765333 2334466789999999999999999999999999999999997 33333210 0
Q ss_pred CccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHH
Q 002021 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953 (979)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ei 953 (979)
....++...+.+ ....+ .+.-+++..+++.+.|.+||++.+.
T Consensus 468 --t~~d~r~g~ip~-----~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 468 --TLTDIRDGIIPP-----EFLQD-YPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --hhhhhhcCCCCh-----HHhhc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence 000011111110 00111 1335678999999999999955544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.1e-16 Score=183.66 Aligned_cols=256 Identities=24% Similarity=0.276 Sum_probs=198.7
Q ss_pred CCCCCCceeeeecceEEEEEEcC--CCcEEEEEEecccc--ccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG--DGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 756 (979)
..|...+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45777788999999999988543 34456777654332 233444555777777776 99999999999999999999
Q ss_pred EEecCCCccceee-ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEEeeccccccCC
Q 002021 757 LEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFSIAKMLTG 834 (979)
Q Consensus 757 ~E~~~~g~L~~~l-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg~~~~~~~ 834 (979)
+||.+++++.+.+ .......+...+...+.|+..++.|+|. ..++.|||+||+|.+++..+ ..++.|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999988 5443356677788899999999999995 67999999999999999999 999999999988766
Q ss_pred -CCCcceeccccc-CCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 835 -EDQSMIQTQTLA-TIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 835 -~~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
.+........+| ++.|+|||...+ +...+..|+||.|+++.-+++|..||.........+..|.......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 250 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF------- 250 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc-------
Confidence 455555566778 999999999887 4567889999999999999999999987665554444443322100
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVT 955 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~ 955 (979)
....+........++..+++..+|..|.+.+++..
T Consensus 251 ---------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 ---------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 01112233445778899999999999999988754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=147.34 Aligned_cols=136 Identities=24% Similarity=0.282 Sum_probs=98.9
Q ss_pred CceeeeecceEEEEEEcCCCcEEEEEEecccccc--chhc----------------------HHHHHHHHHhcCCCC--e
Q 002021 687 NNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR--AFKS----------------------FDVECEIMKSIRHRN--L 740 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 740 (979)
.+.||+|+||.||+|...+|+.||||++...... .... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998778999999998653211 1111 134566666664432 4
Q ss_pred eeEEEeeccCCeeEEEEEecCCCcccee-eccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCC
Q 002021 741 IKVISSCSNEEFKALVLEYMPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDN 818 (979)
Q Consensus 741 v~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~ 818 (979)
.+.+++ ...++||||++++++... +.... . ..++..++.+++.++.++| . ++|+|||+||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 444443 235899999999654322 11111 1 1567889999999999999 7 9999999999999999 8
Q ss_pred CcEEEEeeccccccC
Q 002021 819 MVAHLSDFSIAKMLT 833 (979)
Q Consensus 819 ~~~kl~Dfg~~~~~~ 833 (979)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=4e-15 Score=177.36 Aligned_cols=118 Identities=36% Similarity=0.628 Sum_probs=99.9
Q ss_pred ccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEecc
Q 002021 496 VLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLS 575 (979)
Q Consensus 496 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 575 (979)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 46788999999998999999999999999999999998899889999999999999999999999999999999999999
Q ss_pred CCcccccCCCCC--CCCCcccccccCCccccCCCCCCCCCCC
Q 002021 576 FNQLEGKIPRGG--SFGNFSAQSFEGNELLCGSPNLQIPPCK 615 (979)
Q Consensus 576 ~N~l~~~~p~~~--~~~~~~~~~~~~N~~~c~~p~~~~~~~~ 615 (979)
+|+++|.+|... .+.....+.+.+|+.+|+.|. +++|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence 999999988732 223445678999999999874 45785
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=4e-14 Score=138.30 Aligned_cols=135 Identities=22% Similarity=0.277 Sum_probs=114.1
Q ss_pred CCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCC--CCeeeEEEeeccCCeeEEEEEecCCC
Q 002021 686 ENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHG 763 (979)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g 763 (979)
..+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| ..+.++++++..++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999998744 7899999865432 4678899999999976 58999999988888899999999988
Q ss_pred ccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 764 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 764 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 5567778999999999999943235799999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.4e-16 Score=168.78 Aligned_cols=176 Identities=32% Similarity=0.483 Sum_probs=141.4
Q ss_pred CCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEe
Q 002021 399 LQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNF 478 (979)
Q Consensus 399 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l 478 (979)
+..-...+++.|++. .+|..++.+..|+.+.|..|.|. .+|..+.++..|.+|+|+.|+++.+|..++.++ |+.|-+
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIV 150 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEE
Confidence 444456677777777 67888888888888888888887 678888888888888888888888888777765 788888
Q ss_pred ccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCccccccccccccccccccccc
Q 002021 479 SSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGV 558 (979)
Q Consensus 479 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 558 (979)
++|+++ .+|+.++.+..|..||.|.|.+. .+|..++++.+|+.|++..|++. .+|..+..|+ |..||+|.|+++ .
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~ 225 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-Y 225 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-e
Confidence 888887 67888888888888888888887 67888888888888888888888 5777777554 788888888888 7
Q ss_pred CCccccCccccCeEeccCCccccc
Q 002021 559 IPASLEKLSYLEDLNLSFNQLEGK 582 (979)
Q Consensus 559 ~p~~~~~l~~L~~L~L~~N~l~~~ 582 (979)
+|-.|.+|..|++|-|.+|+|+.+
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred cchhhhhhhhheeeeeccCCCCCC
Confidence 888888888888888888888754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.8e-14 Score=145.33 Aligned_cols=136 Identities=18% Similarity=0.239 Sum_probs=105.2
Q ss_pred Cceee-eecceEEEEEEcCCCcEEEEEEecccc-------------ccchhcHHHHHHHHHhcCCCCe--eeEEEeeccC
Q 002021 687 NNLIG-RGGFGSVYKASLGDGMEVAVKVFTSQC-------------GRAFKSFDVECEIMKSIRHRNL--IKVISSCSNE 750 (979)
Q Consensus 687 ~~~lG-~G~~g~Vy~~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 750 (979)
...|| .|+.|+||+++.. +..+|||.+.... ......+.+|++++..++|+++ ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999774 6789999885321 0122457789999999998775 6667664332
Q ss_pred -C---eeEEEEEecCC-CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEe
Q 002021 751 -E---FKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 825 (979)
Q Consensus 751 -~---~~~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D 825 (979)
. ..++||||++| .+|.+++... .++.. .+.+++.++++|| ++||+||||||.|||++.++.++++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 6888887543 34443 3678999999999 99999999999999999989999999
Q ss_pred ecccccc
Q 002021 826 FSIAKML 832 (979)
Q Consensus 826 fg~~~~~ 832 (979)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9998764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.6e-13 Score=152.58 Aligned_cols=144 Identities=21% Similarity=0.250 Sum_probs=104.3
Q ss_pred CCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccch----------------------------------------
Q 002021 683 GFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAF---------------------------------------- 722 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~---------------------------------------- 722 (979)
.|+ .+.||.|++|+||+|+..+|+.||||+.++......
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 368999999999999998999999999865421100
Q ss_pred hcHHHHHHHHHhcC----CCCeeeEEEee-ccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 002021 723 KSFDVECEIMKSIR----HRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-ALEYLH 796 (979)
Q Consensus 723 ~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~-~L~~LH 796 (979)
-+|.+|++.+.+++ |.+-+.+-.++ ......++||||++|+++.++........ ....++.+++. .+.++|
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 13556776666653 33334443333 22445789999999999988764322122 23456666666 478889
Q ss_pred cCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 797 ~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
..|++|+|++|.||++++++.++++|||++..+.
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8999999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.6e-15 Score=160.34 Aligned_cols=176 Identities=31% Similarity=0.476 Sum_probs=103.0
Q ss_pred EEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCc
Q 002021 380 TIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNE 459 (979)
Q Consensus 380 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 459 (979)
..||+.|++. .+|..+..+..|+.+.|..|.+. .+|..++++..|..|||+.|+++ ..|..++.|+ |+.|-+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 3445555544 33444444445555555555555 45556666666666666666665 4555555554 5666666666
Q ss_pred cccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcc
Q 002021 460 LTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSF 539 (979)
Q Consensus 460 l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 539 (979)
++.+|..++....|..|+.+.|.+. .+|..++++.+|+.|.+.+|++. .+|..+..| .|..||+|.|+++ .+|-.|
T Consensus 155 l~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~f 230 (722)
T KOG0532|consen 155 LTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDF 230 (722)
T ss_pred cccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhh
Confidence 6666666666666666666666665 45556666666666666666665 344455533 3666666666666 566666
Q ss_pred cccccccccccccccccccCCcccc
Q 002021 540 GDLISLKFLNLSNNNLSGVIPASLE 564 (979)
Q Consensus 540 ~~l~~L~~L~Ls~N~l~~~~p~~~~ 564 (979)
.+|..|++|-|.+|.|+ ..|..++
T Consensus 231 r~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 231 RKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred hhhhhheeeeeccCCCC-CChHHHH
Confidence 66666666666666665 4455443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.9e-13 Score=151.65 Aligned_cols=198 Identities=36% Similarity=0.544 Sum_probs=148.8
Q ss_pred EEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCC-CCceEecCCCcccccCCccccCCCcCceEecCCC
Q 002021 380 TIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLA-ELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSN 458 (979)
Q Consensus 380 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 458 (979)
.+++..|.+... ...+..++.++.|++.+|.+. .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 456666655322 223334466777777777776 4566666664 7888888888887 55567788888888888888
Q ss_pred ccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCc
Q 002021 459 ELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNS 538 (979)
Q Consensus 459 ~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 538 (979)
+++++|......++|+.|++++|+++ .+|...+.+..|++|++++|.+. ..+..+..+.++..|.+++|++. .++..
T Consensus 174 ~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~ 250 (394)
T COG4886 174 DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES 250 (394)
T ss_pred hhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence 88888877767888888888888888 46666666677888888888644 56777888888888888888887 45778
Q ss_pred ccccccccccccccccccccCCccccCccccCeEeccCCcccccCCC
Q 002021 539 FGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 539 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
++.+++++.|++++|+++.. +. +..+.+++.|++++|.+....|.
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hccccccceecccccccccc-cc-ccccCccCEEeccCccccccchh
Confidence 88888899999999998844 33 88888899999999988877665
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.9e-12 Score=148.10 Aligned_cols=175 Identities=32% Similarity=0.461 Sum_probs=75.8
Q ss_pred CCccEEEccCCCCcccCCcccccccc-ccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcE
Q 002021 326 KFLKYFDLSYNPLYRILPRTTVGNLS-HSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQD 404 (979)
Q Consensus 326 ~~L~~L~Ls~N~l~~~~~~~~~~~l~-~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 404 (979)
+.++.|++.+|.+.++.+.... . .+|++|++++|++. .+|..+..+++|+.|++++|++... +.....++.|+.
T Consensus 116 ~~l~~L~l~~n~i~~i~~~~~~---~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~~~~L~~ 190 (394)
T COG4886 116 TNLTSLDLDNNNITDIPPLIGL---LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDL-PKLLSNLSNLNN 190 (394)
T ss_pred cceeEEecCCcccccCcccccc---chhhcccccccccchh-hhhhhhhccccccccccCCchhhhh-hhhhhhhhhhhh
Confidence 4455555555555544332211 1 13445555555544 2334455555555555555555422 222224444444
Q ss_pred EEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEecccccc
Q 002021 405 LGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLT 484 (979)
Q Consensus 405 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~ 484 (979)
|++++|++. .+|.....+..|++|.+++|.+. ..+..+.++.++..+.+.+|++..++..+..+++++.|++++|+++
T Consensus 191 L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 191 LDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred eeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc
Confidence 445544444 23333333333444444444322 2333444444444444444444444444444444444444444444
Q ss_pred CCCccccccccccceEeccCCccCc
Q 002021 485 GSLPLEIGSLKVLVGIDLSRNNFSG 509 (979)
Q Consensus 485 ~~~p~~~~~l~~L~~L~Ls~N~l~~ 509 (979)
...+ ++.+.+++.||+++|.++.
T Consensus 269 ~i~~--~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 269 SISS--LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred cccc--ccccCccCEEeccCccccc
Confidence 2211 3344444444444444443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2e-13 Score=140.80 Aligned_cols=89 Identities=25% Similarity=0.374 Sum_probs=41.5
Q ss_pred ccCCCcccEEEecCCCCCch----hHHhhhcCCCCcEEEecCcccCCCccccc-----cCCCCCceEecCCCccccc---
Q 002021 372 ISNLTNLRTIYLGGNKLNGS----ILITLSKLQKLQDLGLKDNKLEGSIPYDI-----CNLAELYRLDLDGNKLSGS--- 439 (979)
Q Consensus 372 l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~--- 439 (979)
|..+++|++|||.+|.++.. ....++.+++|+.|++++|.++..-...| ...++|++|.|.+|.|+..
T Consensus 209 l~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~ 288 (382)
T KOG1909|consen 209 LEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAAL 288 (382)
T ss_pred HHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHH
Confidence 33444444444444444322 12333444444444444444443222211 1245566666666666532
Q ss_pred -CCccccCCCcCceEecCCCcc
Q 002021 440 -IPACFSNLTSLRIVSLGSNEL 460 (979)
Q Consensus 440 -~~~~~~~l~~L~~L~L~~N~l 460 (979)
+..++...+.|..|+|++|++
T Consensus 289 ~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 289 ALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHHhcchhhHHhcCCcccc
Confidence 222344566677777777766
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.5e-11 Score=122.64 Aligned_cols=129 Identities=22% Similarity=0.236 Sum_probs=97.2
Q ss_pred CceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCccc
Q 002021 687 NNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 766 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 766 (979)
.+.++.|.++.||+++.. +..|++|....... ....+..|+++++.+.+.++++-+-.+. .+..++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCCccc
Confidence 357899999999999874 77899998754422 2345788999999987655554333332 23457999999998886
Q ss_pred eeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 767 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 767 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
+.- .....++.+++++++.|| ..+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~---------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 531 112346789999999999 666 59999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.4e-12 Score=131.20 Aligned_cols=202 Identities=20% Similarity=0.305 Sum_probs=141.6
Q ss_pred HHhcCCCCeeeEEEeeccC-----CeeEEEEEecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 002021 732 MKSIRHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPV 803 (979)
Q Consensus 732 l~~l~h~niv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 803 (979)
+-.+-|.|+|+++.|+.+. ....+++|||.-|++.+++++. ...+......+|+.||..||.||| .|+.+|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCcc
Confidence 4455799999999998553 3467899999999999999764 345667777899999999999999 789999
Q ss_pred EecCCCCCCEEeCCCCcEEEEeeccccccCCC--CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCC
Q 002021 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE--DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK 881 (979)
Q Consensus 804 ~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~ 881 (979)
+|+++.-+-|++..++-+|+.--......... ..........+-++|.+||+-.....+.++|||+||+...||.-+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999999999998888532221111000 0011112234568999999987777888999999999999998876
Q ss_pred CCCccccc---CcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 882 KPTDEIFN---GEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 882 ~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
.--..... .++.+.. .++.-.. ..-.+++.+|++..|..||+|.+++.|..
T Consensus 280 iq~tnseS~~~~ee~ia~----------------~i~~len----------~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIAN----------------VIIGLEN----------GLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred eccCCCcceeehhhhhhh----------------heeeccC----------ccccCcCcccccCCCCCCcchhhhhcCce
Confidence 53111100 0111100 0000000 01235688999999999999999988765
Q ss_pred Hh
Q 002021 959 KI 960 (979)
Q Consensus 959 ~~ 960 (979)
.+
T Consensus 334 lf 335 (458)
T KOG1266|consen 334 LF 335 (458)
T ss_pred ee
Confidence 44
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.2e-11 Score=135.45 Aligned_cols=169 Identities=19% Similarity=0.250 Sum_probs=130.9
Q ss_pred EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHH
Q 002021 702 SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 781 (979)
Q Consensus 702 ~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~ 781 (979)
+..++.+|.|++++.......+...+.++.|+.+|||+|+++++.+..++..|+|+|.+. .|..++.+ ++...+
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v 106 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEV 106 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHH
Confidence 556788999998875544445667788899999999999999999999999999999984 55555554 335566
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCC
Q 002021 782 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861 (979)
Q Consensus 782 ~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 861 (979)
...+.||+.||.|||+ +.+++|++|.-+.|++++.|+.||++|.++........ .......-..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 7789999999999986 78999999999999999999999999999865432221 111122233567777654332
Q ss_pred CCchhHHHHHHHHHHHHcCCC
Q 002021 862 SANGDVYSFGIMLMETFTGKK 882 (979)
Q Consensus 862 ~~~~DvwslG~il~el~tg~~ 882 (979)
-..|.|.||++++|++.|..
T Consensus 182 -~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred -cchhhhhHHHHHHHHhCccc
Confidence 34699999999999999943
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.6e-13 Score=140.47 Aligned_cols=209 Identities=26% Similarity=0.294 Sum_probs=100.2
Q ss_pred CCCCCCeeeccCCcccccCC--ccccccCcccEEecccccccccCC--ccccCCCCCcEEEccCCccCchhhhhhhccCC
Q 002021 94 NLSSLQSLNLSFNRLFGSIP--SAIFTTYTLKYVCLRGNQLSGTFP--SFISNKSSLQHLDLSSNALSGEIRANICREIP 169 (979)
Q Consensus 94 ~l~~L~~L~L~~n~~~~~~p--~~~~~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip 169 (979)
++..|+...|.+..+. .++ .-...+++++.||||+|-++.-.| .....+++|+.|+||.|.+......+
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~------ 191 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSN------ 191 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcccc------
Confidence 4555666666655543 222 134455666666666665553221 23345666666666666554321111
Q ss_pred cccCCCCccceeeccccccccc-ccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCC
Q 002021 170 REFGNLPELELMSLAANNLQGK-IPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARL 248 (979)
Q Consensus 170 ~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l 248 (979)
.-..++.|+.|.|+.+.++.. +-..+..+++|+.|+|..|....+.......+..|+.|||++|++-........+.+
T Consensus 192 -~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l 270 (505)
T KOG3207|consen 192 -TTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTL 270 (505)
T ss_pred -chhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccc
Confidence 012445566666666666521 112233456666666666643333333344455666666666666554433344555
Q ss_pred CCcCEEEccCCccccc-cCcc-----cccCCCCcEEecccccccccc-Cccccccccccceeccccccc
Q 002021 249 PNLEILSLWGNNFSGT-IPRF-----IFNASKLSILDLEGNSFSGFI-PNTFGNLRNLSWLVLSDNYLT 310 (979)
Q Consensus 249 ~~L~~L~L~~N~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~ 310 (979)
+.|+.|+++.+++... .|+. ...+++|++|+++.|+|.... -+.+..+++|+.|....|.++
T Consensus 271 ~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 271 PGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 6666666666655532 1222 233445555555555553211 112223344444444444443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.4e-11 Score=139.61 Aligned_cols=146 Identities=18% Similarity=0.168 Sum_probs=97.1
Q ss_pred CCCCCCceeeeecceEEEEEEcCC-CcEEEEEEeccccccc------------------------------h--------
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRA------------------------------F-------- 722 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~------------------------------~-------- 722 (979)
..|+. +.||.|++|+||+|+..+ |+.||||+.++..... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 789999999999998876 9999999987542100 0
Q ss_pred --hcHHHHHHHHHhcC----CCCeeeEEEeecc-CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHH-HHHHH
Q 002021 723 --KSFDVECEIMKSIR----HRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA-SALEY 794 (979)
Q Consensus 723 --~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia-~~L~~ 794 (979)
-++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+++.++-.-.....+... ++...+ .-+..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHH
Confidence 12445655555553 4444554444433 4567899999999999774221111222222 222211 12333
Q ss_pred HhcCCCCCeEecCCCCCCEEeCCCC----cEEEEeeccccccCC
Q 002021 795 LHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFSIAKMLTG 834 (979)
Q Consensus 795 LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfg~~~~~~~ 834 (979)
+. ..|++|+|+||.||+++.++ +++++|||++..+..
T Consensus 276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 44 67999999999999999888 999999999987643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.9e-12 Score=139.47 Aligned_cols=249 Identities=22% Similarity=0.231 Sum_probs=180.5
Q ss_pred CCCCCceeee--ecceEEEEEEc---CCCcEEEEEEeccccc--cchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeE
Q 002021 683 GFSENNLIGR--GGFGSVYKASL---GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 683 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 754 (979)
.|...+.+|. |.+|.||.+.- .++..+|+|+-+.... .....=.+|+...+.+ .|++.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556678999 99999999944 5788999998433221 2223334566666666 4999999999999999999
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEEeeccc
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS----ALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFSIA 829 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfg~~ 829 (979)
+-+|++. .++..+.+.....++...++.++.+..+ |+.++| ...++|-|+||.||++..+ ...+++|||..
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence 9999995 6888888877666788888999999999 999999 9999999999999999999 88999999999
Q ss_pred cccCCCCCcceec---ccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCcc
Q 002021 830 KMLTGEDQSMIQT---QTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 906 (979)
Q Consensus 830 ~~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 906 (979)
..+.......... ...+...|++||.. .+.++.++|+|++|.+..+..++..+..... ...|.........
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK-----NSSWSQLRQGYIP 344 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC-----CCCccccccccCc
Confidence 8876554222111 12467789999986 4567889999999999999999877643210 0111110000000
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+.. +.....+...+..+++.+|..|++++++..+
T Consensus 345 ~e~~---------------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 345 LEFC---------------EGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhhh---------------cCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0000 0112334457889999999999999877543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.9e-13 Score=139.51 Aligned_cols=245 Identities=23% Similarity=0.236 Sum_probs=127.4
Q ss_pred CcEEEEEecCCCcc----ccCCCCCcCCCCCCeeeccCC---cccccCCccccccCcccEEecccccccccCCccccCCC
Q 002021 72 QRVTVLNISSLNLT----GTIPSQLGNLSSLQSLNLSFN---RLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKS 144 (979)
Q Consensus 72 ~~v~~l~l~~~~l~----g~~~~~l~~l~~L~~L~L~~n---~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 144 (979)
..++.|+|+||.+. ..+.+.|.+.++|+..++|+= ++...+|.++..+ .+.+..++
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l-----------------~~aL~~~~ 92 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKML-----------------SKALLGCP 92 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHH-----------------HHHHhcCC
Confidence 35777788877763 234455666777777777752 3334455433210 12223334
Q ss_pred CCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccc----c---------ccccccCCCCCCceecCCCe
Q 002021 145 SLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQG----K---------IPLKIGNLRNLEKLDIGDNK 211 (979)
Q Consensus 145 ~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~----~---------~p~~~~~l~~L~~L~Ls~N~ 211 (979)
.|++||||+|.|....+ +.+-+-+.+++.|++|.|.+|.+.- . ....++.-+.|++++.++|+
T Consensus 93 ~L~~ldLSDNA~G~~g~----~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNr 168 (382)
T KOG1909|consen 93 KLQKLDLSDNAFGPKGI----RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNR 168 (382)
T ss_pred ceeEeeccccccCccch----HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccc
Confidence 44444444444432211 0111223334444444444444431 0 01122334567777777777
Q ss_pred eeecCC----ccccccCccceeeccCCCCcCC---CcccccCCCCCcCEEEccCCccccc----cCcccccCCCCcEEec
Q 002021 212 LVGIAP----IAIFNVSTLKILGLQDNSLSGC---LSSIGYARLPNLEILSLWGNNFSGT----IPRFIFNASKLSILDL 280 (979)
Q Consensus 212 l~~~~p----~~l~~l~~L~~L~L~~N~l~~~---~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L 280 (979)
+..-.. ..|...+.|+.+.++.|.|... ....+|..+++|+.|||.+|.++.. +...+..+++|+.|++
T Consensus 169 len~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l 248 (382)
T KOG1909|consen 169 LENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNL 248 (382)
T ss_pred cccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecc
Confidence 664432 2344456667777777766521 1223566777777777777776522 3344555666777777
Q ss_pred cccccccccCcccc-----ccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCC
Q 002021 281 EGNSFSGFIPNTFG-----NLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPL 338 (979)
Q Consensus 281 s~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 338 (979)
++|.++.....+|. ..++|+.|.+.+|.|+...... ........+.|+.|+|++|++
T Consensus 249 ~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~-la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 249 GDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALA-LAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHH-HHHHHhcchhhHHhcCCcccc
Confidence 77776654333332 2466777777777766543222 122334456666666666666
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.1e-12 Score=129.62 Aligned_cols=142 Identities=25% Similarity=0.239 Sum_probs=117.5
Q ss_pred ccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcC
Q 002021 438 GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGG 517 (979)
Q Consensus 438 ~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 517 (979)
|.....+..+..|+++||++|.|+.+..+..-++.++.|++|+|.|+.. ..+..+.+|+.||||+|.++ .+..+=..
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~K 350 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLK 350 (490)
T ss_pred CceEEecchHhhhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhh
Confidence 3333445566789999999999999999988899999999999999843 34888999999999999998 45566667
Q ss_pred CcccceeecCCccccCCCCCcccccccccccccccccccccC-CccccCccccCeEeccCCcccccCC
Q 002021 518 LKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVI-PASLEKLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 518 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p 584 (979)
+.+.+.|.|++|.|.. -..++.+-+|..||+++|+|.... -..++++|-|+.+.|.+|++.+.+.
T Consensus 351 LGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 351 LGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 8899999999999973 345788899999999999998543 2568899999999999999987544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-12 Score=129.50 Aligned_cols=134 Identities=25% Similarity=0.301 Sum_probs=79.5
Q ss_pred hhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcE
Q 002021 396 LSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILN 475 (979)
Q Consensus 396 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~ 475 (979)
...+..|++++|++|.|+ .+..+..-+++++.|++|+|.|... +.+..+++|+.|||++|.++++..+-.++.+++.
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKT 356 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhhHhhhcCEee
Confidence 344455666666666665 3455555566666666666666532 2256666666666666666665554445555555
Q ss_pred EEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCC-CCccccccccccccccccc
Q 002021 476 LNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI-PNSFGDLISLKFLNLSNNN 554 (979)
Q Consensus 476 L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~ 554 (979)
|.|++|.|.. -..++.+-+|.+||+++|+|.... -..++++|-|+.|.|.+|.
T Consensus 357 L~La~N~iE~--------------------------LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 357 LKLAQNKIET--------------------------LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred eehhhhhHhh--------------------------hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 5555555542 122444555666666666665322 2467777888888888888
Q ss_pred cccc
Q 002021 555 LSGV 558 (979)
Q Consensus 555 l~~~ 558 (979)
+.+.
T Consensus 411 l~~~ 414 (490)
T KOG1259|consen 411 LAGS 414 (490)
T ss_pred cccc
Confidence 7743
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.5e-10 Score=118.72 Aligned_cols=273 Identities=15% Similarity=0.121 Sum_probs=175.2
Q ss_pred CCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEee------cc-CCeeEE
Q 002021 685 SENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSC------SN-EEFKAL 755 (979)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~-~~~~~l 755 (979)
...+.||+|+-+.+|-. +.. ..+-|+++....... .+-...|... .||-+-.-+.+= .+ .....+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhh---chhheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34678999999999965 332 235577665432211 1123333333 455443322221 11 223567
Q ss_pred EEEecCCC-ccceeec-----cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 756 VLEYMPHG-SLEKYLY-----SSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 756 v~E~~~~g-~L~~~l~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
.|..+.+. ....+.. +.-....|.-.++++..+|.+.+.|| .+|.+-+|+.++|+|+.+++.|.+.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccce
Confidence 78877663 1222221 12235789999999999999999999 999999999999999999999999987654
Q ss_pred cccCCCCCcceecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcC-CCCCcccccC-------cchHhH
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTG-KKPTDEIFNG-------EMTLKH 896 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg-~~P~~~~~~~-------~~~~~~ 896 (979)
... .........+|...|.+||... +.+.++..|.|.+||++++++.| ++||...... +.++..
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 432 2333345567899999999654 44567789999999999999995 9999754211 111111
Q ss_pred hhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccC--cCCCCCHHHHHHHHHHhHHhhccCC-CCcce
Q 002021 897 WVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEF--PKQRINAKEIVTKLLKIRDSLLRNV-GGRCV 973 (979)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~Rps~~eil~~L~~~~~~~~~~~-~~~~~ 973 (979)
-. ....-+.+.-.+.....+...--++.+..++.+|+... +.-|||++.++..|-++.++++.++ ..+-+
T Consensus 242 g~-------f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~ 314 (637)
T COG4248 242 GR-------FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHV 314 (637)
T ss_pred ce-------eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhccccc
Confidence 00 00111111111111222333445677888999999874 4579999999999999999999887 33444
Q ss_pred ecc
Q 002021 974 RQS 976 (979)
Q Consensus 974 ~~~ 976 (979)
||+
T Consensus 315 y~~ 317 (637)
T COG4248 315 YPV 317 (637)
T ss_pred ccC
Confidence 554
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.6e-12 Score=134.16 Aligned_cols=184 Identities=25% Similarity=0.307 Sum_probs=103.3
Q ss_pred hhcCCCCcEEEecCcccCCCcc--ccccCCCCCceEecCCCcccccCCccc-cCCCcCceEecCCCccc--cccccccCc
Q 002021 396 LSKLQKLQDLGLKDNKLEGSIP--YDICNLAELYRLDLDGNKLSGSIPACF-SNLTSLRIVSLGSNELT--SIPLTFWNL 470 (979)
Q Consensus 396 l~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~--~lp~~~~~l 470 (979)
...+++++.|+|++|-+....+ .-...+++|+.|+|+.|++........ ..+++|+.|.|+.|.|+ ++-.....+
T Consensus 142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~f 221 (505)
T KOG3207|consen 142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTF 221 (505)
T ss_pred hhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhC
Confidence 3444444445555444443221 223455566666666666542222111 24567888888888877 333345567
Q ss_pred CCCcEEEeccccccCCCccccccccccceEeccCCccCccc-chhhcCCcccceeecCCccccCCC-CCc-----ccccc
Q 002021 471 KDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVI-PTEIGGLKNLEYLFLGYNRLQGSI-PNS-----FGDLI 543 (979)
Q Consensus 471 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~-p~~-----~~~l~ 543 (979)
++|+.|+|..|...+.-.....-++.|++|||++|++-... -...+.++.|+.|+++.+.++..- |+. ...++
T Consensus 222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~ 301 (505)
T KOG3207|consen 222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFP 301 (505)
T ss_pred CcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccc
Confidence 77888888877533333444455677778888887775332 134566777777777777776432 222 24456
Q ss_pred cccccccccccccccCC--ccccCccccCeEeccCCccc
Q 002021 544 SLKFLNLSNNNLSGVIP--ASLEKLSYLEDLNLSFNQLE 580 (979)
Q Consensus 544 ~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~ 580 (979)
+|++|+++.|++.. .+ ..+..+++|+.|....|.|+
T Consensus 302 kL~~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 302 KLEYLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cceeeecccCcccc-ccccchhhccchhhhhhccccccc
Confidence 67777777777641 11 22334455555555555554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.3e-12 Score=142.40 Aligned_cols=176 Identities=30% Similarity=0.344 Sum_probs=78.9
Q ss_pred CCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCc
Q 002021 91 QLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPR 170 (979)
Q Consensus 91 ~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~ 170 (979)
.+..+++|+.|+|.+|++.+ +...+..+.+|++|+|++|.|+..- .+..++.|+.|++++|.|+.. .
T Consensus 90 ~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~----------~ 156 (414)
T KOG0531|consen 90 HLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI----------S 156 (414)
T ss_pred ccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhheeccCcchhc----------c
Confidence 35555555555555555552 2222444555555555555555332 233444455555555555422 2
Q ss_pred ccCCCCccceeeccccccccccc-ccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCC
Q 002021 171 EFGNLPELELMSLAANNLQGKIP-LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLP 249 (979)
Q Consensus 171 ~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~ 249 (979)
.+..++.|+.+++++|++...-+ . ...+.+|+.+++.+|.+..+. .+..+..+..+++..|.++.+.+. ..+.
T Consensus 157 ~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~--~~~~~~~l~~~~l~~n~i~~~~~l---~~~~ 230 (414)
T KOG0531|consen 157 GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIE--GLDLLKKLVLLSLLDNKISKLEGL---NELV 230 (414)
T ss_pred CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhccc--chHHHHHHHHhhcccccceeccCc---ccch
Confidence 33445555555555555543222 1 344455555555555554332 222333333445555554432211 1111
Q ss_pred C--cCEEEccCCccccccCcccccCCCCcEEeccccccc
Q 002021 250 N--LEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFS 286 (979)
Q Consensus 250 ~--L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 286 (979)
. |+.+++++|.+. ..+..+..+.++..|++.+|++.
T Consensus 231 ~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 231 MLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred hHHHHHHhcccCccc-cccccccccccccccchhhcccc
Confidence 1 444444544444 22233334444444444444444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.7e-10 Score=110.37 Aligned_cols=136 Identities=23% Similarity=0.237 Sum_probs=98.3
Q ss_pred ceeeeecceEEEEEEcCC-------CcEEEEEEecccc------------c-c---------chhcHH----HHHHHHHh
Q 002021 688 NLIGRGGFGSVYKASLGD-------GMEVAVKVFTSQC------------G-R---------AFKSFD----VECEIMKS 734 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~-------~~~vAvK~~~~~~------------~-~---------~~~~~~----~E~~~l~~ 734 (979)
..||.|.-+.||.|.-.+ +..+|||+++... + + ..+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 5799999875321 0 0 011233 79999999
Q ss_pred cCC--CCeeeEEEeeccCCeeEEEEEecCCCccce-eeccCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCC
Q 002021 735 IRH--RNLIKVISSCSNEEFKALVLEYMPHGSLEK-YLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAPVIHCDLKP 810 (979)
Q Consensus 735 l~h--~niv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~i~H~Dik~ 810 (979)
+.. -++.+.+++ ...++||||+.++.+.. .+.+ ..++.++...+..+++.++.++ | +.+++|+|+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 853 455555654 45679999997653321 1222 1345566778899999999999 8 89999999999
Q ss_pred CCEEeCCCCcEEEEeeccccccC
Q 002021 811 SNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 811 ~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
.||+++ ++.+.++|||-+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.9e-11 Score=117.19 Aligned_cols=11 Identities=27% Similarity=0.135 Sum_probs=4.5
Q ss_pred cccccccccee
Q 002021 293 FGNLRNLSWLV 303 (979)
Q Consensus 293 ~~~l~~L~~L~ 303 (979)
+..+|+|+.||
T Consensus 136 i~~lP~Lk~LD 146 (175)
T PF14580_consen 136 IYKLPSLKVLD 146 (175)
T ss_dssp HHH-TT-SEET
T ss_pred HHHcChhheeC
Confidence 34455555554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.5e-11 Score=116.74 Aligned_cols=126 Identities=25% Similarity=0.310 Sum_probs=39.2
Q ss_pred CCCCceecCCCeeeecCCcccc-ccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCccc-ccCCCCcE
Q 002021 200 RNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFI-FNASKLSI 277 (979)
Q Consensus 200 ~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~ 277 (979)
.++++|+|++|+|+.+. .+. .+.+|+.|+|++|.|+.+. ++..+++|++|++++|+|+. ++..+ ..+++|++
T Consensus 19 ~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~l~---~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 19 VKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITKLE---GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQE 92 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S--T---T----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred ccccccccccccccccc--chhhhhcCCCEEECCCCCCcccc---CccChhhhhhcccCCCCCCc-cccchHHhCCcCCE
Confidence 34455555555554432 222 2444555555555554432 24456666666666666663 33333 34667777
Q ss_pred EeccccccccccC-ccccccccccceeccccccccccchhhhhhcccCCCCccEEEc
Q 002021 278 LDLEGNSFSGFIP-NTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDL 333 (979)
Q Consensus 278 L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~L 333 (979)
|+|++|+|..... ..++.+++|+.|+|.+|.++..+..- ...+..+|+|+.||-
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR--~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYR--LFVIYKLPSLKVLDG 147 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHH--HHHHHH-TT-SEETT
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHH--HHHHHHcChhheeCC
Confidence 7777777654321 34556677777777777776543322 123456677777764
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.1e-11 Score=141.64 Aligned_cols=155 Identities=28% Similarity=0.286 Sum_probs=71.9
Q ss_pred CCcccEEEecCCCCCchhH-HhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCC--cCc
Q 002021 375 LTNLRTIYLGGNKLNGSIL-ITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLT--SLR 451 (979)
Q Consensus 375 l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~ 451 (979)
+++|+.+++++|++....+ . ...+.+++.+.+.+|.+.. ...+..+..+..+++..|+++...+ +..+. .|+
T Consensus 161 l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~ 235 (414)
T KOG0531|consen 161 LKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLR 235 (414)
T ss_pred chhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHH
Confidence 4455555555555543333 2 3444455555555555442 2223333444444556666552211 11222 255
Q ss_pred eEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccc
Q 002021 452 IVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRL 531 (979)
Q Consensus 452 ~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 531 (979)
.+++++|.+..++..+..+..+. .||+++|++... ..+.....+..+.++.|.+
T Consensus 236 ~l~l~~n~i~~~~~~~~~~~~l~------------------------~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~ 289 (414)
T KOG0531|consen 236 ELYLSGNRISRSPEGLENLKNLP------------------------VLDLSSNRISNL--EGLERLPKLSELWLNDNKL 289 (414)
T ss_pred HHhcccCcccccccccccccccc------------------------ccchhhcccccc--ccccccchHHHhccCcchh
Confidence 66666666555543333444444 444444444322 1233344455555555555
Q ss_pred cCC---CCCc-ccccccccccccccccccccCC
Q 002021 532 QGS---IPNS-FGDLISLKFLNLSNNNLSGVIP 560 (979)
Q Consensus 532 ~~~---~p~~-~~~l~~L~~L~Ls~N~l~~~~p 560 (979)
... .... ....+.++.+.+..|.+....+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 290 ALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cchhhhhccccccccccccccccccCccccccc
Confidence 421 1111 4455667777777777665544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.1e-10 Score=107.54 Aligned_cols=131 Identities=23% Similarity=0.323 Sum_probs=101.5
Q ss_pred ceeeeecceEEEEEEcCCCcEEEEEEecccccc--------chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR--------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..+++|+-+.||.+.+. |.++++|.-.+..-+ ..+...+|++++.+++--.|.-.+-+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36789999999999884 445667643222111 124566799999998766666555666677778899999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
++|..|.+++... ...++..+-.-+.-|| ..||+|+|+.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999988888664 2457778888889999 99999999999999998765 99999999875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-09 Score=114.34 Aligned_cols=142 Identities=18% Similarity=0.234 Sum_probs=112.0
Q ss_pred ceeeeecceEEEEEEcCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCC--CeeeEEEeeccC---CeeEEEEEecC
Q 002021 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHR--NLIKVISSCSNE---EFKALVLEYMP 761 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~E~~~ 761 (979)
+.|+.|.++.||+++..+|+.+++|....... .....+.+|+++++.+++. .+.+++.+..+. +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999876678999998764432 2356788999999999763 456677776654 36689999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG------------------------------------------- 798 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------- 798 (979)
|.++.+.+.. ..++.++...++.++++++++||..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988876542 2467788888999999999999831
Q ss_pred ----------CCCCeEecCCCCCCEEeCC--CCcEEEEeeccccc
Q 002021 799 ----------YSAPVIHCDLKPSNVLLDD--NMVAHLSDFSIAKM 831 (979)
Q Consensus 799 ----------~~~~i~H~Dik~~NIll~~--~~~~kl~Dfg~~~~ 831 (979)
....++|+|+++.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1e-09 Score=103.92 Aligned_cols=142 Identities=18% Similarity=0.237 Sum_probs=106.0
Q ss_pred CCceeeeecceEEEEEEcCCCcEEEEEE-ecccc-------ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 686 ENNLIGRGGFGSVYKASLGDGMEVAVKV-FTSQC-------GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~-~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
....+-+|+-+.|+++.+ .|+...||. +.+.. .-..+...+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999998 577777774 32211 112355678999999987556555555565666667999
Q ss_pred EecCC-CccceeeccCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEEeeccccc
Q 002021 758 EYMPH-GSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFSIAKM 831 (979)
Q Consensus 758 E~~~~-g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~Dfg~~~~ 831 (979)
||++| .++.+++..... ..+.+.....+..|-+.+.-|| ..+|+|+|+..+||++.+++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 478888765522 2333333789999999999999 99999999999999997544 468999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.2e-10 Score=130.10 Aligned_cols=251 Identities=21% Similarity=0.178 Sum_probs=176.5
Q ss_pred HhhCCCCCCceeeeecceEEEEEEc--CCCcEEEEEEeccccccchhc--HHHHHHHHHhc-CCCCeeeEEEeeccCCee
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASL--GDGMEVAVKVFTSQCGRAFKS--FDVECEIMKSI-RHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vAvK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (979)
..+.+|..+..||.|.|+.|++... .++..+++|...........+ -..|+.+...+ .|.+++..+..+..-+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3457888999999999999999844 467789999775443222111 12355555555 589999988888887788
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEEeecccccc
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFSIAKML 832 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfg~~~~~ 832 (979)
|+=-||++++++...... ...+++..++++..|++.++.++| ++.++|+|+||+||++..+ +..++.|||.+..+
T Consensus 342 ~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence 888999999988776622 335777889999999999999999 9999999999999999886 78899999998753
Q ss_pred CCCCCcceecccccCCCCC--CccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 833 TGEDQSMIQTQTLATIGYM--APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
.-. ......+-+++ +|+......+..++|+||||.-+.|..++..--.. + . +|.. +.
T Consensus 418 ~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~-~---~~~~---------i~ 476 (524)
T KOG0601|consen 418 AFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---G-V---QSLT---------IR 476 (524)
T ss_pred cee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcc---c-c---ccee---------ee
Confidence 111 11122333444 55555666788999999999999999987653111 0 0 1100 00
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
....... ......+..+...+..+++..||.+.+...+.+..++
T Consensus 477 ~~~~p~~--------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 477 SGDTPNL--------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred cccccCC--------CchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 0000000 1111346677888889999999999998887766554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.7e-10 Score=134.91 Aligned_cols=251 Identities=24% Similarity=0.281 Sum_probs=176.9
Q ss_pred HhhCCCCCCceeeeecceEEEEEEcC-CCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
...+.+...+-+-+|.++.++.++.. .|...+.|+..... ....+....+-.+.-..++|.++.....+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34466777788899999999988543 35445555443221 122333444555555566788888777777778889
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
||++|..++++...++... ..+.+........+..+.+||| ...+.|||++|.|.++..++..++.|||.......
T Consensus 881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999999888765 3555566667788889999999 88899999999999999999999999984321110
Q ss_pred C-----------------------------CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCc
Q 002021 835 E-----------------------------DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTD 885 (979)
Q Consensus 835 ~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~ 885 (979)
. +.........+|+.|.+||...+......+|.|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00011234568999999999999999999999999999999999999997
Q ss_pred ccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHH
Q 002021 886 EIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAK 951 (979)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 951 (979)
+....+. +........+.. ..++....+..+++.+.+..+|.+|..+.
T Consensus 1037 a~tpq~~-f~ni~~~~~~~p-----------------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI-FENILNRDIPWP-----------------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhh-hhccccCCCCCC-----------------CCccccChhhhhhhhhhhccCchhccCcc
Confidence 6433221 111111111110 11223445677888889899999998776
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.8e-10 Score=134.69 Aligned_cols=141 Identities=23% Similarity=0.343 Sum_probs=59.2
Q ss_pred CCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCC-cccccC
Q 002021 168 IPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL-SSIGYA 246 (979)
Q Consensus 168 ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~ 246 (979)
+|.++++|-+|++|+|+...++ .+|..+++|..|.+|++..+.-...+|.....+++|++|.+..-...... .-..+.
T Consensus 587 LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~ 665 (889)
T KOG4658|consen 587 LPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELE 665 (889)
T ss_pred CChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhh
Confidence 4444444444555544444444 44444455555555555444433333444444455555444443311100 001123
Q ss_pred CCCCcCEEEccCCccccccCcccccCCCCc----EEeccccccccccCccccccccccceeccccccccc
Q 002021 247 RLPNLEILSLWGNNFSGTIPRFIFNASKLS----ILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS 312 (979)
Q Consensus 247 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 312 (979)
.+.+|+.+........ +-..+..+.+|. .+.+.++... ..+..+..+.+|+.|.+.++.+.+.
T Consensus 666 ~Le~L~~ls~~~~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~ 732 (889)
T KOG4658|consen 666 NLEHLENLSITISSVL--LLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEI 732 (889)
T ss_pred cccchhhheeecchhH--hHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchh
Confidence 3344444443322220 001111122222 2332232322 2344566677777777777766543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.7e-10 Score=134.29 Aligned_cols=104 Identities=28% Similarity=0.341 Sum_probs=48.5
Q ss_pred CCCeeeccCCcc-cccCCcc-ccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCC
Q 002021 97 SLQSLNLSFNRL-FGSIPSA-IFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGN 174 (979)
Q Consensus 97 ~L~~L~L~~n~~-~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~ 174 (979)
.|++|-+..|.- ...++.. |..++.|++|||++|.=-+.+|..++++-+||+|+|++..++ .+|..+++
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~---------~LP~~l~~ 616 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS---------HLPSGLGN 616 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc---------ccchHHHH
Confidence 344455544431 1123322 333455555555554444455555555555555555554443 24555555
Q ss_pred CCccceeecccccccccccccccCCCCCCceecCC
Q 002021 175 LPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGD 209 (979)
Q Consensus 175 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 209 (979)
|..|.+|++..+.-...+|..+..+++|++|.+..
T Consensus 617 Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~ 651 (889)
T KOG4658|consen 617 LKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPR 651 (889)
T ss_pred HHhhheeccccccccccccchhhhcccccEEEeec
Confidence 55555555554443333344444455555555443
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.1e-09 Score=77.90 Aligned_cols=40 Identities=43% Similarity=0.980 Sum_probs=30.3
Q ss_pred hhHHHHHHHHHHhcccCCCCccccccCCC--CCCCccceeEee
Q 002021 28 ITDQDALLALKAHITHDPTNFLAKNWNTS--TPVCNWTGVACE 68 (979)
Q Consensus 28 ~~~~~all~~k~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~ 68 (979)
..|++||++||+++..+|.+.+ .+|+.+ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l-~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVL-SSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCC-TT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCccc-ccCCCcCCCCCeeeccEEeC
Confidence 4799999999999987887776 599887 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.5e-08 Score=99.25 Aligned_cols=125 Identities=26% Similarity=0.304 Sum_probs=82.4
Q ss_pred EEEEEEcCCCcEEEEEEecccc-------------cc-------------chhcHHHHHHHHHhcCCC--CeeeEEEeec
Q 002021 697 SVYKASLGDGMEVAVKVFTSQC-------------GR-------------AFKSFDVECEIMKSIRHR--NLIKVISSCS 748 (979)
Q Consensus 697 ~Vy~~~~~~~~~vAvK~~~~~~-------------~~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 748 (979)
.||.|.-.+|..||||..+... .+ ......+|++.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899988889999999875321 00 012356799999999765 445555442
Q ss_pred cCCeeEEEEEecC--CCccceeeccCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCCCCCEEeCCCCcEEEEe
Q 002021 749 NEEFKALVLEYMP--HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY-LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 825 (979)
Q Consensus 749 ~~~~~~lv~E~~~--~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D 825 (979)
..++||||++ |..+.. +.... ++.+....++.++...+.. +| ..||+|+|+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDVD--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHCG--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhh-HHhcc--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3469999998 544543 32221 1234556778888885555 57 9999999999999999988 999999
Q ss_pred ecccccc
Q 002021 826 FSIAKML 832 (979)
Q Consensus 826 fg~~~~~ 832 (979)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.5e-09 Score=85.83 Aligned_cols=59 Identities=44% Similarity=0.589 Sum_probs=28.7
Q ss_pred ccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCc
Q 002021 520 NLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578 (979)
Q Consensus 520 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 578 (979)
+|++|++++|+|+...+..|.++++|++|++++|+++.+.|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333444445555555555555544444445555555555555544
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.6e-09 Score=85.79 Aligned_cols=60 Identities=42% Similarity=0.631 Sum_probs=39.5
Q ss_pred ccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccc
Q 002021 496 VLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNL 555 (979)
Q Consensus 496 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 555 (979)
+|+.|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 456666666666655556666666666666666666665566666666666666666654
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.7e-08 Score=103.51 Aligned_cols=140 Identities=15% Similarity=0.105 Sum_probs=101.1
Q ss_pred ceeeeecceEEEEEEcCCCcEEEEEEecccccc-----------chhcHHHHHHHHHhcCC--CCeeeEEEeecc-----
Q 002021 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR-----------AFKSFDVECEIMKSIRH--RNLIKVISSCSN----- 749 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~h--~niv~l~~~~~~----- 749 (979)
+.+-+.....|++.++ +|+.|.||........ ....+.+|.+.+.++.. -.+.+.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455555556778777 6788999977433210 11137789999888843 233344444432
Q ss_pred CCeeEEEEEecCCC-ccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-------CCc
Q 002021 750 EEFKALVLEYMPHG-SLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-------NMV 820 (979)
Q Consensus 750 ~~~~~lv~E~~~~g-~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-------~~~ 820 (979)
....++|||++++. +|.+++... ....+...+..++.+++..++.|| ..||+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23568999999886 788887532 234566778899999999999999 999999999999999975 568
Q ss_pred EEEEeeccccc
Q 002021 821 AHLSDFSIAKM 831 (979)
Q Consensus 821 ~kl~Dfg~~~~ 831 (979)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998854
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.8e-10 Score=128.82 Aligned_cols=128 Identities=32% Similarity=0.219 Sum_probs=71.0
Q ss_pred cCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCC
Q 002021 449 SLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGY 528 (979)
Q Consensus 449 ~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 528 (979)
.|...+.+.|.+..+..++.-++.++.|+|++|+++... .+..+..|+.|||++|.++.+.--...++. |+.|++++
T Consensus 165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn 241 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN 241 (1096)
T ss_pred hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence 355555666666655555555566666666666665432 555566666666666666533222233333 66666666
Q ss_pred ccccCCCCCcccccccccccccccccccccCC-ccccCccccCeEeccCCcccc
Q 002021 529 NRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP-ASLEKLSYLEDLNLSFNQLEG 581 (979)
Q Consensus 529 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ 581 (979)
|.++.. ..+.+|.+|+.|||++|-|.+.-. ..+..|..|..|+|.||++.|
T Consensus 242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 666521 235566666666666666653211 123445566666666666654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3e-07 Score=100.55 Aligned_cols=167 Identities=20% Similarity=0.216 Sum_probs=126.4
Q ss_pred cceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeec----cCCeeEEEEEecCC-Cccce
Q 002021 694 GFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS----NEEFKALVLEYMPH-GSLEK 767 (979)
Q Consensus 694 ~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~E~~~~-g~L~~ 767 (979)
.-.+.||+ ...||..|++|+++.........-..-+++++++.|+|+|++.++|. .+-..++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34578888 55689999999995443222222234578899999999999999886 34567899999887 46655
Q ss_pred eecc--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 768 YLYS--------------SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 768 ~l~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
+-.. .....+++.+|.++.|+..||.++| +.|+..+-+.+.+|+++.+.+++|+.-|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 4322 1335678899999999999999999 9999999999999999999999998888776654
Q ss_pred CCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCC
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKK 882 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~ 882 (979)
..+. |.+. -..+-|.=.+|.++..|.||+.
T Consensus 445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 3321 1111 1236799999999999999976
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.5e-10 Score=126.54 Aligned_cols=181 Identities=29% Similarity=0.361 Sum_probs=125.0
Q ss_pred cccccCCCCCceEecCCCcccccCCccccCC-CcCceEecCCCccccccc-------cccC---cCCCcEEEeccccccC
Q 002021 417 PYDICNLAELYRLDLDGNKLSGSIPACFSNL-TSLRIVSLGSNELTSIPL-------TFWN---LKDILNLNFSSNFLTG 485 (979)
Q Consensus 417 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~lp~-------~~~~---l~~L~~L~ls~N~l~~ 485 (979)
|-.+..+.+|++|.|.++.|.. .. .+..+ ..|++|.. +|.++.+-. .+.+ -..|...+.+.|.++
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~-~~-GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST-AK-GLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh-hh-hhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 4455666667777777666652 11 11111 22444432 233322111 1111 135778889999998
Q ss_pred CCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccC
Q 002021 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEK 565 (979)
Q Consensus 486 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 565 (979)
.+-..+.-++.|+.||||+|+++... .+..++.|+.|||++|.|+-..--...++. |..|.|+||.++.. ..+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence 56667888899999999999998654 899999999999999999943334445555 99999999999855 46789
Q ss_pred ccccCeEeccCCccccc--CCCCCCCCCcccccccCCccccCC
Q 002021 566 LSYLEDLNLSFNQLEGK--IPRGGSFGNFSAQSFEGNELLCGS 606 (979)
Q Consensus 566 l~~L~~L~L~~N~l~~~--~p~~~~~~~~~~~~~~~N~~~c~~ 606 (979)
|.+|+.|||++|-|++. .-....+..+..+.++|||.-|.+
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99999999999998863 222345566778899999876653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.7e-07 Score=95.39 Aligned_cols=134 Identities=22% Similarity=0.206 Sum_probs=98.1
Q ss_pred CCCceeeeecceEEEEEEcCCCcEEEEEEecccc----------------------ccchhcHHHHHHHHHhcCCC--Ce
Q 002021 685 SENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC----------------------GRAFKSFDVECEIMKSIRHR--NL 740 (979)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--ni 740 (979)
.++..||.|.-+.||.|..++|.++|||-=+... .......++|.++|.++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4567999999999999998899999999532110 00113456799999998654 55
Q ss_pred eeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc
Q 002021 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 820 (979)
Q Consensus 741 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~ 820 (979)
.+.+++ ....+||||++|-.|...- ++.+..-.++..|.+-+.-.- ..|++|+|+.+-||+++++|.
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCC
Confidence 555554 4457999999996665432 234444556666666666666 689999999999999999999
Q ss_pred EEEEeeccccc
Q 002021 821 AHLSDFSIAKM 831 (979)
Q Consensus 821 ~kl~Dfg~~~~ 831 (979)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999965543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.9e-09 Score=105.91 Aligned_cols=113 Identities=27% Similarity=0.311 Sum_probs=70.8
Q ss_pred cCCCCCCceecCCCeeeecCCc-ccc-ccCccceeeccCCCCcCCCc-ccccCCCCCcCEEEccCCccccccCcccccCC
Q 002021 197 GNLRNLEKLDIGDNKLVGIAPI-AIF-NVSTLKILGLQDNSLSGCLS-SIGYARLPNLEILSLWGNNFSGTIPRFIFNAS 273 (979)
Q Consensus 197 ~~l~~L~~L~Ls~N~l~~~~p~-~l~-~l~~L~~L~L~~N~l~~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 273 (979)
..+.-++.|-+.++.|...... .|+ .++.++.|||..|.|+.+.. ...+.++|.|++|+|+.|.+...|...-....
T Consensus 42 ~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~ 121 (418)
T KOG2982|consen 42 SSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLK 121 (418)
T ss_pred ccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCccccc
Confidence 3334455566666655533221 122 35677888888888886643 33467888888888888888755433223467
Q ss_pred CCcEEeccccccccc-cCccccccccccceecccccc
Q 002021 274 KLSILDLEGNSFSGF-IPNTFGNLRNLSWLVLSDNYL 309 (979)
Q Consensus 274 ~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l 309 (979)
+|++|-|.+..+.-. ....+..++.++.|++|.|.+
T Consensus 122 nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 122 NLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL 158 (418)
T ss_pred ceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence 788888888877532 233455667777777777743
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.6e-09 Score=95.66 Aligned_cols=133 Identities=20% Similarity=0.218 Sum_probs=76.3
Q ss_pred ceEecCCCccccccccc---cCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecC
Q 002021 451 RIVSLGSNELTSIPLTF---WNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLG 527 (979)
Q Consensus 451 ~~L~L~~N~l~~lp~~~---~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 527 (979)
..++|+++++-.+++.. .....|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|..+..++.|+.|+++
T Consensus 30 h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~ 108 (177)
T KOG4579|consen 30 HFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLR 108 (177)
T ss_pred hhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccc
Confidence 34444444444333322 22233333445555544322222223345666777777776 556667778888888888
Q ss_pred CccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCC
Q 002021 528 YNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG 586 (979)
Q Consensus 528 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 586 (979)
.|.+. ..|..+..|.+|-.||..+|.+. .+|..+-.-+.....++.+++|.+..|..
T Consensus 109 ~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 109 FNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred cCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 88877 66777777778888888888776 44443333333444555667777666653
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.2e-09 Score=105.05 Aligned_cols=73 Identities=21% Similarity=0.275 Sum_probs=34.4
Q ss_pred cCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeeccccccc---ccccc-------cccCCCCCCceecCCC
Q 002021 141 SNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQ---GKIPL-------KIGNLRNLEKLDIGDN 210 (979)
Q Consensus 141 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~---~~~p~-------~~~~l~~L~~L~Ls~N 210 (979)
..+..+..+|||+|.|...-. +.+...+.+-.+|+..+++.-... ..+++ .+..+++|+..+||+|
T Consensus 27 ~~~d~~~evdLSGNtigtEA~----e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDN 102 (388)
T COG5238 27 EMMDELVEVDLSGNTIGTEAM----EELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDN 102 (388)
T ss_pred HhhcceeEEeccCCcccHHHH----HHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeecccc
Confidence 345666666666666653322 223334444555555555433221 11221 2334455555555555
Q ss_pred eeeecCC
Q 002021 211 KLVGIAP 217 (979)
Q Consensus 211 ~l~~~~p 217 (979)
.+....|
T Consensus 103 Afg~~~~ 109 (388)
T COG5238 103 AFGSEFP 109 (388)
T ss_pred ccCcccc
Confidence 5544433
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1e-08 Score=116.22 Aligned_cols=153 Identities=20% Similarity=0.288 Sum_probs=104.5
Q ss_pred HHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc-------eecccccCCCCCCccccC
Q 002021 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM-------IQTQTLATIGYMAPEYGR 857 (979)
Q Consensus 785 ~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~ 857 (979)
+.+++.|+.|+|. +.++||+.|.|++|.++.++..||+.|+++....++.... ...-......|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4455599999996 7899999999999999999999999999987654422110 011112356799999999
Q ss_pred CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHH
Q 002021 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 937 (979)
Q Consensus 858 ~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 937 (979)
+...++++|+||+||++|-+..|..+.-........+.. .. ...+... +....+.+.++.+=+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~--------~~~~~~~-------~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SR--------NLLNAGA-------FGYSNNLPSELRESLK 246 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hh--------ccccccc-------ccccccCcHHHHHHHH
Confidence 888899999999999999998555442221211111110 00 0011111 1111356677888999
Q ss_pred hccccCcCCCCCHHHHHH
Q 002021 938 ECTMEFPKQRINAKEIVT 955 (979)
Q Consensus 938 ~cl~~dP~~Rps~~eil~ 955 (979)
+.+..++..||++.++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999997776653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.3e-07 Score=108.22 Aligned_cols=140 Identities=21% Similarity=0.207 Sum_probs=97.6
Q ss_pred ceeeeecceEEEEEEcCCCcEEEEEEeccccccch----------------------------------------hcHHH
Q 002021 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAF----------------------------------------KSFDV 727 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~----------------------------------------~~~~~ 727 (979)
+.|+.++-|+||+|++.+|+.||||+.++.-.... =++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999999865421100 12455
Q ss_pred HHHHHHhcC----CCCeeeEEEee-ccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHH-HHHHhcCCCC
Q 002021 728 ECEIMKSIR----HRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA-LEYLHFGYSA 801 (979)
Q Consensus 728 E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~-L~~LH~~~~~ 801 (979)
|+..+.+++ ...-+.+-.+| +-.....|+|||++|-.+.+...-.....+.+.+ +..++++ +..+- ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~i---a~~~~~~f~~q~~---~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKEL---AELLVRAFLRQLL---RD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHH---HHHHHHHHHHHHH---hc
Confidence 666666653 33333333333 3356678999999999998885333334554333 3333332 22333 56
Q ss_pred CeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 802 ~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
|+.|.|..|.||+++.++++.+.|||+...+.
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999999987764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 979 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-35 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-34 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 7e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 6e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 9e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 4e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-07 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 6e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 5e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-06 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 7e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 501 bits (1292), Expect = e-165
Identities = 169/555 (30%), Positives = 250/555 (45%), Gaps = 31/555 (5%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
L+IS L+G + + L+ LN+S N+ G IP + L+Y+ L N+ +G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS--LQYLSLAENKFTG 283
Query: 135 TFPSFISNK-SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
P F+S +L LDLS N G + P FG+ LE ++L++NN G++P
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAV--------PPFFGSCSLLESLALSSNNFSGELP 335
Query: 194 LK-IGNLRNLEKLDIGDNKLVGIAPIAIFNVST-LKILGLQDNSLSGCL-SSIGYARLPN 250
+ + +R L+ LD+ N+ G P ++ N+S L L L N+ SG + ++
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 251 LEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLT 310
L+ L L N F+G IP + N S+L L L N SG IP++ G+L L L L N L
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 311 SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPE 370
L K L+ L +N L +P + N + +L +SN ++G IP+
Sbjct: 456 GE-----IPQELMYVKTLETLILDFNDLTGEIPSG-LSNCT-NLNWISLSNNRLTGEIPK 508
Query: 371 EISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLD 430
I L NL + L N +G+I L + L L L N G+IP +
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGK 564
Query: 431 LDGNKLSGSIPACFSNLTSLRIVSLGSNELT---SIPLTFWNLKDILNLNFSSNFLTGSL 487
+ N ++G N + N L L N +S G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 488 PLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKF 547
+ ++ +D+S N SG IP EIG + L L LG+N + GSIP+ GDL L
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 548 LNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607
L+LS+N L G IP ++ L+ L +++LS N L G IP G F F F N LCG P
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744
Query: 608 NLQIPPCKTSIHHKS 622
+P C S
Sbjct: 745 ---LPRCDPSNADGY 756
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 458 bits (1181), Expect = e-148
Identities = 167/589 (28%), Positives = 270/589 (45%), Gaps = 40/589 (6%)
Query: 18 AAATANTSSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVL 77
+ + + S + L++ K + N L +W+++ C + GV C +VT +
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVL--PDKNLLP-DWSSNKNPCTFDGVTC--RDDKVTSI 55
Query: 78 NISSLNLT---GTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
++SS L + S L +L+ L+SL LS + + GS+ + +L + L N LSG
Sbjct: 56 DLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSG 114
Query: 135 TFPSF--ISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKI 192
+ + + S L+ L++SSN L ++ L LE++ L+AN++ G
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPG------KVS-GGLKLNSLEVLDLSANSISGAN 167
Query: 193 PLKI---GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLP 249
+ L+ L I NK+ G + + L+ L + N+ S + +G
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISG--DVDVSRCVNLEFLDVSSNNFSTGIPFLG--DCS 223
Query: 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
L+ L + GN SG R I ++L +L++ N F G IP L++L +L L++N
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF 281
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
T + C L DLS N Y +P G+ S LE +S+ N SG +P
Sbjct: 282 TGEIPD----FLSGACDTLTGLDLSGNHFYGAVPP-FFGSCS-LLESLALSSNNFSGELP 335
Query: 370 EE-ISNLTNLRTIYLGGNKLNGSILITLSKL-QKLQDLGLKDNKLEGSIPYDICN--LAE 425
+ + + L+ + L N+ +G + +L+ L L L L N G I ++C
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 426 LYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLT 484
L L L N +G IP SN + L + L N L+ +IP + +L + +L N L
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 485 GSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLIS 544
G +P E+ +K L + L N+ +G IP+ + NL ++ L NRL G IP G L +
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
Query: 545 LKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFS 593
L L LSNN+ SG IPA L L L+L+ N G IP + S
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA--AMFKQS 562
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-23
Identities = 42/138 (30%), Positives = 59/138 (42%), Gaps = 9/138 (6%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
NI+S G N S+ L++S+N L G IP I + L + L N +S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
G+ P + + L LDLSSN L G IP+ L L + L+ NNL G IP
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDG--------RIPQAMSALTMLTEIDLSNNNLSGPIP 721
Query: 194 LKIGNLRNLEKLDIGDNK 211
++G +N
Sbjct: 722 -EMGQFETFPPAKFLNNP 738
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-107
Identities = 103/609 (16%), Positives = 194/609 (31%), Gaps = 77/609 (12%)
Query: 24 TSSTITDQDALLALKAHI------THDPTNFLAKNWNTSTPVCNWT---GVACEVHSQRV 74
T+ I D AL + + NWN + + W GV+ + RV
Sbjct: 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN-SNGRV 83
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFG----SIPSAIFTTYTLKYVCLRGN 130
T L++ +G +P +G L+ L+ L L + P I + +
Sbjct: 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143
Query: 131 QLSGTFPSFIS--NKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNL 188
TF + + S L ++S+ I + + + +NN+
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSI--------KKSSRITLKDTQIGQLSNNI 195
Query: 189 QGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL-SSIGYAR 247
+ + L L + +G++ V + +
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWD--N 247
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSF--------SGFIPNTFGNLRNL 299
L +L + ++ +P F+ ++ ++++ N +
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
Query: 300 SWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKM 359
+ + N L + E +SL K L + YN L LP G+ L +
Sbjct: 308 QIIYIGYNNLKTFPVE----TSLQKMKKLGMLECLYNQLEGKLP--AFGSEI-KLASLNL 360
Query: 360 SNCNISGGIPEEISNLTNLRTIYLGGNKLNG-SILITLSKLQKLQDLGLKDNKLEG---- 414
+ I+ + + NKL + + + + N++
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420
Query: 415 ---SIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP------- 464
+ + ++L N++S FS + L ++L N LT IP
Sbjct: 421 NFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDE 480
Query: 465 -LTFWNLKDILNLNFSSNFLTGSLPLEI--GSLKVLVGIDLSRNNFSGVIPTEIGGLKNL 521
F N + +++ N LT L + +L LVGIDLS N+FS PT+ L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 522 EYLFLG------YNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLS 575
+ + NR P SL L + +N++ V +S L++
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISV---LDIK 595
Query: 576 FNQLEGKIP 584
N
Sbjct: 596 DNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 1e-83
Identities = 77/453 (16%), Positives = 153/453 (33%), Gaps = 45/453 (9%)
Query: 171 EFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIA----PIAIFNVSTL 226
+ + +SL G++P IG L LE L +G + P I +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 227 KILGLQDNSLSGC-LSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSF 285
+ + +L + + +I + K + + N+
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 286 SGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRT 345
+ + L L + ++ + + C+ + + Y Y+
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAE----------NICEAWENENSEYAQQYKTEDLK 244
Query: 346 TVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKL--------NGSILITLS 397
NL L + ++ NC +P + L ++ I + N+ + L
Sbjct: 245 -WDNLK-DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 398 KLQKLQDLGLKDNKL-EGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLG 456
+K+Q + + N L + + + +L L+ N+L G +PA F + L ++L
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLA 361
Query: 457 SNELTSIPLTFW-NLKDILNLNFSSNFLTG-SLPLEIGSLKVLVGIDLSRNNFSGV---- 510
N++T IP F + + NL+F+ N L + S+ V+ ID S N V
Sbjct: 362 YNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421
Query: 511 ---IPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGV-------IP 560
+ N+ + L N++ F L +NL N L+ +
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
Query: 561 ASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFS 593
+ + L ++L FN+L +
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-15
Identities = 20/117 (17%), Positives = 38/117 (32%), Gaps = 6/117 (5%)
Query: 475 NLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG- 533
N N + + + S + G+ L SG +P IG L LE L LG + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 534 ---SIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSY--LEDLNLSFNQLEGKIPR 585
P +S + + + + L ++ + + I +
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 331 bits (850), Expect = e-101
Identities = 113/561 (20%), Positives = 207/561 (36%), Gaps = 34/561 (6%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
VLN+ L+ ++L L+L N + + L + L N LS
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
T +LQ L LS+N + + + L+ + L++N ++ P
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEEL------DIFANSSLKKLELSSNQIKEFSPG 189
Query: 195 KIGNLRNLEKLDIGDNKLVGIAPIAIF---NVSTLKILGLQDNSLSGCL-SSIGYARLPN 250
+ L L + + +L + ++++ L L ++ LS ++ + N
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249
Query: 251 LEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLT 310
L +L L NN + +L LE N+ ++ L N+ +L L ++
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 311 SSTQELSF----LSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISG 366
S S S K L++ ++ N + + L +L+ +SN S
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDI-PGIKSNMFTGLI-NLKYLSLSNSFTSL 367
Query: 367 GIPEEIS----NLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD-IC 421
+ + L + L NK++ S L L+ L L N++ +
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 422 NLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSI---PLTFWNLKDILNLNF 478
L ++ + L NK F+ + SL+ + L L ++ P F L+++ L+
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 479 SSNFLTGSLPLEIGSLKVLVGIDLSRNNFS--------GVIPTEIGGLKNLEYLFLGYNR 530
S+N + + L+ L +DL NN + G + GL +L L L N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 531 LQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR--GGS 588
F DL LK ++L NNL+ + + L+ LNL N + + G +
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
Query: 589 FGNFSAQSFEGNELLCGSPNL 609
F N + N C ++
Sbjct: 608 FRNLTELDMRFNPFDCTCESI 628
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = 2e-98
Identities = 121/569 (21%), Positives = 211/569 (37%), Gaps = 50/569 (8%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
T L++ S ++ + +L +L+LS N L + L+ + L N++
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 135 TFPSFISNK--SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKI 192
+ SSL+ L+LSSN + P F + L + L L +
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFS--------PGCFHAIGRLFGLFLNNVQLGPSL 211
Query: 193 PLKIG---NLRNLEKLDIGDNKLVGIAPIAIFN--VSTLKILGLQDNSLSGCLSSIGYAR 247
K+ ++ L + +++L + + L +L L N+L+ + + +A
Sbjct: 212 TEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV-VGNDSFAW 270
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGN---------SFSGFIPNTFGNLRN 298
LP LE L NN + + L+L+ + S +F L+
Sbjct: 271 LPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKC 330
Query: 299 LSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPL-YRILPRTTVGNLSH-SLEE 356
L L + DN + + + LKY LS + R L T +L+H L
Sbjct: 331 LEHLNMEDNDIPGIKS-----NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385
Query: 357 FKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILI-TLSKLQKLQDLGLKDNKLEGS 415
++ IS + S L +L + LG N++ + L+ + ++ L NK
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
Query: 416 IPYDICNLAELYRLDLDGNKLSG--SIPACFSNLTSLRIVSLGSNELTSIP-LTFWNLKD 472
+ L RL L L S P+ F L +L I+ L +N + +I L+
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505
Query: 473 ILNLNFSSNFLT--------GSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYL 524
+ L+ N L G + L L ++L N F + L L+ +
Sbjct: 506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565
Query: 525 FLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEK-LSYLEDLNLSFNQLEGKI 583
LG N L + F + +SLK LNL N ++ V L +L++ FN +
Sbjct: 566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625
Query: 584 PRGGSFGNF-----SAQSFEGNELLCGSP 607
F N+ + + LC +P
Sbjct: 626 ESIAWFVNWINETHTNIPELSSHYLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = 2e-94
Identities = 116/516 (22%), Positives = 187/516 (36%), Gaps = 35/516 (6%)
Query: 97 SLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNAL 156
S + + S +L +P + T + + L NQL + + S L LD+ N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 157 SGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIA 216
S P LP L++++L N L NL +L + N + I
Sbjct: 62 SK--------LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK 113
Query: 217 PIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFI--FNASK 274
L L L N LS +L NL+ L L N + F S
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172
Query: 275 LSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLS 334
L L+L N F P F + L L L++ L S E L ++ LS
Sbjct: 173 LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE--LANTSIRNLSLS 230
Query: 335 YNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILI 394
+ L T +G +L +S N++ + + L L +L N +
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
Query: 395 TLSKLQKLQDLGLKDN---------KLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFS 445
+L L ++ L LK + L + L L L+++ N + G F+
Sbjct: 291 SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFT 350
Query: 446 NLTSLRIVSLGSNELTSIPLTFWNLKDILN-----LNFSSNFLTGSLPLEIGSLKVLVGI 500
L +L+ +SL ++ + LT + + LN + N ++ L L +
Sbjct: 351 GLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVL 410
Query: 501 DLSRNNFSGVIP-TEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGV- 558
DL N + E GL+N+ ++L YN+ NSF + SL+ L L L V
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470
Query: 559 -IPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFS 593
P+ + L L L+LS N +
Sbjct: 471 SSPSPFQPLRNLTILDLSNNNIANIND--DMLEGLE 504
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 5e-66
Identities = 82/389 (21%), Positives = 145/389 (37%), Gaps = 28/389 (7%)
Query: 225 TLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNS 284
+ ++ L+ + N+ +L+L N S+L+ LD+ N+
Sbjct: 5 SHEVADCSHLKLTQVPDDL----PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 285 FSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPR 344
S P L L L L N L+ + + + + C L L N + +I
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDK-----TFAFCTNLTELHLMSNSIQKI-KN 114
Query: 345 TTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSI--LITLSKLQKL 402
+L +S+ +S L NL+ + L NK+ + + L
Sbjct: 115 NPFVKQK-NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173
Query: 403 QDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA---CFSNLTSLRIVSLGSNE 459
+ L L N+++ P + L+ L L+ +L S+ TS+R +SL +++
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233
Query: 460 LTSI-PLTFWNLKD--ILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIG 516
L++ TF LK + L+ S N L L L L NN + +
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
Query: 517 GLKNLEYLFLGYN---------RLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLS 567
GL N+ YL L + L SF L L+ LN+ +N++ G+ L
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353
Query: 568 YLEDLNLSFNQLEGKIPRGGSFGNFSAQS 596
L+ L+LS + + +F + +
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-38
Identities = 68/330 (20%), Positives = 118/330 (35%), Gaps = 23/330 (6%)
Query: 49 LAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRL 108
L+ ++ + + N T V+ + +LN++ ++ L L+ L+L N +
Sbjct: 360 LSNSFTSLRTLTNETFVSLAHSP--LHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417
Query: 109 FGSIPSAIFTTYT-LKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICRE 167
+ + + + L N+ + + SLQ L L AL
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN------VDS 471
Query: 168 IPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNV---- 223
P F L L ++ L+ NN+ + L LE LD+ N L + A
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531
Query: 224 ----STLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILD 279
S L IL L+ N + + L L+I+ L NN + N L L+
Sbjct: 532 LKGLSHLHILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLN 590
Query: 280 LEGNSFSGFIPNTFG-NLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPL 338
L+ N + FG RNL+ L + N + + +++ + N +LS + L
Sbjct: 591 LQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYL 650
Query: 339 YRILPRTTVGNLSHSLEEFKMSNCNISGGI 368
P + F S+C S
Sbjct: 651 CNTPPHYH----GFPVRLFDTSSCKDSAHH 676
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-27
Identities = 33/146 (22%), Positives = 52/146 (35%), Gaps = 4/146 (2%)
Query: 448 TSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNF 507
S + +LT +P +I LN + N L L +D+ N
Sbjct: 4 VSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 508 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLS 567
S + P L L+ L L +N L +F +L L+L +N++ + K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 568 YLEDLNLSFNQLEGKIPRGGSFGNFS 593
L L+LS N L G+
Sbjct: 122 NLITLDLSHNGLSSTKL--GTQVQLE 145
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = 3e-98
Identities = 110/645 (17%), Positives = 207/645 (32%), Gaps = 75/645 (11%)
Query: 17 IAAATANTSSTITDQDALLALKAHITHDPTNF---------LAKNWNTSTPVCNW---TG 64
+ T+ I D AL A+ + + + NWN + + W G
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPG 316
Query: 65 VACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKY 124
V + ++ RVT L+++ G +P +G L+ L+ L+ + S T
Sbjct: 317 VDLD-NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375
Query: 125 VCLRGNQLSGTFPS-FISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSL 183
R +++ + F+ L DL +A++ + +L + ++ +L
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNL 433
Query: 184 AANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSI 243
N I I L L+ + ++ V S
Sbjct: 434 --TNRITFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSW 487
Query: 244 GYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGF---------IPNTFG 294
L +L + L+ +P F+++ +L L++ N + +
Sbjct: 488 S--NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED 545
Query: 295 NLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSL 354
+ + N L S L D +N + R L G L
Sbjct: 546 TGPKIQIFYMGYNNLEEFPASASL----QKMVKLGLLDCVHNKV-RHLE--AFGTNV-KL 597
Query: 355 EEFKMSNCNISGGIPEEI-SNLTNLRTIYLGGNKLNG-SILITLSKLQKLQDLGLKDNKL 412
+ K+ I IPE+ + + + NKL + + + + NK+
Sbjct: 598 TDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKI 656
Query: 413 EG-----SIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP--- 464
S D + L N++ F+ + + + L +N +TSIP
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716
Query: 465 -----LTFWNLKDILNLNFSSNFLTGSLPLEI--GSLKVLVGIDLSRNNFSGVIPTEIGG 517
+ N + ++ N LT SL + +L L +D+S N FS PT+
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLN 774
Query: 518 LKNLEYL------FLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLED 571
L+ NR+ P SL L + +N++ + L L
Sbjct: 775 SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYI 831
Query: 572 LNLSFNQLEGKIPRGGSFGNFSAQ----SFEGNELLCGSPNLQIP 612
L+++ N I A ++ + + G L I
Sbjct: 832 LDIADNPNIS-IDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = 1e-92
Identities = 103/529 (19%), Positives = 185/529 (34%), Gaps = 42/529 (7%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
VL++S + +LS L +L L+ N + A +L+ + L+
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
I + +L+ L+++ N + ++P F NL LE + L++N +Q
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSF-------KLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
Query: 195 KIGNLRNLE----KLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPN 250
+ L + LD+ N + I P F L L L++N S + L
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG 226
Query: 251 LEILSLWGNNFSGT--IPRFIFNA----SKLSILDLEGNSFSGF---IPNTFGNLRNLSW 301
LE+ L F + +F +A L+I + + I + F L N+S
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286
Query: 302 LVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSN 361
L + + S ++ +L + +
Sbjct: 287 FSLVSVTIER-------VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF------- 332
Query: 362 CNISGGIPEEISNLTNLRTIYLGGNKLN--GSILITLSKLQKLQDLGLKDNKLEGSIPYD 419
+ GG +L +L + L N L+ G + L+ L L N + + +
Sbjct: 333 TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSN 391
Query: 420 ICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSI-PLTFWNLKDILNLN 477
L +L LD + L F +L +L + + F L + L
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451
Query: 478 FSSNFLTGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 536
+ N + +I L+ L +DLS+ + PT L +L+ L + +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 537 NSFGDLISLKFLNLSNNNLSGVIPASLEKL-SYLEDLNLSFNQLEGKIP 584
+ L SL+ L+ S N++ L+ S L LNL+ N
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 3e-89
Identities = 118/532 (22%), Positives = 195/532 (36%), Gaps = 36/532 (6%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
LN IP L S ++L+LSFN L + F+ L+ + L ++
Sbjct: 10 ITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
+ S L L L+ N + F L L+ + NL
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQS--------LALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 195 KIGNLRNLEKLDIGDNKLVGI-APIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
IG+L+ L++L++ N + P N++ L+ L L N + + L + +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPL 177
Query: 254 LSLW---GNNFSGTIPRFIFNASKLSILDLEGNSFSGFIP-NTFGNLRNLSWLVLSDNYL 309
L+L N I F +L L L N S + L L L
Sbjct: 178 LNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF 237
Query: 310 TSSTQ----ELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNIS 365
+ + S L L N F L+Y Y L++ + F + + I
Sbjct: 238 RNEGNLEKFDKSALEGLCNLTIE-EFRLAYLDYYLDDIIDLFNCLTN-VSSFSLVSVTIE 295
Query: 366 GGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAE 425
++ S + + L K + L L++L K G + +L
Sbjct: 296 R--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK-----GGNAFSEVDLPS 348
Query: 426 LYRLDLDGNKLS--GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFL 483
L LDL N LS G TSL+ + L N + ++ F L+ + +L+F + L
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNL 408
Query: 484 TGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI-PNSFGD 541
+ SL+ L+ +D+S + GL +LE L + N Q + P+ F +
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 542 LISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFS 593
L +L FL+LS L + P + LS L+ LN+S N + +
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLN 518
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 5e-74
Identities = 98/536 (18%), Positives = 176/536 (32%), Gaps = 49/536 (9%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQL-S 133
+ L ++ + LSSLQ L L I TLK + + N + S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELM----SLAANNLQ 189
P + SN ++L+HLDLSSN + + L ++ L+ L+ N +
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIY--------CTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 190 GKIPLKIGNLRNLEKLDIGDNKL-VGIAPIAIFNVSTLKILGLQDNSLSGC--LSSIGYA 246
P + L KL + +N + + I ++ L++ L L +
Sbjct: 191 FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 247 RLPNLEILSLWGNNFS------GTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLS 300
L L L++ + I + +S L + F
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQ 307
Query: 301 WLVLSDNYLTS-------STQELSFLS-------SLSNCKFLKYFDLSYNPLYRI-LPRT 345
L L + S + L+F S S + L++ DLS N L
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 346 TVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSI-LITLSKLQKLQD 404
+ + SL+ +S + + L L + + L L+ L
Sbjct: 368 SDFGTT-SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 405 LGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPAC-FSNLTSLRIVSLGSNELTSI 463
L + + L+ L L + GN + F+ L +L + L +L +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 464 -PLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGL-KNL 521
P F +L + LN S N L L +D S N+ E+ +L
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 545
Query: 522 EYLFLGYNRLQGSIPNS--FGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLS 575
+L L N + + + + L + + P+ + + + LN++
Sbjct: 546 AFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-51
Identities = 80/433 (18%), Positives = 143/433 (33%), Gaps = 46/433 (10%)
Query: 73 RVTVLNISSLNLTGTIPSQ-LGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131
R+ L + + + + + L+ L+ L F L+ +C
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC----- 255
Query: 132 LSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGK 191
+++ L+ + +I F L + SL + ++
Sbjct: 256 -----------NLTIEEFRLAYLDYYLD-------DIIDLFNCLTNVSSFSLVSVTIERV 297
Query: 192 IPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL 251
+ L++ + K + + ++ L N S + LP+L
Sbjct: 298 KDF--SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT---SNKGGNAFSEVD---LPSL 349
Query: 252 EILSLWGN--NFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
E L L N +F G + F + L LDL N + + F L L L + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGI- 368
+S S + + L Y D+S+ R+ LS SLE KM+ +
Sbjct: 409 KQ----MSEFSVFLSLRNLIYLDISHTHT-RVAFNGIFNGLS-SLEVLKMAGNSFQENFL 462
Query: 369 PEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYR 428
P+ + L NL + L +L + L LQ L + N + L L
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 522
Query: 429 LDLDGNKLSGSIPACFSNL-TSLRIVSLGSNELT-SIPLT--FWNLKDILNLNFSSNFLT 484
LD N + S + +SL ++L N+ + +KD L +
Sbjct: 523 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERME 582
Query: 485 GSLPLEIGSLKVL 497
+ P + + VL
Sbjct: 583 CATPSDKQGMPVL 595
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-27
Identities = 34/151 (22%), Positives = 54/151 (35%), Gaps = 4/151 (2%)
Query: 443 CFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDL 502
C + ++ IP NL+ S N L S L +DL
Sbjct: 3 CVEVVPNI-TYQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 503 SRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPAS 562
SR + L +L L L N +Q +F L SL+ L NL+ +
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 563 LEKLSYLEDLNLSFNQLEGKIPRGGSFGNFS 593
+ L L++LN++ N ++ F N +
Sbjct: 120 IGHLKTLKELNVAHNLIQS-FKLPEYFSNLT 149
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-13
Identities = 25/130 (19%), Positives = 47/130 (36%), Gaps = 7/130 (5%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131
+ +T L++S L P+ +LSSLQ LN+S N F +L+ + N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 132 LSGTFPS-FISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQG 190
+ + SSL L+L+ N + E + + + + ++
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTC------EHQSFLQWIKDQRQLLVEVERMEC 583
Query: 191 KIPLKIGNLR 200
P +
Sbjct: 584 ATPSDKQGMP 593
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 2e-91
Identities = 93/337 (27%), Positives = 145/337 (43%), Gaps = 55/337 (16%)
Query: 278 LDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNP 337
D ++ G + +T ++ L LS L SSL+N +L + +
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP---YPIPSSLANLPYLNFLYIG--- 84
Query: 338 LYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLS 397
N+ G IP I+ LT L +Y+ ++G+I LS
Sbjct: 85 ----------------------GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 398 KLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGS 457
+++ L L N L G++P I +L L + DGN++SG+IP + + + L
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL------- 175
Query: 458 NELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGG 517
++ S N LTG +P +L L +DLSRN G G
Sbjct: 176 ---------------FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGS 219
Query: 518 LKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577
KN + + L N L + G +L L+L NN + G +P L +L +L LN+SFN
Sbjct: 220 DKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 578 QLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQIPPC 614
L G+IP+GG+ F ++ N+ LCGSP +P C
Sbjct: 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 5e-71
Identities = 101/374 (27%), Positives = 142/374 (37%), Gaps = 79/374 (21%)
Query: 29 TDQDALLALKAHITHDPTNFLAKNWNTSTPVCN--WTGVACEV--HSQRVTVLNISSLNL 84
D+ ALL +K + +PT +W +T CN W GV C+ + RV L++S LNL
Sbjct: 6 QDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 85 TGT--IPSQLGNLSSLQSLNLS-FNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFIS 141
IPS L NL L L + N L G IP AI L Y+ + +SG P F+S
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 142 NKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRN 201
+L LD S NALSG +P +LP L ++ N + G IP G+
Sbjct: 123 QIKTLVTLDFSYNALSG--------TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174
Query: 202 L-EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNN 260
L + I N+L G P N+ NL + L N
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANL--------------------------NLAFVDLSRNM 208
Query: 261 FSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLS 320
G + + L NS + + G +NL+ L L +N + +
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYG-----TLPQ 262
Query: 321 SLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRT 380
L+ KFL ++S+N N+ G IP+ NL
Sbjct: 263 GLTQLKFLHSLNVSFN--------------------------NLCGEIPQG-GNLQRFDV 295
Query: 381 IYLGGNK-LNGSIL 393
NK L GS L
Sbjct: 296 SAYANNKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 7e-59
Identities = 74/309 (23%), Positives = 123/309 (39%), Gaps = 22/309 (7%)
Query: 167 EIPREFGNLPEL----ELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPI--AI 220
+I ++ GN L G + + LD+ L PI ++
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 221 FNVSTLKILGLQD-NSLSGCL-SSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSIL 278
N+ L L + N+L G + +I +L L L + N SG IP F+ L L
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIA--KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 279 DLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST-QELSFLSSLSNCKFLKYFDLSYNP 337
D N+ SG +P + +L NL + N ++ + S L +S N
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT-----SMTISRNR 185
Query: 338 LYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLS 397
L +P T NL +L +S + G + N + I+L N L + +
Sbjct: 186 LTGKIPP-TFANL--NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVG 241
Query: 398 KLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGS 457
+ L L L++N++ G++P + L L+ L++ N L G IP NL + + +
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYAN 300
Query: 458 NE-LTSIPL 465
N+ L PL
Sbjct: 301 NKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 31/121 (25%), Positives = 53/121 (43%), Gaps = 10/121 (8%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
+++S L G G+ + Q ++L+ N L + + + L + LR N++ G
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYG 258
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
T P ++ L L++S N L GEI P+ GNL ++ + A N PL
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEI--------PQG-GNLQRFDVSAYANNKCLCGSPL 309
Query: 195 K 195
Sbjct: 310 P 310
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 1e-84
Identities = 108/520 (20%), Positives = 197/520 (37%), Gaps = 31/520 (5%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
T L+++ + + L +L L+ N L +A+ LK++ +S
Sbjct: 60 TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
+ N+ +L+ L L SN +S + +L+++ N +
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISS--------IKLPKGFPTEKLKVLDFQNNAIHYLSKE 171
Query: 195 KIGNLRNLE--KLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSG-CLSSIGYARLPNL 251
+ +L+ L++ N + GI P F+ + + L + + + +L
Sbjct: 172 DMSSLQQATNLSLNLNGNDIAGIEP-GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSI--LDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
+ + + P ++S+ ++L+ + F NTF L L L+ +L
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
+ S L LK LS N L + + N SL + +
Sbjct: 291 S------ELPSGLVGLSTLKKLVLSANKF-ENLCQISASNFP-SLTHLSIKGNTKRLELG 342
Query: 370 EE-ISNLTNLRTIYLGGNKLNGSILI--TLSKLQKLQDLGLKDNKLEGSIPYDICNLAEL 426
+ NL NLR + L + + S L L LQ L L N+ +L
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402
Query: 427 YRLDLDGNKLSGSIP-ACFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNFLT 484
LDL +L + F NL L++++L + L F L + +LN N
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462
Query: 485 GSLPLEIGSLKV---LVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD 541
+ SL+ L + LS + S + LK + ++ L +NRL S +
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 542 LISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEG 581
L + +LNL++N++S ++P+ L LS +NL N L+
Sbjct: 523 LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 2e-84
Identities = 109/548 (19%), Positives = 193/548 (35%), Gaps = 38/548 (6%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
L S L + L +L L+L+ +++ + + L + L N L
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
+ +S +L+HL +S N LE + L +N++
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISS--------IDFIPLHNQKTLESLYLGSNHISSIKL 146
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKI--LGLQDNSLSGCLSSIGYARLPNL 251
K L+ LD +N + ++ + ++ L L N ++G
Sbjct: 147 PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF--DSAVF 204
Query: 252 EILSLWGNNFSGTIPRFIFNAS--KLSILDLEGNSFSGFIPNTFGNLRNLS--WLVLSDN 307
+ L+ G I + + N++ L + E P F L +S + L +
Sbjct: 205 QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
Y + + + L+ DL+ L + + LS +L++ +S
Sbjct: 265 YFFNISSN-----TFHCFSGLQELDLTATHLSELPS--GLVGLS-TLKKLVLSANKFENL 316
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSIL-ITLSKLQKLQDLGLKDNKLEGS--IPYDICNLA 424
SN +L + + GN + L L+ L++L L + +E S + NL+
Sbjct: 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376
Query: 425 ELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL--TFWNLKDILNLNFSSNF 482
L L+L N+ F L ++ L L F NL + LN S +
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 483 LTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIG---GLKNLEYLFLGYNRLQGSIPNSF 539
L S L L ++L N+F + L LE L L + L ++F
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496
Query: 540 GDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQS--- 596
L + ++LS+N L+ +L L + LNL+ N + +P S Q
Sbjct: 497 TSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILP--SLLPILSQQRTIN 553
Query: 597 FEGNELLC 604
N L C
Sbjct: 554 LRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 1e-82
Identities = 110/535 (20%), Positives = 194/535 (36%), Gaps = 33/535 (6%)
Query: 69 VHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCL 127
+ + N +L L IP L +S + L SFN L +I + F+ L ++ L
Sbjct: 9 IEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVL-PTIQNTTFSRLINLTFLDL 64
Query: 128 RGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANN 187
Q+ ++ L L L++N L L+ +
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIF--------MAETALSGPKALKHLFFIQTG 116
Query: 188 LQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYAR 247
+ + + N + LE L +G N + I F LK+L Q+N++ LS +
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMSS 175
Query: 248 LPNLEILSLW-GNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPN--TFGNLRNLSWLVL 304
L LSL N I F+++ L+ G I +++L
Sbjct: 176 LQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 305 SDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNI 364
D + + + ++ +L + + I T S L+E ++ ++
Sbjct: 236 EDMDDEDISPAVFEGLCEMS---VESINLQKHYFFNISSN-TFHCFS-GLQELDLTATHL 290
Query: 365 SGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD-ICNL 423
S +P + L+ L+ + L NK I+ S L L +K N + + NL
Sbjct: 291 S-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL 349
Query: 424 AELYRLDLDGNKL--SGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSS 480
L LDL + + S NL+ L+ ++L NE S+ F + L+ +
Sbjct: 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409
Query: 481 NFLTGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI---P 536
L +L +L ++LS + GL L++L L N
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 537 NSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGN 591
NS L L+ L LS +LS + + L + ++LS N+L + +
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI--EALSH 522
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 4e-67
Identities = 84/454 (18%), Positives = 147/454 (32%), Gaps = 50/454 (11%)
Query: 147 QHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLD 206
+ + + L+ EIP E + + N L L NL LD
Sbjct: 15 KTYNCENLGLN---------EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLD 63
Query: 207 IGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIP 266
+ ++ I + L L L N L ++ + L+ L S
Sbjct: 64 LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDF 122
Query: 267 RFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCK 326
+ N L L L N S L L +N + ++E +SSL
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED--MSSLQQAT 180
Query: 327 FLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGN 386
L +L+ N + GI + +++ GG
Sbjct: 181 NL-SLNLNGNDI---------------------------AGIEPGAFDSAVFQSLNFGGT 212
Query: 387 KLNGSILITLS--KLQKLQDLGLKDNKLEGSIPYDICNLAELY--RLDLDGNKLSGSIPA 442
+ I L +Q L +D E P L E+ ++L +
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 443 CFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDL 502
F + L+ + L + L+ +P L + L S+N + + L + +
Sbjct: 273 TFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332
Query: 503 SRNNFSGVIPTE-IGGLKNLEYLFLGYNRLQGS--IPNSFGDLISLKFLNLSNNNLSGVI 559
N + T + L+NL L L ++ ++ S +L L+ LNLS N +
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392
Query: 560 PASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFS 593
+ ++ LE L+L+F +L+ F N
Sbjct: 393 TEAFKECPQLELLDLAFTRLKV-KDAQSPFQNLH 425
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-62
Identities = 98/496 (19%), Positives = 175/496 (35%), Gaps = 27/496 (5%)
Query: 70 HSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAI--FTTYTLKYVCL 127
+ + + L + S +++ + L+ L+ N + + T + L
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186
Query: 128 RGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANN 187
GN ++ + + Q L+ I + + + L L + +
Sbjct: 187 NGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGL------KNSTIQSLWLGTFEDMD 239
Query: 188 LQGKIPLKIGNLR--NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGY 245
+ P L ++E +++ + I+ S L+ L L LS S +
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLV- 298
Query: 246 ARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFI-PNTFGNLRNLSWLVL 304
L L+ L L N F N L+ L ++GN+ + NL NL L L
Sbjct: 299 -GLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 305 SDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNI 364
S + + +S L +LS+ L+ +LSYN + LE ++ +
Sbjct: 358 SHDDIETSDCCNLQLRNLSH---LQSLNLSYNEPLSL-KTEAFKECP-QLELLDLAFTRL 412
Query: 365 SGGIPEEI-SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSI---PYDI 420
+ NL L+ + L + L+ S L LQ L L+ N +
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 421 CNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSS 480
L L L L LS F++L + V L N LTS + + + LN +S
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLAS 532
Query: 481 NFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFG 540
N ++ LP + L I+L +N LE+ +L+ +
Sbjct: 533 NHISIILPSLLPILSQQRTINLRQNPLDCTC--SNIYF--LEWYKENMQKLEDTEDTLCE 588
Query: 541 DLISLKFLNLSNNNLS 556
+ L+ + LS+ LS
Sbjct: 589 NPPLLRGVRLSDVTLS 604
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 270 bits (694), Expect = 3e-83
Identities = 94/321 (29%), Positives = 158/321 (49%), Gaps = 17/321 (5%)
Query: 653 RGKRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVK 712
+ ++ + ++L AT+ F LIG G FG VYK L DG +VA+K
Sbjct: 10 NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69
Query: 713 VFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 772
T + + + F+ E E + RH +L+ +I C L+ +YM +G+L+++LY S
Sbjct: 70 RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129
Query: 773 N---CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829
+ + QRL I I A L YLH +IH D+K N+LLD+N V ++DF I+
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186
Query: 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF- 888
K T DQ+ + T T+GY+ PEY +GR++ DVYSFG++L E + +
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 889 NGEMTLKHWVNDWLPIST-MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQR 947
+ L W + ++VD NL + + K + A++C + R
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK------FGDTAVKCLALSSEDR 300
Query: 948 INAKEIVTKL---LKIRDSLL 965
+ +++ KL L++++S++
Sbjct: 301 PSMGDVLWKLEYALRLQESVI 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 3e-80
Identities = 100/540 (18%), Positives = 174/540 (32%), Gaps = 50/540 (9%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
+++S L N S LQ L+LS + A + L + L GN +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQG-KI 192
P S +SL++L L+ G L L+ +++A N + K+
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLE--------SFPIGQLITLKKLNVAHNFIHSCKL 145
Query: 193 PLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVS----TLKILGLQDNSLSGCLSSIGYARL 248
P NL NL +D+ N + I + + L + N + +
Sbjct: 146 PAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF--QG 203
Query: 249 PNLEILSLWGNNFSGTIPRFIFNA-SKLSILDLEGNSFSG------FIPNTFGNLRNLSW 301
L L+L GN S I + + L + L F F P+ L +++
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 302 LVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSH--------- 352
Y + ++ L+N + L+ + +
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLAN---VSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK 320
Query: 353 --------SLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQ--KL 402
L+ ++ S I + L +L + L N L+ S + S L L
Sbjct: 321 QFPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378
Query: 403 QDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELT 461
+ L L N + + L EL LD + L F +L L + +
Sbjct: 379 RHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 462 SIPL-TFWNLKDILNLNFSSNFLTGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLK 519
F L + L + N + + + L +DLS+ + L
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 520 NLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
L+ L + +N L + + L SL L+ S N + L NL+ N +
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-76
Identities = 118/538 (21%), Positives = 197/538 (36%), Gaps = 46/538 (8%)
Query: 86 GTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSS 145
G++ + + ++ + +L +P I ++ K + L N L SN S
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPSS--TKNIDLSFNPLKILKSYSFSNFSE 57
Query: 146 LQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKL 205
LQ LDLS + + + L L + L N +Q P L +LE L
Sbjct: 58 LQWLDLSRCEIET--------IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENL 109
Query: 206 DIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTI 265
+ KL + I + TLK L + N + C ++ L NL + L N
Sbjct: 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169
Query: 266 PRFIFNASKLSI----LDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSF--L 319
+ + LD+ N F + L L L N+ +S+ + L
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNL 228
Query: 320 SSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLR 379
+ L + + L P G +++EF+++ N + L N+
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVS 288
Query: 380 TIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLE-------------------GSIPYDI 420
+ L G + L + K K Q L + +L+ GSI +
Sbjct: 289 AMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKK 346
Query: 421 CNLAELYRLDLDGNKLSGSIPACFSNL--TSLRIVSLGSNELTSIPLTFWNLKDILNLNF 478
L L LDL N LS S +S+L SLR + L N + F L+++ +L+F
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDF 406
Query: 479 SSNFLTGSLPLE-IGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP- 536
+ L SL+ L+ +D+S N GL +L L + N + +
Sbjct: 407 QHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466
Query: 537 NSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSA 594
N F + +L FL+LS L + + L L+ LN+S N L + +
Sbjct: 467 NVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS--SHYNQLYS 522
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-44
Identities = 75/363 (20%), Positives = 126/363 (34%), Gaps = 32/363 (8%)
Query: 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNY 308
+ + + L N N S+L LDL + L +LS L+L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 309 LTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISG-G 367
+ S + S S L+ L + +G L +L++ +++ I
Sbjct: 92 IQSFSPG-----SFSGLTSLENLVAVETKLASL-ESFPIGQL-ITLKKLNVAHNFIHSCK 144
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKL----QDLGLKDNKLEGSIPYDICNL 423
+P SNLTNL + L N + + L L++ L + N ++ I
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQG 203
Query: 424 AELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSI-------PLTFWNLKDI-- 473
+L+ L L GN S +I C NL L + L E P L D+
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 474 LNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 533
+ ++ L + + L+ + + ++ + L + +L+
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQ 321
Query: 534 SIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFS 593
DL LK L L+ N S I L L L+LS N L S+ +
Sbjct: 322 ---FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGC--CSYSDLG 374
Query: 594 AQS 596
S
Sbjct: 375 TNS 377
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-39
Identities = 57/320 (17%), Positives = 102/320 (31%), Gaps = 26/320 (8%)
Query: 73 RVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQL 132
+ ++ N + L+++ +++L+ + + + + + QL
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHF-KWQSLSIIRCQL 319
Query: 133 SGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKI 192
+ L+ L L+ N S I + LP L + L+ N L
Sbjct: 320 KQFPTLDLPF---LKSLTLTMNKGS----------ISFKKVALPSLSYLDLSRNALSFSG 366
Query: 193 P--LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPN 250
+L LD+ N + + + L+ L Q ++L + L
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 251 LEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIP-NTFGNLRNLSWLVLSDNYL 309
L L + N + L+ L + GNSF N F N NL++L LS L
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
+ L+ ++S+N L L + L SL S I
Sbjct: 486 EQISW-----GVFDTLHRLQLLNMSHNNL-LFLDSSHYNQLY-SLSTLDCSFNRIETSKG 538
Query: 370 EEISNLTNLRTIYLGGNKLN 389
+L L N +
Sbjct: 539 ILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 20/86 (23%), Positives = 35/86 (40%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131
+T L++S L L LQ LN+S N L S Y+L + N+
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 132 LSGTFPSFISNKSSLQHLDLSSNALS 157
+ + SL +L++N+++
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 7e-79
Identities = 100/311 (32%), Positives = 152/311 (48%), Gaps = 19/311 (6%)
Query: 657 PSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTS 716
P+ + + + FS EL A+D FS N++GRGGFG VYK L DG VAVK
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 64
Query: 717 QCGRAFKS-FDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---SS 772
+ + + F E E++ HRNL+++ C + LV YM +GS+ L S
Sbjct: 65 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 124
Query: 773 NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832
LD +R I + A L YLH +IH D+K +N+LLD+ A + DF +AK L
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-L 183
Query: 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF---N 889
+ + T TIG++APEY G+ S DV+ +G+ML+E TG++ D +
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 890 GEMTLKHWVNDWLPIST---MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQ 946
++ L WV + +VD +L ++ +E V + +A+ CT P +
Sbjct: 244 DDVMLLDWV--KGLLKEKKLEALVDVDLQG----NYKDEE--VEQLIQVALLCTQSSPME 295
Query: 947 RINAKEIVTKL 957
R E+V L
Sbjct: 296 RPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 6e-71
Identities = 87/308 (28%), Positives = 141/308 (45%), Gaps = 27/308 (8%)
Query: 670 RMFSYLELCRATDGFSE------NNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRA-- 721
FS+ EL T+ F E N +G GGFG VYK + + VAVK +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 722 --FKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY--SSNCILD 777
+ FD E ++M +H NL++++ S+ + LV YMP+GSL L L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 778 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837
R I A+ + +LH IH D+K +N+LLD+ A +SDF +A+ Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 897
+++ ++ + T YMAPE R G ++ D+YSFG++L+E TG DE L
Sbjct: 189 TVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDI 246
Query: 898 VNDWL--PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVT 955
+ + + +D + D + E ++A +C E +R + K++
Sbjct: 247 KEEIEDEEKTIEDYIDKKM---NDADSTSVEAMY----SVASQCLHEKKNKRPDIKKVQQ 299
Query: 956 KLLKIRDS 963
L ++ S
Sbjct: 300 LLQEMTAS 307
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 3e-67
Identities = 109/523 (20%), Positives = 186/523 (35%), Gaps = 39/523 (7%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
L++S L + LQ L+LS + A + L + L GN +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQ-GKI 192
S SSLQ L L+ G+L L+ +++A N +Q K+
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLA--------SLENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 193 PLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKI----LGLQDNSLSGCLSSIGYARL 248
P NL NLE LD+ NK+ I + + + + L L N ++ +
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF--KE 199
Query: 249 PNLEILSLWGNNFSGTIPRFIFNA-SKLSILDLEGNSFSG------FIPNTFGNLRNLSW 301
L L+L N S + + + L + L F F + L NL+
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 302 LVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSN 361
YL ++ + + F L + R+ + LE
Sbjct: 260 EEFRLAYLDYYLDDII--DLFNCLTNVSSFSLVSVTIERVKDFSYNFGW-QHLELVNCKF 316
Query: 362 CNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLE--GSIPYD 419
L +L+ + NK + L L+ L L N L G
Sbjct: 317 GQFPTL------KLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP--LTFWNLKDILNLN 477
L LDL N + ++ + F L L + + L + F +L++++ L+
Sbjct: 369 DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 478 FSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIP 536
S + L L + ++ N+F +I L+NL +L L +L+ P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 537 NSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
+F L SL+ LN+++N L V ++L+ L+ + L N
Sbjct: 488 TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 8e-61
Identities = 103/521 (19%), Positives = 184/521 (35%), Gaps = 62/521 (11%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQLS 133
LN IP L S ++L+LSFN L + S F ++ L+ + L ++
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANNLQGKI 192
+ S L L L+ N + + F L L+ + NL
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQ---------SLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 193 PLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLE 252
IG+L+ L++L++ N + F+ L NLE
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFS------------------------NLTNLE 152
Query: 253 ILSLWGNNFSGTIPRFIFNASKLSI----LDLEGNSFSGFIPNTFGNLRNLSWLVLSDNY 308
L L N + ++ + LDL N + P F + L L L +N+
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNF 211
Query: 309 LTSSTQELSF--LSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISG 366
+ + + L+ L + + + L + G + ++EEF+++ +
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 367 -GIPEEISNLTNLRTIYLGGNKLNG-SILITLSKLQKLQDLGLKDNKLEGSIPYDICNLA 424
I + + LTN+ + L + Q L+ + K + L
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLK 325
Query: 425 ELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLT---FWNLKDILNLNFSSN 481
L RL NK + +L SL + L N L+ + + L+ S N
Sbjct: 326 SLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 482 FLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPNSFG 540
+ ++ L+ L +D +N + + L+NL YL + + + + F
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 541 DLISLKFLNLSNNNLSGVIPA-SLEKLSYLEDLNLSFNQLE 580
L SL+ L ++ N+ +L L L+LS QLE
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-45
Identities = 89/489 (18%), Positives = 161/489 (32%), Gaps = 57/489 (11%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQL-S 133
+ L ++ + LSSLQ L L I TLK + + N + S
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELEL-MSLAANNLQGKI 192
P + SN ++L+HLDLSSN + +I R +P L L + L+ N + I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQ-----SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 193 PLKIGNLRNLEKLDIGDNKL-VGIAPIAIFNVSTLKILGLQDNSLSGC--LSSIGYARLP 249
L KL + +N + + I ++ L++ L L + L
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 250 NLEILSLWGNN------FSGTIPRFIFNASKLSILDLEGNSFSGFIPNTF-GNLRNLSWL 302
L L++ + I + +S L + ++ ++L +
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELV 312
Query: 303 VLSDNYLTS-----------STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLS 351
+ ++ + S + L++ DLS N L + +
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 352 HSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNG-SILITLSKLQKLQDLGLKDN 410
SL+ +S + + L L + + L S L+ L L +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 411 KLEGSIPYDICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIP-LTFW 468
+ L+ L L + GN + F+ L +L + L +L + F
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 469 NLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGY 528
+L SL+VL +++ N V L +L+ ++L
Sbjct: 492 SLS---------------------SLQVL---NMASNQLKSVPDGIFDRLTSLQKIWLHT 527
Query: 529 NRLQGSIPN 537
N S P
Sbjct: 528 NPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-40
Identities = 84/410 (20%), Positives = 140/410 (34%), Gaps = 60/410 (14%)
Query: 224 STLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGN 283
+ K L L N L L S + P L++L L + S LS L L GN
Sbjct: 28 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 284 SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILP 343
F L +L LV + L S + + K LK ++++N +
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENF-----PIGHLKTLKELNVAHNLIQSFKL 141
Query: 344 RTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLR----TIYLGGNKLNGSILITLSKL 399
NL+ +LE +S+ I ++ L + ++ L N +N I K
Sbjct: 142 PEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199
Query: 400 QKLQDLGLKDNKLEGSIPYDIC-------------------------------NLAELYR 428
+L L L++N ++ L L
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 429 LDLDGNKLSGS---IPACFSNLTSLRIVSLGSNELTSIP--LTFWNLKDILNLNFSSNFL 483
+ L I F+ LT++ SL S + + + + + +N
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319
Query: 484 TGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ--GSIPNSFGD 541
L++ SLK L + N L +LE+L L N L G S
Sbjct: 320 P---TLKLKSLKRL---TFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 542 LISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGN 591
SLK+L+LS N + + ++ L LE L+ + L+ ++ F +
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 72/397 (18%), Positives = 131/397 (32%), Gaps = 63/397 (15%)
Query: 73 RVTVLNISSLNLTGTIPSQLGNLSSLQ----SLNLSFNRLFGSIPSAIFTTYTLKYVCLR 128
+ L++SS + + L L + SL+LS N + I F L + LR
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLR 208
Query: 129 GNQLSGTFPS-FISNKSSLQHLDLSSNALSGEIRA------------------------- 162
N S I + L+ L E
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 163 NICREIPREFGNLPELELMSLAANNLQG-------------------KIPLKIGNLRNLE 203
+I F L + SL + ++ L++L+
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 204 KLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGC-LSSIGYARLPNLEILSLWGNNFS 262
+L NK + ++ +L+ L L N LS S +L+ L L N
Sbjct: 329 RLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 263 GTIPRFIFNASKLSILDLEGNSFSGFIP-NTFGNLRNLSWLVLSDNYLTSSTQELSFLSS 321
T+ +L LD + ++ + F +LRNL +L +S + + + +
Sbjct: 387 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI--FNG 443
Query: 322 LSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI-SNLTNLRT 380
LS+ L+ ++ N L +L +S C + + ++L++L+
Sbjct: 444 LSS---LEVLKMAGNSFQENFLPDIFTELR-NLTFLDLSQCQLEQ-LSPTAFNSLSSLQV 498
Query: 381 IYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIP 417
+ + N+L +L LQ + L N + S P
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-27
Identities = 59/249 (23%), Positives = 93/249 (37%), Gaps = 16/249 (6%)
Query: 77 LNISSLNLTGTIPSQL--GNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS- 133
L L Q L SL+ L + N+ G+ S + +L+++ L N LS
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG-GNAFSEVDLP-SLEFLDLSRNGLSF 361
Query: 134 -GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKI 192
G +SL++LDLS N + + F L +LE + +NL+
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI---------TMSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 193 PLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL 251
+ +LRNL LDI +S+L++L + NS + L NL
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
L L P + S L +L++ N F L +L + L N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532
Query: 312 STQELSFLS 320
S + +LS
Sbjct: 533 SCPRIDYLS 541
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-20
Identities = 35/152 (23%), Positives = 57/152 (37%), Gaps = 6/152 (3%)
Query: 443 CFSNLTSLRIVSLGSNELTSIPLT-FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGID 501
C + ++ IP ++ K NL+ S N L S L +D
Sbjct: 3 CVEVVPNI-TYQCMELNFYKIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 502 LSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA 561
LSR + L +L L L N +Q +F L SL+ L NL+ +
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 562 SLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFS 593
+ L L++LN++ N ++ F N +
Sbjct: 119 PIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-63
Identities = 101/510 (19%), Positives = 193/510 (37%), Gaps = 75/510 (14%)
Query: 73 RVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQL 132
+ I+ I L+ L + ++ + + +
Sbjct: 2 PLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVSQTDLDQ--VTTLQADRLGI 58
Query: 133 SGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKI 192
+ ++L ++ S+N L+ NL +L + + N +
Sbjct: 59 KS--IDGVEYLNNLTQINFSNNQLTDIT----------PLKNLTKLVDILMNNNQIADIT 106
Query: 193 PLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLE 252
PL NL NL L + +N++ I P+ N++ L L L N++S +S++ L +L+
Sbjct: 107 PL--ANLTNLTGLTLFNNQITDIDPLK--NLTNLNRLELSSNTISD-ISALSG--LTSLQ 159
Query: 253 ILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS 312
LS GN + P + N + L LD+ N S + L NL L+ ++N ++
Sbjct: 160 QLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD- 213
Query: 313 TQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI 372
++ L L L+ N L I T+ +L+ +L + ++N IS +
Sbjct: 214 ------ITPLGILTNLDELSLNGNQLKDI---GTLASLT-NLTDLDLANNQISN--LAPL 261
Query: 373 SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLD 432
S LT L + LG N+++ + L+ L L +L L +N+LE P I NL L L L
Sbjct: 262 SGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLY 317
Query: 433 GNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIG 492
N +S P S+LT L+ + +N+++ + +
Sbjct: 318 FNNISDISP--VSSLTKLQRLFFYNNKVSDVS-------------------------SLA 350
Query: 493 SLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSN 552
+L + + N S + P + L + L L + N ++ +
Sbjct: 351 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVT 408
Query: 553 NNLSGVIPASLEKLSYLEDLNLSFNQLEGK 582
L + PA++ + ++++N
Sbjct: 409 GAL--IAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 9e-55
Identities = 104/438 (23%), Positives = 182/438 (41%), Gaps = 47/438 (10%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
T +N S+ LT P L NL+ L + ++ N++ + + + L + L NQ++
Sbjct: 71 TQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQITD 126
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
+ N ++L L+LSSN +S L L+ +S N + PL
Sbjct: 127 --IDPLKNLTNLNRLELSSNTISD----------ISALSGLTSLQQLSFG-NQVTDLKPL 173
Query: 195 KIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEIL 254
NL LE+LDI NK+ I+ +A ++ L+ L +N +S ++ +G L NL+ L
Sbjct: 174 --ANLTTLERLDISSNKVSDISVLA--KLTNLESLIATNNQISD-ITPLGI--LTNLDEL 226
Query: 255 SLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQ 314
SL GN + + + L+ LDL N S P L L+ L L N +++
Sbjct: 227 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--- 279
Query: 315 ELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISN 374
+S L+ L +L+ N L I P + NL +L + NIS +S+
Sbjct: 280 ----ISPLAGLTALTNLELNENQLEDISP---ISNLK-NLTYLTLYFNNISD--ISPVSS 329
Query: 375 LTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGN 434
LT L+ ++ NK++ + +L+ L + L N++ P + NL + +L L+
Sbjct: 330 LTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 385
Query: 435 KLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSL 494
+ + +N++ V P T + + + N + +
Sbjct: 386 AWTNAPVNYKANVSIPNTV-KNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTF 443
Query: 495 KVLVGIDLSRNNFSGVIP 512
V I FSG +
Sbjct: 444 SQPVTIGKGTTTFSGTVT 461
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-62
Identities = 65/307 (21%), Positives = 122/307 (39%), Gaps = 22/307 (7%)
Query: 672 FSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEI 731
L + + RG FG V+KA L VAVK+F Q ++++ + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 732 MKSIRHRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 787
+ ++H N+++ I + L+ + GSL +L ++ ++ + +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129
Query: 788 VASALEYLH-------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840
+A L YLH G+ + H D+K NVLL +N+ A ++DF +A +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 841 QTQTLATIGYMAPEYGREGRVSANG-----DVYSFGIMLMETFTGKKPTDEIFNGEMT-L 894
+ T YMAPE D+Y+ G++L E + D + M
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 895 KHWVNDWLPISTM-EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ + + M EVV + K ++ + EC + R++A +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 954 VTKLLKI 960
++ ++
Sbjct: 310 GERITQM 316
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-61
Identities = 123/601 (20%), Positives = 218/601 (36%), Gaps = 77/601 (12%)
Query: 66 ACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKY 124
+C + + NLT +P L++ + L LSFN + ++ ++ F L+
Sbjct: 1 SCSFDGR---IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYI-RTVTASSFPFLEQLQL 52
Query: 125 VCLRGNQLSGTF-PSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMS 182
+ L T N +L+ LDL S+ + + + F L L +
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI---------YFLHPDAFQGLFHLFELR 103
Query: 183 LAANNLQGKI--PLKIGNLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSG- 238
L L + NL+ L +LD+ N++ + F +++LK + N +
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 239 CLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASK------LSILDLEGNSFSGFIPNT 292
C + + L SL N+ + L ILD+ GN ++ I
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGN 223
Query: 293 FGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSH 352
F N S +Q S + + + ++ + T G
Sbjct: 224 FSNA-------------ISKSQAFSLILAHH----IMGAGFGFHNIKDPDQNTFAGLARS 266
Query: 353 SLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKL 412
S+ +S+ + L +L+ + L NK+N L LQ L L N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 413 EGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP-------- 464
+ L ++ +DL N ++ F L L+ + L N LT+I
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDI 386
Query: 465 -LTFWNLKDILNLNFSSNFL-----------TGSLPLEIGSLKVLVGIDLSRNNFSGVIP 512
L+ L + +N ++N + L + L++L L++N FS
Sbjct: 387 FLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQIL---ILNQNRFSSCSG 443
Query: 513 TEI-GGLKNLEYLFLGYNRLQGSI-----PNSFGDLISLKFLNLSNNNLSGVIPASLEKL 566
+ +LE LFLG N LQ + + F L L+ L L++N L+ + P L
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503
Query: 567 SYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQIPPCKTSIHHKSWKKS 626
+ L L+L+ N+L + N N+LL +P++ + I H +
Sbjct: 504 TALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE 562
Query: 627 I 627
Sbjct: 563 C 563
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 7e-32
Identities = 79/400 (19%), Positives = 140/400 (35%), Gaps = 43/400 (10%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
V L++S + L L+ LNL++N++ A + L+ + L N L
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
+ S + ++DL N ++ I+ F L +L+ + L N L
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIA-IIQDQT-------FKFLEKLQTLDLRDNALT---- 375
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
I + ++ + + NKLV + I + ++ L +N L R+P+L+I
Sbjct: 376 -TIHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQI 430
Query: 254 LSLWGNNFSGTIPRFIFNA-SKLSILDLEGNSF-----SGFIPNTFGNLRNLSWLVLSDN 307
L L N FS + L L L N + + F L +L L L+ N
Sbjct: 431 LILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHN 490
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
YL S + S L+ L+ L+ N L + +L +LE +S +
Sbjct: 491 YLNSLPPGV--FSHLTA---LRGLSLNSNRLTVLSH----NDLPANLEILDISRNQLLAP 541
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427
P +L + + NK +L N +I ++ +Y
Sbjct: 542 NP---DVFVSLSVLDITHNKFICEC--------ELSTFINWLNHTNVTIAGPPADIYCVY 590
Query: 428 RLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTF 467
G L L+ + + ++ LT
Sbjct: 591 PDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTL 630
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-29
Identities = 73/301 (24%), Positives = 111/301 (36%), Gaps = 33/301 (10%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTT-YTLKYVCLRGN 130
+ + VLN++ + L +LQ LNLS+N L G + S+ F + Y+ L+ N
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL-GELYSSNFYGLPKVAYIDLQKN 348
Query: 131 QLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQG 190
++ LQ LDL NAL+ +P + + L+ N L
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNALT-------------TIHFIPSIPDIFLSGNKLVT 395
Query: 191 KIPLKIGNLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSGCLSSIGYARLP 249
L NL + + +N+L + + V L+IL L N S C + P
Sbjct: 396 ---LPKINL-TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451
Query: 250 NLEILSLWGNNFSG----TIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVL 304
+LE L L N + +F S L +L L N + P F +L L L L
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511
Query: 305 SDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNI 364
+ N L+ LS L+ D+S N L +LS C
Sbjct: 512 NSN-------RLTVLSHNDLPANLEILDISRNQL-LAPNPDVFVSLSVLDITHNKFICEC 563
Query: 365 S 365
Sbjct: 564 E 564
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 9e-59
Identities = 79/401 (19%), Positives = 155/401 (38%), Gaps = 56/401 (13%)
Query: 180 LMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGC 239
+LA +L + + + + + ++ L + ++
Sbjct: 2 AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS- 58
Query: 240 LSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNL 299
+ I Y L NLE L+L GN + P + N KL+ L + N + NL NL
Sbjct: 59 IQGIEY--LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTNL 112
Query: 300 SWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKM 359
L L+++ ++ +S L+N + +L N
Sbjct: 113 RELYLNEDNISD-------ISPLANLTKMYSLNLGANHN--------------------- 144
Query: 360 SNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD 419
+SN+T L + + +K+ + ++ L L L L N++E P
Sbjct: 145 ------LSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP-- 194
Query: 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFS 479
+ +L L+ N+++ P +N+T L + +G+N++T + NL + L
Sbjct: 195 LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS-PLANLSQLTWLEIG 251
Query: 480 SNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSF 539
+N ++ + + L L +++ N S + + L L LFL N+L
Sbjct: 252 TNQIS-DIN-AVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVI 307
Query: 540 GDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
G L +L L LS N+++ + P L LS ++ + + ++
Sbjct: 308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 4e-52
Identities = 72/387 (18%), Positives = 148/387 (38%), Gaps = 43/387 (11%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
L + P +L+ L + + ++ + + G +++
Sbjct: 3 ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQEELE--SITKLVVAGEKVAS 58
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
I ++L++L+L+ N ++ NL +L + + N +
Sbjct: 59 --IQGIEYLTNLEYLNLNGNQITDIS----------PLSNLVKLTNLYIGTNKI--TDIS 104
Query: 195 KIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEIL 254
+ NL NL +L + ++ + I+P+A N++ + L L N LS + + L L
Sbjct: 105 ALQNLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLSDLSPLSN--MTGLNYL 160
Query: 255 SLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQ 314
++ + P I N + L L L N P +L +L + N +T
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--- 213
Query: 315 ELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISN 374
++ ++N L + N + + P + NLS L ++ IS + +
Sbjct: 214 ----ITPVANMTRLNSLKIGNNKITDLSP---LANLS-QLTWLEIGTNQISD--INAVKD 263
Query: 375 LTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGN 434
LT L+ + +G N+++ + L+ L +L L L +N+L I L L L L N
Sbjct: 264 LTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
Query: 435 KLSGSIPACFSNLTSLRIVSLGSNELT 461
++ P ++L+ + + +
Sbjct: 322 HITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 176 bits (450), Expect = 4e-49
Identities = 72/340 (21%), Positives = 151/340 (44%), Gaps = 39/340 (11%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
+T L ++ + +I + L++L+ LNL+ N++ P + L + + N+++
Sbjct: 46 ITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISPLSNLV--KLTNLYIGTNKIT 101
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
S + N ++L+ L L+ + +S NL ++ ++L AN+ +
Sbjct: 102 D--ISALQNLTNLRELYLNEDNISD----------ISPLANLTKMYSLNLGANHNLSDLS 149
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
+ N+ L L + ++K+ + PIA N++ L L L N + +S + L +L
Sbjct: 150 -PLSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLSLNYNQIED-ISPLA--SLTSLHY 203
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313
+ + N + P + N ++L+ L + N + P NL L+WL + N ++
Sbjct: 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-- 257
Query: 314 QELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEIS 373
++++ + LK ++ N + I + + NLS L ++N + E I
Sbjct: 258 -----INAVKDLTKLKMLNVGSNQISDI---SVLNNLS-QLNSLFLNNNQLGNEDMEVIG 308
Query: 374 NLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLE 413
LTNL T++L N + + L+ L K+ + ++
Sbjct: 309 GLTNLTTLFLSQNHITD--IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-47
Identities = 75/335 (22%), Positives = 138/335 (41%), Gaps = 31/335 (9%)
Query: 251 LEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLT 310
L+ + P + ++ L+ S + + L +++ LV++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 311 SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPE 370
S + + L+Y +L+ N + I P + NL L + I+
Sbjct: 58 S-------IQGIEYLTNLEYLNLNGNQITDISP---LSNLV-KLTNLYIGTNKIT--DIS 104
Query: 371 EISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLD 430
+ NLTNLR +YL + ++ + L+ L K+ L L N + + N+ L L
Sbjct: 105 ALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLT 161
Query: 431 LDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLE 490
+ +K+ P +NLT L +SL N++ I +L + N +T P+
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITPV- 217
Query: 491 IGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNL 550
++ L + + N + + P + L L +L +G N++ N+ DL LK LN+
Sbjct: 218 -ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNV 272
Query: 551 SNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585
+N +S + L LS L L L+ NQL +
Sbjct: 273 GSNQISDISV--LNNLSQLNSLFLNNNQLGNEDME 305
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 8e-56
Identities = 104/507 (20%), Positives = 198/507 (39%), Gaps = 43/507 (8%)
Query: 94 NLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSS 153
+ + + SIPS + +K + L N+++ + ++LQ L L S
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGLTAA--MKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 154 NALSGEIRANICREIPRE-FGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKL 212
+ ++ I + F +L LE + L+ N+L G L +L+ L++ N
Sbjct: 60 SRIN---------TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
Query: 213 VGIAPIAIF-NVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFN 271
+ ++F N++ L+ L + + + I +A L +L L + + + + +
Sbjct: 111 QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170
Query: 272 ASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS------STQELSFLSSLSNC 325
+ L L + + + L ++ +L L D L E+S
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
Query: 326 KFLKYFDLSYNPLYRILPRTTVGN----LSHSLEEFKMSNCNISGGIPEEIS-NLTNLRT 380
+ D S+N L ++L + +L N + S + E +R
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290
Query: 381 IYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDIC-NLAELYRLDLDGNKLSGS 439
+++ L + S L+K++ + ++++K+ +P +L L LDL N +
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 440 I---PACFSNLTSLRIVSLGSNELTSIPL---TFWNLKDILNLNFSSNFLTGSLPLEIGS 493
AC SL+ + L N L S+ LK++ +L+ S N +P
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
Query: 494 LKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNN 553
+ + ++LS V+ T I + LE L + N L S L L+ L +S N
Sbjct: 409 PEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRN 461
Query: 554 NLSGVIPASLEKLSYLEDLNLSFNQLE 580
L + ASL L + +S NQL+
Sbjct: 462 KLKTLPDASL--FPVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-51
Identities = 90/506 (17%), Positives = 173/506 (34%), Gaps = 48/506 (9%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQL 132
+ L++S +T L ++LQ L L +R+ +I F + L+++ L N L
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 133 SGTFPSFISNKSSLQHLDLSSNALSGEI-----------------RANICREIPRE-FGN 174
S S+ SSL++L+L N EI R F
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 175 LPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDN 234
L L + + A +L+ + ++R++ L + ++ + I +S+++ L L+D
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 235 SLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFG 294
+L+ + + FN + + S F T
Sbjct: 207 NLA-RFQFSPLPVDEVSSPMKKL-AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264
Query: 295 NLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSL 354
L + + + EL + +++ ++ + L+ L +
Sbjct: 265 GLGDFN------PSESDVVSELGKVETVT----IRRLHIPQFYLFYDLSTVYSLL--EKV 312
Query: 355 EEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILIT---LSKLQKLQDLGLKDNK 411
+ + N + +L +L + L N + L LQ L L N
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372
Query: 412 LE--GSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWN 469
L + L L LD+ N +P +R ++L S + +
Sbjct: 373 LRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTC--I 429
Query: 470 LKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYN 529
+ + L+ S+N L S L + L+ L +SRN + + L + + N
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLFLPRLQEL---YISRNKLKTL--PDASLFPVLLVMKISRN 483
Query: 530 RLQGSIPNSFGDLISLKFLNLSNNNL 555
+L+ F L SL+ + L N
Sbjct: 484 QLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 62/341 (18%), Positives = 119/341 (34%), Gaps = 27/341 (7%)
Query: 4 FLLLHCLILISLFIAAATANTSSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWT 63
+L + + L S + + +K + + +++N + +
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK-KLAFRGSVLTDESFNELLKLLRYI 250
Query: 64 GVACEVHSQRVTVLNISSLNLTG-TIPSQLGNLS--SLQSLNLSFNRLFGSIPSAIFTTY 120
EV T+ + N + + S+LG + +++ L++ LF + +
Sbjct: 251 LELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLE 310
Query: 121 TLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELEL 180
+K + + +++ SF + SL+ LDLS N + E N G P L+
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN-----SACKGAWPSLQT 365
Query: 181 MSLAANNLQ--GKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSG 238
+ L+ N+L+ K + L+NL LDI N + P + ++ L L
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPM-PDSCQWPEKMRFLNLSSTG--- 421
Query: 239 CLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRN 298
+ + LE+L + NN + F+ L L + N +
Sbjct: 422 -IRVVKTCIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLKTLPDASL--FPV 474
Query: 299 LSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLY 339
L + +S N L S L+ L NP
Sbjct: 475 LLVMKISRNQLKSVPD-----GIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-26
Identities = 48/270 (17%), Positives = 96/270 (35%), Gaps = 8/270 (2%)
Query: 332 DLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGS 391
D I L+ +++ +S I+ ++ NL+ + L +++N
Sbjct: 11 DGRSRSFTSIPS-----GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 392 ILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSG-SIPACFSNLTSL 450
L L+ L L DN L L+ L L+L GN + + F NLT+L
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 451 RIVSLGS-NELTSIP-LTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFS 508
+ + +G+ + I + F L + L + L + S++ + + L + +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 509 GVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSY 568
++ L ++ YL L L + + S + S +L
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 569 LEDLNLSFNQLEGKIPRGGSFGNFSAQSFE 598
L L +++E G+F+ +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESD 275
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 57/367 (15%), Positives = 123/367 (33%), Gaps = 59/367 (16%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTT-YTLKYVCLRGNQLS 133
L I +L+L L ++ + L L + + +++Y+ LR L+
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES-AFLLEIFADILSSVRYLELRDTNLA 209
Query: 134 GTFPSFISNK---SSLQHLDLSSNALSGEIRANICR------------------------ 166
S + S ++ L + L+ E + +
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269
Query: 167 --EIPREFGNLPELELMSLAANNLQGKIPLKI-----GNLRNLEKLDIGDNKLVGIAPIA 219
L ++E +++ ++ L ++++ + ++K+ +
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329
Query: 220 IFNVSTLKILGLQDNSLS--GCLSSIGYARLPNLEILSLWGNNFS--GTIPRFIFNASKL 275
++ +L+ L L +N + +S P+L+ L L N+ + L
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL 389
Query: 276 SILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQE----LSFLSSLSNCKF---- 327
+ LD+ N+F +P++ + +L LS + L L +SN
Sbjct: 390 TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLD-VSNNNLDSFS 447
Query: 328 -----LKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIY 382
L+ +S N L + +L L K+S + LT+L+ I+
Sbjct: 448 LFLPRLQELYISRNKLKTLPD----ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503
Query: 383 LGGNKLN 389
L N +
Sbjct: 504 LHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 47/256 (18%), Positives = 94/256 (36%), Gaps = 22/256 (8%)
Query: 69 VHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFT-TYTLKYVCL 127
V + + L+I L + + L ++ + + +++F +P + +L+++ L
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL 341
Query: 128 RGNQLSGTF---PSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLA 184
N + + + SLQ L LS N L ++ L L + ++
Sbjct: 342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR------SMQKTGEILLTLKNLTSLDIS 395
Query: 185 ANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIG 244
N +P + L++ + + I TL++L + +N+L S
Sbjct: 396 RNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCIP--QTLEVLDVSNNNLD----SFS 447
Query: 245 YARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVL 304
LP L+ L + N T+P L ++ + N F L +L + L
Sbjct: 448 -LFLPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504
Query: 305 SDNYLTSSTQELSFLS 320
N S + +LS
Sbjct: 505 HTNPWDCSCPRIDYLS 520
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-15
Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 6/117 (5%)
Query: 476 LNFSSNFLTGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 534
+ S T S+P + ++K L DLS N + + ++ NL+ L L +R+
Sbjct: 10 CDGRSRSFT-SIPSGLTAAMKSL---DLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 535 IPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGN 591
++F L SL+ L+LS+N+LS + + LS L+ LNL N + + F N
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-56
Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 27/280 (9%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSC 747
IG G FG+V++A G +VAVK+ Q F E IMK +RH N++ + +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
+ ++V EY+ GSL + L+ S LD +RL++ DVA + YLH + P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
+LK N+L+D + DF ++++ S T +MAPE R+ +
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 866 DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925
DVYSFG++L E T ++P + ++ +VV A + +
Sbjct: 221 DVYSFGVILWELATLQQP----WGN-------------LNPAQVVAA--VGFKCKRLEIP 261
Query: 926 EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965
V + C P +R + I+ L + S +
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-55
Identities = 71/289 (24%), Positives = 122/289 (42%), Gaps = 46/289 (15%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRA-------FKSFDVECEIMKSIRHRNLI 741
IG+GGFG V+K + D VA+K F+ F E IM ++ H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
K+ N +V+E++P G L L + +L +M+D+A +EY+ +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 802 PVIHCDLKPSNVLLD-----DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-- 854
P++H DL+ N+ L + A ++DF +++ S+ + L +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSV--SGLLGNFQWMAPETI 198
Query: 855 YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW---LPISTMEVVD 911
E + D YSF ++L TG+ P DE G++ + + + I
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP------ 252
Query: 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
E C + N+ C PK+R + IV +L ++
Sbjct: 253 --------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-55
Identities = 102/516 (19%), Positives = 174/516 (33%), Gaps = 92/516 (17%)
Query: 77 LNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTF 136
S NLT +P + N+ S +++ + P + LR
Sbjct: 16 PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR--- 71
Query: 137 PSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI 196
L+L++ LS +P +L L + N+L ++P
Sbjct: 72 --------QAHELELNNLGLS---------SLPELPPHLESL---VASCNSLT-ELPELP 110
Query: 197 GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSL 256
+L++L + L + P L+ LG+ +N L L + L+I+ +
Sbjct: 111 QSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPELQ--NSSFLKIIDV 160
Query: 257 WGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS----- 311
N+ +P + L + N +P NL L+ + +N L
Sbjct: 161 DNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKKLPDLP 214
Query: 312 --------STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCN 363
L L L N FL N L T+ +L SLE + +
Sbjct: 215 LSLESIVAGNNILEELPELQNLPFLTTIYADNNLL------KTLPDLPPSLEALNVRDNY 268
Query: 364 ISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNL 423
++ +PE +LT L + L+ L L N++ S+ +L
Sbjct: 269 LTD-LPELPQSLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIR-SLCDLPPSL 319
Query: 424 AELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFL 483
EL ++ NKL +PA L L N L +P NLK L+ N L
Sbjct: 320 EEL---NVSNNKLI-ELPALPPRLERL---IASFNHLAEVPELPQNLK---QLHVEYNPL 369
Query: 484 TGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLI 543
P S++ DL N+ +P NL+ L + N L+ P+
Sbjct: 370 R-EFPDIPESVE-----DLRMNSHLAEVPELPQ---NLKQLHVETNPLR-EFPDIPE--- 416
Query: 544 SLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
S++ L +++ + + E LED +
Sbjct: 417 SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-47
Identities = 96/439 (21%), Positives = 155/439 (35%), Gaps = 77/439 (17%)
Query: 142 NKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRN 201
+ + LQ S+ L E+P E N+ A + + P G R
Sbjct: 9 SNTFLQEPLRHSSNL---------TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59
Query: 202 LEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNF 261
+ + D L L + LS +LE L N+
Sbjct: 60 MAVSRLRDCLD-----------RQAHELELNNLGLSSLPELPP-----HLESLVASCNSL 103
Query: 262 SGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSS 321
+ +P + L + + + S P L +L +S+N L L
Sbjct: 104 T-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK-------LPE 148
Query: 322 LSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTI 381
L N FLK D+ N L + +L SLE N + +P E+ NL L I
Sbjct: 149 LQNSSFLKIIDVDNNSL------KKLPDLPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAI 200
Query: 382 YLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIP 441
Y N L L+ + +N LE +P ++ NL L + D N L ++P
Sbjct: 201 YADNNSLKKLP----DLPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLP 253
Query: 442 ACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGID 501
+L +L ++ N LT +P +L L+ S N + L +L L +
Sbjct: 254 DLPPSLEAL---NVRDNYLTDLPELPQSLT---FLDVSENIFS-GLSELPPNLYYL---N 303
Query: 502 LSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA 561
S N + +LE L + N+L +P L+ L S N+L+ +P
Sbjct: 304 ASSNEIRSLCDL----PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 354
Query: 562 SLEKLSYLEDLNLSFNQLE 580
+ L L++ +N L
Sbjct: 355 LPQNLKQ---LHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-33
Identities = 62/323 (19%), Positives = 112/323 (34%), Gaps = 53/323 (16%)
Query: 288 FIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTT- 346
FI + L + + LT N K + +++ R P
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT------EMPVEAENVKSKTEYYNAWSEWERNAPPGNG 55
Query: 347 ----------VGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITL 396
L E +++N +S +PE +L +L N L +
Sbjct: 56 EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELP 110
Query: 397 SKLQKLQDLGLKDNKLEGSIPY---------------DICNLAELYRLDLDGNKLSGSIP 441
L+ L L P ++ N + L +D+D N L +P
Sbjct: 111 QSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLP 169
Query: 442 ACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGID 501
+L + + G+N+L +P NL + + +N L LP SL+ +
Sbjct: 170 DLPPSLEFI---AAGNNQLEELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---V 221
Query: 502 LSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA 561
N E+ L L ++ N L+ ++P+ SL+ LN+ +N L+ +P
Sbjct: 222 AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLTD-LPE 274
Query: 562 SLEKLSYLEDLNLSFNQLEGKIP 584
+ L++L+ F+ L P
Sbjct: 275 LPQSLTFLDVSENIFSGLSELPP 297
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-14
Identities = 50/248 (20%), Positives = 89/248 (35%), Gaps = 46/248 (18%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
+ + L +L NL L ++ N L ++P + L+ + +R N L+
Sbjct: 218 ESIVAGNNILE--ELPELQNLPFLTTIYADNNLL-KTLPDLPPS---LEALNVRDNYLT- 270
Query: 135 TFPSFISNKSSLQHLDLSSNALSG-----------EIRANICREIPREFGNLPELELMSL 183
P + L LD+S N SG +N R + +L EL ++
Sbjct: 271 DLPELPQS---LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEEL---NV 324
Query: 184 AANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSI 243
+ N L ++P L E+L N L + P N LK L ++ N L
Sbjct: 325 SNNKLI-ELPALPPRL---ERLIASFNHLAEV-PELPQN---LKQLHVEYNPLREFPDIP 376
Query: 244 GYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLV 303
++E L + N+ +P L L +E N P+ ++ +L
Sbjct: 377 E-----SVEDLRM--NSHLAEVPELP---QNLKQLHVETNPLR-EFPDIPESVEDL---R 422
Query: 304 LSDNYLTS 311
++ +
Sbjct: 423 MNSERVVD 430
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-55
Identities = 80/329 (24%), Positives = 121/329 (36%), Gaps = 41/329 (12%)
Query: 672 FSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEI 731
+ E D LIGRG +G+VYK SL D VAVKVF+ ++F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNI 58
Query: 732 MK--SIRHRNLIKVISSC-----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 784
+ + H N+ + I LV+EY P+GSL KYL D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116
Query: 785 MIDVASALEYLH------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838
V L YLH Y + H DL NVL+ ++ +SDF ++ LTG
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 839 MIQTQTLA------TIGYMAPEYGRE-------GRVSANGDVYSFGIMLMETFTGKKPTD 885
+ A TI YMAPE D+Y+ G++ E F TD
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TD 234
Query: 886 EIFNGEMT-----LKHWVNDWLPISTME--VVDANLLSQEDIHFVAKEQCVSFVFNLAME 938
+ + V + M+ V + + V + +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 939 CTMEFPKQRINAKEIVTKLLKIRDSLLRN 967
C + + R+ A+ ++ ++ RN
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-54
Identities = 75/280 (26%), Positives = 115/280 (41%), Gaps = 35/280 (12%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
+GRG FG V KA +VA+K S+ K+F VE + + H N++K+ +C N
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 750 EEFKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
LV+EY GSL L+ + ++ + + + YLH +IH D
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 808 LKPSNVLLDDNM-VAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGD 866
LKP N+LL V + DF A D T + +MAPE S D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 867 VYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL--PISTMEVVDANLLSQEDIHFVA 924
V+S+GI+L E T +KP DEI + V++ P+
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI------------------- 226
Query: 925 KEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964
+ + +L C + P QR + +EIV + +
Sbjct: 227 -KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-53
Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 26/273 (9%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSC 747
IG G FG+VYK +VAVK+ + ++F E +++ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
+ + A+V ++ SL +L++S ++ + ++I A ++YLH + +IH D
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE---YGREGRVSAN 864
LK +N+ L ++ + DF +A + S Q +I +MAPE S
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 865 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVA 924
DVY+FGI+L E TG+ P I N + + E+V LS +
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQII-------------EMVGRGSLSPDLS--KV 250
Query: 925 KEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
+ C + L EC + +R + I+ ++
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-53
Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 36/281 (12%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+ G ++K G ++ VKV + R + F+ EC ++ H N++ V+ +C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 748 SNEEFK--ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+ L+ +MP+GSL L+ +D Q + +D+A + +LH +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSAN 864
L +V++D++M A +S + S + ++APE ++ N
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 865 G---DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921
D++SF ++L E T + P F +S ME+ ++ E +
Sbjct: 189 RRSADMWSFAVLLWELVTREVP----FAD-------------LSNMEIGMK--VALEGLR 229
Query: 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962
V L C E P +R IV L K++D
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 3e-51
Identities = 68/297 (22%), Positives = 112/297 (37%), Gaps = 26/297 (8%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEI--MKSIRHRNLIKVIS 745
IG+G +G V+ G +VAVKVF + S+ E EI +RH N++ I+
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98
Query: 746 SCSNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH----- 796
+ L+ +Y +GSL YL S+ LD L + S L +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA--TIGYMAPE 854
+ H DLK N+L+ N ++D +A + + T YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 855 ------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908
+ D+YSFG++L E + ++ V M
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 909 VVDANLLSQEDI-HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964
+ + + + ++C+ + L EC P R+ A + L K+ +S
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-51
Identities = 72/283 (25%), Positives = 113/283 (39%), Gaps = 38/283 (13%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQC----GRAFKSFDVECEIMKSIRHRNLIKVIS 745
IG GGFG VY+A G EVAVK + ++ E ++ ++H N+I +
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
C E LV+E+ G L + L + +N + +A + YLH P+IH
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 806 CDLKPSNVLLD--------DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
DLK SN+L+ N + ++DF +A+ + +MAPE R
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIR 187
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917
S DV+S+G++L E TG+ P F G I + V ++
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP----FRG-------------IDGLAVAYG--VAM 228
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ C L +C P R + I+ +L I
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 66/302 (21%), Positives = 121/302 (40%), Gaps = 38/302 (12%)
Query: 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
+G+G FG K + G + +K ++F E ++M+ + H N++K I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 808
++ + EY+ G+L + S + QR++ D+AS + YLH S +IH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 809 KPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM---------IQTQTLATIG---YMAPEYG 856
N L+ +N ++DF +A+++ E + + +G +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916
DV+SFGI+L E D+LP + +D L
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADP--------------DYLPRT----MDFGLNV 236
Query: 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQS 976
+ + C F + + C P++R + ++ L ++L ++ G
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL----ETLRMHLAGHLPLGP 292
Query: 977 NL 978
L
Sbjct: 293 QL 294
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-50
Identities = 71/297 (23%), Positives = 115/297 (38%), Gaps = 34/297 (11%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEI--MKSIRHRNLIKVIS 745
+G+G +G V++ S G VAVK+F+S+ KS+ E E+ +RH N++ I+
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69
Query: 746 SCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH----- 796
S + L+ Y GSL YL LD L I++ +AS L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA--TIGYMAPE 854
+ H DLK N+L+ N ++D +A M + + T YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 855 ------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908
D+++FG++L E + + + V + M
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 909 --VVDANL---LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
V + + ++ + L EC + P R+ A I L KI
Sbjct: 248 KVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-50
Identities = 50/287 (17%), Positives = 108/287 (37%), Gaps = 39/287 (13%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVIS 745
LIG+G FG VY EVA+++ + K+F E + RH N++ +
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
+C + A++ +L + + +LD+ + I ++ + YLH + ++H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA---TIGYMAPEYGREGRVS 862
DLK NV D+ V ++DF + + + + + ++APE R+
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 863 ANG---------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913
DV++ G + E + P F + + +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QP---------AEAIIWQMGTG 258
Query: 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ +++ + ++ + C ++R +++ L K+
Sbjct: 259 MKPN-----LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-49
Identities = 51/328 (15%), Positives = 113/328 (34%), Gaps = 25/328 (7%)
Query: 263 GTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSL 322
G+ ++S L +G++ + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNA---------DRNRWHSAWRQ 52
Query: 323 SNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIY 382
+N + + L + ++ + + P++ L++L+ +
Sbjct: 53 ANSNNPQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMT 110
Query: 383 LGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA 442
+ L + T+ + L+ L L N L ++P I +L L L + +P
Sbjct: 111 IDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168
Query: 443 CFSN---------LTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGS 493
++ L +L+ + L + S+P + NL+++ +L ++ L+ +L I
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227
Query: 494 LKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFL-GYNRLQGSIPNSFGDLISLKFLNLSN 552
L L +DL P GG L+ L L + L ++P L L+ L+L
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRG 286
Query: 553 NNLSGVIPASLEKLSYLEDLNLSFNQLE 580
+P+ + +L + + +
Sbjct: 287 CVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 8e-45
Identities = 59/388 (15%), Positives = 105/388 (27%), Gaps = 78/388 (20%)
Query: 169 PREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKI 228
+ E + + + + D N + +I
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQI 60
Query: 229 LGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGF 288
+L + A P L L P F S L + ++
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME- 118
Query: 289 IPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVG 348
+P+T L L L+ N L + LP ++
Sbjct: 119 LPDTMQQFAGLETLTLARNPLRA------------------------------LPA-SIA 147
Query: 349 NLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408
+L+ L E + C +PE +++ L LQ L L+
Sbjct: 148 SLN-RLRELSIRACPELTELPEPLASTDASGEH---------------QGLVNLQSLRLE 191
Query: 409 DNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFW 468
+ S+P I NL L L + + LS ++ +L L + L
Sbjct: 192 WTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC---------- 239
Query: 469 NLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGY 528
L + P G L + L + +P +I L LE L L
Sbjct: 240 ------------TALR-NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286
Query: 529 NRLQGSIPNSFGDLISLKFLNLSNNNLS 556
+P+ L + + + + +
Sbjct: 287 CVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-42
Identities = 64/397 (16%), Positives = 114/397 (28%), Gaps = 91/397 (22%)
Query: 70 HSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRG 129
HS L L + + + ++ + G
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTG 65
Query: 130 NQLSGTFPSFISNKSS--LQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANN 187
L + + + L+L S L + P + L L+ M++ A
Sbjct: 66 RALK-ATADLLEDATQPGRVALELRSVPLP---------QFPDQAFRLSHLQHMTIDAAG 115
Query: 188 LQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYAR 247
L ++P + LE L + N L + P +SI
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRAL-P-----------------------ASIA--S 148
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
L L LS+ +P + + L NL L L
Sbjct: 149 LNRLRELSIRACPELTELPEPLASTD---------------ASGEHQGLVNLQSLRLEWT 193
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
+ S +S++N + LK + +PL L + +L LEE + C
Sbjct: 194 GIR------SLPASIANLQNLKSLKIRNSPL-SALG-PAIHHL-PKLEELDLRGCTALRN 244
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427
P L+ + L + L ++P DI L +L
Sbjct: 245 YPPIFGGRAPLKRLILKDC-----------------------SNLL-TLPLDIHRLTQLE 280
Query: 428 RLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP 464
+LDL G +P+ + L + I+ + + +
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 53/248 (21%), Positives = 97/248 (39%), Gaps = 9/248 (3%)
Query: 71 SQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGN 130
L + S+ L P Q LS LQ + + L +P + L+ + L N
Sbjct: 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARN 137
Query: 131 QLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICR-EIPREFGNLPELELMSLAANNLQ 189
L P+ I++ + L+ L + + E+ + + E L L+ + L ++
Sbjct: 138 PLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196
Query: 190 GKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL-SSIGYARL 248
+P I NL+NL+ L I ++ L + AI ++ L+ L L+ + G
Sbjct: 197 -SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGG--R 252
Query: 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNY 308
L+ L L + T+P I ++L LDL G +P+ L +++ +
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
Query: 309 LTSSTQEL 316
Q
Sbjct: 313 QAQLDQHR 320
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 9e-48
Identities = 73/467 (15%), Positives = 151/467 (32%), Gaps = 35/467 (7%)
Query: 70 HSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRG 129
+ R + ++ +L + S + +++ L+LS N L + + L+ + L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 130 NQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQ 189
N L T + + S+L+ LDL++N + E P +E + A NN+
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNNYVQ-------------ELLVGPSIETLHAANNNIS 112
Query: 190 GKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLP 249
+ + + + + +NK+ + + S ++ L L+ N + + A
Sbjct: 113 R---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
LE L+L N + + +KL LDL N + F+ F + ++W+ L +N L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
+ L F + L++FDL N + R K + ++G
Sbjct: 227 VLIEKALRFSQN------LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG--- 277
Query: 370 EEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGS----IPYDICNLAE 425
+ T + G +L L+ +GS + + N A
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337
Query: 426 LYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTG 485
+D + I + + L L+
Sbjct: 338 QREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI 397
Query: 486 SLPLEIGSLKVLVGIDLSRNNFS-GVIPTEIGGLKNLEYLFLGYNRL 531
L L + + + + + + ++
Sbjct: 398 ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-40
Identities = 55/335 (16%), Positives = 114/335 (34%), Gaps = 48/335 (14%)
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
+I + ++ + +A + LDL GN S L L LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
L L + L+ DL+ N +
Sbjct: 69 VLYE-------TLDLESLSTLRTLDLNNNYV----------------------------- 92
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427
+E+ ++ T++ N ++ ++ S+ Q +++ L +NK+ D + +
Sbjct: 93 --QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 428 RLDLDGNKLSG-SIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486
LDL N++ + ++ +L ++L N + + + L+ SSN L
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLA-F 205
Query: 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ-GSIPNSFGDLISL 545
+ E S + I L N +I + +NLE+ L N G++ + F +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 546 KFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
++ + + + E+ + + E
Sbjct: 265 --QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 42/216 (19%), Positives = 86/216 (39%), Gaps = 14/216 (6%)
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAEL 426
I E N + + + L ++ +++L L N L D+ +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486
L+L N L ++ +L++LR + L +N + + I L+ ++N ++
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL----VGPSIETLHAANNNIS-R 113
Query: 487 LPLEIG-SLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPNSFGDLIS 544
+ G K + L+ N + + + G ++YL L N + + +
Sbjct: 114 VSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 545 LKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
L+ LNL N + + + + L+ L+LS N+L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 22/103 (21%), Positives = 42/103 (40%), Gaps = 3/103 (2%)
Query: 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISL 545
++ + ++ ++ + + N++ L L N L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 546 KFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGS 588
+ LNLS+N L + LE LS L L+L+ N ++ ++ G S
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGPS 100
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-46
Identities = 65/297 (21%), Positives = 113/297 (38%), Gaps = 28/297 (9%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEI--MKSIRHRNLIKVIS 745
IG+G FG V++ G EVAVK+F+S+ +S+ E EI +RH N++ I+
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103
Query: 746 SCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH----- 796
+ + + LV +Y HGSL YL + + + + + AS L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA--TIGYMAPE 854
+ H DLK N+L+ N ++D +A ++ T YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 855 ------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908
+ D+Y+ G++ E + ++ V + M
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 909 --VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
V + L + + + + + EC R+ A I L ++
Sbjct: 282 KVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-46
Identities = 92/499 (18%), Positives = 172/499 (34%), Gaps = 41/499 (8%)
Query: 100 SLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGE 159
++ S N L +P + + + N +S + S I + S L+ L +S N +
Sbjct: 4 LVDRSKNGLI-HVPKDLSQK--TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-- 58
Query: 160 IRANICREIPRE-FGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPI 218
+ F ELE + L+ N L + NL+ LD+ N +
Sbjct: 59 -------YLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPIC 108
Query: 219 AIF-NVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRF------IFN 271
F N+S LK LGL L + +L I + + FN
Sbjct: 109 KEFGNMSQLKFLGLSTTHLE----KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164
Query: 272 ASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN-YLTSSTQELSFLSSLSNCKFLKY 330
L I+ F + + + NL + + LS L+ L L
Sbjct: 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN 224
Query: 331 FDLSYNPLYRILPRTTVGNLSHS-LEEFKMSNCNISGGIPEEI-----SNLTNLRTIYLG 384
L+ + + H+ + F +SN + G + ++L L +
Sbjct: 225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
Query: 385 GNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACF 444
+ + + ++ LD N L+ ++
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344
Query: 445 SNLTSLRIVSLGSNELTSIPLT---FWNLKDILNLNFSSNFLTGSLPLEI-GSLKVLVGI 500
+LT L + L N+L + +K + L+ S N ++ K L+ +
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404
Query: 501 DLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP 560
++S N + I + ++ L L N+++ SIP L +L+ LN+++N L V
Sbjct: 405 NMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPD 461
Query: 561 ASLEKLSYLEDLNLSFNQL 579
++L+ L+ + L N
Sbjct: 462 GIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 70/396 (17%), Positives = 130/396 (32%), Gaps = 47/396 (11%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
L +S+ +L + + +L+ + L + + + L +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES--LHIVFPTN 175
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELM---SLAANNLQGK 191
FI + S +L + + + N C L + +L
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 192 IPLKIGNL---RNLEKLDIGDNKLVGIAPIAIFNVS-----TLKILGLQDNSLSGCLSSI 243
++I L + I + KL G F+ S L I + + S
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF-PQSY 294
Query: 244 GYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLV 303
Y N+ I + + S LD N + + G+L L L+
Sbjct: 295 IYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLI 354
Query: 304 LSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCN 363
L N L ++ + + + L+ D+S N +
Sbjct: 355 LQMNQLKELSKIAEMTTQMKS---LQQLDISQNSVSYDEK-------------------- 391
Query: 364 ISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNL 423
+ S +L ++ + N L +I L +++ L L NK++ SIP + L
Sbjct: 392 -----KGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKL 443
Query: 424 AELYRLDLDGNKLSGSIPAC-FSNLTSLRIVSLGSN 458
L L++ N+L S+P F LTSL+ + L +N
Sbjct: 444 EALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-27
Identities = 64/352 (18%), Positives = 111/352 (31%), Gaps = 31/352 (8%)
Query: 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNY 308
IL++ N S I + SKL IL + N + F + L +L LS N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 309 LTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGI 368
L +S N LK+ DLS+N + GN+S L+ +S ++
Sbjct: 81 LVK----ISC-HPTVN---LKHLDLSFNAFDALPICKEFGNMS-QLKFLGLSTTHLEKSS 131
Query: 369 PEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYR 428
I++L + + + G LQ L + I +++
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTV 189
Query: 429 LDLDGNKLSGSIPACFSNLT----------------SLRIVSLGSNELTSIPLTFWNLK- 471
+L+ + + + + +L + N I W+
Sbjct: 190 ANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTV 249
Query: 472 ---DILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGY 528
I N+ SLK L + + F N+
Sbjct: 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309
Query: 529 NRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
+ + + L+ SNN L+ + + L+ LE L L NQL+
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 56/256 (21%), Positives = 103/256 (40%), Gaps = 22/256 (8%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLS--SLQSLNLS--FNRLFGSIPSAIFTTYT-LKYVCLR 128
V +IS++ L G + + + S SL++L++ + +FG S I+ ++ +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
Query: 129 GNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNL 188
+ S S HLD S+N L+ + G+L ELE + L N L
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLT--------DTVFENCGHLTELETLILQMNQL 360
Query: 189 QGKIPLKIG---NLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSGCLSSIG 244
+ ++ +++L++LDI N + +L L + N L+ +I
Sbjct: 361 K-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT---DTIF 416
Query: 245 YARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVL 304
P +++L L N +IP+ + L L++ N F L +L + L
Sbjct: 417 RCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWL 475
Query: 305 SDNYLTSSTQELSFLS 320
N S + +LS
Sbjct: 476 HTNPWDCSCPRIDYLS 491
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 9e-14
Identities = 33/117 (28%), Positives = 58/117 (49%), Gaps = 9/117 (7%)
Query: 476 LNFSSNFLTGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 534
++ S N L +P ++ +L ++S+N S + ++I L L L + +NR+Q
Sbjct: 5 VDRSKNGLI-HVPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 535 IPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGN 591
+ F L++L+LS+N L + S L+ L+LSFN + +P FGN
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFD-ALPICKEFGN 113
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-45
Identities = 66/401 (16%), Positives = 138/401 (34%), Gaps = 29/401 (7%)
Query: 165 CREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVS 224
+ I + + + L N + + ++ + + + +
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 69
Query: 225 TLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGN 283
+++L L D + + + +A ++ L + N +P +F N L++L LE N
Sbjct: 70 QVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 127
Query: 284 SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILP 343
S F N L+ L +S+N L + L+ LS N L +
Sbjct: 128 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT-----FQATTSLQNLQLSSNRLTHV-- 180
Query: 344 RTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQ 403
+ + SL +S +S ++ + + N +N + +L
Sbjct: 181 --DLSLIP-SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV---VRGPVNVELT 229
Query: 404 DLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSI 463
L L+ N L + N L +DL N+L + F + L + + +N L ++
Sbjct: 230 ILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL 287
Query: 464 PLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEY 523
L + + L+ S N L + L + L N+ + ++ L+
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKN 343
Query: 524 LFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLE 564
L L +N + + ++ + + + I LE
Sbjct: 344 LTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-43
Identities = 71/382 (18%), Positives = 126/382 (32%), Gaps = 55/382 (14%)
Query: 229 LGLQDNSLSGCLSSIGYA----RLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGN 283
D + + + L N +I++ + +P + + ++ +L+L
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 79
Query: 284 SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILP 343
F + L + N + + N L L N L LP
Sbjct: 80 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV-----FQNVPLLTVLVLERNDL-SSLP 133
Query: 344 RTTVGNLSHSLEEFKMSNCNISGGIPEEI-SNLTNLRTIYLGGNKLNGSILITLSKLQKL 402
R N L MSN N+ I ++ T+L+ + L N+L + LS + L
Sbjct: 134 RGIFHNTP-KLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSL 188
Query: 403 QDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTS 462
+ N L + + LD N ++ LT L L N LT
Sbjct: 189 FHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNLTD 240
Query: 463 IPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLE 522
N L + DLS N ++ ++ LE
Sbjct: 241 TA-WLLNYP---------------------GLVEV---DLSYNELEKIMYHPFVKMQRLE 275
Query: 523 YLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGK 582
L++ NRL ++ + +LK L+LS+N+L + + + LE+L L N +
Sbjct: 276 RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 332
Query: 583 IPRGGSFGNFSAQSFEGNELLC 604
+ + + N+ C
Sbjct: 333 LKL-STHHTLKNLTLSHNDWDC 353
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-41
Identities = 82/440 (18%), Positives = 161/440 (36%), Gaps = 63/440 (14%)
Query: 109 FGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREI 168
+ I S + V + F ++ + + ++ + ++
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR---------KL 60
Query: 169 PREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKI 228
P + + R +E L++ D ++ I A T++
Sbjct: 61 PAAL-----------------------LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQK 97
Query: 229 LGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSG 287
L + N++ L + +P L +L L N+ S ++PR IF N KL+ L + N+
Sbjct: 98 LYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER 155
Query: 288 FIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTV 347
+TF +L L LS N LT + S + + L + ++SYN L +T+
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLTH----VDL-SLIPS---LFHANVSYNLL------STL 201
Query: 348 GNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGL 407
++EE S+ +I+ + + L + L N L + L L ++ L
Sbjct: 202 AIPI-AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDL 255
Query: 408 KDNKLEGSIPYDI-CNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLT 466
N+LE I Y + L RL + N+L ++ + +L+++ L N L +
Sbjct: 256 SYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERN 313
Query: 467 FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFL 526
+ NL N + L++ + L + LS N++ + +N+ +
Sbjct: 314 QPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAV 368
Query: 527 GYNRLQGSIPNSFGDLISLK 546
I + K
Sbjct: 369 DDADQHCKIDYQLEHGLCCK 388
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-40
Identities = 74/416 (17%), Positives = 139/416 (33%), Gaps = 87/416 (20%)
Query: 68 EVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCL 127
++ ++ + + + L + ++ LNL+ ++ I + F
Sbjct: 41 DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAF---------- 89
Query: 128 RGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAAN 186
+ ++Q L + NA+ +P F N+P L ++ L N
Sbjct: 90 -------------AYAHTIQKLYMGFNAIR---------YLPPHVFQNVPLLTVLVLERN 127
Query: 187 NLQGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGY 245
+L +P I N L L + +N L I ++L+ L L N L+ +
Sbjct: 128 DLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR----LTHVDL 182
Query: 246 ARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLS 305
+ +P+L ++ N S + + LD NS + L L L
Sbjct: 183 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILK---LQ 234
Query: 306 DNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNIS 365
N LT + L N L DLSYN L +I+
Sbjct: 235 HNNLTD-------TAWLLNYPGLVEVDLSYNELEKIMYHP-------------------- 267
Query: 366 GGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAE 425
+ L +Y+ N+L ++ + + L+ L L N L + +
Sbjct: 268 ------FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 319
Query: 426 LYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSN 481
L L LD N + ++ S +L+ ++L N+ L +++
Sbjct: 320 LENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL-FRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-37
Identities = 59/325 (18%), Positives = 117/325 (36%), Gaps = 25/325 (7%)
Query: 264 TIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLS 323
I + + ++ + + L N + ++ + L L
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL-----LD 66
Query: 324 NCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI-SNLTNLRTIY 382
+ + ++ +L+ + + H++++ M I +P + N+ L +
Sbjct: 67 SFRQVELLNLNDLQI-EEIDTYAFAYA-HTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLV 123
Query: 383 LGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI-CNLAELYRLDLDGNKLSGSIP 441
L N L+ KL L + +N LE I D L L L N+L+ +
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD 181
Query: 442 ACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGID 501
S + SL ++ N L+++ + L+ S N + + L +
Sbjct: 182 --LSLIPSLFHANVSYNLLSTLA----IPIAVEELDASHNSINV---VRGPVNVELTILK 232
Query: 502 LSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA 561
L NN + + L + L YN L+ + + F + L+ L +SNN L +
Sbjct: 233 LQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNL 289
Query: 562 SLEKLSYLEDLNLSFNQLEGKIPRG 586
+ + L+ L+LS N L + R
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-HVERN 313
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 71/351 (20%), Positives = 130/351 (37%), Gaps = 40/351 (11%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGN 130
++V +LN++ L + ++Q L + FN + +P +F L + L N
Sbjct: 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERN 127
Query: 131 QLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANNLQ 189
LS N L L +S+N L I + F L+ + L++N L
Sbjct: 128 DLSSLPRGIFHNTPKLTTLSMSNNNL---------ERIEDDTFQATTSLQNLQLSSNRLT 178
Query: 190 GKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLP 249
+ + + +L ++ N L +A ++ L NS ++ +
Sbjct: 179 H---VDLSLIPSLFHANVSYNLLSTLAIP-----IAVEELDASHNS----INVVRGPVNV 226
Query: 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
L IL L NN + + N L +DL N + + F ++ L L +S+N L
Sbjct: 227 ELTILKLQHNNLT-DTAWLL-NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
+ + + LK DLS+N L + R LE + + +I +
Sbjct: 285 VALNLYGQPIPT------LKVLDLSHNHL-LHVERNQPQF--DRLENLYLDHNSIV-TLK 334
Query: 370 EEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI 420
+S L+ + L N + + L L + + + D I Y +
Sbjct: 335 --LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQL 381
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 33/200 (16%), Positives = 70/200 (35%), Gaps = 7/200 (3%)
Query: 415 SIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP-LTFWNLKDI 473
I ++ Y + +D L + +IV+ ++ + +P + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 474 LNLNFSSNFLTGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 532
LN + + + + + + N + P + L L L N L
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 533 GSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNF 592
F + L L++SNNNL + + + + L++L LS N+L + +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL-IPSL 188
Query: 593 SAQSFEGNEL--LCGSPNLQ 610
+ N L L ++
Sbjct: 189 FHANVSYNLLSTLAIPIAVE 208
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 19/128 (14%), Positives = 42/128 (32%), Gaps = 1/128 (0%)
Query: 459 ELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGL 518
E I +++ E +L + + + +
Sbjct: 9 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 68
Query: 519 KNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578
+ +E L L +++ +F +++ L + N + + P + + L L L N
Sbjct: 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128
Query: 579 LEGKIPRG 586
L +PRG
Sbjct: 129 LS-SLPRG 135
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 14/83 (16%), Positives = 28/83 (33%), Gaps = 1/83 (1%)
Query: 504 RNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASL 563
R I + + + + L + K + N+ + + A L
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 564 EKLSYLEDLNLSFNQLEGKIPRG 586
+ +E LNL+ Q+E +I
Sbjct: 66 DSFRQVELLNLNDLQIE-EIDTY 87
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-43
Identities = 66/416 (15%), Positives = 142/416 (34%), Gaps = 29/416 (6%)
Query: 165 CREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVS 224
+ I + + + L N + + ++ + + + +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 225 TLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGN 283
+++L L D + + + +A ++ L + N +P +F N L++L LE N
Sbjct: 76 QVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 133
Query: 284 SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILP 343
S F N L+ L +S+N L + L+ LS N L +
Sbjct: 134 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT-----FQATTSLQNLQLSSNRLTHV-- 186
Query: 344 RTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQ 403
+ + SL +S +S ++ + + N +N + +L
Sbjct: 187 --DLSLIP-SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV---VRGPVNVELT 235
Query: 404 DLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSI 463
L L+ N L + N L +DL N+L + F + L + + +N L ++
Sbjct: 236 ILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL 293
Query: 464 PLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEY 523
L + + L+ S N L + L + L N+ + ++ L+
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKN 349
Query: 524 LFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
L L +N + + ++ + + + I LE ++ + +
Sbjct: 350 LTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDR 403
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-39
Identities = 89/520 (17%), Positives = 166/520 (31%), Gaps = 75/520 (14%)
Query: 68 EVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCL 127
++ ++ + + + L + ++ LNL+ ++ I + F
Sbjct: 47 DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAF---------- 95
Query: 128 RGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAAN 186
+ ++Q L + NA+ +P F N+P L ++ L N
Sbjct: 96 -------------AYAHTIQKLYMGFNAIR---------YLPPHVFQNVPLLTVLVLERN 133
Query: 187 NLQGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGY 245
+L +P I N L L + +N L I ++L+ L L N L+ +
Sbjct: 134 DLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR----LTHVDL 188
Query: 246 ARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLS 305
+ +P+L ++ N S + + LD NS + L L L
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILK---LQ 240
Query: 306 DNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNIS 365
N LT + L N L DLSYN L + + LE +SN +
Sbjct: 241 HNNLTD-------TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQ-RLERLYISNNRLV 291
Query: 366 GGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAE 425
+ + L+ + L N L + + +L++L L N + ++
Sbjct: 292 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHT 346
Query: 426 LYRLDLDGNKLSG-SIPACFSNLTSLRIVSLGSNELTSIPLTFW--------NLKDILNL 476
L L L N S+ A F N+ + + L D L
Sbjct: 347 LKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQ 406
Query: 477 NFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 536
+ + + G I+ ++ + L+ E L N L+ +
Sbjct: 407 YIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466
Query: 537 NSFGDLIS----LKFLNLSNNNLSGVIPASLEKLSYLEDL 572
+ I L+ L+ + + L+ D
Sbjct: 467 QLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDN 506
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-39
Identities = 82/437 (18%), Positives = 160/437 (36%), Gaps = 63/437 (14%)
Query: 109 FGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREI 168
+ I S + V + F ++ + + ++ + ++
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR---------KL 66
Query: 169 PREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKI 228
P + + R +E L++ D ++ I A T++
Sbjct: 67 PAAL-----------------------LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQK 103
Query: 229 LGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSG 287
L + N++ L + +P L +L L N+ S ++PR IF N KL+ L + N+
Sbjct: 104 LYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER 161
Query: 288 FIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTV 347
+TF +L L LS N LT LS + + L + ++SYN L +T+
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLTHVD-----LSLIPS---LFHANVSYNLL------STL 207
Query: 348 GNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGL 407
++EE S+ +I+ + + L + L N L + L L ++ L
Sbjct: 208 AIPI-AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDL 261
Query: 408 KDNKLEGSIPYDIC-NLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLT 466
N+LE I Y + L RL + N+L ++ + +L+++ L N L +
Sbjct: 262 SYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERN 319
Query: 467 FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFL 526
+ NL N + L++ + L + LS N++ + +N+ +
Sbjct: 320 QPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAV 374
Query: 527 GYNRLQGSIPNSFGDLI 543
I +
Sbjct: 375 DDADQHCKIDYQLEHGL 391
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-35
Identities = 64/292 (21%), Positives = 108/292 (36%), Gaps = 20/292 (6%)
Query: 292 TFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLS 351
+ V D ++ TQ++ F K + + R LP + +
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFR 75
Query: 352 HSLEEFKMSNCNISGGIPEEI-SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDN 410
+E +++ I I + ++ +Y+G N + + L L L+ N
Sbjct: 76 -QVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133
Query: 411 KLEGSIPYDI-CNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFW 468
L S+P I N +L L + N L F TSL+ + L SN LT + L
Sbjct: 134 DLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP 192
Query: 469 NLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGY 528
+L + N S N L+ + + +D S N+ + V L L L +
Sbjct: 193 SLF---HANVSYNLLS-----TLAIPIAVEELDASHNSINVV---RGPVNVELTILKLQH 241
Query: 529 NRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
N L + L ++LS N L ++ K+ LE L +S N+L
Sbjct: 242 NNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 93/518 (17%), Positives = 170/518 (32%), Gaps = 45/518 (8%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGN 130
++V +LN++ L + ++Q L + FN + +P +F L + L N
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERN 133
Query: 131 QLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQG 190
LS N L L +S+N L I + F L+ + L++N L
Sbjct: 134 DLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT-------FQATTSLQNLQLSSNRLTH 185
Query: 191 KIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPN 250
+ + + +L ++ N L +A ++ L NS ++ +
Sbjct: 186 ---VDLSLIPSLFHANVSYNLLSTLAIP-----IAVEELDASHNS----INVVRGPVNVE 233
Query: 251 LEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLT 310
L IL L NN + + N L +DL N + + F ++ L L +S+N L
Sbjct: 234 LTILKLQHNNLT-DTAWLL-NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
Query: 311 SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPE 370
+ + + LK DLS+N L + LE + + +I +
Sbjct: 292 ALNLYGQPIPT------LKVLDLSHNHLLHVER--NQPQFD-RLENLYLDHNSIV-TLK- 340
Query: 371 EISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLD 430
+S L+ + L N + + L L + + + D I Y + + D
Sbjct: 341 -LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESD 397
Query: 431 LDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLE 490
A S + ++ + +I I L E
Sbjct: 398 KPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAE 457
Query: 491 IGSLKV----LVGIDLSRNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPNSFGDLISL 545
+ L+ L + + + EI L+ G R ++ F L
Sbjct: 458 VNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKER 517
Query: 546 KFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKI 583
+ L + K EDL LE ++
Sbjct: 518 QAFKLRETQAR--RTEADAKQKETEDLEQENIALEKQL 553
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 7e-14
Identities = 19/128 (14%), Positives = 42/128 (32%), Gaps = 1/128 (0%)
Query: 459 ELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGL 518
E I +++ E +L + + + +
Sbjct: 15 EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 74
Query: 519 KNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578
+ +E L L +++ +F +++ L + N + + P + + L L L N
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134
Query: 579 LEGKIPRG 586
L +PRG
Sbjct: 135 LS-SLPRG 141
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-43
Identities = 57/333 (17%), Positives = 113/333 (33%), Gaps = 54/333 (16%)
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
+I + ++ + +A + LDL GN S L L LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
L L + L+ DL+ N +
Sbjct: 69 VLYE-------TLDLESLSTLRTLDLNNNYV----------------------------- 92
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427
+E+ ++ T++ N ++ ++ S+ Q +++ L +NK+ D + +
Sbjct: 93 --QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 428 RLDLDGNKLSG-SIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486
LDL N++ + ++ +L ++L N + + + L+ SSN L
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLA-F 205
Query: 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLK 546
+ E S + I L N +I + +NLE+ L N +L+
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH---------CGTLR 255
Query: 547 FLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
N + V +++KL+ + + L
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 65/311 (20%), Positives = 124/311 (39%), Gaps = 29/311 (9%)
Query: 70 HSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLR 128
+ R + ++ +L + S + +++ L+LS N L I +A +T L+ + L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL-SQISAADLAPFTKLELLNLS 66
Query: 129 GNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNL 188
N L T + + S+L+ LDL++N + E P +E + A NN+
Sbjct: 67 SNVLYETLD--LESLSTLRTLDLNNNYVQ-------------ELLVGPSIETLHAANNNI 111
Query: 189 QGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARL 248
+ + + + + +NK+ + + S ++ L L+ N + + A
Sbjct: 112 SR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNY 308
LE L+L N + + +KL LDL N + F+ F + ++W+ L +N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 309 LTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGI 368
L + L F + L++FDL N + R K + ++G
Sbjct: 226 LVLIEKALRFSQN------LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279
Query: 369 PEEISNLTNLR 379
EE + T
Sbjct: 280 EEECTVPTLGH 290
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-37
Identities = 67/375 (17%), Positives = 129/375 (34%), Gaps = 63/375 (16%)
Query: 88 IPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQ 147
I N + + ++ + L ++ S + + +K + L GN LS + ++ + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 148 HLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDI 207
L+LSSN L E + +L L + L N +Q ++ ++E L
Sbjct: 62 LLNLSSNVLY---------ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHA 106
Query: 208 GDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPR 267
+N +S + +R + + L N +
Sbjct: 107 ANNN----------------------------ISRVSCSRGQGKKNIYLANNKITMLRDL 138
Query: 268 FIFNASKLSILDLEGNSFSGF-IPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCK 326
S++ LDL+ N + L L L N++ +
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-------VKGQVVFA 191
Query: 327 FLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGN 386
LK DLS N L + P + + + + N + I + + NL L GN
Sbjct: 192 KLKTLDLSSNKLAFMGP--EFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 387 KLN-GSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFS 445
+ G++ SK Q++Q + + K + C + L G +P
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY---GAYCCEDLP---- 300
Query: 446 NLTSLRIVSLGSNEL 460
+ R+++LG +
Sbjct: 301 APFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 42/216 (19%), Positives = 84/216 (38%), Gaps = 14/216 (6%)
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAEL 426
I E N + + + L ++ +++L L N L D+ +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486
L+L N L +L++LR + L +N + + I L+ ++N ++
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQELL----VGPSIETLHAANNNIS-R 113
Query: 487 LPLEIG-SLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPNSFGDLIS 544
+ G K + L+ N + + + G ++YL L N + + +
Sbjct: 114 VSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 545 LKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
L+ LNL N + + + + L+ L+LS N+L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 22/103 (21%), Positives = 42/103 (40%), Gaps = 3/103 (2%)
Query: 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISL 545
++ + ++ ++ + + N++ L L N L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 546 KFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGS 588
+ LNLS+N L + LE LS L L+L+ N ++ ++ G S
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGPS 100
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-41
Identities = 77/347 (22%), Positives = 128/347 (36%), Gaps = 50/347 (14%)
Query: 232 QDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPN 291
+ + + + +L++ + + T+P + ++ L + N+ + +P
Sbjct: 23 ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPA 78
Query: 292 TFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLS 351
LR L +S N LTS L F L +
Sbjct: 79 LPPELRTLE---VSGNQLTS------LPVLPPGLLELSIFSNPLTHLPALPS-------- 121
Query: 352 HSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNK 411
L + + ++ +P L L + N+L S+ S+L KL +N+
Sbjct: 122 -GLCKLWIFGNQLTS-LPVLPPGLQEL---SVSDNQLA-SLPALPSELCKLW---AYNNQ 172
Query: 412 LEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLK 471
L S+P L EL + N+L+ S+P S L L +N LTS+P LK
Sbjct: 173 LT-SLPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKL---WAYNNRLTSLPALPSGLK 224
Query: 472 DILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRL 531
L S N LT SLP+ LK L +S N + +P L L + N+L
Sbjct: 225 ---ELIVSGNRLT-SLPVLPSELKEL---MVSGNRLTS-LPMLPS---GLLSLSVYRNQL 273
Query: 532 QGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578
+P S L S +NL N LS +L +++ + +
Sbjct: 274 T-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-38
Identities = 78/375 (20%), Positives = 141/375 (37%), Gaps = 55/375 (14%)
Query: 224 STLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGN 283
+ +L + ++ L+ + ++ L + NN + ++P +L L++ GN
Sbjct: 40 NGNAVLNVGESGLTTLPDCLP----AHITTLVIPDNNLT-SLPALP---PELRTLEVSGN 91
Query: 284 SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILP 343
+ +P L LS +L + L L + N L
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKL------------WIFGNQL----- 133
Query: 344 RTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSK-LQKL 402
T++ L L+E +S+ ++ +P S L L + N+L +L L
Sbjct: 134 -TSLPVLPPGLQELSVSDNQLAS-LPALPSELCKL---WAYNNQLT-----SLPMLPSGL 183
Query: 403 QDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTS 462
Q+L + DN+L S+P L +L+ + N+L+ S+PA S L L + N LTS
Sbjct: 184 QELSVSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPALPSGLKEL---IVSGNRLTS 235
Query: 463 IPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLE 522
+P+ LK L S N LT SLP+ L L + RN + +P + L +
Sbjct: 236 LPVLPSELK---ELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSET 287
Query: 523 YLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA--SLEKLSYLEDLNLSFNQLE 580
+ L N L + ++ S + + + +L + E
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE 347
Query: 581 GKIPRGGSFGNFSAQ 595
G+ + F +
Sbjct: 348 GEPAPADRWHMFGQE 362
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-36
Identities = 80/401 (19%), Positives = 135/401 (33%), Gaps = 70/401 (17%)
Query: 143 KSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNL 202
+ L++ + L+ +P + + + NNL +P LR
Sbjct: 39 NNGNAVLNVGESGLT---------TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRT- 85
Query: 203 EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS 262
L++ N+L + P+ + L I L A L L ++GN +
Sbjct: 86 --LEVSGNQLTSL-PVLPPGLLELSIFSNPLTHLP--------ALPSGLCKLWIFGNQLT 134
Query: 263 GTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSL 322
++P L L + N + +P L L +N LTS S L L
Sbjct: 135 -SLPVLPPG---LQELSVSDNQLAS-LPALPSELCKLW---AYNNQLTSLPMLPSGLQEL 186
Query: 323 SNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIY 382
+S N L LP L L + N ++ +P S L L
Sbjct: 187 ---------SVSDNQL-ASLP-----TLPSELYKLWAYNNRLT-SLPALPSGLKEL---I 227
Query: 383 LGGNKLNGSILITL-SKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIP 441
+ GN+L +L +L++L + N+L S+P L L + N+L+ +P
Sbjct: 228 VSGNRLT-----SLPVLPSELKELMVSGNRLT-SLPMLPSGLLS---LSVYRNQLT-RLP 277
Query: 442 ACFSNLTSLRIVSLGSNELTSIPLTF----WNLKDILNLNFSSNFLTGSLPLEIGSLKVL 497
+L+S V+L N L+ L + + S P E +L +
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
Query: 498 VGIDLSRNNFSGVIPTE----IGGLKNLEYLFLGYNRLQGS 534
L P + G N + L +RL +
Sbjct: 338 AADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 74/398 (18%), Positives = 134/398 (33%), Gaps = 63/398 (15%)
Query: 95 LSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSN 154
+ LN+ + L ++P + + + + N L+ + P+ L+ L++S N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLPAH--ITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91
Query: 155 ALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVG 214
L+ +P L EL + S +L L KL I N+L
Sbjct: 92 QLT---------SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLTS 135
Query: 215 IAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASK 274
+ P+ L+ L + DN L+ + L L + N + ++P S
Sbjct: 136 L-PVLPPG---LQELSVSDNQLASLPALPS-----ELCKLWAYNNQLT-SLPMLP---SG 182
Query: 275 LSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSL--SNCKF----- 327
L L + N + +P L L +N LTS S L L S +
Sbjct: 183 LQELSVSDNQLA-SLPTLPSELYKLW---AYNNRLTSLPALPSGLKELIVSGNRLTSLPV 238
Query: 328 ----LKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYL 383
LK +S N L T++ L L + ++ +PE + +L++ T+ L
Sbjct: 239 LPSELKELMVSGNRL------TSLPMLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNL 291
Query: 384 GGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPAC 443
GN L+ TL L+++ + + R +PA
Sbjct: 292 EGNPLSE---RTLQALREITSAPGYSGPII-RFDMAGASAPRETRALHLAAADW-LVPAR 346
Query: 444 FSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSN 481
+ E + + + + NF +
Sbjct: 347 EGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKD 384
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-41
Identities = 77/357 (21%), Positives = 132/357 (36%), Gaps = 42/357 (11%)
Query: 253 ILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS 312
+ F +P I ++ +LDL N + F + +L L L++N +++
Sbjct: 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 313 TQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI 372
+ +N L+ L N L I
Sbjct: 72 EPG-----AFNNLFNLRTLGLRSNRLKLIPLGV--------------------------F 100
Query: 373 SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI-CNLAELYRLDL 431
+ L+NL + + NK+ + L L+ L + DN L I + L L +L L
Sbjct: 101 TGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTL 159
Query: 432 DGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNFLTGSLPL 489
+ L+ SIP S+L L ++ L + +I +F L + L S ++
Sbjct: 160 EKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP 218
Query: 490 EIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLN 549
L + ++ N + V + L L +L L YN + + +L+ L+ +
Sbjct: 219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278
Query: 550 LSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG--GSFGNFSAQSFEGNELLC 604
L L+ V P + L+YL LN+S NQL + S GN + N L C
Sbjct: 279 LVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-39
Identities = 61/323 (18%), Positives = 126/323 (39%), Gaps = 24/323 (7%)
Query: 71 SQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFT-TYTLKYVCLRG 129
+L++ + + + L+ L L+ N + ++ F + L+ + LR
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRS 89
Query: 130 NQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANNL 188
N+L + S+L LD+S N + + F +L L+ + + N+L
Sbjct: 90 NRLKLIPLGVFTGLSNLTKLDISENKIV---------ILLDYMFQDLYNLKSLEVGDNDL 140
Query: 189 QGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYAR 247
I + L +LE+L + L I A+ ++ L +L L+ +++ + + R
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKR 198
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
L L++L + + T+ L+ L + + + +L L +L LS N
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYN 258
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
+++ S L L+ L L ++ L+ L +S ++
Sbjct: 259 PISTIEG-----SMLHELLRLQEIQLVGGQL-AVVEPYAFRGLN-YLRVLNVSGNQLT-T 310
Query: 368 IPEEI-SNLTNLRTIYLGGNKLN 389
+ E + ++ NL T+ L N L
Sbjct: 311 LEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 33/138 (23%), Positives = 51/138 (36%), Gaps = 3/138 (2%)
Query: 449 SLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFS 508
R V ++P + L+ N + E S L ++L+ N S
Sbjct: 12 QDRAVLCHRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69
Query: 509 GVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSY 568
V P L NL L L NRL+ F L +L L++S N + ++ + L
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129
Query: 569 LEDLNLSFNQLEGKIPRG 586
L+ L + N L I
Sbjct: 130 LKSLEVGDNDLV-YISHR 146
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-40
Identities = 78/282 (27%), Positives = 116/282 (41%), Gaps = 40/282 (14%)
Query: 690 IGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSC 747
IGRG FG V+ L D VAVK F E I+K H N++++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
+ ++ +V+E + G +L + L + L ++ D A+ +EYL S IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDV 867
L N L+ + V +SDF +++ + + + APE GR S+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 868 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK- 925
+SFGI+L ETF+ G P + +S + FV K
Sbjct: 299 WSFGILLWETFSLGASP----YPN-------------LSNQQT----------REFVEKG 331
Query: 926 ------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961
E C VF L +C P QR + I +L IR
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-39
Identities = 89/408 (21%), Positives = 149/408 (36%), Gaps = 60/408 (14%)
Query: 201 NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNN 260
++ +D+ N + + + + L+ L ++ + + + + L +L IL L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 261 FSGTIPRFIFNA-SKLSILDLEGNSF-SGFIP-NTFGNLRNLSWLVLSDNYLTSSTQELS 317
F + FN + L +L L + + N F L +L LVL DN + Q S
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK-IQPAS 148
Query: 318 FLSSLSNCKFLKYFDLSYNPLYRI-------LPRTTVGNLS-HSLEEFKMSNCNISGGIP 369
F ++ DL++N + I L S+ M+ +
Sbjct: 149 FFLNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 370 EEISNLTNLRTIYLGGNKLNGS---ILITLSKLQKLQDLGLKDNKLEG---------SIP 417
T++ T+ L GN S K+Q L L ++ G
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265
Query: 418 YDICN---LAELYRLDLDGNKLSGSIPAC-FSNLTSLRIVSLGSNELTSIPL-TFWNLKD 472
+ + DL +K+ ++ FS+ T L ++L NE+ I FW L
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324
Query: 473 ILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 532
+L LN S NFL + F L LE L L YN ++
Sbjct: 325 LLKLNLSQNFLG----------------SIDSRMFEN--------LDKLEVLDLSYNHIR 360
Query: 533 GSIPN-SFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
++ + SF L +LK L L N L V ++L+ L+ + L N
Sbjct: 361 -ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-38
Identities = 81/392 (20%), Positives = 135/392 (34%), Gaps = 61/392 (15%)
Query: 224 STLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEG 282
+ + + L NS++ L+ ++RL +L+ L + I F S L IL L+
Sbjct: 30 AHVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 283 NSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRIL 342
N F F L NL L L+ L + +F L++ L+ L N + +I
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS---LEMLVLRDNNIKKIQ 145
Query: 343 PRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLN---GSILITLSKL 399
P + N+ + L NK+ L+
Sbjct: 146 PASF-------------------------FLNMRRFHVLDLTFNKVKSICEEDLLNFQGK 180
Query: 400 QKLQDLGLKDNKLEGSIPYDIC--------NLAELYRLDLDGNKLSGSIPACFSNLTSL- 450
L L L+ Y + + LDL GN S+ F + +
Sbjct: 181 H-FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT 239
Query: 451 ------------RIVSLGSNELTSIP-LTFWNLK--DILNLNFSSNFLTGSLPLEI-GSL 494
S G TF L+ + + S + + +L +
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHF 298
Query: 495 KVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNN 554
L + L++N + + GL +L L L N L F +L L+ L+LS N+
Sbjct: 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH 358
Query: 555 LSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG 586
+ + S L L++L L NQL+ +P G
Sbjct: 359 IRALGDQSFLGLPNLKELALDTNQLK-SVPDG 389
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 83/425 (19%), Positives = 146/425 (34%), Gaps = 68/425 (16%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
V +++S ++ + L LQ L + I + F +
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS------------ 79
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANNLQG-K 191
SL L L N ++ F L LE+++L NL G
Sbjct: 80 -----------SLIILKLDYNQFL---------QLETGAFNGLANLEVLTLTQCNLDGAV 119
Query: 192 IPLKI-GNLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSG-CLSSIGYARL 248
+ L +LE L + DN + I P + F N+ +L L N + C + +
Sbjct: 120 LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG 179
Query: 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNY 308
+ +L L + D+ +++ L LS N
Sbjct: 180 KHFTLLRLSSIT----------------LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 309 LTSSTQELSF-------LSSLS-NCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMS 360
S + F + SL + + + T G + ++ +S
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS 283
Query: 361 NCNISGGIPEEI-SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD 419
I + + + S+ T+L + L N++N L L L L N L GSI
Sbjct: 284 KSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSR 341
Query: 420 IC-NLAELYRLDLDGNKLSGSIPAC-FSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNL 476
+ NL +L LDL N + ++ F L +L+ ++L +N+L S+P F L + +
Sbjct: 342 MFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKI 400
Query: 477 NFSSN 481
+N
Sbjct: 401 WLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 78/401 (19%), Positives = 150/401 (37%), Gaps = 34/401 (8%)
Query: 144 SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI-GNLRNL 202
+ + ++DLS N+++ E+ F L +L+ + + I L +L
Sbjct: 30 AHVNYVDLSLNSIA-ELN-------ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 203 EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSL-SGCLSSIGYARLPNLEILSLWGNNF 261
L + N+ + + A ++ L++L L +L LS + L +LE+L L NN
Sbjct: 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 262 SGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNL--RNLSWLVLSDNYLTSSTQ---E 315
P F N + +LDL N N ++ + L LS L +
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG 201
Query: 316 LSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNL 375
+ + DLS N + + ++ + + + + + + G +N
Sbjct: 202 WEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF 261
Query: 376 TNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDIC-NLAELYRLDLDGN 434
+ G + + ++ L +K+ ++ + + +L +L L N
Sbjct: 262 KDPDNFTFKGLEAS-----------GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQN 309
Query: 435 KLSGSIPA-CFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNFLTGSLPLEI- 491
+++ I F LT L ++L N L SI F NL + L+ S N + +L +
Sbjct: 310 EIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSF 367
Query: 492 GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 532
L L + L N V L +L+ ++L N
Sbjct: 368 LGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 50/264 (18%), Positives = 86/264 (32%), Gaps = 24/264 (9%)
Query: 345 TTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSI-LITLSKLQKLQ 403
V L + +S +I+ S L +L+ + + I T L L
Sbjct: 23 HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82
Query: 404 DLGLKDNKLEGSIPYDI-CNLAELYRLDLDGNKL-SGSIPA-CFSNLTSLRIVSLGSNEL 460
L L N+ + LA L L L L + F LTSL ++ L N +
Sbjct: 83 ILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 461 TSIPL--TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGL 518
I F N++ L+ + N + S+ E L G + L
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVK-SICEED--LLNFQGKHFTLLR-----------L 187
Query: 519 KNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA---SLEKLSYLEDLNLS 575
++ + L + S+ L+LS N + + ++ L LS
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247
Query: 576 FNQLEGKIPRGGSFGNFSAQSFEG 599
+ G +F + +F+G
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 50/271 (18%), Positives = 87/271 (32%), Gaps = 46/271 (16%)
Query: 94 NLSSLQSLNLSFNRLFGSIPSAIF---TTYTLKYVCLRGNQLSGTFPSFISNK------- 143
N+ L+L+FN++ SI + L L ++ +
Sbjct: 152 NMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 144 -SSLQHLDLSSNALSGEIRANICREIPR---------------------EFGNLPELELM 181
+S+ LDLS N + I F +
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 182 SLAANNLQ---------GKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGL 231
L A+ ++ + + + +LE+L + N++ I A + ++ L L L
Sbjct: 271 GLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNL 330
Query: 232 QDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIP 290
N L + S + L LE+L L N+ + F L L L+ N
Sbjct: 331 SQNFLGS-IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPD 388
Query: 291 NTFGNLRNLSWLVLSDNYLTSSTQELSFLSS 321
F L +L + L N S + +LS
Sbjct: 389 GIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 419
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 42/220 (19%), Positives = 81/220 (36%), Gaps = 36/220 (16%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT---LKYVCLRGNQ 131
T+ +++ L +S+ +L+LS N S+ F ++ + L +
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250
Query: 132 LSGTFPSFISNK------------SSLQHLDLSSNALSGEIRANICR------------- 166
G+ + K S ++ DLS + + + ++
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQN 309
Query: 167 ---EIPRE-FGNLPELELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIF 221
+I F L L ++L+ N L I ++ NL LE LD+ N + + +
Sbjct: 310 EINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368
Query: 222 NVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNF 261
+ LK L L N L + + RL +L+ + L N +
Sbjct: 369 GLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-38
Identities = 99/543 (18%), Positives = 180/543 (33%), Gaps = 81/543 (14%)
Query: 64 GVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLK 123
G ++ ++++ S+ NLT +P ++L+LS N + + + +
Sbjct: 23 GSMTPFSNELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSIS-ELRMPDISFLS-- 76
Query: 124 YVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMS 182
L+ L LS N + + F +LE +
Sbjct: 77 ---------------------ELRVLRLSHNRIR---------SLDFHVFLFNQDLEYLD 106
Query: 183 LAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSGCLS 241
++ N LQ I + +L LD+ N + F N++ L LGL
Sbjct: 107 VSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR---- 159
Query: 242 SIGYARLPNLEILSLWGNNFSGTIPRF---IFNASKLSILDLEGNSFSGFIPNTFGNLRN 298
+ + +L + + + S I ++L L + S F ++
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 299 LSWLVLSDNYLT--SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHS-LE 355
L L LS+ L + + ++FLS L+ L L + +E
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 356 EFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGS 415
+ N I+ I E + L+ L +K+ S
Sbjct: 280 YLNIYNLTITERIDREEFTYSET-------------------ALKSLMIEHVKNQVFLFS 320
Query: 416 IPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLT-FWNLKDIL 474
AE+ L + C + +S ++ N T LK +
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380
Query: 475 NLNFSSNFLTGSLPLEIG---SLKVLVGIDLSRNNF-SGVIPTEIGGLKNLEYLFLGYNR 530
L N L + ++ L +D+S N+ S +++ L L N
Sbjct: 381 TLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM 439
Query: 531 LQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFG 590
L GS+ +K L+L NN + IP + L L++LN++ NQL+ +P G F
Sbjct: 440 LTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD-GVFD 494
Query: 591 NFS 593
+
Sbjct: 495 RLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 5e-13
Identities = 45/231 (19%), Positives = 75/231 (32%), Gaps = 29/231 (12%)
Query: 369 PEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYR 428
+IS L+ LR + L N++ Q L+ L + N+L+ +I +A L
Sbjct: 69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRH 125
Query: 429 LDLDGNKLSGSIPAC--FSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486
LDL N +P C F NLT L + L + + + L + +L+ S L
Sbjct: 126 LDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLL-----PVAHLHLSCILL--- 176
Query: 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLK 546
DL + G + N L L ++ + +L
Sbjct: 177 --------------DLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 547 FLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSF 597
L LSN L+ L + + + + F
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 38/165 (23%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQL-- 132
T LN + T ++ L LQ+L L N L + T + + L
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNS 414
Query: 133 --SGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPE-LELMSLAANNLQ 189
S + + S+ L+LSSN L+G + F LP ++++ L N +
Sbjct: 415 LNSHAYDRTCAWAESILVLNLSSNMLTGSV-----------FRCLPPKVKVLDLHNNRIM 463
Query: 190 GKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDN 234
IP + +L+ L++L++ N+L + +++L+ + L DN
Sbjct: 464 -SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 50/289 (17%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
IG G FG V+ + +VA+K + F E E+M + H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAPVI 804
+ LV E+M HG L YL + + L + +DV + YL I
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------I 126
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSAN 864
H DL N L+ +N V +SDF + + + +DQ T T + + +PE R S+
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 865 GDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 923
DV+SFG+++ E F+ GK P + N E + +
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSN---------------------------SEVVEDI 218
Query: 924 AK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965
+ + V+ + C E P+ R ++ +L +I +S L
Sbjct: 219 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 68/289 (23%), Positives = 110/289 (38%), Gaps = 38/289 (13%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKVF---TSQCGRAFKSFDVECEIMKSIRHRNLIK 742
+G G FG V + G + VAVK A F E M S+ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGY 799
+ K +V E P GSL L + + VA + YL F
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ-TLATIGYMAPEYGRE 858
IH DL N+LL + + DF + + L D + + + APE +
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 859 GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917
S D + FG+ L E FT G++P W+ ++ +++ + +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILHK--IDK 239
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966
E E C ++N+ ++C P+ R + LL+ + + +R
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 60/342 (17%), Positives = 132/342 (38%), Gaps = 58/342 (16%)
Query: 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
+L ++ +P+ + ++LDL+ N + F NL+NL L+L +N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
+ + + L L+ LS N L + + +L+E ++ I+ +
Sbjct: 89 SKISPGA--FAPLVK---LERLYLSKNQLKELPE-----KMPKTLQELRVHENEITK-VR 137
Query: 370 EEI-SNLTNLRTIYLGGNKLNGSILI--TLSKLQKLQDLGLKDNKLEGSIPYDICNLAEL 426
+ + + L + + LG N L S + ++KL + + D + +IP + L
Sbjct: 138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSL 194
Query: 427 YRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNFLT 484
L LDGNK++ + A L +L + L N ++++ + N + L+ ++N L
Sbjct: 195 TELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253
Query: 485 GSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNS------ 538
+P + K ++ ++L N + +I ++
Sbjct: 254 -------------------------KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPG 287
Query: 539 -FGDLISLKFLNLSNNNL--SGVIPASLEKLSYLEDLNLSFN 577
S ++L +N + + P++ + + L
Sbjct: 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 22/266 (8%)
Query: 349 NLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408
+L + N I+ + NL NL T+ L NK++ + L KL+ L L
Sbjct: 49 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108
Query: 409 DNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPL-- 465
N+L+ +P + L L + N+++ + F+ L + +V LG+N L S +
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIEN 164
Query: 466 -TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYL 524
F +K + + + +T ++P G L + L N + V + GL NL L
Sbjct: 165 GAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKL 221
Query: 525 FLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584
L +N + S + L+ L+L+NN L +P L Y++ + L N +
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS---- 276
Query: 585 RGGSFGNFSAQSFEGNELLCGSPNLQ 610
+ F +
Sbjct: 277 ------AIGSNDFCPPGYNTKKASYS 296
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 69/349 (19%), Positives = 120/349 (34%), Gaps = 63/349 (18%)
Query: 145 SLQHLDLSSNALSGEIRANICREIPREFGNLPE-LELMSLAANNLQGKIPLKIGNLRNLE 203
L+ + S L ++P+ +LP L+ L N + NL+NL
Sbjct: 32 HLRVVQCSDLGLE---------KVPK---DLPPDTALLDLQNNKITEIKDGDFKNLKNLH 79
Query: 204 KLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSG 263
L + +NK+ I+P A + L+ L L N L
Sbjct: 80 TLILINNKISKISPGAFAPLVKLERLYLSKNQLK-------------------------- 113
Query: 264 TIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLS 323
+P + L L + N + + F L + + L N L SS E +
Sbjct: 114 ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171
Query: 324 NCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI-SNLTNLRTIY 382
L Y ++ + I L SL E + I+ + L NL +
Sbjct: 172 K---LSYIRIADTNITTIPQ-----GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLG 222
Query: 383 LGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA 442
L N ++ +L+ L++L L +NKL +P + + + + L N +S +I +
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS 280
Query: 443 -------CFSNLTSLRIVSLGSNELTSIPL---TFWNLKDILNLNFSSN 481
+ S VSL SN + + TF + + +
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 69/388 (17%), Positives = 133/388 (34%), Gaps = 96/388 (24%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
V+ S L L +P L L+L N++ I F
Sbjct: 34 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKI-TEIKDGDFKNLK------------- 76
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANNLQGKIP 193
+L L L +N +S +I F L +LE + L+ N L+ ++P
Sbjct: 77 ----------NLHTLILINNKIS---------KISPGAFAPLVKLERLYLSKNQLK-ELP 116
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSL-SGCLSSIGYARLPNLE 252
+ L++L + +N++ + ++ + ++ L N L S + + + + L
Sbjct: 117 --EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174
Query: 253 ILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS 312
+ + N + TIP+ + L+ L L+GN + + L NL+ L LS N +++
Sbjct: 175 YIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231
Query: 313 TQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI 372
SL+N L+ L+ N L + +P +
Sbjct: 232 DNG-----SLANTPHLRELHLNNNKLVK---------------------------VPGGL 259
Query: 373 SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLD 432
++ ++ +YL N ++ + N A + L
Sbjct: 260 ADHKYIQVVYLHNNNIS----------------AIGSNDFCPPGYNT--KKASYSGVSLF 301
Query: 433 GNKLSGSI--PACFSNLTSLRIVSLGSN 458
N + P+ F + V LG+
Sbjct: 302 SNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 58/325 (17%), Positives = 110/325 (33%), Gaps = 59/325 (18%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQL 132
+L++ + +T NL +L +L L N++ I F L+ + L NQL
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQL 112
Query: 133 S----GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANN 187
+LQ L + N ++ ++ + F L ++ ++ L N
Sbjct: 113 KELPEKMPK-------TLQELRVHENEIT---------KVRKSVFNGLNQMIVVELGTNP 156
Query: 188 LQ-GKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGY 245
L+ I ++ L + I D + I P + +L L L N ++ + +
Sbjct: 157 LKSSGIENGAFQGMKKLSYIRIADTNITTI-PQGLP--PSLTELHLDGNKIT-KVDAASL 212
Query: 246 ARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVL 304
L NL L L N+ S + N L L L N +P + + + + L
Sbjct: 213 KGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270
Query: 305 SDNYLTS-STQELSFLSSLSNCKFLKYFDLSYNPL-YRILPRTTVGNLSHSLEEFKMSNC 362
+N +++ + + + L NP+ Y + +T F
Sbjct: 271 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST----------F----- 315
Query: 363 NISGGIPEEISNLTNLRTIYLGGNK 387
+ + LG K
Sbjct: 316 ----------RCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 32/138 (23%), Positives = 52/138 (37%), Gaps = 30/138 (21%)
Query: 449 SLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFS 508
LR+V L +P LP + L DL N +
Sbjct: 32 HLRVVQCSDLGLEKVP--------------------KDLPPDTALL------DLQNNKIT 65
Query: 509 GVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSY 568
+ + LKNL L L N++ P +F L+ L+ L LS N L +P +
Sbjct: 66 EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKT 122
Query: 569 LEDLNLSFNQLEGKIPRG 586
L++L + N++ K+ +
Sbjct: 123 LQELRVHENEIT-KVRKS 139
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-37
Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 40/291 (13%)
Query: 689 LIGRGGFGSVYKASLGD---GMEVAVKVFTSQCGR--AFKS-FDVECEIMKSIRHRNLIK 742
+G GG +VY A D ++VA+K F+ E + H+N++
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+I ++ LV+EY+ +L +Y+ S+ L + +N + +++ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-LATIGYMAPEYGREGRV 861
++H D+KP N+L+D N + DF IAK L+ + S+ QT L T+ Y +PE +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLPISTMEVVDANLLSQ 917
D+YS GI+L E G+ P FNGE + +KH + D +P T +V + Q
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDVRKD--IPQ 242
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQR-INAKEIVTKLLKIRDSLLRN 967
+ N+ + T + R +E+ L + N
Sbjct: 243 S-------------LSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 70/296 (23%), Positives = 125/296 (42%), Gaps = 33/296 (11%)
Query: 690 IGRGGFGSVYKASL-----GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
+G+G FGSV G VAVK + F+ E EI+KS++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 745 SSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
C + + L++EY+P+GSL YL +D + L + +EYL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKML-TGEDQSMIQTQTLATIGYMAPEYGREGRV 861
IH DL N+L+++ + DF + K+L ++ ++ + I + APE E +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921
S DV+SFG++L E FT + + M + + + I
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHL----------IE 243
Query: 922 FVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGG 970
+ + C ++ + EC QR + +++ ++ D + N+ G
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV----DQIRDNMAG 295
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 70/290 (24%), Positives = 125/290 (43%), Gaps = 29/290 (10%)
Query: 690 IGRGGFGSVYKASL-----GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
+G+G FGSV G VAVK + F+ E EI+KS++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 745 SSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
C + + L++EY+P+GSL YL +D + L + +EYL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKML-TGEDQSMIQTQTLATIGYMAPEYGREGRV 861
IH DL N+L+++ + DF + K+L ++ ++ + I + APE E +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921
S DV+SFG++L E FT + + M + + + I
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIVFHL----------IE 274
Query: 922 FVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964
+ + C ++ + EC QR + +++ ++ +IRD +
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 66/296 (22%), Positives = 120/296 (40%), Gaps = 52/296 (17%)
Query: 688 NLIGRGGFGSVYKASL----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIK 742
+IGRG FG VY +L G + AVK F E IMK H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 743 VISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 798
++ C E L VL YM HG L ++ + + + + VA ++YL F
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IGYMAPEYG 856
+H DL N +LD+ ++DF +A+ + ++ + +T A + +MA E
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 857 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915
+ + + DV+SFG++L E T G P ++ ++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------------- 241
Query: 916 SQEDIHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964
++ + E C ++ + ++C + R + E+V+++ I +
Sbjct: 242 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 62/294 (21%), Positives = 121/294 (41%), Gaps = 37/294 (12%)
Query: 690 IGRGGFGSVYKASL-----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG V G +VAVK + G E EI++++ H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 744 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
C+ + L++E++P GSL++YL + +++ Q+L + + ++YL S
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKML-TGEDQSMIQTQTLATIGYMAPEYGREGR 860
+H DL NVL++ + DF + K + T ++ ++ + + + APE + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
DV+SFG+ L E T + + + M V
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP------THGQMTVTRL------- 252
Query: 920 IHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966
++ + + C V+ L +C P R + + ++ ++LL+
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF----EALLK 302
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 67/300 (22%), Positives = 125/300 (41%), Gaps = 52/300 (17%)
Query: 686 ENNLIGRGGFGSVYKASLGDG----MEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNL 740
+ +IG+G FG VY D ++ A+K + + ++F E +M+ + H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 741 IKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---H 796
+ +I E ++L YM HG L +++ S + ++ + VA +EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IGYMAPE 854
F +H DL N +LD++ ++DF +A+ + + +Q A + + A E
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 855 YGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913
+ R + DV+SFG++L E T G P I ++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--------------------- 237
Query: 914 LLSQEDIHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966
HF+A+ E C ++ + +C P R + +V ++ +I +LL
Sbjct: 238 ------THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-37
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 690 IGRGGFGSVYKASLGDGME-----VAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG+VYK E VA+K +A K E +M S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYS 800
+ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
+H DL NVL+ ++DF +AK+L E++ I +MA E
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 891
+ DV+S+G+ + E T G KP D I E
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 46/295 (15%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKV 743
+G G FGSV + +L G ++VAVK R + F E MK H N+I++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 744 ISSCSNEEFKA-----LVLEYMPHGSLEKYL-----YSSNCILDIFQRLNIMIDVASALE 793
+ C + ++L +M +G L YL + + + L M+D+A +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 794 YL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
YL +F +H DL N +L D+M ++DF ++K + D + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 851 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909
+A E + ++ DV++FG+ + E T G P + N EM + +
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-YDY------------L 262
Query: 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964
+ + L Q E C+ ++ + C P R + +L K+ +SL
Sbjct: 263 LHGHRLKQ-------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-36
Identities = 65/298 (21%), Positives = 121/298 (40%), Gaps = 52/298 (17%)
Query: 688 NLIGRGGFGSVYKASL----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIK 742
+IGRG FG VY +L G + AVK F E IMK H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 743 VISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 798
++ C E L VL YM HG L ++ + + + + VA +++L F
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IGYMAPEYG 856
+H DL N +LD+ ++DF +A+ + ++ + +T A + +MA E
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 857 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915
+ + + DV+SFG++L E T G P ++ ++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI----------------------- 305
Query: 916 SQEDIHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966
++ + E C ++ + ++C + R + E+V+++ I + +
Sbjct: 306 ----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 70/286 (24%), Positives = 117/286 (40%), Gaps = 50/286 (17%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G G FG V +VAVK+ S F E + M + H L+K C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVC 72
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAPVI 804
S E +V EY+ +G L YL S L+ Q L + DV + +L F I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------I 126
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSAN 864
H DL N L+D ++ +SDF + + + +DQ + T + + APE + S+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 865 GDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 923
DV++FGI++ E F+ GK P D N E + V
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTN---------------------------SEVVLKV 218
Query: 924 AK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962
++ ++ + C E P++R +++++ + +R+
Sbjct: 219 SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 62/289 (21%), Positives = 115/289 (39%), Gaps = 54/289 (18%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVF----TSQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
+G G FG V +VA+K+ S+ F E ++M ++ H L+++
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAP 802
C+ + ++ EYM +G L YL Q L + DV A+EYL F
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF----- 141
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS 862
+H DL N L++D V +SDF +++ + +D+ + + + PE + S
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 863 ANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921
+ D+++FG+++ E ++ GK P + N E
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTN---------------------------SETAE 232
Query: 922 FVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
+A+ V+ + C E +R K +++ +L + D
Sbjct: 233 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 17/213 (7%)
Query: 690 IGRGGFGSVYKASL-----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG+V+K + V +KV + G ++F++ + S+ H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYS 800
+ C + LV +Y+P GSL ++ L LN + +A + YL
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM--- 136
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
+H +L NVLL ++DF +A +L +D+ ++ ++ I +MA E G+
Sbjct: 137 ---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 892
+ DV+S+G+ + E T G +P + E+
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-36
Identities = 68/280 (24%), Positives = 116/280 (41%), Gaps = 36/280 (12%)
Query: 688 NLIGRGGFGSVYKASL-GDGMEVAVKV----FTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
+ +G G +G VY+ + VAVK + F E +MK I+H NL++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-----EEFLKEAAVMKEIKHPNLVQ 280
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSA 801
++ C+ E ++ E+M +G+L YL N + L + ++SA+EYL
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 337
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
IH +L N L+ +N + ++DF +++++T D I + APE +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 862 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920
S DV++FG++L E T G P I + E+++ +D
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------VYELLE------KDY 436
Query: 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
E C V+ L C P R + EI +
Sbjct: 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 72/296 (24%), Positives = 128/296 (43%), Gaps = 47/296 (15%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKV 743
+G+G FGSV +A L G ++VAVK+ + + F E MK H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 744 ISSCSNEEFKA------LVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASAL 792
+ K ++L +M HG L +L +S L + + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 793 EYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG 849
EYL +F IH DL N +L ++M ++DF +++ + D + +
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 850 YMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTME 908
++A E + + + DV++FG+ + E T G+ P I N E+ +
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNY------------ 251
Query: 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964
++ N L Q +C+ V++L +C PKQR + + +L I L
Sbjct: 252 LIGGNRLKQ-------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-36
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 8/206 (3%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G+G FG V+ + VA+K + ++F E ++MK +RH L+++ +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
S E +V EYM GSL +L L + Q +++ +AS + Y+ +H
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGD 866
DL+ +N+L+ +N+V ++DF +A+++ + + Q I + APE GR + D
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 363
Query: 867 VYSFGIMLMETFT-GKKPTDEIFNGE 891
V+SFGI+L E T G+ P + N E
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNRE 389
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 689 LIGRGGFGSVYKASLGD---GMEVAVKVFTSQCGR--AFKS-FDVECEIMKSIRHRNLIK 742
L+GRGG G VY+A D VA+K+ + F++ E ++ +++
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ + + + + L L L + + I+ + SAL+ H +A
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-LATIGYMAPEYGREGRV 861
H D+KP N+L+ + A+L DF IA T D+ + Q + T+ YMAPE E
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEIFNGE---MTLKH 896
+ D+Y+ +L E TG P + G+ + H
Sbjct: 213 TYRADIYALTCVLYECLTGSPP----YQGDQLSVMGAH 246
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 35/291 (12%)
Query: 690 IGRGGFGSVYKASL-----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG V G G VAVK + G + + E +I++++ H ++IK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 744 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
C + + LV+EY+P GSL YL + + + Q L + + YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKML-TGEDQSMIQTQTLATIGYMAPEYGREGR 860
IH DL NVLLD++ + + DF +AK + G + ++ + + + APE +E +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
DV+SFG+ L E T + + M V+
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG------IAQGQMTVLRL------- 260
Query: 920 IHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
+ + ++C + V++L C R + ++ L + +
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-36
Identities = 65/290 (22%), Positives = 110/290 (37%), Gaps = 32/290 (11%)
Query: 690 IGRGGFGSVYKASL-----GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
+G+G FGSV G VAVK + F E +I+K++ ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 745 SSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
++ LV+EY+P G L +L LD + L + +EYL S
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKML-TGEDQSMIQTQTLATIGYMAPEYGREGRV 861
+H DL N+L++ ++DF +AK+L +D +++ + I + APE +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 862 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920
S DV+SFG++L E FT K + M +
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKS-------------CSPSAEFLRMMGCERDVPALSRLL 254
Query: 921 HFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
+ + C + V L C P+ R + + +L +
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-36
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 8/206 (3%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G+G FG V+ + VA+K + ++F E ++MK +RH L+++ +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
S E +V EYM GSL +L L + Q +++ +AS + Y+ +H
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGD 866
DL+ +N+L+ +N+V ++DF +A+++ + + Q I + APE GR + D
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSD 446
Query: 867 VYSFGIMLMETFT-GKKPTDEIFNGE 891
V+SFGI+L E T G+ P + N E
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNRE 472
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 66/293 (22%), Positives = 121/293 (41%), Gaps = 40/293 (13%)
Query: 690 IGRGGFGSVYKASL---GDGMEVAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNLIKVIS 745
+G G FGSV + ++VA+KV +A E +IM + + ++++I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAP 802
C E LV+E G L K+L + + ++ V+ ++YL +F
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IGYMAPEYGREGR 860
+H DL NVLL + A +SDF ++K L G D S ++ + + APE +
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN-LLSQE 918
S+ DV+S+G+ + E + G+KP ++ E M ++ +
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQGKRMEC- 234
Query: 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGR 971
+C ++ L +C + + R + + ++ SL V G
Sbjct: 235 ------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 690 IGRGGFGSVYKASL-GDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
+G G +G VY+ + VAVK + F E +MK I+H NL++++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGV 77
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
C+ E ++ E+M +G+L YL N + L + ++SA+EYL IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
DL N L+ +N + ++DF +++++T D I + APE + S
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 866 DVYSFGIMLMETFT-GKKP 883
DV++FG++L E T G P
Sbjct: 194 DVWAFGVLLWEIATYGMSP 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 81/306 (26%), Positives = 129/306 (42%), Gaps = 65/306 (21%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG V+ A D M VAVK A K F E E++ +++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCILDIFQRLNIMIDV 788
C + + +V EYM HG L K+L + L + Q L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 789 ASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
AS + YL HF +H DL N L+ N++ + DF +++ + D + T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPI 904
I +M PE + + DV+SFG++L E FT GK+P W +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------------WFQL 239
Query: 905 STMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
S EV I + + C V+++ + C P+QR+N KEI L
Sbjct: 240 SNTEV----------IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289
Query: 958 LKIRDS 963
+ +
Sbjct: 290 HALGKA 295
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 76/480 (15%), Positives = 154/480 (32%), Gaps = 82/480 (17%)
Query: 77 LNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTF 136
++ + T L++L SL+ + + T
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSI--------------------------TD 56
Query: 137 PSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI 196
+ I + L L +SN ++ + L ++ +N L L +
Sbjct: 57 MTGIEKLTGLTKLICTSNNIT---------TLD--LSQNTNLTYLACDSNKLTN---LDV 102
Query: 197 GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSL 256
L L L+ NKL + + L L N+L+ I + L L
Sbjct: 103 TPLTKLTYLNCDTNKL---TKLDVSQNPLLTYLNCARNTLT----EIDVSHNTQLTELDC 155
Query: 257 WGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQEL 316
N + + ++L+ LD N + + L+ L N +T
Sbjct: 156 HLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITKL---- 206
Query: 317 SFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLT 376
L+ L + D S N L I V L+ L F S ++ + +S L+
Sbjct: 207 ----DLNQNIQLTFLDCSSNKLTEI----DVTPLT-QLTYFDCSVNPLTE-LD--VSTLS 254
Query: 377 NLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKL 436
L T++ L I L+ +L + + + D+ + +LY LD +
Sbjct: 255 KLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGI 309
Query: 437 SGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKV 496
+ + S L + L + ELT + ++ + + +L+ + + +G +
Sbjct: 310 T-ELD--LSQNPKLVYLYLNNTELTELDVS--HNTKLKSLSCVNAHIQ-DFS-SVGKIPA 362
Query: 497 LVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLS 556
L + +P E +L + + + L + + + N ++
Sbjct: 363 LNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 71/379 (18%), Positives = 123/379 (32%), Gaps = 67/379 (17%)
Query: 201 NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNN 260
N ++ I+ ++TL L ++S++ ++ I L L L NN
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGIEK--LTGLTKLICTSNN 75
Query: 261 FSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLS 320
+ T+ + + L+ L + N + L L++L N LT
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKL-------- 121
Query: 321 SLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRT 380
+S L Y + + N L I V + + L E +++ T L T
Sbjct: 122 DVSQNPLLTYLNCARNTLTEI----DVSHNT-QLTELDCHLNKKIT--KLDVTPQTQLTT 174
Query: 381 IYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSI 440
+ NK+ + +S+ + L L N + + D+ +L LD NKL+ I
Sbjct: 175 LDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLT-EI 227
Query: 441 PACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGI 500
+ LT L N LT + L + L+ L I
Sbjct: 228 D--VTPLTQLTYFDCSVNPLTELD--VSTLSKLTTLHCIQTDLLE--------------I 269
Query: 501 DLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP 560
DL+ N L Y R + L L+ ++ +
Sbjct: 270 DLTHNT-------------QLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL-- 312
Query: 561 ASLEKLSYLEDLNLSFNQL 579
L + L L L+ +L
Sbjct: 313 -DLSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 60/300 (20%), Positives = 108/300 (36%), Gaps = 39/300 (13%)
Query: 281 EGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYR 340
+ SF+ + P+ N + + S L D + +
Sbjct: 7 QTQSFNDWFPDD--NFASEVAAAFEMQATDTI--------SEEQLATLTSLDCHNSSITD 56
Query: 341 ILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQ 400
+ T + L+ L + ++ NI+ ++S TNL + NKL + ++ L
Sbjct: 57 M---TGIEKLT-GLTKLICTSNNITT---LDLSQNTNLTYLACDSNKLTN---LDVTPLT 106
Query: 401 KLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNEL 460
KL L NKL D+ L L+ N L+ I S+ T L + N+
Sbjct: 107 KLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK 160
Query: 461 TSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKN 520
+ + L+ S N +T L++ K+L ++ NN + + ++
Sbjct: 161 ITKL-DVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITKL---DLNQNIQ 213
Query: 521 LEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
L +L N+L I L L + + S N L+ + + LS L L+ L
Sbjct: 214 LTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 41/264 (15%), Positives = 90/264 (34%), Gaps = 34/264 (12%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
T L+ S +T + + L LN N + + L ++ N+L+
Sbjct: 173 TTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQNIQ--LTFLDCSSNKLT- 225
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
++ + L + D S N L+ E+ L +L + +L +
Sbjct: 226 EID--VTPLTQLTYFDCSVNPLT---------ELD--VSTLSKLTTLHCIQTDLLE---I 269
Query: 195 KIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEIL 254
+ + L + I + + + + L +L Q ++ + ++ P L L
Sbjct: 270 DLTHNTQLIYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGIT----ELDLSQNPKLVYL 323
Query: 255 SLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQ 314
L + + + + +KL L F ++ G + L+ ++ + +
Sbjct: 324 YLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPK 378
Query: 315 ELSFLSSLSNCKFLKYFDLSYNPL 338
E +SL+ D NP+
Sbjct: 379 ETLTNNSLTIAVSPDLLDQFGNPM 402
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G G FG V+ A+ +VAVK + ++F E +MK+++H L+K+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
+ E ++ E+M GSL +L S + + ++ +A + ++ IH
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGD 866
DL+ +N+L+ ++V ++DF +A+++ +++ + I + APE G + D
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 867 VYSFGIMLMETFT-GKKPTDEIFNGE 891
V+SFGI+LME T G+ P + N E
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPE 393
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 73/308 (23%), Positives = 135/308 (43%), Gaps = 52/308 (16%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVI 744
+G G FG V L + VA+K + + F E IM H N+I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSA 801
+ + +V EYM +GSL+ +L + + Q + ++ +AS ++YL +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ-TLATIGYMAPEYGREGR 860
+H DL N+L++ N+V +SDF + ++L + ++ T+ I + +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
++ DV+S+GI+L E + G++P E+ N Q+
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSN---------------------------QDV 259
Query: 920 IHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK-IRD-SLLRNVGG 970
I V + C + ++ L ++C + R ++IV+ L K IR+ L+ +
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITS 319
Query: 971 RCVRQSNL 978
R SNL
Sbjct: 320 AAARPSNL 327
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 61/296 (20%), Positives = 122/296 (41%), Gaps = 40/296 (13%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIK 742
+G+G FG VY+ VA+K R F E +MK ++++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLNIMIDVASALE 793
++ S + +++E M G L+ YL + + + + ++A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
YL+ + +H DL N ++ ++ + DF + + + D + L + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 854 EYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912
E ++G + DV+SFG++L E T ++P + N ++ L+ V++
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-LRF------------VMEG 256
Query: 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968
LL + + C +F L C PK R + EI++ + + + R V
Sbjct: 257 GLLDK-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 77/342 (22%), Positives = 134/342 (39%), Gaps = 57/342 (16%)
Query: 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
+L ++ +P+ I ++LDL+ N S + F L++L LVL +N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
+ ++ + S + L+ +S N L I P NL SL E ++ + I +P
Sbjct: 91 SKIHEK-----AFSPLRKLQKLYISKNHLVEIPP-----NLPSSLVELRIHDNRIRK-VP 139
Query: 370 EEI-SNLTNLRTIYLGGNKLNGSIL--ITLSKLQKLQDLGLKDNKLEGSIPYDICNLAEL 426
+ + S L N+ I +GGN L S L KL L + + KL IP D+ L
Sbjct: 140 KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDL--PETL 195
Query: 427 YRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNFLT 484
L LD NK+ +I + L + LG N++ I + L + L+ +N L+
Sbjct: 196 NELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
Query: 485 GSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDL-- 542
+P + LK L+ ++L N + N F +
Sbjct: 255 -------------------------RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF 289
Query: 543 ----ISLKFLNLSNNNLS--GVIPASLEKLSYLEDLNLSFNQ 578
++L NN + V PA+ ++ + +
Sbjct: 290 GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 64/310 (20%), Positives = 112/310 (36%), Gaps = 38/310 (12%)
Query: 249 PNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
P+ +L L N+ S + + F L L L N S F LR L L +S N
Sbjct: 54 PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNI-SG 366
+L L S+ L + N + ++ G ++ +M + +
Sbjct: 113 HLVEIPPNL-----PSS---LVELRIHDNRIRKVPKGVFSGL--RNMNCIEMGGNPLENS 162
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIP-YDICNLAE 425
G + L + + KL G I + L +L L NK++ +I D+ ++
Sbjct: 163 GFEPGAFDGLKLNYLRISEAKLTG---IPKDLPETLNELHLDHNKIQ-AIELEDLLRYSK 218
Query: 426 LYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTG 485
LYRL L N++ S L +LR + L +N+L+ +P +LK + + +N +T
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT- 277
Query: 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI--PNSFGDLI 543
+ N+F V + L N + P +F +
Sbjct: 278 ---------------KVGVNDFCPVGFGV--KRAYYNGISLFNNPVPYWEVQPATFRCVT 320
Query: 544 SLKFLNLSNN 553
+ N
Sbjct: 321 DRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 70/326 (21%), Positives = 119/326 (36%), Gaps = 40/326 (12%)
Query: 290 PNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCK-FLKYFDLSYNPLYRILPRTTVG 348
T + +L L + + + C L+ S L + P+
Sbjct: 7 AETTSGIPDLDSLPPTYSAMCPF-----------GCHCHLRVVQCSDLGLKAV-PK---- 50
Query: 349 NLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408
+S + N +IS ++ L +L + L NK++ S L+KLQ L +
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 409 DNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL--- 465
N L IP ++ + L L + N++ FS L ++ + +G N L +
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 466 TFWNLKDILNLNFSSNFLTGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYL 524
F LK + L S LT +P ++ +L L L N + ++ L L
Sbjct: 168 AFDGLK-LNYLRISEAKLT-GIPKDLPETLNEL---HLDHNKIQAIELEDLLRYSKLYRL 222
Query: 525 FLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584
LG+N+++ S L +L+ L+L NN LS +PA L L L+ + L N +
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT---- 277
Query: 585 RGGSFGNFSAQSFEGNELLCGSPNLQ 610
F
Sbjct: 278 ------KVGVNDFCPVGFGVKRAYYN 297
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 60/326 (18%), Positives = 101/326 (30%), Gaps = 56/326 (17%)
Query: 71 SQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTT-YTLKYVCLRG 129
S T+L++ + +++ L L +L L N++ I F+ L+ + +
Sbjct: 53 SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISK 111
Query: 130 NQLS----GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLA 184
N L SL L + N + ++P+ F L + + +
Sbjct: 112 NHLVEIPPNLPS-------SLVELRIHDNRIR---------KVPKGVFSGLRNMNCIEMG 155
Query: 185 ANNLQ-GKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSI 243
N L+ + L L I + KL GI P + TL L L N + +
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLTGI-PKDLP--ETLNELHLDHNKIQA-IELE 211
Query: 244 GYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLSWL 302
R L L L N I L L L+ N S +P +L+ L +
Sbjct: 212 DLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVV 269
Query: 303 VLSDNYLTS-STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSN 361
L N +T + + + L NP+
Sbjct: 270 YLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV---------------------PY 308
Query: 362 CNISGGIPEEISNLTNLRTIYLGGNK 387
+ P +T+ I G K
Sbjct: 309 WEVQ---PATFRCVTDRLAIQFGNYK 331
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 70/289 (24%), Positives = 128/289 (44%), Gaps = 51/289 (17%)
Query: 690 IGRGGFGSVYKASL-----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743
IG G FG VYK L + VA+K + + F E IM H N+I++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYS 800
S + ++ EYM +G+L+K+L + + Q + ++ +A+ ++YL ++
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ-TLATIGYMAPEYGREG 859
+H DL N+L++ N+V +SDF ++++L + ++ T I + APE
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 860 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918
+ ++ DV+SFGI++ E T G++P E+ N E
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSN---------------------------HE 258
Query: 919 DIHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ + C S ++ L M+C + +R +IV+ L K+
Sbjct: 259 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 72/295 (24%), Positives = 122/295 (41%), Gaps = 54/295 (18%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVI 744
IG G G V L + VA+K + R + F E IM H N+I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSA 801
+ +V EYM +GSL+ +L + + I Q + ++ V + + YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG-EDQSMIQTQTLATIGYMAPEYGREGR 860
+H DL NVL+D N+V +SDF ++++L D + T I + APE
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
S+ DV+SFG+++ E G++P + N ++
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTN---------------------------RDV 263
Query: 920 IHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRN 967
I V + C + L ++C + QR +IV+ L D+L+R+
Sbjct: 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-35
Identities = 43/212 (20%), Positives = 85/212 (40%), Gaps = 28/212 (13%)
Query: 689 LIGRGGFGSVYKA---SLGDGMEVAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNLIKVI 744
I GG G +Y A ++ +G V +K ++ E + + + H +++++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 745 -----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+ + +V+EY+ SL++ L + + + ++++ AL YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG 859
S +++ DLKP N++L + + L D + + T G+ APE R
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRIN--SFGYL----YGTPGFQAPEIVR-T 251
Query: 860 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
+ D+Y+ G L NG
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 690 IGRGGFGSVYKASLGDGME-----VAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG+VYK E VA+K +A K E +M S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYS 800
+ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
+H DL NVL+ ++DF +AK+L E++ I +MA E
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 891
+ DV+S+G+ + E T G KP D I E
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 64/287 (22%), Positives = 115/287 (40%), Gaps = 42/287 (14%)
Query: 690 IGRGGFGSVYKASL---GDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
+G G FG+V K VAVK+ + E +M+ + + ++++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSA 801
C E + LV+E G L KYL N + + ++ V+ ++YL +F
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF---- 138
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IGYMAPEYGREG 859
+H DL NVLL A +SDF ++K L D++ + QT + + APE
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 860 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL-LSQ 917
+ S+ DV+SFG+++ E F+ G+KP + E +++ +
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKGERMGC 241
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964
C +++L C + R + +L +
Sbjct: 242 -------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-35
Identities = 78/279 (27%), Positives = 120/279 (43%), Gaps = 34/279 (12%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
IG+G FG V G +VAVK + ++F E +M +RH NL++++
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 750 EEFKA-LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
E+ +V EYM GSL YL S +L L +DV A+EYL +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDV 867
L NVL+ ++ VA +SDF + K + S Q + + APE RE + S DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 868 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKE 926
+SFGI+L E ++ G+ P I + + V+ + A +
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKD--------------VVPRVE------KGYKMDAPD 409
Query: 927 QCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965
C V+++ C R ++ +L IR L
Sbjct: 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 689 LIGRGGFGSVYKASLGD---GMEVAVKVFTSQCGR--AFKS-FDVECEIMKSIRHRNLIK 742
++G GG V+ A D +VAVKV + R +F F E + ++ H ++
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 743 VISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 798
V + E +V+EY+ +L + + + + + ++ D AL + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT-LATIGYMAPEYGR 857
+IH D+KP+N+++ + DF IA+ + S+ QT + T Y++PE R
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLP 903
V A DVYS G +L E TG+ P F G+ + +H V +
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQH-VREDPI 237
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G G FG V+ +VAVK S AF + E +MK ++H+ L+++ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAVV 77
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
+ E ++ EYM +GSL +L + + L I + L++ +A + ++ IH
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGD 866
DL+ +N+L+ D + ++DF +A+++ +++ + I + APE G + D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 867 VYSFGIMLMETFT-GKKPTDEIFNGE 891
V+SFGI+L E T G+ P + N E
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 62/282 (21%), Positives = 110/282 (39%), Gaps = 39/282 (13%)
Query: 687 NNLIGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
+ IGRG F +VYK +EVA + F E E++K ++H N+++
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 744 ISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
S + LV E M G+L+ YL ++ I + + L++LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 800 SAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGED-QSMIQTQTLATIGYMAPEYGR 857
+ P+IH DLK N+ + + D +A + +++I T +MAPE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI-----GTPEFMAPEMYE 203
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917
E + DVY+FG+ ++E T + P E + V + ++ + +
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFD----KVAIP 257
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959
E + C + +R + K+ LL
Sbjct: 258 EVKEIIEG-------------CIRQNKDERYSIKD----LLN 282
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 59/293 (20%), Positives = 105/293 (35%), Gaps = 57/293 (19%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKV----FTSQCGRAFKSFDVECEIMKSIRHRNLI 741
IG G FG V++ + VA+K + F E M+ H +++
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ---EALTMRQFDHPHIV 79
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 798
K+I + +++E G L +L LD+ + +++AL YL F
Sbjct: 80 KLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF- 137
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
+H D+ NVL+ N L DF +++ + ++ I +MAPE
Sbjct: 138 -----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINF 191
Query: 859 GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917
R ++ DV+ FG+ + E G KP + N
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---------------------------N 224
Query: 918 EDIHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
+ I + C +++L +C P +R E+ +L I +
Sbjct: 225 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 66/294 (22%), Positives = 115/294 (39%), Gaps = 46/294 (15%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIK 742
+G G FG VY+ + ++VAVK C + F +E I+ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYL- 795
I + +++E M G L+ +L + L + L++ D+A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 796 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
HF IH D+ N LL VA + DF +A+ + + + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 851 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909
M PE EG ++ D +SFG++L E F+ G P N E+ L+ V
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-LEF------------V 258
Query: 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
+ + C V+ + +C P+ R N I+ ++
Sbjct: 259 TSGGRMDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 64/287 (22%), Positives = 112/287 (39%), Gaps = 51/287 (17%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVI 744
+G G FG VY+ G+ + VAVK C + F E IMK++ H +++K+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSA 801
E +++E P+G L YL + L + + + + A+ YL +
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
+H D+ N+L+ L DF +++ + ED + T I +M+PE R
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRF 191
Query: 862 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920
+ DV+ F + + E + GK+P + + +V I
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP-----------------FFWLENKDV----------I 224
Query: 921 HFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ K + C ++ L C P R E+V L +
Sbjct: 225 GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 48/286 (16%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
IG+G FG V G +VAVK + ++F E +M +RH NL++++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 748 SNEEFKA-LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
E+ +V EYM GSL YL S +L L +DV A+EYL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
DL NVL+ ++ VA +SDF + K + S Q + + APE RE + S
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 866 DVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVA 924
DV+SFGI+L E ++ G+ P I ++ + V
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPL---------------------------KDVVPRVE 228
Query: 925 K-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
K + C V+ + C R + ++ +L I+
Sbjct: 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-34
Identities = 65/303 (21%), Positives = 122/303 (40%), Gaps = 52/303 (17%)
Query: 690 IGRGGFGSVYKASL---GDGMEVAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNLIKVIS 745
+G G FGSV + ++VA+KV +A E +IM + + ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSAP 802
C E LV+E G L K+L + + ++ V+ ++YL +F
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT--IGYMAPEYGREGR 860
+H +L NVLL + A +SDF ++K L G D S ++ + + APE +
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 861 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
S+ DV+S+G+ + E + G+KP ++ E
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKG---------------------------PEV 548
Query: 920 IHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRC 972
+ F+ + +C ++ L +C + + R + + ++ SL V G
Sbjct: 549 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGS 608
Query: 973 VRQ 975
+
Sbjct: 609 ALE 611
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 73/298 (24%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG V+ A D M VAVK A + F E E++ ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSS--------------NCILDIFQRLNIMIDVA 789
C+ +V EYM HG L ++L S L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 790 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846
+ + YL HF +H DL N L+ +V + DF +++ + D + +T+
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 847 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 905
I +M PE + + DV+SFG++L E FT GK+P ++ N E +
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-IDC--------- 272
Query: 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
+ L + C V+ + C P+QR + K++ +L + +
Sbjct: 273 ---ITQGRELER-------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-34
Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 46/294 (15%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIK 742
+G G FG VY+ + ++VAVK C + F +E I+ H+N+++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQRLNIMIDVASALEYL- 795
I + ++LE M G L+ +L + L + L++ D+A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 796 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
HF IH D+ N LL VA + DF +A+ + + + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 851 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909
M PE EG ++ D +SFG++L E F+ G P N E+ L+ V
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-LEF------------V 299
Query: 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
+ + C V+ + +C P+ R N I+ ++
Sbjct: 300 TSGGRMDP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 58/281 (20%), Positives = 112/281 (39%), Gaps = 39/281 (13%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKV--FTSQCGRAFKSFDVECEIMKSIRHRNL--IKV 743
IG GG V++ A+K + S+ E + ++ + I++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
+++ +V+E + L +L +D ++R + ++ A+ +H +
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--------- 854
+H DLKP+N L+ D M+ L DF IA + + S+++ + T+ YM PE
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 855 --YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912
+ ++S DV+S G +L GK P +I N L ++ I
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-----FP 262
Query: 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
++ ++ + C + PKQRI+ E+
Sbjct: 263 DIPEKDLQDVLKC--C--LKRD---------PKQRISIPEL 290
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 48/210 (22%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMK-SIRHRNLIK 742
F +++G G G++ + D +VAVK +C F D E ++++ S H N+I+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ + +F+ + +E +L++Y+ + + + ++ S L +LH S
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 803 VIHCDLKPSNVLL-----DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEY- 855
++H DLKP N+L+ + A +SDF + K L S + + T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 856 --GREGRVSANGDVYSFGIMLMETFTGKKP 883
+ + D++S G + +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 58/281 (20%), Positives = 113/281 (40%), Gaps = 39/281 (13%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKV--FTSQCGRAFKSFDVECEIMKSIRHRNL--IKV 743
IG GG V++ A+K + S+ E + ++ + I++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
+++ +V+E + L +L +D ++R + ++ A+ +H +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 129
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--------- 854
+H DLKP+N L+ D M+ L DF IA + + S+++ + T+ YM PE
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 855 --YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912
+ ++S DV+S G +L GK P +I N L ++ I
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-----FP 243
Query: 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
++ ++ + + C + PKQRI+ E+
Sbjct: 244 DIPEKDLQDVL--KCC--LKRD---------PKQRISIPEL 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 57/281 (20%), Positives = 112/281 (39%), Gaps = 39/281 (13%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKV--FTSQCGRAFKSFDVECEIMKSIRHRNL--IKV 743
IG GG V++ A+K + S+ E + ++ + I++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
+++ +V+E + L +L +D ++R + ++ A+ +H +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 176
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--------- 854
+H DLKP+N L+ D M+ L DF IA + + S+++ + + YM PE
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 855 --YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912
+ ++S DV+S G +L GK P +I N L ++ I ++
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP-- 293
Query: 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
++ + + C + PKQRI+ E+
Sbjct: 294 ---EKDLQDVL--KCC--LKRD---------PKQRISIPEL 318
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 33/215 (15%)
Query: 690 IGRGGFGSVYKASL--------GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI 741
+G+G F ++K EV +KV +SF +M + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFG 798
C + LV E++ GSL+ YL + ++I +L + +A+A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134
Query: 799 YSAPVIHCDLKPSNVLLD--------DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
IH ++ N+LL + LSD I+ + +D I +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPW 183
Query: 851 MAPEYGREGRV-SANGDVYSFGIMLMETFT-GKKP 883
+ PE + + D +SFG L E + G KP
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-33
Identities = 60/290 (20%), Positives = 106/290 (36%), Gaps = 51/290 (17%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVI 744
IG G FG V++ M VA+K + + F E M+ H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGYSA 801
+ +++E G L +L LD+ + +++AL YL F
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
+H D+ NVL+ N L DF +++ + ++ I +MAPE R
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRF 569
Query: 862 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920
++ DV+ FG+ + E G KP + N + I
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKN---------------------------NDVI 602
Query: 921 HFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
+ C +++L +C P +R E+ +L I +
Sbjct: 603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 66/306 (21%), Positives = 127/306 (41%), Gaps = 66/306 (21%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIK 742
+G FG VYK L VA+K + G + F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCILDIFQRLNIMID 787
++ + ++ +++ Y HG L ++L + L+ ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 788 VASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
+A+ +EYL H +H DL NVL+ D + +SD + + + D + +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLP 903
L I +MAPE G+ S + D++S+G++L E F+ G +P +
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----------------YCG 233
Query: 904 ISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956
S +V + + + C ++V+ L +EC EFP +R K+I ++
Sbjct: 234 YSNQDV----------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
Query: 957 LLKIRD 962
L +
Sbjct: 284 LRAWGN 289
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 68/269 (25%), Positives = 112/269 (41%), Gaps = 23/269 (8%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQLS 133
T + +S LT ++P+ + SS L L N+L S+P +F T L + L N LS
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKL-QSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 134 --GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGK 191
G +SL++LDLS N + + F L +LE + +NL+
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI---------TMSSNFLGLEQLEHLDFQHSNLKQM 116
Query: 192 IPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPN 250
+ +LRNL LDI +S+L++L + NS + L N
Sbjct: 117 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176
Query: 251 LEILSLWGNNFSGTIPRFIFNA-SKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
L L L + FN+ S L +L++ N+F + L +L L S N++
Sbjct: 177 LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPL 338
+S ++ S+ L + +L+ N
Sbjct: 236 MTSKKQE-LQHFPSS---LAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 49/238 (20%), Positives = 88/238 (36%), Gaps = 32/238 (13%)
Query: 349 NLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILI--TLSKLQKLQDLG 406
+ S ++ + + LT L + L N L+ + L+ L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 407 LKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPAC--FSNLTSLRIVSLGSNELTSIP 464
L N + ++ + L +L LD + L + F +L +L + +
Sbjct: 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 142
Query: 465 L-TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEI-GGLKNLE 522
F L SL+VL ++ N+F +I L+NL
Sbjct: 143 NGIFNGLS---------------------SLEVL---KMAGNSFQENFLPDIFTELRNLT 178
Query: 523 YLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
+L L +L+ P +F L SL+ LN+S+NN + + L+ L+ L+ S N +
Sbjct: 179 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 58/312 (18%), Positives = 95/312 (30%), Gaps = 63/312 (20%)
Query: 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
+ + + ++P I S + L+LE N F L L+ L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKL------- 57
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
LS N L + + SL+ +S + +
Sbjct: 58 ----------------------SLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 94
Query: 370 EEISNLTNLRTIYLGGNKLNG-SILITLSKLQKLQDLGLKDNKLEGSIPYDIC-NLAELY 427
L L + + L S L+ L L + I L+ L
Sbjct: 95 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLE 153
Query: 428 RLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNFLTG 485
L + GN + F+ L +L + L +L + F +L
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS-------------- 199
Query: 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLI-S 544
SL+VL ++S NNF + L +L+ L N + S S
Sbjct: 200 -------SLQVL---NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249
Query: 545 LKFLNLSNNNLS 556
L FLNL+ N+ +
Sbjct: 250 LAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 35/192 (18%), Positives = 75/192 (39%), Gaps = 11/192 (5%)
Query: 73 RVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQ 131
+ L++S + T+ S L L+ L+ + L ++F + L Y+ +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 132 LSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGK 191
F + SSL+ L ++ N+ +I F L L + L+ L+ +
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI-------FTELRNLTFLDLSQCQLE-Q 189
Query: 192 IPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPN 250
+ +L +L+ L++ N + +++L++L N + +
Sbjct: 190 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249
Query: 251 LEILSLWGNNFS 262
L L+L N+F+
Sbjct: 250 LAFLNLTQNDFA 261
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 69/300 (23%), Positives = 123/300 (41%), Gaps = 55/300 (18%)
Query: 690 IGRGGFGSVYKASL--------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRN 739
+G G FG V A + + VAVK+ + E E+MK I +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNI 784
+I ++ +C+ + +++EY G+L +YL + + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 785 MIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841
+A +EYL IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900
T + +MAPE + + DV+SFG+++ E FT G P I E+ K
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKL---- 317
Query: 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ + + + + C + ++ + +C P QR K++V L +I
Sbjct: 318 --------LKEGHRMDK-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 71/308 (23%), Positives = 123/308 (39%), Gaps = 60/308 (19%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIK 742
IG G FG V++A VAVK+ + F E +M + N++K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSS-----------------------NCILDIF 779
++ C+ + L+ EYM +G L ++L S L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 780 QRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836
++L I VA+ + YL F +H DL N L+ +NMV ++DF +++ + D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 895
I +M PE R + DV+++G++L E F+ G +P + + E+ +
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-IY 287
Query: 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVT 955
+ V D N+L+ E C ++NL C + P R + I
Sbjct: 288 Y------------VRDGNILAC-------PENCPLELYNLMRLCWSKLPADRPSFCSIHR 328
Query: 956 KLLKIRDS 963
L ++ +
Sbjct: 329 ILQRMCER 336
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-32
Identities = 69/300 (23%), Positives = 123/300 (41%), Gaps = 55/300 (18%)
Query: 690 IGRGGFGSVYKASL--------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRN 739
+G G FG V A + + VAVK+ + E E+MK I +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNI 784
+I ++ +C+ + +++EY G+L +YL + + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 785 MIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841
+A +EYL IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 163 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900
T + +MAPE + + DV+SFG+++ E FT G P I E+ K
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKL---- 271
Query: 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ + + + + C + ++ + +C P QR K++V L +I
Sbjct: 272 --------LKEGHRMDK-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 62/305 (20%), Positives = 118/305 (38%), Gaps = 60/305 (19%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIK 742
+G G FG V KA+ VAVK+ + E ++K + H ++IK
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSS-----------------------NCILDIF 779
+ +CS + L++EY +GSL +L S L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 780 QRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836
++ ++ ++YL +H DL N+L+ + +SDF +++ + ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 895
+ ++Q + +MA E + + DV+SFG++L E T G P I +
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-FN 263
Query: 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVT 955
+ + + + + C ++ L ++C + P +R +I
Sbjct: 264 L------------LKTGHRMER-------PDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 956 KLLKI 960
L K+
Sbjct: 305 DLEKM 309
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 54/237 (22%), Positives = 87/237 (36%), Gaps = 14/237 (5%)
Query: 652 QRGKRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVA 710
QR + D G L+ + E + +GRG FG V++ G + A
Sbjct: 28 QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87
Query: 711 VKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY 770
VK + R E + ++ + + + + +E + GSL + +
Sbjct: 88 VKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK 142
Query: 771 SSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFSIA 829
C L + L + LEYLH + ++H D+K NVLL + A L DF A
Sbjct: 143 QMGC-LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 830 KMLTGEDQSMIQTQTLATIG---YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
L + G +MAPE A D++S M++ G P
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 60/297 (20%), Positives = 112/297 (37%), Gaps = 48/297 (16%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLI 741
+G G FG V +A+ M VAVK+ ++ E +++ + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYL-----------------YSSNCILDIFQRLNI 784
++ +C+ ++ EY +G L +L LD+ L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
VA + +L S IH DL N+LL + + DF +A+ + + +++
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLP 903
+ +MAPE + DV+S+GI L E F+ G P + K
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM------- 260
Query: 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ + + E + ++++ C P +R K+IV + K
Sbjct: 261 -----IKEGFRMLS-------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 56/301 (18%)
Query: 688 NLIGRGGFGSVYKASL------GDGMEVAVK----VFTSQCGRAFKSFDVECEIMKSI-R 736
+G G FG V +A+ ++VAVK + A S E +IM + +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQ 108
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-------------YSSNCILDIFQRLN 783
H N++ ++ +C++ ++ EY +G L +L +N L+
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 784 IMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840
VA + +L + IH D+ NVLL + VA + DF +A+ + + ++
Sbjct: 169 FSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVN 899
+ + +MAPE + + DV+S+GI+L E F+ G P I K
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL--- 279
Query: 900 DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959
V D ++Q ++++ C P R ++I + L +
Sbjct: 280 ---------VKDGYQMAQ-------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323
Query: 960 I 960
Sbjct: 324 Q 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-31
Identities = 71/300 (23%), Positives = 123/300 (41%), Gaps = 55/300 (18%)
Query: 690 IGRGGFGSVYKASL--------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRN 739
+G G FG V A +VAVK+ S + E E+MK I +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNI 784
+I ++ +C+ + +++EY G+L +YL + L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 785 MIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841
VA +EYL IH DL NVL+ ++ V ++DF +A+ + D
Sbjct: 197 AYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900
T + +MAPE + + DV+SFG++L E FT G P + E+ K
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKL---- 305
Query: 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ + + + + C + ++ + +C P QR K++V L +I
Sbjct: 306 --------LKEGHRMDK-------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 63/296 (21%), Positives = 113/296 (38%), Gaps = 47/296 (15%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLI 741
+GRG FG V +A VAVK+ ++ E +I+ I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 742 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSS---------------NCILDIFQRLNIM 785
++ +C+ +V +E+ G+L YL S L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
VA +E+L S IH DL N+LL + V + DF +A+ + + + +
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 846 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPI 904
+ +MAPE + + DV+SFG++L E F+ G P + E +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------- 263
Query: 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ + + + ++ ++C P QR E+V L +
Sbjct: 264 ----LKEGTRMRA-------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
++G+G +G VY L + + +A+K + R + E + K ++H+N+++ + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLHFGYSAPVIH 805
S F + +E +P GSL L S L ++ + L+YLH ++H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 806 CDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEYGREGRVSA 863
D+K NVL++ + V +SDF +K L G T+T T+ YMAPE +G
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 864 NG--DVYSFGIMLMETFTGKKP 883
D++S G ++E TGK P
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP 224
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-31
Identities = 60/291 (20%), Positives = 113/291 (38%), Gaps = 35/291 (12%)
Query: 294 GNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHS 353
N +LS N ++ + + S+ + + N +L +
Sbjct: 8 NNNFSLS-QNSFYNTISGTYADY--FSAWDKWEKQALPGENRNEAVSLLKECLINQF--- 61
Query: 354 LEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLE 413
E +++ N+S +P+ + + + + N L S+ + L+ L DN+L
Sbjct: 62 -SELQLNRLNLSS-LPDNL--PPQITVLEITQNAL-ISLPELPASLEYLD---ACDNRLS 113
Query: 414 GSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDI 473
++P +L L D+D N+L+ +P + L + + +N+LT +P +L+
Sbjct: 114 -TLPELPASLKHL---DVDNNQLT-MLPELPALLEYI---NADNNQLTMLPELPTSLEV- 164
Query: 474 LNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLE----YLFLGYN 529
L+ +N LT LP SL+ L D+S N +P + E + N
Sbjct: 165 --LSVRNNQLT-FLPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETEIFFRCREN 217
Query: 530 RLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
R+ IP + L + L +N LS I SL + + D +
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-29
Identities = 56/329 (17%), Positives = 106/329 (32%), Gaps = 40/329 (12%)
Query: 192 IPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL 251
I L I N +L + N + G + L + + +S + +
Sbjct: 3 IMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF 61
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
L L N S ++P + ++++L++ N+ +P +L L DN L++
Sbjct: 62 SELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLST 114
Query: 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
+ + L L D+ N L T + L LE N ++ +PE
Sbjct: 115 LPELPASLKHL---------DVDNNQL------TMLPELPALLEYINADNNQLT-MLPEL 158
Query: 372 ISNLTNLRTIYLGGNKLNGSILITL-SKLQKLQDLGLKDNKLEGSIPYDICNLAEL---- 426
++L L + N+L L + L+ L + N LE S+P
Sbjct: 159 PTSLEVL---SVRNNQLT-----FLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETE 209
Query: 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486
N+++ IP +L + L N L+S + +
Sbjct: 210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268
Query: 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEI 515
+ D F +++
Sbjct: 269 SDGQQN-TLHRPLADAVTAWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-26
Identities = 71/420 (16%), Positives = 124/420 (29%), Gaps = 45/420 (10%)
Query: 144 SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLE 203
+ LS N+ I + + + + L N + +
Sbjct: 6 PINNNFSLSQNSFYNTI-SGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFS 62
Query: 204 KLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSG 263
+L + L + P + + +L + N+L +LE L N S
Sbjct: 63 ELQLNRLNLSSL-PDNLP--PQITVLEITQNALISLPELPA-----SLEYLDACDNRLS- 113
Query: 264 TIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSL- 322
T+P + L LD++ N + +P L ++ +N LT + + L L
Sbjct: 114 TLPELPAS---LKHLDVDNNQLT-MLPELPALLEYIN---ADNNQLTMLPELPTSLEVLS 166
Query: 323 -SNCKF---------LKYFDLSYNPLYRILPRT--TVGNLSHSLEEFKMSNCNISGGIPE 370
N + L+ D+S N L LP + + F+ I+ IPE
Sbjct: 167 VRNNQLTFLPELPESLEALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRITH-IPE 224
Query: 371 EISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLD 430
I +L TI L N L+ I +LS+ D S N D
Sbjct: 225 NILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLAD 282
Query: 431 LDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLE 490
+ + S + +N ++ + N + + L
Sbjct: 283 AVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLE-- 340
Query: 491 IGSLKVLVGIDLSRNNFSGVIPTEIG-----GLKNLEYLFLGYNRLQGSIPNSFGDLISL 545
L + + NL L + +G N G L+SL
Sbjct: 341 --KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 43/247 (17%), Positives = 88/247 (35%), Gaps = 40/247 (16%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131
++ + + + L ++ L L+ L S+P + + + + N
Sbjct: 37 EKQALPGENRNEAVSLLKECL--INQFSELQLNRLNL-SSLPDNLPP--QITVLEITQNA 91
Query: 132 LSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGK 191
L + P ++ L++LD N LS +P +L L + N L
Sbjct: 92 LI-SLPELPAS---LEYLDACDNRLS---------TLPELPASLKHL---DVDNNQLT-M 134
Query: 192 IPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL 251
+P LE ++ +N+L + ++L++L +++N L+ +L
Sbjct: 135 LPELPA---LLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTFLPELPE-----SL 182
Query: 252 EILSLWGNNFSGTIPRFIFNASKLS----ILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
E L + N ++P N + IP +L ++L DN
Sbjct: 183 EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN 240
Query: 308 YLTSSTQ 314
L+S +
Sbjct: 241 PLSSRIR 247
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 3e-18
Identities = 48/260 (18%), Positives = 91/260 (35%), Gaps = 38/260 (14%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131
++TVL I+ L ++P +L + L+ NRL ++P +LK++ + NQ
Sbjct: 80 PQITVLEITQNALI-SLPELPASL---EYLDACDNRL-STLPELPA---SLKHLDVDNNQ 131
Query: 132 LSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGK 191
L+ P + L++++ +N L+ +P +L L + NN
Sbjct: 132 LT-MLPELPAL---LEYINADNNQLT---------MLPELPTSLEVLSV----RNNQLTF 174
Query: 192 IPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLK----ILGLQDNSLSGCLSSIGYAR 247
+P +LE LD+ N L + P + ++N ++ +I
Sbjct: 175 LP---ELPESLEALDVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRITHIPENIL--S 228
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLV---L 304
L + L N S I + + FS R L+ V
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWF 288
Query: 305 SDNYLTSSTQELSFLSSLSN 324
+N + +Q +
Sbjct: 289 PENKQSDVSQIWHAFEHEEH 308
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 36/255 (14%), Positives = 82/255 (32%), Gaps = 26/255 (10%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFT----TYTLKYVCL 127
+ VL++ + LT +P +L ++L++S N L S+P+ T +
Sbjct: 160 TSLEVLSVRNNQLT-FLPELPESL---EALDVSTNLL-ESLPAVPVRNHHSEETEIFFRC 214
Query: 128 RGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANN 187
R N+++ P I + + L N LS IR ++ ++ + + P +
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 188 LQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYAR 247
PL + D + ++++ + +
Sbjct: 274 NTLHRPLADAVTAWFPENKQSDVSQI------------WHAFEHEEHANTFSAFLDRLSD 321
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
+ S + + ++ S + L + + + + + L+W L
Sbjct: 322 TVSARNTSGFREQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKT 377
Query: 308 YLTSSTQELSFLSSL 322
L E F +
Sbjct: 378 LLVHQASEGLFDNDT 392
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 51/214 (23%), Positives = 81/214 (37%), Gaps = 18/214 (8%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKV--FTSQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
IG G +G K DG + K + S + E +++ ++H N+++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 746 SCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLH--FG 798
+ L V+EY G L + L +M + AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEYGR 857
V+H DLKP+NV LD L DF +A++L + +T T YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFVGTPYYMSPEQMN 189
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
+ D++S G +L E P F
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-31
Identities = 62/303 (20%), Positives = 118/303 (38%), Gaps = 26/303 (8%)
Query: 95 LSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSN 154
S L SIPS + +K + L N+++ S + +LQ L L+SN
Sbjct: 30 CDRNGICKGSSGSL-NSIPSGLTEA--VKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 155 ALSGEIRANICREIPRE-FGNLPELELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNKL 212
++ I + F +L LE + L+ N L + L +L L++ N
Sbjct: 87 GIN---------TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPY 136
Query: 213 VGIAPIAIF-NVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF- 270
+ ++F +++ L+IL + + + +A L LE L + ++ +
Sbjct: 137 KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLK 195
Query: 271 NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST-QELSFLS--SLSNCKF 327
+ +S L L + ++ L L D L + ELS SL
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255
Query: 328 LKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI-SNLTNLRTIYLGGN 386
+ ++ L++++ +S L E + S + +P+ I LT+L+ I+L N
Sbjct: 256 FRNVKITDESLFQVMKLLN--QIS-GLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
Query: 387 KLN 389
+
Sbjct: 312 PWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 60/335 (17%), Positives = 105/335 (31%), Gaps = 56/335 (16%)
Query: 247 RLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSD 306
I + + +IP + + LDL N + + NL LVL+
Sbjct: 29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTS 85
Query: 307 NYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISG 366
N + + +E SF SSL + L++ DLSYN L + F
Sbjct: 86 NGINT-IEEDSF-SSLGS---LEHLDLSYNYLSNLSSSW-----------F--------- 120
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSIL--ITLSKLQKLQDLGLKDNKLEGSIPYDI-CNL 423
L++L + L GN ++ S L KLQ L + + I L
Sbjct: 121 ------KPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173
Query: 424 AELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNF 482
L L++D + L P ++ ++ + L + + + + L
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233
Query: 483 LTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDL 542
L + S + + + L + +
Sbjct: 234 LDT----------------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQI 276
Query: 543 ISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577
L L S N L V ++L+ L+ + L N
Sbjct: 277 SGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 58/282 (20%), Positives = 102/282 (36%), Gaps = 37/282 (13%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQL 132
V L++S+ +T S L +LQ+L L+ N + +I F++ L+++ L N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 133 S----GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE--FGNLPELELMSLAAN 186
S F SSL L+L N + F +L +L+++ +
Sbjct: 113 SNLSSSWF----KPLSSLTFLNLLGNPYK---------TLGETSLFSHLTKLQILRVGNM 159
Query: 187 NLQGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGY 245
+ KI K L LE+L+I + L P ++ ++ + L L L I
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFV 218
Query: 246 ARLPNLEILSLWGNNFSGT----IPRFIFNA----SKLSILDLEGNSFSGFIPNTFGNLR 297
++E L L + + N+ + + S + +
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQIS 277
Query: 298 NLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLY 339
L L S N L S + L++ L+ L NP
Sbjct: 278 GLLELEFSRNQLKSVPDGI--FDRLTS---LQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 55/251 (21%), Positives = 108/251 (43%), Gaps = 17/251 (6%)
Query: 349 NLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408
L+ +++ +SN I+ ++ NL+ + L N +N + S L L+ L L
Sbjct: 49 GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108
Query: 409 DNKLEGSIPYDI-CNLAELYRLDLDGNKLSGSIP--ACFSNLTSLRIVSLGSNE-LTSIP 464
N L ++ L+ L L+L GN ++ + FS+LT L+I+ +G+ + T I
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 465 L-TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEY 523
F L + L ++ L P + S++ + + L ++ + ++E
Sbjct: 167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226
Query: 524 LFLGYNRLQG----SIP----NSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLS 575
L L L + NS + + + +++ +L + L ++S L +L S
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFS 285
Query: 576 FNQLEGKIPRG 586
NQL+ +P G
Sbjct: 286 RNQLKS-VPDG 295
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 22/236 (9%)
Query: 655 KRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVK- 712
+ A P + + F IGRG F VY+A L DG+ VA+K
Sbjct: 15 QFQPQKALRPDMGYNTL----------ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK 64
Query: 713 --VFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY 770
+F +A E +++K + H N+IK +S + +VLE G L + +
Sbjct: 65 VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 771 SSNCILDIF---QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFS 827
+ + + SALE++H S V+H D+KP+NV + V L D
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 181
Query: 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
+ + + + + + T YM+PE E + D++S G +L E + P
Sbjct: 182 LGRFFSSKT-TAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 44/200 (22%), Positives = 86/200 (43%), Gaps = 11/200 (5%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKV--FTSQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
IG G FG S DG + +K + + + E ++ +++H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 746 SCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
S +V++Y G L K + + Q L+ + + AL+++H ++
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEYGREGRVSA 863
H D+K N+ L + L DF IA++L + ++ + T Y++PE +
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 864 NGDVYSFGIMLMETFTGKKP 883
D+++ G +L E T K
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 27/228 (11%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G GGF V L DG A+K + + E ++ + H N++++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 748 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGYS 800
E L+L + G+L + + Q L +++ + LE +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDF---SIAKMLTGEDQSMIQTQTLA----TIGYMAP 853
H DLKP+N+LL D L D + A + + + Q A TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 854 E------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 895
E + + DV+S G +L G+ P D +F ++
Sbjct: 213 ELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 61/302 (20%), Positives = 111/302 (36%), Gaps = 53/302 (17%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLI 741
+G G FG V A+ G ++VAVK+ + ++ E ++M + H N++
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYL----------------------YSSNCILDIF 779
++ +C+ L+ EY +G L YL +L
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 780 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839
L VA +E+L +H DL NVL+ V + DF +A+ + + +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWV 898
++ + +MAPE EG + DV+S+GI+L E F+ G P I K
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL-- 287
Query: 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958
+ + + Q ++ + C ++R + + + L
Sbjct: 288 ----------IQNGFKMDQ-------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330
Query: 959 KI 960
Sbjct: 331 CQ 332
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 679 RATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH 737
R F E LIG GGFG V+KA DG +K +A + E + + + H
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63
Query: 738 RNLIKVISSCSNEEFKA----------------LVLEYMPHGSLEKYLYSSNCI-LDIFQ 780
N++ ++ + +E+ G+LE+++ LD
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 781 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840
L + + ++Y+H S +I+ DLKPSN+ L D + DF + L + +
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--- 177
Query: 841 QTQTLATIGYMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 889
+T++ T+ YM+PE YG+E D+Y+ G++L E E
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKE------VDLYALGLILAELLHVCDTAFETSK 226
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-30
Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 8/235 (3%)
Query: 349 NLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408
+S + + I +L +L + L N + + + L L L L
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120
Query: 409 DNKLEGSIPYDI-CNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGS-NELTSIPL 465
DN+L +IP L++L L L N + SIP+ F+ + SLR + LG L+ I
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISE 178
Query: 466 -TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYL 524
F L ++ LN + L +P + L L +DLS N+ S + P GL +L+ L
Sbjct: 179 GAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL 236
Query: 525 FLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
++ +++Q N+F +L SL +NL++NNL+ + L +LE ++L N
Sbjct: 237 WMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-30
Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 15/244 (6%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI-CNLAEL 426
+P+ IS TN R + L N++ + + L+ L+ L L N + +I LA L
Sbjct: 58 VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114
Query: 427 YRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSS-NFL 483
L+L N+L+ +IP F L+ L+ + L +N + SIP F + + L+ L
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 484 TGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDL 542
+ + L L ++L+ N IP + L L+ L L N L P SF L
Sbjct: 174 S-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGL 230
Query: 543 ISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG--GSFGNFSAQSFEGN 600
+ L+ L + + + + + + L L ++NL+ N L +P + N
Sbjct: 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
Query: 601 ELLC 604
C
Sbjct: 290 PWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 68/278 (24%), Positives = 114/278 (41%), Gaps = 38/278 (13%)
Query: 71 SQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRG 129
S + + + NL +P + ++ + LNL N++ I F L+ + L
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQI-QIIKVNSFKHLRHLEILQLSR 97
Query: 130 NQLS----GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLA 184
N + G F + ++L L+L N L+ IP F L +L+ + L
Sbjct: 98 NHIRTIEIGAF----NGLANLNTLELFDNRLT---------TIPNGAFVYLSKLKELWLR 144
Query: 185 ANNLQGKIPLKI-GNLRNLEKLDIGD-NKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSS 242
N ++ IP + +L +LD+G+ +L I+ A +S L+ L L +L
Sbjct: 145 NNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR----E 199
Query: 243 IGY-ARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLS 300
I L L+ L L GN+ S I F L L + + N F NL++L
Sbjct: 200 IPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258
Query: 301 WLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPL 338
+ L+ N LT +L + L + L+ L +NP
Sbjct: 259 EINLAHNNLTLLPHDL--FTPLHH---LERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 65/270 (24%), Positives = 98/270 (36%), Gaps = 26/270 (9%)
Query: 144 SSLQHLDLSSNALSGEIRANICREIPREFGNLP-ELELMSLAANNLQGKIPLKIGNLRNL 202
+ + L E+P + L++L N +Q +LR+L
Sbjct: 43 NQFSKVICVRKNLR---------EVPD---GISTNTRLLNLHENQIQIIKVNSFKHLRHL 90
Query: 203 EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS 262
E L + N + I A ++ L L L DN L+ + + + L L+ L L N
Sbjct: 91 EILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE 149
Query: 263 GTIPRFIFNA-SKLSILDL-EGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLS 320
+IP + FN L LDL E S F L NL +L L+ L +
Sbjct: 150 -SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-------IP 201
Query: 321 SLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRT 380
+L+ L DLS N L + + L L++ M I NL +L
Sbjct: 202 NLTPLIKLDELDLSGNHL-SAIRPGSFQGL-MHLQKLWMIQSQIQVIERNAFDNLQSLVE 259
Query: 381 IYLGGNKLNGSILITLSKLQKLQDLGLKDN 410
I L N L + L L+ + L N
Sbjct: 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 9e-15
Identities = 36/145 (24%), Positives = 53/145 (36%), Gaps = 7/145 (4%)
Query: 443 CFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDL 502
C + + V L +P + LN N + L+ L + L
Sbjct: 41 CSNQFSK---VICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95
Query: 503 SRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPAS 562
SRN+ + GL NL L L NRL +F L LK L L NN + + +
Sbjct: 96 SRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYA 155
Query: 563 LEKLSYLEDLNLS-FNQLEGKIPRG 586
++ L L+L +L I G
Sbjct: 156 FNRIPSLRRLDLGELKRLS-YISEG 179
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 688 NLIGRGGFGSVYKASL---GDGMEVAVKV----FTSQCGRAFKSFDVECEIMKSI-RHRN 739
++IG G FG V KA + G M+ A+K + R F E E++ + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLCKLGHHPN 87
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCILDIFQRLNI 784
+I ++ +C + + L +EY PHG+L +L S+ L Q L+
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 785 MIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841
DVA ++YL F IH DL N+L+ +N VA ++DF +++ G++ + +
Sbjct: 148 AADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 198
Query: 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 883
T + +MA E + N DV+S+G++L E + G P
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-30
Identities = 64/235 (27%), Positives = 105/235 (44%), Gaps = 8/235 (3%)
Query: 349 NLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408
+ + + NI + +L +L + LG N + + + L L L L
Sbjct: 72 GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131
Query: 409 DNKLEGSIPYDI-CNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGS-NELTSIPL 465
DN L IP L++L L L N + SIP+ F+ + SL + LG +L I
Sbjct: 132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISE 189
Query: 466 -TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYL 524
F L ++ LN + +P + L L +++S N+F + P GL +L+ L
Sbjct: 190 GAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247
Query: 525 FLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
++ +++ N+F L SL LNL++NNLS + L YL +L+L N
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-30
Identities = 63/244 (25%), Positives = 97/244 (39%), Gaps = 15/244 (6%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI-CNLAEL 426
+P+ I +N R + L N + T L L+ L L N + I LA L
Sbjct: 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125
Query: 427 YRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSS-NFL 483
L+L N L+ IP+ F L+ LR + L +N + SIP F + ++ L+ L
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL 184
Query: 484 TGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDL 542
+ L L ++L N + + L LE L + N P SF L
Sbjct: 185 E-YISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGL 241
Query: 543 ISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG--GSFGNFSAQSFEGN 600
SLK L + N+ +S + + + L+ L +LNL+ N L +P N
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
Query: 601 ELLC 604
C
Sbjct: 301 PWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 70/278 (25%), Positives = 112/278 (40%), Gaps = 38/278 (13%)
Query: 71 SQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRG 129
S + + + + L+ +P + S+ + LNL N + I + F L+ + L
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNI-QMIQADTFRHLHHLEVLQLGR 108
Query: 130 NQLS----GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLA 184
N + G F + +SL L+L N L+ IP F L +L + L
Sbjct: 109 NSIRQIEVGAF----NGLASLNTLELFDNWLT---------VIPSGAFEYLSKLRELWLR 155
Query: 185 ANNLQGKIPLKI-GNLRNLEKLDIGD-NKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSS 242
N ++ IP + +L +LD+G+ KL I+ A + LK L L ++
Sbjct: 156 NNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK----D 210
Query: 243 IGY-ARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLS 300
+ L LE L + GN+F I F S L L + + S N F L +L
Sbjct: 211 MPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV 269
Query: 301 WLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPL 338
L L+ N L+S +L + L L L +NP
Sbjct: 270 ELNLAHNNLSSLPHDL--FTPLRY---LVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 34/144 (23%), Positives = 51/144 (35%), Gaps = 30/144 (20%)
Query: 443 CFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDL 502
C + + V L+ +P +P L +L
Sbjct: 52 CSNQFSK---VVCTRRGLSEVP--------------------QGIPSNTRYL------NL 82
Query: 503 SRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPAS 562
NN + L +LE L LG N ++ +F L SL L L +N L+ + +
Sbjct: 83 MENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGA 142
Query: 563 LEKLSYLEDLNLSFNQLEGKIPRG 586
E LS L +L L N +E IP
Sbjct: 143 FEYLSKLRELWLRNNPIE-SIPSY 165
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 14/117 (11%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQLS 133
LN+ N+ +P+ L L L+ L +S N I F + LK + + +Q+S
Sbjct: 199 KYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVS 255
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANNLQ 189
+ +SL L+L+ N LS +P + F L L + L N
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLS---------SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 54/249 (21%), Positives = 90/249 (36%), Gaps = 22/249 (8%)
Query: 649 RYRQRGKRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGM 707
R S P R S+ + F + +G G +G V+K S DG
Sbjct: 29 RRVSFRGEASETLQSPGYDPSRPESFFQ-----QSFQRLSRLGHGSYGEVFKVRSKEDGR 83
Query: 708 EVAVKV--FTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 764
AVK + + E + + +H +++ + L E S
Sbjct: 84 LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPS 142
Query: 765 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 824
L+++ + L Q + D AL +LH S ++H D+KP+N+ L L
Sbjct: 143 LQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLG 199
Query: 825 DFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
DF + L + + YMAPE + +A DV+S G+ ++E +
Sbjct: 200 DFGLLVELG----TAGAGEVQEGDPRYMAPELLQGSYGTA-ADVFSLGLTILEVACNMEL 254
Query: 884 TDEIFNGEM 892
GE
Sbjct: 255 P---HGGEG 260
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFT-SQCGRAFKSFDVECEIMKSIRHRN 739
+ ++++G+G +V++ G A+KVF R E E++K + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 740 LIK---VISSCSNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEY 794
++K + + L++E+ P GSL L + L + L ++ DV + +
Sbjct: 69 IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 795 LHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
L ++H ++KP N++ D V L+DF A+ L ED + T Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEY 181
Query: 851 MAPE-YGREGRVSANG-------DVYSFGIMLMETFTGKKP 883
+ P+ Y R + D++S G+ TG P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-29
Identities = 60/307 (19%), Positives = 103/307 (33%), Gaps = 67/307 (21%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIM-KSIRHRNLIK 742
++G G G+V G VAVK +E +++ +S H N+I+
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------NIMIDVASALEYLH 796
S + + F + LE +L+ + S N + + +++ +AS + +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 797 FGYSAPVIHCDLKPSNVLLD-------------DNMVAHLSDFSIAKMLTGEDQSMIQTQ 843
S +IH DLKP N+L+ +N+ +SDF + K L S
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 844 TLA--TIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGKKP--------TDE 886
T G+ APE E D++S G + + K
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 887 IFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQ 946
I G +L L E + Q + + P +
Sbjct: 250 IIRGIFSLDEMKCLHDR----------SLIAEATDLI--SQM------IDHD-----PLK 286
Query: 947 RINAKEI 953
R A ++
Sbjct: 287 RPTAMKV 293
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 55/288 (19%), Positives = 113/288 (39%), Gaps = 26/288 (9%)
Query: 295 NLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSL 354
L N + + +T + ++ + + I V L++ L
Sbjct: 17 ALANAIKIAAGKSNVTD-------TVTQADLDGITTLSAFGTGVTTIEG---VQYLNN-L 65
Query: 355 EEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEG 414
++ + I+ + NLT + + L GN L + ++ LQ ++ L L ++
Sbjct: 66 IGLELKDNQITD--LAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD 121
Query: 415 SIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDIL 474
P + L+ L L LD N+++ +I + LT+L+ +S+G+ +++ + NL +
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLT-PLANLSKLT 176
Query: 475 NLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 534
L N ++ PL SL L+ + L N S V P + NL + L +
Sbjct: 177 TLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232
Query: 535 IPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGK 582
+L+ + + + + PA++ NL++N
Sbjct: 233 PVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 68/313 (21%), Positives = 123/313 (39%), Gaps = 51/313 (16%)
Query: 198 NLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLW 257
L N K+ G + + A ++ + L ++ + + Y L NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEGVQY--LNNLIGLELK 71
Query: 258 GNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELS 317
N I DL NL ++ L LS N L +
Sbjct: 72 DNQ----------------ITDLAP----------LKNLTKITELELSGNPLKN------ 99
Query: 318 FLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTN 377
+S+++ + +K DL+ + + P + LS +L+ + I+ ++ LTN
Sbjct: 100 -VSAIAGLQSIKTLDLTSTQITDVTP---LAGLS-NLQVLYLDLNQITN--ISPLAGLTN 152
Query: 378 LRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLS 437
L+ + +G ++ S L L+ L KL L DNK+ I + +L L + L N++S
Sbjct: 153 LQYLSIGNAQV--SDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQIS 208
Query: 438 GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVL 497
P +N ++L IV+L + +T+ P+ + N + N+ P I
Sbjct: 209 DVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV-VKGPSGAPIAPATISDNGTY 265
Query: 498 VGIDLSRNNFSGV 510
+L+ N S +
Sbjct: 266 ASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 54/298 (18%), Positives = 118/298 (39%), Gaps = 36/298 (12%)
Query: 92 LGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDL 151
L++ + + + ++ A + + G ++ + ++L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLD--GITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70
Query: 152 SSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNK 211
N ++ ++ NL ++ + L+ N L+ + L++++ LD+ +
Sbjct: 71 KDNQIT---------DLA-PLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQ 118
Query: 212 LVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFN 271
+ + P+A +S L++L L N ++ +S + L NL+ LS+ S P + N
Sbjct: 119 ITDVTPLA--GLSNLQVLYLDLNQITN-ISPLAG--LTNLQYLSIGNAQVSDLTP--LAN 171
Query: 272 ASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYF 331
SKL+ L + N S P +L NL + L +N ++ +S L+N L
Sbjct: 172 LSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD-------VSPLANTSNLFIV 222
Query: 332 DLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLN 389
L+ + V ++ + + + + P IS+ + L N +
Sbjct: 223 TLTNQTITNQ----PVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 52/283 (18%), Positives = 105/283 (37%), Gaps = 36/283 (12%)
Query: 130 NQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQ 189
++ FP ++ + + ++ + +L + +S +
Sbjct: 7 TAINVIFP--DPALANAIKIAAGKSNVTDTV----------TQADLDGITTLSAFGTGVT 54
Query: 190 GKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLP 249
I + L NL L++ DN++ +AP+ N++ + L L N L +S+I L
Sbjct: 55 -TIE-GVQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGNPLKN-VSAIAG--LQ 107
Query: 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
+++ L L + P + S L +L L+ N + P L NL +L + + +
Sbjct: 108 SIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV 163
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
+ L+ L+N L N + I P + +L +L E + N IS
Sbjct: 164 SD-------LTPLANLSKLTTLKADDNKISDISP---LASLP-NLIEVHLKNNQISD--V 210
Query: 370 EEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKL 412
++N +NL + L + + + L +
Sbjct: 211 SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 55/303 (18%), Positives = 117/303 (38%), Gaps = 41/303 (13%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
+ N+T T+ +L + +L+ + +I + L + L+ NQ++
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-TTI-EGVQYLNNLIGLELKDNQIT 76
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
+ + N + + L+LS N L + L ++ + L + + P
Sbjct: 77 D--LAPLKNLTKITELELSGNPLK---------NVS-AIAGLQSIKTLDLTSTQITDVTP 124
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
L L NL+ L + N++ I+P+A ++ L+ L + + +S L+ + A L L
Sbjct: 125 LA--GLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSD-LTPL--ANLSKLTT 177
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313
L N S P + + L + L+ N S P N NL + L++ +T+
Sbjct: 178 LKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233
Query: 314 QELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEIS 373
+ L ++ P + T+ + ++ N++ + I+
Sbjct: 234 VFYN--------NNLVVPNVVKGPSGAPIAPATISD------NGTYASPNLTWNLTSFIN 279
Query: 374 NLT 376
N++
Sbjct: 280 NVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 60/255 (23%), Positives = 108/255 (42%), Gaps = 26/255 (10%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131
+T L+ +T TI + L++L L L N++ + + + + + L GN
Sbjct: 41 DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNP 96
Query: 132 LSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGK 191
L I+ S++ LDL+S ++ ++ L L+++ L N +
Sbjct: 97 LKNVSA--IAGLQSIKTLDLTSTQIT---------DVT-PLAGLSNLQVLYLDLNQITNI 144
Query: 192 IPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL 251
PL L NL+ L IG+ ++ + P+A N+S L L DN +S +S + A LPNL
Sbjct: 145 SPLA--GLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADDNKISD-ISPL--ASLPNL 197
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
+ L N S P + N S L I+ L + + NL + +V +
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPN-VVKGPSGAPI 254
Query: 312 STQELSFLSSLSNCK 326
+ +S + ++
Sbjct: 255 APATISDNGTYASPN 269
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 60/244 (24%), Positives = 103/244 (42%), Gaps = 26/244 (10%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
L + +T P L NL+ + L LS N L SAI ++K + L Q++
Sbjct: 66 IGLELKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD 121
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
P ++ S+LQ L L N ++ I L L+ +S+ + PL
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQIT---------NIS-PLAGLTNLQYLSIGNAQVSDLTPL 169
Query: 195 KIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEIL 254
NL L L DNK+ I+P+A ++ L + L++N +S +S + NL I+
Sbjct: 170 A--NLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISD-VSPLAN--TSNLFIV 222
Query: 255 SLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQ 314
+L + +N + + ++G S + P T + + L+ N LTS
Sbjct: 223 TLTNQTITNQPV--FYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN-LTSFIN 279
Query: 315 ELSF 318
+S+
Sbjct: 280 NVSY 283
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 34/244 (13%), Positives = 70/244 (28%), Gaps = 49/244 (20%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIR-------- 736
++G+ + +A G V V A K E ++ +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 737 -----------------HRNLIKVISSCSNEEFKALVLEYM-PHGSLEKYL------YSS 772
+ +I+V + + Y +L+ + S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 773 NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832
+ L RL + + V L LH ++H L+P +++LD L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 833 TGEDQSMIQTQTLATIGYMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKPTDEI 887
G + A A ++ D ++ G+ + + P
Sbjct: 262 -GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316
Query: 888 FNGE 891
+
Sbjct: 317 NTDD 320
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-28
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQ-CGRAFKSFDVECEIMKSIRHRNLIKVI--- 744
+G GGFG V + G +VA+K + + + + +E +IMK + H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 745 ---SSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+ + L +EY G L KYL + + C L ++ D++SAL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138
Query: 800 SAPVIHCDLKPSNVLLD---DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYG 856
+IH DLKP N++L ++ + D AK L + + + T+ Y+APE
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPELL 195
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 896
+ + + D +SFG + E TG +P +
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 46/224 (20%), Positives = 93/224 (41%), Gaps = 29/224 (12%)
Query: 679 RATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVK-VFTSQCGRAFKSFDVECEIMKSIR 736
R F +GRGGFG V++A + D A+K + A + E + + +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 737 HRNLIKVISSCSNEEFKA------------LVLEYMPHGSLEKYL--YSSNCILDIFQRL 782
H +++ ++ + + ++ +L+ ++ + + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 783 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ----- 837
+I + +A A+E+LH S ++H DLKPSN+ + V + DF + + +++
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 838 --SMIQTQTLATIG---YMAPEYGREGRVSANGDVYSFGIMLME 876
+ +G YM+PE S D++S G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVF-TSQCGRAFKSFDVECEIMKSIRHRNLIK---V 743
++G+G +V++ G A+KVF R E E++K + H+N++K +
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ L++E+ P GSL L + L + L ++ DV + +L
Sbjct: 76 EEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 802 PVIHCDLKPSNVLL----DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-YG 856
++H ++KP N++ D V L+DF A+ L ED + T Y+ P+ Y
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYE 188
Query: 857 REGRVSANG-------DVYSFGIMLMETFTGKKP 883
R + D++S G+ TG P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 53/267 (19%), Positives = 95/267 (35%), Gaps = 52/267 (19%)
Query: 679 RATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH 737
R F E ++G+G FG V KA + D A+K + E ++ S+ H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNH 61
Query: 738 RNLIKVISSCSNEEFKA-------------LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 784
+ +++ ++ + +EY +G+L ++S N + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
+ AL Y+H S +IH DLKP N+ +D++ + DF +AK + +
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 845 LAT---------IG---YMAPE-------YGREGRVSANGDVYSFGIMLME----TFTGK 881
IG Y+A E Y + D+YS GI+ E TG
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIYPFSTGM 232
Query: 882 ---KPTDEIFNGEMTLKHWVNDWLPIS 905
++ + +
Sbjct: 233 ERVNILKKLRSVSIEFPPD--FDDNKM 257
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-28
Identities = 42/242 (17%), Positives = 80/242 (33%), Gaps = 36/242 (14%)
Query: 681 TDGFSENNLIGRGGFGSVYKASLGD------GMEVAVKVFTSQCGRAFKSFDVECEIMKS 734
+ ++L+G G F VY+A+ GD + +KV F E +K
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 735 IRHRNLIKVISSCSNEEFKALVLEYMPHGSL----EKYLYSSNCILDIFQRLNIMIDVAS 790
+K S+ + LV E +G+L Y + ++ ++ + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH-----------LSDFSIAKMLTGEDQSM 839
+E +H +IH D+KP N +L + + L D + + +
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 840 IQTQTLATIGYMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 893
I T T G+ E + + D + + G + GE
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQ------IDYFGVAATVYCMLFGTYMKVKNEGGECK 294
Query: 894 LK 895
+
Sbjct: 295 PE 296
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 61/234 (26%), Positives = 88/234 (37%), Gaps = 28/234 (11%)
Query: 349 NLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408
+ + + + IS NL ++L N L + L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 409 DNKLEGSIPYDI-CNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIP-L 465
DN S+ L L+ L LD L + F L +L+ + L N L ++P
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 466 TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLF 525
TF +L G+L L L N S V GL +L+ L
Sbjct: 148 TFRDL---------------------GNLTHL---FLHGNRISSVPERAFRGLHSLDRLL 183
Query: 526 LGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
L NR+ P++F DL L L L NNLS + +L L L+ L L+ N
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 62/235 (26%), Positives = 93/235 (39%), Gaps = 19/235 (8%)
Query: 106 NRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANIC 165
+ ++P I + + L GN++S + +L L L SN L+ I A
Sbjct: 20 QQGLQAVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAA- 75
Query: 166 REIPREFGNLPELELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVS 224
F L LE + L+ N + L L L + L + P ++
Sbjct: 76 ------FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129
Query: 225 TLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGN 283
L+ L LQDN+L L + L NL L L GN S ++P F L L L N
Sbjct: 130 ALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQN 187
Query: 284 SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPL 338
+ P+ F +L L L L N L++ E L+ + L+Y L+ NP
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA-----LAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 56/222 (25%), Positives = 77/222 (34%), Gaps = 31/222 (13%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI-CNLAEL 426
+P I + I+L GN+++ + + L L L N L I LA L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82
Query: 427 YRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNFLT 484
+LDL N S+ F L L + L L + F L + L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 485 GSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLIS 544
L + F L NL +LFL NR+ +F L S
Sbjct: 143 ----------------ALPDDTFRD--------LGNLTHLFLHGNRISSVPERAFRGLHS 178
Query: 545 LKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG 586
L L L N ++ V P + L L L L N L +P
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 51/224 (22%), Positives = 85/224 (37%), Gaps = 15/224 (6%)
Query: 166 REIPREFGNLP-ELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVS 224
+ +P +P + + L N + RNL L + N L I A ++
Sbjct: 24 QAVPV---GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80
Query: 225 TLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGN 283
L+ L L DN+ + + L L L L + +F + L L L+ N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139
Query: 284 SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILP 343
+ +TF +L NL+ L L N ++ S E +F L + L L N + +
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAF-RGLHS---LDRLLLHQNRV-AHVH 193
Query: 344 RTTVGNLSHSLEEFKMSNCNISGGIPEEI-SNLTNLRTIYLGGN 386
+L L + N+S +P E + L L+ + L N
Sbjct: 194 PHAFRDLG-RLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 49/217 (22%), Positives = 75/217 (34%), Gaps = 40/217 (18%)
Query: 73 RVTVLNISSLNLTGTIPSQ-LGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131
+T+L + S L I + L+ L+ L+LS N S+ A F
Sbjct: 57 NLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATF-------------- 101
Query: 132 LSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANNLQG 190
L L L L E+ F L L+ + L N LQ
Sbjct: 102 ---------HGLGRLHTLHLDRCGLQ---------ELGPGLFRGLAALQYLYLQDNALQ- 142
Query: 191 KIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLP 249
+P +L NL L + N++ + A + +L L L N ++ + + L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLG 201
Query: 250 NLEILSLWGNNFSGTIPRFIFNA-SKLSILDLEGNSF 285
L L L+ NN S +P L L L N +
Sbjct: 202 RLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 29/135 (21%), Positives = 48/135 (35%), Gaps = 4/135 (2%)
Query: 453 VSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIP 512
S L ++P+ + N ++ + + L + L N + +
Sbjct: 16 TSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 513 TEIGGLKNLEYLFLGYNRLQGSIP-NSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLED 571
GL LE L L N S+ +F L L L+L L + P L+ L+
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 572 LNLSFNQLEGKIPRG 586
L L N L+ +P
Sbjct: 134 LYLQDNALQ-ALPDD 147
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 25/232 (10%), Positives = 55/232 (23%), Gaps = 45/232 (19%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFT---SQCGRAFKSFDVECEIMKSIRHRNLI--- 741
+ G V+ + + A+KVFT + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 742 ------------------KVISSCSNEEFKA-----LVLEYM-----PHGSLEKYLYSSN 773
++ A L++ S ++Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 774 CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833
I + + L S ++H P N+ + + L D S +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV- 244
Query: 834 GEDQSMIQTQTLATIGYMAPEY--GREGRVSANGDVYSFGIMLMETFTGKKP 883
G + Y E+ + + + G+ + + P
Sbjct: 245 GTRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 58/244 (23%), Positives = 95/244 (38%), Gaps = 61/244 (25%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKVF----------TSQCGRAFKSFDVECEIMKSIR 736
+G+G FG+VY A +A+KV Q R E EI +R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR-------EVEIQSHLR 67
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVAS 790
H N++++ + L+LEY P G++ + L + + + ++A+
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELAN 120
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIG 849
AL Y H S VIH D+KP N+LL ++DF + + L T+
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLD 172
Query: 850 YMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTL 894
Y+ PE + + D++S G++ E GK P + I E T
Sbjct: 173 YLPPEMIEGRMHDEK------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 226
Query: 895 KHWV 898
+V
Sbjct: 227 PDFV 230
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 17/222 (7%)
Query: 669 RRMFSYLELCRATDG---FSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKS 724
R++ E F +G G +GSVYKA G VA+K + +
Sbjct: 13 RQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQE 70
Query: 725 FDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 784
E IM+ +++K S +V+EY GS+ + N L + I
Sbjct: 71 IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI 130
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
+ LEYLH IH D+K N+LL+ A L+DF +A LT +M + T
Sbjct: 131 LQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT---DTMAKRNT 184
Query: 845 LATIG---YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883
+ IG +MAPE +E + D++S GI +E GK P
Sbjct: 185 V--IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVF---TSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
L+G+G F VY+A S+ G+EVA+K+ + E +I ++H +++++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+ + + LVLE +G + +YL + + + M + + + YLH S ++
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE------YGR 857
H DL SN+LL NM ++DF +A L + TL T Y++PE +G
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGL 191
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVND 900
E DV+S G M G+ P D + + + +++
Sbjct: 192 E------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 9/200 (4%)
Query: 395 TLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVS 454
+SK+ ++ L ++P D+ + L L N L A T L ++
Sbjct: 5 EVSKVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 455 LGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTE 514
L ELT + L + L+ S N L SLPL +L L +D+S N + +
Sbjct: 62 LDRAELTKLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 515 IGGLKNLEYLFLGYNRLQGSIPNS-FGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLN 573
+ GL L+ L+L N L+ ++P L+ L+L+NNNL+ + L L L+ L
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 574 LSFNQLEGKIPRGGSFGNFS 593
L N L IP+ G FG+
Sbjct: 179 LQENSLYT-IPK-GFFGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 54/215 (25%), Positives = 84/215 (39%), Gaps = 18/215 (8%)
Query: 94 NLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSS 153
++S +N L ++P + + L N L + + + L L+L
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 154 NALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLV 213
L+ ++ G LP L + L+ N LQ +PL L L LD+ N+L
Sbjct: 65 AELT---------KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT 113
Query: 214 GIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNA- 272
+ A+ + L+ L L+ N L L P LE LSL NN + +P + N
Sbjct: 114 SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGL 171
Query: 273 SKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
L L L+ NS FG+ L + L N
Sbjct: 172 ENLDTLLLQENSLYTIPKGFFGSH-LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 53/192 (27%), Positives = 79/192 (41%), Gaps = 13/192 (6%)
Query: 364 ISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNL 423
+ +P + ++L N L L TL +L L L +L L
Sbjct: 25 LPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TL 76
Query: 424 AELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNF 482
L LDL N+L S+P L +L ++ + N LTS+PL L ++ L N
Sbjct: 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE 135
Query: 483 LTGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD 541
L +LP + L + L+ NN + + + GL+NL+ L L N L +IP F
Sbjct: 136 LK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193
Query: 542 LISLKFLNLSNN 553
L F L N
Sbjct: 194 SHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 53/240 (22%), Positives = 86/240 (35%), Gaps = 49/240 (20%)
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
+ + ++ N + +P + +IL L N F T L+ L L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
LT L +L L DLS+N L +
Sbjct: 66 ELTK----LQVDGTLPV---LGTLDLSHNQL------QS--------------------- 91
Query: 368 IPEEISNLTNLRTIYLGGNKL----NGSILITLSKLQKLQDLGLKDNKLEGSIPYDIC-N 422
+P L L + + N+L G L L +LQ+L LK N+L+ ++P +
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTSLPLG----ALRGLGELQELYLKGNELK-TLPPGLLTP 146
Query: 423 LAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSN 481
+L +L L N L+ +PA + L +L + L N L +IP F+ + N
Sbjct: 147 TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 53/212 (25%), Positives = 79/212 (37%), Gaps = 43/212 (20%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQLS 133
T+L++S L + L + L LNL L + + T L + L NQL
Sbjct: 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQ--VDGTLPVLGTLDLSHNQLQ 90
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANNLQGKI 192
+ P +L LD+S N L+ +P L EL+ + L N L+ +
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT---------SLPLGALRGLGELQELYLKGNELK-TL 139
Query: 193 PLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL 251
P + LEKL + +N L + P + N L NL
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTEL-PAGLLN------------------------GLENL 174
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGN 283
+ L L N+ TIP+ F + L L GN
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 44/216 (20%), Positives = 75/216 (34%), Gaps = 15/216 (6%)
Query: 171 EFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILG 230
E + ++ NL +P + ++ L + +N L + + + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 231 LQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIP 290
L L+ LP L L L N ++P L++LD+ N +
Sbjct: 62 LDRAELT---KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 291 NTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNL 350
L L L L N L + L L+ L+ L+ N L LP + L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGL--LTPTPK---LEKLSLANNNL-TELPAGLLNGL 171
Query: 351 SHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGN 386
+ L+ + ++ IP+ L +L GN
Sbjct: 172 EN-LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
++ IG+G G+VY A + G EVA++ Q + E +M+ ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ S + +V+EY+ GSL + + +D Q + + ALE+LH S
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG---YMAPEYGREG 859
VIH D+K N+LL + L+DF +T + T+ +G +MAPE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT---PEQSKRSTM--VGTPYWMAPEVVTRK 191
Query: 860 RVSANGDVYSFGIMLMETFTGKKP 883
D++S GIM +E G+ P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 676 ELCRATD---GFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEI 731
+ R D + +G G FG VYKA + G A KV ++ + + VE EI
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 732 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 791
+ + H ++K++ + ++ +++E+ P G+++ + + L Q + + A
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG-- 849
L +LH S +IH DLK NVL+ L+DF ++ +++ + + IG
Sbjct: 130 LNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKRDSF--IGTP 181
Query: 850 -YMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKP 883
+MAPE ++ D++S GI L+E + P
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 56/232 (24%), Positives = 90/232 (38%), Gaps = 31/232 (13%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISS 746
++ GGF VY+A +G G E A+K S ++ E MK + H N+++ S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 747 CS-------NEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHF 797
S + + L+L + G L ++L S L L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA----------T 847
P+IH DLK N+LL + L DF A ++ Q A T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 848 IGYMAPE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 895
Y PE Y + D+++ G +L + P F L+
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FEDGAKLR 260
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
IG G G V A G +VAVK+ + + + E IM+ +H N+++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ S E +++E++ G+L + S L+ Q + V AL YLH +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQG 161
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG---YMAPEYGREG 859
VIH D+K ++LL + LSDF ++ + + + ++L +G +MAPE
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS---KDVPKRKSL--VGTPYWMAPEVISRS 216
Query: 860 RVSANGDVYSFGIMLMETFTGKKP 883
+ D++S GIM++E G+ P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-25
Identities = 34/242 (14%), Positives = 75/242 (30%), Gaps = 56/242 (23%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTS----------------QCGRAFK-------- 723
++G+ + +A G V V R +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 724 ----SFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM-PHGSLEKYL------YSS 772
F +++K + + +I+V + + Y +L+ + S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 773 NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832
+ L RL + + V L LH ++H L+P +++LD L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 833 TGEDQSMIQTQTLATIGYMAPEY-----------GREGRVSANGDVYSFGIMLMETFTGK 881
+ + G+ PE R ++ + D ++ G+++ +
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 882 KP 883
P
Sbjct: 311 LP 312
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 9/204 (4%)
Query: 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRA-FKSFDVECEIMKSIRHRN 739
D F + + +G G G V+K S G+ +A K+ + A E +++
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
++ + ++ ++ +E+M GSL++ + + + I V L YL +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG 859
++H D+KPSN+L++ L DF ++ L SM + + T YM+PE +
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGT 205
Query: 860 RVSANGDVYSFGIMLMETFTGKKP 883
S D++S G+ L+E G+ P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 58/303 (19%), Positives = 101/303 (33%), Gaps = 60/303 (19%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKV-----------FTSQCGRAFKSFDV------ECEIM 732
+ +G F + D A+K FT E +I+
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 733 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-------YSSNCILDIFQRLNIM 785
I++ + +N + ++ EYM + S+ K+ + C + I I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL 845
V ++ Y+H + H D+KPSN+L+D N LSDF ++ + + +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGS 210
Query: 846 A-TIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDE----------IFNGEM 892
T +M PE A D++S GI L F P I +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270
Query: 893 TL--KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA 950
+ + N LS EDI F+ + P +RI +
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN-------------PAERITS 317
Query: 951 KEI 953
++
Sbjct: 318 EDA 320
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 47/235 (20%), Positives = 88/235 (37%), Gaps = 39/235 (16%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVF---TSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
+G+GGF ++ A K+ + +E I +S+ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+ +F +VLE SL + + + R + + +YLH VI
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI-G---YMAPE------ 854
H DLK N+ L++++ + DF +A + + + G Y+APE
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 855 YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVND 900
+ E DV+S G ++ GK P + I E ++ +N
Sbjct: 192 HSFE------VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 58/243 (23%), Positives = 98/243 (40%), Gaps = 61/243 (25%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKS----FDV------ECEIMKSIRH 737
+G+G FG+VY A + +A+KV FKS V E EI +RH
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVL-------FKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASA 791
N++++ + + + L+LE+ P G L K L R + M ++A A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADA 126
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGY 850
L Y H VIH D+KP N+L+ ++DF + + +T+ T+ Y
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDY 178
Query: 851 MAPE------YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLK 895
+ PE + + D++ G++ E G P D I N ++
Sbjct: 179 LPPEMIEGKTHDEK------VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP 232
Query: 896 HWV 898
++
Sbjct: 233 PFL 235
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 48/232 (20%), Positives = 90/232 (38%), Gaps = 33/232 (14%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVF---TSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
+G+GGF ++ A K+ + +E I +S+ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+ +F +VLE SL + + + R + + +YLH VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE------YGR 857
H DLK N+ L++++ + DF +A + + + + L T Y+APE +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSF 220
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVND 900
E DV+S G ++ GK P + I E ++ +N
Sbjct: 221 E------VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 266
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 49/213 (23%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKV-----FTSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
IG+G F V + G + AVK+ FTS G + + E I ++H +++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 744 ISSCSNEEFKALVLEYMPHGSL---------EKYLYS----SNCILDIFQRLNIMIDVAS 790
+ + S++ +V E+M L ++YS S+ + I
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
AL Y H +IH D+KP VLL +++ L F +A L + T
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196
Query: 848 IGYMAPE------YGREGRVSANGDVYSFGIML 874
+MAPE YG+ DV+ G++L
Sbjct: 197 PHFMAPEVVKREPYGKP------VDVWGCGVIL 223
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 71/283 (25%), Positives = 107/283 (37%), Gaps = 40/283 (14%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRA-FKSFDVECEI-MKSIRHRNLIKVISS 746
IGRG +GSV K G +AVK S K ++ ++ M+S +++ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGYS 800
E + +E M S +K+ + + I + AL +L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE----YG 856
+IH D+KPSN+LLD + L DF I+ L S+ +T+ YMAPE
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSA 201
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916
DV+S GI L E TG+ P + + L V P + + S
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP--QLSNSEEREFS 259
Query: 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959
I+FV C + +R KE LLK
Sbjct: 260 PSFINFVNL-------------CLTKDESKRPKYKE----LLK 285
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFT-SQCGRAFKSFDVECEIMKSIRHRNLI 741
F++ IG+G FG V+K VA+K+ + + E ++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
K S + +++EY+ GS L LD Q I+ ++ L+YLH S
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH---SE 138
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG---YMAPEYGRE 858
IH D+K +NVLL ++ L+DF +A LT + I+ T +G +MAPE ++
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTF--VGTPFWMAPEVIKQ 193
Query: 859 GRVSANGDVYSFGIMLMETFTGKKP 883
+ D++S GI +E G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 21/222 (9%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDIC-NLAEL 426
IP+ + + + + L N L + +LQ L L +++ +I +L+ L
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 427 YRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNFLT 484
L L GN + S+ FS L+SL+ + L S+ +LK + LN + N +
Sbjct: 79 STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 485 GSLPLE-----IGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEY----LFLGYNRLQGSI 535
S L + +L+ L DLS N + T++ L + L L N + I
Sbjct: 138 -SFKLPEYFSNLTNLEHL---DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 536 PNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577
I LK L L N L V ++L+ L+ + L N
Sbjct: 193 QPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 56/234 (23%), Positives = 85/234 (36%), Gaps = 26/234 (11%)
Query: 111 SIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPR 170
IP + + K + L N L + LQ LDLS + I
Sbjct: 21 KIPDNLPFS--TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA------ 71
Query: 171 EFGNLPELELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKIL 229
+ +L L + L N +Q + L L +L+KL + L + I ++ TLK L
Sbjct: 72 -YQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 230 GLQDNSLSGCLSSIGY-ARLPNLEILSLWGNNFSGTIPRFIF-NASKLSI----LDLEGN 283
+ N + Y + L NLE L L N +I ++ + LDL N
Sbjct: 130 NVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 284 SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNP 337
+ P F + L L L N L S + L++ L+ L NP
Sbjct: 188 PMNFIQPGAFKEI-RLKELALDTNQLKSVPDGI--FDRLTS---LQKIWLHTNP 235
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 45/239 (18%), Positives = 78/239 (32%), Gaps = 41/239 (17%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
L++S L + LQ L+LS + +I +
Sbjct: 31 KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAY----------------- 72
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
+ S L L L+ N + + F L L+ + NL +
Sbjct: 73 ------QSLSHLSTLILTGNPIQ-SLALGA-------FSGLSSLQKLVAVETNLA-SLEN 117
Query: 195 KI-GNLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSGCLSSIGYARLPNLE 252
G+L+ L++L++ N + F N++ L+ L L N + + L +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMP 176
Query: 253 I----LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
+ L L N + I F +L L L+ N F L +L + L N
Sbjct: 177 LLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 34/178 (19%), Positives = 57/178 (32%), Gaps = 52/178 (29%)
Query: 415 SIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDIL 474
IP ++ LDL N L F + L+++ L E+ +I
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE---------- 68
Query: 475 NLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 534
G + L +L L L N +Q S
Sbjct: 69 -----------------------DGA------YQS--------LSHLSTLILTGNPIQ-S 90
Query: 535 IP-NSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGN 591
+ +F L SL+ L NL+ + + L L++LN++ N ++ F N
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSN 147
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 40/207 (19%), Positives = 80/207 (38%), Gaps = 16/207 (7%)
Query: 690 IGRG--GFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
IG+G +V A G V V+ + E + K H N++
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
++ + +V +M +GS + + ++ I+ V AL+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKML--TGEDQSMIQTQTLATIG---YMAPEYGRE 858
+H +K S++L+ + +LS + G+ Q ++ ++ +++PE ++
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 859 GRVSANG--DVYSFGIMLMETFTGKKP 883
+ D+YS GI E G P
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 43/230 (18%), Positives = 90/230 (39%), Gaps = 32/230 (13%)
Query: 679 RATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKV--FTSQCGRAFKSFDVECEIMKSI 735
R T F E IG G FGSV+K DG A+K ++ E +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 736 -RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASA 791
+H ++++ S+ + ++ + EY GSL + + I+ F + ++++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ---------- 841
L Y+H S ++H D+KPSN+ + + + + + ++ M +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 842 TQTLATIG---YMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKP 883
+ G ++A E Y + D+++ + ++ +
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKA----DIFALALTVVCAAGAEPL 230
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 42/206 (20%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDV--ECEIMKSIRHRNLIKVISS 746
+G+G F V + + G E A + ++ A + E I + ++H N++++ S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 747 CSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF 797
S E L+ + + G L + YS S+CI I A+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLHCH- 127
Query: 798 GYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
V+H +LKP N+LL L+DF +A + GE Q+ T GY++PE
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPE 183
Query: 855 ------YGREGRVSANGDVYSFGIML 874
YG+ D+++ G++L
Sbjct: 184 VLRKDPYGKP------VDLWACGVIL 203
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 44/283 (15%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRA-FKSFDVECEI-MKSIRHRNLIKVISS 746
+GRG +G V K + G +AVK + K ++ +I M+++ + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGYS 800
E + +E M SL+K+ ++D Q + I + + ALE+LH S
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQ---VIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE----YG 856
VIH D+KPSNVL++ + DF I+ L + + YMAPE
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPEL 185
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916
+ S D++S GI ++E + P D LK V + P A+ S
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL-----PADKFS 240
Query: 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959
E + F ++ C + K+R E L++
Sbjct: 241 AEFVDFTSQ-------------CLKKNSKERPTYPE----LMQ 266
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 16/215 (7%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFT-SQCGRAFKSFDVECEIMKSIRHRN 739
D + +IG G V A +VA+K +C + E + M H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSL-------EKYLYSSNCILDIFQRLNIMIDVASAL 792
++ +S ++ LV++ + GS+ + +LD I+ +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG--- 849
EYLH IH D+K N+LL ++ ++DF ++ L +G
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 850 YMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKP 883
+MAPE + R D++SFGI +E TG P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 58/232 (25%)
Query: 679 RATDGFSEN----NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDV------ 727
+T GF EN ++GRG V + E AVK+ G +F + +V
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 728 ---ECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNC 774
E +I++ + H N+I++ + F LV + M G L EK S
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 775 ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834
+ + + LH ++H DLKP N+LLDD+M L+DF + L
Sbjct: 130 MRALL----------EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-D 175
Query: 835 EDQSMIQTQTLATIGYMAPE------------YGREGRVSANGDVYSFGIML 874
+ + + T Y+APE YG+E D++S G+++
Sbjct: 176 PGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 54/242 (22%), Positives = 98/242 (40%), Gaps = 43/242 (17%)
Query: 654 GKRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVK 712
G ++ G + F + +D + +G+G F V + G+E A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 713 VF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL----- 765
+ R F+ + E I + ++H N++++ S E F LV + + G L
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 766 EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDN 818
+ YS S+CI I ++ Y H S ++H +LKP N+LL
Sbjct: 121 AREFYSEADASHCIQQIL----------ESIAYCH---SNGIVHRNLKPENLLLASKAKG 167
Query: 819 MVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE------YGREGRVSANGDVYSFGI 872
L+DF +A + + ++ T GY++PE Y + D+++ G+
Sbjct: 168 AAVKLADFGLAIEV-NDSEAW--HGFAGTPGYLSPEVLKKDPYSKP------VDIWACGV 218
Query: 873 ML 874
+L
Sbjct: 219 IL 220
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 61/334 (18%), Positives = 103/334 (30%), Gaps = 51/334 (15%)
Query: 260 NFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFL 319
NFS P + + L D+E +G R+L +L+ + Q +
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVE----------LYGGGRSLEYLLKRVDTEADLGQFTDII 65
Query: 320 SSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHS-LEEFKMSNCNISGGIPEEISNLT-- 376
SLS LK + + + + L S L+E + N ++G P + T
Sbjct: 66 KSLS----LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGP 121
Query: 377 NLRTIYLGGNKLNGSILITLS----KLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLD 432
+L + L L+ L + + L LDL
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 433 GNKLSGSIP----ACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLP 488
N G C +L++++L + + + L
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV------------- 228
Query: 489 LEIGSLKVLVGIDLSRNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPNSFGDLISLKF 547
L+ L DLS N+ L L L + L+ +P L
Sbjct: 229 ----QLQGL---DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSV 278
Query: 548 LNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEG 581
L+LS N L S ++L + +L+L N
Sbjct: 279 LDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 50/274 (18%), Positives = 90/274 (32%), Gaps = 20/274 (7%)
Query: 49 LAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRL 108
L K +T + +T + + +R+TV + ++ +S LQ L L +
Sbjct: 48 LLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEV 107
Query: 109 FGSIPSAIF--TTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICR 166
G+ P + T L + LR + ++++ L +++
Sbjct: 108 TGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQ----AHSL 162
Query: 167 EIP-REFGNLPELELMSLAANNLQGKIPLKI----GNLRNLEKLDIGDNK---LVGIAPI 218
+ P L + L+ N G+ L L+ L + + G+
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222
Query: 219 AIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSIL 278
L+ L L NSL + L L+L +P+ + +KLS+L
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVL 279
Query: 279 DLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS 312
DL N L + L L N S
Sbjct: 280 DLSYNRLDRNPS--PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-19
Identities = 59/340 (17%), Positives = 111/340 (32%), Gaps = 47/340 (13%)
Query: 81 SLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSF- 139
S N + P S+ L + L+G S L+Y+ R + +
Sbjct: 14 SCNFSDPKPDWS---SAFNCLGAADVELYGGGRS-------LEYLLKRVDTEADLGQFTD 63
Query: 140 ISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNL 199
I SL+ L + + + I R + L+ ++L + G P +
Sbjct: 64 IIKSLSLKRLTVRAARIPSRILFGALR-----VLGISGLQELTLENLEVTGTAPPPLLEA 118
Query: 200 RNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGN 259
+++ L + + + L+ + P L++LS+
Sbjct: 119 TGP-------------------DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159
Query: 260 NFSGTIPRFIFNASKLSILDLEGNSFSGFIPNT----FGNLRNLSWLVLSDNYLTSSTQE 315
+ + LS LDL N G L L L + + + +
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 316 LSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNL 375
S L + L+ DLS+N L + S L +S + +P+ +
Sbjct: 220 CSAL--AAARVQLQGLDLSHNSLRDAAGAPSCDWPS-QLNSLNLSFTGLK-QVPKGLP-- 273
Query: 376 TNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGS 415
L + L N+L+ + +L ++ +L LK N S
Sbjct: 274 AKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 57/318 (17%), Positives = 95/318 (29%), Gaps = 60/318 (18%)
Query: 176 PELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNS 235
L+ + A+ Q +K +L+ L + + + +S L+ L L++
Sbjct: 47 YLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE 106
Query: 236 LSG-CLSSIGYARLPNLEILSLWGNNFSGTIPR----FIFNASKLSILDLEGNSFSGFIP 290
++G + A P+L IL+L +++ + L +L + F
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSC 166
Query: 291 NTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNL 350
LS L LSDN L
Sbjct: 167 EQVRVFPALSTLDLSDNPELGER-----------------------------------GL 191
Query: 351 SHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDN 410
+L P + L L G +G + +LQ L L N
Sbjct: 192 ISAL-------------CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238
Query: 411 KLEGSIPYDIC-NLAELYRLDLDGNKLSGSIPAC-FSNLTSLRIVSLGSNELTSIPLTFW 468
L + C ++L L+L L +P + L+ L L N L P
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVL---DLSYNRLDRNPS-PD 293
Query: 469 NLKDILNLNFSSNFLTGS 486
L + NL+ N S
Sbjct: 294 ELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 45/243 (18%), Positives = 71/243 (29%), Gaps = 26/243 (10%)
Query: 362 CNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDIC 421
CN S P+ S L + S+ L ++ D + + DI
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRV---------DTEADLGQFTDII 65
Query: 422 NLAELYRLDLDGNKLSGSIPAC------FSNLTSLRIVSLGSNELTSIPLTFWNLKDILN 475
L RL + ++ I S L L + +L PL D+
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 476 LNFSSNFLTGSLP----LEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRL 531
LN + L+ L + +++ + ++ L L L N
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 532 QGSIPNS----FGDLISLKFLNLSNNN---LSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584
G +L+ L L N SGV A L+ L+LS N L
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 585 RGG 587
Sbjct: 246 APS 248
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 46/215 (21%), Positives = 87/215 (40%), Gaps = 15/215 (6%)
Query: 370 EEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRL 429
L + +T ++L + + ++ ++ S+ I L + +L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 70
Query: 430 DLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPL 489
L+GNKL+ I +NL +L + L N++ + + +LK + +L+ N ++ L
Sbjct: 71 FLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDLS-SLKDLKKLKSLSLEHNGISDINGL 127
Query: 490 EIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLN 549
L L + L N + + + L L+ L L N++ I L L+ L
Sbjct: 128 V--HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 181
Query: 550 LSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584
LS N++S + L L L+ L L + K
Sbjct: 182 LSKNHISDLRA--LAGLKNLDVLELFSQECLNKPI 214
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 61/368 (16%), Positives = 121/368 (32%), Gaps = 63/368 (17%)
Query: 127 LRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAAN 186
+ FP + +L +++ + L ++ + +
Sbjct: 6 TVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAV----------TQNELNSIDQIIANNS 53
Query: 187 NLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYA 246
+++ + I L N+ KL + NKL I P+ N+ L L L +N + LSS+
Sbjct: 54 DIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIK-DLSSL--K 106
Query: 247 RLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSD 306
L L+ LSL N S I + + +L L L N + L L L L D
Sbjct: 107 DLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 162
Query: 307 NYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISG 366
N ++ + L+ L+ LS N + +
Sbjct: 163 NQISD-------IVPLAGLTKLQNLYLSKNHISDL------------------------- 190
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAEL 426
++ L NL + L + + S L + D L P I + +
Sbjct: 191 ---RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDY 245
Query: 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486
+ ++ + + + + V++G + LK++ +++ +
Sbjct: 246 EKPNVKWHLPEFTNE---VSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIK 302
Query: 487 LPLEIGSL 494
+E G+
Sbjct: 303 TKVEAGTR 310
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 49/252 (19%), Positives = 92/252 (36%), Gaps = 19/252 (7%)
Query: 328 LKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNK 387
+ P+ +I P + + + +++ + + L ++ I +
Sbjct: 1 MGETITVSTPIKQIFP---DDAFAE-TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 54
Query: 388 LNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNL 447
+ + + L + L L NKL I + NL L L LD NK+ + + +L
Sbjct: 55 I--KSVQGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DLSS-LKDL 108
Query: 448 TSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNF 507
L+ +SL N ++ I +L + +L +N +T L L L + L N
Sbjct: 109 KKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQI 165
Query: 508 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLS 567
S + + GL L+ L+L N + S + L +L L L + L
Sbjct: 166 SDI--VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221
Query: 568 YLEDLNLSFNQL 579
+ + L
Sbjct: 222 VPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.8 bits (248), Expect = 1e-21
Identities = 57/349 (16%), Positives = 121/349 (34%), Gaps = 31/349 (8%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
N+ ++T + L+S+ + + + + S+ I + + L GN+L+
Sbjct: 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSV-QGIQYLPNVTKLFLNGNKLT 78
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
P ++N +L L L N + ++ +L +L+ +SL N + I
Sbjct: 79 DIKP--LTNLKNLGWLFLDENKIK-----DLS-----SLKDLKKLKSLSLEHNGIS-DIN 125
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
+ +L LE L +G+NK+ I ++ ++ L L L+DN +S + + A L L+
Sbjct: 126 -GLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISD-IVPL--AGLTKLQN 179
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313
L L N+ S + L +L+L N NL + + +D L +
Sbjct: 180 LYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP- 236
Query: 314 QELSFLSSLSNCKFLKYFD-----LSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGI 368
+ +S + +S+ + + + +S +
Sbjct: 237 EIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDV 296
Query: 369 PEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIP 417
+ + K ++ G + N +
Sbjct: 297 DGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMS 345
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 98.3 bits (244), Expect = 3e-21
Identities = 43/203 (21%), Positives = 81/203 (39%), Gaps = 15/203 (7%)
Query: 378 LRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLS 437
+ + + + LK + ++ L + ++ + + +
Sbjct: 1 MGETITVSTPIK--QIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 438 GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVL 497
S+ L ++ + L N+LT I NLK++ L N + L+ LK L
Sbjct: 57 -SVQ-GIQYLPNVTKLFLNGNKLTDIK-PLTNLKNLGWLFLDENKIKDLSSLK--DLKKL 111
Query: 498 VGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSG 557
+ L N S + + L LE L+LG N++ + L L L+L +N +S
Sbjct: 112 KSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD 167
Query: 558 VIPASLEKLSYLEDLNLSFNQLE 580
++P L L+ L++L LS N +
Sbjct: 168 IVP--LAGLTKLQNLYLSKNHIS 188
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 30/204 (14%), Positives = 55/204 (26%), Gaps = 43/204 (21%)
Query: 689 LIGRGGFGSVYKA---SLGDGMEVAVKVFTSQCGRA--FKS-FDVECEIMKSIRHRNLIK 742
G ++A +L +VA+ Q + I + +
Sbjct: 38 FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
V+ +V E++ GSL++ +S + M +A+A + H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS 862
V PS V + + L+ M +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPD-------AN 180
Query: 863 ANGDVYSFGIMLMETFTGKKPTDE 886
D+ G L + P E
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPE 204
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 8e-23
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 21/235 (8%)
Query: 663 GPLVASRRMFSYLELCRATDGFSENNL-----IGRGGFGSVYKAS-LGDGMEVAVKVFTS 716
G +S + YL + N+L +G G G V+K G +AVK
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 717 QCGRA-FKSFDVECEI-MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC 774
+ K ++ ++ +KS +++ + + +E M + +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 775 IL-DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833
I I + + + + AL YL + VIH D+KPSN+LLD+ L DF I+ L
Sbjct: 121 IPERILGK--MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
Query: 834 GEDQSMIQTQTLATIGYMAPE-----YGREGRVSANGDVYSFGIMLMETFTGKKP 883
+ ++ YMAPE + DV+S GI L+E TG+ P
Sbjct: 177 ---DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 42/205 (20%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
++G G F V+ G A+K S + E ++K I+H N++ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 748 SNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFG 798
+ LV++ + G L E+ +Y+ S I + SA++YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----------SAVKYLH-- 123
Query: 799 YSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE- 854
++H DLKP N+L ++N ++DF ++KM ++ M + T GY+APE
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIM--STACGTPGYVAPEV 178
Query: 855 -----YGREGRVSANGDVYSFGIML 874
Y + D +S G++
Sbjct: 179 LAQKPYSKA------VDCWSIGVIT 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 67/175 (38%), Positives = 92/175 (52%), Gaps = 8/175 (4%)
Query: 415 SIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDI 473
+IP +I A+ +LDL NKLS F LT LR++ L N+L ++P F LK++
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 474 LNLNFSSNFLTGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 532
L + N L +LP+ + L L + L RN + P L L YL LGYN LQ
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 533 GSIP-NSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG 586
S+P F L SLK L L NN L V + +KL+ L+ L L NQL+ ++P G
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 65/214 (30%), Positives = 93/214 (43%), Gaps = 33/214 (15%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICN-LAEL 426
IP I + + + L NKL+ +L KL+ L L DNKL+ ++P I L L
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 427 YRLDLDGNKLSGSIPAC-FSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNFLT 484
L + NKL ++P F L +L + L N+L S+P F +L + L+ N L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 485 GSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP-NSFGDLI 543
SLP GV L +L+ L L N+L+ +P +F L
Sbjct: 147 -SLP-------------------KGVF----DKLTSLKELRLYNNQLK-RVPEGAFDKLT 181
Query: 544 SLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577
LK L L NN L V + + L L+ L L N
Sbjct: 182 ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 98 LQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALS 157
S++ S +L +IPS I K + L+ N+LS + L+ L L+ N L
Sbjct: 18 KNSVDCSSKKL-TAIPSNIPAD--TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 158 GEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNKLVGIA 216
+ A I F L LE + + N LQ +P+ + L NL +L + N+L +
Sbjct: 75 -TLPAGI-------FKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLP 125
Query: 217 PIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKL 275
P +++ L L L N L L + +L +L+ L L+ N +P F ++L
Sbjct: 126 PRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTEL 183
Query: 276 SILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
L L+ N F +L L L L +N
Sbjct: 184 KTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 59/226 (26%), Positives = 86/226 (38%), Gaps = 48/226 (21%)
Query: 264 TIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELS---FLS 320
IP I + LDL+ N S F L L L L+DN L + L F
Sbjct: 30 AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT----LPAGIF-K 82
Query: 321 SLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI-SNLTNLR 379
L N L+ ++ N L +P + L NL
Sbjct: 83 ELKN---LETLWVTDNKL------QA---------------------LPIGVFDQLVNLA 112
Query: 380 TIYLGGNKLNGSILITL-SKLQKLQDLGLKDNKLEGSIPYDIC-NLAELYRLDLDGNKLS 437
+ L N+L S+ + L KL L L N+L+ S+P + L L L L N+L
Sbjct: 113 ELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170
Query: 438 GSIPA-CFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSN 481
+P F LT L+ + L +N+L +P F +L+ + L N
Sbjct: 171 -RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 15/188 (7%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQLS 133
L++ S L+ L+ L+ L L+ N+L ++P+ IF L+ + + N+L
Sbjct: 40 KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 134 GTFPSFISNK-SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKI 192
P + ++ +L L L N L + + F +L +L +SL N LQ +
Sbjct: 99 -ALPIGVFDQLVNLAELRLDRNQLK-SLPPRV-------FDSLTKLTYLSLGYNELQ-SL 148
Query: 193 PLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL 251
P + L +L++L + +N+L + A ++ LK L L +N L + + L L
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKL 207
Query: 252 EILSLWGN 259
++L L N
Sbjct: 208 KMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 57/218 (26%), Positives = 87/218 (39%), Gaps = 23/218 (10%)
Query: 146 LQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI-GNLRNLEK 204
+D SS L+ I +NI + +L+L S N L +P K L L
Sbjct: 18 KNSVDCSSKKLT-AIPSNI-------PADTKKLDLQS---NKLS-SLPSKAFHRLTKLRL 65
Query: 205 LDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGT 264
L + DNKL + + L+ L + DN L L + +L NL L L N +
Sbjct: 66 LYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-S 123
Query: 265 IPRFIFNA-SKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLS 323
+P +F++ +KL+ L L N F L +L L L +N L + L+
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGA--FDKLT 181
Query: 324 NCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSN 361
LK L N L R+ P +L L+ ++
Sbjct: 182 E---LKTLKLDNNQLKRV-PEGAFDSLE-KLKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 8/110 (7%)
Query: 479 SSNFLTGSLPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP- 536
SS LT ++P I K L DL N S + L L L+L N+LQ ++P
Sbjct: 24 SSKKLT-AIPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA 78
Query: 537 NSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG 586
F +L +L+ L +++N L + ++L L +L L NQL+ +P
Sbjct: 79 GIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPR 127
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 43/206 (20%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVF-TSQC-GRAFKSFDVECEIMKSIRHRNLIKVISS 746
+G+G F V + G+E A K+ T + R F+ + E I + ++H N++++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 747 CSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHF 797
E F LV + + G L + YS S+CI I ++ Y H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCH- 122
Query: 798 GYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
S ++H +LKP N+LL L+DF +A + + ++ T GY++PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAW--HGFAGTPGYLSPE 177
Query: 855 ------YGREGRVSANGDVYSFGIML 874
Y + V D+++ G++L
Sbjct: 178 VLKKDPYSKP--V----DIWACGVIL 197
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 38/214 (17%), Positives = 76/214 (35%), Gaps = 9/214 (4%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI-CNLAEL 426
IP ++ N + KL S L+ + + N + I D+ NL +L
Sbjct: 24 IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 427 YRLDL-DGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNFL 483
+ + + N L I F NL +L+ + + + + +P + + + L+ N
Sbjct: 82 HEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 484 TGSLPLEI--GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD 541
++ G V + L++N + + G + E N L+ + F
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200
Query: 542 LISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLS 575
L++S + + LE L L +
Sbjct: 201 ASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 4e-22
Identities = 54/259 (20%), Positives = 91/259 (35%), Gaps = 31/259 (11%)
Query: 97 SLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNAL 156
S + +++ IPS + + +L S L+ +++S N +
Sbjct: 10 SNRVFLCQESKV-TEIPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 157 SGEIRANICREIPREFGNLPEL-ELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNKLVG 214
I A++ F NLP+L E+ ANNL I + NL NL+ L I + +
Sbjct: 67 LEVIEADV-------FSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKH 118
Query: 215 IAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLP-NLEILSLWGNNFSGTIPRFIFNAS 273
+ + + +L +QDN + + L IL L N I FN +
Sbjct: 119 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGT 177
Query: 274 KL-SILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS---------------STQELS 317
+L + + N+ + F L +S + S ST L
Sbjct: 178 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
Query: 318 FLSSLSNCKFLKYFDLSYN 336
L +L L L+Y
Sbjct: 238 KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 42/308 (13%), Positives = 83/308 (26%), Gaps = 65/308 (21%)
Query: 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
+ + + + IP + L F +L +
Sbjct: 10 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKI------- 59
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
++S N + ++ NL L E ++ N I
Sbjct: 60 ----------------------EISQNDVLEVIEADVFSNL-PKLHEIRIEKANNLLYIN 96
Query: 370 EEI-SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD-ICNL-AEL 426
E NL NL+ + + + + + L ++DN +I + L E
Sbjct: 97 PEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 156
Query: 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNFLTG 485
L L+ N + + F+ + +N L +P F + L+ S +
Sbjct: 157 VILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH- 215
Query: 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISL 545
L LK L + +P + L++L
Sbjct: 216 ---------------SLPSYGLE--------NLKKLRARSTYNLK---KLP-TLEKLVAL 248
Query: 546 KFLNLSNN 553
+L+
Sbjct: 249 MEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 55/286 (19%), Positives = 94/286 (32%), Gaps = 25/286 (8%)
Query: 73 RVTVLNISSLNLTGTIPSQ-LGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGN 130
+ + IS ++ I + NL L + + I F L+Y+ +
Sbjct: 55 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 114
Query: 131 QLSGTFPSFISNKS-SLQHLDLSSNALSGEIRANICREIPREFGNLP-ELELMSLAANNL 188
+ P S LD+ N I N F L E ++ L N +
Sbjct: 115 GIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNS-------FVGLSFESVILWLNKNGI 166
Query: 189 QGKIPLKIGNLRNLEKLDI-GDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYAR 247
Q +I N L++L++ +N L + S IL + + L S G
Sbjct: 167 Q-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLEN 224
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNS----FSGFIPNT--FGNLRNLSW 301
L L S + +P L L S F+ + + N S
Sbjct: 225 LKKLRARSTYNLK---KLPTL-EKLVALMEASLTYPSHCCAFANWRRQISELHPICNKSI 280
Query: 302 LVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTV 347
L +Y+T + + S L+ + + + FD++Y L V
Sbjct: 281 LRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTEFDYDLCNEVV 326
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 17/207 (8%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKV---FTSQCGRAFKSFDVECEIMKSIRHRN 739
FS+ IG G FG+VY A + + VA+K Q ++ E ++ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
I+ E LV+EY GS L L + + L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE---YG 856
S +IH D+K N+LL + + L DF A ++ S + T +MAPE
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-PANSFVGTPY-----WMAPEVILAM 225
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKP 883
EG+ DV+S GI +E K P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 45/241 (18%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
+G G +G V +E A+K+ TS + E ++K + H N++K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 747 CSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
++ LV+E G L + ++ I+ V S + YLH
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEV------DAAVIIKQVLSGVTYLH---KH 155
Query: 802 PVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE---- 854
++H DLKP N+LL + + + + DF ++ + + M + L T Y+APE
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKM--KERLGTAYYIAPEVLRK 212
Query: 855 -YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIF----NGEMTLKHWVNDWLPI 904
Y + DV+S G++L G P EI G+ T +W +
Sbjct: 213 KYDEK------CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP--EWKNV 264
Query: 905 S 905
S
Sbjct: 265 S 265
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 58/257 (22%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVF--------------------TSQCGRAFKSFDV 727
IG+G +G V A + D A+KV G +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 728 ------ECEIMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYL----YSSNC 774
E I+K + H N++K V+ + + +V E + G + + S +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 775 ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834
FQ D+ +EYLH +IH D+KPSN+L+ ++ ++DF ++ G
Sbjct: 139 ARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANG---DVYSFGIMLMETFTGKKPTDE----- 886
D +++ T+ T +MAPE E R +G DV++ G+ L G+ P +
Sbjct: 190 SD-ALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 887 ----IFNGEMTLKHWVN 899
I + + +
Sbjct: 248 LHSKIKSQALEFPDQPD 264
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 48/208 (23%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
+G+G FG V K E AVKV S + + E E++K + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEY 794
+ +V E G L F + I+ V S + Y
Sbjct: 90 LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 795 LHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYM 851
+H ++H DLKP N+LL + + + DF ++ ++ M + T Y+
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYI 190
Query: 852 APE-----YGREGRVSANGDVYSFGIML 874
APE Y + DV+S G++L
Sbjct: 191 APEVLRGTYDEK------CDVWSAGVIL 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 50/208 (24%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSC 747
+G G F K AVK+ + R + E +K H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYL 795
++ LV+E + G L F+R+ IM + SA+ ++
Sbjct: 76 HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 796 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
H V+H DLKP N+L +DN+ + DF A++ ++Q + T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177
Query: 853 PE------YGREGRVSANGDVYSFGIML 874
PE Y D++S G++L
Sbjct: 178 PELLNQNGYDES------CDLWSLGVIL 199
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 30/192 (15%), Positives = 65/192 (33%), Gaps = 11/192 (5%)
Query: 389 NGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLT 448
++ I S + + L + + L + L ++ +
Sbjct: 12 QDNVNIPDSTFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAH 66
Query: 449 SLRIVSLGSNELTSI-PLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNF 507
+++ +++ + T+ P++ L ++ L +T + L L +D+S +
Sbjct: 67 NIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124
Query: 508 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLS 567
I T+I L + + L YN I L LK LN+ + + +E
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFP 181
Query: 568 YLEDLNLSFNQL 579
L L +
Sbjct: 182 KLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 29/172 (16%), Positives = 67/172 (38%), Gaps = 14/172 (8%)
Query: 292 TFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLS 351
T + +L+++ L++ +T L+ + +K ++ P + LS
Sbjct: 39 TEAQMNSLTYITLANINVTD-------LTGIEYAHNIKDLTINNIHATNYNP---ISGLS 88
Query: 352 HSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNK 411
+LE ++ +++ +S LT+L + + + + SIL ++ L K+ + L N
Sbjct: 89 -NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 412 LEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSI 463
I + L EL L++ + + + L + S +
Sbjct: 148 AITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-18
Identities = 26/165 (15%), Positives = 57/165 (34%), Gaps = 7/165 (4%)
Query: 346 TVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDL 405
T ++ SL ++N N++ I N++ + + + +S L L+ L
Sbjct: 39 TEAQMN-SLTYITLANINVTD--LTGIEYAHNIKDLTINNIHA--TNYNPISGLSNLERL 93
Query: 406 GLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL 465
+ + ++ L L LD+ + SI + L + + L N + +
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
Query: 466 TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGV 510
L ++ +LN + + +E L + G
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 27/217 (12%), Positives = 67/217 (30%), Gaps = 42/217 (19%)
Query: 174 NLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQD 233
L ++ + + +L + + + + + I +K L + +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIEYA--HNIKDLTINN 75
Query: 234 NSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTF 293
+ + I + L NLE L + G + + + + L++LD+ ++ I
Sbjct: 76 IHATN-YNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 294 GNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHS 353
L ++ + LS N + + L LK ++ ++ ++
Sbjct: 133 NTLPKVNSIDLSYNGAITD------IMPLKTLPELKSLNIQFDGVHDY------------ 174
Query: 354 LEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNG 390
I + L +Y + G
Sbjct: 175 ----------------RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 27/165 (16%), Positives = 64/165 (38%), Gaps = 15/165 (9%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
+T + ++++N+T + +++ L ++ + + I L+ + + G ++
Sbjct: 46 LTYITLANINVTDLTG--IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVT 101
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
+S +SL LD+S + I + LP++ + L+ N I
Sbjct: 102 SDKIPNLSGLTSLTLLDISHS--------AHDDSILTKINTLPKVNSIDLSYNGAITDIM 153
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSG 238
+ L L+ L+I + + I + L L ++ G
Sbjct: 154 -PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 31/184 (16%), Positives = 62/184 (33%), Gaps = 18/184 (9%)
Query: 81 SLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFI 140
L + T ++SL + L+ + +K + + + + I
Sbjct: 29 LLGQSSTANITEAQMNSLTYITLANINVTDLTGIEYAH--NIKDLTINNIHATNY--NPI 84
Query: 141 SNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLR 200
S S+L+ L + ++ + L L L+ ++ + I KI L
Sbjct: 85 SGLSNLERLRIMGK--------DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 201 NLEKLDIGDN-KLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGN 259
+ +D+ N + I P+ + LK L +Q + + I P L L +
Sbjct: 137 KVNSIDLSYNGAITDIMPLK--TLPELKSLNIQFDGVHD-YRGI--EDFPKLNQLYAFSQ 191
Query: 260 NFSG 263
G
Sbjct: 192 TIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 26/167 (15%), Positives = 57/167 (34%), Gaps = 16/167 (9%)
Query: 121 TLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELEL 180
+L Y+ L ++ + I +++ L +++ + N L LE
Sbjct: 45 SLTYITLANINVTDL--TGIEYAHNIKDLTINNIHAT-----NY-----NPISGLSNLER 92
Query: 181 MSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL 240
+ + ++ + L +L LDI + I + + + L N +
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 241 SSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSG 287
+ LP L+ L++ + I + KL+ L + G
Sbjct: 153 MPL--KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 24/128 (18%), Positives = 48/128 (37%), Gaps = 9/128 (7%)
Query: 457 SNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIG 516
S + +IP + K LN + + + L I L+ N + + T I
Sbjct: 11 SQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIE 63
Query: 517 GLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSF 576
N++ L + P L +L+ L + +++ +L L+ L L++S
Sbjct: 64 YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 577 NQLEGKIP 584
+ + I
Sbjct: 122 SAHDDSIL 129
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 22/141 (15%), Positives = 53/141 (37%), Gaps = 13/141 (9%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
L I++++ T P + LS+L+ L + + + +L + + +
Sbjct: 69 KDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
+ + I+ + +DLS N +I LPEL+ +++ + + +
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIMP---------LKTLPELKSLNIQFDGVHDYRGI 177
Query: 195 KIGNLRNLEKLDIGDNKLVGI 215
+ + L +L + G
Sbjct: 178 E--DFPKLNQLYAFSQTIGGK 196
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 60/231 (25%), Positives = 92/231 (39%), Gaps = 52/231 (22%)
Query: 680 ATDGFSEN---------NLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVEC 729
+TD FS +++G G V +L E AVK+ Q G E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 730 EIMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------ 782
E++ + HRN++++I E+ LV E M GS+ +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHF 108
Query: 783 ------NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLT 833
++ DVASAL++LH + + H DLKP N+L + + DF + +
Sbjct: 109 NELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165
Query: 834 -GEDQSMIQTQTLATI----GYMAPEYGREGRVSANG-----DVYSFGIML 874
D S I T L T YMAPE A+ D++S G++L
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 6e-22
Identities = 63/262 (24%), Positives = 99/262 (37%), Gaps = 63/262 (24%)
Query: 651 RQRGKRPSNDANGPLVASRRMFSYLELCRATDGFSEN----NLIGRGGFGSVYKAS-LGD 705
++ S L A F + ++IGRG V +
Sbjct: 59 KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 706 GMEVAVKVF--------TSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALV 756
G E AVK+ Q ++ E I++ + H ++I +I S + F LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 757 LEYMPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYLHFGYSAPVI 804
+ M G L F L +IM + A+ +LH + ++
Sbjct: 179 FDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIV 222
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE---------- 854
H DLKP N+LLDDNM LSDF + L + + + T GY+APE
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKL--RELCGTPGYLAPEILKCSMDETH 279
Query: 855 --YGREGRVSANGDVYSFGIML 874
YG+E D+++ G++L
Sbjct: 280 PGYGKE------VDLWACGVIL 295
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 45/241 (18%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
+G+G FG V K E AVKV S + + E E++K + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 747 CSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ +V E G L ++ +S + I+ V S + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEH------DAARIIKQVFSGITYMH---KH 140
Query: 802 PVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE---- 854
++H DLKP N+LL + + + DF ++ ++ M + T Y+APE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKM--KDRIGTAYYIAPEVLRG 197
Query: 855 -YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIF----NGEMTLKHWVNDWLPI 904
Y + DV+S G++L +G P +I G+ W I
Sbjct: 198 TYDEK------CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--PQWRTI 249
Query: 905 S 905
S
Sbjct: 250 S 250
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 46/242 (19%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF-TSQCGRAFKSFDV--ECEIMKSIRHRNLIKVIS 745
+G+G FG V G E AVKV Q + + E +++K + H N++K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 746 SCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
++ + LV E G L + +S I ++ V S + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYMH---K 144
Query: 801 APVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--- 854
++H DLKP N+LL + + DF ++ + M + T Y+APE
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKM--KDKIGTAYYIAPEVLH 201
Query: 855 --YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIF----NGEMTLKHWVNDWLP 903
Y + DV+S G++L +G P +I G+ T + W
Sbjct: 202 GTYDEK------CDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL--PQWKK 253
Query: 904 IS 905
+S
Sbjct: 254 VS 255
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 2e-21
Identities = 54/266 (20%), Positives = 97/266 (36%), Gaps = 72/266 (27%)
Query: 690 IGRGGFGSVYKASL------GDGMEVAVKVFTSQ-CGRAFKSFDVECEIMKSI-RHRNLI 741
+GRG FG V +A VAVK+ ++ E +I+ I H N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 742 KVISSCSNEEFKALV-LEYMPHGSLEKYL----------------------YSSNCILDI 778
++ +C+ +V +E+ G+L YL Y +D+
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 779 FQRLNIMI------------------------------DVASALEYLHFGY--------- 799
+RL+ + D + + + +
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 800 -SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
S IH DL N+LL + V + DF +A+ + + + + + +MAPE +
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269
Query: 859 GRVSANGDVYSFGIMLMETFT-GKKP 883
+ DV+SFG++L E F+ G P
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 51/228 (22%), Positives = 87/228 (38%), Gaps = 58/228 (25%)
Query: 676 ELCRATDGFSEN----NLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECE 730
+L R + F++ IG G + + ME AVK+ + E E
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTE-EIE 67
Query: 731 IM-KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------- 782
I+ + +H N+I + + ++ +V E M G L ++
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFS 114
Query: 783 -----NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIAKMLT 833
++ + +EYLH + V+H DLKPSN+L + + DF AK L
Sbjct: 115 EREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 834 GEDQSMIQTQTLA-TIGYMAPE------YGREGRVSANGDVYSFGIML 874
E+ + T T ++APE Y D++S G++L
Sbjct: 172 AENGLL---MTPCYTANFVAPEVLERQGYDAA--C----DIWSLGVLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 60/247 (24%), Positives = 92/247 (37%), Gaps = 47/247 (19%)
Query: 651 RQRGKRPSNDANGPLVASRRMFSYLELCRATDGFSEN----NLIGRGGFGSVYKAS-LGD 705
S A+ + + Y D S+ + +GRG VY+ G
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77
Query: 706 GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765
A+KV K E ++ + H N+IK+ +LVLE + G L
Sbjct: 78 QKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 766 -----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL- 815
EK YS ++ + I A+ YLH ++H DLKP N+L
Sbjct: 136 FDRIVEKGYYSERDAADAVKQIL----------EAVAYLH---ENGIVHRDLKPENLLYA 182
Query: 816 --DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE------YGREGRVSANGDV 867
+ ++DF ++K++ M T GY APE YG E V D+
Sbjct: 183 TPAPDAPLKIADFGLSKIV-EHQVLM--KTVCGTPGYCAPEILRGCAYGPE--V----DM 233
Query: 868 YSFGIML 874
+S GI+
Sbjct: 234 WSVGIIT 240
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 59/237 (24%), Positives = 92/237 (38%), Gaps = 29/237 (12%)
Query: 667 ASRRMFSYLELCRATD---GFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAF 722
+ R ++L D F L+G G +G VYK + G A+KV G
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEE 64
Query: 723 KSFDVECEIMKSI-RHRNLIKVISSCSNEEFKA------LVLEYMPHGSL-EKYLYSSNC 774
+ E ++K HRN+ + + LV+E+ GS+ + +
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN 124
Query: 775 ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834
L I ++ L +LH VIH D+K NVLL +N L DF ++ L
Sbjct: 125 TLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD- 180
Query: 835 EDQSMIQTQTLATIG---YMAPEYGREGRVSANG-----DVYSFGIMLMETFTGKKP 883
+++ + T IG +MAPE D++S GI +E G P
Sbjct: 181 --RTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 49/232 (21%), Positives = 92/232 (39%), Gaps = 27/232 (11%)
Query: 246 ARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLS 305
+L + + + + + + + L N++ L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 306 DNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSH--SLEEFKMSNCN 363
N LT + L+N K L + L N + + +L L+ + +
Sbjct: 77 GNKLTD-------IKPLANLKNLGWLFLDENKV------KDLSSLKDLKKLKSLSLEHNG 123
Query: 364 ISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNL 423
IS + +L L ++YLG NK+ + + LS+L KL L L+DN++ I + L
Sbjct: 124 IS--DINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGL 177
Query: 424 AELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILN 475
+L L L N +S + A + L +L ++ L S E + P+ + + N
Sbjct: 178 TKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPN 227
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 46/226 (20%), Positives = 85/226 (37%), Gaps = 15/226 (6%)
Query: 354 LEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLE 413
+ + +++ + L ++ I + + + + L + L L NKL
Sbjct: 26 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGNKLT 81
Query: 414 GSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDI 473
I + NL L L LD NK+ + + +L L+ +SL N ++ I +L +
Sbjct: 82 -DIK-PLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDIN-GLVHLPQL 136
Query: 474 LNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 533
+L +N +T L L L + L N S ++P + GL L+ L+L N +
Sbjct: 137 ESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS- 191
Query: 534 SIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
+ L +L L L + L + + L
Sbjct: 192 DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 48/266 (18%), Positives = 92/266 (34%), Gaps = 30/266 (11%)
Query: 174 NLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQD 233
E +L ++ + L +++++ ++ + + I + + L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77
Query: 234 NSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTF 293
N L+ + + A L NL L L N + + KL L LE N S
Sbjct: 78 NKLTD-IKPL--ANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDING--L 130
Query: 294 GNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSH- 352
+L L L L +N +T ++ LS L L N + + + L+
Sbjct: 131 VHLPQLESLYLGNNKITD-------ITVLSRLTKLDTLSLEDNQI------SDIVPLAGL 177
Query: 353 -SLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNK 411
L+ +S +IS ++ L NL + L + + S L + D
Sbjct: 178 TKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235
Query: 412 LEGSIPYDICNLAELYRLDLDGNKLS 437
L P I + + + ++ +
Sbjct: 236 L--VTPEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 51/288 (17%), Positives = 105/288 (36%), Gaps = 29/288 (10%)
Query: 295 NLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSL 354
L +T + + + + + + + + L + +
Sbjct: 22 AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDIKSVQG---IQYLPN-V 70
Query: 355 EEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEG 414
+ ++ ++ + ++NL NL ++L NK+ L +L L+KL+ L L+ N +
Sbjct: 71 TKLFLNGNKLTDI--KPLANLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNGIS- 125
Query: 415 SIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDIL 474
I + +L +L L L NK++ I S LT L +SL N+++ I L +
Sbjct: 126 DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIV-PLAGLTKLQ 181
Query: 475 NLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 534
NL S N ++ L LK L ++L L + L
Sbjct: 182 NLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--V 237
Query: 535 IPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGK 582
P D + N+ + P ++S++ ++ + + +
Sbjct: 238 TPEIISDDGDYEKPNVKWHL-----PEFTNEVSFIFYQPVTIGKAKAR 280
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 44/201 (21%), Positives = 81/201 (40%), Gaps = 15/201 (7%)
Query: 380 TIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGS 439
+ + + + LK + ++ L + ++ + + + S
Sbjct: 6 ETITVPTPIKQ--IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-S 60
Query: 440 IPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVG 499
+ L ++ + L N+LT I NLK++ L N + L+ LK L
Sbjct: 61 VQ-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLSSLK--DLKKLKS 116
Query: 500 IDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVI 559
+ L N S + + L LE L+LG N++ I L L L+L +N +S ++
Sbjct: 117 LSLEHNGISDING--LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIV 172
Query: 560 PASLEKLSYLEDLNLSFNQLE 580
P L L+ L++L LS N +
Sbjct: 173 P--LAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 52/263 (19%), Positives = 106/263 (40%), Gaps = 32/263 (12%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
N+ ++T + L+S+ + + + + S+ I + + L GN+L+
Sbjct: 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSV-QGIQYLPNVTKLFLNGNKLT 81
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
P ++N +L L L N + ++ +L +L+ +SL N +
Sbjct: 82 DIKP--LANLKNLGWLFLDENKVK-----DLS-----SLKDLKKLKSLSLEHNGISDING 129
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
L +L LE L +G+NK+ I ++ ++ L L L+DN +S + + A L L+
Sbjct: 130 LV--HLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISD-IVPL--AGLTKLQN 182
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313
L L N+ S + L +L+L N NL + + +D L +
Sbjct: 183 LYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT-- 238
Query: 314 QELSFLSSLSNCKFLKYFDLSYN 336
+S+ + ++ ++
Sbjct: 239 -----PEIISDDGDYEKPNVKWH 256
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 56/199 (28%), Positives = 80/199 (40%), Gaps = 32/199 (16%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
IGRG +G V A G + A K F E EIMKS+ H N+I++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 749 NEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
+ LV+E G L K ++ + I + DV SA+ Y H V
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNV 127
Query: 804 IHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-----Y 855
H DLKP N L + L DF +A + M + T Y++P+ Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMM--RTKVGTPYYVSPQVLEGLY 184
Query: 856 GREGRVSANGDVYSFGIML 874
G E D +S G+M+
Sbjct: 185 GPE------CDEWSAGVMM 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-21
Identities = 60/339 (17%), Positives = 113/339 (33%), Gaps = 80/339 (23%)
Query: 651 RQRGKRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEV 709
N + + M+ + + + + + +G G +G V E
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK 64
Query: 710 AVKV-------------FTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756
A+KV + + E ++KS+ H N+IK+ ++++ LV
Sbjct: 65 AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLV 124
Query: 757 LEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPS 811
E+ G L ++ + +I ++ + S + YLH ++H D+KP
Sbjct: 125 TEFYEGGELFEQIINRHKFDECDAANIMKQ------ILSGICYLH---KHNIVHRDIKPE 175
Query: 812 NVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-----YGREGRVSA 863
N+LL + + + DF ++ +D + L T Y+APE Y +
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFF-SKDYKL--RDRLGTAYYIAPEVLKKKYNEK----- 227
Query: 864 NGDVYSFGIMLMETFTGKKP-----TDEIF----NGEMTLKHWVNDWLPISTMEVVDANL 914
DV+S G+++ G P +I G+ DW I
Sbjct: 228 -CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN--DWKNI---------- 274
Query: 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
S E + +R A+E
Sbjct: 275 -SDEAKELIKLMLTYD-------------YNKRCTAEEA 299
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 58/272 (21%), Positives = 98/272 (36%), Gaps = 56/272 (20%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVK-------------VFTSQ--CGRAFKSFDVECEIMKS 734
I G +G+V +G+ VA+K + + C R + E ++
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR----EIRLLNH 85
Query: 735 IRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 789
H N++ + LV E M L + ++ ++ M +
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 790 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG 849
L LH A V+H DL P N+LL DN + DF++A+ D + T +
Sbjct: 145 LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARE-DTADANK--THYVTHRW 198
Query: 850 YMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902
Y APE + + D++S G ++ E F K +F G + N
Sbjct: 199 YRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK----ALFRG----STFYNQLN 244
Query: 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 934
I +EVV ED+ + ++ N
Sbjct: 245 KI--VEVVGT--PKIEDVVMFSSPSARDYLRN 272
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 53/248 (21%), Positives = 92/248 (37%), Gaps = 33/248 (13%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV----ECEIMKSIRHRNLIK- 742
L+G G +G V + AVK+ + R + + E ++++ +RH+N+I+
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 743 --VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
V+ + ++ +V+EY G E + Q + LEYLH S
Sbjct: 72 VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---S 127
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI----GYMAPE-- 854
++H D+KP N+LL +S +A+ L T T + PE
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQGSPAFQPPEIA 183
Query: 855 YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVNDWLP-- 903
G + D++S G+ L TG P + I G + L
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDL 243
Query: 904 ISTMEVVD 911
+ M +
Sbjct: 244 LKGMLEYE 251
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 9e-21
Identities = 45/195 (23%), Positives = 79/195 (40%), Gaps = 23/195 (11%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS 748
+G G FG V++ G K + + E IM + H LI + +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 749 NEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSA 801
++ L+LE++ G L E Y S + I N M L+++H
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI-------NYMRQACEGLKHMH---EH 168
Query: 802 PVIHCDLKPSNVLLDDNMVAHL--SDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG 859
++H D+KP N++ + + + DF +A L D+ + T AT + APE
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIV--KVTTATAEFAAPEIVDRE 225
Query: 860 RVSANGDVYSFGIML 874
V D+++ G++
Sbjct: 226 PVGFYTDMWAIGVLG 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 49/198 (24%), Positives = 84/198 (42%), Gaps = 25/198 (12%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF-TSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G G FG V+ G+E +K + + + E E++KS+ H N+IK+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGYSAPVI 804
+ +V+E G L + + S+ +M + +AL Y H S V+
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 805 HCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-----YG 856
H DLKP N+L + + DF +A++ D+ T T YMAPE
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHS--TNAAGTALYMAPEVFKRDVT 203
Query: 857 REGRVSANGDVYSFGIML 874
+ D++S G+++
Sbjct: 204 FK------CDIWSAGVVM 215
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 59/215 (27%), Positives = 86/215 (40%), Gaps = 53/215 (24%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVF------TSQCGRAFKSFDV--ECEIMKSIRHRNL 740
+G G G V A +VA+K+ A + +V E EI+K + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 741 IKVISSCSNEEFKA----LVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASA 791
IK+ F A +VLE M G L F + A
Sbjct: 78 IKIK-----NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLA 126
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI 848
++YLH +IH DLKP NVLL +++ + ++DF +K+L GE M T
Sbjct: 127 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM--RTLCGTP 180
Query: 849 GYMAPE---------YGREGRVSANGDVYSFGIML 874
Y+APE Y R V D +S G++L
Sbjct: 181 TYLAPEVLVSVGTAGYNRA--V----DCWSLGVIL 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 58/259 (22%), Positives = 86/259 (33%), Gaps = 70/259 (27%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV-----ECEIMKSIRHRNLIKV 743
IG+G +G V A A+K+ R DV E +MK + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--------------------- 782
+E++ LV+E G L L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 783 ------------------NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL- 823
NIM + SAL YLH + + H D+KP N L N +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 824 -SDFSIAKMLTGEDQSMIQT-QTLA-TIGYMAPE--------YGREGRVSANGDVYSFGI 872
DF ++K + T A T ++APE YG + D +S G+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK------CDAWSAGV 264
Query: 873 MLMETFTGKKPTDEIFNGE 891
+L G P F G
Sbjct: 265 LLHLLLMGAVP----FPGV 279
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 59/244 (24%), Positives = 94/244 (38%), Gaps = 35/244 (14%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKV--------FTSQCGRAFKSFDVECEIMKSIRHRNL 740
+G G FG V+ A EV VK +E I+ + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILD------IFQRLNIMIDVASALE 793
IKV+ N+ F LV+E G L+ + + + LD IF++L SA+
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQL------VSAVG 144
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
YL +IH D+K N+++ ++ L DF A L E + T TI Y AP
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEYCAP 198
Query: 854 E-YGREGRVSANGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVNDWLP--ISTM 907
E +++S G+ L + P +E + + V+ L +S +
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGL 258
Query: 908 EVVD 911
Sbjct: 259 LQPV 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-20
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 45/211 (21%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF--------TSQCGRAFKSFDVECEIMKSIRHRNL 740
+G G G V A +VA+++ +++ + + E EI+K + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 741 IKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYL 795
IK+ + E++ +VLE M G L F + A++YL
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 255
Query: 796 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
H +IH DLKP NVLL +++ + ++DF +K+L GE M T Y+A
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM--RTLCGTPTYLA 309
Query: 853 PE---------YGREGRVSANGDVYSFGIML 874
PE Y R V D +S G++L
Sbjct: 310 PEVLVSVGTAGYNRA--V----DCWSLGVIL 334
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-20
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 29/235 (12%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFT-SQCGRAFKSFDVECEIMKSIRHRNLIK---V 743
+G G +G V A + VAVK+ + ++ E I K + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFG 798
N ++ L LEY G L + + F +L + + YLH
Sbjct: 74 RRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH-- 122
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-YGR 857
+ H D+KP N+LLD+ +SDF +A + ++ + + T+ Y+APE R
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN------DWLPIST 906
+ DV+S GI+L G+ P D+ + W W I +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427
P++ L + + +T ++L + + ++ ++ L +
Sbjct: 13 FPDDAF--AETIKANLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQGIQY--LPNVR 66
Query: 428 RLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLT-FWNLKDILNLNFSSNFLTGS 486
L L GNKL I A LT+L + L N+L S+P F L ++ L N L S
Sbjct: 67 YLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-S 123
Query: 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNS-FGDLISL 545
LP GV L NL YL L +N+LQ S+P F L +L
Sbjct: 124 LP-------------------DGVFDK----LTNLTYLNLAHNQLQ-SLPKGVFDKLTNL 159
Query: 546 KFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG 586
L+LS N L + +KL+ L+DL L NQL+ +P G
Sbjct: 160 TELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS-VPDG 199
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 45/217 (20%), Positives = 80/217 (36%), Gaps = 26/217 (11%)
Query: 99 QSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSG 158
+++ +S P F L+ ++ + +S+ + +++ +
Sbjct: 1 ETITVSTPIK-QIFPDDAFAETI--KANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKS 55
Query: 159 EIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIG---NLRNLEKLDIGDNKLVGI 215
+ LP + ++L N L I L NL L + N+L +
Sbjct: 56 V----------QGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSL 100
Query: 216 APIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNA-SK 274
++ LK L L +N L L + +L NL L+L N ++P+ +F+ +
Sbjct: 101 PNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTN 158
Query: 275 LSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
L+ LDL N F L L L L N L S
Sbjct: 159 LTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 62/264 (23%), Positives = 95/264 (35%), Gaps = 78/264 (29%)
Query: 203 EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS 262
K ++ + + ++++ + ++ + S G LPN+ L+L GN
Sbjct: 22 IKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK---SVQGIQYLPNVRYLALGGNKLH 76
Query: 263 GTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSL 322
I + L+ L L GN F L NL LVL +N L S
Sbjct: 77 -DISAL-KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS----------- 123
Query: 323 SNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIY 382
LP G+ ++++NLT L
Sbjct: 124 -------------------LP----------------------DGVFDKLTNLTYL---N 139
Query: 383 LGGNKL----NGSILITLSKLQKLQDLGLKDNKLEGSIP---YDICNLAELYRLDLDGNK 435
L N+L G KL L +L L N+L+ S+P +D L +L L L N+
Sbjct: 140 LAHNQLQSLPKG----VFDKLTNLTELDLSYNQLQ-SLPEGVFD--KLTQLKDLRLYQNQ 192
Query: 436 LSGSIP-ACFSNLTSLRIVSLGSN 458
L S+P F LTSL+ + L N
Sbjct: 193 LK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 21/165 (12%)
Query: 78 NISSLNLTGTIPSQLG---NLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQLS 133
N+ L L G + L++L L L+ N+L S+P+ +F T LK + L NQL
Sbjct: 64 NVRYLALGGNKLHDISALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ 122
Query: 134 GTFPSFISNK-SSLQHLDLSSNALSGEIRANICREIP-REFGNLPELELMSLAANNLQGK 191
+ P + +K ++L +L+L+ N L +P F L L + L+ N LQ
Sbjct: 123 -SLPDGVFDKLTNLTYLNLAHNQLQ---------SLPKGVFDKLTNLTELDLSYNQLQ-S 171
Query: 192 IPLKI-GNLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDN 234
+P + L L+ L + N+L + P +F +++L+ + L DN
Sbjct: 172 LPEGVFDKLTQLKDLRLYQNQLKSV-PDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 25/172 (14%)
Query: 95 LSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQLSGTFPSFISNK-SSLQHLDLS 152
L +++ L L N+L I T L Y+ L GNQL + P+ + +K ++L+ L L
Sbjct: 62 LPNVRYLALGGNKL-HDIS--ALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLV 117
Query: 153 SNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNK 211
N L + + F L L ++LA N LQ +P + L NL +LD+ N+
Sbjct: 118 ENQLQ-SLPDGV-------FDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQ 168
Query: 212 LVGIAPIAIFNVST-LKILGLQDNSLSGCLSSI---GYARLPNLEILSLWGN 259
L + P +F+ T LK L L N L S+ + RL +L+ + L N
Sbjct: 169 LQSL-PEGVFDKLTQLKDLRLYQNQ----LKSVPDGVFDRLTSLQYIWLHDN 215
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 37/224 (16%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK----VFTSQ--CGRAFKSFDVECEIMKSIRHRNLIK 742
IG G G V A VA+K F +Q RA++ E +MK + H+N+I
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIG 88
Query: 743 V----ISSCSNEEFKA--LVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 793
+ S EEF+ +V+E M ++ L ++Q L ++
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-------GIK 141
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
+LH SA +IH DLKPSN+++ + + DF +A+ S + T + T Y AP
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 195
Query: 854 EYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 897
E N D++S G ++ E G +F G + W
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVEC-----EIMKSIRHRNLIK 742
++G G F +V A L E A+K+ + K V ++M + H +K
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ + ++E L Y +G L KY+ + R ++ SALEYLH
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH---GKG 150
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPEYGREGRV 861
+IH DLKP N+LL+++M ++DF AK+L+ E + + + T Y++PE E
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELLTEKSA 209
Query: 862 SANGDVYSFGIMLMETFTGKKP-----TDEIF 888
+ D+++ G ++ + G P IF
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 241
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 50/202 (24%), Positives = 77/202 (38%), Gaps = 30/202 (14%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF-TSQCGRAFKSFDV-----ECEIMKSIRHRNLIK 742
+G G F V K G G E A K + + + E I++ IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 743 VISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 796
+ N+ L+LE + G L EK + + + + YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQILDGVHYLH 125
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
S + H DLKP N++L D V + L DF IA + T ++A
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGTPEFVA 179
Query: 853 PEYGREGRVSANGDVYSFGIML 874
PE + D++S G++
Sbjct: 180 PEIVNYEPLGLEADMWSIGVIT 201
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 23/201 (11%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
S+ ++G G FG V+K G+++A K+ ++ + + E +M + H NLI+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 743 VISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASALEYL 795
+ + ++ LV+EY+ G L E Y + + I M + + ++
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-------LFMKQICEGIRHM 203
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
H Y ++H DLKP N+L + + DF +A+ + + T ++AP
Sbjct: 204 HQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKL--KVNFGTPEFLAP 257
Query: 854 EYGREGRVSANGDVYSFGIML 874
E VS D++S G++
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIA 278
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 44/202 (21%), Positives = 74/202 (36%), Gaps = 30/202 (14%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF-TSQCGRAFKSFDV-----ECEIMKSIRHRNLIK 742
+G G F V K G+E A K Q + + E I++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 743 VISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 796
+ N L+LE + G L +K S + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132
Query: 797 FGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
+ + H DLKP N++L L DF +A + + T ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPEFVA 186
Query: 853 PEYGREGRVSANGDVYSFGIML 874
PE + D++S G++
Sbjct: 187 PEIVNYEPLGLEADMWSIGVIT 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 45/204 (22%), Positives = 76/204 (37%), Gaps = 23/204 (11%)
Query: 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN 739
D + + +G G FG V++ G A K + ++ E + M +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASAL 792
L+ + + ++ ++ E+M G L E S + M V L
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-------EYMRQVCKGL 268
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFSIAKMLTGEDQSMIQTQTLATIGY 850
++H +H DLKP N++ L DF + L QS+ T T +
Sbjct: 269 CHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSV--KVTTGTAEF 322
Query: 851 MAPEYGREGRVSANGDVYSFGIML 874
APE V D++S G++
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 29/235 (12%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFT-SQCGRAFKSFDVECEIMKSIRHRNLIK---V 743
+G G +G V A + VAVK+ + ++ E I K + H N++K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFG 798
N ++ L LEY G L + + F +L + + YLH
Sbjct: 74 RRE-GNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH-- 122
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-YGR 857
+ H D+KP N+LLD+ +SDF +A + ++ + + T+ Y+APE R
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN------DWLPIST 906
+ DV+S GI+L G+ P D+ + W W I +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 44/202 (21%), Positives = 75/202 (37%), Gaps = 30/202 (14%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF-TSQCGRAFKSFDV-----ECEIMKSIRHRNLIK 742
+G G F V K G++ A K + + + E I+K I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 743 VISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 796
+ N+ L+LE + G L EK + + + + + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQILNGVYYLH 131
Query: 797 FGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
S + H DLKP N++L + DF +A + T ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEF--KNIFGTPEFVA 185
Query: 853 PEYGREGRVSANGDVYSFGIML 874
PE + D++S G++
Sbjct: 186 PEIVNYEPLGLEADMWSIGVIT 207
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 64/272 (23%), Positives = 112/272 (41%), Gaps = 48/272 (17%)
Query: 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVK----VFTSQ--CGRAFKSFDVECEIMK 733
+ +G G +GSV A G +VA+K F S+ RA++ E ++K
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78
Query: 734 SIRHRNLIK----VISSCSNEEFKA--LVLEYMP---HGSLEKYLYSSNCILDIFQRLNI 784
++H N+I + S F LV+ +M + ++Q L
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK- 137
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
L+Y+H SA V+H DLKP N+ ++++ + DF +A+ D M T
Sbjct: 138 ------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGY 183
Query: 845 LATIGYMAPE-YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 903
+ T Y APE + D++S G ++ E TGK +F G K +++
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKG----KDYLDQLTQ 235
Query: 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 935
I ++V E + + + S++ +L
Sbjct: 236 I--LKVTGV--PGTEFVQKLNDKAAKSYIQSL 263
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-19
Identities = 38/175 (21%), Positives = 71/175 (40%), Gaps = 15/175 (8%)
Query: 724 SFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQR 781
+ V+ M +N + + S + + + ++ +L+ ++ + +
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 782 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML--------- 832
L+I I +A A+E+LH S ++H DLKPSN+ + V + DF + +
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 833 -TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 886
T T + T YM+PE S D++S G++L E E
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 17/96 (17%), Positives = 35/96 (36%), Gaps = 2/96 (2%)
Query: 679 RATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVK-VFTSQCGRAFKSFDVECEIMKSIR 736
R F +GRGGFG V++A + D A+K + A + E + + +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 772
H +++ ++ + E ++
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 44/202 (21%), Positives = 74/202 (36%), Gaps = 30/202 (14%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF-TSQCGRAFKSFDV-----ECEIMKSIRHRNLIK 742
+G G F V K G+E A K Q + + E I++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 743 VISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLH 796
+ N L+LE + G L +K S + + + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132
Query: 797 FGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
+ + H DLKP N++L L DF +A + + T ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTPEFVA 186
Query: 853 PEYGREGRVSANGDVYSFGIML 874
PE + D++S G++
Sbjct: 187 PEIVNYEPLGLEADMWSIGVIT 208
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 47/259 (18%), Positives = 92/259 (35%), Gaps = 45/259 (17%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
++ ++ IPS S Q+L L L +IPS F+
Sbjct: 14 EDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHL-RTIPSHAFSNLP------------- 55
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPL 194
++ + +S + ++ ++ F NL ++ + + I
Sbjct: 56 ----------NISRIYVSIDVTLQQLESHS-------FYNLSKVTHIEIRNTRNLTYIDP 98
Query: 195 KI-GNLRNLEKLDIGDNKLVGI-APIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPN-L 251
L L+ L I + L +++ IL + DN + + L N
Sbjct: 99 DALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIP-NTFGNLRN-LSWLVLSDNYL 309
L L+ N F+ ++ + FN +KL + L N + I + FG + + S L +S +
Sbjct: 159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217
Query: 310 TS----STQELSFLSSLSN 324
T+ + L L + +
Sbjct: 218 TALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 39/210 (18%), Positives = 78/210 (37%), Gaps = 9/210 (4%)
Query: 373 SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI-CNLAELYRLDL 431
S + +T+ L L S L + + + + + NL+++ +++
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 432 DGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIP-LTFWNLKDIL-NLNFSSNFLTGSLP 488
+ I L L+ + + + L P LT DI L + N S+P
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIP 147
Query: 489 LEI--GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP-NSFGDLIS- 544
+ G + + L N F+ + L+ ++L N+ I ++FG + S
Sbjct: 148 VNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 545 LKFLNLSNNNLSGVIPASLEKLSYLEDLNL 574
L++S +++ + LE L L N
Sbjct: 207 PSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 38/260 (14%), Positives = 82/260 (31%), Gaps = 56/260 (21%)
Query: 199 LRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWG 258
+ + L + + L I ++ S LPN+ + +
Sbjct: 30 PPSTQTLKLIETHLRTIPS----------------HAFSN---------LPNISRIYVSI 64
Query: 259 NNFSGTIPRFIFNA-SKLSILDLEGNSFSGFIP-NTFGNLRNLSWLVLSDNYLTSSTQEL 316
+ + F SK++ +++ +I + L L +L + + L +L
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMF-PDL 123
Query: 317 SFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLT 376
+ + S +++ NP +P L + K+ N + + N T
Sbjct: 124 TKVYSTDI---FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGT 179
Query: 377 NLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKL 436
L +YL NK L+ + K G+ LD+ +
Sbjct: 180 KLDAVYLNKNKY-------LTVIDKDAFGGVYSG---------------PSLLDVSQTSV 217
Query: 437 SGSIPA-CFSNLTSLRIVSL 455
+ ++P+ +L L +
Sbjct: 218 T-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 40/196 (20%), Positives = 73/196 (37%), Gaps = 14/196 (7%)
Query: 402 LQDLGLKDNKLEGSIPYDI-CNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSN- 458
Q L L + L +IP NL + R+ + + + + F NL+ + + + +
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 459 ELTSIPL-TFWNLKDILNLNFSSNFLTGSLP--LEIGSLKVLVGIDLSRNNFSGVIPTEI 515
LT I L + L + L P ++ S + ++++ N + IP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 516 -GGLKN-LEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA-SLEKL-SYLED 571
GL N L L N S+ + L + L+ N VI + + S
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 572 LNLSFNQLEGKIPRGG 587
L++S + +P G
Sbjct: 210 LDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 37/212 (17%), Positives = 74/212 (34%), Gaps = 18/212 (8%)
Query: 275 LSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLS 334
L L + F NL N+S + +S + + SF +LS + + ++
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSF-YNLSK---VTHIEIR 88
Query: 335 YNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE--ISNLTNLRTIYLGGNKLNGSI 392
+ + L L+ + N + P+ + + + + N SI
Sbjct: 89 NTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 393 ----LITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA-CFSNL 447
L L L +N S+ N +L + L+ NK I F +
Sbjct: 147 PVNAFQGLCNE--TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203
Query: 448 TS-LRIVSLGSNELTSIP-LTFWNLKDILNLN 477
S ++ + +T++P +LK+++ N
Sbjct: 204 YSGPSLLDVSQTSVTALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 46/238 (19%), Positives = 82/238 (34%), Gaps = 23/238 (9%)
Query: 120 YTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPEL 178
+ + + + PS + Q L L L IP F NLP +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSLPPS---TQTLKLIETHLR---------TIPSHAFSNLPNI 57
Query: 179 ELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNK-LVGIAPIAIFNVSTLKILGLQDNSL 236
+ ++ + ++ NL + ++I + + L I P A+ + LK LG+ + L
Sbjct: 58 SRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL 117
Query: 237 SGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFN--ASKLSILDLEGNSFSGFIPNTFG 294
IL + N + +IP F ++ L L N F+ F
Sbjct: 118 KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAF- 176
Query: 295 NLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSH 352
N L + L+ N + + +F S D+S + LP + +L
Sbjct: 177 NGTKLDAVYLNKNKYLTVIDKDAFGGVYSG---PSLLDVSQTSV-TALPSKGLEHLKE 230
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 43/238 (18%), Positives = 83/238 (34%), Gaps = 19/238 (7%)
Query: 325 CKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLG 384
C + F ++ + + +L S + K+ ++ SNL N+ IY+
Sbjct: 10 CHQEEDFRVTCKDI------QRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS 63
Query: 385 GNKLNGSILI-TLSKLQKLQDLGLKDNKLEGSIPYDIC-NLAELYRLDLDGNKLSGSIPA 442
+ + + L K+ + +++ + I D L L L + L P
Sbjct: 64 IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122
Query: 443 C--FSNLTSLRIVSLGSN-ELTSIPL-TFWNLKDIL-NLNFSSNFLTGSLPLEIGSLKVL 497
+ I+ + N +TSIP+ F L + L +N T S+ + L
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181
Query: 498 VGIDLSRNNFSGVIPTEI--GGLKNLEYLFLGYNRLQGSIP-NSFGDLISLKFLNLSN 552
+ L++N + VI + G L + + ++P L L N
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 35/192 (18%), Positives = 64/192 (33%), Gaps = 17/192 (8%)
Query: 73 RVTVLNISSLNLTGTIPSQL-GNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGN 130
++ + +S + S NLS + + + R I LK++ +
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 131 QLSGTFP--SFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLP-ELELMSLAANN 187
L FP + + + L+++ N I N F L E + L N
Sbjct: 116 GLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA-------FQGLCNETLTLKLYNNG 167
Query: 188 LQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFN--VSTLKILGLQDNSLSGCLSSIGY 245
+ N L+ + + NK + + F S +L + S++ L S G
Sbjct: 168 FT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGL 225
Query: 246 ARLPNLEILSLW 257
L L + W
Sbjct: 226 EHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 18/117 (15%), Positives = 44/117 (37%), Gaps = 8/117 (6%)
Query: 497 LVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP-NSFGDLISLKFLNLSNNN- 554
+ L + + L N+ +++ + + +SF +L + + + N
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 555 LSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQI 611
L+ + P +L++L L+ L + L+ P S + +L + N +
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV-----YSTDIFFILEITDNPYM 143
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 34/212 (16%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFT-SQCGRAFKSFDVEC-----EIMKSIRHRNLI 741
IG+G FG V D ++ A+K +C + +V +IM+ + H L+
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC---VERNEVRNVFKELQIMQGLEHPFLV 78
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ S +EE +V++ + G L +L + + +L I ++ AL+YL +
Sbjct: 79 NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQ---NQ 134
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPE------ 854
+IH D+KP N+LLD++ H++DF+IA ML E Q T+A T YMAPE
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKPYMAPEMFSSRK 190
Query: 855 ---YGREGRVSANGDVYSFGIMLMETFTGKKP 883
Y V D +S G+ E G++P
Sbjct: 191 GAGYSFA--V----DWWSLGVTAYELLRGRRP 216
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 74/304 (24%), Positives = 134/304 (44%), Gaps = 69/304 (22%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK---VFTSQ--CGRAFKSFDVECEIMKSIRHRNLIK- 742
IG G +G V A + + VA+K F Q C R + E +I+ RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 743 --VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 798
+I + + E+ K +V + M L K L + + + + + L+Y+H
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICY-FLYQILRGLKYIH-- 145
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE-DQSMIQTQTLATIGYMAPE--- 854
SA V+H DLKPSN+LL+ + DF +A++ + D + T+ +AT Y APE
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 855 ----YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910
Y + + D++S G +L E + + IF G KH+++ I + ++
Sbjct: 205 NSKGY------TKSIDIWSVGCILAEMLSNR----PIFPG----KHYLDQLNHI--LGIL 248
Query: 911 DANLLSQEDIHFVAKEQCVSFVFNLA---------------------MECTMEF-PKQRI 948
+ SQED++ + + +++ +L ++ + F P +RI
Sbjct: 249 GS--PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306
Query: 949 NAKE 952
++
Sbjct: 307 EVEQ 310
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 35/231 (15%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDV------ECEIMKSIRHR--N 739
L+G GGFGSVY + D + VA+K + E ++K +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 740 LIKVISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 798
+I+++ + L+LE P L ++ + + R + V A+ + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 166
Query: 799 YSAPVIHCDLKPSNVLLDDN-MVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY-- 855
+ V+H D+K N+L+D N L DF +L ++ T Y PE+
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTD-FDGTRVYSPPEWIR 221
Query: 856 -----GREGRVSANGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWV 898
GR V+S GI+L + G P +EI G++ + V
Sbjct: 222 YHRYHGRS------AAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 38/197 (19%), Positives = 74/197 (37%), Gaps = 28/197 (14%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV--ECEIMKSIRHRNLIKVISS 746
+GRG FG V++ K + V E I+ RHRN++ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 747 CSNEEFKALVLEYMPHGSL------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGY 799
+ E ++ E++ + + + + + + V AL++LH
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIV-------SYVHQVCEALQFLHSHN 122
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHL--SDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
+ H D++P N++ + + +F A+ L + Y APE +
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNF--RLLFTAPEYYAPEVHQ 176
Query: 858 EGRVSANGDVYSFGIML 874
VS D++S G ++
Sbjct: 177 HDVVSTATDMWSLGTLV 193
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 68/236 (28%), Positives = 108/236 (45%), Gaps = 43/236 (18%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDV------ECEIMKSIRHRNLI 741
+G G FG V G +VAVK+ Q +S DV E + +K RH ++I
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 742 K---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALE 793
K VIS+ + F +V+EY+ G L Y+ + +FQ++ SA++
Sbjct: 75 KLYQVIST-PTDFF--MVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVD 125
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
Y H V+H DLKP NVLLD +M A ++DF ++ M++ D ++T + + Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRT-SCGSPNYAAP 179
Query: 854 E-YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVN 899
E D++S G++L G P D+ I G + ++N
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLN 235
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVK-VFTSQC--GRAFKSFDVECEIMKSIRHRNLIK---- 742
IG G FG V++A L + EVA+K V + R E +IM+ ++H N++
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLKAF 100
Query: 743 VISSCSNEEFKA--LVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHF 797
S+ ++ LVLEY+P ++ + + + M + +L Y+H
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH- 158
Query: 798 GYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-- 854
S + H D+KP N+LLD + V L DF AK+L + + + Y APE
Sbjct: 159 --SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPN--VSYICSRYYRAPELI 213
Query: 855 -----YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
Y + N D++S G ++ E G +P +F GE
Sbjct: 214 FGATNY------TTNIDIWSTGCVMAELMQG-QP---LFPGE 245
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 66/260 (25%), Positives = 112/260 (43%), Gaps = 41/260 (15%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK----VFTSQ--CGRAFKSFDVECEIMKSIRHRNLIK 742
+G G +GSV A G+ VAVK F S R ++ E ++K ++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 743 V----ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
+ + S EEF LV M L + D Q ++ + L+Y+H
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIH 149
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-Y 855
SA +IH DLKPSN+ ++++ + DF +A+ M T +AT Y APE
Sbjct: 150 ---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEM--TGYVATRWYRAPEIM 201
Query: 856 GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915
+ D++S G ++ E TG+ +F G ++ I + +V
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGR----TLFPG----TDHIDQLKLI--LRLVGT--P 249
Query: 916 SQEDIHFVAKEQCVSFVFNL 935
E + ++ E +++ +L
Sbjct: 250 GAELLKKISSESARNYIQSL 269
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 71/313 (22%), Positives = 126/313 (40%), Gaps = 62/313 (19%)
Query: 675 LELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVK-VFTSQCGRAFKSFDV----E 728
L++ + + + +G G F +VYKA VA+K + A + E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 729 CEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 788
++++ + H N+I ++ + ++ +LV ++M LE + ++ +L M+
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 789 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI 848
LEYLH ++H DLKP+N+LLD+N V L+DF +AK +++ T + T
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTR 176
Query: 849 GYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGK-------------------- 881
Y APE YG V D+++ G +L E
Sbjct: 177 WYRAPELLFGARMYGVG--V----DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230
Query: 882 KPTDEIFNGEMTLKHWVN--DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMEC 939
PT+E + +L +V + I + A + + + F+FN
Sbjct: 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA--AGDDLLDLIQG----LFLFN----- 279
Query: 940 TMEFPKQRINAKE 952
P RI A +
Sbjct: 280 ----PCARITATQ 288
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 65/297 (21%), Positives = 112/297 (37%), Gaps = 60/297 (20%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVF-TSQCGRAFKSFDV-ECEIMKSIRHRNLIKVISS 746
IG G +G V+K + G VA+K F S+ K + E ++K ++H NL+ ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
+ LV EY H ++ L + +I A+ + H IH
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-------YGREG 859
D+KP N+L+ + V L DF A++LTG +AT Y +PE YG
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQYGPP- 183
Query: 860 RVSANGDVYSFGIMLMETFTGK--------------------KPTDEIFNGEMTLKHWVN 899
V DV++ G + E +G T +++
Sbjct: 184 -V----DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 900 ----DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKE 952
D + +E+ N +S + + + C L M+ P +R+ ++
Sbjct: 239 VKIPDPEDMEPLELKFPN-ISYPALGLL--KGC------LHMD-----PTERLTCEQ 281
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 53/202 (26%), Positives = 78/202 (38%), Gaps = 42/202 (20%)
Query: 415 SIPYDICNLAELYRLDLDGNKLSGSIPA--CFSNLTSLRIVSLGSNELTSIP-LTFWNLK 471
++P + + LDL N LS + A + LT+L + L N L I F +
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88
Query: 472 DILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRL 531
++ L+ SSN L +L + FS L+ LE L L N +
Sbjct: 89 NLRYLDLSSNHLH-TLDEFL---------------FSD--------LQALEVLLLYNNHI 124
Query: 532 QGSIP-NSFGDLISLKFLNLSNNNLSGVIP---ASLEKLSYLEDLNLSFNQLEGKIPRGG 587
+ N+F D+ L+ L LS N +S KL L L+LS N+L+ K+P
Sbjct: 125 V-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL-T 181
Query: 588 SFGNFSAQ-----SFEGNELLC 604
A N L C
Sbjct: 182 DLQKLPAWVKNGLYLHNNPLEC 203
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 13/151 (8%)
Query: 449 SLRIVSLGSNELTSIPLTFWNL-KDILNLNFSSNFLTGSLPLEI--GSLKVLVGIDLSRN 505
+ I+S +L ++P +L L+ S N L+ L E L L + LS N
Sbjct: 19 ASNILSCSKQQLPNVPQ---SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHN 74
Query: 506 NFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIP-NSFGDLISLKFLNLSNNNLSGVIPASL 563
+ + I +E + NL YL L N L ++ F DL +L+ L L NN++ V +
Sbjct: 75 HLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAF 132
Query: 564 EKLSYLEDLNLSFNQLEGKIPRGGSFGNFSA 594
E ++ L+ L LS NQ+ + P + +
Sbjct: 133 EDMAQLQKLYLSQNQIS-RFPV-ELIKDGNK 161
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 49/180 (27%), Positives = 77/180 (42%), Gaps = 21/180 (11%)
Query: 264 TIPRFIFNASKLSILDLEGNSFSGFIPNT-FGNLRNLSWLVLSDNYLTSSTQELSFLSS- 321
+P+ + S ++LDL N+ S L NL L+LS N L+F+SS
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN-------HLNFISSE 82
Query: 322 -LSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI-SNLTNLR 379
L+Y DLS N L L +L +LE + N +I + ++ L+
Sbjct: 83 AFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQ-ALEVLLLYNNHIVV-VDRNAFEDMAQLQ 139
Query: 380 TIYLGGNKLN---GSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYR--LDLDGN 434
+YL N+++ ++ +KL KL L L NKL+ D+ L + L L N
Sbjct: 140 KLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 40/171 (23%), Positives = 64/171 (37%), Gaps = 12/171 (7%)
Query: 224 STLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEG 282
S +L L N+LS + RL NL L L N+ + I F L LDL
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 283 NSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRIL 342
N F +L+ L L+L +N++ +F + L+ LS N + R
Sbjct: 98 NHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAF----EDMAQLQKLYLSQNQISRF- 151
Query: 343 PRTTVGNLSH--SLEEFKMSNCNISGGIPEEISNLTNL--RTIYLGGNKLN 389
P + + + L +S+ + ++ L +YL N L
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 46/191 (24%), Positives = 72/191 (37%), Gaps = 28/191 (14%)
Query: 80 SSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQLS----G 134
S L +P L S L+LS N L T T L + L N L+
Sbjct: 26 SKQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSE 82
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANNLQGKIP 193
F +L++LDLSSN L + F +L LE++ L N++ +
Sbjct: 83 AF----VPVPNLRYLDLSSNHL---------HTLDEFLFSDLQALEVLLLYNNHIV-VVD 128
Query: 194 LKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVS---TLKILGLQDNSLSGCLSSIGYARLP 249
++ L+KL + N++ I + + L +L L N L L +LP
Sbjct: 129 RNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLP 187
Query: 250 NLEILSLWGNN 260
L+ +N
Sbjct: 188 AWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 51/208 (24%), Positives = 72/208 (34%), Gaps = 46/208 (22%)
Query: 137 PSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI 196
P + S LDLS N LS +RA L L + L+ N+L I +
Sbjct: 34 PQSLP--SYTALLDLSHNNLS-RLRAE------WTPTRLTNLHSLLLSHNHLN-FISSEA 83
Query: 197 -GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILS 255
+ NL LD+ N L + +F + L LE+L
Sbjct: 84 FVPVPNLRYLDLSSNHLHTL-DEFLF------------------------SDLQALEVLL 118
Query: 256 LWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGN---LRNLSWLVLSDNYLTS 311
L+ N+ + R F + ++L L L N S F + L L L LS N L
Sbjct: 119 LYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177
Query: 312 -STQELSFLSSLSNCKFLKYFDLSYNPL 338
+L L + L NPL
Sbjct: 178 LPLTDLQKLPAWV----KNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 30/177 (16%)
Query: 74 VTVLNISSLNLTGTIPSQ--LGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGN 130
+L++S NL+ + ++ L++L SL LS N L I S F L+Y+ L N
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSN 98
Query: 131 QL----SGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAA 185
L F S+ +L+ L L +N + + R F ++ +L+ + L+
Sbjct: 99 HLHTLDEFLF----SDLQALEVLLLYNNHIV---------VVDRNAFEDMAQLQKLYLSQ 145
Query: 186 NNLQGKIPLKI----GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLK--ILGLQDNSL 236
N + + P+++ L L LD+ NKL + + + L L +N L
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 37/233 (15%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFT----SQCGRAFKSFDVECEI--MKSIR----H 737
L+G+GGFG+V+ L D ++VA+KV S E+ + + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 738 RNLIKVISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
+I+++ +E LVLE +P L Y+ + + R V +A+++ H
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 797 FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY 855
S V+H D+K N+L+D A L DF +L T Y PE+
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTD-FDGTRVYSPPEW 209
Query: 856 -------GREGRVSANGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWV 898
V+S GI+L + G P EI E+ V
Sbjct: 210 ISRHQYHALP------ATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 71/336 (21%), Positives = 118/336 (35%), Gaps = 70/336 (20%)
Query: 651 RQRGKRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEV 709
D + + M Y L L+G G +G V K + G V
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMEKYENL----------GLVGEGSYGMVMKCRNKDTGRIV 53
Query: 710 AVKVF-TSQCGRAFKSFDV-ECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 767
A+K F S + K + E +++K +RH NL+ ++ C ++ LV E++ H ++
Sbjct: 54 AIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILD 112
Query: 768 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFS 827
L LD + + + + + H S +IH D+KP N+L+ + V L DF
Sbjct: 113 DLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFG 169
Query: 828 IAKMLTGEDQSMIQTQTLATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTG 880
A+ L + +AT Y APE YG+ V DV++ G ++ E F G
Sbjct: 170 FARTLAAPGEVY--DDEVATRWYRAPELLVGDVKYGKA--V----DVWAIGCLVTEMFMG 221
Query: 881 K--------------------KPTDEIFNGEMTLKHWVN----DWLPISTMEVVDANLLS 916
+ + + +E LS
Sbjct: 222 EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK-LS 280
Query: 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKE 952
+ I K C L ++ P +R E
Sbjct: 281 EVVIDLAKK--C------LHID-----PDKRPFCAE 303
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 4e-18
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 37/233 (15%)
Query: 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVK----VFTSQ--CGRAFKSFDVECEIMK 733
+ IG G G V A VA+K F +Q RA++ E +MK
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 116
Query: 734 SIRHRNLIKVI----SSCSNEEFKA--LVLEYMP---HGSLEKYLYSSNCILDIFQRLNI 784
+ H+N+I ++ + EEF+ LV+E M ++ L ++Q L
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC- 175
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
+++LH SA +IH DLKPSN+++ + + DF +A+ G M T
Sbjct: 176 ------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMM--TPY 223
Query: 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 897
+ T Y APE N D++S G ++ E K +F G + W
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQW 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 44/248 (17%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVF------TSQCGRAFKSFDVECEIMKSIRHRNLIK 742
IG+G F V A + G EVA+K+ + + F+ E IMK + H N++K
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-----IFQRLNIMIDVASALEYLHF 797
+ E+ L++EY G + YL + + + F+++ SA++Y H
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCH- 131
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ--TLATIGYMAPE- 854
++H DLK N+LLD +M ++DF + T + Y APE
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPP---YAAPEL 184
Query: 855 YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVNDWLP-- 903
+ + DV+S G++L +G P D + G+ + +++
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244
Query: 904 ISTMEVVD 911
+ V++
Sbjct: 245 LKRFLVLN 252
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 43/214 (20%), Positives = 82/214 (38%), Gaps = 58/214 (27%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV--ECEIMKSI-RHRNLIKVI 744
++G G G V + G + A+K+ S E + +++ ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 745 ----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVA 789
+ + +++E M G L I +R + IM D+
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138
Query: 790 SALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA 846
+A+++LH S + H D+KP N+L + + V L+DF AK ++
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCY 191
Query: 847 TIGYMAPE------YGREGRVSANGDVYSFGIML 874
T Y+APE Y + D++S G+++
Sbjct: 192 TPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-18
Identities = 75/441 (17%), Positives = 140/441 (31%), Gaps = 79/441 (17%)
Query: 72 QRVTVLNISSLNLTGT----IPSQLGNLSSLQSLNLSFNRLFGSIPSAIF-----TTYTL 122
Q+ V+ + LT I S L +L LNL N L + + +
Sbjct: 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 87
Query: 123 KYVCLRGNQLSGT----FPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPEL 178
+ + L+ L+G S + +LQ L LS N L +C + L +L
Sbjct: 88 QKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKL 147
Query: 179 ELMSLAANNLQGKIPLKIG----NLRNLEKLDIGDNKL--VGIAPIA---IFNVSTLKIL 229
+L +L + + ++L + +N + G+ + + L+ L
Sbjct: 148 QLEY---CSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL 204
Query: 230 GLQDNSLSG-CLSSIGYA--RLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFS 286
L+ ++ + +L L+L N ++L L +
Sbjct: 205 KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV------GMAELCPGLLHPS--- 255
Query: 287 GFIPNTFGNLRNLSWLVLSDNYLTS-STQELSFLSSLSNCKFLKYFDLSYNPL----YRI 341
L L + + +T+ +L L + LK L+ N L R+
Sbjct: 256 ----------SRLRTLWIWECGITAKGCGDLC--RVLRAKESLKELSLAGNELGDEGARL 303
Query: 342 LPRTTVGNLSHSLEEFKMSNCNISG----GIPEEISNLTNLRTIYLGGNKLNGSILITLS 397
L T+ LE + +C+ + ++ L + + N+L + + L
Sbjct: 304 L-CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 362
Query: 398 KL-----QKLQDLGLKDNKLEGSIPYDICNLAE-------LYRLDLDGNKLSGSIPACFS 445
+ L+ L L D + +LA L LDL N L +
Sbjct: 363 QGLGQPGSVLRVLWLADCDVS---DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 419
Query: 446 -----NLTSLRIVSLGSNELT 461
L + L +
Sbjct: 420 ESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-16
Identities = 86/441 (19%), Positives = 147/441 (33%), Gaps = 65/441 (14%)
Query: 200 RNLEKLDIGDNKL--VGIAPIAIFNVSTLKILGLQDNSLS-GCLSSIGYA--RLPNLEIL 254
+++ LDI +L A + + +++ L D L+ I A P L L
Sbjct: 3 LDIQSLDIQCEELSDARWA-ELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 255 SLWGNNFSGTIPRFIFNA-----SKLSILDLEGNSFS----GFIPNTFGNLRNLSWLVLS 305
+L N + K+ L L+ + G + +T L L L LS
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 306 DNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPL----YRILPRTTVGNLSHSLEEFKMSN 361
DN L + +L L L+ L Y L L +E +SN
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAK--PDFKELTVSN 179
Query: 362 CNISGGIPEEIS-----NLTNLRTIYLGGNKLN----GSILITLSKLQKLQDLGLKDNKL 412
+I+ + + L + L + + ++ L++L L NKL
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 413 EGSIPYDICNLAE-----LYRLDLDGNKLS----GSIPACFSNLTSLRIVSLGSNELT-- 461
++C L L + ++ G + SL+ +SL NEL
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
Query: 462 -----SIPLTFWNLKDILNLNFSSNFLTG----SLPLEIGSLKVLVGIDLSRNNFSGVIP 512
L + + +L S T + + L+ + +S N
Sbjct: 300 GARLLCETLLEPGCQ-LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358
Query: 513 TEIG-GLKN----LEYLFLGYNRLQ----GSIPNSFGDLISLKFLNLSNNNL--SGV--I 559
E+ GL L L+L + S+ + SL+ L+LSNN L +G+ +
Sbjct: 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 418
Query: 560 PASLEKLSY-LEDLNLSFNQL 579
S+ + LE L L
Sbjct: 419 VESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-09
Identities = 47/268 (17%), Positives = 85/268 (31%), Gaps = 38/268 (14%)
Query: 350 LSHSLEEFKMSNCNIS-GGIPEEISNLTNLRTIYLGGNKLN----GSILITLSKLQKLQD 404
+S ++ + +S E + L + + L L I L L +
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 405 LGLKDNKLEGSIPYDICNL-----AELYRLDLDGNKLS----GSIPACFSNLTSLRIVSL 455
L L+ N+L + + ++ +L L L+ G + + L +L+ + L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 456 GSNELTSIPLTF------WNLKDILNLNFSSNFLT----GSLPLEIGSLKVLVGIDLSRN 505
N L L + L L+ L + + + +S N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 506 NFSGVIPTEIG-GLK----NLEYLFLGYNRLQ----GSIPNSFGDLISLKFLNLSNNNL- 555
+ + + GLK LE L L + + SL+ L L +N L
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 556 -SGVI---PASLEKLSYLEDLNLSFNQL 579
G+ P L S L L + +
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGI 268
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-18
Identities = 42/202 (20%), Positives = 79/202 (39%), Gaps = 32/202 (15%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV-----ECEIMKSIRHR-NLIK 742
+GRG F V + S G E A K R E +++ + +I
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 743 VISSCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRL------NIMIDVASALEYL 795
+ N L+LEY G + C+ ++ + + ++ + + YL
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSL------CLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAH---LSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
H ++H DLKP N+LL + DF +++ + G + + + T Y+A
Sbjct: 148 HQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACEL--REIMGTPEYLA 201
Query: 853 PEYGREGRVSANGDVYSFGIML 874
PE ++ D+++ GI+
Sbjct: 202 PEILNYDPITTATDMWNIGIIA 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 7e-18
Identities = 58/257 (22%), Positives = 98/257 (38%), Gaps = 45/257 (17%)
Query: 678 CRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKV---------FTSQCGRAFKSFDVE 728
+ + + +G G +G VYKA G VA+K S R E
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-------E 69
Query: 729 CEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 788
++K + H N++ +I +E LV E+M L+K L + L Q + +
Sbjct: 70 ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 789 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI 848
+ + H ++H DLKP N+L++ + L+DF +A+ +S T + T+
Sbjct: 129 LRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTL 183
Query: 849 GYMAPE--YGREGRVSANGDVYSFGIMLMETFTGK--------------------KPTDE 886
Y AP+ G + + S + D++S G + E TGK P
Sbjct: 184 WYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 887 IFNGEMTLKHWVNDWLP 903
+ L W
Sbjct: 243 EWPQVQELPLWKQRTFQ 259
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-18
Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 690 IGRGGFGSVYKASLGD-GMEVAVK-VFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVI- 744
IG G FG VY+A L D G VA+K V + R E +IM+ + H N++++
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 114
Query: 745 -----SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
+E + LVL+Y+P + Y + + I+ +L M + +L Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIH 173
Query: 797 FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE- 854
S + H D+KP N+LLD D V L DF AK L + + + Y APE
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPN--VSYICSRYYRAPEL 227
Query: 855 ------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
Y +++ DV+S G +L E G +P IF G+
Sbjct: 228 IFGATDY------TSSIDVWSAGCVLAELLLG-QP---IFPGD 260
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKV---------FTSQCGRAFKSFDVECEIMKSIRHRN 739
IG G +G+V+KA + VA+K S R E ++K ++H+N
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-------EICLLKELKHKN 62
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
++++ +++ LV E+ L+KY S N LD + + + L + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--YGR 857
S V+H DLKP N+L++ N L++F +A+ + + + T+ Y P+ +G
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGA 176
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
+ S + D++S G + E +P +F G
Sbjct: 177 K-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 8e-18
Identities = 72/311 (23%), Positives = 122/311 (39%), Gaps = 75/311 (24%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK---VFTSQ--CGRAFKSFDVECEIMKSIRHRNLIK- 742
+G G +G V A+ G VA+K F R + E +I+K +H N+I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74
Query: 743 --VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 798
+ S E F ++ E M L + + S+ + D + + A++ LH
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-STQMLSDDHIQY-FIYQTLRAVKVLH-- 129
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ--------TQTLATIGY 850
+ VIH DLKPSN+L++ N + DF +A+++ + + +AT Y
Sbjct: 130 -GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 851 MAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 903
APE Y S DV+S G +L E F + IF G + + + L
Sbjct: 189 RAPEVMLTSAKY------SRAMDVWSCGCILAELFLRRP----IFPG----RDYRHQLLL 234
Query: 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA---------------------MECTME 942
I ++ S D+ + + ++ +L ++ +
Sbjct: 235 I--FGII-GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291
Query: 943 F-PKQRINAKE 952
F P +RI AKE
Sbjct: 292 FDPAKRITAKE 302
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 48/270 (17%), Positives = 95/270 (35%), Gaps = 46/270 (17%)
Query: 315 ELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISN 374
++ + +L + + + LS ++ F N NI +
Sbjct: 8 PINQVFPDPGLANAVKQNLGKQSVTDL---VSQKELSG-VQNFNGDNSNIQ--SLAGMQF 61
Query: 375 LTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAE--LYRLDLD 432
TNL+ ++L N++ S L L L KL++L + N+L+ ++ + L RL LD
Sbjct: 62 FTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLD 114
Query: 433 GNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIG 492
N+L + +L +L I+S+ +N+L SI +G
Sbjct: 115 NNELR-DTDS-LIHLKNLEILSIRNNKLKSIV-------------------------MLG 147
Query: 493 SLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSN 552
L L +DL N + + LK + ++ L + +L + +
Sbjct: 148 FLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITN--TVKD 203
Query: 553 NNLSGVIPASLEKLSYLEDLNLSFNQLEGK 582
+ + P + D + +
Sbjct: 204 PDGRWISPYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 45/259 (17%), Positives = 85/259 (32%), Gaps = 31/259 (11%)
Query: 196 IGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILS 255
L N K ++G + + +S ++ ++++ L+ + + NL+ L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQS-LAGMQF--FTNLKELH 69
Query: 256 LWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQE 315
L N S P + + +KL L + N L L L +N L
Sbjct: 70 LSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD---- 120
Query: 316 LSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSH--SLEEFKMSNCNISGGIPEEIS 373
SL + K L+ + N L ++ L LE + I+ ++
Sbjct: 121 ---TDSLIHLKNLEILSIRNNKL------KSIVMLGFLSKLEVLDLHGNEITN--TGGLT 169
Query: 374 NLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDL-- 431
L + I L G K + +L + D + PY I N +
Sbjct: 170 RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLW 227
Query: 432 DGNKLSGSIPACFSNLTSL 450
+ + + FS ++
Sbjct: 228 ELPVYTDEVSYKFSEYINV 246
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 42/247 (17%), Positives = 87/247 (35%), Gaps = 31/247 (12%)
Query: 90 SQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHL 149
L++ NL + + + ++ + + + ++L+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQKELS--GVQNFNGDNSNIQSLAG--MQFFTNLKEL 68
Query: 150 DLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGD 209
LS N +S ++ +L +LE +S+ N L+ L L +L + +
Sbjct: 69 HLSHNQIS-DLSP---------LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDN 115
Query: 210 NKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFI 269
N+L + ++ L+IL +++N L + + L LE+L L GN + T +
Sbjct: 116 NELRDTDSLI--HLKNLEILSIRNNKLKS-IVML--GFLSKLEVLDLHGNEITNTGG--L 168
Query: 270 FNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLK 329
K++ +DL G L + + D S +SN
Sbjct: 169 TRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS-------PYYISNGGSYV 221
Query: 330 YFDLSYN 336
+ +
Sbjct: 222 DGCVLWE 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 50/246 (20%), Positives = 92/246 (37%), Gaps = 29/246 (11%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
N+ ++T + LS +Q+ N + + + + LK + L NQ+S
Sbjct: 21 AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQIS 76
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
S + + + L+ L ++ N L N+ L + L N L+
Sbjct: 77 DL--SPLKDLTKLEELSVNRNRLK-----NL------NGIPSACLSRLFLDNNELRDTDS 123
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
L +L+NLE L I +NKL I + +S L++L L N ++ + RL +
Sbjct: 124 LI--HLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEIT-NTGGL--TRLKKVNW 176
Query: 254 LSLWGNNFSGTIPRFIFNASKL-SILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS 312
+ L G ++ ++ D +G S P N + +
Sbjct: 177 IDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPV-Y 232
Query: 313 TQELSF 318
T E+S+
Sbjct: 233 TDEVSY 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 41/240 (17%)
Query: 682 DGFSENNLIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVEC-----EIMKSI 735
D F + ++GRGGFG V+ + ++ A K + R K + +I+ +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK--RLKKRKGYQGAMVEKKILAKV 242
Query: 736 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASAL 792
R ++ + + + LV+ M G + ++Y+ + F R + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYM 851
E+LH +I+ DLKP NVLLDD+ +SD +A L T+ A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFM 356
Query: 852 APE------YGREGRVSANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKH 896
APE Y S D ++ G+ L E + P E+ + L+
Sbjct: 357 APELLLGEEYDF----SV--DYFALGVTLYEMIAARGPFRARGEKVENKELK--QRVLEQ 408
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 57/236 (24%), Positives = 92/236 (38%), Gaps = 47/236 (19%)
Query: 681 TDGFSENNLIGRGGFGSVYKASLGD-GMEVAVK-VF--TSQCGRAFKSFDVECEIMK--- 733
D F + G+G FG+V GM VA+K V R E +IM+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-------ELQIMQDLA 74
Query: 734 SIRHRNLIK---VISSCSNEEFK----ALVLEYMP---HGSLEKYLYSSNCILDIFQRLN 783
+ H N+++ + + + +V+EY+P H Y I ++
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV- 133
Query: 784 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQT 842
+ + ++ LH S V H D+KP NVL++ + L DF AK L +
Sbjct: 134 FLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPN--V 189
Query: 843 QTLATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
+ + Y APE Y + D++S G + E G +P IF G+
Sbjct: 190 AYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG-EP---IFRGD 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 56/244 (22%), Positives = 101/244 (41%), Gaps = 54/244 (22%)
Query: 678 CRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFK-SFDVECE----- 730
C + + IG+G FG V+KA G +VA+K K + E E
Sbjct: 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK----------KVLMENEKEGFPIT 62
Query: 731 ------IMKSIRHRN---LIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCIL 776
I++ ++H N LI++ + ++ + LV ++ H L L +
Sbjct: 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKF 121
Query: 777 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836
+ + +M + + L Y+H ++H D+K +NVL+ + V L+DF +A+ +
Sbjct: 122 TLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 837 QSMIQ--TQTLATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEI 887
S T + T+ Y PE YG + D++ G ++ E +T + P I
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPP--I----DLWGAGCIMAEMWT-RSP---I 228
Query: 888 FNGE 891
G
Sbjct: 229 MQGN 232
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-17
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVEC--------EIMKS 734
FS + +IGRGGFG VY D ++ A+K + R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK--RIKMKQGETLALNERIMLSLVST 248
Query: 735 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 794
++ + + + + +L+ M G L +L + R ++ LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAP 853
+H + V++ DLKP+N+LLD++ +SD +A + + + T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359
Query: 854 E-YGREGRVSANGDVYSFGIMLMETFTGKKP 883
E + ++ D +S G ML + G P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 63/260 (24%), Positives = 115/260 (44%), Gaps = 41/260 (15%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK----VFTSQ--CGRAFKSFDVECEIMKSIRHRNLIK 742
+G G +G+V A G +VA+K F S+ RA++ E ++K +RH N+I
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 743 VI----SSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
++ + ++F LV+ +M L K + L + ++ + L Y+H
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH 145
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY- 855
+A +IH DLKP N+ ++++ + DF +A+ D M T + T Y APE
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--TGYVVTRWYRAPEVI 197
Query: 856 GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915
R + D++S G ++ E TGK +F G ++ I M+V
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK----TLFKG----SDHLDQLKEI--MKVTGT--P 245
Query: 916 SQEDIHFVAKEQCVSFVFNL 935
E + + ++ +++ L
Sbjct: 246 PAEFVQRLQSDEAKNYMKGL 265
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 49/239 (20%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDV------ECEIMKSIRHRNLI 741
+G G FG V G +VAVK+ Q +S DV E + +K RH ++I
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 742 K---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALE 793
K VIS+ ++ F +V+EY+ G L Y+ + + +FQ++ S ++
Sbjct: 80 KLYQVIST-PSDIF--MVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVD 130
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIG---Y 850
Y H V+H DLKP NVLLD +M A ++DF ++ M++ D ++T + G Y
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRT----SCGSPNY 181
Query: 851 MAPE-YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVN 899
APE D++S G++L G P D+ I +G ++N
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLN 240
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 44/217 (20%), Positives = 81/217 (37%), Gaps = 65/217 (29%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV--ECEIMKSI-RHRNLIKVI- 744
+G G G V + + + A+K+ E E+ + ++++++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122
Query: 745 ---SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVAS 790
+ + + +V+E + G L I R + IM +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
A++YLH S + H D+KP N+L N + L+DF AK T +L T
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-------NSLTT 222
Query: 848 I----GYMAPE------YGREGRVSANGDVYSFGIML 874
Y+APE Y + D++S G+++
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 54/213 (25%), Positives = 80/213 (37%), Gaps = 34/213 (15%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVF------TSQCGRAFKSFDVECEIMKSIRHRNLI 741
IG G FG VAVK R E +S+RH N++
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-------EIINHRSLRHPNIV 79
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLH 796
+ A+++EY G L + + ++ FQ+L S + Y H
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH 133
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
S + H DLK N LLD + L DF +K S ++ T+ T Y+APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKS-TVGTPAYIAPE 187
Query: 855 -YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 886
R+ DV+S G+ L G P ++
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 62/340 (18%), Positives = 120/340 (35%), Gaps = 92/340 (27%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK----VFTSQ--CGRAFKSFDVECEIMKSIRHRNLIK 742
IGRG +G VY A VA+K +F C R + E I+ ++ +I+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89
Query: 743 ---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
+I +F +VLE L+K + + + + I+ ++ ++H
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH- 146
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ---------------- 841
+ +IH DLKP+N LL+ + + DF +A+ + E + I
Sbjct: 147 --ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 842 ----TQTLATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---- 886
T + T Y APE Y + + D++S G + E +
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENY------TKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 887 ---IFNGEMTLKHWVNDWLPISTME-VVD-----ANLL---SQEDIHFVAKEQCVSFVFN 934
+F G + + D N++ +++D+ + K + + ++
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318
Query: 935 LA---------------------MECTMEF-PKQRINAKE 952
+E ++F P +RI +
Sbjct: 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQ 358
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 5e-17
Identities = 52/239 (21%), Positives = 99/239 (41%), Gaps = 30/239 (12%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVEC-----EIMKSIRH 737
F + ++G+GGFG V + ++ A K + R K +I++ +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK--RIKKRKGEAMALNEKQILEKVNS 243
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEY 794
R ++ + + ++ LVL M G L+ ++Y + F + ++ LE
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLED 301
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAP 853
LH +++ DLKP N+LLDD+ +SD +A + + T+GYMAP
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAP 354
Query: 854 EYGREGRVSANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKHWVNDWLP 903
E + R + + D ++ G +L E G+ P +E+ + ++
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS 413
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 9e-17
Identities = 39/187 (20%), Positives = 78/187 (41%), Gaps = 21/187 (11%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK----VFTSQ--CGRAFKSFDVECEIMKSIRHRNLIK 742
IG G +G V +A + VA+K VF C R + E I+ + H +++K
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116
Query: 743 ---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
++ E+F +VLE +K + + ++ + ++ ++ ++Y+H
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH- 173
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
SA ++H DLKP+N L++ + + DF +A+ + + Q M
Sbjct: 174 --SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 858 EGRVSAN 864
+
Sbjct: 232 HTKNLKR 238
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 64/341 (18%), Positives = 113/341 (33%), Gaps = 73/341 (21%)
Query: 654 GKRPSNDANGPLVASRRMFSYLELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVK 712
S + D + +G G +G VYKA VA+K
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65
Query: 713 VFTSQCGRAFKSFDVECE-----------IMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761
+ E E ++K ++HRN+I++ S + L+ EY
Sbjct: 66 RI---------RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116
Query: 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821
+ L+KY+ N + + + + + + + + H S +H DLKP N+LL + +
Sbjct: 117 N-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDAS 171
Query: 822 H-----LSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE--YGREGRVSANGDVYSFGIML 874
+ DF +A+ + T + T+ Y PE G S + D++S +
Sbjct: 172 ETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILLGSR-HYSTSVDIWSIACIW 228
Query: 875 METFTGK--------------------KPTDEIFNGEMTLKHWVND---WLPISTMEVVD 911
E P D + G L W + + V+
Sbjct: 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL- 287
Query: 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKE 952
LL E + + + P +RI+AK
Sbjct: 288 GALLDDEGLDLLTA----MLEMD---------PVKRISAKN 315
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 68/313 (21%), Positives = 120/313 (38%), Gaps = 79/313 (25%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK--VFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVI 744
+G GG G V+ A VA+K V T A + E +I++ + H N++KV
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74
Query: 745 ------------SSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 790
S E + +V EYM L L + + + M +
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHAR--LFMYQLLR 131
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGE-DQSMIQTQTLATI 848
L+Y+H SA V+H DLKP+N+ ++ +++V + DF +A+++ ++ L T
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 849 GYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 901
Y +P Y + D+++ G + E TGK +F G H +
Sbjct: 189 WYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK----TLFAG----AHELEQM 234
Query: 902 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA---------------------MECT 940
I +E + + +ED + ++ N +E
Sbjct: 235 QLI--LESIPV--VHEEDRQEL-LSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQI 289
Query: 941 MEF-PKQRINAKE 952
+ F P R+ A+E
Sbjct: 290 LTFSPMDRLTAEE 302
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 62/307 (20%), Positives = 113/307 (36%), Gaps = 67/307 (21%)
Query: 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECE----------- 730
+ + IG G +G VYKA G A+K + E E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI---------RLEKEDEGIPSTTIREIS 52
Query: 731 IMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 790
I+K ++H N++K+ ++ LV E++ L+K L L+ + ++ + +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
+ Y H V+H DLKP N+L++ ++DF +A+ + T + T+ Y
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWY 166
Query: 851 MAPE--YGREGRVSANGDVYSFGIMLMETFTGK--------------------KPTDEIF 888
AP+ G + + S D++S G + E G P + +
Sbjct: 167 RAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 889 NGEMTLKHWVND---WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPK 945
L + + + P+ + L + I +L + P
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKG--LDESGI-------------DLLSKMLKLDPN 270
Query: 946 QRINAKE 952
QRI AK+
Sbjct: 271 QRITAKQ 277
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 3e-16
Identities = 59/347 (17%), Positives = 108/347 (31%), Gaps = 36/347 (10%)
Query: 236 LSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFI-PNTFG 294
L + +S S R + S++ L L + + T
Sbjct: 232 HRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPD 291
Query: 295 NLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSL 354
S + L D S +L + L + P + +
Sbjct: 292 GRNRPSHVWLCDLPAASLNDQLP--QHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDE 349
Query: 355 EEFKMS-NCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLE 413
+ F+ + S + E+ + L+ + + +L + ++ L L + L+
Sbjct: 350 QLFRCELSVEKSTVLQSELESCKELQELEP---ENKWCLLTIILLMRALDPLLYEKETLQ 406
Query: 414 GSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDI 473
+ L +D + + + L S L + D+
Sbjct: 407 --------YFSTLKAVD---------------PMRAAYLDDLRSKFLLENSVLKMEYADV 443
Query: 474 LNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 533
L+ + LT L + L ++ +DLS N +P + L+ LE L N L+
Sbjct: 444 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499
Query: 534 SIPNSFGDLISLKFLNLSNNNLSGV-IPASLEKLSYLEDLNLSFNQL 579
++ +L L+ L L NN L L L LNL N L
Sbjct: 500 NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 32/164 (19%), Positives = 62/164 (37%), Gaps = 6/164 (3%)
Query: 417 PYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNL 476
D +L+R +L K + + + + L+ + N+ + + ++ + L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEP-ENKWCLLTII-LLMRALDPL 398
Query: 477 NFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP 536
+ L L+ +D R+ F ++ L L + L +
Sbjct: 399 LYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC 457
Query: 537 NSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
+ L+ + L+LS+N L +P +L L LE L S N LE
Sbjct: 458 H-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 38/175 (21%), Positives = 64/175 (36%), Gaps = 21/175 (12%)
Query: 89 PSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQH 148
L L + F+ L P L+ L N + + ++
Sbjct: 392 MRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL------KMEYADVRV 445
Query: 149 LDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIG 208
L L+ L+ + L + + L+ N L+ +P + LR LE L
Sbjct: 446 LHLAHKDLT---------VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQAS 494
Query: 209 DNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGY-ARLPNLEILSLWGNNFS 262
DN L + +A N+ L+ L L +N L ++I P L +L+L GN+
Sbjct: 495 DNALENVDGVA--NLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 2e-09
Identities = 36/166 (21%), Positives = 66/166 (39%), Gaps = 17/166 (10%)
Query: 44 DPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNL 103
DP + S + + + E RV L+++ +LT + L L + L+L
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRV--LHLAHKDLT-VLCH-LEQLLLVTHLDL 470
Query: 104 SFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRAN 163
S NRL ++P A+ L+ + N L ++N LQ L L +N L
Sbjct: 471 SHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQS---- 523
Query: 164 ICREIPREFGNLPELELMSLAANNLQGKIPLK---IGNLRNLEKLD 206
+ + P L L++L N+L + ++ L ++ +
Sbjct: 524 ---AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 62/340 (18%), Positives = 117/340 (34%), Gaps = 86/340 (25%)
Query: 676 ELCRATDGFS-ENNLIGRGGFGSVYKA---SLGDGMEVAVKVF-------TSQCGRAFKS 724
E R D F E +GRG +G VYKA D + A+K ++
Sbjct: 14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------ 67
Query: 725 FDVECEIMKSIRHRN---LIKVISSCSNEEFKALVLEYMPHGSLEKYL--------YSSN 773
E +++ ++H N L KV S ++ + L+ +Y H L +
Sbjct: 68 ---EIALLRELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 774 CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFSIA 829
L +++ + + YLH + V+H DLKP+N+L+ ++D A
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 830 KMLTGEDQSMIQ-TQTLATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGK 881
++ + + + T Y APE Y + + D+++ G + E T +
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA--I----DIWAIGCIFAELLTSE 233
Query: 882 -----------------------------KPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912
P D+ + + +
Sbjct: 234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC 293
Query: 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKE 952
+L+ + H V + S F+L + P +RI +++
Sbjct: 294 SLIKYMEKHKVKPD---SKAFHLLQKLLTMDPIKRITSEQ 330
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 48/211 (22%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKV--------FTSQCGRAFKSFDVECEIM 732
+ + + + +G G + +VYK S VA+K R E ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLL 54
Query: 733 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 792
K ++H N++ + E+ LV EY+ L++YL I+++ + + L
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
Y H V+H DLKP N+L+++ L+DF +A+ + ++ + T+ Y
Sbjct: 114 AYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRP 168
Query: 853 PE--YGREGRVSANGDVYSFGIMLMETFTGK 881
P+ G S D++ G + E TG+
Sbjct: 169 PDILLGST-DYSTQIDMWGVGCIFYEMATGR 198
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 36/165 (21%), Positives = 69/165 (41%), Gaps = 29/165 (17%)
Query: 415 SIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDI 473
IP ++ + + L+ N + P FS LR + L +N+++ + F L+ +
Sbjct: 25 EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 474 LNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 533
+L N +T LP + F G L +L+ L L N++
Sbjct: 83 NSLVLYGNKIT-ELPKSL---------------FEG--------LFSLQLLLLNANKIN- 117
Query: 534 SIPN-SFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577
+ +F DL +L L+L +N L + + L ++ ++L+ N
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 22/87 (25%), Positives = 38/87 (43%), Gaps = 1/87 (1%)
Query: 500 IDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVI 559
I L +N + P K L + L N++ P++F L SL L L N ++ +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELP 96
Query: 560 PASLEKLSYLEDLNLSFNQLEGKIPRG 586
+ E L L+ L L+ N++ +
Sbjct: 97 KSLFEGLFSLQLLLLNANKIN-CLRVD 122
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 34/139 (24%), Positives = 56/139 (40%), Gaps = 9/139 (6%)
Query: 249 PNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
+ + L N IP F KL +DL N S P+ F LR+L+ LVL N
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
+T + L L + L+ L+ N + + +L H+L + + +
Sbjct: 91 KITELPKSL--FEGLFS---LQLLLLNANKINCL-RVDAFQDL-HNLNLLSLYDNKLQTI 143
Query: 368 IPEEISNLTNLRTIYLGGN 386
S L ++T++L N
Sbjct: 144 AKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 34/154 (22%), Positives = 65/154 (42%), Gaps = 17/154 (11%)
Query: 111 SIPSAIFT-TYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIP 169
IP+ + ++ L N + P S L+ +DLS+N + E+
Sbjct: 25 EIPTNLPETITEIR---LEQNTIKVIPPGAFSPYKKLRRIDLSNNQI---------SELA 72
Query: 170 RE-FGNLPELELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLK 227
+ F L L + L N + ++P + L +L+ L + NK+ + A ++ L
Sbjct: 73 PDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLN 131
Query: 228 ILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNF 261
+L L DN L ++ ++ L ++ + L N F
Sbjct: 132 LLSLYDNKLQT-IAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 32/134 (23%), Positives = 55/134 (41%), Gaps = 9/134 (6%)
Query: 278 LDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNP 337
+ LE N+ P F + L + LS+N ++ + L + L L N
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA--FQGLRS---LNSLVLYGNK 91
Query: 338 LYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI-SNLTNLRTIYLGGNKLNGSILITL 396
+ LP++ L SL+ ++ I+ + + +L NL + L NKL T
Sbjct: 92 I-TELPKSLFEGLF-SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF 148
Query: 397 SKLQKLQDLGLKDN 410
S L+ +Q + L N
Sbjct: 149 SPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 32/144 (22%), Positives = 59/144 (40%), Gaps = 13/144 (9%)
Query: 144 SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI-GNLRNL 202
++ + L N + I F +L + L+ N + ++ LR+L
Sbjct: 32 ETITEIRLEQNTIK-VIPPGA-------FSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 203 EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS 262
L + NK+ + + +L++L L N ++ CL + L NL +LSL+ N
Sbjct: 83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 263 GTIPRFIFNA-SKLSILDLEGNSF 285
TI + F+ + + L N F
Sbjct: 142 -TIAKGTFSPLRAIQTMHLAQNPF 164
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-16
Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 52/222 (23%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVEC-----EIMKSIRHRNLIK 742
+IGRG FG V +V A+K+ + K D +IM +++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKF--EMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA--------SALEY 794
+ + ++ + +V+EYMP G L + ++ A AL+
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAEVVLALDA 183
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQTL-ATIGYM 851
+H S IH D+KP N+LLD + H L+DF + E M++ T T Y+
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYI 236
Query: 852 APE----------YGREGRVSANGDVYSFGIMLMETFTGKKP 883
+PE YGRE D +S G+ L E G P
Sbjct: 237 SPEVLKSQGGDGYYGRE--C----DWWSVGVFLYEMLVGDTP 272
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 36/219 (16%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVEC-----EIMKSIRHRNLIK 742
+G G FG V + A+K+ Q + K +E I++++ L+K
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQ--KVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ S + +V+EY+ G + +L + R + EYLH S
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH---SLD 161
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE------Y 855
+I+ DLKP N+L+D ++DF AK + G +T TL T +APE Y
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEIILSKGY 215
Query: 856 GREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
+ V D ++ G+++ E G P +I+
Sbjct: 216 NKA--V----DWWALGVLIYEMAAGYPPFFADQPIQIYE 248
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 44/236 (18%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDV------ECEIMKSIRHRNLI 741
+G G FG V A+ +VA+K + Q K D+ E +K +RH ++I
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQ---LLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 742 K---VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALE 793
K VI++ + +V+EY G L Y+ + FQ++ A+E
Sbjct: 73 KLYDVITT-PTDIV--MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI------ICAIE 122
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
Y H ++H DLKP N+LLDDN+ ++DF ++ ++T D + ++T + + Y AP
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 176
Query: 854 E-YGREGRVSANGDVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVN 899
E + DV+S GI+L G+ P D+ + + + +++
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLS 232
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 45/219 (20%), Positives = 84/219 (38%), Gaps = 43/219 (19%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVEC-----EIMKSIRHRNLIK 742
+IGRG FG V L + +V A+K+ K + C +++ + + +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGDSKWITT 138
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID----------VASAL 792
+ + ++ LV++Y G L L + + + A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYLAEMVIAI 188
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQTL-ATIG 849
+ +H +H D+KP N+L+D N H L+DF L + +Q+ T
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDG--TVQSSVAVGTPD 241
Query: 850 YMAPEYGREGRVSANG-----DVYSFGIMLMETFTGKKP 883
Y++PE + D +S G+ + E G+ P
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 5/154 (3%)
Query: 428 RLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNFLTGS 486
+LDL L+ A F LT L ++L N+L ++ F +L ++ L ++N L S
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 487 LPLEI-GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNS-FGDLIS 544
LPL + L L + L N + L L+ L L N+LQ SIP F L +
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156
Query: 545 LKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578
L+ L+LS N L V + ++L L+ + L NQ
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 55/191 (28%), Positives = 81/191 (42%), Gaps = 37/191 (19%)
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICN-LAE 425
GIP + + L L T L KL L L N+L+ ++ + + L E
Sbjct: 32 GIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTE 84
Query: 426 LYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNFL 483
L L L N+L+ S+P F +LT L + LG N+L S+P F L + L ++N L
Sbjct: 85 LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143
Query: 484 TGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP-NSFGDL 542
S+P +G L NL+ L L N+LQ S+P +F L
Sbjct: 144 Q-SIP-------------------AGA----FDKLTNLQTLSLSTNQLQ-SVPHGAFDRL 178
Query: 543 ISLKFLNLSNN 553
L+ + L N
Sbjct: 179 GKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 1/86 (1%)
Query: 501 DLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP 560
DL + + GL L +L L YN+LQ F DL L L L+NN L+ +
Sbjct: 41 DLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPL 100
Query: 561 ASLEKLSYLEDLNLSFNQLEGKIPRG 586
+ L+ L+ L L NQL+ +P G
Sbjct: 101 GVFDHLTQLDKLYLGGNQLK-SLPSG 125
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 52/215 (24%), Positives = 77/215 (35%), Gaps = 71/215 (33%)
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
E L L + +KL+ L+L+ N F +L L L L++N L S
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
LP G+ +
Sbjct: 98 ------------------------------LPL----------------------GVFDH 105
Query: 372 ISNLTNLRTIYLGGNKL----NGSILITLSKLQKLQDLGLKDNKLEGSIP---YDICNLA 424
++ L L YLGGN+L +G +L KL++L L N+L+ SIP +D L
Sbjct: 106 LTQLDKL---YLGGNQLKSLPSG----VFDRLTKLKELRLNTNQLQ-SIPAGAFD--KLT 155
Query: 425 ELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSN 458
L L L N+L S+P F L L+ ++L N
Sbjct: 156 NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 20/195 (10%)
Query: 71 SQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRG 129
++ ++ +L ++PS G + + L+L L ++ A F T L ++ L
Sbjct: 13 NEGKKEVDCQGKSLD-SVPS--GIPADTEKLDLQSTGL-ATLSDATFRGLTKLTWLNLDY 68
Query: 130 NQLSGTFPSFISNK-SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNL 188
NQL T + + + + L L L++N L+ + + F +L +L+ + L N L
Sbjct: 69 NQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGV-------FDHLTQLDKLYLGGNQL 119
Query: 189 QGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFN-VSTLKILGLQDNSLSGCLSSIGYA 246
+ +P + L L++L + N+L I P F+ ++ L+ L L N L +
Sbjct: 120 K-SLPSGVFDRLTKLKELRLNTNQLQSI-PAGAFDKLTNLQTLSLSTNQLQSVPHGA-FD 176
Query: 247 RLPNLEILSLWGNNF 261
RL L+ ++L+GN F
Sbjct: 177 RLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 40/157 (25%), Positives = 60/157 (38%), Gaps = 10/157 (6%)
Query: 183 LAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFN-VSTLKILGLQDNSLSGCLS 241
L + L L L L++ N+L + +F+ ++ L LGL +N L+
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL-SAGVFDDLTELGTLGLANNQLASLPL 100
Query: 242 SIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLS 300
+ + L L+ L L GN ++P +F +KL L L N F L NL
Sbjct: 101 GV-FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQ 158
Query: 301 WLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNP 337
L LS N L S + L+ L N
Sbjct: 159 TLSLSTNQLQSVPH-----GAFDRLGKLQTITLFGNQ 190
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 54/252 (21%), Positives = 96/252 (38%), Gaps = 71/252 (28%)
Query: 690 IGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVI---- 744
+G G FG V + + G A+K + E +IMK + H N+IK++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 745 ----------------------------------SSCSNEEFKALVLEYMP---HGSLEK 767
+ S ++ +++EY+P H L+
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 768 YLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDF 826
++ S I + + + A+ ++H S + H D+KP N+L++ + L DF
Sbjct: 131 FIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 827 SIAKMLTGEDQSMIQTQTLATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFT 879
AK L + + + Y APE Y + + D++S G + E
Sbjct: 187 GSAKKLI-PSEPS--VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGELIL 237
Query: 880 GKKPTDEIFNGE 891
G KP +F+GE
Sbjct: 238 G-KP---LFSGE 245
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 62/302 (20%), Positives = 113/302 (37%), Gaps = 63/302 (20%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKV--------FTSQCGRAFKSFDVECEIMKSIRHRNL 740
+G G + +VYK + G+ VA+K S R E +MK ++H N+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-------EISLMKELKHENI 65
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYL 795
+++ E LV E+M + L+KY+ S L++ + L +
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE- 854
H ++H DLKP N+L++ L DF +A+ + + + T+ Y AP+
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPDV 179
Query: 855 -YGREGRVSANGDVYSFGIMLMETFTGK--------------------KPTDEIFNGEMT 893
G S + D++S G +L E TGK P + ++
Sbjct: 180 LMGSR-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 894 LKHWVND---WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA 950
L + + P +V+ + D + + + P R++A
Sbjct: 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLM----------DFLHGLLQLNPDMRLSA 288
Query: 951 KE 952
K+
Sbjct: 289 KQ 290
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 7e-15
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 40/221 (18%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVEC-----EIMKSIRHRNLIK 742
+G G FG V+ S +G A+KV + + VE ++ + H +I+
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKE--IVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ + + + ++++Y+ G L L S + + +V ALEYLH S
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCLALEYLH---SKD 126
Query: 803 VIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE----- 854
+I+ DLKP N+LLD N H ++DF AK + T TL T Y+APE
Sbjct: 127 IIYRDLKPENILLDKN--GHIKITDFGFAKYVPD------VTYTLCGTPDYIAPEVVSTK 178
Query: 855 -YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
Y + S D +SFGI++ E G P T + +
Sbjct: 179 PYNK----SI--DWWSFGILIYEMLAGYTPFYDSNTMKTYE 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 49/232 (21%), Positives = 86/232 (37%), Gaps = 50/232 (21%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVEC-----EIMKSIRHRNLIK 742
+IGRG F V + +V A+K+ K +V C +++ + R + +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKW--DMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID----------VASAL 792
+ + +E + LV+EY G L L + I + A+
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLL----------SKFGERIPAEMARFYLAEIVMAI 175
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQTL-ATIG 849
+ +H +H D+KP N+LLD H L+DF L + +++ T
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADG--TVRSLVAVGTPD 228
Query: 850 YMAPEYGREGRVSANGDVY-------SFGIMLMETFTGKKP-----TDEIFN 889
Y++PE + Y + G+ E F G+ P T E +
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSF-----DVEC-----EIMKSIRH 737
L+G+G FG V A+K+ K +V ++++ RH
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
L + S + V+EY G L +L + R ++ SAL+YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE-- 854
+ V++ DLK N++LD + ++DF + K + + +T T Y+APE
Sbjct: 267 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVL 321
Query: 855 ----YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
YGR V D + G+++ E G+ P +++F
Sbjct: 322 EDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 30/168 (17%)
Query: 415 SIPYDICNLAELYRLDLDGNKLSGSIP-ACFSNLTSLRIVSLGSNELTSIPL-TFWNLKD 472
IP I L L+ N+ + F L LR ++ +N++T I F
Sbjct: 25 KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 473 ILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 532
+ + +SN L ++ ++ F G L++L+ L L NR+
Sbjct: 83 VNEILLTSNRLE-NVQHKM---------------FKG--------LESLKTLMLRSNRIT 118
Query: 533 GSIPN-SFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
+ N SF L S++ L+L +N ++ V P + + L L LNL N
Sbjct: 119 -CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 8/138 (5%)
Query: 452 IVSLGSNELTSIPLTFWNL-KDILNLNFSSNFLTGSLPLEI-GSLKVLVGIDLSRNNFSG 509
V + +L IP ++ + L ++N T I L L I+ S N +
Sbjct: 15 TVDCSNQKLNKIPE---HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD 71
Query: 510 VIPTEIGGLKNLEYLFLGYNRLQGSIPNS-FGDLISLKFLNLSNNNLSGVIPASLEKLSY 568
+ G + + L NRL+ ++ + F L SLK L L +N ++ V S LS
Sbjct: 72 IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSS 130
Query: 569 LEDLNLSFNQLEGKIPRG 586
+ L+L NQ+ + G
Sbjct: 131 VRLLSLYDNQIT-TVAPG 147
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 20/113 (17%), Positives = 44/113 (38%), Gaps = 4/113 (3%)
Query: 201 NLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGN 259
+L + +N+ + IF + L+ + +N ++ + + + + L N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSN 91
Query: 260 NFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
+ +F L L L N + ++F L ++ L L DN +T+
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT 143
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 37/203 (18%), Positives = 73/203 (35%), Gaps = 49/203 (24%)
Query: 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTT 119
C T V C S+ L IP + L L+ N + IF
Sbjct: 11 CEGTTVDC------------SNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKK 55
Query: 120 YTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELE 179
L+ ++ S+N ++ +I F +
Sbjct: 56 LP-----------------------QLRKINFSNNKIT-DIEEGA-------FEGASGVN 84
Query: 180 LMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSG 238
+ L +N L+ + K+ L +L+ L + N++ + + +S++++L L DN ++
Sbjct: 85 EILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT 143
Query: 239 CLSSIGYARLPNLEILSLWGNNF 261
++ + L +L L+L N F
Sbjct: 144 -VAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 33/163 (20%), Positives = 54/163 (33%), Gaps = 42/163 (25%)
Query: 278 LDLEGNSFSGFIPN-TFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYN 336
L L N F+ F L L + S+N +T E S + L+ N
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT--DIEEGAFEGASG---VNEILLTSN 91
Query: 337 PLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKL----NGSI 392
L + + FK L +L+T+ L N++ N
Sbjct: 92 RLENVQHKM-----------FK---------------GLESLKTLMLRSNRITCVGND-- 123
Query: 393 LITLSKLQKLQDLGLKDNKLEGSIPYDI-CNLAELYRLDLDGN 434
+ L ++ L L DN++ ++ L L L+L N
Sbjct: 124 --SFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 65/282 (23%), Positives = 116/282 (41%), Gaps = 64/282 (22%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVK----VFTSQ--CGRAFKSFDVECEIMKSIR-HRNLI 741
+G+G +G V+K+ G VAVK F + R F+ E I+ + H N++
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIV 72
Query: 742 KVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+++ + + LV +YM L + ++ IL+ + ++ + ++YLH
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH--- 126
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ------------------ 841
S ++H D+KPSN+LL+ ++DF +++ +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 842 -TQTLATIGYMAPE-------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 893
T +AT Y APE Y + D++S G +L E G KP IF G
Sbjct: 187 LTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCG-KP---IFPG--- 233
Query: 894 LKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 935
+N I + V+D S ED+ + + + +L
Sbjct: 234 -SSTMNQLERI--IGVIDF--PSNEDVESIQSPFAKTMIESL 270
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 67/374 (17%), Positives = 121/374 (32%), Gaps = 86/374 (22%)
Query: 92 LGNLSSLQSLNLSFNRL----FGSIPSAIFTTYTLKYVCLRGNQLSGT----FPSFISNK 143
+ S ++ +L + + S+ + + ++K + L GN + I++K
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 144 SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLE 203
L+ + S + EIP L + +L L
Sbjct: 60 KDLEIAEFSDIFTG-----RVKDEIPEALRLLLQ----ALLKC-------------PKLH 97
Query: 204 KLDIGDNKL--VGIAPIA--IFNVSTLKILGLQDNSLS-GCLSSIGYARLPNLEILSLWG 258
+ + DN P+ + + L+ L L +N L + I A L L +
Sbjct: 98 TVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-LQELAVNKKAK 156
Query: 259 NNFSGTIPRFIFNASKLSILDLEGNSFSG----FIPNTFGNLRNLSWLVLSDNYLTSSTQ 314
N L + N TF + R L + + N +
Sbjct: 157 NA------------PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 315 ELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISN 374
E L L+ C+ LK DL N T +G S + + +
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTF------THLG----------------SSALAIALKS 242
Query: 375 LTNLRTIYLGGNKL--NGSILI----TLSKLQKLQDLGLKDNKLEGSIPYDIC-----NL 423
NLR + L L G+ + + + LQ L L+ N++E + +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 302
Query: 424 AELYRLDLDGNKLS 437
+L L+L+GN+ S
Sbjct: 303 PDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 39/262 (14%), Positives = 81/262 (30%), Gaps = 45/262 (17%)
Query: 353 SLEEFKMSNCNISG----GIPEEISNLTNLRTIYLGGNKLN--GSILI--TLSKLQKLQD 404
S+E + I+ + + +++ I L GN + + + ++ + L+
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 405 LGLKDN---KLEGSIPYDICNLAE-------LYRLDLDGNKLSG----SIPACFSNLTSL 450
D +++ IP + L + L+ + L N + S T L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 451 RIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGV 510
+ L +N L + L + + PL I RN
Sbjct: 125 EHLYLHNNGLGPQAGAK--IARALQELAVNKKAKNAPPLRS--------IICGRNRLENG 174
Query: 511 ----IPTEIGGLKNLEYLFLGYNRL-----QGSIPNSFGDLISLKFLNLSNNNLSG---- 557
+ L + + N + + + LK L+L +N +
Sbjct: 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 234
Query: 558 VIPASLEKLSYLEDLNLSFNQL 579
+ +L+ L +L L+ L
Sbjct: 235 ALAIALKSWPNLRELGLNDCLL 256
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 59/358 (16%), Positives = 106/358 (29%), Gaps = 99/358 (27%)
Query: 251 LEILSLWGNNFSG----TIPRFIFNASKLSILDLEGNSFSG----FIPNTFGNLRNLSWL 302
+E SL + + ++ + + + L GN+ ++ + ++L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 303 VLSDNYLTSSTQEL-----SFLSSLSNCKFLKYFDLSYN--------PLYRILPRTTVGN 349
SD + E+ L +L C L LS N PL L +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK----- 120
Query: 350 LSHSLEEFKMSNCNIS-------------GGIPEEISNLTNLRTIYLGGNKL--NGSILI 394
LE + N + + ++ N LR+I G N+L
Sbjct: 121 -HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179
Query: 395 --TLSKLQKLQDLGLKDNKL-----EGSIPYDICNLAELYRLDLDGNKLSG----SIPAC 443
T + L + + N + E + + EL LDL N + ++
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239
Query: 444 FSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLS 503
+ +LR + L L++ G+ V+
Sbjct: 240 LKSWPNLRELGLNDCLLSAR----------------------------GAAAVVDAFSKL 271
Query: 504 RNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLI-----SLKFLNLSNNNLS 556
N L+ L L YN ++ + +I L FL L+ N S
Sbjct: 272 EN-------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 56/322 (17%), Positives = 98/322 (30%), Gaps = 73/322 (22%)
Query: 295 NLRNLSWLVLSDNYLT-SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHS 353
++ +VLS N + + + LS ++++ K L+ + S R+
Sbjct: 30 EDDSVKEIVLSGNTIGTEAARWLS--ENIASKKDLEIAEFSDIFTGRVKDEIPEALRL-- 85
Query: 354 LEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKL--NGSILIT--LSKLQKLQDLGLKD 409
+ + + L T+ L N + LSK L+ L L +
Sbjct: 86 --------------LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHN 131
Query: 410 NKL-------------EGSIPYDICNLAELYRLDLDGNKLSG----SIPACFSNLTSLRI 452
N L E ++ N L + N+L F + L
Sbjct: 132 NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191
Query: 453 VSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSG--- 509
V + N + ++ +L + LKVL DL N F+
Sbjct: 192 VKMVQNGIRPE-----GIEHLLLEGLAYC----------QELKVL---DLQDNTFTHLGS 233
Query: 510 -VIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLI------SLKFLNLSNNNLSG----V 558
+ + NL L L L + D L+ L L N +
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 293
Query: 559 IPASL-EKLSYLEDLNLSFNQL 579
+ + EK+ L L L+ N+
Sbjct: 294 LKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 36/195 (18%), Positives = 61/195 (31%), Gaps = 47/195 (24%)
Query: 87 TIPSQLGNLSSLQSLNLSFNRLFG----SIPSAIFTTYTLKYVCLRGNQL-----SGTFP 137
+ + N L+S+ NRL + L V + N +
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 138 SFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIG 197
++ L+ LDL N + + + +L +
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAI---------------ALKSW----------- 243
Query: 198 NLRNLEKLDIGDNKL--VGIAPIA----IFNVSTLKILGLQDNSLSG----CLSSIGYAR 247
NL +L + D L G A + L+ L LQ N + L ++ +
Sbjct: 244 --PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 301
Query: 248 LPNLEILSLWGNNFS 262
+P+L L L GN FS
Sbjct: 302 MPDLLFLELNGNRFS 316
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 26/221 (11%)
Query: 678 CRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVK-VFTSQCGRAFKSFDVEC--EI-- 731
AT + IG G +G+VYKA G VA+K V G + E+
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 732 ---MKSIRHRN---LIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCI-LDIFQRL 782
+++ H N L+ V ++ + LV E++ L YL + L
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 783 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQT 842
++M L++LH + ++H DLKP N+L+ L+DF +A++ ++ T
Sbjct: 124 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMAL--T 177
Query: 843 QTLATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGK 881
+ T+ Y APE + D++S G + E F K
Sbjct: 178 PVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 36/171 (21%), Positives = 64/171 (37%), Gaps = 48/171 (28%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDV--ECEIMKSI-RHRNLIKVI- 744
+G G G V + + A+K+ E E+ + ++++++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78
Query: 745 ---SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--------------NIMID 787
+ + + +V+E + G L F R+ IM
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGE 835
+ A++YLH S + H D+KP N+L N + L+DF AK TGE
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 40/240 (16%), Positives = 84/240 (35%), Gaps = 46/240 (19%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR--------HRN 739
+G G F +V+ A + + VA+K+ ++ + E ++++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 740 LIKVISSCSNEEFKA-------LVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMI 786
++ + K +V E + +L + + + I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-----HRGIPLIYVKQISK 138
Query: 787 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH------LSDFSIAKMLTGEDQSMI 840
+ L+Y+H +IH D+KP NVL++ ++D A + I
Sbjct: 139 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVND 900
QT+ Y +PE D++S ++ E TG +F + + +D
Sbjct: 197 QTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFEPDEGHSYTKDD 247
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 46/238 (19%)
Query: 678 CRATDGFSENNLIGRGGFGSVYKA--SLGDGMEVAVKV---------FTSQCGRAFKSFD 726
CRA + IG G +G V+KA G VA+K R
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------ 60
Query: 727 VECEI-----MKSIRHRN---LIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYS-SNCI 775
E+ +++ H N L V + + LV E++ L YL
Sbjct: 61 ---EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116
Query: 776 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835
+ ++M + L++LH S V+H DLKP N+L+ + L+DF +A++
Sbjct: 117 VPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SF 172
Query: 836 DQSMIQTQTLATIGYMAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
++ T + T+ Y APE + D++S G + E F +KP +F G
Sbjct: 173 QMAL--TSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFR-RKP---LFRGS 222
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 43/224 (19%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSF-----DVEC-----EIMKSIRH 737
L+G+G FG V A+K+ K +V ++++ RH
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILR-------KEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
L + + + V+EY G L +L + R ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH- 122
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE-- 854
S V++ D+K N++LD + ++DF + K + + +T T Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVL 177
Query: 855 ----YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
YGR V D + G+++ E G+ P + +F
Sbjct: 178 EDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 55/231 (23%)
Query: 689 LIGRGGFGSVY---KASLGDGMEV-AVKVFTSQCGRAFKSF-----DVEC----EIMKSI 735
++G+G FG V+ K S D ++ A+KV K+ V +I+ +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKMERDILVEV 83
Query: 736 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASAL 792
H ++K+ + E L+L+++ G L L F + + + ++A AL
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM----FTEEDVKFYLAELALAL 139
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQTL-ATIG 849
++LH S +I+ DLKP N+LLD+ H L+DF ++K ++ + T+
Sbjct: 140 DHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFCGTVE 191
Query: 850 YMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
YMAPE + + SA D +SFG+++ E TG P E
Sbjct: 192 YMAPEVVNRRGHTQ----SA--DWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 59/238 (24%), Positives = 96/238 (40%), Gaps = 67/238 (28%)
Query: 689 LIGRGGFGSVY---KASLGDGMEV-AVKVFTSQCGRAFKSF------DVEC-----EIMK 733
++G+GG+G V+ K + + ++ A+KV K+ D I++
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILE 76
Query: 734 SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA---- 789
++H ++ +I + L+LEY+ G L L IF M D A
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----IF-----MEDTACFYL 127
Query: 790 ----SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQ 843
AL +LH +I+ DLKP N++L+ H L+DF + K + T
Sbjct: 128 AEISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---TH 179
Query: 844 TLA-TIGYMAPE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
T TI YMAPE + R V D +S G ++ + TG P + +
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPPFTGENRKKTID 231
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 28/165 (16%)
Query: 415 SIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDI 473
S+P I L L N+++ P F +L +L+ + LGSN+L ++P+ F +L +
Sbjct: 33 SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 474 LNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 533
L+ +N LT LP S V L +L+ LF+ N+L
Sbjct: 91 TVLDLGTNQLT-VLP-------------------SAVF----DRLVHLKELFMCCNKLT- 125
Query: 534 SIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578
+P L L L L N L + + ++LS L L N
Sbjct: 126 ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 40/142 (28%), Positives = 64/142 (45%), Gaps = 12/142 (8%)
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICN-LAE 425
GIP TN + +YL N++ L L++L L N+L ++P + + L +
Sbjct: 37 GIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89
Query: 426 LYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLT 484
L LDL N+L+ +P+ F L L+ + + N+LT +P L + +L N L
Sbjct: 90 LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLK 148
Query: 485 GSLPLEI-GSLKVLVGIDLSRN 505
S+P L L L N
Sbjct: 149 -SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 45/187 (24%), Positives = 60/187 (32%), Gaps = 66/187 (35%)
Query: 277 ILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYN 336
IL L N + P F +L NL L L N L +
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA------------------------- 78
Query: 337 PLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITL 396
LP G+ + ++ LT L LG N+L L
Sbjct: 79 -----LP----------------------VGVFDSLTQLTVL---DLGTNQLT-----VL 103
Query: 397 S-----KLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLR 451
+L L++L + NKL +P I L L L LD N+L F L+SL
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162
Query: 452 IVSLGSN 458
L N
Sbjct: 163 HAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 45/178 (25%), Positives = 74/178 (41%), Gaps = 30/178 (16%)
Query: 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTT 119
C+ T V C S+R ++P+ G ++ Q L L N++ + +F +
Sbjct: 19 CSGTTVDC--RSKRHA-----------SVPA--GIPTNAQILYLHDNQI-TKLEPGVFDS 62
Query: 120 YT-LKYVCLRGNQLSGTFPSFISNK-SSLQHLDLSSNALSGEIRANICREIP-REFGNLP 176
LK + L NQL P + + + L LDL +N L+ +P F L
Sbjct: 63 LINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT---------VLPSAVFDRLV 112
Query: 177 ELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDN 234
L+ + + N L ++P I L +L L + N+L I A +S+L L N
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 29/110 (26%), Positives = 47/110 (42%), Gaps = 4/110 (3%)
Query: 203 EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS 262
+ L + DN++ + P ++ LK L L N L L + L L +L L N +
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101
Query: 263 GTIPRFIFNA-SKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
+P +F+ L L + N + +P L +L+ L L N L S
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS 149
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 25/76 (32%), Positives = 36/76 (47%), Gaps = 7/76 (9%)
Query: 511 IPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLE 570
IPT N + L+L N++ P F LI+LK L L +N L + + L+ L
Sbjct: 38 IPT------NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91
Query: 571 DLNLSFNQLEGKIPRG 586
L+L NQL +P
Sbjct: 92 VLDLGTNQLT-VLPSA 106
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 34/159 (21%), Positives = 47/159 (29%), Gaps = 32/159 (20%)
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
+IL L N + P + L L L N F +L L+ L L N LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
+ L + LK + N L +P
Sbjct: 103 --LPSAVFDRLVH---LKELFMCCNKLTE---------------------------LPRG 130
Query: 372 ISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDN 410
I LT+L + L N+L +L L L N
Sbjct: 131 IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 3e-12
Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 50/228 (21%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSF-----DVECEIM------KSIR 736
++G+G FG V + E+ AVK+ K DVEC ++ +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGK 400
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALE 793
L ++ S + V+EY+ G L ++ F ++A L
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLF 456
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMA 852
+L S +I+ DLK NV+LD ++DF + K + T+T T Y+A
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIA 510
Query: 853 PE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
PE YG+ V D ++FG++L E G+ P DE+F
Sbjct: 511 PEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 44/282 (15%), Positives = 99/282 (35%), Gaps = 38/282 (13%)
Query: 92 LGNLSSLQSLNLSFNRLFGSIPSAIF-----TTYTLKYVCLRGNQLSGT-----FPSFIS 141
+ SL+LS N L+ + T ++ + L GN L +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 142 NKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNL-- 199
+++ L+LS N LS + + + + + L+L N+ K +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW---NDFSSKSSSEFKQAFS 134
Query: 200 ---RNLEKLDIGDNKL-----VGIAPIAIFNVSTLKILGLQDNSLS--GC--LSSIGYAR 247
++ L++ N L + I + + L L+ N+L+ C L+ +
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI 194
Query: 248 LPNLEILSLWGNNFSGTIPRFI-----FNASKLSILDLEGNSFSG----FIPNTFGNLRN 298
++ L L N + + + L+L N G + +L++
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254
Query: 299 LSWLVLSDNYLTSSTQEL--SFLSSLSNCKFLKYFDLSYNPL 338
L + L + + + ++E + ++ N + + D + +
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 50/305 (16%), Positives = 96/305 (31%), Gaps = 54/305 (17%)
Query: 138 SFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIG 197
F S + LDLS N L + + ++ L +L+ N+L K ++
Sbjct: 16 EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSL---NLSGNSLGFKNSDELV 72
Query: 198 -----NLRNLEKLDIGDNKL-----VGIAPIAIFNVSTLKILGLQDNSLS--GC--LSSI 243
N+ L++ N L + T+ +L L N S
Sbjct: 73 QILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA 132
Query: 244 GYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLV 303
++ L+L GN+ + + N+ +L+
Sbjct: 133 FSNLPASITSLNLRGNDLG----------------IKSSDELIQILAAIPANVNSLN--- 173
Query: 304 LSDNYLTSS-TQELSFLSSLSNCKFLKYFDLSYNPL----YRILPRTTVGNLSHSLEEFK 358
L N L S EL+ + + DLS N L Y L +H +
Sbjct: 174 LRGNNLASKNCAELAKFLASIPAS-VTSLDLSANLLGLKSYAELAYIFSSIPNH-VVSLN 231
Query: 359 MSNCNISG----GIPEEISNLTNLRTIYLGGNKLNG-------SILITLSKLQKLQDLGL 407
+ + G + +L +L+T+YL + + ++ +QK+ +
Sbjct: 232 LCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDK 291
Query: 408 KDNKL 412
++
Sbjct: 292 NGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 56/310 (18%), Positives = 109/310 (35%), Gaps = 58/310 (18%)
Query: 322 LSNCKFLKYFDLSYNPLYRILPRTTVGNLSH---SLEEFKMSNCNISGGIPEEI-----S 373
S + DLS N LY I + ++ S+ +S ++ +E+ +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 374 NLTNLRTIYLGGNKLNGSILITLSKL-----QKLQDLGLKDNKLEGSIPYDICNL----- 423
N+ ++ L GN L+ L K + L L N +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 424 AELYRLDLDGNK--------LSGSIPACFSNLTSLRIVSLGSNELTSI-------PLTFW 468
A + L+L GN L + A +N+ SL L N L S L
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLN---LRGNNLASKNCAELAKFLASI 194
Query: 469 NLKDILNLNFSSNFLTGSLPLEIGSL-----KVLVGIDLSRNNFSGVIPTEIGGL----K 519
+ +L+ S+N L E+ + +V ++L N G + L K
Sbjct: 195 PAS-VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLK 253
Query: 520 NLEYLFLGYNRLQG-------SIPNSFGDLISLKFLNLSNNNL--SGV--IPASLEKLSY 568
+L+ ++L Y+ ++ ++ +F ++ + ++ + + S I + +LS
Sbjct: 254 HLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSG 313
Query: 569 -LEDLNLSFN 577
+ +L
Sbjct: 314 KADVPSLLNQ 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 48/272 (17%), Positives = 84/272 (30%), Gaps = 58/272 (21%)
Query: 359 MSNCNISG----GIPEEISNLTNLRTIYLGGNKLNGSILITLSKL-----QKLQDLGLKD 409
M+ + E S + ++ L N L + L + + L L
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 410 NKLEGSIPYDIC-----NLAELYRLDLDGNK--------LSGSIPACFSNLTSLRIVSLG 456
N L ++ A + L+L GN L ++ A +T L LG
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLD---LG 117
Query: 457 SNELTSI-------PLTFWNLKDILNLNFSSN--------FLTGSLPLEIGSLKVLVGID 501
N+ +S + I +LN N L L ++ L +
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPAS-ITSLNLRGNDLGIKSSDELIQILAAIPANVNSL---N 173
Query: 502 LSRNNFSGVIPTEIGGL-----KNLEYLFLGYNRLQGSIPNSFGDLI-----SLKFLNLS 551
L NN + E+ ++ L L N L + + LNL
Sbjct: 174 LRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLC 233
Query: 552 NNNLSGV----IPASLEKLSYLEDLNLSFNQL 579
N L G + + L +L+ + L ++ +
Sbjct: 234 LNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV 265
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 49/220 (22%), Positives = 95/220 (43%), Gaps = 46/220 (20%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTS-QCGRAFKSFDVECEIMKSIR-HRNLIK---- 742
+GRG + V++A + + +V VK+ + + + E +I++++R N+I
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGY 799
V S ALV E++ + ++ + + +++ L AL+Y H
Sbjct: 100 VKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCH--- 147
Query: 800 SAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE---- 854
S ++H D+KP NV++D ++ L D+ +A+ Q +A+ + PE
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEY--NVRVASRYFKGPELLVD 204
Query: 855 ---YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
Y + D++S G ML K+P F+G
Sbjct: 205 YQMY------DYSLDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 44/225 (19%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSF-----DVECEIM------KSIR 736
++G+G FG V A + + ++ AVKV K DVEC + +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLK-------KDVILQDDDVECTMTEKRILSLARN 82
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
H L ++ + V+E++ G L ++ S + R ++ SAL +LH
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH 141
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE- 854
+I+ DLK NVLLD L+DF + K + T T T Y+APE
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPEI 195
Query: 855 -----YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
YG V D ++ G++L E G P D++F
Sbjct: 196 LQEMLYGPA--V----DWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 34/118 (28%), Positives = 59/118 (50%), Gaps = 12/118 (10%)
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDIC-NLAE 425
GIP +++ L YL GN+ + LS + L + L +N++ ++ N+ +
Sbjct: 28 GIPRDVTEL------YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79
Query: 426 LYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSN 481
L L L N+L IP F L SLR++SL N+++ +P F +L + +L +N
Sbjct: 80 LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 26/86 (30%), Positives = 41/86 (47%), Gaps = 2/86 (2%)
Query: 501 DLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP 560
L N F+ ++P E+ K+L + L NR+ SF ++ L L LS N L + P
Sbjct: 37 YLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPP 95
Query: 561 ASLEKLSYLEDLNLSFNQLEGKIPRG 586
+ + L L L+L N + +P G
Sbjct: 96 RTFDGLKSLRLLSLHGNDIS-VVPEG 120
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 34/153 (22%), Positives = 52/153 (33%), Gaps = 52/153 (33%)
Query: 403 QDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELT 461
+L L N+ +P ++ N L +DL N++S ++ FSN+T L + L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 462 SIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNL 521
IP GLK+L
Sbjct: 92 CIP-------------------------------------------PRT----FDGLKSL 104
Query: 522 EYLFLGYNRLQGSIPN-SFGDLISLKFLNLSNN 553
L L N + +P +F DL +L L + N
Sbjct: 105 RLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 37/141 (26%), Positives = 58/141 (41%), Gaps = 32/141 (22%)
Query: 440 IPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVG 499
IP ++T L L N+ T +P N K + ++ S+N ++ +L
Sbjct: 29 IPR---DVTELY---LDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLS----------- 70
Query: 500 IDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPN-SFGDLISLKFLNLSNNNLSGV 558
+ + L L L YNRL+ IP +F L SL+ L+L N++S V
Sbjct: 71 --------NQS----FSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVV 117
Query: 559 IPASLEKLSYLEDLNLSFNQL 579
+ LS L L + N L
Sbjct: 118 PEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 29/102 (28%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 183 LAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSS 242
L N +P ++ N ++L +D+ +N++ ++ + N++ L L L N L C+
Sbjct: 38 LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPP 95
Query: 243 IGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGN 283
+ L +L +LSL GN+ S +P F + S LS L + N
Sbjct: 96 RTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 36/140 (25%), Positives = 61/140 (43%), Gaps = 26/140 (18%)
Query: 60 CNWTGVACEVHSQRVTVL------NISSLNLTG----TIPSQLGNLSSLQSLNLSFNRLF 109
C T V C ++ + VL +++ L L G +P +L N L ++LS NR+
Sbjct: 10 CLDTVVRC--SNKGLKVLPKGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRI- 66
Query: 110 GSIPSAIFTTYT-LKYVCLRGNQLSGTFPSFISNK-SSLQHLDLSSNALSGEIRANICRE 167
++ + F+ T L + L N+L P + SL+ L L N +S
Sbjct: 67 STLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS---------V 116
Query: 168 IPRE-FGNLPELELMSLAAN 186
+P F +L L +++ AN
Sbjct: 117 VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 34/136 (25%)
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
L L GN F+ +P+ + N L+++DL N S +F N+ L L+LS N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
+F L + L+ L N + +PE
Sbjct: 92 CIPPRTF-DGLKS---LRLLSLHGNDISV---------------------------VPEG 120
Query: 372 I-SNLTNLRTIYLGGN 386
++L+ L + +G N
Sbjct: 121 AFNDLSALSHLAIGAN 136
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 48/227 (21%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSF-----DVECEIM------KSIR 736
++G+G FG V+ A + A+K K DVEC ++ +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALK-------KDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
H L + + +E V+EY+ G L ++ S + ++ L++LH
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-EIILGLQFLH 135
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAP 853
S +++ DLK N+LLD + H ++DF + K D T T T Y+AP
Sbjct: 136 ---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAP 187
Query: 854 E------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
E Y D +SFG++L E G+ P +E+F+
Sbjct: 188 EILLGQKYNHS------VDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 64/227 (28%), Positives = 95/227 (41%), Gaps = 48/227 (21%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSF-----DVECEIM------KSIR 736
+IG+G FG V A AVKV K + + + K+++
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQ-------KKAILKKKEEKHIMSERNVLLKNVK 97
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
H L+ + S + VL+Y+ G L +L C L+ R ++ASAL YLH
Sbjct: 98 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLH 156
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAP 853
S +++ DLKP N+LLD H L+DF + K + + T T T Y+AP
Sbjct: 157 ---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAP 208
Query: 854 E------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
E Y R V D + G +L E G P T E+++
Sbjct: 209 EVLHKQPYDRT--V----DWWCLGAVLYEMLYGLPPFYSRNTAEMYD 249
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 30/150 (20%), Positives = 58/150 (38%), Gaps = 15/150 (10%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI-KVISSC 747
IG G FG +++ +L + +VA+K + E K + I V
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
LV++ + SLE L + + + ++ +H +++ D
Sbjct: 76 QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131
Query: 808 LKPSNVLL------DDNMVAHLSDFSIAKM 831
+KP N L+ + NM+ ++ DF + K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVKF 160
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 17/150 (11%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI-KVISSC 747
IG G FG + +L VA+K+ + +E K + + I +V
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 748 SNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
++ A+VLE + G SLE + + L I I + S +EY+H S +I+
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129
Query: 807 DLKPSNVLL------DDNMVAHLSDFSIAK 830
D+KP N L+ ++ H+ DF++AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 54/230 (23%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSF-----DVECEIM------KSIR 736
++G+G FG V + E+ AVK+ K DVEC ++ +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILK-------KDVVIQDDDVECTMVEKRVLALPGK 79
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALE 793
L ++ S + V+EY+ G L ++ F ++A L
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLF 135
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQTL-ATIGY 850
+L S +I+ DLK NV+LD H ++DF + K + T+T T Y
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGV---TTKTFCGTPDY 187
Query: 851 MAPE------YGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIFN 889
+APE YG+ V D ++FG++L E G+ P DE+F
Sbjct: 188 IAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 11/147 (7%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI-KVISSC 747
IG G FG +Y + G EVA+K+ + +E +I K ++ I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
+ ++ +V+E + SLE + + L + + S +EY+H S IH D
Sbjct: 75 AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130
Query: 808 LKPSNVLL---DDNMVAHLSDFSIAKM 831
+KP N L+ + ++ DF +AK
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 54/172 (31%), Positives = 74/172 (43%), Gaps = 29/172 (16%)
Query: 409 DNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TF 467
++ S+P I A+ LDL+ N L F LTSL + LG N+L S+P F
Sbjct: 15 YSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72
Query: 468 WNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLG 527
L + LN S+N L SLP +GV L L+ L L
Sbjct: 73 NKLTSLTYLNLSTNQLQ-SLP-------------------NGVFDK----LTQLKELALN 108
Query: 528 YNRLQGSIPN-SFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578
N+LQ S+P+ F L LK L L N L V ++L+ L+ + L N
Sbjct: 109 TNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 29/154 (18%)
Query: 403 QDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELT 461
L L+ N L+ L L +L L GNKL S+P F+ LTSL ++L +N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 462 SIPL-TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKN 520
S+P F L + L ++N L SLP GV L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLP-------------------DGVFDK----LTQ 125
Query: 521 LEYLFLGYNRLQGSIPN-SFGDLISLKFLNLSNN 553
L+ L L N+L+ S+P+ F L SL+++ L +N
Sbjct: 126 LKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 1/86 (1%)
Query: 501 DLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP 560
DL N+ + L +L L+LG N+LQ F L SL +LNLS N L +
Sbjct: 34 DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPN 93
Query: 561 ASLEKLSYLEDLNLSFNQLEGKIPRG 586
+KL+ L++L L+ NQL+ +P G
Sbjct: 94 GVFDKLTQLKELALNTNQLQ-SLPDG 118
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 13/143 (9%)
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICN-LAE 425
GIP + + L L N L +L L L L NKL+ S+P + N L
Sbjct: 25 GIPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 426 LYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNFL 483
L L+L N+L S+P F LT L+ ++L +N+L S+P F L + +L N L
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136
Query: 484 TGSLPLEI-GSLKVLVGIDLSRN 505
S+P + L L I L N
Sbjct: 137 K-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 29/110 (26%), Positives = 45/110 (40%), Gaps = 3/110 (2%)
Query: 203 EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS 262
LD+ N L + +++L L L N L L + + +L +L L+L N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 263 GTIPRFIFNA-SKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
++P +F+ ++L L L N F L L L L N L S
Sbjct: 90 -SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS 138
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 42/159 (26%), Positives = 67/159 (42%), Gaps = 21/159 (13%)
Query: 106 NRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANIC 165
++ S+P+ I T Y+ L N L +SL L L N L + +
Sbjct: 16 SQGRTSVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGV- 71
Query: 166 REIPREFGNLPELELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDNKLVGIAPIAIFNVS 224
F L L ++L+ N LQ +P + L L++L + N+L + P +F+
Sbjct: 72 ------FNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSL-PDGVFDKL 123
Query: 225 T-LKILGLQDNSLSGCLSSI---GYARLPNLEILSLWGN 259
T LK L L N L S+ + RL +L+ + L N
Sbjct: 124 TQLKDLRLYQNQ----LKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 35/169 (20%)
Query: 60 CNWTGVACEVHSQRVT-----------VLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRL 108
C+ T V C +SQ T L++ + +L L+SL L L N+L
Sbjct: 7 CSGTTVEC--YSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL 64
Query: 109 FGSIPSAIFTTYT-LKYVCLRGNQL----SGTFPSFISNKSSLQHLDLSSNALSGEIRAN 163
S+P+ +F T L Y+ L NQL +G F + L+ L L++N L
Sbjct: 65 -QSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKL----TQLKELALNTNQLQ------ 113
Query: 164 ICREIPRE-FGNLPELELMSLAANNLQGKIPLKI-GNLRNLEKLDIGDN 210
+P F L +L+ + L N L+ +P + L +L+ + + DN
Sbjct: 114 ---SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 9/136 (6%)
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
L L N+ + L+ L L GN F L +L++L LS N L S
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
L+ LK L+ N L LP L+ L++ ++ N +P+
Sbjct: 91 --LPNGVFDKLTQ---LKELALNTNQLQS-LPDGVFDKLT-QLKDLRLYQ-NQLKSVPDG 142
Query: 372 I-SNLTNLRTIYLGGN 386
+ LT+L+ I+L N
Sbjct: 143 VFDRLTSLQYIWLHDN 158
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 1e-10
Identities = 98/631 (15%), Positives = 177/631 (28%), Gaps = 202/631 (32%)
Query: 266 PRFIFNASKLSILDLEGNSFSG----FI---PNTFGNLRNLSWL---------------V 303
F+ N + D+ + S I + L W V
Sbjct: 27 DAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV 86
Query: 304 LSDNY--LTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSN 361
L NY L S + S+ +++ D YN
Sbjct: 87 LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY----------------- 129
Query: 362 CNISGGIPEEISNLTN----LR-----TIY--LGGNKLNGSILITLSKLQKLQDLGLKDN 410
N+S + L LR I LG K + +
Sbjct: 130 -NVS--RLQPYLKLRQALLELRPAKNVLIDGVLGSGK---TWVALDV---------CLSY 174
Query: 411 KLEGSIPYDI-------CNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSI 463
K++ + + I CN E L KL I N TS S+ ++I
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEML--QKLLYQID---PNWTSR------SDHSSNI 223
Query: 464 PLTFWNLKDILNLNFSSNFLTGSL-------------PLEIGSLKVLVGIDLSRNNFSGV 510
L +++ L S L + K+L+ +R V
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC-KILL---TTRF--KQV 277
Query: 511 IPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLS-----------GVI 559
T+ ++ L ++ + + + LK+L+ +L +I
Sbjct: 278 --TDFLSAATTTHISLDHHSMTLTPDEVKS--LLLKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 560 PASLEK----LSYLEDLN---------LSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGS 606
S+ + +N S N LE R F S F
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK-MFDRLSV--FP-------- 382
Query: 607 PNLQIPP----------------------CKTSIHHKSWKKSI--LLGIVLPLSTTFMIV 642
P+ IP K S+ K K+S + I L L
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE 442
Query: 643 VIL---LILRYRQRGKRPSNDANGPLVASRRMFSY----LELCRATDGFSENNLIGRGGF 695
L ++ Y S+D P + +S+ L+ + + F
Sbjct: 443 YALHRSIVDHYNIPKTFDSDDL-IPPYLDQYFYSHIGHHLKNIEHPERMTL--------F 493
Query: 696 GSVYKASLGDG-MEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNE-EFK 753
V+ L +E ++ ++ + + ++ ++ I C N+ +++
Sbjct: 494 RMVF---LDFRFLEQKIRHDSTAWNASGSILNTLQQLKF---YKPYI-----CDNDPKYE 542
Query: 754 ALV---LEYMPHGSLEKYLYSSNCILDIFQR 781
LV L+++P +E+ L S D+ +
Sbjct: 543 RLVNAILDFLP--KIEENLICSKY-TDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 2e-09
Identities = 77/543 (14%), Positives = 158/543 (29%), Gaps = 125/543 (23%)
Query: 112 IPSAIFTTYTLKYVCLRGNQLSGTFPSFI----SNKSSLQH-----LDLSSNALSGEIRA 162
+P +I + + ++ + + +SGT F + +Q L ++ L I+
Sbjct: 41 MPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT 100
Query: 163 NICREIPREFGNLPEL--ELMSLAANNLQGKIPL----------KIGNLRN-LEKLDIGD 209
R+ P + + + L + LR L +L
Sbjct: 101 E-QRQ--------PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR--P 149
Query: 210 NKLVGIAPIAIFNVSTLKILGLQDNSLSGCLS------SIGYARLPNLEILSLWGNNFSG 263
K V I + + + + + + ++ P + L
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML--QKLL- 206
Query: 264 TIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRN-LSWLVLSDNYLTSSTQELSFLSSL 322
++ + S I +++ L L+ S Y L L ++
Sbjct: 207 ---------YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC----LLVLLNV 253
Query: 323 SNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIY 382
N K F+LS +IL T ++ L ++ ++ LT
Sbjct: 254 QNAKAWNAFNLSC----KILLTTRFKQVTDFLSAATTTHISLD----HHSMTLTPDEVKS 305
Query: 383 LGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYR---------LDLDG 433
L L+ + QDL L + P + +AE R ++
Sbjct: 306 LLLKYLD----------CRPQDL--PREVLTTN-PRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 434 NKLSGSIPACFSNLT---------SLRIVSLGSNELTSIPL----TFW-NLKDILNLNFS 479
+KL+ I + + L L + ++ IP W ++ +
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH----IPTILLSLIWFDVIKSDVMVVV 408
Query: 480 SNFLTGSLPLEIGSLKVLVGI-DLSRNNFSGVIPTEIGGLKNLEYLFLG-YNRLQGSIPN 537
+ SL +E + + I + + ++ L + YN + +
Sbjct: 409 NKLHKYSL-VEKQPKESTISIPSIYLE-----LKVKLENEYALHRSIVDHYNIPKTFDSD 462
Query: 538 SFGDLI----SLKFL--NLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGN 591
+ +L N E+++ + L F LE KI + N
Sbjct: 463 DLIPPYLDQYFYSHIGHHLKNIEHP-------ERMTLFRMVFLDFRFLEQKIRHDSTAWN 515
Query: 592 FSA 594
S
Sbjct: 516 ASG 518
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 9e-05
Identities = 77/460 (16%), Positives = 142/460 (30%), Gaps = 118/460 (25%)
Query: 31 QDALLALKAHITHDPTNFLA--------KNWNTSTPVCNWTGVACEVHSQRVTVLNISSL 82
+ ALL L+ P + K W VC V C+ ++ LN+ +
Sbjct: 141 RQALLELR------PAKNVLIDGVLGSGKTWVALD-VCLSYKVQCK-MDFKIFWLNLKNC 192
Query: 83 NLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSF--- 139
N T+ L L ++ ++ + ++++ LR S + +
Sbjct: 193 NSPETVLEMLQKLLYQ--IDPNWTSRSDHSSNIKLRIHSIQAE-LRRLLKSKPYENCLLV 249
Query: 140 ---ISNKSSLQHLDLSS------------NALSGEIRANICREIPREFGNLPELELMSLA 184
+ N + +LS + LS +I + L E+ SL
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSM--TLTPDEVKSLL 307
Query: 185 ANNLQGKI-----------PLKIG----NLRNLEKLDIGDN-KLVGIAPIAIFNVSTLKI 228
L + P ++ ++R + L DN K V + S+L +
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIR--DGLATWDNWKHVNCDKLTTIIESSLNV 365
Query: 229 LGLQDNSLSGCLSSIGY----ARLPN--LEILSLWGNNFSGTIPRFIFNASKLSILDLEG 282
L+ + A +P L + +W + + + K S+++ +
Sbjct: 366 --LEPAEYRKMFDRLSVFPPSAHIPTILLSL--IWFDVIKSDVMVVVNKLHKYSLVEKQP 421
Query: 283 NSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQEL--SFLSSLSNCKFLKYFDLSYNPL-- 338
+ IP+ + L V +N L S + + K DL L
Sbjct: 422 KESTISIPSIY-----LELKVKLENE-----YALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
Query: 339 --YRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLG----GNKLN--- 389
Y + H + N E L R ++L K+
Sbjct: 472 YFYSHIGH-------H------LKNIE-----HPERMTL--FRMVFLDFRFLEQKIRHDS 511
Query: 390 ------GSILITLSKLQKLQD-LGLKDNKLEGSIPYDICN 422
GSIL TL +L+ + + D K E + I +
Sbjct: 512 TAWNASGSILNTLQQLKFYKPYICDNDPKYERLV-NAILD 550
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 1e-04
Identities = 67/540 (12%), Positives = 148/540 (27%), Gaps = 182/540 (33%)
Query: 419 DICN-LAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNL------- 470
DI + + + + D + + S I+ + ++ FW L
Sbjct: 20 DILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK-DAVSGTLRLFWTLLSKQEEM 78
Query: 471 -----KDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLF 525
+++L +N+ FL + E + + + L N +F
Sbjct: 79 VQKFVEEVLRINY--KFLMSPIKTE------QRQPSMMTRMYI----EQRDRLYNDNQVF 126
Query: 526 LGYN--RLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKI 583
YN RLQ +L L +L +L N+ ++G
Sbjct: 127 AKYNVSRLQ-------------PYLKLRQ---------ALLELR--PAKNVL---IDGV- 158
Query: 584 PRGGSFGN--FSAQSFEGNELLCGSPNLQIPPCKTSIHHKSWKKSILLGIVLPLSTTFMI 641
G G + ++ C I W + L ++ +
Sbjct: 159 --LG-SGKTWVALDVCLSYKVQCKMDF--------KIF---W---LNLKNC---NSPETV 198
Query: 642 VVILLILRYRQRGK---RPSNDANGPLVAS------RRMFSYLELCRATDGFSENNLIGR 692
+ +L L Y+ R + +N L RR+ L+
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL-------LV-- 249
Query: 693 GGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF 752
L + V + +A+ +F++ C+I+ + R + V S
Sbjct: 250 ----------LLN-------VQNA---KAWNAFNLSCKILLTTRFKQ---VTDFLSAATT 286
Query: 753 KALVLEYMPHGSLEKYLYSSNCILDIFQR-LNIMIDVASALEYLHFGYSAPVIHCDLKPS 811
+ L++ + + + L+ L P P
Sbjct: 287 THISLDHHSMTLTPDEV------KSLLLKYLDCRPQ---DL---------PREVLTTNP- 327
Query: 812 NVLLDDNMV-AHLSDFSIA----KMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGD 866
+++ + D K + + + I +L + P R+
Sbjct: 328 ---RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL---EPAEYRK-------- 373
Query: 867 VY-SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925
++ + F P + +P + ++ +++ + + V K
Sbjct: 374 MFDRLSV-----F----PPS------------AH--IPTILLSLIWFDVIKSDVMVVVNK 410
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 29/209 (13%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSFDVECEIM------KSIRHRNLI 741
+IGRG + V L + A+KV + D++ ++ H L+
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVV--KKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ S E V+EY+ G L ++ + + R +++ AL YLH
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ER 129
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE------ 854
+I+ DLK NVLLD L+D+ + K T T T Y+APE
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGED 186
Query: 855 YGREGRVSANGDVYSFGIMLMETFTGKKP 883
YG V D ++ G+++ E G+ P
Sbjct: 187 YGFS--V----DWWALGVLMFEMMAGRSP 209
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHR------NLI 741
+IG+G FG V KA VA+K+ ++ R + E I++ +R + N+I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYL 795
++ + + + E + +L + + + FQ + + L+ L
Sbjct: 163 HMLENFTFRNHICMTFELL-SMNLYELIKKNK-----FQGFSLPLVRKFAHSILQCLDAL 216
Query: 796 HFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
H +IHCDLKP N+LL + + DF + + IQ++ Y AP
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAP 268
Query: 854 EYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891
E R D++S G +L E TG + GE
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGY----PLLPGE 302
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 48/222 (21%)
Query: 689 LIGRGGFGSVY---KASLGDGMEV-AVKVFTSQCGRAFKSF------DVEC-----EIMK 733
++G G +G V+ K S D ++ A+KV K+ E ++++
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTRTERQVLE 113
Query: 734 SIRHRN-LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI------MI 786
IR L+ + + E L+L+Y+ G L +L +R +
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVG 166
Query: 787 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQT 844
++ ALE+LH +I+ D+K N+LLD N H L+DF ++K ++
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER--AYD 219
Query: 845 LA-TIGYMAPEYGREGRVSANGDV--YSFGIMLMETFTGKKP 883
TI YMAP+ R G + V +S G+++ E TG P
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 52/214 (24%), Positives = 84/214 (39%), Gaps = 39/214 (18%)
Query: 689 LIGRGGFGSVYKASLGDGMEV-AVKVFTSQCGRAFKSF-----DVECEIM------KSIR 736
+IGRG + V L + A++V K D++ ++
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVK-------KELVNDDEDIDWVQTEKHVFEQASN 111
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
H L+ + S E V+EY+ G L ++ + + R +++ AL YLH
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH 170
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTL-ATIGYMAPE- 854
+I+ DLK NVLLD L+D+ + K T T T Y+APE
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEI 224
Query: 855 -----YGREGRVSANGDVYSFGIMLMETFTGKKP 883
YG V D ++ G+++ E G+ P
Sbjct: 225 LRGEDYGFS--V----DWWALGVLMFEMMAGRSP 252
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 3e-10
Identities = 37/204 (18%), Positives = 59/204 (28%), Gaps = 54/204 (26%)
Query: 678 CRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKV--------FTSQCGRAFKSFDVEC 729
C T+ IG G FG V++ D VA+K+ + F+ E
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 730 EIMKSI---------RHRNLIKVISSC------------------------------SNE 750
I K + R I + S +
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 751 EFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 809
+ +VLE+ G LE+ + + +I+ + ++L H DL
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 810 PSNVLLDDNMVAHLSDFSIAKMLT 833
NVLL + L K T
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST 213
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 37/171 (21%), Positives = 66/171 (38%), Gaps = 39/171 (22%)
Query: 689 LIGRGGFGSVYKA------SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
IG+GGFG +Y A S+G VKV S G F E + + I+
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF----TELKFYQRAAKPEQIQ 97
Query: 743 VISS-------------------CSNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRL 782
+ + ++ ++++ G L+K ++ L
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVL 155
Query: 783 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAK 830
+ + + LEY+H +H D+K SN+LL + + V +L D+ +A
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 6e-10
Identities = 35/146 (23%), Positives = 64/146 (43%), Gaps = 11/146 (7%)
Query: 690 IGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI-KVISSC 747
IG G FG +Y ++ EVA+K+ + E +I + ++ I V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
++ LV++ + SLE + L + L + + + +E++H S +H D
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128
Query: 808 LKPSNVLLDDNMVAH---LSDFSIAK 830
+KP N L+ A+ + DF +AK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 34/166 (20%), Positives = 62/166 (37%), Gaps = 31/166 (18%)
Query: 690 IGRGGFGSVYKA---------SLGDGMEVAVKV-------FTSQ--CGRAFKSFDVECEI 731
R G +Y+A S + ++K+ F Q RA K V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 732 -MKSIRHRNLIKVISSCSNE-EFKALVLEYMPHG-SLEKYL-YSSNCILDIFQRLNIMID 787
+ S + + ++ +++ LVL + G SL+ L S +L L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAK 830
+ ALE+LH +H ++ N+ + D + V L+ + A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 64/490 (13%), Positives = 143/490 (29%), Gaps = 75/490 (15%)
Query: 70 HSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRG 129
++V + N +++ + + ++S+ L F Y +
Sbjct: 44 CRRKVFIGNCYAVSP----ATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIE- 98
Query: 130 NQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQ 189
+ S+ + L+ + L ++ + I + F N L L S +
Sbjct: 99 --------AMSSSYTWLEEIRLKRMVVT----DDCLELIAKSFKNFKVLVLSSCEGFSTD 146
Query: 190 GKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYA--- 246
G + RNL++LD+ ++ + ++ + + L ++S S + ++
Sbjct: 147 GLAAI-AATCRNLKELDLRESDVDDVSGHWLSHFPDTY-TSLVSLNISCLASEVSFSALE 204
Query: 247 ----RLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEG------NSFSGFIPNTFGNL 296
R PNL+ L L + + A +L L G +
Sbjct: 205 RLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGC 264
Query: 297 RNLSWL----VLSDNYLTSSTQELSFLSSL----------------SNCKFLKYFDLSYN 336
+ L L YL + S L++L C L+ +
Sbjct: 265 KELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY 324
Query: 337 -------PLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEIS-NLTNLRTIYLGGNKL 388
L + S N ++ +S L ++ ++
Sbjct: 325 IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQM 384
Query: 389 NGSILITLSK-LQKLQDLGL-----------KDNKLEGSIPYDICNLAELYRLDLDGNKL 436
+ LIT+++ + L L+ + + +L RL L G
Sbjct: 385 TNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLT 444
Query: 437 SGSIPACFSNLTSLRIVSLGSNELT--SIPLTFWNLKDILNLNFSS-NFLTGSLPLEIGS 493
+ + ++S+ + + + L F +L
Sbjct: 445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASK 504
Query: 494 LKVLVGIDLS 503
L+ + + +S
Sbjct: 505 LETMRSLWMS 514
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 51/385 (13%), Positives = 108/385 (28%), Gaps = 92/385 (23%)
Query: 78 NISSLNLTGTIPSQLG---------NLSSLQSLNLSFNRL---FGSIPSAIFTTYTLKYV 125
N+ L+L + + +SL SLN+S F ++ + LK +
Sbjct: 157 NLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSL 216
Query: 126 CLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAA 185
L + + L+ L + E+R ++ + EL +S
Sbjct: 217 KLNRAVPLEKLATLLQRAPQLEELGTGG--YTAEVRPDVYSGLSVALSGCKELRCLSGFW 274
Query: 186 NNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKIL--------------- 229
+ + +P L L++ + + + L+ L
Sbjct: 275 DAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLA 334
Query: 230 ----GLQDNSLSGCLSSIGYA--------------RLPNLEILSLWGNNFSG-TIPRFIF 270
L++ + + P LE + + + +
Sbjct: 335 STCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIAR 394
Query: 271 NASKLSILDLEGNSFSGFIPNTFG-----------NLRNLSWLVLSD-------NYLTSS 312
N ++ L T + ++L L LS Y+ +
Sbjct: 395 NRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTY 454
Query: 313 TQELSFLSS-------------LSNCKFLKYFDLSYNPLYRILPRTTVGNLSH-----SL 354
+++ LS LS C L+ ++ P L++ ++
Sbjct: 455 AKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF------GDKALLANASKLETM 508
Query: 355 EEFKMSNCNIS-GGIPEEISNLTNL 378
MS+C++S G + L
Sbjct: 509 RSLWMSSCSVSFGACKLLGQKMPKL 533
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 23/95 (24%), Positives = 40/95 (42%), Gaps = 2/95 (2%)
Query: 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTE-IGGLKNLEYLFLGYNRLQGSIPNSFGDLIS 544
+ + L + + + + GL L L + + L+ P++F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 545 LKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
L LNLS N L + +++ LS L++L LS N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 22/92 (23%), Positives = 30/92 (32%), Gaps = 7/92 (7%)
Query: 248 LPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSD 306
NL L + + +L L + + P+ F LS L LS
Sbjct: 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89
Query: 307 NYLTSSTQELSFLSSLSNCKFLKYFDLSYNPL 338
N L S + + SL LS NPL
Sbjct: 90 NALESLSWKTVQGLSLQEL------VLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 20/101 (19%), Positives = 35/101 (34%), Gaps = 3/101 (2%)
Query: 386 NKLNGSILITLSKLQKLQDLGLKDNKLEGSIP-YDICNLAELYRLDLDGNKLSGSIPA-C 443
L L + L +L +++ + + D+ L EL L + + L +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 444 FSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLT 484
F L ++L N L S+ + L S N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 21/120 (17%), Positives = 33/120 (27%), Gaps = 27/120 (22%)
Query: 167 EIPREFGNLPELELMSLAANNLQGKIPLK-IGNLRNLEKLDIGDNKLVGIAPIAIFNVST 225
+ L + + + L+ + L L L I + L +AP A F+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA-FH--- 77
Query: 226 LKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSF 285
P L L+L N ++ L L L GN
Sbjct: 78 ---------------------FTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 3e-06
Identities = 19/140 (13%), Positives = 40/140 (28%), Gaps = 35/140 (25%)
Query: 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG 134
+ L + L +L L + + +
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDL----------------- 52
Query: 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE-FGNLPELELMSLAANNLQGKIP 193
L++L + + L R + + F P L ++L+ N L+ +
Sbjct: 53 ------RGLGELRNLTIVKSGL---------RFVAPDAFHFTPRLSRLNLSFNALE-SLS 96
Query: 194 LKIGNLRNLEKLDIGDNKLV 213
K +L++L + N L
Sbjct: 97 WKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 19/98 (19%), Positives = 30/98 (30%), Gaps = 4/98 (4%)
Query: 316 LSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI-SN 374
L L L + L + + L + L L + + + +
Sbjct: 21 LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGE-LRNLTIVKSGLR-FVAPDAFHF 78
Query: 375 LTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKL 412
L + L N L T+ L LQ+L L N L
Sbjct: 79 TPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 5e-05
Identities = 19/91 (20%), Positives = 28/91 (30%), Gaps = 7/91 (7%)
Query: 264 TIPRFIFNASKLSILDLEGNSFSGFIPN-TFGNLRNLSWLVLSDNYLTSSTQELSFLSSL 322
+ A L+ L +E + L L L + + L +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAF---- 76
Query: 323 SNCKFLKYFDLSYNPLYRILPRTTVGNLSHS 353
L +LS+N L L TV LS
Sbjct: 77 HFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQ 106
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 20/86 (23%), Positives = 31/86 (36%), Gaps = 4/86 (4%)
Query: 353 SLEEFKMSNCNISGGIPEE-ISNLTNLRTIYLGGNKLNGSILI-TLSKLQKLQDLGLKDN 410
+L E + N + + L LR + + + L + +L L L N
Sbjct: 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFN 90
Query: 411 KLEGSIPYDICNLAELYRLDLDGNKL 436
LE S+ + L L L GN L
Sbjct: 91 ALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 8/59 (13%), Positives = 16/59 (27%), Gaps = 2/59 (3%)
Query: 529 NRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA-SLEKLSYLEDLNLSFNQLEGKIPRG 586
+ +L L + N + L L L +L + + L +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 4e-09
Identities = 75/443 (16%), Positives = 148/443 (33%), Gaps = 65/443 (14%)
Query: 198 NLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLS-GCLSSIGYARLPNLEILSL 256
+ NL + G + I+ N+ LK + + +S L + AR +LE L L
Sbjct: 87 AMFNLIPENWGGYVTPWVTEIS-NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKL 145
Query: 257 WG-NNFSGT-IPRFIFNASKLSILDLEGNSFSGFIPNTFGNL-RNLSWLVLSDNYLTSST 313
+ F+ + + + K+ L +E +SFS L ++ + L + + Y+T
Sbjct: 146 DKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFA 205
Query: 314 Q--ELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
+ + NC+ L + + L + +LEEF + N G+PE+
Sbjct: 206 KISPKDLETIARNCRSLVSVKVGDFEI---LELVGFFKAAANLEEFCGGSLNEDIGMPEK 262
Query: 372 ISNL--------------------------TNLRTIYLGGNKLNGSILITL-SKLQKLQD 404
NL +R + L L TL K L+
Sbjct: 263 YMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEV 322
Query: 405 LGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSN--ELTS 462
L ++ + + +L RL ++ + ++ +++L EL
Sbjct: 323 LETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEY 382
Query: 463 IPLTFWNLKD-----------------ILNLNFSSNFLTGSLPLEIGSL----KVLVGID 501
+ + ++ + ++ L+ L + SL K L
Sbjct: 383 MAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFA 442
Query: 502 LSRN--NFSGVIPTEIG-GLKNLEYLFLGYNRLQ-GSIPNSFGDLISLKFLNLSNNNLSG 557
+ + + IG N+ ++ LGY + +L+ L + S
Sbjct: 443 FYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE 502
Query: 558 V-IPASLEKLSYLEDLNLSFNQL 579
I A++ KL L L + +
Sbjct: 503 RAIAAAVTKLPSLRYLWVQGYRA 525
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 51/355 (14%), Positives = 102/355 (28%), Gaps = 55/355 (15%)
Query: 94 NLSSLQSLNLSFNRLFG----SIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHL 149
+ +SL+ LN + + +L V + ++ F ++L+
Sbjct: 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFKAAANLEEF 248
Query: 150 DLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKI--GNLRNLEKLDI 207
S N +P ++ NL + + G + I + KLD+
Sbjct: 249 CGGSL--------NEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDL 300
Query: 208 GDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARL----PNLEILSLWGNNFSG 263
L + L+ + G L L+ L +
Sbjct: 301 LYALLETEDHCTLIQKCP----NLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQ 356
Query: 264 TIPRFIF------------NASKLSILDLEGNSFSGF----IPNTFGNLRNLSWLVLSD- 306
+ +L + + + + I NL + ++L
Sbjct: 357 GMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDRE 416
Query: 307 NYLTSSTQELSFLSSLSNCKFLKYFDLSYNP-------LYRILPRTTVGNLSHSLEEFKM 359
+T + S L CK L+ F L I G S ++ +
Sbjct: 417 ERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI------GQYSPNVRWMLL 470
Query: 360 SNCNIS-GGIPEEISNLTNLRTIYLGGNKL-NGSILITLSKLQKLQDLGLKDNKL 412
S G+ E NL+ + + G +I ++KL L+ L ++ +
Sbjct: 471 GYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 37/274 (13%), Positives = 87/274 (31%), Gaps = 19/274 (6%)
Query: 321 SLSNCKFLKYFDLSYNPLYRILPR--TTVGNLSHSLEEFKMSNCNISGGIPEEI--SNLT 376
L F+L + T + N L+ +S + + +
Sbjct: 79 KLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARAD 138
Query: 377 NLRTIYLGG-NKLNGSILITLSK-LQKLQDLGLKDNKLEGSIPYDICNLAE----LYRLD 430
+L T+ L + L+++ +K++ L ++++ + LA+ L L+
Sbjct: 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLN 198
Query: 431 LDGNKLSG-------SIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFL 483
+ + +I +L S+++ EL NL++ + + +
Sbjct: 199 FYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIG 258
Query: 484 TGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPNSFGDL 542
+ + + L + LS + +P + L L Y L+
Sbjct: 259 MPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKC 317
Query: 543 ISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSF 576
+L+ L N + + L+ L +
Sbjct: 318 PNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-09
Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 11/118 (9%)
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICN-LAE 425
GIP ++ + L NKL KL +L L L N+++ S+P + + L +
Sbjct: 25 GIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 426 LYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSN 481
L L L NKL S+P F LT L+ ++L +N+L S+P F L + + +N
Sbjct: 78 LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 3/87 (3%)
Query: 501 DLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNS-FGDLISLKFLNLSNNNLSGVI 559
+L N + L L L L N++Q S+P+ F L L L L N L +
Sbjct: 34 ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQSLP 92
Query: 560 PASLEKLSYLEDLNLSFNQLEGKIPRG 586
+KL+ L++L L NQL+ +P G
Sbjct: 93 NGVFDKLTQLKELALDTNQLK-SVPDG 118
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 39/128 (30%), Positives = 54/128 (42%), Gaps = 27/128 (21%)
Query: 428 RLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNFLTGS 486
RL+L+ NKL F LT L +SL N++ S+P F L + L N L S
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPN-SFGDLISL 545
LP +GV L L+ L L N+L+ S+P+ F L SL
Sbjct: 91 LP-------------------NGVFDK----LTQLKELALDTNQLK-SVPDGIFDRLTSL 126
Query: 546 KFLNLSNN 553
+ + L N
Sbjct: 127 QKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 23/76 (30%), Positives = 34/76 (44%), Gaps = 7/76 (9%)
Query: 511 IPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLE 570
IP+ + L L N+LQ F L L L+LS N + + +KL+ L
Sbjct: 26 IPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79
Query: 571 DLNLSFNQLEGKIPRG 586
L L N+L+ +P G
Sbjct: 80 ILYLHENKLQ-SLPNG 94
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 35/106 (33%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 403 QDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELT 461
L L+ NKL+ L +L +L L N++ S+P F LT L I+ L N+L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89
Query: 462 SIPL-TFWNLKDILNLNFSSNFLTGSLPLEI-GSLKVLVGIDLSRN 505
S+P F L + L +N L S+P I L L I L N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 26/106 (24%), Positives = 43/106 (40%), Gaps = 3/106 (2%)
Query: 203 EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS 262
+L++ NKL + ++ L L L N + L + +L L IL L N
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ 89
Query: 263 GTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
++P +F ++L L L+ N F L +L + L N
Sbjct: 90 -SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 24/88 (27%), Positives = 38/88 (43%), Gaps = 2/88 (2%)
Query: 500 IDLSRNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGV 558
+ L+ N + + G L +L L L N+L G PN+F ++ L L N + +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93
Query: 559 IPASLEKLSYLEDLNLSFNQLEGKIPRG 586
L L+ LNL NQ+ + G
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISC-VMPG 120
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 39/153 (25%), Positives = 55/153 (35%), Gaps = 52/153 (33%)
Query: 428 RLDLDGNKLSGSIPAC--FSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTG 485
L L+ N+L I + F L L + L N+LT I
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIE--------------------- 70
Query: 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPN-SFGDLIS 544
G +++ L LG N+++ I N F L
Sbjct: 71 ----------------------PNAF----EGASHIQELQLGENKIK-EISNKMFLGLHQ 103
Query: 545 LKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577
LK LNL +N +S V+P S E L+ L LNL+ N
Sbjct: 104 LKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 32/154 (20%), Positives = 53/154 (34%), Gaps = 52/154 (33%)
Query: 403 QDLGLKDNKLEGSIPYDI-CNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNEL 460
+L L DN+L + L L +L+L N+L+ I F + ++ + LG N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 461 TSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKN 520
I + + GL
Sbjct: 91 KEIS-------------------------------------------NKM----FLGLHQ 103
Query: 521 LEYLFLGYNRLQGSIPN-SFGDLISLKFLNLSNN 553
L+ L L N++ + SF L SL LNL++N
Sbjct: 104 LKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 27/89 (30%), Positives = 33/89 (37%), Gaps = 2/89 (2%)
Query: 224 STLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEG 282
L L DN L S + RLP+L L L N + I F AS + L L
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGE 87
Query: 283 NSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
N F L L L L DN ++
Sbjct: 88 NKIKEISNKMFLGLHQLKTLNLYDNQISC 116
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 4/107 (3%)
Query: 203 EKLDIGDNKLVGIAPIAIFNVST-LKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNF 261
+L + DN+L I+ +F L L L+ N L+G + + +++ L L N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI 90
Query: 262 SGTIPRFIFNA-SKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
I +F +L L+L N S +P +F +L +L+ L L+ N
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 3/89 (3%)
Query: 198 NLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLW 257
L +L KL++ N+L GI P A S ++ L L +N + +S+ + L L+ L+L+
Sbjct: 52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLY 110
Query: 258 GNNFSGTIPRFIF-NASKLSILDLEGNSF 285
N S + F + + L+ L+L N F
Sbjct: 111 DNQIS-CVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 21/66 (31%), Positives = 33/66 (50%), Gaps = 10/66 (15%)
Query: 94 NLSSLQSLNLSFNRLFGSIPSAIFTTYT-LKYVCLRGNQLS----GTFPSFISNKSSLQH 148
S +Q L L N++ I + +F LK + L NQ+S G+F + +SL
Sbjct: 76 GASHIQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQISCVMPGSF----EHLNSLTS 130
Query: 149 LDLSSN 154
L+L+SN
Sbjct: 131 LNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 29/145 (20%), Positives = 51/145 (35%), Gaps = 34/145 (23%)
Query: 60 CNWTGVACEVHSQRVTVL--NI----SSLNLTGTIPSQL------GNLSSLQSLNLSFNR 107
C T V C + + + +I + L L ++ G L L L L N+
Sbjct: 8 CEGTTVDC--TGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 108 LFGSIPSAIFTTYT-LKYVCLRGNQLS----GTFPSFISNKSSLQHLDLSSNALSGEIRA 162
L I F + ++ + L N++ F L+ L+L N +
Sbjct: 66 L-TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGL----HQLKTLNLYDNQI------ 114
Query: 163 NICREIPRE-FGNLPELELMSLAAN 186
+ F +L L ++LA+N
Sbjct: 115 ---SCVMPGSFEHLNSLTSLNLASN 136
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 28/139 (20%), Positives = 52/139 (37%), Gaps = 14/139 (10%)
Query: 271 NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKY 330
NA + LDL G I N L + SDN + L + LK
Sbjct: 17 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-------LDGFPLLRRLKT 68
Query: 331 FDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISG-GIPEEISNLTNLRTIYLGGN--- 386
++ N + RI + L E ++N ++ G + +++L +L + + N
Sbjct: 69 LLVNNNRICRIGE--GLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
Query: 387 KLNGSILITLSKLQKLQDL 405
L + K+ +++ L
Sbjct: 127 NKKHYRLYVIYKVPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 22/113 (19%), Positives = 40/113 (35%), Gaps = 4/113 (3%)
Query: 353 SLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKL 412
E + I I + L I N++ L L++L+ L + +N++
Sbjct: 20 RDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRI 76
Query: 413 EGSIPYDICNLAELYRLDLDGNKLSG-SIPACFSNLTSLRIVSLGSNELTSIP 464
L +L L L N L ++L SL + + N +T+
Sbjct: 77 CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 129
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 26/123 (21%), Positives = 46/123 (37%), Gaps = 19/123 (15%)
Query: 141 SNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGN-- 198
+N + LDL + I L + + + + N ++ K+
Sbjct: 16 TNAVRDRELDLRGYKIP---------VIENLGATLDQFDAIDFSDNEIR-----KLDGFP 61
Query: 199 -LRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGY-ARLPNLEILSL 256
LR L+ L + +N++ I + L L L +NSL L + A L +L L +
Sbjct: 62 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCI 120
Query: 257 WGN 259
N
Sbjct: 121 LRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 29/161 (18%), Positives = 54/161 (33%), Gaps = 34/161 (21%)
Query: 181 MSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCL 240
+ L A ++ + + N +LD+ K+ I + + + DN +
Sbjct: 2 VKLTAELIE-QAA-QYTNAVRDRELDLRGYKIPVIENLGA-TLDQFDAIDFSDNEIR--- 55
Query: 241 SSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLS 300
+L +L +L L + N L +L+
Sbjct: 56 ------KLDGFPLLR------------------RLKTLLVNNNRICRIGEGLDQALPDLT 91
Query: 301 WLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRI 341
L+L++N L EL L L++ K L Y + NP+
Sbjct: 92 ELILTNNSLV----ELGDLDPLASLKSLTYLCILRNPVTNK 128
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 26/132 (19%), Positives = 45/132 (34%), Gaps = 25/132 (18%)
Query: 422 NLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSN 481
N LDL G K+ I + L + NE+ + F L+ + L ++N
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNN 74
Query: 482 FLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD 541
+ +L L + L+ N+ + L +L+ L
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNS--------LVELGDLDPLA---------------S 111
Query: 542 LISLKFLNLSNN 553
L SL +L + N
Sbjct: 112 LKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 476 LNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI 535
+ ++ + + + +DL R VI L + + N ++ +
Sbjct: 2 VKLTAELIEQAAQYT--NAVRDRELDL-RGYKIPVIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 536 PNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580
F L LK L ++NN + + + L L +L L+ N L
Sbjct: 58 DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 37/173 (21%), Positives = 64/173 (36%), Gaps = 38/173 (21%)
Query: 424 AELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFL 483
AE L + + A S L + + ++L +N + I S+
Sbjct: 25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI----------------SS-- 65
Query: 484 TGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGL----KNLEYLFLGYNRLQGSIPNSF 539
+ ++ L + L RN +I L LE L++ YN++ S+
Sbjct: 66 -------LSGMENLRILSLGRNLI-----KKIENLDAVADTLEELWISYNQIA-SLSG-I 111
Query: 540 GDLISLKFLNLSNNNLSGVIP-ASLEKLSYLEDLNLSFNQLEGKIPRGGSFGN 591
L++L+ L +SNN ++ L L LEDL L+ N L +
Sbjct: 112 EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 35/194 (18%), Positives = 61/194 (31%), Gaps = 32/194 (16%)
Query: 387 KLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSN 446
+ + K+ +L +E + + L L L N + I + S
Sbjct: 16 ERKSVVATEAEKV----ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSG 68
Query: 447 LTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNN 506
+ +LRI+SLG N + I + L S N + +E L L + +S N
Sbjct: 69 MENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIE--KLVNLRVLYMSNNK 126
Query: 507 FSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKL 566
I ++ L L L+ L L+ N L +
Sbjct: 127 --------ITNWGEIDKL---------------AALDKLEDLLLAGNPLYNDYKENNATS 163
Query: 567 SYLEDLNLSFNQLE 580
Y ++ L+
Sbjct: 164 EYRIEVVKRLPNLK 177
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 24/120 (20%), Positives = 53/120 (44%), Gaps = 15/120 (12%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427
+ +S L + + L N + + +LS ++ L+ L L N ++ I NL +
Sbjct: 40 MDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNLIK-----KIENLDAVA 92
Query: 428 R----LDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP--LTFWNLKDILNLNFSSN 481
L + N+++ S+ L +LR++ + +N++T+ L + +L + N
Sbjct: 93 DTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 31/160 (19%), Positives = 51/160 (31%), Gaps = 37/160 (23%)
Query: 229 LGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGF 288
L + +++ + L + L+L NN I + L IL L N
Sbjct: 30 LHGMIPPIEKMDATL--STLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK- 84
Query: 289 IPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVG 348
I N L L +S N + S LS + L+ +S N +
Sbjct: 85 IENLDAVADTLEELWISYNQIAS-------LSGIEKLVNLRVLYMSNNKI---------- 127
Query: 349 NLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKL 388
+ E ++++ L L + L GN L
Sbjct: 128 ---TNWGEI------------DKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 35/177 (19%), Positives = 58/177 (32%), Gaps = 47/177 (26%)
Query: 88 IPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQ 147
+ + L L + + L LS N + ++S +S +L+
Sbjct: 40 MDATLSTLKACKHLALSTNNI---------------------EKISS-----LSGMENLR 73
Query: 148 HLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDI 207
L L N + +I LE + ++ N + + I L NL L +
Sbjct: 74 ILSLGRNLIK---------KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122
Query: 208 GDNKLVGIAPIAIF-NVSTLKILGLQDNSLSGCLSSIGY---------ARLPNLEIL 254
+NK+ I + L+ L L N L RLPNL+ L
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 32/127 (25%), Positives = 54/127 (42%), Gaps = 24/127 (18%)
Query: 92 LGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDL 151
L + +L+ L+L N + I + TL+ + + NQ++ S I +L+ L +
Sbjct: 66 LSGMENLRILSLGRNLI-KKIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYM 122
Query: 152 SSNALS--GEIRANICREIPREFGNLPELELMSLAANNLQGKIPLK----------IGNL 199
S+N ++ GEI + L +LE + LA N L + L
Sbjct: 123 SNNKITNWGEI---------DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173
Query: 200 RNLEKLD 206
NL+KLD
Sbjct: 174 PNLKKLD 180
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 36/142 (25%), Positives = 50/142 (35%), Gaps = 35/142 (24%)
Query: 271 NASKLSILDLEGNSFS-GFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLK 329
+ + L L+ + G I NL +L L + L S +S+L LK
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-------VSNLPKLPKLK 74
Query: 330 YFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLN 389
+LS N I GG+ L NL + L GNKL
Sbjct: 75 KLELSEN--------------------------RIFGGLDMLAEKLPNLTHLNLSGNKLK 108
Query: 390 G-SILITLSKLQKLQDLGLKDN 410
S L L KL+ L+ L L +
Sbjct: 109 DISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 32/88 (36%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 493 SLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSN 552
+++ LV +D ++N G I NLE+L L L S+ N L LK L LS
Sbjct: 25 AVRELV-LDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80
Query: 553 NNLSGVIPASLEKLSYLEDLNLSFNQLE 580
N + G + EKL L LNLS N+L+
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 4/104 (3%)
Query: 374 NLTNLRTIYLGGNKLN-GSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLD 432
+R + L K N G I ++ L+ L L + L S+ ++ L +L +L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 433 GNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNL 476
N++ G + L +L ++L N+L I T LK + L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDIS-TLEPLKKLECL 122
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 33/134 (24%), Positives = 47/134 (35%), Gaps = 27/134 (20%)
Query: 422 NLAELYRLDLDGNKLS-GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSS 480
A + L LD K + G I + +L +SL + L S+ N
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVS------------NLPK 69
Query: 481 NFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPNSF 539
L L ++LS N G + L NL +L L N+L+ S
Sbjct: 70 -------------LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116
Query: 540 GDLISLKFLNLSNN 553
L LK L+L N
Sbjct: 117 KKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 29/141 (20%), Positives = 55/141 (39%), Gaps = 20/141 (14%)
Query: 121 TLKYVCLRGNQLS-GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELE 179
++ + L + + G + +L+ L L + L + LP+L+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI---------SVSN-LPKLPKLK 74
Query: 180 LMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSG 238
+ L+ N + G + + L NL L++ NKL I+ + + LK L L + ++
Sbjct: 75 KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT- 133
Query: 239 CLSSIGY-----ARLPNLEIL 254
+ Y LP L L
Sbjct: 134 --NLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 20/65 (30%), Positives = 32/65 (49%), Gaps = 3/65 (4%)
Query: 518 LKNLEYLFLGYNRLQ-GSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSF 576
+ L L + G I + ++L+FL+L N L V ++L KL L+ L LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80
Query: 577 NQLEG 581
N++ G
Sbjct: 81 NRIFG 85
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 32/158 (20%), Positives = 52/158 (32%), Gaps = 31/158 (19%)
Query: 152 SSNALSGEIRANICREIP-REFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDN 210
SS + +++ I E+ R + EL L + + GKI NLE L + +
Sbjct: 2 SSGSSGMDMKRRIHLELRNRTPAAVRELVLDNC--KSNDGKIEGLTAEFVNLEFLSLINV 59
Query: 211 KLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF 270
L+ ++ + +LP L+ L L N G +
Sbjct: 60 GLISVSNLP---------------------------KLPKLKKLELSENRIFGGLDMLAE 92
Query: 271 NASKLSILDLEGNSFSGF-IPNTFGNLRNLSWLVLSDN 307
L+ L+L GN L L L L +
Sbjct: 93 KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 687 NNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHR------N 739
++LIG+G FG V KA + VA+K+ ++ +E +++ +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALE 793
++ + LV E + +L L ++N F+ ++ + +AL
Sbjct: 118 IVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTN-----FRGVSLNLTRKFAQQMCTALL 171
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFSIAKMLTGEDQSMIQTQTLATIGYM 851
+L +IHCDLKP N+LL + + + DF + L IQ++ Y
Sbjct: 172 FLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YR 225
Query: 852 APEYGREGRVSANGDVYSFGIMLMETFTGK 881
+PE D++S G +L+E TG+
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 27/114 (23%), Positives = 48/114 (42%), Gaps = 4/114 (3%)
Query: 353 SLEEFKMSNCNIS-GGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNK 411
++E + N + G + L + L + + L KL KL+ L L DN+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELSDNR 75
Query: 412 LEGSIPYDICNLAELYRLDLDGNKLSG-SIPACFSNLTSLRIVSLGSNELTSIP 464
+ G + L L+L GNK+ S L +L+ + L + E+T++
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 32/88 (36%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 493 SLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSN 552
+K LV +D SR+N G + + LE+L L SI N L LK L LS+
Sbjct: 18 DVKELV-LDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73
Query: 553 NNLSGVIPASLEKLSYLEDLNLSFNQLE 580
N +SG + EK L LNLS N+++
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 30/134 (22%), Positives = 48/134 (35%), Gaps = 27/134 (20%)
Query: 422 NLAELYRLDLDGNKLS-GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSS 480
+++ L LD ++ + G + L +S + LTSI N
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIA------------NLPK 62
Query: 481 NFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPNSF 539
L L ++LS N SG + NL +L L N+++ S
Sbjct: 63 -------------LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPL 109
Query: 540 GDLISLKFLNLSNN 553
L +LK L+L N
Sbjct: 110 KKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 27/141 (19%), Positives = 50/141 (35%), Gaps = 20/141 (14%)
Query: 121 TLKYVCLRGNQLS-GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELE 179
+K + L ++ + G L+ L + L+ I L +L+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT---------SIA-NLPKLNKLK 67
Query: 180 LMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSG 238
+ L+ N + G + + NL L++ NK+ ++ I + LK L L +
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCE--- 124
Query: 239 CLSSIGY-----ARLPNLEIL 254
+ Y LP L L
Sbjct: 125 VTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 24/117 (20%), Positives = 43/117 (36%), Gaps = 7/117 (5%)
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSGCLSSI-GYARLPNL 251
L+ ++++L + +++ + L+ L + L+SI +L L
Sbjct: 11 LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV----GLTSIANLPKLNKL 66
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGF-IPNTFGNLRNLSWLVLSDN 307
+ L L N SG + L+ L+L GN L NL L L +
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 19/65 (29%), Positives = 34/65 (52%), Gaps = 3/65 (4%)
Query: 518 LKNLEYLFLGYNRLQ-GSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSF 576
+++ L L +R G + + L+FL+ N L+ + A+L KL+ L+ L LS
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSD 73
Query: 577 NQLEG 581
N++ G
Sbjct: 74 NRVSG 78
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 40/170 (23%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVA---VKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV- 743
IG GGFG +Y A + A VKV + G F + K + I+
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 744 --------------ISSCSNEEFKALVLEYMPHG-SLEKYL-----YSSNCILDIFQRLN 783
++ ++ +V+E + G L+K + + +L + R
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIR-- 159
Query: 784 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAK 830
M+DV LEY+H +H D+K +N+LL + + V +L+D+ ++
Sbjct: 160 -MLDV---LEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 69/369 (18%), Positives = 113/369 (30%), Gaps = 127/369 (34%)
Query: 690 IGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-----HRNLIKV 743
+G G F +V+ + + VA+KV S + D E ++KS+R N V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNREMV 103
Query: 744 ISSCSNEEFK---------ALVLEYMPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASA 791
+ ++FK +V E + H L K++ SN L ++ I+ V
Sbjct: 104 VQLL--DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVLQG 158
Query: 792 LEYLHFGYSAPVIHCDLKPSNVLL------------------------------------ 815
L+YLH +IH D+KP N+LL
Sbjct: 159 LDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 816 -------------DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS 862
+ + ++D A + IQT+ Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271
Query: 863 ANGDVYSFGIMLMETFTGK------------------------------------KPTDE 886
D++S M E TG K + E
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331
Query: 887 IFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEF-PK 945
F + LKH +V+ SQE+ F + +E P+
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE-----AAGFTDF-----LLPMLELIPE 381
Query: 946 QRINAKEIV 954
+R A E +
Sbjct: 382 KRATAAECL 390
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 43/238 (18%), Positives = 78/238 (32%), Gaps = 72/238 (30%)
Query: 689 LIGRGGFGSVYKA--SLGDGMEVAVKVFTSQCGRAFKSF----DVECEIMKSIRHR---- 738
+G G FG V + +VA+K+ R + +E ++K I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 739 --NLIKVISS-------CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------ 783
+ + C + E + + ++L +N FQ
Sbjct: 81 KFLCVLMSDWFNFHGHMC-------IAFELL-GKNTFEFLKENN-----FQPYPLPHVRH 127
Query: 784 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI--- 840
+ + AL +LH + H DLKP N+L ++ L + + + I
Sbjct: 128 MAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 841 -------QTQTLATI----GYMAPE------YGREGRVSANGDVYSFGIMLMETFTGK 881
+ TI Y PE + + DV+S G +L E + G
Sbjct: 185 DFGSATFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYRGF 236
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 7/76 (9%)
Query: 511 IPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLE 570
IPT + L+L N++ P F L L L+L NN L+ + +KL+ L
Sbjct: 28 IPT------TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLT 81
Query: 571 DLNLSFNQLEGKIPRG 586
L+L+ NQL+ IPRG
Sbjct: 82 QLSLNDNQLKS-IPRG 96
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 33/84 (39%), Positives = 47/84 (55%), Gaps = 9/84 (10%)
Query: 403 QDLGLKDNKLEGSIP---YDICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSN 458
Q L L DN++ + +D L +L RLDLD N+L+ +PA F LT L +SL N
Sbjct: 33 QVLYLYDNQIT-KLEPGVFD--RLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
Query: 459 ELTSIPL-TFWNLKDILNLNFSSN 481
+L SIP F NLK + ++ +N
Sbjct: 89 QLKSIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIP---YDICNL 423
GIP T + +YL N++ +L +L L L +N+L +P +D L
Sbjct: 27 GIP------TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFD--KL 77
Query: 424 AELYRLDLDGNKLSGSIP-ACFSNLTSLRIVSLGSN 458
+L +L L+ N+L SIP F NL SL + L +N
Sbjct: 78 TQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 7/76 (9%)
Query: 511 IPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLE 570
IPT + + L+L N++ P F L++L+ L ++N L+ + +KL+ L
Sbjct: 31 IPT------DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLT 84
Query: 571 DLNLSFNQLEGKIPRG 586
L+L+ N L+ IPRG
Sbjct: 85 QLDLNDNHLKS-IPRG 99
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 28/84 (33%), Positives = 43/84 (51%), Gaps = 9/84 (10%)
Query: 403 QDLGLKDNKLEGSIP---YDICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSN 458
Q L L +N++ + +D +L L +L + NKL+ +IP F LT L + L N
Sbjct: 36 QRLWLNNNQIT-KLEPGVFD--HLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91
Query: 459 ELTSIPL-TFWNLKDILNLNFSSN 481
L SIP F NLK + ++ +N
Sbjct: 92 HLKSIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 34/101 (33%), Positives = 47/101 (46%), Gaps = 24/101 (23%)
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLS-----KLQKLQDLGLKDNKLEGSIP---Y 418
GIP T+ + ++L N++ L L LQ L NKL +IP +
Sbjct: 30 GIP------TDKQRLWLNNNQIT-----KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVF 77
Query: 419 DICNLAELYRLDLDGNKLSGSIP-ACFSNLTSLRIVSLGSN 458
D L +L +LDL+ N L SIP F NL SL + L +N
Sbjct: 78 D--KLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 6e-07
Identities = 39/215 (18%), Positives = 63/215 (29%), Gaps = 26/215 (12%)
Query: 146 LQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNL---------QGKIPLKI 196
L+ + + GE ++I I E + + Q + +
Sbjct: 109 LKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVL 168
Query: 197 GNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSG-CLSSIGYARLPNLEILS 255
+ L L I + I LK L + L + I + LPNLE L
Sbjct: 169 DAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLV 225
Query: 256 LW-------GNNFSGTIPRFIFNAS--KLSILDLEGNSFSGFIPNTFGN---LRNLSWLV 303
L+ + L L + + F L L +
Sbjct: 226 LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285
Query: 304 LSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPL 338
+S LT L L + K LK+ ++ YN L
Sbjct: 286 ISAGVLTDEGARL-LLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 2e-06
Identities = 28/186 (15%), Positives = 62/186 (33%), Gaps = 21/186 (11%)
Query: 159 EIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPI 218
EI ++ +P L + + N NL++LE + G + I
Sbjct: 155 EISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE-IISGGLPDSVVEDI 213
Query: 219 AIFNVSTLKILGLQ--------DNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF 270
++ L+ L L D ++ R PNL+ L + +
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273
Query: 271 NA---SKLSILDLEGNSFSGF----IPNTFGNLRNLSWLVLSDNYLTSS-----TQELSF 318
+ +L +D+ + + + +++L ++ + NYL+ + L
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPM 333
Query: 319 LSSLSN 324
+S+
Sbjct: 334 KIDVSD 339
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 2e-05
Identities = 29/162 (17%), Positives = 63/162 (38%), Gaps = 24/162 (14%)
Query: 438 GSIPACFSNLTSLRIVSL-GSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGS--- 493
+ + L + + G+N L+ NLK +L S L S+ +I
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLK---SLEIISGGLPDSVVEDILGSDL 218
Query: 494 --LKVLVGIDLSRNNFSGVIPTEI-------GGLKNLEYLFLGYNRLQGSIPNSFGD--- 541
L+ LV + + ++ + NL++L + Q + F +
Sbjct: 219 PNLEKLV-LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 542 LISLKFLNLSNNNLSGV----IPASLEKLSYLEDLNLSFNQL 579
L L+ +++S L+ + ++K+ +L+ +N+ +N L
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 2e-04
Identities = 32/225 (14%), Positives = 63/225 (28%), Gaps = 41/225 (18%)
Query: 362 CNISGGIPEEISNLTNLRTIYLGGNKLN---------GSILITLSKLQKLQDLGLKDNKL 412
+I+ GI E + ++ G + L + L +L +K
Sbjct: 125 SDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT-- 182
Query: 413 EGSIPYDICNLAELYRLDLDGNKLSGSIP-----ACFSNLTSLRIVSLGSNELTSIPLTF 467
++ L L++ L S+ + NL L + +
Sbjct: 183 -NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG---- 237
Query: 468 WNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGG---LKNLEYL 524
++ L L + + V+ L LE +
Sbjct: 238 -DMNVFRPL------------FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284
Query: 525 FLGYNRLQGS----IPNSFGDLISLKFLNLSNNNLSGVIPASLEK 565
+ L + + + LKF+N+ N LS + L+K
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 7e-07
Identities = 40/231 (17%), Positives = 78/231 (33%), Gaps = 58/231 (25%)
Query: 689 LIGRGGFGSVYKA--SLGDGMEVAVKVFTSQCGRAFKSF----DVECEIMKSIRHR---- 738
+G G FG V + G VAVK+ + + E ++++ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 739 --NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVAS 790
++++ + +V E + S ++ + F + +
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENG-----FLPFRLDHIRKMAYQICK 129
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI---------- 840
++ +LH S + H DLKP N+L + + I + I
Sbjct: 130 SVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 841 QTQTLATI----GYMAPE------YGREGRVSANGDVYSFGIMLMETFTGK 881
+ +T+ Y APE + S DV+S G +L+E + G
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYLGF 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 52/242 (21%), Positives = 85/242 (35%), Gaps = 76/242 (31%)
Query: 689 LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSF----DVECEIMKSIRHR----- 738
+G G FG V + + AVKV R K + +E +I+K I++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 739 NLIKVISS-------CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------IM 785
N++K C L+ E + SL + + +N + +
Sbjct: 97 NIVKYHGKFMYYDHMC-------LIFEPL-GPSLYEIITRNN-----YNGFHIEDIKLYC 143
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ-------- 837
I++ AL YL + H DLKP N+LLDD + Q
Sbjct: 144 IEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 838 --------SMIQTQTLATI----GYMAPE------YGREGRVSANGDVYSFGIMLMETFT 879
+ ++ +I Y APE + + D++SFG +L E +T
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYT 254
Query: 880 GK 881
G
Sbjct: 255 GS 256
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 45/256 (17%), Positives = 90/256 (35%), Gaps = 36/256 (14%)
Query: 229 LGLQDNSLSGC------LSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEG 282
+Q LS L I ++ L+ LSL G S I + S L L+L G
Sbjct: 93 FRVQHMDLSNSVIEVSTLHGIL-SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151
Query: 283 NSF--SGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYR 340
S + + L L LS + + ++ + + +LS +
Sbjct: 152 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA--HVSETITQLNLSG--YRK 207
Query: 341 ILPRTTVGNLSHS---LEEFKMSNC-NISGGIPEEISNLTNLRTIYLGG-NKLNGSILIT 395
L ++ + L L +S+ + +E L L+ + L + L+
Sbjct: 208 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE 267
Query: 396 LSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSL 455
L ++ L+ L + +G++ L L +++ S+ T++ ++
Sbjct: 268 LGEIPTLKTLQVFGIVPDGTLQLLKEALPHL-QINC-------------SHFTTIARPTI 313
Query: 456 GSNELTSIPLTFWNLK 471
G+ + I W +K
Sbjct: 314 GNKKNQEI----WGIK 325
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 38/253 (15%), Positives = 67/253 (26%), Gaps = 81/253 (32%)
Query: 95 LSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSN 154
LSSL+ LNL+ R+ + + L S + +L ++L+S
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVV--AAVLG-----------------SGRHALDEVNLASC 111
Query: 155 ALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKL-- 212
L + KL + N L
Sbjct: 112 QLDPAGLRTLLPV-------------------------------FLRARKLGLQLNSLGP 140
Query: 213 VGIAPIA---IFNVSTLKILGLQDNSL--SGCLS-SIGYARLPNLEILSLWGNNFSGTIP 266
+ + + + L L +N L +G G A ++ LSL
Sbjct: 141 EACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGL 200
Query: 267 RFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST-QELSFLSSLSNC 325
+ L+ N L L ++ N + L+ +
Sbjct: 201 ELLAAQ-------LDRNR-------------QLQELNVAYNGAGDTAALALA--RAAREH 238
Query: 326 KFLKYFDLSYNPL 338
L+ L +N L
Sbjct: 239 PSLELLHLYFNEL 251
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 979 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.59 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.34 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.32 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.32 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.02 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.0 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.98 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.72 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.82 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.71 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.69 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.62 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.62 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.28 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.02 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.98 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.91 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.88 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.82 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.29 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.26 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.17 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.77 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.57 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 85.31 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.44 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-79 Score=759.44 Aligned_cols=584 Identities=32% Similarity=0.494 Sum_probs=446.4
Q ss_pred CCChhHHHHHHHHHHhcccCCCCccccccCCCCCCCccceeEeeCCCCcEEEEEecCCCcccc---CC------------
Q 002021 25 SSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGT---IP------------ 89 (979)
Q Consensus 25 ~~~~~~~~all~~k~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~---~~------------ 89 (979)
.+..+|++||++||+++. ||. .+ ++|+.+++||+|.||+|+ +++|+.|||++++++|. +|
T Consensus 8 ~~~~~~~~all~~k~~~~-~~~-~l-~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLP-DKN-LL-PDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp CCHHHHHHHHHHHHTTCS-CTT-SS-TTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cCCHHHHHHHHHHHhhCC-Ccc-cc-cCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 446789999999999996 887 66 699888899999999998 68999999999999987 43
Q ss_pred -----------CCCcCCCCCCeeeccCCcccccCCc--cccccCcccEEecccccccccCCccc-cCCCCCcEEEccCCc
Q 002021 90 -----------SQLGNLSSLQSLNLSFNRLFGSIPS--AIFTTYTLKYVCLRGNQLSGTFPSFI-SNKSSLQHLDLSSNA 155 (979)
Q Consensus 90 -----------~~l~~l~~L~~L~L~~n~~~~~~p~--~~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~N~ 155 (979)
+.++.+++|++|||++|+++|.+|. .++.+++|++|+|++|.+++.+|..+ .++++|++|||++|.
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 5788899999999999999999998 99999999999999999998888775 788888888888888
Q ss_pred cCchhhhhh--hccC---------------CcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCc
Q 002021 156 LSGEIRANI--CREI---------------PREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPI 218 (979)
Q Consensus 156 l~~~~~~~~--~~~i---------------p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 218 (979)
+++..+... ...+ ...++.+++|++|+|++|++++.+|. ++++++|++|+|++|++++..|.
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~ 241 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSR 241 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHH
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccH
Confidence 876533210 0000 01125566666666666666665655 66677777777777777666666
Q ss_pred cccccCccceeeccCCCCcCCCcc----------------------cccCCCCCcCEEEccCCccccccCcccccCCCCc
Q 002021 219 AIFNVSTLKILGLQDNSLSGCLSS----------------------IGYARLPNLEILSLWGNNFSGTIPRFIFNASKLS 276 (979)
Q Consensus 219 ~l~~l~~L~~L~L~~N~l~~~~~~----------------------~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 276 (979)
.+.++++|+.|+|++|++++..+. ..+..+++|++|+|++|++++.+|..+.++++|+
T Consensus 242 ~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 321 (768)
T 3rgz_A 242 AISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321 (768)
T ss_dssp HTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCC
T ss_pred HHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCcc
Confidence 666666666666666666544332 2122234555555555555555555555555555
Q ss_pred EEeccccccccccCcc-ccccccccceeccccccc-cccchhhhhh-------------------cccC--CCCccEEEc
Q 002021 277 ILDLEGNSFSGFIPNT-FGNLRNLSWLVLSDNYLT-SSTQELSFLS-------------------SLSN--CKFLKYFDL 333 (979)
Q Consensus 277 ~L~Ls~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~~~-------------------~l~~--l~~L~~L~L 333 (979)
+|+|++|.+++.+|.. |.++++|++|+|++|+++ ..+..+..+. .+.. +++|++|++
T Consensus 322 ~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L 401 (768)
T 3rgz_A 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401 (768)
T ss_dssp EEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEEC
T ss_pred EEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEEC
Confidence 5555555554444433 455555555555555544 2222111110 0111 334455555
Q ss_pred cCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccC
Q 002021 334 SYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLE 413 (979)
Q Consensus 334 s~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 413 (979)
++|++.+..+..+ .. .++|++|++++|++++.+|..++.+++|+.|++++|++.+.+|..+..+++|++|++++|++.
T Consensus 402 ~~n~l~~~~p~~l-~~-l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 479 (768)
T 3rgz_A 402 QNNGFTGKIPPTL-SN-CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLT 479 (768)
T ss_dssp CSSEEEEECCGGG-GG-CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCccccccCHHH-hc-CCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCccc
Confidence 5554444333322 11 246888888888888888888888888888888888888888888888888999999999998
Q ss_pred CCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccc-cccccccCcCCCcEEEeccccccCCCcccc-
Q 002021 414 GSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLEI- 491 (979)
Q Consensus 414 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~- 491 (979)
+.+|..+.++++|++|+|++|++++.+|..++.+++|++|+|++|+++ .+|..+..+++|+.|++++|+++|.+|..+
T Consensus 480 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~ 559 (768)
T 3rgz_A 480 GEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF 559 (768)
T ss_dssp SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGG
T ss_pred CcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHh
Confidence 888888999999999999999999889999999999999999999998 788889999999999999999987777543
Q ss_pred ---------------------------------------------------------------------ccccccceEec
Q 002021 492 ---------------------------------------------------------------------GSLKVLVGIDL 502 (979)
Q Consensus 492 ---------------------------------------------------------------------~~l~~L~~L~L 502 (979)
+.+++|+.|||
T Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdL 639 (768)
T 3rgz_A 560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639 (768)
T ss_dssp TTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEEC
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEEC
Confidence 33567899999
Q ss_pred cCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCccccc
Q 002021 503 SRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGK 582 (979)
Q Consensus 503 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 582 (979)
++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|+.|+|++|+++|.
T Consensus 640 s~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~ 719 (768)
T 3rgz_A 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 719 (768)
T ss_dssp CSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEE
T ss_pred cCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccccccCCccccCCCCCCCCCCCCccc
Q 002021 583 IPRGGSFGNFSAQSFEGNELLCGSPNLQIPPCKTSIH 619 (979)
Q Consensus 583 ~p~~~~~~~~~~~~~~~N~~~c~~p~~~~~~~~~~~~ 619 (979)
||.++.|.++...+|.||+++||.| +++|.....
T Consensus 720 iP~~~~~~~~~~~~~~gN~~Lcg~~---l~~C~~~~~ 753 (768)
T 3rgz_A 720 IPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNA 753 (768)
T ss_dssp CCSSSSGGGSCGGGGCSCTEEESTT---SCCCCSCC-
T ss_pred CCCchhhccCCHHHhcCCchhcCCC---CcCCCCCcc
Confidence 9999999999999999999999998 568976443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-61 Score=594.86 Aligned_cols=488 Identities=34% Similarity=0.477 Sum_probs=425.2
Q ss_pred cEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEcc
Q 002021 73 RVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLS 152 (979)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 152 (979)
+++.|++++|.++|.+|. +.+++|++|+|++|++++.+|. ++.+++|++|+|++|++++.+|..++++++|++|+|+
T Consensus 179 ~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls 255 (768)
T 3rgz_A 179 ELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS 255 (768)
T ss_dssp TCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECC
T ss_pred CCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECC
Confidence 455555555555554432 6777888888888888877776 8888888888888888888888888888888888888
Q ss_pred CCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCC-CCCCceecCCCeeeecCCccccccCccceeec
Q 002021 153 SNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNL-RNLEKLDIGDNKLVGIAPIAIFNVSTLKILGL 231 (979)
Q Consensus 153 ~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 231 (979)
+|.+++. +|.. .+++|++|+|++|++++.+|..+..+ ++|++|+|++|++++..|..|.++++|+.|+|
T Consensus 256 ~n~l~~~--------~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 325 (768)
T 3rgz_A 256 SNQFVGP--------IPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 325 (768)
T ss_dssp SSCCEES--------CCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEEC
T ss_pred CCcccCc--------cCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEEC
Confidence 8888764 4443 78889999999999988889888775 99999999999999999999999999999999
Q ss_pred cCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCC-CCcEEeccccccccccCccccc--cccccceeccccc
Q 002021 232 QDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNAS-KLSILDLEGNSFSGFIPNTFGN--LRNLSWLVLSDNY 308 (979)
Q Consensus 232 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~--l~~L~~L~Ls~N~ 308 (979)
++|++++..+...+..+++|++|+|++|++++.+|..+.+++ +|++|++++|++++.+|..+.. +++|++|++++|.
T Consensus 326 ~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~ 405 (768)
T 3rgz_A 326 SSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405 (768)
T ss_dssp CSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSE
T ss_pred CCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCc
Confidence 999998766665688999999999999999999999998887 8999999999999888888877 8899999999999
Q ss_pred cccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCC
Q 002021 309 LTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKL 388 (979)
Q Consensus 309 l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l 388 (979)
+++..+. .+.++++|++|++++|++.+..+..+. . .++|+.|++++|.+++.+|..+..+++|++|++++|++
T Consensus 406 l~~~~p~-----~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~-l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 478 (768)
T 3rgz_A 406 FTGKIPP-----TLSNCSELVSLHLSFNYLSGTIPSSLG-S-LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478 (768)
T ss_dssp EEEECCG-----GGGGCTTCCEEECCSSEEESCCCGGGG-G-CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccCH-----HHhcCCCCCEEECcCCcccCcccHHHh-c-CCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence 9854332 478899999999999999877665543 3 35899999999999999999999999999999999999
Q ss_pred CchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccc-cccccc
Q 002021 389 NGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTF 467 (979)
Q Consensus 389 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~ 467 (979)
++.+|..+.++++|++|++++|++.+.+|.+++.+++|++|+|++|++++.+|..++++++|++|++++|+++ .+|..+
T Consensus 479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~ 558 (768)
T 3rgz_A 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGG
T ss_pred cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHH
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999987 666543
Q ss_pred ----------------------------------------------------------------------cCcCCCcEEE
Q 002021 468 ----------------------------------------------------------------------WNLKDILNLN 477 (979)
Q Consensus 468 ----------------------------------------------------------------------~~l~~L~~L~ 477 (979)
..+++|+.|+
T Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~Ld 638 (768)
T 3rgz_A 559 FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638 (768)
T ss_dssp GTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEE
T ss_pred hcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEE
Confidence 3357789999
Q ss_pred eccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccc
Q 002021 478 FSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSG 557 (979)
Q Consensus 478 ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 557 (979)
|++|+++|.+|..++.++.|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+.++++|++|||++|+++|
T Consensus 639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 718 (768)
T 3rgz_A 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718 (768)
T ss_dssp CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCccccCccccCeEeccCCc-ccc
Q 002021 558 VIPASLEKLSYLEDLNLSFNQ-LEG 581 (979)
Q Consensus 558 ~~p~~~~~l~~L~~L~L~~N~-l~~ 581 (979)
.+|.. ..+..+....+.+|+ +.|
T Consensus 719 ~iP~~-~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 719 PIPEM-GQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp ECCSS-SSGGGSCGGGGCSCTEEES
T ss_pred cCCCc-hhhccCCHHHhcCCchhcC
Confidence 99965 456667777788997 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-58 Score=564.87 Aligned_cols=521 Identities=23% Similarity=0.252 Sum_probs=418.6
Q ss_pred CcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEc
Q 002021 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDL 151 (979)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 151 (979)
.+++.|+|++|++++..+..++++++|++|||++|++++..|.+++.+++|++|+|++|++++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 57999999999999877778999999999999999999999999999999999999999999776678999999999999
Q ss_pred cCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCcccc--ccCcccee
Q 002021 152 SSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIF--NVSTLKIL 229 (979)
Q Consensus 152 s~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~--~l~~L~~L 229 (979)
++|.+++. .|..|+++++|++|+|++|.+++..|..++++++|++|++++|++++..+..+. .+++|+.|
T Consensus 105 ~~n~l~~~--------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 176 (680)
T 1ziw_A 105 MSNSIQKI--------KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176 (680)
T ss_dssp CSSCCCCC--------CSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEE
T ss_pred CCCccCcc--------ChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEE
Confidence 99999753 457899999999999999999999999999999999999999999998887665 45899999
Q ss_pred eccCCCCcCCCcccccCC---------------------------CCCcCEEEccCCccccccCcccccCCC--CcEEec
Q 002021 230 GLQDNSLSGCLSSIGYAR---------------------------LPNLEILSLWGNNFSGTIPRFIFNASK--LSILDL 280 (979)
Q Consensus 230 ~L~~N~l~~~~~~~~~~~---------------------------l~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~L 280 (979)
++++|++++..+.. |.. .++|++|++++|.+++..|..+.+++. |++|+|
T Consensus 177 ~L~~n~l~~~~~~~-~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~L 255 (680)
T 1ziw_A 177 ELSSNQIKEFSPGC-FHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255 (680)
T ss_dssp ECTTCCCCCBCTTG-GGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEEC
T ss_pred ECCCCcccccChhh-hhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEEC
Confidence 99999998765431 222 256777778888887777777777644 888888
Q ss_pred cccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCC--------ccccccccc
Q 002021 281 EGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILP--------RTTVGNLSH 352 (979)
Q Consensus 281 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~--------~~~~~~l~~ 352 (979)
++|++++..|..|+.+++|++|++++|+++...+. .+.++++|++|++++|......+ ...+. ..+
T Consensus 256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~-~l~ 329 (680)
T 1ziw_A 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH-----SLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ-WLK 329 (680)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTT-----TTTTCTTCCEEECTTCBCCC------CCEECTTTTT-TCT
T ss_pred CCCCcCccCcccccCcccccEeeCCCCccCccChh-----hhcCCCCccEEeccchhhhcccccccccccChhhcc-cCC
Confidence 88888877777788888888888888887765432 24445555555554443221000 00011 123
Q ss_pred cccEEEccCccccCCCCccccCCC----------------------------cccEEEecCCCCCchhHHhhhcCCCCcE
Q 002021 353 SLEEFKMSNCNISGGIPEEISNLT----------------------------NLRTIYLGGNKLNGSILITLSKLQKLQD 404 (979)
Q Consensus 353 ~L~~L~L~~n~i~~~~p~~l~~l~----------------------------~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 404 (979)
+|++|++++|++++..+..|..++ +|+.|++++|++++..+..|..+++|+.
T Consensus 330 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 409 (680)
T 1ziw_A 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409 (680)
T ss_dssp TCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCE
Confidence 455555555555544444444444 4555556666777777788888888888
Q ss_pred EEecCcccCCCcc-ccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccc---cccccccCcCCCcEEEecc
Q 002021 405 LGLKDNKLEGSIP-YDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT---SIPLTFWNLKDILNLNFSS 480 (979)
Q Consensus 405 L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---~lp~~~~~l~~L~~L~ls~ 480 (979)
|++++|.+.+.+| ..+.++++|++|++++|++.+..+..|..+++|+.|++++|.++ .+|..+..+++|+.|++++
T Consensus 410 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~ 489 (680)
T 1ziw_A 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489 (680)
T ss_dssp EECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCS
T ss_pred EeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCC
Confidence 8888888876555 67888888888888888888888888888889999999998876 5678899999999999999
Q ss_pred ccccCCCccccccccccceEeccCCccCcccc--------hhhcCCcccceeecCCccccCCCCCccccccccccccccc
Q 002021 481 NFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIP--------TEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSN 552 (979)
Q Consensus 481 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 552 (979)
|++++..|..|..+++|+.|+|++|++++..+ ..|.++++|+.|+|++|+++...+..|.++++|+.|+|++
T Consensus 490 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 569 (680)
T 1ziw_A 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCC
Confidence 99998888889999999999999999986532 2478899999999999999965556799999999999999
Q ss_pred ccccccCCccccCccccCeEeccCCcccccCCCCC--CCCCcccccccCCccccCCC
Q 002021 553 NNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGG--SFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 553 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~--~~~~~~~~~~~~N~~~c~~p 607 (979)
|+|++..+..|..+++|+.|+|++|++++..|... .++++..+.+.+||+.|+++
T Consensus 570 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 99998888888999999999999999998776522 46788889999999999876
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=566.82 Aligned_cols=494 Identities=19% Similarity=0.238 Sum_probs=295.6
Q ss_pred ChhHHHHHHHHHHhcccCCCCcc------ccccCCCCCCCcc---ceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCC
Q 002021 27 TITDQDALLALKAHITHDPTNFL------AKNWNTSTPVCNW---TGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSS 97 (979)
Q Consensus 27 ~~~~~~all~~k~~~~~~~~~~~------~~~w~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~ 97 (979)
...|++||.+||+++..+++... ..+|+.+.+||.| .||+|+.. +||+.|+|++++++|.+|+++++|++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCcc
Confidence 34789999999999865544321 1379999999999 99999865 89999999999999999999999999
Q ss_pred CCeeeccCCcc------cc------cCCccccccCcccEEecccccccccCCccccCC-CCCcEEEcc------------
Q 002021 98 LQSLNLSFNRL------FG------SIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNK-SSLQHLDLS------------ 152 (979)
Q Consensus 98 L~~L~L~~n~~------~~------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls------------ 152 (979)
|++|||++|++ .| .+|... +..|+ +++++|.+.+.+|..++.+ ..+..+++.
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l 183 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred ceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence 99999999987 44 455444 45566 6777777766666555421 111222222
Q ss_pred --------CCccCchhhhhhhccCCcccCCCCccceeeccccccccc-----------------cccccc--CCCCCCce
Q 002021 153 --------SNALSGEIRANICREIPREFGNLPELELMSLAANNLQGK-----------------IPLKIG--NLRNLEKL 205 (979)
Q Consensus 153 --------~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L 205 (979)
.|+++| ||++++++++|++|+|++|+++|. +|..++ ++++|++|
T Consensus 184 ~~l~l~~~~n~l~~---------ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L 254 (636)
T 4eco_A 184 KDTQIGQLSNNITF---------VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV 254 (636)
T ss_dssp CTTTTTCCSCEEEE---------ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred hhhhhccccCCCcc---------CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEE
Confidence 233332 455555555555555555555553 555555 55555555
Q ss_pred ecCCCeeeecCCccccccCccceeeccCCC-CcC-CCcccccC------CCCCcCEEEccCCccccccCc--ccccCCCC
Q 002021 206 DIGDNKLVGIAPIAIFNVSTLKILGLQDNS-LSG-CLSSIGYA------RLPNLEILSLWGNNFSGTIPR--FIFNASKL 275 (979)
Q Consensus 206 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~~~~~~~------~l~~L~~L~L~~N~l~~~~p~--~l~~l~~L 275 (979)
+|++|++.+.+|..|.++++|+.|+|++|+ +++ ..+. .+. .+++|++|+|++|+++ .+|. .+.++++|
T Consensus 255 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~-~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L 332 (636)
T 4eco_A 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD-DWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKL 332 (636)
T ss_dssp EEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHH-HHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTC
T ss_pred EecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchH-HHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCC
Confidence 555555555555555555555555555555 554 2221 122 2356666666666666 5555 56666666
Q ss_pred cEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCC-ccEEEccCCCCcccCCccccccccccc
Q 002021 276 SILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKF-LKYFDLSYNPLYRILPRTTVGNLSHSL 354 (979)
Q Consensus 276 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~~~~~~~~l~~~L 354 (979)
++|++++|+++|.+| .|+.+++|++|+|++|+++.++. .+..+++ |++|++++|++..++. .+...-.++|
T Consensus 333 ~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~------~l~~l~~~L~~L~Ls~N~l~~lp~-~~~~~~l~~L 404 (636)
T 4eco_A 333 GMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPA------NFCGFTEQVENLSFAHNKLKYIPN-IFDAKSVSVM 404 (636)
T ss_dssp CEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCT------TSEEECTTCCEEECCSSCCSSCCS-CCCTTCSSCE
T ss_pred CEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccH------hhhhhcccCcEEEccCCcCcccch-hhhhcccCcc
Confidence 666666666665566 66666666666666666664432 2445555 6666666665553321 1111111245
Q ss_pred cEEEccCccccCCCCcccc-------CCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCc
Q 002021 355 EEFKMSNCNISGGIPEEIS-------NLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427 (979)
Q Consensus 355 ~~L~L~~n~i~~~~p~~l~-------~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 427 (979)
++|++++|.+++.+|..+. .+++|++|+|++|+++..++..+..+++|++|++++|+++ .+|.......
T Consensus 405 ~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~--- 480 (636)
T 4eco_A 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDE--- 480 (636)
T ss_dssp EEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEET---
T ss_pred CEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccc---
Confidence 5555555555555555555 4555555555555555444444444455555555555544 2222211100
Q ss_pred eEecCCCcccccCCccccCCCcCceEecCCCcccccccccc--CcCCCcEEEeccccccCCCccccccccccceEeccCC
Q 002021 428 RLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFW--NLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRN 505 (979)
Q Consensus 428 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~--~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 505 (979)
+..+.++++|++|+|++|+++.+|..+. .+++|+.|++++|++++ +|..+..+++|+.|+|++|
T Consensus 481 -------------~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N 546 (636)
T 4eco_A 481 -------------NENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546 (636)
T ss_dssp -------------TEECTTGGGCCEEECCSSCCCBCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred -------------cccccccCCccEEECcCCcCCccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence 0001123367777777777777776665 67777777777777775 6666667777777777665
Q ss_pred ccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCccccc
Q 002021 506 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGK 582 (979)
Q Consensus 506 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 582 (979)
+ ++++|++.+.+|..+.++++|++|+|++|++ +.+|..+. ++|+.|+|++|++.+.
T Consensus 547 ~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 547 R------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISI 602 (636)
T ss_dssp B------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEE
T ss_pred c------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCccc
Confidence 4 4455666666666666666666666666666 35555444 5666666666665543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-58 Score=561.12 Aligned_cols=496 Identities=20% Similarity=0.215 Sum_probs=319.3
Q ss_pred CCChhHHHHHHHHHHhcccCCCCccccccCCCC-----CC--Ccc------------ceeEeeCCCCcEEEEEecCCCcc
Q 002021 25 SSTITDQDALLALKAHITHDPTNFLAKNWNTST-----PV--CNW------------TGVACEVHSQRVTVLNISSLNLT 85 (979)
Q Consensus 25 ~~~~~~~~all~~k~~~~~~~~~~~~~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~l~l~~~~l~ 85 (979)
++..+|++||++||+++. || +|+.+. +| |+| .||+|+. .+||+.|+|++++++
T Consensus 265 ~~~~~d~~ALl~~k~~l~-~~------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~ 336 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALD-GK------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAK 336 (876)
T ss_dssp CHHHHHHHHHHHHHHHTT-GG------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCE
T ss_pred ccchHHHHHHHHHHHHcC-CC------CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCC
Confidence 344579999999999994 44 575443 44 999 9999986 689999999999999
Q ss_pred ccCCCCCcCCCCCCeeec-cCCcccccCCcccc-----------------------------------------------
Q 002021 86 GTIPSQLGNLSSLQSLNL-SFNRLFGSIPSAIF----------------------------------------------- 117 (979)
Q Consensus 86 g~~~~~l~~l~~L~~L~L-~~n~~~~~~p~~~~----------------------------------------------- 117 (979)
|.+|+++++|++|++||| ++|.++|..|-...
T Consensus 337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~ 416 (876)
T 4ecn_A 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416 (876)
T ss_dssp EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence 999999999999999999 99999887553311
Q ss_pred ----ccCcccEEeccc--ccccccCCccccCCCCCcEEEccCCccCchh-hhh--------hhccCCcccC--CCCccce
Q 002021 118 ----TTYTLKYVCLRG--NQLSGTFPSFISNKSSLQHLDLSSNALSGEI-RAN--------ICREIPREFG--NLPELEL 180 (979)
Q Consensus 118 ----~l~~L~~L~L~~--n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~--------~~~~ip~~l~--~l~~L~~ 180 (979)
....++.+.+.. |++++ +|..|+++++|++|+|++|.|+|.. ... ....+|+.++ ++++|++
T Consensus 417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~ 495 (876)
T 4ecn_A 417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495 (876)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence 122334444443 88887 8888888888999999988888620 000 0001555555 6666666
Q ss_pred eecccccccccccccccCCCCCCceecCCCe-eee-cCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccC
Q 002021 181 MSLAANNLQGKIPLKIGNLRNLEKLDIGDNK-LVG-IAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWG 258 (979)
Q Consensus 181 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~ 258 (979)
|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+.+++ ..+..+++|++|+|++
T Consensus 496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~------------------~~~~~l~~L~~L~Ls~ 557 (876)
T 4ecn_A 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA------------------DDEDTGPKIQIFYMGY 557 (876)
T ss_dssp EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHH------------------HCTTTTTTCCEEECCS
T ss_pred EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhh------------------hcccccCCccEEEeeC
Confidence 6666666666666666666666666666665 555 4455444433 0233455666666666
Q ss_pred CccccccCc--ccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCC-ccEEEccC
Q 002021 259 NNFSGTIPR--FIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKF-LKYFDLSY 335 (979)
Q Consensus 259 N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~-L~~L~Ls~ 335 (979)
|+++ .+|. .+.++++|++|+|++|+++ .+| .|+.+++|+.|+|++|+++.++. .+.++++ |++|+|++
T Consensus 558 N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~lp~------~l~~l~~~L~~L~Ls~ 628 (876)
T 4ecn_A 558 NNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPE------DFCAFTDQVEGLGFSH 628 (876)
T ss_dssp SCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSCCCT------TSCEECTTCCEEECCS
T ss_pred CcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccccchH------HHhhccccCCEEECcC
Confidence 6666 5555 5666666666666666666 445 56666666666666666664442 2455555 66666666
Q ss_pred CCCcccCCccccccccccccEEEccCccccCCCCcc---cc--CCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCc
Q 002021 336 NPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE---IS--NLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDN 410 (979)
Q Consensus 336 N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~---l~--~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 410 (979)
|++..++ ..+...-.++|+.|++++|++++.+|.. +. .+++|+.|+|++|+++..+...+..+++|+.|+|++|
T Consensus 629 N~L~~lp-~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N 707 (876)
T 4ecn_A 629 NKLKYIP-NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707 (876)
T ss_dssp SCCCSCC-SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSC
T ss_pred CCCCcCc-hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCC
Confidence 6665432 2111111124777777777776655432 22 3447888888888888665566667777888888777
Q ss_pred ccCCCccccccCC--------CCCceEecCCCcccccCCcccc--CCCcCceEecCCCccccccccccCcCCCcEEEecc
Q 002021 411 KLEGSIPYDICNL--------AELYRLDLDGNKLSGSIPACFS--NLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSS 480 (979)
Q Consensus 411 ~l~~~~p~~~~~l--------~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~ 480 (979)
++. .+|..+... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|+.+|..+..+++|+.|+|++
T Consensus 708 ~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~ 785 (876)
T 4ecn_A 708 LMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRH 785 (876)
T ss_dssp CCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCC
T ss_pred cCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCC
Confidence 777 455443322 25666666666665 4455554 55555555555555555555555555555555555
Q ss_pred ccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCC
Q 002021 481 NFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP 560 (979)
Q Consensus 481 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 560 (979)
|+ ++++|++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+
T Consensus 786 N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 786 QR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDV 844 (876)
T ss_dssp CB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEEC
T ss_pred CC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccCh
Confidence 44 3455777777777777777777777777777 46666654 577777777777776666
Q ss_pred ccccCccccCeEeccCCccc
Q 002021 561 ASLEKLSYLEDLNLSFNQLE 580 (979)
Q Consensus 561 ~~~~~l~~L~~L~L~~N~l~ 580 (979)
..+.....+..+.|.+|++.
T Consensus 845 ~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 845 TSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp GGGHHHHHTTCCEEECCTTS
T ss_pred HHccccccchheeecCCCcc
Confidence 66666656666666666554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=550.68 Aligned_cols=504 Identities=22% Similarity=0.209 Sum_probs=350.9
Q ss_pred cceeEeeCC---------CCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccc
Q 002021 62 WTGVACEVH---------SQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQL 132 (979)
Q Consensus 62 w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l 132 (979)
+.-|.|... ...++.|||++|.+++..|..++++++|++|||++|++++..|.+|..+++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 445677532 24688889999998887788888899999999999988888888888888999999999988
Q ss_pred cccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCee
Q 002021 133 SGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKL 212 (979)
Q Consensus 133 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 212 (979)
++..|..|+++++|++|+|++|.+++. .|..++++++|++|+|++|++++..+..+..+++|++|++++|++
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l--------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 165 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSI--------DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCG--------GGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCC
T ss_pred cccChhhhcccccccEeeccccCcccC--------CcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcc
Confidence 888888888899999999999888753 256688888899999999988875444455588899999999988
Q ss_pred eecCCccccccCccc--eeeccCCCCcCCCcccccCCCCCcCEEEccCCcccc--------------------------c
Q 002021 213 VGIAPIAIFNVSTLK--ILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSG--------------------------T 264 (979)
Q Consensus 213 ~~~~p~~l~~l~~L~--~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~--------------------------~ 264 (979)
+++.|..|..+++|+ .|++++|.+++..+.. | ...+|++|++++|.... .
T Consensus 166 ~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~-~-~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i 243 (606)
T 3t6q_A 166 HYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGA-F-DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243 (606)
T ss_dssp CEECHHHHHTTTTCCSEEEECTTCCCCEECTTT-T-TTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCC
T ss_pred cccChhhhhhhcccceeEEecCCCccCccChhH-h-hhccccccccCCchhHHHHhhhccccchhheechhhcccccccc
Confidence 888888888888888 8888888888766543 2 44678888888775110 0
Q ss_pred cCcccccCC--CCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccC
Q 002021 265 IPRFIFNAS--KLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRIL 342 (979)
Q Consensus 265 ~p~~l~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 342 (979)
.+..+..+. +|+.|++++|.+++..+..|+++++|++|++++|+++.+|. .+..+++|++|++++|++..+.
T Consensus 244 ~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~------~l~~l~~L~~L~l~~n~l~~~~ 317 (606)
T 3t6q_A 244 SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS------GLVGLSTLKKLVLSANKFENLC 317 (606)
T ss_dssp CGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCS------SCCSCTTCCEEECTTCCCSBGG
T ss_pred ChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCCh------hhcccccCCEEECccCCcCcCc
Confidence 011111111 56667777777766666667777777777777777665543 2556666777777777666654
Q ss_pred CccccccccccccEEEccCccccCCCCc-cccCCCcccEEEecCCCCCchh--HHhhhcCCCCcEEEecCcccCCCcccc
Q 002021 343 PRTTVGNLSHSLEEFKMSNCNISGGIPE-EISNLTNLRTIYLGGNKLNGSI--LITLSKLQKLQDLGLKDNKLEGSIPYD 419 (979)
Q Consensus 343 ~~~~~~~l~~~L~~L~L~~n~i~~~~p~-~l~~l~~L~~L~L~~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~ 419 (979)
+..+ .. .++|++|++++|.+.+.+|. .+..+++|++|++++|.+++.. +..+..+++|++|++++|.+.+..|..
T Consensus 318 ~~~~-~~-l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 395 (606)
T 3t6q_A 318 QISA-SN-FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395 (606)
T ss_dssp GGCG-GG-CTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTT
T ss_pred hhhh-hc-cCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHH
Confidence 4322 22 24567777777766654443 3666677777777777766655 556666677777777777666666666
Q ss_pred ccCCCCCceEecCCCcccccCCc-cccCCCcCceEecCCCccccc-cccccCcCCCcEEEeccccccCC---Cccccccc
Q 002021 420 ICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSI-PLTFWNLKDILNLNFSSNFLTGS---LPLEIGSL 494 (979)
Q Consensus 420 ~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~ls~N~l~~~---~p~~~~~l 494 (979)
+..+++|+.|++++|++.+..+. .+..+++|++|++++|.++.. |..+..+++|+.|++++|++++. .+..+..+
T Consensus 396 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l 475 (606)
T 3t6q_A 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475 (606)
T ss_dssp TTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGC
T ss_pred hcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccC
Confidence 66666777777777776655443 366666777777777766643 44566666677777777766652 23456666
Q ss_pred cccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEec
Q 002021 495 KVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNL 574 (979)
Q Consensus 495 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 574 (979)
++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..+.++++| +|+|++|++++.+|..+..+++|+.|++
T Consensus 476 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l 554 (606)
T 3t6q_A 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEEC
T ss_pred CCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeC
Confidence 667777777777766666666667777777777777766666666666666 6777777776666666666666777777
Q ss_pred cCCcccccCC
Q 002021 575 SFNQLEGKIP 584 (979)
Q Consensus 575 ~~N~l~~~~p 584 (979)
++|+++|.++
T Consensus 555 ~~N~~~c~c~ 564 (606)
T 3t6q_A 555 RQNPLDCTCS 564 (606)
T ss_dssp TTCCEECSGG
T ss_pred CCCCccccCC
Confidence 7777666555
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=557.00 Aligned_cols=516 Identities=24% Similarity=0.272 Sum_probs=344.1
Q ss_pred CccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccC-CccccccCcccEEecccccccccCCc
Q 002021 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSI-PSAIFTTYTLKYVCLRGNQLSGTFPS 138 (979)
Q Consensus 60 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~L~~n~l~~~~p~ 138 (979)
|.|.+|.+ ...+++.|||++|.+++..|..+.++++|++|||++|.+.+.+ |.++..+++|++|+|++|++++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 67888877 4678999999999999988999999999999999999877777 78899999999999999999999999
Q ss_pred cccCCCCCcEEEccCCccCchhhhhhhccCCcc--cCCCCccceeeccccccccccc-ccccCCCCCCceecCCCeeeec
Q 002021 139 FISNKSSLQHLDLSSNALSGEIRANICREIPRE--FGNLPELELMSLAANNLQGKIP-LKIGNLRNLEKLDIGDNKLVGI 215 (979)
Q Consensus 139 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~--l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ 215 (979)
.|+++++|++|+|++|.+++. +|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|++++.
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~--------~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDA--------VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSC--------CSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred HccCCcccCEeeCcCCCCCcc--------cccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999999864 4544 9999999999999999998765 6799999999999999999999
Q ss_pred CCcccccc--CccceeeccCCCCcCCCcccccCCCC------CcCEEEccCCccccccCcccccC---CCCcEEeccc--
Q 002021 216 APIAIFNV--STLKILGLQDNSLSGCLSSIGYARLP------NLEILSLWGNNFSGTIPRFIFNA---SKLSILDLEG-- 282 (979)
Q Consensus 216 ~p~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~~l~------~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~Ls~-- 282 (979)
.+..+..+ ++|+.|+|+.|.+.+..+. .+..++ +|++|++++|++++.+|..+... .+++.|+++.
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~-~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~ 242 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSV-DWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCC-CCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred CHHHcccccCCccceEECCCCcccccccc-chhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence 99999988 8999999999999875543 233444 49999999999988777766543 4455555542
Q ss_pred -------cccccccCcccccc--ccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCcccccccccc
Q 002021 283 -------NSFSGFIPNTFGNL--RNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHS 353 (979)
Q Consensus 283 -------N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~ 353 (979)
|.+.+..+..|.++ ++|+.|+|++|.++..+.. .+..+++|++|+|++|++..+.+..+. . .++
T Consensus 243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~L~~n~i~~~~~~~~~-~-l~~ 315 (844)
T 3j0a_A 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSR-----VFETLKDLKVLNLAYNKINKIADEAFY-G-LDN 315 (844)
T ss_dssp CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSC-----CSSSCCCCCEEEEESCCCCEECTTTTT-T-CSS
T ss_pred ccccccccccCCCChhhhhccccCCccEEECCCCcccccChh-----hhhcCCCCCEEECCCCcCCCCChHHhc-C-CCC
Confidence 22333333344443 4566666666655554332 245555666666666665555443322 1 235
Q ss_pred ccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCC
Q 002021 354 LEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDG 433 (979)
Q Consensus 354 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 433 (979)
|++|++++|.+++..|..|..+++|+.|++++|++.+..+..|..+++|+.|++++|.+++. + .+++|+.|++++
T Consensus 316 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~ 390 (844)
T 3j0a_A 316 LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSG 390 (844)
T ss_dssp CCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEES
T ss_pred CCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCC
Confidence 66666666666555555566666666666666666555555555566666666666655531 1 245555666666
Q ss_pred CcccccCCccccCCCcCceEecCCCccccccc--cccCcCCCcEEEeccccccCCCcc-ccccccccceEeccCCccC--
Q 002021 434 NKLSGSIPACFSNLTSLRIVSLGSNELTSIPL--TFWNLKDILNLNFSSNFLTGSLPL-EIGSLKVLVGIDLSRNNFS-- 508 (979)
Q Consensus 434 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-- 508 (979)
|+++ .+|.. ..+++.|++++|+++.++. .+..+++|+.|++++|++++..+. .+..+++|+.|+|++|.++
T Consensus 391 N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 466 (844)
T 3j0a_A 391 NKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466 (844)
T ss_dssp CCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSS
T ss_pred CCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccc
Confidence 6655 22322 3345555566665554433 233555556666666655543322 2334555555566665554
Q ss_pred ---cccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCC
Q 002021 509 ---GVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 509 ---~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
+..+..|.++++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|++++.+|.
T Consensus 467 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~ 544 (844)
T 3j0a_A 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD 544 (844)
T ss_dssp CCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC
T ss_pred cccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh
Confidence 23334455555566666666666555555555556666666666665554444443 5555566666666555553
Q ss_pred CCCCCCcccccccCCccccCC
Q 002021 586 GGSFGNFSAQSFEGNELLCGS 606 (979)
Q Consensus 586 ~~~~~~~~~~~~~~N~~~c~~ 606 (979)
.|..+..+.+.+||+.|.+
T Consensus 545 --~~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 545 --VFVSLSVLDITHNKFICEC 563 (844)
T ss_dssp --CCSSCCEEEEEEECCCCSS
T ss_pred --HhCCcCEEEecCCCccccc
Confidence 2445555555555555544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=540.42 Aligned_cols=488 Identities=21% Similarity=0.174 Sum_probs=396.7
Q ss_pred CCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEE
Q 002021 71 SQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLD 150 (979)
Q Consensus 71 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 150 (979)
..+++.|+|++|.+++..+..++++++|++|||++|++++..|.++..+++|++|+|++|++++..|..|+++++|++|+
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 35799999999999998888999999999999999999988899999999999999999999999999999999999999
Q ss_pred ccCCccCchhhhhhhccCCcccCCCCccceeecccccccc-cccccccCCCCCCceecCCCeeeecCCccccccCccc--
Q 002021 151 LSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQG-KIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLK-- 227 (979)
Q Consensus 151 Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~-- 227 (979)
|++|.+++. .|..++++++|++|+|++|.+++ .+|..++++++|++|+|++|+++++.|..+..+++|+
T Consensus 111 L~~n~l~~~--------~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~ 182 (606)
T 3vq2_A 111 AVETKLASL--------ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQV 182 (606)
T ss_dssp CTTSCCCCS--------SSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTC
T ss_pred ccCCccccc--------cccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccc
Confidence 999999853 34779999999999999999986 6799999999999999999999999999998888776
Q ss_pred --eeeccCCCCcCCCcccccCCCCCcCEEEccCCccc-cccCcccccCCCCcEEec------------------------
Q 002021 228 --ILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS-GTIPRFIFNASKLSILDL------------------------ 280 (979)
Q Consensus 228 --~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L------------------------ 280 (979)
.|++++|.+++..+.. +... +|++|++++|.++ +.+|..+.++++|+.+++
T Consensus 183 l~~L~l~~n~l~~~~~~~-~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~ 260 (606)
T 3vq2_A 183 NLSLDMSLNPIDFIQDQA-FQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260 (606)
T ss_dssp CCEEECTTCCCCEECTTT-TTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGG
T ss_pred cceeeccCCCcceeCccc-ccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhh
Confidence 7999999999766543 4444 8999999999987 456777888888887776
Q ss_pred ---------cccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCcccccccc
Q 002021 281 ---------EGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLS 351 (979)
Q Consensus 281 ---------s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 351 (979)
..|.+++.+|. |..+++|+.|++++|.++.++ .+..+++|++|++++|.+..++. + ..
T Consensus 261 l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~-------~l~~~~~L~~L~l~~n~l~~lp~--~---~l 327 (606)
T 3vq2_A 261 VTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE-------DVPKHFKWQSLSIIRCQLKQFPT--L---DL 327 (606)
T ss_dssp SEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC-------CCCTTCCCSEEEEESCCCSSCCC--C---CC
T ss_pred ccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh-------hccccccCCEEEcccccCccccc--C---CC
Confidence 55666666666 777888888888888877655 36677788888888888855541 1 23
Q ss_pred ccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchh--HHhhhcCCCCcEEEecCcccCCCccccccCCCCCceE
Q 002021 352 HSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSI--LITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRL 429 (979)
Q Consensus 352 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 429 (979)
++|++|++++|...+.. .+..+++|++|++++|++++.. +..+..+++|++|++++|.+.+ +|..+..+++|+.|
T Consensus 328 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L 404 (606)
T 3vq2_A 328 PFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHL 404 (606)
T ss_dssp SSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEE
T ss_pred CccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCee
Confidence 57888888888554333 5667888888888888887663 6777888888888888888774 55777788888888
Q ss_pred ecCCCcccccCC-ccccCCCcCceEecCCCcccc-ccccccCcCCCcEEEeccccccC-CCccccccccccceEeccCCc
Q 002021 430 DLDGNKLSGSIP-ACFSNLTSLRIVSLGSNELTS-IPLTFWNLKDILNLNFSSNFLTG-SLPLEIGSLKVLVGIDLSRNN 506 (979)
Q Consensus 430 ~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~ 506 (979)
++++|++.+..| ..+.++++|++|++++|+++. .|..+..+++|+.|++++|++++ .+|..++.+++|+.|+|++|+
T Consensus 405 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 484 (606)
T 3vq2_A 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484 (606)
T ss_dssp ECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCc
Confidence 888888877766 577788888888888888874 45667778888888888888876 367778888888888888888
Q ss_pred cCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCcc-ccCeEeccCCcccccCCC
Q 002021 507 FSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLS-YLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 507 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~ 585 (979)
+++..|..|.++++|++|+|++|++++.+|..|.++++|++|||++|+|+ .+|..+..++ +|+.|++++|++.|..+.
T Consensus 485 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 88777788888888888888888888777888888888888888888887 5566677776 588888888888877664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-56 Score=546.25 Aligned_cols=504 Identities=23% Similarity=0.253 Sum_probs=382.1
Q ss_pred CcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEc
Q 002021 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDL 151 (979)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 151 (979)
.+++.|+|++|.+++..|..++++++|++|+|++|++++..+.+++.+++|++|+|++|++++..|..|+++++|++|||
T Consensus 49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 128 (680)
T 1ziw_A 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128 (680)
T ss_dssp TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence 45778888888888777777888888888888888887544456788888888888888888777777888888888888
Q ss_pred cCCccCchhhhhhhccCCcccCCCCccceeeccccccccccccccc--CCCCCCceecCCCeeeecCCccccccC-----
Q 002021 152 SSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIG--NLRNLEKLDIGDNKLVGIAPIAIFNVS----- 224 (979)
Q Consensus 152 s~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~----- 224 (979)
++|.+++. .|..++++++|++|++++|.+++..+..++ .+++|++|++++|++++..|..+..++
T Consensus 129 s~n~l~~~--------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 200 (680)
T 1ziw_A 129 SHNGLSST--------KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGL 200 (680)
T ss_dssp CSSCCSCC--------CCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEE
T ss_pred CCCccccc--------CchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhh
Confidence 88887754 456677777777777777777766665543 346777777777777766666554432
Q ss_pred ----------------------ccceeeccCCCCcCCCcccccCCCC--CcCEEEccCCccccccCcccccCCCCcEEec
Q 002021 225 ----------------------TLKILGLQDNSLSGCLSSIGYARLP--NLEILSLWGNNFSGTIPRFIFNASKLSILDL 280 (979)
Q Consensus 225 ----------------------~L~~L~L~~N~l~~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 280 (979)
+|+.|++++|.+++..+. .|..++ +|++|+|++|++++..|..+..+++|++|+|
T Consensus 201 ~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~-~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 279 (680)
T 1ziw_A 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT-TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279 (680)
T ss_dssp ECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT-TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred hccccccChhhHHHHHHHhhhccccEEEccCCcccccChh-HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeC
Confidence 334444455544443322 233332 2666666666665555555555566666666
Q ss_pred cccccccccCccccc---------------------------------cccccceeccccccccccchhhhhhcccCCCC
Q 002021 281 EGNSFSGFIPNTFGN---------------------------------LRNLSWLVLSDNYLTSSTQELSFLSSLSNCKF 327 (979)
Q Consensus 281 s~N~l~~~~~~~~~~---------------------------------l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~ 327 (979)
++|.+++..|..|.+ +++|++|++++|.++..+.. .+.++++
T Consensus 280 ~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~ 354 (680)
T 1ziw_A 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN-----MFTGLIN 354 (680)
T ss_dssp CSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTT-----TTTTCTT
T ss_pred CCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChh-----HhccccC
Confidence 666655555554444 45555555555555544332 2455666
Q ss_pred ccEEEccCCCCc--ccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhH-HhhhcCCCCcE
Q 002021 328 LKYFDLSYNPLY--RILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSIL-ITLSKLQKLQD 404 (979)
Q Consensus 328 L~~L~Ls~N~l~--~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~ 404 (979)
|++|++++|.+. .+....+......+|+.|++++|++++..|..+..+++|+.|+|++|++.+.++ ..|..+++|++
T Consensus 355 L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~ 434 (680)
T 1ziw_A 355 LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434 (680)
T ss_dssp CCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCE
T ss_pred CcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccE
Confidence 666666666532 222222221112478999999999999999999999999999999999987554 78999999999
Q ss_pred EEecCcccCCCccccccCCCCCceEecCCCccc--ccCCccccCCCcCceEecCCCccccccc-cccCcCCCcEEEeccc
Q 002021 405 LGLKDNKLEGSIPYDICNLAELYRLDLDGNKLS--GSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSN 481 (979)
Q Consensus 405 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~ls~N 481 (979)
|++++|++.+..+..|..+++|+.|++++|.+. +..|..|.++++|++|++++|+++.+|. .+..+++|+.|++++|
T Consensus 435 L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N 514 (680)
T 1ziw_A 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514 (680)
T ss_dssp EECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCC
Confidence 999999999988999999999999999999997 5788999999999999999999998876 4889999999999999
Q ss_pred cccCCCc--------cccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccc
Q 002021 482 FLTGSLP--------LEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNN 553 (979)
Q Consensus 482 ~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 553 (979)
++++..+ ..+..+++|+.|+|++|+++...+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 515 ~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N 594 (680)
T 1ziw_A 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594 (680)
T ss_dssp CCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence 9986422 24789999999999999999776678999999999999999999877788999999999999999
Q ss_pred cccccCCcccc-CccccCeEeccCCcccccCCCCCCC
Q 002021 554 NLSGVIPASLE-KLSYLEDLNLSFNQLEGKIPRGGSF 589 (979)
Q Consensus 554 ~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~ 589 (979)
+|++..|..+. .+++|+.|++++|++.|.++...+|
T Consensus 595 ~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~ 631 (680)
T 1ziw_A 595 LITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 631 (680)
T ss_dssp CCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSE
T ss_pred cCCccChhHhcccccccCEEEccCCCcccCCccHHHH
Confidence 99998888887 7999999999999999998753344
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-56 Score=540.85 Aligned_cols=510 Identities=22% Similarity=0.266 Sum_probs=451.4
Q ss_pred EEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCc
Q 002021 76 VLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNA 155 (979)
Q Consensus 76 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 155 (979)
.++.++.+++ .+|..+.. ++++|||++|++++..|.+++.+++|++|+|++|++++..|..|+++++|++|+|++|.
T Consensus 16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence 5788999888 67776654 79999999999999889999999999999999999999999999999999999999999
Q ss_pred cCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCC
Q 002021 156 LSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNS 235 (979)
Q Consensus 156 l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 235 (979)
+++. .|..|+++++|++|+|++|++++..|..++++++|++|+|++|+++++.+..+..+++|+.|++++|.
T Consensus 93 l~~~--------~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 164 (606)
T 3t6q_A 93 LIFM--------AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164 (606)
T ss_dssp CSEE--------CTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC
T ss_pred cccc--------ChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc
Confidence 9864 68899999999999999999998878999999999999999999999776667779999999999999
Q ss_pred CcCCCcccccCCCCCcC--EEEccCCccccccCcccccCCCCcEEecccccc--------------------------cc
Q 002021 236 LSGCLSSIGYARLPNLE--ILSLWGNNFSGTIPRFIFNASKLSILDLEGNSF--------------------------SG 287 (979)
Q Consensus 236 l~~~~~~~~~~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l--------------------------~~ 287 (979)
+++..+. .|..+++|+ .|++++|.+++..|..+. ..+|++|++++|.. ..
T Consensus 165 l~~~~~~-~~~~l~~L~~l~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~ 242 (606)
T 3t6q_A 165 IHYLSKE-DMSSLQQATNLSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242 (606)
T ss_dssp CCEECHH-HHHTTTTCCSEEEECTTCCCCEECTTTTT-TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCC
T ss_pred ccccChh-hhhhhcccceeEEecCCCccCccChhHhh-hccccccccCCchhHHHHhhhccccchhheechhhccccccc
Confidence 9976543 477899999 999999999987776655 46899999998851 11
Q ss_pred ccCccccccc--cccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCcccc
Q 002021 288 FIPNTFGNLR--NLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNIS 365 (979)
Q Consensus 288 ~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~ 365 (979)
..+..|.++. +|+.|++++|.++.++.. .+..+++|++|++++|++..++.. +.. .++|++|++++|.++
T Consensus 243 i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~lp~~--l~~-l~~L~~L~l~~n~l~ 314 (606)
T 3t6q_A 243 ISPAVFEGLCEMSVESINLQKHYFFNISSN-----TFHCFSGLQELDLTATHLSELPSG--LVG-LSTLKKLVLSANKFE 314 (606)
T ss_dssp CCGGGGGGGGGSEEEEEECTTCCCSSCCTT-----TTTTCTTCSEEECTTSCCSCCCSS--CCS-CTTCCEEECTTCCCS
T ss_pred cChhHhchhhcCceeEEEeecCccCccCHH-----HhccccCCCEEeccCCccCCCChh--hcc-cccCCEEECccCCcC
Confidence 2233344443 799999999999988764 478899999999999999976443 233 368999999999999
Q ss_pred CCCCccccCCCcccEEEecCCCCCchhH-HhhhcCCCCcEEEecCcccCCCc--cccccCCCCCceEecCCCcccccCCc
Q 002021 366 GGIPEEISNLTNLRTIYLGGNKLNGSIL-ITLSKLQKLQDLGLKDNKLEGSI--PYDICNLAELYRLDLDGNKLSGSIPA 442 (979)
Q Consensus 366 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~ 442 (979)
+..|..+..+++|++|++++|.+.+..+ ..+..+++|++|++++|.+.+.. +..+..+++|++|++++|++.+..|.
T Consensus 315 ~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 394 (606)
T 3t6q_A 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394 (606)
T ss_dssp BGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTT
T ss_pred cCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHH
Confidence 9889999999999999999999985554 56999999999999999999766 77899999999999999999999999
Q ss_pred cccCCCcCceEecCCCccccc-cc-cccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcc---cchhhcC
Q 002021 443 CFSNLTSLRIVSLGSNELTSI-PL-TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGV---IPTEIGG 517 (979)
Q Consensus 443 ~~~~l~~L~~L~L~~N~l~~l-p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~ 517 (979)
.|..+++|++|++++|+++.. |. .+..+++|+.|++++|.+++..|..++.+++|+.|++++|++++. .+..+..
T Consensus 395 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~ 474 (606)
T 3t6q_A 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474 (606)
T ss_dssp TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGG
T ss_pred HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhcc
Confidence 999999999999999999965 33 488999999999999999999999999999999999999999873 3367999
Q ss_pred CcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCC-CCCCCccccc
Q 002021 518 LKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG-GSFGNFSAQS 596 (979)
Q Consensus 518 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~~~~ 596 (979)
+++|++|+|++|++++..|..|..+++|++|+|++|++++.+|..+..+++| .|++++|++++.+|.. ..++.+..+.
T Consensus 475 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~ 553 (606)
T 3t6q_A 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTIN 553 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEE
T ss_pred CCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEe
Confidence 9999999999999999889999999999999999999999999999999999 9999999999887753 3466778899
Q ss_pred ccCCccccCCC
Q 002021 597 FEGNELLCGSP 607 (979)
Q Consensus 597 ~~~N~~~c~~p 607 (979)
+.+|++.|.++
T Consensus 554 l~~N~~~c~c~ 564 (606)
T 3t6q_A 554 LRQNPLDCTCS 564 (606)
T ss_dssp CTTCCEECSGG
T ss_pred CCCCCccccCC
Confidence 99999999765
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-55 Score=528.85 Aligned_cols=502 Identities=22% Similarity=0.227 Sum_probs=436.9
Q ss_pred EEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCc
Q 002021 76 VLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNA 155 (979)
Q Consensus 76 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 155 (979)
.++.++++++ .+|..+. ++|++|||++|++++..|..+..+++|++|+|++|++++..|..|+++++|++|+|++|.
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 4677888888 5777664 899999999999998888899999999999999999999999999999999999999999
Q ss_pred cCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeec-CCccccccCccceeeccCC
Q 002021 156 LSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGI-APIAIFNVSTLKILGLQDN 234 (979)
Q Consensus 156 l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N 234 (979)
+++. .|..|+++++|++|+|++|.+++..+..++++++|++|+|++|++.+. .|..|.++++|++|++++|
T Consensus 92 l~~~--------~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 92 IQSF--------SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp CCCC--------CTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred cccc--------ChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 9864 588999999999999999999988888999999999999999999974 5999999999999999999
Q ss_pred CCcCCCcccccCCCCCc----CEEEccCCccccccCcccccCCCCcEEeccccccc-cccCccccccccccceeccc---
Q 002021 235 SLSGCLSSIGYARLPNL----EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFS-GFIPNTFGNLRNLSWLVLSD--- 306 (979)
Q Consensus 235 ~l~~~~~~~~~~~l~~L----~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~--- 306 (979)
++++..+. .+..+.+| ++|++++|.+++..+..+. ..+|++|++++|.++ +..|..+.++++|+.+++..
T Consensus 164 ~l~~~~~~-~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~-~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~ 241 (606)
T 3vq2_A 164 YIQTITVN-DLQFLRENPQVNLSLDMSLNPIDFIQDQAFQ-GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241 (606)
T ss_dssp CCCEECTT-TTHHHHHCTTCCCEEECTTCCCCEECTTTTT-TCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECC
T ss_pred cceecChh-hhhhhhccccccceeeccCCCcceeCccccc-CceeeeeeccCCccchhHHHHHhcccccccccccccccc
Confidence 99986543 34455544 4899999999966655554 459999999999987 45667778888887777643
Q ss_pred ------------------------------cccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccE
Q 002021 307 ------------------------------NYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEE 356 (979)
Q Consensus 307 ------------------------------N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~ 356 (979)
|.++... ..+..+++|+.|++++|.+..+. .+.. .++|++
T Consensus 242 ~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~------~~~~~l~~L~~L~l~~~~~~~l~---~l~~-~~~L~~ 311 (606)
T 3vq2_A 242 KDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI------VKFHCLANVSAMSLAGVSIKYLE---DVPK-HFKWQS 311 (606)
T ss_dssp TTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGG------GSCGGGTTCSEEEEESCCCCCCC---CCCT-TCCCSE
T ss_pred ccCCcccccChHHhhhhhhccHhheeccccccccccc------cccccCCCCCEEEecCccchhhh---hccc-cccCCE
Confidence 3333222 23677899999999999998775 2332 358999
Q ss_pred EEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCC--ccccccCCCCCceEecCCC
Q 002021 357 FKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGS--IPYDICNLAELYRLDLDGN 434 (979)
Q Consensus 357 L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N 434 (979)
|++++|.+ +.+| .+ .+++|++|++++|+..+.. .+..+++|++|++++|.+++. .|..+..+++|++|++++|
T Consensus 312 L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n 386 (606)
T 3vq2_A 312 LSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386 (606)
T ss_dssp EEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSC
T ss_pred EEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCC
Confidence 99999999 5777 55 9999999999999765544 778999999999999999876 3788999999999999999
Q ss_pred cccccCCccccCCCcCceEecCCCccccccc--cccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCc-cc
Q 002021 435 KLSGSIPACFSNLTSLRIVSLGSNELTSIPL--TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSG-VI 511 (979)
Q Consensus 435 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~ 511 (979)
.+.+ +|..+..+++|++|++++|+++.++. .+..+++|+.|++++|.+++..|..++.+++|+.|++++|++++ .+
T Consensus 387 ~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 465 (606)
T 3vq2_A 387 GAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465 (606)
T ss_dssp SEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEE
T ss_pred cccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcch
Confidence 9985 66899999999999999999997754 78899999999999999999999999999999999999999998 47
Q ss_pred chhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCC-CCCC
Q 002021 512 PTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG-GSFG 590 (979)
Q Consensus 512 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~ 590 (979)
|..|+.+++|+.|+|++|++++..|..|.++++|++|+|++|++++.+|..+..+++|+.|+|++|+++. +|.. ..++
T Consensus 466 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~ 544 (606)
T 3vq2_A 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFP 544 (606)
T ss_dssp CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSC
T ss_pred HHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999995 5543 3444
Q ss_pred -CcccccccCCccccCCC
Q 002021 591 -NFSAQSFEGNELLCGSP 607 (979)
Q Consensus 591 -~~~~~~~~~N~~~c~~p 607 (979)
.+..+.+.+|++.|+++
T Consensus 545 ~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 545 KSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTCCEEECCSCCCCCSST
T ss_pred ccCcEEEccCCCcccCCc
Confidence 47888999999999877
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=502.34 Aligned_cols=494 Identities=23% Similarity=0.253 Sum_probs=316.1
Q ss_pred CCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCc
Q 002021 59 VCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPS 138 (979)
Q Consensus 59 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 138 (979)
.|.|.|| |+. ++++++ .+|+.+. ++|++|||++|++++..|.++..+++|++|+|++|++++..|.
T Consensus 3 ~C~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~ 68 (549)
T 2z81_A 3 SCDASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68 (549)
T ss_dssp EECTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred cCCCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence 4999999 863 334444 3444432 4556666666665555555555566666666666666555555
Q ss_pred cccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccc-cccccccCCCCCCceecCCCe-eeecC
Q 002021 139 FISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQG-KIPLKIGNLRNLEKLDIGDNK-LVGIA 216 (979)
Q Consensus 139 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~-l~~~~ 216 (979)
.|+++++|++|||++|.+++. .|..|+++++|++|+|++|.+++ ..|..++++++|++|++++|+ +..+.
T Consensus 69 ~~~~l~~L~~L~Ls~n~l~~~--------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~ 140 (549)
T 2z81_A 69 AFYSLGSLEHLDLSDNHLSSL--------SSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140 (549)
T ss_dssp TTTTCTTCCEEECTTSCCCSC--------CHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred hccccccCCEEECCCCccCcc--------CHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccC
Confidence 555666666666666655532 22335555666666666665554 234455555666666666555 33443
Q ss_pred CccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEecccccccccc--C-ccc
Q 002021 217 PIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFI--P-NTF 293 (979)
Q Consensus 217 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~--~-~~~ 293 (979)
+..|.++++|++|++++|++++..+. .+..+++|++|++++|.+....+..+..+++|++|++++|++++.. | ...
T Consensus 141 ~~~~~~l~~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 219 (549)
T 2z81_A 141 RIDFAGLTSLNELEIKALSLRNYQSQ-SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219 (549)
T ss_dssp TTTTTTCCEEEEEEEEETTCCEECTT-TTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSC
T ss_pred HhhhhcccccCeeeccCCcccccChh-hhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchh
Confidence 44555556666666666655543332 3445555666666665554222222234556666666666655431 1 122
Q ss_pred cccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccc----cccccccccEEEccCccccCC--
Q 002021 294 GNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTT----VGNLSHSLEEFKMSNCNISGG-- 367 (979)
Q Consensus 294 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~----~~~l~~~L~~L~L~~n~i~~~-- 367 (979)
..+++|+.|++++|.+++.... .....+..+++|+.+++++|.+.++..... ......+|+.|++.++.+...
T Consensus 220 ~~~~~L~~L~l~~n~l~~~~~~-~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~ 298 (549)
T 2z81_A 220 EVSSPMKKLAFRGSVLTDESFN-ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298 (549)
T ss_dssp CCCCCCCEEEEESCEEEHHHHH-HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG
T ss_pred hhhhcccceeccccccchhHHH-HHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhh
Confidence 3345566666666655543221 122234455566666666665544321100 001123566666666655431
Q ss_pred ---CCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccc---cccCCCCCceEecCCCcccccCC
Q 002021 368 ---IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPY---DICNLAELYRLDLDGNKLSGSIP 441 (979)
Q Consensus 368 ---~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~~ 441 (979)
++..+...++|+.|++++|++...+...+..+++|++|++++|++.+.+|. .++.+++|+.|++++|++++..+
T Consensus 299 ~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 378 (549)
T 2z81_A 299 FYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQK 378 (549)
T ss_dssp SCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHH
T ss_pred cccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccccccc
Confidence 122233456788888888888755555556788888888888888876543 36778888888888888876533
Q ss_pred --ccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCc
Q 002021 442 --ACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLK 519 (979)
Q Consensus 442 --~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 519 (979)
..+..+++|++|++++|+++.+|..+..+++|+.|++++|++++ +|..+. ++|+.|||++|++++.+ ..++
T Consensus 379 ~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~ 451 (549)
T 2z81_A 379 TGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLP 451 (549)
T ss_dssp HHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCT
T ss_pred chhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCC
Confidence 45788888888888888888888888888888889999888874 343332 58999999999998753 5789
Q ss_pred ccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCC
Q 002021 520 NLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 520 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
+|++|+|++|+|+ .+|. ...+++|++|||++|++++.+|..+..+++|+.|++++|+++|.+|.
T Consensus 452 ~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 452 RLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp TCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred hhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 9999999999999 6776 57899999999999999999888899999999999999999998884
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=505.12 Aligned_cols=503 Identities=23% Similarity=0.238 Sum_probs=429.4
Q ss_pred EEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccC-CccccCCCCCcEEEccCC
Q 002021 76 VLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTF-PSFISNKSSLQHLDLSSN 154 (979)
Q Consensus 76 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~Ls~N 154 (979)
..|.++++++. +|. -.++|++|||++|++++..|..+..+++|++|+|++|...+.+ |..|+++++|++|+|++|
T Consensus 8 ~~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 45677888984 565 4689999999999999999999999999999999999777666 788999999999999999
Q ss_pred ccCchhhhhhhccCCcccCCCCccceeeccccccccccccc--ccCCCCCCceecCCCeeeecCC-ccccccCccceeec
Q 002021 155 ALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLK--IGNLRNLEKLDIGDNKLVGIAP-IAIFNVSTLKILGL 231 (979)
Q Consensus 155 ~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L 231 (979)
.+++. .|..|+++++|++|+|++|.+++.+|.. ++++++|++|+|++|++++..+ ..|.++++|+.|+|
T Consensus 84 ~l~~~--------~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~L 155 (844)
T 3j0a_A 84 KIYFL--------HPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDF 155 (844)
T ss_dssp CCCEE--------CTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEE
T ss_pred cCccc--------CHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEEC
Confidence 99864 6899999999999999999999877665 9999999999999999998865 57999999999999
Q ss_pred cCCCCcCCCcccccCCC--CCcCEEEccCCccccccCcccccCCC------CcEEeccccccccccCcccccc---cccc
Q 002021 232 QDNSLSGCLSSIGYARL--PNLEILSLWGNNFSGTIPRFIFNASK------LSILDLEGNSFSGFIPNTFGNL---RNLS 300 (979)
Q Consensus 232 ~~N~l~~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~Ls~N~l~~~~~~~~~~l---~~L~ 300 (979)
++|.+++..+. .+..+ ++|+.|+|++|.+.+..|..+..+.+ |++|++++|.+++..+..+... .+++
T Consensus 156 s~N~i~~~~~~-~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~ 234 (844)
T 3j0a_A 156 SSNQIFLVCEH-ELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAF 234 (844)
T ss_dssp ESSCCCCCCSG-GGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBS
T ss_pred CCCcCCeeCHH-HcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCccccc
Confidence 99999876544 34555 89999999999999988887777665 9999999999998888877654 5788
Q ss_pred ceecccccc---------ccccchhhhhhcccCC--CCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCC
Q 002021 301 WLVLSDNYL---------TSSTQELSFLSSLSNC--KFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369 (979)
Q Consensus 301 ~L~Ls~N~l---------~~~~~~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p 369 (979)
.|.++.+.+ ..... ..+..+ ++|++|++++|.+..+.+..+ .. .++|+.|+|++|+|++..|
T Consensus 235 ~L~l~~~~~~~~~~~~~l~~~~~-----~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~-~~-l~~L~~L~L~~n~i~~~~~ 307 (844)
T 3j0a_A 235 SLILAHHIMGAGFGFHNIKDPDQ-----NTFAGLARSSVRHLDLSHGFVFSLNSRVF-ET-LKDLKVLNLAYNKINKIAD 307 (844)
T ss_dssp EEECCSSCCBCSSSCSSSTTGGG-----TTTTTTTTSCCCEEECTTCCCCEECSCCS-SS-CCCCCEEEEESCCCCEECT
T ss_pred ceecccccccccccccccCCCCh-----hhhhccccCCccEEECCCCcccccChhhh-hc-CCCCCEEECCCCcCCCCCh
Confidence 888874433 22221 123343 789999999999988765543 22 4689999999999999999
Q ss_pred ccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCc
Q 002021 370 EEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTS 449 (979)
Q Consensus 370 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 449 (979)
..|..+++|++|+|++|++++..+..|..+++|+.|++++|.+.+..+..|..+++|+.|+|++|.+++. ..+++
T Consensus 308 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~ 382 (844)
T 3j0a_A 308 EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPS 382 (844)
T ss_dssp TTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCS
T ss_pred HHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCC
Confidence 9999999999999999999999899999999999999999999988888899999999999999999843 33889
Q ss_pred CceEecCCCccccccccccCcCCCcEEEeccccccCCC-ccccccccccceEeccCCccCcccch-hhcCCcccceeecC
Q 002021 450 LRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSL-PLEIGSLKVLVGIDLSRNNFSGVIPT-EIGGLKNLEYLFLG 527 (979)
Q Consensus 450 L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls 527 (979)
|+.|++++|+++.+|.. ..+++.|++++|++++.. +..+..+++|+.|+|++|++++..+. .+..+++|+.|+|+
T Consensus 383 L~~L~l~~N~l~~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls 459 (844)
T 3j0a_A 383 IPDIFLSGNKLVTLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459 (844)
T ss_dssp CSEEEEESCCCCCCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEE
T ss_pred cchhccCCCCccccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCC
Confidence 99999999999998865 467899999999999743 33466899999999999999976554 46678999999999
Q ss_pred Ccccc-----CCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCCCCCCCcccccccCCcc
Q 002021 528 YNRLQ-----GSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNEL 602 (979)
Q Consensus 528 ~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 602 (979)
+|.++ +..+..|.++++|+.|+|++|+|++.+|..|..+++|+.|+|++|+|++.+|.... +++..+.+++|..
T Consensus 460 ~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l 538 (844)
T 3j0a_A 460 ENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQL 538 (844)
T ss_dssp SCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECC
T ss_pred CCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcC
Confidence 99997 44567799999999999999999999999999999999999999999986665433 7788888999976
Q ss_pred ccCCC
Q 002021 603 LCGSP 607 (979)
Q Consensus 603 ~c~~p 607 (979)
..-.|
T Consensus 539 ~~~~~ 543 (844)
T 3j0a_A 539 LAPNP 543 (844)
T ss_dssp CCCCS
T ss_pred CCCCh
Confidence 54444
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-53 Score=454.90 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=217.3
Q ss_pred CCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777899999999999999753 478899999987665667889999999999999999999999999999999
Q ss_pred EEEecCCCccceeeccC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 002021 756 VLEYMPHGSLEKYLYSS------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 823 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl 823 (979)
|||||++|+|.++++.. ...+++.++++|+.|||+||+||| +++|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999753 246999999999999999999999 899999999999999999999999
Q ss_pred EeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhc
Q 002021 824 SDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 824 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
+|||+|+.....+.........||+.|||||++.++.|+.++|||||||++|||+| |+.||...... .....+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~~- 246 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQG- 246 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHHT-
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC-
Confidence 99999987654444433445679999999999999999999999999999999999 89999763221 111111100
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
.....+..+++++.+++.+||+.||++|||++||++.|+++.++.
T Consensus 247 -----------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 247 -----------------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -----------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 011123456788999999999999999999999999999988653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=457.00 Aligned_cols=259 Identities=27% Similarity=0.461 Sum_probs=209.1
Q ss_pred CCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|...+.||+|+||+||+|++. +++.||||+++.......+.|.+|+++|++++|||||+++++|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999753 478999999987655567889999999999999999999999999999999
Q ss_pred EEEecCCCccceeeccC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 002021 756 VLEYMPHGSLEKYLYSS--------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~ 821 (979)
|||||++|+|.++++.. ...+++.+++.|+.|||+||+||| +++|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 99999999999998754 235899999999999999999999 8999999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhh
Q 002021 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~ 900 (979)
||+|||+++.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||......+ ....+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~ 275 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCITQ 275 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHHHc
Confidence 9999999987654444444455679999999999999999999999999999999999 899997632211 1111100
Q ss_pred hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
..+...+..+++++.++|.+||+.||++||||+||+++|+.+.++
T Consensus 276 ------------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 ------------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ------------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 001122345778899999999999999999999999999999864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=487.00 Aligned_cols=482 Identities=22% Similarity=0.272 Sum_probs=379.8
Q ss_pred EEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCcc
Q 002021 77 LNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNAL 156 (979)
Q Consensus 77 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 156 (979)
++.++.+++ .+|..+. +++++|||++|++++..|.++..+++|++|+|++|++++..|..|+++++|++|+|++|.+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 555666776 5676553 5899999999999988888999999999999999999998889999999999999999999
Q ss_pred CchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeec-CCccccccCccceeeccCCC
Q 002021 157 SGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGI-APIAIFNVSTLKILGLQDNS 235 (979)
Q Consensus 157 ~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~ 235 (979)
++. .|..|+++++|++|++++|++++..+..++++++|++|+|++|+++++ .|..|.++++|+.|++++|+
T Consensus 89 ~~~--------~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~ 160 (570)
T 2z63_A 89 QSL--------ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (570)
T ss_dssp CEE--------CTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSC
T ss_pred Ccc--------CHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCc
Confidence 853 457899999999999999999977777899999999999999999985 58999999999999999999
Q ss_pred CcCCCcccccCCCCCc----CEEEccCCccccccCcccccCCCCcEEecccccccc-ccCccccccccc-----------
Q 002021 236 LSGCLSSIGYARLPNL----EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSG-FIPNTFGNLRNL----------- 299 (979)
Q Consensus 236 l~~~~~~~~~~~l~~L----~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L----------- 299 (979)
+++..+. .+..+++| +.|++++|.+++..|..+... +|++|++++|.... ..+..+.+++++
T Consensus 161 l~~~~~~-~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~ 238 (570)
T 2z63_A 161 IQSIYCT-DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238 (570)
T ss_dssp CCEECGG-GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECC
T ss_pred cceecHH-HccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeecccccc
Confidence 9876543 46667777 899999999998888777655 89999999984321 112223333333
Q ss_pred ---------------------cceecccc-ccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEE
Q 002021 300 ---------------------SWLVLSDN-YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEF 357 (979)
Q Consensus 300 ---------------------~~L~Ls~N-~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L 357 (979)
+.+++++| .+.... ...+..+++|++|++++|.+..++.. +..+ +|++|
T Consensus 239 ~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~-----~~~~~~l~~L~~L~l~~~~l~~l~~~--~~~~--~L~~L 309 (570)
T 2z63_A 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDI-----IDLFNCLTNVSSFSLVSVTIERVKDF--SYNF--GWQHL 309 (570)
T ss_dssp CCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCS-----TTTTGGGTTCSEEEEESCEECSCCBC--CSCC--CCSEE
T ss_pred Cchhhhhcchhhhccccccchhhhhhhcchhhhhhc-----hhhhcCcCcccEEEecCccchhhhhh--hccC--CccEE
Confidence 33444444 232222 12356678888888888888765332 2223 78888
Q ss_pred EccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCc--cccccCCCCCceEecCCCc
Q 002021 358 KMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSI--PYDICNLAELYRLDLDGNK 435 (979)
Q Consensus 358 ~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~ 435 (979)
++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|.+.+.. |..+..+++|++|++++|+
T Consensus 310 ~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~ 384 (570)
T 2z63_A 310 ELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384 (570)
T ss_dssp EEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCS
T ss_pred eeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCc
Confidence 88888887 4443 4677888888888887765544 67888888888888887544 6677788888888888888
Q ss_pred ccccCCccccCCCcCceEecCCCccccccc--cccCcCCCcEEEeccccccCCCccccccccccceEeccCCccC-cccc
Q 002021 436 LSGSIPACFSNLTSLRIVSLGSNELTSIPL--TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFS-GVIP 512 (979)
Q Consensus 436 l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p 512 (979)
+.+..+. +..+++|++|++++|+++.++. .+..+++|+.|++++|.+++..|..+..+++|+.|+|++|+++ +.+|
T Consensus 385 l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p 463 (570)
T 2z63_A 385 VITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463 (570)
T ss_dssp EEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEEC
T ss_pred ccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccch
Confidence 8765444 8888888888888888886543 5777888888888888888888888888888888888888887 5678
Q ss_pred hhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCC
Q 002021 513 TEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG 586 (979)
Q Consensus 513 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 586 (979)
..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|..
T Consensus 464 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 88888888888888888888777888888888888888888888877777888888888888888888887764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=444.90 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=208.3
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++++..+.||+|+||+||+|++.+ .||||+++... ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3677888999999999999998753 59999986432 2345789999999999999999999999865 56899999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
||++|+|.++++..+..+++.++..|+.|||+||+||| +++|+||||||+|||+++++.+||+|||+|+........
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999887778999999999999999999999 899999999999999999999999999999876443333
Q ss_pred ceecccccCCCCCCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 839 MIQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||....... .....+...... +..
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~~~-------p~~- 259 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGYAS-------PDL- 259 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTCCC-------CCS-
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCCC-------CCc-
Confidence 33455689999999999853 468999999999999999999999997532221 111111110000 000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
...+..+++++.+++.+||+.||++||||.||+++|+.+..++
T Consensus 260 ------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 260 ------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp ------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 0122356778999999999999999999999999999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=452.27 Aligned_cols=256 Identities=25% Similarity=0.455 Sum_probs=212.9
Q ss_pred CCCCCceeeeecceEEEEEEc------CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 683 GFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
+++..+.||+|+||+||+|.+ .+++.||||+++.... ...+.|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 456678999999999999976 2568899999975533 345789999999999999999999999999999999
Q ss_pred EEEecCCCccceeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc
Q 002021 756 VLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 820 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~ 820 (979)
|||||++|+|.+++... +..+++.++++|+.|||+||+||| +++|+||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence 99999999999999643 245899999999999999999999 999999999999999999999
Q ss_pred EEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhh
Q 002021 821 AHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVN 899 (979)
Q Consensus 821 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~ 899 (979)
+||+|||+++.....+.........||+.|||||++.++.|+.++|||||||++|||+| |+.||...... .....+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~i~ 261 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMIR 261 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH
Confidence 99999999987654444444456689999999999999999999999999999999999 89999763221 1111111
Q ss_pred hhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 900 DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
.. ...+.+..|+.++.++|.+||+.||++||||+||+++|+.+.
T Consensus 262 ~~------------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 262 NR------------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp TT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred cC------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 00 011223467788999999999999999999999999998754
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=477.97 Aligned_cols=465 Identities=22% Similarity=0.195 Sum_probs=408.8
Q ss_pred CCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEE
Q 002021 71 SQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLD 150 (979)
Q Consensus 71 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 150 (979)
..+++.|||++|++++..+.+++++++|++|||++|++++..|.++..+++|++|+|++|++++..|..|+++++|++|+
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 34789999999999988888999999999999999999988889999999999999999999998889999999999999
Q ss_pred ccCCccCchhhhhhhccCCc-ccCCCCccceeecccccccc-cccccccCCCCCCceecCCCeeeecCCccccccCcc--
Q 002021 151 LSSNALSGEIRANICREIPR-EFGNLPELELMSLAANNLQG-KIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTL-- 226 (979)
Q Consensus 151 Ls~N~l~~~~~~~~~~~ip~-~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L-- 226 (979)
|++|.+++ +|. .++++++|++|++++|.+++ .+|..|+++++|++|++++|+++++.|..+..+++|
T Consensus 107 L~~n~l~~---------l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 177 (570)
T 2z63_A 107 AVETNLAS---------LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177 (570)
T ss_dssp CTTSCCCC---------STTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTT
T ss_pred cccccccc---------CCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccch
Confidence 99999985 343 69999999999999999987 479999999999999999999999999999999999
Q ss_pred --ceeeccCCCCcCCCcccccCCCCCcCEEEccCCcccc-ccCcccccCC------------------------------
Q 002021 227 --KILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSG-TIPRFIFNAS------------------------------ 273 (979)
Q Consensus 227 --~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~------------------------------ 273 (979)
+.|++++|.+++..+. .|... +|++|++++|.... .++..+..++
T Consensus 178 ~~~~L~l~~n~l~~~~~~-~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~ 255 (570)
T 2z63_A 178 LNLSLDLSLNPMNFIQPG-AFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255 (570)
T ss_dssp CCCEEECTTCCCCEECTT-TTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGG
T ss_pred hhhhcccCCCCceecCHH-HhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhcccc
Confidence 8999999999987654 34444 89999999984321 1122222222
Q ss_pred --CCcEEecccc-ccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccc
Q 002021 274 --KLSILDLEGN-SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNL 350 (979)
Q Consensus 274 --~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 350 (979)
+++.+++++| .+.+..|..|..+++|+.|++++|.++.++.. +..+ +|++|++++|.+..++.. .
T Consensus 256 ~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~------~~~~-~L~~L~l~~n~~~~l~~~-----~ 323 (570)
T 2z63_A 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF------SYNF-GWQHLELVNCKFGQFPTL-----K 323 (570)
T ss_dssp GSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBC------CSCC-CCSEEEEESCBCSSCCBC-----B
T ss_pred ccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhhhhh------hccC-CccEEeeccCcccccCcc-----c
Confidence 2556777777 77888899999999999999999999987653 5666 999999999999866442 2
Q ss_pred cccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchh--HHhhhcCCCCcEEEecCcccCCCccccccCCCCCce
Q 002021 351 SHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSI--LITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYR 428 (979)
Q Consensus 351 ~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 428 (979)
.++|+.|++++|.+.+..+. ..+++|++|++++|++++.. +..+..+++|++|++++|.+.+..+ .+..+++|++
T Consensus 324 l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~ 400 (570)
T 2z63_A 324 LKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEH 400 (570)
T ss_dssp CSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCE
T ss_pred ccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCE
Confidence 46899999999999877665 78999999999999998765 7889999999999999999996544 4999999999
Q ss_pred EecCCCcccccCC-ccccCCCcCceEecCCCcccc-ccccccCcCCCcEEEecccccc-CCCccccccccccceEeccCC
Q 002021 429 LDLDGNKLSGSIP-ACFSNLTSLRIVSLGSNELTS-IPLTFWNLKDILNLNFSSNFLT-GSLPLEIGSLKVLVGIDLSRN 505 (979)
Q Consensus 429 L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N 505 (979)
|++++|++.+..+ ..+.++++|++|++++|+++. .|..+..+++|+.|++++|.++ +.+|..+..+++|+.|+|++|
T Consensus 401 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n 480 (570)
T 2z63_A 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480 (570)
T ss_dssp EECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred EEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCC
Confidence 9999999998766 578999999999999999995 5667889999999999999998 678999999999999999999
Q ss_pred ccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCc
Q 002021 506 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA 561 (979)
Q Consensus 506 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 561 (979)
++++..|..|..+++|++|+|++|++++..|..|.++++|+.|++++|++++..|.
T Consensus 481 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 481 QLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99999999999999999999999999998888999999999999999999987764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=475.91 Aligned_cols=483 Identities=20% Similarity=0.176 Sum_probs=408.7
Q ss_pred CccceeEeeCC--CCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCC
Q 002021 60 CNWTGVACEVH--SQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFP 137 (979)
Q Consensus 60 c~w~gv~c~~~--~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 137 (979)
|++.+++.-+. ...++.|+|++|++++..|..++++++|++|+|++|++++..|.+++.+++|++|+|++|++++..|
T Consensus 12 ~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 91 (549)
T 2z81_A 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS 91 (549)
T ss_dssp CTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred CCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence 56666665432 3579999999999999889999999999999999999999999999999999999999999999888
Q ss_pred ccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeeccccccccccc-ccccCCCCCCceecCCCeeeecC
Q 002021 138 SFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP-LKIGNLRNLEKLDIGDNKLVGIA 216 (979)
Q Consensus 138 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~ 216 (979)
..++++++|++|+|++|.+++. .+|..++++++|++|++++|.+.+.+| ..++++++|++|++++|++++..
T Consensus 92 ~~~~~l~~L~~L~Ls~n~l~~~-------~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 164 (549)
T 2z81_A 92 SWFGPLSSLKYLNLMGNPYQTL-------GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164 (549)
T ss_dssp HHHTTCTTCCEEECTTCCCSSS-------CSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred HHhccCCCCcEEECCCCccccc-------chhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccC
Confidence 8899999999999999999853 357889999999999999999554554 68999999999999999999999
Q ss_pred CccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCcccccc--C-cccccCCCCcEEeccccccccccCc--
Q 002021 217 PIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTI--P-RFIFNASKLSILDLEGNSFSGFIPN-- 291 (979)
Q Consensus 217 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p-~~l~~l~~L~~L~Ls~N~l~~~~~~-- 291 (979)
|..+.++++|+.|+++.|.+.... ...+..+++|++|++++|++++.. | .....+++|+.|++++|.+++..+.
T Consensus 165 ~~~l~~l~~L~~L~l~~n~~~~~~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l 243 (549)
T 2z81_A 165 SQSLKSIRDIHHLTLHLSESAFLL-EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243 (549)
T ss_dssp TTTTTTCSEEEEEEEECSBSTTHH-HHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHH
T ss_pred hhhhhccccCceEecccCcccccc-hhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHH
Confidence 999999999999999999987543 333567999999999999998742 2 2234578999999999999875543
Q ss_pred --cccccccccceeccccccccccchh-hhhhcccCCCCccEEEccCCCCcccCCccc---cccccccccEEEccCcccc
Q 002021 292 --TFGNLRNLSWLVLSDNYLTSSTQEL-SFLSSLSNCKFLKYFDLSYNPLYRILPRTT---VGNLSHSLEEFKMSNCNIS 365 (979)
Q Consensus 292 --~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~---~~~l~~~L~~L~L~~n~i~ 365 (979)
.+..+++|+.|++++|.+.+...-. .....+..+.+|+.|+++++.+........ ......+|+.|++++|.++
T Consensus 244 ~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~ 323 (549)
T 2z81_A 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323 (549)
T ss_dssp HGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC
T ss_pred HHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc
Confidence 4567789999999999987653211 112345778899999999998765421111 1122458999999999998
Q ss_pred CCCCccc-cCCCcccEEEecCCCCCchhHHh---hhcCCCCcEEEecCcccCCCcc--ccccCCCCCceEecCCCccccc
Q 002021 366 GGIPEEI-SNLTNLRTIYLGGNKLNGSILIT---LSKLQKLQDLGLKDNKLEGSIP--YDICNLAELYRLDLDGNKLSGS 439 (979)
Q Consensus 366 ~~~p~~l-~~l~~L~~L~L~~N~l~~~~~~~---l~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~ 439 (979)
.+|..+ ..+++|++|++++|++++..+.. +..+++|++|++++|++++..+ ..+..+++|++|++++|+++ .
T Consensus 324 -~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ 401 (549)
T 2z81_A 324 -LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-P 401 (549)
T ss_dssp -CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-C
T ss_pred -cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-c
Confidence 566655 68999999999999999877543 7899999999999999986543 56899999999999999999 6
Q ss_pred CCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCc
Q 002021 440 IPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLK 519 (979)
Q Consensus 440 ~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 519 (979)
+|..+..+++|++|++++|+++.+|..+. ++|+.|++++|++++.. ..+++|+.|+|++|+|+ .+|. ...++
T Consensus 402 lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~ 473 (549)
T 2z81_A 402 MPDSCQWPEKMRFLNLSSTGIRVVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFP 473 (549)
T ss_dssp CCSCCCCCTTCCEEECTTSCCSCCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCT
T ss_pred CChhhcccccccEEECCCCCcccccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCc
Confidence 78889999999999999999999887653 68999999999999753 57899999999999999 5665 56799
Q ss_pred ccceeecCCccccCCCCCcccccccccccccccccccccCC
Q 002021 520 NLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP 560 (979)
Q Consensus 520 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 560 (979)
+|++|+|++|++++.+|..|..+++|+.|+|++|++++..|
T Consensus 474 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 474 VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp TCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred cCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99999999999999889999999999999999999987765
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=489.10 Aligned_cols=506 Identities=18% Similarity=0.257 Sum_probs=332.8
Q ss_pred CChhHHHHHHHHHHhcccCCCCccccccCCCCC----CCccceeE-eeCC--CCcEEEEEecCCCccccCCCCCcCCCCC
Q 002021 26 STITDQDALLALKAHITHDPTNFLAKNWNTSTP----VCNWTGVA-CEVH--SQRVTVLNISSLNLTGTIPSQLGNLSSL 98 (979)
Q Consensus 26 ~~~~~~~all~~k~~~~~~~~~~~~~~w~~~~~----~c~w~gv~-c~~~--~~~v~~l~l~~~~l~g~~~~~l~~l~~L 98 (979)
...++...-.++++-...-. ...|....+ .|+|..-+ |..- ...|+. + . -.++
T Consensus 24 ~~~~~~~d~~aL~~~~~~~~----~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C---~---------~----~~~V 83 (636)
T 4eco_A 24 RTAEYIKDYLALKEIWDALN----GKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL---N---------S----NGRV 83 (636)
T ss_dssp CCCHHHHHHHHHHHHHHHTT----GGGCCCCC------CCCCCSSCGGGTTCCTTEEE---C---------T----TCCE
T ss_pred hhhhHHHHHHHHHHHHHHcC----CCCcccCCcCCccCCCCCCCCCcccccCCCCeEE---c---------C----CCCE
Confidence 34556677888887765432 247874332 25796321 2110 012221 0 0 0467
Q ss_pred CeeeccCCcccccCCccccccCcccEEecccccc------cc------cCCccccCCCCCcEEEccCCccCchhhhhhhc
Q 002021 99 QSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQL------SG------TFPSFISNKSSLQHLDLSSNALSGEIRANICR 166 (979)
Q Consensus 99 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l------~~------~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 166 (979)
+.|+|++|+++|.+|++++.+++|++|+|++|.+ .| .+|... +..|+ +++++|.+.+.
T Consensus 84 ~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~------- 153 (636)
T 4eco_A 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYD------- 153 (636)
T ss_dssp EEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCC-------
T ss_pred EEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccC-------
Confidence 8888888888888888888888888888888876 22 333333 44555 66666665543
Q ss_pred cCCcccCC-CCccceeecccccccccccccccCCCCCCceecC--CCeeeecCCccccccCccceeeccCCCCcC-----
Q 002021 167 EIPREFGN-LPELELMSLAANNLQGKIPLKIGNLRNLEKLDIG--DNKLVGIAPIAIFNVSTLKILGLQDNSLSG----- 238 (979)
Q Consensus 167 ~ip~~l~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls--~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~----- 238 (979)
+|..++. +..+..+++....+. ......++.+.+. +|++++ +|..+.++++|++|+|++|++++
T Consensus 154 -~~~~~~~~~~~l~~~~l~~~~~~------~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~ 225 (636)
T 4eco_A 154 -PREDFSDLIKDCINSDPQQKSIK------KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICE 225 (636)
T ss_dssp -GGGGSCHHHHHHHHHCTTSCCCC------CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSS
T ss_pred -chhhHHHHHHHHhhcCccccccc------cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccc
Confidence 2222221 122223333222221 1112234444443 577888 67778888888888888887776
Q ss_pred -------------CCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccc-ccc-ccCcccccc------c
Q 002021 239 -------------CLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNS-FSG-FIPNTFGNL------R 297 (979)
Q Consensus 239 -------------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l------~ 297 (979)
++....|..+++|++|+|++|++.+.+|..++++++|++|+|++|+ +++ .+|..++.+ +
T Consensus 226 ~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~ 305 (636)
T 4eco_A 226 AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305 (636)
T ss_dssp SCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGG
T ss_pred cccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCC
Confidence 3332222255555555555555555555555555555555555555 555 455555444 5
Q ss_pred cccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCc
Q 002021 298 NLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTN 377 (979)
Q Consensus 298 ~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~ 377 (979)
+|++|+|++|+++.+|.. ..+.+++ +|++|++++|+++|.+| .++.+++
T Consensus 306 ~L~~L~L~~n~l~~ip~~----~~l~~l~--------------------------~L~~L~L~~N~l~g~ip-~~~~l~~ 354 (636)
T 4eco_A 306 KIQIIYIGYNNLKTFPVE----TSLQKMK--------------------------KLGMLECLYNQLEGKLP-AFGSEIK 354 (636)
T ss_dssp TCCEEECCSSCCSSCCCH----HHHTTCT--------------------------TCCEEECCSCCCEEECC-CCEEEEE
T ss_pred CCCEEECCCCcCCccCch----hhhccCC--------------------------CCCEEeCcCCcCccchh-hhCCCCC
Confidence 555555555555433320 0133334 45555555555555566 6677777
Q ss_pred ccEEEecCCCCCchhHHhhhcCCC-CcEEEecCcccCCCccccccCCC--CCceEecCCCcccccCCcccc-------CC
Q 002021 378 LRTIYLGGNKLNGSILITLSKLQK-LQDLGLKDNKLEGSIPYDICNLA--ELYRLDLDGNKLSGSIPACFS-------NL 447 (979)
Q Consensus 378 L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~l 447 (979)
|++|+|++|+++ .+|..+..+++ |++|++++|.++ .+|..+..+. +|+.|++++|++++..|..+. .+
T Consensus 355 L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~ 432 (636)
T 4eco_A 355 LASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKG 432 (636)
T ss_dssp ESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCC
T ss_pred CCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccC
Confidence 777777777777 55566777777 777777777777 5676666554 788888888888877777777 67
Q ss_pred CcCceEecCCCcccccccccc-CcCCCcEEEeccccccCCCccc-cccc-------cccceEeccCCccCcccchhhc--
Q 002021 448 TSLRIVSLGSNELTSIPLTFW-NLKDILNLNFSSNFLTGSLPLE-IGSL-------KVLVGIDLSRNNFSGVIPTEIG-- 516 (979)
Q Consensus 448 ~~L~~L~L~~N~l~~lp~~~~-~l~~L~~L~ls~N~l~~~~p~~-~~~l-------~~L~~L~Ls~N~l~~~~p~~~~-- 516 (979)
++|++|+|++|+++.+|..+. .+++|+.|++++|+++ .+|.. +... ++|+.|+|++|+++ .+|..+.
T Consensus 433 ~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~ 510 (636)
T 4eco_A 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRAT 510 (636)
T ss_dssp CCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTT
T ss_pred CCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhc
Confidence 788888888888888877544 4788888888888888 44443 3322 38999999999998 6777776
Q ss_pred CCcccceeecCCccccCCCCCccccccccccccc------ccccccccCCccccCccccCeEeccCCcccccCCCCCCCC
Q 002021 517 GLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNL------SNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFG 590 (979)
Q Consensus 517 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 590 (979)
.+++|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|+.|+|++|++ +.+|.. .++
T Consensus 511 ~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~ 587 (636)
T 4eco_A 511 TLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITP 587 (636)
T ss_dssp TCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCT
T ss_pred cCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhC
Confidence 88999999999999996 8888889999999998 67889999999999999999999999999 788875 448
Q ss_pred CcccccccCCccccCCC
Q 002021 591 NFSAQSFEGNELLCGSP 607 (979)
Q Consensus 591 ~~~~~~~~~N~~~c~~p 607 (979)
.+..+.+++|+..|-..
T Consensus 588 ~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 588 NISVLDIKDNPNISIDL 604 (636)
T ss_dssp TCCEEECCSCTTCEEEC
T ss_pred cCCEEECcCCCCccccH
Confidence 89999999999988554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=437.51 Aligned_cols=250 Identities=24% Similarity=0.287 Sum_probs=210.7
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
..|+..+.||+|+||+||+|. ..+|+.||||++........+.+.+|+++|+.++|||||+++++|.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 458888999999999999995 4679999999997665556677899999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
+||+|.+++... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 226 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence 999999998764 5999999999999999999999 99999999999999999999999999999987643322 2
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+....+ .
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~----------------~ 288 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLP----------------P 288 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSC----------------C
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCC----------------C
Confidence 3557899999999999999999999999999999999999999975221 111111111100 0
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..+++++.+++.+||+.||++|||++|+++|
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111223456779999999999999999999999886
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=469.19 Aligned_cols=461 Identities=19% Similarity=0.209 Sum_probs=325.8
Q ss_pred EEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCc
Q 002021 76 VLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNA 155 (979)
Q Consensus 76 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 155 (979)
.||+++|+++ .+|..+. ++|++|||++|++++..|.++..+++|++|+|++|++++..|..|+++++|++|||++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 5666677666 4565554 666666666666665555666666666666666666666666666666666666666666
Q ss_pred cCchhhhhhhccCCcccCCCCccceeecccccccc-cccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCC
Q 002021 156 LSGEIRANICREIPREFGNLPELELMSLAANNLQG-KIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDN 234 (979)
Q Consensus 156 l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 234 (979)
+++ +|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++ ..+..+++|
T Consensus 81 l~~---------lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L-------- 138 (520)
T 2z7x_B 81 LVK---------ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHL-------- 138 (520)
T ss_dssp CCE---------EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTS--------
T ss_pred eee---------cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccc--------
Confidence 652 4443 55666666666666654 345556666666666666655554 233334444
Q ss_pred CCcCCCcccccCCCCCcCEEEccCCcc--ccccCcccccCC-CCcEEeccccccccccC-ccccccccccceeccccc--
Q 002021 235 SLSGCLSSIGYARLPNLEILSLWGNNF--SGTIPRFIFNAS-KLSILDLEGNSFSGFIP-NTFGNLRNLSWLVLSDNY-- 308 (979)
Q Consensus 235 ~l~~~~~~~~~~~l~~L~~L~L~~N~l--~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~-- 308 (979)
+|++|++++|.+ .+..|..+..+. +...+++++|.+.+.++ ..+.++++|+.|++++|.
T Consensus 139 ---------------~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 203 (520)
T 2z7x_B 139 ---------------NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203 (520)
T ss_dssp ---------------CEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCST
T ss_pred ---------------eeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccc
Confidence 015555555555 444454444433 23345566666554433 345566666666666664
Q ss_pred --cccccchhhhhhcccCCCCccEEEccCCCCcccCCcccccc-ccccccEEEccCccccCCCCccc-----cCCCcccE
Q 002021 309 --LTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGN-LSHSLEEFKMSNCNISGGIPEEI-----SNLTNLRT 380 (979)
Q Consensus 309 --l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~-l~~~L~~L~L~~n~i~~~~p~~l-----~~l~~L~~ 380 (979)
+..... .+..+..+++|++|++++|.+.+......... ..++|++|++++|++++.+|..+ +.+++|+.
T Consensus 204 ~~~~~~~~---~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~ 280 (520)
T 2z7x_B 204 NKCSYFLS---ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSI 280 (520)
T ss_dssp TTTHHHHH---HHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEE
T ss_pred cccceeec---chhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEe
Confidence 111111 12245566667777776666543211111100 02378999999999998899888 99999999
Q ss_pred EEecCCCCCchhHHhhhcC---CCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCC
Q 002021 381 IYLGGNKLNGSILITLSKL---QKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGS 457 (979)
Q Consensus 381 L~L~~N~l~~~~~~~l~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 457 (979)
+++++|.+ ..+...+..+ .+|+.|++++|.+.... .+..+++|++|++++|++++..|..+..+++|++|++++
T Consensus 281 l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 357 (520)
T 2z7x_B 281 HQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357 (520)
T ss_dssp EEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCS
T ss_pred ccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccC
Confidence 99999999 3333555544 78999999999987532 136889999999999999998999999999999999999
Q ss_pred Ccccc---ccccccCcCCCcEEEeccccccCCCcc-ccccccccceEeccCCccCcccchhhcCCcccceeecCCccccC
Q 002021 458 NELTS---IPLTFWNLKDILNLNFSSNFLTGSLPL-EIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 533 (979)
Q Consensus 458 N~l~~---lp~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 533 (979)
|+++. +|..+..+++|+.|++++|++++.+|. .+..+++|+.|++++|++++..|..+. ++|+.|+|++|+++
T Consensus 358 N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~- 434 (520)
T 2z7x_B 358 NQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK- 434 (520)
T ss_dssp SCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-
T ss_pred CccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-
Confidence 99995 456789999999999999999985665 488999999999999999988888775 79999999999999
Q ss_pred CCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCC
Q 002021 534 SIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 534 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
.+|..+..+++|++|+|++|+|++..+..+..+++|+.|++++|+++|.++.
T Consensus 435 ~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 435 SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 7888888999999999999999954444499999999999999999998763
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=434.64 Aligned_cols=256 Identities=22% Similarity=0.273 Sum_probs=209.0
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
+.|+..++||+|+||+||+|. ..+|+.||||+++... ...+|+++++.++|||||++++++.+++..|+||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 456777899999999999995 5679999999996532 2246999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEEeeccccccCCCCCc-
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFSIAKMLTGEDQS- 838 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg~~~~~~~~~~~- 838 (979)
+||+|.+++.+.+ .+++.++..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999999997654 6999999999999999999999 99999999999999999987 6999999999876533221
Q ss_pred --ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 839 --MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 839 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||......+... .......
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~i~~~~~-------------- 273 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEPP-------------- 273 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH-HHHHSCC--------------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-HHHcCCC--------------
Confidence 12234579999999999999999999999999999999999999997643332211 1111000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
.....+..+++++.+++.+||+.||.+|||+.|+++++.+.....
T Consensus 274 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 274 ---PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ---GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 001122356778999999999999999999999999998887643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=443.45 Aligned_cols=271 Identities=24% Similarity=0.378 Sum_probs=222.1
Q ss_pred ccHHHHHHhhCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCC-CCeeeE
Q 002021 672 FSYLELCRATDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRH-RNLIKV 743 (979)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l 743 (979)
+...+++...++|++.+.||+|+||+||+|.+. .++.||||++..... ...+.|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 344555556678999999999999999999642 346899999975543 345678999999999975 899999
Q ss_pred EEeeccC-CeeEEEEEecCCCccceeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 002021 744 ISSCSNE-EFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807 (979)
Q Consensus 744 ~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~D 807 (979)
+++|.++ +..++|||||++|+|.++++.. +..+++.+++.++.|||+||+||| +++|+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence 9998764 5689999999999999999753 235899999999999999999999 99999999
Q ss_pred CCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcc
Q 002021 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDE 886 (979)
Q Consensus 808 ik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~ 886 (979)
|||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987755544445566789999999999999999999999999999999998 9999976
Q ss_pred cccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 887 IFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
....+. +...+.. ..+...+..+++++.++|.+||+.||++||||.||+++|+++.++-
T Consensus 291 ~~~~~~-~~~~i~~------------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKIDEE-FCRRLKE------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCSHH-HHHHHHH------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHHH-HHHHHHc------------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 432221 1111111 0111223456778999999999999999999999999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=439.86 Aligned_cols=251 Identities=20% Similarity=0.311 Sum_probs=203.4
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.++|+..+.||+|+||+||+|. ..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 3679999999999999999995 5679999999996542 234567899999999999999999999999999999999
Q ss_pred EecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 758 EYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
||++||+|.+++... ...+++.+++.|+.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 999999999999754 345799999999999999999999 999999999999999999999999999999876322
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||......+ .+........+
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~------------- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFP------------- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC-------------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCC-------------
Confidence 112245679999999999999999999999999999999999999997532111 11111111100
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+.+..+++++.+++.+||+.||++|||++|+++|
T Consensus 244 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 ------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122456679999999999999999999999886
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=432.21 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=210.3
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|++.+.||+|+||+||+|. ..+|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 569999999999999999994 5689999999996532 334567899999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||++||+|.+++.+.+ .+++.+++.++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999997654 6999999999999999999999 99999999999999999999999999999998754444
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||...... ..+........
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~~--------------- 251 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-LIFAKIIKLEY--------------- 251 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC---------------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCC---------------
Confidence 44445678999999999999999999999999999999999999999752211 11111111000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..++.+++++.+++.+|++.||++|||++|++.+
T Consensus 252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 0112345678999999999999999999997554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=432.39 Aligned_cols=277 Identities=22% Similarity=0.294 Sum_probs=202.7
Q ss_pred CCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC----eeEEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----FKALVLE 758 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~E 758 (979)
+|...+.||+|+||+||+|++ +|+.||||++..... ....+++|+..+.+++|||||+++++|.+++ ..++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 466778999999999999988 689999999965422 1122334555567889999999999997653 5799999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY-----SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
|+++|+|.++++.. .++++++.+++.|+|+||+|||..+ .++|+||||||+|||+++++.+||+|||+|+...
T Consensus 82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999999999765 5899999999999999999999321 2399999999999999999999999999998765
Q ss_pred CCCCc--ceecccccCCCCCCccccCCC------CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 834 GEDQS--MIQTQTLATIGYMAPEYGREG------RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 834 ~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
..... ......+||+.|||||++.+. .+++++|||||||++|||+||+.||......+..+..+........
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 43322 122345799999999998653 4678999999999999999999887654433332221111000000
Q ss_pred -cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 906 -TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 906 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+.....+..-........++..+.++|.+||+.||++||||.||+++|+++.++
T Consensus 240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0000000111111111122234667899999999999999999999999999998764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=438.57 Aligned_cols=250 Identities=24% Similarity=0.287 Sum_probs=210.6
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
+.|+..+.||+|+||.||+|. ..+|+.||||++........+.+.+|+++|+.++|||||+++++|.+++..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 468899999999999999995 5679999999997665556678999999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
+||+|.+++... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+..... .
T Consensus 231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 303 (423)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--C
T ss_pred CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--c
Confidence 999999998754 5899999999999999999999 99999999999999999999999999999987643322 2
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+....+.
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~---------------- 365 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP---------------- 365 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCC----------------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC----------------
Confidence 3557899999999999999999999999999999999999999965221 1111111111000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..+++++.+|+.+||+.||++|||+.|+++|
T Consensus 366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001123456679999999999999999999999886
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=420.55 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=197.1
Q ss_pred CCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeecc----CCeeEEEE
Q 002021 685 SENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKALVL 757 (979)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 757 (979)
+..+.||+|+||+||+|. ..+++.||||++.... ....+.|.+|++++++++|||||+++++|.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 456689999999999995 4578999999986442 2345678999999999999999999999854 45689999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEeC-CCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dik~~NIll~-~~~~~kl~Dfg~~~~~~~ 834 (979)
|||++|+|.+++.+.+ .+++..+..++.||+.||+||| +++ |+||||||+|||++ +++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999997643 6899999999999999999999 777 99999999999998 489999999999986432
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
. .....+||+.|||||++.+ .|++++||||+||++|||+||+.||..................
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~------------ 247 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------------ 247 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------------
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC------------
Confidence 2 2245689999999998864 6999999999999999999999999653221111111100000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..+++++.+++.+||+.||++|||++|+++|
T Consensus 248 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 248 ------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011122345678999999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=417.18 Aligned_cols=246 Identities=23% Similarity=0.366 Sum_probs=191.9
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|++.+.||+|+||+||+|. ..+|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999995 4579999999986542 233467889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+ +|+|.+++.+.+ .+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 679999987654 6999999999999999999999 9999999999999999999999999999998754322
Q ss_pred cceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.....+||+.|||||++.+..+ ++++||||+||++|||+||+.||...... ..+.......
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-~~~~~i~~~~--------------- 228 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-VLFKNISNGV--------------- 228 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTC---------------
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCC---------------
Confidence 2345689999999999988775 58999999999999999999999752111 1111111100
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+..+++++.+++.+|++.||++|||++|+++|
T Consensus 229 -----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 -----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00112345678999999999999999999999986
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=468.87 Aligned_cols=490 Identities=19% Similarity=0.195 Sum_probs=299.8
Q ss_pred CCCCeeeccCCcccccCCccccccCcccEEec-ccccccccCCccccCCCCCcEEEccCCccCch---hhhhhhccCCcc
Q 002021 96 SSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCL-RGNQLSGTFPSFISNKSSLQHLDLSSNALSGE---IRANICREIPRE 171 (979)
Q Consensus 96 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L-~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~---~~~~~~~~ip~~ 171 (979)
.+++.|+|++|+++|.+|++++.+++|++|+| ++|.++|..|...... .++++...+... .........|.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~----~~~l~~~~l~~lr~~~~~~~l~~~~~- 397 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL----TPDMSEERKHRIRMHYKKMFLDYDQR- 397 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCC----CSSCCHHHHHHHHTHHHHHHTCCCGG-
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeeccccccccccccccccc----ccccchhHHHHHHHhhhhhhhccCcc-
Confidence 46777888888888888888888888888888 7777777644321111 000000000000 00000000000
Q ss_pred cCCCCccceeecccccccccccccccCCCCCCceecCC--CeeeecCCccccccCccceeeccCCCCcC-----------
Q 002021 172 FGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGD--NKLVGIAPIAIFNVSTLKILGLQDNSLSG----------- 238 (979)
Q Consensus 172 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~--N~l~~~~p~~l~~l~~L~~L~L~~N~l~~----------- 238 (979)
..+..+....+..+. ...+........++.+.++. |++++ +|..|.++++|+.|+|++|+|++
T Consensus 398 -~~~s~l~~~~l~~~~--~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s 473 (876)
T 4ecn_A 398 -LNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN 473 (876)
T ss_dssp -GGSCHHHHHHHHTCT--TSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTT
T ss_pred -hhhhHHHHHHhhhCc--cccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccc
Confidence 000000000000000 00011111222333333333 55555 35555555555555555555555
Q ss_pred -------CCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccc-ccc-ccCccccccc-------cccce
Q 002021 239 -------CLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNS-FSG-FIPNTFGNLR-------NLSWL 302 (979)
Q Consensus 239 -------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l~-------~L~~L 302 (979)
++....|..+++|++|+|++|++.+.+|..++++++|++|+|++|+ +++ .+|..++.++ +|++|
T Consensus 474 ~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L 553 (876)
T 4ecn_A 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553 (876)
T ss_dssp SHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEE
T ss_pred cccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEE
Confidence 3333334466666666666666666666666666777777777776 666 5666555554 67777
Q ss_pred eccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCc-ccEE
Q 002021 303 VLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTN-LRTI 381 (979)
Q Consensus 303 ~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~-L~~L 381 (979)
+|++|+++.+|.. ..+.++++|++|+|++|++..++ .++. .++|+.|+|++|+++ .+|..+..+++ |+.|
T Consensus 554 ~Ls~N~L~~ip~~----~~l~~L~~L~~L~Ls~N~l~~lp---~~~~-L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L 624 (876)
T 4ecn_A 554 YMGYNNLEEFPAS----ASLQKMVKLGLLDCVHNKVRHLE---AFGT-NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624 (876)
T ss_dssp ECCSSCCCBCCCH----HHHTTCTTCCEEECTTSCCCBCC---CCCT-TSEESEEECCSSCCS-CCCTTSCEECTTCCEE
T ss_pred EeeCCcCCccCCh----hhhhcCCCCCEEECCCCCcccch---hhcC-CCcceEEECcCCccc-cchHHHhhccccCCEE
Confidence 7777776654430 12556666777777777666432 2222 246777777777777 66667777777 7777
Q ss_pred EecCCCCCchhHHhhhcCCC--CcEEEecCcccCCCccccc---c--CCCCCceEecCCCcccccCCccccCCCcCceEe
Q 002021 382 YLGGNKLNGSILITLSKLQK--LQDLGLKDNKLEGSIPYDI---C--NLAELYRLDLDGNKLSGSIPACFSNLTSLRIVS 454 (979)
Q Consensus 382 ~L~~N~l~~~~~~~l~~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 454 (979)
+|++|+++ .+|..+..++. |+.|++++|++.+.+|... . .+++|+.|+|++|+++...+..+..+++|+.|+
T Consensus 625 ~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~ 703 (876)
T 4ecn_A 625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703 (876)
T ss_dssp ECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEE
T ss_pred ECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEE
Confidence 77777777 45556655543 7777777777776555322 2 334788888888888743333344778888888
Q ss_pred cCCCccccccccccCc--------CCCcEEEeccccccCCCccccc--cccccceEeccCCccCcccchhhcCCccccee
Q 002021 455 LGSNELTSIPLTFWNL--------KDILNLNFSSNFLTGSLPLEIG--SLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYL 524 (979)
Q Consensus 455 L~~N~l~~lp~~~~~l--------~~L~~L~ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 524 (979)
|++|+|+.+|..+... ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|
T Consensus 704 Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L 781 (876)
T 4ecn_A 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAF 781 (876)
T ss_dssp CCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEE
T ss_pred CCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEE
Confidence 8888888777755432 27888888888888 5777776 78888888888888886 67778888888888
Q ss_pred ecCC------ccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCCC-CCCCcccccc
Q 002021 525 FLGY------NRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGG-SFGNFSAQSF 597 (979)
Q Consensus 525 ~Ls~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~~~~~~~~~ 597 (979)
+|++ |++.+.+|..|.++++|+.|+|++|+| +.+|..+. ++|+.|+|++|++....+... .........+
T Consensus 782 ~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L 858 (876)
T 4ecn_A 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVL 858 (876)
T ss_dssp ECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEE
T ss_pred ECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheee
Confidence 8865 889999999999999999999999999 68888866 699999999999976544311 0111233455
Q ss_pred cCCcc--ccCCCCC
Q 002021 598 EGNEL--LCGSPNL 609 (979)
Q Consensus 598 ~~N~~--~c~~p~~ 609 (979)
.+|+. .+|+|..
T Consensus 859 ~~n~~~~I~gC~~L 872 (876)
T 4ecn_A 859 LYDKTQDIRGCDAL 872 (876)
T ss_dssp ECCTTSEEESCGGG
T ss_pred cCCCccccCCCCCc
Confidence 55544 4466643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=459.09 Aligned_cols=488 Identities=22% Similarity=0.174 Sum_probs=383.6
Q ss_pred CcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEc
Q 002021 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDL 151 (979)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 151 (979)
..+++|||++|+|++..+.+|.++++|++|||++|+|++..|.+|..+++|++|+|++|+|++..|..|+++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 36889999999999777778999999999999999999877888999999999999999999887788999999999999
Q ss_pred cCCccCchhhhhhhccCCcccCCCCccceeecccccccc-cccccccCCCCCCceecCCCeeeecCCccccccCccc---
Q 002021 152 SSNALSGEIRANICREIPREFGNLPELELMSLAANNLQG-KIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLK--- 227 (979)
Q Consensus 152 s~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~--- 227 (979)
++|++++. .+..|+++++|++|+|++|.+++ .+|..++.+++|++|+|++|+|+++.+..|..+.+++
T Consensus 132 s~N~l~~l--------~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~ 203 (635)
T 4g8a_A 132 VETNLASL--------ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 203 (635)
T ss_dssp TTSCCCCS--------TTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCC
T ss_pred CCCcCCCC--------ChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhh
Confidence 99999753 33568999999999999999975 4678889999999999999999999888888776554
Q ss_pred -eeeccCCCCcCCCcccccCCCCCcCEEEccCCcccc-ccCcccccCCCCcEEeccccccc------c------------
Q 002021 228 -ILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSG-TIPRFIFNASKLSILDLEGNSFS------G------------ 287 (979)
Q Consensus 228 -~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~------~------------ 287 (979)
.++++.|.++...+.. .....++.+++++|.... ..+..+..+..++...+..+... .
T Consensus 204 ~~~~ls~n~l~~i~~~~--~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l 281 (635)
T 4g8a_A 204 LSLDLSLNPMNFIQPGA--FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 281 (635)
T ss_dssp CEEECTTCCCCEECTTT--TTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGS
T ss_pred hhhhcccCcccccCccc--ccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccch
Confidence 5788889887655432 244566777887775542 22334444555554444322211 1
Q ss_pred ---------------ccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccc
Q 002021 288 ---------------FIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSH 352 (979)
Q Consensus 288 ---------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 352 (979)
..+..+..+.+++.+++.+|.+.... .+.....|+.|++++|.+..+.... ..
T Consensus 282 ~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~-------~~~~~~~L~~L~l~~~~~~~~~~~~-----l~ 349 (635)
T 4g8a_A 282 TIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK-------DFSYNFGWQHLELVNCKFGQFPTLK-----LK 349 (635)
T ss_dssp EEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG-------GGGSCCCCSEEEEESCEESSCCCCB-----CT
T ss_pred hhhhhhhhhhcccccchhhhhhhhccccccccccccccccc-------ccccchhhhhhhcccccccCcCccc-----ch
Confidence 11223444556666666666665443 2455677888888888876654432 34
Q ss_pred cccEEEccCccccCCCCccccCCCcccEEEecCCCCCc--hhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEe
Q 002021 353 SLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNG--SILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLD 430 (979)
Q Consensus 353 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 430 (979)
.|+.+++.+|.+... .....+++|+.|++++|.+.. ..+..+..+.+|+.+++..|.+.. .+..+..+++|+.++
T Consensus 350 ~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~ 426 (635)
T 4g8a_A 350 SLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 426 (635)
T ss_dssp TCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEE
T ss_pred hhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchh
Confidence 688888888877643 345578899999999998864 445677788899999999988874 566788889999999
Q ss_pred cCCCcccccCC-ccccCCCcCceEecCCCccccc-cccccCcCCCcEEEecccccc-CCCccccccccccceEeccCCcc
Q 002021 431 LDGNKLSGSIP-ACFSNLTSLRIVSLGSNELTSI-PLTFWNLKDILNLNFSSNFLT-GSLPLEIGSLKVLVGIDLSRNNF 507 (979)
Q Consensus 431 Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l 507 (979)
++.|+.....+ ..|..+++++.+++++|+++.+ |..+..++.++.|++++|.+. +..|..|..+++|+.|||++|+|
T Consensus 427 l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L 506 (635)
T 4g8a_A 427 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 506 (635)
T ss_dssp CTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred hhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCcc
Confidence 99888765544 5678899999999999999855 456778899999999998754 45788899999999999999999
Q ss_pred CcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCc-cccCeEeccCCcccccCC
Q 002021 508 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKL-SYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 508 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p 584 (979)
++.+|..|.++++|++|+|++|+|++..|..|.++++|++|||++|+|++..|..+..+ ++|+.|+|++|+|+|...
T Consensus 507 ~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 507 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 98889999999999999999999998888889999999999999999999999999888 689999999999998765
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=454.71 Aligned_cols=441 Identities=23% Similarity=0.245 Sum_probs=339.3
Q ss_pred CcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEc
Q 002021 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDL 151 (979)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 151 (979)
.+++.|+|++|.+++..|..+.++++|++|+|++|++++..|..++.+++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 67999999999999888889999999999999999999988999999999999999999999 56666 8999999999
Q ss_pred cCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCC--CceecCCCee--eecCCccccccC-cc
Q 002021 152 SSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNL--EKLDIGDNKL--VGIAPIAIFNVS-TL 226 (979)
Q Consensus 152 s~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~l~~l~-~L 226 (979)
++|.+++. .+|..|+++++|++|+|++|++++ ..++.+++| ++|++++|++ .+..|..+..+. +.
T Consensus 98 ~~N~l~~~-------~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~ 167 (520)
T 2z7x_B 98 SFNAFDAL-------PICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167 (520)
T ss_dssp CSSCCSSC-------CCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEE
T ss_pred cCCccccc-------cchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccce
Confidence 99999863 378899999999999999999986 457778888 9999999999 888888888776 45
Q ss_pred ceeeccCCCCcCCCcccccCCCCCcCEEEccCCc-------cccccCcccccCCCCcEEeccccccccccCcccc---cc
Q 002021 227 KILGLQDNSLSGCLSSIGYARLPNLEILSLWGNN-------FSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFG---NL 296 (979)
Q Consensus 227 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~-------l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~---~l 296 (979)
..+++++|.+.+......+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.+++..+..+. ..
T Consensus 168 l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~ 246 (520)
T 2z7x_B 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246 (520)
T ss_dssp EEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHT
T ss_pred EEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhh
Confidence 5678999999887777778889999999999987 777666 778888999999988888764332221 13
Q ss_pred ccccceeccccccc-cccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCC
Q 002021 297 RNLSWLVLSDNYLT-SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNL 375 (979)
Q Consensus 297 ~~L~~L~Ls~N~l~-~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l 375 (979)
++|++|++++|+++ .++... +......++.|+.+++++|.+ .++ ...+..+
T Consensus 247 ~~L~~L~l~~n~l~~~~p~~~-~~~~~~~l~~L~~l~l~~n~~-~~p--------------------------~~~~~~~ 298 (520)
T 2z7x_B 247 TTVWYFSISNVKLQGQLDFRD-FDYSGTSLKALSIHQVVSDVF-GFP--------------------------QSYIYEI 298 (520)
T ss_dssp SSCSEEEEEEEEEESCCCCCC-CCCCSCCCCEEEEEEEEECCC-CSC--------------------------THHHHHH
T ss_pred CcccEEEeecccccCccccch-hhcccccCceeEeccccccce-ecc--------------------------hhhhhcc
Confidence 47788888888776 333221 000014555555555555555 221 1223222
Q ss_pred ---CcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccc--cCCccccCCCcC
Q 002021 376 ---TNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSG--SIPACFSNLTSL 450 (979)
Q Consensus 376 ---~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L 450 (979)
++|+.|++++|.+.... .+..+++|++|++++|++.+..|..++.+++|++|++++|++++ .+|..+..+++|
T Consensus 299 ~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L 376 (520)
T 2z7x_B 299 FSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL 376 (520)
T ss_dssp HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTC
T ss_pred cccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCC
Confidence 45666666666554322 12456667777777777776667777777777777777777775 445667777778
Q ss_pred ceEecCCCcccc-cccc-ccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCC
Q 002021 451 RIVSLGSNELTS-IPLT-FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGY 528 (979)
Q Consensus 451 ~~L~L~~N~l~~-lp~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 528 (979)
++|++++|+++. +|.. +..+++|+.|++++|++++..|..+. ++|+.|||++|+|+ .+|..+..+++|++|+|++
T Consensus 377 ~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~ 453 (520)
T 2z7x_B 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS 453 (520)
T ss_dssp CEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCS
T ss_pred CEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCC
Confidence 888888887776 7764 66778888888888888777776664 78899999999998 6777777999999999999
Q ss_pred ccccCCCCC-cccccccccccccccccccccCC
Q 002021 529 NRLQGSIPN-SFGDLISLKFLNLSNNNLSGVIP 560 (979)
Q Consensus 529 N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p 560 (979)
|+|+. +|. .|..+++|++|+|++|++++..+
T Consensus 454 N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 454 NQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CcCCc-cCHHHhccCCcccEEECcCCCCcccCC
Confidence 99994 555 48899999999999999986543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=423.00 Aligned_cols=248 Identities=25% Similarity=0.313 Sum_probs=198.3
Q ss_pred CCCCCCceeeeecceEEEEEEc----CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|++.+.||+|+||+||+|+. .+++.||||++.... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4688999999999999999954 357899999986543 2334568889999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||++||+|.+++.+.+ .+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999997654 6999999999999999999999 999999999999999999999999999999865332
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||......+ .+.......
T Consensus 180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~-------------- 242 (304)
T 3ubd_A 180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILKAK-------------- 242 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC--------------
T ss_pred C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCC--------------
Confidence 2 22345689999999999999999999999999999999999999997532111 111111100
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH-----HHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA-----KEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~eil~~ 956 (979)
...+..+++++.+++.+||+.||++|||+ +|+++|
T Consensus 243 ------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 243 ------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 01123456779999999999999999984 677765
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=454.48 Aligned_cols=529 Identities=21% Similarity=0.248 Sum_probs=414.6
Q ss_pred ccCCCCCCCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEeccccc
Q 002021 52 NWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131 (979)
Q Consensus 52 ~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~ 131 (979)
+|+.+. +..|....|..... ..+.++.+++ .+|+.+- +++++|||++|+|++..|.+|..+++|++|+|++|+
T Consensus 15 ~~~~~~-p~~~~~c~~~~~~~---~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 15 AANSSI-PESWEPCVEVVPNI---TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp -----------CCSEEEETTT---EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred cccCCC-CCCCCCccccCCCC---EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc
Confidence 454433 23455544442221 2356677787 5776553 479999999999998778899999999999999999
Q ss_pred ccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCe
Q 002021 132 LSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNK 211 (979)
Q Consensus 132 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 211 (979)
|++..|.+|+++++|++|+|++|+|++. .|..|+++++|++|+|++|++++..+..|+++++|++|+|++|+
T Consensus 88 i~~i~~~~f~~L~~L~~L~Ls~N~l~~l--------~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~ 159 (635)
T 4g8a_A 88 IQTIEDGAYQSLSHLSTLILTGNPIQSL--------ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 159 (635)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEE--------CGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred CCCcChhHhcCCCCCCEEEccCCcCCCC--------CHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCc
Confidence 9988888999999999999999999853 23568999999999999999998888889999999999999999
Q ss_pred eeec-CCccccccCccceeeccCCCCcCCCcccccCCCCC----cCEEEccCCccccccCcccccCCCCcEEeccccccc
Q 002021 212 LVGI-APIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPN----LEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFS 286 (979)
Q Consensus 212 l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~----L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 286 (979)
+++. .|..+.++++|+.|+|++|+|++..+. .|..+.+ +..++++.|.++...+. ......+..+++++|...
T Consensus 160 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~l~~L~~l~~~~~~~~ls~n~l~~i~~~-~~~~~~~~~l~l~~n~~~ 237 (635)
T 4g8a_A 160 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT-DLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLHKLTLRNNFDS 237 (635)
T ss_dssp CCCCCCCGGGGGCTTCCEEECCSSCCCEECGG-GGHHHHTCTTCCCEEECTTCCCCEECTT-TTTTCEEEEEEEESCCSS
T ss_pred cccCCCchhhccchhhhhhcccCccccccccc-cccchhhhhhhhhhhhcccCcccccCcc-cccchhhhhhhhhccccc
Confidence 9875 578889999999999999999986543 2333333 45789999999865544 445567888999998765
Q ss_pred cc-cCccccccccccceecccccccccc------ch----------------------hhhhhcccCCCCccEEEccCCC
Q 002021 287 GF-IPNTFGNLRNLSWLVLSDNYLTSST------QE----------------------LSFLSSLSNCKFLKYFDLSYNP 337 (979)
Q Consensus 287 ~~-~~~~~~~l~~L~~L~Ls~N~l~~~~------~~----------------------~~~~~~l~~l~~L~~L~Ls~N~ 337 (979)
.. .+..+.++..++...+..+...... .. ......+..+.+++.+++..|.
T Consensus 238 ~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~ 317 (635)
T 4g8a_A 238 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVT 317 (635)
T ss_dssp HHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCE
T ss_pred ccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccc
Confidence 32 2344556666655554332211100 00 0001224455678888888888
Q ss_pred CcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCC--C
Q 002021 338 LYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEG--S 415 (979)
Q Consensus 338 l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~ 415 (979)
+..+.+..+ ..+++.|++.+|.+.+..+. .+..|+.+++.+|.+... .....+++|+.|++++|.+.. .
T Consensus 318 ~~~~~~~~~----~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~ 388 (635)
T 4g8a_A 318 IERVKDFSY----NFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGC 388 (635)
T ss_dssp EEECGGGGS----CCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEE
T ss_pred ccccccccc----chhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccc
Confidence 776644322 34789999999998865543 467788999999987653 345678999999999999864 4
Q ss_pred ccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCcccccc--ccccCcCCCcEEEeccccccCCCcccccc
Q 002021 416 IPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP--LTFWNLKDILNLNFSSNFLTGSLPLEIGS 493 (979)
Q Consensus 416 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp--~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 493 (979)
.+..+..+.+|+.|+++.|.+.. .+..+..+++|+.+++.+|+....+ ..+..+.+++.++++.|.+++..|..+..
T Consensus 389 ~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~ 467 (635)
T 4g8a_A 389 CSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 467 (635)
T ss_dssp CCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred cccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccccccccccccccccccccccccccc
Confidence 55667788999999999999874 5667889999999999999877543 35778999999999999999999999999
Q ss_pred ccccceEeccCCcc-CcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeE
Q 002021 494 LKVLVGIDLSRNNF-SGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDL 572 (979)
Q Consensus 494 l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 572 (979)
++.|+.|+|++|++ .+.+|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|
T Consensus 468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 547 (635)
T 4g8a_A 468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 547 (635)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence 99999999999985 45688999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCcccccCCCCC-CC-CCcccccccCCccccCCC
Q 002021 573 NLSFNQLEGKIPRGG-SF-GNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 573 ~L~~N~l~~~~p~~~-~~-~~~~~~~~~~N~~~c~~p 607 (979)
+|++|+|++.+|... .+ .++..+.+.+||+.|.+.
T Consensus 548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999988632 23 567889999999999765
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=447.87 Aligned_cols=462 Identities=21% Similarity=0.190 Sum_probs=342.9
Q ss_pred EEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCC
Q 002021 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSN 154 (979)
Q Consensus 75 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N 154 (979)
..+|++++++++ +|..+. ++|++|||++|++++..|.++..+++|++|+|++|++++..|..|+++++|++|||++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 678888888885 776654 78888888888888777778888888888888888888777788888888888888888
Q ss_pred ccCchhhhhhhccCCcccCCCCccceeecccccccc-cccccccCCCCCCceecCCCeeeecCCccccccCccceeeccC
Q 002021 155 ALSGEIRANICREIPREFGNLPELELMSLAANNLQG-KIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQD 233 (979)
Q Consensus 155 ~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 233 (979)
.++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++. .+..+++|
T Consensus 111 ~l~---------~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L------- 169 (562)
T 3a79_B 111 RLQ---------NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHL------- 169 (562)
T ss_dssp CCC---------EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTS-------
T ss_pred cCC---------ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhc-------
Confidence 876 25655 67777777777777765 3356677777777777777766542 23333333
Q ss_pred CCCcCCCcccccCCCCCcCEEEccCCcc--ccccCcccccCC-CCcEEeccccccccccCc-cccccccccceecccccc
Q 002021 234 NSLSGCLSSIGYARLPNLEILSLWGNNF--SGTIPRFIFNAS-KLSILDLEGNSFSGFIPN-TFGNLRNLSWLVLSDNYL 309 (979)
Q Consensus 234 N~l~~~~~~~~~~~l~~L~~L~L~~N~l--~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l 309 (979)
+|++|++++|.+ ++..|..+..+. +...+++++|.+.+.++. .+..+++|+.|++++|+.
T Consensus 170 ----------------~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~ 233 (562)
T 3a79_B 170 ----------------HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233 (562)
T ss_dssp ----------------CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCST
T ss_pred ----------------eeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccccccc
Confidence 225555555555 445555555433 122456666666654443 455677777777777742
Q ss_pred c--cccchhhhhhcccCCCCccEEEccCCCCcccCCccccc-cccccccEEEccCccccCCCCccc-----cCCCcccEE
Q 002021 310 T--SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVG-NLSHSLEEFKMSNCNISGGIPEEI-----SNLTNLRTI 381 (979)
Q Consensus 310 ~--~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-~l~~~L~~L~L~~n~i~~~~p~~l-----~~l~~L~~L 381 (979)
. ..+ ..+..+..++.|+.|+++++.+.......... ....+|++|++++|.+++.+|..+ ..++.|+.+
T Consensus 234 ~~~~l~---~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~ 310 (562)
T 3a79_B 234 NCQRLM---TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310 (562)
T ss_dssp THHHHH---HHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEE
T ss_pred ccchHH---HHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehh
Confidence 1 111 12334566777777777766654321110000 012379999999999998899887 888889889
Q ss_pred EecCCCCCchhHHhhh---cCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCC
Q 002021 382 YLGGNKLNGSILITLS---KLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSN 458 (979)
Q Consensus 382 ~L~~N~l~~~~~~~l~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 458 (979)
++..|.+ ..+...+. ...+|+.|++++|.+.... ....+++|++|++++|++++..|..+.++++|++|++++|
T Consensus 311 ~~~~~~~-~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 387 (562)
T 3a79_B 311 HVKNQVF-LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387 (562)
T ss_dssp EEEECCC-SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSS
T ss_pred hccccee-ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCC
Confidence 9988887 23323333 2378999999999986432 1268899999999999999989999999999999999999
Q ss_pred cccccc---ccccCcCCCcEEEeccccccCCCcc-ccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCC
Q 002021 459 ELTSIP---LTFWNLKDILNLNFSSNFLTGSLPL-EIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 534 (979)
Q Consensus 459 ~l~~lp---~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 534 (979)
+++.++ ..+..+++|+.|++++|++++.+|. .+..+++|+.|+|++|++++.+|..+. ++|++|+|++|+|+ .
T Consensus 388 ~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ 464 (562)
T 3a79_B 388 GLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-S 464 (562)
T ss_dssp CCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-C
T ss_pred CcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-c
Confidence 999664 5688999999999999999985554 588999999999999999988777665 79999999999999 6
Q ss_pred CCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCC
Q 002021 535 IPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 535 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
+|..+..+++|++|+|++|+|++..+..+..+++|+.|++++|+++|.+|.
T Consensus 465 ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 465 IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 887777999999999999999954444499999999999999999998774
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=407.34 Aligned_cols=250 Identities=21% Similarity=0.338 Sum_probs=189.1
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCC--------
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-------- 751 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 751 (979)
++|+..+.||+|+||+||+|. ..+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 458889999999999999995 56799999999875432 34467889999999999999999999986543
Q ss_pred ----eeEEEEEecCCCccceeeccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEe
Q 002021 752 ----FKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 825 (979)
Q Consensus 752 ----~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~D 825 (979)
..|+||||+++|+|.+++.... ...++..++.++.||++||+||| +++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 3689999999999999997653 23566778999999999999999 99999999999999999999999999
Q ss_pred eccccccCCCCCc----------ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHh
Q 002021 826 FSIAKMLTGEDQS----------MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 895 (979)
Q Consensus 826 fg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~ 895 (979)
||+|+........ ......+||+.|||||++.+..|+.++||||+||++|||++ ||...... ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~---~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER---VR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH---HH
Confidence 9999876433211 12234579999999999999999999999999999999996 77532111 11
Q ss_pred HhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ...... ...+.....++...+++.+||+.||++|||+.|+++|
T Consensus 236 ~~-~~~~~~---------------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TL-TDVRNL---------------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH-HHHHTT---------------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH-HHHhcC---------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 000000 0011223344567889999999999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=430.59 Aligned_cols=440 Identities=22% Similarity=0.236 Sum_probs=324.0
Q ss_pred CcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEc
Q 002021 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDL 151 (979)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 151 (979)
..++.|+|++|.+++..|..++++++|++|+|++|++++..|.++..+++|++|+|++|+++ .+|.. .+++|++|||
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 57999999999999888889999999999999999999999999999999999999999999 56666 8999999999
Q ss_pred cCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCC--CceecCCCee--eecCCccccccC-cc
Q 002021 152 SSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNL--EKLDIGDNKL--VGIAPIAIFNVS-TL 226 (979)
Q Consensus 152 s~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~l~~l~-~L 226 (979)
++|++++. .+|..|+++++|++|+|++|++++. .+..+++| ++|+|++|++ ++..|..+.++. +.
T Consensus 129 s~N~l~~l-------~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~ 198 (562)
T 3a79_B 129 SFNDFDVL-------PVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV 198 (562)
T ss_dssp CSSCCSBC-------CCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEE
T ss_pred CCCCcccc-------CchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcce
Confidence 99999863 2568999999999999999999863 45555666 9999999999 888898888765 22
Q ss_pred ceeeccCCCCcCCCcccccCCCCCcCEEEccCCc-----cccccCcccccCCCCcEEeccccccccccCcc---cccccc
Q 002021 227 KILGLQDNSLSGCLSSIGYARLPNLEILSLWGNN-----FSGTIPRFIFNASKLSILDLEGNSFSGFIPNT---FGNLRN 298 (979)
Q Consensus 227 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~-----l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~---~~~l~~ 298 (979)
-.++++.|.+.+......+..+++|+.|++++|+ +.+. ...+..+++|+.|+++++.+++..... ....++
T Consensus 199 l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~ 277 (562)
T 3a79_B 199 LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP 277 (562)
T ss_dssp EEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSS
T ss_pred EEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcCcHHHHHHHHHhhhccc
Confidence 3568899999887777778888999999999885 3322 234667778888888777765431111 111236
Q ss_pred ccceeccccccc-cccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCC-ccccC--
Q 002021 299 LSWLVLSDNYLT-SSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP-EEISN-- 374 (979)
Q Consensus 299 L~~L~Ls~N~l~-~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p-~~l~~-- 374 (979)
|++|++++|.++ .+|... +.....+++.|+.++++.|.+ . +| ..+..
T Consensus 278 L~~L~l~~n~l~~~ip~~~-~~~~~~~L~~L~~~~~~~~~~-~---------------------------~p~~~~~~~~ 328 (562)
T 3a79_B 278 VEYLNIYNLTITERIDREE-FTYSETALKSLMIEHVKNQVF-L---------------------------FSKEALYSVF 328 (562)
T ss_dssp EEEEEEEEEEECSCCCCCC-CCCCSCSCCEEEEEEEEECCC-S---------------------------SCHHHHHHHH
T ss_pred ccEEEEeccEeeccccchh-hhcccccchheehhhccccee-e---------------------------cChhhhhhhh
Confidence 677777777666 333221 000013344444444444433 1 22 11111
Q ss_pred -CCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCccccc--CCccccCCCcCc
Q 002021 375 -LTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGS--IPACFSNLTSLR 451 (979)
Q Consensus 375 -l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~ 451 (979)
..+|++|++++|.+.... ....+++|++|++++|++++..|..+.++++|++|++++|++++. .|..+.++++|+
T Consensus 329 ~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~ 406 (562)
T 3a79_B 329 AEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE 406 (562)
T ss_dssp HTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCC
T ss_pred ccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCC
Confidence 145666666666654322 115666777777777777776777777777777777777777753 245677777888
Q ss_pred eEecCCCcccc-cccc-ccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCc
Q 002021 452 IVSLGSNELTS-IPLT-FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYN 529 (979)
Q Consensus 452 ~L~L~~N~l~~-lp~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 529 (979)
+|++++|+++. +|.. +..+++|+.|++++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|
T Consensus 407 ~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N 483 (562)
T 3a79_B 407 TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN 483 (562)
T ss_dssp EEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSS
T ss_pred EEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCC
Confidence 88888888775 7664 66778888888888888776666554 68889999999998 56766668999999999999
Q ss_pred cccCCCCCc-ccccccccccccccccccccCC
Q 002021 530 RLQGSIPNS-FGDLISLKFLNLSNNNLSGVIP 560 (979)
Q Consensus 530 ~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 560 (979)
+|++ +|.. |..+++|+.|+|++|++++..|
T Consensus 484 ~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 484 QLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CCCC-CCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CCCC-CCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 9994 5554 8899999999999999986544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=401.66 Aligned_cols=270 Identities=20% Similarity=0.292 Sum_probs=201.6
Q ss_pred HHhhCCCCCCceeeeecceEEEEEEc----CCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCe
Q 002021 678 CRATDGFSENNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF 752 (979)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (979)
....+.|++.+.||+|+||+||+|+. .+++.||||++... .....+.+|+++++.+ +|||||++++++.+.++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 34567899999999999999999953 35788999998654 2345678899999998 69999999999999999
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEEeeccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFSIAKM 831 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfg~~~~ 831 (979)
.|+||||+++|+|.+++. .+++.+++.++.|++.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999999884 4899999999999999999999 9999999999999999876 7999999999976
Q ss_pred cCCCCCc--------------------------ceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCC
Q 002021 832 LTGEDQS--------------------------MIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPT 884 (979)
Q Consensus 832 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~ 884 (979)
....... ......+||+.|+|||++.+. .|+.++||||+||++|||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5322110 112345799999999998765 5899999999999999999999999
Q ss_pred cccccCcchHhHhhhh------------h---------cCCc-cchhhc---------ccccC---chhhhhHHHHHHHH
Q 002021 885 DEIFNGEMTLKHWVND------------W---------LPIS-TMEVVD---------ANLLS---QEDIHFVAKEQCVS 930 (979)
Q Consensus 885 ~~~~~~~~~~~~~~~~------------~---------~~~~-~~~~~~---------~~~~~---~~~~~~~~~~~~~~ 930 (979)
....+....+...... . .+.. ...... +.... ........+..+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 6433221111111100 0 0000 000000 00000 00001112234567
Q ss_pred HHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 931 FVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 931 ~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
++.+|+.+|++.||++|||++|+++|
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 79999999999999999999999876
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=408.56 Aligned_cols=405 Identities=26% Similarity=0.314 Sum_probs=204.3
Q ss_pred CCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCC-------------cEEEccCCccCchhh
Q 002021 95 LSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSL-------------QHLDLSSNALSGEIR 161 (979)
Q Consensus 95 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L-------------~~L~Ls~N~l~~~~~ 161 (979)
.++|++|++++|++ |.+|++++.+++|++|+|++|+++|.+|..++++++| ++|++++|.+++
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~--- 85 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS--- 85 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC---
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc---
Confidence 45555566665555 4556555556666666666666655555555555554 555665555543
Q ss_pred hhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCc
Q 002021 162 ANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLS 241 (979)
Q Consensus 162 ~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 241 (979)
+|.. .++|++|++++|.+++ +|.. +++|++|++++|+++++...
T Consensus 86 ------lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~----------------------- 129 (454)
T 1jl5_A 86 ------LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDL----------------------- 129 (454)
T ss_dssp ------CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSC-----------------------
T ss_pred ------CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCC-----------------------
Confidence 2321 2345555555555554 3322 24455555555555443110
Q ss_pred ccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhc
Q 002021 242 SIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSS 321 (979)
Q Consensus 242 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 321 (979)
.++|++|++++|++++ +| .+.++++|++|++++|++++ +|..+ .+|++|++++|+++.++ +
T Consensus 130 ------~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~-------~ 190 (454)
T 1jl5_A 130 ------PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP-------E 190 (454)
T ss_dssp ------CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC-------C
T ss_pred ------CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc-------c
Confidence 1345555555555543 34 34555555555555555553 23222 35555555555555432 2
Q ss_pred ccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCC
Q 002021 322 LSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQK 401 (979)
Q Consensus 322 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 401 (979)
+.++++|++|++++|++.+++. .+.+|++|++++|.++ .+| .++.+++|++|++++|++++... .+++
T Consensus 191 ~~~l~~L~~L~l~~N~l~~l~~------~~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~----~~~~ 258 (454)
T 1jl5_A 191 LQNLPFLTAIYADNNSLKKLPD------LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPD----LPPS 258 (454)
T ss_dssp CTTCTTCCEEECCSSCCSSCCC------CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCS----CCTT
T ss_pred ccCCCCCCEEECCCCcCCcCCC------CcCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcccc----cccc
Confidence 4455555666666665554321 1246777777777777 455 37788888888888888876332 2477
Q ss_pred CcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccc
Q 002021 402 LQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSN 481 (979)
Q Consensus 402 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N 481 (979)
|+.|++++|++++ +|.. +++|+.|++++|++++. |.. .++|++|++++|+++.++.. .++|+.|++++|
T Consensus 259 L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~~~---~~~L~~L~Ls~N 327 (454)
T 1jl5_A 259 LEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSLCDL---PPSLEELNVSNN 327 (454)
T ss_dssp CCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEECCC---CTTCCEEECCSS
T ss_pred cCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcccCC---cCcCCEEECCCC
Confidence 8888888888875 4443 36788888888888762 211 26788888888888876532 257888888888
Q ss_pred cccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccC--CCCCcccccccccccccccccccccC
Q 002021 482 FLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG--SIPNSFGDLISLKFLNLSNNNLSGVI 559 (979)
Q Consensus 482 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~ 559 (979)
++++ +|.. +++|+.|++++|++++ +|. .+++|++|++++|++++ .+|.++..+ +.|++.+.+
T Consensus 328 ~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i 391 (454)
T 1jl5_A 328 KLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEV 391 (454)
T ss_dssp CCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC-----
T ss_pred cccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhccccccc
Confidence 8886 5543 4778888888888884 455 46788888888888887 567666543 346666666
Q ss_pred CccccCccccCeEeccCCcccc--cCCCCCCCCCcccccccCCccccC
Q 002021 560 PASLEKLSYLEDLNLSFNQLEG--KIPRGGSFGNFSAQSFEGNELLCG 605 (979)
Q Consensus 560 p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~~~~~~~~~~~N~~~c~ 605 (979)
|.. +++|+.|++++|++++ .+|. .+..+.+.+|...|.
T Consensus 392 ~~~---~~~L~~L~ls~N~l~~~~~iP~-----sl~~L~~~~~~~~~~ 431 (454)
T 1jl5_A 392 PEL---PQNLKQLHVETNPLREFPDIPE-----SVEDLRMNSERVVDP 431 (454)
T ss_dssp ------------------------------------------------
T ss_pred ccc---cCcCCEEECCCCcCCccccchh-----hHhheeCcCcccCCc
Confidence 653 4677778888888876 5553 233444555544443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=403.55 Aligned_cols=269 Identities=24% Similarity=0.256 Sum_probs=202.4
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeecc------CCe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSN------EEF 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 752 (979)
++|++.+.||+|+||+||+|. ..+|+.||||+++.... ...+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 578999999999999999995 56899999999965432 234567889999999999999999998753 467
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.|+|||||+ |+|.+++...+ .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 68999887654 7999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCC--CcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc--cc
Q 002021 833 TGED--QSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS--TM 907 (979)
Q Consensus 833 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~--~~ 907 (979)
.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||......+ .+........... ..
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCGGGT
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCChHHh
Confidence 4322 12233557899999999998765 56999999999999999999999997532111 1111111110000 00
Q ss_pred hhhc--------ccccCc-hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 908 EVVD--------ANLLSQ-EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 908 ~~~~--------~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.... ...... ...-......+++++.+|+.+|++.||++|||+.|+++|
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000000 000001112345778999999999999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=418.90 Aligned_cols=253 Identities=19% Similarity=0.272 Sum_probs=211.6
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.++|++.+.||+|+||+||+| ...+|+.||||++........+.+.+|+++|+.++|||||+++++|.+++..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367999999999999999999 4568999999999765545567788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC--CcEEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN--MVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~--~~~kl~Dfg~~~~~~~~~~ 837 (979)
|+||+|.+++......+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 9999999999877668999999999999999999999 9999999999999999854 899999999999874332
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+ .+........
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~i~~~~~--------------- 373 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDW--------------- 373 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCC---------------
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHhCCC---------------
Confidence 2345689999999999999999999999999999999999999997532111 1111111000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+..++.++.+|+.+||+.||.+|||+.|+++|
T Consensus 374 -~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 374 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111223456678999999999999999999999986
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=399.19 Aligned_cols=406 Identities=24% Similarity=0.288 Sum_probs=244.3
Q ss_pred CcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcc-------------cEEecccccccccCCc
Q 002021 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTL-------------KYVCLRGNQLSGTFPS 138 (979)
Q Consensus 72 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L-------------~~L~L~~n~l~~~~p~ 138 (979)
.++.+|++++|++ |.+|+++++|++|++|++++|++.|.+|.+++.+.+| ++|++++|++++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 5688999999999 8999999999999999999999999999999998875 999999999996 444
Q ss_pred cccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCc
Q 002021 139 FISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPI 218 (979)
Q Consensus 139 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 218 (979)
. .++|++|+|++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|+++++ |
T Consensus 89 ~---~~~L~~L~l~~n~l~~---------lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~l-p- 147 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE---------LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEKL-P- 147 (454)
T ss_dssp C---CTTCSEEECCSSCCSS---------CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSSC-C-
T ss_pred C---cCCCCEEEccCCcCCc---------cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCCC-c-
Confidence 2 4799999999999985 5643 4789999999999985 3322 27999999999999985 5
Q ss_pred cccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCcccccccc
Q 002021 219 AIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRN 298 (979)
Q Consensus 219 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 298 (979)
.+.++++|++|++++|++++.+. ..++|++|++++|++++ +| .+.++++|++|++++|++++ +|... ++
T Consensus 148 ~~~~l~~L~~L~l~~N~l~~lp~-----~~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~ 216 (454)
T 1jl5_A 148 ELQNSSFLKIIDVDNNSLKKLPD-----LPPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LS 216 (454)
T ss_dssp CCTTCTTCCEEECCSSCCSCCCC-----CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TT
T ss_pred ccCCCCCCCEEECCCCcCcccCC-----CcccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---Cc
Confidence 59999999999999999997543 23699999999999996 56 58899999999999999986 34433 58
Q ss_pred ccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcc
Q 002021 299 LSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNL 378 (979)
Q Consensus 299 L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L 378 (979)
|++|++++|.++.++ .+..+++|++|++++|++..+.. .+.+|++|++++|++++ +|.. .++|
T Consensus 217 L~~L~l~~n~l~~lp-------~~~~l~~L~~L~l~~N~l~~l~~------~~~~L~~L~l~~N~l~~-l~~~---~~~L 279 (454)
T 1jl5_A 217 LESIVAGNNILEELP-------ELQNLPFLTTIYADNNLLKTLPD------LPPSLEALNVRDNYLTD-LPEL---PQSL 279 (454)
T ss_dssp CCEEECCSSCCSSCC-------CCTTCTTCCEEECCSSCCSSCCS------CCTTCCEEECCSSCCSC-CCCC---CTTC
T ss_pred ccEEECcCCcCCccc-------ccCCCCCCCEEECCCCcCCcccc------cccccCEEECCCCcccc-cCcc---cCcC
Confidence 999999999998655 26788889999999998876532 23577788888877775 3432 3566
Q ss_pred cEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCC-CcCceEecCC
Q 002021 379 RTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNL-TSLRIVSLGS 457 (979)
Q Consensus 379 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~ 457 (979)
++|++++|++++... -.+ +|+.|++++|++++. + .+ ++|++|++++
T Consensus 280 ~~L~ls~N~l~~l~~----~~~------------------------~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~ 326 (454)
T 1jl5_A 280 TFLDVSENIFSGLSE----LPP------------------------NLYYLNASSNEIRSL-C----DLPPSLEELNVSN 326 (454)
T ss_dssp CEEECCSSCCSEESC----CCT------------------------TCCEEECCSSCCSEE-C----CCCTTCCEEECCS
T ss_pred CEEECcCCccCcccC----cCC------------------------cCCEEECcCCcCCcc-c----CCcCcCCEEECCC
Confidence 667776666664210 013 445555555555431 1 11 3555555555
Q ss_pred CccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCc--ccchhhcCCcccceeecCCccccCCC
Q 002021 458 NELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSG--VIPTEIGGLKNLEYLFLGYNRLQGSI 535 (979)
Q Consensus 458 N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~ 535 (979)
|+++.+|.. +++|+.|++++|++++ +|. .+++|+.|++++|++++ .+|..++. |+.|.+.+.+
T Consensus 327 N~l~~lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i 391 (454)
T 1jl5_A 327 NKLIELPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEV 391 (454)
T ss_dssp SCCSCCCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-----
T ss_pred Ccccccccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhccccccc
Confidence 555555543 3556666666666653 443 35667777777777776 45555443 2346666666
Q ss_pred CCcccccccccccccccccccc--cCCccccCccccCeEeccCCcccccCCC
Q 002021 536 PNSFGDLISLKFLNLSNNNLSG--VIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 536 p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
|.. +++|+.||+++|++++ .+|.+ ++.|.+.+|.+.+.+|.
T Consensus 392 ~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 392 PEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp ----------------------------------------------------
T ss_pred ccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCcccc
Confidence 653 4678888888888886 55543 55667788888877764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=384.63 Aligned_cols=293 Identities=32% Similarity=0.482 Sum_probs=265.9
Q ss_pred CCChhHHHHHHHHHHhcccCCCCccccccCCCCCCCc--cceeEeeCCC--CcEEEEEecCCCccc--cCCCCCcCCCCC
Q 002021 25 SSTITDQDALLALKAHITHDPTNFLAKNWNTSTPVCN--WTGVACEVHS--QRVTVLNISSLNLTG--TIPSQLGNLSSL 98 (979)
Q Consensus 25 ~~~~~~~~all~~k~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L 98 (979)
.|.++|++||++||+++ .||. .+ ++|..+++||. |.||+|+..+ ++|+.|+|++++++| .+|+.++++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~-~~~~-~l-~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDL-GNPT-TL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHT-TCCG-GG-TTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhc-CCcc-cc-cCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 47789999999999999 4776 45 58988889998 9999998655 899999999999999 999999999999
Q ss_pred CeeeccC-CcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCc
Q 002021 99 QSLNLSF-NRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPE 177 (979)
Q Consensus 99 ~~L~L~~-n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~ 177 (979)
++|+|++ |++.+.+|..++.+++|++|+|++|++++.+|..++++++|++|||++|.+++. +|..++++++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--------~p~~~~~l~~ 150 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT--------LPPSISSLPN 150 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESC--------CCGGGGGCTT
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCc--------CChHHhcCCC
Confidence 9999995 999999999999999999999999999999999999999999999999999864 7899999999
Q ss_pred cceeecccccccccccccccCCC-CCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEc
Q 002021 178 LELMSLAANNLQGKIPLKIGNLR-NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSL 256 (979)
Q Consensus 178 L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 256 (979)
|++|+|++|++++.+|..++.++ +|++|+|++|++++..|..+..++ |+.|++++|++++..+. .|..+++|++|+|
T Consensus 151 L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L 228 (313)
T 1ogq_A 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV-LFGSDKNTQKIHL 228 (313)
T ss_dssp CCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGG-GCCTTSCCSEEEC
T ss_pred CCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCH-HHhcCCCCCEEEC
Confidence 99999999999999999999998 999999999999999999999997 99999999999876543 5789999999999
Q ss_pred cCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCC
Q 002021 257 WGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYN 336 (979)
Q Consensus 257 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N 336 (979)
++|++++.+|. +..+++|++|+|++|++++.+|..|..+++|++|+|++|++++..+. ...+++|+.+++++|
T Consensus 229 ~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~------~~~l~~L~~l~l~~N 301 (313)
T 1ogq_A 229 AKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ------GGNLQRFDVSAYANN 301 (313)
T ss_dssp CSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC------STTGGGSCGGGTCSS
T ss_pred CCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC------CccccccChHHhcCC
Confidence 99999977766 78889999999999999999999999999999999999999854332 356777888888888
Q ss_pred C
Q 002021 337 P 337 (979)
Q Consensus 337 ~ 337 (979)
+
T Consensus 302 ~ 302 (313)
T 1ogq_A 302 K 302 (313)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=397.25 Aligned_cols=371 Identities=20% Similarity=0.238 Sum_probs=250.0
Q ss_pred CccceeecccccccccccccccCCCCCCceecCCCeee-ecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEE
Q 002021 176 PELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLV-GIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEIL 254 (979)
Q Consensus 176 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L 254 (979)
++|++|+|++|.+++..|..|+++++|++|+|++|++. .+.+..|.++++|++|+|++|++
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l------------------ 91 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF------------------ 91 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTT------------------
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCcc------------------
Confidence 45666666666666555555666666666666666554 23344455555555555555554
Q ss_pred EccCCccccccCcccccCCCCcEEeccccccccccCcc--ccccccccceeccccccccccchhhhhhcccCCCCccEEE
Q 002021 255 SLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNT--FGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFD 332 (979)
Q Consensus 255 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~ 332 (979)
++..|..+.++++|++|+|++|++++..+.. |+++++|++|+|++|+++...+.. .+.++++|++|+
T Consensus 92 -------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----~~~~l~~L~~L~ 160 (455)
T 3v47_A 92 -------LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS----FFLNMRRFHVLD 160 (455)
T ss_dssp -------CEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCG----GGGGCTTCCEEE
T ss_pred -------CccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCccc----ccCCCCcccEEe
Confidence 4444444444444444444444444422222 444445555555555444432210 133445555555
Q ss_pred ccCCCCcccCCccccccccccccEEEccCccccCCCCcc--------ccCCCcccEEEecCCCCCchhHHhhhcC---CC
Q 002021 333 LSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE--------ISNLTNLRTIYLGGNKLNGSILITLSKL---QK 401 (979)
Q Consensus 333 Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~--------l~~l~~L~~L~L~~N~l~~~~~~~l~~l---~~ 401 (979)
+++|++..+.+..+..-...+|+.|++++|.+.+..+.. +..+++|++|++++|++++..+..+... ++
T Consensus 161 L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~ 240 (455)
T 3v47_A 161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTK 240 (455)
T ss_dssp CTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCC
T ss_pred CCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccc
Confidence 555555444333322222235666666666666544433 3467889999999999998888877655 88
Q ss_pred CcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccC--CCcCceEecCCCccccc-cccccCcCCCcEEEe
Q 002021 402 LQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSN--LTSLRIVSLGSNELTSI-PLTFWNLKDILNLNF 478 (979)
Q Consensus 402 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l 478 (979)
|+.|++++|.+.+.. +..+.+.+..+..+.. .++|++|++++|+++.+ |..+..+++|+.|++
T Consensus 241 L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 306 (455)
T 3v47_A 241 IQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306 (455)
T ss_dssp EEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred eeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEEC
Confidence 889999888766421 1223333333333333 36788888888888854 556788888899999
Q ss_pred ccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCccccccccccccccccccccc
Q 002021 479 SSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGV 558 (979)
Q Consensus 479 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 558 (979)
++|++++..|..|+.+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++.
T Consensus 307 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 386 (455)
T 3v47_A 307 AQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSV 386 (455)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccC
Confidence 99999888888999999999999999999988899999999999999999999988899999999999999999999988
Q ss_pred CCccccCccccCeEeccCCcccccCCCCCCC
Q 002021 559 IPASLEKLSYLEDLNLSFNQLEGKIPRGGSF 589 (979)
Q Consensus 559 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 589 (979)
.+..+..+++|+.|++++|+++|.+|...++
T Consensus 387 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~l 417 (455)
T 3v47_A 387 PDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 417 (455)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred CHhHhccCCcccEEEccCCCcccCCCcchHH
Confidence 7778899999999999999999999964433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=409.99 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=201.3
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHH---HHHHHhcCCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVE---CEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
.++|++.+.||+|+||+||+|+ ..+|+.||||++.+.. ......+.+| +++++.++|||||+++++|.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 3679999999999999999994 5679999999996432 1222333344 5566677899999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
|+||||++||+|.+++.+.+ .+++..++.++.||+.||+||| +++|+||||||+|||++.+|.+||+|||+|+...
T Consensus 268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999997654 6999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc-hHhHhhhhhcCCccchhhc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM-TLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 911 (979)
... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||........ .+.......
T Consensus 344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---------- 409 (689)
T 3v5w_A 344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------- 409 (689)
T ss_dssp SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----------
T ss_pred CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----------
Confidence 322 245689999999999865 5799999999999999999999999976332211 111100000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
....+..+++++.+|+.+|++.||.+|++ ++||++|
T Consensus 410 ---------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 410 ---------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 00112345677999999999999999998 7888876
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=398.96 Aligned_cols=365 Identities=21% Similarity=0.273 Sum_probs=200.5
Q ss_pred CCCCeeeccCCcccccCCccccccCcccEEecccccccccC-CccccCCCCCcEEEccCCccCchhhhhhhccCCcccCC
Q 002021 96 SSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTF-PSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGN 174 (979)
Q Consensus 96 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~ 174 (979)
++|++|||++|++++..|..+..+++|++|+|++|.+.+.+ |..|+++++|++|||++|.+++. .|..|++
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~--------~~~~~~~ 101 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQL--------ETGAFNG 101 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEE--------CTTTTTT
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCcc--------ChhhccC
Confidence 56666777776666666666666666777777766665444 34566667777777777666542 4566666
Q ss_pred CCccceeeccccccccccccc--ccCCCCCCceecCCCeeeecCCcc-ccccCccceeeccCCCCcCCCcccccCCC--C
Q 002021 175 LPELELMSLAANNLQGKIPLK--IGNLRNLEKLDIGDNKLVGIAPIA-IFNVSTLKILGLQDNSLSGCLSSIGYARL--P 249 (979)
Q Consensus 175 l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~~l--~ 249 (979)
+++|++|+|++|++++.+|.. ++++++|++|+|++|++++..|.. +.++++|+.|++++|++++..+.. +..+ .
T Consensus 102 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-l~~l~~~ 180 (455)
T 3v47_A 102 LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEED-LLNFQGK 180 (455)
T ss_dssp CTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTT-SGGGTTC
T ss_pred cccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhh-hhccccc
Confidence 677777777777666544443 666667777777777776665554 566677777777777666543321 2222 4
Q ss_pred CcCEEEccCCccccccCcc--------cccCCCCcEEeccccccccccCcccccc---ccccceeccccccccccchhhh
Q 002021 250 NLEILSLWGNNFSGTIPRF--------IFNASKLSILDLEGNSFSGFIPNTFGNL---RNLSWLVLSDNYLTSSTQELSF 318 (979)
Q Consensus 250 ~L~~L~L~~N~l~~~~p~~--------l~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~ 318 (979)
+|+.|++++|.+.+..+.. +..+++|++|++++|++++..|..+..+ ++|+.|++++|.+....
T Consensus 181 ~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~----- 255 (455)
T 3v47_A 181 HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS----- 255 (455)
T ss_dssp EEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC-----
T ss_pred cccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc-----
Confidence 5666666666665433322 2244566666666666666555555443 55555555555443211
Q ss_pred hhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhc
Q 002021 319 LSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSK 398 (979)
Q Consensus 319 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~ 398 (979)
+..+.+.......+.+....+|++|++++|++++.+|..++.+++|++|+|++|++++..+.
T Consensus 256 --------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~---- 317 (455)
T 3v47_A 256 --------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDN---- 317 (455)
T ss_dssp --------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT----
T ss_pred --------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChh----
Confidence 01111111111111111113445555555555544455555555555555555555544444
Q ss_pred CCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccc-cccccCcCCCcEEE
Q 002021 399 LQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSI-PLTFWNLKDILNLN 477 (979)
Q Consensus 399 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~ 477 (979)
.|.++++|++|+|++|++++..|..|.++++|++|+|++|+++.+ |..+..+++|+.|+
T Consensus 318 --------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 318 --------------------AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp --------------------TTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred --------------------HhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 444445555555555555444444455555555555555555543 33444555555555
Q ss_pred eccccccCCCccccccccccceEeccCCccCcccc
Q 002021 478 FSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIP 512 (979)
Q Consensus 478 ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 512 (979)
+++|++++..+..+..+++|+.|+|++|++++..|
T Consensus 378 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 378 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 55555554444455666666666666666665544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=381.32 Aligned_cols=282 Identities=33% Similarity=0.536 Sum_probs=229.7
Q ss_pred ccHHHHHHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC
Q 002021 672 FSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE 751 (979)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (979)
+++.++...+++|+..+.||+|+||.||+|...+++.||||++........+.+.+|+++++.++||||+++++++.+++
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33344556778999999999999999999998889999999987665566678999999999999999999999999999
Q ss_pred eeEEEEEecCCCccceeeccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSI 828 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~ 828 (979)
..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997653 35899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc-hHhHhhhhhc-CCcc
Q 002021 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM-TLKHWVNDWL-PIST 906 (979)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~-~~~~~~~~~~-~~~~ 906 (979)
+................||+.|+|||.+.++.++.++||||+|+++|||++|+.||......+. ....|..... ....
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 9875433333333445689999999999888999999999999999999999999976443322 2233322211 1112
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
....++.... .....++..+.+++.+||+.||++|||+.|++++|+++.+
T Consensus 266 ~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 266 EQIVDPNLAD------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CSSSSSSCTT------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcChhhcc------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 2222222211 1224567789999999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=376.20 Aligned_cols=282 Identities=35% Similarity=0.550 Sum_probs=231.3
Q ss_pred ccccccHHHHHHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEe
Q 002021 668 SRRMFSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISS 746 (979)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~ 746 (979)
....+++.++....++|+..+.||+|+||.||+|...+|+.||||++..... .....+.+|+++++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3456888999999999999999999999999999887899999999875532 234468999999999999999999999
Q ss_pred eccCCeeEEEEEecCCCccceeeccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCC---CeEecCCCCCCEEeCCCCc
Q 002021 747 CSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSA---PVIHCDLKPSNVLLDDNMV 820 (979)
Q Consensus 747 ~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~---~i~H~Dik~~NIll~~~~~ 820 (979)
+.+++..++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++ +|+||||||+||+++.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999987653 35899999999999999999999 66 9999999999999999999
Q ss_pred EEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccc---cCcchHhHh
Q 002021 821 AHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF---NGEMTLKHW 897 (979)
Q Consensus 821 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~---~~~~~~~~~ 897 (979)
+||+|||++....... ........||+.|+|||.+.+..++.++||||+|+++|||++|+.||+... ........|
T Consensus 173 ~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999998764332 223344569999999999988889999999999999999999999996422 233344455
Q ss_pred hhhhcCCc-cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 898 VNDWLPIS-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 898 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
+....... .....+..... .....++..+.+++.+||+.||++|||+.|++++|++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQG------NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTT------SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHhhchhhhhhcChhhcc------ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 54444332 22222222211 1224556789999999999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=375.56 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=218.1
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
++|...+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 5688889999999999999954 579999999987655556778999999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc-
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM- 839 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~- 839 (979)
++|+|.+++......+++.+++.++.|+++||+||| +++|+||||||+||+++.++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999999999887678999999999999999999999 9999999999999999999999999999998764332211
Q ss_pred -----------eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccch
Q 002021 840 -----------IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908 (979)
Q Consensus 840 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (979)
......||+.|+|||++.+..+++++||||+|+++|||++|..||..............
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~---------- 236 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV---------- 236 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH----------
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh----------
Confidence 11145789999999999999999999999999999999999999875433222111000
Q ss_pred hhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
........+..+++.+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 237 --------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 237 --------RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp --------HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred --------hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00001111234556789999999999999999999999999999887654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=368.32 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=210.0
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4679999999999999999995 567999999999766555667789999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++|+|.+++... .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence 9999999998765 5899999999999999999999 99999999999999999999999999999987643322
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
......||+.|+|||++.+..+++++||||+||++|||++|+.||.......... .......
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~----------------- 233 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGT----------------- 233 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHHCS-----------------
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhCCC-----------------
Confidence 2345679999999999999999999999999999999999999996532111111 1000000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+..++..+.+++.+||+.||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0011123456678999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=376.25 Aligned_cols=276 Identities=22% Similarity=0.291 Sum_probs=212.0
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC----eeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----FKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 756 (979)
.++|+..+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 367888999999999999999874 7999999986542 23345566888999999999999999987644 46999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEecCCCCCCEEeCCCCcEEEEee
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA----------PVIHCDLKPSNVLLDDNMVAHLSDF 826 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~----------~i~H~Dik~~NIll~~~~~~kl~Df 826 (979)
|||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||+++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999765 4899999999999999999999 88 9999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCCCCCCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc-hHhHhhhh
Q 002021 827 SIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM-TLKHWVND 900 (979)
Q Consensus 827 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~-~~~~~~~~ 900 (979)
|+++...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ .+......
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99987654443333445679999999999876 3566789999999999999999999976433211 11111110
Q ss_pred hcCCc-cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 901 WLPIS-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 901 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
..... ..+...................++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00000 0011111111111111122335667799999999999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=382.20 Aligned_cols=262 Identities=27% Similarity=0.442 Sum_probs=214.7
Q ss_pred hCCCCCCceeeeecceEEEEEEc--------CCCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeeeEEEeeccC
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL--------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIKVISSCSNE 750 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (979)
.++|+..+.||+|+||.||+|+. .++..||||+++.... ...+.+.+|+++++.+ +||||+++++++.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 36788889999999999999964 2456899999975532 3456788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
+..++||||+++|+|.+++.... ..+++.+++.++.||+.||+||| +++|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 99999999999999999987643 35789999999999999999999 9999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchH
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTL 894 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~ 894 (979)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 9999999999999987654433333344567889999999998899999999999999999999 999987532211 1
Q ss_pred hHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 895 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
...+.... ....+..++.++.+++.+||+.||++||++.|++++|+++.....
T Consensus 315 ~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 315 FKLLKEGH------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HHHHHTTC------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHhcCC------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 11111000 001123456679999999999999999999999999999987543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=361.41 Aligned_cols=281 Identities=30% Similarity=0.485 Sum_probs=226.6
Q ss_pred cccccHHHHHHhhCCCCCC------ceeeeecceEEEEEEcCCCcEEEEEEecccc----ccchhcHHHHHHHHHhcCCC
Q 002021 669 RRMFSYLELCRATDGFSEN------NLIGRGGFGSVYKASLGDGMEVAVKVFTSQC----GRAFKSFDVECEIMKSIRHR 738 (979)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~ 738 (979)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+++++.++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4668999999999999877 8999999999999987 68899999986532 23356788999999999999
Q ss_pred CeeeEEEeeccCCeeEEEEEecCCCccceeeccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC
Q 002021 739 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 816 (979)
Q Consensus 739 niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~ 816 (979)
||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence 9999999999999999999999999999998643 346899999999999999999999 99999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhH
Q 002021 817 DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 896 (979)
Q Consensus 817 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~ 896 (979)
+++.+||+|||++................||+.|+|||.+.+ .++.++||||+|+++|||++|+.||........ ...
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~ 245 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLD 245 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHH
Confidence 999999999999987654333333345678999999998764 589999999999999999999999976443322 112
Q ss_pred hhhhhcC--CccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 897 WVNDWLP--ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 897 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
+...... ....+..+..... .+..++..+.+++.+||+.||.+|||+.|++++|+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMND-------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCSC-------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhccccccc-------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2111111 1111222221111 123456779999999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=386.64 Aligned_cols=261 Identities=29% Similarity=0.431 Sum_probs=214.5
Q ss_pred hCCCCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|...+.||+|+||.||+|... +++.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888899999999999999664 789999999875432 334678899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++|+|.+++...+..+++.+++.++.|+++||+||| +++|+||||||+||++++++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999876667999999999999999999999 999999999999999999999999999999865322211
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.......+++.|+|||.+.++.++.++|||||||++|||+| |+.||...... .....+...
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~---------------- 331 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKG---------------- 331 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTT----------------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC----------------
Confidence 11122345778999999988889999999999999999999 99998753221 111111100
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
.+.+.+..++.++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 332 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 332 --GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 011122346677999999999999999999999999999998653
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=378.43 Aligned_cols=360 Identities=19% Similarity=0.167 Sum_probs=207.4
Q ss_pred cCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhc
Q 002021 87 TIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICR 166 (979)
Q Consensus 87 ~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 166 (979)
..+..++++++|++|||++|++++ +| .++.+++|++|+|++|++++. | ++.+++|++|+|++|.+++
T Consensus 33 ~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-------- 99 (457)
T 3bz5_A 33 TDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-------- 99 (457)
T ss_dssp TSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC--------
T ss_pred ccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce--------
Confidence 334456777888888888888775 35 577777788888888877764 3 7777778888888777764
Q ss_pred cCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccC
Q 002021 167 EIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYA 246 (979)
Q Consensus 167 ~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~ 246 (979)
+| ++++++|++|++++|++++ +| ++.+++|++|++++|+++++ .+.++++|+.|++++|+..+.. .+.
T Consensus 100 -~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~---~~~ 167 (457)
T 3bz5_A 100 -LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL---DVT 167 (457)
T ss_dssp -CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC---CCT
T ss_pred -ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc---ccc
Confidence 33 6777777777777777775 33 67777777777777777764 2556666666666666433222 244
Q ss_pred CCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCC
Q 002021 247 RLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCK 326 (979)
Q Consensus 247 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~ 326 (979)
.+++|++|++++|++++ +| +..+++|++|++++|++++. .++.+++|++|++++|++++++ +..++
T Consensus 168 ~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--------~~~l~ 233 (457)
T 3bz5_A 168 PQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID--------VTPLT 233 (457)
T ss_dssp TCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC--------CTTCT
T ss_pred cCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC--------ccccC
Confidence 55555666666555554 23 44555555555555555543 2444444555555544444422 22333
Q ss_pred CccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEE
Q 002021 327 FLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLG 406 (979)
Q Consensus 327 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 406 (979)
+ |+.|++++|++++.. ++.+++|+.|++++|+ |+.|+
T Consensus 234 ~--------------------------L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~ 270 (457)
T 3bz5_A 234 Q--------------------------LTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEID 270 (457)
T ss_dssp T--------------------------CSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCC
T ss_pred C--------------------------CCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEE
Confidence 3 444444444444332 3345566666665543 34556
Q ss_pred ecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCC
Q 002021 407 LKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486 (979)
Q Consensus 407 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~ 486 (979)
+++|.+.+.+| ++.+++|+.|++++|...+.+|. ..++|+.|++++|
T Consensus 271 l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~---------------------------- 317 (457)
T 3bz5_A 271 LTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN---------------------------- 317 (457)
T ss_dssp CTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC----------------------------
T ss_pred CCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc----------------------------
Confidence 66666555554 34556666666666665554442 2233333333322
Q ss_pred CccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCc
Q 002021 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKL 566 (979)
Q Consensus 487 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 566 (979)
++|+.|++++|++++. + ++.+++|+.|++++|+|++ ++.|..|++++|+++|. ..+
T Consensus 318 --------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~ 373 (457)
T 3bz5_A 318 --------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQT 373 (457)
T ss_dssp --------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEE
T ss_pred --------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----cee
Confidence 3455555555555543 1 5555566666666666553 23455556666666654 234
Q ss_pred cccCeEeccCCcccccCCC
Q 002021 567 SYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~ 585 (979)
..|..+++++|+++|.+|.
T Consensus 374 ~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 374 ITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp EECCCBCCBTTBEEEECCT
T ss_pred eecCccccccCcEEEEcCh
Confidence 4556666666666666664
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=371.51 Aligned_cols=263 Identities=27% Similarity=0.387 Sum_probs=204.7
Q ss_pred hhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
..++|+..+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 446788899999999999999977 68899999986543 223457889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 758 EYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +++ |+||||||+||+++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999997753 24899999999999999999999 888 9999999999999999999999999997643
Q ss_pred CCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
.. ........||+.|+|||.+.+..+++++||||+|+++|||++|+.||......+ ....+.....
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~~---------- 256 (309)
T 3p86_A 191 ST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKCK---------- 256 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHSCC----------
T ss_pred cc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcCC----------
Confidence 22 122344678999999999999999999999999999999999999997532211 1111100000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccC
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRN 967 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~ 967 (979)
....+..+++++.+++.+||+.||++|||+.|+++.|+++.++..+.
T Consensus 257 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 257 -------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 00112245567899999999999999999999999999998876554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=362.79 Aligned_cols=275 Identities=14% Similarity=0.107 Sum_probs=227.5
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++... ...+.+.+|+++++.+ +|++++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 3678899999999999999996 468999999998644 3446788999999999 79999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc-----EEEEeeccccccC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-----AHLSDFSIAKMLT 833 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~-----~kl~Dfg~~~~~~ 833 (979)
|+ +++|.+++...+..+++.+++.++.|++.||+||| +++|+||||||+||+++.++. +||+|||++....
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999877667999999999999999999999 999999999999999987776 9999999998765
Q ss_pred CCCCc-----ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchH--hHhhhhhcCCcc
Q 002021 834 GEDQS-----MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL--KHWVNDWLPIST 906 (979)
Q Consensus 834 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~--~~~~~~~~~~~~ 906 (979)
..... .......||+.|+|||.+.+..+++++||||+|+++|||++|+.||.......... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 238 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ---- 238 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH----
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc----
Confidence 43221 12345579999999999999899999999999999999999999997643221110 00000000
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceecc
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQS 976 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~~ 976 (979)
..........++.++.+++.+||+.||++||+++|+++.|+++.++.......+.+|+.
T Consensus 239 -----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 239 -----------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp -----------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred -----------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 00001111245678999999999999999999999999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=373.15 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=211.5
Q ss_pred CCCCCCceeeeecceEEEEEEcC----CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
++|+..+.||+|+||.||+|... .+..||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 45777899999999999999653 45569999997543 33456789999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999877678999999999999999999999 9999999999999999999999999999998765332
Q ss_pred C-cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 837 Q-SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 837 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
. ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......+ ....+...
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~------------- 270 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEG------------- 270 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT-------------
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcC-------------
Confidence 2 222233456788999999988899999999999999999999 999986532211 11111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
.....+..++..+.+++.+||..||++|||+.|+++.|+++.+..
T Consensus 271 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 271 -----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 001112345677999999999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=377.40 Aligned_cols=274 Identities=24% Similarity=0.375 Sum_probs=220.6
Q ss_pred cccccHHHHHHhhCCCCCCceeeeecceEEEEEE------cCCCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCe
Q 002021 669 RRMFSYLELCRATDGFSENNLIGRGGFGSVYKAS------LGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNL 740 (979)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni 740 (979)
...+....+....++|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+++++++ +||||
T Consensus 9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni 88 (359)
T 3vhe_A 9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88 (359)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence 3345556666777899999999999999999995 34568999999975432 3346789999999999 79999
Q ss_pred eeEEEeeccCC-eeEEEEEecCCCccceeeccCCC---------------------------------------------
Q 002021 741 IKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNC--------------------------------------------- 774 (979)
Q Consensus 741 v~l~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~--------------------------------------------- 774 (979)
+++++++.+.+ ..++||||+++|+|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 99999987754 48999999999999999876432
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 775 --------------------ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 775 --------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
.+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 2899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
...........+|+.|+|||++.+..++.++||||+||++|||+| |+.||......+...... .....
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~---------- 314 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTR---------- 314 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH-HHTCC----------
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH-HcCCC----------
Confidence 444444456678999999999988899999999999999999998 999997543222111111 11000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
...+..+++++.+++.+||+.||++|||+.|++++|+++..+-
T Consensus 315 --------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 315 --------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 0011234567899999999999999999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=363.04 Aligned_cols=257 Identities=27% Similarity=0.428 Sum_probs=213.9
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|+..+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5688889999999999999988788999999997543 334678999999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+++|.+++......+++..++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||++....... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 164 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccc
Confidence 99999999887778999999999999999999999 9999999999999999999999999999998654221 1222
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....+|+.|+|||.+.+..+++++||||+|+++|||++ |+.||......+ ....+....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~~~------------------ 224 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGF------------------ 224 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTC------------------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhcCc------------------
Confidence 34456788999999988899999999999999999999 999987532211 111100000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+..++..+.+++.+||+.||++|||+.|++++|+++.++
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0001122346689999999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=371.54 Aligned_cols=274 Identities=25% Similarity=0.422 Sum_probs=211.9
Q ss_pred CCCCCCceeeeecceEEEEEEc-----CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc--CCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-----GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 754 (979)
++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5688899999999999999973 3689999999986655556788999999999999999999999854 45689
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+++|+|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999999999887767999999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccc--hhhc
Q 002021 835 EDQS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM--EVVD 911 (979)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 911 (979)
.... .......++..|+|||.+.+..+++++||||+|+++|||+||..||...... .............. ...+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHHHHH
Confidence 3221 2223345677899999999889999999999999999999999998653211 11110000000000 0000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
.. ....+.+.+..+++++.+++.+||+.||++|||+.|+++.|+++.+.+
T Consensus 244 -~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 -LL--KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp -HH--HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -HH--hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 00 001111223456778999999999999999999999999999998765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=361.09 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=213.8
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.++|+..+.||+|+||.||+|+..++..||||++.... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35788899999999999999988888899999997543 33467899999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++......+++.+++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+....... ...
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS 161 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence 999999999877667999999999999999999999 9999999999999999999999999999998764332 222
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
.....+|+.|+|||.+.+..+++++||||+|+++|||++ |+.||......+.. ........
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~----------------- 223 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-LKVSQGHR----------------- 223 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCC-----------------
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-HHHHcCCC-----------------
Confidence 334456778999999988889999999999999999999 99998653222111 11000000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
...+..+++.+.+++.+||+.||++|||+.|++++|+++.+..
T Consensus 224 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 224 --LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 0011223456899999999999999999999999999987653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=366.57 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=207.9
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 36789999999999999999954 579999999986443 2334678999999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++|+|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..+......
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999997653 5899999999999999999999 999999999999999999999999999999876433333
Q ss_pred ceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.........+..+......
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 227 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 227 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------------
Confidence 33345679999999999877665 778999999999999999999997644433333332221110
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......++..+.+++.+|++.||++|||+.|++++
T Consensus 228 ----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01112345678899999999999999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=367.77 Aligned_cols=275 Identities=20% Similarity=0.172 Sum_probs=222.4
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|. ..+|+.||||++... ...+.+.+|+++++.+ +||||+++++++.+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3678899999999999999995 468999999998654 2346789999999999 99999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc-----EEEEeeccccccC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-----AHLSDFSIAKMLT 833 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~-----~kl~Dfg~~~~~~ 833 (979)
|+ +++|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++. +||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 89999999876668999999999999999999999 899999999999999998887 9999999998764
Q ss_pred CCCCcc-----eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccch
Q 002021 834 GEDQSM-----IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908 (979)
Q Consensus 834 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (979)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~~~i------- 232 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERYQKI------- 232 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHHHHH-------
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHHHHH-------
Confidence 332211 12456799999999999999999999999999999999999999976432211 1000000
Q ss_pred hhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceec
Q 002021 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQ 975 (979)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~ 975 (979)
........ .......++ ++.+++.+||+.||.+||+++++++.|+++.+.......+..+|.
T Consensus 233 -~~~~~~~~---~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 233 -GDTKRATP---IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp -HHHHHHSC---HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred -HhhhccCC---HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 00000000 000111244 799999999999999999999999999999998877777777775
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=363.30 Aligned_cols=262 Identities=23% Similarity=0.270 Sum_probs=214.1
Q ss_pred ccccHHHHHHhhCC----------CCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCC
Q 002021 670 RMFSYLELCRATDG----------FSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHR 738 (979)
Q Consensus 670 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ 738 (979)
..++++++..++.. |+..+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45777777776654 56667999999999999965 47999999999766555667789999999999999
Q ss_pred CeeeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC
Q 002021 739 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN 818 (979)
Q Consensus 739 niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~ 818 (979)
||+++++++...+..++||||+++++|.+++... .+++.++..++.|++.||+||| +++|+||||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999988654 5899999999999999999999 8999999999999999999
Q ss_pred CcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhh
Q 002021 819 MVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 898 (979)
Q Consensus 819 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~ 898 (979)
+.+||+|||++........ ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~~ 253 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRL 253 (321)
T ss_dssp CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH
T ss_pred CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence 9999999999987643222 224457999999999999999999999999999999999999999653211 111111
Q ss_pred hhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....... ......+++.+.+++.+||+.||++|||+.|+++|
T Consensus 254 ~~~~~~~----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 254 RDSPPPK----------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHSSCCC----------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcCCCCC----------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111000 01112345678999999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=370.63 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=206.0
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
..++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346799999999999999999954 689999999986542 23346688999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++...+ .+++.+++.++.|+++|++||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999987653 5899999999999999999999 9999999999999999999999999999998764332
Q ss_pred CcceecccccCCCCCCccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVS-ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.....+||+.|+|||++.+..+. +++||||+||++|||++|+.||...... .....+. .. .
T Consensus 169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~-----------~~-~- 230 (328)
T 3fe3_A 169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVL-----------RG-K- 230 (328)
T ss_dssp ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH-----------HC-C-
T ss_pred ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH-----------hC-C-
Confidence 23456799999999999887764 7999999999999999999999753211 1111000 00 0
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+..+++++.+++.+|++.||.+|||++|+++|
T Consensus 231 ------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 ------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00112345668899999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=365.99 Aligned_cols=253 Identities=20% Similarity=0.280 Sum_probs=209.7
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.++|+..+.||+|+||.||+|. ..+++.||+|++... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4678899999999999999995 457899999998644 23446688999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC--CCcEEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~--~~~~kl~Dfg~~~~~~~~~~ 837 (979)
+++|+|.+++......+++.+++.++.|++.|++||| +++|+||||||+||+++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999999877667999999999999999999999 999999999999999997 7899999999998764332
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
......||+.|+|||++.+..+++++||||+||++|||++|+.||......+ ..........
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~--------------- 220 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEY--------------- 220 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC---------------
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCC---------------
Confidence 2344678999999999988889999999999999999999999996532111 1111111000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.........++.++.+++.+|+..||++|||+.|+++|-
T Consensus 221 -~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 221 -TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 011122334567799999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=376.69 Aligned_cols=259 Identities=25% Similarity=0.455 Sum_probs=201.9
Q ss_pred CCCCCCceeeeecceEEEEEEcC----CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
++|+..+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999653 57789999987543 23456789999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++......+++.+++.++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999999999887778999999999999999999999 8999999999999999999999999999998764332
Q ss_pred Cc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 837 QS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 837 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. .......+++.|+|||++.+..++.++||||||+++||+++ |+.||......+ ....+ ....
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i------------~~~~ 267 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAV------------DEGY 267 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHH------------HTTE
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH------------HcCC
Confidence 21 11223345778999999998899999999999999999998 999986532111 11111 0000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
+.+.+..++..+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 268 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 ------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0111224566799999999999999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=367.98 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=207.1
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccccc------chhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGR------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
.+.|+..+.||+|+||.||+|. ..+|+.||||++...... ..+.+.+|+++++.++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4678899999999999999995 457999999998754321 246788999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----cEEEEeeccc
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFSIA 829 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfg~~ 829 (979)
++||||+++|+|.+++... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999998764 36899999999999999999999 99999999999999998776 7999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||...... ..+......
T Consensus 167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~--------- 233 (361)
T 2yab_A 167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITAV--------- 233 (361)
T ss_dssp EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTT---------
T ss_pred eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc---------
Confidence 8764322 224467999999999999889999999999999999999999999653211 111111000
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........+..++..+.+++.+|+..||++|||+.|+++|
T Consensus 234 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 -------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -------CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001112234556779999999999999999999999865
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=371.72 Aligned_cols=358 Identities=19% Similarity=0.175 Sum_probs=210.9
Q ss_pred CcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeeccc
Q 002021 106 NRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAA 185 (979)
Q Consensus 106 n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~ 185 (979)
....+..|..++.+++|++|+|++|.+++. | .++.+++|++|+|++|.+++ +| ++.+++|++|+|++
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~---------~~--~~~l~~L~~L~Ls~ 94 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT---------LD--LSQNTNLTYLACDS 94 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC---------CC--CTTCTTCSEEECCS
T ss_pred cCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe---------Ec--cccCCCCCEEECcC
Confidence 334445555666777777777777777753 4 56777777777777777764 33 66667777777777
Q ss_pred ccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCcccccc
Q 002021 186 NNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTI 265 (979)
Q Consensus 186 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 265 (979)
|++++. | ++++++|++|++++|+++++ | +.++++|+.|++++|++++. .+..+++|++|++++|+..+.+
T Consensus 95 N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l----~l~~l~~L~~L~l~~n~~~~~~ 164 (457)
T 3bz5_A 95 NKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI----DVSHNTQLTELDCHLNKKITKL 164 (457)
T ss_dssp SCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC----CCTTCTTCCEEECTTCSCCCCC
T ss_pred CCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee----ccccCCcCCEEECCCCCccccc
Confidence 776653 2 66666667777766666664 2 55556666666666665553 1345555555555555333333
Q ss_pred CcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCcc
Q 002021 266 PRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRT 345 (979)
Q Consensus 266 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~ 345 (979)
.+..+++|++|++++|++++. | ++.+++|+.|++++|+++..+ +..+
T Consensus 165 --~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~~--------l~~l-------------------- 211 (457)
T 3bz5_A 165 --DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKLD--------LNQN-------------------- 211 (457)
T ss_dssp --CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCCC--------CTTC--------------------
T ss_pred --ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCeec--------cccC--------------------
Confidence 244445555555555554432 2 344444444444444433321 1222
Q ss_pred ccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCC
Q 002021 346 TVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAE 425 (979)
Q Consensus 346 ~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 425 (979)
++|++|++++|++++ +| ++.+++|+.|++++|++++.. +..+ ++
T Consensus 212 ------~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l------------------------~~ 255 (457)
T 3bz5_A 212 ------IQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTL------------------------SK 255 (457)
T ss_dssp ------TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTC------------------------TT
T ss_pred ------CCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHC------------------------CC
Confidence 233444444444443 22 455555666666665555432 2333 44
Q ss_pred CceEecCCCcccccCCccccCCCcCceEecCCCccc-cccccccCcCCCcEEEeccccccCCCccccccccccceEeccC
Q 002021 426 LYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSR 504 (979)
Q Consensus 426 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 504 (979)
|+.|++++| +|+.|++++|.+. .+| ++.+++|+.|++++|.+.+.+|. ...+|+.|++++
T Consensus 256 L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~ 316 (457)
T 3bz5_A 256 LTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQ 316 (457)
T ss_dssp CCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTT
T ss_pred CCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhh
Confidence 444444443 2334444444432 333 24456666666666666655553 335566666666
Q ss_pred CccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCC
Q 002021 505 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 505 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 584 (979)
| ++|++|+|++|+|++. + ++++++|+.||+++|+|++ ++.|..|++++|.++|. +
T Consensus 317 ~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-~ 371 (457)
T 3bz5_A 317 N-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-G 371 (457)
T ss_dssp C-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-E
T ss_pred c-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-c
Confidence 5 6899999999999974 3 8999999999999999996 35677889999999987 2
Q ss_pred CCCCCCCcccccccCCcc
Q 002021 585 RGGSFGNFSAQSFEGNEL 602 (979)
Q Consensus 585 ~~~~~~~~~~~~~~~N~~ 602 (979)
.+..++...++.|..
T Consensus 372 ---~~~~l~~l~l~~N~l 386 (457)
T 3bz5_A 372 ---QTITMPKETLTNNSL 386 (457)
T ss_dssp ---EEEECCCBCCBTTBE
T ss_pred ---eeeecCccccccCcE
Confidence 344566667777754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=373.46 Aligned_cols=268 Identities=25% Similarity=0.404 Sum_probs=214.2
Q ss_pred HHhhCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccC
Q 002021 678 CRATDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNE 750 (979)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 750 (979)
....++|+..+.||+|+||.||+|... +++.||||+++.... ...+.+.+|++++++++||||+++++++.++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 334578999999999999999999653 458899999975432 3356789999999999999999999999999
Q ss_pred CeeEEEEEecCCCccceeeccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~D 807 (979)
+..++||||+++|+|.+++.... ..+++.+++.++.||++||+||| +++|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 99999999999999999987632 46899999999999999999999 99999999
Q ss_pred CCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcc
Q 002021 808 LKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDE 886 (979)
Q Consensus 808 ik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~ 886 (979)
|||+||++++++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987643333233345568899999999988889999999999999999999 9999875
Q ss_pred cccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 887 IFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
.... .....+.... . ...+..++..+.+++.+||+.||++|||+.|++++|+++.+.+..
T Consensus 280 ~~~~--~~~~~~~~~~-----------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 280 MAHE--EVIYYVRDGN-----------I-------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp SCHH--HHHHHHHTTC-----------C-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred CChH--HHHHHHhCCC-----------c-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 3211 1111111000 0 001124556799999999999999999999999999999877655
Q ss_pred CC
Q 002021 967 NV 968 (979)
Q Consensus 967 ~~ 968 (979)
.+
T Consensus 340 ~~ 341 (343)
T 1luf_A 340 TV 341 (343)
T ss_dssp --
T ss_pred hc
Confidence 44
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=383.81 Aligned_cols=262 Identities=19% Similarity=0.248 Sum_probs=211.4
Q ss_pred HHHHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeecc
Q 002021 674 YLELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749 (979)
Q Consensus 674 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 749 (979)
+.++....++|+..+.||+|+||+||+|+. .+++.||||++.+.. ....+.+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 344555668899999999999999999965 468899999986532 2334568999999999999999999999999
Q ss_pred CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 750 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
++..|+||||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||++
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999999886667999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 904 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 904 (979)
+...... .......+||+.|+|||++. .+.++.++||||+||++|||++|+.||......+ .+...+....
T Consensus 223 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~-- 298 (437)
T 4aw2_A 223 LKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKE-- 298 (437)
T ss_dssp EECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHH--
T ss_pred hhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-HHHhhhhccc--
Confidence 8764332 22234467999999999986 5678999999999999999999999997532111 1111110000
Q ss_pred ccchhhcccccCchhhhhH-HHHHHHHHHHHHHHhccccCcCC--CCCHHHHHHH
Q 002021 905 STMEVVDANLLSQEDIHFV-AKEQCVSFVFNLAMECTMEFPKQ--RINAKEIVTK 956 (979)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~--Rps~~eil~~ 956 (979)
...++ ....+++++.+++.+|+..+|++ ||+++|+++|
T Consensus 299 --------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 --------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00000 00124567899999999988888 9999999886
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=359.73 Aligned_cols=269 Identities=22% Similarity=0.285 Sum_probs=207.6
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 477899999999999999999887899999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++ +|.+++......+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9975 888888877777999999999999999999999 99999999999999999999999999999987643222
Q ss_pred ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh---cCCccchhhc---
Q 002021 839 MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW---LPISTMEVVD--- 911 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--- 911 (979)
......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ........ .+.......+
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhccch
Confidence 2344578999999998876 5689999999999999999999999976433322 22211111 1111111000
Q ss_pred --ccccCc--hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 --ANLLSQ--EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 --~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...... ..........++.++.+++.+|++.||++|||++|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 000111223355678999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=360.92 Aligned_cols=258 Identities=23% Similarity=0.413 Sum_probs=211.2
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.++|+..+.||+|+||.||+|...++..||||++.... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 46788889999999999999988888899999997543 23467889999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++++|.+++......+++.+++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+....... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 177 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence 999999999876667999999999999999999999 9999999999999999999999999999998764321 122
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
.....+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||......+ ....+....
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~----------------- 238 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGL----------------- 238 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTC-----------------
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--HHHHHhccc-----------------
Confidence 233456788999999988889999999999999999998 999987532211 111100000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+..++..+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus 239 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 -RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0001122345689999999999999999999999999998864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=371.92 Aligned_cols=283 Identities=16% Similarity=0.178 Sum_probs=217.8
Q ss_pred hCCCCCCceeeeecceEEEEEEcCC------CcEEEEEEeccccccc-----------hhcHHHHHHHHHhcCCCCeeeE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGD------GMEVAVKVFTSQCGRA-----------FKSFDVECEIMKSIRHRNLIKV 743 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l 743 (979)
.++|+..+.||+|+||.||+|...+ ++.||||++....... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999996643 4789999986543111 1223345566777789999999
Q ss_pred EEeeccC----CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--C
Q 002021 744 ISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--D 817 (979)
Q Consensus 744 ~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~--~ 817 (979)
++++... ...++||||+ +++|.+++......+++.+++.++.||+.||+||| +++|+||||||+||+++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence 9998664 5589999999 99999999887678999999999999999999999 89999999999999999 8
Q ss_pred CCcEEEEeeccccccCCCCCcc-----eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc
Q 002021 818 NMVAHLSDFSIAKMLTGEDQSM-----IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 892 (979)
Q Consensus 818 ~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~ 892 (979)
++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 8999999999998764332211 11334599999999999998999999999999999999999999986332221
Q ss_pred hHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcc
Q 002021 893 TLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRC 972 (979)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~ 972 (979)
. ..+..........++.+... ....++.++.+++..||..||++||++.++++.|+++.+..........
T Consensus 270 ~-~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~ 339 (364)
T 3op5_A 270 Y-VRDSKIRYRENIASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKL 339 (364)
T ss_dssp H-HHHHHHHHHHCHHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred H-HHHHHHHhhhhHHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCcc
Confidence 1 11111111111111111111 0123467899999999999999999999999999999999999999999
Q ss_pred eeccC
Q 002021 973 VRQSN 977 (979)
Q Consensus 973 ~~~~~ 977 (979)
+|...
T Consensus 340 dw~~~ 344 (364)
T 3op5_A 340 DLSVV 344 (364)
T ss_dssp CC---
T ss_pred ceEec
Confidence 98754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=365.65 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=205.9
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|+ ..+|+.||||++++.. ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 3578889999999999999995 4579999999997542 33456788899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++...+ .+++.+++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999887643 6899999999999999999999 9999999999999999999999999999998643222
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.. ...
T Consensus 160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~-----------~~~-- 222 (337)
T 1o6l_A 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILM-----------EEI-- 222 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-----------CCC--
T ss_pred --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHHHHHc-----------CCC--
Confidence 2234567999999999999999999999999999999999999999652211 11110000 000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
..+..+++++.+++.+|++.||++|| +++|+++|
T Consensus 223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 01123456789999999999999999 99999887
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=369.52 Aligned_cols=211 Identities=26% Similarity=0.350 Sum_probs=98.8
Q ss_pred CCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCC
Q 002021 96 SSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNL 175 (979)
Q Consensus 96 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l 175 (979)
++|++|++++|.++ .+|. +..+++|++|+|++|.+++..| ++++++|++|+|++|.+++ ++. ++++
T Consensus 46 ~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~---------~~~-~~~l 111 (466)
T 1o6v_A 46 DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD---------ITP-LANL 111 (466)
T ss_dssp HTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC---------CGG-GTTC
T ss_pred ccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCcccc---------Chh-hcCC
Confidence 34444444444443 2332 3444444444444444443322 4444455555555444442 122 4444
Q ss_pred CccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEE
Q 002021 176 PELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILS 255 (979)
Q Consensus 176 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~ 255 (979)
++|++|++++|.+++..+ +.++++|++|++++|++.++. .+.++++|+.|+++ |.+.+.. .+..+++|++|+
T Consensus 112 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~~---~~~~l~~L~~L~ 183 (466)
T 1o6v_A 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDLK---PLANLTTLERLD 183 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCCG---GGTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCch---hhccCCCCCEEE
Confidence 445555554444443322 444555555555555554431 24444455555543 2232221 144555555555
Q ss_pred ccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccC
Q 002021 256 LWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSY 335 (979)
Q Consensus 256 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~ 335 (979)
+++|.+++. ..+..+++|++|++++|.+++..| ++.+++|+.|++++|+++..+ .+..+++|++|++++
T Consensus 184 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-------~l~~l~~L~~L~l~~ 252 (466)
T 1o6v_A 184 ISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG-------TLASLTNLTDLDLAN 252 (466)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG-------GGGGCTTCSEEECCS
T ss_pred CcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccch-------hhhcCCCCCEEECCC
Confidence 555555532 235555666666666666655433 455555555555555555432 233444455555554
Q ss_pred CCCc
Q 002021 336 NPLY 339 (979)
Q Consensus 336 N~l~ 339 (979)
|.+.
T Consensus 253 n~l~ 256 (466)
T 1o6v_A 253 NQIS 256 (466)
T ss_dssp SCCC
T ss_pred Cccc
Confidence 4443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=373.87 Aligned_cols=267 Identities=27% Similarity=0.418 Sum_probs=216.9
Q ss_pred hCCCCCCceeeeecceEEEEEEc--------CCCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeeeEEEeeccC
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL--------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIKVISSCSNE 750 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (979)
.++|...+.||+|+||.||+|.. .++..||||++..... ...+.+.+|+++++++ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 35788889999999999999964 2346799999976532 3446788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence 99999999999999999987643 35899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchH
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTL 894 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~ 894 (979)
++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987654433333445567889999999999999999999999999999999 99998653211 11
Q ss_pred hHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCC
Q 002021 895 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGG 970 (979)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~ 970 (979)
...+.... ....+..++.++.+++.+||+.||++|||+.|++++|+++.......-.+
T Consensus 303 ~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (382)
T 3tt0_A 303 FKLLKEGH------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360 (382)
T ss_dssp HHHHHTTC------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred HHHHHcCC------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence 11111000 00011235567999999999999999999999999999999766554433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=361.40 Aligned_cols=264 Identities=23% Similarity=0.377 Sum_probs=217.0
Q ss_pred hCCCCCCceeeeecceEEEEEEc------CCCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (979)
.++|+..+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 36788899999999999999963 4578999999975432 2456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCccceeeccCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 753 KALVLEYMPHGSLEKYLYSSNC-----------------ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
.++||||+++|+|.+++..... .+++.+++.++.|++.||+||| +++|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 9999999999999999876532 4899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchH
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTL 894 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~ 894 (979)
+.++.+||+|||++................+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||........ .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-F 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-H
Confidence 9999999999999987754443333445567889999999988899999999999999999999 9999876432221 1
Q ss_pred hHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 895 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
...+..... ...+..++..+.+++.+||+.||.+|||+.|++++|+++.+....
T Consensus 258 ~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 258 YKMIKEGFR------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HHHHHHTCC------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred HHHhccCCC------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 111111100 001123456789999999999999999999999999999876544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=366.54 Aligned_cols=267 Identities=22% Similarity=0.368 Sum_probs=212.4
Q ss_pred hhCCCCCCceeeeecceEEEEEEc------CCCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCC
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEE 751 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 751 (979)
..++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788899999999999999964 356789999997543 33457789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCccceeeccCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNC----------------------ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 809 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik 809 (979)
..++||||+++|+|.+++..... .+++..++.++.|++.||+||| +++|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 99999999999999999976532 3789999999999999999999 9999999999
Q ss_pred CCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccc
Q 002021 810 PSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 888 (979)
Q Consensus 810 ~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~ 888 (979)
|+||+++.++.+||+|||++................+|+.|+|||.+.++.+++++||||||+++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654443334455667889999999988899999999999999999998 999997643
Q ss_pred cCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 889 NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
... .....+..... ...+..+++++.+++.+||+.||.+|||+.|++++|+.+........
T Consensus 280 ~~~-~~~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 340 (344)
T 1rjb_A 280 VDA-NFYKLIQNGFK------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340 (344)
T ss_dssp CSH-HHHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred cHH-HHHHHHhcCCC------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHH
Confidence 221 11111111100 01112345679999999999999999999999999999987665543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=367.03 Aligned_cols=258 Identities=25% Similarity=0.403 Sum_probs=204.6
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcE----EEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGME----VAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|+..+.||+|+||.||+|.. .+++. ||+|++.... ....+.+.+|++++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5688889999999999999964 34443 5888775433 234577899999999999999999999998765 779
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|+||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999999887778999999999999999999999 899999999999999999999999999999877544
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
..........+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+ ....+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~------------ 236 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE------------ 236 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC------------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHcCC------------
Confidence 44433445567889999999999999999999999999999999 999997532221 111111110
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+..++..+.+++.+||+.||++||++.|++++|+++.+.
T Consensus 237 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0011223456789999999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=355.06 Aligned_cols=265 Identities=27% Similarity=0.378 Sum_probs=206.2
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHh--cCCCCeeeEEEeecc----CCeeE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKS--IRHRNLIKVISSCSN----EEFKA 754 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~ 754 (979)
.++|+..+.||+|+||.||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.+ ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46789999999999999999987 7899999998643 33556667777776 789999999998643 45689
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY-----SAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
+||||+++|+|.++++.. .+++..++.++.|++.||+|||... +++|+||||||+||+++.++.+||+|||++
T Consensus 83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 999999999999999654 6899999999999999999999322 679999999999999999999999999999
Q ss_pred cccCCCCCcc--eecccccCCCCCCccccCCC------CCCCchhHHHHHHHHHHHHcC----------CCCCcccccCc
Q 002021 830 KMLTGEDQSM--IQTQTLATIGYMAPEYGREG------RVSANGDVYSFGIMLMETFTG----------KKPTDEIFNGE 891 (979)
Q Consensus 830 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg----------~~P~~~~~~~~ 891 (979)
+......... ......||+.|+|||.+.+. .+++++||||+||++|||+|| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8664332221 12334799999999998776 456799999999999999999 77776544443
Q ss_pred chHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 892 MTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
................ ...........++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQR---------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCCC---------CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCC---------CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3333222211111100 00011112235677899999999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=375.47 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=210.3
Q ss_pred CCCCCCceeeeecceEEEEEEcC------CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
++|+..+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888899999999999999742 46789999986542 234457889999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEEe
Q 002021 755 LVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSD 825 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~D 825 (979)
+||||+++|+|.+++.... ..+++.+++.++.|+++||+||| +++|+||||||+||+++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999987542 45899999999999999999999 99999999999999999555 599999
Q ss_pred eccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCC
Q 002021 826 FSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPI 904 (979)
Q Consensus 826 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~ 904 (979)
||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .....+....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~~i~~~~-- 303 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGG-- 303 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTC--
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC--
Confidence 999986543333333344568899999999988899999999999999999998 99998753211 1111111000
Q ss_pred ccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+..++..+.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 304 ----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 ----------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 0011224556789999999999999999999999999988763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=363.37 Aligned_cols=260 Identities=24% Similarity=0.394 Sum_probs=214.1
Q ss_pred hCCCCCCceeeeecceEEEEEEc------CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788889999999999999954 356889999997543 23456788999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 002021 754 ALVLEYMPHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKP 810 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~ 810 (979)
++||||+++|+|.+++.... ..+++.+++.++.|+++||+||| +++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 99999999999999987643 24889999999999999999999 99999999999
Q ss_pred CCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCccccc
Q 002021 811 SNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFN 889 (979)
Q Consensus 811 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~ 889 (979)
+||++++++.+||+|||++................+|+.|+|||.+.+..+++++||||+|+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443333344567889999999988889999999999999999999 9999875322
Q ss_pred CcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 890 GEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
.. ....+..... ...+..+++.+.+++.+||+.||++||++.|++++|+++.+.
T Consensus 259 ~~--~~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ER--LFNLLKTGHR------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG--HHHHHHTTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH--HHHHhhcCCc------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 21 1111111000 011124556799999999999999999999999999998864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.29 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=205.7
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccccc------chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGR------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
+.|+..+.||+|+||.||+|. ..+|+.||||++...... ..+.+.+|+++++.++||||+++++++.+++..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 458888999999999999995 457999999998654321 3467889999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----cEEEEeecccc
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFSIAK 830 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfg~~~ 830 (979)
+||||+++|+|.+++... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.++ .+||+|||++.
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999998764 46899999999999999999999 99999999999999999887 89999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .........
T Consensus 167 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~--------- 233 (326)
T 2y0a_A 167 KIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVN--------- 233 (326)
T ss_dssp ECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHTC---------
T ss_pred ECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHhcC---------
Confidence 7643221 234579999999999988899999999999999999999999996532111 111100000
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..........++..+.+++.+|++.||++|||+.|+++|
T Consensus 234 -------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 -------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000111223456778999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=377.70 Aligned_cols=252 Identities=30% Similarity=0.454 Sum_probs=208.9
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC-eeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-FKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~ 759 (979)
.++|+..+.||+|+||.||+|.+ .|+.||||+++... ..+.+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 46688889999999999999988 47899999997543 4578999999999999999999999976654 78999999
Q ss_pred cCCCccceeeccCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++|+|.+++...+. .+++..++.++.|+++||+||| +++|+||||||+||++++++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999986543 4799999999999999999999 999999999999999999999999999999854321
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....+++.|+|||.+.+..++.++|||||||++|||+| |+.||......+. ...+..
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~~----------------- 401 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEK----------------- 401 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHHHHT-----------------
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHc-----------------
Confidence 122357889999999999999999999999999999998 9999975432211 111100
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
..+...+..+++.+.++|.+||+.||++|||+.|+++.|+++...
T Consensus 402 -~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 402 -GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 001112345677899999999999999999999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=384.96 Aligned_cols=264 Identities=24% Similarity=0.420 Sum_probs=215.9
Q ss_pred hhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..++|+..+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+++++.++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346788889999999999999988888999999997543 35678999999999999999999999986 5678999999
Q ss_pred cCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++|+|.+++.... ..+++.+++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-H
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-e
Confidence 99999999997542 36889999999999999999999 9999999999999999999999999999998764221 1
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.......+|+.|+|||.+..+.++.++|||||||++|||+| |+.||......+ ....+...
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~---------------- 401 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERG---------------- 401 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHT----------------
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----------------
Confidence 11233456788999999988899999999999999999999 999997532211 11111100
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCC
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVG 969 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~ 969 (979)
.+.+.+..+++++.++|.+||+.||++|||+.+|++.|+++..+...++.
T Consensus 402 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~~ 451 (454)
T 1qcf_A 402 --YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYE 451 (454)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSSB
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccccc
Confidence 01112235677899999999999999999999999999998876555543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=363.46 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=203.5
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|...+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3678899999999999999995 4689999999986432 22345788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+ +|+|.+++...+ .+++.+++.++.|++.|++||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 679988886643 6899999999999999999999 8999999999999999999999999999998764332
Q ss_pred CcceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
. ....+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||......... ..+...
T Consensus 163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------------~~i~~~-- 223 (336)
T 3h4j_B 163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--------------KKVNSC-- 223 (336)
T ss_dssp T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--------------CCCCSS--
T ss_pred c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--------------HHHHcC--
Confidence 1 244579999999999987775 78999999999999999999999753221110 000000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..+++++.+++.+|++.||.+|||+.|+++|
T Consensus 224 -----~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 -----VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -----CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -----CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 001122345678999999999999999999999886
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=356.38 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=207.5
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|. ..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 3678899999999999999995 55789999999854322 2346788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++...+ .+++.+++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999987654 6899999999999999999999 9999999999999999999999999999998764322
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
........||+.|+|||.+.+..++.++||||+|+++|||++|+.||............ ... .
T Consensus 166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~----~~~-~----------- 228 (294)
T 4eqm_A 166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH----IQD-S----------- 228 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH----HSS-C-----------
T ss_pred -ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----hhc-c-----------
Confidence 12223456899999999999989999999999999999999999999753221111111 000 0
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCC-CHHHHHHHHHHhHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-NAKEIVTKLLKIRD 962 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~eil~~L~~~~~ 962 (979)
...........++..+.+++.+|+..||++|| +++++.+.|+++..
T Consensus 229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 00011112234567799999999999999999 99999999988764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=366.03 Aligned_cols=345 Identities=24% Similarity=0.361 Sum_probs=163.4
Q ss_pred ccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeeccccccccccccccc
Q 002021 118 TTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIG 197 (979)
Q Consensus 118 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 197 (979)
.+.+|+.|++++|.+.. +|. +..+++|++|||++|.+++ +|. ++++++|++|++++|.+++..+ ++
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~---------~~~-~~~l~~L~~L~l~~n~l~~~~~--~~ 109 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTD---------ITP-LKNLTKLVDILMNNNQIADITP--LA 109 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCC---------CGG-GTTCTTCCEEECCSSCCCCCGG--GT
T ss_pred HhccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCC---------chh-hhccccCCEEECCCCccccChh--hc
Confidence 35566677777666663 342 5666666666666666653 233 5666666666666666664443 66
Q ss_pred CCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcE
Q 002021 198 NLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSI 277 (979)
Q Consensus 198 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 277 (979)
++++|++|++++|+++++.+ +.++++|++|++++|.+++.. .+..+++|++|+++ |.+.
T Consensus 110 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~---~~~~l~~L~~L~l~-~~~~--------------- 168 (466)
T 1o6v_A 110 NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS---ALSGLTSLQQLSFG-NQVT--------------- 168 (466)
T ss_dssp TCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG---GGTTCTTCSEEEEE-ESCC---------------
T ss_pred CCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh---hhccCCcccEeecC-Cccc---------------
Confidence 66666666666666665533 455555555555555554422 13444444444443 2222
Q ss_pred EeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEE
Q 002021 278 LDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEF 357 (979)
Q Consensus 278 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L 357 (979)
+..+ +.++++|++|++++|.++..+ .+..+++|++|++++|.+.++.+ ++ ..++|++|
T Consensus 169 ---------~~~~--~~~l~~L~~L~l~~n~l~~~~-------~l~~l~~L~~L~l~~n~l~~~~~---~~-~l~~L~~L 226 (466)
T 1o6v_A 169 ---------DLKP--LANLTTLERLDISSNKVSDIS-------VLAKLTNLESLIATNNQISDITP---LG-ILTNLDEL 226 (466)
T ss_dssp ---------CCGG--GTTCTTCCEEECCSSCCCCCG-------GGGGCTTCSEEECCSSCCCCCGG---GG-GCTTCCEE
T ss_pred ---------Cchh--hccCCCCCEEECcCCcCCCCh-------hhccCCCCCEEEecCCccccccc---cc-ccCCCCEE
Confidence 2211 444444444444444443321 13334444444444444433322 00 01233333
Q ss_pred EccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCccc
Q 002021 358 KMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLS 437 (979)
Q Consensus 358 ~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 437 (979)
++++|++++. +.+..+++|++|++++|.+++..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|++.
T Consensus 227 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~ 300 (466)
T 1o6v_A 227 SLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE 300 (466)
T ss_dssp ECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS
T ss_pred ECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCccc
Confidence 3333333321 234445555555555555544333 4444455555555554443222 444444555555555544
Q ss_pred ccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcC
Q 002021 438 GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGG 517 (979)
Q Consensus 438 ~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 517 (979)
+..+ +..+++|+.|++++|+++.++. +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..
T Consensus 301 ~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 373 (466)
T 1o6v_A 301 DISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LAN 373 (466)
T ss_dssp CCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTT
T ss_pred Cchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhc
Confidence 3322 4444444444444444444332 33444444444444444432 234444444444444444444433 444
Q ss_pred CcccceeecCCcccc
Q 002021 518 LKNLEYLFLGYNRLQ 532 (979)
Q Consensus 518 l~~L~~L~Ls~N~l~ 532 (979)
+++|+.|++++|+++
T Consensus 374 l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 374 LTRITQLGLNDQAWT 388 (466)
T ss_dssp CTTCCEEECCCEEEE
T ss_pred CCCCCEEeccCCccc
Confidence 444444444444444
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.08 Aligned_cols=274 Identities=26% Similarity=0.358 Sum_probs=208.8
Q ss_pred cHHHHHHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhc--CCCCeeeEEEeeccC
Q 002021 673 SYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI--RHRNLIKVISSCSNE 750 (979)
Q Consensus 673 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~ 750 (979)
+........++|+..+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 33344445578999999999999999999874 899999998643 224455566666654 899999999998776
Q ss_pred ----CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEecCCCCCCEEeCCC
Q 002021 751 ----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA--------PVIHCDLKPSNVLLDDN 818 (979)
Q Consensus 751 ----~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~--------~i~H~Dik~~NIll~~~ 818 (979)
...++||||+++|+|.+++... .+++..++.++.|++.||+||| ++ +|+||||||+||+++.+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCC
Confidence 6889999999999999999765 5899999999999999999999 77 99999999999999999
Q ss_pred CcEEEEeeccccccCCCCCcc--eecccccCCCCCCccccCCCCCCCc------hhHHHHHHHHHHHHcCC---------
Q 002021 819 MVAHLSDFSIAKMLTGEDQSM--IQTQTLATIGYMAPEYGREGRVSAN------GDVYSFGIMLMETFTGK--------- 881 (979)
Q Consensus 819 ~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~el~tg~--------- 881 (979)
+.+||+|||++.......... ......||+.|+|||++.+..++.+ +|||||||++|||+||+
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999997664332221 1234579999999999887766654 99999999999999994
Q ss_pred -CCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 882 -KPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 882 -~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
.||............+...... ...............++.++.+++.+||+.||++|||+.|++++|+++
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCI---------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTT---------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHhhhcCCCCchhhhHHHHhh---------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 4544333222222221111111 111111111222346788899999999999999999999999999999
Q ss_pred HHhh
Q 002021 961 RDSL 964 (979)
Q Consensus 961 ~~~~ 964 (979)
.++.
T Consensus 330 ~~~~ 333 (337)
T 3mdy_A 330 SESQ 333 (337)
T ss_dssp HHTT
T ss_pred Hhhc
Confidence 8754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=369.04 Aligned_cols=253 Identities=19% Similarity=0.261 Sum_probs=208.4
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.+.|+..+.||+|+||.||+|. ..+|+.||+|++..........+.+|+++++.++||||+++++++.+++..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4678999999999999999995 457899999998765444556788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC--CCcEEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~--~~~~kl~Dfg~~~~~~~~~~ 837 (979)
+++|+|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++. ++.+||+|||++........
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999999877667999999999999999999999 999999999999999984 57899999999987643322
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~-------------- 268 (387)
T 1kob_A 207 ---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWE-------------- 268 (387)
T ss_dssp ---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCC--------------
T ss_pred ---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC--------------
Confidence 23457899999999999889999999999999999999999999753211 111111100000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........+++++.+++.+||+.||++|||+.|+++|
T Consensus 269 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 --FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000112345678999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=364.90 Aligned_cols=258 Identities=23% Similarity=0.397 Sum_probs=207.6
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcE----EEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGME----VAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|+..+.||+|+||.||+|.. .+++. ||+|++.... ....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 5688889999999999999964 44543 7888775443 334567788999999999999999999986 456889
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999999999887668999999999999999999999 999999999999999999999999999999987655
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
..........+|..|+|||.+.++.++.++||||+|+++|||+| |+.||......+ ....+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~------------ 234 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGE------------ 234 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTTC------------
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcCC------------
Confidence 44444455678889999999998899999999999999999999 999997633221 111111100
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+..++.++.+++.+||..||++|||+.|++++|+++...
T Consensus 235 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 235 ------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0001112344578899999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=353.41 Aligned_cols=276 Identities=19% Similarity=0.198 Sum_probs=223.8
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEee-ccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC-SNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++.... ..+.+.+|+++++.++|+++++.+.++ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4678999999999999999996 4689999999986542 345688999999999998877766655 66778899999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEEeeccccccCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|+ +++|.+++......+++.+++.++.|++.||+||| +++|+||||||+||++ ++++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 89999999866667999999999999999999999 9999999999999999 48889999999999876543
Q ss_pred CCc-----ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCc--chHhHhhhhhcCCccch
Q 002021 836 DQS-----MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE--MTLKHWVNDWLPISTME 908 (979)
Q Consensus 836 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~ 908 (979)
... .......||+.|+|||.+.+..+++++||||+||++|||++|+.||....... ..+.......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 234 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------- 234 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-------
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc-------
Confidence 221 11244578999999999999899999999999999999999999997643221 1111110000
Q ss_pred hhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceeccC
Q 002021 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQSN 977 (979)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~~~ 977 (979)
... ........+++++.+++.+||+.||++|||+.|+++.|+++............+|+.+
T Consensus 235 -----~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 235 -----MST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp -----HHS---CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred -----cCC---chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 000 0001113456779999999999999999999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.99 Aligned_cols=273 Identities=19% Similarity=0.278 Sum_probs=210.2
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC--eeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE--FKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 757 (979)
+.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 5688899999999999999954 468999999987543 234567789999999999999999999987654 779999
Q ss_pred EecCCCccceeeccCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----CCCCcEEEEeeccccc
Q 002021 758 EYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIAKM 831 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll----~~~~~~kl~Dfg~~~~ 831 (979)
||+++++|.+++..... .+++.+++.++.|++.||+||| +++|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976532 3899999999999999999999 9999999999999999 7888999999999987
Q ss_pred cCCCCCcceecccccCCCCCCccccC--------CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcch---HhHhhhh
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGR--------EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT---LKHWVND 900 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~---~~~~~~~ 900 (979)
...... .....||+.|+|||++. +..++.++||||+||++|||++|+.||......... .......
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 643322 23456899999999875 467899999999999999999999999754332221 1122221
Q ss_pred hcCCccchhhccc-----ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 901 WLPISTMEVVDAN-----LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 901 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
..+.....+.... ...............+..+.+++.+|++.||++|||++|+++|..+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1111111100000 00000011112245667899999999999999999999999998854
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=365.90 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=204.9
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-----ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-----GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
+.|+..+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 468889999999999999995 4679999999986431 1235678999999999999999999999999999999
Q ss_pred EEEecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc---EEEEeeccc
Q 002021 756 VLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFSIA 829 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~Dfg~~ 829 (979)
||||+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998887543 335899999999999999999999 999999999999999986654 999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... +..........
T Consensus 181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~i~~~~-------- 248 (351)
T 3c0i_A 181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGK-------- 248 (351)
T ss_dssp EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--HHHHHHHHHTC--------
T ss_pred eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--HHHHHHHHcCC--------
Confidence 8764332 22345679999999999998899999999999999999999999997521 11111111000
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..........++.++.+++.+||+.||++|||+.|+++|
T Consensus 249 --------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 249 --------YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001112223456779999999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=374.54 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=205.8
Q ss_pred hhCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
..++|+..+.||+|+||.||+| ...+|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567889999999999999999 45689999999986543 23346688999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC---CCCcEEEEeeccccccC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~Dfg~~~~~~ 833 (979)
|||+++|+|.+++...+ .+++.++..++.||+.|++||| +++|+||||||+||+++ .++.+||+|||++....
T Consensus 89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999887654 6899999999999999999999 99999999999999998 46789999999998764
Q ss_pred CCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
.... ......||+.|+|||++.+..+++++||||+||++|+|++|+.||......+ ...........
T Consensus 165 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~---------- 231 (444)
T 3soa_A 165 GEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGAYD---------- 231 (444)
T ss_dssp TTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCC----------
T ss_pred CCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCCCC----------
Confidence 3322 2245679999999999998899999999999999999999999996522111 11111110000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+....+++++.+++.+|++.||++|||+.|+++|
T Consensus 232 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 ------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0011122456679999999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.07 Aligned_cols=268 Identities=22% Similarity=0.270 Sum_probs=203.4
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||.||+|...+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688889999999999999987789999999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++ +|.+++......+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--
Confidence 975 999998877677999999999999999999999 99999999999999999999999999999987643221
Q ss_pred eecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc---CCccchh-----h
Q 002021 840 IQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL---PISTMEV-----V 910 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~-----~ 910 (979)
......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ......... ....... .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCChhhchhhhccccc
Confidence 2244578999999999865 4589999999999999999999999975332211 111111100 0000000 0
Q ss_pred cccccCchh-hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DANLLSQED-IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
++....... ........++.++.+++.+|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000 0000112345678999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=350.80 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=206.2
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc-------chhcHHHHHHHHHhcCCCCeeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR-------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36788899999999999999954 68999999998644321 1267889999999999999999999997665
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEeCCCCc-----EEEEe
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMV-----AHLSD 825 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dik~~NIll~~~~~-----~kl~D 825 (979)
++||||+++|+|.+++......+++..++.++.|++.|++||| +++ |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 6999999999999999887778999999999999999999999 888 999999999999988776 99999
Q ss_pred eccccccCCCCCcceecccccCCCCCCcccc--CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC
Q 002021 826 FSIAKMLTGEDQSMIQTQTLATIGYMAPEYG--REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 903 (979)
Q Consensus 826 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 903 (979)
||+++.... ......||+.|+|||.+ ....+++++||||+|+++|||++|+.||...................
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 999975432 12446789999999998 34567899999999999999999999997644333222221111100
Q ss_pred CccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
....+..+++.+.+++.+||+.||++|||+.|+++.|+++
T Consensus 248 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 -----------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -----------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0011234566799999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=365.85 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=206.0
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
..++|+..+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 34678999999999999999995 4578999999986542 23446788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEEeeccccccC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFSIAKMLT 833 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~Dfg~~~~~~ 833 (979)
|||+++|+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+||+++.++ .+||+|||++....
T Consensus 107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999887653 6899999999999999999999 99999999999999998654 59999999998764
Q ss_pred CCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+....
T Consensus 183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~i~~~~----------- 246 (362)
T 2bdw_A 183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGA----------- 246 (362)
T ss_dssp TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTC-----------
T ss_pred CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCC-----------
Confidence 322 224467999999999999889999999999999999999999998653211 1111110000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. .........+++++.+++.+||+.||++|||+.|+++|
T Consensus 247 -~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 -Y---DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -C---CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -C---CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00011123456779999999999999999999999887
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=355.73 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=201.1
Q ss_pred hCCCCCCceeeeecceEEEEEEcC----CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
.++|+..+.||+|+||.||+|... .+..||||++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 357888899999999999999653 35679999986543 234567889999999999999999999985 456889
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++++|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 99999999999999877667999999999999999999999 999999999999999999999999999999876433
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. .......+|+.|+|||.+.+..++.++||||+|+++|||++ |..||......+ ....+....
T Consensus 170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~~------------ 234 (281)
T 1mp8_A 170 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGE------------ 234 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC------------
T ss_pred cc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcCC------------
Confidence 21 22234456789999999988889999999999999999997 999987533221 111111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
....+..+++.+.+++.+||..||++|||+.|++++|+++.++.+
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 001123456779999999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=353.31 Aligned_cols=269 Identities=22% Similarity=0.237 Sum_probs=205.0
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688899999999999999954 5789999999875432 234678899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++ ++.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence 9975 666666665667999999999999999999999 9999999999999999999999999999998764322
Q ss_pred ceecccccCCCCCCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC---Cccchhhc---
Q 002021 839 MIQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP---ISTMEVVD--- 911 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--- 911 (979)
.......+|+.|+|||++.+.. ++.++||||+||++|||++|+.||................... .......+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2234557899999999987765 7999999999999999999999864432222222222211110 00000000
Q ss_pred cc---ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 AN---LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ..............++.++.+++.+|++.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000000001112355678999999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=355.32 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=197.8
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--------------------------cchhcHHHHHHHHH
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--------------------------RAFKSFDVECEIMK 733 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~ 733 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4678899999999999999995 46789999999864321 12356889999999
Q ss_pred hcCCCCeeeEEEeecc--CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 002021 734 SIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPS 811 (979)
Q Consensus 734 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~ 811 (979)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++.+++.++.|+++||+||| +++|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence 9999999999999876 6788999999999999987654 36899999999999999999999 899999999999
Q ss_pred CEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCcccc
Q 002021 812 NVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR---VSANGDVYSFGIMLMETFTGKKPTDEIF 888 (979)
Q Consensus 812 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~P~~~~~ 888 (979)
||+++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999987643322 234567999999999987654 4788999999999999999999996521
Q ss_pred cCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 889 NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. .....+.... . ..+....+++++.+++.+||+.||++|||+.|+++|
T Consensus 245 ~~--~~~~~~~~~~------------~-----~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IM--CLHSKIKSQA------------L-----EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HH--HHHHHHHHCC------------C-----CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HH--HHHHHHhccc------------C-----CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 11 1111000000 0 000112345678999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=352.50 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=213.0
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|+..+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+++++.++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5678889999999999999988788999999997543 234678999999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+++|.+++......+++..++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+....... ....
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS 162 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-cccc
Confidence 99999999877667999999999999999999999 9999999999999999999999999999998754221 1122
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....+++.|+|||.+.+..+++++||||+|+++|||++ |+.||......+ ....+.....
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~~~~----------------- 223 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR----------------- 223 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCC-----------------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhcCCc-----------------
Confidence 33456788999999988889999999999999999999 899986532111 1111100000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
...+..++..+.+++.+||+.||++|||+.|++++|+++.++
T Consensus 224 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 -LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 001122356689999999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=352.22 Aligned_cols=275 Identities=19% Similarity=0.210 Sum_probs=219.1
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEee-ccCCeeEEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC-SNEEFKALVL 757 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 757 (979)
..++|+..+.||+|+||.||+|. ..+++.||||++... ...+.+.+|+++++.++|++++..++++ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 35789999999999999999995 468999999987544 2345788999999999988877777655 6677889999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfg~~~~~~~ 834 (979)
||+ +++|.+++......+++.+++.++.|++.||+||| +++|+||||||+||++ ++++.+||+|||++.....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 89999999866667999999999999999999999 9999999999999999 7889999999999987654
Q ss_pred CCCc-----ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc--hHhHhhhhhcCCccc
Q 002021 835 EDQS-----MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM--TLKHWVNDWLPISTM 907 (979)
Q Consensus 835 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~--~~~~~~~~~~~~~~~ 907 (979)
.... .......||+.|+|||.+.+..+++++||||+||++|||++|+.||........ .+......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 233 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK------- 233 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-------
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc-------
Confidence 3221 122345789999999999998999999999999999999999999976432211 11110000
Q ss_pred hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceec
Q 002021 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQ 975 (979)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~ 975 (979)
.... ........+++++.+++.+||+.||++|||+.|+++.|+++.+..........+|.
T Consensus 234 -----~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 234 -----KMST---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp -----HHHS---CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred -----cccc---hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 0000 00011123467899999999999999999999999999999999998888888886
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.20 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=199.7
Q ss_pred CceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 687 NNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
.+.||+|+||.||+|. ..+|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5679999999999995 467999999999765545567889999999999999999999999999999999999999999
Q ss_pred ceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe--CCCCcEEEEeeccccccCCCCCcceecc
Q 002021 766 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL--DDNMVAHLSDFSIAKMLTGEDQSMIQTQ 843 (979)
Q Consensus 766 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 843 (979)
.+++......+++.+++.++.||+.||+||| +++|+||||||+||++ +.++.+||+|||+++.+..... ...
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~ 247 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKV 247 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---ccc
Confidence 9999877667999999999999999999999 9999999999999999 5778999999999987643322 234
Q ss_pred cccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhH
Q 002021 844 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 923 (979)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 923 (979)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ ....
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~----------------~~~~ 310 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWD----------------LEDE 310 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC----------------SCSG
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC----------------CChh
Confidence 56999999999998889999999999999999999999999653211 111111111000 0001
Q ss_pred HHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 924 AKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 924 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+++++.+++.+|++.||++|||+.|+++|
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 122345679999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=372.62 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=209.2
Q ss_pred HHHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC
Q 002021 675 LELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE 750 (979)
Q Consensus 675 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 750 (979)
.++....++|+..+.||+|+||.||+|+. .+++.||+|++.+.. ....+.+.+|+++++.++||||++++++|.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34445567899999999999999999954 568999999986532 23456688999999999999999999999999
Q ss_pred CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
+..|+||||+++|+|.+++... .+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999998764 5899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCcc
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGR----VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 906 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 906 (979)
...... .......+||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... ..+.......
T Consensus 217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~----- 289 (410)
T 3v8s_A 217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHK----- 289 (410)
T ss_dssp ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHH-----
T ss_pred eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHHHhcc-----
Confidence 764332 22234568999999999987654 789999999999999999999999752211 1111111100
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCC--CCCHHHHHHH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQ--RINAKEIVTK 956 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~eil~~ 956 (979)
....++....++.++.+++.+|++.+|.+ ||+++||++|
T Consensus 290 -----------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 -----------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -----------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -----------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00011111234567899999999999998 9999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=364.85 Aligned_cols=278 Identities=12% Similarity=0.109 Sum_probs=220.6
Q ss_pred CCCCCCceeeeecceEEEEEEcC---------CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeee----------
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG---------DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIK---------- 742 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 742 (979)
++|+..+.||+|+||.||+|... +++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 67889999999999999999654 3789999998643 56889999999999999998
Q ss_pred -----EEEeecc-CCeeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 743 -----VISSCSN-EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 743 -----l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
+++++.. ++..++||||+ +++|.+++... ...+++.+++.++.|++.||+||| +++|+||||||+||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence 5666654 77889999999 99999999865 357999999999999999999999 8999999999999999
Q ss_pred CCCC--cEEEEeeccccccCCCCCc-----ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccc
Q 002021 816 DDNM--VAHLSDFSIAKMLTGEDQS-----MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF 888 (979)
Q Consensus 816 ~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~ 888 (979)
+.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999876433211 11233478999999999998899999999999999999999999998754
Q ss_pred cCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 889 NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
................. ....+. ......++.++.+++.+||+.||++|||+.|+++.|+++.+......
T Consensus 273 ~~~~~~~~~~~~~~~~~-~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKP-GPFVGP---------CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp TCHHHHHHHHHHHHHSC-CCEECT---------TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred cCHHHHHHHHHhccCCh-hhhhhh---------ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 33333322221111000 000000 00011235679999999999999999999999999999999999999
Q ss_pred CCcceeccCC
Q 002021 969 GGRCVRQSNL 978 (979)
Q Consensus 969 ~~~~~~~~~~ 978 (979)
.++.+|..+|
T Consensus 343 ~~~~dw~~~p 352 (352)
T 2jii_A 343 YDPIGLPMVP 352 (352)
T ss_dssp TSCCCCCC--
T ss_pred CccccCcCCC
Confidence 9999998876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.16 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=197.3
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|.... .||||++.... ....+.+.+|+++++.++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4679999999999999999998743 59999986543 23456788999999999999999999965 4556889999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++++|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999999999877778999999999999999999999 999999999999999999999999999999865433333
Q ss_pred ceecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh-cCCccchhhcccc
Q 002021 839 MIQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW-LPISTMEVVDANL 914 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 914 (979)
.......||+.|+|||.+. +..++.++||||+|+++|||++|+.||......+. ....+... ......
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~------- 248 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVGRGSLSPDLS------- 248 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HHHHHHHTSCCCCTT-------
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HHHHhcccccCcchh-------
Confidence 3334567899999999886 56688899999999999999999999976432221 11111111 100000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
.....+++.+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 249 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 --------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0112455779999999999999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=368.26 Aligned_cols=255 Identities=20% Similarity=0.264 Sum_probs=202.8
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 755 (979)
.++|+..+.||+|+||.||+|+ ..+++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4678899999999999999995 4568899999997542 23345688899999887 89999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++...+ .+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999887643 6899999999999999999999 999999999999999999999999999999863322
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchH---hHhhhhhcCCccchhhcc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL---KHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 912 (979)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+... ..++.. .+...
T Consensus 207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~-------~i~~~ 277 (396)
T 4dc2_A 207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------VILEK 277 (396)
T ss_dssp T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH-------HHHHC
T ss_pred C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH-------HHhcc
Confidence 2 22345689999999999999999999999999999999999999996432111100 000000 00000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH------HHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA------KEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~eil~~ 956 (979)
....+..++.++.+++.+||+.||++||++ .|+++|
T Consensus 278 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 278 --------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred --------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 001122345678999999999999999995 667665
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=367.76 Aligned_cols=249 Identities=24% Similarity=0.292 Sum_probs=200.6
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 755 (979)
.++|+..+.||+|+||.||+|+ ..+|+.||||++.... ....+.+.+|.++++.+ +||||+++++++.+++..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4789999999999999999995 4578999999997542 23446678899999988 69999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++...+ .+++.+++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 102 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999987653 6899999999999999999999 999999999999999999999999999999864322
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+........
T Consensus 178 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~------------- 241 (353)
T 3txo_A 178 --GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDEV------------- 241 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-------------
T ss_pred --CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC-------------
Confidence 222345679999999999988889999999999999999999999997532111 1111111000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH------HHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA------KEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~eil~~ 956 (979)
..+...+..+.+++.+|++.||++||++ .|+++|
T Consensus 242 -------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 -------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 0112245668999999999999999998 777765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=362.28 Aligned_cols=260 Identities=26% Similarity=0.443 Sum_probs=195.7
Q ss_pred hCCCCCCceeeeecceEEEEEEcCC-C---cEEEEEEeccc--cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee-
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGD-G---MEVAVKVFTSQ--CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK- 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 753 (979)
.++|+..+.||+|+||.||+|.... + ..||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4678999999999999999996543 3 27999998754 234457789999999999999999999999776655
Q ss_pred -----EEEEEecCCCccceeeccC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 002021 754 -----ALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 823 (979)
Q Consensus 754 -----~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl 823 (979)
++||||+++|+|.+++... ...+++.+++.++.|+++||+||| +++|+||||||+||++++++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence 9999999999999998643 225899999999999999999999 999999999999999999999999
Q ss_pred EeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhc
Q 002021 824 SDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 824 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
+|||+++...............+++.|+|||.+.+..++.++||||+||++|||++ |+.||......+. .........
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-HHHHhcCCC
Confidence 99999987654433333344567889999999988899999999999999999999 9999875332211 111110000
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
...+..++.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 258 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 258 -------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 011123456789999999999999999999999999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=353.07 Aligned_cols=256 Identities=28% Similarity=0.380 Sum_probs=200.9
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|+..+.||+|+||.||+|++ .++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 5678889999999999999987 4789999998643 345678999999999999999999999874 4789999999
Q ss_pred CCccceeeccCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc-EEEEeeccccccCCCCCc
Q 002021 762 HGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-AHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 762 ~g~L~~~l~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~-~kl~Dfg~~~~~~~~~~~ 838 (979)
+|+|.+++..... .+++..++.++.|+++|++|||....++|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976542 4789999999999999999999221289999999999999998886 799999999765322
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...................
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 222 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR--------------- 222 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---------------
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---------------
Confidence 133468999999999998899999999999999999999999997533222111111000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
......++..+.+++.+||+.||++|||+.|++++|+++.+...
T Consensus 223 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 223 ---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp ---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred ---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00112345668999999999999999999999999999986543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.45 Aligned_cols=272 Identities=22% Similarity=0.375 Sum_probs=209.9
Q ss_pred CCCCCCceeeeecceEEEEEE-----cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC--Cee
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-----LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 753 (979)
..|+..+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+++++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 447788999999999999997 3468999999987543 33457788999999999999999999999776 668
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||+++|+|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999776667999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 834 GEDQS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 834 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
..... .......+|..|+|||.+.+..++.++||||+|+++|||++|+.|+...... ...................
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCGGGHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcccccCHHHHHH
Confidence 43322 2234456788899999998888999999999999999999999986542110 0000000000000000000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
... .......+..+++.+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 255 ~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLK--EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHH--TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh--ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000 00011122345677999999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=357.97 Aligned_cols=273 Identities=23% Similarity=0.372 Sum_probs=219.8
Q ss_pred cccHHHHHHhhCCCCCCceeeeecceEEEEEEc------CCCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeee
Q 002021 671 MFSYLELCRATDGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIK 742 (979)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~ 742 (979)
.+....+....++|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 344555556678899999999999999999963 4678999999975432 2346788999999999 7999999
Q ss_pred EEEeeccCC-eeEEEEEecCCCccceeeccCCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 002021 743 VISSCSNEE-FKALVLEYMPHGSLEKYLYSSNC---------------ILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806 (979)
Q Consensus 743 l~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~---------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~ 806 (979)
+++++...+ ..++||||+++|+|.+++..... .+++.+++.++.|++.|++||| +++|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 999987654 58999999999999999976543 2789999999999999999999 9999999
Q ss_pred CCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCc
Q 002021 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTD 885 (979)
Q Consensus 807 Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~ 885 (979)
||||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654444444455678899999999988899999999999999999998 999987
Q ss_pred ccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 886 EIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
.....+...... ..... ...+..+++.+.+++.+||+.||++|||+.|++++|+++.++..
T Consensus 253 ~~~~~~~~~~~~-~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 253 GVKIDEEFCRRL-KEGTR------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TCCCSHHHHHHH-HHTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchhHHHHHHh-ccCcc------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 533222111111 11000 00112345668999999999999999999999999999987643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=362.84 Aligned_cols=275 Identities=24% Similarity=0.332 Sum_probs=213.5
Q ss_pred CCCCCCceeeeecceEEEEEE-----cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeec--cCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-----LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS--NEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 754 (979)
++|+..+.||+|+||.||+|+ ..+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 568888999999999999997 3468899999997665555677899999999999999999999875 556789
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+++++|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999876667999999999999999999999 99999999999999999999999999999987653
Q ss_pred CCCc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc-cchhhcc
Q 002021 835 EDQS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS-TMEVVDA 912 (979)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 912 (979)
.... .......+|+.|+|||.+.+..+++++||||+|+++|||++|+.||.......... ........ ...+.+.
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM---MGCERDVPALSRLLEL 256 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH---CC----CCHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh---cccccccccHHHHHHH
Confidence 3322 22234567888999999988889999999999999999999999986532111000 00000000 0000000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
. ........+..+++.+.+++.+||+.||++|||+.|++++|+++..+..
T Consensus 257 -~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 -L--EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp -H--HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred -h--hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 0 0001111234566789999999999999999999999999999876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=361.14 Aligned_cols=263 Identities=27% Similarity=0.438 Sum_probs=213.1
Q ss_pred hCCCCCCceeeeecceEEEEEEc--------CCCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccC
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL--------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNE 750 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 36788899999999999999964 356789999997543 23456788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 99999999999999999987653 24899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchH
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTL 894 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~ 894 (979)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||+|+++|||++ |+.||...... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--HH
Confidence 9999999999999987654433333344567889999999988889999999999999999999 99998653211 11
Q ss_pred hHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 895 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
...+..... ...+..++..+.+++.+||+.||.+|||+.|++++|+++......
T Consensus 269 ~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 269 FKLLKEGHR------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHhcCCC------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 111110000 001123556789999999999999999999999999999886543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.24 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=195.0
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccc----cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCG----RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|.. .++.||||++..... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788899999999999999987 489999999865432 2346788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEecCCCCCCEEeCC--------CCcEEEEe
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP---VIHCDLKPSNVLLDD--------NMVAHLSD 825 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~---i~H~Dik~~NIll~~--------~~~~kl~D 825 (979)
|||+++++|.+++... .+++..++.++.|++.|++||| +++ |+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998643 6899999999999999999999 777 999999999999986 77899999
Q ss_pred eccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 826 FSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 826 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
||.+........ ....||+.|+|||.+.+..+++++||||+|+++|||++|+.||............ ....
T Consensus 160 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~---- 230 (271)
T 3dtc_A 160 FGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-AMNK---- 230 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-HTSC----
T ss_pred CCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh-hcCC----
Confidence 999986543221 2456899999999998888999999999999999999999999753221111100 0000
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
.....+..+++.+.+++.+||+.||++|||+.|++++|+++
T Consensus 231 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 --------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00011224456799999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=370.41 Aligned_cols=262 Identities=22% Similarity=0.273 Sum_probs=210.0
Q ss_pred HHHHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeecc
Q 002021 674 YLELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749 (979)
Q Consensus 674 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 749 (979)
+.+.....++|+..+.||+|+||.||+|+. .+|+.||||++.+.. ....+.+.+|++++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 344445568899999999999999999954 579999999986532 2345678999999999999999999999999
Q ss_pred CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 750 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
++..|+||||+++|+|.+++.+.+..+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999999876567999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccC-------CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGR-------EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
+...... .......+||+.|+|||++. ...++.++||||+||++|||++|+.||......+ .+...+....
T Consensus 210 ~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~ 287 (412)
T 2vd5_A 210 LKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-TYGKIVHYKE 287 (412)
T ss_dssp EECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHH
T ss_pred eeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhccc
Confidence 8764332 22223467999999999886 4578999999999999999999999997532111 1111111000
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCC---CCHHHHHHH
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQR---INAKEIVTK 956 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps~~eil~~ 956 (979)
. ... ......+++++.+++.+|+. +|++| |+++|+++|
T Consensus 288 ~-----------~~~----p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 288 H-----------LSL----PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp H-----------CCC----C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred C-----------cCC----CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0 000 00123456779999999999 99998 599999876
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=356.45 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=204.4
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 578889999999999999995 4579999999987542 234566788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++.... .+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 9999999999997654 6899999999999999999999 999999999999999999999999999999875322
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+...... ..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~------------~~--- 220 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNA------------EL--- 220 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHC------------CC---
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhC------------CC---
Confidence 23457999999999999999999999999999999999999999652211 111111110 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
..+..++.++.+++.+|++.||++|| +++|+++|
T Consensus 221 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 00123456689999999999999999 89999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=361.97 Aligned_cols=266 Identities=23% Similarity=0.360 Sum_probs=214.6
Q ss_pred HHhhCCCCCCceeeeecceEEEEEEcC-C-----CcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeeeEEEeecc
Q 002021 678 CRATDGFSENNLIGRGGFGSVYKASLG-D-----GMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIKVISSCSN 749 (979)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 749 (979)
....++|+..+.||+|+||.||+|... + +..||||++..... ...+.+.+|+++++.+ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 334577889999999999999999642 2 34799999875532 3456788999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCccceeeccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC
Q 002021 750 EEFKALVLEYMPHGSLEKYLYSS-------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 816 (979)
Q Consensus 750 ~~~~~lv~E~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~ 816 (979)
++..++||||+++|+|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEEC
Confidence 99999999999999999998653 235799999999999999999999 89999999999999999
Q ss_pred CCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHh
Q 002021 817 DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 895 (979)
Q Consensus 817 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~ 895 (979)
.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |..||........ ..
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HH
Confidence 999999999999987654433333445567889999999988889999999999999999999 9999875332211 11
Q ss_pred HhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
..+..... ...+..++..+.+++.+||+.||.+|||+.|++++|+++.....
T Consensus 278 ~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 278 KLVKDGYQ------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HHHHHTCC------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCC------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 11111100 00112335668999999999999999999999999999887543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=371.47 Aligned_cols=345 Identities=22% Similarity=0.199 Sum_probs=246.5
Q ss_pred eeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecccc
Q 002021 228 ILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307 (979)
Q Consensus 228 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 307 (979)
.++++++.++.++... .+++++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 15 ~v~c~~~~l~~ip~~~----~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 15 AVLCHRKRFVAVPEGI----PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp EEECCSCCCSSCCSCC----CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCcCCCCC----CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 4455555555443321 246677777777777666667777777777777777777766777777777777777777
Q ss_pred ccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCC
Q 002021 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNK 387 (979)
Q Consensus 308 ~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~ 387 (979)
+++.++.. .+.++++|++|+|++|++.. ..+..|..+++|++|+|++|.
T Consensus 91 ~l~~~~~~-----~~~~l~~L~~L~Ls~n~i~~--------------------------~~~~~~~~l~~L~~L~l~~n~ 139 (477)
T 2id5_A 91 RLKLIPLG-----VFTGLSNLTKLDISENKIVI--------------------------LLDYMFQDLYNLKSLEVGDND 139 (477)
T ss_dssp CCCSCCTT-----SSTTCTTCCEEECTTSCCCE--------------------------ECTTTTTTCTTCCEEEECCTT
T ss_pred cCCccCcc-----cccCCCCCCEEECCCCcccc--------------------------CChhHccccccCCEEECCCCc
Confidence 77665543 24555555555555555443 344556666666777777776
Q ss_pred CCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccc-ccccc
Q 002021 388 LNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLT 466 (979)
Q Consensus 388 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~ 466 (979)
+++..+..|..+++|+.|++++|.+++..+..+.++++|+.|++++|.+.+..+..|..+++|+.|++++|.+. .+|..
T Consensus 140 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~ 219 (477)
T 2id5_A 140 LVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219 (477)
T ss_dssp CCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTT
T ss_pred cceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcc
Confidence 66666666666777777777777776655566677777777777777777666667777777777777776543 56666
Q ss_pred ccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCccccccccc
Q 002021 467 FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLK 546 (979)
Q Consensus 467 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 546 (979)
.....+|+.|++++|++++..+..+..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..|.++++|+
T Consensus 220 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 299 (477)
T 2id5_A 220 CLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLR 299 (477)
T ss_dssp TTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCC
T ss_pred cccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCC
Confidence 66666788888888888865556788888888888888888888888888889999999999999888888888999999
Q ss_pred ccccccccccccCCccccCccccCeEeccCCcccccCCCCCCCCCcccccccCCccccCCC
Q 002021 547 FLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 547 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~p 607 (979)
.|+|++|+|++..+..|..+++|+.|+|++|+|+|..+....+.......+.++...|..|
T Consensus 300 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 300 VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp EEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred EEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 9999999998877778888999999999999998876543223333446677888888766
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=360.94 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=191.3
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
..+.|+..+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 346788999999999999999965 468899999987543 34668889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEEeeccccccCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfg~~~~~~~~ 835 (979)
|+++|+|.+++...+ .+++.+++.++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 999999999987653 5899999999999999999999 899999999999999975 889999999999865422
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
. ......||+.|+|||++.+..+++++|||||||++|||++|+.||......+.............
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~----------- 270 (349)
T 2w4o_A 205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF----------- 270 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-----------
T ss_pred c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-----------
Confidence 1 22345789999999999988999999999999999999999999965332221222111110000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+....++.++.+++.+|++.||++|||+.|+++|
T Consensus 271 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 -----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112345678999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=360.16 Aligned_cols=249 Identities=26% Similarity=0.333 Sum_probs=202.8
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 578889999999999999995 5578999999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 95 e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp CCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 999999999998765 36999999999999999999999 9999999999999999999999999999998764322
Q ss_pred cceecccccCCCCCCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 838 SMIQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
......||+.|+|||++.. ..++.++||||+||++|||++|+.||........ ........ ...
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~~~---------~~~ 236 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHTFE---------TTV 236 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHHHH---------HCC
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHHHh---------hcc
Confidence 2345679999999999864 4589999999999999999999999975322211 11110000 000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-HHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-AKEIVT 955 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~eil~ 955 (979)
...+..++..+.+++.+||+.||++||+ ++++++
T Consensus 237 -------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0011234567899999999999999998 777665
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=378.21 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=209.5
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.++|+..+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 45678889999999999999988878889999997543 345678999999999999999999999876 6789999999
Q ss_pred CCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++|+|.+++... ...+++.+++.++.|++.||+||| +++|+||||||+||++++++.+||+|||+++...... ..
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 336 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence 999999999753 345899999999999999999999 9999999999999999999999999999998764322 12
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......+++.|+|||.+.++.++.++||||||+++|||++ |+.||......+ ....+...
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~----------------- 397 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERG----------------- 397 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT-----------------
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-----------------
Confidence 2234457789999999988899999999999999999999 999986532211 11111000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
.+.+.+..++..+.++|.+||+.||++|||++++++.|+++..+..+++
T Consensus 398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 0111223566779999999999999999999999999999887655544
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=353.77 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=204.9
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CC-------cEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DG-------MEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
++|+..+.||+|+||.||+|... ++ ..||+|++........+.+.+|+++++.++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 56888899999999999999543 33 57999999766556667899999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc--------EEEEe
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--------AHLSD 825 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~--------~kl~D 825 (979)
++||||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999999999887767999999999999999999999 999999999999999998876 99999
Q ss_pred eccccccCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC
Q 002021 826 FSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 904 (979)
Q Consensus 826 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 904 (979)
||.+...... ....+|+.|+|||.+.+ ..++.++||||+|+++|||++|..|+............ ......
T Consensus 165 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~~~~- 236 (289)
T 4fvq_A 165 PGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YEDRHQ- 236 (289)
T ss_dssp CCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCC-
T ss_pred CcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hhccCC-
Confidence 9998765321 23457889999999877 67899999999999999999966554332211111111 110000
Q ss_pred ccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
.+..++.++.+++.+||+.||++|||+.|++++|+++...
T Consensus 237 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 237 -------------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp -------------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0011234478999999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=386.72 Aligned_cols=264 Identities=23% Similarity=0.378 Sum_probs=213.3
Q ss_pred eeeeecceEEEEEEcC---CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCCCc
Q 002021 689 LIGRGGFGSVYKASLG---DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 764 (979)
Q Consensus 689 ~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 764 (979)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|+++++.++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999652 56789999997653 2346789999999999999999999999976 56899999999999
Q ss_pred cceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc-ceecc
Q 002021 765 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS-MIQTQ 843 (979)
Q Consensus 765 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~ 843 (979)
|.+++......+++.+++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++........ .....
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999877777999999999999999999999 999999999999999999999999999999876433221 11223
Q ss_pred cccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhh
Q 002021 844 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922 (979)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 922 (979)
..+|+.|+|||++.++.++.++|||||||++|||++ |+.||......+ ....+... .+.
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~------------------~~~ 558 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQG------------------KRM 558 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTT------------------CCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcC------------------CCC
Confidence 346789999999988899999999999999999998 999997632221 11111100 011
Q ss_pred HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceecc
Q 002021 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQS 976 (979)
Q Consensus 923 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~~ 976 (979)
..+..+++++.++|.+||..||++||++.|+++.|+++..+.........+.++
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s~lev 612 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALEV 612 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSSSCSC
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCccceec
Confidence 122356778999999999999999999999999999999988888777766654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=351.31 Aligned_cols=260 Identities=24% Similarity=0.413 Sum_probs=211.2
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.++|+..+.||+|+||.||+|...+++.||||++.... ...+.+.+|+++++.++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 46788899999999999999988788899999986543 345778999999999999999999999864 4588999999
Q ss_pred CCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||++++++.+||+|||.+....... ..
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cc
Confidence 9999999987642 36899999999999999999999 9999999999999999999999999999998764332 12
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......++..|+|||.+.++.++.++||||+|+++|||++ |+.||......+ ....+....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~---------------- 227 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGY---------------- 227 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC----------------
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhccc----------------
Confidence 2234456789999999988889999999999999999999 999986532211 111110000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
....+..++.++.+++.+|+..||++|||+.|+++.|+++..+...
T Consensus 228 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 228 --RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred --CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 0001123456799999999999999999999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=365.69 Aligned_cols=273 Identities=17% Similarity=0.229 Sum_probs=205.8
Q ss_pred hCCCCCCceeeee--cceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRG--GFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G--~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
.++|+..+.||+| +||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3678899999999 9999999954 579999999997543 2334677889999999999999999999999999999
Q ss_pred EEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 756 VLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
||||+++|+|.+++... ...+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999998764 346899999999999999999999 99999999999999999999999999999865432
Q ss_pred CCC-----cceecccccCCCCCCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc--
Q 002021 835 EDQ-----SMIQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS-- 905 (979)
Q Consensus 835 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-- 905 (979)
... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.....+........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 211 111233478999999999887 57899999999999999999999999764333222111100000000
Q ss_pred --------------------cchhhc---ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 --------------------TMEVVD---ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 --------------------~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+... .............+..+++++.+++.+||+.||++|||+.|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 000000001112334566789999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=366.81 Aligned_cols=262 Identities=25% Similarity=0.435 Sum_probs=200.8
Q ss_pred CCCCceeeeecceEEEEEEcC--CC--cEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeec-cCCeeEEEE
Q 002021 684 FSENNLIGRGGFGSVYKASLG--DG--MEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCS-NEEFKALVL 757 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~--~~--~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~ 757 (979)
|+..+.||+|+||.||+|... ++ ..||||.+.... ....+.+.+|+.++++++||||+++++++. .++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 556689999999999999652 22 468999986543 234577899999999999999999999865 456789999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++......+++.+++.++.|+++||+||| +++|+||||||+||++++++.+||+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 999999999999887777899999999999999999999 99999999999999999999999999999986643321
Q ss_pred c--ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 838 S--MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 838 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
. .......+|+.|+|||.+.+..++.++|||||||++|||+| |..||......+ ....+....
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~------------ 313 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGR------------ 313 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTC------------
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCC------------
Confidence 1 12234457889999999998899999999999999999999 666775532221 111111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
+...+..++..+.+++.+||+.||++|||+.|++++|+++.+++..+.
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 001123456679999999999999999999999999999998776544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=363.03 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=204.2
Q ss_pred HhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCee
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (979)
...++|+..+.||+|+||.||+|+. .+|+.||||+++... ....+.+..|.++++.+ +||||+++++++.+++..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3457899999999999999999964 578999999997542 23456678899999887 899999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
|+||||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999999987643 6899999999999999999999 9999999999999999999999999999998643
Q ss_pred CCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+....
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~----------- 234 (345)
T 1xjd_A 170 LGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDN----------- 234 (345)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-----------
T ss_pred cCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHhCC-----------
Confidence 2221 234567999999999999989999999999999999999999999753211 1111100000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHH-HHHHH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAK-EIVTK 956 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-eil~~ 956 (979)
...+..++.++.+++.+|++.||++||++. |+++|
T Consensus 235 --------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 235 --------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 001123456789999999999999999997 66643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.78 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=208.2
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 5688899999999999999954 478999999986443 23456788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|.+++... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+..........
T Consensus 87 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999998764 36899999999999999999999 9999999999999999999999999999998654332222
Q ss_pred eecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||............|......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 227 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------------- 227 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT---------------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc---------------
Confidence 2345678999999999987665 778999999999999999999997644333333333221100
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......++..+.+++.+|++.||++|||+.|+++|
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01112345678999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=353.38 Aligned_cols=269 Identities=23% Similarity=0.296 Sum_probs=192.0
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46789999999999999999954 578999999987543 2344678899999999999999999999999999999999
Q ss_pred ecCCCccceeeccC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 759 YMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 759 ~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
|++ |+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5998887643 245899999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc--CCc-cchh
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL--PIS-TMEV 909 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~--~~~-~~~~ 909 (979)
.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .......... ... ...+
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhh
Confidence 3222 2244578999999999876 468999999999999999999999997532211 1111111000 000 0000
Q ss_pred hc-----ccccCc--h----hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VD-----ANLLSQ--E----DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~-----~~~~~~--~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+ ...... . .........++.++.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 000000 0 00011112355679999999999999999999999886
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.76 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=202.8
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcE----EEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGME----VAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|+..+.||+|+||.||+|.. .+++. ||+|.+.... ....+.+.+|+++++.++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 6788999999999999999964 44544 5777765432 335577899999999999999999999998765 789
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|+||+++|+|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999999999887778999999999999999999999 999999999999999999999999999999876544
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
..........+|+.|+|||.+.+..+++++||||+||++|||++ |+.||......+ ....+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~------------ 236 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE------------ 236 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC------------
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCC------------
Confidence 43333445567889999999999999999999999999999999 999997633221 111111100
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+..++.++.+++.+||..||++||++.|+++.|+++.+.
T Consensus 237 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 ------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0011223456789999999999999999999999999999853
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=349.79 Aligned_cols=263 Identities=23% Similarity=0.380 Sum_probs=212.6
Q ss_pred CCCCCCc-eeeeecceEEEEEEc---CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENN-LIGRGGFGSVYKASL---GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
++|...+ .||+|+||.||+|.. .++..||||++.... ....+.+.+|+++++.++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 899999999999964 367889999997643 23456788999999999999999999999 45668999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999999877677999999999999999999999 9999999999999999999999999999998764333
Q ss_pred Cc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 837 QS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 837 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....+....
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~~------------ 230 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK------------ 230 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTC------------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcCC------------
Confidence 22 11233456889999999988889999999999999999999 99999753221 1111111100
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
....+..+++.+.+++.+||+.||++||++.|++++|+++..+.....
T Consensus 231 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 231 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 001122456779999999999999999999999999999998765443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=345.98 Aligned_cols=251 Identities=25% Similarity=0.307 Sum_probs=206.3
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.+.|+..+.||+|+||.||+|. ..++..||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4568889999999999999995 456789999999776556677899999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEEeeccccccCCCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
+++++|.+++.... .+++.+++.++.|++.|++||| +++|+||||||+||++ +.++.+||+|||.+.......
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999999887643 5899999999999999999999 9999999999999999 788999999999998764332
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
......+|+.|+|||.+.+ .+++++||||+|+++|||++|+.||......+. .........
T Consensus 164 ---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~-------------- 224 (277)
T 3f3z_A 164 ---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLKIREGTF-------------- 224 (277)
T ss_dssp ---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC--------------
T ss_pred ---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCC--------------
Confidence 2244578999999998865 489999999999999999999999975322111 111100000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.........+++.+.+++.+|++.||++|||+.|+++|
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 --TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp --CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111122456779999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=346.34 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=205.2
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC--CeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE--EFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5688899999999999999987 48899999987543 23346788999999999999999999999876 7889999
Q ss_pred EecCCCccceeeccCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
||+++|+|.+++..... .+++.+++.++.|++.||+||| +++ |+||||||+||+++.++.++++|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999987643 5899999999999999999999 888 99999999999999999999999998765321
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCC---chhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSA---NGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
....+|+.|+|||.+.+..++. ++||||+|+++|||++|+.||......+..... .....
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~--------- 228 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-ALEGL--------- 228 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH-HHSCC---------
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH-HhcCC---------
Confidence 2346889999999987765544 799999999999999999999753222111110 00000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
....+..+++.+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 ---------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 001112355679999999999999999999999999998864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.92 Aligned_cols=263 Identities=24% Similarity=0.408 Sum_probs=207.5
Q ss_pred CCCCCCceeeeecceEEEEEEcCC----CcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEee-ccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGD----GMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSC-SNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 755 (979)
..|+..+.||+|+||.||+|...+ ...||||++..... ...+.+.+|++++++++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457788999999999999996532 23689999875432 3456788999999999999999999985 55678899
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++......+++.+++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999999887777999999999999999999999 999999999999999999999999999999876433
Q ss_pred CC--cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCC-CCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 836 DQ--SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK-KPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 836 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.. ........+|+.|+|||.+.+..+++++||||+|+++|||++|. .||......+ ..........
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~~~~~~---------- 250 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLLQGRR---------- 250 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-HHHHHHTTCC----------
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHhcCCC----------
Confidence 21 12233456788999999998889999999999999999999954 4554322111 1111111000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccC
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRN 967 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~ 967 (979)
...+..++..+.+++.+||+.||++|||+.|+++.|+++.+++..+
T Consensus 251 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 251 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred ---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 0011234566899999999999999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=359.16 Aligned_cols=280 Identities=27% Similarity=0.335 Sum_probs=202.9
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHH--HHhcCCCCeeeEEEee-----ccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEI--MKSIRHRNLIKVISSC-----SNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~-----~~~~~~ 753 (979)
.++|+..+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++ ......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788999999999999999977 68999999986432 2344445555 4458999999999744 234467
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEecCCCCCCEEeCCCCcEEEE
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA---------PVIHCDLKPSNVLLDDNMVAHLS 824 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~---------~i~H~Dik~~NIll~~~~~~kl~ 824 (979)
++||||+++|+|.+++.... .++..++.++.|+++||+||| +. +|+||||||+||+++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 89999999999999997654 588999999999999999999 77 99999999999999999999999
Q ss_pred eeccccccCCCCC------cceecccccCCCCCCccccCC-------CCCCCchhHHHHHHHHHHHHcCCCCCcccccCc
Q 002021 825 DFSIAKMLTGEDQ------SMIQTQTLATIGYMAPEYGRE-------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891 (979)
Q Consensus 825 Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~ 891 (979)
|||+++.+..... ........||+.|+|||++.+ ..+++++|||||||++|||++|+.||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987643221 112234569999999999876 456778999999999999999988765432211
Q ss_pred chHhHhhhhhcCCccch----hhc-ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 892 MTLKHWVNDWLPISTME----VVD-ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 892 ~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
.....+..........+ ... ................++..+.+++.+||+.||++|||++|+++.|+++.+.+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 11111100000000000 000 0000000001111234667899999999999999999999999999999988776
Q ss_pred CCC
Q 002021 967 NVG 969 (979)
Q Consensus 967 ~~~ 969 (979)
+-+
T Consensus 323 ~~~ 325 (336)
T 3g2f_A 323 NKS 325 (336)
T ss_dssp ---
T ss_pred ccc
Confidence 544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=357.34 Aligned_cols=275 Identities=25% Similarity=0.410 Sum_probs=215.2
Q ss_pred CCCCCCceeeeecceEEEEEE-----cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC--eeE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-----LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE--FKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~ 754 (979)
+.|+..+.||+|+||.||+|. ..+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 557888999999999999997 3468999999997765556678999999999999999999999886644 789
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+++++|.+++......+++.+++.++.|+++||+||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999999999887667999999999999999999999 99999999999999999999999999999987654
Q ss_pred CCCcc-eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccc--hhhc
Q 002021 835 EDQSM-IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM--EVVD 911 (979)
Q Consensus 835 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 911 (979)
..... ......++..|+|||.+.+..++.++||||+|+++|||+||..||...... +............. .+..
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHHH
Confidence 33221 122345677899999998888999999999999999999999997642110 00000000000000 0000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
... ...+.+.+..++.++.+++.+||+.||++|||+.|+++.|+++++++.
T Consensus 275 -~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 275 -LLK--NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp -HHH--TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -Hhh--cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 000 000111223566789999999999999999999999999999998763
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=364.67 Aligned_cols=272 Identities=23% Similarity=0.399 Sum_probs=217.5
Q ss_pred HHHHHhhCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEee
Q 002021 675 LELCRATDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSC 747 (979)
Q Consensus 675 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 747 (979)
.++....++|+..+.||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 334445678999999999999999999643 467899999875432 2345688999999999999999999999
Q ss_pred ccCCeeEEEEEecCCCccceeeccCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC
Q 002021 748 SNEEFKALVLEYMPHGSLEKYLYSSN---------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN 818 (979)
Q Consensus 748 ~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~ 818 (979)
.+.+..++||||+++|+|.+++...+ ..+++..++.++.|++.||+||| +++|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence 99999999999999999999987532 35689999999999999999999 8999999999999999999
Q ss_pred CcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHh
Q 002021 819 MVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHW 897 (979)
Q Consensus 819 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~ 897 (979)
+.+||+|||++................+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~ 252 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRF 252 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HHHHH
Confidence 9999999999987643333223344567889999999988889999999999999999999 88998653211 11111
Q ss_pred hhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCC
Q 002021 898 VNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVG 969 (979)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~ 969 (979)
+.. .. .. ..+..++..+.+++.+||+.||++|||+.|++++|+++.+....++.
T Consensus 253 ~~~---~~--------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~ 306 (322)
T 1p4o_A 253 VME---GG--------LL-------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306 (322)
T ss_dssp HHT---TC--------CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred HHc---CC--------cC-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence 100 00 00 01124556789999999999999999999999999988765554443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=379.53 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=212.3
Q ss_pred hCCCCCCceeeeecceEEEEEEcC-CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..+|+..+.||+|+||.||+|.+. ++..||||+++... ...+.|.+|++++++++||||++++++|.+++..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 356788899999999999999664 48899999997543 3457799999999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++|+|.+++... ...+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence 9999999999764 346899999999999999999999 9999999999999999999999999999998764322 2
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.......+++.|+|||.+....++.++|||||||++|||+| |+.||......+ ....+...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~---------------- 435 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKD---------------- 435 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTT----------------
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC----------------
Confidence 22234456789999999988899999999999999999999 999987532211 11111100
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
.+...+..++..+.++|.+||+.||++|||+.|+++.|+++.
T Consensus 436 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 011122356678999999999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=354.87 Aligned_cols=273 Identities=24% Similarity=0.399 Sum_probs=211.6
Q ss_pred CCCCceeeeecceEEEEEEc-----CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeecc--CCeeEE
Q 002021 684 FSENNLIGRGGFGSVYKASL-----GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKAL 755 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 755 (979)
|+..+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 47889999999999998854 2688999999976532 335678899999999999999999999976 467899
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++... .+++.+++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999999765 4899999999999999999999 999999999999999999999999999999877543
Q ss_pred CCc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC-Cccchhhccc
Q 002021 836 DQS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP-ISTMEVVDAN 913 (979)
Q Consensus 836 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 913 (979)
... .......+|..|+|||.+.+..++.++||||+|+++|||++|+.||............+...... ....+..+..
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 322 22334567888999999988889999999999999999999999986532211110000000000 0000011100
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccC
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRN 967 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~ 967 (979)
.....+..++.++.+++.+||+.||++|||+.|+++.|+++.+++...
T Consensus 268 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 268 ------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 111122356678999999999999999999999999999999877543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=356.78 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=195.5
Q ss_pred hCCCCCCceeeeecceEEEEEEc----CCCcEEEEEEecccc----ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQC----GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++++.++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36788999999999999999965 578999999987542 2234567889999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.++||||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999999987643 5899999999999999999999 899999999999999999999999999999764
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ ..........
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~---------- 238 (327)
T 3a62_A 172 IHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKILKCKL---------- 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCC----------
T ss_pred ccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCC----------
Confidence 3222 12244578999999999998899999999999999999999999997532111 1111111000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
..+..++.++.+++.+||+.||++|| ++.|+++|
T Consensus 239 ----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 01123456789999999999999999 78888876
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=352.48 Aligned_cols=245 Identities=21% Similarity=0.203 Sum_probs=195.2
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc--chhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||+||+|.. .+|+.||||++...... ....+..|+..+.++ +||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 5688899999999999999965 47999999998654322 223444555555555 8999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+ +++|.+++...+..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 66999998877777999999999999999999999 8999999999999999999999999999998764322
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+... .........
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~----------------- 267 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQG----------------- 267 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTT-----------------
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhcc-----------------
Confidence 2244568999999998875 7899999999999999999997765431 111111000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+..++.++.+++.+|++.||++|||+.|+++|
T Consensus 268 -~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 268 -YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 00112233456779999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=359.37 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=202.9
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (979)
++|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5688899999999999999954 578999999997543 22345678899999988 899999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++...+ .+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999987643 6899999999999999999999 9999999999999999999999999999998643222
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcch---HhHhhhhhcCCccchhhccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT---LKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 913 (979)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||......... ....... .+....
T Consensus 165 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------~i~~~~ 235 (345)
T 3a8x_A 165 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------VILEKQ 235 (345)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH-------HHHHCC
T ss_pred --CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH-------HHHcCC
Confidence 1234567999999999999989999999999999999999999999653211100 0000000 000000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH------HHHHHH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA------KEIVTK 956 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~eil~~ 956 (979)
...+..++.++.+++.+|++.||++||++ .|+++|
T Consensus 236 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 --------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 00112345678999999999999999995 677765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=351.61 Aligned_cols=278 Identities=23% Similarity=0.339 Sum_probs=216.6
Q ss_pred ccHHHHHHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHh--cCCCCeeeEEEeecc
Q 002021 672 FSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKS--IRHRNLIKVISSCSN 749 (979)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 749 (979)
.+........++|+..+.||+|+||.||+|+. +|+.||||++... ..+.+.+|+++++. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34444455567899999999999999999987 5899999998643 34567789999888 789999999999977
Q ss_pred CC----eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecCCCCCCEEeCCCCc
Q 002021 750 EE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY-----SAPVIHCDLKPSNVLLDDNMV 820 (979)
Q Consensus 750 ~~----~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~i~H~Dik~~NIll~~~~~ 820 (979)
.. ..++||||+++|+|.+++... .+++.+++.++.|++.|++|||... +++|+||||||+||+++.++.
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence 65 789999999999999999764 5899999999999999999999321 479999999999999999999
Q ss_pred EEEEeeccccccCCCCCcc--eecccccCCCCCCccccCCC------CCCCchhHHHHHHHHHHHHcC----------CC
Q 002021 821 AHLSDFSIAKMLTGEDQSM--IQTQTLATIGYMAPEYGREG------RVSANGDVYSFGIMLMETFTG----------KK 882 (979)
Q Consensus 821 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg----------~~ 882 (979)
+||+|||++.......... ......||+.|+|||.+.+. .+++++||||||+++|||+|| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999998765433221 22445789999999998765 334789999999999999999 67
Q ss_pred CCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 883 PTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 883 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
||............+.......... ...........++..+.+++.+||+.||++|||+.|++++|+++.+
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLR---------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCC---------CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCcCcccHHHHHHHHHHHHhC---------CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 7765444333333332222111110 0000111223567789999999999999999999999999999987
Q ss_pred hh
Q 002021 963 SL 964 (979)
Q Consensus 963 ~~ 964 (979)
+.
T Consensus 337 ~~ 338 (342)
T 1b6c_B 337 QE 338 (342)
T ss_dssp TT
T ss_pred Hh
Confidence 64
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=348.96 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=207.2
Q ss_pred hCCCCCCceeeeecceEEEEEEcC----CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
.++|+..+.||+|+||.||+|... ++..||||++.... ....+.+.+|+++++.++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 467888899999999999999642 23469999987553 23456788999999999999999999998754 5689
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++++|.+++......+++..++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999999999877667999999999999999999999 999999999999999999999999999999876433
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. .......+|+.|+|||.+.+..+++++||||+|+++|||++ |+.||......+ ....+.....
T Consensus 167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~----------- 232 (281)
T 3cc6_A 167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDR----------- 232 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCC-----------
T ss_pred cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCC-----------
Confidence 21 22234457889999999988889999999999999999998 999986532221 1111110000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
...+..+++.+.+++.+||..||++|||+.|++++|+++.+..
T Consensus 233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 0011234567899999999999999999999999999988643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=359.64 Aligned_cols=245 Identities=22% Similarity=0.237 Sum_probs=204.8
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5788899999999999999954 579999999986542 234567888999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++...+ .+++.+++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 9999999999987643 5899999999999999999999 999999999999999999999999999999876432
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+........
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~--------------- 255 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGKV--------------- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC---------------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHcCCC---------------
Confidence 13457899999999999989999999999999999999999999753211 11111111000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
..+..++.++.+++.+|++.||++||+ ++|+++|
T Consensus 256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 011234567899999999999999998 8888876
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=347.59 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=186.3
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46788899999999999999954 689999999986442 22346788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++......+++.+++.++.|+++|++||| +++|+||||||+||+++.++.+||+|||.+.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999877677999999999999999999999 9999999999999999999999999999998764322
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
. ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+. ... . .....
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----~--------~~~~~-- 229 (278)
T 3cok_A 167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNK----V--------VLADY-- 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------C--------CSSCC--
T ss_pred C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHH----H--------hhccc--
Confidence 1 12345689999999999888899999999999999999999999875321111 000 0 00000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+..++.++.+++.+||+.||++|||+.|+++|
T Consensus 230 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 ------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0112345668999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.83 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=202.9
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
..++|+..+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 34678899999999999999995 4679999999987532 2345678899999999999999999999999999999
Q ss_pred EEEecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 756 VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
||||+++++|.+++.. ....+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999998864 3456899999999999999999999 999999999999999999999999999999865
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
..... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.............+.... ..
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~----- 256 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD---YP----- 256 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC---SC-----
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc---CC-----
Confidence 43221 123456899999999999889999999999999999999999998653222111111111000 00
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
......++.++.+++.+||..||++|||+.|++++|+++........
T Consensus 257 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 257 ---------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ---------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ---------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 00012345678999999999999999999999999999998776554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=357.62 Aligned_cols=257 Identities=22% Similarity=0.283 Sum_probs=200.6
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccc-----cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQ-----CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
..++|+..+.||+|+||.||+|. ..+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 45679999999999999999995 467889999998643 234456788999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeccC---------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 002021 754 ALVLEYMPHGSLEKYLYSS---------------------------------------NCILDIFQRLNIMIDVASALEY 794 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~~L~~ 794 (979)
++||||+++|+|.+++... ...+++..++.++.|++.||+|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 9999999999999988521 1123577888999999999999
Q ss_pred HhcCCCCCeEecCCCCCCEEeCCCC--cEEEEeeccccccCCCCC--cceecccccCCCCCCccccCC--CCCCCchhHH
Q 002021 795 LHFGYSAPVIHCDLKPSNVLLDDNM--VAHLSDFSIAKMLTGEDQ--SMIQTQTLATIGYMAPEYGRE--GRVSANGDVY 868 (979)
Q Consensus 795 LH~~~~~~i~H~Dik~~NIll~~~~--~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvw 868 (979)
|| +++|+||||||+||+++.++ .+||+|||++..+..... ........||+.|+|||.+.+ ..+++++|||
T Consensus 184 LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 184 LH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 99 89999999999999998776 899999999986543221 222345679999999998865 6789999999
Q ss_pred HHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC
Q 002021 869 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI 948 (979)
Q Consensus 869 slG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 948 (979)
|+|+++|||++|+.||......+. ......... ....+....+++++.+++.+|++.||.+||
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADT-ISQVLNKKL----------------CFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC----------------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHCCCCCCCCChHHH-HHHHHhccc----------------ccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999975322211 111111000 001112223567799999999999999999
Q ss_pred CHHHHHHH
Q 002021 949 NAKEIVTK 956 (979)
Q Consensus 949 s~~eil~~ 956 (979)
++.|+++|
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999886
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=353.81 Aligned_cols=249 Identities=20% Similarity=0.250 Sum_probs=182.2
Q ss_pred CceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEEEecCCCc
Q 002021 687 NNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGS 764 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~g~ 764 (979)
.+.||+|+||.||+|.. .+++.||||++... ....+.+|+++++.++ ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999954 57899999998643 3456788999999997 9999999999999999999999999999
Q ss_pred cceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEEeeccccccCCCCCccee
Q 002021 765 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 765 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
|.+++... ..+++.++..++.|++.||+||| +++|+||||||+||+++.++ .+||+|||+++...... ...
T Consensus 93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 166 (325)
T 3kn6_A 93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPL 166 (325)
T ss_dssp HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Ccc
Confidence 99999775 36899999999999999999999 99999999999999998665 89999999998654322 222
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCc--chHhHhhhhhcCCccchhhcccccCchh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE--MTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........... .....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~------------~~~~~ 234 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK------------KGDFS 234 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT------------TTCCC
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH------------cCCCC
Confidence 44568999999999999999999999999999999999999997633211 01111111111 00111
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+..++.++.+++.+|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1112334567789999999999999999999998865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.73 Aligned_cols=262 Identities=23% Similarity=0.388 Sum_probs=209.0
Q ss_pred CCCCceeeeecceEEEEEEc-CC---CcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee-EEEE
Q 002021 684 FSENNLIGRGGFGSVYKASL-GD---GMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK-ALVL 757 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~---~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~ 757 (979)
|+..+.||+|+||.||+|.. .+ +..||+|++..... ...+.+.+|+++++.++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 45568999999999999964 22 33799999875432 3456788999999999999999999999766554 9999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+.+|+|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++........
T Consensus 103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999999887778999999999999999999999 89999999999999999999999999999986543221
Q ss_pred --cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 838 --SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 838 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
........+|+.|+|||.+.+..+++++||||+|+++|||++|..|+....... .....+.....
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~------------ 246 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLAQGRR------------ 246 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHHTTCC------------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhhcCCC------------
Confidence 122234567889999999999999999999999999999999766654322221 11111111110
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccC
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRN 967 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~ 967 (979)
...+..++..+.+++.+||+.||++|||+.|+++.|+++.+++...
T Consensus 247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 0111234567899999999999999999999999999999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=356.72 Aligned_cols=260 Identities=27% Similarity=0.462 Sum_probs=204.2
Q ss_pred CCCCCCceeeeecceEEEEEEcCC-----CcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGD-----GMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
..|+..+.||+|+||.||+|.... +..||||++..... .....+.+|+++++.++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456667899999999999996432 34699999875432 334578899999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999877678999999999999999999999 899999999999999999999999999999876433
Q ss_pred CC-cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 836 DQ-SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 836 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
.. ........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....+....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~~~~~~~~----------- 267 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAINDGF----------- 267 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTC-----------
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHCCC-----------
Confidence 22 112233456788999999988899999999999999999999 99998653221 1111110000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
+.+.+..++..+.+++.+||+.||++||++.|++++|+++.+..
T Consensus 268 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 268 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00111235567899999999999999999999999999988743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=359.72 Aligned_cols=249 Identities=20% Similarity=0.257 Sum_probs=204.3
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 755 (979)
.++|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+..|.+++..+ +||+|+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 46799999999999999999965 458899999987542 23456678899999988 79999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++...+ .+++.+++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 999999999999987643 5899999999999999999999 999999999999999999999999999999864322
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+........
T Consensus 175 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~~~~------------- 238 (353)
T 2i0e_A 175 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNV------------- 238 (353)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC-------------
T ss_pred C--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHHHHHhCCC-------------
Confidence 2 2234567999999999999899999999999999999999999999753211 11111111000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
..+..++.++.+++.+|++.||++||+ +.|+++|
T Consensus 239 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 -------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011234567899999999999999995 6888776
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=354.04 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=199.3
Q ss_pred hhCCCCCCceeeeecceEEEEEEcC----CCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC--
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE-- 751 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 751 (979)
..++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3466888899999999999999542 35589999987542 233467889999999999999999999987654
Q ss_pred ---eeEEEEEecCCCccceeecc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEE
Q 002021 752 ---FKALVLEYMPHGSLEKYLYS-----SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 823 (979)
Q Consensus 752 ---~~~lv~E~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl 823 (979)
..++||||+++|+|.+++.. ....+++.+++.++.|+++||+||| +++|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence 35999999999999999842 2356899999999999999999999 999999999999999999999999
Q ss_pred EeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhc
Q 002021 824 SDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 824 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
+|||++................+++.|+|||.+.+..+++++||||||+++|||++ |..||......+. .........
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~~ 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-YDYLLHGHR 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HHHHHTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHHcCCC
Confidence 99999987654333333344567889999999988899999999999999999999 8888865322211 111111000
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
...+..++..+.+++.+||..||++|||+.|++++|+++.++..
T Consensus 268 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 268 -------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp -------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 01112455679999999999999999999999999999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=351.23 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=205.9
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccccc------chhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGR------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
.+.|+..+.||+|+||.||+|. ..+|+.||||++...... ..+.+.+|+++++.++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3568889999999999999995 457999999998654321 246688999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----cEEEEeeccc
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFSIA 829 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfg~~ 829 (979)
++||||+++++|.+++... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999764 36899999999999999999999 99999999999999999887 7999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
....... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+ .........
T Consensus 167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~-------- 234 (321)
T 2a2a_A 167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITSVS-------- 234 (321)
T ss_dssp EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTC--------
T ss_pred eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhcc--------
Confidence 8764322 1234568999999999998899999999999999999999999996532111 111110000
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..........++..+.+++.+|+..||++|||+.|+++|
T Consensus 235 --------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 --------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000111223456678999999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=359.40 Aligned_cols=253 Identities=22% Similarity=0.254 Sum_probs=195.1
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46799999999999999999954 579999999996543 2346688999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc--EEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~--~kl~Dfg~~~~~~~~~~ 837 (979)
+++|+|.+++...+ .+++..++.++.|++.||+||| +++|+||||||+||+++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 99999999986643 5899999999999999999999 999999999999999987765 999999999753222
Q ss_pred cceecccccCCCCCCccccCCCCCCCc-hhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSAN-GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.......||+.|+|||++.+..+..+ +||||+||++|||++|+.||........ +...+.......
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~----------- 238 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVK----------- 238 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTC-----------
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCC-----------
Confidence 12244579999999999888777655 8999999999999999999976433222 111111111000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+....+++++.+++.+||+.||++|||+.|+++|
T Consensus 239 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 ---YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0001111345678999999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=358.55 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=197.0
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCC--CCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRH--RNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 756 (979)
.+.|+..+.||+|+||.||+|...+++.||||++.... ....+.+.+|+++++.++| |||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35688899999999999999988889999999986543 2234678899999999986 9999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
||+ .+++|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++ ++.+||+|||++.......
T Consensus 88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 995 5789999997753 6899999999999999999999 89999999999999997 5789999999998765443
Q ss_pred CcceecccccCCCCCCccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 837 QSMIQTQTLATIGYMAPEYGRE-----------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
.........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....................
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~- 240 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI- 240 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC-
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc-
Confidence 3333445679999999998754 6788999999999999999999999975322211111111100000
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
..+..++.++.+++.+||+.||.+|||+.|+++|-
T Consensus 241 -----------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 241 -----------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -----------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 00112234688999999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=363.85 Aligned_cols=277 Identities=19% Similarity=0.263 Sum_probs=212.5
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC--eeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE--FKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 757 (979)
+.|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 5688899999999999999954 469999999997543 234567789999999999999999999987654 779999
Q ss_pred EecCCCccceeeccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----CCCCcEEEEeeccccc
Q 002021 758 EYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFSIAKM 831 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll----~~~~~~kl~Dfg~~~~ 831 (979)
||+++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997653 23899999999999999999999 9999999999999999 7888899999999987
Q ss_pred cCCCCCcceecccccCCCCCCccccCC--------CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchH---hHhhhh
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGRE--------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL---KHWVND 900 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~---~~~~~~ 900 (979)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ......
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 64322 2234579999999998764 567889999999999999999999997543322221 111111
Q ss_pred hcCCccchhhccc-----ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 901 WLPISTMEVVDAN-----LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 901 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
..+.....+.... ...............+..+.+++.+|++.||++||+++|+++.++++.+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 1111111000000 000000011122456678999999999999999999999999999988743
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=351.14 Aligned_cols=271 Identities=21% Similarity=0.248 Sum_probs=201.8
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc---chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR---AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999964 57899999998754322 246788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++.... .+++.+++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999987643 6899999999999999999999 9999999999999999999999999999998654322
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
........+++.|+|||.+.+..++.++||||+|+++|||++|+.||...... .....+....+.
T Consensus 189 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~------------ 253 (309)
T 2h34_A 189 -LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR------------ 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC------------
T ss_pred -cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC------------
Confidence 12223456899999999999889999999999999999999999999753211 111111100000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCC-CHHHHHHHHHHhHHhhccCCCCccee
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-NAKEIVTKLLKIRDSLLRNVGGRCVR 974 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~eil~~L~~~~~~~~~~~~~~~~~ 974 (979)
....+..++.++.+++.+||+.||++|| +++|+++.|+++......+.....+|
T Consensus 254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~~~~~~ 308 (309)
T 2h34_A 254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDILR 308 (309)
T ss_dssp ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------------
T ss_pred ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccchhhhhh
Confidence 0011234556789999999999999999 99999999999887766555444443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.07 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=198.2
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC-------
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------- 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 751 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 35688899999999999999965 489999999987543 234577899999999999999999999885433
Q ss_pred --------------------------------------------------eeEEEEEecCCCccceeeccCC--CCCCHH
Q 002021 752 --------------------------------------------------FKALVLEYMPHGSLEKYLYSSN--CILDIF 779 (979)
Q Consensus 752 --------------------------------------------------~~~lv~E~~~~g~L~~~l~~~~--~~l~~~ 779 (979)
..++||||+++|+|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3799999999999999997653 345677
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc----------ceecccccCCC
Q 002021 780 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS----------MIQTQTLATIG 849 (979)
Q Consensus 780 ~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~ 849 (979)
.++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999 999999999999999999999999999999876543211 12234579999
Q ss_pred CCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHH
Q 002021 850 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 929 (979)
Q Consensus 850 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (979)
|+|||.+.+..+++++||||+||++|||++|..|+..... ... ..... .........+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~----~~~---~~~~~---------------~~~~~~~~~~ 299 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR----IIT---DVRNL---------------KFPLLFTQKY 299 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH----HHH---HHHTT---------------CCCHHHHHHC
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH----HHH---Hhhcc---------------CCCcccccCC
Confidence 9999999988999999999999999999998877532110 000 00000 0011223445
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 930 SFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 930 ~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+.+.+++.+||+.||++|||+.|+++|
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 668999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=353.55 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=208.2
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeec----cCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS----NEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~l 755 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++........+.+.+|+++++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 36788999999999999999954 689999999987655556678899999999999999999999986 3457899
Q ss_pred EEEecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 756 VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
||||+++|+|.+++.. ....+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999875 3557999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCc-------ceecccccCCCCCCccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc
Q 002021 833 TGEDQS-------MIQTQTLATIGYMAPEYGREGR---VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 833 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
...... .......||+.|+|||.+.+.. +++++||||||+++|||++|+.||..................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 321111 0112345799999999987543 789999999999999999999999753322222211111100
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
..+....++.++.+++.+||+.||.+|||+.|++++|+++....
T Consensus 265 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 265 ------------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred ------------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00111234567999999999999999999999999999886543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=347.01 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=201.3
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4678889999999999999994 5568899999986432 22346688999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++.... .+++..++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 99999999999987643 5899999999999999999999 9999999999999999999999999999986543221
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.....||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+ ..... ...
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~--------------- 222 (279)
T 3fdn_A 164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRI-SRV--------------- 222 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHH-HHT---------------
T ss_pred ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HHHHH-HhC---------------
Confidence 234578999999999998889999999999999999999999987522111 01100 000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..++..+.+++.+||+.||++|||+.|+++|
T Consensus 223 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 ----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000112345668899999999999999999999997
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=369.06 Aligned_cols=247 Identities=26% Similarity=0.357 Sum_probs=204.7
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 6788899999999999999954 579999999986542 223467889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++... ..+++.+++.++.||+.|++||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp ECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 999999999999764 36899999999999999999999 9999999999999999999999999999998764322
Q ss_pred cceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.....+||+.|+|||++.+..+ ++++||||+||++|||++|+.||....... ......... .
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~-------------~- 233 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDGI-------------F- 233 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-HHHHHHTTC-------------C-
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCC-------------c-
Confidence 2244579999999999987765 689999999999999999999997532111 111110000 0
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+..+++++.+++.+||+.||++|||+.|+++|
T Consensus 234 ------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 ------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0112345668999999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.34 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=205.0
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.++|+..+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4778999999999999999995 4578999999986543 233467889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc---EEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~Dfg~~~~~~~ 834 (979)
||+++++|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++. +||+|||.+.....
T Consensus 85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 9999999988886653 6899999999999999999999 999999999999999986655 99999999987643
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||....... ...........
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~----------- 225 (284)
T 3kk8_A 161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYD----------- 225 (284)
T ss_dssp SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC-----------
T ss_pred Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhcccc-----------
Confidence 22 2244578999999999999999999999999999999999999986532111 11111100000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........+++++.+++.+|++.||++|||+.|+++|
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0001112345678999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=355.85 Aligned_cols=256 Identities=16% Similarity=0.163 Sum_probs=209.9
Q ss_pred hhCCCCCCceeeeecceEEEEEE------cCCCcEEEEEEeccccccchhcHHHHHHHHHhcC---CCCeeeEEEeeccC
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS------LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR---HRNLIKVISSCSNE 750 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 750 (979)
..+.|...+.||+|+||.||+|. ..+++.||||++... ....+..|+++++.++ |+||+++++++..+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678888999999999999993 457889999998654 3456788898888887 99999999999999
Q ss_pred CeeEEEEEecCCCccceeecc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---------
Q 002021 751 EFKALVLEYMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--------- 817 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~--------- 817 (979)
+..++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +++|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999974 3456999999999999999999999 999999999999999998
Q ss_pred --CCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHh
Q 002021 818 --NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 895 (979)
Q Consensus 818 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~ 895 (979)
++.+||+|||+++.+............+||+.|+|||++.+..+++++|||||||++|||+||+.||.....+.....
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~ 296 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec
Confidence 899999999999765433334445667899999999999999999999999999999999999999865433211100
Q ss_pred HhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCC-CCHHHHHHHHHHhHHhhcc
Q 002021 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQR-INAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-ps~~eil~~L~~~~~~~~~ 966 (979)
. .... . .....+.+++.+|++.+|.+| |+++++.+.|+++.++...
T Consensus 297 ~-----------------~~~~----~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~ 343 (365)
T 3e7e_A 297 G-----------------LFRR----L----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343 (365)
T ss_dssp S-----------------CCTT----C----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTT
T ss_pred h-----------------hccc----c----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhh
Confidence 0 0000 0 113446789999999999998 6888999999988876443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=356.24 Aligned_cols=261 Identities=23% Similarity=0.386 Sum_probs=198.4
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe----
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF---- 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 752 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++..... .....+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4678999999999999999995 46899999999975432 223568899999999999999999999866543
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.++||||+++++|.+++...+ .+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 499999999999999987643 6899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 833 TGEDQS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 833 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+..... ..
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~------------ 233 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VR------------ 233 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HH------------
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hc------------
Confidence 433222 2223456899999999999889999999999999999999999999653221111110 00
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHH-HHHHHhHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIV-TKLLKIRD 962 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil-~~L~~~~~ 962 (979)
............++.++.+++.+||+.||++||++.+++ +.+.++..
T Consensus 234 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 234 ----EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp ----CCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ----CCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 000011112234567799999999999999999666554 55555543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=354.23 Aligned_cols=268 Identities=20% Similarity=0.256 Sum_probs=199.6
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|...+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4688889999999999999954 5789999999865432 2233456799999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++ |+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K 155 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence 97 5999998887778999999999999999999999 9999999999999999999999999999998654222 2
Q ss_pred eecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh---cCCccchhhccc--
Q 002021 840 IQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW---LPISTMEVVDAN-- 913 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-- 913 (979)
......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ......... ....+.......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcchhh
Confidence 2244578999999998876 568999999999999999999999997632211 111111111 011111111000
Q ss_pred ----ccC-chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 914 ----LLS-QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 914 ----~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... ...........+++++.+++.+|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 0000112223456778999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=349.14 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=214.2
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
..++|+..+.||+|+||.||+|.. .++..||||++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 346788889999999999999965 45889999998654 3345778899999999999999999999999999999999
Q ss_pred ecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 759 YMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
|+++++|.+++... ...+++..++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT- 165 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence 99999999999764 346899999999999999999999 8999999999999999999999999999998765332
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
........+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||....... ....+....
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~~~~~~-------------- 229 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDY-------------- 229 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTC--------------
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhccC--------------
Confidence 233344567889999999988899999999999999999999 999986532211 111111000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
....+..+++.+.+++.+|+..||++|||+.|+++.|+++...
T Consensus 230 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 230 ----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 0011134556799999999999999999999999999988764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=357.98 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=200.6
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||.||+|. ..+|+.||||++.... ....+|++++.++ +||||+++++++.+++..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4568889999999999999995 4578999999996542 2346788998888 79999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC----CcEEEEeeccccccCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFSIAKMLTG 834 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~----~~~kl~Dfg~~~~~~~ 834 (979)
|+++|+|.+++...+ .+++.++..++.||+.||+||| +++|+||||||+||++.++ +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999987654 6899999999999999999999 9999999999999998533 3599999999987643
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......... ...
T Consensus 173 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~---------~~~ 239 (342)
T 2qr7_A 173 ENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILARIG---------SGK 239 (342)
T ss_dssp TTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHHHH---------HCC
T ss_pred CCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHHHc---------cCC
Confidence 322 2244578999999999988789999999999999999999999997532111 111111000 000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. .....+..++.++.+++.+|+..||++|||+.|+++|
T Consensus 240 ~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 240 FS---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CC---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cc---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0001123456678999999999999999999999886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=347.20 Aligned_cols=269 Identities=23% Similarity=0.268 Sum_probs=202.4
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-----ccchhcHHHHHHHHHhcC---CCCeeeEEEeeccC
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-----GRAFKSFDVECEIMKSIR---HRNLIKVISSCSNE 750 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 750 (979)
..++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999964 678999999986432 122346778888888775 99999999998765
Q ss_pred C-----eeEEEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEE
Q 002021 751 E-----FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 824 (979)
Q Consensus 751 ~-----~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~ 824 (979)
. ..++||||++ ++|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5799999997 59999987654 34899999999999999999999 9999999999999999999999999
Q ss_pred eeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc--
Q 002021 825 DFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-- 902 (979)
Q Consensus 825 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~-- 902 (979)
|||++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..........
T Consensus 163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 999998754222 2345678999999999998999999999999999999999999997532221 1111111110
Q ss_pred -CCccchhh--cccccCc--hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 903 -PISTMEVV--DANLLSQ--EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 903 -~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+.... ....... ..........++..+.+++.+|++.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000000 0000000 000111223456778999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=360.19 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=192.8
Q ss_pred CCCCCC-ceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHH-hcCCCCeeeEEEeecc----CCeeE
Q 002021 682 DGFSEN-NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMK-SIRHRNLIKVISSCSN----EEFKA 754 (979)
Q Consensus 682 ~~~~~~-~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~ 754 (979)
++|... +.||+|+||.||+|. ..+|+.||||++.. ...+.+|++++. ..+||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456655 689999999999995 45789999999853 245678888875 4589999999998865 66789
Q ss_pred EEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEEeecccc
Q 002021 755 LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFSIAK 830 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfg~~~ 830 (979)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+||| +++|+||||||+||+++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998753 46899999999999999999999 899999999999999997 7899999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcch--HhHhhhhhcCCccch
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT--LKHWVNDWLPISTME 908 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~--~~~~~~~~~~~~~~~ 908 (979)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+...
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~------- 282 (400)
T 1nxk_A 213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG------- 282 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-------
T ss_pred ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-------
Confidence 654222 224567899999999999999999999999999999999999999764322110 11110000
Q ss_pred hhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.. .........++.++.+++.+||+.||++|||+.|+++|-
T Consensus 283 -----~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 283 -----QY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp -----CC---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred -----cc---cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00 000011234567799999999999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=363.05 Aligned_cols=276 Identities=17% Similarity=0.176 Sum_probs=220.2
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCC-CCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH-RNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|++.+.||+|+||.||+|. ..+++.||||++... ...+.+.+|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT--CSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc--cccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4679999999999999999996 467999999987654 234578899999999987 555566666677888999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEEeeccccccCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|+ +++|.+++......+++.+++.|+.||+.||+||| +++|+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 89999999876668999999999999999999999 9999999999999999 58899999999999876543
Q ss_pred CCc-----ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 836 DQS-----MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 836 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............ . .+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--~--------~i~ 229 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY--E--------KIS 229 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH--H--------HHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH--H--------HHh
Confidence 321 1123567999999999999999999999999999999999999999764332211110 0 000
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceec
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQ 975 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~ 975 (979)
..... .........++.++.+++.+||+.+|++||++.+|++.|+++............+|.
T Consensus 230 ~~~~~---~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~ 291 (483)
T 3sv0_A 230 EKKVA---TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 291 (483)
T ss_dssp HHHHH---SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHH
T ss_pred hcccc---ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCch
Confidence 00000 000112234567899999999999999999999999999999988777776666664
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=360.11 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=194.9
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--------ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--------GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE 750 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 750 (979)
..++|...+.||+|+||.||+|. ..+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 45789999999999999999994 5678999999986432 1223468899999999999999999999854
Q ss_pred CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEEEEeec
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFS 827 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~kl~Dfg 827 (979)
+..++||||+++|+|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+||+++.++ .+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 45789999999999999887654 6899999999999999999999 89999999999999997544 59999999
Q ss_pred cccccCCCCCcceecccccCCCCCCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC
Q 002021 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 904 (979)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 904 (979)
+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.................
T Consensus 288 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~--- 361 (419)
T 3i6u_A 288 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK--- 361 (419)
T ss_dssp TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC---
T ss_pred cceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC---
Confidence 99876422 22245679999999999853 5678899999999999999999999975332221111110000
Q ss_pred ccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..........++..+.+++.+|++.||++|||+.|+++|
T Consensus 362 -------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 362 -------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000112223456779999999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=356.07 Aligned_cols=243 Identities=24% Similarity=0.324 Sum_probs=203.4
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--------cchhcHHHHHHHHHhcCCCCeeeEEEeeccC
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--------RAFKSFDVECEIMKSIRHRNLIKVISSCSNE 750 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 750 (979)
..++|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45678999999999999999995 56899999999875421 1345678899999999999999999999999
Q ss_pred CeeEEEEEecCCC-ccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 751 EFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 751 ~~~~lv~E~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
+..++||||+.+| +|.+++.... .+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 9999887654 5899999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccch
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (979)
........ .....||+.|+|||++.+..+ ++++||||+||++|||++|+.||.......
T Consensus 178 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------- 237 (335)
T 3dls_A 178 AYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV----------------- 237 (335)
T ss_dssp EECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------
T ss_pred eECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------
Confidence 87643322 234568999999999887776 789999999999999999999996521110
Q ss_pred hhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.... ..+..++.++.+++.+||+.||++|||+.|++++
T Consensus 238 --~~~~--------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 --EAAI--------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TTCC--------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --hhcc--------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0011245668999999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=365.24 Aligned_cols=262 Identities=21% Similarity=0.228 Sum_probs=195.9
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC------C
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------E 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 751 (979)
.++|+..+.||+|+||.||+| ...+++.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 477999999999999999999 45679999999997542 23456788999999999999999999998654 4
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..|+||||+++ ++.+.+.. .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 57999999976 56665543 4899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc---------
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL--------- 902 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~--------- 902 (979)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+...+....
T Consensus 214 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 214 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp ---C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHTT
T ss_pred cCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHH
Confidence 5422 22345679999999999999999999999999999999999999997532111 1111111000
Q ss_pred -------------CCc---cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 903 -------------PIS---TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 903 -------------~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... ....+....... ........++++.+++.+|++.||++|||++|+++|
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPA---DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCC---SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCccccccc---ccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000000000 001122346779999999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=360.95 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=197.0
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcC--CCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIR--HRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 757 (979)
..|+..+.||+|+||.||+|...+++.||||++.... ....+.+.+|+++++.++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4588899999999999999987789999999986542 234567889999999996 599999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
| +.+++|.+++.... .+++.+++.++.||+.||+||| +++|+||||||+||+++ ++.+||+|||+++.+.....
T Consensus 136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 56789999987754 6899999999999999999999 99999999999999996 58999999999987654333
Q ss_pred cceecccccCCCCCCccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCcc
Q 002021 838 SMIQTQTLATIGYMAPEYGRE-----------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST 906 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 906 (979)
.......+||+.|+|||++.+ ..+++++|||||||++|||++|+.||.........+...+......
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~-- 287 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI-- 287 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC--
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC--
Confidence 333345679999999998754 3688999999999999999999999965322111111111100000
Q ss_pred chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+...+.++.+++.+||+.||.+|||+.|+++|
T Consensus 288 ----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 288 ----------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 0011123568899999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=348.04 Aligned_cols=265 Identities=21% Similarity=0.271 Sum_probs=200.0
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++|+..+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5788899999999999999955 56999999998654322 24567889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++++|.+++... ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 99999998887654 36899999999999999999999 99999999999999999999999999999987643322
Q ss_pred ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC-----------Ccc
Q 002021 839 MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP-----------IST 906 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~-----------~~~ 906 (979)
......+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+.. ......... ...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL-YLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHHHHTCGG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhcccccccccccccccc
Confidence 2244578999999998865 56899999999999999999999999764322111 110000000 000
Q ss_pred ---chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 907 ---MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 907 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....++.... ........++..+.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDME---PLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCC---CHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccc---hhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 0111123456779999999999999999999999976
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.17 Aligned_cols=268 Identities=21% Similarity=0.265 Sum_probs=200.0
Q ss_pred CCCCCC-ceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSEN-NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~-~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 758 (979)
+.|++. +.||+|+||.||+|. ..+++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 556663 789999999999995 457999999999766555567889999999985 79999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc---EEEEeeccccccCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFSIAKMLTGE 835 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~Dfg~~~~~~~~ 835 (979)
|+++|+|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+||+++.++. +||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 999999999987653 6899999999999999999999 899999999999999998776 999999998765322
Q ss_pred CC-----cceecccccCCCCCCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 836 DQ-----SMIQTQTLATIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 836 ~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
.. ........||+.|+|||++.. ..++.++||||+||++|||++|+.||......+..... ......
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~ 244 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---GEACPA 244 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-------CCHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc---cccchh
Confidence 11 111233468999999998864 56889999999999999999999999764332211000 000000
Q ss_pred -cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 -TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+..................++.++.+++.+|++.||++|||+.|+++|
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000000000000000111223456779999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=380.99 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=213.9
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.++|+..+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45678889999999999999988888889999997543 345679999999999999999999999876 6789999999
Q ss_pred CCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++|+|.+++... ...+++.+++.++.||++||+||| +++|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 419 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HH
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-ee
Confidence 999999999753 345899999999999999999999 9999999999999999999999999999998754221 11
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......++..|+|||.+..+.++.++|||||||++|||++ |+.||......+ ....+...
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~----------------- 480 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERG----------------- 480 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTT-----------------
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-----------------
Confidence 1233456788999999988899999999999999999999 999987532211 11111000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
.+...+..++..+.++|.+||+.||++|||+.||++.|+++..+...++
T Consensus 481 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~ 529 (535)
T 2h8h_A 481 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529 (535)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence 0111223566779999999999999999999999999998876655554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.96 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=200.9
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
+.|+..+.||+|+||.||+|. ..+|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 347788999999999999995 46899999999865422 23457889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||++ |++.+++......+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 6888888766667999999999999999999999 899999999999999999999999999999865322
Q ss_pred cceecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 838 SMIQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
....||+.|+|||++. ++.++.++|||||||++|||++|+.||....... ..........+.
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~---------- 272 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPA---------- 272 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCC----------
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCC----------
Confidence 2356899999999874 5678999999999999999999999986532111 111111100000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
.....++..+.+++.+||+.||++|||+.|+++|-
T Consensus 273 --------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 273 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred --------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 00123345688999999999999999999998763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=346.17 Aligned_cols=253 Identities=29% Similarity=0.432 Sum_probs=200.7
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc-CCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~ 759 (979)
.++|+..+.||+|+||.||+|+. +|+.||||++... ...+.+.+|++++++++||||+++++++.+ .+..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788899999999999999987 5889999998754 345678899999999999999999998654 4578999999
Q ss_pred cCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++.... ..+++..++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999999987653 23789999999999999999999 9999999999999999999999999999997653221
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
....+++.|+|||.+.+..+++++||||+|+++|||++ |+.||......+ ....+....
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~~--------------- 231 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGY--------------- 231 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTTC---------------
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCC---------------
Confidence 23457889999999988889999999999999999998 999987532211 111110000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
....+..+++.+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 232 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 00112245667999999999999999999999999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=362.60 Aligned_cols=271 Identities=20% Similarity=0.249 Sum_probs=199.3
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccC-----Ce
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 752 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+++++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999995 56789999999965422 2346788999999999999999999998765 57
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.|+||||++ |+|.+++... ..+++.+++.++.||++||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999996 5999988764 46899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCc--------------------ceecccccCCCCCCcccc-CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCc
Q 002021 833 TGEDQS--------------------MIQTQTLATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 891 (979)
Q Consensus 833 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~ 891 (979)
...... ......+||+.|+|||++ ....++.++||||+||++|||++|..||.....+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 433211 123556799999999985 55679999999999999999999776665322111
Q ss_pred chH-----------------------hH---hhhhhcCCccch------------hhcccccCchhhhhHHHHHHHHHHH
Q 002021 892 MTL-----------------------KH---WVNDWLPISTME------------VVDANLLSQEDIHFVAKEQCVSFVF 933 (979)
Q Consensus 892 ~~~-----------------------~~---~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~ 933 (979)
... .. .+.........+ ...................+++++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 000 00 000000000000 0000000000000111134567899
Q ss_pred HHHHhccccCcCCCCCHHHHHHH
Q 002021 934 NLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 934 ~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+++.+||+.||++|||++|+++|
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.89 Aligned_cols=261 Identities=28% Similarity=0.455 Sum_probs=208.0
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEE--EEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEV--AVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~v--AvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (979)
++|+..+.||+|+||.||+|.. .++..+ |||++.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5788899999999999999954 456654 999886532 33456789999999999 899999999999999999999
Q ss_pred EEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 002021 757 LEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~ 821 (979)
|||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 46899999999999999999999 9999999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhh
Q 002021 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVND 900 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~ 900 (979)
||+|||+++.... ........+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......+ ....+..
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~ 256 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQ 256 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGGG
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHhhc
Confidence 9999999974321 112233457889999999988889999999999999999998 999986532111 1110000
Q ss_pred hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
.. ....+..++..+.+++.+||..||++|||+.|++++|.++.+......
T Consensus 257 ~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 257 GY------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp TC------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred CC------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 00 001112345678999999999999999999999999999998665443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=369.09 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=207.0
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 35688889999999999999954 579999999986532 23345678899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 757 LEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|||++||+|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999987653 35899999999999999999999 999999999999999999999999999999876432
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc--hHhHhhhhhcCCccchhhccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM--TLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 913 (979)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||........ .+...+.... .
T Consensus 340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~-~--------- 406 (576)
T 2acx_A 340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP-E--------- 406 (576)
T ss_dssp C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC-C---------
T ss_pred c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc-c---------
Confidence 2 22345799999999999988999999999999999999999999976432211 1111111000 0
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
..+..+++++.+++.+|++.||++|| +++|+++|
T Consensus 407 ---------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 ---------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01123456789999999999999999 78999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.64 Aligned_cols=266 Identities=18% Similarity=0.190 Sum_probs=201.7
Q ss_pred CCCCCCceeeeecceEEEEEEcC----CCcEEEEEEecccccc-----------chhcHHHHHHHHHhcCCCCeeeEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQCGR-----------AFKSFDVECEIMKSIRHRNLIKVISS 746 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~ 746 (979)
++|+..+.||+|+||.||+|... ++..||||++...... ..+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57889999999999999999654 5788999998654321 12346678888999999999999999
Q ss_pred ecc----CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC--c
Q 002021 747 CSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM--V 820 (979)
Q Consensus 747 ~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~--~ 820 (979)
+.+ ....++||||+ +++|.+++...+ .+++.+++.++.|++.||+||| +++|+||||||+||+++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence 877 77899999999 999999998765 7999999999999999999999 89999999999999999887 9
Q ss_pred EEEEeeccccccCCCCCc-----ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHh
Q 002021 821 AHLSDFSIAKMLTGEDQS-----MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 895 (979)
Q Consensus 821 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~ 895 (979)
+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 999999999876432211 112445789999999999988899999999999999999999999965333222221
Q ss_pred HhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
............. . ........++.++.+++.+||+.||++||++.|+++.|+++.-
T Consensus 272 ~~~~~~~~~~~~~-~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 272 TAKTNLLDELPQS-V---------LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHTTTHH-H---------HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHhhcccccHH-H---------HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111110000000 0 0000011456689999999999999999999999999987653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=354.57 Aligned_cols=260 Identities=24% Similarity=0.400 Sum_probs=206.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc------CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46789999999999999999974 357789999986442 23456788999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeccCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEE
Q 002021 754 ALVLEYMPHGSLEKYLYSSN------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLS 824 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~ 824 (979)
++||||+++++|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999997653 45899999999999999999999 999999999999999994 4469999
Q ss_pred eeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcC
Q 002021 825 DFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLP 903 (979)
Q Consensus 825 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~ 903 (979)
|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+.....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~ 263 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGGR 263 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHHhcCCC
Confidence 9999986543333333344567899999999988889999999999999999998 99998653211 11111111000
Q ss_pred CccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
...+..++..+.+++.+||+.||++||++.|++++|+.+...
T Consensus 264 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 264 ------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 001123456789999999999999999999999999988763
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=355.61 Aligned_cols=276 Identities=24% Similarity=0.265 Sum_probs=209.3
Q ss_pred ccccHHHHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcC-----CCCeeeE
Q 002021 670 RMFSYLELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-----HRNLIKV 743 (979)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l 743 (979)
..+++.+.....++|+..+.||+|+||.||+|.. .+++.||||++... ....+.+..|+++++.++ ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3455555556678899999999999999999954 67899999998643 233456778999999996 9999999
Q ss_pred EEeeccCCeeEEEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----
Q 002021 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD----- 817 (979)
Q Consensus 744 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~----- 817 (979)
++++...+..++||||+ +++|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccc
Confidence 99999999999999999 889999987653 45899999999999999999999 999999999999999975
Q ss_pred --------------------CCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHH
Q 002021 818 --------------------NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMET 877 (979)
Q Consensus 818 --------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 877 (979)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||+||++|||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 7899999999998653221 345789999999999999999999999999999999
Q ss_pred HcCCCCCcccccCcchHhHhhhhhcCCc-----------cchhhcccccCc----h-----------hhhhHHHHHHHHH
Q 002021 878 FTGKKPTDEIFNGEMTLKHWVNDWLPIS-----------TMEVVDANLLSQ----E-----------DIHFVAKEQCVSF 931 (979)
Q Consensus 878 ~tg~~P~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~----~-----------~~~~~~~~~~~~~ 931 (979)
++|+.||......+ ..........+.. .....+...... . ...........+.
T Consensus 253 l~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 253 YTGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999997532211 1111111000000 000000000000 0 0000011112356
Q ss_pred HHHHHHhccccCcCCCCCHHHHHHH
Q 002021 932 VFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 932 l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+.+++.+||+.||++|||+.|+++|
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcC
Confidence 8899999999999999999999865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=351.88 Aligned_cols=271 Identities=21% Similarity=0.251 Sum_probs=197.5
Q ss_pred HHhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 678 CRATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
....++|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|++++++++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3445789999999999999999995 56899999999865432 23456778999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe-----CCCCcEEEEeeccc
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL-----DDNMVAHLSDFSIA 829 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll-----~~~~~~kl~Dfg~~ 829 (979)
+||||+++ +|.+++.... .+++..++.++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++
T Consensus 110 lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99999974 9999987654 5899999999999999999999 8999999999999999 45556999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc-C-C-c
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-P-I-S 905 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~-~-~-~ 905 (979)
........ ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+. ......... + . .
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTT
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhCCCchhh
Confidence 87643222 22445689999999998764 489999999999999999999999975322211 111111100 0 0 0
Q ss_pred cchhhc-----cc--ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 TMEVVD-----AN--LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 ~~~~~~-----~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...... .. ..............++.++.+++.+|++.||++|||+.|+++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000000 00 0011111222233456789999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=360.40 Aligned_cols=269 Identities=22% Similarity=0.319 Sum_probs=193.5
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcC-CCCeeeEEEeeccC--Cee
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIR-HRNLIKVISSCSNE--EFK 753 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~ 753 (979)
..++|+..+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+.+++.+. ||||+++++++..+ ...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 45789999999999999999994 5679999999986432 234456778999999997 99999999998644 478
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
|+||||++ ++|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999997 5898888764 6899999999999999999999 9999999999999999999999999999998653
Q ss_pred CCC-------------------CcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcch
Q 002021 834 GED-------------------QSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 893 (979)
Q Consensus 834 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~ 893 (979)
... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~ 239 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM-NQ 239 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence 211 1112244579999999999876 67899999999999999999999999753211 11
Q ss_pred HhHhhhhhcCCccchhhcc---------------------cccCchh-------hhhHHHHHHHHHHHHHHHhccccCcC
Q 002021 894 LKHWVNDWLPISTMEVVDA---------------------NLLSQED-------IHFVAKEQCVSFVFNLAMECTMEFPK 945 (979)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~-------~~~~~~~~~~~~l~~l~~~cl~~dP~ 945 (979)
+....... .....+.... ....... .....+..+++++.+++.+||+.||+
T Consensus 240 ~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 240 LERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 11111111 1000000000 0000000 00001114567899999999999999
Q ss_pred CCCCHHHHHHH
Q 002021 946 QRINAKEIVTK 956 (979)
Q Consensus 946 ~Rps~~eil~~ 956 (979)
+|||+.|+++|
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999988
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=340.73 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=202.4
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc------cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG------RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
++|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+++..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4588889999999999999955 4799999999865421 13567889999999999999999999999999999
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----cEEEEeecccc
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFSIAK 830 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfg~~~ 830 (979)
+||||+++++|.+++... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.++ .+||+|||.+.
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999998654 36899999999999999999999 99999999999999999877 89999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
...... ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||......+ ........
T Consensus 161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~---------- 226 (283)
T 3bhy_A 161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNISAV---------- 226 (283)
T ss_dssp ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTT----------
T ss_pred eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHhHhc----------
Confidence 764322 1234568999999999998899999999999999999999999986532111 11111000
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...........++..+.+++.+||..||++|||+.|+++|
T Consensus 227 ------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 227 ------NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ------CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ------ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000112223456678999999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=371.85 Aligned_cols=249 Identities=23% Similarity=0.278 Sum_probs=195.9
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccc---cccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQ---CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|. ..+|+.||||++... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 3678899999999999999995 567999999998754 223445677899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
|||+++|+|.+++.... .+++..+..++.|++.||+||| + ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999887643 6899999999999999999999 7 89999999999999999999999999999864322
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+... ..
T Consensus 303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~-----------~~- 366 (446)
T 4ejn_A 303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILME-----------EI- 366 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-----------CC-
T ss_pred C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHhC-----------CC-
Confidence 2 2234567999999999999999999999999999999999999999653211 111100000 00
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
..+..+++++.+++.+||+.||.+|| +++|+++|
T Consensus 367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 01123456789999999999999999 99999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.97 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=197.5
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+.|...+.||+|+||.||+|. ..++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 568888999999999999995 4578999999987553 23457788999999999999999999999999999999999
Q ss_pred cCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEEeeccccccC
Q 002021 760 MPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 760 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfg~~~~~~ 833 (979)
+++|+|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988543 356999999999999999999999 9999999999999999 456789999999998654
Q ss_pred CCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
... ......||+.|+|||.+. +.++.++||||+|+++|||++|+.||......+. .............
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~------ 246 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATYKEPNYAV------ 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCCCCCC------
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--HhhhccCCccccc------
Confidence 322 224456899999999875 5688999999999999999999999975322111 1110000000000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....++.+.+++.+|++.||++|||+.|+++|
T Consensus 247 ----------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 ----------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ----------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001134568899999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=351.24 Aligned_cols=271 Identities=22% Similarity=0.252 Sum_probs=201.9
Q ss_pred HhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-----cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-----RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF 752 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 752 (979)
...++|+..+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999965 4689999999864321 123567899999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.++||||+++ +|.+++......+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999986 898888877667899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc---CCccch
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL---PISTME 908 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~ 908 (979)
.... .......+|+.|+|||.+.+. .++.++||||+||++|||++|..||......+ .+........ ...+.+
T Consensus 163 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 163 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSS
T ss_pred cCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhh
Confidence 4332 223456789999999998654 58899999999999999999999986532211 1111111110 000000
Q ss_pred h---hcccccCc--hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 909 V---VDANLLSQ--EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 909 ~---~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. .+...... ..........++.++.+++.+|++.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000000 000011123456779999999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.97 Aligned_cols=259 Identities=23% Similarity=0.361 Sum_probs=206.5
Q ss_pred CCCCCCc-eeeeecceEEEEEEc---CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENN-LIGRGGFGSVYKASL---GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
+.|+..+ .||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 999999999999943 3578899999875432 2356788999999999999999999999 5667899
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++++|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++......
T Consensus 95 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp EEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 999999999999997653 5899999999999999999999 999999999999999999999999999999876543
Q ss_pred CCcc-eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhccc
Q 002021 836 DQSM-IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913 (979)
Q Consensus 836 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (979)
.... ......+++.|+|||.+.+..+++++||||+|+++|||++ |+.||...... .....+.....
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~---------- 238 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER---------- 238 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC----------
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC----------
Confidence 3221 1233456788999999988889999999999999999999 99998753221 11111111000
Q ss_pred ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 914 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
...+..++..+.+++.+||+.||++||++.|+++.|+++..+..
T Consensus 239 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 239 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 01112456679999999999999999999999999999987654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=359.88 Aligned_cols=347 Identities=23% Similarity=0.223 Sum_probs=193.0
Q ss_pred cEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCcc
Q 002021 147 QHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTL 226 (979)
Q Consensus 147 ~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 226 (979)
+.++.+++.++ .+|..+. ++++.|+|++|++++..|..|.++++|++|+|++|+++++.|.+|.++++|
T Consensus 14 ~~v~c~~~~l~---------~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 82 (477)
T 2id5_A 14 RAVLCHRKRFV---------AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82 (477)
T ss_dssp TEEECCSCCCS---------SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred CEEEeCCCCcC---------cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccC
Confidence 45666666654 2454432 355666666666665555556666666666666666655555555444444
Q ss_pred ceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccc
Q 002021 227 KILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSD 306 (979)
Q Consensus 227 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 306 (979)
+.|+|++|+++. ..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 83 ~~L~L~~n~l~~-------------------------~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~ 137 (477)
T 2id5_A 83 RTLGLRSNRLKL-------------------------IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137 (477)
T ss_dssp CEEECCSSCCCS-------------------------CCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECC
T ss_pred CEEECCCCcCCc-------------------------cCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCC
Confidence 444444444443 2222333344444444444444443343444433333333333
Q ss_pred cccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCC
Q 002021 307 NYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGN 386 (979)
Q Consensus 307 N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N 386 (979)
|.++.. .+..|..+++|++|+|++|
T Consensus 138 n~l~~~-------------------------------------------------------~~~~~~~l~~L~~L~l~~n 162 (477)
T 2id5_A 138 NDLVYI-------------------------------------------------------SHRAFSGLNSLEQLTLEKC 162 (477)
T ss_dssp TTCCEE-------------------------------------------------------CTTSSTTCTTCCEEEEESC
T ss_pred Ccccee-------------------------------------------------------ChhhccCCCCCCEEECCCC
Confidence 333221 2223333444444444444
Q ss_pred CCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccc-
Q 002021 387 KLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL- 465 (979)
Q Consensus 387 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~- 465 (979)
++++..+..|..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|++|++++|+++.+|.
T Consensus 163 ~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 242 (477)
T 2id5_A 163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL 242 (477)
T ss_dssp CCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHH
T ss_pred cCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHH
Confidence 4444444444455555555555555554444455555555666665555555555554455566666666666666663
Q ss_pred cccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccc
Q 002021 466 TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISL 545 (979)
Q Consensus 466 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 545 (979)
.+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|
T Consensus 243 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 322 (477)
T 2id5_A 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322 (477)
T ss_dssp HHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGC
T ss_pred HhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCccc
Confidence 45566666677777776666666667777777777777777777777777777777777777777776666667777777
Q ss_pred cccccccccccccCCccccCccccCeEeccCCcccccCCC
Q 002021 546 KFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 546 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
+.|+|++|.++...+. ..-...+..+.+.+|...|.-|.
T Consensus 323 ~~L~l~~N~l~c~c~~-~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 323 ETLILDSNPLACDCRL-LWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp CEEECCSSCEECSGGG-HHHHTTTTSSCCTTCCCBEEESG
T ss_pred CEEEccCCCccCccch-HhHHhhhhccccCccCceeCCch
Confidence 7777777777643221 11122234455666776666664
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=346.00 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=202.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.+.|...+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 35688899999999999999954 57999999999765444456788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEEeeccccccCCCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
+++++|.+++...+ .+++.++..++.|++.|++||| +++|+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 99999999886543 5899999999999999999999 8999999999999999 78899999999999764322
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+ ...........
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~------------- 225 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGYYE------------- 225 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCCCC-------------
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCC-------------
Confidence 1234568999999999999899999999999999999999999986532111 11111110000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........++.++.+++.+|+..||++|||+.|+++|
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 ---FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ---CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0001112345678999999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=357.81 Aligned_cols=244 Identities=26% Similarity=0.301 Sum_probs=191.3
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHH-HHhcCCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEI-MKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
.++|+..+.||+|+||.||+|+. .+++.||||++.+.. ....+.+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 36788999999999999999954 568899999997543 2233455667766 567899999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++...+ .+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999987643 6889999999999999999999 999999999999999999999999999999864322
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+...... ..
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~------------~~- 256 (373)
T 2r5t_A 193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNK------------PL- 256 (373)
T ss_dssp C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHHS------------CC-
T ss_pred C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhc------------cc-
Confidence 2 22345679999999999999999999999999999999999999997532111 11111110 00
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAK 951 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ 951 (979)
..+..++..+.+++.+|++.||.+||++.
T Consensus 257 -------~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 257 -------QLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp -------CCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 00123456689999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.56 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=200.0
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
++|.....||+|+||.||+|. ..+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 445566799999999999995 5678999999997665555678899999999999999999999999999999999999
Q ss_pred CCCccceeeccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEEeeccccccCCCCC
Q 002021 761 PHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 761 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfg~~~~~~~~~~ 837 (979)
++++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||+++. ++.+||+|||.+........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999987653 34678899999999999999999 899999999999999987 89999999999987643221
Q ss_pred cceecccccCCCCCCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
......||+.|+|||.+.++. ++.++||||||+++|||++|+.||............. . ...
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~-~~~------------ 242 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-G-MFK------------ 242 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-H-HHC------------
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-c-ccc------------
Confidence 123456899999999987643 7899999999999999999999996532221111100 0 000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+..++.++.+++.+||+.||++||++.|+++|
T Consensus 243 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 243 ----VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ----ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000112345678999999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=351.77 Aligned_cols=277 Identities=20% Similarity=0.226 Sum_probs=204.6
Q ss_pred ccHHHHHHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccccc-----------chhcHHHHHHHHHhcCCCCe
Q 002021 672 FSYLELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR-----------AFKSFDVECEIMKSIRHRNL 740 (979)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni 740 (979)
....++....++|+..+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456777888999999999999999999998778999999998643221 12668899999999999999
Q ss_pred eeEEEeec-----cCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 741 IKVISSCS-----NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 741 v~l~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
+++++++. .....++||||++ |+|.+++......+++..+..++.|++.||+||| +++|+||||||+||++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL 167 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence 99999883 3446899999997 6898888877778999999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchH
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 894 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~ 894 (979)
+.++.+||+|||++....... ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~ 243 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QL 243 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HH
Confidence 999999999999997543222 2244578999999998876 678999999999999999999999997532111 11
Q ss_pred hHhhhhhcCCccc-----------hhhcccccCc-hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 895 KHWVNDWLPISTM-----------EVVDANLLSQ-EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 895 ~~~~~~~~~~~~~-----------~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+......... +......... ..........+++.+.+++.+|++.||++|||+.|+++|
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111000000 0000000000 001111223456779999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=351.89 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=206.9
Q ss_pred HHHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc--------chhcHHHHHHHHHhc-CCCCeeeEE
Q 002021 675 LELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR--------AFKSFDVECEIMKSI-RHRNLIKVI 744 (979)
Q Consensus 675 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~ 744 (979)
.......++|+..+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+++++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 33444556799999999999999999965 47999999998654321 135678899999999 799999999
Q ss_pred EeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEE
Q 002021 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 824 (979)
Q Consensus 745 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~ 824 (979)
+++...+..++||||+++++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999998754 36899999999999999999999 8999999999999999999999999
Q ss_pred eeccccccCCCCCcceecccccCCCCCCccccCC------CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhh
Q 002021 825 DFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 898 (979)
Q Consensus 825 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~ 898 (979)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+
T Consensus 243 DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~i 317 (365)
T 2y7j_A 243 DFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRMI 317 (365)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred ecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHHHH
Confidence 9999987643322 244678999999998753 35889999999999999999999999652111 111110
Q ss_pred hhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... ......+.+..++..+.+++.+|++.||++|||+.|+++|
T Consensus 318 ~~~---------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 MEG---------------QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHT---------------CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhC---------------CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 0001112223456679999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=364.64 Aligned_cols=196 Identities=24% Similarity=0.345 Sum_probs=154.1
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeecc-----CCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSN-----EEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 752 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+++++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3679999999999999999994 45789999999865422 234678899999999999999999999843 357
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.|+||||++ ++|.+++... ..+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 899999984 6898888664 46999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCc-------------------------ceecccccCCCCCCcccc-CCCCCCCchhHHHHHHHHHHHHcCC
Q 002021 833 TGEDQS-------------------------MIQTQTLATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGK 881 (979)
Q Consensus 833 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~ 881 (979)
...... ......+||+.|+|||++ ....++.++||||+||++|||++|.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 422211 123445789999999975 5567999999999999999999943
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=349.77 Aligned_cols=260 Identities=23% Similarity=0.289 Sum_probs=192.3
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEee--------ccCC
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSC--------SNEE 751 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~--------~~~~ 751 (979)
.+|+..+.||+|+||.||+|. ..+++.||||++........+.+.+|+.+++++. ||||+++++++ ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 568889999999999999996 4578999999986655555677889999999996 99999999998 3455
Q ss_pred eeEEEEEecCCCccceeecc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEeCCCCcEEEEeec
Q 002021 752 FKALVLEYMPHGSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFS 827 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dik~~NIll~~~~~~kl~Dfg 827 (979)
..++||||++ |+|.+++.. ....+++.+++.++.|++.||+||| +++ |+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 6899999996 699988865 3456999999999999999999999 888 9999999999999999999999999
Q ss_pred cccccCCCCCcc----------eecccccCCCCCCcccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchH
Q 002021 828 IAKMLTGEDQSM----------IQTQTLATIGYMAPEYG---REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 894 (979)
Q Consensus 828 ~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~ 894 (979)
++.......... ......+|+.|+|||++ .+..+++++||||||+++|||++|+.||........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-- 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-- 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence 998764332211 11244589999999988 566788999999999999999999999865221110
Q ss_pred hHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 895 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
...... ......++..+.+++.+||+.||++|||+.|++++|+++........
T Consensus 262 ---~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 262 ---VNGKYS------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp -------CC------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred ---hcCccc------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 000000 00011223347889999999999999999999999999987654443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=364.20 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=205.2
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 5688889999999999999965 579999999996542 233466888999999999999999999999999999999
Q ss_pred EecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
||++||+|.+++... ...+++..++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999988654 346999999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||........ ........ ....
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i--------~~~~- 409 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRV--------LEQA- 409 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHH--------HHCC-
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHH--------hhcc-
Confidence 322 12345799999999999998999999999999999999999999976422111 11111000 0000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH-----HHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA-----KEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~eil~~ 956 (979)
...+..++.++.+++.+|++.||++||++ +|+++|
T Consensus 410 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 -------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 00112445678999999999999999965 677764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.96 Aligned_cols=265 Identities=19% Similarity=0.284 Sum_probs=206.9
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccc---h--------------hcHHHHHHHHHhcCCCCeeeE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRA---F--------------KSFDVECEIMKSIRHRNLIKV 743 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~---~--------------~~~~~E~~~l~~l~h~niv~l 743 (979)
.++|+..+.||+|+||.||+|.. +|+.||||++....... . +.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36789999999999999999988 89999999986542111 1 778999999999999999999
Q ss_pred EEeeccCCeeEEEEEecCCCcccee------eccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEe
Q 002021 744 ISSCSNEEFKALVLEYMPHGSLEKY------LYSS-NCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLL 815 (979)
Q Consensus 744 ~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll 815 (979)
++++.+.+..++||||+++|+|.++ +... ...+++..++.++.|++.|++||| + ++|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence 9999999999999999999999999 6543 457999999999999999999999 7 999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCC-CCCC-chhHHHHHHHHHHHHcCCCCCcccccCcch
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG-RVSA-NGDVYSFGIMLMETFTGKKPTDEIFNGEMT 893 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~el~tg~~P~~~~~~~~~~ 893 (979)
+.++.+||+|||.+...... ......+|+.|+|||.+.+. .++. ++||||+|+++|||++|+.||.........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999999999999875432 23456789999999999877 5666 999999999999999999999764332222
Q ss_pred HhHhhhhhcCCcc--chhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 894 LKHWVNDWLPIST--MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 894 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
............. ...... .. ..........++..+.+++.+||+.||++|||+.|+++|
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYP-LT--NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTT-TC--C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhcc-cc--ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2221111111100 000000 00 000011123456779999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.85 Aligned_cols=262 Identities=19% Similarity=0.275 Sum_probs=201.3
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeecc--CCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSN--EEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|. ..+++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 568889999999999999994 568999999998643 3467889999999997 9999999999987 66789999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEEeeccccccCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFSIAKMLTGED 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg~~~~~~~~~ 836 (979)
||+++++|.+++.. +++.+++.++.|++.||+||| +++|+||||||+||+++.++ .+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999988753 889999999999999999999 99999999999999999776 89999999998764332
Q ss_pred CcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccc--------
Q 002021 837 QSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM-------- 907 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-------- 907 (979)
. .....+|..|+|||.+.+ ..++.++||||+||++|||++|+.||.......................
T Consensus 186 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 186 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2 244578999999999876 6789999999999999999999999954322211111111100000000
Q ss_pred -------hhhcccccCc--hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 908 -------EVVDANLLSQ--EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 908 -------~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+......... ..........+++++.+++.+|++.||++|||++|+++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000000 000011122356789999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.65 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=197.6
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeecc----CCeeEE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKAL 755 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 755 (979)
.|...+.||+|+||.||+|. ..++..||+|++.... ....+.+.+|+++++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 36677889999999999995 4678899999986542 2345678899999999999999999998754 466899
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEeC-CCCcEEEEeecccccc
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFSIAKML 832 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dik~~NIll~-~~~~~kl~Dfg~~~~~ 832 (979)
||||+++|+|.+++... ..+++..++.++.|++.||+||| +++ |+||||||+||+++ +++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999999999764 35899999999999999999999 888 99999999999998 8899999999999764
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.... .....||+.|+|||.+. +.++.++||||+|+++|+|++|+.||..................+
T Consensus 183 ~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 248 (290)
T 1t4h_A 183 RASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------- 248 (290)
T ss_dssp CTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------
T ss_pred cccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc---------
Confidence 3222 23456899999999876 458999999999999999999999996533222111111100000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+..+++++.+++.+||+.||.+|||+.|+++|
T Consensus 249 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 ---------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01112234568999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=341.15 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=203.9
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 6788899999999999999954 468899999986432 223467889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++...+ .+++..++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 9999999999987653 5899999999999999999999 9999999999999999999999999999997653221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....|++.|+|||.+.+..++.++||||+|+++|||++|+.||......+. ....... ..
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~------------~~--- 229 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HRRIVNV------------DL--- 229 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTT------------CC---
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HHHHhcc------------cc---
Confidence 2345689999999999988999999999999999999999999975321110 1110000 00
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+..++..+.+++.+|++.||.+||++.|+++|
T Consensus 230 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 -----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0112345668999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=377.69 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=201.9
Q ss_pred ceeeeecceEEEEEEc---CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASL---GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||.||+|.+ ..++.||||+++.... ...+.+.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999944 3567899999975432 235779999999999999999999999965 457899999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC-ccee
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ-SMIQ 841 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 841 (979)
|+|.+++... ..+++.+++.++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.+..... ....
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999764 36899999999999999999999 99999999999999999999999999999987653332 1222
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+....
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~------------------ 589 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGE------------------ 589 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC------------------
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC------------------
Confidence 33456789999999998899999999999999999998 999997532211 111111000
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
+...+..++.++.++|.+||+.||++||++.++++.|+++..++.
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 011123466789999999999999999999999999999987654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=346.17 Aligned_cols=252 Identities=27% Similarity=0.351 Sum_probs=202.1
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
..+.|+..+.||+|+||.||+|.. .+|+.||||++... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 346788999999999999999954 46999999998754 345678899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++++|.+++......+++.+++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+.......
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-- 179 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence 99999999998755567999999999999999999999 9999999999999999999999999999998764322
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
.......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........ .........
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~--------------- 242 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IFMIPTNPP--------------- 242 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCC---------------
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCCC---------------
Confidence 122445689999999999988999999999999999999999999975321111 000000000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+..++..+.+++.+||..||++|||+.|+++|
T Consensus 243 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 243 -PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0001122345678999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=342.43 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=204.8
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc----------
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN---------- 749 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 749 (979)
..+|+..+.||+|+||.||+|.. .+++.||||++.... +.+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 35688899999999999999965 479999999986542 467789999999999999999998754
Q ss_pred ------CCeeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEE
Q 002021 750 ------EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 822 (979)
Q Consensus 750 ------~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~k 822 (979)
....++||||+++|+|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEE
Confidence 45579999999999999999754 356899999999999999999999 89999999999999999999999
Q ss_pred EEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc
Q 002021 823 LSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 823 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
|+|||++........ .....+|+.|+|||.+.+..++.++||||+|+++|||++|..|+.... .+.....
T Consensus 163 l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------~~~~~~~ 232 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KFFTDLR 232 (284)
T ss_dssp ECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------HHHHHHH
T ss_pred ECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------HHHHHhh
Confidence 999999987643322 234568999999999988889999999999999999999999864311 0100000
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
. .. .+..++..+.+++.+||+.||++|||+.|++++|..+.++...
T Consensus 233 ~---------~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 233 D---------GI---------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp T---------TC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred c---------cc---------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 0 00 0112345688999999999999999999999999998765443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=343.70 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=205.0
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 35688899999999999999954 468899999986542 22346788899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++... ..+++.+++.++.|+++|++||| +++|+||||||+||+++.++.+||+|||.+.......
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999987654 36899999999999999999999 9999999999999999999999999999998764322
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
. ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+ .........
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~--------------- 231 (294)
T 2rku_A 170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNE--------------- 231 (294)
T ss_dssp C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTC---------------
T ss_pred c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhhcc---------------
Confidence 2 2244568999999999988889999999999999999999999997532111 111110000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
...+..++..+.+++.+||+.||++|||+.|++++-
T Consensus 232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 001123345688999999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=345.67 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=200.9
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.+.|+..+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46788899999999999999965 46899999999766556667889999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|.+++......+++..++.++.|++.|++||| +++++||||||+||+++.++.+||+|||++...... ..
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ 172 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence 9999999998776667999999999999999999999 899999999999999999999999999997643211 11
Q ss_pred eecccccCCCCCCcccc-----CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 840 IQTQTLATIGYMAPEYG-----REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
......||+.|+|||++ ....++.++||||+|+++|||++|+.||....... ..........+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~----------- 240 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSDPP----------- 240 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC-----------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhccCCc-----------
Confidence 12335689999999987 46678999999999999999999999987532211 11111111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..++..+.+++.+||..||++|||+.|+++|
T Consensus 241 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 ------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 001123345678999999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.77 Aligned_cols=253 Identities=18% Similarity=0.236 Sum_probs=200.4
Q ss_pred hCCCCCC-ceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSEN-NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~-~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 755 (979)
.+.|... +.||+|+||.||+|. ..+++.||||++.... ......+.+|+.+++.++ ||||+++++++.+.+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3456555 789999999999995 4579999999987543 223567889999999995 6999999999999999999
Q ss_pred EEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEEeeccccc
Q 002021 756 VLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFSIAKM 831 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfg~~~~ 831 (979)
||||+++|+|.+++... ...+++.+++.++.|++.||+||| +++|+||||||+||+++. ++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999998654 457899999999999999999999 999999999999999997 78999999999987
Q ss_pred cCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||......+. ..........
T Consensus 184 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~-------- 251 (327)
T 3lm5_A 184 IGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQVNVD-------- 251 (327)
T ss_dssp C------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCC--------
T ss_pred cCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhcccc--------
Confidence 64322 12345799999999999999999999999999999999999999965322111 1111000000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........++..+.+++.+||+.||++|||++|+++|
T Consensus 252 --------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 252 --------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0011112345678999999999999999999999876
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=364.84 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=203.1
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc-------------cchhcHHHHHHHHHhcCCCCeeeEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG-------------RAFKSFDVECEIMKSIRHRNLIKVIS 745 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 745 (979)
..+.|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45779999999999999999995 45789999999865421 23456889999999999999999999
Q ss_pred eeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC---cEE
Q 002021 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAH 822 (979)
Q Consensus 746 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~---~~k 822 (979)
++.+++..++||||+++|+|.+++.... .+++..++.++.|++.||+||| +++|+||||||+||+++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence 9999999999999999999999886643 6899999999999999999999 99999999999999998765 699
Q ss_pred EEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc
Q 002021 823 LSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 823 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
|+|||++....... ......||+.|+|||++. +.+++++||||+||++|+|++|+.||...... .....+.
T Consensus 190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~--- 260 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVE--- 260 (504)
T ss_dssp ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH---
T ss_pred EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH---
Confidence 99999998764332 224567999999999886 56899999999999999999999999753211 1111000
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..........+..+++++.+++.+|++.||.+|||+.|+++|
T Consensus 261 ------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 ------------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ------------HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------------cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000111122334566789999999999999999999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=342.79 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=206.8
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
+.|+..+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 568888999999999999995 4578999999987543 33457789999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++++|.+++... .+++.+++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+....... .
T Consensus 102 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 174 (303)
T 3a7i_A 102 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 174 (303)
T ss_dssp CTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence 9999999998653 6899999999999999999999 8999999999999999999999999999998764332 2
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+......
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~--------------- 237 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNNPP--------------- 237 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCC---------------
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCCCC---------------
Confidence 2244578999999999999899999999999999999999999987532111 11111100000
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
..+..++..+.+++.+||+.||++|||+.|++++.-
T Consensus 238 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 238 ---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp ---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred ---CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 011234566899999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.84 Aligned_cols=272 Identities=21% Similarity=0.285 Sum_probs=204.1
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeecc--------
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSN-------- 749 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 749 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36788999999999999999954 6799999999865432 234567889999999999999999999876
Q ss_pred CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 750 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
.+..++||||+++ ++.+.+......+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999975 888888776667999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCC--CcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcch--HhHhhhhhcCC
Q 002021 830 KMLTGED--QSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT--LKHWVNDWLPI 904 (979)
Q Consensus 830 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~--~~~~~~~~~~~ 904 (979)
..+.... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... +........+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 8764222 1222345678999999998875 45899999999999999999999999763222111 01111111111
Q ss_pred ccchhhcccc------cCchh---hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 905 STMEVVDANL------LSQED---IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 905 ~~~~~~~~~~------~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.......... ..... .........++.+.+++.+|++.||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1111100000 00000 0011111234668999999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=365.73 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=203.2
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.+.|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 35688899999999999999954 579999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC---CCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~Dfg~~~~~~~ 834 (979)
||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++ .++.+||+|||++.....
T Consensus 101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999999999886643 6899999999999999999999 99999999999999995 456799999999987643
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. ......||+.|+|||++.+ .+++++||||+||++|+|++|+.||......+ .........
T Consensus 177 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~------------- 238 (486)
T 3mwu_A 177 NT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGK------------- 238 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC-------------
T ss_pred CC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC-------------
Confidence 22 2345679999999999865 58999999999999999999999996532111 111110000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+.+..+++++.+++.+||+.||++|||+.|+++|
T Consensus 239 ---~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 239 ---YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001112233456779999999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=341.85 Aligned_cols=251 Identities=24% Similarity=0.276 Sum_probs=188.0
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.++|+..+.||+|+||.||+|. ..+|+.||||++...... ..+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 4678889999999999999995 468999999998754221 2233445555688889999999999999999999999
Q ss_pred EecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 758 EYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 758 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
||++ |+|.+++.. ....+++..++.++.|++.|++||| ++ +|+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 488777654 3557999999999999999999999 87 99999999999999999999999999998764
Q ss_pred CCCCcceecccccCCCCCCcccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYG----REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
... ......||+.|+|||.+ .+..++.++||||+|+++|||++|+.||..................+..
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 234 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL---- 234 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC----
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc----
Confidence 322 22344689999999995 5567899999999999999999999999753222222222111111000
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....++.++.+++.+|++.||++|||+.|+++|
T Consensus 235 --------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 235 --------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 012345668999999999999999999999885
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=350.03 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=201.2
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 46788899999999999999954 56999999998654322 2455778999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++++|.++.... ..+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+........
T Consensus 104 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999998888876543 36899999999999999999999 99999999999999999999999999999986543222
Q ss_pred cceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC-----------c
Q 002021 838 SMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI-----------S 905 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-----------~ 905 (979)
......+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+. ........... .
T Consensus 180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCG
T ss_pred --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhcc
Confidence 22445789999999998765 789999999999999999999999976432211 11111000000 0
Q ss_pred -cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 -TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+.... ..........++..+.+++.+||+.||++|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKE-REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSS-CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccc-cchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 011111223456789999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=349.94 Aligned_cols=249 Identities=20% Similarity=0.284 Sum_probs=204.8
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35788899999999999999954 568899999986542 22456788899999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999987654 36899999999999999999999 9999999999999999999999999999998764322
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..........
T Consensus 196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~-------------- 258 (335)
T 2owb_A 196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-TYLRIKKNEY-------------- 258 (335)
T ss_dssp C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC--------------
T ss_pred c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHhcCCC--------------
Confidence 2 2244578999999999988889999999999999999999999996532111 1111100000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+..++..+.+++.+||+.||++|||+.|++++
T Consensus 259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112334568899999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.10 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=199.1
Q ss_pred CCCCCCceeeeecceEEEEEEc--CCCc--EEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL--GDGM--EVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~--~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
++|+..+.||+|+||.||+|.+ .+++ .||||+++... ....+.+.+|++++++++||||+++++++.++. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 5788899999999999999964 2333 68999986542 234567889999999999999999999998765 78
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+++++|.+++......+++.++..++.|++.|++||| +++|+||||||+||+++.++.+||+|||++.....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999999999876667999999999999999999999 99999999999999999999999999999987654
Q ss_pred CCCcc-eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 835 EDQSM-IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 835 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
..... ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....+....
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~---------- 241 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEG---------- 241 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSC----------
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccC----------
Confidence 33221 2234467889999999988889999999999999999999 99998653211 1111100000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
.....+..++..+.+++.+||..||++|||+.|++++|+++..+
T Consensus 242 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 00011124556799999999999999999999999999988753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=364.66 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=199.6
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.+.|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 34688899999999999999954 578999999987543 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~---~~~kl~Dfg~~~~~~~ 834 (979)
||+++|+|.+++... ..+++..++.++.||+.||+||| +++|+||||||+||+++.. +.+||+|||++.....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999888654 35899999999999999999999 9999999999999999764 4599999999987643
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. ......||+.|+|||++. +.+++++||||+||++|+|++|+.||......+ ...........
T Consensus 192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~----------- 255 (494)
T 3lij_A 192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKVEKGKYT----------- 255 (494)
T ss_dssp TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC-----------
T ss_pred Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC-----------
Confidence 32 224567999999999876 568999999999999999999999997532211 11111110000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+.+..+++.+.+++.+||+.||.+|||+.|+++|
T Consensus 256 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 -----FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -----CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0111223456679999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=367.24 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=204.9
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
+.|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5688899999999999999954 589999999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe---CCCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll---~~~~~~kl~Dfg~~~~~~~ 834 (979)
||+++|+|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+||++ +.++.+||+|||++..+..
T Consensus 106 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999887654 6899999999999999999999 9999999999999999 4678999999999987643
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. ......||+.|+|||++.+ .+++++||||+||++|+|++|+.||...... .....+...
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~------------- 242 (484)
T 3nyv_A 182 SK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEKG------------- 242 (484)
T ss_dssp CC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC-------------
T ss_pred cc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHcC-------------
Confidence 32 2244579999999998865 6899999999999999999999999753211 111111100
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+.+..+++.+.+++.+|++.||++|||+.|+++|
T Consensus 243 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 243 --KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0000112233456779999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=352.32 Aligned_cols=272 Identities=23% Similarity=0.320 Sum_probs=201.0
Q ss_pred HhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc--------
Q 002021 679 RATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN-------- 749 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 749 (979)
...++|+..+.||+|+||.||+|. ..+|+.||||++.... ....+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 345789999999999999999995 5689999999986442 233479999999999999999998833
Q ss_pred ------------------------------CCeeEEEEEecCCCccceeecc---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 002021 750 ------------------------------EEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLH 796 (979)
Q Consensus 750 ------------------------------~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH 796 (979)
....++||||++ |+|.+.+.. ....+++..++.++.|+++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334889999998 487777653 3457999999999999999999999
Q ss_pred cCCCCCeEecCCCCCCEEeC-CCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHH
Q 002021 797 FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIML 874 (979)
Q Consensus 797 ~~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il 874 (979)
+++|+||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||+||++
T Consensus 159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999998 689999999999987643322 2345689999999988764 589999999999999
Q ss_pred HHHHcCCCCCcccccCcchHhHhhhhhcCCccchh--hccc-------ccCchhhhhHHHHHHHHHHHHHHHhccccCcC
Q 002021 875 METFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV--VDAN-------LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPK 945 (979)
Q Consensus 875 ~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 945 (979)
|||++|+.||......+ .....+..........+ ..+. ...........+..+++++.+++.+||+.||+
T Consensus 233 ~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 233 GELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999997532211 11111111110000000 0000 00011111222334667799999999999999
Q ss_pred CCCCHHHHHHH--HHHhHH
Q 002021 946 QRINAKEIVTK--LLKIRD 962 (979)
Q Consensus 946 ~Rps~~eil~~--L~~~~~ 962 (979)
+|||+.|+++| +.++.+
T Consensus 312 ~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp GSCCHHHHHTSGGGHHHHH
T ss_pred hCCCHHHHhcCHHHHHHHh
Confidence 99999999975 444444
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=347.09 Aligned_cols=262 Identities=21% Similarity=0.222 Sum_probs=193.6
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC------
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------ 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 751 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4678999999999999999994 5578999999986532 223466889999999999999999999987654
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..++||||+++ +|.+++.. .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999975 78777753 4899999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccc----
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM---- 907 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---- 907 (979)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+...+... .....
T Consensus 177 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~-~~~~~~~~~ 251 (371)
T 2xrw_A 177 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQL-GTPCPEFMK 251 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-C-CCCCHHHHT
T ss_pred cccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh-CCCCHHHHH
Confidence 5322 12244578999999999998899999999999999999999999997532111 111111000 00000
Q ss_pred ----------------------hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 908 ----------------------EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 908 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
......... .........+.++.+++.+|++.||++|||++|+++|=
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFP---ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSC---CSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCc---ccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000000000 00112234467899999999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=360.80 Aligned_cols=241 Identities=15% Similarity=0.153 Sum_probs=188.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccc---cccchhcHHHHHHH---HHhcCCCCeeeEE-------Ee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQ---CGRAFKSFDVECEI---MKSIRHRNLIKVI-------SS 746 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~---~~~~~~~~~~E~~~---l~~l~h~niv~l~-------~~ 746 (979)
.+.|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++ ++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35677889999999999999975 57999999998743 23345778899954 5555799999998 55
Q ss_pred eccCC-----------------eeEEEEEecCCCccceeeccCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 002021 747 CSNEE-----------------FKALVLEYMPHGSLEKYLYSSNC------ILDIFQRLNIMIDVASALEYLHFGYSAPV 803 (979)
Q Consensus 747 ~~~~~-----------------~~~lv~E~~~~g~L~~~l~~~~~------~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 803 (979)
+.+++ ..++||||+ +|+|.+++...+. .+++..++.|+.||+.||+||| +++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 55443 278999999 6799999876421 2335888899999999999999 9999
Q ss_pred EecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCC-----------CCCCchhHHHHHH
Q 002021 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG-----------RVSANGDVYSFGI 872 (979)
Q Consensus 804 ~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~ 872 (979)
+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986321 2234567 999999999877 8999999999999
Q ss_pred HHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHH
Q 002021 873 MLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKE 952 (979)
Q Consensus 873 il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e 952 (979)
++|||++|+.||......... . .+.. ....+++++.+++.+||+.||++|||+.|
T Consensus 302 il~elltg~~Pf~~~~~~~~~-~------------~~~~------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS-E------------WIFR------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp HHHHHHHSSCCC------CCS-G------------GGGS------------SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred HHHHHHHCCCCCcccccccch-h------------hhhh------------hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 999999999999653221110 0 0000 00234567899999999999999999999
Q ss_pred HHHH
Q 002021 953 IVTK 956 (979)
Q Consensus 953 il~~ 956 (979)
+++|
T Consensus 357 ~l~h 360 (377)
T 3byv_A 357 AMET 360 (377)
T ss_dssp HHTS
T ss_pred HhhC
Confidence 9874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=350.46 Aligned_cols=254 Identities=24% Similarity=0.319 Sum_probs=202.5
Q ss_pred CCCCCCceeeeecceEEEEEEc----CCCcEEEEEEecccc----ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQC----GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (979)
++|+..+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++.+ +||||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999965 478999999986532 22345677899999999 69999999999999999
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.++||||+++|+|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 999999999999999987643 6899999999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCcceecccccCCCCCCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+.....
T Consensus 210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~-------- 279 (355)
T 1vzo_A 210 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRIL-------- 279 (355)
T ss_dssp CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHH--------
T ss_pred ccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHh--------
Confidence 43222 22234579999999999875 3478999999999999999999999975322211 111111000
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTKL 957 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~L 957 (979)
.. ....+..++..+.+++.+||..||++|| +++|+++|.
T Consensus 280 ~~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 280 KS--------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cc--------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00 0011123456688999999999999999 999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=341.11 Aligned_cols=252 Identities=24% Similarity=0.303 Sum_probs=198.0
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--------ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--------GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 751 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++.... ......+.+|+++++.++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 4568899999999999999995 4578999999986432 122356889999999999999999999987665
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc---EEEEeecc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFSI 828 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~Dfg~ 828 (979)
.++||||+++++|.+++... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 79999999999999988754 36899999999999999999999 999999999999999987654 99999999
Q ss_pred ccccCCCCCcceecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
+....... ......||+.|+|||++. ...++.++||||+||++|||++|+.||........ ....+....
T Consensus 164 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~--- 236 (322)
T 2ycf_A 164 SKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSGK--- 236 (322)
T ss_dssp CEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHHHTC---
T ss_pred ceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHHhCc---
Confidence 98764221 123456899999999863 56788999999999999999999999975332221 111111000
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..........++..+.+++.+||..||++||++.|+++|
T Consensus 237 ------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 237 ------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp ------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------------cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 000011223456779999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.89 Aligned_cols=263 Identities=24% Similarity=0.287 Sum_probs=195.8
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC------
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------ 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 751 (979)
.+.|+..+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4678889999999999999995 4679999999986432 223467889999999999999999999987653
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..|+||||+ +++|.+++... .+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 78999998763 5899999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
.... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+....... .....+..
T Consensus 178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~-g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVT-GTPPAEFV 250 (367)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH-CCCCHHHH
T ss_pred cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc-CCCCHHHH
Confidence 5322 234578999999998876 67999999999999999999999999753211 1111111100 00000000
Q ss_pred cc-----------cccCchhh-hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DA-----------NLLSQEDI-HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~-----------~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ........ .......+++.+.+++.+|++.||++|||+.|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 00000000 001112446779999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=357.31 Aligned_cols=254 Identities=12% Similarity=0.108 Sum_probs=183.7
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc---cchhcHHHHHHHHHhc--CCCCeeeEEE-------eec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSI--RHRNLIKVIS-------SCS 748 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~~-------~~~ 748 (979)
..|+..+.||+|+||.||+|. ..+|+.||||++..... ...+.+.+|+++++.+ +||||++++. ++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 457888999999999999996 45899999999976532 2345677886555555 6999888653 332
Q ss_pred cC-----------------CeeEEEEEecCCCccceeeccCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeEe
Q 002021 749 NE-----------------EFKALVLEYMPHGSLEKYLYSSNCILDIFQR------LNIMIDVASALEYLHFGYSAPVIH 805 (979)
Q Consensus 749 ~~-----------------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~i~H 805 (979)
.+ ...++||||++ |+|.+++...+..+++..+ ..++.||++||+||| +++|+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCcc
Confidence 22 34799999998 8999999875444555566 788899999999999 999999
Q ss_pred cCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCC--CCCCCchhHHHHHHHHHHHHcCCCC
Q 002021 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKP 883 (979)
Q Consensus 806 ~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~P 883 (979)
|||||+||+++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.|
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999865321 124557799999999987 6799999999999999999999999
Q ss_pred CcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 884 TDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 884 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
|.......... |..... . .........+....+++.+.+++.+||+.||++|||+.|+++|
T Consensus 293 f~~~~~~~~~~--~~~~~~----~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 293 FGLVTPGIKGS--WKRPSL----R------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TTBCCTTCTTC--CCBCCT----T------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCcCcccccc--hhhhhh----h------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 98653321110 000000 0 0000011111123456779999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.66 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=202.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEee--ccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSC--SNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~l 755 (979)
.++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++ ......++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 36788899999999999999954 578999999987543 23456788999999999999999999987 44678899
Q ss_pred EEEecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCEEeCCCCcEEEEeec
Q 002021 756 VLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFS 827 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----i~H~Dik~~NIll~~~~~~kl~Dfg 827 (979)
||||+++++|.+++... ...+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998753 335899999999999999999999 777 9999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccc
Q 002021 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM 907 (979)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 907 (979)
.+........ ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .....+.....
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~~---- 233 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGKF---- 233 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCC----
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHHhhccc----
Confidence 9987643221 123456899999999998888999999999999999999999998753211 11111110000
Q ss_pred hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHH
Q 002021 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLK 959 (979)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~ 959 (979)
. ..+..++.++.+++.+||+.||++|||+.|+++++..
T Consensus 234 --------~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 --------R------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --------C------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------c------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 0 0112345678999999999999999999999987643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.66 Aligned_cols=248 Identities=26% Similarity=0.363 Sum_probs=195.8
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 36788899999999999999965 479999999986542 23346788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++.... .+++.++..++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+.......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999987653 5899999999999999999999 8999999999999999999999999999998764322
Q ss_pred CcceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
......+++.|+|||.+.+..+ ++++||||+|+++|||++|+.||...... .....+... ..
T Consensus 166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~------------~~ 228 (276)
T 2h6d_A 166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGG------------VF 228 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC------------CC
T ss_pred ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcC------------cc
Confidence 1234568999999999887665 68999999999999999999998652111 111100000 00
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+..++..+.+++.+|++.||++|||+.|+++|
T Consensus 229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0112234568899999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=348.32 Aligned_cols=273 Identities=20% Similarity=0.281 Sum_probs=201.7
Q ss_pred hhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
..++|+..+.||+|+||.||+|...+ .||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35788999999999999999997743 49999986542 234567788999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC-
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED- 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~- 836 (979)
||+++++|.+++...+..+++.+++.++.|++.|++||| +++|+||||||+||+++ ++.+||+|||++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 999999999999887767999999999999999999999 99999999999999998 6799999999987543211
Q ss_pred --CcceecccccCCCCCCccccCC---------CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 837 --QSMIQTQTLATIGYMAPEYGRE---------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 837 --~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
.........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ .........+
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~-- 261 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQMGTGMKP-- 261 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HHHHHTTCCC--
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhccCCCC--
Confidence 1112234468899999998764 3578899999999999999999999975322111 1110000000
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceeccC
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQSN 977 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~~~ 977 (979)
.. ....++.++.+++.+||..||++|||+.|+++.|+++.+.........-.|+++
T Consensus 262 -------~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~~ 317 (319)
T 2y4i_B 262 -------NL---------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKSA 317 (319)
T ss_dssp -------CC---------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------------
T ss_pred -------CC---------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccccc
Confidence 00 001234558899999999999999999999999999998776665555556554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=344.41 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=188.0
Q ss_pred HhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
...++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3457899999999999999999964 478999999986442 33456788899999999999999999999999999999
Q ss_pred EEecCCCccceeecc-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 757 LEYMPHGSLEKYLYS-------SNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
|||+++++|.+++.. ....+++..++.++.|++.|++||| +++|+||||||+||+++.++.+||+|||.+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999864 2446899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCC---cceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 830 KMLTGEDQ---SMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 830 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
........ ........||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+..... .....+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~ 247 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-LQNDPPSL 247 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-HTSSCCCT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-hccCCCcc
Confidence 76543221 111234568999999998865 56899999999999999999999999764322211111 11110000
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+.. ....++..+.+++.+||+.||++|||+.|+++|
T Consensus 248 ~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKE----------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----C----------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccch----------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000100 112345668999999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=354.71 Aligned_cols=265 Identities=21% Similarity=0.313 Sum_probs=203.7
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 5688899999999999999954 478999999987553 23356788999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++++|.+++...+ .+++..+..++.|++.|++||| +. +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 99999999987653 5899999999999999999999 75 9999999999999999999999999999765322
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhh--h-----------------
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV--N----------------- 899 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~--~----------------- 899 (979)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....... .
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 12345789999999999999999999999999999999999999975322111100000 0
Q ss_pred ------hhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 900 ------DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 900 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........+..+...... ........++.++.+++.+||+.||++|||+.|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000000000000 0000112245679999999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=339.08 Aligned_cols=251 Identities=20% Similarity=0.288 Sum_probs=198.8
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc----ccchhcHHHHHHHHHhcCCCCeeeEEEee--ccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC----GRAFKSFDVECEIMKSIRHRNLIKVISSC--SNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~ 753 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999954 578999999986542 23456788999999999999999999988 455688
Q ss_pred EEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 754 ALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
++||||++++ +.+++... ...+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||.+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 66665543 456899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCcceecccccCCCCCCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
.............||+.|+|||++.+.. ++.++||||+|+++|||++|+.||...... .....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~--------- 228 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFENIGKG--------- 228 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHC---------
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHHhcC---------
Confidence 5433333344567899999999987643 477999999999999999999998752111 111100000
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. ...+..+++.+.+++.+||+.||++|||+.|+++|
T Consensus 229 ---~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 ---S-------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---C-------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---C-------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00112345678899999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.69 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=203.5
Q ss_pred hhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc---------cchhcHHHHHHHHHhcC-CCCeeeEEEeec
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG---------RAFKSFDVECEIMKSIR-HRNLIKVISSCS 748 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 748 (979)
..++|+..+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 347889999999999999999954 5789999999865421 12356778999999996 999999999999
Q ss_pred cCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecc
Q 002021 749 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSI 828 (979)
Q Consensus 749 ~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~ 828 (979)
+++..++||||+++++|.+++... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999998764 36899999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCCCCCCccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc
Q 002021 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGR------EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
+........ .....+++.|+|||++. ...++.++||||+|+++|||++|+.||....... ..........
T Consensus 171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~ 246 (298)
T 1phk_A 171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNY 246 (298)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC
T ss_pred hhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HHHHHhcCCc
Confidence 987643221 23456899999999874 4568899999999999999999999986532111 0111000000
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. ...+....++..+.+++.+||+.||++|||+.|+++|
T Consensus 247 ~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 247 Q----------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp C----------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred c----------------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 0 0001123456679999999999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=348.49 Aligned_cols=263 Identities=23% Similarity=0.279 Sum_probs=185.3
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccC------C
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNE------E 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 751 (979)
.++|+..+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4778999999999999999995 5679999999986532 22346778999999999999999999998654 5
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..++||||+ +++|.+++... .+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 679999999 68999998763 6899999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ......... ......+..
T Consensus 182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~-~g~p~~~~~ 254 (367)
T 2fst_X 182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRL-VGTPGAELL 254 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHH-HCSCCHHHH
T ss_pred cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-hCCCCHHHH
Confidence 5322 234578999999999876 67899999999999999999999999753211 111111111 011000000
Q ss_pred c-----------ccccCchhhh-hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 D-----------ANLLSQEDIH-FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~-----------~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. ..+....... ......+++.+.+++.+|++.||++|||+.|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0000000000 01112345779999999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=335.23 Aligned_cols=244 Identities=19% Similarity=0.265 Sum_probs=197.9
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46788899999999999999955 479999999987542 23456678899999999 999999999999999999999
Q ss_pred EEecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---------------
Q 002021 757 LEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN--------------- 818 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~--------------- 818 (979)
|||+++++|.+++... ...+++.+++.++.|++.||+||| +++|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999764 246899999999999999999999 9999999999999999844
Q ss_pred ----CcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcch
Q 002021 819 ----MVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 893 (979)
Q Consensus 819 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~ 893 (979)
..+||+|||.+....... ...||+.|+|||.+.+. .+++++||||+|+++|||++|..|+... ..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~ 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQ 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HH
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hH
Confidence 479999999998764322 23589999999998765 5668999999999999999998875431 11
Q ss_pred HhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 894 LKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.........+ ..+..++..+.+++.+||+.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 WHEIRQGRLP-------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHHTTCCC-------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHcCCCC-------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111110000 0112345678999999999999999999999876
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=341.47 Aligned_cols=348 Identities=18% Similarity=0.174 Sum_probs=197.6
Q ss_pred cccCCCCCCCc-cceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCcc-ccccCcccEEecc
Q 002021 51 KNWNTSTPVCN-WTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSA-IFTTYTLKYVCLR 128 (979)
Q Consensus 51 ~~w~~~~~~c~-w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~-~~~l~~L~~L~L~ 128 (979)
++|..+.+||. |.+..|.....+ +............-..++++++|++++|.++. +|.. +..+++|++|+|+
T Consensus 4 ~~~~~~~~C~~~~~~~~c~~~~~~-----i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~-l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 4 KPRQPEYKCIDSNLQYDCVFYDVH-----IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ---CCEECBCC------EEEESCE-----ECSSCCCCEESCSSGGGCCCSEEEEESCEESE-ECTHHHHHCCCCSEEECT
T ss_pred CCCCCccceehhhhhhccceeeee-----eecccccccccccccccCCceEEEecCCchhh-CChhHhcccccCcEEECC
Confidence 57888878875 555555422211 12111111112222356888899998888874 4544 5778888888888
Q ss_pred cccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecC
Q 002021 129 GNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIG 208 (979)
Q Consensus 129 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 208 (979)
+|++++..|..++.+++|++|+|++|.+++. .|..|+++++|++|+|++|+++...+..|+++++|++|+|+
T Consensus 78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~--------~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 149 (390)
T 3o6n_A 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL--------PPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 149 (390)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCCC--------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcccccChhhccCCCCcCEEECCCCCCCcC--------CHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECC
Confidence 8888877777888888888888888888753 45567788888888888888875555556778888888888
Q ss_pred CCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccc
Q 002021 209 DNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGF 288 (979)
Q Consensus 209 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 288 (979)
+|+++++.|..+.++++|+.|++++|++++.. +..+++ |++|++++|.+++.
T Consensus 150 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~----~~~l~~------------------------L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 150 NNNLERIEDDTFQATTSLQNLQLSSNRLTHVD----LSLIPS------------------------LFHANVSYNLLSTL 201 (390)
T ss_dssp SSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC----GGGCTT------------------------CSEEECCSSCCSEE
T ss_pred CCccCccChhhccCCCCCCEEECCCCcCCccc----cccccc------------------------cceeeccccccccc
Confidence 88887777766666666666666666665431 223444 44444444444321
Q ss_pred cCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCC
Q 002021 289 IPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGI 368 (979)
Q Consensus 289 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~ 368 (979)
...++|+.|++++|.++..+.. .. ++|+.|++++|++++.
T Consensus 202 -----~~~~~L~~L~l~~n~l~~~~~~--------~~--------------------------~~L~~L~l~~n~l~~~- 241 (390)
T 3o6n_A 202 -----AIPIAVEELDASHNSINVVRGP--------VN--------------------------VELTILKLQHNNLTDT- 241 (390)
T ss_dssp -----ECCSSCSEEECCSSCCCEEECC--------CC--------------------------SSCCEEECCSSCCCCC-
T ss_pred -----CCCCcceEEECCCCeeeecccc--------cc--------------------------ccccEEECCCCCCccc-
Confidence 1112344444444444332210 01 1233333333333321
Q ss_pred CccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCC
Q 002021 369 PEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLT 448 (979)
Q Consensus 369 p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 448 (979)
..+..+++|++|+|++|.+++ ..|..+..+++|+.|+|++|++++ +|..+..++
T Consensus 242 -~~l~~l~~L~~L~Ls~n~l~~------------------------~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~ 295 (390)
T 3o6n_A 242 -AWLLNYPGLVEVDLSYNELEK------------------------IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP 295 (390)
T ss_dssp -GGGGGCTTCSEEECCSSCCCE------------------------EESGGGTTCSSCCEEECCSSCCCE-EECSSSCCT
T ss_pred -HHHcCCCCccEEECCCCcCCC------------------------cChhHccccccCCEEECCCCcCcc-cCcccCCCC
Confidence 233444444444444444443 344444444555555555555543 233444555
Q ss_pred cCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCc
Q 002021 449 SLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSG 509 (979)
Q Consensus 449 ~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 509 (979)
+|++|++++|+++.+|..+..+++|+.|++++|+++.. | +..+++|+.|++++|.++.
T Consensus 296 ~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 296 TLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp TCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred CCCEEECCCCcceecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence 66666666666666666566666666666666666543 2 5556677777777777764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.40 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=198.1
Q ss_pred HHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeecc----
Q 002021 676 ELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSN---- 749 (979)
Q Consensus 676 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 749 (979)
++....+.|+..+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3344567899999999999999999964 578999999986542 3456788999999999 79999999999865
Q ss_pred --CCeeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEee
Q 002021 750 --EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 826 (979)
Q Consensus 750 --~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df 826 (979)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 56789999999999999998764 356899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh
Q 002021 827 SIAKMLTGEDQSMIQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 901 (979)
Q Consensus 827 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~ 901 (979)
|++....... .......||+.|+|||++. +..++.++||||+||++|||++|+.||........ ........
T Consensus 174 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~ 250 (326)
T 2x7f_A 174 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPRNP 250 (326)
T ss_dssp TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSC
T ss_pred cCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhcCc
Confidence 9998654221 1223456899999999986 56788999999999999999999999865321111 00000000
Q ss_pred cCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 902 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+ .. ....++..+.+++.+||..||++||++.|+++|
T Consensus 251 ~~---------~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 251 AP---------RL---------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CC---------CC---------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cc---------cC---------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00 011234668999999999999999999999885
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=352.40 Aligned_cols=197 Identities=23% Similarity=0.309 Sum_probs=171.2
Q ss_pred hCCCCCCceeeeecceEEEEE-EcCCCcEEEEEEeccccccchhcHHHHHHHHHhc------CCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI------RHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 753 (979)
..+|+..+.||+|+||.||+| ...+++.||||++... ....+.+.+|+++++.+ .|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 356889999999999999999 4557899999998653 23345677899998887 577999999999999999
Q ss_pred EEEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc--EEEEeecccc
Q 002021 754 ALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFSIAK 830 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~--~kl~Dfg~~~ 830 (979)
++||||++ ++|.+++.... ..+++..++.++.||+.||+||| +++|+||||||+||+++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 58998887653 45899999999999999999999 899999999999999999887 9999999997
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCccc
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEI 887 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~ 887 (979)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 64322 23457899999999999999999999999999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=374.48 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=205.5
Q ss_pred hhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeE
Q 002021 680 ATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 754 (979)
..++|+..+.||+|+||.||+|. ..+++.||||++.... ....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34679999999999999999995 4578899999987542 33456678899999987 7999999999999999999
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+++|+|.+++...+ .+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999997654 6999999999999999999999 99999999999999999999999999999986432
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+....... .
T Consensus 495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~------------~ 559 (674)
T 3pfq_A 495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHN------------V 559 (674)
T ss_dssp TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHSSC------------C
T ss_pred CC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-HHHHHHHhCC------------C
Confidence 22 2234567999999999999999999999999999999999999999753211 1111111100 0
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH-----HHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA-----KEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~eil~~ 956 (979)
..+...+.++.+++.+|++.||++||++ +||++|
T Consensus 560 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred --------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 0112345679999999999999999997 777764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=351.57 Aligned_cols=265 Identities=20% Similarity=0.237 Sum_probs=200.6
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcC--------CCCeeeEEEeec---
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR--------HRNLIKVISSCS--- 748 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 748 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++... ....+.+.+|+++++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 3678999999999999999995 567899999998643 234567889999999986 788999999987
Q ss_pred -cCCeeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEeCCCC------
Q 002021 749 -NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNM------ 819 (979)
Q Consensus 749 -~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~i~H~Dik~~NIll~~~~------ 819 (979)
+....++||||+ ++++.+++... ...+++..++.++.||+.||+||| ++ +|+||||||+||+++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence 567899999999 45666655443 356999999999999999999999 87 999999999999999775
Q ss_pred -------------------------------------------cEEEEeeccccccCCCCCcceecccccCCCCCCcccc
Q 002021 820 -------------------------------------------VAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYG 856 (979)
Q Consensus 820 -------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 856 (979)
.+||+|||.+...... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999999876422 2345789999999999
Q ss_pred CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcch-----HhHhhhhhcCCccchh----------hcc----ccc--
Q 002021 857 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT-----LKHWVNDWLPISTMEV----------VDA----NLL-- 915 (979)
Q Consensus 857 ~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~-----~~~~~~~~~~~~~~~~----------~~~----~~~-- 915 (979)
.+..++.++|||||||++|||++|+.||......+.. ...... ......... +.. ...
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE-LLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH-HHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH-hcCCCChHHhhcccccccccCCccccccccc
Confidence 9889999999999999999999999999754332211 011000 000000000 000 000
Q ss_pred -------CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 -------SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 -------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.............+..+.+++.+||+.||++|||+.|+++|
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000011124556789999999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=344.73 Aligned_cols=268 Identities=22% Similarity=0.251 Sum_probs=202.3
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccC-----Cee
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 753 (979)
.++|+..+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4678999999999999999995 45789999999875432 2346788999999999999999999998654 468
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||++ |+|.+++... .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 99999997 5999888764 5899999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCCc-ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 834 GEDQS-MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 834 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ........... ...+...
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~-~~~~~~~ 257 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGS-PSQEDLN 257 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCS-CCHHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCC-CCHHHHH
Confidence 33221 11234578999999998654 458999999999999999999999997532221 11111111110 0000000
Q ss_pred c-----------cccCc-hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 A-----------NLLSQ-EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~-----------~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. ..... ..........++.++.+++.+|++.||++|||+.|+++|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000 000011112345779999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.21 Aligned_cols=256 Identities=22% Similarity=0.349 Sum_probs=197.5
Q ss_pred HHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcC--CCCeeeEEEeeccCCee
Q 002021 678 CRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIR--HRNLIKVISSCSNEEFK 753 (979)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~ 753 (979)
....+.|+..+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ ||||+++++++.+++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34456789999999999999999988889999999986442 234567889999999997 59999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||| +.+++|.+++.... .+++.+++.++.|+++||+||| +++|+||||||+||++++ +.+||+|||++....
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 99999 55789999987654 6899999999999999999999 899999999999999965 899999999998765
Q ss_pred CCCCcceecccccCCCCCCccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGRE-----------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
............||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||..................
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 4333333345578999999998865 46888999999999999999999999753322111111111000
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
. . ..+..++.++.+++.+||+.||++||++.|++++-
T Consensus 258 ~---~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 258 E---I---------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp C---C---------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred c---c---------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 0 0 00112245688999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=371.84 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=207.3
Q ss_pred hCCCCCCceeeeecceEEEEEEcC----CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
.++|+..+.||+|+||.||+|... .+..||||++.... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 356888899999999999999653 35679999986543 2334678899999999999999999999854 56899
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|+|.+++...+..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999999877667999999999999999999999 899999999999999999999999999999876433
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
. ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+ ....+....
T Consensus 545 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~~~~------------ 609 (656)
T 2j0j_A 545 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGE------------ 609 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHHTC------------
T ss_pred c-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCC------------
Confidence 2 222234457789999999988899999999999999999997 999987532211 111111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
....+..+++.+.+++.+||..||++|||+.|+++.|+++.+..
T Consensus 610 ------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 610 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 00112345677999999999999999999999999999998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=336.34 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=193.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc----------
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN---------- 749 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 749 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45688899999999999999964 57999999998643 2345678899999999999999999998754
Q ss_pred ---CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEee
Q 002021 750 ---EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 826 (979)
Q Consensus 750 ---~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df 826 (979)
.+..++||||+++|+|.+++......+++.+++.++.|+++|++||| +++|+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 45789999999999999999877667889999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCC------------cceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcch
Q 002021 827 SIAKMLTGEDQ------------SMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT 893 (979)
Q Consensus 827 g~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~ 893 (979)
|.+........ ........||+.|+|||.+.+. .++.++||||+||++|||++ ||.........
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 99986542210 1122345689999999998754 68999999999999999998 55432111111
Q ss_pred HhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 894 LKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.... ..... .. .......++..+.+++.+||+.||.+|||+.|+++|
T Consensus 238 ~~~~-~~~~~-~~--------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKL-RSVSI-EF--------------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHH-HSTTC-CC--------------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhc-ccccc-cc--------------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111 00000 00 000112344568899999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=349.78 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=193.7
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc------CCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN------EEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~ 754 (979)
..|+..+.||+|+||.||+|.. .+|+.||||++.... +...+|+++++.++||||++++++|.. ....+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3578889999999999999965 569999999986432 234479999999999999999998743 22467
Q ss_pred EEEEecCCCccceeec---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-CcEEEEeecccc
Q 002021 755 LVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFSIAK 830 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~-~~~kl~Dfg~~~ 830 (979)
+||||+++ ++.+.+. .....+++..++.++.||++||+||| +++|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999976 6665553 23457999999999999999999999 9999999999999999955 678999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
....... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+...+..........+
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 7643222 2345789999999998764 7899999999999999999999999763211 122222211100000000
Q ss_pred --hcccc----c---CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 --VDANL----L---SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 --~~~~~----~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+.. . .............++++.+|+.+||+.||++|||+.|+++|
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000 0 00000001112345779999999999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=344.95 Aligned_cols=262 Identities=22% Similarity=0.255 Sum_probs=197.6
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee----
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK---- 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 753 (979)
.+.|...+.||+|+||.||+|. ..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4678889999999999999995 55799999999975432 2346788999999999999999999999876654
Q ss_pred --EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 754 --ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 754 --~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
++||||++ ++|.+++.. .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 588777643 4899999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
.... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .......... ....+..
T Consensus 194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~-~~~~~~~ 266 (371)
T 4exu_A 194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTG-VPGTEFV 266 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC-CCCHHHH
T ss_pred cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC-CCcHHHH
Confidence 5322 234578999999999877 678999999999999999999999997532111 1111111000 0000000
Q ss_pred c-----------ccccCch-hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 D-----------ANLLSQE-DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~-----------~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. ....... .........+++.+.+++.+|++.||++|||+.|+++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 0000000 00011123456789999999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=348.20 Aligned_cols=264 Identities=24% Similarity=0.314 Sum_probs=194.2
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC------eeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------FKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 755 (979)
..|+..+.||+|+||.||+|+...+..||+|++.... +...+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4688899999999999999987666779999885432 22346999999999999999999984433 3789
Q ss_pred EEEecCCCccceee--ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEEeecccccc
Q 002021 756 VLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKML 832 (979)
Q Consensus 756 v~E~~~~g~L~~~l--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~Dfg~~~~~ 832 (979)
||||++++.+.... ......+++..++.++.|+++||+||| +++|+||||||+||+++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 99999874333222 122457899999999999999999999 99999999999999999 7999999999999876
Q ss_pred CCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCcc--chh
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST--MEV 909 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~ 909 (979)
..... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||...... ............... ...
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 43322 2345789999999988664 5899999999999999999999999753221 111111111100000 000
Q ss_pred hcccc-------cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANL-------LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~-------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..+.. ..........+..+++++.+++.+||+.||++|||+.|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000 000001111122356789999999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=338.34 Aligned_cols=269 Identities=21% Similarity=0.268 Sum_probs=196.3
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeec-----------
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCS----------- 748 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 748 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 46788899999999999999955 468999999987655555678889999999999999999999873
Q ss_pred ---cCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEE
Q 002021 749 ---NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLS 824 (979)
Q Consensus 749 ---~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~ 824 (979)
+....++||||++ |+|.+++... .+++..++.++.|++.||+||| +++|+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 5999988653 5899999999999999999999 99999999999999997 56799999
Q ss_pred eeccccccCCCCC-cceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc
Q 002021 825 DFSIAKMLTGEDQ-SMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 825 Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
|||.+........ ........+|..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+ ..........
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~ 242 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILESIP 242 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHSC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 9999987642211 112234567899999998765 678999999999999999999999997532211 1111111111
Q ss_pred CCccc---hh-------hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 903 PISTM---EV-------VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 903 ~~~~~---~~-------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..... +. ..................++.++.+++.+|++.||++|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000 00 00000000000111123456789999999999999999999999886
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=335.39 Aligned_cols=269 Identities=24% Similarity=0.301 Sum_probs=203.7
Q ss_pred hhCCCCCCceeeeecceEEEEEEc--CCCcEEEEEEeccccc--cchhcHHHHHHHHHhc---CCCCeeeEEEeec----
Q 002021 680 ATDGFSENNLIGRGGFGSVYKASL--GDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSI---RHRNLIKVISSCS---- 748 (979)
Q Consensus 680 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 748 (979)
..++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999965 5789999999865432 2345677888888877 8999999999986
Q ss_pred -cCCeeEEEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEee
Q 002021 749 -NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 826 (979)
Q Consensus 749 -~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df 826 (979)
.....++||||++ |+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5677899999998 59999987653 35899999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc-
Q 002021 827 SIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS- 905 (979)
Q Consensus 827 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~- 905 (979)
|.+...... .......+|+.|+|||.+.+..++.++||||+|+++|||++|+.||......+ .....+.......
T Consensus 165 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 165 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred cccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCc
Confidence 999865322 12244578999999999998899999999999999999999999997532211 1111111100000
Q ss_pred --cch-h--hcccccCc-hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 --TME-V--VDANLLSQ-EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 --~~~-~--~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... . ........ ..........++..+.+++.+||..||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0 00000000 000001123456778999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.23 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=202.9
Q ss_pred HhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
...++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 3446799999999999999999955 478999999986543 2345678899999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC---CcEEEEeecccccc
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFSIAKML 832 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~---~~~kl~Dfg~~~~~ 832 (979)
||||+++++|.+++.... .+++.+++.++.|++.||+||| +++|+||||||+||+++.+ +.+||+|||++...
T Consensus 99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 999999999998886543 6899999999999999999999 9999999999999999754 47999999999876
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
..... .....+|+.|+|||.+.+ .++.++||||+|+++|+|++|+.||...... .....+....
T Consensus 175 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~---------- 238 (287)
T 2wei_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKRVETGK---------- 238 (287)
T ss_dssp CCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC----------
T ss_pred cCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC----------
Confidence 43221 233458899999998865 4899999999999999999999998753211 1111110000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+....++.++.+++.+|+..||++|||+.|++++
T Consensus 239 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 239 -----YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -----CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000011123445678999999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=356.19 Aligned_cols=347 Identities=17% Similarity=0.171 Sum_probs=218.5
Q ss_pred cccCCCCCCCc----cceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEe
Q 002021 51 KNWNTSTPVCN----WTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVC 126 (979)
Q Consensus 51 ~~w~~~~~~c~----w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~ 126 (979)
++|..+.+||. |.++.|+. .++......... ..-..+++++.|++++|.+++..|..+..+++|++|+
T Consensus 10 ~~~~~~~~C~~~~~~~~c~~~~~------~i~~~~~~~~~~--~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~ 81 (597)
T 3oja_B 10 KPRQPEYKCIDSNLQYDCVFYDV------HIDMQTQDVYFG--FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN 81 (597)
T ss_dssp -CCCSEECCCCC--CCSEEECSC------EECSSCCCCEES--CSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEE
T ss_pred cCCCCCCcCcccCcCceeEecCc------eecccccccccC--cccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEE
Confidence 58988888874 66666542 111111111111 1122467888888888888754444567788888888
Q ss_pred cccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCcee
Q 002021 127 LRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLD 206 (979)
Q Consensus 127 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 206 (979)
|++|.+++..|..|+.+++|++|+|++|.+++. .|..|+++++|++|+|++|.+++..+..|+++++|++|+
T Consensus 82 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--------~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL--------PPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCC--------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCCCCCChHHhcCCCCCCEEECCCCcCCCC--------CHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 888888887777888888888888888888753 455678888888888888888766666667888888888
Q ss_pred cCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccc
Q 002021 207 IGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFS 286 (979)
Q Consensus 207 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 286 (979)
|++|+++++.|..|.++++|+.|+|++|.+++.. +..+++|+.|++++|.++
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----------------------------~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD----------------------------LSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC----------------------------GGGCTTCSEEECCSSCCS
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC----------------------------hhhhhhhhhhhcccCccc
Confidence 8888888777777766666666666666665432 223344555555555444
Q ss_pred cccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccC
Q 002021 287 GFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISG 366 (979)
Q Consensus 287 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~ 366 (979)
+. ...++|+.|++++|.++..+.. .+.+|+.|+|++|.+++
T Consensus 206 ~l-----~~~~~L~~L~ls~n~l~~~~~~----------------------------------~~~~L~~L~L~~n~l~~ 246 (597)
T 3oja_B 206 TL-----AIPIAVEELDASHNSINVVRGP----------------------------------VNVELTILKLQHNNLTD 246 (597)
T ss_dssp EE-----ECCTTCSEEECCSSCCCEEECS----------------------------------CCSCCCEEECCSSCCCC
T ss_pred cc-----cCCchhheeeccCCcccccccc----------------------------------cCCCCCEEECCCCCCCC
Confidence 21 1122344444444444332211 01123333344443332
Q ss_pred CCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccC
Q 002021 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSN 446 (979)
Q Consensus 367 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 446 (979)
+..+.. +++|+.|++++|.+.+..|..|+.+++|+.|+|++|++++ +|..+..
T Consensus 247 --~~~l~~------------------------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~ 299 (597)
T 3oja_B 247 --TAWLLN------------------------YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQP 299 (597)
T ss_dssp --CGGGGG------------------------CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSC
T ss_pred --Chhhcc------------------------CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCccccc
Confidence 133444 4444444444444544555556666666666666666664 3555566
Q ss_pred CCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcc
Q 002021 447 LTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGV 510 (979)
Q Consensus 447 l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 510 (979)
+++|+.|+|++|.++.+|..+..+++|+.|++++|.+++. | +..+++|+.|+|++|.+++.
T Consensus 300 l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 300 IPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred CCCCcEEECCCCCCCccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 7777777777777777777777778888888888888754 2 66778889999999998754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=346.53 Aligned_cols=268 Identities=20% Similarity=0.241 Sum_probs=183.1
Q ss_pred CCCC-CceeeeecceEEEEEEcC---CCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEee--ccCCeeEEE
Q 002021 683 GFSE-NNLIGRGGFGSVYKASLG---DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC--SNEEFKALV 756 (979)
Q Consensus 683 ~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~lv 756 (979)
.|+. .++||+|+||.||+|... +++.||||++... .....+.+|+++++.++||||+++++++ ......++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3544 568999999999999754 5788999998644 2345688999999999999999999998 457789999
Q ss_pred EEecCCCccceeeccC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----CCCCcEEEE
Q 002021 757 LEYMPHGSLEKYLYSS--------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLS 824 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll----~~~~~~kl~ 824 (979)
|||+++ +|.+++... ...+++..++.++.||+.||+||| +++|+||||||+||++ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999964 887776532 224899999999999999999999 9999999999999999 678899999
Q ss_pred eeccccccCCCCC-cceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCc--------chH
Q 002021 825 DFSIAKMLTGEDQ-SMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGE--------MTL 894 (979)
Q Consensus 825 Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~--------~~~ 894 (979)
|||+++....... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ..+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987643221 1223456789999999998774 58999999999999999999999996532210 111
Q ss_pred hHhhhhhc---CCccchhhccc-------ccCchhh------hh--HHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 895 KHWVNDWL---PISTMEVVDAN-------LLSQEDI------HF--VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 895 ~~~~~~~~---~~~~~~~~~~~-------~~~~~~~------~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........ ...+..+.... ....... .. ......+..+.+|+.+|++.||++|||++|+++|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111000 00010000000 0000000 00 0000114568899999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=337.67 Aligned_cols=265 Identities=19% Similarity=0.264 Sum_probs=202.8
Q ss_pred hCCCCCCceeeeecceEEEEEEc--CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCC------eeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL--GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN------LIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 752 (979)
.++|+..+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 36789999999999999999954 47899999998643 234567888999999987654 9999999999999
Q ss_pred eEEEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC--------------
Q 002021 753 KALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-------------- 817 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-------------- 817 (979)
.++||||+ +++|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999987653 36899999999999999999999 999999999999999987
Q ss_pred -----CCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc
Q 002021 818 -----NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 892 (979)
Q Consensus 818 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~ 892 (979)
++.+||+|||.+...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 241 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE- 241 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence 668999999999865322 234578999999999998899999999999999999999999997532211
Q ss_pred hHhHhhhhhcCCc--cch------hhc---c-------------cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC
Q 002021 893 TLKHWVNDWLPIS--TME------VVD---A-------------NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI 948 (979)
Q Consensus 893 ~~~~~~~~~~~~~--~~~------~~~---~-------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp 948 (979)
..........+.. ... ... . ...............+++++.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 1111111000000 000 000 0 000000000111234567899999999999999999
Q ss_pred CHHHHHHH
Q 002021 949 NAKEIVTK 956 (979)
Q Consensus 949 s~~eil~~ 956 (979)
|+.|+++|
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.09 Aligned_cols=269 Identities=23% Similarity=0.238 Sum_probs=200.2
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccC-----Cee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNE-----EFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 753 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+|+++++.++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46788999999999999999964 5789999999864332 2345678899999999999999999987654 678
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
++||||++ ++|.+++... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 5899888764 5899999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCCcc--------eecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc-C
Q 002021 834 GEDQSM--------IQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-P 903 (979)
Q Consensus 834 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~-~ 903 (979)
...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .......... +
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence 322111 1123468999999998654 678999999999999999999999997532111 1111111000 0
Q ss_pred --Cccch---------hhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 904 --ISTME---------VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 904 --~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..... ...................+++++.+++.+||+.||++|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000000000000011123466789999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=338.14 Aligned_cols=253 Identities=20% Similarity=0.247 Sum_probs=174.7
Q ss_pred hCCCCCCc-eeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc----CCeeE
Q 002021 681 TDGFSENN-LIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKA 754 (979)
Q Consensus 681 ~~~~~~~~-~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 754 (979)
.++|...+ .||+|+||.||+|.. .+|+.||||++.... ....+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788754 699999999999954 479999999986431 222223344667799999999999865 45689
Q ss_pred EEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEEeecccc
Q 002021 755 LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFSIAK 830 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfg~~~ 830 (979)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||+++. ++.+||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998653 46999999999999999999999 899999999999999986 4559999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
...... .....+|+.|+|||++.+..+++++||||+|+++|||++|+.||............ .. ..
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~---------~~ 245 (336)
T 3fhr_A 180 ETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-KR---------RI 245 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH-HH---------hh
Confidence 654221 23456899999999998888999999999999999999999999754322110000 00 00
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
. .............++.++.+++.+|++.||++|||+.|+++|-
T Consensus 246 ~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 246 R---LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred h---ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 0000001111234567799999999999999999999999863
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=335.30 Aligned_cols=334 Identities=19% Similarity=0.201 Sum_probs=238.4
Q ss_pred CCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCc
Q 002021 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFL 328 (979)
Q Consensus 249 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L 328 (979)
+++++|++++|.++...+..+..+++|++|+|++|.+++..+..|+++++|++|+|++|.++..++. .+.++++|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L 119 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----VFQNVPLL 119 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHH-----HhcCCCCC
Confidence 3444444444444433333334444444444444444444444444444444444444444443322 23444444
Q ss_pred cEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEec
Q 002021 329 KYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408 (979)
Q Consensus 329 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 408 (979)
++|++++|++..+++..+ .. .++|++|++++|.+++..+..+..+++|++|++++|++++. .+..+++|+.|+++
T Consensus 120 ~~L~L~~n~l~~l~~~~~-~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~ 194 (390)
T 3o6n_A 120 TVLVLERNDLSSLPRGIF-HN-TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVS 194 (390)
T ss_dssp CEEECCSSCCCCCCTTTT-TT-CTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECC
T ss_pred CEEECCCCccCcCCHHHh-cC-CCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecc
Confidence 455555554444332211 11 23566666666666666777788888899999999988865 35677889999999
Q ss_pred CcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCc
Q 002021 409 DNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLP 488 (979)
Q Consensus 409 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p 488 (979)
+|.+.+ +...++|+.|++++|++... |.. ..++|+.|++++|+++.++ .+..+++|+.|++++|.+++..|
T Consensus 195 ~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~~~ 265 (390)
T 3o6n_A 195 YNLLST-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDTA-WLLNYPGLVEVDLSYNELEKIMY 265 (390)
T ss_dssp SSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCEEES
T ss_pred cccccc-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCcccH-HHcCCCCccEEECCCCcCCCcCh
Confidence 998874 23456899999999999855 332 3478999999999999874 78889999999999999999889
Q ss_pred cccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccc
Q 002021 489 LEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSY 568 (979)
Q Consensus 489 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 568 (979)
..|..+++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+++.. | +..+++
T Consensus 266 ~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~ 340 (390)
T 3o6n_A 266 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHT 340 (390)
T ss_dssp GGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCC
T ss_pred hHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhcc
Confidence 999999999999999999985 5777788999999999999999 6787899999999999999999855 3 778899
Q ss_pred cCeEeccCCcccccCCCCCCCCCcccccccCCccccCCC
Q 002021 569 LEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 569 L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~p 607 (979)
|+.|++++|+++|.... ..+..+....+.+++..|..+
T Consensus 341 L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 341 LKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp CSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred CCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence 99999999999986443 355666677788888888765
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=337.28 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=192.2
Q ss_pred HHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc------cchhcHHHHHHHHHhc----CCCCeeeEEE
Q 002021 677 LCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG------RAFKSFDVECEIMKSI----RHRNLIKVIS 745 (979)
Q Consensus 677 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~ 745 (979)
.....++|+..+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999954 5789999999865432 1234566799999998 8999999999
Q ss_pred eeccCCeeEEEEEe-cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEE
Q 002021 746 SCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHL 823 (979)
Q Consensus 746 ~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl 823 (979)
++.+.+..++|||| +.+++|.+++.... .+++..++.++.|++.||+||| +++|+||||||+||+++ .++.+||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999999 78999999987643 5899999999999999999999 89999999999999999 8899999
Q ss_pred EeeccccccCCCCCcceecccccCCCCCCccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc
Q 002021 824 SDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVS-ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL 902 (979)
Q Consensus 824 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~ 902 (979)
+|||++....... .....||..|+|||++.+..+. .++||||+|+++|||++|+.||.... .....
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~-- 248 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEA-- 248 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHT--
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhh--
Confidence 9999998764332 2345689999999988766654 58999999999999999999986421 00000
Q ss_pred CCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 903 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... .+..++..+.+++.+||+.||++|||+.|+++|
T Consensus 249 ----------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 ----------ELH--------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----------CCC--------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------ccC--------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 012345668899999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=336.65 Aligned_cols=275 Identities=20% Similarity=0.238 Sum_probs=191.3
Q ss_pred HHHHHhhCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe-
Q 002021 675 LELCRATDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF- 752 (979)
Q Consensus 675 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 752 (979)
.......++|+..+.||+|+||.||+|.. .+|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34455678999999999999999999954 578999999986442 334566778888899999999999999855332
Q ss_pred ------eEEEEEecCCCccceeec---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEE
Q 002021 753 ------KALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAH 822 (979)
Q Consensus 753 ------~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~k 822 (979)
.++||||+++ ++.+.+. .....+++..+..++.|++.|++|||. .+++|+||||||+||+++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence 7899999986 5544433 234568999999999999999999992 3679999999999999996 89999
Q ss_pred EEeeccccccCCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhh
Q 002021 823 LSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 901 (979)
Q Consensus 823 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~ 901 (979)
|+|||++........ .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ......+...
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~~~~~~ 248 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHEIVRVL 248 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHHHHHHc
Confidence 999999987643322 2345689999999988654 4899999999999999999999999763221 1112221111
Q ss_pred cCCc------------cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 902 LPIS------------TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 902 ~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.... .....+.....-..........++.++.+++.+||+.||.+|||+.|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1000 000000000000000001111246789999999999999999999999986
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=329.11 Aligned_cols=258 Identities=33% Similarity=0.583 Sum_probs=246.0
Q ss_pred ccccEEEccCccccC--CCCccccCCCcccEEEecC-CCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCce
Q 002021 352 HSLEEFKMSNCNISG--GIPEEISNLTNLRTIYLGG-NKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYR 428 (979)
Q Consensus 352 ~~L~~L~L~~n~i~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 428 (979)
.++++|++++|++++ .+|..++.+++|++|+|++ |.+.+.+|..|.++++|++|++++|.+.+.+|..+.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 468899999999998 8999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccCCccccCCCcCceEecCCCccc-cccccccCcC-CCcEEEeccccccCCCccccccccccceEeccCCc
Q 002021 429 LDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLK-DILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNN 506 (979)
Q Consensus 429 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 506 (979)
|+|++|++++.+|..+..+++|++|++++|+++ .+|..+..++ +|+.|++++|++++.+|..+..+. |+.|+|++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 999999999999999999999999999999999 8999999998 999999999999999999999998 9999999999
Q ss_pred cCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCC
Q 002021 507 FSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG 586 (979)
Q Consensus 507 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 586 (979)
+++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9999999999999999999999999977665 888999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccccccCCccccCCCCCCCCCC
Q 002021 587 GSFGNFSAQSFEGNELLCGSPNLQIPPC 614 (979)
Q Consensus 587 ~~~~~~~~~~~~~N~~~c~~p~~~~~~~ 614 (979)
..++++..+.+.+|+++||.| +++|
T Consensus 288 ~~l~~L~~l~l~~N~~lc~~p---~~~C 312 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCGSP---LPAC 312 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTT---SSCC
T ss_pred ccccccChHHhcCCCCccCCC---CCCC
Confidence 889999999999999999988 5577
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=338.05 Aligned_cols=262 Identities=22% Similarity=0.259 Sum_probs=196.5
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe-----
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF----- 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 752 (979)
.++|...+.||+|+||.||+|. ..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3678889999999999999995 45799999999865432 234678899999999999999999999977654
Q ss_pred -eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 753 -KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 753 -~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
.++||||++ ++|.+++.. .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999997 588887754 4899999999999999999999 99999999999999999999999999999986
Q ss_pred cCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
.... .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ......... .....+..
T Consensus 176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~-~~~~~~~~ 248 (353)
T 3coi_A 176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT-GVPGTEFV 248 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHH-CBCCHHHH
T ss_pred CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh-CCCCHHHH
Confidence 5322 234578999999998876 678999999999999999999999997532111 111111100 00000000
Q ss_pred c-----------ccccCchhhh-hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 D-----------ANLLSQEDIH-FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~-----------~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
. .......... ......+++++.+++.+|++.||++|||+.|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0000000000 00112456779999999999999999999999986
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=329.93 Aligned_cols=273 Identities=22% Similarity=0.296 Sum_probs=240.3
Q ss_pred CCChhHHHHHHHHHHhcccCCCCcccccc----CCCCCCCccceeEee--------CCCCcEEEEEecCCCccccCCCCC
Q 002021 25 SSTITDQDALLALKAHITHDPTNFLAKNW----NTSTPVCNWTGVACE--------VHSQRVTVLNISSLNLTGTIPSQL 92 (979)
Q Consensus 25 ~~~~~~~~all~~k~~~~~~~~~~~~~~w----~~~~~~c~w~gv~c~--------~~~~~v~~l~l~~~~l~g~~~~~l 92 (979)
.+..+|++||++||+++..||.+.+ .+| ..+.++|.|.|++|. ....+|+.|+|++|+++ .+|+.+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~-~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWH-SAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHH-HHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred ccCchHHHHHHHHHHhccCCchhhh-hhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 3456899999999999988888776 589 567789999999995 24578999999999999 889999
Q ss_pred cCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCccc
Q 002021 93 GNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREF 172 (979)
Q Consensus 93 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l 172 (979)
+++++|++|+|++|+++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+|++|++.+. +|..+
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~--------~p~~~ 170 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTE--------LPEPL 170 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCC--------CCSCS
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccc--------cChhH
Confidence 99999999999999999 99999999999999999999999 8899999999999999999988765 56655
Q ss_pred C---------CCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCccc
Q 002021 173 G---------NLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSI 243 (979)
Q Consensus 173 ~---------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 243 (979)
+ ++++|++|+|++|+++ .+|..++++++|++|+|++|+++++ |..+.++++|+.|+|++|.+.+..+.
T Consensus 171 ~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l-~~~l~~l~~L~~L~Ls~n~~~~~~p~- 247 (328)
T 4fcg_A 171 ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPP- 247 (328)
T ss_dssp EEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCC-CGGGGGCTTCCEEECTTCTTCCBCCC-
T ss_pred hhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcC-chhhccCCCCCEEECcCCcchhhhHH-
Confidence 4 4999999999999998 7888899999999999999999976 55788999999999999988876654
Q ss_pred ccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccc
Q 002021 244 GYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS 312 (979)
Q Consensus 244 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 312 (979)
.+..+++|++|+|++|++.+.+|..+.++++|++|+|++|.+.+.+|..++++++|+.+++..|.+...
T Consensus 248 ~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l 316 (328)
T 4fcg_A 248 IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQL 316 (328)
T ss_dssp CTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC-
T ss_pred HhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHH
Confidence 477889999999999998889998899999999999999999989999999999999999888766543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=347.14 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=189.5
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.+|+..+.||+|+||+||.....+++.||||++.... ...+.+|+++++.+ +|||||++++++.+....++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4578889999999999665555589999999986432 34567899999999 7999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----CCcEEEEeeccccccCCC
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-----~~~~kl~Dfg~~~~~~~~ 835 (979)
+ |+|.+++........+.+++.++.||++||+||| +++|+||||||+||+++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6 5999999877655666677899999999999999 999999999999999953 336889999999876433
Q ss_pred CC-cceecccccCCCCCCccccC---CCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 836 DQ-SMIQTQTLATIGYMAPEYGR---EGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 836 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
.. ........||+.|+|||++. ...++.++||||+||++|||++ |..||........ .. ..........
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~----~~~~~~~~~~ 250 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NI----LLGACSLDCL 250 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HH----HTTCCCCTTS
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HH----HhccCCcccc
Confidence 21 12234567999999999987 4567889999999999999999 9999864321111 10 0000000000
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
......+..+.+++.+||+.||++|||+.|+++|
T Consensus 251 ------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 251 ------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ------------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0112334568899999999999999999999964
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.67 Aligned_cols=254 Identities=25% Similarity=0.300 Sum_probs=178.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-cchhcHHHHHH-HHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-RAFKSFDVECE-IMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 36788899999999999999955 5799999999975432 23344555655 677789999999999999999999999
Q ss_pred EecCCCccceeecc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 758 EYMPHGSLEKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 758 E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
||+++ +|.+++.. ....+++..+..++.|++.|++||| +. +|+||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 77777652 2456899999999999999999999 77 9999999999999999999999999999876
Q ss_pred CCCCCcceecccccCCCCCCcccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccch
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYG----REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (979)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||............. .....
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~-- 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV----VKGDP-- 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC----CCSCC--
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH----hcCCC--
Confidence 4322 12334689999999998 45678999999999999999999999997532211111100 00000
Q ss_pred hhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
+.. .......++..+.+++.+||+.||++|||+.|++++
T Consensus 248 ---~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 ---PQL------SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ---CCC------CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---CCC------CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000 000112345679999999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=341.59 Aligned_cols=201 Identities=24% Similarity=0.326 Sum_probs=171.0
Q ss_pred HhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CC-----CeeeEEEeeccCC
Q 002021 679 RATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HR-----NLIKVISSCSNEE 751 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 751 (979)
...++|+..+.||+|+||.||+|. ..+++.||||++... ....+.+..|+++++.++ |+ +++++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 345789999999999999999995 457899999998643 233456778999988885 44 4999999999999
Q ss_pred eeEEEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--CCCcEEEEeecc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFSI 828 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~--~~~~~kl~Dfg~ 828 (979)
..++||||++ |+|.+++.... ..+++..++.++.|++.||+|||. .+.+|+||||||+||+++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 49999987653 468999999999999999999992 146899999999999995 578899999999
Q ss_pred ccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCccc
Q 002021 829 AKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEI 887 (979)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~ 887 (979)
++..... .....||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9876322 23457899999999999989999999999999999999999999753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=338.75 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=200.5
Q ss_pred HHhhCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccccc------chhcHHHHHHHHHhcC--CCCeeeEEEeec
Q 002021 678 CRATDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGR------AFKSFDVECEIMKSIR--HRNLIKVISSCS 748 (979)
Q Consensus 678 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 748 (979)
....++|+..+.||+|+||.||+|. ..+++.||||++...... ..+.+.+|++++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3445789999999999999999995 567899999998754321 2356778999999996 599999999999
Q ss_pred cCCeeEEEEEecCC-CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC-CCCcEEEEee
Q 002021 749 NEEFKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDF 826 (979)
Q Consensus 749 ~~~~~~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~-~~~~~kl~Df 826 (979)
+++..++||||+.+ ++|.+++... ..+++..++.++.|++.||+||| +++|+||||||+||+++ +++.+||+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999999976 8999998764 36899999999999999999999 99999999999999999 7899999999
Q ss_pred ccccccCCCCCcceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc
Q 002021 827 SIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 905 (979)
Q Consensus 827 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 905 (979)
|++....... .....||+.|+|||++.+..+ ++++||||||+++|||++|+.||.... ......
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~---- 259 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRGQ---- 259 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHCC----
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhccc----
Confidence 9998764322 234568999999999876665 678999999999999999999986421 000000
Q ss_pred cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. .+..++.++.+++.+||+.||++|||+.|++++
T Consensus 260 --------~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 --------VF--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --------CC--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------cc--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011244668999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=345.56 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=186.6
Q ss_pred CCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 3446789999999998776668999999998643 235578899999886 89999999999999999999999996
Q ss_pred CccceeeccCCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC-------------CcEEE
Q 002021 763 GSLEKYLYSSNCI------LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-------------MVAHL 823 (979)
Q Consensus 763 g~L~~~l~~~~~~------l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~-------------~~~kl 823 (979)
|+|.+++...... .++..++.++.||+.||+||| +++|+||||||+||+++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999998765321 123346789999999999999 9999999999999999754 48999
Q ss_pred EeeccccccCCCCCcc--eecccccCCCCCCccccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcch
Q 002021 824 SDFSIAKMLTGEDQSM--IQTQTLATIGYMAPEYGRE-------GRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 893 (979)
Q Consensus 824 ~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~ 893 (979)
+|||+++......... ......||+.|+|||++.+ ..++.++||||+||++|||+| |+.||........
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~- 248 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-
Confidence 9999998765432211 1234579999999999865 568999999999999999999 9999975332211
Q ss_pred HhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 894 LKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........... ........++.++.+++.+||+.||++|||+.|+++|
T Consensus 249 --~i~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 249 --NIIRGIFSLDE-------------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp --HHHHTCCCCCC-------------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHhcCCCCccc-------------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 11111111000 0011123456779999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=334.96 Aligned_cols=264 Identities=21% Similarity=0.261 Sum_probs=199.2
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCC-cEEEEEEeccccccchhcHHHHHHHHHhcCCCC------eeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDG-MEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN------LIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 752 (979)
.++|+..+.||+|+||.||+|.. .++ +.||||++... ....+.+.+|+++++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 36789999999999999999954 344 78999998643 234567888999999997766 9999999999999
Q ss_pred eEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe----------------
Q 002021 753 KALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---------------- 815 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll---------------- 815 (979)
.++||||+ ++++.+++... ...+++.+++.++.||+.||+||| +++|+||||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 55676666554 356899999999999999999999 9999999999999999
Q ss_pred ---CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc
Q 002021 816 ---DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM 892 (979)
Q Consensus 816 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~ 892 (979)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE- 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 56789999999999864322 134578999999999999899999999999999999999999997532211
Q ss_pred hHhHhhhhhcCCccchhhc----------cc---------------ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCC
Q 002021 893 TLKHWVNDWLPISTMEVVD----------AN---------------LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQR 947 (979)
Q Consensus 893 ~~~~~~~~~~~~~~~~~~~----------~~---------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 947 (979)
..........+.. ..... .. ...............+.++.+++.+||+.||++|
T Consensus 247 ~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 HLVMMEKILGPIP-SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHCCCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHcCCCc-HHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 1111111000000 00000 00 0000000001112345679999999999999999
Q ss_pred CCHHHHHHH
Q 002021 948 INAKEIVTK 956 (979)
Q Consensus 948 ps~~eil~~ 956 (979)
||+.|+++|
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999875
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=350.86 Aligned_cols=334 Identities=19% Similarity=0.198 Sum_probs=243.7
Q ss_pred CCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCc
Q 002021 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFL 328 (979)
Q Consensus 249 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L 328 (979)
++++.|++++|.++...+..+.++++|++|+|++|.+++..|..|+.+++|++|+|++|.++..++. .+.++++|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L 125 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----VFQNVPLL 125 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH-----HHcCCCCC
Confidence 3444444444444433333344444444444444444444444444444444444444444444332 23444445
Q ss_pred cEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEec
Q 002021 329 KYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408 (979)
Q Consensus 329 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 408 (979)
++|+|++|.+..+++..+ .. .++|++|+|++|.+++..|..|+.+++|++|+|++|.+++.. +..+++|+.|+++
T Consensus 126 ~~L~L~~n~l~~l~~~~~-~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~ 200 (597)
T 3oja_B 126 TVLVLERNDLSSLPRGIF-HN-TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVS 200 (597)
T ss_dssp CEEECCSSCCCCCCTTTT-TT-CTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECC
T ss_pred CEEEeeCCCCCCCCHHHh-cc-CCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcc
Confidence 555555555444433221 11 245666666666677777778888999999999999988753 5667889999999
Q ss_pred CcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCc
Q 002021 409 DNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLP 488 (979)
Q Consensus 409 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p 488 (979)
+|.+.+ +....+|+.|++++|.+....+.. .++|+.|+|++|.++.. ..+..+++|+.|+|++|.+++..|
T Consensus 201 ~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~ 271 (597)
T 3oja_B 201 YNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMY 271 (597)
T ss_dssp SSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEES
T ss_pred cCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCH
Confidence 998874 334568999999999998554333 36899999999999985 578899999999999999999999
Q ss_pred cccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccc
Q 002021 489 LEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSY 568 (979)
Q Consensus 489 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 568 (979)
..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+|++. | +..+++
T Consensus 272 ~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~ 346 (597)
T 3oja_B 272 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHT 346 (597)
T ss_dssp GGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCC
T ss_pred HHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCC
Confidence 999999999999999999996 5778888999999999999999 6888899999999999999999865 3 778899
Q ss_pred cCeEeccCCcccccCCCCCCCCCcccccccCCccccCCC
Q 002021 569 LEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 569 L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~p 607 (979)
|+.|+|++|+|+|..+. ..+..+....+.+++..|+.+
T Consensus 347 L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 347 LKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp CSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred CCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 99999999999997643 456777778889999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=340.89 Aligned_cols=265 Identities=15% Similarity=0.236 Sum_probs=198.6
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-----------CCCeeeEEEeecc
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-----------HRNLIKVISSCSN 749 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 749 (979)
++|+..+.||+|+||.||+|. ..+++.||||++... ....+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 678899999999999999995 467999999998643 223466788999999886 8999999999875
Q ss_pred CC----eeEEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEeC------C
Q 002021 750 EE----FKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLD------D 817 (979)
Q Consensus 750 ~~----~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~i~H~Dik~~NIll~------~ 817 (979)
.+ ..++||||+ +++|.+++... ...+++..++.++.||+.||+||| ++ +|+||||||+||+++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcC
Confidence 44 789999999 88999998764 345899999999999999999999 87 999999999999994 4
Q ss_pred CCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc-----
Q 002021 818 NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM----- 892 (979)
Q Consensus 818 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~----- 892 (979)
.+.+||+|||++...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||........
T Consensus 174 ~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 458999999999876422 2345789999999999988999999999999999999999999975432111
Q ss_pred hHhHhhhhhcCCc------------------cchhh-ccccc---CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCH
Q 002021 893 TLKHWVNDWLPIS------------------TMEVV-DANLL---SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINA 950 (979)
Q Consensus 893 ~~~~~~~~~~~~~------------------~~~~~-~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~ 950 (979)
............. ..... ..... .........+..++.++.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1111111000000 00000 00000 00000111224567889999999999999999999
Q ss_pred HHHHHH
Q 002021 951 KEIVTK 956 (979)
Q Consensus 951 ~eil~~ 956 (979)
.|+++|
T Consensus 329 ~ell~h 334 (373)
T 1q8y_A 329 GGLVNH 334 (373)
T ss_dssp HHHHTC
T ss_pred HHHhhC
Confidence 999886
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=331.78 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=181.4
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccccc--chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGR--AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++...... ..+.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 35688889999999999999965 57999999998754322 2233445556788889999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
||+ ++.+..+.......+++..++.++.|+++||+||| ++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 44555555444557899999999999999999999 74 99999999999999999999999999997654322
Q ss_pred CcceecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 837 QSMIQTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
......+|+.|+|||.+. ...++.++||||+|+++|||++|+.||..................+.
T Consensus 180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 249 (318)
T 2dyl_A 180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL------- 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-------
T ss_pred ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-------
Confidence 123456899999999984 45688999999999999999999999975322211111111111000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.+....++.++.+++.+||+.||.+||++.|+++|
T Consensus 250 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 ----------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ----------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00111345668999999999999999999999886
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=319.88 Aligned_cols=307 Identities=24% Similarity=0.365 Sum_probs=201.6
Q ss_pred ccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccc
Q 002021 220 IFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNL 299 (979)
Q Consensus 220 l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 299 (979)
+..+++|+.|++++|.+.... .+..+++|++|++++|++++..+ +..+++|++|++++|.+++. +.|.++++|
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~~---~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L 112 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASIQ---GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNL 112 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCCT---TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred chhcccccEEEEeCCccccch---hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence 456677777777777776543 25567777777777777764332 66677777777777777653 246666777
Q ss_pred cceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCccc
Q 002021 300 SWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLR 379 (979)
Q Consensus 300 ~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~ 379 (979)
++|++++|.++..+. +..+++|++|++++|.... .+ ..+..+++|+
T Consensus 113 ~~L~l~~n~i~~~~~-------~~~l~~L~~L~l~~n~~~~--------------------------~~-~~~~~l~~L~ 158 (347)
T 4fmz_A 113 RELYLNEDNISDISP-------LANLTKMYSLNLGANHNLS--------------------------DL-SPLSNMTGLN 158 (347)
T ss_dssp SEEECTTSCCCCCGG-------GTTCTTCCEEECTTCTTCC--------------------------CC-GGGTTCTTCC
T ss_pred CEEECcCCcccCchh-------hccCCceeEEECCCCCCcc--------------------------cc-cchhhCCCCc
Confidence 777777776665432 4555666666666654322 22 2256666666
Q ss_pred EEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCc
Q 002021 380 TIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNE 459 (979)
Q Consensus 380 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 459 (979)
+|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|+
T Consensus 159 ~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~ 232 (347)
T 4fmz_A 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK 232 (347)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred EEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCc
Confidence 66666666665444 6666667777777776664332 6666777777777777765433 6667777777777777
Q ss_pred cccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcc
Q 002021 460 LTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSF 539 (979)
Q Consensus 460 l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 539 (979)
++.++. +..+++|+.|++++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..|..+
T Consensus 233 l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 233 ITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp CCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred cCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence 776665 66677777777777777653 3566777777777777777754 346777777777777777777677777
Q ss_pred cccccccccccccccccccCCccccCccccCeEeccCCccc
Q 002021 540 GDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580 (979)
Q Consensus 540 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 580 (979)
..+++|++|+|++|++++..| +..+++|+.|++++|+++
T Consensus 308 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 308 GGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 777777777777777776555 677777777777777764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=350.09 Aligned_cols=272 Identities=25% Similarity=0.340 Sum_probs=202.3
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeecc------CCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSN------EEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 752 (979)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999954 578999999987542 2345678899999999999999999999765 677
Q ss_pred eEEEEEecCCCccceeeccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCc---EEEEeec
Q 002021 753 KALVLEYMPHGSLEKYLYSSN--CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFS 827 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~---~kl~Dfg 827 (979)
.++||||+++|+|.+++.... ..+++..++.++.|++.|++||| +++|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999987643 35889999999999999999999 899999999999999997664 9999999
Q ss_pred cccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccc
Q 002021 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM 907 (979)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 907 (979)
.+....... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.... ....|..........
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHHSSTTCC-----
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhhhhhhhhcccch
Confidence 998764332 2244678999999999999999999999999999999999999986521 111221111111000
Q ss_pred hh-----hcccc-c-CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHH-----HHHHHHHhHH
Q 002021 908 EV-----VDANL-L-SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKE-----IVTKLLKIRD 962 (979)
Q Consensus 908 ~~-----~~~~~-~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e-----il~~L~~~~~ 962 (979)
.. ..... . .............+..+.+++.+|+..||++|||+.| +.+.+.++.+
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00 00000 0 0000000112346678999999999999999999988 5556665554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=315.63 Aligned_cols=305 Identities=26% Similarity=0.376 Sum_probs=186.3
Q ss_pred CCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcE
Q 002021 198 NLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSI 277 (979)
Q Consensus 198 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 277 (979)
.+++|++|++++|++..+. .+..+++|+.|++++|++++..+ +..+++|++|++++|.+++ +| .+..+++|++
T Consensus 42 ~l~~L~~L~l~~~~i~~~~--~~~~~~~L~~L~l~~n~i~~~~~---~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~ 114 (347)
T 4fmz_A 42 ELESITKLVVAGEKVASIQ--GIEYLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRE 114 (347)
T ss_dssp HHTTCSEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSE
T ss_pred hcccccEEEEeCCccccch--hhhhcCCccEEEccCCccccchh---hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCE
Confidence 3444555555555554431 24445555555555555544332 4455555555555555553 22 3555666666
Q ss_pred EeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEE
Q 002021 278 LDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEF 357 (979)
Q Consensus 278 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L 357 (979)
|++++|.+++..+ +..+++|++|++++|....... .+..+++|++|++++|.+..+.+
T Consensus 115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~------~~~~l~~L~~L~l~~~~~~~~~~-------------- 172 (347)
T 4fmz_A 115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS------PLSNMTGLNYLTVTESKVKDVTP-------------- 172 (347)
T ss_dssp EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG------GGTTCTTCCEEECCSSCCCCCGG--------------
T ss_pred EECcCCcccCchh--hccCCceeEEECCCCCCccccc------chhhCCCCcEEEecCCCcCCchh--------------
Confidence 6666666654432 5566666666666664332211 24455555665555555443211
Q ss_pred EccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCccc
Q 002021 358 KMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLS 437 (979)
Q Consensus 358 ~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 437 (979)
+..+++|++|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|+++
T Consensus 173 --------------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~ 234 (347)
T 4fmz_A 173 --------------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234 (347)
T ss_dssp --------------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred --------------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccC
Confidence 3444555555555555554333 5555566666666666554333 556666666666666666
Q ss_pred ccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcC
Q 002021 438 GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGG 517 (979)
Q Consensus 438 ~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 517 (979)
+..+ +..+++|++|++++|+++.++ .+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..|..|+.
T Consensus 235 ~~~~--~~~l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~ 309 (347)
T 4fmz_A 235 DLSP--LANLSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGG 309 (347)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHT
T ss_pred CCcc--hhcCCCCCEEECCCCccCCCh-hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhc
Confidence 4433 666777777777777777663 466677777777777777754 35777888888888888888888888888
Q ss_pred CcccceeecCCccccCCCCCccccccccccccccccccc
Q 002021 518 LKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLS 556 (979)
Q Consensus 518 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 556 (979)
+++|++|+|++|++++..| +..+++|++|++++|+|+
T Consensus 310 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 310 LTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 8999999999999887666 888889999999999876
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=315.96 Aligned_cols=234 Identities=14% Similarity=0.036 Sum_probs=185.7
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
+.|+..+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 6799999999999999999965 4689999999975532 22467889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++++|.+++... ....++.+++.|++.||+||| +++|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999998543 466688999999999999999 9999999999999999999999997443
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
|++| ++.++|||||||++|||+||+.||......+..... .......
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------------~~~~~~~ 221 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------------ERDTAGQ 221 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------------CBCTTSC
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------------HHHhccC
Confidence 3332 678999999999999999999999763322110000 0000000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
..........++.++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 000111223456779999999999999999 99999999999876544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=351.01 Aligned_cols=242 Identities=21% Similarity=0.316 Sum_probs=194.6
Q ss_pred hCCCCCCceeeeecceEEEEEEcC--CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCe-----
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG--DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEF----- 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 752 (979)
.++|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999999999999653 689999999865432 344578899999999999999999999977655
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.|+||||+++++|.+++.. .+++.+++.++.||+.||+||| +++|+||||||+||+++.+ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 6999999999999998765 5899999999999999999999 9999999999999999985 8999999999876
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
... ....||++|+|||++.++ ++.++|||||||++|||++|..||........ +
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~--------- 285 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P--------- 285 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C---------
T ss_pred ccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------c---------
Confidence 432 345699999999988655 48899999999999999999888754211100 0
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC-CHHHHHHHHHHhHHh
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-NAKEIVTKLLKIRDS 963 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~eil~~L~~~~~~ 963 (979)
.. ......++.+.+++.+||+.||++|| +++++.+.+..+...
T Consensus 286 ----~~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 286 ----ED----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp ----TT----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred ----cc----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 00 01112345688999999999999999 566677777766543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=314.06 Aligned_cols=231 Identities=20% Similarity=0.286 Sum_probs=181.5
Q ss_pred CCCCCC-ceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHH-HhcCCCCeeeEEEeecc----CCeeE
Q 002021 682 DGFSEN-NLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIM-KSIRHRNLIKVISSCSN----EEFKA 754 (979)
Q Consensus 682 ~~~~~~-~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 754 (979)
++|... +.||+|+||.||+|. ..+++.||||++.. ...+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 566666 789999999999995 46789999999853 24577899888 55689999999999876 67789
Q ss_pred EEEEecCCCccceeeccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEEeecccc
Q 002021 755 LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFSIAK 830 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfg~~~ 830 (979)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +++|+||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999997653 46899999999999999999999 999999999999999997 7899999999986
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
... +..++.++||||+||++|||++|+.||.......... ......
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~----------~~~~~~ 214 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----------GMKTRI 214 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C----------CSCCSS
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH----------HHHHHH
Confidence 542 1346789999999999999999999996532211000 000000
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
..............++.++.+++.+||+.||++|||+.|+++|-
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 215 ---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp ---CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 00001111122345677899999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=333.36 Aligned_cols=240 Identities=16% Similarity=0.156 Sum_probs=180.0
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCC-CCee---------------
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRH-RNLI--------------- 741 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv--------------- 741 (979)
..|...+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+.+++.++| ++..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 446677899999999999996 6689999999987432 2336778999999999987 2211
Q ss_pred ------eEEEeecc-----CCeeEEEEEecCCCccceeec------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 002021 742 ------KVISSCSN-----EEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804 (979)
Q Consensus 742 ------~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~ 804 (979)
.++.++.. ....+++|+++ +++|.+++. .....+++..++.++.|+++||+||| +++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 11111111 22356777765 679998884 23446788899999999999999999 99999
Q ss_pred ecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCcccc----------CCCCCCCchhHHHHHHHH
Q 002021 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYG----------REGRVSANGDVYSFGIML 874 (979)
Q Consensus 805 H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~il 874 (979)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999998864322 244567 999999998 556688999999999999
Q ss_pred HHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHH
Q 002021 875 METFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIV 954 (979)
Q Consensus 875 ~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil 954 (979)
|||++|+.||......+.. ..++. ....++..+.+++.+||+.||++||++.|++
T Consensus 308 ~elltg~~Pf~~~~~~~~~-------------~~~~~------------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGS-------------EWIFR------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCS-------------GGGGS------------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhhH-------------HHHHh------------hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999753221110 00000 0012346689999999999999999998886
Q ss_pred HH
Q 002021 955 TK 956 (979)
Q Consensus 955 ~~ 956 (979)
++
T Consensus 363 ~~ 364 (413)
T 3dzo_A 363 ET 364 (413)
T ss_dssp TS
T ss_pred hC
Confidence 55
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=319.29 Aligned_cols=244 Identities=16% Similarity=0.191 Sum_probs=185.4
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccc--------cchhcHHHHHHHHHhcC---------CCCeeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCG--------RAFKSFDVECEIMKSIR---------HRNLIKVI 744 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~l~ 744 (979)
++|+..+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+++++.++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5678889999999999999987 789999999975421 22367889999999886 66666666
Q ss_pred Ee-----------------ecc-------------CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHH
Q 002021 745 SS-----------------CSN-------------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 794 (979)
Q Consensus 745 ~~-----------------~~~-------------~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~ 794 (979)
++ +.+ .+..++||||+++|++.+.+.+ ..+++.+++.++.||+.||+|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence 54 332 6789999999999987777654 358999999999999999999
Q ss_pred HhcCCCCCeEecCCCCCCEEeCCCC--------------------cEEEEeeccccccCCCCCcceecccccCCCCCCcc
Q 002021 795 LHFGYSAPVIHCDLKPSNVLLDDNM--------------------VAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854 (979)
Q Consensus 795 LH~~~~~~i~H~Dik~~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 854 (979)
||+ +++|+||||||+|||++.++ .+||+|||+|+.... ....||+.|+|||
T Consensus 177 lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 993 47999999999999999887 899999999987642 2347999999999
Q ss_pred ccCCCCCCCchhHHHHHHH-HHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHH
Q 002021 855 YGREGRVSANGDVYSFGIM-LMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 933 (979)
Q Consensus 855 ~~~~~~~~~~~DvwslG~i-l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 933 (979)
++.+.. +.++||||+|++ .+++++|..||.... |..... ..+...... ........+..+++++.
T Consensus 248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--------~~~~~~----~~~~~~~~~-~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--------WLHYLT----DKMLKQMTF-KTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--------HHHHHH----HHHHHTCCC-SSCCCSHHHHHHHHHHH
T ss_pred hhcCCC-ccceehhhhhCCCCcccccccCCCcchh--------hhhHHH----Hhhhhhhcc-CcccchhhhhhcCHHHH
Confidence 998665 889999998777 778888999975411 100000 000000000 01111223456788899
Q ss_pred HHHHhccccCcCCCCCHHHHH-HH
Q 002021 934 NLAMECTMEFPKQRINAKEIV-TK 956 (979)
Q Consensus 934 ~l~~~cl~~dP~~Rps~~eil-~~ 956 (979)
+++.+|++.| |+.|++ +|
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999976 999998 64
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-32 Score=299.91 Aligned_cols=292 Identities=21% Similarity=0.212 Sum_probs=235.3
Q ss_pred EEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCc
Q 002021 76 VLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNA 155 (979)
Q Consensus 76 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 155 (979)
.+++++++++ .+|..+. ++|++|+|++|++++..|..+..+++|++|+|++|++++..|..++++++|++|+|++|.
T Consensus 35 ~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (330)
T 1xku_A 35 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111 (330)
T ss_dssp EEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence 3455566666 4666554 689999999999998877899999999999999999999889999999999999999999
Q ss_pred cCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeee--cCCccccccCccceeeccC
Q 002021 156 LSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVG--IAPIAIFNVSTLKILGLQD 233 (979)
Q Consensus 156 l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~ 233 (979)
++ .+|..+. ++|++|++++|.+++..+..+.++++|++|++++|++.. ..+..+.++++|+.|++++
T Consensus 112 l~---------~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~ 180 (330)
T 1xku_A 112 LK---------ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180 (330)
T ss_dssp CS---------BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCS
T ss_pred CC---------ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCC
Confidence 97 3676655 799999999999998888889999999999999999964 7788899999999999999
Q ss_pred CCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecccccccccc
Q 002021 234 NSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313 (979)
Q Consensus 234 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 313 (979)
|.++..+... .++|++|++++|++++..|..+..+++|++|+|++|.+++..+..|..+++|++|+|++|+++.++
T Consensus 181 n~l~~l~~~~----~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp 256 (330)
T 1xku_A 181 TNITTIPQGL----PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 256 (330)
T ss_dssp SCCCSCCSSC----CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCC
T ss_pred CccccCCccc----cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCC
Confidence 9999765432 389999999999999888999999999999999999999888889999999999999999999776
Q ss_pred chhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCc--h
Q 002021 314 QELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNG--S 391 (979)
Q Consensus 314 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~--~ 391 (979)
. .+..+++|++|++++|+++.+.+..+.... .....+.|+.|++++|.+.. .
T Consensus 257 ~------~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~--------------------~~~~~~~l~~l~l~~N~~~~~~i 310 (330)
T 1xku_A 257 G------GLADHKYIQVVYLHNNNISAIGSNDFCPPG--------------------YNTKKASYSGVSLFSNPVQYWEI 310 (330)
T ss_dssp T------TTTTCSSCCEEECCSSCCCCCCTTSSSCSS--------------------CCTTSCCCSEEECCSSSSCGGGS
T ss_pred h------hhccCCCcCEEECCCCcCCccChhhcCCcc--------------------cccccccccceEeecCccccccc
Confidence 4 367788899999999998877655443210 01123455555666665542 3
Q ss_pred hHHhhhcCCCCcEEEecCcc
Q 002021 392 ILITLSKLQKLQDLGLKDNK 411 (979)
Q Consensus 392 ~~~~l~~l~~L~~L~L~~N~ 411 (979)
.+..|..+.+++.+++++|+
T Consensus 311 ~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 311 QPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CGGGGTTCCCGGGEEC----
T ss_pred CccccccccceeEEEecccC
Confidence 44556666666666666553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-32 Score=303.07 Aligned_cols=291 Identities=22% Similarity=0.202 Sum_probs=233.4
Q ss_pred EEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCc
Q 002021 76 VLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNA 155 (979)
Q Consensus 76 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 155 (979)
.+++++++++ .+|..+. ++|++|+|++|++++..|.++..+++|++|+|++|++++..|..++++++|++|+|++|.
T Consensus 37 ~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 113 (332)
T 2ft3_A 37 VVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113 (332)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSC
T ss_pred EEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCc
Confidence 4556667777 6777663 799999999999998888899999999999999999999989999999999999999999
Q ss_pred cCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeee--ecCCccccccCccceeeccC
Q 002021 156 LSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLV--GIAPIAIFNVSTLKILGLQD 233 (979)
Q Consensus 156 l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~L~~ 233 (979)
++ .+|..+. ++|++|++++|++++..+..++++++|++|++++|+++ +..|..+..+ +|+.|++++
T Consensus 114 l~---------~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~ 181 (332)
T 2ft3_A 114 LV---------EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISE 181 (332)
T ss_dssp CC---------SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCS
T ss_pred CC---------ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcC
Confidence 97 3677665 89999999999999877788999999999999999996 4778888888 999999999
Q ss_pred CCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecccccccccc
Q 002021 234 NSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313 (979)
Q Consensus 234 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 313 (979)
|++++.+... .++|++|++++|++++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|+++.++
T Consensus 182 n~l~~l~~~~----~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp 257 (332)
T 2ft3_A 182 AKLTGIPKDL----PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVP 257 (332)
T ss_dssp SBCSSCCSSS----CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCC
T ss_pred CCCCccCccc----cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecC
Confidence 9999865432 378999999999999888888999999999999999999888888999999999999999998776
Q ss_pred chhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCC--ch
Q 002021 314 QELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLN--GS 391 (979)
Q Consensus 314 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~--~~ 391 (979)
.. +..+++|++|++++|+++.+.+..+..... -...++|+.|++++|.+. +.
T Consensus 258 ~~------l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~--------------------~~~~~~l~~L~l~~N~~~~~~~ 311 (332)
T 2ft3_A 258 AG------LPDLKLLQVVYLHTNNITKVGVNDFCPVGF--------------------GVKRAYYNGISLFNNPVPYWEV 311 (332)
T ss_dssp TT------GGGCTTCCEEECCSSCCCBCCTTSSSCSSC--------------------CSSSCCBSEEECCSSSSCGGGS
T ss_pred hh------hhcCccCCEEECCCCCCCccChhHcccccc--------------------ccccccccceEeecCccccccc
Confidence 53 567888888999888888775544332110 011345556666666555 44
Q ss_pred hHHhhhcCCCCcEEEecCcc
Q 002021 392 ILITLSKLQKLQDLGLKDNK 411 (979)
Q Consensus 392 ~~~~l~~l~~L~~L~L~~N~ 411 (979)
.+..|..+++|+.+++++|+
T Consensus 312 ~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 312 QPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CGGGGTTBCCSTTEEC----
T ss_pred Ccccccccchhhhhhccccc
Confidence 55556666666666665553
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=345.46 Aligned_cols=360 Identities=20% Similarity=0.207 Sum_probs=179.5
Q ss_pred CCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccc----cccccccCCCCCCceecCCCeeeecCCcc
Q 002021 144 SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQG----KIPLKIGNLRNLEKLDIGDNKLVGIAPIA 219 (979)
Q Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 219 (979)
++|++|||++|+++... ....+..+++|++|+|++|.+++ .++..+..+++|++|+|++|++.+..+..
T Consensus 3 ~~l~~L~Ls~~~l~~~~-------~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~ 75 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDAR-------WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHC 75 (461)
T ss_dssp EEEEEEEEESCCCCHHH-------HHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHH
T ss_pred ccceehhhhhcccCchh-------HHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHH
Confidence 56788888888887542 22335667788888888888774 34566777788888888888877654433
Q ss_pred ccc-cC----ccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCcccc
Q 002021 220 IFN-VS----TLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFG 294 (979)
Q Consensus 220 l~~-l~----~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 294 (979)
+.. ++ +|+.|+|++|+++.... ..++..+..+++|++|+|++|.+++..+..+.
T Consensus 76 l~~~l~~~~~~L~~L~L~~n~i~~~~~---------------------~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 134 (461)
T 1z7x_W 76 VLQGLQTPSCKIQKLSLQNCCLTGAGC---------------------GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLC 134 (461)
T ss_dssp HHHTTCSTTCCCCEEECTTSCCBGGGH---------------------HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHH
T ss_pred HHHHHhhCCCceeEEEccCCCCCHHHH---------------------HHHHHHHccCCceeEEECCCCcCchHHHHHHH
Confidence 322 33 45555555555543110 12334444444444444444444332222221
Q ss_pred c-----cccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccc---cccccEEEccCccccC
Q 002021 295 N-----LRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNL---SHSLEEFKMSNCNISG 366 (979)
Q Consensus 295 ~-----l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l---~~~L~~L~L~~n~i~~ 366 (979)
. .++|++|+|++|+++..... .+...+..+++|++|++++|.+.+.........+ .++|++|++++|.+++
T Consensus 135 ~~l~~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~ 213 (461)
T 1z7x_W 135 EGLLDPQCRLEKLQLEYCSLSAASCE-PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTS 213 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHH-HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBT
T ss_pred HHHhcCCCcceEEECCCCCCCHHHHH-HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcH
Confidence 1 23444445544444432211 0112233445555555555554332211111100 1245555555555544
Q ss_pred C----CCccccCCCcccEEEecCCCCCchhHH-----hhhcCCCCcEEEecCcccCCC----ccccccCCCCCceEecCC
Q 002021 367 G----IPEEISNLTNLRTIYLGGNKLNGSILI-----TLSKLQKLQDLGLKDNKLEGS----IPYDICNLAELYRLDLDG 433 (979)
Q Consensus 367 ~----~p~~l~~l~~L~~L~L~~N~l~~~~~~-----~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~ 433 (979)
. ++..+..+++|++|++++|++++.... .+..+++|++|++++|.+++. ++..+..+++|++|++++
T Consensus 214 ~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~ 293 (461)
T 1z7x_W 214 DNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293 (461)
T ss_dssp THHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCC
Confidence 2 345555666777777777766554322 222456666666666666542 344555566666666666
Q ss_pred CcccccCCccccC-----CCcCceEecCCCcccc-----ccccccCcCCCcEEEeccccccCCCcccccc-----ccccc
Q 002021 434 NKLSGSIPACFSN-----LTSLRIVSLGSNELTS-----IPLTFWNLKDILNLNFSSNFLTGSLPLEIGS-----LKVLV 498 (979)
Q Consensus 434 N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~-----lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~ 498 (979)
|.+.+..+..+.. .++|++|++++|.++. ++..+..+++|+.|++++|.+++..+..+.. .++|+
T Consensus 294 n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~ 373 (461)
T 1z7x_W 294 NELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR 373 (461)
T ss_dssp CCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCC
T ss_pred CCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceE
Confidence 6665433333322 2455555555555553 2333444444555555555444332222221 33444
Q ss_pred eEeccCCccCc----ccchhhcCCcccceeecCCcccc
Q 002021 499 GIDLSRNNFSG----VIPTEIGGLKNLEYLFLGYNRLQ 532 (979)
Q Consensus 499 ~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 532 (979)
.|+|++|++++ .+|..+..+++|++|+|++|+++
T Consensus 374 ~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 374 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp EEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred EEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 44444444443 34444444444444444444444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-32 Score=300.65 Aligned_cols=268 Identities=25% Similarity=0.279 Sum_probs=146.9
Q ss_pred CCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCc
Q 002021 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFL 328 (979)
Q Consensus 249 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L 328 (979)
++|++|+|++|++++..|..+.++++|++|+|++|++++..|..|+++++|++|+|++|+++.++..
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~------------- 120 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPN------------- 120 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSS-------------
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCcc-------------
Confidence 4555555555555555555555555666666666665555555555555555555555555443321
Q ss_pred cEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCc--hhHHhhhcCCCCcEEE
Q 002021 329 KYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNG--SILITLSKLQKLQDLG 406 (979)
Q Consensus 329 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~ 406 (979)
. .++|++|++++|++++..+..|..+++|++|++++|.++. ..+..+..+ +|+.|+
T Consensus 121 ----------------~-----~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~ 178 (332)
T 2ft3_A 121 ----------------L-----PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLR 178 (332)
T ss_dssp ----------------C-----CTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCB
T ss_pred ----------------c-----cccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEE
Confidence 1 1356666666666665555667777777777777777753 334444444 555555
Q ss_pred ecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCC
Q 002021 407 LKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486 (979)
Q Consensus 407 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~ 486 (979)
+++|++++ +|..+. ++|++|++++|++++..+..|..+ ++|+.|++++|++++.
T Consensus 179 l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l-----------------------~~L~~L~L~~N~l~~~ 232 (332)
T 2ft3_A 179 ISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRY-----------------------SKLYRLGLGHNQIRMI 232 (332)
T ss_dssp CCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTC-----------------------TTCSCCBCCSSCCCCC
T ss_pred CcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCC-----------------------CCCCEEECCCCcCCcC
Confidence 55555543 332222 344445555555544444444444 4444444445555444
Q ss_pred CccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccc------ccccccccccccccc--cc
Q 002021 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD------LISLKFLNLSNNNLS--GV 558 (979)
Q Consensus 487 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--~~ 558 (979)
.+..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++..+..|.. ..+|+.|++++|.+. +.
T Consensus 233 ~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~ 311 (332)
T 2ft3_A 233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311 (332)
T ss_dssp CTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGS
T ss_pred ChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccccc
Confidence 4445555555666666666655 44555666666666666666666554454443 245666777777665 55
Q ss_pred CCccccCccccCeEeccCCc
Q 002021 559 IPASLEKLSYLEDLNLSFNQ 578 (979)
Q Consensus 559 ~p~~~~~l~~L~~L~L~~N~ 578 (979)
.|..|..+++|+.+++++|+
T Consensus 312 ~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 312 QPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CGGGGTTBCCSTTEEC----
T ss_pred Ccccccccchhhhhhccccc
Confidence 66667777777777777664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-31 Score=297.86 Aligned_cols=269 Identities=22% Similarity=0.285 Sum_probs=145.4
Q ss_pred CCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCc
Q 002021 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFL 328 (979)
Q Consensus 249 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L 328 (979)
++|++|+|++|++++..+..+.++++|++|+|++|++++..|..|+++++|++|+|++|+++.++...
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~------------ 119 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM------------ 119 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSC------------
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhh------------
Confidence 45566666666666555555666666666666666666555666666666666666555555433211
Q ss_pred cEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCc--hhHHhhhcCCCCcEEE
Q 002021 329 KYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNG--SILITLSKLQKLQDLG 406 (979)
Q Consensus 329 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~ 406 (979)
.++|++|++++|.+++..+..+..+++|++|++++|.++. ..+..+..+++|+.|+
T Consensus 120 ----------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~ 177 (330)
T 1xku_A 120 ----------------------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177 (330)
T ss_dssp ----------------------CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred ----------------------cccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEE
Confidence 1345555555555555555556666666666666666643 3444555555555555
Q ss_pred ecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCC
Q 002021 407 LKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486 (979)
Q Consensus 407 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~ 486 (979)
+++|.++. +|..+. ++|++|++++|++++..+..|..+++|++|++++|+++ +.
T Consensus 178 l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-----------------------~~ 231 (330)
T 1xku_A 178 IADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-----------------------AV 231 (330)
T ss_dssp CCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC-----------------------EE
T ss_pred CCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc-----------------------ee
Confidence 55555553 333222 44555555555555444445555555555555555444 43
Q ss_pred CccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccc------cccccccccccccccc--c
Q 002021 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD------LISLKFLNLSNNNLSG--V 558 (979)
Q Consensus 487 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~ 558 (979)
.+..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|.. .+.|+.|++++|.+.. +
T Consensus 232 ~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i 310 (330)
T 1xku_A 232 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310 (330)
T ss_dssp CTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGS
T ss_pred ChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccccc
Confidence 3444444555555555555555 44455555555555555555555444444432 2556666666666642 4
Q ss_pred CCccccCccccCeEeccCCc
Q 002021 559 IPASLEKLSYLEDLNLSFNQ 578 (979)
Q Consensus 559 ~p~~~~~l~~L~~L~L~~N~ 578 (979)
.|..|..+.+++.++|++|+
T Consensus 311 ~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 311 QPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CGGGGTTCCCGGGEEC----
T ss_pred CccccccccceeEEEecccC
Confidence 45666666777777776664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-35 Score=339.84 Aligned_cols=360 Identities=20% Similarity=0.206 Sum_probs=215.0
Q ss_pred CCCCceecCCCeeeecCCcc-ccccCccceeeccCCCCcCCC---cccccCCCCCcCEEEccCCccccccCcccc-cCC-
Q 002021 200 RNLEKLDIGDNKLVGIAPIA-IFNVSTLKILGLQDNSLSGCL---SSIGYARLPNLEILSLWGNNFSGTIPRFIF-NAS- 273 (979)
Q Consensus 200 ~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~---~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~- 273 (979)
++|++|||++|+++...... +..+++|+.|+|++|.+++.. ....+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 56778888888877654333 566777777777777776421 122355667777777777777654333332 233
Q ss_pred ---CCcEEecccccccc----ccCccccccccccceeccccccccccchhhhhhc-ccCCCCccEEEccCCCCcccCCcc
Q 002021 274 ---KLSILDLEGNSFSG----FIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSS-LSNCKFLKYFDLSYNPLYRILPRT 345 (979)
Q Consensus 274 ---~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~ 345 (979)
+|++|+|++|+++. .++..|..+++|++|+|++|.++...... +... ...+++|++|++++|++......
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~-l~~~l~~~~~~L~~L~L~~n~l~~~~~~- 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL-LCEGLLDPQCRLEKLQLEYCSLSAASCE- 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH-HHHHHTSTTCCCCEEECTTSCCBGGGHH-
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHH-HHHHHhcCCCcceEEECCCCCCCHHHHH-
Confidence 57777777777663 34566666666666776666665432211 0111 12234455555555554432111
Q ss_pred ccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhh-----cCCCCcEEEecCcccCCC----c
Q 002021 346 TVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLS-----KLQKLQDLGLKDNKLEGS----I 416 (979)
Q Consensus 346 ~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~-----~l~~L~~L~L~~N~l~~~----~ 416 (979)
.++..+..+++|++|++++|.+++..+..+. ..++|++|++++|.+++. +
T Consensus 161 ---------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 219 (461)
T 1z7x_W 161 ---------------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219 (461)
T ss_dssp ---------------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHH
T ss_pred ---------------------HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHH
Confidence 1234455566677777777766655444443 255677777777766653 3
Q ss_pred cccccCCCCCceEecCCCcccccC-----CccccCCCcCceEecCCCcccc-----ccccccCcCCCcEEEeccccccCC
Q 002021 417 PYDICNLAELYRLDLDGNKLSGSI-----PACFSNLTSLRIVSLGSNELTS-----IPLTFWNLKDILNLNFSSNFLTGS 486 (979)
Q Consensus 417 p~~~~~l~~L~~L~Ls~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~-----lp~~~~~l~~L~~L~ls~N~l~~~ 486 (979)
+..+..+++|++|++++|++.+.. +..+..+++|++|++++|+++. ++..+..+++|+.|++++|.+++.
T Consensus 220 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 299 (461)
T 1z7x_W 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred HHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH
Confidence 555666667777777777665432 2223346667777777777765 555666667777777777776544
Q ss_pred Cccccccc-----cccceEeccCCccCcc----cchhhcCCcccceeecCCccccCCCCCcccc-----ccccccccccc
Q 002021 487 LPLEIGSL-----KVLVGIDLSRNNFSGV----IPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD-----LISLKFLNLSN 552 (979)
Q Consensus 487 ~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~ 552 (979)
.+..+... ++|+.|+|++|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|++|+|++
T Consensus 300 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~ 379 (461)
T 1z7x_W 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCC
Confidence 33333322 4677777777777654 4555666677777777777776544444433 45777777777
Q ss_pred ccccc----cCCccccCccccCeEeccCCccccc
Q 002021 553 NNLSG----VIPASLEKLSYLEDLNLSFNQLEGK 582 (979)
Q Consensus 553 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~ 582 (979)
|++++ .+|..+..+++|++|++++|++++.
T Consensus 380 n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp SCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred CCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 77765 5666666777777777777777643
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-33 Score=340.92 Aligned_cols=450 Identities=15% Similarity=0.052 Sum_probs=214.1
Q ss_pred CCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcc---cccCCcccc------------ccCccc
Q 002021 59 VCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRL---FGSIPSAIF------------TTYTLK 123 (979)
Q Consensus 59 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~---~~~~p~~~~------------~l~~L~ 123 (979)
|++|+++.+.. . ..+.+.. .....++..+..+++|++|+|+++.. .+.+|..++ .+++|+
T Consensus 41 ck~W~~~~~~~--~--~~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSET--R--EHVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHH--C--CEEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhcc--c--cEEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 44899985432 1 1222322 23333344567788899999987532 244554443 344444
Q ss_pred EEecccccccccCCccccCC-CCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeeccccc-ccc-cccccccCCC
Q 002021 124 YVCLRGNQLSGTFPSFISNK-SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANN-LQG-KIPLKIGNLR 200 (979)
Q Consensus 124 ~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~-l~~-~~p~~~~~l~ 200 (979)
+|+|++|.+++..+..++.. ++ +|++|+|++|. ++. .++....+++
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~-------------------------------~L~~L~L~~~~~~~~~~l~~~~~~~~ 164 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARAD-------------------------------DLETLKLDKCSGFTTDGLLSIVTHCR 164 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGG-------------------------------GCCEEEEESCEEEEHHHHHHHHHHCT
T ss_pred eEEeeccEecHHHHHHHHHhccc-------------------------------cCcEEECcCCCCcCHHHHHHHHhhCC
Confidence 44444444444333333332 11 25555554443 110 1122223455
Q ss_pred CCCceecCCCeeeecCC----ccccccCccceeeccCCCCcCCCc---ccccCCCCCcCEEEccCCccccccCcccccCC
Q 002021 201 NLEKLDIGDNKLVGIAP----IAIFNVSTLKILGLQDNSLSGCLS---SIGYARLPNLEILSLWGNNFSGTIPRFIFNAS 273 (979)
Q Consensus 201 ~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~~~---~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 273 (979)
+|++|+|++|.+++... ..+.++++|+.|++++|.+++... ...+..+++|++|+|++|.+.+ +|..+.+++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 56666666665554421 123344555555555555442111 1123345555555555555553 445555555
Q ss_pred CCcEEeccccccc---cccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccc
Q 002021 274 KLSILDLEGNSFS---GFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNL 350 (979)
Q Consensus 274 ~L~~L~Ls~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 350 (979)
+|++|+++.+... ...+..+..+++|+.|+++++....++. .+..+++|++|++++|.+
T Consensus 244 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~------~~~~~~~L~~L~Ls~~~l------------ 305 (592)
T 3ogk_B 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPI------LFPFAAQIRKLDLLYALL------------ 305 (592)
T ss_dssp TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGG------GGGGGGGCCEEEETTCCC------------
T ss_pred HHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHH------HHhhcCCCcEEecCCCcC------------
Confidence 5665555542221 1122334444455555544432222221 122333444444444432
Q ss_pred cccccEEEccCccccCCCC-ccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecC-----------cccCCCc-c
Q 002021 351 SHSLEEFKMSNCNISGGIP-EEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKD-----------NKLEGSI-P 417 (979)
Q Consensus 351 ~~~L~~L~L~~n~i~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~-----------N~l~~~~-p 417 (979)
++... ..+..+++|++|+++++...+..+..+..+++|++|++++ |.+++.. +
T Consensus 306 --------------~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~ 371 (592)
T 3ogk_B 306 --------------ETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLI 371 (592)
T ss_dssp --------------CHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHH
T ss_pred --------------CHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHH
Confidence 21111 2234455555555552211222223334455555555552 3333221 1
Q ss_pred ccccCCCCCceEecCCCcccccCCccccC-CCcCceEecC----CCcccccc------ccccCcCCCcEEEeccc--ccc
Q 002021 418 YDICNLAELYRLDLDGNKLSGSIPACFSN-LTSLRIVSLG----SNELTSIP------LTFWNLKDILNLNFSSN--FLT 484 (979)
Q Consensus 418 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~lp------~~~~~l~~L~~L~ls~N--~l~ 484 (979)
.....+++|++|+++.|++++..+..+.. +++|+.|+++ .|+++..| ..+..+++|+.|+++.+ .++
T Consensus 372 ~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~ 451 (592)
T 3ogk_B 372 ALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLT 451 (592)
T ss_dssp HHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCC
T ss_pred HHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCcc
Confidence 11233555555555555555544444443 5556666663 45555432 22445666666666532 244
Q ss_pred CCCcccccc-ccccceEeccCCccCc-ccchhhcCCcccceeecCCccccCC-CCCcccccccccccccccccccccCCc
Q 002021 485 GSLPLEIGS-LKVLVGIDLSRNNFSG-VIPTEIGGLKNLEYLFLGYNRLQGS-IPNSFGDLISLKFLNLSNNNLSGVIPA 561 (979)
Q Consensus 485 ~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 561 (979)
+..+..++. +++|+.|+|++|++++ .++..+.++++|++|+|++|.+++. ++..+..+++|++|+|++|+++..--.
T Consensus 452 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~ 531 (592)
T 3ogk_B 452 DLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQD 531 (592)
T ss_dssp HHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTT
T ss_pred HHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHH
Confidence 333333332 5667777777777765 2344556677777777777776543 233345667777777777777654222
Q ss_pred cc-cCccccCeEeccCC
Q 002021 562 SL-EKLSYLEDLNLSFN 577 (979)
Q Consensus 562 ~~-~~l~~L~~L~L~~N 577 (979)
.+ ..++.+....+..+
T Consensus 532 ~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 532 LMQMARPYWNIELIPSR 548 (592)
T ss_dssp GGGGCCTTEEEEEECCC
T ss_pred HHHHhCCCcEEEEecCc
Confidence 22 24555555544443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=289.76 Aligned_cols=91 Identities=35% Similarity=0.422 Sum_probs=54.8
Q ss_pred cCCCCCCCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccc
Q 002021 53 WNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQL 132 (979)
Q Consensus 53 w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l 132 (979)
|.....+|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|++++..+..+..+++|++|+|++|++
T Consensus 23 ~~~~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 88 (353)
T 2z80_A 23 SNQASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI 88 (353)
T ss_dssp ----CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred CCccCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCcc
Confidence 4445567999998 75 4566666 4565543 4677777777777654444566666666666666666
Q ss_pred cccCCccccCCCCCcEEEccCCccC
Q 002021 133 SGTFPSFISNKSSLQHLDLSSNALS 157 (979)
Q Consensus 133 ~~~~p~~l~~l~~L~~L~Ls~N~l~ 157 (979)
++..|..++++++|++|||++|.++
T Consensus 89 ~~~~~~~~~~l~~L~~L~Ls~n~l~ 113 (353)
T 2z80_A 89 NTIEEDSFSSLGSLEHLDLSYNYLS 113 (353)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CccCHhhcCCCCCCCEEECCCCcCC
Confidence 6555555555555555555555554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=283.37 Aligned_cols=252 Identities=25% Similarity=0.270 Sum_probs=160.6
Q ss_pred CccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccc--cCC
Q 002021 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSG--TFP 137 (979)
Q Consensus 60 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~--~~p 137 (979)
|.|.+|.|+. ++++ .+|..+. ++|++|+|++|+++...+..+..+++|++|+|++|+++. ..|
T Consensus 7 C~~~~l~c~~------------~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 71 (306)
T 2z66_A 7 CSGTEIRCNS------------KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71 (306)
T ss_dssp EETTEEECCS------------SCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEE
T ss_pred eCCCEEEcCC------------CCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcc
Confidence 8999998863 2344 3454332 577777777777773333345677777777777777763 235
Q ss_pred ccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeeccccccccccc-ccccCCCCCCceecCCCeeeecC
Q 002021 138 SFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP-LKIGNLRNLEKLDIGDNKLVGIA 216 (979)
Q Consensus 138 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~ 216 (979)
..+..+++|++|+|++|.++ .+|..+.++++|++|++++|++++..+ ..+..+++|++|++++|++.+..
T Consensus 72 ~~~~~~~~L~~L~Ls~n~i~---------~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 142 (306)
T 2z66_A 72 QSDFGTTSLKYLDLSFNGVI---------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 142 (306)
T ss_dssp HHHHSCSCCCEEECCSCSEE---------EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECS
T ss_pred cccccccccCEEECCCCccc---------cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccc
Confidence 56666777777777777765 256667777777777777777765544 46677777777777777777776
Q ss_pred CccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCcccccc
Q 002021 217 PIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNL 296 (979)
Q Consensus 217 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 296 (979)
+..+.++++|+.|++++|.+++......+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..|..+
T Consensus 143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 222 (306)
T 2z66_A 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 222 (306)
T ss_dssp TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC
T ss_pred hhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc
Confidence 66666666666666666666552222345566666666666666666556666666666666666666666555556666
Q ss_pred ccccceeccccccccccchhhhhhcccCC-CCccEEEccCCCCcc
Q 002021 297 RNLSWLVLSDNYLTSSTQELSFLSSLSNC-KFLKYFDLSYNPLYR 340 (979)
Q Consensus 297 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~~ 340 (979)
++|++|+|++|++++.... .+..+ ++|++|++++|++..
T Consensus 223 ~~L~~L~L~~N~l~~~~~~-----~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 223 NSLQVLDYSLNHIMTSKKQ-----ELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp TTCCEEECTTSCCCBCSSS-----SCCCCCTTCCEEECTTCCEEC
T ss_pred ccCCEeECCCCCCcccCHH-----HHHhhhccCCEEEccCCCeec
Confidence 6666666666666554332 23444 255566666555543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=300.84 Aligned_cols=290 Identities=27% Similarity=0.328 Sum_probs=192.5
Q ss_pred CccccccCCCCCCCccceeEee------CCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccC
Q 002021 47 NFLAKNWNTSTPVCNWTGVACE------VHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTY 120 (979)
Q Consensus 47 ~~~~~~w~~~~~~c~w~gv~c~------~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~ 120 (979)
..+ +.|..+.+||.|.|..|. +....++.|++++|+|+ .+|..+. ++|++|+|++|+++ .+|. .++
T Consensus 10 ~~w-~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 10 AVW-SAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp CHH-HHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred HHH-HHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence 344 579888889999775432 22335788999999998 7787776 89999999999988 5776 567
Q ss_pred cccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCC
Q 002021 121 TLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLR 200 (979)
Q Consensus 121 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 200 (979)
+|++|+|++|++++ +|. .+++|++|+|++|.+++ +|. .+++|+.|++++|++++ +|.. ++
T Consensus 82 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~---------l~~---~l~~L~~L~L~~N~l~~-lp~~---l~ 141 (622)
T 3g06_A 82 ELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH---------LPA---LPSGLCKLWIFGNQLTS-LPVL---PP 141 (622)
T ss_dssp TCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC---------CCC---CCTTCCEEECCSSCCSC-CCCC---CT
T ss_pred CCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC---------CCC---CCCCcCEEECCCCCCCc-CCCC---CC
Confidence 88999999998884 555 67888899999888874 455 56778888888888874 4543 47
Q ss_pred CCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEec
Q 002021 201 NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDL 280 (979)
Q Consensus 201 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 280 (979)
+|++|+|++|+++++.+ .+++|+.|++++|.|++++ ..+++|+.|+|++|++++ +|.. +++|+.|++
T Consensus 142 ~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l~-----~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L 208 (622)
T 3g06_A 142 GLQELSVSDNQLASLPA----LPSELCKLWAYNNQLTSLP-----MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWA 208 (622)
T ss_dssp TCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCC-----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred CCCEEECcCCcCCCcCC----ccCCCCEEECCCCCCCCCc-----ccCCCCcEEECCCCCCCC-CCCc---cchhhEEEC
Confidence 78888888888877532 2456777777777777644 245677777777777764 3332 356777777
Q ss_pred cccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEcc
Q 002021 281 EGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMS 360 (979)
Q Consensus 281 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~ 360 (979)
++|.++.. |.. +++|+.|+|++|+|+.++ ..+++|++|++++|++..++. .+++|+.|+|+
T Consensus 209 ~~N~l~~l-~~~---~~~L~~L~Ls~N~L~~lp---------~~l~~L~~L~Ls~N~L~~lp~------~~~~L~~L~Ls 269 (622)
T 3g06_A 209 YNNRLTSL-PAL---PSGLKELIVSGNRLTSLP---------VLPSELKELMVSGNRLTSLPM------LPSGLLSLSVY 269 (622)
T ss_dssp CSSCCSSC-CCC---CTTCCEEECCSSCCSCCC---------CCCTTCCEEECCSSCCSCCCC------CCTTCCEEECC
T ss_pred cCCccccc-CCC---CCCCCEEEccCCccCcCC---------CCCCcCcEEECCCCCCCcCCc------ccccCcEEeCC
Confidence 77777643 322 356666777776666544 123556666666666654432 12345555555
Q ss_pred CccccCCCCccccCCCcccEEEecCCCCCchhHHhhh
Q 002021 361 NCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLS 397 (979)
Q Consensus 361 ~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 397 (979)
+|+|+ .+|..+..+++|+.|+|++|++++..+..+.
T Consensus 270 ~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 305 (622)
T 3g06_A 270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 305 (622)
T ss_dssp SSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHH
T ss_pred CCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHH
Confidence 55555 3444455555555555555555544444443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=278.94 Aligned_cols=273 Identities=19% Similarity=0.193 Sum_probs=230.3
Q ss_pred EEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCch--hHHhhhcCCCCcEEEe
Q 002021 330 YFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGS--ILITLSKLQKLQDLGL 407 (979)
Q Consensus 330 ~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~--~~~~l~~l~~L~~L~L 407 (979)
.++++++.++.++.. ++++|++|++++|+++...+..|..+++|++|+|++|+++.. .+..+..+++|++|++
T Consensus 11 ~l~c~~~~l~~ip~~-----~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 11 EIRCNSKGLTSVPTG-----IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EEECCSSCCSSCCSC-----CCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred EEEcCCCCcccCCCC-----CCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 455666665555332 235788888888888866666789999999999999999854 3677788999999999
Q ss_pred cCcccCCCccccccCCCCCceEecCCCcccccCC-ccccCCCcCceEecCCCccccc-cccccCcCCCcEEEeccccccC
Q 002021 408 KDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIP-ACFSNLTSLRIVSLGSNELTSI-PLTFWNLKDILNLNFSSNFLTG 485 (979)
Q Consensus 408 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~ls~N~l~~ 485 (979)
++|.+. .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|+++.+ |..+..+++|+.|++++|.+++
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 999998 477789999999999999999997665 6899999999999999999955 5568889999999999999987
Q ss_pred -CCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCcccc
Q 002021 486 -SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLE 564 (979)
Q Consensus 486 -~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 564 (979)
..|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|++|||++|++++..|..+.
T Consensus 165 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 244 (306)
T 2z66_A 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244 (306)
T ss_dssp GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred ccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence 6889999999999999999999998899999999999999999999987777899999999999999999999999999
Q ss_pred Ccc-ccCeEeccCCcccccCCCC---CCCCCcccccccCCccccCCCC
Q 002021 565 KLS-YLEDLNLSFNQLEGKIPRG---GSFGNFSAQSFEGNELLCGSPN 608 (979)
Q Consensus 565 ~l~-~L~~L~L~~N~l~~~~p~~---~~~~~~~~~~~~~N~~~c~~p~ 608 (979)
.++ +|+.|+|++|+++|..+.. .++..........+...|..|.
T Consensus 245 ~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 245 HFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp CCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred hhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence 985 9999999999999875532 1233334455667778887763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-31 Score=318.71 Aligned_cols=413 Identities=15% Similarity=0.109 Sum_probs=264.0
Q ss_pred cCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccC------------CCCccceeecccccccccccccccCC--C
Q 002021 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFG------------NLPELELMSLAANNLQGKIPLKIGNL--R 200 (979)
Q Consensus 135 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~------------~l~~L~~L~L~~N~l~~~~p~~~~~l--~ 200 (979)
.++..+..+++|++|+|+++..-.. ...+|..++ .+++|++|+|++|.+++..+..++.. .
T Consensus 64 ~~~~~~~~~~~L~~L~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 138 (592)
T 3ogk_B 64 TPDRLSRRFPNLRSLKLKGKPRAAM-----FNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARAD 138 (592)
T ss_dssp CHHHHHHHCTTCSEEEEECSCGGGG-----GTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGG
T ss_pred ChHHHHHhCCCCeEEEecCCcchhh-----cccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccc
Confidence 3344556677788888876532100 012333333 56667777777776665555555543 3
Q ss_pred CCCceecCCCe-eeec-CCccccccCccceeeccCCCCcCCCcc---cccCCCCCcCEEEccCCccc----cccCccccc
Q 002021 201 NLEKLDIGDNK-LVGI-APIAIFNVSTLKILGLQDNSLSGCLSS---IGYARLPNLEILSLWGNNFS----GTIPRFIFN 271 (979)
Q Consensus 201 ~L~~L~Ls~N~-l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~---~~~~~l~~L~~L~L~~N~l~----~~~p~~l~~ 271 (979)
+|++|+|++|. ++.. .+....++++|++|+|++|.+++.... ..+..+++|++|++++|.++ +.++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 37777777665 2211 111223455666666666655433211 12234555566666555554 233334445
Q ss_pred CCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCcccccccc
Q 002021 272 ASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLS 351 (979)
Q Consensus 272 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 351 (979)
+++|++|++++|.+.+ ++..+.++++|+.|+++.+...... ......+..++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~--~~~~~~l~~~~------------------------- 270 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGM--PEKYMNLVFPR------------------------- 270 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTC--TTSSSCCCCCT-------------------------
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccch--HHHHHHhhccc-------------------------
Confidence 5555555555555554 3445555555555555532211000 00111233333
Q ss_pred ccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhH-HhhhcCCCCcEEEecCcccCCCccccccCCCCCceEe
Q 002021 352 HSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSIL-ITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLD 430 (979)
Q Consensus 352 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 430 (979)
+|+.|+++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++++...+.++..+..+++|++|+
T Consensus 271 -~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~ 348 (592)
T 3ogk_B 271 -KLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLR 348 (592)
T ss_dssp -TCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEE
T ss_pred -cccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEE
Confidence 455555555422 3567778889999999999999887665 4578999999999994433334444557789999999
Q ss_pred cC-----------CCcccccCC-ccccCCCcCceEecCCCcccc-ccccccC-cCCCcEEEec----cccccCC-----C
Q 002021 431 LD-----------GNKLSGSIP-ACFSNLTSLRIVSLGSNELTS-IPLTFWN-LKDILNLNFS----SNFLTGS-----L 487 (979)
Q Consensus 431 Ls-----------~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~-lp~~~~~-l~~L~~L~ls----~N~l~~~-----~ 487 (979)
++ .|.+++... ..+..+++|++|+++.|+++. .+..+.. +++|+.|+++ .|.+++. +
T Consensus 349 L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~ 428 (592)
T 3ogk_B 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGV 428 (592)
T ss_dssp EECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHH
T ss_pred eecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHH
Confidence 99 467764422 234568999999999999983 3445554 8899999996 7788864 3
Q ss_pred ccccccccccceEeccCC--ccCcccchhhcC-CcccceeecCCccccC-CCCCccccccccccccccccccccc-CCcc
Q 002021 488 PLEIGSLKVLVGIDLSRN--NFSGVIPTEIGG-LKNLEYLFLGYNRLQG-SIPNSFGDLISLKFLNLSNNNLSGV-IPAS 562 (979)
Q Consensus 488 p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~ 562 (979)
+..+..+++|+.|+|++| .+++..+..+.. +++|++|+|++|++++ .++..+..+++|++|+|++|.+++. ++..
T Consensus 429 ~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 508 (592)
T 3ogk_B 429 RSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAA 508 (592)
T ss_dssp HHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHH
T ss_pred HHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHH
Confidence 444677999999999854 477776666654 8999999999999986 3455667899999999999998755 4445
Q ss_pred ccCccccCeEeccCCccccc
Q 002021 563 LEKLSYLEDLNLSFNQLEGK 582 (979)
Q Consensus 563 ~~~l~~L~~L~L~~N~l~~~ 582 (979)
+..+++|+.|+|++|+++..
T Consensus 509 ~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 509 VTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHCSSCCEEEEESCBCCTT
T ss_pred HHhcCccCeeECcCCcCCHH
Confidence 56799999999999998764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=285.88 Aligned_cols=244 Identities=24% Similarity=0.237 Sum_probs=209.9
Q ss_pred EEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCcc
Q 002021 77 LNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNAL 156 (979)
Q Consensus 77 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 156 (979)
++.++.+++ .+|..+. ++|++|+|++|++++..|..+..+++|++|+|++|++++..|..|.++++|++|+|++|.+
T Consensus 59 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 59 VVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 444555666 4666554 6899999999999988899999999999999999999988889999999999999999999
Q ss_pred CchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCC-CeeeecCCccccccCccceeeccCCC
Q 002021 157 SGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGD-NKLVGIAPIAIFNVSTLKILGLQDNS 235 (979)
Q Consensus 157 ~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~ 235 (979)
++. .+..|+++++|++|+|++|++++..+..|.++++|++|+|++ |.+..+.+..|.++++|+.|+|++|+
T Consensus 136 ~~~--------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~ 207 (452)
T 3zyi_A 136 TVI--------PSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207 (452)
T ss_dssp SBC--------CTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSC
T ss_pred Ccc--------ChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCc
Confidence 743 345588999999999999999977777899999999999998 56777777789999999999999999
Q ss_pred CcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccch
Q 002021 236 LSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQE 315 (979)
Q Consensus 236 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 315 (979)
+++.+ .+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|+|+.++..
T Consensus 208 l~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 284 (452)
T 3zyi_A 208 IKDMP---NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD 284 (452)
T ss_dssp CSSCC---CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred ccccc---cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChH
Confidence 98764 367889999999999999988899999999999999999999988889999999999999999999887764
Q ss_pred hhhhhcccCCCCccEEEccCCCCc
Q 002021 316 LSFLSSLSNCKFLKYFDLSYNPLY 339 (979)
Q Consensus 316 ~~~~~~l~~l~~L~~L~Ls~N~l~ 339 (979)
.+..+++|++|+|++|++.
T Consensus 285 -----~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 285 -----LFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp -----SSTTCTTCCEEECCSSCEE
T ss_pred -----HhccccCCCEEEccCCCcC
Confidence 3677888888888888764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=283.98 Aligned_cols=280 Identities=20% Similarity=0.208 Sum_probs=168.6
Q ss_pred cCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccE
Q 002021 251 LEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKY 330 (979)
Q Consensus 251 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~ 330 (979)
....++++|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|+|++|+++..+.. .+.++++|++
T Consensus 33 ~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~ 104 (353)
T 2z80_A 33 NGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED-----SFSSLGSLEH 104 (353)
T ss_dssp TSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCE
T ss_pred CeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHh-----hcCCCCCCCE
Confidence 334555556655 3444433 3566666666666655555666666666666666665544322 2334444444
Q ss_pred EEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhH-HhhhcCCCCcEEEecC
Q 002021 331 FDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSIL-ITLSKLQKLQDLGLKD 409 (979)
Q Consensus 331 L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~ 409 (979)
|++++|+ +++..+..++.+++|++|++++|++++... ..+..+++|++|++++
T Consensus 105 L~Ls~n~--------------------------l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~ 158 (353)
T 2z80_A 105 LDLSYNY--------------------------LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158 (353)
T ss_dssp EECCSSC--------------------------CSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEE
T ss_pred EECCCCc--------------------------CCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCC
Confidence 4444443 333334446777888888888888876555 5677788888888887
Q ss_pred c-ccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCcccccccccc-CcCCCcEEEeccccccCCC
Q 002021 410 N-KLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFW-NLKDILNLNFSSNFLTGSL 487 (979)
Q Consensus 410 N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~-~l~~L~~L~ls~N~l~~~~ 487 (979)
| .+.+..+..+.++++|++|++++|++++..|..+..+++|++|++++|+++.+|..+. .+++|+.|++++|.+++..
T Consensus 159 n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~ 238 (353)
T 2z80_A 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238 (353)
T ss_dssp SSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCC
T ss_pred CccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccc
Confidence 7 4665556677777788888888888877777777777788888888887777766433 4667777777777776544
Q ss_pred cccccc---ccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCcccc
Q 002021 488 PLEIGS---LKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLE 564 (979)
Q Consensus 488 p~~~~~---l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 564 (979)
+..+.. ...++.++|++|.+++ |.+. .+|..+..+++|+.|||++|+++...+..|.
T Consensus 239 ~~~l~~~~~~~~l~~l~L~~~~l~~-------------------~~l~-~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~ 298 (353)
T 2z80_A 239 FSELSTGETNSLIKKFTFRNVKITD-------------------ESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFD 298 (353)
T ss_dssp CC------CCCCCCEEEEESCBCCH-------------------HHHH-HHHHHHHTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred ccccccccccchhhccccccccccC-------------------cchh-hhHHHHhcccCCCEEECCCCCCCccCHHHHh
Confidence 433321 2333334444333332 1111 3455566666666666666666633333346
Q ss_pred CccccCeEeccCCcccccCC
Q 002021 565 KLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 565 ~l~~L~~L~L~~N~l~~~~p 584 (979)
.+++|++|+|++|+++|.+|
T Consensus 299 ~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 299 RLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp TCTTCCEEECCSSCBCCCHH
T ss_pred cCCCCCEEEeeCCCccCcCC
Confidence 66677777777777766665
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=282.18 Aligned_cols=250 Identities=21% Similarity=0.251 Sum_probs=176.7
Q ss_pred CcCCCCCCeeeccCCcccccCCccccccCcccEEecccccc-cccCCcccc-------CCCCCcEEEccCCccCchhhhh
Q 002021 92 LGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQL-SGTFPSFIS-------NKSSLQHLDLSSNALSGEIRAN 163 (979)
Q Consensus 92 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l-~~~~p~~l~-------~l~~L~~L~Ls~N~l~~~~~~~ 163 (979)
++..++|++|++++|++ .+|..+... |++|+|++|++ .+.+|..+. ++++|++|+|++|.+++.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~---- 110 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGT---- 110 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSC----
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccch----
Confidence 34566788888888888 788777665 88888888888 456777665 788888888888888764
Q ss_pred hhccCCccc--CCCCccceeecccccccccccccccCC-----CCCCceecCCCeeeecCCccccccCccceeeccCCCC
Q 002021 164 ICREIPREF--GNLPELELMSLAANNLQGKIPLKIGNL-----RNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSL 236 (979)
Q Consensus 164 ~~~~ip~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 236 (979)
+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|+|++|+++++.|..|.++++|+.|+|++|++
T Consensus 111 ----~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 185 (312)
T 1wwl_A 111 ----APPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185 (312)
T ss_dssp ----CCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTT
T ss_pred ----hHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCc
Confidence 66665 7888888888888888876 7777776 8888888888888888888888888888888888887
Q ss_pred cCC---CcccccCCCCCcCEEEccCCcccc---ccCcccccCCCCcEEeccccccccccC-ccccccccccceecccccc
Q 002021 237 SGC---LSSIGYARLPNLEILSLWGNNFSG---TIPRFIFNASKLSILDLEGNSFSGFIP-NTFGNLRNLSWLVLSDNYL 309 (979)
Q Consensus 237 ~~~---~~~~~~~~l~~L~~L~L~~N~l~~---~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l 309 (979)
.+. +....+..+++|++|+|++|++++ .....+.++++|++|+|++|++++.+| ..+..+++|++|+|++|+|
T Consensus 186 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l 265 (312)
T 1wwl_A 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265 (312)
T ss_dssp CHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCC
T ss_pred CcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCcc
Confidence 653 222234677778888888887772 122333456777777777777776553 3444555566666555555
Q ss_pred ccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCC
Q 002021 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLN 389 (979)
Q Consensus 310 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~ 389 (979)
+.++... .++|++|++++|+|++. |. +..+++|++|+|++|+++
T Consensus 266 ~~ip~~~----------------------------------~~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 266 KQVPKGL----------------------------------PAKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp SSCCSSC----------------------------------CSEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred Chhhhhc----------------------------------cCCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 5433211 13566666666666654 44 777777888888777776
Q ss_pred c
Q 002021 390 G 390 (979)
Q Consensus 390 ~ 390 (979)
+
T Consensus 310 ~ 310 (312)
T 1wwl_A 310 D 310 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=284.21 Aligned_cols=249 Identities=24% Similarity=0.276 Sum_probs=220.7
Q ss_pred cEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEec
Q 002021 329 KYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408 (979)
Q Consensus 329 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 408 (979)
..++.+++.+..++. .++++++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 57 ~~v~c~~~~l~~iP~-----~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 57 SKVVCTRRGLSEVPQ-----GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp CEEECCSSCCSSCCS-----CCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred cEEEECCCCcCccCC-----CCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 455666666655532 234678888888888888888999999999999999999999999999999999999999
Q ss_pred CcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCC-Cccccccc-cccCcCCCcEEEeccccccCC
Q 002021 409 DNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGS-NELTSIPL-TFWNLKDILNLNFSSNFLTGS 486 (979)
Q Consensus 409 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~lp~-~~~~l~~L~~L~ls~N~l~~~ 486 (979)
+|++++..+..|..+++|++|+|++|++++..+..|.++++|++|++++ |.++.+|. .+..+++|+.|++++|++++.
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 9999987777899999999999999999988888999999999999998 67778876 588899999999999999964
Q ss_pred CccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCc
Q 002021 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKL 566 (979)
Q Consensus 487 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 566 (979)
| .+..+.+|+.|+|++|+|++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+
T Consensus 212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 4 58889999999999999999999999999999999999999998889999999999999999999998888889999
Q ss_pred cccCeEeccCCcccccCC
Q 002021 567 SYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p 584 (979)
++|+.|+|++|++.|...
T Consensus 290 ~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp TTCCEEECCSSCEECSTT
T ss_pred cCCCEEEccCCCcCCCCC
Confidence 999999999999988654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=282.03 Aligned_cols=250 Identities=24% Similarity=0.283 Sum_probs=219.1
Q ss_pred ccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEe
Q 002021 328 LKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGL 407 (979)
Q Consensus 328 L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 407 (979)
...++.+++.+..++.. ++.+++.|+|++|+|++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~-----~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L 119 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDG-----ISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL 119 (440)
T ss_dssp SCEEECCSCCCSSCCSC-----CCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred CCEEEeCCCCcCcCCCC-----CCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence 34555666665555332 2357888888888888888889999999999999999999998999999999999999
Q ss_pred cCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCC-Cccccccc-cccCcCCCcEEEeccccccC
Q 002021 408 KDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGS-NELTSIPL-TFWNLKDILNLNFSSNFLTG 485 (979)
Q Consensus 408 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~lp~-~~~~l~~L~~L~ls~N~l~~ 485 (979)
++|++++..+..|..+++|++|+|++|+|....+..|.++++|++|+|++ |.++.++. .|.++++|+.|++++|+++.
T Consensus 120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 199 (440)
T 3zyj_A 120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE 199 (440)
T ss_dssp CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence 99999977777899999999999999999988888999999999999998 56777776 58889999999999999984
Q ss_pred CCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccC
Q 002021 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEK 565 (979)
Q Consensus 486 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 565 (979)
+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..
T Consensus 200 -~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 277 (440)
T 3zyj_A 200 -IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP 277 (440)
T ss_dssp -CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred -cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence 45 5888999999999999999999999999999999999999999888999999999999999999999888888999
Q ss_pred ccccCeEeccCCcccccCC
Q 002021 566 LSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 566 l~~L~~L~L~~N~l~~~~p 584 (979)
+++|+.|+|++|+|.|...
T Consensus 278 l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 278 LHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CTTCCEEECCSSCEECSST
T ss_pred ccCCCEEEcCCCCccCCCC
Confidence 9999999999999987654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=286.20 Aligned_cols=267 Identities=21% Similarity=0.208 Sum_probs=226.0
Q ss_pred cccCCCCCCCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcc-cccCCcccc-------ccCcc
Q 002021 51 KNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRL-FGSIPSAIF-------TTYTL 122 (979)
Q Consensus 51 ~~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~-~~~~p~~~~-------~l~~L 122 (979)
..|.....|+.|..+.+.....+++.|++++|.+ .+|..+... |++|+|++|++ .+.+|..++ .+++|
T Consensus 22 ~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L 97 (312)
T 1wwl_A 22 PDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97 (312)
T ss_dssp CCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCC
T ss_pred cchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCc
Confidence 4687767788888776554556788899999999 788776655 99999999999 567888877 79999
Q ss_pred cEEecccccccccCCccc--cCCCCCcEEEccCCccCchhhhhhhccCCcccCCC-----Cccceeeccccccccccccc
Q 002021 123 KYVCLRGNQLSGTFPSFI--SNKSSLQHLDLSSNALSGEIRANICREIPREFGNL-----PELELMSLAANNLQGKIPLK 195 (979)
Q Consensus 123 ~~L~L~~n~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l-----~~L~~L~L~~N~l~~~~p~~ 195 (979)
++|+|++|++++.+|..+ +.+++|++|+|++|.+++ +|..++.+ ++|++|+|++|++++..|..
T Consensus 98 ~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~---------~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~ 168 (312)
T 1wwl_A 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT---------RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168 (312)
T ss_dssp CEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSS---------SSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTT
T ss_pred cEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcc---------hhHHHHHHHHhhcCCCcEEEeeCCCCccchHHH
Confidence 999999999999999986 999999999999999985 46666666 99999999999999988899
Q ss_pred ccCCCCCCceecCCCeeeec--CCccc--cccCccceeeccCCCCcCCC--cccccCCCCCcCEEEccCCccccccC-cc
Q 002021 196 IGNLRNLEKLDIGDNKLVGI--APIAI--FNVSTLKILGLQDNSLSGCL--SSIGYARLPNLEILSLWGNNFSGTIP-RF 268 (979)
Q Consensus 196 ~~~l~~L~~L~Ls~N~l~~~--~p~~l--~~l~~L~~L~L~~N~l~~~~--~~~~~~~l~~L~~L~L~~N~l~~~~p-~~ 268 (979)
|+++++|++|+|++|++.+. .|..+ .++++|+.|+|++|+|++.. ....+..+++|++|+|++|++++.+| ..
T Consensus 169 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 248 (312)
T 1wwl_A 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248 (312)
T ss_dssp CCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSC
T ss_pred hccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhh
Confidence 99999999999999998765 23334 88999999999999998543 23345688999999999999998775 45
Q ss_pred cccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcc
Q 002021 269 IFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYR 340 (979)
Q Consensus 269 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~ 340 (979)
+..+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++.+. +..+++|++|++++|++++
T Consensus 249 ~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~p~-------~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 249 CDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS-------PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSCCC-------TTTSCEEEEEECTTCTTTC
T ss_pred hhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCChh-------HhhCCCCCEEeccCCCCCC
Confidence 667899999999999999 5677666 899999999999998742 5678888888888888765
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=272.04 Aligned_cols=224 Identities=20% Similarity=0.251 Sum_probs=187.3
Q ss_pred cccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecC
Q 002021 353 SLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLD 432 (979)
Q Consensus 353 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 432 (979)
.++.|++++|+++ .+|..+..+++|++|+|++|.++ .+|..+.++++|++|++++|.++ .+|..+.++++|++|+++
T Consensus 82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158 (328)
T ss_dssp TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence 4556666666665 45666667777777777777777 56666777777777777777777 567777777777777777
Q ss_pred CCcccccCCcccc---------CCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEecc
Q 002021 433 GNKLSGSIPACFS---------NLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLS 503 (979)
Q Consensus 433 ~N~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls 503 (979)
+|++.+.+|..+. ++++|++|+|++|+++.+|..+..+++|+.|++++|++++ +|..++.+++|+.|+|+
T Consensus 159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls 237 (328)
T 4fcg_A 159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLR 237 (328)
T ss_dssp EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECT
T ss_pred CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECc
Confidence 7777777776655 4899999999999999999999999999999999999995 66679999999999999
Q ss_pred CCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCccc
Q 002021 504 RNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580 (979)
Q Consensus 504 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 580 (979)
+|++.+.+|..|+++++|++|+|++|++.+.+|..+.++++|++|+|++|++.+.+|..+.++++|+.+++..|.+.
T Consensus 238 ~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999887765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=265.28 Aligned_cols=227 Identities=24% Similarity=0.267 Sum_probs=184.6
Q ss_pred EEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCC
Q 002021 75 TVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSN 154 (979)
Q Consensus 75 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N 154 (979)
+.+++++++++ .+|..+ .++|++|+|++|++++..|..+..+++|++|+|++|++++..|..++++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 56778888887 456544 578999999999999877788999999999999999999888889999999999999999
Q ss_pred c-cCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccC
Q 002021 155 A-LSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQD 233 (979)
Q Consensus 155 ~-l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 233 (979)
. +++. .|..+.++++|++|++++|.+++..|..+.++++|++|+|++|+++++.+..|.++++|+.|+|++
T Consensus 91 ~~l~~~--------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 162 (285)
T 1ozn_A 91 AQLRSV--------DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162 (285)
T ss_dssp TTCCCC--------CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCcccc--------CHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCC
Confidence 7 6532 367788899999999999999888888888899999999999999888777788888888888888
Q ss_pred CCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecccccccccc
Q 002021 234 NSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313 (979)
Q Consensus 234 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 313 (979)
|++++.... .|..+++|++|+|++|++++..|..+..+++|++|++++|++++..+..|..+++|++|+|++|.+....
T Consensus 163 n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 163 NRISSVPER-AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp SCCCEECTT-TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CcccccCHH-HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCC
Confidence 888765433 3667788888888888887777777777788888888888887766666777777777777777776543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-28 Score=277.75 Aligned_cols=244 Identities=23% Similarity=0.237 Sum_probs=214.5
Q ss_pred EEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCcc
Q 002021 77 LNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNAL 156 (979)
Q Consensus 77 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 156 (979)
++.++.+++ .+|..+. ++++.|+|++|++++..|..+..+++|++|+|++|++++..+..|.++++|++|+|++|++
T Consensus 48 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 48 VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp EECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred EEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 444555666 5777664 7899999999999988889999999999999999999988889999999999999999999
Q ss_pred CchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCC-CeeeecCCccccccCccceeeccCCC
Q 002021 157 SGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGD-NKLVGIAPIAIFNVSTLKILGLQDNS 235 (979)
Q Consensus 157 ~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~ 235 (979)
++. .+..|.++++|++|+|++|.+++..+..|.++++|++|+|++ |.+..+.+..|.++++|+.|+|++|+
T Consensus 125 ~~~--------~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~ 196 (440)
T 3zyj_A 125 TTI--------PNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCN 196 (440)
T ss_dssp SSC--------CTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSC
T ss_pred Cee--------CHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCc
Confidence 843 334799999999999999999988888999999999999998 56777777789999999999999999
Q ss_pred CcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccch
Q 002021 236 LSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQE 315 (979)
Q Consensus 236 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 315 (979)
++..+ .+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|+++.++..
T Consensus 197 l~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 273 (440)
T 3zyj_A 197 LREIP---NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273 (440)
T ss_dssp CSSCC---CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTT
T ss_pred Ccccc---ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChh
Confidence 98765 367899999999999999988899999999999999999999999899999999999999999999988765
Q ss_pred hhhhhcccCCCCccEEEccCCCCc
Q 002021 316 LSFLSSLSNCKFLKYFDLSYNPLY 339 (979)
Q Consensus 316 ~~~~~~l~~l~~L~~L~Ls~N~l~ 339 (979)
.+..+++|++|+|++|++.
T Consensus 274 -----~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 274 -----LFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp -----TTSSCTTCCEEECCSSCEE
T ss_pred -----HhccccCCCEEEcCCCCcc
Confidence 3677888888888888864
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=265.95 Aligned_cols=251 Identities=22% Similarity=0.256 Sum_probs=144.6
Q ss_pred cEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEec
Q 002021 329 KYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408 (979)
Q Consensus 329 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 408 (979)
+.++++++.+..++. .++++|++|++++|+|++..+..|..+++|++|+|++|.+++..+..|..+++|++|+++
T Consensus 14 ~~~~c~~~~l~~ip~-----~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 88 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPV-----GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88 (285)
T ss_dssp CEEECCSSCCSSCCT-----TCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred eEEEcCcCCcccCCc-----CCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCC
Confidence 345555555554422 123456666666666666666667777777777777777776666666667777777777
Q ss_pred Ccc-cCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCcccccccc-ccCcCCCcEEEeccccccCC
Q 002021 409 DNK-LEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLT-FWNLKDILNLNFSSNFLTGS 486 (979)
Q Consensus 409 ~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~ls~N~l~~~ 486 (979)
+|. +....|..+..+++|++|++++|++++..+..|.++++|++|++++|+++.+|.. +..+++|+.|++++|++++.
T Consensus 89 ~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 168 (285)
T 1ozn_A 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (285)
T ss_dssp SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccccc
Confidence 775 5555566666666666666666666666666666666666666666666655543 45555555555555555544
Q ss_pred CccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCc
Q 002021 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKL 566 (979)
Q Consensus 487 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 566 (979)
.+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++...+.. .-.
T Consensus 169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~ 247 (285)
T 1ozn_A 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLW 247 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHH
T ss_pred CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHH
Confidence 4444555555555555555555555555555555555555555555444444555555555555555554322211 111
Q ss_pred cccCeEeccCCcccccCCC
Q 002021 567 SYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~ 585 (979)
..++.+..+.|.+.|..|.
T Consensus 248 ~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 248 AWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp HHHHHCCSEECCCBEEESG
T ss_pred HHHHhcccccCccccCCch
Confidence 2334444455555555553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-30 Score=300.57 Aligned_cols=217 Identities=24% Similarity=0.249 Sum_probs=113.4
Q ss_pred cccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecC
Q 002021 377 NLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLG 456 (979)
Q Consensus 377 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 456 (979)
+|++|+|++|.+++..+..|..+++|++|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 45555555555555444555555555555555555544333 5555555555555555543221 2455555555
Q ss_pred CCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhc-CCcccceeecCCccccCCC
Q 002021 457 SNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIG-GLKNLEYLFLGYNRLQGSI 535 (979)
Q Consensus 457 ~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~ 535 (979)
+|.++.++.. .+++|+.|++++|.+++..|..++.+++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.|++..
T Consensus 108 ~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~ 185 (487)
T 3oja_A 108 NNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK 185 (487)
T ss_dssp SSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE
T ss_pred CCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccc
Confidence 5555554432 234555555555555555555555555555555655555555555554 4555566666666555432
Q ss_pred CCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCCCCCCCcccccccCCccccC
Q 002021 536 PNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCG 605 (979)
Q Consensus 536 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~ 605 (979)
+ +..+++|+.|+|++|+|++.+| .+..+++|+.|+|++|++++.++....++.+..+.+.+|++.|+
T Consensus 186 ~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 186 G--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp C--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred c--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 2 2235555566666665554332 35555556666666665554333333344555555555655554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-31 Score=321.75 Aligned_cols=461 Identities=16% Similarity=0.159 Sum_probs=226.6
Q ss_pred CCccceeEeeCCCCcEEEEEecCCCccccCC-CCCcCCCCCCeeeccCCcccc---cCCccccccCcccEEecccccccc
Q 002021 59 VCNWTGVACEVHSQRVTVLNISSLNLTGTIP-SQLGNLSSLQSLNLSFNRLFG---SIPSAIFTTYTLKYVCLRGNQLSG 134 (979)
Q Consensus 59 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~-~~l~~l~~L~~L~L~~n~~~~---~~p~~~~~l~~L~~L~L~~n~l~~ 134 (979)
|++|+++.. .....++++... +..| ..+..+++|++|+|+++.... ..|..++. ....
T Consensus 34 ck~W~~~~~----~~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~------------~~~~ 95 (594)
T 2p1m_B 34 CKSWYEIER----WCRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGG------------YVYP 95 (594)
T ss_dssp CHHHHHHHH----HHCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCC------------BCHH
T ss_pred HHHHHHhhh----hhceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccc------------hhhH
Confidence 457888821 123355655432 2223 245677888999998875321 12221100 0000
Q ss_pred cCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccC-CCCccceeecccc-ccccc-ccccccCCCCCCceecCCCe
Q 002021 135 TFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFG-NLPELELMSLAAN-NLQGK-IPLKIGNLRNLEKLDIGDNK 211 (979)
Q Consensus 135 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~ 211 (979)
.++.....+++|++|+|++|.+++... ..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.
T Consensus 96 ~l~~l~~~~~~L~~L~L~~~~~~~~~~--------~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~ 167 (594)
T 2p1m_B 96 WIEAMSSSYTWLEEIRLKRMVVTDDCL--------ELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESD 167 (594)
T ss_dssp HHHHHHHHCTTCCEEEEESCBCCHHHH--------HHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCE
T ss_pred HHHHHHHhCCCCCeEEeeCcEEcHHHH--------HHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCc
Confidence 111122344555555555555544321 1121 3455555555555 33321 33333456666666666666
Q ss_pred eeecCCcccc----ccCccceeeccCCC--CcCCCcccccCCCCCcCEEEccCC-ccccccCcccccCCCCcEEecccc-
Q 002021 212 LVGIAPIAIF----NVSTLKILGLQDNS--LSGCLSSIGYARLPNLEILSLWGN-NFSGTIPRFIFNASKLSILDLEGN- 283 (979)
Q Consensus 212 l~~~~p~~l~----~l~~L~~L~L~~N~--l~~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N- 283 (979)
+++..+..+. .+++|+.|++++|. ++..........+++|++|+|++| .+.+ +|..+..+++|++|+++.+
T Consensus 168 i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~ 246 (594)
T 2p1m_B 168 VDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYT 246 (594)
T ss_dssp EECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCC
T ss_pred cCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEccccccc
Confidence 6654443333 34455666665554 111000111233566777777666 3333 5666666677777764333
Q ss_pred ------ccccccCccccccccccce-eccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccE
Q 002021 284 ------SFSGFIPNTFGNLRNLSWL-VLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEE 356 (979)
Q Consensus 284 ------~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~ 356 (979)
.+.+. +..+.++++|+.| .+.+.....++ ..+..+++|++|++++|.+....
T Consensus 247 ~~~~~~~~~~l-~~~l~~~~~L~~Ls~~~~~~~~~l~------~~~~~~~~L~~L~L~~~~l~~~~-------------- 305 (594)
T 2p1m_B 247 AEVRPDVYSGL-SVALSGCKELRCLSGFWDAVPAYLP------AVYSVCSRLTTLNLSYATVQSYD-------------- 305 (594)
T ss_dssp CCCCHHHHHHH-HHHHHTCTTCCEEECCBTCCGGGGG------GGHHHHTTCCEEECTTCCCCHHH--------------
T ss_pred CccchhhHHHH-HHHHhcCCCcccccCCcccchhhHH------HHHHhhCCCCEEEccCCCCCHHH--------------
Confidence 33332 2245555555555 23222111111 01123444555555555432211
Q ss_pred EEccCccccCCCCccccCCCcccEEEecCCCCCchhH-HhhhcCCCCcEEEecC---------cccCCCcccccc-CCCC
Q 002021 357 FKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSIL-ITLSKLQKLQDLGLKD---------NKLEGSIPYDIC-NLAE 425 (979)
Q Consensus 357 L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~---------N~l~~~~p~~~~-~l~~ 425 (979)
++..+..+++|++|++++| +..... .....+++|++|++++ +.+++.....+. .+++
T Consensus 306 -----------l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~ 373 (594)
T 2p1m_B 306 -----------LVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPK 373 (594)
T ss_dssp -----------HHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTT
T ss_pred -----------HHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchh
Confidence 1112334555555555555 322222 2223455566665522 233322222222 2555
Q ss_pred CceEecCCCcccccCCcccc-CCCcCceEecC--C----Cccccccc------cccCcCCCcEEEeccccccCCCccccc
Q 002021 426 LYRLDLDGNKLSGSIPACFS-NLTSLRIVSLG--S----NELTSIPL------TFWNLKDILNLNFSSNFLTGSLPLEIG 492 (979)
Q Consensus 426 L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~lp~------~~~~l~~L~~L~ls~N~l~~~~p~~~~ 492 (979)
|+.|+++.|.+++..+..+. .+++|+.|+++ + |.++..|. .+..+++|+.|++++ .+++..+..++
T Consensus 374 L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~ 452 (594)
T 2p1m_B 374 LESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIG 452 (594)
T ss_dssp CCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHH
T ss_pred HHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHH
Confidence 66666655665544443343 35666666666 3 44553322 244566777777765 55544444444
Q ss_pred c-ccccceEeccCCccCcccchhh-cCCcccceeecCCccccCCCCC-cccccccccccccccccccccCCccc-cCccc
Q 002021 493 S-LKVLVGIDLSRNNFSGVIPTEI-GGLKNLEYLFLGYNRLQGSIPN-SFGDLISLKFLNLSNNNLSGVIPASL-EKLSY 568 (979)
Q Consensus 493 ~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 568 (979)
. +++|+.|+|++|.+++..+..+ .++++|+.|+|++|.+++..+. .+..+++|+.|++++|+++......+ ..+++
T Consensus 453 ~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~ 532 (594)
T 2p1m_B 453 TYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPK 532 (594)
T ss_dssp HHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTT
T ss_pred HhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCC
Confidence 4 6677777777777766555554 5677778888887777543332 33457778888888877753333333 44566
Q ss_pred cCeEeccCCccc
Q 002021 569 LEDLNLSFNQLE 580 (979)
Q Consensus 569 L~~L~L~~N~l~ 580 (979)
|+...+..+.-.
T Consensus 533 l~i~~~~~~~~~ 544 (594)
T 2p1m_B 533 LNVEVIDERGAP 544 (594)
T ss_dssp EEEEEECSSSCG
T ss_pred CEEEEecCCCcc
Confidence 666566555443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-29 Score=275.10 Aligned_cols=268 Identities=23% Similarity=0.197 Sum_probs=135.0
Q ss_pred cceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecc
Q 002021 226 LKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLS 305 (979)
Q Consensus 226 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 305 (979)
++.++++.+.+...... .+..+++|++|+|++|++++..|..+..+++|++|+|++|.+++..+ |..+++|++|+|+
T Consensus 12 l~i~~ls~~~l~~~~~~-~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 12 YKIEKVTDSSLKQALAS-LRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEESCCTTTHHHHHHH-HHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred eeEeeccccchhhhHHH-HhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 44445555555433222 23445566666666666665555555666666666666666654433 5555555555555
Q ss_pred ccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecC
Q 002021 306 DNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGG 385 (979)
Q Consensus 306 ~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~ 385 (979)
+|++++++ .+++|++|++++|+ +++..+.. +++|++|++++
T Consensus 89 ~n~l~~l~----------~~~~L~~L~l~~n~--------------------------l~~~~~~~---~~~L~~L~l~~ 129 (317)
T 3o53_A 89 NNYVQELL----------VGPSIETLHAANNN--------------------------ISRVSCSR---GQGKKNIYLAN 129 (317)
T ss_dssp SSEEEEEE----------ECTTCCEEECCSSC--------------------------CSEEEECC---CSSCEEEECCS
T ss_pred CCcccccc----------CCCCcCEEECCCCc--------------------------cCCcCccc---cCCCCEEECCC
Confidence 55554432 12334444444444 33322221 33455555555
Q ss_pred CCCCchhHHhhhcCCCCcEEEecCcccCCCcccccc-CCCCCceEecCCCcccccCCccccCCCcCceEecCCCcccccc
Q 002021 386 NKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDIC-NLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP 464 (979)
Q Consensus 386 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp 464 (979)
|++++..+..+..+++|++|++++|.+.+..+..+. .+++|++|+|++|++ +.+|
T Consensus 130 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l------------------------~~~~ 185 (317)
T 3o53_A 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI------------------------YDVK 185 (317)
T ss_dssp SCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC------------------------CEEE
T ss_pred CCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcC------------------------cccc
Confidence 555444444444444444444444444433333332 344444444444444 4333
Q ss_pred ccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCcccc-CCCCCcccccc
Q 002021 465 LTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ-GSIPNSFGDLI 543 (979)
Q Consensus 465 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~ 543 (979)
.. ..+++|+.|++++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +.+|..+..++
T Consensus 186 ~~-~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~ 262 (317)
T 3o53_A 186 GQ-VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262 (317)
T ss_dssp CC-CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCH
T ss_pred cc-cccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccc
Confidence 21 124444444444444443 2223555555666666666665 34555666666666666666666 55666666777
Q ss_pred cccccccc-cccccccCCcc
Q 002021 544 SLKFLNLS-NNNLSGVIPAS 562 (979)
Q Consensus 544 ~L~~L~Ls-~N~l~~~~p~~ 562 (979)
+|+.|+++ .+.+++..|..
T Consensus 263 ~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 263 RVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp HHHHHHHHHHHHHHSSSSCC
T ss_pred cceEEECCCchhccCCchhc
Confidence 77777777 34555555443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=281.28 Aligned_cols=268 Identities=23% Similarity=0.264 Sum_probs=139.3
Q ss_pred ccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceec
Q 002021 225 TLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVL 304 (979)
Q Consensus 225 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 304 (979)
+++.|++++|.|+.++... .++|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|
T Consensus 41 ~l~~L~ls~n~L~~lp~~l----~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLTTLPDCL----PAHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCSCCCSCC----CTTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCcEEEecCCCcCccChhh----CCCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 4566666666665443321 145555555555555 3333 34555555555555553 222 3445555555
Q ss_pred cccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEec
Q 002021 305 SDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLG 384 (979)
Q Consensus 305 s~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~ 384 (979)
++|+++.++. .++ +|+.|++++|+|++ +|.. +++|++|+|+
T Consensus 109 s~N~l~~l~~---------~l~--------------------------~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls 149 (622)
T 3g06_A 109 FSNPLTHLPA---------LPS--------------------------GLCKLWIFGNQLTS-LPVL---PPGLQELSVS 149 (622)
T ss_dssp CSCCCCCCCC---------CCT--------------------------TCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred cCCcCCCCCC---------CCC--------------------------CcCEEECCCCCCCc-CCCC---CCCCCEEECc
Confidence 5555544332 123 44444444444443 2221 2455555555
Q ss_pred CCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCcccccc
Q 002021 385 GNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP 464 (979)
Q Consensus 385 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp 464 (979)
+|++++... .+++|+.|++++|.+++ +| ..+++|+.|++++|+|++ +|.. +++|+.|++++|.++.+|
T Consensus 150 ~N~l~~l~~----~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~ 217 (622)
T 3g06_A 150 DNQLASLPA----LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLP 217 (622)
T ss_dssp SSCCSCCCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCC
T ss_pred CCcCCCcCC----ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccC
Confidence 555553221 23455555555555553 33 334566666666666653 2322 355666666666666665
Q ss_pred ccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCccccccc
Q 002021 465 LTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLIS 544 (979)
Q Consensus 465 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 544 (979)
.. +++|+.|++++|+|++ +| ..+++|+.|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|..|.++++
T Consensus 218 ~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~ 285 (622)
T 3g06_A 218 AL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSS 285 (622)
T ss_dssp CC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCT
T ss_pred CC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccc
Confidence 42 2556666666666654 33 334556666666666653 333 3455666666666666 45555666666
Q ss_pred ccccccccccccccCCccccCcc
Q 002021 545 LKFLNLSNNNLSGVIPASLEKLS 567 (979)
Q Consensus 545 L~~L~Ls~N~l~~~~p~~~~~l~ 567 (979)
|+.|+|++|++++.+|..+..++
T Consensus 286 L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 286 ETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp TCEEECCSCCCCHHHHHHHHHHH
T ss_pred cCEEEecCCCCCCcCHHHHHhcc
Confidence 66666666666665555554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=272.08 Aligned_cols=269 Identities=20% Similarity=0.190 Sum_probs=197.5
Q ss_pred CCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEec
Q 002021 201 NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDL 280 (979)
Q Consensus 201 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 280 (979)
+++.++++.+.+....+..+..+++|+.|+|++|++++..+. .|..+++|++|+|++|++++..+ +..+++|++|+|
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA-DLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHH-HHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHH-HhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 456678888888877777777888999999999999986543 57899999999999999997665 889999999999
Q ss_pred cccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEcc
Q 002021 281 EGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMS 360 (979)
Q Consensus 281 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~ 360 (979)
++|++++.. ..++|++|++++|+++..+.. .+++ |++|+++
T Consensus 88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~--------~~~~--------------------------L~~L~l~ 128 (317)
T 3o53_A 88 NNNYVQELL-----VGPSIETLHAANNNISRVSCS--------RGQG--------------------------KKNIYLA 128 (317)
T ss_dssp CSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC--------CCSS--------------------------CEEEECC
T ss_pred cCCcccccc-----CCCCcCEEECCCCccCCcCcc--------ccCC--------------------------CCEEECC
Confidence 999998654 348999999999999876532 1333 5555555
Q ss_pred CccccCCCCccccCCCcccEEEecCCCCCchhHHhh-hcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCccccc
Q 002021 361 NCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITL-SKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGS 439 (979)
Q Consensus 361 ~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 439 (979)
+|++++..+..++.+++|++|+|++|++++..+..+ ..+++|++|++++|.+++. + ....+++|++|+|++|++++.
T Consensus 129 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l 206 (317)
T 3o53_A 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM 206 (317)
T ss_dssp SSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE
T ss_pred CCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc
Confidence 555665566678888999999999999998877776 4789999999999998854 3 223366677777777766643
Q ss_pred CCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccC-cccchhhcCC
Q 002021 440 IPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFS-GVIPTEIGGL 518 (979)
Q Consensus 440 ~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l 518 (979)
|..+..+++|++|+|++|+++.+|.. +..+++|+.|++++|.++ +.+|..+..+
T Consensus 207 -~~~~~~l~~L~~L~L~~N~l~~l~~~------------------------~~~l~~L~~L~l~~N~~~~~~~~~~~~~~ 261 (317)
T 3o53_A 207 -GPEFQSAAGVTWISLRNNKLVLIEKA------------------------LRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261 (317)
T ss_dssp -CGGGGGGTTCSEEECTTSCCCEECTT------------------------CCCCTTCCEEECTTCCCBHHHHHHHHHTC
T ss_pred -hhhhcccCcccEEECcCCcccchhhH------------------------hhcCCCCCEEEccCCCccCcCHHHHHhcc
Confidence 33355666666666666666555544 444555666666666665 5666777777
Q ss_pred cccceeecC-CccccCCCCCc
Q 002021 519 KNLEYLFLG-YNRLQGSIPNS 538 (979)
Q Consensus 519 ~~L~~L~Ls-~N~l~~~~p~~ 538 (979)
++|+.|+++ .+.++|..|..
T Consensus 262 ~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 262 QRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp HHHHHHHHHHHHHHHSSSSCC
T ss_pred ccceEEECCCchhccCCchhc
Confidence 777777777 44566555543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=248.16 Aligned_cols=218 Identities=24% Similarity=0.310 Sum_probs=143.7
Q ss_pred CCCCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccC
Q 002021 57 TPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTF 136 (979)
Q Consensus 57 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 136 (979)
.++|.|.|+.|... ..++.+++++++++ .+|..+. ++|++|+|++|++++..|.++..+++|++|+|++|+++...
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 47899999999753 34567888988888 4676554 67888888888888666667777888888888888887655
Q ss_pred CccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecC
Q 002021 137 PSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIA 216 (979)
Q Consensus 137 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 216 (979)
+..+.++++|++|+|++|.+++. .+..|.++++|++|+|++|++++..+..|+.+++|++|+|++|+++++.
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~--------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQAL--------PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCC--------CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred hhhhcCCCCCCEEECCCCcCCcC--------CHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence 55667777777777777777642 2344566777777777777777666666666777777777777666665
Q ss_pred CccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCcccccc
Q 002021 217 PIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNL 296 (979)
Q Consensus 217 p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 296 (979)
+..|..+++|+.|+|++|++++ ..+..+..+++|++|+|++|++++..+..|..+
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~-------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 204 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKR-------------------------VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSC-------------------------CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred HhHccCCcccceeEecCCcCcE-------------------------eChhHhccCCCcCEEECCCCcCCcCCHHHhccc
Confidence 5555555555555555555544 333444455555555555555554444445555
Q ss_pred ccccceecccccccc
Q 002021 297 RNLSWLVLSDNYLTS 311 (979)
Q Consensus 297 ~~L~~L~Ls~N~l~~ 311 (979)
++|+.|+|++|.+..
T Consensus 205 ~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 205 EKLKMLQLQENPWDC 219 (270)
T ss_dssp TTCCEEECCSSCBCC
T ss_pred cCCCEEEecCCCeeC
Confidence 555555555555543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-28 Score=291.10 Aligned_cols=186 Identities=19% Similarity=0.087 Sum_probs=132.2
Q ss_pred eeeeecceEEEEE-EcCCCcEEEEEEecccc----------ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEE
Q 002021 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC----------GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 689 ~lG~G~~g~Vy~~-~~~~~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (979)
..+.|++|.+..+ +...|+.||||++.+.. ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566677766665 33458889999986542 12345689999999999 799999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||++|++|.+++.+.+ .+++. +|+.||+.||+|+| ++||+||||||+|||+++++.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999998754 46654 58999999999999 9999999999999999999999999999998764322
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPT 884 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~ 884 (979)
......+||++|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus 394 --~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 --SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred --ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 22355689999999999864 5677899999999998887765553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=273.63 Aligned_cols=235 Identities=23% Similarity=0.204 Sum_probs=120.4
Q ss_pred CCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCc
Q 002021 249 PNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFL 328 (979)
Q Consensus 249 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L 328 (979)
++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| |+.+++|++|+|++|.|++++. .+
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~----------~~-- 99 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV----------GP-- 99 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE----------CT--
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC----------CC--
Confidence 356666666666665555555556666666666666555443 5555555555555555544321 13
Q ss_pred cEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEec
Q 002021 329 KYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK 408 (979)
Q Consensus 329 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 408 (979)
+|+.|++++|.|++..+. .+++|+.|+|++|.+++..+..+..+++|+.|+++
T Consensus 100 ------------------------~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (487)
T 3oja_A 100 ------------------------SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (487)
T ss_dssp ------------------------TCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECT
T ss_pred ------------------------CcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECC
Confidence 344444444444433322 23445555555555555444444444444444444
Q ss_pred CcccCCCcccccc-CCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCC
Q 002021 409 DNKLEGSIPYDIC-NLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSL 487 (979)
Q Consensus 409 ~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~ 487 (979)
+|.+++..|..+. .+++|+.|+|++|.|++..+ +..+++|++|+|++|+|+.+|..
T Consensus 153 ~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~--------------------- 209 (487)
T 3oja_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPE--------------------- 209 (487)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGG---------------------
T ss_pred CCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHh---------------------
Confidence 4444444444443 44555555555555543311 22344444444444444444433
Q ss_pred ccccccccccceEeccCCccCcccchhhcCCcccceeecCCcccc-CCCCCcccccccccccccc
Q 002021 488 PLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ-GSIPNSFGDLISLKFLNLS 551 (979)
Q Consensus 488 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls 551 (979)
+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|.+. +.+|..+..++.|+.|+++
T Consensus 210 ---~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 210 ---FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp ---GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred ---HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 4445555555555555553 4445555566666666666665 4455556666666666665
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-26 Score=243.70 Aligned_cols=210 Identities=26% Similarity=0.292 Sum_probs=151.5
Q ss_pred cccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecC
Q 002021 377 NLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLG 456 (979)
Q Consensus 377 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 456 (979)
+|++|++++|++++..+..|.++++|++|++++|++.+..+..|.++++|++|++++|++++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555555555555555555555555555555555556666666666666666666666666666677777777
Q ss_pred CCccccccc-cccCcCCCcEEEeccccccCC-CccccccccccceEeccCCccCcccchhhcCCcccc----eeecCCcc
Q 002021 457 SNELTSIPL-TFWNLKDILNLNFSSNFLTGS-LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLE----YLFLGYNR 530 (979)
Q Consensus 457 ~N~l~~lp~-~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~ 530 (979)
+|+++.++. .+..+++|+.|++++|++++. +|..++.+++|+.|+|++|++++..+..|..+++|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 776666554 466677777777777777653 477788888888888888888887777888777777 88999999
Q ss_pred ccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCCC
Q 002021 531 LQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGG 587 (979)
Q Consensus 531 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 587 (979)
+++..+..+.. .+|+.|+|++|++++..+..|..+++|+.|+|++|+++|..|...
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~ 244 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 244 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTH
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchH
Confidence 98655555544 589999999999998777778999999999999999999887543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-28 Score=292.18 Aligned_cols=379 Identities=17% Similarity=0.127 Sum_probs=272.3
Q ss_pred CCCCccceeeccccccccccccccc-CCCCCCceecCCC-eeeec-CCccccccCccceeeccCCCCcCCCcc---cccC
Q 002021 173 GNLPELELMSLAANNLQGKIPLKIG-NLRNLEKLDIGDN-KLVGI-APIAIFNVSTLKILGLQDNSLSGCLSS---IGYA 246 (979)
Q Consensus 173 ~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~---~~~~ 246 (979)
..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. .+..+.++++|++|+|++|.+++.... ....
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 4678999999999999987777776 7899999999999 56543 344455799999999999998764321 2234
Q ss_pred CCCCcCEEEccCCc--ccc-ccCcccccCCCCcEEecccc-ccccccCccccccccccceeccccccccccchh-hhhhc
Q 002021 247 RLPNLEILSLWGNN--FSG-TIPRFIFNASKLSILDLEGN-SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQEL-SFLSS 321 (979)
Q Consensus 247 ~l~~L~~L~L~~N~--l~~-~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~ 321 (979)
.+++|++|++++|. ++. .++..+.++++|++|+|++| .+.+ ++..+..+++|+.|+++.+...-..... .....
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~ 260 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVA 260 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHH
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHH
Confidence 77899999999987 321 12333455789999999998 4554 6777888899999986655321000000 11224
Q ss_pred ccCCCCccEEE-ccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHH-hhhcC
Q 002021 322 LSNCKFLKYFD-LSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILI-TLSKL 399 (979)
Q Consensus 322 l~~l~~L~~L~-Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~-~l~~l 399 (979)
+.++++|+.|. +.... .+.++..+..+++|++|+|++|.+++.... .+..+
T Consensus 261 l~~~~~L~~Ls~~~~~~---------------------------~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~ 313 (594)
T 2p1m_B 261 LSGCKELRCLSGFWDAV---------------------------PAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQC 313 (594)
T ss_dssp HHTCTTCCEEECCBTCC---------------------------GGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTC
T ss_pred HhcCCCcccccCCcccc---------------------------hhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcC
Confidence 56777777772 22211 012444555789999999999998865444 46789
Q ss_pred CCCcEEEecCcccCCC-ccccccCCCCCceEec---------CCCcccccCCcccc-CCCcCceEecCCCccccc-cccc
Q 002021 400 QKLQDLGLKDNKLEGS-IPYDICNLAELYRLDL---------DGNKLSGSIPACFS-NLTSLRIVSLGSNELTSI-PLTF 467 (979)
Q Consensus 400 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L---------s~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~l-p~~~ 467 (979)
++|+.|++++| +... ++.....+++|++|++ +.|.+++.....+. .+++|+.|.++.|+++.. +..+
T Consensus 314 ~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l 392 (594)
T 2p1m_B 314 PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI 392 (594)
T ss_dssp TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHH
T ss_pred CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHH
Confidence 99999999998 4422 2333345899999999 34566544333343 489999999999999843 3334
Q ss_pred c-CcCCCcEEEec--c----ccccCCC-----ccccccccccceEeccCCccCcccchhhcC-CcccceeecCCccccCC
Q 002021 468 W-NLKDILNLNFS--S----NFLTGSL-----PLEIGSLKVLVGIDLSRNNFSGVIPTEIGG-LKNLEYLFLGYNRLQGS 534 (979)
Q Consensus 468 ~-~l~~L~~L~ls--~----N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~ 534 (979)
. .+++|+.|+++ + |.++... +..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++.
T Consensus 393 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~ 471 (594)
T 2p1m_B 393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDL 471 (594)
T ss_dssp HHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHH
T ss_pred HhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHH
Confidence 3 58999999999 4 5666321 22366788999999988 787777777766 89999999999999866
Q ss_pred CCCcc-cccccccccccccccccccCCc-cccCccccCeEeccCCcccc
Q 002021 535 IPNSF-GDLISLKFLNLSNNNLSGVIPA-SLEKLSYLEDLNLSFNQLEG 581 (979)
Q Consensus 535 ~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~ 581 (979)
.+..+ ..+++|++|+|++|.+++.... ....+++|+.|++++|+++.
T Consensus 472 ~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 472 GMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp HHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred HHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 55555 6789999999999999755444 44568999999999999853
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=238.28 Aligned_cols=223 Identities=21% Similarity=0.205 Sum_probs=193.0
Q ss_pred EEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCc
Q 002021 331 FDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDN 410 (979)
Q Consensus 331 L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 410 (979)
++.++..+..++. .++++|++|++++|++++..+..|..+++|++|++++|++++..+..|.++++|++|++++|
T Consensus 12 ~~c~~~~l~~ip~-----~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 12 YQCMELNFYKIPD-----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp EECTTSCCSSCCS-----SSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred EEecCCCccccCC-----CCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 4444555544432 23457888888888888877778999999999999999999888889999999999999999
Q ss_pred ccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCcccc--ccccccCcCCCcEEEeccccccCCCc
Q 002021 411 KLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTS--IPLTFWNLKDILNLNFSSNFLTGSLP 488 (979)
Q Consensus 411 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--lp~~~~~l~~L~~L~ls~N~l~~~~p 488 (979)
.+++..+..|.++++|++|++++|++.+..+..+..+++|++|++++|+++. +|..+..+++|+.|++++|++++..+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 9998888889999999999999999998877789999999999999999986 68889999999999999999998888
Q ss_pred cccccccccc----eEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccC
Q 002021 489 LEIGSLKVLV----GIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVI 559 (979)
Q Consensus 489 ~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 559 (979)
..+..+.+|+ .|++++|++++..+..+.. .+|++|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus 167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp GGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCT
T ss_pred HHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccC
Confidence 8888888887 8999999999776666654 48999999999999777777899999999999999999654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=8.6e-25 Score=236.91 Aligned_cols=206 Identities=23% Similarity=0.160 Sum_probs=152.4
Q ss_pred ccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCc
Q 002021 372 ISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLR 451 (979)
Q Consensus 372 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 451 (979)
++++++++++++++|.++..++. + .++++.|++++|.+++..+..|.++++|+.|+|++|.|++..+. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~-~--~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPD-L--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSC-C--CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCCcCCCC-C--CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 44455556666666555533221 2 14566666666666655566666777777777777777654332 6677788
Q ss_pred eEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccc
Q 002021 452 IVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRL 531 (979)
Q Consensus 452 ~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 531 (979)
+|++++|+++.+|..+..+++|+.|++++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus 81 ~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 81 TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp EEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 88888888888887777788888888888888877777788888888888888888877777888888888888888888
Q ss_pred cCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccC
Q 002021 532 QGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKI 583 (979)
Q Consensus 532 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 583 (979)
++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.|..
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 8666667788888888888888888 66777777888888888888887754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=229.99 Aligned_cols=184 Identities=27% Similarity=0.325 Sum_probs=133.3
Q ss_pred CCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccc-cccCcCCCcEEEec
Q 002021 401 KLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFS 479 (979)
Q Consensus 401 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~ls 479 (979)
+++.|++++|++++..+..|.++++|++|++++|+++...+..|.++++|++|++++|+++.+|. .+..+++|+.|+++
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 34444445555544444455566666666666666665555555666666666666666666654 34566677777777
Q ss_pred cccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccC
Q 002021 480 SNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVI 559 (979)
Q Consensus 480 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 559 (979)
+|++++..+..|+.+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 77777666677778888888888888888777777888888888888888888777777888888888888888888777
Q ss_pred CccccCccccCeEeccCCcccccCC
Q 002021 560 PASLEKLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 560 p~~~~~l~~L~~L~L~~N~l~~~~p 584 (979)
+..|..+++|+.|+|++|++.|..+
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 198 EGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred HHHhccccCCCEEEecCCCeeCCCc
Confidence 7778888889999999998887765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=232.88 Aligned_cols=185 Identities=29% Similarity=0.347 Sum_probs=96.8
Q ss_pred ccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCc
Q 002021 372 ISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLR 451 (979)
Q Consensus 372 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 451 (979)
+..+++|++|++++|.+++. ..+..+++|++|++++|.+++..+..+..+++|++|++++|++++..+..|..+++|+
T Consensus 59 l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 136 (272)
T 3rfs_A 59 IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT 136 (272)
T ss_dssp GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence 45556666666666666542 2455555555555555555555555555566666666666666555555555555566
Q ss_pred eEecCCCcccccccc-ccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCcc
Q 002021 452 IVSLGSNELTSIPLT-FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNR 530 (979)
Q Consensus 452 ~L~L~~N~l~~lp~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 530 (979)
+|++++|+++.+|.. +..+++|+.|++++|++++..+..++.+++|+.|+|++|++++..|..|..+++|++|+|++|.
T Consensus 137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (272)
T 3rfs_A 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence 665555555554432 3444455555555555544444444445555555555555554444444555555555555554
Q ss_pred ccCCCCCcccccccccccccccccccccCCccccC
Q 002021 531 LQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEK 565 (979)
Q Consensus 531 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 565 (979)
+.+. +++|+.|+++.|+++|.+|..++.
T Consensus 217 ~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~ 244 (272)
T 3rfs_A 217 WDCT-------CPGIRYLSEWINKHSGVVRNSAGS 244 (272)
T ss_dssp BCCC-------TTTTHHHHHHHHHTGGGBBCTTSC
T ss_pred cccc-------CcHHHHHHHHHHhCCCcccCcccc
Confidence 4432 223444445555555444444433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=231.42 Aligned_cols=208 Identities=27% Similarity=0.271 Sum_probs=186.6
Q ss_pred hhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCc
Q 002021 395 TLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDIL 474 (979)
Q Consensus 395 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~ 474 (979)
.+.++++++++++++|.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|+|+.++.. ..+++|+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~ 80 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLG 80 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCC
Confidence 4678899999999999998 4665553 6899999999999998899999999999999999999998875 7899999
Q ss_pred EEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCccccccccccccccccc
Q 002021 475 NLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNN 554 (979)
Q Consensus 475 ~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 554 (979)
.|++++|+++ .+|..+..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999999 678899999999999999999998888999999999999999999998888889999999999999999
Q ss_pred ccccCCccccCccccCeEeccCCcccccCCCCCCCCCcccccccCCccccCCC
Q 002021 555 LSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 555 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~p 607 (979)
|++..+..|..+++|+.|+|++|+++...+.......+..+.+.+||+.|.+.
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence 99877778899999999999999999543334445667888999999999643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=232.83 Aligned_cols=219 Identities=23% Similarity=0.271 Sum_probs=192.7
Q ss_pred ccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCC
Q 002021 354 LEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDG 433 (979)
Q Consensus 354 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 433 (979)
+..+++..+.+... ..+..+++|+.|++++|.++.. ..+..+++|++|++++|.+.+. ..+..+++|++|++++
T Consensus 21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT
T ss_pred HHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC
Confidence 44455555555433 3466788999999999998854 3588999999999999999863 4789999999999999
Q ss_pred CcccccCCccccCCCcCceEecCCCcccccccc-ccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccc
Q 002021 434 NKLSGSIPACFSNLTSLRIVSLGSNELTSIPLT-FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIP 512 (979)
Q Consensus 434 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 512 (979)
|++++..+..|.++++|++|++++|+++.+|.. +..+++|+.|++++|++++..+..++.+++|+.|++++|++++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 999988888899999999999999999988765 7889999999999999998888888999999999999999998888
Q ss_pred hhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCC
Q 002021 513 TEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 513 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
..|+.+++|++|+|++|++++..|..+..+++|+.|+|++|.+.+. +++|+.|+++.|+++|.+|.
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 8899999999999999999988888899999999999999998855 45789999999999999997
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=260.36 Aligned_cols=186 Identities=17% Similarity=0.192 Sum_probs=144.5
Q ss_pred CCCceeeeecceEEEEEEcCCCcEEEEEEecccccc--------chhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 685 SENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR--------AFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
...+.||+|+||.||+|.. .++.+|+|+....... ..+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999965 5788999986432111 134578999999999999999655555566778999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++++|.+++.. +..++.|+++||+||| +++|+||||||+||++++ .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999876 5689999999999999 999999999999999999 99999999999874332
Q ss_pred Ccc-----eecccccCCCCCCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCc
Q 002021 837 QSM-----IQTQTLATIGYMAPEYGRE--GRVSANGDVYSFGIMLMETFTGKKPTD 885 (979)
Q Consensus 837 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~P~~ 885 (979)
... ......||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 1235679999999999876 567788899999988888887777653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-25 Score=248.51 Aligned_cols=268 Identities=18% Similarity=0.242 Sum_probs=163.1
Q ss_pred CCCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCC--CCCCeeeccCCcccccCCccccccCcccEEeccccccccc
Q 002021 58 PVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNL--SSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGT 135 (979)
Q Consensus 58 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~ 135 (979)
-|..|+++.|+. ..++.+|++++.+. +..+..+ ++++.|++++|.+.+..|. ++.+++|++|+|++|.+++.
T Consensus 35 vc~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~ 108 (336)
T 2ast_B 35 VCKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS 108 (336)
T ss_dssp SCHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred HHHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence 356899998863 34667888887776 3445566 7778888888877766554 45677777777777777655
Q ss_pred -CCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccc-cccc-cccccccCCCCCCceecCCC-e
Q 002021 136 -FPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAAN-NLQG-KIPLKIGNLRNLEKLDIGDN-K 211 (979)
Q Consensus 136 -~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L~Ls~N-~ 211 (979)
+|..+..+++|++|+|++|.+++. .|..++.+++|++|+|++| .+++ .++..+.++++|++|+|++| +
T Consensus 109 ~~~~~~~~~~~L~~L~L~~~~l~~~--------~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~ 180 (336)
T 2ast_B 109 TLHGILSQCSKLQNLSLEGLRLSDP--------IVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180 (336)
T ss_dssp HHHHHHTTBCCCSEEECTTCBCCHH--------HHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTT
T ss_pred HHHHHHhhCCCCCEEeCcCcccCHH--------HHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCC
Confidence 666667777777777777766543 3445556666666666666 4554 24555556666666666666 5
Q ss_pred eeec-CCccccccCccceeeccCCCCcCCCcccccCCCC-CcCEEEccCC--ccc-cccCcccccCCCCcEEeccccc-c
Q 002021 212 LVGI-APIAIFNVSTLKILGLQDNSLSGCLSSIGYARLP-NLEILSLWGN--NFS-GTIPRFIFNASKLSILDLEGNS-F 285 (979)
Q Consensus 212 l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l 285 (979)
+++. .+..+. .++ +|++|+|++| .++ +.+|..+..+++|++|++++|. +
T Consensus 181 l~~~~~~~~~~-------------------------~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l 235 (336)
T 2ast_B 181 FTEKHVQVAVA-------------------------HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 235 (336)
T ss_dssp CCHHHHHHHHH-------------------------HSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTC
T ss_pred cChHHHHHHHH-------------------------hcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcC
Confidence 5542 233333 445 5555555555 333 3445555666677777777776 5
Q ss_pred ccccCccccccccccceeccccc-cccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccc
Q 002021 286 SGFIPNTFGNLRNLSWLVLSDNY-LTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNI 364 (979)
Q Consensus 286 ~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i 364 (979)
++..+..+..+++|++|++++|. ++. . .+..+.++++|++|++++| +. ...+..+..++..|++++|++
T Consensus 236 ~~~~~~~l~~l~~L~~L~l~~~~~~~~--~---~~~~l~~~~~L~~L~l~~~-i~----~~~~~~l~~~l~~L~l~~n~l 305 (336)
T 2ast_B 236 KNDCFQEFFQLNYLQHLSLSRCYDIIP--E---TLLELGEIPTLKTLQVFGI-VP----DGTLQLLKEALPHLQINCSHF 305 (336)
T ss_dssp CGGGGGGGGGCTTCCEEECTTCTTCCG--G---GGGGGGGCTTCCEEECTTS-SC----TTCHHHHHHHSTTSEESCCCS
T ss_pred CHHHHHHHhCCCCCCEeeCCCCCCCCH--H---HHHHHhcCCCCCEEeccCc-cC----HHHHHHHHhhCcceEEecccC
Confidence 55556666667777777777764 211 1 1234556777777777776 22 222222333455566666666
Q ss_pred cCCCCccccC
Q 002021 365 SGGIPEEISN 374 (979)
Q Consensus 365 ~~~~p~~l~~ 374 (979)
++..|..++.
T Consensus 306 ~~~~~~~~~~ 315 (336)
T 2ast_B 306 TTIARPTIGN 315 (336)
T ss_dssp CCTTCSSCSS
T ss_pred ccccCCcccc
Confidence 6666655543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=223.58 Aligned_cols=191 Identities=23% Similarity=0.267 Sum_probs=130.7
Q ss_pred CCCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCC
Q 002021 58 PVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFP 137 (979)
Q Consensus 58 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 137 (979)
+||.|.|++|... ...+++++++++ .+|..+. ++|+.|+|++|++++..|..+..+++|++|+|++|++++..|
T Consensus 3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 5889999999632 346888888888 5666554 578888888888887777778888888888888888887777
Q ss_pred ccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCC
Q 002021 138 SFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAP 217 (979)
Q Consensus 138 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 217 (979)
..+.++++|++|+|++|.+++. .|..|+.+++|++|+|++|++++..+..|..+++|++|+|++|+|+++.+
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~--------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 148 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASL--------PLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA 148 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCC--------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred hHhccCCcCCEEECCCCccccc--------ChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence 7777777788888777777642 33456667777777777777765555556666666666666666666655
Q ss_pred ccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEecccccccc
Q 002021 218 IAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSG 287 (979)
Q Consensus 218 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 287 (979)
..|.+++ +|++|+|++|++++..+..+..+++|++|+|++|.++.
T Consensus 149 ~~~~~l~-------------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 149 GAFDKLT-------------------------NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp TTTTTCT-------------------------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred HHcCcCc-------------------------CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 5555444 45555555555554444455556666666666666654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=243.12 Aligned_cols=265 Identities=19% Similarity=0.215 Sum_probs=125.1
Q ss_pred EEccCCccccccCcccccCCCCcEEeccccccccccC----ccccccc-cccceeccccccccccchhhhhhcccCC-CC
Q 002021 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIP----NTFGNLR-NLSWLVLSDNYLTSSTQELSFLSSLSNC-KF 327 (979)
Q Consensus 254 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~l~~l-~~ 327 (979)
+++++|++++.+|..+...++|++|+|++|.+++..+ +.|.+++ +|++|+|++|.++...... +...+... ++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~-l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE-LVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHH-HHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHH-HHHHHhccCCC
Confidence 4455555555555555555556666666666655544 4455555 5666666666555443221 11112222 45
Q ss_pred ccEEEccCCCCcccCCccccc---cccccccEEEccCccccCCCCccc----cC-CCcccEEEecCCCCCchh----HHh
Q 002021 328 LKYFDLSYNPLYRILPRTTVG---NLSHSLEEFKMSNCNISGGIPEEI----SN-LTNLRTIYLGGNKLNGSI----LIT 395 (979)
Q Consensus 328 L~~L~Ls~N~l~~~~~~~~~~---~l~~~L~~L~L~~n~i~~~~p~~l----~~-l~~L~~L~L~~N~l~~~~----~~~ 395 (979)
|++|+|++|++.+..+..+.. ..+++|++|++++|.|++..+..+ .. .++|++|+|++|.+++.. +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 555555555544332221111 111234444444444443333222 22 135555555555555322 222
Q ss_pred hhcCC-CCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCC-CcCceEecCCCcccc-----cccccc
Q 002021 396 LSKLQ-KLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNL-TSLRIVSLGSNELTS-----IPLTFW 468 (979)
Q Consensus 396 l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~-----lp~~~~ 468 (979)
+..++ +|++|++++|++++..+..+... +... ++|++|+|++|+|+. ++..+.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKF--------------------LASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHH--------------------HHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 33333 45555555554444333322211 1122 345555555555443 343443
Q ss_pred C-cCCCcEEEeccccccCCCc----cccccccccceEeccCCccCcc-------cchhhcCCcccceeecCCccccCCCC
Q 002021 469 N-LKDILNLNFSSNFLTGSLP----LEIGSLKVLVGIDLSRNNFSGV-------IPTEIGGLKNLEYLFLGYNRLQGSIP 536 (979)
Q Consensus 469 ~-l~~L~~L~ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l~~~~p 536 (979)
. .++|+.|+|++|.+++..+ ..+..+++|+.|+|++|.+.+. ++..+..+++|++||+++|++.+..+
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 3 2355555555555554333 2234455666666666664332 23456677778888888888775544
Q ss_pred Ccc
Q 002021 537 NSF 539 (979)
Q Consensus 537 ~~~ 539 (979)
..+
T Consensus 302 ~~~ 304 (362)
T 3goz_A 302 IPI 304 (362)
T ss_dssp HHH
T ss_pred HHH
Confidence 333
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-25 Score=250.94 Aligned_cols=187 Identities=22% Similarity=0.262 Sum_probs=93.7
Q ss_pred cCCCcccEEEecCCCCCc----hhHHhhhcCCCCcEEEecCcccCCCcccccc----CC---------CCCceEecCCCc
Q 002021 373 SNLTNLRTIYLGGNKLNG----SILITLSKLQKLQDLGLKDNKLEGSIPYDIC----NL---------AELYRLDLDGNK 435 (979)
Q Consensus 373 ~~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~Ls~N~ 435 (979)
..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+.+..+..+. .+ ++|++|+|++|+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~ 170 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence 444555555555555544 2444445555555555555554432222222 22 455555555555
Q ss_pred cc-ccCC---ccccCCCcCceEecCCCccc------cccccccCcCCCcEEEecccccc----CCCccccccccccceEe
Q 002021 436 LS-GSIP---ACFSNLTSLRIVSLGSNELT------SIPLTFWNLKDILNLNFSSNFLT----GSLPLEIGSLKVLVGID 501 (979)
Q Consensus 436 l~-~~~~---~~~~~l~~L~~L~L~~N~l~------~lp~~~~~l~~L~~L~ls~N~l~----~~~p~~~~~l~~L~~L~ 501 (979)
++ +..+ ..+..+++|++|+|++|+++ -+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+
T Consensus 171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250 (386)
T ss_dssp CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence 54 2222 23444555555555555555 12224445555555555555553 34455555555566666
Q ss_pred ccCCccCcc----cchhhc--CCcccceeecCCccccC----CCCCcc-cccccccccccccccccccC
Q 002021 502 LSRNNFSGV----IPTEIG--GLKNLEYLFLGYNRLQG----SIPNSF-GDLISLKFLNLSNNNLSGVI 559 (979)
Q Consensus 502 Ls~N~l~~~----~p~~~~--~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~ 559 (979)
|++|+|++. +|..+. .+++|+.|+|++|++++ .+|..+ .++++|++|+|++|++++..
T Consensus 251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 666655544 344442 25666666666666654 245444 44566666666666665444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-24 Score=242.84 Aligned_cols=232 Identities=18% Similarity=0.194 Sum_probs=154.0
Q ss_pred cccEEEccCccccCCCC----ccccCCC-cccEEEecCCCCCchhHHhhhcC-----CCCcEEEecCcccCCCccccccC
Q 002021 353 SLEEFKMSNCNISGGIP----EEISNLT-NLRTIYLGGNKLNGSILITLSKL-----QKLQDLGLKDNKLEGSIPYDICN 422 (979)
Q Consensus 353 ~L~~L~L~~n~i~~~~p----~~l~~l~-~L~~L~L~~N~l~~~~~~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~ 422 (979)
+|++|+|++|.|++..+ +.+..++ +|++|+|++|++++..+..+..+ ++|++|++++|.+++..+..+..
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 34444444444444444 5556666 67777777777776666555554 77777777777777655554433
Q ss_pred ----C-CCCceEecCCCcccccCCcccc----C-CCcCceEecCCCccc-----cccccccCcC-CCcEEEeccccccCC
Q 002021 423 ----L-AELYRLDLDGNKLSGSIPACFS----N-LTSLRIVSLGSNELT-----SIPLTFWNLK-DILNLNFSSNFLTGS 486 (979)
Q Consensus 423 ----l-~~L~~L~Ls~N~l~~~~~~~~~----~-l~~L~~L~L~~N~l~-----~lp~~~~~l~-~L~~L~ls~N~l~~~ 486 (979)
+ ++|++|+|++|++++..+..+. . .++|++|+|++|+++ .++..+...+ +|++|+|++|++++.
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~ 182 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchh
Confidence 3 6777777777777765554433 2 257777788777777 3344455554 788888888888776
Q ss_pred Cccccccc-----cccceEeccCCccCcc----cchhhcCC-cccceeecCCccccCCCC----Cccccccccccccccc
Q 002021 487 LPLEIGSL-----KVLVGIDLSRNNFSGV----IPTEIGGL-KNLEYLFLGYNRLQGSIP----NSFGDLISLKFLNLSN 552 (979)
Q Consensus 487 ~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~ 552 (979)
.+..+... .+|+.|||++|+|++. ++..+..+ ++|++|+|++|++++..+ ..+..+++|++|+|++
T Consensus 183 ~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~ 262 (362)
T 3goz_A 183 NCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDY 262 (362)
T ss_dssp CHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEH
T ss_pred hHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEecc
Confidence 66544433 5888888888888763 45555553 488888888888886544 3345678888888888
Q ss_pred ccccccC-------CccccCccccCeEeccCCcccccCC
Q 002021 553 NNLSGVI-------PASLEKLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 553 N~l~~~~-------p~~~~~l~~L~~L~L~~N~l~~~~p 584 (979)
|++++.. +..+..+++|+.|++++|++.+..|
T Consensus 263 n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred CCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 8855433 3356778888888999988876533
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=219.60 Aligned_cols=196 Identities=18% Similarity=0.246 Sum_probs=134.4
Q ss_pred cccEEEecCCCCCchhHHhhhcCCCCcEEEecCcc-cCCCccccccCCCCCceEecCC-CcccccCCccccCCCcCceEe
Q 002021 377 NLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNK-LEGSIPYDICNLAELYRLDLDG-NKLSGSIPACFSNLTSLRIVS 454 (979)
Q Consensus 377 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~ 454 (979)
+|++|++++|++++..+..|.++++|++|++++|+ +++..+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666666666666665566666666666666665 6555555667777777777776 777766666777777777777
Q ss_pred cCCCccccccccccCcCCCc---EEEeccc-cccCCCccccccccccc-eEeccCCccCcccchhhcCCcccceeecCCc
Q 002021 455 LGSNELTSIPLTFWNLKDIL---NLNFSSN-FLTGSLPLEIGSLKVLV-GIDLSRNNFSGVIPTEIGGLKNLEYLFLGYN 529 (979)
Q Consensus 455 L~~N~l~~lp~~~~~l~~L~---~L~ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 529 (979)
+++|+++.+|. +..+++|+ .|++++| ++++..+..|..+++|+ .|++++|+++...+..|.. ++|+.|+|++|
T Consensus 112 l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n 189 (239)
T 2xwt_C 112 IFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN 189 (239)
T ss_dssp EEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred CCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence 77777777765 66666666 7777777 77766666677777777 7777777777444444444 77888888888
Q ss_pred c-ccCCCCCccccc-ccccccccccccccccCCccccCccccCeEeccCC
Q 002021 530 R-LQGSIPNSFGDL-ISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577 (979)
Q Consensus 530 ~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 577 (979)
+ +++..+..|.++ ++|+.|+|++|++++. |.. .+++|+.|+++++
T Consensus 190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp TTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 4 776556677777 7788888888887744 333 5667777777665
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=217.89 Aligned_cols=186 Identities=20% Similarity=0.224 Sum_probs=128.3
Q ss_pred cCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEeccccc-ccccCCccccCCCCCcEEEccC-CccCchhhhhh
Q 002021 87 TIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ-LSGTFPSFISNKSSLQHLDLSS-NALSGEIRANI 164 (979)
Q Consensus 87 ~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~ 164 (979)
.+|. +. ++|++|+|++|++++..|..+..+++|++|+|++|+ +++..+..|+++++|++|+|++ |.+++.
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i----- 96 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI----- 96 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEE-----
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEc-----
Confidence 4565 33 388999999999987767788888899999999986 8877667888888999999988 888743
Q ss_pred hccCCcccCCCCccceeecccccccccccccccCCCCCC---ceecCCC-eeeecCCccccccCccc-eeeccCCCCcCC
Q 002021 165 CREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLE---KLDIGDN-KLVGIAPIAIFNVSTLK-ILGLQDNSLSGC 239 (979)
Q Consensus 165 ~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~ 239 (979)
.|..|.++++|++|++++|++++ +|. ++.+++|+ +|++++| +++++.+..|.++++|+ .|++++|+++.+
T Consensus 97 ---~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i 171 (239)
T 2xwt_C 97 ---DPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSV 171 (239)
T ss_dssp ---CTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEE
T ss_pred ---CHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCccc
Confidence 23567888888888888888886 555 77777777 8888888 88877776677676666 666666666533
Q ss_pred CcccccCCCCCcCEEEccCCc-cccccCcccccC-CCCcEEecccccccc
Q 002021 240 LSSIGYARLPNLEILSLWGNN-FSGTIPRFIFNA-SKLSILDLEGNSFSG 287 (979)
Q Consensus 240 ~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~~ 287 (979)
+. ..|.. ++|++|+|++|+ +++..+..+..+ ++|++|++++|++++
T Consensus 172 ~~-~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~ 219 (239)
T 2xwt_C 172 QG-YAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219 (239)
T ss_dssp CT-TTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC
T ss_pred CH-hhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc
Confidence 22 22333 455555555552 544434444444 455555555555543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-24 Score=232.63 Aligned_cols=228 Identities=18% Similarity=0.204 Sum_probs=140.6
Q ss_pred CCCeeeccCCcccccC-Cc--cccccCcccEEecccccccccCCccc--cCCCCCcEEEccCCccCchhhhhhhccCC-c
Q 002021 97 SLQSLNLSFNRLFGSI-PS--AIFTTYTLKYVCLRGNQLSGTFPSFI--SNKSSLQHLDLSSNALSGEIRANICREIP-R 170 (979)
Q Consensus 97 ~L~~L~L~~n~~~~~~-p~--~~~~l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip-~ 170 (979)
.++.|++.++.++... .. ....+++|++|+|++|++++.+|..+ +.+++|++|+|++|.+++.... ++ .
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~-----~~~~ 139 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSW-----LAEL 139 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSS-----HHHH
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhh-----hHHH
Confidence 4667777777665321 11 11234568888888888887777777 7788888888888887753110 01 2
Q ss_pred ccCCCCccceeecccccccccccccccCCCCCCceecCCCeeee---cCC-ccccccCccceeeccCCCCcCCCcc--cc
Q 002021 171 EFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVG---IAP-IAIFNVSTLKILGLQDNSLSGCLSS--IG 244 (979)
Q Consensus 171 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p-~~l~~l~~L~~L~L~~N~l~~~~~~--~~ 244 (979)
.+..+++|++|+|++|++++..|..++.+++|++|+|++|++.+ ..+ ..+.++++|++|+|++|+++..... ..
T Consensus 140 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l 219 (310)
T 4glp_A 140 QQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAAL 219 (310)
T ss_dssp HTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHH
T ss_pred HhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHH
Confidence 34567777777777777777777777777777777777777654 222 2235666777777777777543211 12
Q ss_pred cCCCCCcCEEEccCCccccccCcccccC---CCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhc
Q 002021 245 YARLPNLEILSLWGNNFSGTIPRFIFNA---SKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSS 321 (979)
Q Consensus 245 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 321 (979)
+..+++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++++.
T Consensus 220 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~------- 289 (310)
T 4glp_A 220 AAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQ------- 289 (310)
T ss_dssp HHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCC-------
T ss_pred HhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCch-------
Confidence 3456666666666666666556555555 46666666666666 3444443 566666666666665432
Q ss_pred ccCCCCccEEEccCCCCc
Q 002021 322 LSNCKFLKYFDLSYNPLY 339 (979)
Q Consensus 322 l~~l~~L~~L~Ls~N~l~ 339 (979)
+..+++|++|++++|+++
T Consensus 290 ~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 290 PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp TTSCCCCSCEECSSTTTS
T ss_pred hhhCCCccEEECcCCCCC
Confidence 344556666666666554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=8.1e-23 Score=223.68 Aligned_cols=197 Identities=22% Similarity=0.343 Sum_probs=132.4
Q ss_pred CcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcc
Q 002021 92 LGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE 171 (979)
Q Consensus 92 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~ 171 (979)
...+++|++|++++|+++ .+| .+..+++|++|+|++|++++..+ +..+++|++|+|++|.+++ + +.
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~---------~-~~ 102 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN---------V-SA 102 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC---------C-GG
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC---------c-hh
Confidence 345667777777777776 345 56677777777777777775443 7777777777777777763 2 25
Q ss_pred cCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCc
Q 002021 172 FGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL 251 (979)
Q Consensus 172 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L 251 (979)
++.+++|++|+|++|++++. + .+..+++|++|+|++|+++++.+ +.++++|+.|++++|++++..+ +..+++|
T Consensus 103 ~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~---l~~l~~L 175 (308)
T 1h6u_A 103 IAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP---LANLSKL 175 (308)
T ss_dssp GTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG---GTTCTTC
T ss_pred hcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh---hcCCCCC
Confidence 67777777777777777653 3 26777777777777777776644 6667777777777777765433 5566777
Q ss_pred CEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecccccccccc
Q 002021 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313 (979)
Q Consensus 252 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 313 (979)
++|++++|++++..+ +..+++|++|+|++|++++..+ +..+++|+.|+|++|.++..+
T Consensus 176 ~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 176 TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp CEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred CEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence 777777777764433 5666777777777777765542 666667777777777666544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-24 Score=244.99 Aligned_cols=265 Identities=17% Similarity=0.209 Sum_probs=173.0
Q ss_pred ccCcccccCCCCcEEeccccccccccC----ccccccccccceecccccccccc----chh-hhhhcccCCCCccEEEcc
Q 002021 264 TIPRFIFNASKLSILDLEGNSFSGFIP----NTFGNLRNLSWLVLSDNYLTSST----QEL-SFLSSLSNCKFLKYFDLS 334 (979)
Q Consensus 264 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~----~~~-~~~~~l~~l~~L~~L~Ls 334 (979)
.++..+..+++|++|+|++|.+++..+ ..|..+++|++|+|++|.+..+. ..+ ....++..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 344555555666666666666654432 22445566666666665443221 111 112234556666666666
Q ss_pred CCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhc----C---------CC
Q 002021 335 YNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSK----L---------QK 401 (979)
Q Consensus 335 ~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~----l---------~~ 401 (979)
+|.+...... .+|..+..+++|++|+|++|.++...+..+.. + ++
T Consensus 103 ~n~l~~~~~~----------------------~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~ 160 (386)
T 2ca6_A 103 DNAFGPTAQE----------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPP 160 (386)
T ss_dssp SCCCCTTTHH----------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred CCcCCHHHHH----------------------HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCC
Confidence 6665432100 24556667777777888877776554444333 3 78
Q ss_pred CcEEEecCcccC-CCcc---ccccCCCCCceEecCCCcccc-----cCCccccCCCcCceEecCCCcc-----ccccccc
Q 002021 402 LQDLGLKDNKLE-GSIP---YDICNLAELYRLDLDGNKLSG-----SIPACFSNLTSLRIVSLGSNEL-----TSIPLTF 467 (979)
Q Consensus 402 L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l-----~~lp~~~ 467 (979)
|++|++++|++. +.++ ..+..+++|++|+|++|+++. ..+..+..+++|++|+|++|.+ ..+|..+
T Consensus 161 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l 240 (386)
T 2ca6_A 161 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240 (386)
T ss_dssp CCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred CcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHH
Confidence 888888888876 3344 356677788888888888862 3444777888888888888888 4577778
Q ss_pred cCcCCCcEEEeccccccCC----Ccccc--ccccccceEeccCCccCc----ccchhh-cCCcccceeecCCccccCCCC
Q 002021 468 WNLKDILNLNFSSNFLTGS----LPLEI--GSLKVLVGIDLSRNNFSG----VIPTEI-GGLKNLEYLFLGYNRLQGSIP 536 (979)
Q Consensus 468 ~~l~~L~~L~ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~p 536 (979)
..+++|+.|+|++|.+++. +|..+ +.+++|+.|+|++|.+++ .+|..+ .++++|++|+|++|++++..+
T Consensus 241 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp GGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred ccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 8888888888888888765 45666 348899999999999997 478777 668999999999999997653
Q ss_pred --Ccc-ccccccccccc
Q 002021 537 --NSF-GDLISLKFLNL 550 (979)
Q Consensus 537 --~~~-~~l~~L~~L~L 550 (979)
..+ ..+++++.+++
T Consensus 321 ~~~~l~~~l~~~~~~~l 337 (386)
T 2ca6_A 321 VVDEIREVFSTRGRGEL 337 (386)
T ss_dssp HHHHHHHHHHHHTCCEE
T ss_pred HHHHHHHHhhhcCcchh
Confidence 222 22455554444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-23 Score=226.39 Aligned_cols=202 Identities=18% Similarity=0.216 Sum_probs=130.2
Q ss_pred cccEEEccCccccCCCCccc--cCCCcccEEEecCCCCCchhH----HhhhcCCCCcEEEecCcccCCCccccccCCCCC
Q 002021 353 SLEEFKMSNCNISGGIPEEI--SNLTNLRTIYLGGNKLNGSIL----ITLSKLQKLQDLGLKDNKLEGSIPYDICNLAEL 426 (979)
Q Consensus 353 ~L~~L~L~~n~i~~~~p~~l--~~l~~L~~L~L~~N~l~~~~~----~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 426 (979)
+|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|++++|.+.+..+..+..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 46677777777777777777 888899999999998886433 455678888888888888887777788888888
Q ss_pred ceEecCCCccccc---C-CccccCCCcCceEecCCCcccccccc----ccCcCCCcEEEeccccccCCCccccccccccc
Q 002021 427 YRLDLDGNKLSGS---I-PACFSNLTSLRIVSLGSNELTSIPLT----FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLV 498 (979)
Q Consensus 427 ~~L~Ls~N~l~~~---~-~~~~~~l~~L~~L~L~~N~l~~lp~~----~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 498 (979)
++|+|++|++.+. . +..+..+++|++|+|++|+++.+|.. +..+++|++|+|++|++++..|..+..+.
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~--- 248 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM--- 248 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC---
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc---
Confidence 8888888887642 1 23346777788888888877765542 23445555555555555544444433331
Q ss_pred eEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCc
Q 002021 499 GIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578 (979)
Q Consensus 499 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 578 (979)
.+++|++|+|++|+|+ .+|..+. ++|++|||++|+|++. |. +..+++|+.|+|++|+
T Consensus 249 ------------------~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~ 305 (310)
T 4glp_A 249 ------------------WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNP 305 (310)
T ss_dssp ------------------CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTT
T ss_pred ------------------CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCC
Confidence 0145566666666665 4454443 5666666666666643 22 4556666666666666
Q ss_pred cc
Q 002021 579 LE 580 (979)
Q Consensus 579 l~ 580 (979)
|+
T Consensus 306 l~ 307 (310)
T 4glp_A 306 FL 307 (310)
T ss_dssp TS
T ss_pred CC
Confidence 65
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-23 Score=242.87 Aligned_cols=209 Identities=24% Similarity=0.373 Sum_probs=163.0
Q ss_pred cccCCCCCCC-----cccee-EeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccE
Q 002021 51 KNWNTSTPVC-----NWTGV-ACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKY 124 (979)
Q Consensus 51 ~~w~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~ 124 (979)
.+|..+.++| .|.|+ .|.. .+++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|++
T Consensus 34 ~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 34 DKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 3676666677 79999 7864 478999999999997 887763 89999999999998 788 45789999
Q ss_pred EecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCc
Q 002021 125 VCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEK 204 (979)
Q Consensus 125 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 204 (979)
|+|++|+|++ +|. +.+ +|++|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. .+++|++
T Consensus 105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~---------lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~ 164 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM---------LPE---LPALLEYINADNNQLTM-LPE---LPTSLEV 164 (571)
T ss_dssp EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC---------CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCE
T ss_pred EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC---------CCC---cCccccEEeCCCCccCc-CCC---cCCCcCE
Confidence 9999999997 676 665 99999999999975 566 67889999999999986 555 5788999
Q ss_pred eecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCc-------CEEEccCCccccccCcccccCCCCcE
Q 002021 205 LDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL-------EILSLWGNNFSGTIPRFIFNASKLSI 277 (979)
Q Consensus 205 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~p~~l~~l~~L~~ 277 (979)
|+|++|+|+++ |. |. ++|+.|+|++|+|+.++. +.. +| ++|+|++|+|+ .+|..++.+++|++
T Consensus 165 L~Ls~N~L~~l-p~-l~--~~L~~L~Ls~N~L~~lp~---~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~ 234 (571)
T 3cvr_A 165 LSVRNNQLTFL-PE-LP--ESLEALDVSTNLLESLPA---VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234 (571)
T ss_dssp EECCSSCCSCC-CC-CC--TTCCEEECCSSCCSSCCC---CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEE
T ss_pred EECCCCCCCCc-ch-hh--CCCCEEECcCCCCCchhh---HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCE
Confidence 99999998885 44 54 788888888888885544 222 55 77788888777 56777777777777
Q ss_pred EeccccccccccCcccccccc
Q 002021 278 LDLEGNSFSGFIPNTFGNLRN 298 (979)
Q Consensus 278 L~Ls~N~l~~~~~~~~~~l~~ 298 (979)
|+|++|.+++.+|..|+.++.
T Consensus 235 L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 235 IILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp EECCSSSCCHHHHHHHHHHHH
T ss_pred EEeeCCcCCCcCHHHHHHhhc
Confidence 777777777777766665543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=221.69 Aligned_cols=190 Identities=21% Similarity=0.356 Sum_probs=95.8
Q ss_pred ccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEec
Q 002021 352 HSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDL 431 (979)
Q Consensus 352 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 431 (979)
++|++|++++|.++.. + .+..+++|++|+|++|.+++..+ +..+++|++|++++|++++. + .+..+++|++|++
T Consensus 41 ~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l 114 (308)
T 1h6u_A 41 DGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDL 114 (308)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEEC
T ss_pred CCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEEC
Confidence 3566666666666532 2 45556666666666666655444 55555555555555555532 2 4555555555555
Q ss_pred CCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCccc
Q 002021 432 DGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVI 511 (979)
Q Consensus 432 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 511 (979)
++|++++. + .+..+++|++|++++|+++.++. +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..
T Consensus 115 ~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~ 189 (308)
T 1h6u_A 115 TSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDIS 189 (308)
T ss_dssp TTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG
T ss_pred CCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcCh
Confidence 55555532 2 25555555555555555555443 4444555555555555543222 444444555555555444332
Q ss_pred chhhcCCcccceeecCCccccCCCCCccccccccccccccccccc
Q 002021 512 PTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLS 556 (979)
Q Consensus 512 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 556 (979)
+ +..+++|++|+|++|++++..| +..+++|+.|+|++|+++
T Consensus 190 ~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp G--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred h--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 2 4444444444444444443221 444444444444444444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-22 Score=212.16 Aligned_cols=181 Identities=26% Similarity=0.323 Sum_probs=137.7
Q ss_pred CcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccc-cccCcCCCcEEEecc
Q 002021 402 LQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSS 480 (979)
Q Consensus 402 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~ls~ 480 (979)
.++++++++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|+++.++. .+..+++|+.|++++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 344555555555 3444433 467777777777776666677777777777777777776554 366777777777777
Q ss_pred ccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCC
Q 002021 481 NFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP 560 (979)
Q Consensus 481 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 560 (979)
|++++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 77777667777888888888888888887777778888888888888888887777788888889999999998888777
Q ss_pred ccccCccccCeEeccCCcccccCCC
Q 002021 561 ASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 561 ~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
..+..+++|+.|+|++|+|+|..+.
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c~~~~ 197 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDCSRCE 197 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred HHHhCCCCCCEEEeeCCceeCCccc
Confidence 7888888999999999998887543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-23 Score=233.21 Aligned_cols=229 Identities=21% Similarity=0.229 Sum_probs=169.7
Q ss_pred ccccEEEccCccccCCCCccccCCCcccEEEecCCCCCch-hHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEe
Q 002021 352 HSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGS-ILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLD 430 (979)
Q Consensus 352 ~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 430 (979)
..++.|++++|.+++..+. +..+++|++|++++|.+++. .+..+..+++|++|++++|.+.+..+..+..+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4566777777777665554 45678888888888887765 677778888888888888887777777777888888888
Q ss_pred cCCC-ccccc-CCccccCCCcCceEecCCC-cccc--ccccccCcC-CCcEEEeccc--ccc-CCCccccccccccceEe
Q 002021 431 LDGN-KLSGS-IPACFSNLTSLRIVSLGSN-ELTS--IPLTFWNLK-DILNLNFSSN--FLT-GSLPLEIGSLKVLVGID 501 (979)
Q Consensus 431 Ls~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~--lp~~~~~l~-~L~~L~ls~N--~l~-~~~p~~~~~l~~L~~L~ 501 (979)
+++| .+++. ++..+.++++|++|++++| .++. ++..+..++ +|++|++++| .++ +.+|..+..+++|+.|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 8888 56652 5566777888888888888 7874 566677788 8888888888 444 44566777788888888
Q ss_pred ccCCc-cCcccchhhcCCcccceeecCCcc-ccCCCCCcccccccccccccccccccccCCccccCc-cccCeEeccCCc
Q 002021 502 LSRNN-FSGVIPTEIGGLKNLEYLFLGYNR-LQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKL-SYLEDLNLSFNQ 578 (979)
Q Consensus 502 Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~ 578 (979)
+++|. +++..+..+..+++|++|++++|. +.......+.++++|+.|++++| ++ ...+..+ ..+..|++++|+
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~ 304 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSH 304 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCC
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEeccc
Confidence 88888 777777788888888888888885 32222235778888899999888 33 2344555 347788888999
Q ss_pred ccccCCC
Q 002021 579 LEGKIPR 585 (979)
Q Consensus 579 l~~~~p~ 585 (979)
+++..|.
T Consensus 305 l~~~~~~ 311 (336)
T 2ast_B 305 FTTIARP 311 (336)
T ss_dssp SCCTTCS
T ss_pred CccccCC
Confidence 9888775
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=207.18 Aligned_cols=183 Identities=25% Similarity=0.298 Sum_probs=127.3
Q ss_pred CCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCc
Q 002021 59 VCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPS 138 (979)
Q Consensus 59 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 138 (979)
.|.|.+|.|.. ++++ .+|..+ .++|++|+|++|++++..+..+..+++|++|+|++|++++..+.
T Consensus 6 ~C~~~~v~c~~------------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (208)
T 2o6s_A 6 SCSGTTVECYS------------QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG 70 (208)
T ss_dssp EEETTEEECCS------------SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred EECCCEEEecC------------CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence 38999999963 2344 345443 45889999999998866666677888888888888888876666
Q ss_pred cccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCc
Q 002021 139 FISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPI 218 (979)
Q Consensus 139 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 218 (979)
.++.+++|++|+|++|.+++. .+..|+++++|++|+|++|++++..+..+..+++|++|+|++|+++++.+.
T Consensus 71 ~~~~l~~L~~L~Ls~n~l~~~--------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 142 (208)
T 2o6s_A 71 VFNKLTSLTYLNLSTNQLQSL--------PNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG 142 (208)
T ss_dssp TTTTCTTCCEEECCSSCCCCC--------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred hcCCCCCcCEEECCCCcCCcc--------CHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH
Confidence 778888888888888888742 234467778888888888888766666677777788888877777777666
Q ss_pred cccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccC
Q 002021 219 AIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNA 272 (979)
Q Consensus 219 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 272 (979)
.+.++++|+.|++++|.+.+ .+++|++|+++.|+++|.+|..++.+
T Consensus 143 ~~~~l~~L~~L~l~~N~~~~--------~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 143 VFDRLTSLQYIWLHDNPWDC--------TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp TTTTCTTCCEEECCSCCBCC--------CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred HhccCCCccEEEecCCCeec--------CCCCHHHHHHHHHhCCceeeccCccc
Confidence 66666666666666665542 33445555555555555555544443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.8e-22 Score=220.72 Aligned_cols=243 Identities=21% Similarity=0.206 Sum_probs=165.4
Q ss_pred CccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCc-
Q 002021 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPS- 138 (979)
Q Consensus 60 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~- 138 (979)
|+|..|.|+ +++|+ .+|..+ .+++++|+|++|+|+..-+.+|..+++|++|+|++|++.+.+|.
T Consensus 9 C~~~~v~C~------------~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~ 73 (350)
T 4ay9_X 9 CSNRVFLCQ------------ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73 (350)
T ss_dssp EETTEEEEE------------STTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred eeCCEEEec------------CCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence 677777775 45666 567665 36788999999998844445678888888888888888766654
Q ss_pred cccCCCCCcE-EEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCC-CeeeecC
Q 002021 139 FISNKSSLQH-LDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGD-NKLVGIA 216 (979)
Q Consensus 139 ~l~~l~~L~~-L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~ 216 (979)
.|.++++|++ ++++.|++++. .|..|+++++|++|++++|++++..+..+....++..|++.+ |++..+.
T Consensus 74 ~f~~L~~l~~~l~~~~N~l~~l--------~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 74 VFSNLPKLHEIRIEKANNLLYI--------NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp SBCSCTTCCEEEEEEETTCCEE--------CTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred HhhcchhhhhhhcccCCccccc--------CchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 5778887765 56667887643 356788888888888888888876666677777778888854 5777777
Q ss_pred CccccccC-ccceeeccCCCCcCCCcccccCCCCCcCEEEccC-CccccccCcccccCCCCcEEeccccccccccCcccc
Q 002021 217 PIAIFNVS-TLKILGLQDNSLSGCLSSIGYARLPNLEILSLWG-NNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFG 294 (979)
Q Consensus 217 p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 294 (979)
+..|..+. .++.|+|++|+|+.+.... | ...+|++|++++ |.++...+..|.++++|++|||++|+|+.+.+..|.
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~~i~~~~-f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~ 223 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQEIHNSA-F-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 223 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEECTTS-S-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT
T ss_pred ccchhhcchhhhhhccccccccCCChhh-c-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc
Confidence 77776664 5777778777777654432 2 345677777764 455543344566777777777777777766555565
Q ss_pred ccccccceeccccccccccchhhhhhcccCCCCccEEEccCC
Q 002021 295 NLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYN 336 (979)
Q Consensus 295 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N 336 (979)
++++|+.+++ +.++.+| ++.++++|+.++++++
T Consensus 224 ~L~~L~~l~~--~~l~~lP-------~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 224 NLKKLRARST--YNLKKLP-------TLEKLVALMEASLTYP 256 (350)
T ss_dssp TCCEEECTTC--TTCCCCC-------CTTTCCSCCEEECSCH
T ss_pred cchHhhhccC--CCcCcCC-------CchhCcChhhCcCCCC
Confidence 5555554443 2344433 3556666666666654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.9e-22 Score=220.64 Aligned_cols=179 Identities=21% Similarity=0.206 Sum_probs=85.7
Q ss_pred ccCCCcccE-EEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCC-CcccccCCccccCCC-
Q 002021 372 ISNLTNLRT-IYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDG-NKLSGSIPACFSNLT- 448 (979)
Q Consensus 372 l~~l~~L~~-L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~- 448 (979)
|.+++++++ +.+++|+++...+..|..+++|++|++++|++....+..+....++..|++.+ |++....+..|..+.
T Consensus 75 f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~ 154 (350)
T 4ay9_X 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF 154 (350)
T ss_dssp BCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBS
T ss_pred hhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcch
Confidence 334444332 33344555544445555555555555555555544444455555566666643 455544445555543
Q ss_pred cCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCC
Q 002021 449 SLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGY 528 (979)
Q Consensus 449 ~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 528 (979)
.++.|+|++|+|+++|.......+|+.|++++ +|.++.+.++.|.++++|++|+|++
T Consensus 155 ~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~-----------------------~n~l~~i~~~~f~~l~~L~~LdLs~ 211 (350)
T 4ay9_X 155 ESVILWLNKNGIQEIHNSAFNGTQLDELNLSD-----------------------NNNLEELPNDVFHGASGPVILDISR 211 (350)
T ss_dssp SCEEEECCSSCCCEECTTSSTTEEEEEEECTT-----------------------CTTCCCCCTTTTTTEECCSEEECTT
T ss_pred hhhhhccccccccCCChhhccccchhHHhhcc-----------------------CCcccCCCHHHhccCcccchhhcCC
Confidence 45666666666666655444444444444432 1333333333444455555555555
Q ss_pred ccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCC
Q 002021 529 NRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577 (979)
Q Consensus 529 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 577 (979)
|+|+...+..|.++++|+.+++ ++++ .+| .+..+++|+.++++++
T Consensus 212 N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 212 TRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp SCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred CCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCC
Confidence 5555333333444444444333 2222 333 2455555555555433
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.7e-22 Score=213.21 Aligned_cols=150 Identities=17% Similarity=0.123 Sum_probs=119.2
Q ss_pred HHHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccc------------------cchhcHHHHHHHHHhcCCC
Q 002021 677 LCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCG------------------RAFKSFDVECEIMKSIRHR 738 (979)
Q Consensus 677 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~ 738 (979)
+......|+..+.||+|+||.||+|...+|+.||||+++.... .....+.+|++++++++|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~- 163 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG- 163 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence 3344456667799999999999999777899999999864321 123457899999999994
Q ss_pred CeeeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCC
Q 002021 739 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN 818 (979)
Q Consensus 739 niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~ 818 (979)
+++.+++.. +..++||||++||+|.+ +.. .+...++.|++.|++||| +++|+||||||+||+++ +
T Consensus 164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-T
T ss_pred --CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-C
Confidence 555554433 55699999999999998 422 134579999999999999 99999999999999999 9
Q ss_pred CcEEEEeeccccccCCCCCcceecccccCCCCCCccccC
Q 002021 819 MVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857 (979)
Q Consensus 819 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 857 (979)
+.+||+|||+++.. ..++|||++.
T Consensus 229 ~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred CcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 99999999998642 3468888764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.1e-21 Score=225.31 Aligned_cols=169 Identities=25% Similarity=0.294 Sum_probs=98.2
Q ss_pred CcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEec
Q 002021 376 TNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSL 455 (979)
Q Consensus 376 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 455 (979)
++|++|+|++|+|+.. | ..+++|+.|++++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|++|+|
T Consensus 80 ~~L~~L~Ls~N~l~~i-p---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALISL-P---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCccc-c---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 3444444444444422 2 234455555555555554 444 333 56666666666664 333 4566666666
Q ss_pred CCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCccc-------ceeecCC
Q 002021 456 GSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNL-------EYLFLGY 528 (979)
Q Consensus 456 ~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~ 528 (979)
++|+|+.+|. .+++|+.|++++|+|++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++
T Consensus 148 s~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~ 216 (571)
T 3cvr_A 148 DNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRE 216 (571)
T ss_dssp CSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCS
T ss_pred CCCccCcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCC
Confidence 6666666665 35566666666666665 444 44 66666677777666 3444 443 55 7777777
Q ss_pred ccccCCCCCcccccccccccccccccccccCCccccCccc
Q 002021 529 NRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSY 568 (979)
Q Consensus 529 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 568 (979)
|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+..
T Consensus 217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 7777 46666666777777777777777777766665543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.5e-21 Score=197.96 Aligned_cols=156 Identities=27% Similarity=0.328 Sum_probs=129.7
Q ss_pred ceEecCCCcccccCCccccCCCcCceEecCCCccccccc--cccCcCCCcEEEeccccccCCCccccccccccceEeccC
Q 002021 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL--TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSR 504 (979)
Q Consensus 427 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 504 (979)
+.+++++|.++. +|..+. ..+++|+|++|+|+.++. .|..+++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 467777777763 454443 345778888888877643 367788888888888888877777888899999999999
Q ss_pred CccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCC
Q 002021 505 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 505 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 584 (979)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|+|..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99998888889999999999999999998888999999999999999999998889999999999999999999998776
Q ss_pred C
Q 002021 585 R 585 (979)
Q Consensus 585 ~ 585 (979)
-
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.4e-20 Score=193.37 Aligned_cols=163 Identities=25% Similarity=0.271 Sum_probs=127.7
Q ss_pred ccCCCCCCCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEeccccc
Q 002021 52 NWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131 (979)
Q Consensus 52 ~w~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~ 131 (979)
-|..+...|+|.+|.|+. ++++ .+|..+. ++|++|+|++|++++..|..+..+++|++|+|++|+
T Consensus 11 ~~~~~~~~Cs~~~v~c~~------------~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~ 75 (229)
T 3e6j_A 11 AACPSQCSCSGTTVDCRS------------KRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ 75 (229)
T ss_dssp CCCCTTCEEETTEEECTT------------SCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccCCCCCEEeCCEeEccC------------CCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCC
Confidence 455677889999999963 3344 5666554 889999999999998888888889999999999999
Q ss_pred ccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCe
Q 002021 132 LSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNK 211 (979)
Q Consensus 132 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 211 (979)
+++..+..|..+++|++|+|++|+|++. .+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|+
T Consensus 76 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l--------~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 146 (229)
T 3e6j_A 76 LGALPVGVFDSLTQLTVLDLGTNQLTVL--------PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCC--------CTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSC
T ss_pred CCCcChhhcccCCCcCEEECCCCcCCcc--------ChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCc
Confidence 9876667788889999999999988743 3445788888888888888888 677778888888888888888
Q ss_pred eeecCCccccccCccceeeccCCCCcC
Q 002021 212 LVGIAPIAIFNVSTLKILGLQDNSLSG 238 (979)
Q Consensus 212 l~~~~p~~l~~l~~L~~L~L~~N~l~~ 238 (979)
|+++.+..|..+++|+.|+|++|.+..
T Consensus 147 l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 147 LKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 887776666666666666666666653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.1e-20 Score=189.96 Aligned_cols=141 Identities=28% Similarity=0.345 Sum_probs=77.7
Q ss_pred cCCCCCceEecCCCcccccCCccccCCCcCceEecCCCcccccccc-ccCcCCCcEEEeccccccCCCccccccccccce
Q 002021 421 CNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLT-FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVG 499 (979)
Q Consensus 421 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 499 (979)
..+++|++|++++|++++..+..|..+++|++|++++|+++.+|.. +..+++|+.|++++|++++..+..|..+++|+.
T Consensus 49 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 128 (208)
T 2o6s_A 49 DELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKD 128 (208)
T ss_dssp TTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCE
Confidence 3333444444444444333333344444444444444444444332 344444555555555555444444556666666
Q ss_pred EeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccc
Q 002021 500 IDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSY 568 (979)
Q Consensus 500 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 568 (979)
|+|++|++++..+..|..+++|+.|+|++|.+.+ .+++|+.|+++.|+++|.+|..++.++.
T Consensus 129 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 129 LRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred EECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 6666666666555566667777777777776653 2346777777777777777777666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=9.3e-22 Score=239.67 Aligned_cols=267 Identities=21% Similarity=0.194 Sum_probs=109.2
Q ss_pred CChhHHHHHHHHHHhcccCCCCcccccc-CCCCCCCccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeecc
Q 002021 26 STITDQDALLALKAHITHDPTNFLAKNW-NTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLS 104 (979)
Q Consensus 26 ~~~~~~~all~~k~~~~~~~~~~~~~~w-~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~ 104 (979)
....++++|+++........+... ..| ...++++.|.+++++ +.+++.|+|.++++.+ ++. ..|+.++|+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s--~~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls 199 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKK-QQPTGDSTPSGTATNSAVS--TPLTPKIELFANGKDE-ANQ-----ALLQHKKLS 199 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCccc-CCCcCCCCccccCCCceec--CCccceEEeeCCCCCc-chh-----hHhhcCccC
Confidence 455788999999988755444333 355 344567899999886 4679999999999886 233 335666677
Q ss_pred CCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecc
Q 002021 105 FNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLA 184 (979)
Q Consensus 105 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~ 184 (979)
.|.+. .++++.|++. ..|..+..+++|+.|+|++|.++ .+|..+.++++|++|+|+
T Consensus 200 ~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~---------~l~~~~~~l~~L~~L~Ls 255 (727)
T 4b8c_D 200 QYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF---------NISANIFKYDFLTRLYLN 255 (727)
T ss_dssp -------------------------------------CCCCCCEEECTTSCCS---------CCCGGGGGCCSCSCCBCT
T ss_pred ccccc--------------Ccccccccee-cChhhhccCCCCcEEECCCCCCC---------CCChhhcCCCCCCEEEee
Confidence 76655 2344455555 45566666666666666666665 256666666667777777
Q ss_pred cccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccc
Q 002021 185 ANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGT 264 (979)
Q Consensus 185 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 264 (979)
+|.|+ .+|..|+++++|++|+|++|+|+. +|..|.++++|+.|+|++|.|+.++.. |..+++|++|+|++|.|++.
T Consensus 256 ~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~lp~~--~~~l~~L~~L~L~~N~l~~~ 331 (727)
T 4b8c_D 256 GNSLT-ELPAEIKNLSNLRVLDLSHNRLTS-LPAELGSCFQLKYFYFFDNMVTTLPWE--FGNLCNLQFLGVEGNPLEKQ 331 (727)
T ss_dssp TSCCS-CCCGGGGGGTTCCEEECTTSCCSS-CCSSGGGGTTCSEEECCSSCCCCCCSS--TTSCTTCCCEECTTSCCCSH
T ss_pred CCcCc-ccChhhhCCCCCCEEeCcCCcCCc-cChhhcCCCCCCEEECCCCCCCccChh--hhcCCCccEEeCCCCccCCC
Confidence 77666 566666677777777777777663 366666777777777777776644332 66777777777777777777
Q ss_pred cCcccccCCC-CcEEeccccccccccCccccccccccceecccc--------ccccccchhhhhhcccCCCCccEEEccC
Q 002021 265 IPRFIFNASK-LSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN--------YLTSSTQELSFLSSLSNCKFLKYFDLSY 335 (979)
Q Consensus 265 ~p~~l~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N--------~l~~~~~~~~~~~~l~~l~~L~~L~Ls~ 335 (979)
+|..+..+.. +..|+|++|.+++.+|.. |+.|+++.| .+..... ..+.++..+....+++
T Consensus 332 ~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~-----~~~~~l~~~~~~~ls~ 400 (727)
T 4b8c_D 332 FLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTE-----HLATDLAKRTFTVLSY 400 (727)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------------------------------
T ss_pred ChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCcccccc-----chhhcccccceeeeec
Confidence 7776655422 234678888887777653 445556655 1211111 1234566677778888
Q ss_pred CCCcc
Q 002021 336 NPLYR 340 (979)
Q Consensus 336 N~l~~ 340 (979)
|-+.+
T Consensus 401 Nil~~ 405 (727)
T 4b8c_D 401 NTLCQ 405 (727)
T ss_dssp -CCCG
T ss_pred ccccc
Confidence 87754
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=194.51 Aligned_cols=155 Identities=23% Similarity=0.358 Sum_probs=120.2
Q ss_pred ceEecCCCcccccCCccccCCCcCceEecCCCccccccc-cccCcCCCcEEEeccccccCCCccccccccccceEeccCC
Q 002021 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRN 505 (979)
Q Consensus 427 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 505 (979)
+.+++++|.++ .+|..+. ++|++|++++|+|+.+|. .|..+++|+.|+|++|++++..|..|.++++|+.|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45666666666 3444433 567777777777776665 5667777777777777777777778888888888888888
Q ss_pred ccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCC
Q 002021 506 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 506 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 584 (979)
+|+...+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|.|...
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 8887767778888888888888888888778888888888888888888888777788888888888888888887544
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=196.80 Aligned_cols=172 Identities=24% Similarity=0.351 Sum_probs=98.7
Q ss_pred cCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCccc
Q 002021 93 GNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREF 172 (979)
Q Consensus 93 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l 172 (979)
..+++|++|++++|.+++ +| .+..+++|++|+|++|++++..| ++++++|++|+|++|.+++ +| .+
T Consensus 43 ~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~---------~~-~l 108 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD---------LS-SL 108 (291)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC---------GG-GG
T ss_pred hhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC---------Ch-hh
Confidence 456666677777766653 33 35666666666666666665433 6666666666666666653 22 35
Q ss_pred CCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcC
Q 002021 173 GNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLE 252 (979)
Q Consensus 173 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~ 252 (979)
+.+++|++|+|++|++++. ..+..+++|++|++++|+++++ ..+..+++|+.|++++|++++..+ +..+++|+
T Consensus 109 ~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~---l~~l~~L~ 181 (291)
T 1h6t_A 109 KDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP---LAGLTKLQ 181 (291)
T ss_dssp TTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG---GTTCTTCC
T ss_pred ccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh---hcCCCccC
Confidence 6666666666666666542 3455666666666666666654 345555555555555555554332 44555555
Q ss_pred EEEccCCccccccCcccccCCCCcEEecccccccc
Q 002021 253 ILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSG 287 (979)
Q Consensus 253 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 287 (979)
+|+|++|.+++ +| .+..+++|+.|++++|.++.
T Consensus 182 ~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 182 NLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp EEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred EEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 55555555553 22 24455555555555555543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=212.60 Aligned_cols=174 Identities=26% Similarity=0.360 Sum_probs=95.5
Q ss_pred CcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcc
Q 002021 92 LGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPRE 171 (979)
Q Consensus 92 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~ 171 (979)
+..|++|+.|+|++|.+. .+| .+..+++|++|+|++|++++..| ++.+++|++|+|++|.+++ +| .
T Consensus 39 ~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~---------l~-~ 104 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD---------LS-S 104 (605)
T ss_dssp HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC---------CT-T
T ss_pred hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC---------Ch-h
Confidence 345666666666666665 233 45666666666666666665443 6666666666666666653 22 4
Q ss_pred cCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCc
Q 002021 172 FGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL 251 (979)
Q Consensus 172 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L 251 (979)
++.+++|+.|+|++|++++. ..+..+++|+.|+|++|+|+++ ..+.. +++|
T Consensus 105 l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~-------------------------l~~L 155 (605)
T 1m9s_A 105 LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSR-------------------------LTKL 155 (605)
T ss_dssp STTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGS-------------------------CTTC
T ss_pred hccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcc-------------------------cCCC
Confidence 55566666666666666532 2355555555555555555544 23444 4455
Q ss_pred CEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccc
Q 002021 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS 312 (979)
Q Consensus 252 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 312 (979)
+.|+|++|+|++..| +..+++|+.|+|++|.|++. ..|..+++|+.|+|++|.++..
T Consensus 156 ~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 156 DTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp SEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred CEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 555555555544333 44455555555555555543 2355555555555555555443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.1e-22 Score=234.41 Aligned_cols=190 Identities=18% Similarity=0.112 Sum_probs=109.1
Q ss_pred cCCCCCCeeeccCCcccccCCccccccCcccEEeccccc-------------ccccCCccccCCCCCcEEE-ccCCccCc
Q 002021 93 GNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ-------------LSGTFPSFISNKSSLQHLD-LSSNALSG 158 (979)
Q Consensus 93 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~-------------l~~~~p~~l~~l~~L~~L~-Ls~N~l~~ 158 (979)
...++|+.|+|++|+++ .+|.+++.+++|+.|++++|. +.+.+|..++++++|+.|| ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 55677777777777775 667777777777777776664 3445555555555555555 4444331
Q ss_pred hhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcC
Q 002021 159 EIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSG 238 (979)
Q Consensus 159 ~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 238 (979)
.|+.+.+++|.+++..+ ..|++|+|++|+|+++ |. +.++++|+.|+|++|+|+.
T Consensus 424 ------------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~~ 477 (567)
T 1dce_A 424 ------------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLRA 477 (567)
T ss_dssp ------------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCCC
T ss_pred ------------------hhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCcccccc
Confidence 23333444444442221 1355666666666654 33 5566666666666666653
Q ss_pred CCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEecccccccccc-Cccccccccccceeccccccccccc
Q 002021 239 CLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFI-PNTFGNLRNLSWLVLSDNYLTSSTQ 314 (979)
Q Consensus 239 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~ 314 (979)
++. .+..+++|++|+|++|+|++ +| .++++++|++|+|++|+|++.. |..|+.+++|+.|+|++|.+++.++
T Consensus 478 lp~--~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 478 LPP--ALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CCG--GGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred cch--hhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 322 34556666666666666654 44 5556666666666666666554 5566666666666666666655543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=195.38 Aligned_cols=171 Identities=25% Similarity=0.388 Sum_probs=93.2
Q ss_pred CCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceE
Q 002021 374 NLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIV 453 (979)
Q Consensus 374 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 453 (979)
.+++|+.|++++|.++.. ..+..+++|++|++++|++++..+ +..+++|++|++++|++++. ..+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC--hhhccCCCCCEE
Confidence 445555555555555543 124555555555555555554333 55555555555555555531 225555556666
Q ss_pred ecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccC
Q 002021 454 SLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQG 533 (979)
Q Consensus 454 ~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 533 (979)
++++|+++.++ .+..+++|+.|++++|++++. ..++.+++|+.|+|++|++++..| +..+++|+.|+|++|++++
T Consensus 118 ~L~~n~i~~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 118 SLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp ECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred ECCCCcCCCCh-hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 66666555543 344555555555555555543 345555566666666666654433 5556666666666666653
Q ss_pred CCCCcccccccccccccccccccc
Q 002021 534 SIPNSFGDLISLKFLNLSNNNLSG 557 (979)
Q Consensus 534 ~~p~~~~~l~~L~~L~Ls~N~l~~ 557 (979)
+| .+..+++|+.|++++|+++.
T Consensus 193 -l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 193 -LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred -Ch-hhccCCCCCEEECcCCcccC
Confidence 22 25556666666666666553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=203.79 Aligned_cols=177 Identities=26% Similarity=0.262 Sum_probs=115.3
Q ss_pred EEEecCcccCCCccccccCCCCCceEecCCCcccccCCcccc-CCCcCceEecCCCccccccc-cccCcCCCcEEEeccc
Q 002021 404 DLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFS-NLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSN 481 (979)
Q Consensus 404 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~ls~N 481 (979)
.++++++.++ .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|+.++. .|.++++|+.|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 3444444444 2443332 3456666666666666565565 66666777777676666653 4666667777777777
Q ss_pred cccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcc---ccccccccccccccccccc
Q 002021 482 FLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSF---GDLISLKFLNLSNNNLSGV 558 (979)
Q Consensus 482 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~ 558 (979)
+|++..+..|..+.+|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|||++|+|++.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l 178 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCcc
Confidence 7766666667777777777777777777777777777777777777777775444444 4577777777777777765
Q ss_pred CCccccCccc--cCeEeccCCcccccC
Q 002021 559 IPASLEKLSY--LEDLNLSFNQLEGKI 583 (979)
Q Consensus 559 ~p~~~~~l~~--L~~L~L~~N~l~~~~ 583 (979)
.+..+..++. ++.|+|++|+|.|..
T Consensus 179 ~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 179 PLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp CHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred CHHHhhhccHhhcceEEecCCCccCCc
Confidence 5566666666 377777777777653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.5e-19 Score=184.34 Aligned_cols=147 Identities=27% Similarity=0.325 Sum_probs=115.8
Q ss_pred ecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCc
Q 002021 79 ISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSG 158 (979)
Q Consensus 79 l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 158 (979)
+++++++ .+|..+. ++|++|+|++|++++..|..+..+++|++|+|++|++++..|..|.++++|++|+|++|.|++
T Consensus 18 c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 94 (220)
T 2v9t_B 18 CRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94 (220)
T ss_dssp CTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCC
T ss_pred cCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCc
Confidence 3455666 4666554 688999999999987777788888889999999999888888888888888888888888874
Q ss_pred hhhhhhhccCCc-ccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCc
Q 002021 159 EIRANICREIPR-EFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLS 237 (979)
Q Consensus 159 ~~~~~~~~~ip~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 237 (979)
+|. .|.++++|++|+|++|++++..|..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|.+.
T Consensus 95 ---------l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 95 ---------LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp ---------CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ---------cCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 444 4677888888888888888777788888888888888888888877776776777777777666664
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=213.89 Aligned_cols=182 Identities=24% Similarity=0.350 Sum_probs=108.7
Q ss_pred cCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCce
Q 002021 373 SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRI 452 (979)
Q Consensus 373 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 452 (979)
..+++|+.|++++|.+.... .+..+++|+.|+|++|++.+..| +..+++|+.|+|++|+|.+. ..+..+++|++
T Consensus 40 ~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~ 113 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKS 113 (605)
T ss_dssp HHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCE
T ss_pred hcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCE
Confidence 34555555555555555432 35555556666666665554333 55666666666666666532 24566666666
Q ss_pred EecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCcccc
Q 002021 453 VSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 532 (979)
Q Consensus 453 L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 532 (979)
|+|++|+|+.++ .+..+++|+.|+|++|++++. ..++.+++|+.|+|++|+|++..| +..+++|+.|+|++|+|+
T Consensus 114 L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 114 LSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp EECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EEecCCCCCCCc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 666666666653 355666666666666666653 456666667777777777765555 666677777777777776
Q ss_pred CCCCCcccccccccccccccccccccCCccccCcc
Q 002021 533 GSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLS 567 (979)
Q Consensus 533 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 567 (979)
+. ..+..+++|+.|+|++|++++.....+..+.
T Consensus 189 ~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~ 221 (605)
T 1m9s_A 189 DL--RALAGLKNLDVLELFSQECLNKPINHQSNLV 221 (605)
T ss_dssp BC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCE
T ss_pred CC--hHHccCCCCCEEEccCCcCcCCcccccccEE
Confidence 43 2466667777777777777654333333333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=8.7e-19 Score=182.67 Aligned_cols=154 Identities=26% Similarity=0.336 Sum_probs=112.1
Q ss_pred ceEecCCCcccccCCccccCCCcCceEecCCCccccc-cccccCcCCCcEEEeccccccCCCccccccccccceEeccCC
Q 002021 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSI-PLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRN 505 (979)
Q Consensus 427 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 505 (979)
+.++.++++++ .+|..+. ++|++|+|++|+|+.+ |..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 44555555554 3333332 5566666666666654 334556666666666666666555556677788888888888
Q ss_pred ccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCC
Q 002021 506 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 506 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 584 (979)
+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|+++|..+
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 888777777888888888888888888 678888888888888888888887777778888888888888888888765
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=5e-19 Score=198.28 Aligned_cols=127 Identities=26% Similarity=0.228 Sum_probs=63.0
Q ss_pred EEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCcccc-ccCcccEEecccccccccCCccccCCCCCcEEEccCC
Q 002021 76 VLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIF-TTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSN 154 (979)
Q Consensus 76 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N 154 (979)
.+++++++|+. +|..+. +.+++|||++|++++..+..+. .+++|++|+|++|+|++..|..|.++++|++|||++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 45566666763 555443 3466677776666655444444 5555555555555555554455555555555555555
Q ss_pred ccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeee
Q 002021 155 ALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLV 213 (979)
Q Consensus 155 ~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 213 (979)
+|++. .+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|+
T Consensus 99 ~l~~~--------~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 99 HLHTL--------DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp CCCEE--------CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCcC--------CHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence 55421 1223444444444444444444333333333333333333333333
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-19 Score=182.86 Aligned_cols=155 Identities=29% Similarity=0.374 Sum_probs=84.1
Q ss_pred ceEecCCCccccccccccCcCCCcEEEeccccccCCCcc-ccccccccceEeccCCccCcccchhhcCCcccceeecCCc
Q 002021 451 RIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPL-EIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYN 529 (979)
Q Consensus 451 ~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 529 (979)
+++++++|+++++|..+.. +++.|++++|++++..+. .|+.+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 3444555555555543322 455555555555544433 2555566666666666666555666666666666666666
Q ss_pred cccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCCCCCCCcccccccCCccccCCC
Q 002021 530 RLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 530 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~p 607 (979)
+|++..|..|.++++|++|+|++|+|++.+|..+..+++|+.|+|++|+|+|.++.......+....+.++...|+.|
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 666555555666666666666666666666666666666666666666666555421111112222344455555544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=180.77 Aligned_cols=153 Identities=25% Similarity=0.278 Sum_probs=112.6
Q ss_pred EEEecCcccCCCccccccCCCCCceEecCCCcccccCC-ccccCCCcCceEecCCCccccccc-cccCcCCCcEEEeccc
Q 002021 404 DLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIP-ACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSN 481 (979)
Q Consensus 404 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~ls~N 481 (979)
.+++++|.++. +|..+. ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|+.++. .|..+++|+.|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 45555555542 444332 345677777777776543 446777777777777777776655 5777777777777788
Q ss_pred cccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccC
Q 002021 482 FLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVI 559 (979)
Q Consensus 482 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 559 (979)
++++..|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+++..
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 887777777888888888888888888877888888888888888888888777888888888888888888887553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-21 Score=228.35 Aligned_cols=199 Identities=22% Similarity=0.193 Sum_probs=92.0
Q ss_pred cccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEe-c
Q 002021 353 SLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLD-L 431 (979)
Q Consensus 353 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~-L 431 (979)
+|+.|+|++|+++ .+|+.++++++|+.|++++|......+..+ ..+.+.+..|..++.+++|+.|+ +
T Consensus 350 ~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll-----------~~~~~~~~~~~~l~~l~~L~~L~~l 417 (567)
T 1dce_A 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM-----------RALDPLLYEKETLQYFSTLKAVDPM 417 (567)
T ss_dssp TSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHH-----------HHHCTGGGHHHHHHHHHHHHHHCGG
T ss_pred cceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHH-----------HhcccccCCHHHHHHHHhcccCcch
Confidence 3444444444444 355666666666666665543110111000 01113344555555555555555 4
Q ss_pred CCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCccc
Q 002021 432 DGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVI 511 (979)
Q Consensus 432 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 511 (979)
+.|.+. +|+.+.+++|.++.+|.. .|+.|+|++|+|++ +|. ++.+++|+.|+|++|+|+ .+
T Consensus 418 ~~n~~~-----------~L~~l~l~~n~i~~l~~~-----~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~l 478 (567)
T 1dce_A 418 RAAYLD-----------DLRSKFLLENSVLKMEYA-----DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-AL 478 (567)
T ss_dssp GHHHHH-----------HHHHHHHHHHHHHHHHHT-----TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CC
T ss_pred hhcccc-----------hhhhhhhhcccccccCcc-----CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-cc
Confidence 444332 233334444444433321 24445555555443 333 444555555555555554 34
Q ss_pred chhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccC-CccccCccccCeEeccCCcccccCC
Q 002021 512 PTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVI-PASLEKLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 512 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p 584 (979)
|..|+++++|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.+ |..+..+++|+.|+|++|++++.+|
T Consensus 479 p~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 479 PPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred chhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 4445555555555555555543 33 4445555555555555555443 4455555555555555555554444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=176.58 Aligned_cols=154 Identities=18% Similarity=0.244 Sum_probs=120.3
Q ss_pred cCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceE
Q 002021 421 CNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGI 500 (979)
Q Consensus 421 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 500 (979)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++.++ .+..+++|++|++++|++++..|..++.+++|+.|
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 45566777777777776 344 5677777777777777776655 66778888888888888887778888888899999
Q ss_pred eccCCccCcccchhhcCCcccceeecCCcc-ccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcc
Q 002021 501 DLSRNNFSGVIPTEIGGLKNLEYLFLGYNR-LQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579 (979)
Q Consensus 501 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 579 (979)
++++|++++..|..++.+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++. + .+..+++|+.|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence 999999988888888999999999999998 65 555 688899999999999999853 3 788889999999999988
Q ss_pred cc
Q 002021 580 EG 581 (979)
Q Consensus 580 ~~ 581 (979)
.+
T Consensus 194 ~~ 195 (197)
T 4ezg_A 194 GG 195 (197)
T ss_dssp --
T ss_pred CC
Confidence 64
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.6e-19 Score=187.67 Aligned_cols=170 Identities=20% Similarity=0.269 Sum_probs=99.6
Q ss_pred CCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEe
Q 002021 375 LTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVS 454 (979)
Q Consensus 375 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 454 (979)
+.++..+++++|.+++.. .+..+++|+.|++++|.++. ++ .+..+++|+.|+|++|+|++..+ +..+++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 445555566666665433 45556666666666666653 33 45666666666666666665433 66666666666
Q ss_pred cCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCC
Q 002021 455 LGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 534 (979)
Q Consensus 455 L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 534 (979)
|++|+++.+|.... ++|+.|++++|++++. ..++.+++|+.|+|++|++++. + .+..+++|+.|+|++|++++.
T Consensus 92 L~~N~l~~l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 92 VNRNRLKNLNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CCSSCCSCCTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCCccCCcCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 66666666654322 5566666666666542 2355566666666666666543 2 455666666666666666643
Q ss_pred CCCccccccccccccccccccccc
Q 002021 535 IPNSFGDLISLKFLNLSNNNLSGV 558 (979)
Q Consensus 535 ~p~~~~~l~~L~~L~Ls~N~l~~~ 558 (979)
..+..+++|+.|++++|++++.
T Consensus 166 --~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 --GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp --TTSTTCCCCCEEEEEEEEEECC
T ss_pred --HHhccCCCCCEEeCCCCcccCC
Confidence 4455566666666666666543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=6.1e-19 Score=214.84 Aligned_cols=143 Identities=27% Similarity=0.316 Sum_probs=77.1
Q ss_pred hHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcC
Q 002021 392 ILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLK 471 (979)
Q Consensus 392 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~ 471 (979)
.+..|..++.|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|+++++|++|+|++|+|+.+|..+++++
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~ 293 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCF 293 (727)
T ss_dssp ------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGT
T ss_pred ChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCC
Confidence 3455555555566666665555 34444555556666666666665 455555556666666666666665555555555
Q ss_pred CCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcc-cceeecCCccccCCCCC
Q 002021 472 DILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKN-LEYLFLGYNRLQGSIPN 537 (979)
Q Consensus 472 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~ 537 (979)
+|+.|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus 294 ~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 294 QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 5666666655555 34555555555555666666655555555544322 22355555555555553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=185.65 Aligned_cols=167 Identities=18% Similarity=0.273 Sum_probs=107.2
Q ss_pred ccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCC
Q 002021 354 LEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDG 433 (979)
Q Consensus 354 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 433 (979)
+..+++++|.+++.. .+..+++|++|++++|.++... .+..+++|+.|++++|++++..+ +..+++|+.|+|++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 444444555554322 3555666666666666666433 56666666666666666665433 66667777777777
Q ss_pred CcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccch
Q 002021 434 NKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPT 513 (979)
Q Consensus 434 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 513 (979)
|++++. |. +.. ++|++|+|++|+++.++ .+..+++|+.|++++|++++. + .++.+++|+.|+|++|++++. .
T Consensus 95 N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~ 166 (263)
T 1xeu_A 95 NRLKNL-NG-IPS-ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--G 166 (263)
T ss_dssp SCCSCC-TT-CCC-SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--T
T ss_pred CccCCc-Cc-ccc-CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--H
Confidence 777643 22 222 66777777777777665 466677777777777777754 3 566777777777777777755 5
Q ss_pred hhcCCcccceeecCCccccCC
Q 002021 514 EIGGLKNLEYLFLGYNRLQGS 534 (979)
Q Consensus 514 ~~~~l~~L~~L~Ls~N~l~~~ 534 (979)
.+..+++|+.|++++|++++.
T Consensus 167 ~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 167 GLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TSTTCCCCCEEEEEEEEEECC
T ss_pred HhccCCCCCEEeCCCCcccCC
Confidence 677777777777777777754
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=173.43 Aligned_cols=176 Identities=24% Similarity=0.300 Sum_probs=127.8
Q ss_pred ceEecCCCcccccCCccccCCCcCceEecCCCcccccccc--ccCcCCCcEEEeccccccCCCccccccccccceEeccC
Q 002021 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLT--FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSR 504 (979)
Q Consensus 427 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~--~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 504 (979)
+.+++++|+++ .+|..+.. +|++|++++|+|+.++.. +..+++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56777777775 45554433 677778888877777653 67788888888888888877788888888888888888
Q ss_pred CccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCC
Q 002021 505 NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 505 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 584 (979)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+-.. -...++...+.++...|..|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~-~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH-HHHHHHHcCCCCCCCCCCCC
Confidence 88888888888888888888888888888888888888888888888888886654211 11123334556666666666
Q ss_pred CCCCCCCcccccccCCccccCCCC
Q 002021 585 RGGSFGNFSAQSFEGNELLCGSPN 608 (979)
Q Consensus 585 ~~~~~~~~~~~~~~~N~~~c~~p~ 608 (979)
. .+.......+..+...|..+.
T Consensus 167 ~--~l~~~~l~~l~~~~~~C~~~~ 188 (192)
T 1w8a_A 167 S--KVRDVQIKDLPHSEFKCSSEN 188 (192)
T ss_dssp T--TTTTSBGGGSCTTTCCCCCC-
T ss_pred h--HHcCCChhhCcHhhcCcCCCC
Confidence 4 455566667777877887653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.5e-18 Score=173.71 Aligned_cols=65 Identities=17% Similarity=0.223 Sum_probs=29.2
Q ss_pred ccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCC
Q 002021 171 EFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNS 235 (979)
Q Consensus 171 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 235 (979)
.+..+++|++|++++|.+++..|..++.+++|++|+|++|++++..|..+.++++|+.|++++|+
T Consensus 83 ~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 34444444444444444444444444444444444444444444434444444444444444443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.7e-18 Score=182.35 Aligned_cols=137 Identities=20% Similarity=0.242 Sum_probs=105.0
Q ss_pred CCCCceeeeecceEEEEEEc-CCCcE--EEEEEecccccc------------------------chhcHHHHHHHHHhcC
Q 002021 684 FSENNLIGRGGFGSVYKASL-GDGME--VAVKVFTSQCGR------------------------AFKSFDVECEIMKSIR 736 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 736 (979)
|+..+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999976 68889 999987543111 0125788999999998
Q ss_pred CCCe--eeEEEeeccCCeeEEEEEecCC-C----ccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 002021 737 HRNL--IKVISSCSNEEFKALVLEYMPH-G----SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 809 (979)
Q Consensus 737 h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik 809 (979)
|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.|++|||. +++|+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence 8754 334432 356899999942 4 44443322 2345678899999999999995 5799999999
Q ss_pred CCCEEeCCCCcEEEEeecccccc
Q 002021 810 PSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 810 ~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
|+|||+++ .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.9e-18 Score=170.58 Aligned_cols=131 Identities=31% Similarity=0.417 Sum_probs=102.5
Q ss_pred ceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCcc
Q 002021 451 RIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNR 530 (979)
Q Consensus 451 ~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 530 (979)
+.+++++|+++++|..+. ++|+.|++++|+|+ .+|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 456666666666665543 46777777777776 466777778888888888888887777888888888888888888
Q ss_pred ccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCC
Q 002021 531 LQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584 (979)
Q Consensus 531 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 584 (979)
|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|.|...
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 887777788888888888888888887766678888889999999998887654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.7e-17 Score=183.30 Aligned_cols=100 Identities=15% Similarity=0.092 Sum_probs=44.6
Q ss_pred CCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccc-cccCcCCCc-EEEeccccccCCCccccccccccceE
Q 002021 423 LAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDIL-NLNFSSNFLTGSLPLEIGSLKVLVGI 500 (979)
Q Consensus 423 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~-~L~ls~N~l~~~~p~~~~~l~~L~~L 500 (979)
+++|+.|+|++|+++...+.+|.++++|+.|+|.+| ++.|+. .|.++.+|+ .+++.+ .++.+.+..|.++.+|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 445555555555555444455555555555555554 444433 233344444 444433 3332333334444444444
Q ss_pred eccCCccCcccchhhcCCccccee
Q 002021 501 DLSRNNFSGVIPTEIGGLKNLEYL 524 (979)
Q Consensus 501 ~Ls~N~l~~~~p~~~~~l~~L~~L 524 (979)
++++|+++.+.+.+|.++++|+.+
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEE
T ss_pred EeCCCccCccchhhhcCCcchhhh
Confidence 444444443333344444444433
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.2e-18 Score=186.37 Aligned_cols=102 Identities=15% Similarity=-0.025 Sum_probs=59.9
Q ss_pred CCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCccc-EEEecCCCCCchhHHhhhcCCCCc
Q 002021 325 CKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLR-TIYLGGNKLNGSILITLSKLQKLQ 403 (979)
Q Consensus 325 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~-~L~L~~N~l~~~~~~~l~~l~~L~ 403 (979)
|++|++++|++|++..+.+..|.+ ..+|+++++.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~--~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~ 300 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQ--KKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLR 300 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTT--CTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEE
T ss_pred cCCCeEEECCCCCcceecHhhhhC--CCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCC
Confidence 344444444444444443333322 124455555444 4444555666677776 777766 66666667777777777
Q ss_pred EEEecCcccCCCccccccCCCCCceEe
Q 002021 404 DLGLKDNKLEGSIPYDICNLAELYRLD 430 (979)
Q Consensus 404 ~L~L~~N~l~~~~p~~~~~l~~L~~L~ 430 (979)
.+++++|+++...+..|.++++|+.++
T Consensus 301 ~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 301 YVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EEEeCCCccCccchhhhcCCcchhhhc
Confidence 777777777666666677777777665
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-16 Score=158.71 Aligned_cols=134 Identities=27% Similarity=0.297 Sum_probs=112.4
Q ss_pred CceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCc
Q 002021 450 LRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYN 529 (979)
Q Consensus 450 L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 529 (979)
.+.+++++|+++.+|..+. ++|+.|++++|++++..+..|+.+++|+.|+|++|++++..+..|..+++|++|+|++|
T Consensus 9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 4567777777777775543 57888888888888777777888899999999999998777778889999999999999
Q ss_pred cccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCC
Q 002021 530 RLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 530 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
+|++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+++|.+|.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 99977777788999999999999999977777778899999999999999988774
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-16 Score=156.35 Aligned_cols=132 Identities=23% Similarity=0.241 Sum_probs=67.8
Q ss_pred CCCceEecCCCccc-ccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEec
Q 002021 424 AELYRLDLDGNKLS-GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDL 502 (979)
Q Consensus 424 ~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 502 (979)
++|++|++++|+++ +.+|..+..+++|++|++++|.++.+ ..+..+++|+.|++++|++++.+|..+..+++|+.|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 44555555555554 44455555555555555555555544 34444555555555555555444444444555555555
Q ss_pred cCCccCcccc-hhhcCCcccceeecCCccccCCCC---Cccccccccccccccccccc
Q 002021 503 SRNNFSGVIP-TEIGGLKNLEYLFLGYNRLQGSIP---NSFGDLISLKFLNLSNNNLS 556 (979)
Q Consensus 503 s~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~ 556 (979)
++|++++..+ ..+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 5555554321 445555555555555555553322 24555555555555555554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=157.05 Aligned_cols=131 Identities=21% Similarity=0.234 Sum_probs=67.3
Q ss_pred CCCCeeeccCCccc-ccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCC
Q 002021 96 SSLQSLNLSFNRLF-GSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGN 174 (979)
Q Consensus 96 ~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~ 174 (979)
++|++|+|++|+++ +.+|..+..+++|++|+|++|++++. ..++.+++|++|+|++|.+++. +|..++.
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~--------~~~~~~~ 93 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG--------LDMLAEK 93 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSC--------CCHHHHH
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchH--------HHHHHhh
Confidence 45556666666555 45555555555555555555555543 4455555555555555555432 3444444
Q ss_pred CCccceeecccccccccc-cccccCCCCCCceecCCCeeeecCC---ccccccCccceeeccCCCC
Q 002021 175 LPELELMSLAANNLQGKI-PLKIGNLRNLEKLDIGDNKLVGIAP---IAIFNVSTLKILGLQDNSL 236 (979)
Q Consensus 175 l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~L~~N~l 236 (979)
+++|++|+|++|.+++.. +..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+
T Consensus 94 l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 94 LPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred CCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 555555555555555321 1445555555555555555554433 2344444444444444443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=7.5e-16 Score=155.57 Aligned_cols=128 Identities=23% Similarity=0.299 Sum_probs=111.2
Q ss_pred ceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCc
Q 002021 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNN 506 (979)
Q Consensus 427 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 506 (979)
+.+++++|.++ .+|..+. ++|++|+|++|+|+.+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 56788888887 4555443 57888999999999888888889999999999999998888889999999999999999
Q ss_pred cCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccc
Q 002021 507 FSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSG 557 (979)
Q Consensus 507 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 557 (979)
|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 998888899999999999999999997667789999999999999999974
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.9e-16 Score=153.00 Aligned_cols=126 Identities=20% Similarity=0.243 Sum_probs=57.7
Q ss_pred CCCCeeeccCCccc-ccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCC
Q 002021 96 SSLQSLNLSFNRLF-GSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGN 174 (979)
Q Consensus 96 ~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~ 174 (979)
++|++|++++|+++ +.+|..+..+++|++|+|++|++++. ..++.+++|++|+|++|.+++. +|..++.
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~--------~~~~~~~ 86 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGG--------LEVLAEK 86 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSC--------THHHHHH
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccch--------HHHHhhh
Confidence 44445555555544 44444444444444444444444433 3444444555555555544432 2333334
Q ss_pred CCccceeeccccccccc-ccccccCCCCCCceecCCCeeeecCC---ccccccCccceeec
Q 002021 175 LPELELMSLAANNLQGK-IPLKIGNLRNLEKLDIGDNKLVGIAP---IAIFNVSTLKILGL 231 (979)
Q Consensus 175 l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~L 231 (979)
+++|++|++++|.+++. .+..++.+++|++|++++|++++..+ ..+..+++|+.|++
T Consensus 87 l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 147 (149)
T 2je0_A 87 CPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG 147 (149)
T ss_dssp CTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred CCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence 44444444444444432 22444455555555555555544433 23444444444443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=152.33 Aligned_cols=134 Identities=23% Similarity=0.251 Sum_probs=97.0
Q ss_pred CccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCcc
Q 002021 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSF 139 (979)
Q Consensus 60 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 139 (979)
|+|.+|.|.. ++++ .+|..+ .++|++|++++|++++..|..+..+++|++|+|++|++++..+..
T Consensus 7 C~~~~l~~~~------------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 71 (177)
T 2o6r_A 7 CSGTEIRCNS------------KGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV 71 (177)
T ss_dssp EETTEEECCS------------SCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred eCCCEEEecC------------CCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence 7888888853 3454 345433 368889999998888666666778888888888888888766666
Q ss_pred ccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecC
Q 002021 140 ISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIA 216 (979)
Q Consensus 140 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 216 (979)
++++++|++|+|++|.+++. .+..++.+++|++|+|++|++++..+..+..+++|++|+|++|.+.+..
T Consensus 72 ~~~l~~L~~L~l~~N~l~~~--------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 72 FDKLTKLTILYLHENKLQSL--------PNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp TTTCTTCCEEECCSSCCCCC--------CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ccCCCccCEEECCCCCcccc--------CHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 78888888888888887743 3344677777777777777777655555677777777777777776543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.1e-16 Score=150.56 Aligned_cols=127 Identities=24% Similarity=0.259 Sum_probs=59.1
Q ss_pred CCCceEecCCCccc-ccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEec
Q 002021 424 AELYRLDLDGNKLS-GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDL 502 (979)
Q Consensus 424 ~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 502 (979)
++|+.|++++|.++ +.+|..+..+++|++|++++|+++.+ ..+..+++|+.|++++|.+++.+|..++.+++|+.|++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 44555555555555 44555555555555555555555544 33444444444444444444434444444444444444
Q ss_pred cCCccCcc-cchhhcCCcccceeecCCccccCCCC---Ccccccccccccccc
Q 002021 503 SRNNFSGV-IPTEIGGLKNLEYLFLGYNRLQGSIP---NSFGDLISLKFLNLS 551 (979)
Q Consensus 503 s~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls 551 (979)
++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.||++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 44444432 22444444444444444444443222 234444444444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.62 E-value=6e-15 Score=166.35 Aligned_cols=245 Identities=13% Similarity=0.141 Sum_probs=170.0
Q ss_pred ccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCC
Q 002021 322 LSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQK 401 (979)
Q Consensus 322 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 401 (979)
|.++ +|+.+++..| +..+....|.. .+|+.+.+.+ .++.+.+..|.++++|+.+++.+|+++.+....|. ..+
T Consensus 132 F~~~-~L~~i~l~~~-i~~I~~~aF~~---~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~ 204 (401)
T 4fdw_A 132 FRNS-QIAKVVLNEG-LKSIGDMAFFN---STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAG 204 (401)
T ss_dssp TTTC-CCSEEECCTT-CCEECTTTTTT---CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCC
T ss_pred cccC-CccEEEeCCC-ccEECHHhcCC---CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecc
Confidence 4443 4566665544 55554444443 2466676664 55556667788888888888888888877777776 478
Q ss_pred CcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccc-cccCcCCCcEEEecc
Q 002021 402 LQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSS 480 (979)
Q Consensus 402 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~ls~ 480 (979)
|+.+.+..+ +.......|.++++|+.+++..| ++.....+|.+ .+|+.+.+ .|.++.++. .|.++++|+.+.+.+
T Consensus 205 L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~ 280 (401)
T 4fdw_A 205 IEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYG 280 (401)
T ss_dssp CSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEES
T ss_pred cCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCC
Confidence 888888744 66566677788888888888765 55566667777 67888888 455777754 577788888888877
Q ss_pred cccc-----CCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccc
Q 002021 481 NFLT-----GSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNL 555 (979)
Q Consensus 481 N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 555 (979)
|.+. ...+..|.++.+|+.++|. |.++.+...+|.++++|+.+.|..| ++...+.+|.++ +|+.+++++|.+
T Consensus 281 ~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 281 STFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp SCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred ccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 7664 3455677777788888887 4466666677777788888888554 665556777777 788888888877
Q ss_pred cccCCccccCcc-ccCeEeccCCccc
Q 002021 556 SGVIPASLEKLS-YLEDLNLSFNQLE 580 (979)
Q Consensus 556 ~~~~p~~~~~l~-~L~~L~L~~N~l~ 580 (979)
....+..|..++ .+..|++..|.+.
T Consensus 358 ~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 358 PQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cccccccccCCCCCccEEEeCHHHHH
Confidence 766666777764 5677777666543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3e-16 Score=172.26 Aligned_cols=137 Identities=15% Similarity=0.165 Sum_probs=100.5
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccccc--------------chhc--------HHHHHHHHHhcCCCC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR--------------AFKS--------FDVECEIMKSIRHRN 739 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--------------~~~~--------~~~E~~~l~~l~h~n 739 (979)
.-|++.+.||+|+||.||+|...+|+.||||+++..... .... ..+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348889999999999999998889999999987532100 0001 134566666664433
Q ss_pred ee--eEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC
Q 002021 740 LI--KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 817 (979)
Q Consensus 740 iv--~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~ 817 (979)
+. ..++. ...++||||++|++|.++... +....++.|++.++.||| .+|||||||||.|||+++
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeC
Confidence 32 22222 123799999999888766432 234568899999999999 899999999999999987
Q ss_pred CC----------cEEEEeecccccc
Q 002021 818 NM----------VAHLSDFSIAKML 832 (979)
Q Consensus 818 ~~----------~~kl~Dfg~~~~~ 832 (979)
++ .+.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999987654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.5e-14 Score=163.22 Aligned_cols=242 Identities=12% Similarity=0.142 Sum_probs=128.7
Q ss_pred CCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCcccccccccc
Q 002021 274 KLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHS 353 (979)
Q Consensus 274 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~ 353 (979)
+|+.+++..| ++.+...+|.+. +|+.+.+.+ .++.++.. +|.+|++|+.++++.|.+..+....|. ..+
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~-----aF~~c~~L~~l~l~~n~l~~I~~~aF~---~~~ 204 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKED-----IFYYCYNLKKADLSKTKITKLPASTFV---YAG 204 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSS-----TTTTCTTCCEEECTTSCCSEECTTTTT---TCC
T ss_pred CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHH-----HhhCcccCCeeecCCCcceEechhhEe---ecc
Confidence 4555555444 444444555552 455555553 44444332 355566666666666655555444443 135
Q ss_pred ccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCC
Q 002021 354 LEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDG 433 (979)
Q Consensus 354 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 433 (979)
|+.+.+.++ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++......|.++++|+.+++.+
T Consensus 205 L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~ 280 (401)
T 4fdw_A 205 IEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYG 280 (401)
T ss_dssp CSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEES
T ss_pred cCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCC
Confidence 566666533 55455566777777777777654 45555555655 56666666 3334444455556666666666655
Q ss_pred Cccc-----ccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccC
Q 002021 434 NKLS-----GSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFS 508 (979)
Q Consensus 434 N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 508 (979)
|.+. ...+.+|.++++|+.+.+. +.++.|+ ...|.++.+|+.++|..| ++
T Consensus 281 ~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~-----------------------~~aF~~c~~L~~l~lp~~-l~ 335 (401)
T 4fdw_A 281 STFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILG-----------------------QGLLGGNRKVTQLTIPAN-VT 335 (401)
T ss_dssp SCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEEC-----------------------TTTTTTCCSCCEEEECTT-CC
T ss_pred ccccCCcccEECHHHhhCCccCCeEEeC-CceEEEh-----------------------hhhhcCCCCccEEEECcc-cc
Confidence 5543 2334455555555555555 2344443 344555555555555333 44
Q ss_pred cccchhhcCCcccceeecCCccccCCCCCcccccc-ccccccccccccc
Q 002021 509 GVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLI-SLKFLNLSNNNLS 556 (979)
Q Consensus 509 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~ 556 (979)
.+.+.+|.++ +|+.+++++|.+....+..|.+++ +++.|.+..|.+.
T Consensus 336 ~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 336 QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 4445555555 566666666655544455555553 4555665555543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.4e-17 Score=165.72 Aligned_cols=155 Identities=23% Similarity=0.291 Sum_probs=76.5
Q ss_pred hhcCCCCcEEEecCcccCCCccc------cccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccC
Q 002021 396 LSKLQKLQDLGLKDNKLEGSIPY------DICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWN 469 (979)
Q Consensus 396 l~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~ 469 (979)
+.....++.++++.+.+.+..|. .+..+++|++|++++|++++ +| .+..+++|++|++++|+++.+|..+..
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~ 91 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAV 91 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhc
Confidence 44455555555555555554443 45555555555555555543 33 444455555555555555544444444
Q ss_pred cCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCC-Cccccccccccc
Q 002021 470 LKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP-NSFGDLISLKFL 548 (979)
Q Consensus 470 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L 548 (979)
+++|+.|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|
T Consensus 92 ------------------------~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L 145 (198)
T 1ds9_A 92 ------------------------ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL 145 (198)
T ss_dssp ------------------------HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred ------------------------CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEE
Confidence 4444444444444443 22 34445555555555555543211 244455555555
Q ss_pred ccccccccccCCcc----------ccCccccCeEeccCCccc
Q 002021 549 NLSNNNLSGVIPAS----------LEKLSYLEDLNLSFNQLE 580 (979)
Q Consensus 549 ~Ls~N~l~~~~p~~----------~~~l~~L~~L~L~~N~l~ 580 (979)
++++|++++.+|.. +..+++|+.|+ +|+++
T Consensus 146 ~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred EecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 55555555443332 45556666554 55554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.2e-17 Score=166.75 Aligned_cols=144 Identities=24% Similarity=0.326 Sum_probs=116.4
Q ss_pred ccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccce
Q 002021 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVG 499 (979)
Q Consensus 420 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 499 (979)
+.....++.++++.|.+.+..| .++.+|..+..+++|+.|++++|.+++ +| .+..+++|+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~-----------------~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~ 74 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIP-----------------PIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRI 74 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCT-----------------TCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCE
T ss_pred HHhcccccCcchheeEeccccC-----------------cHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCE
Confidence 4455667777777777765443 344556667777778888888888876 55 7788888888
Q ss_pred EeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCC-ccccCccccCeEeccCCc
Q 002021 500 IDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIP-ASLEKLSYLEDLNLSFNQ 578 (979)
Q Consensus 500 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~ 578 (979)
|++++|+++ .+|..+..+++|++|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|+.|++++|+
T Consensus 75 L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~ 151 (198)
T 1ds9_A 75 LSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp EEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred EECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence 999999888 567888889999999999999996 55 69999999999999999996433 578999999999999999
Q ss_pred ccccCCC
Q 002021 579 LEGKIPR 585 (979)
Q Consensus 579 l~~~~p~ 585 (979)
+++.+|.
T Consensus 152 l~~~~~~ 158 (198)
T 1ds9_A 152 LYNDYKE 158 (198)
T ss_dssp HHHHHHT
T ss_pred ccccccc
Confidence 9998775
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-15 Score=150.11 Aligned_cols=129 Identities=18% Similarity=0.161 Sum_probs=66.4
Q ss_pred CCcCceEecCCCccccccccccCc-CCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceee
Q 002021 447 LTSLRIVSLGSNELTSIPLTFWNL-KDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLF 525 (979)
Q Consensus 447 l~~L~~L~L~~N~l~~lp~~~~~l-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 525 (979)
+++|++|++++|+++.+|. +..+ ++|+.|++++|.+++. ..++.+++|+.|+|++|+|++..+..|..+++|++|+
T Consensus 18 ~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 3344444444444444332 2222 2444444444444432 3445555555555555555544444445566666666
Q ss_pred cCCccccCCCCC--cccccccccccccccccccccCCcc----ccCccccCeEeccCCccc
Q 002021 526 LGYNRLQGSIPN--SFGDLISLKFLNLSNNNLSGVIPAS----LEKLSYLEDLNLSFNQLE 580 (979)
Q Consensus 526 Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 580 (979)
|++|+|+ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.|++++|...
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 6666664 3443 5556666666666666665 33432 556666666666666554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.1e-13 Score=156.73 Aligned_cols=80 Identities=21% Similarity=0.210 Sum_probs=43.2
Q ss_pred cccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccc
Q 002021 489 LEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSY 568 (979)
Q Consensus 489 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 568 (979)
..|.++.+|+.++|..+ ++.+...+|.++++|+.+++..| ++.....+|.++++|+.+++..+ ++ .+...|.++++
T Consensus 314 ~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~ 389 (394)
T 4fs7_A 314 EAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTK 389 (394)
T ss_dssp TTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCE
T ss_pred hhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCC
Confidence 34455555555555432 44444555666666666666555 44344556666666666666544 22 23445666666
Q ss_pred cCeE
Q 002021 569 LEDL 572 (979)
Q Consensus 569 L~~L 572 (979)
|+.+
T Consensus 390 L~~I 393 (394)
T 4fs7_A 390 FKWI 393 (394)
T ss_dssp EEEE
T ss_pred CcEE
Confidence 6543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=8.4e-15 Score=145.70 Aligned_cols=133 Identities=19% Similarity=0.203 Sum_probs=94.4
Q ss_pred ccCCCCCceEecCCCcccccCCccccCCC-cCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccc
Q 002021 420 ICNLAELYRLDLDGNKLSGSIPACFSNLT-SLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLV 498 (979)
Q Consensus 420 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 498 (979)
+.++.+|+.|++++|+++. ++. +..+. +|++|++++|+++.+ ..+..+++|+.|++++|++++..+..++.+++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 4555666666666666663 333 33333 677777777777766 4666677777777777777755444457778888
Q ss_pred eEeccCCccCcccch--hhcCCcccceeecCCccccCCCCCc----ccccccccccccccccccc
Q 002021 499 GIDLSRNNFSGVIPT--EIGGLKNLEYLFLGYNRLQGSIPNS----FGDLISLKFLNLSNNNLSG 557 (979)
Q Consensus 499 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~ 557 (979)
.|+|++|+|+ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.||+++|.+..
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 8888888886 4454 7888888889999999888 55664 8888999999999988763
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.6e-13 Score=152.56 Aligned_cols=197 Identities=15% Similarity=0.109 Sum_probs=137.4
Q ss_pred cccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcC
Q 002021 371 EISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSL 450 (979)
Q Consensus 371 ~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 450 (979)
.|.++++|+.+.+..| ++.+....|.++..|+.+.+..+... +...+....+|+.+.+..+ ++......|.++..|
T Consensus 180 ~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l 255 (394)
T 4fs7_A 180 LFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDL 255 (394)
T ss_dssp TTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSC
T ss_pred cccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccc
Confidence 3445555555555444 34444455555666666555544332 2333344456777776543 333555677778888
Q ss_pred ceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCcc
Q 002021 451 RIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNR 530 (979)
Q Consensus 451 ~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 530 (979)
+.+.+..+..+--...|..+..++.+....+.+. ...|..+.+|+.+.+..+ ++.+...+|.++++|+.++|.++
T Consensus 256 ~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~- 330 (394)
T 4fs7_A 256 ESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL- 330 (394)
T ss_dssp CEEEECCTTCEECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-
T ss_pred eeEEcCCCcceeeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-
Confidence 8888877654433446777788888877766543 346788899999999765 66677788999999999999755
Q ss_pred ccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCC
Q 002021 531 LQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577 (979)
Q Consensus 531 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 577 (979)
++.+...+|.++.+|+.+++..| ++.+-..+|.++++|+.+++..|
T Consensus 331 v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 331 VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 77566789999999999999887 77777889999999999998754
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=2.9e-14 Score=140.67 Aligned_cols=90 Identities=22% Similarity=0.235 Sum_probs=54.8
Q ss_pred cccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEec
Q 002021 495 KVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNL 574 (979)
Q Consensus 495 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 574 (979)
.+|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 44555555555555555556666666666666666666555555566666666666666666555555666666666666
Q ss_pred cCCcccccCC
Q 002021 575 SFNQLEGKIP 584 (979)
Q Consensus 575 ~~N~l~~~~p 584 (979)
++|+|+|..+
T Consensus 110 ~~N~~~c~c~ 119 (170)
T 3g39_A 110 LNNPWDCACS 119 (170)
T ss_dssp CSSCBCTTBG
T ss_pred CCCCCCCCch
Confidence 6666666554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=5.7e-14 Score=138.59 Aligned_cols=108 Identities=24% Similarity=0.218 Sum_probs=89.7
Q ss_pred CceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCc
Q 002021 450 LRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYN 529 (979)
Q Consensus 450 L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 529 (979)
.+.+++++|+++++|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 4677778888887776653 67888888888888877888888888999999999998887778888999999999999
Q ss_pred cccCCCCCcccccccccccccccccccccC
Q 002021 530 RLQGSIPNSFGDLISLKFLNLSNNNLSGVI 559 (979)
Q Consensus 530 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 559 (979)
+|++..+..|..+++|++|+|++|.++...
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 998777777888999999999999888543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=6.8e-14 Score=138.50 Aligned_cols=90 Identities=22% Similarity=0.307 Sum_probs=47.8
Q ss_pred cccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEec
Q 002021 495 KVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNL 574 (979)
Q Consensus 495 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 574 (979)
.+|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34444555555555444555555555555555555555444444455555555555555555444444555555555555
Q ss_pred cCCcccccCC
Q 002021 575 SFNQLEGKIP 584 (979)
Q Consensus 575 ~~N~l~~~~p 584 (979)
++|+|.+..+
T Consensus 113 ~~N~~~c~~~ 122 (174)
T 2r9u_A 113 YNNPWDCECR 122 (174)
T ss_dssp CSSCBCTTBG
T ss_pred CCCCcccccc
Confidence 5555555433
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=7.7e-14 Score=138.10 Aligned_cols=106 Identities=24% Similarity=0.225 Sum_probs=86.5
Q ss_pred ceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCcc
Q 002021 451 RIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNR 530 (979)
Q Consensus 451 ~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 530 (979)
+.+++++|+++++|..+. ++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 567777777777777654 678888888888888778888888888888888888887777778888888888998888
Q ss_pred ccCCCCCccccccccccccccccccccc
Q 002021 531 LQGSIPNSFGDLISLKFLNLSNNNLSGV 558 (979)
Q Consensus 531 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 558 (979)
|++..+..|..+++|++|+|++|++...
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred cceeCHHHhccccCCCEEEeCCCCcccc
Confidence 8866666688888899999999988743
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=9e-13 Score=146.63 Aligned_cols=102 Identities=20% Similarity=0.190 Sum_probs=58.6
Q ss_pred EecCCC-ccccccccccCcCCCcEEEecc-ccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCcc
Q 002021 453 VSLGSN-ELTSIPLTFWNLKDILNLNFSS-NFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNR 530 (979)
Q Consensus 453 L~L~~N-~l~~lp~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 530 (979)
++++++ +|+.+|. +..+++|+.|+|++ |+|++..+..|+.+.+|+.|+|++|+|++.+|..|.++++|++|+|++|+
T Consensus 13 v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 13 LRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp EECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 455554 5555555 55555555555553 55555555555666666666666666666555666666666666666666
Q ss_pred ccCCCCCccccccccccccccccccc
Q 002021 531 LQGSIPNSFGDLISLKFLNLSNNNLS 556 (979)
Q Consensus 531 l~~~~p~~~~~l~~L~~L~Ls~N~l~ 556 (979)
|++..+..|..++ |+.|+|++|.+.
T Consensus 92 l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 92 LESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred cceeCHHHcccCC-ceEEEeeCCCcc
Confidence 6644444444444 666666666655
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=6.1e-14 Score=156.55 Aligned_cols=61 Identities=16% Similarity=0.130 Sum_probs=27.9
Q ss_pred CCCceEecCCCcccccCCccc-----cCCCcCceEecCCCcccc-----ccccccCcCCCcEEEecccccc
Q 002021 424 AELYRLDLDGNKLSGSIPACF-----SNLTSLRIVSLGSNELTS-----IPLTFWNLKDILNLNFSSNFLT 484 (979)
Q Consensus 424 ~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~-----lp~~~~~l~~L~~L~ls~N~l~ 484 (979)
++|+.|+|++|+|+......+ ...++|++|+|++|.|+. ++..+...++|++|+|++|.|+
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 345555555555543322222 123455566666655543 2222334444444444444443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=5.9e-14 Score=156.67 Aligned_cols=17 Identities=12% Similarity=-0.041 Sum_probs=8.2
Q ss_pred cCCCCccEEEccCCCCc
Q 002021 323 SNCKFLKYFDLSYNPLY 339 (979)
Q Consensus 323 ~~l~~L~~L~Ls~N~l~ 339 (979)
..+++|++|+|++|.+.
T Consensus 180 ~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp HTCSSCCEEECTTSSCH
T ss_pred hcCCCcCEEeCCCCCCC
Confidence 34444555555555443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.32 E-value=6.8e-11 Score=133.73 Aligned_cols=332 Identities=16% Similarity=0.166 Sum_probs=160.7
Q ss_pred cccccCCC-CCCceecCCCeeeecCCccccccCccceeeccCCCCcCC--CcccccCCCCCcCEEEccCCccccccCccc
Q 002021 193 PLKIGNLR-NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGC--LSSIGYARLPNLEILSLWGNNFSGTIPRFI 269 (979)
Q Consensus 193 p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l 269 (979)
..+|.+.. .|+.+.+-.+ ++.+...+|.++++|+.+.++.|.-+.+ +...+|..+.+|+.+.+..+ ++......|
T Consensus 56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF 133 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF 133 (394)
T ss_dssp TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence 44566653 4777777644 6666677777777777777766542211 22334555555555554433 222333444
Q ss_pred ccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCcccccc
Q 002021 270 FNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGN 349 (979)
Q Consensus 270 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 349 (979)
..+.+|+.+.+..+ +..+....|.++.+|+.+.+.++ +..+....|..
T Consensus 134 ~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~------------------------------~~~I~~~aF~~- 181 (394)
T 4gt6_A 134 HHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS------------------------------VTAIEERAFTG- 181 (394)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT------------------------------CCEECTTTTTT-
T ss_pred hhhcccccccccce-eeeecccceecccccccccccce------------------------------eeEeccccccc-
Confidence 44555555555432 22233344444444444444332 22232222211
Q ss_pred ccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceE
Q 002021 350 LSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRL 429 (979)
Q Consensus 350 l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 429 (979)
..|+.+.+..+-. ......|..+.+++......+.........+........ ....+.....+..+
T Consensus 182 --~~l~~i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~ 247 (394)
T 4gt6_A 182 --TALTQIHIPAKVT-RIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDY-----------ALIRYPSQREDPAF 247 (394)
T ss_dssp --CCCSEEEECTTCC-EECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCE-----------EEEECCTTCCCSEE
T ss_pred --cceeEEEECCccc-ccccchhhhccccceecccccccccccceeecccccccc-----------cccccccccccceE
Confidence 2344444433221 133445666666666665554433211111111000000 00011112223333
Q ss_pred ecCCCcccccCCccccCCCcCceEecCCCcccccc-ccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccC
Q 002021 430 DLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP-LTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFS 508 (979)
Q Consensus 430 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 508 (979)
.+. +.+......+|.++.+|+.+.+.++.. .++ ..|.++.+|+.+.+. +.++......|.++.+|+.++|..+ ++
T Consensus 248 ~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~ 323 (394)
T 4gt6_A 248 KIP-NGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT 323 (394)
T ss_dssp ECC-TTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC
T ss_pred EcC-CcceEcccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc
Confidence 332 223334455666666677666654433 333 245566666666664 3444444556677777777777644 55
Q ss_pred cccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCccc
Q 002021 509 GVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLE 580 (979)
Q Consensus 509 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 580 (979)
.+...+|.++.+|+.+.+..+ ++.+...+|.++++|+.+++.+|.... ..+.....|+.+.+..|.++
T Consensus 324 ~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 324 QILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp EECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred EehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 455667777777777777544 554555677777777777777765431 34556666777766665543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.29 E-value=9.7e-11 Score=132.48 Aligned_cols=115 Identities=13% Similarity=0.124 Sum_probs=62.9
Q ss_pred ccccCCccccCCC-CCcEEEccCCccCchhhhhhhccCCcccCCCCccceeeccccc---ccccccccccCCCCCCceec
Q 002021 132 LSGTFPSFISNKS-SLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANN---LQGKIPLKIGNLRNLEKLDI 207 (979)
Q Consensus 132 l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~L 207 (979)
++.+...+|.+++ .|+.+.+..+ ++.. -..+|.++++|+.+.+..|. ++..-..+|.++.+|+.+.+
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~I--------g~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~ 121 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEI--------GSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPI 121 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEE--------CTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGG
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEE--------hHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeecc
Confidence 3434455677764 5888887654 3321 13467777777777776653 44333455666666666666
Q ss_pred CCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccC
Q 002021 208 GDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWG 258 (979)
Q Consensus 208 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~ 258 (979)
..+ ++.+...+|.++.+|+.+.+..+. .. .....|..+.+|+.+.+..
T Consensus 122 ~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~~-I~~~~F~~c~~L~~i~~~~ 169 (394)
T 4gt6_A 122 LDS-VTEIDSEAFHHCEELDTVTIPEGV-TS-VADGMFSYCYSLHTVTLPD 169 (394)
T ss_dssp GTT-CSEECTTTTTTCTTCCEEECCTTC-CE-ECTTTTTTCTTCCEEECCT
T ss_pred CCc-cceehhhhhhhhccccccccccee-ee-ecccceecccccccccccc
Confidence 543 444555556666666666654332 11 1222345555555555543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=4.5e-12 Score=140.96 Aligned_cols=131 Identities=21% Similarity=0.228 Sum_probs=108.1
Q ss_pred cEEEeccc-cccCCCccccccccccceEeccC-CccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccc
Q 002021 474 LNLNFSSN-FLTGSLPLEIGSLKVLVGIDLSR-NNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLS 551 (979)
Q Consensus 474 ~~L~ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 551 (979)
..++.+++ +|++ +|. +..+.+|+.|+|++ |+|++..|..|+++++|+.|+|++|+|++..|..|.+|++|+.|||+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35788888 8985 777 99999999999996 99999988999999999999999999999999999999999999999
Q ss_pred cccccccCCccccCccccCeEeccCCcccccCCCCCCCCCc---ccccccCCccccCCCC
Q 002021 552 NNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNF---SAQSFEGNELLCGSPN 608 (979)
Q Consensus 552 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~---~~~~~~~N~~~c~~p~ 608 (979)
+|+|++..+..|..++ |+.|+|++|+|.+...- .+|..+ ....+..+...|..|.
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l-~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCAL-RWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGG-HHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCCcc-HHHHHHHHhCcccccccCCCCCCCh
Confidence 9999987777777777 99999999999986542 111111 1223445667776653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.4e-11 Score=129.22 Aligned_cols=146 Identities=14% Similarity=0.074 Sum_probs=114.7
Q ss_pred HhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEE
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 757 (979)
...++|.....++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34467877788888999999999764 6789999986533234467899999999985 677888999998888999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG--------------------------------------- 798 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------------------------------------- 798 (979)
||++|.++.+.+.. ......++.+++++++.||..
T Consensus 90 e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 90 SEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp ECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999998765321 123447889999999999941
Q ss_pred -----------------CCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 799 -----------------YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 799 -----------------~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
....++|+|+++.||+++++..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014589999999999998766677999987643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.1e-10 Score=123.83 Aligned_cols=129 Identities=17% Similarity=0.102 Sum_probs=99.0
Q ss_pred eeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCC--eeeEEEeeccCCeeEEEEEecCCCcccee
Q 002021 691 GRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN--LIKVISSCSNEEFKALVLEYMPHGSLEKY 768 (979)
Q Consensus 691 G~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 768 (979)
+.|..+.||++...+|+.++||+.... ....+.+|+++++.+++.+ +.+++++...++..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 455669999998777888999987543 3467889999999996544 455888888888899999999998884
Q ss_pred eccCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------
Q 002021 769 LYSSNCILDIFQRLNIMIDVASALEYLHFGY------------------------------------------------- 799 (979)
Q Consensus 769 l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------------- 799 (979)
... .+ ...++.++++.++.||...
T Consensus 104 ~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (264)
T 1nd4_A 104 SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 176 (264)
T ss_dssp TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence 211 12 2367888889999999311
Q ss_pred ------CCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 800 ------SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 800 ------~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
...++|+|++|.||+++++..+.++|||.+..
T Consensus 177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998877678999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.2e-08 Score=114.64 Aligned_cols=76 Identities=12% Similarity=0.104 Sum_probs=40.1
Q ss_pred cccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCc
Q 002021 489 LEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKL 566 (979)
Q Consensus 489 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 566 (979)
..|.++.+|+.+++.++.++.+...+|.++.+|+.+.|..+ ++.+-..+|.++.+|+.+.+..+ ++.+-..+|.+.
T Consensus 280 ~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 280 LLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred cccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 34555555555555555555444555555566666665533 44334455666666666666443 443444455444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.6e-08 Score=113.55 Aligned_cols=154 Identities=14% Similarity=0.161 Sum_probs=113.5
Q ss_pred cccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccc-cccCcCCCcEEEeccccccCCCcccccccccc
Q 002021 419 DICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVL 497 (979)
Q Consensus 419 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 497 (979)
.+.....+..+.+..+.. ......+....+|+.+.+..+ ++.++. .+.++..|+.+.+..+ ++......|.++.+|
T Consensus 189 ~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l 265 (379)
T 4h09_A 189 SYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTAL 265 (379)
T ss_dssp ECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred ccccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehh
Confidence 344444555555544332 244566677777888877654 454543 5667788888888765 555566778888899
Q ss_pred ceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCC
Q 002021 498 VGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577 (979)
Q Consensus 498 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 577 (979)
+.+++..+ ++......|.++++|+.+.+.++.++.....+|.++.+|+.++|..+ ++.+-..+|.++.+|+.+.+..+
T Consensus 266 ~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 266 KTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred cccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 99988654 66566778999999999999999998667789999999999999765 77677788999999999988654
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.1e-10 Score=128.95 Aligned_cols=216 Identities=14% Similarity=0.173 Sum_probs=106.8
Q ss_pred CCcEEEEEecCCCccc-cC-------CCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccC
Q 002021 71 SQRVTVLNISSLNLTG-TI-------PSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISN 142 (979)
Q Consensus 71 ~~~v~~l~l~~~~l~g-~~-------~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 142 (979)
..+|+.|.+....+.| .. .+++..+++|+.|.+.++.... ..++... .+.++..+..
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~--------------~~is~~~-~~~L~~ll~~ 170 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEE--------------QEISWIE-QVDLSPVLDA 170 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTT--------------CCGGGCB-CCBCHHHHHT
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhh--------------ccccccc-ccCHHHHHhc
Confidence 3467777777655543 21 2334556677777665543210 0000000 1123344555
Q ss_pred CCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeeccccccccccccccc--CCCCCCceecCC--CeeeecCCc
Q 002021 143 KSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIG--NLRNLEKLDIGD--NKLVGIAPI 218 (979)
Q Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~~p~ 218 (979)
+++|+.|+|++|. +. .+|. +. +++|+.|+|..+.++......++ .+++|++|+|+. |...+..
T Consensus 171 ~P~L~~L~L~g~~--~l-------~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~-- 237 (362)
T 2ra8_A 171 MPLLNNLKIKGTN--NL-------SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG-- 237 (362)
T ss_dssp CTTCCEEEEECCB--TC-------BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--
T ss_pred CCCCcEEEEeCCC--Cc-------eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--
Confidence 6666666666552 00 1333 22 55666666666655433333332 566666666642 1111100
Q ss_pred cccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccc---cCCCCcEEecccccccccc----Cc
Q 002021 219 AIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIF---NASKLSILDLEGNSFSGFI----PN 291 (979)
Q Consensus 219 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~~~----~~ 291 (979)
.+..+ . .......+|+|++|+|++|.+.+..+..+. .+++|++|+|+.|.+++.. +.
T Consensus 238 ~~~~l---~-------------~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~ 301 (362)
T 2ra8_A 238 DMNVF---R-------------PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLD 301 (362)
T ss_dssp CGGGT---G-------------GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHT
T ss_pred hHHHH---H-------------HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHh
Confidence 00000 0 000012456777777777766643333333 3567777777777776532 33
Q ss_pred cccccccccceeccccccccccchhhhhhcccC-CCCccEEEccCCC
Q 002021 292 TFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSN-CKFLKYFDLSYNP 337 (979)
Q Consensus 292 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~-l~~L~~L~Ls~N~ 337 (979)
.+..+++|+.|+|++|.|+..... .+.. + ...++++.++
T Consensus 302 ~L~~l~~L~~L~L~~n~i~d~~~~-----~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 302 HVDKIKHLKFINMKYNYLSDEMKK-----ELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp THHHHTTCSEEECCSBBCCHHHHH-----HHHHHC--CSEEECCSBC
T ss_pred hcccCCcceEEECCCCcCCHHHHH-----HHHHHc--CCEEEecCCc
Confidence 345567788888888877653322 1221 1 3567888776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.2e-09 Score=119.72 Aligned_cols=142 Identities=11% Similarity=0.163 Sum_probs=107.6
Q ss_pred CCceeeeecceEEEEEEcCCCcEEEEEEec--ccc-ccchhcHHHHHHHHHhcC--CCCeeeEEEeeccC---CeeEEEE
Q 002021 686 ENNLIGRGGFGSVYKASLGDGMEVAVKVFT--SQC-GRAFKSFDVECEIMKSIR--HRNLIKVISSCSNE---EFKALVL 757 (979)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 757 (979)
..+.++.|.++.||+.+..+ ..+++|+.. ... ......+.+|+++++.++ +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998754 578888875 322 123457889999999997 45678888888766 5589999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY-------------------------------------- 799 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 799 (979)
||++|..+.+... ..++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9999988855221 23678888999999999999999420
Q ss_pred -----------------CCCeEecCCCCCCEEeCCCCc--EEEEeeccccc
Q 002021 800 -----------------SAPVIHCDLKPSNVLLDDNMV--AHLSDFSIAKM 831 (979)
Q Consensus 800 -----------------~~~i~H~Dik~~NIll~~~~~--~kl~Dfg~~~~ 831 (979)
...++|+|+++.||+++.++. +.++||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 68999998864
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.1e-11 Score=129.65 Aligned_cols=146 Identities=18% Similarity=0.236 Sum_probs=70.2
Q ss_pred CCccceeEeeCCCCcEEEEEecC---CCccccCCC-CCcCCCCCCeeeccCCcccccCCc-cccccCcccE--Eeccccc
Q 002021 59 VCNWTGVACEVHSQRVTVLNISS---LNLTGTIPS-QLGNLSSLQSLNLSFNRLFGSIPS-AIFTTYTLKY--VCLRGNQ 131 (979)
Q Consensus 59 ~c~w~gv~c~~~~~~v~~l~l~~---~~l~g~~~~-~l~~l~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~--L~L~~n~ 131 (979)
.|+|.|+.|+....+|+.+-..+ ..+.|.+++ .+..++. .|...+|.-++.++- .+...+.|+. ++++.|+
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 48999999998777887766554 234444442 2223322 233333333333221 1333334443 4555553
Q ss_pred cc---ccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCC--CCCcee
Q 002021 132 LS---GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLR--NLEKLD 206 (979)
Q Consensus 132 l~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~ 206 (979)
.. +.++....++++|+.|+||+|.|++. ..+|..++.+++|+.|+|++|+|++. ..+..+. +|++|+
T Consensus 155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l------~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~ 226 (267)
T 3rw6_A 155 RSCMAATLRIIEENIPELLSLNLSNNRLYRL------DDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELW 226 (267)
T ss_dssp HHHHHHHHHHHHHHCTTCCEEECTTSCCCCC------GGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEE
T ss_pred HHHHHHHHHHHHhhCCCCCEEECCCCCCCCC------ccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEE
Confidence 22 22222223455666666666666542 12344444555555555555555532 1222222 455555
Q ss_pred cCCCeeee
Q 002021 207 IGDNKLVG 214 (979)
Q Consensus 207 Ls~N~l~~ 214 (979)
|++|.+.+
T Consensus 227 L~~Npl~~ 234 (267)
T 3rw6_A 227 LDGNSLCD 234 (267)
T ss_dssp CTTSTTGG
T ss_pred ccCCcCcc
Confidence 55555443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.7e-10 Score=124.75 Aligned_cols=84 Identities=21% Similarity=0.229 Sum_probs=56.8
Q ss_pred cccccceEeccCCccCcccchhhc---CCcccceeecCCccccCC----CCCcccccccccccccccccccccCCccccC
Q 002021 493 SLKVLVGIDLSRNNFSGVIPTEIG---GLKNLEYLFLGYNRLQGS----IPNSFGDLISLKFLNLSNNNLSGVIPASLEK 565 (979)
Q Consensus 493 ~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 565 (979)
.+++|+.|+|++|.+....+..+. .+++|+.|+|+.|.|++. ++..+..+++|+.|+|++|.|+...-..+..
T Consensus 250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~ 329 (362)
T 2ra8_A 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329 (362)
T ss_dssp TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence 356788888888777654443433 477888888888888753 3455567788888999888887443333332
Q ss_pred -ccccCeEeccCCc
Q 002021 566 -LSYLEDLNLSFNQ 578 (979)
Q Consensus 566 -l~~L~~L~L~~N~ 578 (979)
+ ...+++++|+
T Consensus 330 al--g~~~~~~~~~ 341 (362)
T 2ra8_A 330 SL--PMKIDVSDSQ 341 (362)
T ss_dssp HC--CSEEECCSBC
T ss_pred Hc--CCEEEecCCc
Confidence 2 3568888887
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=4.9e-09 Score=113.87 Aligned_cols=184 Identities=18% Similarity=0.177 Sum_probs=123.3
Q ss_pred CceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCC--eeeEEEeeccCC---eeEEEEEec
Q 002021 687 NNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRN--LIKVISSCSNEE---FKALVLEYM 760 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~E~~ 760 (979)
.+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4679999999999864 45889986433 33567889999999884 322 334454443333 458999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG------------------------------------------ 798 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 798 (979)
+|.++.+.... .++.+++..++.++++.++.||..
T Consensus 99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99888653322 367788888999999999999841
Q ss_pred -------------CCCCeEecCCCCCCEEeCC--CCcEEEEeeccccccCCCCCcceecccccCCCC---CCccccCC--
Q 002021 799 -------------YSAPVIHCDLKPSNVLLDD--NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY---MAPEYGRE-- 858 (979)
Q Consensus 799 -------------~~~~i~H~Dik~~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-- 858 (979)
....++|+|+++.||++++ ...+.++||+.+..-.+...- . ....+ ..|+....
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl---~---~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF---I---SLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH---H---TTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH---H---HHHhhccccCHHHHHHHH
Confidence 0135899999999999998 566889999998653211000 0 00011 12221110
Q ss_pred ---CC---------CCCchhHHHHHHHHHHHHcCCCCCc
Q 002021 859 ---GR---------VSANGDVYSFGIMLMETFTGKKPTD 885 (979)
Q Consensus 859 ---~~---------~~~~~DvwslG~il~el~tg~~P~~ 885 (979)
+. .....+.|+++.++|.+.+|..+|.
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00 1112589999999999999998753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.72 E-value=6.7e-10 Score=110.80 Aligned_cols=123 Identities=16% Similarity=0.154 Sum_probs=69.7
Q ss_pred cCCCCCcCCCCCCeeeccCC-ccccc----CCccccccCcccEEeccccccccc----CCccccCCCCCcEEEccCCccC
Q 002021 87 TIPSQLGNLSSLQSLNLSFN-RLFGS----IPSAIFTTYTLKYVCLRGNQLSGT----FPSFISNKSSLQHLDLSSNALS 157 (979)
Q Consensus 87 ~~~~~l~~l~~L~~L~L~~n-~~~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 157 (979)
.+...+...+.|++|+|++| .+... +...+...++|++|+|++|+++.. +...+...++|++|+|++|.|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34455667788888888887 77643 334445556677777777776542 2334444566777777777776
Q ss_pred chhhhhhhccCCcccCCCCccceeec--cccccccc----ccccccCCCCCCceecCCCeee
Q 002021 158 GEIRANICREIPREFGNLPELELMSL--AANNLQGK----IPLKIGNLRNLEKLDIGDNKLV 213 (979)
Q Consensus 158 ~~~~~~~~~~ip~~l~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 213 (979)
..+... +...+...+.|++|+| ++|.++.. +...+...++|++|+|++|.+.
T Consensus 107 ~~g~~~----l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGILA----LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHH----HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHH----HHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 543322 3334455555666666 55665532 2233333455555555555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.53 E-value=1.1e-08 Score=101.91 Aligned_cols=124 Identities=10% Similarity=0.068 Sum_probs=58.5
Q ss_pred ccccccCcccEEecccc-ccccc----CCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccc
Q 002021 114 SAIFTTYTLKYVCLRGN-QLSGT----FPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNL 188 (979)
Q Consensus 114 ~~~~~l~~L~~L~L~~n-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l 188 (979)
..+...++|++|+|++| .+... +...+...++|++|||++|.|+..+... +...+...+.|++|+|++|.|
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~----l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA----LAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH----HHHHHHHCSSCCEEECCSSCC
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHH----HHHHHHhCCCcCEEECcCCcC
Confidence 33444555666666666 55432 2333444555666666666655433221 222333344455555555555
Q ss_pred ccc----ccccccCCCCCCceec--CCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccc
Q 002021 189 QGK----IPLKIGNLRNLEKLDI--GDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS 262 (979)
Q Consensus 189 ~~~----~p~~~~~l~~L~~L~L--s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 262 (979)
+.. +...+...++|++|+| ++|.|.......+ ...+...++|++|+|++|.+.
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l---------------------~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEI---------------------ANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHH---------------------HHHHHHCSSCCEEECCCSSHH
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHH---------------------HHHHHhCCCcCEEeccCCCCC
Confidence 422 2333334444444444 4444443211111 112344567777777777765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.36 E-value=9.3e-08 Score=99.90 Aligned_cols=68 Identities=29% Similarity=0.346 Sum_probs=35.0
Q ss_pred cCCCCCCceecCCCeeeecC--CccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCcccccc
Q 002021 197 GNLRNLEKLDIGDNKLVGIA--PIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTI 265 (979)
Q Consensus 197 ~~l~~L~~L~Ls~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 265 (979)
.++++|++|+|++|+|+++. |..+..+++|+.|+|++|+|++...-..+..+ +|++|+|++|.+.+.+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~ 236 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTF 236 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGC
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCcccc
Confidence 45566666666666666632 34444555555555555555544222222222 4555555555554433
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.8e-06 Score=91.86 Aligned_cols=136 Identities=14% Similarity=0.117 Sum_probs=96.2
Q ss_pred CceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCC---CeeeEEEeec-cCCeeEEEEEecCC
Q 002021 687 NNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHR---NLIKVISSCS-NEEFKALVLEYMPH 762 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~ 762 (979)
.+.++.|....||+. |..++||+... ......+.+|+++++.+++. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 457889999999998 46688887532 23346788999999999752 3455666653 45667899999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-------------------------------------------- 798 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------------- 798 (979)
.++.+.... .++..+...++.++++.++.||..
T Consensus 98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 888653211 235555666666666666666621
Q ss_pred -------------CCCCeEecCCCCCCEEeCC---CCc-EEEEeeccccc
Q 002021 799 -------------YSAPVIHCDLKPSNVLLDD---NMV-AHLSDFSIAKM 831 (979)
Q Consensus 799 -------------~~~~i~H~Dik~~NIll~~---~~~-~kl~Dfg~~~~ 831 (979)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335699999999999997 455 48999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=3.1e-06 Score=93.96 Aligned_cols=144 Identities=11% Similarity=0.052 Sum_probs=94.2
Q ss_pred cee-eeecceEEEEEEcC-------CCcEEEEEEecccc---ccchhcHHHHHHHHHhcCC---CCeeeEEEeeccC---
Q 002021 688 NLI-GRGGFGSVYKASLG-------DGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRH---RNLIKVISSCSNE--- 750 (979)
Q Consensus 688 ~~l-G~G~~g~Vy~~~~~-------~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--- 750 (979)
+.| +.|....+|+.+.. +++.+++|+..... ......+.+|+++++.++. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999998653 26788999865432 1123678899999998853 3566788877655
Q ss_pred CeeEEEEEecCCCccceeeccC-----CCCCCHHHHHHHHHHHHHHHHHHhc----------------------------
Q 002021 751 EFKALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYLHF---------------------------- 797 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~---------------------------- 797 (979)
+..++||||++|.++.+.+... -..++.+++..++.++++.|+.||.
T Consensus 106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV 185 (357)
T ss_dssp SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence 4578999999998876532100 0012333333333444443333331
Q ss_pred --------------------------C-------CCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 798 --------------------------G-------YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 798 --------------------------~-------~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
. ....++|+|+.+.||+++++..+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 1 035789999999999999655579999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=3.5e-06 Score=89.45 Aligned_cols=136 Identities=16% Similarity=0.075 Sum_probs=98.5
Q ss_pred ceeeeecce-EEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEEEecCCCc
Q 002021 688 NLIGRGGFG-SVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGS 764 (979)
Q Consensus 688 ~~lG~G~~g-~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~g~ 764 (979)
+.+..|..| .||+... .++..++||+-... ....+.+|+..|+.+. +--+.++++++.+++..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 356666666 6998854 35677899986533 3456788999999885 3346678888888899999999999987
Q ss_pred cceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 002021 765 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG---------------------------------------------- 798 (979)
Q Consensus 765 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------------- 798 (979)
+.+..... ......+..++++.++.||..
T Consensus 107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 76654321 223345677777777777711
Q ss_pred ---------CCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 799 ---------YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 799 ---------~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
....++|+|+.+.||++++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012378999999999999887778999998754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.89 E-value=1e-06 Score=86.88 Aligned_cols=121 Identities=17% Similarity=0.177 Sum_probs=74.4
Q ss_pred CCCCCcCCCCCCeeeccCC-ccccc----CCccccccCcccEEecccccccccC----CccccCCCCCcEEEccCCccCc
Q 002021 88 IPSQLGNLSSLQSLNLSFN-RLFGS----IPSAIFTTYTLKYVCLRGNQLSGTF----PSFISNKSSLQHLDLSSNALSG 158 (979)
Q Consensus 88 ~~~~l~~l~~L~~L~L~~n-~~~~~----~p~~~~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~ 158 (979)
+...+.+-+.|++|+|++| ++... +-.++.....|+.|+|++|+|.... ...+..-+.|++|+|++|.|+.
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3344556678888888885 76532 4455666677888888888887533 3344456788888888888876
Q ss_pred hhhhhhhccCCcccCCCCccceeecccc---cccc----cccccccCCCCCCceecCCCee
Q 002021 159 EIRANICREIPREFGNLPELELMSLAAN---NLQG----KIPLKIGNLRNLEKLDIGDNKL 212 (979)
Q Consensus 159 ~~~~~~~~~ip~~l~~l~~L~~L~L~~N---~l~~----~~p~~~~~l~~L~~L~Ls~N~l 212 (979)
.+...++ +.+..-+.|++|+|++| .+.. .+...+..-+.|++|+++.|.+
T Consensus 113 ~Ga~ala----~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 113 ELLARLL----RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHH----HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHH----HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 6554333 34455566777777654 2332 2333444455666666665544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.82 E-value=6.1e-05 Score=80.54 Aligned_cols=79 Identities=15% Similarity=0.136 Sum_probs=58.1
Q ss_pred CCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCC---CCeeeEEEeeccCCeeEEEEEe
Q 002021 683 GFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH---RNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.+...+.+|.|..+.||+.+..||+.|.||+...........|..|++.|+.+.. -.+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3444678999999999999999999999998765444444568899999998842 2344455442 34789999
Q ss_pred cCCCcc
Q 002021 760 MPHGSL 765 (979)
Q Consensus 760 ~~~g~L 765 (979)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987644
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=3.8e-05 Score=86.39 Aligned_cols=75 Identities=17% Similarity=0.221 Sum_probs=49.9
Q ss_pred CceeeeecceEEEEEEcC-CCcEEEEEEeccccc-------cchhcHHHHHHHHHhcCC--CCee-eEEEeeccCCeeEE
Q 002021 687 NNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQCG-------RAFKSFDVECEIMKSIRH--RNLI-KVISSCSNEEFKAL 755 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l 755 (979)
.+.+|.|.++.||+++.. +++.|+||....... ...+.+..|+++++.+.. |..+ +++.+ +++..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999653 468899997653211 123456789999998742 4444 45544 3445689
Q ss_pred EEEecCCC
Q 002021 756 VLEYMPHG 763 (979)
Q Consensus 756 v~E~~~~g 763 (979)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.71 E-value=4.4e-05 Score=83.93 Aligned_cols=138 Identities=15% Similarity=0.143 Sum_probs=80.6
Q ss_pred ceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCC--CCeeeEEEe------eccCCeeEEEEEe
Q 002021 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH--RNLIKVISS------CSNEEFKALVLEY 759 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~------~~~~~~~~lv~E~ 759 (979)
+.|+.|..+.||+....+| .+++|+.... ......|+++++.+.. -.+.+++.. ....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566678999999977555 4899988642 2334456666666531 123333321 1235678899999
Q ss_pred cCCCccce--------------eeccC--CC-----------CCCHHHH-------------------------------
Q 002021 760 MPHGSLEK--------------YLYSS--NC-----------ILDIFQR------------------------------- 781 (979)
Q Consensus 760 ~~~g~L~~--------------~l~~~--~~-----------~l~~~~~------------------------------- 781 (979)
++|.++.. .++.. .. ...|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 01110 00 0122110
Q ss_pred HHHHHHHHHHHHHHhc----------CCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 782 LNIMIDVASALEYLHF----------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 782 ~~i~~~ia~~L~~LH~----------~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
..+..++..++++|+. .....++|+|+++.||+++.++.+.++||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666652 025789999999999999888899999999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.69 E-value=2.4e-05 Score=75.60 Aligned_cols=82 Identities=13% Similarity=0.133 Sum_probs=41.9
Q ss_pred cccEEEccCccccCCCCccccCCCcccEEEecCCC-CCchhHHhhhcC----CCCcEEEecCcc-cCCCccccccCCCCC
Q 002021 353 SLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNK-LNGSILITLSKL----QKLQDLGLKDNK-LEGSIPYDICNLAEL 426 (979)
Q Consensus 353 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~-l~~~~~~~l~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L 426 (979)
.|++|++++|.|+..--..+..+++|++|+|++|. +++.....++.+ ++|++|++++|. |+..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 35555555555554444455666666666666663 555555555543 245555555553 443222233344444
Q ss_pred ceEecCCC
Q 002021 427 YRLDLDGN 434 (979)
Q Consensus 427 ~~L~Ls~N 434 (979)
+.|+++++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 44444443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00026 Score=76.11 Aligned_cols=137 Identities=13% Similarity=0.097 Sum_probs=92.2
Q ss_pred CCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC---CCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 686 ENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR---HRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
..+.|+.|....+|+.+. ++..++||+.... ....+..|++.|+.+. ...+.+++++....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999986 4678889987532 2456888999999884 35678888888878889999999999
Q ss_pred Ccccee-----------eccCCC---------------------CCCHHHHH---HHH----------------HHHHHH
Q 002021 763 GSLEKY-----------LYSSNC---------------------ILDIFQRL---NIM----------------IDVASA 791 (979)
Q Consensus 763 g~L~~~-----------l~~~~~---------------------~l~~~~~~---~i~----------------~~ia~~ 791 (979)
..+..- ++.... .-+|.+.. ++. .+++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 765321 111100 11343221 111 111111
Q ss_pred -HHHHh-cCCCCCeEecCCCCCCEEeCCCCcEEEEeec
Q 002021 792 -LEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFS 827 (979)
Q Consensus 792 -L~~LH-~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg 827 (979)
.+.|. ......++|+|+.+.|++++.++ +.++||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22342 12356799999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.62 E-value=2.6e-05 Score=75.38 Aligned_cols=93 Identities=10% Similarity=0.115 Sum_probs=68.1
Q ss_pred CccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcc-cCCCccccccCC----CCCceEecCCCc-ccccCCc
Q 002021 369 PEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNK-LEGSIPYDICNL----AELYRLDLDGNK-LSGSIPA 442 (979)
Q Consensus 369 p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~~~ 442 (979)
|.....-.+|++||++++.++......+..+++|+.|+|++|. |++.--..+..+ ++|++|+|++|. |+...-.
T Consensus 54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~ 133 (176)
T 3e4g_A 54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII 133 (176)
T ss_dssp CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence 4433334579999999999998888888999999999999985 664444445554 368888888874 7765555
Q ss_pred cccCCCcCceEecCCCc-cc
Q 002021 443 CFSNLTSLRIVSLGSNE-LT 461 (979)
Q Consensus 443 ~~~~l~~L~~L~L~~N~-l~ 461 (979)
.+..+++|++|+++++. ++
T Consensus 134 ~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 134 ALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp HGGGCTTCCEEEEESCTTCC
T ss_pred HHhcCCCCCEEECCCCCCCC
Confidence 66777788888887763 44
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.51 E-value=2.5e-05 Score=76.99 Aligned_cols=71 Identities=18% Similarity=0.204 Sum_probs=34.2
Q ss_pred ccCCCCCcEEEccCC-ccCchhhhhhhccCCcccCCCCccceeeccccccccc----ccccccCCCCCCceecCCCeeee
Q 002021 140 ISNKSSLQHLDLSSN-ALSGEIRANICREIPREFGNLPELELMSLAANNLQGK----IPLKIGNLRNLEKLDIGDNKLVG 214 (979)
Q Consensus 140 l~~l~~L~~L~Ls~N-~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 214 (979)
+.+-+.|++|+|++| .|...+... +-+.+..-+.|+.|+|++|+|... +.+.+..-+.|++|+|++|+|..
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~----la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRS----LIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHH----HHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHH----HHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 344456666666664 555433322 223334445555555555555422 22223334555555555555553
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00068 Score=73.57 Aligned_cols=156 Identities=15% Similarity=0.143 Sum_probs=87.8
Q ss_pred ccHHHHHHhhCCCCC-----CceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCC--eeeEE
Q 002021 672 FSYLELCRATDGFSE-----NNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN--LIKVI 744 (979)
Q Consensus 672 ~~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 744 (979)
.+.+++......|.. .+.|+.|....+|+.+..+| .+++|+.... ...+.+..|+++++.++... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555555554 24566788899999977656 5889987652 22345677888888774222 22333
Q ss_pred Eee------ccCCeeEEEEEecCCCcccee--------------eccC----CC----CC---CHHHHHH----------
Q 002021 745 SSC------SNEEFKALVLEYMPHGSLEKY--------------LYSS----NC----IL---DIFQRLN---------- 783 (979)
Q Consensus 745 ~~~------~~~~~~~lv~E~~~~g~L~~~--------------l~~~----~~----~l---~~~~~~~---------- 783 (979)
... ...+..+++|||++|..+... ++.. .. .. .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 211 123567899999998765321 1110 00 01 1211100
Q ss_pred --HHHHHHHHHHHHhc----CCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 784 --IMIDVASALEYLHF----GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 784 --i~~~ia~~L~~LH~----~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
+...+.+.+++++. ....+++|+|+.+.||+++++..+.++||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113344555542 124579999999999999987666899998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00084 Score=72.09 Aligned_cols=131 Identities=15% Similarity=0.157 Sum_probs=80.2
Q ss_pred CCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCe-eeEEEeeccCCeeEEEEEec-C
Q 002021 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNL-IKVISSCSNEEFKALVLEYM-P 761 (979)
Q Consensus 684 ~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~ 761 (979)
+.-.+.|+.|....+|+. ..+++|+...... ......+|+.+++.+...++ .++++++. +.-++|+||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCC
Confidence 334678999999999998 4588898764322 22345678888888753333 45555543 3346899999 6
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF-------------------------------------------- 797 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~-------------------------------------------- 797 (979)
|.++...-.. .+..++.++++.|+.+|.
T Consensus 92 g~~l~~~~~~--------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 163 (301)
T 3dxq_A 92 AQTMSPEKFK--------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR 163 (301)
T ss_dssp CEECCHHHHH--------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred CccCCHhhHh--------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence 6555320000 000122333333333331
Q ss_pred ------CCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 798 ------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 798 ------~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
.....++|+|+.+.||+ .+++.+.++||..+..
T Consensus 164 ~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 164 SALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 11345899999999999 6667789999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0013 Score=72.60 Aligned_cols=140 Identities=14% Similarity=0.154 Sum_probs=83.9
Q ss_pred CceeeeecceEEEEEEcC--------CCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEE
Q 002021 687 NNLIGRGGFGSVYKASLG--------DGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 757 (979)
.+.+..|-...+|+.+.. +++.+++|+.... ........+|+++++.+. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777889999999764 3578999986332 223455678999998885 3333566766654 2899
Q ss_pred EecCCCcccee-e----------------ccC----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 002021 758 EYMPHGSLEKY-L----------------YSS----NCILD--IFQRLNIMIDVAS-------------------ALEYL 795 (979)
Q Consensus 758 E~~~~g~L~~~-l----------------~~~----~~~l~--~~~~~~i~~~ia~-------------------~L~~L 795 (979)
||++|.++..- + +.. ..... +.++.++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998766421 1 111 11122 3444444443322 12222
Q ss_pred h----c-CCCCCeEecCCCCCCEEeCCC----CcEEEEeeccccc
Q 002021 796 H----F-GYSAPVIHCDLKPSNVLLDDN----MVAHLSDFSIAKM 831 (979)
Q Consensus 796 H----~-~~~~~i~H~Dik~~NIll~~~----~~~kl~Dfg~~~~ 831 (979)
. . .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1 123578999999999999876 7899999988753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0012 Score=74.70 Aligned_cols=79 Identities=13% Similarity=0.106 Sum_probs=47.6
Q ss_pred CCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC-CCcceecccccCCCCCCccccCCC---CCCCchhHHHHHHHHH
Q 002021 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE-DQSMIQTQTLATIGYMAPEYGREG---RVSANGDVYSFGIMLM 875 (979)
Q Consensus 800 ~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ 875 (979)
...++|+|+++.||+++.++ ++++||+.+..-.+. +-...... -...|.+|+..... ......++.+....+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 77899999999999999876 999999988753211 00000000 01235555544211 1112345567777888
Q ss_pred HHHcCC
Q 002021 876 ETFTGK 881 (979)
Q Consensus 876 el~tg~ 881 (979)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0018 Score=70.64 Aligned_cols=139 Identities=10% Similarity=0.066 Sum_probs=74.5
Q ss_pred ceeeeecceE-EEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCC--CeeeEEEeeccCCeeEEEEEecCCCc
Q 002021 688 NLIGRGGFGS-VYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHR--NLIKVISSCSNEEFKALVLEYMPHGS 764 (979)
Q Consensus 688 ~~lG~G~~g~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~g~ 764 (979)
+.|+.|+... +|+.+..+|..+++|...... .+.+..|+++++.+... .+.+++.+..+.+ ++|||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4565565554 778766446777787654321 14456788888877422 3455666644443 68999997755
Q ss_pred cceeeccC-------------------------CCCCCHHHHH-------H-------------HHHHHHHHHHHHh---
Q 002021 765 LEKYLYSS-------------------------NCILDIFQRL-------N-------------IMIDVASALEYLH--- 796 (979)
Q Consensus 765 L~~~l~~~-------------------------~~~l~~~~~~-------~-------------i~~~ia~~L~~LH--- 796 (979)
+.+++... -..++..... . ....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54332110 0011111100 0 0001111222221
Q ss_pred cCCCCCeEecCCCCCCEEeCCC----CcEEEEeeccccc
Q 002021 797 FGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFSIAKM 831 (979)
Q Consensus 797 ~~~~~~i~H~Dik~~NIll~~~----~~~kl~Dfg~~~~ 831 (979)
......++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1125689999999999999875 6899999998865
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0018 Score=73.17 Aligned_cols=73 Identities=19% Similarity=0.233 Sum_probs=50.7
Q ss_pred CceeeeecceEEEEEEcCC--------CcEEEEEEeccccccchhcHHHHHHHHHhcCCCC-eeeEEEeeccCCeeEEEE
Q 002021 687 NNLIGRGGFGSVYKASLGD--------GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN-LIKVISSCSNEEFKALVL 757 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 757 (979)
.+.|+.|....||++...+ ++.+++|+.... ...+.+..|..+++.+...+ ..++++.+.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3578889999999997643 578999988432 11145567999998885333 3566776643 2899
Q ss_pred EecCCCcc
Q 002021 758 EYMPHGSL 765 (979)
Q Consensus 758 E~~~~g~L 765 (979)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987555
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0032 Score=71.36 Aligned_cols=75 Identities=15% Similarity=0.153 Sum_probs=50.3
Q ss_pred CceeeeecceEEEEEEcCC-CcEEEEEEeccccccchhcHHHHHHHHHhcCCCCe-eeEEEeeccCCeeEEEEEecCCCc
Q 002021 687 NNLIGRGGFGSVYKASLGD-GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHGS 764 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~g~ 764 (979)
.+.|+.|-...+|+....+ +..+++|+...... ..-...+|..+++.+...++ .++++++.. ..||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3578889999999998754 47888998754322 22233689999999965444 466776632 25999999865
Q ss_pred cc
Q 002021 765 LE 766 (979)
Q Consensus 765 L~ 766 (979)
+.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0008 Score=61.90 Aligned_cols=58 Identities=28% Similarity=0.379 Sum_probs=33.2
Q ss_pred eeecCCcccc-CCCCCcccccccccccccccccccccCCccccCccccCeEeccCCccccc
Q 002021 523 YLFLGYNRLQ-GSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGK 582 (979)
Q Consensus 523 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 582 (979)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|+|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~Cd 70 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCD 70 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeecc
Confidence 4455555554 12333221 2466666666666655555666666777777777776653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0052 Score=66.67 Aligned_cols=140 Identities=12% Similarity=0.115 Sum_probs=83.0
Q ss_pred ceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCC--eeeEEEe-----eccCCeeEEEEEec
Q 002021 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN--LIKVISS-----CSNEEFKALVLEYM 760 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~E~~ 760 (979)
..++ |....||+....+|+.+++|...... ...+.+..|..+++.++... +.+++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4576 88899999987778789999986431 23456777888888874222 3334433 11245567899999
Q ss_pred CCCcccee--------------ecc----C----CCCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 002021 761 PHGSLEKY--------------LYS----S----NCILDIFQR----------------------LNIMIDVASALEYLH 796 (979)
Q Consensus 761 ~~g~L~~~--------------l~~----~----~~~l~~~~~----------------------~~i~~~ia~~L~~LH 796 (979)
+|..+... ++. . ....++... ...+.+++..++-.-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 88655310 110 0 011222110 011112222222221
Q ss_pred c-CCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 797 F-GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 797 ~-~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1255688999999999999 4 899999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0022 Score=71.05 Aligned_cols=73 Identities=12% Similarity=0.222 Sum_probs=46.3
Q ss_pred ceeeeecceEEEEEEcCC---------CcEEEEEEeccccccchhcHHHHHHHHHhcCCCC-eeeEEEeeccCCeeEEEE
Q 002021 688 NLIGRGGFGSVYKASLGD---------GMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRN-LIKVISSCSNEEFKALVL 757 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 757 (979)
+.++.|....+|+....+ ++.+++|+...... .......|.++++.+...+ +.++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 467888889999997643 26888998754322 2234577999998885333 346665542 26899
Q ss_pred EecCCCcc
Q 002021 758 EYMPHGSL 765 (979)
Q Consensus 758 E~~~~g~L 765 (979)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.015 Score=63.24 Aligned_cols=67 Identities=12% Similarity=0.152 Sum_probs=44.2
Q ss_pred eecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCC---CCeeeEEEe------eccCCeeEEEEEecCC
Q 002021 692 RGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH---RNLIKVISS------CSNEEFKALVLEYMPH 762 (979)
Q Consensus 692 ~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~------~~~~~~~~lv~E~~~~ 762 (979)
.|....||+....+| .+++|+..... ...|+.+++.+.. |.+.+.+.. ....+..++||||++|
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYH------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSS------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCcc------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 334689999987677 89999875432 1357777776632 224444432 1235678899999998
Q ss_pred Ccc
Q 002021 763 GSL 765 (979)
Q Consensus 763 g~L 765 (979)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 766
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.17 E-value=0.0059 Score=56.04 Aligned_cols=37 Identities=24% Similarity=0.305 Sum_probs=28.4
Q ss_pred ccceEeccCCccCcccchhhcCCcccceeecCCcccc
Q 002021 496 VLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 532 (979)
Q Consensus 496 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 532 (979)
+|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4667777777777666777788888888888888775
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.14 E-value=0.011 Score=58.30 Aligned_cols=102 Identities=14% Similarity=0.063 Sum_probs=67.7
Q ss_pred ccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecc
Q 002021 764 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQ 843 (979)
Q Consensus 764 ~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 843 (979)
+|.+.+...+.+++++++|.++.|.+.+|.-.-. .+.-..+=+.|..|++..+|.|...+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 7888888778899999999999999999888721 11111233456888999999888764 1110
Q ss_pred cccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCC
Q 002021 844 TLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 883 (979)
Q Consensus 844 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P 883 (979)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122466888763 3456788999999999998875554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.77 E-value=0.025 Score=63.15 Aligned_cols=74 Identities=12% Similarity=0.210 Sum_probs=50.6
Q ss_pred CceeeeecceEEEEEEcCC--------CcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEE
Q 002021 687 NNLIGRGGFGSVYKASLGD--------GMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 757 (979)
.+.+..|-...+|+....+ ++.+++|+..... ...-+..+|.++++.+. +.-..++++.+. -+.||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567788899999997653 5789999865432 22334578999999885 333445555442 26899
Q ss_pred EecCCCcc
Q 002021 758 EYMPHGSL 765 (979)
Q Consensus 758 E~~~~g~L 765 (979)
||++|.++
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.57 E-value=0.099 Score=58.24 Aligned_cols=30 Identities=27% Similarity=0.380 Sum_probs=25.1
Q ss_pred CeEecCCCCCCEEe------CCCCcEEEEeeccccc
Q 002021 802 PVIHCDLKPSNVLL------DDNMVAHLSDFSIAKM 831 (979)
Q Consensus 802 ~i~H~Dik~~NIll------~~~~~~kl~Dfg~~~~ 831 (979)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998754
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.31 E-value=1 Score=31.64 Aligned_cols=25 Identities=20% Similarity=0.238 Sum_probs=9.8
Q ss_pred eeehhhhhhHHHHHHHHHHHHHHhH
Q 002021 627 ILLGIVLPLSTTFMIVVILLILRYR 651 (979)
Q Consensus 627 ~~~~iv~~~~~~~~~~~i~~~~~~r 651 (979)
|..+++.++++++++.++++++++|
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RR 37 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRR 37 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhh
Confidence 3344444344333333333343333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.44 E-value=4.3 Score=39.98 Aligned_cols=125 Identities=10% Similarity=0.159 Sum_probs=82.4
Q ss_pred CCCCeeeEEEeeccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 736 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 736 ~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
.||+.++. .+-.+++...+.++ .......|-.- ...+...+++++.+|+....+++ .-+|--+.|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~--~~~~~~~f~~i--k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYD--INDNHTPFDNI--KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEEC--CCTTSEEGGGG--GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEE--cCcccCCHHHH--HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEE
Confidence 58888876 44445555444444 33334444321 24788899999999999886666 33677799999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchH
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 894 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~ 894 (979)
+.++.+++.-.|+...+ +|. ..++..=.-.+=+++..+++++..|++...|...+
T Consensus 113 ~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~lel 167 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNLEL 167 (215)
T ss_dssp CTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCGGG
T ss_pred cCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChHhh
Confidence 99999999877764332 222 11222223346788888999999998766554433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 979 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-30 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-29 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-64
Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 26/282 (9%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
IG G FG+VYK +VAVK+ T+ + ++F E +++ RH N++ +
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
+ A+V ++ SL +L+ ++ + ++I A ++YLH +IH
Sbjct: 72 YST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY---GREGRVS 862
DLK +N+ L +++ + DF +A + + S Q +I +MAPE + S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 863 ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922
DVY+FGI+L E TG+ P I N + + +L +V
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------------- 234
Query: 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964
+ C + L EC + +R +I+ + + SL
Sbjct: 235 --RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-57
Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 26/277 (9%)
Query: 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI 741
+ +G G FG V+ +VAVK Q + +F E +MK ++H+ L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYS 800
++ + + E ++ EYM +GSL +L + + I L I + L++ +A + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
IH DL+ +N+L+ D + ++DF +A+++ +++ + I + APE G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 861 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920
+ DV+SFGI+L E T + +++ +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM----------------- 229
Query: 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
V + C ++ L C E P+ R + + L
Sbjct: 230 --VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (501), Expect = 3e-57
Identities = 69/313 (22%), Positives = 128/313 (40%), Gaps = 43/313 (13%)
Query: 672 FSYLELCRATDGFSEN---------NLIGRGGFGSVYKASL----GDGMEVAVKVFTSQ- 717
F++ + A F++ +IG G FG V L + VA+K S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 718 CGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 777
+ + F E IM H N+I + + ++ E+M +GSL+ +L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 778 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837
+ Q + ++ +A+ ++YL +H DL N+L++ N+V +SDF +++ L +
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 838 SMIQTQTL---ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 894
T L I + APE + + ++ DV+S+GI++ E + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER----------- 232
Query: 895 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIV 954
P M D ++D C S + L ++C + R +IV
Sbjct: 233 --------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 955 TKLLKIRDSLLRN 967
L D ++RN
Sbjct: 285 NTL----DKMIRN 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-57
Identities = 70/280 (25%), Positives = 119/280 (42%), Gaps = 24/280 (8%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
+ IG G FG V+ + +VA+K + + + F E E+M + H L+++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
C + LV E+M HG L YL + + L + +DV + YL A V
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSA 863
IH DL N L+ +N V +SDF + + + +DQ T T + + +PE R S+
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 864 NGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 923
DV+SFG+++ E F+ K E + ++ + + L S
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------RLYKPRLASTH----- 230
Query: 924 AKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
V+ + C E P+ R ++ +L +I +S
Sbjct: 231 --------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-55
Identities = 60/277 (21%), Positives = 116/277 (41%), Gaps = 24/277 (8%)
Query: 684 FSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
+ +G G FG V +VA+K+ + + F E ++M ++ H L+++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
C+ + ++ EYM +G L YL Q L + DV A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSA 863
+H DL N L++D V +SDF +++ + +D+ + + + PE + S+
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 864 NGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 923
D+++FG+++ E ++ K E F T +H +L S++
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------YRPHLASEK----- 229
Query: 924 AKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
V+ + C E +R K +++ +L +
Sbjct: 230 --------VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 4e-55
Identities = 64/302 (21%), Positives = 119/302 (39%), Gaps = 31/302 (10%)
Query: 676 ELCRATDGFS-ENNLIGRGGFGSVYKA---SLGDGMEVAVKVFTSQCGRAF-KSFDVECE 730
+L D + +G G FGSV + ++VA+KV +A + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 731 IMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 790
IM + + ++++I C E LV+E G L K+L + + ++ V+
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIG 849
++YL +H DL NVLL + A +SDF ++K L +D +
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 850 YMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTME 908
+ APE + S+ DV+S+G+ + E + G+KP ++ E+ +
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP--- 234
Query: 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968
+C ++ L +C + + R + + ++ SL V
Sbjct: 235 -----------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
Query: 969 GG 970
G
Sbjct: 278 EG 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 6e-54
Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 22/292 (7%)
Query: 690 IGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN 749
IG+G FG V++ G EVAVK+F+S+ R++ + E +RH N++ I++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 750 EEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGYS 800
+ LV +Y HGSL YL + + + + + AS L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM--IQTQTLATIGYMAPEY--- 855
+ H DLK N+L+ N ++D +A ++ + T YMAPE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 856 ---GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM-EVVD 911
+ D+Y+ G++ E + ++ V + M +VV
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963
L + + + + + EC R+ A I L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 9e-54
Identities = 74/276 (26%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
IG+G FG V G +VAVK + ++F E +M +RH NL++++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 748 SNEEFK-ALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
E+ +V EYM GSL YL S +L L +DV A+EYL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
DL NVL+ ++ VA +SDF + K S Q + + APE RE + S
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 866 DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925
DV+SFGI+L E ++ + P + + D ++ A
Sbjct: 182 DVWSFGILLWEIYSFGRV-------------------PYPRIPLKDVVPRVEKGYKMDAP 222
Query: 926 EQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961
+ C V+ + C R + ++ +L I+
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-53
Identities = 61/277 (22%), Positives = 118/277 (42%), Gaps = 26/277 (9%)
Query: 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLI 741
+ +G+G FG V+ + VA+K + ++F E ++MK +RH L+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF-QRLNIMIDVASALEYLHFGYS 800
++ + S E +V EYM GSL +L Q +++ +AS + Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR 860
+H DL+ +N+L+ +N+V ++DF +A+++ +++ + I + APE GR
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 861 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920
+ DV+SFGI+L E T + L + E ++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES-------- 242
Query: 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
+ +L +C + P++R + + L
Sbjct: 243 -----------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 7e-53
Identities = 57/293 (19%), Positives = 110/293 (37%), Gaps = 16/293 (5%)
Query: 675 LELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKS-FDVECEIM 732
+EL D F + + +G G G V+K G+ +A K+ + A ++ E +++
Sbjct: 1 MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 733 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 792
++ + ++ ++ +E+M GSL++ L + + + I V L
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
YL ++H D+KPSN+L++ L DF ++ L + + T YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171
Query: 853 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912
PE + S D++S G+ L+E G+ P E+ L +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTKLLKI 960
+ + ++ L PK ++ V K L
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 69/291 (23%), Positives = 130/291 (44%), Gaps = 32/291 (10%)
Query: 684 FSENNLIGRGGFGSVYKASLGDG-----MEVAVKVF-TSQCGRAFKSFDVECEIMKSIRH 737
+ +IG G FG VYK L + VA+K + F E IM H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
N+I++ S + ++ EYM +G+L+K+L + + Q + ++ +A+ ++YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEYG 856
+ +H DL N+L++ N+V +SDF ++++L + ++ T I + APE
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916
+ ++ DV+SFGI++ E T + + +K + + + M+ A
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA---- 241
Query: 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVT---KLLKIRDSL 964
++ L M+C + +R +IV+ KL++ DSL
Sbjct: 242 ---------------IYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-52
Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 25/275 (9%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVF-TSQCGRAFKSFDVECEIMKSIRHRN 739
+ + +G G +G V A + VAVK+ + ++ E I K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
++K + L LEY G L + + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG 859
+ H D+KP N+LLD+ +SDF +A + ++ + + T+ Y+APE +
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 860 RVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918
A DV+S GI+L G+ P D+ + W ++ + +D+ L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL--- 237
Query: 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
L + +E P RI +I
Sbjct: 238 ---------------ALLHKILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 5e-52
Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 29/272 (10%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
+G G FG VYKA + + A KV ++ + + VE +I+ S H N++K++ +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
E +++E+ G+++ + L Q + AL YLH +IH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY-----GREGRV 861
DLK N+L + L+DF ++ T Q + T +MAPE ++
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921
DV+S GI L+E + P E+ + LK ++ ++ +N
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK------ 246
Query: 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ +C + R ++
Sbjct: 247 ------------DFLKKCLEKNVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-51
Identities = 61/279 (21%), Positives = 112/279 (40%), Gaps = 32/279 (11%)
Query: 686 ENNLIGRGGFGSVYKASL---GDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNL 740
E+ +G G FG+V K VAVK+ ++ E +M+ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
+++I C E + LV+E G L KYL + + + ++ V+ ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYMAPEYGREG 859
+ +H DL NVLL A +SDF ++K L ++ + + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 860 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918
+ S+ DV+SFG+++ E F+ G+KP + E+T + +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP------------- 232
Query: 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
C +++L C + R + +L
Sbjct: 233 -------AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (457), Expect = 2e-51
Identities = 66/281 (23%), Positives = 114/281 (40%), Gaps = 26/281 (9%)
Query: 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNL 740
+ + +G G +G VY+ + VAVK + + F E +MK I+H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGY 799
++++ C+ E ++ E+M +G+L YL N + L + ++SA+EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG 859
IH DL N L+ +N + ++DF +++++TG D I + APE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 191
Query: 860 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
+ S DV++FG++L E T + + ++D
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------------------EKD 232
Query: 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
E C V+ L C P R + EI +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-51
Identities = 64/288 (22%), Positives = 117/288 (40%), Gaps = 30/288 (10%)
Query: 687 NNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQCGRAF-KSFDVECEIMKSIRHRNLI 741
N +IGRG FG VY +L G + AVK F E IMK H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 742 KVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 800
++ C E +VL YM HG L ++ + + + + VA +++L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148
Query: 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED--QSMIQTQTLATIGYMAPEYGRE 858
+H DL N +LD+ ++DF +A+ + ++ +T + +MA E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 859 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918
+ + DV+SFG++L E T P P + D + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 249
Query: 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966
+ E C ++ + ++C + R + E+V+++ I + +
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-50
Identities = 60/286 (20%), Positives = 98/286 (34%), Gaps = 33/286 (11%)
Query: 679 RATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSI 735
RA D + IG G +G K DG + K S + E +++ +
Sbjct: 2 RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 736 RHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVAS 790
+H N+++ + L V+EY G L + LD L +M +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 791 ALEYLH--FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI 848
AL+ H V+H DLKP+NV LD L DF +A++L + + T
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTP 178
Query: 849 GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908
YM+PE + D++S G +L E P E+ K + I
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP--- 235
Query: 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIV 954
+ + + R + +EI+
Sbjct: 236 -----------------YRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-50
Identities = 61/276 (22%), Positives = 109/276 (39%), Gaps = 33/276 (11%)
Query: 687 NNLIGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
+ IGRG F +VYK +EVA + F E E++K ++H N+++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 744 ISSC----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
S ++ LV E M G+L+ YL ++ I + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 800 SAPVIHCDLKPSNVLLDD-NMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
+ P+IH DLK N+ + + D +A + + T +MAPE E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186
Query: 859 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918
+ + DVY+FG+ ++E T + P E N + + P S +V +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK--- 243
Query: 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIV 954
+ C + +R + K+++
Sbjct: 244 ---------------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 1e-50
Identities = 63/281 (22%), Positives = 103/281 (36%), Gaps = 36/281 (12%)
Query: 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVF---TSQCGRAFKSFDVECEIMKSIR 736
FS+ IG G FG+VY A + + VA+K Q ++ E ++ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
H N I+ E LV+EY + + L + + L YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEY- 855
S +IH D+K N+LL + + L DF A ++ + T +MAPE
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVI 183
Query: 856 --GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913
EG+ DV+S GI +E K P + N+ + +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---- 239
Query: 914 LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIV 954
S+ +FV C + P+ R ++ ++
Sbjct: 240 --SEYFRNFVDS-------------CLQKIPQDRPTSEVLL 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-50
Identities = 58/299 (19%), Positives = 109/299 (36%), Gaps = 51/299 (17%)
Query: 689 LIGRGGFGSVYKASL------GDGMEVAVKVFTSQCGRAF-KSFDVECEIMKSI-RHRNL 740
++G G FG V A+ G ++VAVK+ + + ++ E ++M + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 741 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------------------CILDI 778
+ ++ +C+ L+ EY +G L YL S +L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 779 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838
L VA +E+L +H DL NVL+ V + DF +A+ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 898
+++ + +MAPE EG + DV+S+GI+L E F+ + +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280
Query: 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
Q ++ + C ++R + + + L
Sbjct: 281 ------------------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-49
Identities = 60/292 (20%), Positives = 119/292 (40%), Gaps = 30/292 (10%)
Query: 675 LELCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKV-----FTSQCGRAFKSFDVE 728
L + + T+ F + ++G G FG+VYK + +G +V + V + +A K E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 729 CEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 788
+M S+ + ++ +++ C + L+ + MP G L Y+ + LN + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 789 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATI 848
A + YL ++H DL NVL+ ++DF +AK+L E++ I
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 849 GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTME 908
+MA E + DV+S+G+ + E T P +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------------------PYDGIP 218
Query: 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
+ + + ++ C V+ + ++C M R +E++ + K+
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 1e-49
Identities = 71/319 (22%), Positives = 120/319 (37%), Gaps = 54/319 (16%)
Query: 672 FSYLELCRATDGFSENNLIGRGGFGSVYKA------SLGDGMEVAVKVFTSQCGRAF-KS 724
LE R + IG G FG V++A VAVK+ +
Sbjct: 5 LLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62
Query: 725 FDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC---------- 774
F E +M + N++K++ C+ + L+ EYM +G L ++L S +
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 775 -------------ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821
L ++L I VA+ + YL +H DL N L+ +NMV
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVV 179
Query: 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK 881
++DF +++ + D I +M PE R + DV+++G++L E F+
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 882 KPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTM 941
E + + V D N+L+ E C ++NL C
Sbjct: 240 LQPYYGMAHEEVIYY------------VRDGNILACP-------ENCPLELYNLMRLCWS 280
Query: 942 EFPKQRINAKEIVTKLLKI 960
+ P R + I L ++
Sbjct: 281 KLPADRPSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 60/304 (19%), Positives = 114/304 (37%), Gaps = 46/304 (15%)
Query: 682 DGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFT-SQCGRAFKSFDVECEIMKS 734
+ S +G G FG V +A+ M VAVK+ S ++ E +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 735 I-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-----------------NCIL 776
+ H N++ ++ +C+ ++ EY +G L +L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 777 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836
D+ L+ VA + +L S IH DL N+LL + + DF +A+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 896
+++ + +MAPE + DV+S+GI L E F+ +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 897 WVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956
+ +E ++ E + ++++ C P +R K+IV
Sbjct: 260 MI------------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 957 LLKI 960
+ K
Sbjct: 302 IEKQ 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-49
Identities = 68/280 (24%), Positives = 100/280 (35%), Gaps = 30/280 (10%)
Query: 690 IGRGGFGSVYKASL----GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIK 742
+G G FG V + G + VAVK A F E M S+ HRNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 743 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 802
+ K +V E P GSL L + + VA + YL S
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 803 VIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT-GEDQSMIQTQTLATIGYMAPEYGREGRV 861
IH DL N+LL + + DF + + L +D ++Q + APE +
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921
S D + FG+ L E FT + NG L E
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------------------EGER 233
Query: 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961
E C ++N+ ++C P+ R + LL+ +
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 4e-49
Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 33/277 (11%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFT---SQCGRAFKSFDVECEIMKSIRH 737
+ F +G+G FG+VY A +A+KV + E EI +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
N++++ + L+LEY P G++ + L + D + + ++A+AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
S VIH D+KP N+LL ++DF + ++ + T+ Y+ PE
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIE 177
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917
D++S G++ E GK P F + + IS +E + +++
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKR----ISRVEFTFPDFVTE 229
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIV 954
+++ P QR +E++
Sbjct: 230 GARDLISR-------------LLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-48
Identities = 64/267 (23%), Positives = 105/267 (39%), Gaps = 26/267 (9%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISS 746
IG+G G+VY A + G EVA++ Q + E +M+ ++ N++ + S
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 747 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806
+ +V+EY+ GSL + + D Q + + ALE+LH S VIH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGD 866
D+K N+LL + L+DF +T E + + T +MAPE D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 867 VYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKE 926
++S GIM +E G+ P N + E + A
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR----------- 247
Query: 927 QCVSFVFNLAMECTMEFPKQRINAKEI 953
+ C ++R +AKE+
Sbjct: 248 -------DFLNRCLDMDVEKRGSAKEL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 4e-48
Identities = 61/279 (21%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 679 RATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVF---TSQCGRAFKSFDVECEIMKS 734
+ + F ++G G F +V A L E A+K+ E ++M
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 735 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 794
+ H +K+ + ++E L Y +G L KY+ D ++ SALEY
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
LH +IH DLKP N+LL+++M ++DF AK+L+ E + + T Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 855 YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914
E + D+++ G ++ + G P F + I +E
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQK----IIKLEYDFPEK 232
Query: 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ V K + +R+ +E+
Sbjct: 233 FFPKARDLVEK-------------LLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (437), Expect = 6e-48
Identities = 50/268 (18%), Positives = 97/268 (36%), Gaps = 26/268 (9%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G G FG V++ G A K + ++ E + M +RH L+ + +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
++ ++ E+M G L + + + + + + M V L ++H +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149
Query: 808 LKPSNVLL--DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
LKP N++ + L DF + L + + T T + APE V
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYT 206
Query: 866 DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925
D++S G++ +G P + E DW + + +S++ F+ K
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF----SGISEDGKDFIRK 262
Query: 926 EQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ P R+ +
Sbjct: 263 -------------LLLADPNTRMTIHQA 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 9e-48
Identities = 69/307 (22%), Positives = 124/307 (40%), Gaps = 45/307 (14%)
Query: 682 DGFSENNLIGRGGFGSVYKASL---GDGMEVAVKVF-TSQCGRAFKSFDVECEIMKSI-R 736
+ ++IG G FG V KA + G M+ A+K + F E E++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQR 781
H N+I ++ +C + + L +EY PHG+L +L S + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 782 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841
L+ DVA ++YL IH DL N+L+ +N VA ++DF +++ G++ + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDW 901
T + +MA E + N DV+S+G++L E + + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243
Query: 902 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961
C V++L +C E P +R + +I+ L ++
Sbjct: 244 RL-------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
Query: 962 DSLLRNV 968
+ V
Sbjct: 285 EERKTYV 291
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-47
Identities = 61/301 (20%), Positives = 122/301 (40%), Gaps = 38/301 (12%)
Query: 684 FSENNLIGRGGFGSVYKASL------GDGMEVAVKVFT-SQCGRAFKSFDVECEIMKSIR 736
+ + +G+G FG VY+ VA+K + R F E +MK
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------SSNCILDIFQRLNIMID 787
++++++ S + +++E M G L+ YL + + + + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 788 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLAT 847
+A + YL+ + +H DL N ++ ++ + DF + + + D + L
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 848 IGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTM 907
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----------- 247
Query: 908 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRN 967
V++ LL + D C +F L C PK R + EI++ + + + R
Sbjct: 248 -VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
Query: 968 V 968
V
Sbjct: 300 V 300
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 3e-47
Identities = 61/280 (21%), Positives = 113/280 (40%), Gaps = 31/280 (11%)
Query: 689 LIGRGGFGSVYKASL----GDGMEVAVKVFTSQCGRAFKS-FDVECEIMKSIRHRNLIKV 743
IG G FG V++ + VA+K + + + F E M+ H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
I + E +++E G L +L LD+ + +++AL YL S
Sbjct: 74 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSA 863
+H D+ NVL+ N L DF +++ + + ++ I +MAPE R ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 864 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 922
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP----------------- 231
Query: 923 VAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962
C +++L +C P +R E+ +L I +
Sbjct: 232 ---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (421), Expect = 1e-46
Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 31/292 (10%)
Query: 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGR---AFKSFDVECEIMKSIR 736
+D + ++G GG V+ A L +VAVKV + R + F E + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 737 HRNLIKVISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 792
H ++ V + E +V+EY+ +L +++ + + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLA-TIGYM 851
+ H +IH D+KP+N+++ + DF IA+ + S+ QT + T Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 852 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911
+PE R V A DVYS G +L E TG+ P + +H D +P S
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----R 237
Query: 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-NAKEIVTKLLKIRD 962
LS + V K + P+ R A E+ L+++ +
Sbjct: 238 HEGLSADLDAVVLK-------------ALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (427), Expect = 1e-46
Identities = 50/268 (18%), Positives = 99/268 (36%), Gaps = 26/268 (9%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G G FG V++ G K + + E IM + H LI + +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
++ L+LE++ G L + + + + + +N M L+++H ++H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 808 LKPSNVLLD--DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
+KP N++ + + DF +A L ++ + T AT + APE V
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYT 209
Query: 866 DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925
D+++ G++ +G P + E DW + +S E F+
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA----FSSVSPEAKDFIKN 265
Query: 926 EQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ P++R+ +
Sbjct: 266 -------------LLQKEPRKRLTVHDA 280
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-45
Identities = 71/304 (23%), Positives = 117/304 (38%), Gaps = 47/304 (15%)
Query: 682 DGFSENNLIGRGGFGSVYKA--------SLGDGMEVAVKVFTSQCG-RAFKSFDVECEIM 732
D +G G FG V A +VAVK+ S + E E+M
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 733 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------YSSNCIL 776
K I +H+N+I ++ +C+ + +++EY G+L +YL ++ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 777 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836
++ VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 896
T + +MAPE + + DV+SFG++L E FT E K
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 897 WVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956
C + ++ + +C P QR K++V
Sbjct: 250 LKEGHRM-------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 957 LLKI 960
L +I
Sbjct: 291 LDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-42
Identities = 61/306 (19%), Positives = 107/306 (34%), Gaps = 45/306 (14%)
Query: 682 DGFSENNLIGRGGFGSVYKA------SLGDGMEVAVKVF-TSQCGRAFKSFDVECEIMKS 734
D +GRG FG V +A VAVK+ ++ E +I+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 735 IRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNC---------------ILD 777
I H + + + L ++E+ G+L YL S L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 778 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837
+ + VA +E+L S IH DL N+LL + V + DF +A+ + +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 897
+ + + +MAPE + + DV+SFG++L E F+ +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 898 VNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957
+ +E A + ++ ++C P QR E+V L
Sbjct: 250 L------------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 958 LKIRDS 963
+ +
Sbjct: 292 GNLLQA 297
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (380), Expect = 3e-41
Identities = 63/289 (21%), Positives = 108/289 (37%), Gaps = 41/289 (14%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDV---------ECEI 731
+ + ++GRG V + E AVK+ G +F + +V E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 732 MKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 790
++ + H N+I++ + F LV + M G L YL + L + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121
Query: 791 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
+ LH ++H DLKP N+LLDD+M L+DF + L D + T Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 175
Query: 851 MAPEYGREGRVSANG------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 904
+APE + D++S G+++ G P F
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR------------- 218
Query: 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
M ++ + + V +L + P++R A+E
Sbjct: 219 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-41
Identities = 51/268 (19%), Positives = 104/268 (38%), Gaps = 27/268 (10%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+GRG FG V++ K + G E I+ RHRN++ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
+ E ++ E++ + + + +S L+ + ++ + V AL++LH S + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 808 LKPSNVLLD--DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANG 865
++P N++ + + +F A+ L D Y APE + VS
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 866 DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 925
D++S G ++ +G P F E + ++++ + ++ A
Sbjct: 185 DMWSLGTLVYVLLSGINP----FLAE-------------TNQQIIENIMNAEYTFDEEAF 227
Query: 926 EQCVSFVFNLAMECTMEFPKQRINAKEI 953
++ + ++ K R+ A E
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 8e-41
Identities = 48/275 (17%), Positives = 97/275 (35%), Gaps = 23/275 (8%)
Query: 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAF-KSFDVECEIMKSIRHR 738
D + +++G G F V A VA+K + S + E ++ I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 739 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 798
N++ + + L+++ + G L + ++ V A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
LD++ +SDF ++KM ED + + T GY+APE +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 183
Query: 859 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918
S D +S G++ G P F E + ++ + L ++
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP----FYDE-------------NDAKLFEQILKAEY 226
Query: 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ + + + P++R ++
Sbjct: 227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 3e-40
Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 24/239 (10%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKVF---TSQCGRAFKSFDVECEIMKSIRHRNLIKV 743
+G G FG V+ S +G A+KV + + + E ++ + H +I++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 744 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
+ + + ++++Y+ G L + +V ALEYLH S +
Sbjct: 70 WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125
Query: 804 IHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSA 863
I+ DLKP N+LLD N ++DF AK + ++ T Y+APE +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180
Query: 864 NGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKHWVNDWLP--ISTMEVVD 911
+ D +SFGI++ E G P ++I N E+ + N+ + +S + D
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 56/278 (20%), Positives = 106/278 (38%), Gaps = 32/278 (11%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVF---TSQCGRAFKSFDVECEIM-KSIR 736
+ F + ++G+G FG V+ A A+K + VE ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 737 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 796
H L + + +E V+EY+ G L ++ S + D+ + ++ L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120
Query: 797 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYG 856
S +++ DLK N+LLD + ++DF + K D T Y+APE
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEIL 175
Query: 857 REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916
+ + + D +SFG++L E G+ P + E D L
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYP-------RWLE 227
Query: 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIV 954
+E + K + P++R+ + +
Sbjct: 228 KEAKDLLVK-------------LFVREPEKRLGVRGDI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 4e-39
Identities = 54/281 (19%), Positives = 90/281 (32%), Gaps = 27/281 (9%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
IG G FG +Y + G EVA+K+ + +E +I K ++ I I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
E +++ + SLE + + L + + S +EY+H S IH D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 808 LKPSNVL---LDDNMVAHLSDFSIAKMLTGED-----QSMIQTQTLATIGYMAPEYGREG 859
+KP N L + ++ DF +AK T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 860 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919
S D+ S G +LM G P + K+ +ST V E
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248
Query: 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960
++ C + + + +
Sbjct: 249 ATYLNF-------------CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (371), Expect = 4e-39
Identities = 51/241 (21%), Positives = 97/241 (40%), Gaps = 16/241 (6%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVF------TSQCGRAFKSFDVECEIMKS 734
+ FS + +IGRGGFG VY G A+K Q + + ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 735 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 794
++ + + + + +L+ M G L +L + ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE 854
+H + V++ DLKP+N+LLD++ +SD +A + + T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG----THGYMAPE 175
Query: 855 YGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDAN 913
++G ++ D +S G ML + G P + + + + + +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 914 L 914
L
Sbjct: 236 L 236
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (365), Expect = 4e-39
Identities = 58/277 (20%), Positives = 113/277 (40%), Gaps = 17/277 (6%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
IG G +G VYKA G A+K + + E I+K ++H N++K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 746 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIH 805
++ LV E++ L+K L L+ + ++ + + + Y H V+H
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 806 CDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-YGREGRVSAN 864
DLKP N+L++ ++DF +A+ + + T+ Y AP+ + S
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYT--HEIVTLWYRAPDVLMGSKKYSTT 181
Query: 865 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW-------VNDWLPISTMEVVDANLLSQ 917
D++S G + E G + + ++ + +W ++ + D N
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 918 EDIHFVAKEQCVSFVF-NLAMECTMEFPKQRINAKEI 953
E + + + + + +L + P QRI AK+
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-39
Identities = 48/275 (17%), Positives = 100/275 (36%), Gaps = 34/275 (12%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIM-KSIRHRNLIKVISS 746
++G G G V + + + A+K+ + E E+ ++ + ++++++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 747 C----SNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSA 801
+ + +V+E + G L + + + IM + A++YLH S
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 802 PVIHCDLKPSNVLLD---DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
+ H D+KP N+L N + L+DF AK T + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 859 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918
+ + D++S G+++ G P ++ + + + +S+E
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ P QR+ E
Sbjct: 248 VKMLIRN-------------LLKTEPTQRMTITEF 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-38
Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 26/296 (8%)
Query: 677 LCRATDGFSENNLIGRGGFGSVYKA--SLGDGMEVAVKVFTSQCG--RAFKSFDVECEIM 732
LCRA + IG G +G V+KA G VA+K Q G S E ++
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 733 K---SIRHRNLIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 784
+ + H N++++ C+ LV E++ + ++
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 785 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT 844
M + L++LH S V+H DLKP N+L+ + L+DF +A++ M T
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175
Query: 845 LATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 904
+ T+ Y APE + + D++S G + E F K + + L ++
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLP 234
Query: 905 STMEVVDANLLSQEDIHFVAKEQCVSFV-------FNLAMECTMEFPKQRINAKEI 953
+ L ++ H + + FV +L ++C P +RI+A
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 62/284 (21%), Positives = 113/284 (39%), Gaps = 28/284 (9%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKVF-----TSQCGRAFKSFDVECEIMKSIRHRNLI 741
+ +G G F +VYKA VA+K + ++ E ++++ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 742 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 801
++ + ++ +LV ++M + ++ +L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 802 PVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRV 861
++H DLKP+N+LLD+N V L+DF +AK +++ T + T Y APE R+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARM 177
Query: 862 -SANGDVYSFGIMLMETFTGKKP---------TDEIFN--GEMTLKHWVNDWLPISTMEV 909
D+++ G +L E IF G T + W + +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ I A + + + + P RI A +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLI----QGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-38
Identities = 58/291 (19%), Positives = 113/291 (38%), Gaps = 23/291 (7%)
Query: 681 TDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAF-KSFDVECEIMKSIRHR 738
++ + IG G +G V A + + VA+K + + + + E +I+ RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 739 NLIKVISSCSNEEFKAL----VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 794
N+I + + + ++ ++ L K L + + L + + L+Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT-GEDQSMIQTQTLATIGYMAP 853
+H SA V+H DLKPSN+LL+ + DF +A++ D + T+ +AT Y AP
Sbjct: 125 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 854 EYGREGRVSAN-GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912
E + D++S G +L E + + + P
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 913 NLLSQEDIHFVAKEQCVSF----------VFNLAMECTMEFPKQRINAKEI 953
NL ++ + + + V + +L + P +RI ++
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 56/283 (19%), Positives = 107/283 (37%), Gaps = 35/283 (12%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVF------TSQCGRAFKSFDVECEIMKS 734
D + +G G F V K G++ A K +S+ G + + + E I+K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 735 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 794
I+H N+I + N+ L+LE + G L + + L + + + + + Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128
Query: 795 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFSIAKMLTGEDQSMIQTQTLATIGY 850
LH S + H DLKP N++L D V + DF +A + ++ T +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEF 182
Query: 851 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910
+APE + D++S G++ +G P F G+ + E +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGD-------------TKQETL 225
Query: 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ + + ++ PK+R+ ++
Sbjct: 226 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 60/284 (21%), Positives = 109/284 (38%), Gaps = 17/284 (5%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHR 738
+ F + IG G +G VYKA + G VA+K ++ + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 739 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 798
N++K++ E LV E++ + S+ + + + + + L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 799 YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-YGR 857
S V+H DLKP N+L++ L+DF +A+ ++ T + T+ Y APE
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLG 176
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917
S D++S G + E T + + + + P + ++
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 918 EDIHFVAKEQCVSFVFNLAMECTMEF--------PKQRINAKEI 953
+ Q S V E P +RI+AK
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-37
Identities = 59/288 (20%), Positives = 105/288 (36%), Gaps = 27/288 (9%)
Query: 684 FSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIK 742
+++ +IG G FG VY+A G VA+K + + E +IM+ + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 743 VISSC------SNEEFKALVLEYMPHGSLE--KYLYSSNCILDIFQRLNIMIDVASALEY 794
+ +E + LVL+Y+P ++ + L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 795 LHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
+H S + H D+KP N+LLD D V L DF AK L + +
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPE 192
Query: 854 EYGREGRVSANGDVYSFGIMLMETFTGKKP------TDEIFNGEMTLKHWVNDWLPISTM 907
+++ DV+S G +L E G+ D++ L + +
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 908 EVVDANL--LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ + V + + L P R+ E
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 60/279 (21%), Positives = 96/279 (34%), Gaps = 51/279 (18%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVF------TSQCGRAFKSFDVECEIMKSIR--HRN 739
L+G GGFGSVY + D + VA+K +E ++K +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 740 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+I+++ + L+LE + L + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 800 SAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGRE 858
+ V+H D+K N+L+D + L DF +L T T Y PE+ R
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRY 183
Query: 859 GRV-SANGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914
R + V+S GI+L + G P +EI G++ + V
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------------- 227
Query: 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
S E H + C P R +EI
Sbjct: 228 -SSECQHLIRW-------------CLALRPSDRPTFEEI 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 134 bits (337), Expect = 2e-35
Identities = 39/289 (13%), Positives = 84/289 (29%), Gaps = 33/289 (11%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
IG G FG +++ +L + +VA+K + E K + I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 807
E +++ + SLE L + + + ++ +H +++ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126
Query: 808 LKPSNVLLDDNMVAH-----LSDFSIAKML----TGEDQSMIQTQTLA-TIGYMAPEYGR 857
+KP N L+ + + DF + K T + + + L+ T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 858 EGRVSANGDVYSFGIMLMETFTGK--KPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915
S D+ + G + M G + + + E+
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA---- 242
Query: 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964
+ + + K+ + L
Sbjct: 243 -----------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 5e-35
Identities = 53/279 (18%), Positives = 108/279 (38%), Gaps = 19/279 (6%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVI 744
IG G +G+V+KA + VA+K S E ++K ++H+N++++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 745 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVI 804
+++ LV E+ + + + + D + + + L + H V+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 805 HCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPE-YGREGRVSA 863
H DLKP N+L++ N L++F +A+ + + + T+ Y P+ S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYST 181
Query: 864 NGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN--------DWLPISTMEVVDANLL 915
+ D++S G + E +P + + LK W ++ + +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 916 SQEDIHFVAKEQCVSFVF-NLAMECTMEFPKQRINAKEI 953
V ++ +L P QRI+A+E
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-34
Identities = 57/302 (18%), Positives = 114/302 (37%), Gaps = 29/302 (9%)
Query: 677 LCRATDGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMK 733
C + + IG+G FG V+KA G +VA+K ++ + E +I++
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 734 SIRHRNLIKVISSCSNEEFKA--------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 785
++H N++ +I C + LV ++ H + + +M
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123
Query: 786 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQT- 844
+ + L Y+H ++H D+K +NVL+ + V L+DF +A+ + S T
Sbjct: 124 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 845 -LATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTD-----------EIFNGE 891
+ T+ Y PE R D++ G ++ E +T G
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 892 MTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAK 951
+T + W N ++ ++ + + +L + + P QRI++
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 952 EI 953
+
Sbjct: 301 DA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 8e-34
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRA---FKSFDVECEIMKSIRH 737
+ F L+G+G FG V G A+K+ + A E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
L + + + V+EY G L +L S + + ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
S V++ D+K N++LD + ++DF + K + +M T Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLE 178
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKP 883
+ D + G+++ E G+ P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-33
Identities = 69/309 (22%), Positives = 116/309 (37%), Gaps = 35/309 (11%)
Query: 669 RRMFSYLELCRATDGFSEN----NLIGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRA 721
R F E+ + +G G +G+V A G +VA+K Q
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 722 FKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNCI 775
K E ++K +RH N+I ++ + +E LV+ +M G+ L
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK- 117
Query: 776 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835
L + ++ + L Y+H +A +IH DLKP N+ ++++ + DF +A+ E
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
Query: 836 DQSMIQTQTLATIGYMAPE-YGREGRVSANGDVYSFGIMLMETFTGKKP---------TD 885
+ T+ Y APE R + D++S G ++ E TGK
Sbjct: 175 MTGYVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229
Query: 886 EIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF-NLAMECTMEFP 944
EI T L + L E F + S + NL + +
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289
Query: 945 KQRINAKEI 953
+QR+ A E
Sbjct: 290 EQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (324), Expect = 4e-33
Identities = 50/230 (21%), Positives = 88/230 (38%), Gaps = 20/230 (8%)
Query: 682 DGFSENNLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRH 737
D F +G G FG V G A+K+ Q + + E I++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 738 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 797
L+K+ S + +V+EY+ G + +L + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158
Query: 798 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGR 857
S +I+ DLKP N+L+D ++DF AK + G ++ T +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIIL 211
Query: 858 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE---MTLKHWVNDWLPI 904
+ D ++ G+++ E G P F + + V+ +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVSGKVRF 257
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 9e-32
Identities = 56/255 (21%), Positives = 97/255 (38%), Gaps = 20/255 (7%)
Query: 682 DGFSENNLIGRGGFGSVYKA----SLGDGMEVAVKVF----TSQCGRAFKSFDVECEIMK 733
+ F ++G G +G V+ G A+KV Q + + E ++++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 734 SIRHR-NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 792
IR L+ + + E L+L+Y+ G L +L F + I V +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMA 852
L + +I+ D+K N+LLD N L+DF ++K ++ TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 198
Query: 853 PEYGREGRVSANG--DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910
P+ R G + D +S G+++ E TG P F + I E
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEISRRILKSEPP 254
Query: 911 DANLLSQEDIHFVAK 925
+S + +
Sbjct: 255 YPQEMSALAKDLIQR 269
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 5e-31
Identities = 59/303 (19%), Positives = 108/303 (35%), Gaps = 29/303 (9%)
Query: 672 FSYLELCRATDGFSEN----NLIGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKS 724
F EL + E + +G G +GSV A G+ VAVK Q K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 725 FDVECEIMKSIRHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQ 780
E ++K ++H N+I ++ + EF + L G+ + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122
Query: 781 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840
++ + L+Y+H SA +IH DLKPSN+ ++++ + DF +A+ E +
Sbjct: 123 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179
Query: 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP---------TDEIFNGE 891
T + D++S G ++ E TG+ I
Sbjct: 180 AT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235
Query: 892 MTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS-FVFNLAMECTMEFPKQRINA 950
T + + + +L ++F + +L + + +RI A
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 951 KEI 953
+
Sbjct: 296 AQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (300), Expect = 4e-30
Identities = 51/289 (17%), Positives = 112/289 (38%), Gaps = 36/289 (12%)
Query: 688 NLIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVIS 745
+GRG + V++A ++ + +V VK+ + K E +I++++R N+I +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 97
Query: 746 SCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPV 803
+ + ALV E++ + ++ + L + M ++ AL+Y H S +
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGI 150
Query: 804 IHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGR-V 861
+H D+KP NV++D ++ L D+ +A+ + +A+ + PE + +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMY 207
Query: 862 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS----- 916
+ D++S G ML K+P + L + +D +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 917 ------------QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ +H + + + + R+ A+E
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 118 bits (296), Expect = 4e-29
Identities = 78/386 (20%), Positives = 147/386 (38%), Gaps = 28/386 (7%)
Query: 198 NLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLW 257
L K +G + ++ + L + + + Y L NL ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDGVEY--LNNLTQINFS 74
Query: 258 GNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLS------WLVLSDNYLTS 311
N + P + N +KL + + N + P + +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
+ L S+ + S L T + L++ ++ +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 372 ISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDL 431
++ LTNL ++ N+++ + L L L +L L N+L+ + +L L LDL
Sbjct: 193 LAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 432 DGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEI 491
N++S P S LT L + LG+N++++I L + NL + N L I
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLED--ISPI 303
Query: 492 GSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLS 551
+LK L + L NN S + P + L L+ LF N++ +S +L ++ +L+
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 552 NNNLSGVIPASLEKLSYLEDLNLSFN 577
+N +S + P L L+ + L L+
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 101 bits (252), Expect = 2e-23
Identities = 83/413 (20%), Positives = 154/413 (37%), Gaps = 48/413 (11%)
Query: 141 SNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLR 200
+ + L ++ + + + L+ L ++ G + L
Sbjct: 19 TALAEKMKTVLGKTNVTDTV-------SQTDLDQVTTLQADRLGIKSIDG-----VEYLN 66
Query: 201 NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNN 260
NL +++ +N+L I P+ N++ L + + +N ++ L L + + +
Sbjct: 67 NLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 124
Query: 261 FSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLS 320
N +LS + S + + + L
Sbjct: 125 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV---------------TDLK 169
Query: 321 SLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRT 380
L+N L+ D+S N + I +LE +N IS P I TNL
Sbjct: 170 PLANLTTLERLDISSNKVSDISVL----AKLTNLESLIATNNQISDITPLGIL--TNLDE 223
Query: 381 IYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSI 440
+ L GN+L + TL+ L L DL L +N++ P + L +L L L N++S
Sbjct: 224 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 279
Query: 441 PACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGI 500
P + LT+L + L N+ NLK++ L N ++ P + SL L +
Sbjct: 280 P--LAGLTALTNLELNENQ-LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 334
Query: 501 DLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNN 553
+ N S + + L N+ +L G+N++ P +L + L L++
Sbjct: 335 FFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 100 bits (250), Expect = 3e-23
Identities = 83/391 (21%), Positives = 136/391 (34%), Gaps = 33/391 (8%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131
+ N+T T+ +L + +L + + L + NQ
Sbjct: 22 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQ 77
Query: 132 LSGTFPSFISNKSSLQHLDLSSNALSG----EIRANICREIPREFGNLPELELMSLAANN 187
L+ P + N + L + +++N ++ N+ L +L N
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 188 LQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYAR 247
I ++ L L G + ++ L L D S + A+
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
L NLE L N S P I + L L L GN T +L NL+ L L++N
Sbjct: 196 LTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
+++ L+ LS L L N + I P + L+ N
Sbjct: 252 QISN-------LAPLSGLTKLTELKLGANQISNISP---LAGLTALTNLELNENQLE--- 298
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427
ISNL NL + L N ++ + +S L KLQ L +NK+ + NL +
Sbjct: 299 DISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 428 RLDLDGNKLSGSIPACFSNLTSLRIVSLGSN 458
L N++S P +NLT + + L
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 76.6 bits (187), Expect = 3e-15
Identities = 53/244 (21%), Positives = 96/244 (39%), Gaps = 25/244 (10%)
Query: 40 HITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQ 99
P L + ++ + L ++ ++ P L++L
Sbjct: 165 VTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLD 222
Query: 100 SLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGE 159
L+L+ N+L + + L + L NQ+S P +S + L L L +N +S
Sbjct: 223 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 278
Query: 160 IRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIA 219
L L + L N L+ P I NL+NL L + N + I+P++
Sbjct: 279 S----------PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS 326
Query: 220 IFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILD 279
+++ L+ L +N +S +SS+ L N+ LS N S P + N ++++ L
Sbjct: 327 --SLTKLQRLFFANNKVSD-VSSLA--NLTNINWLSAGHNQISDLTP--LANLTRITQLG 379
Query: 280 LEGN 283
L
Sbjct: 380 LNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 3e-04
Identities = 13/96 (13%), Positives = 33/96 (34%), Gaps = 28/96 (29%)
Query: 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTT 119
N + ++ ++ L ++ ++ S L NL+++ L+ N++ P
Sbjct: 317 NNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP------ 368
Query: 120 YTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNA 155
++N + + L L+ A
Sbjct: 369 --------------------LANLTRITQLGLNDQA 384
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 3e-28
Identities = 52/309 (16%), Positives = 105/309 (33%), Gaps = 47/309 (15%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSC 747
+G G F +V+ A + + VA+K+ ++ + E ++++ + + K S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 748 SNEEFK---------------ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 792
+N K +V E + L + + + I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 793 EYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYM 851
+Y+H +IH D+KP NVL++ + +L IA + T ++ T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 852 APEYGREGRVSANGDVYSFGIMLMETFTGKKP------------TDEIFNGEMTL----K 895
+PE D++S ++ E TG D I L
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEF-----------P 944
+ + + T L + + F E ++ + + + E P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 945 KQRINAKEI 953
++R +A +
Sbjct: 317 RKRADAGGL 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 7e-28
Identities = 58/295 (19%), Positives = 109/295 (36%), Gaps = 40/295 (13%)
Query: 689 LIGRGGFGSVYKA-SLGDGMEVAVKVF--TSQCGRAFKSFDVECEIMKSIRHRNLIKVIS 745
IG G G V A VA+K Q K E +MK + H+N+I +++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 746 SCSNEEFK------ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 799
+ ++ LV+E M + D + ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136
Query: 800 SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREG 859
SA +IH DLKPSN+++ + + DF +A+ S + T + T Y APE
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 860 RVSANGDVYSFGIMLMETFTGKKP---------------------TDEIFNGEMTLKHWV 898
N D++S G ++ E K + + + T++++V
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 899 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953
+ + + S + S +L + + P +RI+ +
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 111 bits (277), Expect = 3e-27
Identities = 81/318 (25%), Positives = 121/318 (38%), Gaps = 28/318 (8%)
Query: 29 TDQDALLALKAHITHDPTNFLAKNWNTSTPVCN--WTGVAC--EVHSQRVTVLNISSLNL 84
D+ ALL +K + +PT +W +T CN W GV C + + RV L++S LNL
Sbjct: 6 QDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 85 TG--TIPSQLGNLSSLQSLNLSFN-RLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFIS 141
IPS L NL L L + L G IP AI L Y+ + +SG P F+S
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 142 NKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRN 201
+L LD S N + +P +LP L ++ N + G IP G+
Sbjct: 123 QIKTLVTLDFSYN--------ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174
Query: 202 LEK-LDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNN 260
L + I N+L G P N++ + ++ G + N
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH---LAKN 231
Query: 261 FSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLS 320
+ + L+ LDL N G +P L+ L L +S N L +
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE------IP 285
Query: 321 SLSNCKFLKYFDLSYNPL 338
N + + N
Sbjct: 286 QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 86.7 bits (213), Expect = 5e-19
Identities = 73/284 (25%), Positives = 116/284 (40%), Gaps = 28/284 (9%)
Query: 332 DLSYNPLYRILP-RTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNG 390
DLS L + P +++ NL + + N+ G IP I+ LT L +Y+ ++G
Sbjct: 56 DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115
Query: 391 SILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSL 450
+I LS+++ L L N L G++P I +L L + DGN++SG+IP + + + L
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175
Query: 451 RIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGV 510
S + + L S + + N
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 511 IPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLE 570
++G KNL L L NR+ G++P L L LN+S NNL
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-------------- 281
Query: 571 DLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSPNLQIPPC 614
G+IP+GG+ F ++ N+ LCGSP +P C
Sbjct: 282 ----------GEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.1 bits (162), Expect = 2e-12
Identities = 51/268 (19%), Positives = 93/268 (34%), Gaps = 55/268 (20%)
Query: 271 NASKLSILDLEGNSFSGF--IPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFL 328
+++ LDL G + IP++ NL L++L + +++ L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP----IPPAIAKLTQL 103
Query: 329 KYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKL 388
Y +++ + +P +L S +SG +P IS+L NL I GN++
Sbjct: 104 HYLYITHTNVSGAIPDFLSQI--KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
Query: 389 NGSILITLSKLQKLQ-DLGLKDNKLEGSIPYDICNLAELYRL------------------ 429
+G+I + KL + + N+L G IP NL +
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDK 221
Query: 430 ----------------------------DLDGNKLSGSIPACFSNLTSLRIVSLGSNELT 461
DL N++ G++P + L L +++ N L
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 462 SIPLTFWNLKDILNLNFSSNFLTGSLPL 489
NL+ +++N PL
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 7e-09
Identities = 20/78 (25%), Positives = 30/78 (38%), Gaps = 1/78 (1%)
Query: 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTT 119
+ S+ + L++ + + GT+P L L L SLN+SFN L G IP
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNL 290
Query: 120 YTLKYVCLRGNQLSGTFP 137
N+ P
Sbjct: 291 QRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.9 bits (133), Expect = 9e-09
Identities = 21/71 (29%), Positives = 32/71 (45%), Gaps = 9/71 (12%)
Query: 124 YVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSL 183
+ LR N++ GT P ++ L L++S N L GEI + GNL ++ +
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP---------QGGNLQRFDVSAY 298
Query: 184 AANNLQGKIPL 194
A N PL
Sbjct: 299 ANNKCLCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 21/75 (28%), Positives = 38/75 (50%), Gaps = 9/75 (12%)
Query: 144 SSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLE 203
+L LDL +N + G + P+ L L ++++ NNL G+IP + GNL+ +
Sbjct: 244 KNLNGLDLRNNRIYGTL--------PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFD 294
Query: 204 KLDIGDNKLVGIAPI 218
+NK + +P+
Sbjct: 295 VSAYANNKCLCGSPL 309
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 101 bits (252), Expect = 5e-24
Identities = 60/313 (19%), Positives = 101/313 (32%), Gaps = 31/313 (9%)
Query: 240 LSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNL 299
L + P+ +L L N + N L L L N S P F L L
Sbjct: 22 LEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 300 SWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKM 359
L LS N L +++ K L+ + N + ++ G + E
Sbjct: 82 ERLYLSKNQLKELPEKM--------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 133
Query: 360 SNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD 419
+ SG + L I + + I L +L L NK+
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAAS 190
Query: 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFS 479
+ L L +L L N +S +N LR + L +N+L +P + K I +
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250
Query: 480 SNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS--IPN 537
+N ++ + N+F P + + L N +Q P+
Sbjct: 251 NNNISA----------------IGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPS 292
Query: 538 SFGDLISLKFLNL 550
+F + + L
Sbjct: 293 TFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.1 bits (235), Expect = 7e-22
Identities = 58/268 (21%), Positives = 101/268 (37%), Gaps = 12/268 (4%)
Query: 328 LKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNK 387
DL N + + NL + L + N IS P + L L +YL N+
Sbjct: 33 TALLDLQNNKI-TEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 388 LNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNL 447
L LQ+L+ + K+ S+ ++ N + L + K SG F +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 448 TSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNF 507
L + + +T+IP + L+ N +T + L L + LS N+
Sbjct: 150 KKLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 508 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGV------IPA 561
S V + +L L L N+L +P D ++ + L NNN+S + P
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 562 SLEKLSYLEDLNLSFNQLEGKIPRGGSF 589
K + ++L N ++ + +F
Sbjct: 267 YNTKKASYSGVSLFSNPVQYWEIQPSTF 294
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.9 bits (224), Expect = 2e-20
Identities = 51/289 (17%), Positives = 94/289 (32%), Gaps = 24/289 (8%)
Query: 60 CNWTGVACEVHS---------QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFG 110
C+ V C +L++ + +T NL +L +L L N++
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 111 SIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPR 170
P A L+ + L NQL L+ + + + + + I
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 171 EFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILG 230
E G P G ++ L + I D + I P + +L L
Sbjct: 130 ELGTNP---------LKSSGIENGAFQGMKKLSYIRIADTNITTI-PQGLP--PSLTELH 177
Query: 231 LQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIP 290
L N ++ ++ L NL L L N+ S + N L L L N +P
Sbjct: 178 LDGNKITKVDAAS-LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 235
Query: 291 NTFGNLRNLSWLVLSDNYLTS-STQELSFLSSLSNCKFLKYFDLSYNPL 338
+ + + + L +N +++ + + + L NP+
Sbjct: 236 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 89.7 bits (221), Expect = 5e-20
Identities = 53/246 (21%), Positives = 89/246 (36%), Gaps = 5/246 (2%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427
+P+++ + + L NK+ L+ L L L +NK+ P L +L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 428 RLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSL 487
RL L N+L L LR+ ++ N ++ L + +G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142
Query: 488 PLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKF 547
+K L I ++ N + + G +L L L N++ S L +L
Sbjct: 143 NGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAK 199
Query: 548 LNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607
L LS N++S V SL +L +L+L+ N+L N +
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGS 259
Query: 608 NLQIPP 613
N PP
Sbjct: 260 NDFCPP 265
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 1e-09
Identities = 28/151 (18%), Positives = 49/151 (32%), Gaps = 5/151 (3%)
Query: 476 LNFSSNFLTGSLPLEIG-SLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGS 534
+ S L +P ++ +L DL N + + + LKNL L L N++
Sbjct: 15 VQCSDLGLE-KVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 535 IPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSA 594
P +F L+ L+ L LS N L + + L L ++ + G +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130
Query: 595 QSFEGNELLCGSPNLQIPPCKTSIHHKSWKK 625
+ K S +
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 9e-21
Identities = 26/203 (12%), Positives = 61/203 (30%), Gaps = 31/203 (15%)
Query: 688 NLIGRGGFGSVYKASLGDGMEVAVKVF----------TSQCGRAFKSFDVECEIMKSIRH 737
L+G G +V+ E VK + F V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 738 RNLIKVISSCSNEEF----KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 793
R L K+ + + A+++E + + + ++ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEVA 117
Query: 794 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAP 853
+ ++H DL NVL+ + + + DF + + + + + +
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEV---GEEGWREILERDVRNIIT 170
Query: 854 EYGREGRVSANGDVYSFGIMLME 876
+ R R D+ S +++
Sbjct: 171 YFSRTYRTEK--DINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (204), Expect = 5e-18
Identities = 57/270 (21%), Positives = 92/270 (34%), Gaps = 9/270 (3%)
Query: 240 LSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNL 299
L ++ + + L GN S L+IL L N + F L L
Sbjct: 23 LQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 300 SWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKM 359
L LSDN S +F L L L + P G +L+ +
Sbjct: 83 EQLDLSDNAQLRSVDPATF----HGLGRLHTLHLDRCGLQELGPGLFRGL--AALQYLYL 136
Query: 360 SNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD 419
+ + + +L NL ++L GN+++ L L L L N++ P+
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFS 479
+L L L L N LS + L +L+ + L N + S
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGS 256
Query: 480 SNFLTGSLPLEIGSLKVLVGIDLSRNNFSG 509
S+ + SLP + + L+ N+ G
Sbjct: 257 SSEVPCSLPQRLAGRDLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (193), Expect = 1e-16
Identities = 55/256 (21%), Positives = 90/256 (35%), Gaps = 8/256 (3%)
Query: 328 LKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNK 387
+ L N + +P + + L + + ++ + L L + L N
Sbjct: 34 SQRIFLHGNRI-SHVPAASFRACRN-LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 388 LNGSIL-ITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSN 446
S+ T L +L L L L+ P LA L L L N L F +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 447 LTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRN 505
L +L + L N ++S+P F L + L N + P L L+ + L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 506 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEK 565
N S + + L+ L+YL L N L+ S++ + +P L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 566 LSYLEDLNLSFNQLEG 581
L+ N L+G
Sbjct: 271 RDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (191), Expect = 2e-16
Identities = 63/296 (21%), Positives = 106/296 (35%), Gaps = 17/296 (5%)
Query: 67 CEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVC 126
C +++ + L +P + ++ Q + L NR+ ++ L +
Sbjct: 6 CVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 127 LRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAAN 186
L N L+ + + + L+ LDLS NA + P F L L + L
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD-------PATFHGLGRLHTLHLDRC 115
Query: 187 NLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYA 246
LQ P L L+ L + DN L + ++ L L L N +S +
Sbjct: 116 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA-FR 174
Query: 247 RLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSD 306
L +L+ L L N + P + +L L L N+ S LR L +L L+D
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234
Query: 307 NYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNC 362
N + + +L+ F S + + LP+ G L + C
Sbjct: 235 NPWVCDCRARPLWA------WLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC 284
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (172), Expect = 8e-14
Identities = 46/239 (19%), Positives = 75/239 (31%), Gaps = 13/239 (5%)
Query: 49 LAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRL 108
L W S + A + + + L P+ L L +L+L L
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 109 FGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREI 168
P L+Y+ L+ N L + +L HL L N I
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN--------RISSVP 169
Query: 169 PREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKI 228
R F L L+ + L N + P +L L L + N L + A+ + L+
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229
Query: 229 LGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSG 287
L L DN + L+ + ++P+ + + L N G
Sbjct: 230 LRLNDNPWVCDCRARPL--WAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (171), Expect = 9e-14
Identities = 62/242 (25%), Positives = 89/242 (36%), Gaps = 4/242 (1%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELY 427
+P I + I+L GN+++ + + L L L N L LA L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 428 RLDLDGNKLSGSI-PACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNF-SSNFLTG 485
+LDL N S+ PA F L L + L L + + L + N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISL 545
L L + L N S V GL +L+ L L NR+ P++F DL L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 546 KFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCG 605
L L NNLS + +L L L+ L L+ N + +E+ C
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263
Query: 606 SP 607
P
Sbjct: 264 LP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (166), Expect = 5e-13
Identities = 48/271 (17%), Positives = 82/271 (30%), Gaps = 37/271 (13%)
Query: 192 IPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNS---------------- 235
+P+ I +++ + N++ + + L IL L N
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 236 --------LSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSG 287
+ + L L L L P + L L L+ N+
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 288 FIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTV 347
+TF +L NL+ L L N ++S + + L L N + + P
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPER-----AFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 348 GNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGL 407
L + N+S E ++ L L+ + L N LQ
Sbjct: 199 DL--GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRG 255
Query: 408 KDNKLEGSIPYDICNLAELYRLDLDGNKLSG 438
+++ S+P LA L N L G
Sbjct: 256 SSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 33/209 (15%), Positives = 57/209 (27%), Gaps = 28/209 (13%)
Query: 441 PACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGI 500
AC S L ++P+ + N ++ + + L +
Sbjct: 4 GACVCYNEPKVTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61
Query: 501 DLSRNNFSGVI-------------------------PTEIGGLKNLEYLFLGYNRLQGSI 535
L N + + P GL L L L LQ
Sbjct: 62 WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121
Query: 536 PNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRG-GSFGNFSA 594
P F L +L++L L +N L + + L L L L N++ R +
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 595 QSFEGNELLCGSPNLQIPPCKTSIHHKSW 623
N + P+ + +
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 59.5 bits (142), Expect = 7e-10
Identities = 56/338 (16%), Positives = 103/338 (30%), Gaps = 25/338 (7%)
Query: 143 KSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNL 202
L+L++ LS +P +L L + N+L ++P +L++L
Sbjct: 37 DRQAHELELNNLGLS---------SLPELPPHLESL---VASCNSLT-ELPELPQSLKSL 83
Query: 203 EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS 262
+ L + P+ + + L + I +L+ L +
Sbjct: 84 LVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143
Query: 263 GTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS---TQELSFL 319
+ +L + N+ L +L + S + EL L
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203
Query: 320 SSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLR 379
L+ + L L V + + + S L+ L
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 380 TIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGS 439
N + I L++L + +NKL +P L RL N L+
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-E 318
Query: 440 IPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLN 477
+P NL L + N L P +++D L +N
Sbjct: 319 VPELPQNLKQL---HVEYNPLREFPDIPESVED-LRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 3e-09
Identities = 50/336 (14%), Positives = 101/336 (30%), Gaps = 26/336 (7%)
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEI 253
L+ R +L++ + L + + L+ L NSL+ + ++
Sbjct: 32 LRDCLDRQAHELELNNLGLSSLPEL----PPHLESLVASCNSLTELPELPQSLKSLLVDN 87
Query: 254 LSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSST 313
+L + + ++ + + + ++F + ++ L +
Sbjct: 88 NNLKALSDLPPLLEYLGVS------NNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPS 141
Query: 314 QELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEIS 373
E + + + +L + + L + N E+
Sbjct: 142 LEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQ 201
Query: 374 NLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEG--------SIPYDICNLAE 425
NL L TIY N L + S + E L+E
Sbjct: 202 NLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE 261
Query: 426 LYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTG 485
L N S I + SL +++ +N+L +P L+ L S N L
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLA- 317
Query: 486 SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNL 521
+P +LK L + N P +++L
Sbjct: 318 EVPELPQNLKQL---HVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.1 bits (136), Expect = 4e-09
Identities = 56/334 (16%), Positives = 102/334 (30%), Gaps = 25/334 (7%)
Query: 122 LKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELM 181
+ L LS + P + L+ L S N+L+ E+P +L L +
Sbjct: 40 AHELELNNLGLS-SLPELPPH---LESLVASCNSLT---------ELPELPQSLKSLLVD 86
Query: 182 SLAANNLQGKIPLKIGNLRNLEKLDIGDNK--LVGIAPIAIFNVSTLKILGLQDNSLSGC 239
+ L PL + +L+ + I + N S K+ L +
Sbjct: 87 NNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIA 146
Query: 240 LSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNL 299
+ LP L+ L ++ LS+ + + NL L
Sbjct: 147 AGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL 206
Query: 300 SWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKM 359
+ + +N L + L +L+ L + S +
Sbjct: 207 TTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL 266
Query: 360 SNCNISGGIPEE-ISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPY 418
N S +L + + NKL + +L++L N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 321
Query: 419 DICNLAELYRLDLDGNKLSGSIPACFSNLTSLRI 452
NL + L ++ N L P ++ LR+
Sbjct: 322 LPQNLKQ---LHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 8e-09
Identities = 56/325 (17%), Positives = 100/325 (30%), Gaps = 22/325 (6%)
Query: 250 NLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYL 309
L L S ++P + L L NS + +P +L++L + L
Sbjct: 39 QAHELELNNLGLS-SLPELPPH---LESLVASCNSLTE-LPELPQSLKSLLVDNNNLKAL 93
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
+ L +SN + K +L + +I+ +
Sbjct: 94 SDLPPLL-EYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 370 EEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRL 429
EE+ L NL + N + L + + E ++ L +Y
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 430 ------DLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFL 483
D ++ + LT L + L F L ++ + N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 484 TGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLI 543
+ + L +++S N +P LE L +N L +P
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLA-EVPELPQ--- 324
Query: 544 SLKFLNLSNNNLSGV--IPASLEKL 566
+LK L++ N L IP S+E L
Sbjct: 325 NLKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 49/334 (14%), Positives = 100/334 (29%), Gaps = 27/334 (8%)
Query: 74 VTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLS 133
L +++L L+ ++P +L +SL S N L +P + LK + + N L
Sbjct: 40 AHELELNNLGLS-SLPELPPHL---ESLVASCNSL-TELPELPQS---LKSLLVDNNNL- 90
Query: 134 GTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIP 193
+ L++L +S+N L + + L+ + +L+
Sbjct: 91 ---KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147
Query: 194 LKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDN-SLSGCLSSIGYARLPNLE 252
E ++ + ++ + L + + LP L
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207
Query: 253 ILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLS---WLVLSDNYL 309
+ N + + + TF ++ L N
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLY 267
Query: 310 TSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIP 369
+ S L+ ++S N L + L LE S +++ +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKL------IELPALPPRLERLIASFNHLAE-VP 320
Query: 370 EEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQ 403
E NL L ++ N L ++ L+
Sbjct: 321 ELPQNLKQL---HVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 20/83 (24%), Positives = 33/83 (39%), Gaps = 9/83 (10%)
Query: 467 FWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFL 526
+ LN S+N L LP L+ L S N+ + V +NL+ L +
Sbjct: 280 CDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAEVPEL----PQNLKQLHV 331
Query: 527 GYNRLQGSIPNSFGDLISLKFLN 549
YN L+ P+ + L+ +
Sbjct: 332 EYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 19/80 (23%), Positives = 32/80 (40%), Gaps = 8/80 (10%)
Query: 502 LSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA 561
N S I + +LE L + N+L +P L+ L S N+L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VPE 321
Query: 562 SLEKLSYLEDLNLSFNQLEG 581
+ L L++ +N L
Sbjct: 322 LPQNLKQ---LHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 3e-05
Identities = 21/106 (19%), Positives = 35/106 (33%), Gaps = 19/106 (17%)
Query: 256 LWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQE 315
+ N S I L L++ N +P L L S N+L +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLAEVPEL 322
Query: 316 LSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSN 361
L L + YNPL ++ S+E+ +M++
Sbjct: 323 PQNLKQL---------HVEYNPL------REFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 3e-05
Identities = 21/102 (20%), Positives = 36/102 (35%), Gaps = 12/102 (11%)
Query: 52 NWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGS 111
+ + + LN+S+ L +P+ L + L SFN L
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHL-AE 318
Query: 112 IPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSS 153
+P LK + + N L FP S++ L ++S
Sbjct: 319 VPELPQ---NLKQLHVEYNPLR-EFPDIP---ESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 26/96 (27%), Positives = 34/96 (35%), Gaps = 13/96 (13%)
Query: 525 FLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584
N I + SL+ LN+SNN L +PA + LE L SFN L ++P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVP 320
Query: 585 RGGSFGNFSAQSFEGNELLCGSPNLQIPPCKTSIHH 620
N E N L P S+
Sbjct: 321 --ELPQNLKQLHVEYNPLRE------FPDIPESVED 348
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 41/310 (13%), Positives = 92/310 (29%), Gaps = 42/310 (13%)
Query: 147 QHLDLSSNALSGEIRANICREIPREFGNLPELELMSL-AANNLQGKIPLKIGNLRNLEKL 205
Q LDL+ L ++ G L +++ + + + + ++ +
Sbjct: 3 QTLDLTGKNLHPDV-----------TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHM 51
Query: 206 DIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTI 265
D+ ++ + I + + L+ LSL G S I
Sbjct: 52 DLSNSVIEVSTLHGILS------------------------QCSKLQNLSLEGLRLSDPI 87
Query: 266 PRFIFNASKLSILDLE--GNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLS 323
+ S L L+L + + L L LS + + ++ +S
Sbjct: 88 VNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS 147
Query: 324 NCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYL 383
L + T V + + + + +E L L+ + L
Sbjct: 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSL 207
Query: 384 GG-NKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA 442
+ L+ L ++ L+ L + +G++ L L ++ + +
Sbjct: 208 SRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFTTIARP 264
Query: 443 CFSNLTSLRI 452
N + I
Sbjct: 265 TIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 3e-09
Identities = 45/285 (15%), Positives = 85/285 (29%), Gaps = 28/285 (9%)
Query: 99 QSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKS-SLQHLDLSSNALS 157
Q+L+L+ L + + + + R + P +QH+DLS++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLL---SQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 158 GEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAP 217
+ +L+ +SL L I + NL +L++
Sbjct: 60 VS-------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA 112
Query: 218 IAIFNVSTLKILGLQDNSLSGCLSSIGYARLPN-------LEILSLWGNNFSGTIPRFIF 270
+ S ++ L + + + L + N + +
Sbjct: 113 LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR 172
Query: 271 NASKLSILDLEGN-SFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLK 329
L LDL + F L L L LS Y L L LK
Sbjct: 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP----ETLLELGEIPTLK 228
Query: 330 YFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISN 374
+ I+P T+ L +L +++ + + I N
Sbjct: 229 TLQVFG-----IVPDGTLQLLKEALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 9e-08
Identities = 45/251 (17%), Positives = 85/251 (33%), Gaps = 16/251 (6%)
Query: 332 DLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGS 391
DL+ L P T LS + F+ + + E S ++ + L + + S
Sbjct: 6 DLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVS 61
Query: 392 ILIT-LSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDG--NKLSGSIPACFSNLT 448
L LS+ KLQ+L L+ +L I + + L RL+L G ++ S+ +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 449 SLRIVSLGSNELTSIPLTFWNLKD--------ILNLNFSSNFLTGSLPLEIGSLKVLVGI 500
L ++L + + L+ + + L ++
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 501 DLSRNNFSGVIPTEIGGLKNLEYLFLGY-NRLQGSIPNSFGDLISLKFLNLSNNNLSGVI 559
E L L++L L + G++ +LK L + G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 560 PASLEKLSYLE 570
E L +L+
Sbjct: 242 QLLKEALPHLQ 252
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 43/264 (16%), Positives = 89/264 (33%), Gaps = 30/264 (11%)
Query: 63 TGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYT- 121
V + SQ V + + +Q ++LS + + S I + +
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSK 72
Query: 122 LKYVCLRGNQLSGTFPSFISNKSSLQHLD------------------------LSSNALS 157
L+ + L G +LS + ++ S+L L+ L+ +
Sbjct: 73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132
Query: 158 GEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLV-GIA 216
++ + + +L L N + + + NL LD+ D+ ++
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192
Query: 217 PIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLS 276
F ++ L+ L L + + +P L+ L ++G GT+ L
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALP 249
Query: 277 ILDLEGNSFSGFIPNTFGNLRNLS 300
L + + F+ T GN +N
Sbjct: 250 HLQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 4e-07
Identities = 36/284 (12%), Positives = 86/284 (30%), Gaps = 22/284 (7%)
Query: 278 LDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNP 337
LDL G + P+ G L + + S +++ DLS +
Sbjct: 5 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR----VQHMDLSNSV 57
Query: 338 LYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRT--------IYLGGNKLN 389
+ + S L+ + +S I ++ +NL +
Sbjct: 58 IEVSTLHGILSQCSK-LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116
Query: 390 GSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTS 449
S L +L + ++ ++ + + +L N + +
Sbjct: 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176
Query: 450 LRIVSLGSNELTS--IPLTFWNLKDILNLNFSS-NFLTGSLPLEIGSLKVLVGIDLSRNN 506
L + L + + F+ L + +L+ S + LE+G + L + +
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236
Query: 507 FSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNL 550
G + L +L+ + + + G+ + + +
Sbjct: 237 PDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 43/212 (20%), Positives = 69/212 (32%), Gaps = 14/212 (6%)
Query: 247 RLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSD 306
++ + ++ N + +P + +IL L N F T L+ L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 307 NYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISG 366
LT L ++ +G +L +S ++
Sbjct: 65 AELTKLQV----------DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS 114
Query: 367 GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAEL 426
+ L L+ +YL GN+L L+ KL+ L L +N L + L L
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSN 458
L L N L +IP F L L N
Sbjct: 175 DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.6 bits (135), Expect = 3e-09
Identities = 50/232 (21%), Positives = 79/232 (34%), Gaps = 16/232 (6%)
Query: 93 GNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLS 152
++S +N L ++P + + L N L + + + L L+L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 153 SNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKL 212
+ G LP L + L+ N LQ L D+ N+L
Sbjct: 64 ----------RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRL 112
Query: 213 VGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNA 272
+ A+ + L+ L L+ N L + P LE LSL NN + +
Sbjct: 113 TSLPLGALRGLGELQELYLKGNELKTLPPGLLT-PTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 273 SKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSN 324
L L L+ NS IP F L + L N + + L F L +
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQD 222
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 53/210 (25%), Positives = 81/210 (38%), Gaps = 5/210 (2%)
Query: 395 TLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVS 454
+SK+ ++ L ++P D+ + L L N L A T L ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 455 LGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTE 514
L ELT + + L S+ SLPL +L L +D+S N + +
Sbjct: 62 LDRAELTKLQVDGTLPV--LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 515 IGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNL 574
+ GL L+ L+L N L+ P L+ L+L+NNNL+ + L L L+ L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 575 SFNQLEGKIPRGGSFGNFSAQSFEGNELLC 604
N L GN LC
Sbjct: 180 QENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 42/251 (16%), Positives = 70/251 (27%), Gaps = 49/251 (19%)
Query: 140 ISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNL 199
+S +S ++ L+ +P + + ++ L+ N L +
Sbjct: 6 VSKVASHLEVNCDKRNLT---------ALPPDLP--KDTTILHLSENLLYTFSLATLMPY 54
Query: 200 RNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGN 259
L +L+ L + TL +LG D S + S + +
Sbjct: 55 TRLTQLN-----LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSF 109
Query: 260 NFSGTIPRFIFNASKLS-ILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSF 318
N ++P L L+GN P L L L++N LT
Sbjct: 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL-----P 164
Query: 319 LSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNL 378
L+ + L L N LY I P+ L
Sbjct: 165 AGLLNGLENLDTLLLQENSLYTI---------------------------PKGFFGSHLL 197
Query: 379 RTIYLGGNKLN 389
+L GN
Sbjct: 198 PFAFLHGNPWL 208
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 34/219 (15%), Positives = 68/219 (31%), Gaps = 16/219 (7%)
Query: 198 NLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLW 257
L N K+ G + + A ++ + L ++ + + Y L NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEGVQY--LNNLIGLELK 71
Query: 258 GNNF-----SGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSS 312
N + + + L T V L++
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 313 TQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLS--HSLEEFKMSNCNISGGIPE 370
L+ ++N L + + L+ L K + IS P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 371 EISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKD 409
+++L NL ++L N+++ + L+ L + L +
Sbjct: 191 -LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 2e-08
Identities = 42/220 (19%), Positives = 76/220 (34%), Gaps = 18/220 (8%)
Query: 359 MSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPY 418
N++ + + ++L + T+ G + + + L L L LKDN++
Sbjct: 26 AGKSNVTDTVTQ--ADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI-----T 76
Query: 419 DICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNF 478
D+ L L ++ + ++ + L ++ L
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136
Query: 479 SSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNS 538
N +T PL + + S N T + L L L N++ P
Sbjct: 137 DLNQITNISPLAGLTNLQYL----SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 539 FGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578
L +L ++L NN +S V P L S L + L+ NQ
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 42/219 (19%), Positives = 79/219 (36%), Gaps = 16/219 (7%)
Query: 248 LPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN 307
L N ++ +N + T+ + ++ L G + L NL L L DN
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 308 YLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGG 367
+T + +T + + ++ +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 368 IPEEISNLTNLRTI-------YLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI 420
+ +++ +TN+ + YL S L L+ L KL L DNK+ P +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 421 CNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNE 459
+L L + L N++S P +N ++L IV+L +N+
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 33/221 (14%), Positives = 80/221 (36%), Gaps = 24/221 (10%)
Query: 271 NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKY 330
+ + ++ + + T +L ++ L +T+ + + L
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67
Query: 331 FDLSYNPLYRI-----LPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGG 385
+L N + + L + T LS + + + + ++++ L G
Sbjct: 68 LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 386 NKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD-------ICNLAELYRLDLDGNKLSG 438
+ + L+++ + L N SI + NL++L L D NK+S
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187
Query: 439 SIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFS 479
P ++L +L V L +N+++ + N ++ + +
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 41/211 (19%), Positives = 71/211 (33%), Gaps = 15/211 (7%)
Query: 374 NLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDG 433
L N I G + + +T + L + L + +I + L L L+L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 434 NKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGS 493
N+++ A NLT + + L N L ++ S+ + + +
Sbjct: 73 NQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 494 LKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNN 553
L+VL I +L Q S +L L L +N
Sbjct: 131 LQVL-------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 554 NLSGVIPASLEKLSYLEDLNLSFNQLEGKIP 584
+S + P L L L +++L NQ+ P
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 6e-05
Identities = 34/240 (14%), Positives = 65/240 (27%), Gaps = 37/240 (15%)
Query: 72 QRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQ 131
+ N+T T+ +L + +L+ +
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV---------------------TT 55
Query: 132 LSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGK 191
+ G + ++L L+L N ++ +I + L+ +S A K
Sbjct: 56 IEG-----VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIK 110
Query: 192 IPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILG-----LQDNSLSGCLSSIGYA 246
G + L + + + G + A
Sbjct: 111 TLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLA 170
Query: 247 RLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSD 306
L L L N S P + + L + L+ N S P N NL + L++
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 51.9 bits (123), Expect = 6e-08
Identities = 41/226 (18%), Positives = 80/226 (35%), Gaps = 24/226 (10%)
Query: 359 MSNCNISGGIPEEIS------NLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKL 412
+ + I+ +P I L + +T ++L + + ++ +
Sbjct: 3 LGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI 58
Query: 413 EGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKD 472
+ I L + +L L+GNKL+ L +L+ + + +
Sbjct: 59 KS--VQGIQYLPNVTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDL 111
Query: 473 ILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQ 532
+ S S + L L + L N + + L L+ L L N++
Sbjct: 112 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQIS 169
Query: 533 GSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQ 578
+P L L+ L LS N++S + +L L L+ L L +Q
Sbjct: 170 DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELF-SQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 6e-06
Identities = 35/210 (16%), Positives = 66/210 (31%), Gaps = 24/210 (11%)
Query: 198 NLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLW 257
K ++ + ++++ + ++ + G LPN+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV---QGIQYLPNVTKLFLN 76
Query: 258 GNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELS 317
GN + I + L L + + + ++ S L
Sbjct: 77 GNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 318 FLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTN 377
L L + L R+ T + + IS +P ++ LT
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDT----------LSLEDNQISDIVP--LAGLTK 179
Query: 378 LRTIYLGGNKLNGSILITLSKLQKLQDLGL 407
L+ +YL N + S L L+ L+ L L L
Sbjct: 180 LQNLYLSKNHI--SDLRALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 29/210 (13%), Positives = 68/210 (32%), Gaps = 22/210 (10%)
Query: 271 NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKY 330
++ +L+ S + + L ++ ++ +++ + S + + +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-------VQGIQYLPNVTK 72
Query: 331 FDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNG 390
L+ N L I L K + + + +
Sbjct: 73 LFLNGNKLTDI----------KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122
Query: 391 SILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSL 450
I + Q L + + + L +L L L+ N++S +P + LT L
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKL 180
Query: 451 RIVSLGSNELTSIPLTFWNLKDILNLNFSS 480
+ + L N ++ + LK++ L S
Sbjct: 181 QNLYLSKNHISDLR-ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 36/228 (15%), Positives = 76/228 (33%), Gaps = 32/228 (14%)
Query: 111 SIPSAIFTTYTL----KYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICR 166
++P+ I ++ + + + S T + +S+ + +++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS-------- 60
Query: 167 EIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTL 226
+ LP + + L N L PL NL+ L + ++
Sbjct: 61 --VQGIQYLPNVTKLFLNGNKLTDIKPLA-----NLKNLGWLFLDENKVKDLSSLKDLKK 113
Query: 227 KILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFS 286
+++ ++ + + + N T + +KL L LE N S
Sbjct: 114 LKSLSLEHNGISDINGLVHLPQLESL----YLGNNKITDITVLSRLTKLDTLSLEDNQIS 169
Query: 287 GFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLS 334
+P L L L LS N+++ L +L+ K L +L
Sbjct: 170 DIVP--LAGLTKLQNLYLSKNHISD-------LRALAGLKNLDVLELF 208
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 29/124 (23%), Positives = 45/124 (36%), Gaps = 5/124 (4%)
Query: 451 RIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGV 510
R++ L +LT + L + +L+ S N L P + +L+ L + S N V
Sbjct: 1 RVLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 511 IPTEIGGLKNLEYLFLGYNRLQG-SIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYL 569
L+ L L NRLQ + L LNL N+L L
Sbjct: 59 DGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 570 EDLN 573
++
Sbjct: 117 PSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 19/132 (14%), Positives = 40/132 (30%), Gaps = 17/132 (12%)
Query: 277 ILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYN 336
+L L + + L ++ L LS N L + L+ L L + + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 337 PLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNG------ 390
+ + + L + N + + + L + L GN L
Sbjct: 60 GVANLPRLQEL-LLCN--------NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110
Query: 391 SILITLSKLQKL 402
+ L + +
Sbjct: 111 RLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 22/117 (18%), Positives = 45/117 (38%), Gaps = 6/117 (5%)
Query: 359 MSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPY 418
+++ +++ + + L + + L N+L L+ L+ L+ L DN LE
Sbjct: 5 LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNALENVDGV 61
Query: 419 DICNLAELYRLDLDGNKL-SGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDIL 474
+ L L N+L + + L +++L N L L ++L
Sbjct: 62 ANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 29/133 (21%), Positives = 54/133 (40%), Gaps = 15/133 (11%)
Query: 76 VLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGT 135
VL+++ +LT + L L + L+LS NRL P+ + L+ + N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LE 56
Query: 136 FPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLK 195
++N LQ L L +N L + + P L L++L N+L + ++
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQS-------AAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109
Query: 196 ---IGNLRNLEKL 205
L ++ +
Sbjct: 110 ERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 27/108 (25%), Positives = 41/108 (37%), Gaps = 6/108 (5%)
Query: 476 LNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI 535
L+ + LT + L ++ +DLS N + P + L+ LE L +
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57
Query: 536 PNSFGDLISLKFLNLSNNNLSGV-IPASLEKLSYLEDLNLSFNQLEGK 582
+ +L L+ L L NN L L L LNL N L +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 4e-06
Identities = 20/119 (16%), Positives = 32/119 (26%), Gaps = 7/119 (5%)
Query: 205 LDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGT 264
L + L + + + + L L N L ++ L LE+L N
Sbjct: 3 LHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLRALPPALA--ALRCLEVLQASDNALENV 58
Query: 265 IPRFIFNASKLSILDLEGNSFSGF-IPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSL 322
+ L L N + L L L N L L+ +
Sbjct: 59 DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 7e-06
Identities = 26/125 (20%), Positives = 47/125 (37%), Gaps = 8/125 (6%)
Query: 405 LGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP 464
L L L ++ + L + LDL N+L P + L L ++ N L ++
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 465 LTFWNLKDILNLNFSSNFLTG-SLPLEIGSLKVLVGIDLSRNNFS---GVIPTEIGGLKN 520
NL + L +N L + + S LV ++L N+ G+ L +
Sbjct: 60 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 521 LEYLF 525
+ +
Sbjct: 119 VSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 2e-05
Identities = 27/117 (23%), Positives = 44/117 (37%), Gaps = 13/117 (11%)
Query: 147 QHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLD 206
+ L L+ L+ + L + + L+ N L+ P + LR LE L
Sbjct: 1 RVLHLAHKDLT----------VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ 49
Query: 207 IGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSG 263
DN L + +A + L L +N L + P L +L+L GN+
Sbjct: 50 ASDNALENVDGVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.7 bits (115), Expect = 4e-07
Identities = 29/155 (18%), Positives = 57/155 (36%), Gaps = 5/155 (3%)
Query: 430 DLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPL 489
+L ++ + S +L L S P + LN S+ +L +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDP-DLVAQNIDVVLNRRSSMAA-TLRI 59
Query: 490 EIGSLKVLVGIDLSRNNFSGV--IPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKF 547
++ L+ ++LS N + + + + NL+ L L N L+ + L+
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 548 LNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGK 582
L L N+LS +S + + +L+G
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 4e-05
Identities = 26/132 (19%), Positives = 44/132 (33%), Gaps = 5/132 (3%)
Query: 455 LGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTE 514
L ++ + L D L ++ + + V ++ ++ + +
Sbjct: 4 LKPEQVEQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLRII 60
Query: 515 IGGLKNLEYLFLGYNRLQG--SIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDL 572
+ L L L NRL + + +LK LNLS N L K LE+L
Sbjct: 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120
Query: 573 NLSFNQLEGKIP 584
L N L
Sbjct: 121 WLDGNSLSDTFR 132
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 1e-06
Identities = 45/160 (28%), Positives = 64/160 (40%), Gaps = 3/160 (1%)
Query: 449 SLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEI-GSLKVLVGIDLSRNNF 507
V L IP L + N L + G L LV ++L RN
Sbjct: 9 EGTTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 508 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLS 567
+G+ P G +++ L LG N+++ F L LK LNL +N +S V+P S E L+
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
Query: 568 YLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607
L LNL+ N +S G CG+P
Sbjct: 127 SLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.3 bits (108), Expect = 4e-06
Identities = 31/160 (19%), Positives = 65/160 (40%), Gaps = 4/160 (2%)
Query: 349 NLSHSLEEFKMSNCNISGGIPEEI-SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGL 407
++ E +++ + + + L +L + L N+L G +Q+L L
Sbjct: 26 DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85
Query: 408 KDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTF 467
+NK++ L +L L+L N++S +P F +L SL ++L SN
Sbjct: 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145
Query: 468 WNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNF 507
W + + + + P ++ +++ DL + F
Sbjct: 146 WFAEWLRKKSLNGGAARCGAPSKVRDVQIK---DLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.9 bits (99), Expect = 6e-05
Identities = 34/174 (19%), Positives = 66/174 (37%), Gaps = 6/174 (3%)
Query: 368 IPEEISNLTNLRTIYLGGNKLNGSILITL-SKLQKLQDLGLKDNKLEGSIPYDICNLAEL 426
IP +I + + L N+L L +L L L LK N+L G P + +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGS 486
L L NK+ F L L+ ++L N+++ + + + L ++
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 487 LPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFG 540
+ L L+ P++ +++++ L ++ + S NS G
Sbjct: 141 NCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 39/336 (11%), Positives = 95/336 (28%), Gaps = 23/336 (6%)
Query: 97 SLQSLNLSFNRL----FGSIPSAIFTTYTLKYVCLRGNQLSG----TFPSFISNKSSLQH 148
S++ +L + + S+ + + ++K + L GN + I++K L+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 149 LDLSSNALS--GEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLD 206
+ S + R + + P+L + L+ N + + +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 207 IGDN-KLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTI 265
G+ P A ++ + N
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 266 PRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNC 325
+ + K+ + + + L L L DN T +L +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA-IALKSW 242
Query: 326 KFLKYFDLSYNPL----YRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEI-----SNLT 376
L+ L+ L + + L+ ++ I + +
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 302
Query: 377 NLRTIYLGGNKLN--GSILITLSKLQKLQDLGLKDN 410
+L + L GN+ + ++ + ++ + G D
Sbjct: 303 DLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE 338
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.6 bits (111), Expect = 5e-06
Identities = 51/332 (15%), Positives = 97/332 (29%), Gaps = 25/332 (7%)
Query: 122 LKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELM 181
LK + + + + S++ + LS N + E R + + +LE+
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEA----ARWLSENIASKKDLEIA 64
Query: 182 SLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILG--LQDNSLSGC 239
+ LR L + + KL + T +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 240 LSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFS----GFIPNTFGN 295
+ L + + + NA L + N TF +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 296 LRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLE 355
R L + + N + E L L+ C+ LK DL N + L
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 356 EFKMS--NCNISGGIPEEISN------LTNLRTIYLGGNKLNGSILITL-----SKLQKL 402
++ +C +S + + L+T+ L N++ + TL K+ L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 403 QDLGLKDNKLEGSIPYDICNLAELYRLDLDGN 434
L L N+ + + E++ G
Sbjct: 305 LFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.2 bits (110), Expect = 6e-06
Identities = 37/353 (10%), Positives = 92/353 (26%), Gaps = 35/353 (9%)
Query: 145 SLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGK----IPLKIGNLR 200
S++ L +A++ + + ++ + L+ N + + + I + +
Sbjct: 4 SIEGKSLKLDAIT----TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 59
Query: 201 NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNN 260
+LE + D + + L + P L + L N
Sbjct: 60 DLEIAEFSDIFTGRVKDEIPEALRLL---------------LQALLKCPKLHTVRLSDNA 104
Query: 261 FSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLS 320
F T + + + + G + L+ N + L +
Sbjct: 105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 164
Query: 321 SLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRT 380
N + ++ + + + + G+
Sbjct: 165 CGRNR-LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQ 223
Query: 381 IYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDI------CNLAELYRLDLDGN 434
+ + ++ I L L++LGL D L + L L L N
Sbjct: 224 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 283
Query: 435 KLSGSIP-----ACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNF 482
++ + L + L N + ++++ +
Sbjct: 284 EIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGEL 336
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 3e-05
Identities = 40/326 (12%), Positives = 85/326 (26%), Gaps = 24/326 (7%)
Query: 267 RFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCK 326
RF L + + + ++ +VLS N + + ++++ K
Sbjct: 2 RFSIEGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKK 59
Query: 327 FLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSN-CNISGGIPEEISNLTNLRTIYLGG 385
L+ + S R+ K + +L
Sbjct: 60 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119
Query: 386 NKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFS 445
+ + + + L + E ++ N L + N+L ++
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179
Query: 446 NLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRN 505
+ + + +L L + + + +
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK----------VLDLQDNTFTH 229
Query: 506 NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGD------LISLKFLNLSNNNLSGVI 559
S + + NL L L L + D I L+ L L N +
Sbjct: 230 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 289
Query: 560 PASL-----EKLSYLEDLNLSFNQLE 580
+L EK+ L L L+ N+
Sbjct: 290 VRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 4e-04
Identities = 36/335 (10%), Positives = 83/335 (24%), Gaps = 21/335 (6%)
Query: 226 LKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSG----TIPRFIFNASKLSILDLE 281
LK+ + + + +++ + L GN + I + L I +
Sbjct: 10 LKLDAITTEDEKSVFAVL--LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 282 GNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRI 341
LR L +L L + + + + + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 342 LPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQK 401
L +G + + + ++ + + N T +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 402 LQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELT 461
L + + N + + Y +L L + + + L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK-SWPNLR 246
Query: 462 SIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEI-----G 516
+ L L F L+ L L N +
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENI----GLQTL---RLQYNEIELDAVRTLKTVIDE 299
Query: 517 GLKNLEYLFLGYNRL--QGSIPNSFGDLISLKFLN 549
+ +L +L L NR + + + ++ S +
Sbjct: 300 KMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 8e-04
Identities = 44/323 (13%), Positives = 96/323 (29%), Gaps = 28/323 (8%)
Query: 265 IPRFIFNASKLSILDLEGNSFSG----FIPNTFGNLRNLSWLVLSDNYLTSSTQELS--- 317
+ + + + L GN+ ++ + ++L SD + E+
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 318 --FLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNL 375
L +L C L LS N + LS + N G
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 376 TNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNK 435
L+ + + N L ++ + + G + + + + ++ + +
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 436 LSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLK 495
+ + + L+++ L N T + + + N L L G+
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 496 VLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLI-----SLKFLNL 550
V+ N L+ L L YN ++ + +I L FL L
Sbjct: 263 VVDAFSKLEN-------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 551 SNNNLSGVIPASLEKLSYLEDLN 573
+ N S ++++ +
Sbjct: 310 NGNRFSE-EDDVVDEIREVFSTR 331
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.2 bits (110), Expect = 4e-06
Identities = 27/225 (12%), Positives = 58/225 (25%), Gaps = 5/225 (2%)
Query: 240 LSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNL 299
++ I N L L +++ N I +
Sbjct: 20 VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79
Query: 300 SWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKM 359
++ + N L+Y +S + + + +L L + +
Sbjct: 80 LH---EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 136
Query: 360 SNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYD 419
+ + + ++L N + + Q + +N LE
Sbjct: 137 NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDV 196
Query: 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIP 464
+ LD+ ++ NL LR S L +P
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 46/253 (18%), Positives = 76/253 (30%), Gaps = 24/253 (9%)
Query: 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTT 119
C+ C +T IPS L + L +L A
Sbjct: 8 CSNRVFLC------------QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGF 52
Query: 120 YTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELE 179
L+ + + N + + + + H E N+ P F NLP L+
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEI------RIEKANNLLYINPEAFQNLPNLQ 106
Query: 180 LMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGC 239
+ ++ ++ + + LDI DN + F + + + L N
Sbjct: 107 YLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166
Query: 240 LSSIGYARLPNLEILSLWGNNFSGTIPRFIF-NASKLSILDLEGNSFSGFIPNTFGNLRN 298
L+ L+L NN +P +F AS ILD+ NL+
Sbjct: 167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKK 226
Query: 299 LSWLVLSDNYLTS 311
L S L
Sbjct: 227 LR--ARSTYNLKK 237
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 7/41 (17%), Positives = 13/41 (31%)
Query: 535 IPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLS 575
+ F L++S + + LE L L +
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 30/238 (12%), Positives = 62/238 (26%), Gaps = 13/238 (5%)
Query: 97 SLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNAL 156
S + +++ IPS + + +L S L+ +++S N +
Sbjct: 9 SNRVFLCQESKV-TEIPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 157 SGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIA 216
I A++ +P+ + A N L L
Sbjct: 66 LEVIEADVFSNLPKLHEIR-----IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120
Query: 217 PIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLS 276
I ++ + + + ++ + IL L N
Sbjct: 121 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDE 180
Query: 277 ILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLS 334
+ + N+ + F L +S + S L N K L+
Sbjct: 181 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY-----GLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 8/57 (14%), Positives = 14/57 (24%)
Query: 497 LVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNN 553
NN + G L + R+ +L L+ + N
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 31/220 (14%), Positives = 65/220 (29%), Gaps = 6/220 (2%)
Query: 192 IPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNL 251
IP + RN +L KL I A L+ + + N + + + ++ LP L
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 252 EILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311
+ + N I F +L+ S ++ + L +
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLP----NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 136
Query: 312 STQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEE 371
+ + + + L N N + E N N+ +
Sbjct: 137 NINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDV 196
Query: 372 ISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNK 411
+ + + +++ L L+KL+ + K
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 16/92 (17%), Positives = 31/92 (33%), Gaps = 10/92 (10%)
Query: 497 LVGIDLSRNNFSGVIPTEI-GGLKNLEYLFLGYNRLQG----SIPNSFGDLISLKFLNLS 551
+ +D+ S E+ L+ + + L L I ++ +L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 552 NNNLSGVIPASL-----EKLSYLEDLNLSFNQ 578
+N L V + ++ L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 16/91 (17%), Positives = 33/91 (36%), Gaps = 5/91 (5%)
Query: 97 SLQSLNLSFNRLFGSIPSAIFTT-YTLKYVCLRGNQLSG----TFPSFISNKSSLQHLDL 151
+QSL++ L + + + + V L L+ S + +L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 152 SSNALSGEIRANICREIPREFGNLPELELMS 182
SN L + + + + +L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 19/91 (20%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 74 VTVLNISSLNLTGTIPSQL-GNLSSLQSLNLSFNRL----FGSIPSAIFTTYTLKYVCLR 128
+ L+I L+ ++L L Q + L L I SA+ L + LR
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 129 GNQLSGTFPSFI-----SNKSSLQHLDLSSN 154
N+L + + +Q L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 13/71 (18%), Positives = 26/71 (36%), Gaps = 5/71 (7%)
Query: 520 NLEYLFLGYNRLQGS-IPNSFGDLISLKFLNLSNNNLSGV----IPASLEKLSYLEDLNL 574
+++ L + L + L + + L + L+ I ++L L +LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 575 SFNQLEGKIPR 585
N+L
Sbjct: 63 RSNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 16/83 (19%), Positives = 29/83 (34%), Gaps = 12/83 (14%)
Query: 493 SLKVLVGIDLSRNNFSGV----IPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLI----- 543
L+VL L+ + S + + +L L L N L + + +
Sbjct: 370 VLRVL---WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 544 SLKFLNLSNNNLSGVIPASLEKL 566
L+ L L + S + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 17/99 (17%), Positives = 31/99 (31%), Gaps = 11/99 (11%)
Query: 145 SLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGK----IPLKIGNLR 200
+Q LD+ LS L + +++ L L I +
Sbjct: 3 DIQSLDIQCEELSDA-------RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNP 55
Query: 201 NLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGC 239
L +L++ N+L + + +Q SL C
Sbjct: 56 ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 17/76 (22%), Positives = 26/76 (34%), Gaps = 9/76 (11%)
Query: 519 KNLEYLFLGYNRLQG----SIPNSFGDLISLKFLNLSNNNLSGVIPASL-----EKLSYL 569
L L+L + S+ + SL+ L+LSNN L L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 570 EDLNLSFNQLEGKIPR 585
E L L ++
Sbjct: 429 EQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 4/97 (4%)
Query: 201 NLEKLDIGDNKLVGIAPIAIF-NVSTLKILGLQDNSLSG-CLSSIGYA--RLPNLEILSL 256
+++ LDI +L + + +++ L D L+ I A P L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 257 WGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTF 293
N + + ++ S
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 20/147 (13%), Positives = 39/147 (26%), Gaps = 27/147 (18%)
Query: 40 HITHDPTNFLAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGT----IPSQLGNL 95
N + VL ++ +++ + + + L
Sbjct: 337 AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 396
Query: 96 SSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNA 155
SL+ L+LS N L + + S L+ L L
Sbjct: 397 HSLRELDLSNNCLGDAGILQLVE-------------------SVRQPGCLLEQLVLYDIY 437
Query: 156 LSGEIRANICREIPREFGNLPELELMS 182
S E + + + P L ++S
Sbjct: 438 WSEE----MEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 10/99 (10%), Positives = 30/99 (30%), Gaps = 5/99 (5%)
Query: 328 LKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISG----GIPEEISNLTNLRTIYL 383
++ D+ L + L + ++ +C ++ I + L + L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQ-CQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 384 GGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICN 422
N+L + + + + ++ L+
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 17/84 (20%), Positives = 27/84 (32%), Gaps = 8/84 (9%)
Query: 222 NVSTLKILGLQDNSLSG-CLSSIGYA--RLPNLEILSLWGNNFSGTIPRFIFNA-----S 273
S L++L L D +S SS+ +L L L N + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 274 KLSILDLEGNSFSGFIPNTFGNLR 297
L L L +S + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 14/65 (21%), Positives = 23/65 (35%), Gaps = 2/65 (3%)
Query: 275 LSILDLEGNSFSGF-IPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDL 333
+ LD++ S L+ + L D LT + + S+L L +L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAELNL 62
Query: 334 SYNPL 338
N L
Sbjct: 63 RSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 17/92 (18%), Positives = 36/92 (39%), Gaps = 10/92 (10%)
Query: 377 NLRTIYLGGNKLNGSILITL-SKLQKLQDLGLKDNKLEG----SIPYDICNLAELYRLDL 431
+++++ + +L+ + L LQ+ Q + L D L I + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 432 DGNKLSGSIPACF-----SNLTSLRIVSLGSN 458
N+L C + ++ +SL +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 14/91 (15%), Positives = 28/91 (30%), Gaps = 5/91 (5%)
Query: 472 DILNLNFSSNFLTGSLPLEI-GSLKVLVGIDLSRNNFSGV----IPTEIGGLKNLEYLFL 526
DI +L+ L+ + E+ L+ + L + I + + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 527 GYNRLQGSIPNSFGDLISLKFLNLSNNNLSG 557
N L + + + +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 10/92 (10%), Positives = 25/92 (27%), Gaps = 5/92 (5%)
Query: 250 NLEILSLWGNNFSGT-IPRFIFNASKLSILDLEGNSFSG----FIPNTFGNLRNLSWLVL 304
+++ L + S + + ++ L+ + I + L+ L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 305 SDNYLTSSTQELSFLSSLSNCKFLKYFDLSYN 336
N L + ++ L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 9/85 (10%)
Query: 352 HSLEEFKMSNCNISG----GIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQK-----L 402
L +++C++S + + +LR + L N L + ++ L + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 403 QDLGLKDNKLEGSIPYDICNLAELY 427
+ L L D + + L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 8/101 (7%)
Query: 288 FIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTV 347
L L L+D ++ S+ S ++L L+ DLS N L V
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCS-SLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 348 GNLSHS---LEEFKMSNCNISGGIPEEISNL----TNLRTI 381
++ LE+ + + S + + + L +LR I
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 16/92 (17%), Positives = 34/92 (36%), Gaps = 8/92 (8%)
Query: 121 TLKYVCLRGNQLSGT----FPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLP 176
L+ + L +S + + + SL+ LDLS+N L + + +
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ---PGC 426
Query: 177 ELELMSLAANNLQGKIPLKIGNLR-NLEKLDI 207
LE + L ++ ++ L + L +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 15/92 (16%), Positives = 22/92 (23%), Gaps = 4/92 (4%)
Query: 257 WGNNFSGTIPRFIFNASKLSILDLEGNSFSG----FIPNTFGNLRNLSWLVLSDNYLTSS 312
S L +L L S + T +L L LS+N L +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 313 TQELSFLSSLSNCKFLKYFDLSYNPLYRILPR 344
S L+ L +
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 17/97 (17%), Positives = 35/97 (36%), Gaps = 14/97 (14%)
Query: 172 FGNLPELELMSLAANNLQGK----IPLKIGNLRNLEKLDIGDNKLVGIAPIAIF-----N 222
L ++ LA ++ + + +L +LD+ +N L + +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 223 VSTLKILGLQDNSLSG----CLSSIGYARLPNLEILS 255
L+ L L D S L ++ P+L ++S
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL-EKDKPSLRVIS 460
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 30/208 (14%), Positives = 66/208 (31%), Gaps = 24/208 (11%)
Query: 198 NLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLW 257
L K +G + ++ + L + + + Y L NL ++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-IDGVEY--LNNLTQINFS 70
Query: 258 GNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELS 317
N + P L+ + I + +++ L N +
Sbjct: 71 NNQLTDITP-------------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 117
Query: 318 FLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTN 377
L + + + + SL++ S+ ++ P ++NLT
Sbjct: 118 ITDIDPLKNLTNLNRLELS--SNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTT 173
Query: 378 LRTIYLGGNKLNGSILITLSKLQKLQDL 405
L + + NK++ + L+KL L+ L
Sbjct: 174 LERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 36/200 (18%), Positives = 73/200 (36%), Gaps = 15/200 (7%)
Query: 373 SNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLD 432
+ L LG + ++ + L ++ L ++ SI + L L +++
Sbjct: 15 TALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFS 70
Query: 433 GNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIG 492
N+L+ NLT L + + +N++ I F++ +
Sbjct: 71 NNQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128
Query: 493 SLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSN 552
+L L S I L ++ Q + +L +L+ L++S+
Sbjct: 129 NLNRL-------ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISS 181
Query: 553 NNLSGVIPASLEKLSYLEDL 572
N +S + + L KL+ LE L
Sbjct: 182 NKVSDI--SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 31/195 (15%), Positives = 58/195 (29%), Gaps = 27/195 (13%)
Query: 271 NASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKY 330
++ L + + + + +L ++ L + S + + L
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLTQ 66
Query: 331 FDLSYNPLY--------------RILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLT 376
+ S N L + + + I +
Sbjct: 67 INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126
Query: 377 NLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKL 436
L + S + LS L LQ L N++ P + NL L RLD+ NK+
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKV 184
Query: 437 SGSIPACFSNLTSLR 451
S + + LT+L
Sbjct: 185 SD--ISVLAKLTNLE 197
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 36/187 (19%), Positives = 63/187 (33%), Gaps = 10/187 (5%)
Query: 49 LAKNWNTSTPVCNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRL 108
LA+ T N T + +VT L L + + L++L +N S N+L
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQL 74
Query: 109 FGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICR-- 166
P T + + + + ++ + N+ R
Sbjct: 75 TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 134
Query: 167 ----EIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFN 222
I L L ++ Q + NL LE+LDI NK+ I+ +A
Sbjct: 135 LSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVLA--K 192
Query: 223 VSTLKIL 229
++ L+ L
Sbjct: 193 LTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 6e-05
Identities = 27/140 (19%), Positives = 50/140 (35%), Gaps = 14/140 (10%)
Query: 270 FNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLK 329
NA + LDL G I N L + SDN + L + LK
Sbjct: 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-------KLDGFPLLRRLK 66
Query: 330 YFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISG-GIPEEISNLTNLRTIYLGGNK- 387
++ N + RI E ++N ++ G + +++L +L + + N
Sbjct: 67 TLLVNNNRICRIGEGLDQALPDL--TELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124
Query: 388 --LNGSILITLSKLQKLQDL 405
L + K+ +++ L
Sbjct: 125 TNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 3e-04
Identities = 24/134 (17%), Positives = 47/134 (35%), Gaps = 6/134 (4%)
Query: 422 NLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSN 481
N LDL G K+ I + L + NE+ + F L+ + L ++N
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNN 73
Query: 482 FLTGSLPLEIGSLKVLVGIDLSRNNFSGV-IPTEIGGLKNLEYLFLG---YNRLQGSIPN 537
+ +L L + L+ N+ + + LK+L YL + +
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133
Query: 538 SFGDLISLKFLNLS 551
+ ++ L+
Sbjct: 134 VIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 5e-04
Identities = 24/136 (17%), Positives = 45/136 (33%), Gaps = 6/136 (4%)
Query: 444 FSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLS 503
++N R + L ++ I L ++FS N + L+ L + ++
Sbjct: 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTLLVN 71
Query: 504 RNNFSGVIPTEIGGLKNLEYLFLGYNRLQG-SIPNSFGDLISLKFLNLSNNN---LSGVI 559
N + L +L L L N L + L SL +L + N
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131
Query: 560 PASLEKLSYLEDLNLS 575
+ K+ + L+
Sbjct: 132 LYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 7/42 (16%), Positives = 18/42 (42%), Gaps = 1/42 (2%)
Query: 538 SFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQL 579
+ + + + L+L + VI L + ++ S N++
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 20/134 (14%), Positives = 44/134 (32%), Gaps = 7/134 (5%)
Query: 73 RVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQL 132
R L++ + I + L +++ S N + + LK + + N++
Sbjct: 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLR--RLKTLLVNNNRI 75
Query: 133 SGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKI 192
L L L++N+L + + +L L ++ N +
Sbjct: 76 CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLK----SLTYLCILRNPVTNKKHYR 131
Query: 193 PLKIGNLRNLEKLD 206
I + + LD
Sbjct: 132 LYVIYKVPQVRVLD 145
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 1e-04
Identities = 25/109 (22%), Positives = 40/109 (36%), Gaps = 2/109 (1%)
Query: 497 LVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIP-NSFGDLISLKFLNLSNNNL 555
G+ +R+ + G +NL L++ + + L L+ L + + L
Sbjct: 10 SSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 556 SGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLC 604
V P + L LNLSFN LE + + GN L C
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 979 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.83 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.61 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.55 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.55 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.46 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.98 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.87 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.62 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.33 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.27 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.98 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.55 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.4 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=426.73 Aligned_cols=264 Identities=26% Similarity=0.398 Sum_probs=209.5
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||+||+|++.+ .||||+++... ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4678999999999999999998743 59999986442 3445788999999999999999999998765 46799999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++|+|.+++...+..+++.++..++.|||+||+||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877778999999999999999999999 899999999999999999999999999999876544333
Q ss_pred ceecccccCCCCCCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 839 MIQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.......||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+....................
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~--------- 231 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL--------- 231 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCG---------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcc---------
Confidence 34455679999999999864 358899999999999999999999997633221111111111100000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhc
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLL 965 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~ 965 (979)
...+..+++++.+++.+||+.||.+||||+||+++|+.+.+++.
T Consensus 232 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 232 ------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11223566789999999999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=422.19 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=205.5
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|+..+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++|||||+++++|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5688889999999999999998888999999987543 345779999999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+|+|.+++......+++..++.++.|||+||+||| +++|+||||||+||++++++.+||+|||+++....... ...
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence 99999999887778999999999999999999999 99999999999999999999999999999987643322 223
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 921 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (979)
....||+.|+|||++.+..++.++|||||||++|||+|+..|+....... .....+.... +
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~------------------~ 220 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGF------------------R 220 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-HHHHHHHHTC------------------C
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-HHHHHHHhcC------------------C
Confidence 34578999999999999999999999999999999999655543322111 1111111100 0
Q ss_pred hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 922 FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 922 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
...+..+++++.+++.+||+.||++|||++||+++|+++.++
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 111234566799999999999999999999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=420.89 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=207.9
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||+||+|. ..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 578899999999999999995 4679999999986543 23456799999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+++|+|.+++... ..+++.+++.++.|+++||+||| +++|+||||||+|||+++++.+||+|||+|+.........
T Consensus 85 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999764 36999999999999999999999 9999999999999999999999999999998765443333
Q ss_pred eecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 840 IQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
.....+||+.|+|||++.+..+ +.++||||+||++|||+||+.||.........+..+.....
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~---------------- 224 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------- 224 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT----------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Confidence 3456789999999999987775 57899999999999999999999764433322222211110
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.......+++++.+++.+||+.||++|||++|+++|
T Consensus 225 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001123445678999999999999999999999765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=412.74 Aligned_cols=254 Identities=23% Similarity=0.414 Sum_probs=215.9
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++++|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999998888999999997643 345789999999999999999999999999999999999999
Q ss_pred CCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCccee
Q 002021 762 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQ 841 (979)
Q Consensus 762 ~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 841 (979)
+|++.+++......+++..+.+++.|+|+||+||| +++|+||||||+||++++++.+||+|||+++...... ....
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSS 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceee
Confidence 99999998887778999999999999999999999 8999999999999999999999999999998765432 2233
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ ....+... .
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~------------------~ 218 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQG------------------L 218 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT------------------C
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhC------------------C
Confidence 44678999999999999999999999999999999998 899987643221 11111100 0
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
+...+..+++++.+++.+||+.||++|||++|++++|.+|
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1112234567799999999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=417.13 Aligned_cols=250 Identities=25% Similarity=0.321 Sum_probs=210.2
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
++|+..+.||+|+||+||+|. ..+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 469999999999999999995 4679999999997665555678999999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++|+|.+++... .+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK 172 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cc
Confidence 999999987654 5999999999999999999999 9999999999999999999999999999998764332 22
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....+||+.|+|||++.+..+++++||||+||++|||+||+.||......+. ......... .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~-----------------~ 234 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGT-----------------P 234 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCS-----------------C
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCC-----------------C
Confidence 3456799999999999999999999999999999999999999965321111 111111000 0
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..+++++.+++.+||+.||.+|||++|+++|
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223456779999999999999999999999876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-49 Score=420.36 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=209.9
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
+.|++.+.||+|+||+||+|. ..+|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 457888999999999999995 4679999999998766667788999999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
++|+|.+++.+....+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence 999999998776667999999999999999999999 999999999999999999999999999999765321 122
Q ss_pred ecccccCCCCCCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 841 QTQTLATIGYMAPEYGR-----EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
.....||+.|+|||++. +..|+.++||||+||++|||+||+.||......+ .+........
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~------------- 232 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEP------------- 232 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCC-------------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCC-------------
Confidence 34567999999999873 4568899999999999999999999997632221 1111111110
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.....+..+++++.+++.+||+.||++|||++|+++|
T Consensus 233 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 ----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111223456779999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=414.98 Aligned_cols=258 Identities=23% Similarity=0.396 Sum_probs=211.2
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
.++|+..+.||+|+||+||+|.+.+++.||||+++... ...+.|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35678889999999999999998888999999996543 345679999999999999999999998865 4578999999
Q ss_pred CCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 761 PHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 761 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++|+|.+++... ...+++.++++|+.|||+||+||| +++|+||||||+||++++++.+||+|||+|+...... ..
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence 999999987654 335899999999999999999999 8999999999999999999999999999998775332 23
Q ss_pred eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchh
Q 002021 840 IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 919 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 919 (979)
......||+.|+|||++.++.++.++|||||||++|||+||..|+............ +...
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-i~~~------------------ 226 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERG------------------ 226 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTT------------------
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH-HHhc------------------
Confidence 334567899999999999889999999999999999999977665432222111111 1100
Q ss_pred hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 920 IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 920 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
.+...+..+++++.+++.+||+.||++|||++||++.|+++..+
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 01112234567799999999999999999999999999988653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=413.70 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=206.5
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|++.+.||+|+||+||+|.. .+++.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5688899999999999999954 579999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++...+ .+++.+++.++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999987644 6899999999999999999999 9999999999999999999999999999998754322
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....||+.|+|||++.+..+++++||||+||++|||++|+.||...... ..+.......
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~---------------- 220 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISRVE---------------- 220 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTC----------------
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HHHHHHHcCC----------------
Confidence 24467999999999999999999999999999999999999999653211 1111111100
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+..+++++.+++.+||+.||++|||++|+++|
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 01122355678999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=415.53 Aligned_cols=264 Identities=23% Similarity=0.389 Sum_probs=215.3
Q ss_pred CCCCCCce-eeeecceEEEEEEcC---CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNL-IGRGGFGSVYKASLG---DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
++|...+. ||+|+||+||+|.+. ++..||||+++.... ...+.|.+|+++|++++|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555554 999999999999653 456899999975543 345779999999999999999999999865 457899
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++...+..+++.+++.++.|||+||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999998877778999999999999999999999 9999999999999999999999999999998775443
Q ss_pred Cc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 837 QS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 837 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .....+..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~-------------- 227 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQ-------------- 227 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHT--------------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHc--------------
Confidence 22 22334568999999999998999999999999999999998 99999764321 11111110
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCC
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVG 969 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~ 969 (979)
..+...+..+++++.+++.+||+.||++|||+.+|++.|+.+..++...+.
T Consensus 228 ----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~ 278 (285)
T d1u59a_ 228 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278 (285)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred ----CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence 001122345677899999999999999999999999999988877665553
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-48 Score=421.28 Aligned_cols=258 Identities=24% Similarity=0.419 Sum_probs=201.9
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CC---cEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DG---MEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
+.|+..+.||+|+||+||+|... ++ ..||||++.... ....+.|.+|+++|++++|||||+++++|.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 44666789999999999999653 33 368999886543 33456799999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++......+++.+++.++.|||+||+||| +++|+||||||+|||+++++.+||+|||+++......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999887778999999999999999999999 9999999999999999999999999999998765332
Q ss_pred Ccc---eecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 837 QSM---IQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 837 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
... ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+.... .....+...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~----------- 249 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQD----------- 249 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTT-----------
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC-----------
Confidence 211 1223457899999999999999999999999999999998 89998753221 111111110
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
.+.+.+..++.++.+++.+||+.||++|||+.||+++|+++.+
T Consensus 250 -------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 -------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111233567789999999999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-48 Score=417.16 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=213.8
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.++|+..+.||+|+||+||+|.+ .+++.||||+++... ...++|.+|++++++++|||||+++++|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 45788889999999999999965 468999999986543 3457799999999999999999999999999999999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++|+|.+++... ...+++..++.|+.|||+||+||| +++|+||||||+|||+++++.+||+|||+|+..... ..
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TY 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SS
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC-Cc
Confidence 9999999998754 457899999999999999999999 899999999999999999999999999999876533 23
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
.......||+.|+|||++.++.++.++|||||||++|||++|+.||........ ....+.. .
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~------------~----- 232 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEK------------D----- 232 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHT------------T-----
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhc------------C-----
Confidence 334455689999999999999999999999999999999998877644222111 1111110 0
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
.+...+..+++++.+++.+||+.||++|||++|+++.|+.+..
T Consensus 233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111223566789999999999999999999999999988754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=414.10 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=204.8
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|++.+.||+|+||+||+|. ..+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 568999999999999999995 4679999999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+++|+|.+++...+ .+++..++.++.|++.||+||| +++|+||||||+||++++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999887654 6999999999999999999999 99999999999999999999999999999988754443
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.......+||+.|+|||++.+..++.++||||+||++|||+||+.||......+ .+.......
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~---------------- 226 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLE---------------- 226 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTC----------------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcCC----------------
Confidence 334455679999999999999999999999999999999999999997531111 111111000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKL 957 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L 957 (979)
...+..+++++.+++.+||+.||.+|||++|++++-
T Consensus 227 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 227 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp ----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 001123456789999999999999999999986653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=411.33 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=193.0
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeecc--CCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSN--EEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 756 (979)
++|++.+.||+|+||+||+|. ..+|+.||||++.... +...+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 678999999999999999995 5679999999986543 2335668899999999999999999998854 4568999
Q ss_pred EEecCCCccceeeccC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 757 LEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGY--SAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
|||+++|+|.+++.+. ...+++..++.++.|++.||+|||+.. ..+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 457999999999999999999999311 13499999999999999999999999999988
Q ss_pred cCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
..... .......||+.|+|||++.+..+++++||||+||++|||+||+.||...... .....+...
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~~---------- 229 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREG---------- 229 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHT----------
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHHHHcC----------
Confidence 64322 2234567999999999999999999999999999999999999999753211 111111100
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... ..+..+++++.+++.+||+.||.+|||++|+++|
T Consensus 230 -~~~-------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 230 -KFR-------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -CCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCC-------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000 0112356679999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=408.40 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=205.0
Q ss_pred CCCCCCceeeeecceEEEEEEcCCC-----cEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDG-----MEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
+.|+..++||+|+||+||+|.+.+. ..||||++..... .....|.+|++++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999965432 4799999865432 334578899999999999999999999999999999
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+.+|++.+++......+++.++++++.||+.|++||| +++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999988877778999999999999999999999 999999999999999999999999999999876433
Q ss_pred CC-cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQ-SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. ........||+.|+|||++.++.++.++|||||||++|||++|..|+....... .....+...
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~------------- 229 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDG------------- 229 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTT-------------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHhcc-------------
Confidence 22 222334568999999999999999999999999999999999777654322221 111111110
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
.+.+.+..++.++.+++.+||+.||++||||.||++.|+++.+.
T Consensus 230 -----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 01112234667799999999999999999999999999988763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=419.16 Aligned_cols=255 Identities=23% Similarity=0.389 Sum_probs=208.9
Q ss_pred CCCCCCceeeeecceEEEEEEcCC------CcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCee
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGD------GMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 753 (979)
++|++.+.||+|+||+||+|++.. ...||||++.... ......+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578889999999999999996532 2369999986543 33456788999999998 899999999999999999
Q ss_pred EEEEEecCCCccceeeccCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 002021 754 ALVLEYMPHGSLEKYLYSSN----------------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPS 811 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~ 811 (979)
++||||+++|+|.++++..+ ..+++.+++.++.||++||+||| +++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence 99999999999999997643 24789999999999999999999 899999999999
Q ss_pred CEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccC
Q 002021 812 NVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNG 890 (979)
Q Consensus 812 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~ 890 (979)
||+++.++.+||+|||+|+...............||+.|||||++.++.+++++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987655544444556678999999999999999999999999999999998 89999753322
Q ss_pred cchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHH
Q 002021 891 EMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLL 958 (979)
Q Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~ 958 (979)
+ .+...+... .+...+..+++++.+++.+||+.||++|||++||+++|.
T Consensus 274 ~-~~~~~~~~~------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 A-NFYKLIQNG------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H-HHHHHHHTT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H-HHHHHHhcC------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 122211111 111223456678999999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=401.32 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=196.5
Q ss_pred CCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeecc----CCeeEEEE
Q 002021 685 SENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSN----EEFKALVL 757 (979)
Q Consensus 685 ~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 757 (979)
+..+.||+|+||+||+|. ..+++.||+|++.... ....+.+.+|++++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 455689999999999995 4578999999986542 2345678999999999999999999999854 45679999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCEEeC-CCCcEEEEeeccccccCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--i~H~Dik~~NIll~-~~~~~kl~Dfg~~~~~~~ 834 (979)
||+++|+|.+++.+.. .+++.+++.++.||++||+||| +++ |+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999997643 6899999999999999999999 777 99999999999996 588999999999986432
Q ss_pred CCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 835 EDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 835 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
.. ....+||+.|+|||++.+ .+++++||||+||++|||++|+.||..................
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~------------ 230 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------------ 230 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------------
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC------------
Confidence 21 235679999999998864 6999999999999999999999999653222211111111000
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..+++++.+++.+||+.||++|||++|+++|
T Consensus 231 ------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 231 ------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 001122345678999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=407.58 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=202.7
Q ss_pred ceeeeecceEEEEEEcC---CCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecCC
Q 002021 688 NLIGRGGFGSVYKASLG---DGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 762 (979)
Q Consensus 688 ~~lG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 762 (979)
+.||+|+||+||+|.+. .++.||||+++... ....+.+.+|++++++++|||||+++++|.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 57999999999999653 35689999986543 22356799999999999999999999999654 57899999999
Q ss_pred CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc-cee
Q 002021 763 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS-MIQ 841 (979)
Q Consensus 763 g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 841 (979)
|+|.+++.... .+++.+++.++.|||.||+||| +++|+||||||+||+++.++.+|++|||+++........ ...
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999987654 6899999999999999999999 899999999999999999999999999999876544332 223
Q ss_pred cccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 842 TQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+.... .....+... .
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~------------------~ 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKG------------------E 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT------------------C
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcC------------------C
Confidence 34578999999999999999999999999999999998 89999763221 111111100 0
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
+...+..+++++.+++.+||+.||++|||++||++.|+.+..+.
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 11122456778999999999999999999999999998876543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.4e-47 Score=417.50 Aligned_cols=253 Identities=19% Similarity=0.264 Sum_probs=211.0
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.++|++.+.||+|+||+||+|. ..+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3579999999999999999995 467999999999766555567789999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--CCCcEEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~--~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
+++|+|.+++......+++.+++.++.||+.||+||| +++|+||||||+|||++ .++.+||+|||+++.......
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999999777667999999999999999999999 99999999999999996 467899999999987643322
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.........
T Consensus 182 ---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~-------------- 243 (350)
T d1koaa2 182 ---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWN-------------- 243 (350)
T ss_dssp ---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC--------------
T ss_pred ---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC--------------
Confidence 24567999999999999999999999999999999999999999653211 111111110000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........+++++.+++.+||+.||++|||++|+++|
T Consensus 244 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 --MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011123456678999999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.8e-47 Score=416.59 Aligned_cols=252 Identities=20% Similarity=0.281 Sum_probs=210.7
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEec
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYM 760 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 760 (979)
+.|++.+.||+|+||.||+|. ..+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 578999999999999999995 4679999999987655445567889999999999999999999999999999999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC--CCCcEEEEeeccccccCCCCCc
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~--~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
++|+|.+++......+++.+++.|+.||+.||+||| +++|+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence 999999988877778999999999999999999999 99999999999999998 67899999999998875332
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
......||+.|+|||++.+..++.++||||+||++|||+||+.||......+ .+.........
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~--------------- 246 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE--------------- 246 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC---------------
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC---------------
Confidence 2245678999999999999999999999999999999999999996532111 11111110000
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........+++++.+++.+||+.||.+|||+.|+++|
T Consensus 247 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 -FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001122456678999999999999999999999886
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=418.26 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=205.9
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.++|+..+.||+|+||+||+|. ..+|+.||||+++.... ...+.+.+|++++++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4679999999999999999995 46799999999875432 334678899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
|+++|+|.+++.+.+ .+++..++.++.|+++||+||| + ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 999999999997654 6899999999999999999999 6 489999999999999999999999999998763221
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhh--hhcC------------
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN--DWLP------------ 903 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~--~~~~------------ 903 (979)
....+||+.|+|||++.+..|++++||||+||++|||++|+.||......+........ ....
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 23468999999999999999999999999999999999999999753322111100000 0000
Q ss_pred -----------CccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 904 -----------ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 904 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+..+....... ........+.++.+++.+|++.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000000000000 000001234678999999999999999999999997
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-47 Score=411.10 Aligned_cols=252 Identities=19% Similarity=0.289 Sum_probs=192.1
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.+.|++.+.||+|+||+||+|. ..+|+.||||++.... ....+.+.+|+++++.++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4568899999999999999995 4579999999987543 2334567889999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeC---CCCcEEEEeeccccccCCC
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~---~~~~~kl~Dfg~~~~~~~~ 835 (979)
|++||+|.+++... ..+++.++..++.||+.||+||| +++|+||||||+||++. +++.+||+|||+++.....
T Consensus 88 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999999999764 36999999999999999999999 99999999999999995 5789999999999865322
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
. .....+||+.|+|||++.+..|++++||||+||++|||++|+.||.+....+ ..........
T Consensus 164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~------------- 226 (307)
T d1a06a_ 164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKAEY------------- 226 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTTCC-------------
T ss_pred C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhccCC-------------
Confidence 2 2245679999999999999999999999999999999999999997532211 1111111000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+....+++++.+++.+||+.||++|||++|+++|
T Consensus 227 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 ---EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00111223456779999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=404.57 Aligned_cols=260 Identities=24% Similarity=0.389 Sum_probs=207.2
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEecC
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEYMP 761 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 761 (979)
++|++.+.||+|+||+||+|.+.+++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 578889999999999999998888889999999654 3345789999999999999999999999865 45789999999
Q ss_pred CCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcce
Q 002021 762 HGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMI 840 (979)
Q Consensus 762 ~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 840 (979)
+|+|.+++... ...+++.+++.++.|||.||+||| +++|+||||||+|||+++++++||+|||+++...... ...
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-cee
Confidence 99999888654 346899999999999999999999 8999999999999999999999999999998764332 223
Q ss_pred ecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCchhh
Q 002021 841 QTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 920 (979)
Q Consensus 841 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (979)
.....||+.|+|||++..+.++.++|||||||++|||+||+.|+................ .
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-------------------~ 231 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-------------------Y 231 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------------C
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------------------C
Confidence 344678999999999999999999999999999999999877765433222211111110 0
Q ss_pred hhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhcc
Q 002021 921 HFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLR 966 (979)
Q Consensus 921 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~ 966 (979)
+.+.+..++.++.+++.+||+.||++|||++||++.|+++.....+
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 1112234567799999999999999999999999999887765443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=408.96 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=207.4
Q ss_pred CCCCCCceeeeecceEEEEEEc-CCCc----EEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL-GDGM----EVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
++|+..+.||+|+||+||+|.+ .+|+ +||||++.... ....+.|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 4688999999999999999965 3444 68999886443 34567899999999999999999999999865 4678
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
++||+.+|+|.+++......+++..+++++.|||+||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999999888888999999999999999999999 899999999999999999999999999999987654
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
..........||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ ....+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~------------- 229 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKG------------- 229 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHT-------------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcC-------------
Confidence 44444445578999999999999999999999999999999999 788886532221 11111110
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
.+.+.+..+++.+.+++.+||+.||++|||+.||+++|.++...
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 11122345667899999999999999999999999999988653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=400.58 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=207.5
Q ss_pred hCCCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccc------cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG------RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
.+.|++.+.||+|+||+||+|.. .+|+.||||++.+... ...+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35689999999999999999954 6799999999864321 2346789999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC----cEEEEeeccc
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFSIA 829 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~----~~kl~Dfg~~ 829 (979)
|+||||+++|+|.+++...+ .+++.+++.++.|++.||+||| +++|+||||||+||+++.++ .+|++|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999987654 6999999999999999999999 99999999999999998776 5999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+......
T Consensus 165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~--------- 231 (293)
T d1jksa_ 165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAV--------- 231 (293)
T ss_dssp EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTT---------
T ss_pred hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHHHHhc---------
Confidence 8764322 2245678999999999999899999999999999999999999997532111 11111000
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
........+..++..+.+++.+||+.||++|||++|+++|
T Consensus 232 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 -------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp -------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011122334566779999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=406.34 Aligned_cols=245 Identities=25% Similarity=0.344 Sum_probs=200.4
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
.|+..+.||+|+||+||+|. ..+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 37888999999999999995 56899999999875432 234568899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+++|++..++... ..+++.+++.++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|......
T Consensus 96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 99999987665443 46999999999999999999999 999999999999999999999999999999865322
Q ss_pred ceecccccCCCCCCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhccccc
Q 002021 839 MIQTQTLATIGYMAPEYGRE---GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLL 915 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (979)
....||+.|+|||++.+ +.|+.++||||+||++|||++|+.||.+....+ .+........+
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~------------ 232 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESP------------ 232 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCC------------
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCC------------
Confidence 34579999999998753 468999999999999999999999996532211 11111110000
Q ss_pred CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 916 SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 916 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...+..+++++.+++.+||+.||++|||++|+++|
T Consensus 233 ------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 233 ------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 00112345679999999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=397.28 Aligned_cols=252 Identities=29% Similarity=0.436 Sum_probs=201.1
Q ss_pred hCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc-CCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~ 759 (979)
.++|+..+.||+|+||.||+|++ .|+.||||+++.. ...+.+.+|++++++++||||++++++|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35678889999999999999988 5889999999654 445789999999999999999999998854 5668999999
Q ss_pred cCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 760 MPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 760 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
+++|+|.+++... ...+++..+++|+.||+.|++||| +++|+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999999764 235899999999999999999999 999999999999999999999999999999865322
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
.....+|..|+|||++.++.+++++|||||||++|||+| |+.||...... +...++...
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~---------------- 216 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKG---------------- 216 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTT----------------
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcC----------------
Confidence 233467899999999999999999999999999999998 67776543221 222221110
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
.+.+.+..+++++.+++.+||+.||.+||||.|++++|+++...
T Consensus 217 --~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 217 --YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 11112234567799999999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=400.76 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=202.2
Q ss_pred hCCCCCCceeeeecceEEEEEEcC----CCcEEEEEEeccccc-cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG----DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKAL 755 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 755 (979)
.++|+..+.||+|+||+||+|.+. .+..||||+++.... ...+.+.+|++++++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 357888999999999999999653 245789998865432 34567899999999999999999999996 467899
Q ss_pred EEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCC
Q 002021 756 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGE 835 (979)
Q Consensus 756 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~ 835 (979)
||||+++|++.+++......+++.+++.++.||++||+||| +++|+||||||+||++++++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999998877778999999999999999999999 999999999999999999999999999999876433
Q ss_pred CCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcccc
Q 002021 836 DQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANL 914 (979)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (979)
. ........||+.|+|||.+.++.++.++|||||||++|||+| |..||......+ ....+....
T Consensus 162 ~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~~------------ 226 (273)
T d1mp8a_ 162 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGE------------ 226 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC------------
T ss_pred c-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCC------------
Confidence 2 223345568999999999999999999999999999999998 888887643221 111111100
Q ss_pred cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 915 LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 915 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
+.+.+..+++++.+++.+||+.||++|||+.||+++|+++.++-
T Consensus 227 ------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 227 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 01122356678999999999999999999999999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-46 Score=404.85 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=212.8
Q ss_pred HHHhhCCCCCCceeeeecceEEEEEEc------CCCcEEEEEEecccccc-chhcHHHHHHHHHhcCCCCeeeEEEeecc
Q 002021 677 LCRATDGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCGR-AFKSFDVECEIMKSIRHRNLIKVISSCSN 749 (979)
Q Consensus 677 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 749 (979)
++...++|+..+.||+|+||+||+|++ .+++.||||++...... ..+.|.+|++++++++||||++++++|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 334457899999999999999999965 34678999998754333 35679999999999999999999999999
Q ss_pred CCeeEEEEEecCCCccceeeccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 002021 750 EEFKALVLEYMPHGSLEKYLYSS-----------------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 806 (979)
Q Consensus 750 ~~~~~lv~E~~~~g~L~~~l~~~-----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~ 806 (979)
++..++||||+++|+|.++++.. ...+++.+++.|+.|+|.||+||| +++|+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence 99999999999999999988642 234889999999999999999999 9999999
Q ss_pred CCCCCCEEeCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCC-CCc
Q 002021 807 DLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKK-PTD 885 (979)
Q Consensus 807 Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~-P~~ 885 (979)
||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..+++++|||||||++|||++|.. ||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999987654444444455678999999999999999999999999999999999864 565
Q ss_pred ccccCcchHhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhH
Q 002021 886 EIFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIR 961 (979)
Q Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~ 961 (979)
..... .....+.... ....+..+++++.+++.+||+.||++||||.||++.|+++.
T Consensus 245 ~~~~~--e~~~~v~~~~------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHE--EVIYYVRDGN------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHH--HHHHHHHTTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHH--HHHHHHHcCC------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 42211 1111111100 01122356677999999999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=401.39 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=202.2
Q ss_pred HhhCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEecccc-ccchhcHHHHHHHHHhc-CCCCeeeEEEeecc-
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSI-RHRNLIKVISSCSN- 749 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 749 (979)
...++|+..+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|.+++.++ +|+||+.+++++.+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 33467899999999999999999642 35789999987543 23456677888888777 68999999998765
Q ss_pred CCeeEEEEEecCCCccceeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEE
Q 002021 750 EEFKALVLEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL 814 (979)
Q Consensus 750 ~~~~~lv~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIl 814 (979)
....++||||+++|+|.++++.. ...+++.+++.++.||++||+||| +++|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcccee
Confidence 45689999999999999998653 235889999999999999999999 999999999999999
Q ss_pred eCCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCC-CCCcccccCcch
Q 002021 815 LDDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK-KPTDEIFNGEMT 893 (979)
Q Consensus 815 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~P~~~~~~~~~~ 893 (979)
+++++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||...... ..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EE 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HH
Confidence 9999999999999998765544444445668999999999999999999999999999999999975 466543222 22
Q ss_pred HhHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 894 LKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
+...+.... +...+..+++++.+++.+||+.||++|||++|+++||+++.++
T Consensus 246 ~~~~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 FCRRLKEGT------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHTC------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCC------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 222111111 1112234567799999999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=404.68 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=208.6
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 756 (979)
.++|++.+.||+|+||.||+|+ ..+|+.||||++.+.. ....+.+.+|+++|++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 3679999999999999999995 5689999999997542 33456788999999999999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++...+ .+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999987654 6899999999999999999999 9999999999999999999999999999998754332
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
. .....+||+.|+|||++.+..|++++||||+||++|||++|+.||......+ .+.......
T Consensus 160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i~~~~--------------- 221 (337)
T d1o6la_ 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILMEE--------------- 221 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC---------------
T ss_pred c--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHHhcCC---------------
Confidence 2 2345689999999999999999999999999999999999999997632211 111110000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
...+..+++++.+++.+|++.||++||+ ++|+++|
T Consensus 222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 0112345677899999999999999994 8999886
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=395.96 Aligned_cols=260 Identities=25% Similarity=0.411 Sum_probs=210.3
Q ss_pred CceeeeecceEEEEEEcCC----CcEEEEEEeccc-cccchhcHHHHHHHHHhcCCCCeeeEEEeecc-CCeeEEEEEec
Q 002021 687 NNLIGRGGFGSVYKASLGD----GMEVAVKVFTSQ-CGRAFKSFDVECEIMKSIRHRNLIKVISSCSN-EEFKALVLEYM 760 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~ 760 (979)
.++||+|+||+||+|.+.+ ...||||++... .....++|.+|++++++++||||+++++++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999997543 236999998643 33355789999999999999999999999764 56889999999
Q ss_pred CCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc--
Q 002021 761 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS-- 838 (979)
Q Consensus 761 ~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~-- 838 (979)
++|+|.+++.......++..+++++.|+|+||.|+| +++|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999888778889999999999999999999 999999999999999999999999999999876433221
Q ss_pred ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCch
Q 002021 839 MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 918 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 918 (979)
.......||+.|+|||.+..+.++.++||||||+++|||+||+.||....... +...++....
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~---------------- 251 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGR---------------- 251 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTC----------------
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCC----------------
Confidence 22334568999999999999999999999999999999999888876533221 1111111100
Q ss_pred hhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 919 DIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 919 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
+...+..+++++.+++.+||+.||++||++.||+++|+++..++..+.
T Consensus 252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 111223456779999999999999999999999999999998766553
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=397.58 Aligned_cols=276 Identities=23% Similarity=0.299 Sum_probs=203.5
Q ss_pred CCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHH--HHHHHhcCCCCeeeEEEeeccCC----eeEEE
Q 002021 683 GFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVE--CEIMKSIRHRNLIKVISSCSNEE----FKALV 756 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~~~----~~~lv 756 (979)
+|...+.||+|+||+||+|++ +|+.||||+++... .+.+.+| +..++.++|||||++++++.+++ ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 456678999999999999987 68999999986432 2334444 44456789999999999986543 57999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG-----YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
|||+++|+|.+++++. .+++.++++++.|+|.|++|+|.. .+++|+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999875 589999999999999999999932 136999999999999999999999999999987
Q ss_pred cCCCCCc--ceecccccCCCCCCccccCCC------CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC
Q 002021 832 LTGEDQS--MIQTQTLATIGYMAPEYGREG------RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 903 (979)
Q Consensus 832 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 903 (979)
....... .......||+.|+|||++.+. .++.++|||||||++|||+||..||......+..+.........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 7543322 223456799999999987654 36778999999999999999999876543332222211000000
Q ss_pred Cc-cchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 904 IS-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 904 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
.. ..........+...........++..+.+++.+||+.||++|||+.||+++|+++.++-
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 00 00011111111111122233456677999999999999999999999999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=398.24 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=208.7
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
.++|++.+.||+|+||+||+|. ..+|+.||||+++... .....+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4678899999999999999995 4679999999997543 2345688999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC--CCcEEEEeeccccccCCCCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~--~~~~kl~Dfg~~~~~~~~~~ 837 (979)
++||+|.+++...+..+++.+++.++.||+.|++||| +++|+||||||+|||++. ...+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 9999999999887767999999999999999999999 999999999999999985 4589999999998764322
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
......+|+.|+|||...+..+++++||||+||++|||++|+.||......+ .+...... .
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~----------------~ 219 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNA----------------E 219 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHT----------------C
T ss_pred --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC----------------C
Confidence 2344678999999999999999999999999999999999999997532111 11111110 0
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..........+++++.+++.+|++.||.+|||++|+++|
T Consensus 220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011112223456779999999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-45 Score=398.53 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=205.5
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|++.+.||+|+||+||+|+ ..+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 578899999999999999995 4679999999986432 334567889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||++||++.+++.... .+++..++.++.||+.|++||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 9999999988877654 6788999999999999999999 9999999999999999999999999999998764322
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
...+||+.|+|||++.+..|++++||||+||++|||+||+.||......+ .........
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~---------------- 217 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAE---------------- 217 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCC----------------
T ss_pred ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHHHHHcCC----------------
Confidence 34679999999999999899999999999999999999999997532111 111111100
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
...+..+++++.+++.+|++.||.+|+ |++|+++|
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 001123456789999999999999996 99999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-45 Score=392.04 Aligned_cols=260 Identities=23% Similarity=0.367 Sum_probs=202.8
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc---cchhcHHHHHHHHHhcCCCCeeeEEEeeccCC----e
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG---RAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----F 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 752 (979)
.++|++.+.||+|+||+||+|. ..+|+.||||+++.... ...+.+.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 3679999999999999999995 56899999999975432 23456889999999999999999999886543 4
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.|+||||++||+|.+++...+ .+++.+++.++.||+.||+||| +++|+||||||+||+++.++.++++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence 789999999999999886654 6899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCC-cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 833 TGEDQ-SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 833 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
..... .......+||+.|+|||++.+..+++++||||+||++|||+||+.||......+. ....+...
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~---------- 230 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVRED---------- 230 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCC----------
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcC----------
Confidence 43322 2233456799999999999998999999999999999999999999975322111 11111100
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC-CHHHHHHHHHHhH
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-NAKEIVTKLLKIR 961 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~eil~~L~~~~ 961 (979)
..........+++++.+++.+|++.||++|| |++|+++.|.+++
T Consensus 231 ------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 ------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0000111234567799999999999999999 8999999998876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=396.05 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=199.0
Q ss_pred CCCCCCceeeeecceEEEEEEc--CCC--cEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeE
Q 002021 682 DGFSENNLIGRGGFGSVYKASL--GDG--MEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~--~~~--~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 754 (979)
++|+..+.||+|+||+||+|+. .++ ..||||++.+.. ....+.|.+|++++++++|||||+++++|.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 5688899999999999999964 222 478999986542 23456789999999999999999999999764 678
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+||||+++|++.+++......+++..++.++.|+|+||+||| +++|+||||||+||+++.++.+|++|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999988877677999999999999999999999 89999999999999999999999999999997754
Q ss_pred CCCc-ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 835 EDQS-MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.... .......+|..|+|||.+.+..++.++|||||||++|||+| |+.||...... ....++...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~~----------- 230 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKE----------- 230 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTS-----------
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHHHHHHhC-----------
Confidence 4332 22334567889999999999999999999999999999998 89998753211 111111100
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHh
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKI 960 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~ 960 (979)
..+.+.+..+++.+.+++.+||+.||.+||||.||++.|++.
T Consensus 231 ------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 ------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 011112234567799999999999999999999999988764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.2e-45 Score=387.52 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=205.4
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccccc---------chhcHHHHHHHHHhcC-CCCeeeEEEeeccC
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGR---------AFKSFDVECEIMKSIR-HRNLIKVISSCSNE 750 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 750 (979)
++|+..+.||+|+||+||+|+ ..+|+.||||++...... ..+.+.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 578899999999999999995 468999999998654311 2245788999999997 99999999999999
Q ss_pred CeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccc
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAK 830 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~ 830 (979)
+..|+||||+++|+|.+++...+ .+++.+++.++.||++||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999999997654 6899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCC------CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCC
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGRE------GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 904 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 904 (979)
...... ......||+.|+|||.+.+ ..+++++||||+||++|||++|+.||....... ..........
T Consensus 159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~-- 232 (277)
T d1phka_ 159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNY-- 232 (277)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC--
T ss_pred EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCC--
Confidence 764322 2245679999999998753 357889999999999999999999997632211 1111111100
Q ss_pred ccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 905 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....+....+++++.+++.+||++||++|||++|+++|
T Consensus 233 --------------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 233 --------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --------------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --------------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01111223566789999999999999999999999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=394.72 Aligned_cols=262 Identities=22% Similarity=0.362 Sum_probs=215.1
Q ss_pred hCCCCCCceeeeecceEEEEEEc------CCCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKASL------GDGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 752 (979)
.++|+..+.||+|+||.||+|++ .+++.||||+++.... .....+.+|+.+++++ +|||||+++++|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 36788889999999999999964 3567899999975432 3445788999999999 69999999999999999
Q ss_pred eEEEEEecCCCccceeeccCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 753 KALVLEYMPHGSLEKYLYSSN-----------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
.++||||+++|+|.++++... ..+++..+..++.||++|++||| +++|+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence 999999999999999986542 35889999999999999999999 9999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHh
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 895 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~ 895 (979)
+.++.+|++|||.++...............||+.|+|||++.++.+++++|||||||++|||+|++.|+.........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999987655545555667899999999999999999999999999999999995555443333322222
Q ss_pred HhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHh
Q 002021 896 HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDS 963 (979)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~ 963 (979)
..+.... +...+..+++.+.+|+.+||+.||.+||||.||+++|+++...
T Consensus 259 ~~i~~~~------------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 KMIKEGF------------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHTC------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCC------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 2222111 1112234556799999999999999999999999999987654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=393.62 Aligned_cols=261 Identities=27% Similarity=0.435 Sum_probs=207.9
Q ss_pred CCCCCCceeeeecceEEEEEEcC-CCc--EEEEEEeccc-cccchhcHHHHHHHHHhc-CCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKASLG-DGM--EVAVKVFTSQ-CGRAFKSFDVECEIMKSI-RHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 756 (979)
++|+..+.||+|+||+||+|.+. +|. .||||++... .....+.+.+|+++++++ +|||||+++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888899999999999999654 444 4788887543 234567799999999998 799999999999999999999
Q ss_pred EEecCCCccceeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcE
Q 002021 757 LEYMPHGSLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 821 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~ 821 (979)
|||+++|+|.++++.. ...+++.++++++.|||+|+.|+| +++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 9999999999998653 357899999999999999999999 9999999999999999999999
Q ss_pred EEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCC-CCcccccCcchHhHhhhh
Q 002021 822 HLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKK-PTDEIFNGEMTLKHWVND 900 (979)
Q Consensus 822 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~-P~~~~~~~~~~~~~~~~~ 900 (979)
||+|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|.. ||.... .......+..
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i~~ 241 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQ 241 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHGGG
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHHHHh
Confidence 99999999764322 22234568999999999999999999999999999999999765 554321 1111111110
Q ss_pred hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCC
Q 002021 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNV 968 (979)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~ 968 (979)
..+...+..+++++.+++.+||+.||++||||+||+++|+++.++....+
T Consensus 242 ------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~ 291 (309)
T d1fvra_ 242 ------------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291 (309)
T ss_dssp ------------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred ------------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCC
Confidence 01112223466789999999999999999999999999999997665443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=394.13 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=200.7
Q ss_pred hCCCCCCc-eeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhc-CCCCeeeEEEeecc----CCee
Q 002021 681 TDGFSENN-LIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSI-RHRNLIKVISSCSN----EEFK 753 (979)
Q Consensus 681 ~~~~~~~~-~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 753 (979)
.++|++.. .||+|+||.||+|. ..+++.||||+++. .+.+.+|++++.++ +|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36787764 69999999999995 56899999999853 25577899987654 89999999998864 5678
Q ss_pred EEEEEecCCCccceeeccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEEeeccc
Q 002021 754 ALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFSIA 829 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfg~~ 829 (979)
|+|||||+||+|.+++... ...+++.+++.++.||+.||+||| +++|+||||||+||++++ ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence 9999999999999999765 346999999999999999999999 999999999999999985 567999999999
Q ss_pred cccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 830 KMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
+....... .....||+.|+|||++.+..|++++||||+||++|||+||+.||.+...... .... ....
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~-~~~i------- 229 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGM-KTRI------- 229 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CC-------
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHH-HHHH-------
Confidence 87643322 2456799999999999999999999999999999999999999975322111 0000 0000
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..............+++++.+++.+|++.||++|||+.|+++|
T Consensus 230 ----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 230 ----RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000111112334567889999999999999999999999886
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=394.53 Aligned_cols=259 Identities=28% Similarity=0.429 Sum_probs=207.8
Q ss_pred hCCCCCCceeeeecceEEEEEEcC--------CCcEEEEEEeccccc-cchhcHHHHHHHHHhc-CCCCeeeEEEeeccC
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG--------DGMEVAVKVFTSQCG-RAFKSFDVECEIMKSI-RHRNLIKVISSCSNE 750 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 750 (979)
.++|++++.||+|+||.||+|+.. ++..||||+++.... .....+.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 357888899999999999999642 235799999976543 3456788899998888 899999999999999
Q ss_pred CeeEEEEEecCCCccceeeccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEe
Q 002021 751 EFKALVLEYMPHGSLEKYLYSSN---------------CILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 815 (979)
Q Consensus 751 ~~~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll 815 (979)
+..++||||+++|+|.+++.... ..+++.+++.++.|+|.||+||| +++|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 99999999999999999996543 35899999999999999999999 9999999999999999
Q ss_pred CCCCcEEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCcccccCcchH
Q 002021 816 DDNMVAHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTL 894 (979)
Q Consensus 816 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~P~~~~~~~~~~~ 894 (979)
+.++.+||+|||+++...............+|+.|+|||.+.++.|++++|||||||++|||++ |..||...... ..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence 9999999999999987755444444455678999999999999999999999999999999998 67787643221 11
Q ss_pred hHhhhhhcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHH
Q 002021 895 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRD 962 (979)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~ 962 (979)
...+... .+...+..+++++.+++.+||+.||++||||.||++.|+++..
T Consensus 247 ~~~i~~~------------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 FKLLKEG------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHTT------------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcC------------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111110 0111223456779999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-44 Score=398.26 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=200.5
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHH---HHHHHhcCCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVE---CEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
.++|++.+.||+|+||.||+|. ..+|+.||||++.+.. ......+.+| +++++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 3679999999999999999995 4579999999986432 1122334444 6667777899999999999999999
Q ss_pred EEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccC
Q 002021 754 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLT 833 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~ 833 (979)
|+||||+++|+|.+++.... .+++.+++.++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999987653 6889999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 834 GEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
... .....||+.|+|||++.. ..|++++||||+||++|||+||+.||......... ..........
T Consensus 159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~~------- 225 (364)
T d1omwa3 159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMA------- 225 (364)
T ss_dssp SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSSSCC-------
T ss_pred CCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcccCC-------
Confidence 332 244579999999999865 46899999999999999999999999763322211 1111100000
Q ss_pred cccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCC-----HHHHHHH
Q 002021 913 NLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRIN-----AKEIVTK 956 (979)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~eil~~ 956 (979)
...+..+++++.+++.+||+.||++||| ++|+++|
T Consensus 226 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0111235567999999999999999999 7999876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-44 Score=398.54 Aligned_cols=245 Identities=22% Similarity=0.234 Sum_probs=205.5
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 757 (979)
++|++.+.||+|+||.||+|. ..+|+.||||++.+.. ....+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 578899999999999999995 4679999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQ 837 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 837 (979)
||+.+|+|.+++...+ .+++.+++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 9999999999987654 6899999999999999999999 9999999999999999999999999999998764322
Q ss_pred cceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccCc
Q 002021 838 SMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 917 (979)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (979)
....||+.|||||++.+..+++++||||+||++|||+||+.||...... ..+.......
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~---------------- 254 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVSGK---------------- 254 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCC----------------
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH-HHHHHHhcCC----------------
Confidence 3467999999999999999999999999999999999999999753111 1111110000
Q ss_pred hhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 918 EDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 918 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
...+..+++++.+++.+|++.||.+|+ |++|+++|
T Consensus 255 ----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 001123556799999999999999994 99999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=395.26 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=203.3
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc---ccchhcHHHHHHHHH-hcCCCCeeeEEEeeccCCeeEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC---GRAFKSFDVECEIMK-SIRHRNLIKVISSCSNEEFKALV 756 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 756 (979)
++|++.+.||+|+||+||+|. ..+|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578899999999999999994 4679999999996532 233455667777765 68999999999999999999999
Q ss_pred EEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCC
Q 002021 757 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 757 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~ 836 (979)
|||+++|+|.+++.... .+++.+++.++.||+.||+||| +++|+||||||+|||+++++.+|++|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999987654 6899999999999999999999 9999999999999999999999999999998654332
Q ss_pred CcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcccccC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDANLLS 916 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (979)
.......||+.|+|||++.+..+++++||||+||++|||+||+.||...... .....+...
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~--------------- 218 (320)
T d1xjda_ 158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMD--------------- 218 (320)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC---------------
T ss_pred --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHcC---------------
Confidence 2234567999999999999999999999999999999999999999753211 111111000
Q ss_pred chhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHH-HHHHH
Q 002021 917 QEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAK-EIVTK 956 (979)
Q Consensus 917 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-eil~~ 956 (979)
....+..+++++.+++.+||+.||++||++. |+++|
T Consensus 219 ----~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 219 ----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ----CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 0011124567799999999999999999995 77654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=393.71 Aligned_cols=261 Identities=22% Similarity=0.386 Sum_probs=212.4
Q ss_pred hCCCCCCceeeeecceEEEEEEcC------CCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCee
Q 002021 681 TDGFSENNLIGRGGFGSVYKASLG------DGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFK 753 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 753 (979)
.++|+..+.||+|+||+||+|.+. +++.||||+++... ......|.+|++++++++|||||+++++|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999652 35789999997543 23445688999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeccC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEE
Q 002021 754 ALVLEYMPHGSLEKYLYSS---------NCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 824 (979)
Q Consensus 754 ~lv~E~~~~g~L~~~l~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~ 824 (979)
++||||+++|+|.+++... ...+++..+.+++.|+|+||+||| +++|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999998643 234689999999999999999999 8999999999999999999999999
Q ss_pred eeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCC-CCCcccccCcchHhHhhhhhcC
Q 002021 825 DFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGK-KPTDEIFNGEMTLKHWVNDWLP 903 (979)
Q Consensus 825 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~P~~~~~~~~~~~~~~~~~~~~ 903 (979)
|||+++...............+|+.|+|||.+.++.++.++||||||+++|||+||+ .||.... ....+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-~~~~~~~i~----- 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLRFVM----- 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-HHHHHHHHH-----
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH-----
Confidence 999998765444444445557899999999999999999999999999999999985 5654321 111111110
Q ss_pred CccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhh
Q 002021 904 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSL 964 (979)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~ 964 (979)
+.. +...+..+++.+.+++.+||+.+|.+|||+.||+++|++..+..
T Consensus 250 -------~~~-------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 250 -------EGG-------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp -------TTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred -------hCC-------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 000 11122345677999999999999999999999999998876543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=387.22 Aligned_cols=264 Identities=22% Similarity=0.241 Sum_probs=196.9
Q ss_pred CCceeeeecceEEEEEEc-CCCcEEEEEEeccccc-----cchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 686 ENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCG-----RAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
..++||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999964 5799999999864321 1245688999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
++++++..+. .....+++.++..++.||+.||+||| +++|+||||||+|||+++++.+||+|||.++.......
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence 9887766554 34457899999999999999999999 99999999999999999999999999999987643322
Q ss_pred eecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc---CCccchhh---cc
Q 002021 840 IQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL---PISTMEVV---DA 912 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~---~~~~~~~~---~~ 912 (979)
.....+||+.|+|||++... .++.++||||+||++|||+||+.||......+ .+....+... ........ ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchh
Confidence 22446799999999988654 57999999999999999999999986532211 1111111100 00000000 00
Q ss_pred ccc-Cchh-hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 NLL-SQED-IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 ~~~-~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... .... .........++++.+++.+|++.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 0000 0011112345679999999999999999999999886
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=384.50 Aligned_cols=269 Identities=22% Similarity=0.223 Sum_probs=202.9
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++|+..+.||+|+||+||+|. ..+|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 678999999999999999995 5689999999996543 2345678899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
|+.++.+..........+++.+++.++.|++.||+||| +++|+||||||+|||++.++.+|++|||.|+......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-- 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence 99765444333444567999999999999999999999 9999999999999999999999999999998764332
Q ss_pred ceecccccCCCCCCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhc-CCc--cchhhc---
Q 002021 839 MIQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWL-PIS--TMEVVD--- 911 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~--- 911 (979)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||......+ .+........ +.. ...+..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhhccccccccc
Confidence 2234567999999999876654 5789999999999999999999997532211 1111111100 000 000000
Q ss_pred --ccccCc-hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 --ANLLSQ-EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 --~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
...... ...........+.++.+++.+|++.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 000011122445678999999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=381.03 Aligned_cols=240 Identities=23% Similarity=0.317 Sum_probs=196.5
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc------cchhcHHHHHHHHHhcC--CCCeeeEEEeeccCCe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG------RAFKSFDVECEIMKSIR--HRNLIKVISSCSNEEF 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 752 (979)
++|++.+.||+|+||+||+|. ..+|+.||||++..... .....+.+|++++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 578899999999999999995 56899999999865421 12345678999999996 8999999999999999
Q ss_pred eEEEEEecCC-CccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-CCcEEEEeecccc
Q 002021 753 KALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFSIAK 830 (979)
Q Consensus 753 ~~lv~E~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-~~~~kl~Dfg~~~ 830 (979)
.++||||+.+ +++.+++... ..+++++++.++.|+++||+||| +++|+||||||+||+++. ++.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 5666766553 46999999999999999999999 999999999999999985 5799999999998
Q ss_pred ccCCCCCcceecccccCCCCCCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchh
Q 002021 831 MLTGEDQSMIQTQTLATIGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEV 909 (979)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (979)
..... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ... ..
T Consensus 160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i~---~~--------- 219 (273)
T d1xwsa_ 160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EII---RG--------- 219 (273)
T ss_dssp ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HHH---HC---------
T ss_pred ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HHh---hc---------
Confidence 75322 2245679999999999877665 577999999999999999999996521 110 00
Q ss_pred hcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 910 VDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
... .+..+++++.+++.+||+.||++|||++|+++|
T Consensus 220 ---~~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 ---QVF--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---CCC--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---ccC--------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000 112345678999999999999999999999886
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.5e-43 Score=378.14 Aligned_cols=268 Identities=21% Similarity=0.243 Sum_probs=202.1
Q ss_pred CCCCCCceeeeecceEEEEEEcCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|+..+.||+|+||+||+|+..+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999988899999999986542 23456789999999999999999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCcc
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQSM 839 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 839 (979)
+.++.+..+. .....+++.++..++.||+.||+||| +++|+||||||+|||++.++.+|++|||.+........
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 155 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-- 155 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--
Confidence 9876655554 44567999999999999999999999 89999999999999999999999999999987643322
Q ss_pred eecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC---Cccchhh-----
Q 002021 840 IQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP---ISTMEVV----- 910 (979)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~---~~~~~~~----- 910 (979)
......+++.|+|||.+.+. .+++++||||+||++|||++|+.||.+....+. +......... .......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhc
Confidence 22445689999999988654 568999999999999999999999975432211 1111111100 0000000
Q ss_pred ccccc-CchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 911 DANLL-SQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 911 ~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..... .............++.+.+++.+|++.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00000111123345678999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=379.98 Aligned_cols=271 Identities=23% Similarity=0.266 Sum_probs=203.9
Q ss_pred HhhCCCCCCceeeeecceEEEEEEc-C-CCcEEEEEEecccc--ccchhcHHHHHHHHHhc---CCCCeeeEEEeec---
Q 002021 679 RATDGFSENNLIGRGGFGSVYKASL-G-DGMEVAVKVFTSQC--GRAFKSFDVECEIMKSI---RHRNLIKVISSCS--- 748 (979)
Q Consensus 679 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 748 (979)
+..++|++.+.||+|+||+||+|.. . +++.||||+++... ......+.+|+++++.+ +||||++++++|.
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 3457899999999999999999964 3 46789999986543 22345677888888776 7999999999884
Q ss_pred --cCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEee
Q 002021 749 --NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 826 (979)
Q Consensus 749 --~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Df 826 (979)
.....+++|||++++.+..........+++..++.++.|++.||+||| +++|+||||||+|||+++++.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence 345789999999998776666566667999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc-
Q 002021 827 SIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS- 905 (979)
Q Consensus 827 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~- 905 (979)
|.++..... .......||+.|+|||++.+..|++++||||+||++|||++|+.||......+ .+...........
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE 236 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCch
Confidence 998765322 22355679999999999999999999999999999999999999997532211 1111111100000
Q ss_pred --cc---hhhcccccCc-hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 --TM---EVVDANLLSQ-EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 --~~---~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. .......... ...........++.+.+|+.+|++.||++|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000000000 000111122345678999999999999999999999887
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.9e-42 Score=368.18 Aligned_cols=275 Identities=14% Similarity=0.126 Sum_probs=223.8
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCC-CCeeeEEEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH-RNLIKVISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~ 759 (979)
++|++.+.||+|+||+||+|+ ..+|+.||||++... ...+.+.+|+++++.++| +|++.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 578899999999999999995 557999999987544 234678899999999975 8999999999999999999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC-----CCcEEEEeeccccccCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~-----~~~~kl~Dfg~~~~~~~ 834 (979)
+ +++|.+++......+++.++..++.|++.||+||| +++|+||||||+||+++. ++.+||+|||+|+.+..
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9 67999998887778999999999999999999999 999999999999999974 57899999999987643
Q ss_pred CCCc-----ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHh-HhhhhhcCCccch
Q 002021 835 EDQS-----MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK-HWVNDWLPISTME 908 (979)
Q Consensus 835 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~-~~~~~~~~~~~~~ 908 (979)
.... ......+||+.|+|||.+.+..+++++||||+||++|||+||+.||........... ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~------- 231 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK------- 231 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-------
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-------
Confidence 3211 122345799999999999999999999999999999999999999975332221111 000000
Q ss_pred hhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceecc
Q 002021 909 VVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQS 976 (979)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~~ 976 (979)
.. ..........+++++.+++..|+..+|++||+++.+.+.|+++.++......++.||..
T Consensus 232 ----~~---~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~ 292 (293)
T d1csna_ 232 ----KQ---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 292 (293)
T ss_dssp ----HH---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred ----cC---CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence 00 00001112346678999999999999999999999999999999998888888899863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-42 Score=370.42 Aligned_cols=275 Identities=19% Similarity=0.181 Sum_probs=213.5
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeE-EEeeccCCeeEEEEEe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKV-ISSCSNEEFKALVLEY 759 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~E~ 759 (979)
+.|++.+.||+|+||+||+|. ..+|+.||||++... ...+.+.+|+++++.++|++++.. .+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 569999999999999999995 467999999988654 234578899999999987765555 5556778889999999
Q ss_pred cCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCC---CCcEEEEeeccccccCCCC
Q 002021 760 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFSIAKMLTGED 836 (979)
Q Consensus 760 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~---~~~~kl~Dfg~~~~~~~~~ 836 (979)
+ ++++.+.+......+++..+..++.|++.||+||| +++|+||||||+||+++. +..+|++|||+|+.+....
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 55777777666678999999999999999999999 999999999999999864 5579999999998765432
Q ss_pred Cc-----ceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhc
Q 002021 837 QS-----MIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVD 911 (979)
Q Consensus 837 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (979)
.. .......||+.|+|||.+.+..+++++|||||||++|||+||+.||............. . ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~-~---------~~~ 230 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-R---------ISE 230 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH-H---------HHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH-H---------hhc
Confidence 21 12244579999999999999999999999999999999999999997643322211100 0 000
Q ss_pred ccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHHHHHhHHhhccCCCCcceec
Q 002021 912 ANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTKLLKIRDSLLRNVGGRCVRQ 975 (979)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~L~~~~~~~~~~~~~~~~~~ 975 (979)
... ..........+++++.+++.+||+.+|++||+++++.+.|+++............+|.
T Consensus 231 ~~~---~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 231 KKM---STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp HHH---HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred ccC---CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence 000 0000112235678899999999999999999999999999998877666666777775
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.1e-41 Score=369.37 Aligned_cols=292 Identities=32% Similarity=0.474 Sum_probs=258.7
Q ss_pred CChhHHHHHHHHHHhcccCCCCccccccCCCCCCC--ccceeEeeCCC--CcEEEEEecCCCccc--cCCCCCcCCCCCC
Q 002021 26 STITDQDALLALKAHITHDPTNFLAKNWNTSTPVC--NWTGVACEVHS--QRVTVLNISSLNLTG--TIPSQLGNLSSLQ 99 (979)
Q Consensus 26 ~~~~~~~all~~k~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~ 99 (979)
|.++|++||++||++++ ||. .+ ++|..++||| .|+||+|+..+ .||+.|||++++++| .+|+++++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~-~~~-~l-~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLG-NPT-TL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTT-CCG-GG-TTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCHHHHHHHHHHHHHCC-CCC-cC-CCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 78899999999999996 554 45 5888888999 59999998644 489999999999998 5899999999999
Q ss_pred eeeccC-CcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCcc
Q 002021 100 SLNLSF-NRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPEL 178 (979)
Q Consensus 100 ~L~L~~-n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L 178 (979)
+|||++ |+++|.+|++++++++|++|+|++|++.+..|..+..+.+|+++++++|.+.+. +|..+++++.|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~--------~p~~l~~l~~L 151 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT--------LPPSISSLPNL 151 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESC--------CCGGGGGCTTC
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccccccc--------CchhhccCccc
Confidence 999997 899999999999999999999999999999999999999999999999998764 89999999999
Q ss_pred ceeecccccccccccccccCCCCC-CceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEcc
Q 002021 179 ELMSLAANNLQGKIPLKIGNLRNL-EKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLW 257 (979)
Q Consensus 179 ~~L~L~~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~ 257 (979)
+.+++++|.+++.+|..+..+.++ +.+++++|++++..|..+.++..+ .++++.|...+..+. .+..+++|+.++++
T Consensus 152 ~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~-~~~~~~~l~~l~~~ 229 (313)
T d1ogqa_ 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASV-LFGSDKNTQKIHLA 229 (313)
T ss_dssp CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGG-GCCTTSCCSEEECC
T ss_pred ceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccc-cccccccccccccc
Confidence 999999999999999999998886 889999999999999888887655 699999988876654 46788999999999
Q ss_pred CCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEccCCC
Q 002021 258 GNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNP 337 (979)
Q Consensus 258 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 337 (979)
+|.+.+.+| .+..+++|++|+|++|+++|.+|..|+++++|++|+|++|+|++..+ .+.++++|+.+++++|+
T Consensus 230 ~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP------~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 230 KNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP------QGGNLQRFDVSAYANNK 302 (313)
T ss_dssp SSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC------CSTTGGGSCGGGTCSSS
T ss_pred ccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC------CcccCCCCCHHHhCCCc
Confidence 999987765 57888999999999999999999999999999999999999984322 24566777777777776
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-41 Score=366.07 Aligned_cols=272 Identities=19% Similarity=0.256 Sum_probs=198.1
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeecc--------
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSN-------- 749 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 749 (979)
.++|++.+.||+|+||+||+|. ..+|+.||||++.... +...+.+.+|+++|++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3678999999999999999996 4689999999986442 3345678899999999999999999998754
Q ss_pred CCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccc
Q 002021 750 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIA 829 (979)
Q Consensus 750 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~ 829 (979)
++..++||||++++.+..+ ......+++..++.++.|++.|+.||| +++|+||||||+|||++.++.+|++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence 3468999999987666544 344557899999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCc--ceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcch--HhHhhhhhcCC
Q 002021 830 KMLTGEDQS--MIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT--LKHWVNDWLPI 904 (979)
Q Consensus 830 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~--~~~~~~~~~~~ 904 (979)
......... ......+||+.|+|||.+.+. .+++++||||+||++|||++|+.||......... +........+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 766433221 122345799999999988754 6899999999999999999999999753221110 11111111111
Q ss_pred ccchh--------hccc-ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 905 STMEV--------VDAN-LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 905 ~~~~~--------~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..... .... ................+++.+|+.+|++.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 10000 0000 0000001111122335678899999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=371.51 Aligned_cols=267 Identities=25% Similarity=0.324 Sum_probs=195.7
Q ss_pred CCCCCceeeeecceEEEEEEc-CCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCeeeEEEeecc------CCeeEE
Q 002021 683 GFSENNLIGRGGFGSVYKASL-GDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNLIKVISSCSN------EEFKAL 755 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~l 755 (979)
+|+..++||+|+||+||+|+. .+|+.||||++.... ....+|+++|++++||||++++++|.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 477788999999999999954 579999999986542 233579999999999999999998843 335789
Q ss_pred EEEecCCCccceeec--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEEeecccccc
Q 002021 756 VLEYMPHGSLEKYLY--SSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFSIAKML 832 (979)
Q Consensus 756 v~E~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg~~~~~ 832 (979)
||||++++.+..... .....+++.+++.++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998754333322 23557999999999999999999999 99999999999999999775 8999999999876
Q ss_pred CCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhh-----------h
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN-----------D 900 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~-----------~ 900 (979)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+....+ .
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhh
Confidence 43322 244679999999998764 578999999999999999999999996532211 1111111 0
Q ss_pred hcCCccchhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH--HHHhHH
Q 002021 901 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK--LLKIRD 962 (979)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~--L~~~~~ 962 (979)
..+.... ..-+...... .........++++.+|+.+|++.||++|||+.|+++| ++++.+
T Consensus 250 ~~~~~~~-~~~~~~~~~~-~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 250 MNPNYTE-FKFPQIKAHP-WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HCC---C-CCCCCCCCCC-GGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hccchhh-ccccccccCc-hhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000000 0000000000 0001112345679999999999999999999999987 455443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=362.47 Aligned_cols=269 Identities=20% Similarity=0.216 Sum_probs=206.3
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCCeeEEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEEFKALVLE 758 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 758 (979)
++|+..+.||+|+||+||+|+ ..+++.||||+++... ....+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 578899999999999999995 5689999999986543 2345778899999999999999999999999999999999
Q ss_pred ecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCCCCCc
Q 002021 759 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTGEDQS 838 (979)
Q Consensus 759 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 838 (979)
++.++++..++... ..+++..++.++.|++.||+||| +++|+||||||+||+++.++.+|++|||.++........
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 99998887776544 46899999999999999999999 999999999999999999999999999999876533322
Q ss_pred ceecccccCCCCCCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcC---Ccc---chhhc
Q 002021 839 MIQTQTLATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP---IST---MEVVD 911 (979)
Q Consensus 839 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~ 911 (979)
.....+++.|+|||.+.... +++++||||+||++|||++|+.||.........+......... ... ....+
T Consensus 158 --~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred --ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 23456788899999877654 6899999999999999999999975433222222221111110 000 00000
Q ss_pred cc---ccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 912 AN---LLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 912 ~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.. ...............++.+.+++.+|++.||.+||||+|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000011111223345678999999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-41 Score=370.33 Aligned_cols=269 Identities=21% Similarity=0.231 Sum_probs=198.0
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc-ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC----eeE
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC-GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE----FKA 754 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 754 (979)
++.|+..+.||+|+||+||+|. ..+|+.||||++.... ....+.+.+|+++|++++||||+++++++..+. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4568899999999999999994 5689999999997543 234567889999999999999999999986543 234
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccccCC
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKMLTG 834 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~~~ 834 (979)
+++||+.+|+|.+++... .+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 556677799999998764 5899999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCc-ceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhhcc
Q 002021 835 EDQS-MIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVVDA 912 (979)
Q Consensus 835 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (979)
.... ......+||+.|+|||++.. ..+++++||||+||++|||++|+.||......+.... ....... ........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~-~~~~~~~-~~~~~~~~ 239 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-ILGILGS-PSQEDLNC 239 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCS-CCHHHHHT
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH-HhhhccC-CChhhhhh
Confidence 3221 22345678999999998754 4678999999999999999999999975322111111 1000000 00000000
Q ss_pred -----------cccCchh-hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 913 -----------NLLSQED-IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 913 -----------~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
....... .........++++.+++.+|++.||.+|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 0001112344678999999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=373.40 Aligned_cols=269 Identities=23% Similarity=0.258 Sum_probs=196.5
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeeccCC------
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSNEE------ 751 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 751 (979)
.+.|+..+.||+|+||+||+|. ..+|+.||||+++... ....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4678889999999999999995 5679999999997542 233567889999999999999999999997654
Q ss_pred eeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 752 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 752 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
..++||||+ +.+|.++.... .+++..++.++.|++.||+||| +++|+||||||+|||++.++.+|++|||.|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence 569999999 55777766543 5999999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCCcceecccccCCCCCCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc--c--
Q 002021 832 LTGEDQSMIQTQTLATIGYMAPEYGRE-GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS--T-- 906 (979)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~--~-- 906 (979)
.... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+........... .
T Consensus 171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHH
T ss_pred cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHhccCCCcHHHHh
Confidence 6432 245679999999998865 45789999999999999999999999753211 11111111100000 0
Q ss_pred ------chhhcccccCchh-hhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH--HHHhH
Q 002021 907 ------MEVVDANLLSQED-IHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK--LLKIR 961 (979)
Q Consensus 907 ------~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~--L~~~~ 961 (979)
............. ........+++++.+|+.+|++.||.+|||++|+++| ++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000000000 0001112345678999999999999999999999998 55443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-40 Score=364.35 Aligned_cols=262 Identities=19% Similarity=0.278 Sum_probs=198.8
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeecc--CCeeEEEE
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSN--EEFKALVL 757 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 757 (979)
++|++.+.||+|+||+||+|+ ..+|+.||||+++.. ..+.+.+|+++|+.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 568899999999999999995 468999999998643 3467889999999995 9999999999864 45689999
Q ss_pred EecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC-cEEEEeeccccccCCCC
Q 002021 758 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFSIAKMLTGED 836 (979)
Q Consensus 758 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~-~~kl~Dfg~~~~~~~~~ 836 (979)
||+++++|.++. ..+++.+++.++.||+.||+||| +++|+||||||+|||++.++ .+|++|||+|.......
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999997764 25899999999999999999999 99999999999999998654 69999999998764332
Q ss_pred CcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhH------------hhhhhcC
Q 002021 837 QSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH------------WVNDWLP 903 (979)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~------------~~~~~~~ 903 (979)
. .....+|+.|+|||.+.+. .++.++||||+||++||+++|+.||............ +......
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 3456789999999987765 4799999999999999999999998753322111111 1100000
Q ss_pred Cccch---hhcccc--cCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 904 ISTME---VVDANL--LSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 904 ~~~~~---~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
..... ...... .............+++++.+|+.+|++.||++|||++|+++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000000 000001111223456789999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-41 Score=365.23 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=202.8
Q ss_pred CCCCCCceeeeecceEEEEEEc----CCCcEEEEEEecccc----ccchhcHHHHHHHHHhcCC-CCeeeEEEeeccCCe
Q 002021 682 DGFSENNLIGRGGFGSVYKASL----GDGMEVAVKVFTSQC----GRAFKSFDVECEIMKSIRH-RNLIKVISSCSNEEF 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 752 (979)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999953 358999999986432 2234667889999999977 899999999999999
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.++||||+.+|+|.+++...+ .+.+..+..++.|++.|++|+| +++|+||||||+||+++.++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999987664 5678899999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCcceecccccCCCCCCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCccchhh
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREG--RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTMEVV 910 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (979)
...... ......|++.|+|||.+.+. .+++++||||+||++|||++|+.||......+.....+......
T Consensus 180 ~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~------- 251 (322)
T d1vzoa_ 180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------- 251 (322)
T ss_dssp CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-------
T ss_pred cccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-------
Confidence 433222 23456799999999988654 46889999999999999999999997643332211111100000
Q ss_pred cccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCC-----CHHHHHHH
Q 002021 911 DANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRI-----NAKEIVTK 956 (979)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~eil~~ 956 (979)
....+..+++++.+++.+||++||++|| |++|+++|
T Consensus 252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0011234567899999999999999999 58999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-40 Score=363.51 Aligned_cols=262 Identities=22% Similarity=0.228 Sum_probs=191.2
Q ss_pred CCCCCCceeeeecceEEEEEE-cCCCcEEEEEEecccc--ccchhcHHHHHHHHHhcCCCCeeeEEEeecc------CCe
Q 002021 682 DGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQC--GRAFKSFDVECEIMKSIRHRNLIKVISSCSN------EEF 752 (979)
Q Consensus 682 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 752 (979)
+.|++.+.||+|+||+||+|. ..+|+.||||++.... ......+.+|+.++++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 679999999999999999995 4579999999997543 2234568899999999999999999999853 467
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.|+||||+.++.+. .+. ..+++..++.++.||+.|++||| ++||+||||||+|||++.++.+|++|||.++..
T Consensus 97 ~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence 89999999765544 443 25899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcch-------------------
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT------------------- 893 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~------------------- 893 (979)
.. ........+|+.|+|||++.+..+++++||||+||++|||++|+.||.........
T Consensus 170 ~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 32 22334567899999999999999999999999999999999999999643211000
Q ss_pred --HhHhhhhhcCCccc---hhhcccccCchhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 894 --LKHWVNDWLPISTM---EVVDANLLSQEDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 894 --~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
.............. ....... ...........++++.+|+.+|+..||++||||+|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSL---FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGG---SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCcccccccccccccccc---ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000111100000 0000000 011112334567789999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=361.74 Aligned_cols=265 Identities=22% Similarity=0.256 Sum_probs=196.5
Q ss_pred hCCCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccc--cchhcHHHHHHHHHhcCCCCeeeEEEeecc-----CCe
Q 002021 681 TDGFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCG--RAFKSFDVECEIMKSIRHRNLIKVISSCSN-----EEF 752 (979)
Q Consensus 681 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 752 (979)
.++|+..+.||+|+||+||+|. ..+|+.||||++..... ...+.+.+|++++++++|||+|++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4679999999999999999995 56899999999975432 234568899999999999999999999853 334
Q ss_pred eEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeecccccc
Q 002021 753 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKML 832 (979)
Q Consensus 753 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~~ 832 (979)
.++||||+.+|+|.+++... .+++.+++.++.||+.||+||| +++|+||||||+||+++.++.+|++|||.+...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence 56778888899999998654 5999999999999999999999 999999999999999999999999999999765
Q ss_pred CCCCCcceecccccCCCCCCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCcccccCcchHhHhhhhhcCCc------
Q 002021 833 TGEDQSMIQTQTLATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS------ 905 (979)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~------ 905 (979)
... .....||+.|+|||...+. .++.++||||+||++|+|++|+.||....... .............
T Consensus 172 ~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 172 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp TGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHTT
T ss_pred Ccc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChHHhhh
Confidence 322 2445788999999986665 46899999999999999999999996532111 1111111000000
Q ss_pred ----cchhhcccccCchhhh-hHHHHHHHHHHHHHHHhccccCcCCCCCHHHHHHH
Q 002021 906 ----TMEVVDANLLSQEDIH-FVAKEQCVSFVFNLAMECTMEFPKQRINAKEIVTK 956 (979)
Q Consensus 906 ----~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~eil~~ 956 (979)
................ ......+++++.+|+.+|++.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000000000 01112456778999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-35 Score=330.43 Aligned_cols=266 Identities=16% Similarity=0.188 Sum_probs=189.1
Q ss_pred CCCCCceeeeecceEEEEEE-cCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-----------CCCeeeEEEeecc-
Q 002021 683 GFSENNLIGRGGFGSVYKAS-LGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-----------HRNLIKVISSCSN- 749 (979)
Q Consensus 683 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~- 749 (979)
.|++++.||+|+||+||+|+ ..+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 48899999999999999995 5689999999997542 23456788999988875 5789999988754
Q ss_pred -CCeeEEEEEecCCCcccee--eccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCC------c
Q 002021 750 -EEFKALVLEYMPHGSLEKY--LYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM------V 820 (979)
Q Consensus 750 -~~~~~lv~E~~~~g~L~~~--l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~------~ 820 (979)
....+++|+++..+..... .......+++..+..++.||+.|++|||+ ..+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 4456677777655443222 23335678999999999999999999993 38999999999999998655 4
Q ss_pred EEEEeeccccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCcccccCcc-----hHh
Q 002021 821 AHLSDFSIAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEM-----TLK 895 (979)
Q Consensus 821 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P~~~~~~~~~-----~~~ 895 (979)
++++|||.+...... ....+||+.|+|||++....+++++||||+||+++||++|+.||........ ...
T Consensus 171 ~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 999999999865322 2446799999999999999999999999999999999999999975322110 011
Q ss_pred HhhhhhcC--Cc-------cchhhcc----cccCc---------hhhhhHHHHHHHHHHHHHHHhccccCcCCCCCHHHH
Q 002021 896 HWVNDWLP--IS-------TMEVVDA----NLLSQ---------EDIHFVAKEQCVSFVFNLAMECTMEFPKQRINAKEI 953 (979)
Q Consensus 896 ~~~~~~~~--~~-------~~~~~~~----~~~~~---------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ei 953 (979)
..+..... .. .....+. ..... ...........++++.+|+.+|++.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 11110000 00 0000000 00000 000111224567789999999999999999999999
Q ss_pred HHH
Q 002021 954 VTK 956 (979)
Q Consensus 954 l~~ 956 (979)
++|
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 887
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.6e-33 Score=303.38 Aligned_cols=258 Identities=33% Similarity=0.588 Sum_probs=241.5
Q ss_pred cccEEEccCccccC--CCCccccCCCcccEEEecC-CCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceE
Q 002021 353 SLEEFKMSNCNISG--GIPEEISNLTNLRTIYLGG-NKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRL 429 (979)
Q Consensus 353 ~L~~L~L~~n~i~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 429 (979)
++++|+|++|++++ .+|+.++++++|++|+|++ |.+.|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 58888888888887 4789999999999999987 89999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccCCccccCCCcCceEecCCCccc-cccccccCcCCC-cEEEeccccccCCCccccccccccceEeccCCcc
Q 002021 430 DLDGNKLSGSIPACFSNLTSLRIVSLGSNELT-SIPLTFWNLKDI-LNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNF 507 (979)
Q Consensus 430 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L-~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 507 (979)
++++|++.+.+|..+.+++.|+++++++|.++ .+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 99999999999999999999999999999998 789988888776 889999999999999999888665 699999999
Q ss_pred CcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCCC
Q 002021 508 SGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGG 587 (979)
Q Consensus 508 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 587 (979)
.+.+|..+..+++|+.|++++|.+++.+| .+..+++|++|+|++|+|+|.+|..+.++++|++|+|++|+|+|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999997655 68899999999999999999999999999999999999999999999988
Q ss_pred CCCCcccccccCCccccCCCCCCCCCCC
Q 002021 588 SFGNFSAQSFEGNELLCGSPNLQIPPCK 615 (979)
Q Consensus 588 ~~~~~~~~~~~~N~~~c~~p~~~~~~~~ 615 (979)
.+.++..+++.||+.+||.| +|+|.
T Consensus 289 ~L~~L~~l~l~~N~~l~g~p---lp~c~ 313 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSP---LPACT 313 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTT---SSCCC
T ss_pred cCCCCCHHHhCCCccccCCC---CCCCC
Confidence 89999999999999999999 78883
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=3e-29 Score=282.04 Aligned_cols=194 Identities=29% Similarity=0.461 Sum_probs=144.4
Q ss_pred CccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCC
Q 002021 369 PEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLT 448 (979)
Q Consensus 369 p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 448 (979)
...+..+++++.+++++|.+++..+ +...++|++|++++|+++. + ..+..+++|+.|++++|++++.. .+..++
T Consensus 190 ~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~ 263 (384)
T d2omza2 190 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLT 263 (384)
T ss_dssp CGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCT
T ss_pred ccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccc
Confidence 3445566677777777777766543 4556677777777777764 2 35667777888888888777543 367777
Q ss_pred cCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCC
Q 002021 449 SLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGY 528 (979)
Q Consensus 449 ~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 528 (979)
+|++|++++|+++.++. +..+..++.+.++.|.+++ ...+..+++++.|++++|++++..+ +..+++|++|++++
T Consensus 264 ~L~~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~ 338 (384)
T d2omza2 264 KLTELKLGANQISNISP-LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN 338 (384)
T ss_dssp TCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCS
T ss_pred cCCEeeccCcccCCCCc-ccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCC
Confidence 88888888888877663 5667778888888888875 2357778888888888888886543 78888899999999
Q ss_pred ccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCC
Q 002021 529 NRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFN 577 (979)
Q Consensus 529 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 577 (979)
|+|++ ++ .+.++++|++|+|++|+|++..| +.++++|+.|+|++|
T Consensus 339 n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 339 NKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 98884 44 58888899999999999887654 788889999999887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=8.9e-29 Score=278.21 Aligned_cols=101 Identities=24% Similarity=0.353 Sum_probs=51.6
Q ss_pred CCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEe
Q 002021 422 NLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGID 501 (979)
Q Consensus 422 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 501 (979)
.++.++.++++.|.+.+ ...+..+++++.|++++|+++.++ .+..+++|++|++++|++++ ++ .++++++|++|+
T Consensus 283 ~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~ 357 (384)
T d2omza2 283 GLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLS 357 (384)
T ss_dssp TCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEE
T ss_pred ccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEE
Confidence 34444444444444432 122444444444444444444443 24444555555555555543 22 355566666666
Q ss_pred ccCCccCcccchhhcCCcccceeecCCc
Q 002021 502 LSRNNFSGVIPTEIGGLKNLEYLFLGYN 529 (979)
Q Consensus 502 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 529 (979)
+++|+|++..| +.++++|+.|+|++|
T Consensus 358 l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 66666665443 666666666666666
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=2.7e-26 Score=248.93 Aligned_cols=285 Identities=21% Similarity=0.250 Sum_probs=229.9
Q ss_pred CccceeEeeCCCCcEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCcc
Q 002021 60 CNWTGVACEVHSQRVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSF 139 (979)
Q Consensus 60 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 139 (979)
|.|++|.|+ +++++ .+|+.+. +++++|||++|+++..-+.+|..+++|++|++++|.++...|..
T Consensus 10 c~~~~~~C~------------~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~ 74 (305)
T d1xkua_ 10 CHLRVVQCS------------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74 (305)
T ss_dssp EETTEEECT------------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred ecCCEEEec------------CCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence 788888886 34566 6777664 68999999999998555567899999999999999999888899
Q ss_pred ccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeee--ecCC
Q 002021 140 ISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLV--GIAP 217 (979)
Q Consensus 140 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p 217 (979)
|.++++|++|++++|+++ .+|..+ ...++.|++..|.+.+..+..+.....+..++...|... ...+
T Consensus 75 f~~l~~L~~L~l~~n~l~---------~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~ 143 (305)
T d1xkua_ 75 FAPLVKLERLYLSKNQLK---------ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143 (305)
T ss_dssp TTTCTTCCEEECCSSCCS---------BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCT
T ss_pred hhCCCccCEecccCCccC---------cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCc
Confidence 999999999999999997 366543 357899999999999877777888888999999988644 4456
Q ss_pred ccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccc
Q 002021 218 IAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLR 297 (979)
Q Consensus 218 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 297 (979)
..+..+++|+.+++++|.++..... .+++|++|++++|.+++..+..+..++.+++|++++|.+++..+..|.+++
T Consensus 144 ~~~~~l~~L~~l~l~~n~l~~l~~~----~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~ 219 (305)
T d1xkua_ 144 GAFQGMKKLSYIRIADTNITTIPQG----LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219 (305)
T ss_dssp TGGGGCTTCCEEECCSSCCCSCCSS----CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred cccccccccCccccccCCccccCcc----cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc
Confidence 6788899999999999998865432 468999999999999988899999999999999999999998899999999
Q ss_pred cccceeccccccccccchhhhhhcccCCCCccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCc
Q 002021 298 NLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTN 377 (979)
Q Consensus 298 ~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~ 377 (979)
+|++|+|++|+|+.++. ++.++++|++|+|++|+|+.+....|. .+..+..+.+
T Consensus 220 ~L~~L~L~~N~L~~lp~------~l~~l~~L~~L~Ls~N~i~~i~~~~f~--------------------~~~~~~~~~~ 273 (305)
T d1xkua_ 220 HLRELHLNNNKLVKVPG------GLADHKYIQVVYLHNNNISAIGSNDFC--------------------PPGYNTKKAS 273 (305)
T ss_dssp TCCEEECCSSCCSSCCT------TTTTCSSCCEEECCSSCCCCCCTTSSS--------------------CSSCCTTSCC
T ss_pred cceeeeccccccccccc------ccccccCCCEEECCCCccCccChhhcc--------------------CcchhcccCC
Confidence 99999999999998764 367888999999999998877554432 2233445666
Q ss_pred ccEEEecCCCCC--chhHHhhhcCC
Q 002021 378 LRTIYLGGNKLN--GSILITLSKLQ 400 (979)
Q Consensus 378 L~~L~L~~N~l~--~~~~~~l~~l~ 400 (979)
|+.|+|++|+++ ...|.+|..+.
T Consensus 274 L~~L~L~~N~~~~~~~~~~~f~~~~ 298 (305)
T d1xkua_ 274 YSGVSLFSNPVQYWEIQPSTFRCVY 298 (305)
T ss_dssp CSEEECCSSSSCGGGSCGGGGTTCC
T ss_pred CCEEECCCCcCccCcCCHhHhcccc
Confidence 777777777664 23344444433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=5.8e-25 Score=238.33 Aligned_cols=224 Identities=22% Similarity=0.272 Sum_probs=117.3
Q ss_pred ccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEc
Q 002021 177 ELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSL 256 (979)
Q Consensus 177 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 256 (979)
++++|+|++|+|+...+.+|.++++|++|++++|++..+.|.+|.++++|+.|++++|+|+.++.. ..+.++.|++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~----~~~~l~~L~~ 107 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK----MPKTLQELRV 107 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS----CCTTCCEEEC
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccc----hhhhhhhhhc
Confidence 455555555555433334455555555555555555555555555555555555555554433221 2234555555
Q ss_pred cCCccccccCcccccCCCCcEEeccccccc--cccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEcc
Q 002021 257 WGNNFSGTIPRFIFNASKLSILDLEGNSFS--GFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLS 334 (979)
Q Consensus 257 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls 334 (979)
++|.+.+..+..+.....+..++...|... ...+..|. .+++|++++++
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~-----------------------------~l~~L~~l~l~ 158 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ-----------------------------GMKKLSYIRIA 158 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGG-----------------------------GCTTCCEEECC
T ss_pred cccchhhhhhhhhhccccccccccccccccccCCCccccc-----------------------------cccccCccccc
Confidence 555555443333444444555555544322 11222333 34445555555
Q ss_pred CCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCC
Q 002021 335 YNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEG 414 (979)
Q Consensus 335 ~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 414 (979)
+|.+..+... ..++|++|++++|.+++..+..+..++.+++|++++|.+++..+..+.++++|++|+|++|+|+
T Consensus 159 ~n~l~~l~~~-----~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~- 232 (305)
T d1xkua_ 159 DTNITTIPQG-----LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV- 232 (305)
T ss_dssp SSCCCSCCSS-----CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-
T ss_pred cCCccccCcc-----cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-
Confidence 5544433211 1245566666666666566666666677777777777666666666666666666666666665
Q ss_pred CccccccCCCCCceEecCCCccccc
Q 002021 415 SIPYDICNLAELYRLDLDGNKLSGS 439 (979)
Q Consensus 415 ~~p~~~~~l~~L~~L~Ls~N~l~~~ 439 (979)
.+|.++..+++|++|+|++|+|+..
T Consensus 233 ~lp~~l~~l~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 233 KVPGGLADHKYIQVVYLHNNNISAI 257 (305)
T ss_dssp SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred ccccccccccCCCEEECCCCccCcc
Confidence 3455566666666666666666543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=7.1e-26 Score=242.70 Aligned_cols=230 Identities=27% Similarity=0.276 Sum_probs=131.9
Q ss_pred ccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecC-CCcccccCCccccCCCcCceEecC
Q 002021 378 LRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLD-GNKLSGSIPACFSNLTSLRIVSLG 456 (979)
Q Consensus 378 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L~ 456 (979)
+++|+|++|+|+...+.+|.++++|++|++++|++....+..+..+..++.++.. .|.++...+..|.++++|++|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 4444444444444444444444444444444444444444444445555554432 344444445555555555555555
Q ss_pred CCccccccc-cccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCC
Q 002021 457 SNELTSIPL-TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI 535 (979)
Q Consensus 457 ~N~l~~lp~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 535 (979)
+|.+..++. .+....+|+.+++++|++++..+..|..+.+|+.|++++|++++..+..|.++++|+++++++|++++..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 555554433 3444555666666666666555556666666677777777776666666777777777777777777666
Q ss_pred CCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCCCCCCCcccccccCCccccCCC
Q 002021 536 PNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 536 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~p 607 (979)
|..|.++++|++||+++|++++..|..|..+++|++|+|++|+|.|..+.......+.......+...|..|
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p 265 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred hhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCc
Confidence 677777777777777777777666666777777777777777777655432111222333344445555433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.4e-25 Score=237.38 Aligned_cols=234 Identities=22% Similarity=0.274 Sum_probs=174.2
Q ss_pred cccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEec-CcccCCCccccccCCCCCceE
Q 002021 351 SHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLK-DNKLEGSIPYDICNLAELYRL 429 (979)
Q Consensus 351 ~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L 429 (979)
+.++++|+|++|+|+...+..|.++++|++|++++|++....+..+..+..++.+... .|.+....+..|.++++|++|
T Consensus 31 p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L 110 (284)
T d1ozna_ 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (284)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEE
Confidence 4556777777777776666677778888888888888877777777777777777654 556666667777788888888
Q ss_pred ecCCCcccccCCccccCCCcCceEecCCCccccccc-cccCcCCCcEEEeccccccCCCccccccccccceEeccCCccC
Q 002021 430 DLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPL-TFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFS 508 (979)
Q Consensus 430 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 508 (979)
++++|.+....+..+...++|+.+++++|+|+.+|. .|..+++|+.|++++|++++..+..|.++++|+.+++++|+++
T Consensus 111 ~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~ 190 (284)
T d1ozna_ 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (284)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccc
Confidence 888888876667777777888888888888887764 4667777888888888888777777888888888888888888
Q ss_pred cccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCC
Q 002021 509 GVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPR 585 (979)
Q Consensus 509 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 585 (979)
+..|..|.++++|++|++++|++.+..|..|..+++|++|+|++|.+.+.-+ ...-...++.+....+++.|..|.
T Consensus 191 ~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~ 266 (284)
T d1ozna_ 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQ 266 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESG
T ss_pred ccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCch
Confidence 7778888888888888888888887777778888888888888888775432 111223456666777777777665
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=2e-23 Score=220.86 Aligned_cols=200 Identities=25% Similarity=0.224 Sum_probs=129.6
Q ss_pred cccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecC
Q 002021 353 SLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLD 432 (979)
Q Consensus 353 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 432 (979)
++.+++.++++++. +|+.+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+. +|
T Consensus 11 ~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~--------------- 71 (266)
T d1p9ag_ 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ--------------- 71 (266)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE---------------
T ss_pred CCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc---------------
Confidence 34556677777763 454443 356666666666665555555555555555555555542 22
Q ss_pred CCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccc
Q 002021 433 GNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIP 512 (979)
Q Consensus 433 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 512 (979)
.++.+++|++|+|++|+++.++..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+
T Consensus 72 ----------~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~ 141 (266)
T d1p9ag_ 72 ----------VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141 (266)
T ss_dssp ----------CCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCT
T ss_pred ----------cccccccccccccccccccccccccccccccccccccccccceeeccccccccccccccccccccceecc
Confidence 2334555555555555555555555555566666666666665556666667777777777777777767
Q ss_pred hhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCccccc
Q 002021 513 TEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGK 582 (979)
Q Consensus 513 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 582 (979)
..+..+++|+.|++++|+|++..+..|..+++|++|||++|+|+ .+|..+..+++|+.|+|++|+|.|.
T Consensus 142 ~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp TTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred ccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence 77777777888888888887766777777888888888888877 6677777777888888888877764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=5.3e-23 Score=217.57 Aligned_cols=204 Identities=28% Similarity=0.315 Sum_probs=180.4
Q ss_pred cCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEE
Q 002021 398 KLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLN 477 (979)
Q Consensus 398 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ 477 (979)
+...+.+++.+++.++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+.+|. +..+++|+.|+
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L~ 83 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTLD 83 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-ccccccccccc
Confidence 4455666777777777 4676553 579999999999998878899999999999999999999885 57899999999
Q ss_pred eccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccc
Q 002021 478 FSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSG 557 (979)
Q Consensus 478 ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 557 (979)
+++|++++ .+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|++
T Consensus 84 Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~ 162 (266)
T d1p9ag_ 84 LSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (266)
T ss_dssp CCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred cccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence 99999985 57789999999999999999999999999999999999999999998888889999999999999999999
Q ss_pred cCCccccCccccCeEeccCCcccccCCCC-CCCCCcccccccCCccccCCC
Q 002021 558 VIPASLEKLSYLEDLNLSFNQLEGKIPRG-GSFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 558 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~~~~~~~~~N~~~c~~p 607 (979)
..+..|..+++|++|+|++|+|+ .+|.+ ..+..++.+.+.|||+.|++.
T Consensus 163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 88899999999999999999999 67753 456778889999999999743
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=7.9e-20 Score=201.56 Aligned_cols=138 Identities=24% Similarity=0.333 Sum_probs=84.5
Q ss_pred CCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCC
Q 002021 96 SSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNL 175 (979)
Q Consensus 96 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l 175 (979)
.+|++|||++|+++ .+|+. .++|++|+|++|+|+ .+|.. +.+|+.|++++|.++. ++.. .
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~---------l~~l---p 97 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA---------LSDL---P 97 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC---------CCSC---C
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccch---------hhhh---c
Confidence 36888999999987 67864 467888888888888 56754 3578888888888763 2221 1
Q ss_pred CccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEE
Q 002021 176 PELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILS 255 (979)
Q Consensus 176 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~ 255 (979)
+.|++|++++|.++ .+|. ++.+++|++|++++|.+....+ ....+..+.+..+...... .+..++.++.|+
T Consensus 98 ~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~~~---~l~~l~~l~~L~ 168 (353)
T d1jl5a_ 98 PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEELP---ELQNLPFLTAIY 168 (353)
T ss_dssp TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSCC---CCTTCTTCCEEE
T ss_pred cccccccccccccc-cccc-hhhhccceeecccccccccccc----ccccccchhhccccccccc---cccccccceecc
Confidence 34777777777776 3443 5667777777777777654422 1233444444444333211 233444555555
Q ss_pred ccCCccc
Q 002021 256 LWGNNFS 262 (979)
Q Consensus 256 L~~N~l~ 262 (979)
+++|.+.
T Consensus 169 l~~n~~~ 175 (353)
T d1jl5a_ 169 ADNNSLK 175 (353)
T ss_dssp CCSSCCS
T ss_pred ccccccc
Confidence 5555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=1.6e-19 Score=199.09 Aligned_cols=200 Identities=26% Similarity=0.328 Sum_probs=142.2
Q ss_pred cEEEEEecCCCccccCCCCCcCCCCCCeeeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEcc
Q 002021 73 RVTVLNISSLNLTGTIPSQLGNLSSLQSLNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLS 152 (979)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 152 (979)
++++|||++++|+ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .++|++|||+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 4678999999998 57764 578999999999998 788764 57899999999988 33321 2469999999
Q ss_pred CCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeecc
Q 002021 153 SNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQ 232 (979)
Q Consensus 153 ~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 232 (979)
+|.++. +|. ++.+++|++|++++|.+... +.. ...+..|++.++.... +..+..++.++.|+++
T Consensus 107 ~n~l~~---------lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~ 170 (353)
T d1jl5a_ 107 NNQLEK---------LPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYAD 170 (353)
T ss_dssp SSCCSS---------CCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECC
T ss_pred cccccc---------ccc-hhhhccceeecccccccccc-ccc---cccccchhhccccccc--cccccccccceecccc
Confidence 999873 664 68899999999999998743 322 3566777777766543 3457788899999999
Q ss_pred CCCCcCCCcccccCCCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceecccccccc
Q 002021 233 DNSLSGCLSSIGYARLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTS 311 (979)
Q Consensus 233 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 311 (979)
.|.+..... .....+.+...++.+. .++ .+..++.|+.+++++|..... +. ...++..+.+.+|.+..
T Consensus 171 ~n~~~~~~~-----~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~-~~---~~~~l~~~~~~~~~~~~ 238 (353)
T d1jl5a_ 171 NNSLKKLPD-----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLTD 238 (353)
T ss_dssp SSCCSSCCC-----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCSC
T ss_pred ccccccccc-----cccccccccccccccc-ccc-ccccccccccccccccccccc-cc---ccccccccccccccccc
Confidence 998876432 2234556666666655 333 345677788888887776632 22 23455666666666554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=3e-22 Score=200.08 Aligned_cols=167 Identities=17% Similarity=0.156 Sum_probs=119.2
Q ss_pred CCceeeeecceEEEEEEcCCCcEEEEEEecccccc------------------chhcHHHHHHHHHhcCCCCeeeEEEee
Q 002021 686 ENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGR------------------AFKSFDVECEIMKSIRHRNLIKVISSC 747 (979)
Q Consensus 686 ~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~~~~ 747 (979)
+.+.||+|+||+||+|...+|+.||||+++..... ......+|+..+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46899999999999998778999999987532110 012345688899999999999988764
Q ss_pred ccCCeeEEEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCEEeCCCCcEEEEeec
Q 002021 748 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFS 827 (979)
Q Consensus 748 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg 827 (979)
. .+++|||++++.+.+ ++...+..++.|++++++||| +++|+||||||+|||+++++ ++++|||
T Consensus 84 ~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liDFG 147 (191)
T d1zara2 84 G----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIIDFP 147 (191)
T ss_dssp T----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECCCT
T ss_pred C----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEECC
Confidence 2 379999998866543 333456789999999999999 99999999999999999654 8999999
Q ss_pred cccccCCCCCcceecccccCCCCCCccccCCCCCCCchhHHHHHHH
Q 002021 828 IAKMLTGEDQSMIQTQTLATIGYMAPEYGREGRVSANGDVYSFGIM 873 (979)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 873 (979)
.|.....+.........+. . -.|. ....|+.++|+||..--
T Consensus 148 ~a~~~~~~~~~~~l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWREILERDVR---N-IITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHHHHHHHHHH---H-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcHHHHHHHHH---H-HHHH-HcCCCCCcccHHHHHHH
Confidence 9976532221100000000 0 0011 23567889999996543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.5e-22 Score=232.22 Aligned_cols=64 Identities=19% Similarity=0.016 Sum_probs=34.3
Q ss_pred CCCcEEEeccccccCC----CccccccccccceEeccCCccCcccchhh----c-CCcccceeecCCccccCC
Q 002021 471 KDILNLNFSSNFLTGS----LPLEIGSLKVLVGIDLSRNNFSGVIPTEI----G-GLKNLEYLFLGYNRLQGS 534 (979)
Q Consensus 471 ~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~~~ 534 (979)
+.|++|+|++|.|+.. ++..+..+++|++|||++|+|+......| . +..+|+.|++++|.+...
T Consensus 369 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred CCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 4455555555555421 23334455666666666666654333222 2 223577777777777643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.82 E-value=9.6e-23 Score=233.94 Aligned_cols=160 Identities=22% Similarity=0.162 Sum_probs=74.5
Q ss_pred cCCCcccEEEecCCCCCch-----hHHhhhcCCCCcEEEecCcccCCCc----cccccCCCCCceEecCCCcccccCCcc
Q 002021 373 SNLTNLRTIYLGGNKLNGS-----ILITLSKLQKLQDLGLKDNKLEGSI----PYDICNLAELYRLDLDGNKLSGSIPAC 443 (979)
Q Consensus 373 ~~l~~L~~L~L~~N~l~~~-----~~~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 443 (979)
...+.++.+++++|.+... ..........++.+++++|.+.... ...+...+.++.+++++|.+.......
T Consensus 223 ~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~ 302 (460)
T d1z7xw1 223 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302 (460)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred cccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 3456666666666665422 2233344556666666666654321 122344555666666666664322111
Q ss_pred c-----cCCCcCceEecCCCcccccc-----ccccCcCCCcEEEeccccccCC----Cccccc-cccccceEeccCCccC
Q 002021 444 F-----SNLTSLRIVSLGSNELTSIP-----LTFWNLKDILNLNFSSNFLTGS----LPLEIG-SLKVLVGIDLSRNNFS 508 (979)
Q Consensus 444 ~-----~~l~~L~~L~L~~N~l~~lp-----~~~~~l~~L~~L~ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~ 508 (979)
+ .....|+.+++++|.++... ..+....+|++|+|++|+++.. ++..+. ....|+.|+|++|+|+
T Consensus 303 l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~ 382 (460)
T d1z7xw1 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 382 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred hhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence 1 12345566666666555321 1122334455555555554421 111221 2334555555555554
Q ss_pred cc----cchhhcCCcccceeecCCcccc
Q 002021 509 GV----IPTEIGGLKNLEYLFLGYNRLQ 532 (979)
Q Consensus 509 ~~----~p~~~~~l~~L~~L~Ls~N~l~ 532 (979)
.. +++.+..+++|++|+|++|+|+
T Consensus 383 ~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 383 DSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred hHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 21 2233344455555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=8.2e-19 Score=180.29 Aligned_cols=202 Identities=21% Similarity=0.291 Sum_probs=108.0
Q ss_pred eeccCCcccccCCccccccCcccEEecccccccccCCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccce
Q 002021 101 LNLSFNRLFGSIPSAIFTTYTLKYVCLRGNQLSGTFPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELEL 180 (979)
Q Consensus 101 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~ 180 (979)
++++.+++++.+ .+..+.+|++|++++|+++. ++ .+..+++|++|+|++|.+++. ..+..+++|++
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~----------~~l~~l~~l~~ 89 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL----------APLKNLTKITE 89 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC----------GGGTTCCSCCE
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecc----------ccccccccccc
Confidence 344444444332 22334444555555555442 22 344555555555555555431 12455555555
Q ss_pred eecccccccccccccccCCCCCCceecCCCeeeecCCccccccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCc
Q 002021 181 MSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAIFNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNN 260 (979)
Q Consensus 181 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 260 (979)
+++++|.++. ++ .+.++++|+++++++|+..+.. .+...+.++.+.++.+.+.... .+...++|++|++++|.
T Consensus 90 l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~---~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 90 LELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS---PLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp EECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG---GGGGCTTCCEEECCSSC
T ss_pred cccccccccc-cc-cccccccccccccccccccccc--hhccccchhhhhchhhhhchhh---hhccccccccccccccc
Confidence 5555555542 22 3455555555555555554432 2444555555666555554332 23455666666666666
Q ss_pred cccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCCCccEEEcc
Q 002021 261 FSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCKFLKYFDLS 334 (979)
Q Consensus 261 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls 334 (979)
+.+.. .+.++++|++|+|++|++++.. .|+++++|++|+|++|++++++ .++++++|++|+++
T Consensus 163 ~~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~-------~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 163 VSDLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS-------PLANTSNLFIVTLT 225 (227)
T ss_dssp CCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG-------GGTTCTTCCEEEEE
T ss_pred cccch--hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc-------ccccCCCCCEEEee
Confidence 65332 2566667777777777766532 2666777777777777776654 25667777777775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=1.1e-18 Score=181.50 Aligned_cols=199 Identities=18% Similarity=0.155 Sum_probs=97.3
Q ss_pred cccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCc-cccccCCCCCceEecCC-CcccccCCccccCCCcCceEe
Q 002021 377 NLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSI-PYDICNLAELYRLDLDG-NKLSGSIPACFSNLTSLRIVS 454 (979)
Q Consensus 377 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~ 454 (979)
++++|+|++|+|+...+.+|.++++|++|++++|.+...+ +..|.++++++++++.. |++....+..|.++++|++++
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 3444444444444444444444444444444444443322 22344455555554432 444444444555555555555
Q ss_pred cCCCccccccc--cccCcCCCcEEEeccccccCCCcccccccc-ccceEeccCCccCcccchhhcCCcccceeecCCccc
Q 002021 455 LGSNELTSIPL--TFWNLKDILNLNFSSNFLTGSLPLEIGSLK-VLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRL 531 (979)
Q Consensus 455 L~~N~l~~lp~--~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 531 (979)
+++|+++.++. .+..+..+..+..+++.+....+..|..+. .++.|++++|+++...+..|.....++.+++++|+|
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l 189 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTC
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhcccccccccc
Confidence 55555554432 122333444444444455444444444433 455566666666644443333322233334566666
Q ss_pred cCCCCCcccccccccccccccccccccCCccccCccccCeEecc
Q 002021 532 QGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLS 575 (979)
Q Consensus 532 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 575 (979)
+...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.
T Consensus 190 ~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred ccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 64334456666666666666666665444556666666655553
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.3e-18 Score=178.71 Aligned_cols=187 Identities=24% Similarity=0.380 Sum_probs=87.9
Q ss_pred CCCCcCEEEccCCccccccCcccccCCCCcEEeccccccccccCccccccccccceeccccccccccchhhhhhcccCCC
Q 002021 247 RLPNLEILSLWGNNFSGTIPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDNYLTSSTQELSFLSSLSNCK 326 (979)
Q Consensus 247 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~l~ 326 (979)
.+.+|++|++.+|+|+. ++ .+..+++|++|++++|++++..| +..+++|+++++++|.++.++ ++.+++
T Consensus 39 ~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i~-------~l~~l~ 107 (227)
T d1h6ua2 39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNVS-------AIAGLQ 107 (227)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCCG-------GGTTCT
T ss_pred HcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccccccc-------cccccc
Confidence 34455555555555552 22 35555666666666666554332 555566666666666555432 244555
Q ss_pred CccEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEE
Q 002021 327 FLKYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLG 406 (979)
Q Consensus 327 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 406 (979)
+|++++++++....+. .+...+.++.+.++++.+.... .+..+++|+.|+
T Consensus 108 ~L~~l~l~~~~~~~~~----------------------------~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~ 157 (227)
T d1h6ua2 108 SIKTLDLTSTQITDVT----------------------------PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLS 157 (227)
T ss_dssp TCCEEECTTSCCCCCG----------------------------GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEE
T ss_pred cccccccccccccccc----------------------------hhccccchhhhhchhhhhchhh--hhcccccccccc
Confidence 5555555555443321 1222333444444444433221 133344444444
Q ss_pred ecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEec
Q 002021 407 LKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFS 479 (979)
Q Consensus 407 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls 479 (979)
+++|.+.+.. .+.++++|+.|+|++|++++. + .++++++|++|+|++|++++++. +.++++|+.|+++
T Consensus 158 l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ls 225 (227)
T d1h6ua2 158 IGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT 225 (227)
T ss_dssp CCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEE
T ss_pred ccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEee
Confidence 4444443211 244455555555555555432 1 24455555555555555555442 4444444444443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.1e-18 Score=174.15 Aligned_cols=156 Identities=23% Similarity=0.257 Sum_probs=78.1
Q ss_pred cCceEecCCCcccc-cc-ccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeec
Q 002021 449 SLRIVSLGSNELTS-IP-LTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFL 526 (979)
Q Consensus 449 ~L~~L~L~~N~l~~-lp-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 526 (979)
++++|+|++|+|+. ++ ..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|+|+++.|..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 44445555555442 21 23344555555555555555555555555555555555555555555555555555555555
Q ss_pred CCccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCCCCCCCcccccccCCccccCC
Q 002021 527 GYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGS 606 (979)
Q Consensus 527 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~ 606 (979)
++|+|++..|.+|..+++|++|+|++|.+....+. ..-...++.+.+..|.++|..|. .+.+.....+..|...|.+
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCC
T ss_pred CCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCcCCC
Confidence 55555554455555555555555555555432211 11112344445555555555543 3344444555555555544
Q ss_pred C
Q 002021 607 P 607 (979)
Q Consensus 607 p 607 (979)
+
T Consensus 187 ~ 187 (192)
T d1w8aa_ 187 E 187 (192)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=3.1e-18 Score=177.93 Aligned_cols=219 Identities=15% Similarity=0.094 Sum_probs=161.5
Q ss_pred cEEEccCCCCcccCCccccccccccccEEEccCccccCCCCccccCCCcccEEEecCCCCCch-hHHhhhcCCCCcEEEe
Q 002021 329 KYFDLSYNPLYRILPRTTVGNLSHSLEEFKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGS-ILITLSKLQKLQDLGL 407 (979)
Q Consensus 329 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L 407 (979)
+.++.+++.++.+++. ++.++++|++++|+|+...+..|.++++|++|++++|.+... .+..|..+++++++.+
T Consensus 11 ~~i~c~~~~l~~iP~~-----l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 11 RVFLCQESKVTEIPSD-----LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp SEEEEESCSCSSCCSC-----SCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CEEEEeCCCCCCcCCC-----CCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 3455555555544321 234677788888888766666788888999999988887654 4567888888888887
Q ss_pred cC-cccCCCccccccCCCCCceEecCCCcccccCCc-cccCCCcCceEecCCCccccccc-cccCc-CCCcEEEeccccc
Q 002021 408 KD-NKLEGSIPYDICNLAELYRLDLDGNKLSGSIPA-CFSNLTSLRIVSLGSNELTSIPL-TFWNL-KDILNLNFSSNFL 483 (979)
Q Consensus 408 ~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~lp~-~~~~l-~~L~~L~ls~N~l 483 (979)
.. |.+....+..|.++++|++|++++|++....+. .+..+..+..+..+++++..++. .+..+ ..++.|++++|++
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l 165 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred cccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccc
Confidence 64 677777777788889999999999988754332 34456667777778888887764 44444 4788899999999
Q ss_pred cCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCccccccccccccccc
Q 002021 484 TGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSN 552 (979)
Q Consensus 484 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 552 (979)
+...+..+.....++.+++++|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.|++.+
T Consensus 166 ~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 166 QEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 865555554444444556788899977677899999999999999999976677899999999988754
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=3.6e-19 Score=177.62 Aligned_cols=156 Identities=29% Similarity=0.369 Sum_probs=137.2
Q ss_pred CceEecCCCccccccccccCcCCCcEEEeccccccC-CCccccccccccceEeccCCccCcccchhhcCCcccceeecCC
Q 002021 450 LRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTG-SLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGY 528 (979)
Q Consensus 450 L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 528 (979)
.+++++++|+++++|..+. +++++|+|++|+|++ ..+..|..+.+|+.|+|++|++++..+..|..+++|++|+|++
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TTEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 4578999999999998764 689999999999986 4467789999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccccccccccccCCccccCccccCeEeccCCcccccCCCCCCCCCcccccccCCccccCCC
Q 002021 529 NRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLSFNQLEGKIPRGGSFGNFSAQSFEGNELLCGSP 607 (979)
Q Consensus 529 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~~~~N~~~c~~p 607 (979)
|+|++..|.+|.++++|++|+|++|+|+++.|..|..+++|++|+|++|++.+..+.......+....+.+|...|+.|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 9999888899999999999999999999999999999999999999999999876543222334556677888888876
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=7.1e-18 Score=170.60 Aligned_cols=145 Identities=27% Similarity=0.339 Sum_probs=71.7
Q ss_pred ccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccce
Q 002021 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVG 499 (979)
Q Consensus 420 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 499 (979)
+..+++|++|++++|+|++.. .++.+++|++|++++|+|+.+| .+..+++|+.|++++|.+.. ...+..+..++.
T Consensus 64 l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~ 138 (210)
T d1h6ta2 64 IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLES 138 (210)
T ss_dssp GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCE
T ss_pred HhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc-cccccccccccccccccccc--cccccccccccc
Confidence 334444444444444444321 2344444444444444444444 24444455555555554432 123445555555
Q ss_pred EeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCccccCeEecc
Q 002021 500 IDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKLSYLEDLNLS 575 (979)
Q Consensus 500 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 575 (979)
+++++|.+++ +..+..+++|+.+++++|++++. + .+.++++|+.|+|++|+|+. +| .+..+++|+.|+|+
T Consensus 139 l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 139 LYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp EECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 5555555543 22344555666666666666532 2 25556666666666666653 33 35566666666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=7e-18 Score=170.64 Aligned_cols=181 Identities=23% Similarity=0.377 Sum_probs=152.9
Q ss_pred EEccCccccCCCCccccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcc
Q 002021 357 FKMSNCNISGGIPEEISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKL 436 (979)
Q Consensus 357 L~L~~n~i~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 436 (979)
..+..+.+++.++. ..+.+|++|++++|.++... .+..+++|++|++++|++++.. .++.+++|++|++++|+|
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 35666777665543 35778999999999998754 4788999999999999999644 368899999999999999
Q ss_pred cccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhc
Q 002021 437 SGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIG 516 (979)
Q Consensus 437 ~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 516 (979)
++ ++ .+.++++|+.|++++|.+..++ .+..++.++.+++++|.+++ +..+..+++|+.+++++|++++..+ +.
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~ 175 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LA 175 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred cc-cc-cccccccccccccccccccccc-cccccccccccccccccccc--ccccccccccccccccccccccccc--cc
Confidence 85 34 5889999999999999998876 57789999999999999985 4467889999999999999986533 88
Q ss_pred CCcccceeecCCccccCCCCCccccccccccccccc
Q 002021 517 GLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSN 552 (979)
Q Consensus 517 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 552 (979)
++++|+.|+|++|+|+. +| .+.++++|++|+|++
T Consensus 176 ~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp TCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred CCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 99999999999999984 55 699999999999975
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=3.4e-18 Score=171.50 Aligned_cols=162 Identities=27% Similarity=0.410 Sum_probs=103.6
Q ss_pred cCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEE
Q 002021 398 KLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLN 477 (979)
Q Consensus 398 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ 477 (979)
.+++++.|++++|.+.. + ..+..+++|++|++++|++++..+ ++++++|++|++++|.+..++. +.+++.|+.|+
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~ 112 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLTNLTGLT 112 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccccc-ccccccccccc
Confidence 34555555555555553 2 235566666666666666664332 6666677777777776666653 56666777777
Q ss_pred eccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccc
Q 002021 478 FSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSG 557 (979)
Q Consensus 478 ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 557 (979)
+++|.+... ..+..+++|+.|++++|++... +.+..+++|++|++++|++++. + .++++++|++|++++|+++.
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC
Confidence 777666543 2366677777777777777632 2466777777777777777743 2 36777777777777777774
Q ss_pred cCCccccCccccCeE
Q 002021 558 VIPASLEKLSYLEDL 572 (979)
Q Consensus 558 ~~p~~~~~l~~L~~L 572 (979)
++ .+.++++|++|
T Consensus 187 -i~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 -IS-VLAKLTNLESL 199 (199)
T ss_dssp -CG-GGGGCTTCSEE
T ss_pred -Cc-cccCCCCCCcC
Confidence 33 46677777654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=1.5e-17 Score=166.73 Aligned_cols=106 Identities=33% Similarity=0.471 Sum_probs=48.5
Q ss_pred ccCCCcccEEEecCCCCCchhHHhhhcCCCCcEEEecCcccCCCccccccCCCCCceEecCCCcccccCCccccCCCcCc
Q 002021 372 ISNLTNLRTIYLGGNKLNGSILITLSKLQKLQDLGLKDNKLEGSIPYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLR 451 (979)
Q Consensus 372 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 451 (979)
+..+++|++|++++|++++..+ ++++++|++|++++|.+.. ++ .+.+++.|+.|++++|.+... ..+..+++|+
T Consensus 58 l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~ 131 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLN 131 (199)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCS
T ss_pred cccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccccccccccccc--cccchhhhhH
Confidence 3344555555555555544322 4444445555555444442 22 244555555555555555422 2244455555
Q ss_pred eEecCCCccccccccccCcCCCcEEEecccccc
Q 002021 452 IVSLGSNELTSIPLTFWNLKDILNLNFSSNFLT 484 (979)
Q Consensus 452 ~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~ 484 (979)
.|++++|+++.++ .+..+++|+.|++++|+++
T Consensus 132 ~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 132 RLELSSNTISDIS-ALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp EEECCSSCCCCCG-GGTTCTTCSEEECCSSCCC
T ss_pred Hhhhhhhhhcccc-ccccccccccccccccccc
Confidence 5555555544433 2333444444444444443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=7.3e-17 Score=171.22 Aligned_cols=183 Identities=20% Similarity=0.200 Sum_probs=101.5
Q ss_pred CCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCC-eeeecC-Ccc
Q 002021 142 NKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDN-KLVGIA-PIA 219 (979)
Q Consensus 142 ~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~-p~~ 219 (979)
...+|++|||+++.++.. .++..+..+++|++|+|+++.+++..+..++.+++|++|+|+++ .++... ...
T Consensus 44 ~~~~L~~LdLs~~~i~~~-------~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l 116 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVS-------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116 (284)
T ss_dssp CCBCCCEEECTTCEECHH-------HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHH
T ss_pred cCCCCCEEECCCCccCHH-------HHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchh
Confidence 344566666666655433 12333455566666666666665555556666666666666663 344221 111
Q ss_pred ccccCccceeeccCC-CCcCCCccccc-CCCCCcCEEEccCC--cccc-ccCcccccCCCCcEEecccc-ccccccCccc
Q 002021 220 IFNVSTLKILGLQDN-SLSGCLSSIGY-ARLPNLEILSLWGN--NFSG-TIPRFIFNASKLSILDLEGN-SFSGFIPNTF 293 (979)
Q Consensus 220 l~~l~~L~~L~L~~N-~l~~~~~~~~~-~~l~~L~~L~L~~N--~l~~-~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~~ 293 (979)
+.++++|++|+++++ .+++......+ ...++|+.|+++++ .++. .+...+.++++|++|++++| .+++.....+
T Consensus 117 ~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l 196 (284)
T d2astb2 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF 196 (284)
T ss_dssp HHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred hHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhh
Confidence 234566666666664 33321111111 23456777777754 2332 13333455677777777775 3666666667
Q ss_pred cccccccceecccc-ccccccchhhhhhcccCCCCccEEEccCC
Q 002021 294 GNLRNLSWLVLSDN-YLTSSTQELSFLSSLSNCKFLKYFDLSYN 336 (979)
Q Consensus 294 ~~l~~L~~L~Ls~N-~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N 336 (979)
.++++|++|+|++| .+++.. +..++++++|++|+++++
T Consensus 197 ~~~~~L~~L~L~~C~~i~~~~-----l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 197 FQLNYLQHLSLSRCYDIIPET-----LLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGCTTCCEEECTTCTTCCGGG-----GGGGGGCTTCCEEECTTS
T ss_pred cccCcCCEEECCCCCCCChHH-----HHHHhcCCCCCEEeeeCC
Confidence 77777777777774 454322 234566777777777765
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.55 E-value=4.6e-16 Score=170.44 Aligned_cols=44 Identities=18% Similarity=0.300 Sum_probs=20.8
Q ss_pred CCccccccCcccEEeccccccccc----CCccccCCCCCcEEEccCCc
Q 002021 112 IPSAIFTTYTLKYVCLRGNQLSGT----FPSFISNKSSLQHLDLSSNA 155 (979)
Q Consensus 112 ~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~ 155 (979)
+..++.....|++|+|++|.++.. +...+...++|+.|+++++.
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~ 70 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCC
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCc
Confidence 334444455555555555555432 12233344555555555443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=1.2e-15 Score=161.76 Aligned_cols=84 Identities=27% Similarity=0.292 Sum_probs=40.1
Q ss_pred CCcCEEEccCCccccc-cCcccccCCCCcEEeccccccccccCccccccccccceecccc-ccccccchhhhhhcccCCC
Q 002021 249 PNLEILSLWGNNFSGT-IPRFIFNASKLSILDLEGNSFSGFIPNTFGNLRNLSWLVLSDN-YLTSSTQELSFLSSLSNCK 326 (979)
Q Consensus 249 ~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~~~l~~l~ 326 (979)
.+|++|+|++|.+++. ++..+..+++|++|+|++|.+++..+..++.+++|++|+++++ .+++.... .-..+++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~----~l~~~~~ 121 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ----TLLSSCS 121 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHH----HHHHHCT
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccc----hhhHHHH
Confidence 3455555555544422 2333444555555555555555444455555555555555553 33321110 0123455
Q ss_pred CccEEEccCC
Q 002021 327 FLKYFDLSYN 336 (979)
Q Consensus 327 ~L~~L~Ls~N 336 (979)
+|++|+++++
T Consensus 122 ~L~~L~ls~c 131 (284)
T d2astb2 122 RLDELNLSWC 131 (284)
T ss_dssp TCCEEECCCC
T ss_pred hccccccccc
Confidence 6666666654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.53 E-value=1.4e-15 Score=166.62 Aligned_cols=86 Identities=14% Similarity=0.218 Sum_probs=38.2
Q ss_pred CCCCcEEEecCcccCCC----ccccccCCCCCceEecCCCccccc-----CCccccCCCcCceEecCCCcccc-----cc
Q 002021 399 LQKLQDLGLKDNKLEGS----IPYDICNLAELYRLDLDGNKLSGS-----IPACFSNLTSLRIVSLGSNELTS-----IP 464 (979)
Q Consensus 399 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~-----lp 464 (979)
.+.|+.+.+++|.+... +...+...+.|+.|+|++|+|... +...+...++|+.|+|++|.++. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 44455555555544321 112233344555555555555421 12234444555555555555442 22
Q ss_pred ccccCcCCCcEEEecccccc
Q 002021 465 LTFWNLKDILNLNFSSNFLT 484 (979)
Q Consensus 465 ~~~~~l~~L~~L~ls~N~l~ 484 (979)
..+...++|++|++++|.|+
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCC
T ss_pred ccccccccchhhhhhcCccC
Confidence 23344444444555444444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=8.1e-15 Score=140.48 Aligned_cols=111 Identities=22% Similarity=0.225 Sum_probs=59.2
Q ss_pred cCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCCccc
Q 002021 141 SNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAPIAI 220 (979)
Q Consensus 141 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 220 (979)
.++.+|++|||++|+|+ .+|..+..+++|+.|+|++|+|+. ++ .+..+++|++|++++|+++.+.+..+
T Consensus 15 ~n~~~lr~L~L~~n~I~---------~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~ 83 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIP---------VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLD 83 (162)
T ss_dssp ECTTSCEEEECTTSCCC---------SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHH
T ss_pred cCcCcCcEEECCCCCCC---------ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccc
Confidence 34445555555555554 234444445555555555555542 22 35556666666666666666655555
Q ss_pred cccCccceeeccCCCCcCCCcccccCCCCCcCEEEccCCccc
Q 002021 221 FNVSTLKILGLQDNSLSGCLSSIGYARLPNLEILSLWGNNFS 262 (979)
Q Consensus 221 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 262 (979)
..+++|+.|++++|+|+....-..+..+++|++|++++|.++
T Consensus 84 ~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 84 QALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp HHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccccccccceeccccccccccccccccccccchhhcCCCccc
Confidence 555666666666665554433223445555555555555554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=7.3e-15 Score=140.83 Aligned_cols=111 Identities=22% Similarity=0.210 Sum_probs=49.9
Q ss_pred ccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccce
Q 002021 420 ICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVG 499 (979)
Q Consensus 420 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 499 (979)
+.+..++++|+|++|+|+. ++..+..+++|+.|+|++|+|++++ .+..+++|+.|++++|+++...+..+..+++|+.
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCccC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence 3344455555555555552 2344444555555555555555443 2344444444444444444332323333444444
Q ss_pred EeccCCccCcccc-hhhcCCcccceeecCCcccc
Q 002021 500 IDLSRNNFSGVIP-TEIGGLKNLEYLFLGYNRLQ 532 (979)
Q Consensus 500 L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 532 (979)
|++++|+|+.... ..+..+++|++|++++|.++
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ceeccccccccccccccccccccchhhcCCCccc
Confidence 4444444442211 23444444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=1.9e-14 Score=130.97 Aligned_cols=85 Identities=32% Similarity=0.396 Sum_probs=37.1
Q ss_pred CcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCccccCCC-CCcccccccccc
Q 002021 469 NLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYNRLQGSI-PNSFGDLISLKF 547 (979)
Q Consensus 469 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~ 547 (979)
.+++|++|++++|+|+ .+|..++.+++|+.|++++|+|++. | .++.+++|++|++++|+|+... ...+..+++|++
T Consensus 18 ~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~ 94 (124)
T d1dcea3 18 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 94 (124)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCE
T ss_pred cCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCCCE
Confidence 3333333333333333 2233344444444444444444422 2 2444555555555555554321 133445555555
Q ss_pred ccccccccc
Q 002021 548 LNLSNNNLS 556 (979)
Q Consensus 548 L~Ls~N~l~ 556 (979)
|++++|+++
T Consensus 95 L~l~~N~i~ 103 (124)
T d1dcea3 95 LNLQGNSLC 103 (124)
T ss_dssp EECTTSGGG
T ss_pred EECCCCcCC
Confidence 555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=3.4e-14 Score=129.29 Aligned_cols=103 Identities=21% Similarity=0.190 Sum_probs=72.2
Q ss_pred ceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCc
Q 002021 427 YRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNN 506 (979)
Q Consensus 427 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 506 (979)
++|+|++|+|+. ++ .+..+++|++|++++|+|+++|..++.+++|+.|++++|+|++. | .++.+++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 456777777763 33 36677777777777777777776677777777777777777743 3 47777778888888888
Q ss_pred cCcccc-hhhcCCcccceeecCCccccC
Q 002021 507 FSGVIP-TEIGGLKNLEYLFLGYNRLQG 533 (979)
Q Consensus 507 l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 533 (979)
|+.... ..+..+++|+.|++++|+++.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 775432 567778888888888888863
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.38 E-value=9.8e-15 Score=145.09 Aligned_cols=113 Identities=26% Similarity=0.249 Sum_probs=60.6
Q ss_pred cccccCCCCCceEecCCCcccccCCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccc
Q 002021 417 PYDICNLAELYRLDLDGNKLSGSIPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKV 496 (979)
Q Consensus 417 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 496 (979)
+..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+.+|..+..+++|+.|++++|+++.. ..+..+++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccccccccccccccccccccccccccc--cccccccc
Confidence 3445555555555555555553 22 35555556666666665555554433444555555555555532 23455556
Q ss_pred cceEeccCCccCcccc-hhhcCCcccceeecCCccccC
Q 002021 497 LVGIDLSRNNFSGVIP-TEIGGLKNLEYLFLGYNRLQG 533 (979)
Q Consensus 497 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 533 (979)
|+.|++++|+|+.... ..+..+++|+.|+|++|++..
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 6666666666653322 345566666666666666553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.37 E-value=8.6e-15 Score=145.51 Aligned_cols=115 Identities=20% Similarity=0.274 Sum_probs=66.0
Q ss_pred CCccccCCCcCceEecCCCccccccccccCcCCCcEEEeccccccCCCccccccccccceEeccCCccCcccchhhcCCc
Q 002021 440 IPACFSNLTSLRIVSLGSNELTSIPLTFWNLKDILNLNFSSNFLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLK 519 (979)
Q Consensus 440 ~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 519 (979)
++..+..+++|++|+|++|+|+.++ .+..+++|+.|++++|+|+. +|..+..+.+|+.|++++|+++.. +.+..++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCCC-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhhHHhcccccceeECcccCCCCcc-cccCCccccChhhccccccc-cccccccccccccccccccccccc--ccccccc
Confidence 3445666666667777666666664 35566666666666666653 344444445566666666666532 2355566
Q ss_pred ccceeecCCccccCCCC-Cccccccccccccccccccccc
Q 002021 520 NLEYLFLGYNRLQGSIP-NSFGDLISLKFLNLSNNNLSGV 558 (979)
Q Consensus 520 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ 558 (979)
+|+.|+|++|+|+.... ..+..+++|+.|+|++|+++..
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccccC
Confidence 66666666666653211 3455566666666666665543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=2.9e-12 Score=121.47 Aligned_cols=94 Identities=23% Similarity=0.224 Sum_probs=55.3
Q ss_pred ccccccccccceEeccCC-ccCcccchhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCccccCc
Q 002021 488 PLEIGSLKVLVGIDLSRN-NFSGVIPTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPASLEKL 566 (979)
Q Consensus 488 p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 566 (979)
|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|++|+|+...+..|..+
T Consensus 24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~ 103 (156)
T d2ifga3 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL 103 (156)
T ss_dssp TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC
T ss_pred cccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccc
Confidence 333444455555555444 3555555566666666666666666665556666666666666666666664433344333
Q ss_pred cccCeEeccCCccccc
Q 002021 567 SYLEDLNLSFNQLEGK 582 (979)
Q Consensus 567 ~~L~~L~L~~N~l~~~ 582 (979)
+|+.|+|++|+|.|.
T Consensus 104 -~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 104 -SLQELVLSGNPLHCS 118 (156)
T ss_dssp -CCCEEECCSSCCCCC
T ss_pred -cccccccCCCcccCC
Confidence 577777777777543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=8.8e-12 Score=118.09 Aligned_cols=105 Identities=17% Similarity=0.131 Sum_probs=55.5
Q ss_pred ceEecCCCccccccccccCcCCCcEEEeccc-cccCCCccccccccccceEeccCCccCcccchhhcCCcccceeecCCc
Q 002021 451 RIVSLGSNELTSIPLTFWNLKDILNLNFSSN-FLTGSLPLEIGSLKVLVGIDLSRNNFSGVIPTEIGGLKNLEYLFLGYN 529 (979)
Q Consensus 451 ~~L~L~~N~l~~lp~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 529 (979)
+.++++++.+.++|..+..+++|++|++++| .++...+..|.++++|+.|+|++|+|+.+.|..|.++++|++|+|++|
T Consensus 11 ~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 11 SGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp SCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred CeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3344444444444444444555555555433 244444445555556666666666665555555666666666666666
Q ss_pred cccCCCCCccccccccccccccccccc
Q 002021 530 RLQGSIPNSFGDLISLKFLNLSNNNLS 556 (979)
Q Consensus 530 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 556 (979)
+|+...+..|.. .+|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 91 ALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCcccChhhhcc-ccccccccCCCccc
Confidence 666333333333 34666666666554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=4.1e-09 Score=100.02 Aligned_cols=85 Identities=24% Similarity=0.210 Sum_probs=45.0
Q ss_pred cccccceEeccCCccCccc--chhhcCCcccceeecCCccccCCCCCcccccccccccccccccccccCCc-------cc
Q 002021 493 SLKVLVGIDLSRNNFSGVI--PTEIGGLKNLEYLFLGYNRLQGSIPNSFGDLISLKFLNLSNNNLSGVIPA-------SL 563 (979)
Q Consensus 493 ~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-------~~ 563 (979)
.++.|++|+||+|+|+... +..+..+++|+.|+|++|.|+...+-.+....+|+.|++++|.++..... .+
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~ 142 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence 3445555555555555332 34455566666666666666633222333334566666666666644332 24
Q ss_pred cCccccCeEeccCCcc
Q 002021 564 EKLSYLEDLNLSFNQL 579 (979)
Q Consensus 564 ~~l~~L~~L~L~~N~l 579 (979)
..+|+|+.|| |+++
T Consensus 143 ~~~P~L~~LD--g~~v 156 (162)
T d1koha1 143 ERFPKLLRLD--GHEL 156 (162)
T ss_dssp TTSTTCCEET--TEEC
T ss_pred HHCCCCCEEC--cCCC
Confidence 5567777654 4444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=1.3e-08 Score=96.55 Aligned_cols=88 Identities=22% Similarity=0.177 Sum_probs=43.3
Q ss_pred CCCCccceeecccccccccccccccCCCCCCceecCCCeeeecCC--ccccccCccceeeccCCCCcCCCcccccCCCCC
Q 002021 173 GNLPELELMSLAANNLQGKIPLKIGNLRNLEKLDIGDNKLVGIAP--IAIFNVSTLKILGLQDNSLSGCLSSIGYARLPN 250 (979)
Q Consensus 173 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~ 250 (979)
..+..+..+...++... .++..+.++++|++|+|++|+|+.+.+ ..+..+++|+.|+|++|.|+...... +....+
T Consensus 39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~-~l~~~~ 116 (162)
T d1koha1 39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELD-KIKGLK 116 (162)
T ss_dssp TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHH-HHTTCC
T ss_pred hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhh-hhhccc
Confidence 33344444444444332 334444556677777777777765532 33445555666666666555433321 122234
Q ss_pred cCEEEccCCccc
Q 002021 251 LEILSLWGNNFS 262 (979)
Q Consensus 251 L~~L~L~~N~l~ 262 (979)
|+.|++++|.+.
T Consensus 117 L~~L~L~~Npl~ 128 (162)
T d1koha1 117 LEELWLDGNSLS 128 (162)
T ss_dssp CSSCCCTTSTTS
T ss_pred cceeecCCCCcC
Confidence 455555555444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=6.1e-07 Score=92.31 Aligned_cols=149 Identities=15% Similarity=0.098 Sum_probs=103.9
Q ss_pred HHHHhhCCCCCCceeeeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeE
Q 002021 676 ELCRATDGFSENNLIGRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKA 754 (979)
Q Consensus 676 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 754 (979)
++......|+..+..+.++.+.||+.+. ++..++||+...........+.+|+.++..+. +--+.+++++..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445556666555544455578999876 45567888876665555667889999988875 334567788888888999
Q ss_pred EEEEecCCCccceeeccCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 002021 755 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG------------------------------------ 798 (979)
Q Consensus 755 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------ 798 (979)
+|||+++|.++.+..... .....++.++++.++.||..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999998775543221 12334566666667777611
Q ss_pred --------------------CCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 799 --------------------YSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 799 --------------------~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
....++|+|+.|.||++++++.+-++||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 022378999999999999877777999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.98 E-value=1.4e-05 Score=81.32 Aligned_cols=131 Identities=18% Similarity=0.134 Sum_probs=90.5
Q ss_pred eeeeecc-eEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCC--CCeeeEEEeeccCCeeEEEEEecCCCcc
Q 002021 689 LIGRGGF-GSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 689 ~lG~G~~-g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g~L 765 (979)
.+..|.. +.||+.+..++..+++|..... ....+..|++.++.+.. -.+.+++++..+++..++||||++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 6899998878888899976533 34567889999888743 3356677787888889999999998776
Q ss_pred ceeeccCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 002021 766 EKYLYSSNCILDIFQRLNIMIDVASALEYLHF------------------------------------------------ 797 (979)
Q Consensus 766 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~------------------------------------------------ 797 (979)
.+.. ... ...+.++++.++.||.
T Consensus 94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 5421 111 1223344445555551
Q ss_pred -------CCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 798 -------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 798 -------~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
.....++|+|+.|.||+++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 0123489999999999999887778999987653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.87 E-value=1.8e-06 Score=81.75 Aligned_cols=113 Identities=17% Similarity=0.179 Sum_probs=63.2
Q ss_pred CCCCCCeeeccCC-ccccc----CCccccccCcccEEeccccccccc----CCccccCCCCCcEEEccCCccCchhhhhh
Q 002021 94 NLSSLQSLNLSFN-RLFGS----IPSAIFTTYTLKYVCLRGNQLSGT----FPSFISNKSSLQHLDLSSNALSGEIRANI 164 (979)
Q Consensus 94 ~l~~L~~L~L~~n-~~~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 164 (979)
+.++|++|+|+++ .++.. +-.++....+|++|+|++|.+... +...+...+.|++|+|++|.+++.+...+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4577888888764 45432 233445566677777777777542 22334456777777777777776544333
Q ss_pred hccCCcccCCCCccceeeccccccccc-------ccccccCCCCCCceecCCC
Q 002021 165 CREIPREFGNLPELELMSLAANNLQGK-------IPLKIGNLRNLEKLDIGDN 210 (979)
Q Consensus 165 ~~~ip~~l~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~Ls~N 210 (979)
+ ..+...+.|++|+|++|.+... +...+...++|++|+++.+
T Consensus 93 ~----~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 93 L----RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp H----HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred H----HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 2 3344456666666666654311 2233333455555555544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.62 E-value=1.9e-05 Score=74.34 Aligned_cols=19 Identities=21% Similarity=0.384 Sum_probs=9.8
Q ss_pred cccCCCCccEEEccCCCCc
Q 002021 321 SLSNCKFLKYFDLSYNPLY 339 (979)
Q Consensus 321 ~l~~l~~L~~L~Ls~N~l~ 339 (979)
++...+.|++|+|++|.+.
T Consensus 39 ~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 39 AACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp HHTTCSCCCEEECTTSCCB
T ss_pred HHhhCCccceeeccccccc
Confidence 3444555555555555543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.33 E-value=1.7e-05 Score=74.71 Aligned_cols=114 Identities=17% Similarity=0.170 Sum_probs=53.7
Q ss_pred cCCCCCCeeeccC-Cccccc----CCccccccCcccEEecccccccccC----CccccCCCCCcEEEccCCccCchhhhh
Q 002021 93 GNLSSLQSLNLSF-NRLFGS----IPSAIFTTYTLKYVCLRGNQLSGTF----PSFISNKSSLQHLDLSSNALSGEIRAN 163 (979)
Q Consensus 93 ~~l~~L~~L~L~~-n~~~~~----~p~~~~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 163 (979)
.+.+.|++|+|++ +.++.. +-.++...++|++|+|++|.++... -..+...++++.|++++|.++..+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3456677777776 345422 2233344555666666666554322 223344556666666666665443222
Q ss_pred hhccCCcccCCCCccceeec--ccccccc----cccccccCCCCCCceecCCC
Q 002021 164 ICREIPREFGNLPELELMSL--AANNLQG----KIPLKIGNLRNLEKLDIGDN 210 (979)
Q Consensus 164 ~~~~ip~~l~~l~~L~~L~L--~~N~l~~----~~p~~~~~l~~L~~L~Ls~N 210 (979)
+-..+...+.|+.++| +.|.+.. .+...+...++|++|+++.+
T Consensus 94 ----l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 94 ----LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp ----HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred ----HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 2233344455554333 3344432 22223334445555555443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.27 E-value=0.00028 Score=76.14 Aligned_cols=77 Identities=17% Similarity=0.198 Sum_probs=49.1
Q ss_pred CceeeeecceEEEEEEcC-CCcEEEEEEecccc-------ccchhcHHHHHHHHHhcC-C-C-CeeeEEEeeccCCeeEE
Q 002021 687 NNLIGRGGFGSVYKASLG-DGMEVAVKVFTSQC-------GRAFKSFDVECEIMKSIR-H-R-NLIKVISSCSNEEFKAL 755 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~l 755 (979)
.+.||.|....||+++.. +++.|+||.-.+.. .....+...|++.++.+. + | .+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 356899999999999764 46789999653221 112344567888888763 2 3 34455554 3445679
Q ss_pred EEEecCCCcc
Q 002021 756 VLEYMPHGSL 765 (979)
Q Consensus 756 v~E~~~~g~L 765 (979)
||||+++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.15 E-value=3.7e-05 Score=72.31 Aligned_cols=68 Identities=7% Similarity=0.111 Sum_probs=32.7
Q ss_pred ccCcccEEeccc-cccccc----CCccccCCCCCcEEEccCCccCchhhhhhhccCCcccCCCCccceeeccccccc
Q 002021 118 TTYTLKYVCLRG-NQLSGT----FPSFISNKSSLQHLDLSSNALSGEIRANICREIPREFGNLPELELMSLAANNLQ 189 (979)
Q Consensus 118 ~l~~L~~L~L~~-n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ip~~l~~l~~L~~L~L~~N~l~ 189 (979)
..+.|++|+|++ +.++.. +-..+...++|++|+|++|.++...... +-..+...+.++.+++++|.++
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~----L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA----LAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH----HHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHH----HHHHHhhcccchhhhhcccccc
Confidence 345566666665 344321 2233445566666666666665433222 2222334445555555555543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.98 E-value=0.00088 Score=70.14 Aligned_cols=136 Identities=13% Similarity=0.113 Sum_probs=81.0
Q ss_pred ecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCe--eeEEE-----eeccCCeeEEEEEecCCCcc
Q 002021 693 GGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNL--IKVIS-----SCSNEEFKALVLEYMPHGSL 765 (979)
Q Consensus 693 G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~E~~~~g~L 765 (979)
+.--.||+++..+|+.|++|+.++. ....+++..|.+.+..+....+ +..+. .+...+..+.+++|++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3345899999989999999998654 2345678889999888752222 11111 12345667889999987544
Q ss_pred ceee--------------cc--------CCCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCC
Q 002021 766 EKYL--------------YS--------SNCILDIF----------------------QRLNIMIDVASALEYL-HFGYS 800 (979)
Q Consensus 766 ~~~l--------------~~--------~~~~l~~~----------------------~~~~i~~~ia~~L~~L-H~~~~ 800 (979)
...- +. .+...+.. .....+.++...+.-. .....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 2210 00 01111111 1122233333333222 12235
Q ss_pred CCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 801 APVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 801 ~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
.+++|+|+.+.||+++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 679999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.55 E-value=0.0032 Score=67.70 Aligned_cols=74 Identities=18% Similarity=0.180 Sum_probs=50.5
Q ss_pred CceeeeecceEEEEEEcCC--------CcEEEEEEeccccccchhcHHHHHHHHHhcC-CCCeeeEEEeeccCCeeEEEE
Q 002021 687 NNLIGRGGFGSVYKASLGD--------GMEVAVKVFTSQCGRAFKSFDVECEIMKSIR-HRNLIKVISSCSNEEFKALVL 757 (979)
Q Consensus 687 ~~~lG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 757 (979)
++.|+.|-.-.+|+++..+ .+.|.+++.. .. .......+|..+++.+. +.-..++++++.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3578889999999997543 3567777664 22 22344567999999885 4334477777653 5899
Q ss_pred EecCCCccc
Q 002021 758 EYMPHGSLE 766 (979)
Q Consensus 758 E~~~~g~L~ 766 (979)
||++|.++.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999886553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.40 E-value=0.0047 Score=64.01 Aligned_cols=157 Identities=15% Similarity=0.066 Sum_probs=88.1
Q ss_pred ccHHHHHHhhCCCCCCcee-----eeecceEEEEEEcCCCcEEEEEEeccccccchhcHHHHHHHHHhcCCCCe--eeEE
Q 002021 672 FSYLELCRATDGFSENNLI-----GRGGFGSVYKASLGDGMEVAVKVFTSQCGRAFKSFDVECEIMKSIRHRNL--IKVI 744 (979)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~ 744 (979)
.+.+++......|..++.. ..|---+.|+.+..+|+ +++|++... ...+....|.+++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 4556777777888776544 35666788999876665 899988643 234556667888777742222 1111
Q ss_pred Ee------eccCCeeEEEEEecCCCccceeecc----------------------CCCCC------------------CH
Q 002021 745 SS------CSNEEFKALVLEYMPHGSLEKYLYS----------------------SNCIL------------------DI 778 (979)
Q Consensus 745 ~~------~~~~~~~~lv~E~~~~g~L~~~l~~----------------------~~~~l------------------~~ 778 (979)
.. ....+....++.++.+......-.. ..... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 1224456677777766544321100 00000 00
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCCeEecCCCCCCEEeCCCCcEEEEeeccccc
Q 002021 779 FQRLNIMIDVASALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFSIAKM 831 (979)
Q Consensus 779 ~~~~~i~~~ia~~L~~LH-~~~~~~i~H~Dik~~NIll~~~~~~kl~Dfg~~~~ 831 (979)
......+......+...+ .....|++|+|+.+.||+++.+...-++||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 011122222233333333 23467899999999999999988788999998753
|